Psyllid ID: psy11874
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 767 | 2.2.26 [Sep-21-2011] | |||||||
| P32866 | 714 | G protein-coupled recepto | yes | N/A | 0.384 | 0.413 | 0.828 | 1e-138 | |
| P43249 | 590 | G protein-coupled recepto | yes | N/A | 0.507 | 0.659 | 0.593 | 1e-132 | |
| Q8VEB1 | 590 | G protein-coupled recepto | yes | N/A | 0.504 | 0.655 | 0.582 | 1e-130 | |
| P34947 | 590 | G protein-coupled recepto | yes | N/A | 0.503 | 0.654 | 0.580 | 1e-130 | |
| Q62833 | 590 | G protein-coupled recepto | yes | N/A | 0.507 | 0.659 | 0.581 | 1e-130 | |
| O70291 | 574 | G protein-coupled recepto | no | N/A | 0.507 | 0.677 | 0.567 | 1e-119 | |
| P70507 | 575 | G protein-coupled recepto | no | N/A | 0.513 | 0.685 | 0.568 | 1e-118 | |
| O70293 | 576 | G protein-coupled recepto | no | N/A | 0.494 | 0.657 | 0.553 | 1e-118 | |
| P97711 | 576 | G protein-coupled recepto | no | N/A | 0.460 | 0.612 | 0.542 | 1e-116 | |
| P43250 | 576 | G protein-coupled recepto | no | N/A | 0.498 | 0.663 | 0.561 | 1e-116 |
| >sp|P32866|GPRK2_DROME G protein-coupled receptor kinase 2 OS=Drosophila melanogaster GN=Gprk2 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 494 bits (1272), Expect = e-138, Method: Compositional matrix adjust.
Identities = 246/297 (82%), Positives = 269/297 (90%), Gaps = 2/297 (0%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQ 166
E QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQ
Sbjct: 300 EAQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQ 359
Query: 167 ILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
ILQKINS FVV+LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGF++ RARFYAAEV
Sbjct: 360 ILQKINSPFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFELERARFYAAEV 419
Query: 227 LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPE 286
CGL+HLH G+VYRDCKPENILLDD+GHVRISDLGLAVEIPEGE VRGRVGTVGYMAPE
Sbjct: 420 ACGLQHLHKQGIVYRDCKPENILLDDHGHVRISDLGLAVEIPEGEMVRGRVGTVGYMAPE 479
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346
VIDNEKY +SPDWFSFGCL++EMIEGQAPFR RKE VKR+EVDRRVKED EKYS +F+D+
Sbjct: 480 VIDNEKYAFSPDWFSFGCLLYEMIEGQAPFRMRKEKVKREEVDRRVKEDPEKYSSKFNDE 539
Query: 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST--NWKRLEAGLCDPPFVPD 401
AK++C+ LL KS + RLGC GR G +++ FF ST NW+RLEAG+ +PPFVPD
Sbjct: 540 AKSMCQQLLAKSIKQRLGCRNGRMGGQDVMAHPFFHSTQLNWRRLEAGMLEPPFVPD 596
|
Specifically phosphorylates the activated forms of G protein-coupled receptors (By similarity). Required during oogenesis and embryogenesis; component of a signaling pathway that functions during egg chamber maturation. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1EC: 6 |
| >sp|P43249|GRK5_BOVIN G protein-coupled receptor kinase 5 OS=Bos taurus GN=GRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1216), Expect = e-132, Method: Compositional matrix adjust.
Identities = 254/428 (59%), Positives = 307/428 (71%), Gaps = 39/428 (9%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMFTLALY--------------V 49
D Y + D+QP+GRLLFRQFC E +P Y + FL ++A Y +
Sbjct: 50 DRDYCSLCDKQPVGRLLFRQFC-ETRPGLESY-IQFLD--SVAEYEVTPDEKLGEKGKEI 105
Query: 50 RYSYIIDQQPI-----GRLLFRQFCAE--AKPQYHKYNVFLDSIENYEL---------EM 93
Y+ + P+ GR L Q + KP ++ + S+ +Y M
Sbjct: 106 MTKYLTPKSPVFITQVGRDLVSQTEEKLLQKPCKELFSACVQSVHDYLRGEPFHEYLDSM 165
Query: 94 DENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 153
+R L K + E QP+T TFR YRVLGKGGFGEVCACQVRATGKMYACK+LEKKRIK
Sbjct: 166 YFDRFLQWK--WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK 223
Query: 154 KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG 213
KRKGESM L EKQIL+K+NSRFVV+LAYAYETKDALCLVLTIMNGGDLKFHIYNMG PG
Sbjct: 224 KRKGESMALNEKQILEKVNSRFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PG 282
Query: 214 FDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273
F+ RA FYAAE+LCGLE LH+ +VYRD KPENILLDDYGH+RISDLGLAV+IPEG+ +
Sbjct: 283 FEEERALFYAAEILCGLEDLHHENIVYRDLKPENILLDDYGHIRISDLGLAVKIPEGDLI 342
Query: 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK 333
RGRVGTVGYMAPEV++N++Y SPD++ GCLI+EMIEGQ+PFR RKE VKR+EVDRRV
Sbjct: 343 RGRVGTVGYMAPEVLNNQRYGLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL 402
Query: 334 EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGL 393
E E YS +FS++AK++CK LL K + RLGC GA E+K+ FF++ N+KRLEAG+
Sbjct: 403 ETEEVYSHKFSEEAKSICKMLLTKDAKQRLGCQ--EEGAAEVKRHPFFRNMNFKRLEAGM 460
Query: 394 CDPPFVPD 401
DPPFVPD
Sbjct: 461 LDPPFVPD 468
|
Serine/threonine kinase that phosphorylates preferentially the activated forms of a variety of G-protein-coupled receptors (GPCRs). Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their down-regulation. Phosphorylates a variety of GPCRs, including adrenergic receptors (Beta-2 adrenergic receptor), muscarinic acetylcholine receptors (more specifically Gi-coupled M2/M4 subtypes), dopamine receptors and opioid receptors. In addition to GPCRs, also phosphorylates various substrates: Hsc70-interacting protein/ST13, TP53/p53, HDAC5, and arrestin-1/ARRB1. Phosphorylation of ARRB1 by GRK5 inhibits G-protein independent MAPK1/MAPK3 signaling downstream of 5HT4-receptors. Phosphorylation of HDAC5, a repressor of myocyte enhancer factor 2 (MEF2) leading to nuclear export of HDAC5 and allowing MEF2-mediated transcription. Phosphorylation of TP53/p53, a crucial tumor suppressor, inhibits TP53/p53-mediated apoptosis. Phosphorylation of ST13 regulates internalization of the chemokine receptor. Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor, LRP6 during Wnt signaling (in vitro). Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 6 |
| >sp|Q8VEB1|GRK5_MOUSE G protein-coupled receptor kinase 5 OS=Mus musculus GN=Grk5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 467 bits (1201), Expect = e-130, Method: Compositional matrix adjust.
Identities = 253/434 (58%), Positives = 307/434 (70%), Gaps = 47/434 (10%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMFTLALY--------------V 49
D Y + D+QPIGRLLFRQFC E +P Y + FL + +A Y +
Sbjct: 50 DRDYYSLCDKQPIGRLLFRQFC-ETRPGLECY-IQFLDL--VAEYEITPDENLGAKGKEI 105
Query: 50 RYSYIIDQQPI-----GRLLFRQF---------------CAEAKPQYHKYNVFLDSIENY 89
Y+ + P+ G+ L Q CA++ Y K + F + +++
Sbjct: 106 MTKYLTPKSPVFIAQVGQDLVSQTEKKLLQSPCKELFSACAQSVHDYLKGDPFHEYLDS- 164
Query: 90 ELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK 149
M +R L K + E QP+T TFR YRVLGKGGFGEVCACQVRATGKMYACK+LEK
Sbjct: 165 ---MYFDRFLQWK--WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEK 219
Query: 150 KRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 209
KRIKKRKGESM L EKQIL+K+NS+FVV+LAYAYETKDALCLVLTIMNGGDLKFHIYNMG
Sbjct: 220 KRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 279
Query: 210 GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269
PGF+ RA FYAAE+LCGLE LH VYRD KPENILLDDYGH+RISDLGLAV+IPE
Sbjct: 280 N-PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 338
Query: 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD 329
G+ +RGRVGTVGYMAPEV++N++Y SPD++ GCLI+EMIEGQ+PFR RKE VKR+EVD
Sbjct: 339 GDLIRGRVGTVGYMAPEVLNNQRYGLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD 398
Query: 330 RRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389
RRV E E YS +FS++AK++C LL K + RLGC GA E+K+ FF++ N+KRL
Sbjct: 399 RRVLETEEVYSSKFSEEAKSICNMLLTKDSKQRLGCQ--EEGAAEVKRHPFFRNMNFKRL 456
Query: 390 EAGLCDPPFVPDVK 403
EAG+ DPPFVPD +
Sbjct: 457 EAGMLDPPFVPDPR 470
|
Serine/threonine kinase that phosphorylates preferentially the activated forms of a variety of G-protein-coupled receptors (GPCRs). Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their down-regulation. Phosphorylates a variety of GPCRs, including adrenergic receptors, muscarinic acetylcholine receptors (more specifically Gi-coupled M2/M4 subtypes), dopamine receptors and opioid receptors. In addition to GPCRs, also phosphorylates various substrates: Hsc70-interacting protein/ST13, TP53/p53, HDAC5, and arrestin-1/ARRB1. Phosphorylation of ARRB1 by GRK5 inhibits G-protein independent MAPK1/MAPK3 signaling downstream of 5HT4-receptors. Phosphorylation of HDAC5, a repressor of myocyte enhancer factor 2 (MEF2) leading to nuclear export of HDAC5 and allowing MEF2-mediated transcription. Phosphorylation of TP53/p53, a crucial tumor suppressor, inhibits TP53/p53-mediated apoptosis. Phosphorylation of ST13 regulates internalization of the chemokine receptor. Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor, LRP6 during Wnt signaling (in vitro). Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 6 |
| >sp|P34947|GRK5_HUMAN G protein-coupled receptor kinase 5 OS=Homo sapiens GN=GRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1198), Expect = e-130, Method: Compositional matrix adjust.
Identities = 250/431 (58%), Positives = 302/431 (70%), Gaps = 45/431 (10%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKY---------------------------- 35
D Y + D+QPIGRLLFRQFC E +P Y
Sbjct: 50 DRDYCSLCDKQPIGRLLFRQFC-ETRPGLECYIQFLDSVAEYEVTPDEKLGEKGKEIMTK 108
Query: 36 -----NVLFLAMFTLALYVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYE 90
+ +F+A L + + Q+P L CA++ +Y + F + +++
Sbjct: 109 YLTPKSPVFIAQVGQDLVSQTEEKLLQKPCKELF--SACAQSVHEYLRGEPFHEYLDS-- 164
Query: 91 LEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 150
M +R L K + E QP+T TFR YRVLGKGGFGEVCACQVRATGKMYACK+LEKK
Sbjct: 165 --MFFDRFLQWK--WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKK 220
Query: 151 RIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGG 210
RIKKRKGESM L EKQIL+K+NS+FVV+LAYAYETKDALCLVLTIMNGGDLKFHIYNMG
Sbjct: 221 RIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN 280
Query: 211 EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270
PGF+ RA FYAAE+LCGLE LH VYRD KPENILLDDYGH+RISDLGLAV+IPEG
Sbjct: 281 -PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 339
Query: 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR 330
+ +RGRVGTVGYMAPEV++N++Y SPD++ GCLI+EMIEGQ+PFR RKE VKR+EVDR
Sbjct: 340 DLIRGRVGTVGYMAPEVLNNQRYGLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR 399
Query: 331 RVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLE 390
RV E E YS +FS++AK++CK LL K + RLGC GA E+K+ FF++ N+KRLE
Sbjct: 400 RVLETEEVYSHKFSEEAKSICKMLLTKDAKQRLGCQ--EEGAAEVKRHPFFRNMNFKRLE 457
Query: 391 AGLCDPPFVPD 401
AG+ DPPFVPD
Sbjct: 458 AGMLDPPFVPD 468
|
Serine/threonine kinase that phosphorylates preferentially the activated forms of a variety of G-protein-coupled receptors (GPCRs). Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their down-regulation. Phosphorylates a variety of GPCRs, including adrenergic receptors, muscarinic acetylcholine receptors (more specifically Gi-coupled M2/M4 subtypes), dopamine receptors and opioid receptors. In addition to GPCRs, also phosphorylates various substrates: Hsc70-interacting protein/ST13, TP53/p53, HDAC5, and arrestin-1/ARRB1. Phosphorylation of ARRB1 by GRK5 inhibits G-protein independent MAPK1/MAPK3 signaling downstream of 5HT4-receptors. Phosphorylation of HDAC5, a repressor of myocyte enhancer factor 2 (MEF2) leading to nuclear export of HDAC5 and allowing MEF2-mediated transcription. Phosphorylation of TP53/p53, a crucial tumor suppressor, inhibits TP53/p53-mediated apoptosis. Phosphorylation of ST13 regulates internalization of the chemokine receptor. Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor, LRP6 during Wnt signaling (in vitro). Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 6 |
| >sp|Q62833|GRK5_RAT G protein-coupled receptor kinase 5 OS=Rattus norvegicus GN=Grk5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1198), Expect = e-130, Method: Compositional matrix adjust.
Identities = 251/432 (58%), Positives = 302/432 (69%), Gaps = 43/432 (9%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFC----------------------------AEAKPQYHKY 35
D Y + D+QPIGRLLFRQFC A+ K KY
Sbjct: 50 DRDYYSLCDKQPIGRLLFRQFCETRPGLECYIQFLDLVAEYEITPDENLGAKGKEIMTKY 109
Query: 36 ----NVLFLAMFTLALYVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYEL 91
+ +F+A L + + Q P L CA++ Y K + F + +++
Sbjct: 110 LSPKSPVFIAQVGQDLVSQTEKKLLQSPCKELF--SACAQSVHDYLKGDPFHEYLDS--- 164
Query: 92 EMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR 151
M +R L K + E QP+T TFR YRVLGKGGFGEVCACQVRATGKMYACK+LEKKR
Sbjct: 165 -MYFDRFLQWK--WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR 221
Query: 152 IKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGE 211
IKKRKGESM L EKQIL+K+NS+FVV+LAYAYETKDALCLVLTIMNGGDLKFHIYNMG
Sbjct: 222 IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN- 280
Query: 212 PGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271
PGF+ RA FYAAE+LCGLE LH VYRD KPENILLDDYGH+RISDLGLAV+IPEG+
Sbjct: 281 PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGD 340
Query: 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR 331
+RGRVGTVGYMAPEV++N++Y SPD++ GCLI+EMIEGQ+PFR RKE VKR+EVDRR
Sbjct: 341 LIRGRVGTVGYMAPEVLNNQRYGLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR 400
Query: 332 VKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEA 391
V E E YS +FS++AK++C LL K + RLGC GA E+K+ FF++ N+KRLEA
Sbjct: 401 VLETEEVYSPKFSEEAKSICNMLLTKDSKQRLGCQ--EEGAAEVKRHPFFRNMNFKRLEA 458
Query: 392 GLCDPPFVPDVK 403
G+ DPPFVPD +
Sbjct: 459 GMLDPPFVPDPR 470
|
Serine/threonine kinase that phosphorylates preferentially the activated forms of a variety of G-protein-coupled receptors (GPCRs). Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their down-regulation. Phosphorylates a variety of GPCRs, including adrenergic receptors, muscarinic acetylcholine receptors (more specifically Gi-coupled M2/M4 subtypes), dopamine receptors and opioid receptors. In addition to GPCRs, also phosphorylates various substrates: Hsc70-interacting protein/ST13, TP53/p53, HDAC5, and arrestin-1/ARRB1. Phosphorylation of ARRB1 by GRK5 inhibits G-protein independent MAPK1/MAPK3 signaling downstream of 5HT4-receptors. Phosphorylation of HDAC5, a repressor of myocyte enhancer factor 2 (MEF2) leading to nuclear export of HDAC5 and allowing MEF2-mediated transcription. Phosphorylation of TP53/p53, a crucial tumor suppressor, inhibits TP53/p53-mediated apoptosis. Phosphorylation of ST13 regulates internalization of the chemokine receptor (By similarity). Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor, LRP6 during Wnt signaling (in vitro). Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 6 |
| >sp|O70291|GRK4_MOUSE G protein-coupled receptor kinase 4 OS=Mus musculus GN=Grk4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 429 bits (1102), Expect = e-119, Method: Compositional matrix adjust.
Identities = 240/423 (56%), Positives = 295/423 (69%), Gaps = 34/423 (8%)
Query: 7 YSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAM-------------FTLALYVRYSY 53
+S + D+QPIGRLLFRQFC + KP + A+ F LA++ R+
Sbjct: 52 FSSLCDKQPIGRLLFRQFC-DTKPDLKRCIEFLDAVAEYEVTIEEEQREFGLAIFSRFFK 110
Query: 54 IIDQQPIGRL---LFRQFCAEAKPQYHKYNVFLD------------SIENYELEMDENRR 98
+ P+ + + ++ K NVF + E Y+ NR
Sbjct: 111 EKSEVPLPEIPPDIVKECKWNLKQNSPSQNVFEECAGIVCKYLSETPFEEYQESTYFNRF 170
Query: 99 LSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 158
L K + E +P+T TFR YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE
Sbjct: 171 LQWK--WLERRPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 228
Query: 159 SMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIAR 218
+M L EK+IL+K++SRFVVSLAY YETKDALCLVLTIMNGGDLK+HIYN+G +PGF+ R
Sbjct: 229 AMALNEKRILEKLHSRFVVSLAYTYETKDALCLVLTIMNGGDLKYHIYNLG-DPGFEEPR 287
Query: 219 ARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG 278
A FYAAE+ CGLE L +VYRD KPENILLDD+GH+RISDLGLA+E+PEGE VRGRVG
Sbjct: 288 AVFYAAELCCGLEDLQRKRIVYRDLKPENILLDDHGHIRISDLGLAMEVPEGEMVRGRVG 347
Query: 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK 338
TVGYMAPE+I++EKYT+SPDW+ GCLI+EMI G +PFR+ KE V R+E++RRVK + E+
Sbjct: 348 TVGYMAPEIINHEKYTFSPDWWGLGCLIYEMIAGHSPFRKYKEKVNREELERRVKNETEE 407
Query: 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPF 398
YS RFS+DAK++C LL K P RLGC R G +KQ FK N+ RLEA + DPPF
Sbjct: 408 YSERFSEDAKSICSMLLIKDPSKRLGCQ--RDGVSAVKQHPIFKDINFSRLEANMLDPPF 465
Query: 399 VPD 401
+PD
Sbjct: 466 IPD 468
|
Specifically phosphorylates the activated forms of G protein-coupled receptors. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 6 |
| >sp|P70507|GRK4_RAT G protein-coupled receptor kinase 4 OS=Rattus norvegicus GN=Grk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1097), Expect = e-118, Method: Compositional matrix adjust.
Identities = 248/436 (56%), Positives = 296/436 (67%), Gaps = 42/436 (9%)
Query: 1 MFTDVR------YSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAM------------ 42
M +D+R +S + DQQPIGRLLFRQFC KP K + FL
Sbjct: 40 MCSDLRHSIEKDFSSLCDQQPIGRLLFRQFC-NTKPDL-KRCIEFLDAAAEYEVTIEEEQ 97
Query: 43 --FTLALYVRY---SYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLD------------S 85
F L++Y R+ + + I L ++ K NVF D
Sbjct: 98 REFGLSIYSRFFKENSEVSLPQIPPDLVKECKCNLKQSSPSQNVFQDCAGVIYKYLSEKP 157
Query: 86 IENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACK 145
E Y+ NR L K + E +P+T TFR YRVLGKGGFGEVCACQVRATGKMYACK
Sbjct: 158 FEEYQESTYYNRFLQWK--WLERRPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACK 215
Query: 146 KLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHI 205
KLEKKRIKKRKGE+M L EK+IL+K++SRFVVSLAY YETKDALCLVLTIMNGGDLK+HI
Sbjct: 216 KLEKKRIKKRKGEAMALNEKRILEKLHSRFVVSLAYTYETKDALCLVLTIMNGGDLKYHI 275
Query: 206 YNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265
YN+G PGF+ RA FYAAE+ CGLE L +VYRD KPENILLDD+GH+RISDLGLA+
Sbjct: 276 YNLGN-PGFEEQRAVFYAAELCCGLEDLQRERIVYRDLKPENILLDDHGHIRISDLGLAL 334
Query: 266 EIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKR 325
EIPEGE VRGRVGTVGYMAPE+I +EKYT+SPDW+ GCLI+EMI G +PFR+ KE V R
Sbjct: 335 EIPEGEMVRGRVGTVGYMAPEIISHEKYTFSPDWWGLGCLIYEMIAGHSPFRKYKEKVNR 394
Query: 326 DEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385
+E++RRVK + E+YS RFS++AK++C LL K P RLGC GA +KQ FK N
Sbjct: 395 EEMERRVKTETEEYSERFSENAKSICSMLLTKDPSKRLGCQSD--GASAVKQHPIFKDIN 452
Query: 386 WKRLEAGLCDPPFVPD 401
+ RLEA + DPPF PD
Sbjct: 453 FSRLEANMLDPPFCPD 468
|
Specifically phosphorylates the activated forms of G protein-coupled receptors. Plays an important role in the regulation of renal sodium handling and blood pressure. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 6 |
| >sp|O70293|GRK6_MOUSE G protein-coupled receptor kinase 6 OS=Mus musculus GN=Grk6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1095), Expect = e-118, Method: Compositional matrix adjust.
Identities = 239/432 (55%), Positives = 295/432 (68%), Gaps = 53/432 (12%)
Query: 7 YSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMFTLALYVRYSYIIDQQ--PIGRLL 64
Y + ++QPIGRLLFR+FCA +P+ + + Y D++ GR L
Sbjct: 53 YHSLCERQPIGRLLFREFCA-TRPELTRCTAFLDGV------SEYEVTPDEKRKACGRRL 105
Query: 65 FRQFCAEAKP-----------------------------------QYHKYNVFLDSIENY 89
+ F + P +Y F D +++
Sbjct: 106 MQNFLSHTGPDLIPEVPRQLVSNCAQRLEQGPCKDLFQELTRLTHEYLSTAPFADYLDSI 165
Query: 90 ELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK 149
NR L K + E QP+T TFR YRVLGKGGFGEVCACQVRATGKMYACKKLEK
Sbjct: 166 YF----NRFLQWK--WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEK 219
Query: 150 KRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 209
KRIKKRKGE+M L EKQIL+K+NSRFVVSLAYAYETKDALCLVLT+MNGGDLKFHIY+MG
Sbjct: 220 KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 279
Query: 210 GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269
+ GF ARA FYAAE+ CGLE LH +VYRD KPENILLDD+GH+RISDLGLAV +PE
Sbjct: 280 -QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338
Query: 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD 329
G++++GRVGTVGYMAPEV+ NE+YT+SPDW++ GCL++EMI GQ+PF++RK+ +KR+EV+
Sbjct: 339 GQTIKGRVGTVGYMAPEVVRNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398
Query: 330 RRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389
R VKE AE+Y+ RFS A++LC LL K P RLGC G GARE+K+ FK N+KRL
Sbjct: 399 RLVKEVAEEYTDRFSSQARSLCSQLLSKDPAERLGCRGG--GAREVKEHPLFKKLNFKRL 456
Query: 390 EAGLCDPPFVPD 401
AG+ +PPF PD
Sbjct: 457 GAGMLEPPFKPD 468
|
Specifically phosphorylates the activated forms of G protein-coupled receptors. Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their desensitization. Seems to be involved in the desensitization of D2-like dopamin receptors in striatum and chemokine receptor CXCR4 which is critical for CXCL12-induced cell chemotaxis (By similarity). Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor, LRP6 during Wnt signaling (in vitro). Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 6 |
| >sp|P97711|GRK6_RAT G protein-coupled receptor kinase 6 OS=Rattus norvegicus GN=Grk6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 231/426 (54%), Positives = 286/426 (67%), Gaps = 73/426 (17%)
Query: 45 LALYVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRL----- 99
L+L Y + ++QPIGRLLFR+FCA +P+ + FLD + YE+ DE R+
Sbjct: 47 LSLERDYHSLCERQPIGRLLFREFCA-TRPELTRCTAFLDGVAEYEVTPDEKRKACGCRL 105
Query: 100 -------------------------------STKDIYNEIQPITYKTFRM---------- 118
KD++ E+ +T++ M
Sbjct: 106 MQNFLSHTGPDLIPEVPRQLVSNCAQRLEQGPCKDLFQELTRLTHEYLSMAPFADYLDSI 165
Query: 119 -----------------------YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 155
YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR
Sbjct: 166 YFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 225
Query: 156 KGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD 215
KGE+M L EKQIL+K+NSRFVVSLAYAYETKDALCLVLT+MNGGDLKFHIY+M G+ GF
Sbjct: 226 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-GQAGFP 284
Query: 216 IARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG 275
ARA FYAAE+ CGLE LH +VYRD KPENILLDD+GH+RISDLGL V +PEG++++G
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLTVHVPEGQTIKG 344
Query: 276 RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED 335
RVGTVGYMAPEV+ NE+YT+SPDW++ GCL++EMI GQ+PF++RK+ +KR+EV+R VKE
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404
Query: 336 AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCD 395
AE+Y+ RFS A++LC L K P RLGC G GARE+K+ FK N+KRL AG+ +
Sbjct: 405 AEEYTDRFSPQARSLCSQLPNKDPAERLGCRGG--GAREVKEHPLFKKLNFKRLGAGMLE 462
Query: 396 PPFVPD 401
PPF PD
Sbjct: 463 PPFKPD 468
|
Specifically phosphorylates the activated forms of G protein-coupled receptors. Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their desensitization. Seems to be involved in the desensitization of D2-like dopamin receptors in striatum and chemokine receptor CXCR4 which is critical for CXCL12-induced cell chemotaxis (By similarity). Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor: LRP6 during Wnt signaling (in vitro). Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 6 |
| >sp|P43250|GRK6_HUMAN G protein-coupled receptor kinase 6 OS=Homo sapiens GN=GRK6 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 241/429 (56%), Positives = 296/429 (68%), Gaps = 47/429 (10%)
Query: 7 YSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMFTLALYVRYSYIID--QQPIGRLL 64
Y + ++QPIGRLLFR+FCA +P+ + V FL Y D ++ GR L
Sbjct: 53 YHSLCERQPIGRLLFREFCA-TRPELSRC-VAFLDGV-----AEYEVTPDDKRKACGRQL 105
Query: 65 FRQFCAEAKPQY--------------------------------HKYNVFLDSIENYELE 92
+ F + P H+Y + + +Y
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEY-LSVAPFADYLDS 164
Query: 93 MDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 152
+ NR L K + E QP+T TFR YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI
Sbjct: 165 IYFNRFLQWK--WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 222
Query: 153 KKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEP 212
KKRKGE+M L EKQIL+K+NSRFVVSLAYAYETKDALCLVLT+MNGGDLKFHIY+MG +
Sbjct: 223 KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-QA 281
Query: 213 GFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272
GF ARA FYAAE+ CGLE LH +VYRD KPENILLDD+GH+RISDLGLAV +PEG++
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341
Query: 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV 332
++GRVGTVGYMAPEV+ NE+YT+SPDW++ GCL++EMI GQ+PF++RK+ +KR+EV+R V
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 401
Query: 333 KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAG 392
KE E+YS RFS A++LC LL K P RLGC G ARE+K+ FK N+KRL AG
Sbjct: 402 KEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGG--SAREVKEHPLFKKLNFKRLGAG 459
Query: 393 LCDPPFVPD 401
+ +PPF PD
Sbjct: 460 MLEPPFKPD 468
|
Specifically phosphorylates the activated forms of G protein-coupled receptors. Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their desensitization. Seems to be involved in the desensitization of D2-like dopamin receptors in striatum and chemokine receptor CXCR4 which is critical for CXCL12-induced cell chemotaxis (By similarity). Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor: LRP6 during Wnt signaling (in vitro). Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 6 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 767 | ||||||
| 307203847 | 574 | G protein-coupled receptor kinase 2 [Har | 0.503 | 0.672 | 0.668 | 1e-156 | |
| 156537339 | 591 | PREDICTED: G protein-coupled receptor ki | 0.504 | 0.654 | 0.667 | 1e-156 | |
| 307177632 | 695 | G protein-coupled receptor kinase 2 [Cam | 0.511 | 0.564 | 0.674 | 1e-154 | |
| 270013096 | 534 | hypothetical protein TcasGA2_TC011652 [T | 0.460 | 0.661 | 0.742 | 1e-153 | |
| 322789870 | 471 | hypothetical protein SINV_15381 [Solenop | 0.508 | 0.828 | 0.673 | 1e-153 | |
| 350425946 | 591 | PREDICTED: G protein-coupled receptor ki | 0.501 | 0.651 | 0.657 | 1e-153 | |
| 340726422 | 585 | PREDICTED: LOW QUALITY PROTEIN: G protei | 0.501 | 0.658 | 0.657 | 1e-153 | |
| 383851812 | 604 | PREDICTED: G protein-coupled receptor ki | 0.462 | 0.587 | 0.671 | 1e-150 | |
| 193669324 | 589 | PREDICTED: G protein-coupled receptor ki | 0.513 | 0.668 | 0.694 | 1e-150 | |
| 328779954 | 591 | PREDICTED: G protein-coupled receptor ki | 0.462 | 0.600 | 0.669 | 1e-150 |
| >gi|307203847|gb|EFN82783.1| G protein-coupled receptor kinase 2 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1442), Expect = e-156, Method: Compositional matrix adjust.
Identities = 290/434 (66%), Positives = 335/434 (77%), Gaps = 48/434 (11%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMFTLALYVRYSYIIDQQ--PIG 61
D+RYSY++DQQPIGRLLFRQFC + KP YH+YN+ AM +Y +D+ +
Sbjct: 33 DIRYSYVVDQQPIGRLLFRQFCQDRKPTYHRYNLFLDAM------EKYEIEMDENRTELA 86
Query: 62 RLLFRQFCAEAKPQYHKYNVFLDSIENYE-LEMDENRRLSTKDIYNEI------------ 108
+ LF Q+ + +D + + + L+ +E K++Y E+
Sbjct: 87 KELFEQYLKREDSE------VIDILNDSQILQCEERLSTGAKELYVEVAQTVKNFLAGLP 140
Query: 109 ---------------------QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL 147
QP+TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL
Sbjct: 141 FTLFLNSFYFYRYLQWKWLEAQPVTYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL 200
Query: 148 EKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN 207
EKKRIKKRKGESMVLIEK ILQKINS+FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN
Sbjct: 201 EKKRIKKRKGESMVLIEKNILQKINSKFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN 260
Query: 208 MGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267
MGGEPGFDI RARFYAAEV+CGLEHLH G+VYRDCKPENILLDD+GHVRISDLGLAVEI
Sbjct: 261 MGGEPGFDINRARFYAAEVVCGLEHLHLQGIVYRDCKPENILLDDHGHVRISDLGLAVEI 320
Query: 268 PEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDE 327
EG+ VRGRVGTVGYMAPEVIDNEKYT+SPDWFSFGCL++EMIEGQAPFR RKE VKR+E
Sbjct: 321 TEGDMVRGRVGTVGYMAPEVIDNEKYTFSPDWFSFGCLLYEMIEGQAPFRARKEKVKREE 380
Query: 328 VDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387
VDRRVKED E+YS +FS+DAK+LC+ LLKKSP+SRLGC CGR+GA+E+K FF+ NWK
Sbjct: 381 VDRRVKEDQERYSSKFSEDAKSLCQQLLKKSPKSRLGCKCGRHGAKEVKLHGFFQCLNWK 440
Query: 388 RLEAGLCDPPFVPD 401
R+EAG+ +PPFVPD
Sbjct: 441 RVEAGMWEPPFVPD 454
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156537339|ref|XP_001606366.1| PREDICTED: G protein-coupled receptor kinase 2-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1438), Expect = e-156, Method: Compositional matrix adjust.
Identities = 289/433 (66%), Positives = 336/433 (77%), Gaps = 46/433 (10%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMFTLALYVRYSYIIDQQ--PIG 61
D+RYSY++DQQPIGRLLFRQ+C + KP YH+YN+ A+ +Y +D+ +
Sbjct: 50 DIRYSYVVDQQPIGRLLFRQYCQDKKPAYHRYNLFLDAI------EKYEVEMDENRTEMA 103
Query: 62 RLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEI------------- 108
+LLF Q+ + ++ DS+ + +E + K+I+ EI
Sbjct: 104 KLLFEQYLKREGSEV--VDILNDSLIT---QCEERLGSAGKEIFVEIAQTVKNFLAGEPF 158
Query: 109 --------------------QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLE 148
QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLE
Sbjct: 159 AAFLTTFYFYRYLQWKWLEAQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLE 218
Query: 149 KKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM 208
KKRIKKRKGE+MVLIEK ILQKINS+FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM
Sbjct: 219 KKRIKKRKGEAMVLIEKNILQKINSKFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM 278
Query: 209 GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268
GGEPGFDI RARFYAAEV+CGLEHLH G+VYRDCKPENILLDD+GHVRISDLGLAVEI
Sbjct: 279 GGEPGFDINRARFYAAEVVCGLEHLHLQGIVYRDCKPENILLDDHGHVRISDLGLAVEIT 338
Query: 269 EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEV 328
EG+ VRGRVGTVGYMAPEVIDNEKYT+SPDWFSFGCL++EMIEGQAPFR RKE VKRDEV
Sbjct: 339 EGDMVRGRVGTVGYMAPEVIDNEKYTFSPDWFSFGCLLYEMIEGQAPFRARKEKVKRDEV 398
Query: 329 DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388
DRRVKED EKYS +F+++AK+LC+ LLKKSP+SRLGC CGR+GA+E+K FF+ NWKR
Sbjct: 399 DRRVKEDQEKYSHKFTEEAKSLCQQLLKKSPKSRLGCKCGRHGAKEVKLHNFFQCLNWKR 458
Query: 389 LEAGLCDPPFVPD 401
+EAG+ +PPF+PD
Sbjct: 459 VEAGMWEPPFIPD 471
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307177632|gb|EFN66691.1| G protein-coupled receptor kinase 2 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1425), Expect = e-154, Method: Compositional matrix adjust.
Identities = 288/427 (67%), Positives = 333/427 (77%), Gaps = 35/427 (8%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMFTLALYVRYSYIIDQQPIGRL 63
D+RY Y++DQQPIGRLLFRQFC + KP YH+YN+ A+ +Y +D+ I R
Sbjct: 155 DIRYGYVVDQQPIGRLLFRQFCQDKKPAYHRYNLFLDAI------EKYEIELDENRIERA 208
Query: 64 --LFRQFCAEAKPQYHKYNVFL--------------------DSIENYELEMDENRRLST 101
LF Q+ E+ N L +++N+ + L++
Sbjct: 209 KELFEQYLRESSEVVDILNDSLISQCEERLSTGGKELFVEVAQTVKNFLASEPFSAFLNS 268
Query: 102 KDIYN-------EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 154
Y E QP+TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK
Sbjct: 269 FYFYRYLQWKWLEAQPVTYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 328
Query: 155 RKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGF 214
RKGESMVLIEK ILQKINS+FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGG+PGF
Sbjct: 329 RKGESMVLIEKNILQKINSKFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGDPGF 388
Query: 215 DIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274
DI RARFYAAEV+CGLEHLH G+VYRDCKPENILLDD+GHVRISDLGLAVEI EG+ VR
Sbjct: 389 DINRARFYAAEVVCGLEHLHLQGIVYRDCKPENILLDDHGHVRISDLGLAVEITEGDMVR 448
Query: 275 GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE 334
GRVGTVGYMAPEVIDNEKYT+SPDWFSFGCL++EMIEGQAPFR RKE VKR+EVDRRVKE
Sbjct: 449 GRVGTVGYMAPEVIDNEKYTFSPDWFSFGCLLYEMIEGQAPFRARKEKVKREEVDRRVKE 508
Query: 335 DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLC 394
D E+YS +FS+DA++LC+ LLKKSP++RLGC CGR+GA+E+K FF+ NWKR+EAG+
Sbjct: 509 DQERYSPKFSEDARSLCQQLLKKSPKNRLGCKCGRHGAKEVKLHGFFQCLNWKRVEAGMW 568
Query: 395 DPPFVPD 401
+PPFVPD
Sbjct: 569 EPPFVPD 575
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270013096|gb|EFA09544.1| hypothetical protein TcasGA2_TC011652 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 549 bits (1415), Expect = e-153, Method: Compositional matrix adjust.
Identities = 277/373 (74%), Positives = 308/373 (82%), Gaps = 20/373 (5%)
Query: 49 VRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDI---- 104
VRY Y++DQQPIG+LLF Q+C + +YH+ FLD + YE+E DE R I
Sbjct: 51 VRYEYVVDQQPIGKLLFEQWCEVKRHEYHRCVKFLDIAKRYEVETDEQRLELANAIKKNS 110
Query: 105 ----------------YNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLE 148
+ E QP+TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLE
Sbjct: 111 WEFTNSMYFHRYLQWKWLEAQPVTYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLE 170
Query: 149 KKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM 208
KKRIKKRKGE+MVLIEKQILQKINSRFVV+LAYAYETKDALCLVLTIMNGGDLKFHIYNM
Sbjct: 171 KKRIKKRKGEAMVLIEKQILQKINSRFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM 230
Query: 209 GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268
GGEPG DIARARFYAAEV+CGL+HLH G+VYRDCKPENILLDD GHVRISDLGLAV+IP
Sbjct: 231 GGEPGLDIARARFYAAEVVCGLDHLHQQGIVYRDCKPENILLDDAGHVRISDLGLAVDIP 290
Query: 269 EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEV 328
EGE VRGRVGTVGYMAPEVIDNE+YT+SPDWFSFGCL++EMIEGQAPFR RKE VKR+EV
Sbjct: 291 EGEFVRGRVGTVGYMAPEVIDNERYTFSPDWFSFGCLLYEMIEGQAPFRARKEKVKREEV 350
Query: 329 DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388
DRRVK D EKYS +FS+DAK+LC+ LL KSP RLG GRYGA +KQ FF+S NW+R
Sbjct: 351 DRRVKSDQEKYSSKFSEDAKSLCQQLLAKSPAQRLGGKAGRYGAAVVKQHAFFQSLNWRR 410
Query: 389 LEAGLCDPPFVPD 401
LEAG+ +PPFVPD
Sbjct: 411 LEAGMVEPPFVPD 423
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|322789870|gb|EFZ15017.1| hypothetical protein SINV_15381 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 549 bits (1414), Expect = e-153, Method: Compositional matrix adjust.
Identities = 291/432 (67%), Positives = 329/432 (76%), Gaps = 42/432 (9%)
Query: 3 TDVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLA------------------MFT 44
TD++Y Y++DQQPIGRLLFRQFC + KP YH+YN+ A +F
Sbjct: 2 TDIKYGYVVDQQPIGRLLFRQFCQDKKPAYHRYNLFLDAIEKYEIELDENRLDLAKELFE 61
Query: 45 LALYVRYSYIID-------------QQPIGRLLFRQFCAEAKP--QYHKYNVFLDSIENY 89
L S +ID G+ LF + K ++ FL S Y
Sbjct: 62 QYLKREGSEVIDILNDSLISQCEERLSTGGKELFTEVAQTVKNFLAGEPFSAFLSSFYFY 121
Query: 90 ELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK 149
R L K + E QP+TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK
Sbjct: 122 -------RYLQWK--WLEAQPVTYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK 172
Query: 150 KRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 209
KRIKKRKGESMVLIEK ILQKINS+FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG
Sbjct: 173 KRIKKRKGESMVLIEKNILQKINSKFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 232
Query: 210 GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269
GEPGFDI RARFYAAEV+CGLEHLH G+VYRDCKPENILLDD+GHVRISDLGLAVEI E
Sbjct: 233 GEPGFDINRARFYAAEVVCGLEHLHLQGIVYRDCKPENILLDDHGHVRISDLGLAVEITE 292
Query: 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD 329
G+ VRGRVGTVGYMAPEVIDNEKYT+SPDWFSFGCL++EMIEGQAPFR RKE VKR+EVD
Sbjct: 293 GDMVRGRVGTVGYMAPEVIDNEKYTFSPDWFSFGCLLYEMIEGQAPFRARKEKVKREEVD 352
Query: 330 RRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389
RRVKED E+YS +FS+DAK LC+ LLKKSP++RLGC C R+GA+++K FF+ NWKR+
Sbjct: 353 RRVKEDQERYSPKFSEDAKNLCQQLLKKSPKNRLGCKCRRHGAKDVKLHSFFQCLNWKRV 412
Query: 390 EAGLCDPPFVPD 401
EAG+ +PPFVPD
Sbjct: 413 EAGMWEPPFVPD 424
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350425946|ref|XP_003494283.1| PREDICTED: G protein-coupled receptor kinase 2-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1412), Expect = e-153, Method: Compositional matrix adjust.
Identities = 286/435 (65%), Positives = 331/435 (76%), Gaps = 50/435 (11%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMFTLALYVRYSYIIDQQ--PIG 61
D+RYSY++DQQPIGRLLFRQFC + KP YH+YN+ A+ +Y +D+ +
Sbjct: 50 DIRYSYVVDQQPIGRLLFRQFCQDKKPSYHRYNLFLDAI------EKYEIEMDENRTELA 103
Query: 62 RLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLST--KDIYNEI----------- 108
+ LF Q+ + + I N L RL T K+++ EI
Sbjct: 104 KDLFEQYLKREGSE-------VVDILNDSLIAQCEERLGTGGKELFVEIAQTVKNFLAGE 156
Query: 109 ----------------------QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK 146
QP+TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK
Sbjct: 157 PFSAFQTSFYFYRYLQWKWLEAQPVTYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK 216
Query: 147 LEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY 206
LEKKRIKKRKGE+MVLIEK ILQKINS+FVVSLAYAYETKDALCLVLTIMNGGDLKFHIY
Sbjct: 217 LEKKRIKKRKGEAMVLIEKNILQKINSKFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY 276
Query: 207 NMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266
NMGGEPGFDI RARFYAAEV+CGLEHLH G+VYRDCKPENILLDD+GHVRISDLGLAVE
Sbjct: 277 NMGGEPGFDINRARFYAAEVVCGLEHLHLQGIVYRDCKPENILLDDHGHVRISDLGLAVE 336
Query: 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD 326
I EG+ V GRVGTVGYMAPEVIDNEKYT+SPDWFSFGCL++EMIEGQAPFR RKE VKR+
Sbjct: 337 ITEGDMVTGRVGTVGYMAPEVIDNEKYTFSPDWFSFGCLLYEMIEGQAPFRARKEKVKRE 396
Query: 327 EVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386
EVDRRVKED E+YS +F+++AK+LC+ LLKKSP++RLGC CGR+GA+E+K FF+ NW
Sbjct: 397 EVDRRVKEDQERYSTKFTEEAKSLCQQLLKKSPKNRLGCKCGRHGAKEVKLHSFFQCLNW 456
Query: 387 KRLEAGLCDPPFVPD 401
KR+E G+ +PPFVPD
Sbjct: 457 KRVEVGMWEPPFVPD 471
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340726422|ref|XP_003401557.1| PREDICTED: LOW QUALITY PROTEIN: G protein-coupled receptor kinase 2-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 547 bits (1410), Expect = e-153, Method: Compositional matrix adjust.
Identities = 286/435 (65%), Positives = 331/435 (76%), Gaps = 50/435 (11%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMFTLALYVRYSYIIDQQ--PIG 61
D+RYSY++DQQPIGRLLFRQFC + KP YH+YN+ A+ +Y +D+ +
Sbjct: 44 DIRYSYVVDQQPIGRLLFRQFCQDKKPSYHRYNLFLDAI------EKYEIEMDENRTELA 97
Query: 62 RLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLST--KDIYNEI----------- 108
+ LF Q+ + + I N L RL T K+++ EI
Sbjct: 98 KDLFEQYLKREGSE-------VVDILNDSLIAQCEERLGTGGKELFVEIAQTVKNFLAGE 150
Query: 109 ----------------------QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK 146
QP+TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK
Sbjct: 151 PFSAFQTSFYFYRYLQWKWLEAQPVTYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK 210
Query: 147 LEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY 206
LEKKRIKKRKGE+MVLIEK ILQKINS+FVVSLAYAYETKDALCLVLTIMNGGDLKFHIY
Sbjct: 211 LEKKRIKKRKGEAMVLIEKNILQKINSKFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY 270
Query: 207 NMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266
NMGGEPGFDI RARFYAAEV+CGLEHLH G+VYRDCKPENILLDD+GHVRISDLGLAVE
Sbjct: 271 NMGGEPGFDINRARFYAAEVVCGLEHLHLQGIVYRDCKPENILLDDHGHVRISDLGLAVE 330
Query: 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD 326
I EG+ V GRVGTVGYMAPEVIDNEKYT+SPDWFSFGCL++EMIEGQAPFR RKE VKR+
Sbjct: 331 ITEGDMVTGRVGTVGYMAPEVIDNEKYTFSPDWFSFGCLLYEMIEGQAPFRARKEKVKRE 390
Query: 327 EVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386
EVDRRVKED E+YS +F+++AK+LC+ LLKKSP++RLGC CGR+GA+E+K FF+ NW
Sbjct: 391 EVDRRVKEDQERYSTKFTEEAKSLCQQLLKKSPKNRLGCKCGRHGAKEVKLHSFFQCLNW 450
Query: 387 KRLEAGLCDPPFVPD 401
KR+E G+ +PPFVPD
Sbjct: 451 KRVEVGMWEPPFVPD 465
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383851812|ref|XP_003701425.1| PREDICTED: G protein-coupled receptor kinase 2-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 539 bits (1389), Expect = e-150, Method: Compositional matrix adjust.
Identities = 284/423 (67%), Positives = 319/423 (75%), Gaps = 68/423 (16%)
Query: 47 LYVRYSYIIDQQPIGRLLFRQFCAEAKPQYH----------KYNVFLD------------ 84
L +RY Y++DQQPIGRLLFRQFC + KP YH KY + +D
Sbjct: 62 LDIRYGYVVDQQPIGRLLFRQFCQDKKPAYHRYNLFLDAIEKYEIEMDENRIELAKDLFE 121
Query: 85 -----------SIENYELEMDENRRLST--KDIYNEI----------------------- 108
I N L RLST K+++ EI
Sbjct: 122 QYLKSEGSEVVDILNDSLIAQCEERLSTGGKELFVEIAQTVKNFLAGEPFSAFQTSFYFY 181
Query: 109 ----------QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 158
QP+TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE
Sbjct: 182 RYLQWKWLEAQPVTYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 241
Query: 159 SMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIAR 218
+MVLIEK ILQKINS+FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDI R
Sbjct: 242 AMVLIEKNILQKINSKFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDINR 301
Query: 219 ARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG 278
ARFYAAEV+CGLEHLH G+VYRDCKPENILLDD+GHVRISDLGLAVEI EG+ VRGRVG
Sbjct: 302 ARFYAAEVVCGLEHLHLQGIVYRDCKPENILLDDHGHVRISDLGLAVEITEGDMVRGRVG 361
Query: 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK 338
TVGYMAPEVIDNEKYT+SPDWFSFGCL++EMIEGQAPFR RKE VKR+EVDRRVKED E+
Sbjct: 362 TVGYMAPEVIDNEKYTFSPDWFSFGCLLYEMIEGQAPFRARKEKVKREEVDRRVKEDQER 421
Query: 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPF 398
YS +F+++AK+LC+ LLKKSP+SRLGC CGR+GA+E+K FF+ NWKR+EAG+ +PPF
Sbjct: 422 YSTKFTEEAKSLCQQLLKKSPKSRLGCKCGRHGAKEVKLHSFFQCLNWKRVEAGMWEPPF 481
Query: 399 VPD 401
VPD
Sbjct: 482 VPD 484
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|193669324|ref|XP_001944864.1| PREDICTED: G protein-coupled receptor kinase 2-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1386), Expect = e-150, Method: Compositional matrix adjust.
Identities = 296/426 (69%), Positives = 330/426 (77%), Gaps = 32/426 (7%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLF----------------LAMFTLAL 47
D++YSYIIDQQPIGRLLF QFC E + ++H+YNV LA
Sbjct: 50 DMKYSYIIDQQPIGRLLFLQFCEEERHEFHRYNVFLDSIEKYEIESDENRIELAKILYDR 109
Query: 48 YVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLD------------SIENYELEMDE 95
Y+R + + + + C H+ +F D +E M
Sbjct: 110 YIRRDAVNAVDVLSEDMIVR-CRHQLDSAHR-ELFTDCSTAVKSFLAGRPFSLFESSMYF 167
Query: 96 NRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 155
+R L K + E Q +TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR
Sbjct: 168 HRYLQWK--WLERQTVTYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 225
Query: 156 KGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD 215
KGE+MVLIEKQILQKINS+FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG EPGFD
Sbjct: 226 KGEAMVLIEKQILQKINSKFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGSEPGFD 285
Query: 216 IARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG 275
I+R+RFYAAEVLCGLEHLH G+VYRDCKPENILLDD GHVRISDLGLA+EIPEGESVRG
Sbjct: 286 ISRSRFYAAEVLCGLEHLHVQGIVYRDCKPENILLDDAGHVRISDLGLAMEIPEGESVRG 345
Query: 276 RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED 335
RVGTVGYMAPEVIDNEKYTYS DWFSFGCL+FEMIEGQAPFR RKE VKR+ VDRRVKE+
Sbjct: 346 RVGTVGYMAPEVIDNEKYTYSTDWFSFGCLVFEMIEGQAPFRARKEKVKREVVDRRVKEE 405
Query: 336 AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCD 395
EKYS +F+D+AK LCK LLKKSP+SRLGCH GRYGARE+KQ EFFK+ NWKRLEAG+ D
Sbjct: 406 QEKYSQKFTDEAKLLCKQLLKKSPKSRLGCHFGRYGAREVKQHEFFKTINWKRLEAGVED 465
Query: 396 PPFVPD 401
PPF+PD
Sbjct: 466 PPFLPD 471
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328779954|ref|XP_394109.3| PREDICTED: G protein-coupled receptor kinase 2 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1386), Expect = e-150, Method: Compositional matrix adjust.
Identities = 283/423 (66%), Positives = 319/423 (75%), Gaps = 68/423 (16%)
Query: 47 LYVRYSYIIDQQPIGRLLFRQFCAEAKPQYH----------KYNVFLD------------ 84
L +RYSY++DQQPIGRLLFRQFC + KP YH KY + +D
Sbjct: 49 LDIRYSYVVDQQPIGRLLFRQFCQDKKPSYHRYNLFLDAIEKYEIEMDENRTELAKDLFE 108
Query: 85 -----------SIENYELEMDENRRLST--KDIYNEI----------------------- 108
I N L RLST K+++ EI
Sbjct: 109 QYLKREGSEVVDILNDSLIAQCEERLSTGGKELFVEIAQTVKNFLAGEPFSAFQTSFYFY 168
Query: 109 ----------QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 158
QP+TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE
Sbjct: 169 RYLQWKWLEAQPVTYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 228
Query: 159 SMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIAR 218
+MVLIEK ILQKINS+FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDI R
Sbjct: 229 AMVLIEKNILQKINSKFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDINR 288
Query: 219 ARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG 278
ARFYAAEV+CGLEHLH G+VYRDCKPENILLDD+GHVRISDLGLAVEI EG+ V GRVG
Sbjct: 289 ARFYAAEVVCGLEHLHLQGIVYRDCKPENILLDDHGHVRISDLGLAVEITEGDMVTGRVG 348
Query: 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK 338
TVGYMAPEVIDNEKYT+SPDWFSFGCL++EMIEGQAPFR RKE VKR+EVDRRVKED E+
Sbjct: 349 TVGYMAPEVIDNEKYTFSPDWFSFGCLLYEMIEGQAPFRARKEKVKREEVDRRVKEDQER 408
Query: 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPF 398
YS +F+++AK+LC+ LLKKSP++RLGC CGR+GA+E+K FF+ NWKR+EAG+ +PPF
Sbjct: 409 YSAKFTEEAKSLCQQLLKKSPKNRLGCKCGRHGAKEVKLHNFFQCLNWKRVEAGMWEPPF 468
Query: 399 VPD 401
VPD
Sbjct: 469 VPD 471
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 767 | ||||||
| FB|FBgn0261988 | 714 | Gprk2 "G protein-coupled recep | 0.411 | 0.442 | 0.728 | 3.8e-171 | |
| UNIPROTKB|E1BQG4 | 592 | GRK5 "Uncharacterized protein" | 0.408 | 0.528 | 0.660 | 1.3e-147 | |
| MGI|MGI:109161 | 590 | Grk5 "G protein-coupled recept | 0.422 | 0.549 | 0.627 | 2.1e-147 | |
| RGD|61985 | 590 | Grk5 "G protein-coupled recept | 0.422 | 0.549 | 0.627 | 3.4e-147 | |
| UNIPROTKB|Q66HL7 | 590 | Grk5 "G protein-coupled recept | 0.422 | 0.549 | 0.627 | 3.4e-147 | |
| UNIPROTKB|P43249 | 590 | GRK5 "G protein-coupled recept | 0.380 | 0.494 | 0.681 | 3e-146 | |
| UNIPROTKB|E2RBX1 | 590 | GRK5 "Uncharacterized protein" | 0.435 | 0.566 | 0.617 | 9.1e-143 | |
| UNIPROTKB|P34947 | 590 | GRK5 "G protein-coupled recept | 0.435 | 0.566 | 0.611 | 2.4e-142 | |
| UNIPROTKB|Q5ZKL2 | 569 | GRK4 "Uncharacterized protein" | 0.415 | 0.560 | 0.643 | 3.1e-142 | |
| UNIPROTKB|F1S417 | 590 | GRK5 "Uncharacterized protein" | 0.435 | 0.566 | 0.608 | 6.3e-142 |
| FB|FBgn0261988 Gprk2 "G protein-coupled receptor kinase 2" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1208 (430.3 bits), Expect = 3.8e-171, Sum P(4) = 3.8e-171
Identities = 233/320 (72%), Positives = 257/320 (80%)
Query: 84 DSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYA 143
+ +E M +R L K + E QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYA
Sbjct: 279 EPFREFESSMYFHRYLQWK--WLEAQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYA 336
Query: 144 CXXXXXXXXXXXXGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKF 203
C GESMVLIEKQILQKINS FVV+LAYAYETKDALCLVLTIMNGGDLKF
Sbjct: 337 CKKLEKKRIKKRKGESMVLIEKQILQKINSPFVVNLAYAYETKDALCLVLTIMNGGDLKF 396
Query: 204 HIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263
HIYNMGGEPGF++ RARFYAAEV CGL+HLH G+VYRDCKPENILLDD+GHVRISDLGL
Sbjct: 397 HIYNMGGEPGFELERARFYAAEVACGLQHLHKQGIVYRDCKPENILLDDHGHVRISDLGL 456
Query: 264 AVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV 323
AVEIPEGE VRGRVGTVGYMAPEVIDNEKY +SPDWFSFGCL++EMIEGQAPFR RKE V
Sbjct: 457 AVEIPEGEMVRGRVGTVGYMAPEVIDNEKYAFSPDWFSFGCLLYEMIEGQAPFRMRKEKV 516
Query: 324 KRDEVDRRVKEDAEKYSCRFSDDXXXXXXXXXXXSPRSRLGCHCGRYGARELKQAEFFKS 383
KR+EVDRRVKED EKYS +F+D+ S + RLGC GR G +++ FF S
Sbjct: 517 KREEVDRRVKEDPEKYSSKFNDEAKSMCQQLLAKSIKQRLGCRNGRMGGQDVMAHPFFHS 576
Query: 384 T--NWKRLEAGLCDPPFVPD 401
T NW+RLEAG+ +PPFVPD
Sbjct: 577 TQLNWRRLEAGMLEPPFVPD 596
|
|
| UNIPROTKB|E1BQG4 GRK5 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1052 (375.4 bits), Expect = 1.3e-147, Sum P(3) = 1.3e-147
Identities = 210/318 (66%), Positives = 241/318 (75%)
Query: 84 DSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYA 143
+ + Y M +R L K + E QP+T TFR YRVLGKGGFGEVCACQVRATGKMYA
Sbjct: 158 EPFQEYLNSMYFDRFLQWK--WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 215
Query: 144 CXXXXXXXXXXXXGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKF 203
C GESM L EKQIL+K+NS+FVV+LAYAYETKDALCLVLTIMNGGDLKF
Sbjct: 216 CKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKF 275
Query: 204 HIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263
HIYNMG PGF+ RA FYAAE+LCGLE LH VYRD KPENILLDDYGH+RISDLGL
Sbjct: 276 HIYNMGN-PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL 334
Query: 264 AVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV 323
AV+IPEGES+RGRVGTVGYMAPEV++N++YT SPD++ GCLI+EMI GQ+PFR RKE V
Sbjct: 335 AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIAGQSPFRGRKEKV 394
Query: 324 KRDEVDRRVKEDAEKYSCRFSDDXXXXXXXXXXXSPRSRLGCHCGRYGARELKQAEFFKS 383
KR+EVDRRV E E YS +FS++ + RLGC G GA E+K+ FFKS
Sbjct: 395 KREEVDRRVLETEEVYSHKFSEEAKSICKMLLTKDVKQRLGCQ-GE-GATEVKRHPFFKS 452
Query: 384 TNWKRLEAGLCDPPFVPD 401
N+KRLEAG+ DPPFVPD
Sbjct: 453 MNFKRLEAGMLDPPFVPD 470
|
|
| MGI|MGI:109161 Grk5 "G protein-coupled receptor kinase 5" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1044 (372.6 bits), Expect = 2.1e-147, Sum P(3) = 2.1e-147
Identities = 209/333 (62%), Positives = 248/333 (74%)
Query: 69 CAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFG 128
CA++ Y K + F + +++ M +R L K + E QP+T TFR YRVLGKGGFG
Sbjct: 145 CAQSVHDYLKGDPFHEYLDS----MYFDRFLQWK--WLERQPVTKNTFRQYRVLGKGGFG 198
Query: 129 EVCACQVRATGKMYACXXXXXXXXXXXXGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188
EVCACQVRATGKMYAC GESM L EKQIL+K+NS+FVV+LAYAYETKDA
Sbjct: 199 EVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA 258
Query: 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248
LCLVLTIMNGGDLKFHIYNMG PGF+ RA FYAAE+LCGLE LH VYRD KPENI
Sbjct: 259 LCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI 317
Query: 249 LLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFE 308
LLDDYGH+RISDLGLAV+IPEG+ +RGRVGTVGYMAPEV++N++Y SPD++ GCLI+E
Sbjct: 318 LLDDYGHIRISDLGLAVKIPEGDLIRGRVGTVGYMAPEVLNNQRYGLSPDYWGLGCLIYE 377
Query: 309 MIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDXXXXXXXXXXXSPRSRLGCHCG 368
MIEGQ+PFR RKE VKR+EVDRRV E E YS +FS++ + RLGC
Sbjct: 378 MIEGQSPFRGRKEKVKREEVDRRVLETEEVYSSKFSEEAKSICNMLLTKDSKQRLGCQ-- 435
Query: 369 RYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
GA E+K+ FF++ N+KRLEAG+ DPPFVPD
Sbjct: 436 EEGAAEVKRHPFFRNMNFKRLEAGMLDPPFVPD 468
|
|
| RGD|61985 Grk5 "G protein-coupled receptor kinase 5" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1042 (371.9 bits), Expect = 3.4e-147, Sum P(3) = 3.4e-147
Identities = 209/333 (62%), Positives = 248/333 (74%)
Query: 69 CAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFG 128
CA++ Y K + F + +++ M +R L K + E QP+T TFR YRVLGKGGFG
Sbjct: 145 CAQSVHDYLKGDPFHEYLDS----MYFDRFLQWK--WLERQPVTKNTFRQYRVLGKGGFG 198
Query: 129 EVCACQVRATGKMYACXXXXXXXXXXXXGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188
EVCACQVRATGKMYAC GESM L EKQIL+K+NS+FVV+LAYAYETKDA
Sbjct: 199 EVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA 258
Query: 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248
LCLVLTIMNGGDLKFHIYNMG PGF+ RA FYAAE+LCGLE LH VYRD KPENI
Sbjct: 259 LCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI 317
Query: 249 LLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFE 308
LLDDYGH+RISDLGLAV+IPEG+ +RGRVGTVGYMAPEV++N++Y SPD++ GCLI+E
Sbjct: 318 LLDDYGHIRISDLGLAVKIPEGDLIRGRVGTVGYMAPEVLNNQRYGLSPDYWGLGCLIYE 377
Query: 309 MIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDXXXXXXXXXXXSPRSRLGCHCG 368
MIEGQ+PFR RKE VKR+EVDRRV E E YS +FS++ + RLGC
Sbjct: 378 MIEGQSPFRGRKEKVKREEVDRRVLETEEVYSPKFSEEAKSICNMLLTKDSKQRLGCQ-- 435
Query: 369 RYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
GA E+K+ FF++ N+KRLEAG+ DPPFVPD
Sbjct: 436 EEGAAEVKRHPFFRNMNFKRLEAGMLDPPFVPD 468
|
|
| UNIPROTKB|Q66HL7 Grk5 "G protein-coupled receptor kinase 5" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1042 (371.9 bits), Expect = 3.4e-147, Sum P(3) = 3.4e-147
Identities = 209/333 (62%), Positives = 248/333 (74%)
Query: 69 CAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFG 128
CA++ Y K + F + +++ M +R L K + E QP+T TFR YRVLGKGGFG
Sbjct: 145 CAQSVHDYLKGDPFHEYLDS----MYFDRFLQWK--WLERQPVTKNTFRQYRVLGKGGFG 198
Query: 129 EVCACQVRATGKMYACXXXXXXXXXXXXGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188
EVCACQVRATGKMYAC GESM L EKQIL+K+NS+FVV+LAYAYETKDA
Sbjct: 199 EVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA 258
Query: 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248
LCLVLTIMNGGDLKFHIYNMG PGF+ RA FYAAE+LCGLE LH VYRD KPENI
Sbjct: 259 LCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI 317
Query: 249 LLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFE 308
LLDDYGH+RISDLGLAV+IPEG+ +RGRVGTVGYMAPEV++N++Y SPD++ GCLI+E
Sbjct: 318 LLDDYGHIRISDLGLAVKIPEGDLIRGRVGTVGYMAPEVLNNQRYGLSPDYWGLGCLIYE 377
Query: 309 MIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDXXXXXXXXXXXSPRSRLGCHCG 368
MIEGQ+PFR RKE VKR+EVDRRV E E YS +FS++ + RLGC
Sbjct: 378 MIEGQSPFRGRKEKVKREEVDRRVLETEEVYSPKFSEEAKSICNMLLTKDSKQRLGCQ-- 435
Query: 369 RYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
GA E+K+ FF++ N+KRLEAG+ DPPFVPD
Sbjct: 436 EEGAAEVKRHPFFRNMNFKRLEAGMLDPPFVPD 468
|
|
| UNIPROTKB|P43249 GRK5 "G protein-coupled receptor kinase 5" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1046 (373.3 bits), Expect = 3.0e-146, Sum P(3) = 3.0e-146
Identities = 201/295 (68%), Positives = 232/295 (78%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACXXXXXXXXXXXXGESMVLIEKQ 166
E QP+T TFR YRVLGKGGFGEVCACQVRATGKMYAC GESM L EKQ
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ 236
Query: 167 ILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
IL+K+NSRFVV+LAYAYETKDALCLVLTIMNGGDLKFHIYNMG PGF+ RA FYAAE+
Sbjct: 237 ILEKVNSRFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEI 295
Query: 227 LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPE 286
LCGLE LH+ +VYRD KPENILLDDYGH+RISDLGLAV+IPEG+ +RGRVGTVGYMAPE
Sbjct: 296 LCGLEDLHHENIVYRDLKPENILLDDYGHIRISDLGLAVKIPEGDLIRGRVGTVGYMAPE 355
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346
V++N++Y SPD++ GCLI+EMIEGQ+PFR RKE VKR+EVDRRV E E YS +FS++
Sbjct: 356 VLNNQRYGLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSHKFSEE 415
Query: 347 XXXXXXXXXXXSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
+ RLGC GA E+K+ FF++ N+KRLEAG+ DPPFVPD
Sbjct: 416 AKSICKMLLTKDAKQRLGCQ--EEGAAEVKRHPFFRNMNFKRLEAGMLDPPFVPD 468
|
|
| UNIPROTKB|E2RBX1 GRK5 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1047 (373.6 bits), Expect = 9.1e-143, Sum P(3) = 9.1e-143
Identities = 213/345 (61%), Positives = 253/345 (73%)
Query: 57 QQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTF 116
Q+P + LF CA++ Y K F + +++ M +R L K + E QP+T TF
Sbjct: 135 QRP-SKELFSA-CAQSVHDYLKGEPFHEYLDS----MYFDRFLQWK--WLERQPVTKNTF 186
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACXXXXXXXXXXXXGESMVLIEKQILQKINSRFV 176
R YRVLGKGGFGEVCACQVRATGKMYAC GESM L EKQIL+K+NS+FV
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFV 246
Query: 177 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI 236
V+LAYAYETKDALCLVLTIMNGGDLKFHIYNMG PGFD RA FYAAE+LCGLE LH
Sbjct: 247 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFDEERALFYAAEILCGLEDLHRE 305
Query: 237 GLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYS 296
VYRD KPENILLDDYGH+RISDLGLAV+IPEG+ +RGRVGTVGYMAPEV++N++Y S
Sbjct: 306 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGDLIRGRVGTVGYMAPEVLNNQRYGLS 365
Query: 297 PDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDXXXXXXXXXX 356
PD++ GCLI+EMIEGQ+PFR RKE VKR+EVDRRV E E YS +FS++
Sbjct: 366 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEETYSQKFSEEAKSICKMLLT 425
Query: 357 XSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
+ RLGC GA E+K+ FF++ N+KRLEAG+ DPPF+PD
Sbjct: 426 KDAKQRLGCR--EEGAAEVKRHPFFRNMNFKRLEAGMLDPPFIPD 468
|
|
| UNIPROTKB|P34947 GRK5 "G protein-coupled receptor kinase 5" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1041 (371.5 bits), Expect = 2.4e-142, Sum P(3) = 2.4e-142
Identities = 211/345 (61%), Positives = 252/345 (73%)
Query: 57 QQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTF 116
Q+P L CA++ +Y + F + +++ M +R L K + E QP+T TF
Sbjct: 135 QKPCKELF--SACAQSVHEYLRGEPFHEYLDS----MFFDRFLQWK--WLERQPVTKNTF 186
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACXXXXXXXXXXXXGESMVLIEKQILQKINSRFV 176
R YRVLGKGGFGEVCACQVRATGKMYAC GESM L EKQIL+K+NS+FV
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFV 246
Query: 177 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI 236
V+LAYAYETKDALCLVLTIMNGGDLKFHIYNMG PGF+ RA FYAAE+LCGLE LH
Sbjct: 247 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE 305
Query: 237 GLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYS 296
VYRD KPENILLDDYGH+RISDLGLAV+IPEG+ +RGRVGTVGYMAPEV++N++Y S
Sbjct: 306 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGDLIRGRVGTVGYMAPEVLNNQRYGLS 365
Query: 297 PDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDXXXXXXXXXX 356
PD++ GCLI+EMIEGQ+PFR RKE VKR+EVDRRV E E YS +FS++
Sbjct: 366 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSHKFSEEAKSICKMLLT 425
Query: 357 XSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
+ RLGC GA E+K+ FF++ N+KRLEAG+ DPPFVPD
Sbjct: 426 KDAKQRLGCQ--EEGAAEVKRHPFFRNMNFKRLEAGMLDPPFVPD 468
|
|
| UNIPROTKB|Q5ZKL2 GRK4 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1043 (372.2 bits), Expect = 3.1e-142, Sum P(3) = 3.1e-142
Identities = 209/325 (64%), Positives = 242/325 (74%)
Query: 77 HKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVR 136
H+Y + E Y+ + +R L K + E QP+T TFR YRVLGKGGFGEVCACQVR
Sbjct: 147 HEY-LSRRPFEAYQESVYFSRFLQWK--WLEKQPVTKHTFRHYRVLGKGGFGEVCACQVR 203
Query: 137 ATGKMYACXXXXXXXXXXXXGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIM 196
ATGKMYAC GESM L EK+IL+K+NSRFVVSL+Y YETKDALCLVLTIM
Sbjct: 204 ATGKMYACKKLEKKRIKKRKGESMALNEKRILEKVNSRFVVSLSYTYETKDALCLVLTIM 263
Query: 197 NGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHV 256
NGGDLKFHIYNMG PGFD RA FYAAE+ CGLE L +VYRD KPENILLDD GH+
Sbjct: 264 NGGDLKFHIYNMGN-PGFDEERAIFYAAELCCGLEDLQKERIVYRDLKPENILLDDCGHI 322
Query: 257 RISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
RISDLGLAV+IPEGE+VRGRVGTVGYMAPEV+ NEKYT+SPDW+ GCLI+EMIEGQ+PF
Sbjct: 323 RISDLGLAVQIPEGETVRGRVGTVGYMAPEVLKNEKYTFSPDWWGLGCLIYEMIEGQSPF 382
Query: 317 RRRKEMVKRDEVDRRVKEDAEKYSCRFSDDXXXXXXXXXXXSPRSRLGCHCGRYGARELK 376
R+ KE VKRDE+DRRVKED E YS +FS++ +P RLGC GA +K
Sbjct: 383 RKHKERVKRDEIDRRVKEDQETYSDKFSEEAKSICRMLLAKNPGERLGCT--ENGAAIVK 440
Query: 377 QAEFFKSTNWKRLEAGLCDPPFVPD 401
Q FK+ N+KRLEA + +PPF+PD
Sbjct: 441 QHPIFKNINFKRLEANMLEPPFLPD 465
|
|
| UNIPROTKB|F1S417 GRK5 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 6.3e-142, Sum P(3) = 6.3e-142
Identities = 210/345 (60%), Positives = 251/345 (72%)
Query: 57 QQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTF 116
Q+P L C ++ +Y + F + +++ M +R L K + E QP+T TF
Sbjct: 135 QKPCKELF--STCVQSVHEYLRGGPFHEYLDS----MYFDRFLQWK--WLERQPVTKTTF 186
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACXXXXXXXXXXXXGESMVLIEKQILQKINSRFV 176
R YRVLGKGGFGEVCACQVRATGKMYAC GESM L EKQIL+K+NS+FV
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFV 246
Query: 177 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI 236
V+LAYAYETKDALCLVLTIMNGGDLKFHIYNMG PGF+ RA FYAAE+LCGLE LH
Sbjct: 247 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE 305
Query: 237 GLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYS 296
VYRD KPENILLDDYGH+RISDLGLAV+IPEG+ +RGRVGTVGYMAPEV++N++Y S
Sbjct: 306 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGDLIRGRVGTVGYMAPEVLNNQRYGLS 365
Query: 297 PDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDXXXXXXXXXX 356
PD++ GCLI+EMIEGQ+PFR RKE VKR+EVDRRV E E YS +FS++
Sbjct: 366 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSHKFSEEAKSICKMLLT 425
Query: 357 XSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
+ RLGC GA E+K+ FF++ N+KRLEAG+ DPPFVPD
Sbjct: 426 KDAKQRLGCQ--EEGAAEVKRHPFFRNMNFKRLEAGMLDPPFVPD 468
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q09537 | GRK1_CAEEL | 2, ., 7, ., 1, 1, ., 1, 6 | 0.6516 | 0.3846 | 0.4595 | yes | N/A |
| P34947 | GRK5_HUMAN | 2, ., 7, ., 1, 1, ., 1, 6 | 0.5800 | 0.5032 | 0.6542 | yes | N/A |
| Q62833 | GRK5_RAT | 2, ., 7, ., 1, 1, ., 1, 6 | 0.5810 | 0.5071 | 0.6593 | yes | N/A |
| Q8VEB1 | GRK5_MOUSE | 2, ., 7, ., 1, 1, ., 1, 6 | 0.5829 | 0.5045 | 0.6559 | yes | N/A |
| P43249 | GRK5_BOVIN | 2, ., 7, ., 1, 1, ., 1, 6 | 0.5934 | 0.5071 | 0.6593 | yes | N/A |
| P32866 | GPRK2_DROME | 2, ., 7, ., 1, 1, ., 1, 6 | 0.8282 | 0.3846 | 0.4131 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 767 | |||
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-179 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-166 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-165 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-159 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-152 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-122 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-118 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-97 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-80 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-79 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-74 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-72 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-67 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-64 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-63 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-62 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-62 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-61 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-61 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-61 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-61 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-59 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-58 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-58 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-58 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-58 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-57 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-57 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-57 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-57 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-56 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-56 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-56 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-56 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-55 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-54 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-53 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-53 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-52 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-52 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-52 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-52 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-52 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-51 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-50 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-50 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-49 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-49 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-48 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-48 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-47 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-46 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-45 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-45 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-44 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-43 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-43 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-43 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-41 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-40 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-40 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-39 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-39 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-39 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-38 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-37 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-36 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-34 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-34 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-33 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-29 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-29 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-28 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-21 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-17 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-13 | |
| cd08750 | 132 | cd08750, RGS_GRK4, Regulator of G protein signalin | 6e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-12 | |
| cd08724 | 114 | cd08724, RGS_GRK-like, Regulator of G protein sign | 6e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd08752 | 123 | cd08752, RGS_GRK5, Regulator of G protein signalin | 3e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-10 | |
| cd08751 | 145 | cd08751, RGS_GRK6, Regulator of G protein signalin | 8e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-09 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-09 | |
| cd08750 | 132 | cd08750, RGS_GRK4, Regulator of G protein signalin | 5e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-08 | |
| cd08752 | 123 | cd08752, RGS_GRK5, Regulator of G protein signalin | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd08748 | 138 | cd08748, RGS_GRK1, Regulator of G protein signalin | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd08749 | 139 | cd08749, RGS_GRK7, Regulator of G protein signalin | 1e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-07 | |
| cd08751 | 145 | cd08751, RGS_GRK6, Regulator of G protein signalin | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-06 | |
| cd08724 | 114 | cd08724, RGS_GRK-like, Regulator of G protein sign | 2e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-06 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-06 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-05 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd08749 | 139 | cd08749, RGS_GRK7, Regulator of G protein signalin | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-05 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-05 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-05 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-04 | |
| smart00315 | 118 | smart00315, RGS, Regulator of G protein signalling | 1e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-04 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-04 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| pfam00615 | 117 | pfam00615, RGS, Regulator of G protein signaling d | 0.001 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.001 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.002 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.003 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.003 | |
| cd08750 | 132 | cd08750, RGS_GRK4, Regulator of G protein signalin | 0.003 | |
| cd08752 | 123 | cd08752, RGS_GRK5, Regulator of G protein signalin | 0.003 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.003 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 0.004 | |
| smart00315 | 118 | smart00315, RGS, Regulator of G protein signalling | 0.004 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 514 bits (1325), Expect = e-179
Identities = 217/287 (75%), Positives = 249/287 (86%), Gaps = 3/287 (1%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 174
TFR YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE+M L EKQIL+K+NSR
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
FVVSLAYAYETKDALCLVLT+MNGGDLKFHIYNMG PGFD RA FYAAE+ CGLE LH
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLH 119
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYT 294
+VYRD KPENILLDDYGH+RISDLGLAVEIPEGE++RGRVGTVGYMAPEV+ NE+YT
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYT 179
Query: 295 YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354
+SPDW+ GCLI+EMIEG++PFR+RKE VKR+EV+RRVKED E+YS +FS+ A+++C+ L
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239
Query: 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
L K P RLGC GA E+K FF++ N+KRLEAG+ +PPF PD
Sbjct: 240 LTKDPGFRLGCR--GEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 479 bits (1235), Expect = e-166
Identities = 218/287 (75%), Positives = 249/287 (86%), Gaps = 3/287 (1%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 174
TFR YRVLGKGGFGEVCACQVRATGKMYACK+LEKKRIKKRKGESM L EKQIL+K+NS+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
FVV+LAYAYETKDALCLVLTIMNGGDLKFHIYNMG PGF+ RA FYAAE+LCGLE LH
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLH 119
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYT 294
VYRD KPENILLDDYGH+RISDLGLAV+IPEGES+RGRVGTVGYMAPEV++N++YT
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 295 YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354
SPD++ GCLI+EMIEGQ+PFR RKE VKR+EVDRRV E E YS +FS++AK++CK L
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239
Query: 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
L K P+ RLGC GA E+K+ FF++ N+KRLEAG+ DPPFVPD
Sbjct: 240 LTKDPKQRLGCQ--EEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 477 bits (1229), Expect = e-165
Identities = 219/287 (76%), Positives = 249/287 (86%), Gaps = 3/287 (1%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 174
TFR YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE+M L EK+IL+K+NSR
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG PGFD RA FYAAE+ CGLE L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYT 294
+VYRD KPENILLDD GH+RISDLGLAV+IPEGE+VRGRVGTVGYMAPEVI+NEKYT
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179
Query: 295 YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354
+SPDW+ GCLI+EMI+GQ+PFR+RKE VKR+EVDRRVKED E+YS +FS+DAK++C+ L
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239
Query: 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
L K+P+ RLGC GA +KQ FK+ N+KRLEA + +PPF PD
Sbjct: 240 LTKNPKERLGCRGN--GAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 462 bits (1190), Expect = e-159
Identities = 210/287 (73%), Positives = 248/287 (86%), Gaps = 3/287 (1%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 174
TFR YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM L EKQIL+K+NSR
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
FVVSLAYAYETKDALCLVLT+MNGGDLKFHIY+MG E GF+ RA FYAAE+ CGLE LH
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLH 119
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYT 294
+VYRD KPENILLDD+GH+RISDLGLAV +PEG++++GRVGTVGYMAPEV+ NE+YT
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 179
Query: 295 YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354
+SPDW++ GCL++EMI GQ+PF++RK+ +KR+EV+R VKE E+YS +FS DA++LCK L
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239
Query: 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
L K P+ RLGC G GARE+K+ FK N+KRLEAG+ +PPF PD
Sbjct: 240 LCKDPKERLGCQGG--GAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 445 bits (1146), Expect = e-152
Identities = 182/280 (65%), Positives = 230/280 (82%), Gaps = 3/280 (1%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
LGKGGFGEVCACQV+ATGKMYACKKL+KKR+KKRKGE M L EK+IL+K++SRF+VSLAY
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
A+ETKD LCLV+T+MNGGDLK+HIYN+G EPGF ARA FYAA+++CGLEHLH +VYR
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFS 301
D KPEN+LLDD+G+VRISDLGLAVE+ G+ ++GR GT GYMAPEV+ E Y +S DWF+
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFA 179
Query: 302 FGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRS 361
GC ++EMI G++PFR+RKE V+++E+ RR E A +Y +FS +AK LC+ALL+K P
Sbjct: 180 LGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239
Query: 362 RLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
RLGC G A E+++ FK NW+RLEAG+ +PPF+PD
Sbjct: 240 RLGCRGG--SADEVREHPLFKDLNWRRLEAGMLEPPFIPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 367 bits (944), Expect = e-122
Identities = 156/282 (55%), Positives = 207/282 (73%), Gaps = 4/282 (1%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
LGKGGFGEV ACQ+RATGK+YACKKL KKR+KKRKG ++EK+IL K++SRF+VSLAY
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGE-PGFDIARARFYAAEVLCGLEHLHYIGLVY 240
A++TK LCLV+TIMNGGDL++HIYN+ E PGF RA FY A+++ GLEHLH ++Y
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 241 RDCKPENILLDDYGHVRISDLGLAVEIPEGES-VRGRVGTVGYMAPEVIDNEKYTYSPDW 299
RD KPEN+LLD+ G+VRISDLGLAVE+ +G+S +G GT G+MAPE++ E+Y +S D+
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180
Query: 300 FSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSP 359
F+ G ++EMI + PFR R E V+ E+ +R+ D+ Y +FS +K+ C+ALL K P
Sbjct: 181 FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP 240
Query: 360 RSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
RLG G L+ F+ NW++LEAG+ PPFVPD
Sbjct: 241 EKRLGFRDGN--CDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 356 bits (916), Expect = e-118
Identities = 155/281 (55%), Positives = 211/281 (75%), Gaps = 5/281 (1%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
LGKGGFGEVCA QV+ TGKMYACKKL+KKR+KK+ GE M L+EK+IL+K+NS F+V+LAY
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
A+E+K LCLV+++MNGGDLK+HIYN+G E G ++ R Y+A++ CG+ HLH + +VYR
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFS 301
D KPEN+LLDD G+ R+SDLGLAVE+ +G+++ R GT GYMAPE++ E Y+Y DWF+
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFA 179
Query: 302 FGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS-CRFSDDAKALCKALLKKSPR 360
GC I+EM+ G+ PF+ KE V ++E+ RR ED K+ F++++K +C+ L K P
Sbjct: 180 MGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239
Query: 361 SRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
RLG R + ++ EFFK+ N+ RLEAGL PPFVPD
Sbjct: 240 DRLG---SREKNDDPRKHEFFKTINFPRLEAGLIPPPFVPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 300 bits (771), Expect = 6e-97
Identities = 111/261 (42%), Positives = 155/261 (59%), Gaps = 12/261 (4%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
LGKG FG+V + + TGK+YA K L+KK+I KRK L E+ IL +IN F+V L Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
A++T++ L LVL GG+L H+ G F RARFYAAE++ LE+LH +G++YR
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEG---RFSEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 242 DCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWF 300
D KPENILLD GH++++D GLA E EG GT Y+APEV+ + Y + DW+
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWW 177
Query: 301 SFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPR 360
S G L++EM+ G+ PF E+ ++ +D ++ S +A+ L LL+K P
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDPLRFPEFLSPEARDLISGLLQKDPT 233
Query: 361 SRLGCHCGRYGARELKQAEFF 381
RLG GA E+K FF
Sbjct: 234 KRLGSG----GAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 255 bits (655), Expect = 8e-80
Identities = 96/266 (36%), Positives = 146/266 (54%), Gaps = 12/266 (4%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + LG+G FG+V + + TGK+ A K ++KK+IKK + +L E +IL+K+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V L +E +D L LV+ GGDL + G ARFY ++L LE+LH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR---LSEDEARFYLRQILSALEYLHS 115
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
G+V+RD KPENILLD+ GHV+++D GLA ++ GE + VGT YMAPEV+ + Y
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355
+ D +S G +++E++ G+ PF ++++ + + K S +AK L + LL
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235
Query: 356 KKSPRSRLGCHCGRYGARELKQAEFF 381
K P RL A E Q FF
Sbjct: 236 VKDPEKRL-------TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 255 bits (652), Expect = 4e-79
Identities = 126/284 (44%), Positives = 181/284 (63%), Gaps = 11/284 (3%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR---FVV 177
++G+GGFGEV C+ TGKMYA K L+KKRIK ++GE++ L E+ +L +++ F+V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 178 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG 237
++YA+ T D L +L +MNGGDL +H+ G F A RFYAAE++ GLEH+H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEAEMRFYAAEIILGLEHMHNRF 117
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN-EKYTYS 296
+VYRD KP NILLD++GHVRISDLGLA + + + VGT GYMAPEV+ Y S
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGVAYDSS 176
Query: 297 PDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLK 356
DWFS GC++F+++ G +PFR+ K K E+DR A + FS + ++L + LL+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235
Query: 357 KSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400
+ RLGC GA+E+K+ FF+S +W+ + PP +P
Sbjct: 236 RDVNRRLGCLGR--GAQEVKEHPFFRSLDWQMVFLQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 2e-74
Identities = 125/284 (44%), Positives = 178/284 (62%), Gaps = 11/284 (3%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS---RFVV 177
++G+GGFGEV C+ TGKMYA K L+KKRIK ++GE++ L E+ +L +++ F+V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 178 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG 237
+ YA+ T D LC +L +MNGGDL +H+ G F RFYA E++ GLEH+H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV---FSEKEMRFYATEIILGLEHMHNRF 117
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN-EKYTYS 296
+VYRD KP NILLD++GHVRISDLGLA + + + VGT GYMAPEV+ Y S
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGTAYDSS 176
Query: 297 PDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLK 356
DWFS GC++F+++ G +PFR+ K K E+DR + FS + K+L + LL+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235
Query: 357 KSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400
+ RLGC GA+E+K+ FFK +W+++ PP +P
Sbjct: 236 RDVSKRLGCLGR--GAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 1e-72
Identities = 111/286 (38%), Positives = 167/286 (58%), Gaps = 11/286 (3%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR-FVVS 178
+VLGKG FG+V +++ T ++YA K L+K I + + EK++L F+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L ++TKD L V+ +NGGDL FHI G FD RARFYAAE++ GL+ LH G+
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLHERGI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSP 297
+YRD K +N+LLD GH++I+D G+ E I G + GT Y+APE++ + Y +
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAV 177
Query: 298 DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357
DW++ G L++EM+ GQ+PF E DE+ + + ED +Y S +AK++ K+ L K
Sbjct: 178 DWWALGVLLYEMLAGQSPF----EGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTK 233
Query: 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403
+P RLGC G +++K FF+ +W +LE PPF P +K
Sbjct: 234 NPEKRLGCL--PTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIK 277
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 223 bits (572), Expect = 3e-67
Identities = 104/293 (35%), Positives = 155/293 (52%), Gaps = 11/293 (3%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
F + LG G FG V + + +GK YA K L K +I K K VL EK+ILQ I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
F+V+L +++ L LV+ + GG+L H+ G F ARFYAA+V+ LE+L
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR---FPEPVARFYAAQVVLALEYL 117
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKY 293
H + +VYRD KPEN+LLD G+++I+D G A + GT Y+APE+I ++ Y
Sbjct: 118 HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT--LCGTPEYLAPEIILSKGY 175
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353
+ DW++ G LI+EM+ G PF + ++ ++ E ++ FS DAK L +
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYEKILEGKVRFPSFFSPDAKDLIRN 231
Query: 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
LL+ RLG + G ++K +F +W L + PF+P VK
Sbjct: 232 LLQVDLTKRLG--NLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPG 282
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 214 bits (548), Expect = 2e-64
Identities = 88/250 (35%), Positives = 149/250 (59%), Gaps = 4/250 (1%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + RV+GKG FG+VC Q R T KM+A K + K++ ++ VL E++ILQ++N F
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V+L Y+++ ++ + LV+ ++ GGDL++H+ F + +F+ E++ LE+LH
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK---FSEEQVKFWICEIVLALEYLHS 118
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
G+++RD KP+NILLD+ GHV I+D +A ++ GT GYMAPEV+ + Y+
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSV 178
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355
+ DW+S G +E + G+ P+R + RD++ + + Y +S +A LL
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 356 KKSPRSRLGC 365
++ P+ RLG
Sbjct: 238 ERDPQKRLGD 247
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 3e-63
Identities = 109/294 (37%), Positives = 158/294 (53%), Gaps = 16/294 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRI-KKRKGESMVLIEKQILQKI 171
F + RVLG G +G+V + GK+YA K L+K I +K K E+Q+L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 172 NSR-FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
F+V+L YA++T L L+L +NGG+L H+Y F + R Y AE++ L
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLAL 118
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI--PEGESVRGRVGTVGYMAPEVI 288
+HLH +G++YRD K ENILLD GHV ++D GL+ E E E GT+ YMAPEVI
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 289 DNEKYTYSP--DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346
+ DW+S G L FE++ G +PF E + E+ RR+ + + S +
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238
Query: 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400
A+ + LL+K P+ RLG + GA E+K FF+ +W L A PF P
Sbjct: 239 ARDFIQKLLEKDPKKRLGAN----GADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 1e-62
Identities = 95/273 (34%), Positives = 148/273 (54%), Gaps = 20/273 (7%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + R LG G FG V + + TGK+ A K L+K+ K +K ++ E +IL++++
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQT-ARREIRILRRLSHPN 59
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V L A+E KD L LV+ GGDL F + GG A+ A ++L GLE+LH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDL-FDYLSRGG--PLSEDEAKKIALQILRGLEYLHS 116
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRVGTVGYMAPEVI-DNEKY 293
G+++RD KPENILLD+ G V+I+D GLA ++ + S+ VGT YMAPEV+ Y
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFR-----RRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348
D +S G +++E++ G+ PF + ++++R + ++ D E S++AK
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI-LGPPLEFD-EPKWSSGSEEAK 234
Query: 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381
L K L K P R A E+ Q +F
Sbjct: 235 DLIKKCLNKDPSKRP-------TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 2e-62
Identities = 111/297 (37%), Positives = 170/297 (57%), Gaps = 21/297 (7%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
++LGKG FG+V + +ATGK YA K L+K+ I + + L E ++LQ F+ +L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
Y+++T D LC V+ NGG+L FH+ E F RARFY AE++ L +LH +V
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCDVV 117
Query: 240 YRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPD 298
YRD K EN++LD GH++I+D GL E I +G +++ GT Y+APEV+++ Y + D
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 299 WFSFGCLIFEMIEGQAPFRRRK-----EMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353
W+ G +++EM+ G+ PF + E++ +E+ ++ S +AK+L
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------RFPRTLSPEAKSLLAG 228
Query: 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRR 410
LLKK P+ RLG G A+E+ + FF S NW+ + +PPF P V E D R
Sbjct: 229 LLKKDPKQRLG--GGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVT-SETDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 210 bits (535), Expect = 1e-61
Identities = 116/317 (36%), Positives = 174/317 (54%), Gaps = 20/317 (6%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR- 174
F VLGKG FG+V + + T ++YA K L+K I + ++EK++L + +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVL-ALPGKP 60
Query: 175 -FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
F+ L ++T D L V+ +NGGDL +HI +G F A FYAAE+ GL L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFL 117
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEK 292
H G++YRD K +N++LD GH++I+D G+ E I G++ R GT Y+APE+I +
Sbjct: 118 HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP 177
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352
Y S DW++FG L++EM+ GQ PF E DE+ + + E Y S +A ++CK
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQSIMEHNVSYPKSLSKEAVSICK 233
Query: 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVK 412
LL K P RLG CG G R++++ FF+ +W++LE PPF P VK +
Sbjct: 234 GLLTKHPAKRLG--CGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKG-------R 284
Query: 413 EDAEKYSCRFSDDAKAL 429
AE + F+ + L
Sbjct: 285 RSAENFDKFFTREPPVL 301
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 209 bits (535), Expect = 1e-61
Identities = 111/292 (38%), Positives = 164/292 (56%), Gaps = 14/292 (4%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR- 174
FR VLG+G FG+V + + TG++YA K L+K I R ++ EK+I + NS
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 175 --FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
F+V+L ++T+D +C V+ GGDL HI+ F RA FYAA V+ GL++
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQY 116
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNE 291
LH +VYRD K +N+LLD G V+I+D GL E + G+ GT ++APEV+
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 292 KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351
YT + DW+ G LI+EM+ G++PF E +EV + D +Y S +A ++
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESPFPGDDE----EEVFDSIVNDEVRYPRFLSREAISIM 232
Query: 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403
+ LL+++P RLG G A ++K+ FF+ NW L A PPFVP +K
Sbjct: 233 RRLLRRNPERRLG--SGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIK 282
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 2e-61
Identities = 109/288 (37%), Positives = 163/288 (56%), Gaps = 15/288 (5%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVS 178
+VLGKG FG+V +++ T + +A K L+K + + ++E+++L F+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L ++TK+ L V+ +NGGDL FHI + G FD ARARFYAAE++CGL+ LH G+
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKGI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEKYTYSP 297
+YRD K +N+LLD GH++I+D G+ E GE GT Y+APE++ +KY S
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177
Query: 298 DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357
DW+SFG L++EM+ GQ+PF E DE+ + D + S +AK L ++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDE----DELFDSILNDRPHFPRWISKEAKDCLSKLFER 233
Query: 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRD 405
P RLG +++Q FF+ +W+RLE PPF P VK
Sbjct: 234 DPTKRLGV------DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSP 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 9e-61
Identities = 112/322 (34%), Positives = 163/322 (50%), Gaps = 46/322 (14%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K F+ ++LGKG G V +++ TGK++A K L+KK + KR VL E++IL ++
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG--FDIARARFYAAEVLCGLE 231
F+ +L +++T+ LCLV+ GG+L F + +PG ARFYAAEVL LE
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQR--QPGKCLSEEVARFYAAEVLLALE 117
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR--------------- 276
+LH +G+VYRD KPENILL + GH+ +SD L+ + +
Sbjct: 118 YLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 277 ---------------VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKE 321
VGT Y+APEVI + + + DW++ G L++EM+ G PF+
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS-- 235
Query: 322 MVKRDEVDRRV--KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAE 379
RDE + KE S S A+ L + LL K P RLG + GA E+KQ
Sbjct: 236 --NRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGS---KRGAAEIKQHP 290
Query: 380 FFKSTNWKRLEAGLCDPPFVPD 401
FF+ NW + PP +P
Sbjct: 291 FFRGVNWALIR--HTTPPIIPR 310
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 202 bits (514), Expect = 9e-59
Identities = 107/286 (37%), Positives = 165/286 (57%), Gaps = 15/286 (5%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVS 178
+VLGKG FG+V +++ G+ +A K L+K + ++EK++L + F+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L ++TK+ L V+ +NGGDL FHI + G FD+ RA FYAAE++CGL+ LH G+
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-VRGRVGTVGYMAPEVIDNEKYTYSP 297
+YRD K +N++LD GH++I+D G+ E G++ GT Y+APE++ KYT+S
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177
Query: 298 DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357
DW+SFG L++EM+ GQ+PF E DE+ ++ D Y + ++K + + L ++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDE----DELFESIRVDTPHYPRWITKESKDILEKLFER 233
Query: 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403
P RLG ++ FFK+ NW LE DPPF P VK
Sbjct: 234 DPTRRLGV------VGNIRGHPFFKTINWTALEKRELDPPFKPKVK 273
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 1e-58
Identities = 110/289 (38%), Positives = 156/289 (53%), Gaps = 18/289 (6%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL-QKINSRFVVS 178
+V+GKG FG+V + +A GK YA K L+KK I K+K + ++ E+ +L + + F+V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L Y+++T D L VL +NGG+L FH+ E F RARFYAAE+ L +LH + +
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEKYTYSP 297
+YRD KPENILLD GHV ++D GL E E GT Y+APEV+ + Y +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177
Query: 298 DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEV---DRRVKEDAEKYSCRFSDDAKALCKAL 354
DW+ G +++EM+ G PF R D + R+K + S A+ L + L
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN-------ISVSARHLLEGL 230
Query: 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403
L+K RLG + E+K FF S NW L PPF P+V
Sbjct: 231 LQKDRTKRLG---AKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVS 276
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 2e-58
Identities = 106/282 (37%), Positives = 162/282 (57%), Gaps = 12/282 (4%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
+GKG FG+V + R T ++YA K + K I R + L E+ +L ++N F+V L +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
++++ + L LVL +NGG+L H+ G FD++RARFY AE+LC LE+LH ++YR
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR---FDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 242 DCKPENILLDDYGHVRISDLGLA-VEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWF 300
D KPENILLD GH+ + D GL + + + + GT Y+APE++ YT + DW+
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177
Query: 301 SFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPR 360
+ G L++EM+ G PF +E+ R++ ++ ++ F DAK L LL + P
Sbjct: 178 TLGVLLYEMLTGLPPFYDENV----NEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPT 233
Query: 361 SRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDV 402
RLG + GA+E+K FF +WK+L PPF P V
Sbjct: 234 RRLGYN----GAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAV 271
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 8e-58
Identities = 116/314 (36%), Positives = 173/314 (55%), Gaps = 31/314 (9%)
Query: 120 RVLGKGGFGEVCACQVRAT-----GKMYACKKLEKKRI-KKRKGESMVLIEKQILQKINS 173
+VLGKGG+G+V QVR GK++A K L+K I + +K + E+ IL+ +
Sbjct: 2 KVLGKGGYGKVF--QVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH 59
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
F+V L YA++T L L+L ++GG+L H+ G F A FY +E+ LEHL
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI---FMEDTACFYLSEISLALEHL 116
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEK 292
H G++YRD KPENILLD GHV+++D GL E I EG GT+ YMAPE++
Sbjct: 117 HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG 176
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPF---RRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349
+ + DW+S G L+++M+ G PF R+K + K + K + Y + +A+
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI----LKGKLNLPPY---LTPEARD 229
Query: 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDR 409
L K LLK++P SRLG G A E++ FF+ NW L A +PPF P ++ +
Sbjct: 230 LLKKLLKRNPSSRLG--AGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSE---- 283
Query: 410 RVKEDAEKYSCRFS 423
ED ++ +F+
Sbjct: 284 ---EDVSQFDSKFT 294
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 9e-58
Identities = 94/288 (32%), Positives = 147/288 (51%), Gaps = 32/288 (11%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SR 174
F+ +++G+G F V + + T K YA K L+K+++ K K V IEK++L ++N
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
++ L Y ++ ++ L VL G+L +I G D RFYAAE+L LE+LH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH 119
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-----------------GESVRGR- 276
G+++RD KPENILLD H++I+D G A + E R R
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 277 ---VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK 333
VGT Y++PE+++ + S D ++ GC+I++M+ G+ PFR E +++
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLTFQKIL 235
Query: 334 EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381
+ + F DAK L + LL P+ RLG + G ELK FF
Sbjct: 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVN---EGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 3e-57
Identities = 109/286 (38%), Positives = 156/286 (54%), Gaps = 9/286 (3%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVS 178
+VLGKG FG+V +++ T ++YA K L+K I + + EK+IL F+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L ++TKD L V+ +NGGDL F I FD R+RFYAAEV L LH G+
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHGV 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSP 297
+YRD K +NILLD GH +++D G+ E I G + GT Y+APE++ +Y S
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 298 DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357
DW++ G L++EM+ GQ PF E D++ + D Y S +A ++ KA + K
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNE----DDLFESILHDDVLYPVWLSKEAVSILKAFMTK 233
Query: 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403
+P RLGC + G +KQ FFK +W LE PPF P +K
Sbjct: 234 NPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIK 279
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 3e-57
Identities = 114/295 (38%), Positives = 170/295 (57%), Gaps = 22/295 (7%)
Query: 120 RVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 174
+VLG+G FG+V VR G++YA K L+K +K R +E+ IL ++N
Sbjct: 2 KVLGQGSFGKVFL--VRKITGPDAGQLYAMKVLKKATLKVRD-RVRTKMERDILAEVNHP 58
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
F+V L YA++T+ L L+L + GGDL + E F +FY AE+ L+HLH
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-VRGRVGTVGYMAPEVIDNEKY 293
+G++YRD KPENILLD+ GH++++D GL+ E + E GTV YMAPEV++ +
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 294 TYSPDWFSFGCLIFEMIEGQAPF--RRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351
T S DW+SFG L+FEM+ G PF + RKE + + + K ++ S +A++L
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT---MILKAKLGMPQF---LSPEAQSLL 229
Query: 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
+AL K++P +RLG G G E+K+ FF + +W +L PPF P V R +
Sbjct: 230 RALFKRNPANRLG--AGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPD 282
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 197 bits (501), Expect = 5e-57
Identities = 107/290 (36%), Positives = 164/290 (56%), Gaps = 11/290 (3%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL-QKINS 173
F VLGKG FG+V + + T ++YA K L+K + + ++EK++L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
F+ L ++T D L V+ +NGGDL +HI +G F +A FYAAE+ GL L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFL 117
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEK 292
H G++YRD K +N++LD GH++I+D G+ E + +G + R GT Y+APE+I +
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352
Y S DW+++G L++EM+ GQ PF E DE+ + + E Y S +A ++CK
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSIMEHNVSYPKSLSKEAVSICK 233
Query: 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDV 402
L+ K P RLG CG G R++++ FF+ +W +LE PPF P V
Sbjct: 234 GLMTKHPSKRLG--CGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKV 281
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 197 bits (501), Expect = 6e-57
Identities = 114/301 (37%), Positives = 172/301 (57%), Gaps = 21/301 (6%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
++LGKG FG+V + +ATG+ YA K L K+ I + + + E ++LQ F+ +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
YA++T D LC V+ NGG+L FH + E F RARFY AE++ LE+LH +V
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFH---LSRERVFTEERARFYGAEIVSALEYLHSRDVV 117
Query: 240 YRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPD 298
YRD K EN++LD GH++I+D GL E I +G +++ GT Y+APEV+++ Y + D
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 299 WFSFGCLIFEMIEGQAPF-----RRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353
W+ G +++EM+ G+ PF R E++ +E+ ++ S +AK+L
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------RFPRTLSPEAKSLLAG 228
Query: 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKE 413
LLKK P+ RLG G A+E+ + FF S NW+ + PPF P V EVD R +
Sbjct: 229 LLKKDPKQRLG--GGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVT-SEVDTRYFD 285
Query: 414 D 414
D
Sbjct: 286 D 286
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 1e-56
Identities = 119/314 (37%), Positives = 178/314 (56%), Gaps = 20/314 (6%)
Query: 116 FRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRI-KKRKGESMVLIEKQILQ 169
F + +VLG G +G+V VR TGK+YA K L+K + +K K E+ +L+
Sbjct: 2 FELLKVLGTGAYGKVFL--VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE 59
Query: 170 KI-NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC 228
+ S F+V+L YA++T+ L L+L ++GG++ H+Y F RFY+ E++
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIIL 116
Query: 229 GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--GRVGTVGYMAPE 286
LEHLH +G+VYRD K ENILLD GHV ++D GL+ E E R GT+ YMAPE
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 287 VIDNEK-YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345
+I + + + DW+S G LIFE++ G +PF E + EV RR+ + +
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGP 236
Query: 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRD 405
+A+ L LL+K P+ RLG G GA E+K+ FFK +W+ L +PPF P + R+
Sbjct: 237 EAQDLLHKLLRKDPKKRLG--AGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSI-RN 293
Query: 406 EVDRRVKEDAEKYS 419
E+D V AE+++
Sbjct: 294 ELD--VGNFAEEFT 305
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 195 bits (496), Expect = 3e-56
Identities = 105/286 (36%), Positives = 162/286 (56%), Gaps = 15/286 (5%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVS 178
++LGKG FG+V +++ T + +A K L+K + ++EK++L F+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L ++TK+ L V+ +NGGDL FHI + FD+ RA FYAAE++CGL+ LH G+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKGI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-VRGRVGTVGYMAPEVIDNEKYTYSP 297
VYRD K +NILLD GH++I+D G+ E G++ GT Y+APE++ +KY S
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177
Query: 298 DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357
DW+SFG L++EM+ GQ+PF E +E+ + ++ D Y + +AK + L +
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDE----EELFQSIRMDNPCYPRWLTREAKDILVKLFVR 233
Query: 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403
P RLG +++Q FF+ +W LE +PPF P VK
Sbjct: 234 EPERRLGVK------GDIRQHPFFREIDWSALEEREIEPPFKPKVK 273
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 194 bits (493), Expect = 8e-56
Identities = 107/287 (37%), Positives = 162/287 (56%), Gaps = 11/287 (3%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSR 174
F VLGKG FG+V + + T ++YA K L+K + + ++EK++L
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
F+ L ++T D L V+ +NGGDL + I +G F A FYAAE+ GL LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLH 118
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKY 293
G++YRD K +N++LD GH++I+D G+ E + +G + + GT Y+APE+I + Y
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY 178
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353
S DW++FG L++EM+ GQAPF E DE+ + + E Y S +A A+CK
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPKSMSKEAVAICKG 234
Query: 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400
L+ K P RLG CG G R++K+ FF+ +W++LE PP+ P
Sbjct: 235 LMTKHPGKRLG--CGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKP 279
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 9e-56
Identities = 110/291 (37%), Positives = 160/291 (54%), Gaps = 11/291 (3%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVS 178
RVLGKG FG+V +++ +G++YA K L+K I + + EK+IL N F+
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L ++T D L V+ +NGGDL FHI FD ARARFYAAE+ L LH G+
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKGI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSP 297
+YRD K +N+LLD GH +++D G+ E I G++ GT Y+APE++ Y S
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 298 DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357
DW++ G L++EM+ G APF E D++ + D Y S DA + KA + K
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENE----DDLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233
Query: 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK-RDEV 407
+P RLG G + + FFK +W++L +PPF P +K R++V
Sbjct: 234 NPTMRLGS-LTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDV 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 2e-55
Identities = 90/274 (32%), Positives = 140/274 (51%), Gaps = 18/274 (6%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
+ KG +G V + ++TG +YA K ++K + ++ VL E+ IL + S +VV L Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
+++ K L LV+ + GGDL + N+G D AR Y AE++ LE+LH G+++R
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHSNGIIHR 117
Query: 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESV---------RGRVGTVGYMAPEVIDNEK 292
D KP+NIL+D GH++++D GL+ + + VGT Y+APEVI +
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352
++ + DW+S GC+++E + G PF + E E SD+A L
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLIS 235
Query: 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386
LL P RLG E+K FFK +W
Sbjct: 236 KLLVPDPEKRLGAK----SIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 3e-54
Identities = 99/321 (30%), Positives = 149/321 (46%), Gaps = 52/321 (16%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLA 180
V+G+G FGEV + + TG++YA K L K + KR + V E+ IL +S ++V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVY 240
Y+++ ++ L LV+ M GGDL + F ARFY AE++ L+ +H +G ++
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV---FPEETARFYIAELVLALDSVHKLGFIH 124
Query: 241 RDCKPENILLDDYGHVRISDLGLA------------------VEIPEGESVRGR------ 276
RD KP+NIL+D GH++++D GL + + VR R
Sbjct: 125 RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184
Query: 277 ------VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF-----RRRKEMVKR 325
VGT Y+APEV+ Y DW+S G +++EM+ G PF + +
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIIN 244
Query: 326 DEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385
+ R D S +A L LL P RLG E+K FFK +
Sbjct: 245 WKESLRFPPDPP-----VSPEAIDLICRLLCD-PEDRLG------SFEEIKSHPFFKGID 292
Query: 386 WKRLEAGLCDPPFVPDVKRDE 406
W+ L PPFVP++
Sbjct: 293 WENLRET--KPPFVPELSSPL 311
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 1e-53
Identities = 109/293 (37%), Positives = 160/293 (54%), Gaps = 20/293 (6%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI---NSRFVVS 178
+GKG FG+V + + T ++YA K L KK I +K + + E+ IL + S F+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L ++++T L LV M+GG+L +H+ G F RA+FY AE++ LEHLH +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKYDI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLA-VEIPEGESVRGRVGTVGYMAPEVIDNEK-YTYS 296
VYRD KPENILLD GH+ + D GL+ + + ++ GT Y+APEV+ +EK YT
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 297 PDWFSFGCLIFEMIEGQAPF--RRRKEMVKRDEVDR-RVKEDAEKYSCRFSDDAKALCKA 353
D++S G L+FEM G +PF ++M + + R ++ SD+ + K
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNV------LSDEGRQFVKG 231
Query: 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
LL ++P+ RLG H A ELK+ FF +W L PPF P V DE
Sbjct: 232 LLNRNPQHRLGAHR---DAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDE 281
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 7e-53
Identities = 99/317 (31%), Positives = 160/317 (50%), Gaps = 37/317 (11%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K F++ +G+GG+G+V + + TG++ A K+++K + K VL E+ IL S
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
++V L YA++ + L L + + GGD + + N+G ARFY AE+ ++ L
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV---LSEDHARFYMAEMFEAVDAL 117
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRVGTVGYMAPEVIDNEK 292
H +G ++RD KPEN L+D GH++++D GL+ I SV VG+ YMAPEV+ +
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV---VGSPDYMAPEVLRGKG 174
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPF------------RRRKEMVKRDEVDRRVKEDAEKYS 340
Y ++ D++S GC+++E + G PF + KE ++R D
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN------ 228
Query: 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400
SD+A L L+ P R G ++K FFK +W L PPFVP
Sbjct: 229 --LSDEAWDLITKLI-NDPSRRFG------SLEDIKNHPFFKEVDWNELRE--LKPPFVP 277
Query: 401 DVKRDEVDRRVKEDAEK 417
+++ E+D +D E
Sbjct: 278 ELE-SEIDTGYFDDFEN 293
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 1e-52
Identities = 109/294 (37%), Positives = 163/294 (55%), Gaps = 14/294 (4%)
Query: 116 FRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRI-KKRKGESMVLIEKQILQKI 171
F + +VLG G +G+V + + +GK+YA K L+K I +K K E+Q+L+ I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 172 -NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
S F+V+L YA++T L L+L +NGG+L H+ F + Y+ E++ L
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLAL 118
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR--VGTVGYMAPEVI 288
EHLH +G++YRD K ENILLD GHV ++D GL+ E E E R GT+ YMAP+++
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 289 --DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346
+ + + DW+S G L++E++ G +PF E + E+ RR+ + Y S
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
Query: 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400
AK + + LL K P+ RLG CG A E+K+ FF+ NW L A PF P
Sbjct: 239 AKDIIQRLLMKDPKKRLG--CGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 1e-52
Identities = 106/296 (35%), Positives = 167/296 (56%), Gaps = 10/296 (3%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
++LGKG FG+V + +A+GK YA K L+K+ I + + L E ++L+ F+ SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
Y+++TKD LC V+ +NGG+L FH + E F R RFY AE++ L++LH +V
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFH---LSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117
Query: 240 YRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPD 298
YRD K EN++LD GH++I+D GL E I + +++ GT Y+APEV+++ Y + D
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 299 WFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKS 358
W+ G +++EM+ G+ PF + +++ + + K+ S DAK+L LL K
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDH----EKLFELILMEDIKFPRTLSADAKSLLSGLLIKD 233
Query: 359 PRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKED 414
P RLG G A+E+ + FF NW+ + PPF P V + R E+
Sbjct: 234 PNKRLG--GGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEE 287
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 2e-52
Identities = 108/302 (35%), Positives = 170/302 (56%), Gaps = 21/302 (6%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
++LGKG FG+V + +ATG+ YA K L+K+ I + + L E ++LQ F+ +L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGL 238
Y+++T D LC V+ NGG+L FH + E F RARFY AE++ L++LH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFH---LSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSP 297
VYRD K EN++LD GH++I+D GL E I +G +++ GT Y+APEV+++ Y +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 177
Query: 298 DWFSFGCLIFEMIEGQAPFRRRK-----EMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352
DW+ G +++EM+ G+ PF + E++ +E+ ++ S +AK+L
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------RFPRTLSPEAKSLLS 228
Query: 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVK 412
LLKK P+ RLG G A+E+ Q +FF W+ + PPF P V + R
Sbjct: 229 GLLKKDPKQRLG--GGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFD 286
Query: 413 ED 414
E+
Sbjct: 287 EE 288
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 3e-52
Identities = 117/323 (36%), Positives = 171/323 (52%), Gaps = 38/323 (11%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVS 178
+V+GKG FG+V + + GK YA K L+KK + RK + ++ E+ +L K + F+V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L Y+++T + L VL +NGG+L FH+ E F RARFYAAE+ L +LH I +
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSP 297
VYRD KPENILLD GHV ++D GL E I + ++ GT Y+APEVI + Y +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 298 DWFSFGCLIFEMIEGQAPFRRR-----------KEMVKRDEVDRRVKEDAEKYSCRFSDD 346
DW+ G +++EM+ G PF R K +V R S
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGA---------------SLT 222
Query: 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK-RD 405
A ++ + LL+K + RLG + E+++ FF+S +W LE PPF P+V+ D
Sbjct: 223 AWSILEELLEKDRQRRLG---AKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPD 279
Query: 406 EV---DRRVKEDAEKYSCRFSDD 425
++ D E+ YS FS D
Sbjct: 280 DISNFDAVFTEETVPYSVCFSSD 302
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 7e-52
Identities = 89/268 (33%), Positives = 148/268 (55%), Gaps = 11/268 (4%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
LG GGFG V +V++ + +A K ++K+ I + + + EK+IL++ N F+V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
++ K + +++ GG+L + I G FD ARFY A V+ E+LH G++YR
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL-WTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFS 301
D KPEN+LLD G+V++ D G A ++ G+ GT Y+APE+I N+ Y +S D++S
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWS 177
Query: 302 FGCLIFEMIEGQAPFRRRKE---MVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKS 358
G L++E++ G+ PF E + D + ++ AK L K LL+++
Sbjct: 178 LGILLYELLTGRPPFGEDDEDPMEIYNDILK---GNGKLEFPNYIDKAAKDLIKQLLRRN 234
Query: 359 PRSRLGCHCGRYGARELKQAEFFKSTNW 386
P RLG G G +++K+ ++F +W
Sbjct: 235 PEERLGNLKG--GIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 182 bits (462), Expect = 2e-51
Identities = 105/286 (36%), Positives = 155/286 (54%), Gaps = 12/286 (4%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVS 178
+V+GKG FG+V + ++ G YA K L+KK I K+K ++ ++ E+ +L K + F+V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L Y+++T + L VL +NGG+L FH+ E F RARFYAAEV + +LH + +
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLNI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSP 297
+YRD KPENILLD GHV ++D GL E + E+ GT Y+APEV+ E Y +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 298 DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357
DW+ G +++EM+ G PF R D + + + + + + A L LL K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI---LHKPLQLPGGK-TVAACDLLVGLLHK 233
Query: 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403
R RLG + E+K FF NW L PP+ P+V
Sbjct: 234 DQRRRLG---AKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVA 276
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 1e-50
Identities = 92/294 (31%), Positives = 148/294 (50%), Gaps = 19/294 (6%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ +G G FG V + R + YA K + + + K E V EK++L++++ F
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
++ L + + L +++ + GG+L ++ N G F + FYA+E++C LE+LH
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLHS 119
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRV----GTVGYMAPEVIDNE 291
+VYRD KPENILLD GH++++D G A + +R R GT Y+APEVI ++
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKK------LRDRTWTLCGTPEYLAPEVIQSK 173
Query: 292 KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351
+ + DW++ G LI+EM+ G PF + ++ ++ AK L
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNP----FGIYEKILAGKLEFPRHLDLYAKDLI 229
Query: 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRD 405
K LL RLG + GA ++K +FKS +W + PP VP V D
Sbjct: 230 KKLLVVDRTRRLGNM--KNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHD 281
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 6e-50
Identities = 105/285 (36%), Positives = 154/285 (54%), Gaps = 12/285 (4%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVS 178
+V+GKG FG+V + +A K YA K L+KK I K+K E ++ E+ +L K + F+V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L ++++T D L VL +NGG+L +H+ E F RARFYAAE+ L +LH + +
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLNI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSP 297
VYRD KPENILLD GH+ ++D GL E I + GT Y+APEV+ + Y +
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV 177
Query: 298 DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357
DW+ G +++EM+ G PF R D + + + ++ A+ L + LL+K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----PLQLKPNITNSARHLLEGLLQK 233
Query: 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDV 402
RLG + E+K FF NW L PPF P+V
Sbjct: 234 DRTKRLG---AKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNV 275
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 4e-49
Identities = 74/83 (89%), Positives = 80/83 (96%)
Query: 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 712
TFR YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE+M L EKQIL+K+NSR
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 713 FVVSLAYAYETKDALCLVLTIID 735
FVVSLAYAYETKDALCLVLT+++
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMN 83
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 7e-49
Identities = 98/291 (33%), Positives = 159/291 (54%), Gaps = 9/291 (3%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR-FVVS 178
RV+G+G + +V +++ ++YA K ++K+ + + V EK + ++ +S F+V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L ++T L LV+ +NGGDL FH+ P ARFYAAE+ L LH G+
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPE---EHARFYAAEICIALNFLHERGI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSP 297
+YRD K +N+LLD GH++++D G+ E + G++ GT Y+APE++ E+Y +S
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 298 DWFSFGCLIFEMIEGQAPF---RRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354
DW++ G L+FEM+ G++PF +M D + + + E + S A + K
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRD 405
L K P+ RLGC + G ++K FF+S +W LE PPF P + D
Sbjct: 238 LNKDPKERLGCQP-QTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDD 287
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 1e-48
Identities = 96/293 (32%), Positives = 160/293 (54%), Gaps = 11/293 (3%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL-QKINSRFVVS 178
RV+G+G + +V +++ T ++YA K ++K+ + + V EK + N F+V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L ++T+ L V+ ++GGDL FH+ P ARFY+AE+ L LH G+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPE---EHARFYSAEISLALNFLHERGI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSP 297
+YRD K +N+LLD GH++++D G+ E I G++ GT Y+APE++ E Y +S
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 298 DWFSFGCLIFEMIEGQAPF-----RRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352
DW++ G L+FEM+ G++PF + D + + + E + S A ++ K
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRD 405
L K P+ RLGCH + G R++K FF++ +W LE PP+ P+++ D
Sbjct: 238 GFLNKDPKERLGCH-PQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESD 289
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 96/266 (36%), Positives = 138/266 (51%), Gaps = 15/266 (5%)
Query: 124 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVSLAYA 182
KG FG V + R+TG +A K L+K + + + V E+ I+ + S +V L Y+
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 183 YETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRD 242
+++KD L LV+ +NGGD I +GG P A+ Y AEV+ G+E LH G+++RD
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLP---EDWAKQYIAEVVLGVEDLHQRGIIHRD 122
Query: 243 CKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSF 302
KPEN+L+D GH++++D GL+ G + VGT Y+APE I DW+S
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 303 GCLIFEMIEGQAPFRRR--KEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPR 360
GC+IFE + G PF + R + K C S +A L LL P
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFC--SPEAVDLINRLLCMDPA 237
Query: 361 SRLGCHCGRYGARELKQAEFFKSTNW 386
RLG + G +E+K FFKS NW
Sbjct: 238 KRLGAN----GYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 2e-47
Identities = 96/290 (33%), Positives = 151/290 (52%), Gaps = 11/290 (3%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F M LG G FG V + + TG+ YA K L+K+ I K K V EK IL +++ F
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V++ +++ ++ + +L + GG+L H+ G P D+A+ FY AE++ E+LH
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN-DVAK--FYHAELVLAFEYLHS 136
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
++YRD KPEN+LLD+ GHV+++D G A ++P + GT Y+APEVI ++ +
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQSKGHGK 194
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355
+ DW++ G L++E I G PF + ++ K+ F A+ L K LL
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFDDTPF----RIYEKILAGRLKFPNWFDGRARDLVKGLL 250
Query: 356 KKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRD 405
+ RLG G G ++K +F NW +L A P VK
Sbjct: 251 QTDHTKRLGTLKG--GVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSP 298
|
Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-46
Identities = 93/290 (32%), Positives = 159/290 (54%), Gaps = 11/290 (3%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL-QKINSRFVVS 178
RV+G+G + +V +++ T ++YA K ++K+ + + V EK + Q N F+V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L ++T+ L V+ +NGGDL FH+ P ARFY+AE+ L +LH G+
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISLALNYLHERGI 117
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSP 297
+YRD K +N+LLD GH++++D G+ E + G++ GT Y+APE++ E Y +S
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 298 DWFSFGCLIFEMIEGQAPF-----RRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352
DW++ G L+FEM+ G++PF + D + + + E + S A ++ K
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDV 402
+ L K P+ RLGC + G +++ FF++ +W +E PPF P++
Sbjct: 238 SFLNKDPKERLGC-HPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNI 286
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 3e-45
Identities = 75/83 (90%), Positives = 80/83 (96%)
Query: 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 712
TFR YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM L EKQIL+K+NSR
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 713 FVVSLAYAYETKDALCLVLTIID 735
FVVSLAYAYETKDALCLVLT+++
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMN 83
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 4e-45
Identities = 74/83 (89%), Positives = 80/83 (96%)
Query: 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 712
TFR YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE+M L EK+IL+K+NSR
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 713 FVVSLAYAYETKDALCLVLTIID 735
FVVSLAYAYETKDALCLVLTI++
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMN 83
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 73/83 (87%), Positives = 80/83 (96%)
Query: 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 712
TFR YRVLGKGGFGEVCACQVRATGKMYACK+LEKKRIKKRKGESM L EKQIL+K+NS+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 713 FVVSLAYAYETKDALCLVLTIID 735
FVV+LAYAYETKDALCLVLTI++
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMN 83
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 9/202 (4%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
+LG+G FG V + TG++ A K +E + + E+ + E +IL + +V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA-LEREIRILSSLQHPNIVRY 64
Query: 180 AYAY--ETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG 237
+ E K+ L + L ++GG L + G P I R Y ++L GL +LH G
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI---RKYTRQILEGLAYLHSNG 121
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV---RGRVGTVGYMAPEVIDNEKYT 294
+V+RD K NIL+D G V+++D G A + + E+ GT +MAPEVI E+Y
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 295 YSPDWFSFGCLIFEMIEGQAPF 316
+ D +S GC + EM G+ P+
Sbjct: 182 RAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-44
Identities = 104/318 (32%), Positives = 157/318 (49%), Gaps = 32/318 (10%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ F + +V+G+G FGEV + +++ ++YA K L K + KR + E+ I+ NS
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIAR--ARFYAAEVLCGLE 231
++V L YA++ L +V+ M GGDL + N +DI ARFY AEV+ L+
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALD 156
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR--VGTVGYMAPEVID 289
+H +G ++RD KP+N+LLD GH++++D G +++ VR VGT Y++PEV+
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 290 NE----KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345
++ Y DW+S G ++EM+ G PF V K K S F D
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF------YADSLVGTYSKIMDHKNSLTFPD 270
Query: 346 D------AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFV 399
D AK L A L RL GR G E+K FFK+ W P V
Sbjct: 271 DIEISKQAKDLICAFLTDRE-VRL----GRNGVDEIKSHPFFKNDQWTFDNIRETVAPVV 325
Query: 400 PDVKRDEVDRRVKEDAEK 417
P++ D +D +D E
Sbjct: 326 PELSSD-IDTSNFDDIED 342
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-43
Identities = 68/191 (35%), Positives = 106/191 (55%), Gaps = 7/191 (3%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
LG+GGFG V + + TGK A K ++K+ +L E +IL+K+N +V L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
+E ++ L LV+ GG LK + E ++L GLE+LH G+++R
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 242 DCKPENILLD-DYGHVRISDLGLAVEIPEGESV-RGRVGTVGYMAPEVIDNE-KYTYSPD 298
D KPENILLD D G V+++D GL+ + +S+ + VGT YMAPEV+ + Y+ D
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 299 WFSFGCLIFEM 309
+S G +++E+
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 108/329 (32%), Positives = 167/329 (50%), Gaps = 37/329 (11%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K F + ++G+G FGEV + +ATG +YA K ++K + ++ S E+ IL NS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
++ L YA++ KD L LV+ GGDL + N + FD A+FY AE++ + +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQ-FDEDMAQFYLAELVLAIHSV 118
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR--VGTVGYMAPEVID-- 289
H +G V+RD KPEN+L+D GH++++D G A + + V + VGT Y+APEV+
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 290 --NEKYTYSP--DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEV---DRRVKEDAEKYSCR 342
+ K TY DW+S G + +EMI G++PF + + R +K + +
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP---K 235
Query: 343 FSDDAKALCKALLKKSPRSRLG-----CHCGRYGARELKQAEFFKSTNWKRLEAGLCDPP 397
S D L ++LL + RLG CH FF +W + L PP
Sbjct: 236 VSSDFLDLIQSLL-CGQKERLGYEGLCCH------------PFFSKIDWNNIRNSL--PP 280
Query: 398 FVPDVKRDEVDRRVKEDAEKYSCRFSDDA 426
FVP +K D+ D ++ EK S R S +
Sbjct: 281 FVPTLKSDD-DTSNFDEPEKNSTRRSQSS 308
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 94/307 (30%), Positives = 157/307 (51%), Gaps = 39/307 (12%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + +V+G+G FGEV +++ TG++YA K L K + KR + E+ +L + R+
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+ +L YA++ ++ L LV+ GGDL + D+ ARFY AE++ ++ +H
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM--ARFYLAEMVLAIDSVHQ 120
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR--VGTVGYMAPEVI---DN 290
+G V+RD KP+N+LLD GH+R++D G + + +V+ VGT Y++PE++ ++
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 291 EKYTYSP--DWFSFGCLIFEMIEGQAPF------------RRRKEMVKRDEVDRRVKEDA 336
K Y P DW+S G ++EM+ G+ PF KE + V E+A
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240
Query: 337 EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDP 396
+ R +C SP +RL GR G ++ K FF+ +W +
Sbjct: 241 KDLIRRL------IC------SPETRL----GRNGLQDFKDHPFFEGIDWDNIRN--STA 282
Query: 397 PFVPDVK 403
P+VP+V
Sbjct: 283 PYVPEVS 289
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 97/335 (28%), Positives = 149/335 (44%), Gaps = 53/335 (15%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + +G G FGEVC + T +YA K L K + R + V E+ IL + ++ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
VV L Y+++ KD L V+ + GGD+ + +G F+ ARFY AE+ C +E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI---FEEDLARFYIAELTCAIESVHK 119
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGL----------------------AVEIPEGESV 273
+G ++RD KP+NIL+D GH++++D GL ++E E S
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 274 RGR----------------------VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE 311
R VGT Y+APEV+ YT DW+S G +++EM+
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 312 GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYG 371
GQ PF + +V + S +A L L RLG + G
Sbjct: 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKN----G 294
Query: 372 ARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
A E+K FFK ++ L P++P +
Sbjct: 295 ADEIKAHPFFKGIDFASL-IRRQKAPYIPKITHPT 328
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 94/295 (31%), Positives = 152/295 (51%), Gaps = 34/295 (11%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F +++ G +G V + + T + +A KK+ K+ + R V +E+ IL + F
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
VVS+ ++ETK LC+V+ + GGD + N+G P + AR Y AE + LE+LH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALP---VDMARMYFAETVLALEYLHN 119
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGL--------AVEIPEG-------ESVRGRV-GT 279
G+V+RD KP+N+L+ GH++++D GL + EG E + +V GT
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 280 VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF--RRRKEM---VKRDEVDRRVKE 334
Y+APEVI + Y DW++ G +++E + G PF +E+ V D+++ +
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239
Query: 335 DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389
+A DA+ L LL+++P RLG GA E+KQ FF +W L
Sbjct: 240 EA------LPADAQDLISRLLRQNPLERLGTG----GAFEVKQHRFFLGLDWNGL 284
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 96/345 (27%), Positives = 153/345 (44%), Gaps = 85/345 (24%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F +V+G+G FGEV Q + TG +YA KKL K + +++ + V E+ IL + ++ +
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDL-----KFHIYNMGGEPGFDIARARFYAAEVLCGL 230
VV L Y+++ ++ L L++ + GGD+ K F RFY AE + +
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--------FTEEETRFYIAETILAI 114
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGL------------------------AVE 266
+ +H +G ++RD KP+N+LLD GH+++SD GL
Sbjct: 115 DSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 267 IPEGESVRGR---------------VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE 311
I + S + + VGT Y+APEV Y DW+S G +++EM+
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 312 GQAPF---------RR----RKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKS 358
G PF R+ ++ + DEV S +AK L K L
Sbjct: 235 GYPPFCSDNPQETYRKIINWKETLQFPDEV-------------PLSPEAKDLIKRLC-CE 280
Query: 359 PRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403
RL G G E+K FFK +W+ + P +P++K
Sbjct: 281 AERRL----GNNGVNEIKSHPFFKGVDWEHIRER--PAPIIPELK 319
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 3e-39
Identities = 101/344 (29%), Positives = 161/344 (46%), Gaps = 74/344 (21%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F +V+GKG FGEV Q + TGK+YA K L K + K+ + V E+ +L + +S +
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHI--YNMGGEPGFDIARARFYAAEVLCGLEHL 233
VVSL Y+++ L L++ + GGDL + Y+ E D+ RFY AE + +E +
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE---DV--TRFYMAECVLAIEAV 117
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAV------------EIPEGESVRGR----- 276
H +G ++RD KP+NIL+D GH+++SD GL+ ++ +G+S + R
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 277 -------------------------------VGTVGYMAPEVIDNEKYTYSPDWFSFGCL 305
VGT Y+APE+ + Y DW+S G +
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 306 IFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD------AKALCKALLKKSP 359
+FE + G PF + + K + + F DD A+ L + L+ +
Sbjct: 238 MFECLIGWPPF------CSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNA 290
Query: 360 RSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403
+RL GR GA E+K FF+ +W + PF+P +K
Sbjct: 291 ENRL----GRGGAHEIKSHPFFRGVDWDTIRQ--IRAPFIPQLK 328
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 3e-39
Identities = 106/337 (31%), Positives = 170/337 (50%), Gaps = 44/337 (13%)
Query: 102 KDIYNEIQPITYKT--FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES 159
KD N+I+ + K + + +V+G+G FGEV + ++T K+YA K L K + KR +
Sbjct: 29 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88
Query: 160 MVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIAR- 218
E+ I+ NS +VV L YA++ L +V+ M GGDL + N +D+
Sbjct: 89 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN------YDVPEK 142
Query: 219 -ARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--G 275
ARFY AEV+ L+ +H +G ++RD KP+N+LLD GH++++D G +++ + VR
Sbjct: 143 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202
Query: 276 RVGTVGYMAPEVIDNEK----YTYSPDWFSFGCLIFEMIEGQAPF-------RRRKEMVK 324
VGT Y++PEV+ ++ Y DW+S G ++EM+ G PF K M
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 262
Query: 325 RDEV----DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEF 380
++ + D + ++A+ C F D + RL GR G E+K+ F
Sbjct: 263 KNSLTFPDDNDISKEAKNLICAFLTDREV------------RL----GRNGVEEIKRHLF 306
Query: 381 FKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEK 417
FK+ W P VPD+ D +D +D E+
Sbjct: 307 FKNDQWAWETLRDTVAPVVPDLSSD-IDTSNFDDIEE 342
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 6e-39
Identities = 107/331 (32%), Positives = 168/331 (50%), Gaps = 38/331 (11%)
Query: 104 IYNEIQPITYKT--FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV 161
I +I+ + K + + +V+G+G FGEV + +++ K+YA K L K + KR +
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 162 LIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIAR--A 219
E+ I+ NS +VV L A++ L +V+ M GGDL + N +D+ A
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN------YDVPEKWA 144
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--GRV 277
+FY AEV+ L+ +H +GL++RD KP+N+LLD +GH++++D G +++ E VR V
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204
Query: 278 GTVGYMAPEVIDNEK----YTYSPDWFSFGCLIFEMIEGQAPF-------RRRKEMVKRD 326
GT Y++PEV+ ++ Y DW+S G +FEM+ G PF K M ++
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN 264
Query: 327 EVDRRVKEDAEKYSCRFSDDAKAL-CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385
++ ED E S AK L C L + R GR G E+KQ FFK+
Sbjct: 265 SLN--FPEDVE-----ISKHAKNLICAFLTDREVR------LGRNGVEEIKQHPFFKNDQ 311
Query: 386 WKRLEAGLCDPPFVPDVKRDEVDRRVKEDAE 416
W P VP++ D +D +D E
Sbjct: 312 WNWDNIRETAAPVVPELSSD-IDSSNFDDIE 341
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 59/76 (77%), Positives = 72/76 (94%)
Query: 660 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 719
LGKGGFGEVCACQV+ATGKMYACKKL+KKR+KKRKGE M L EK+IL+K++SRF+VSLAY
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 720 AYETKDALCLVLTIID 735
A+ETKD LCLV+T+++
Sbjct: 61 AFETKDDLCLVMTLMN 76
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 67/203 (33%), Positives = 111/203 (54%), Gaps = 5/203 (2%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + +GKGGFGEV + + TGK A K + +++ ++ + ++ E QIL+K
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCKHPN 58
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V +Y KD L +V+ +GG LK + + ++ + E+L GLE+LH
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLK-DLLKSTNQT-LTESQIAYVCKELLKGLEYLHS 116
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
G+++RD K NILL G V++ D GL+ ++ + ++ VGT +MAPEVI+ + Y Y
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 296 SPDWFSFGCLIFEMIEGQAPFRR 318
D +S G E+ EG+ P+
Sbjct: 177 KADIWSLGITAIELAEGKPPYSE 199
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 147 bits (370), Expect = 2e-38
Identities = 93/295 (31%), Positives = 138/295 (46%), Gaps = 26/295 (8%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-R 174
+R+ R LG+G FGEV + R K+ A K L KK K K L E QIL +N
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+V L ++ + +L LV+ ++GG L+ + +G + + A F A++L LE+LH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 235 YIGLVYRDCKPENILLDDYGH-VRISDLGLAVEIPEGES-------VRGRVGTVGYMAPE 286
G+++RD KPENILLD G V++ D GLA +P+ S VGT GYMAPE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 287 VI---DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA------- 336
V+ + S D +S G ++E++ G PF K + + + E
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 337 --EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389
S A L K LL K P++RL + +L K ++ L
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSS--SDLSHDLLAHLKLKESDLSDL 291
|
Length = 384 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 8e-37
Identities = 96/321 (29%), Positives = 147/321 (45%), Gaps = 56/321 (17%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + LG G FGEVC + T +YA K L KK + R + V E+ IL + ++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
VV L Y+++ KD L V+ + GGD+ + MG F ARFY AE+ C +E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHK 119
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGL--------------------------AVEIPE 269
+G ++RD KP+NIL+D GH++++D GL + E +
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 270 GESVR----------------------GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIF 307
+ R VGT Y+APEV+ YT DW+S G +++
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 308 EMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHC 367
EM+ GQ PF + + + +V + S +A L L + P RL
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRL---- 294
Query: 368 GRYGARELKQAEFFKSTNWKR 388
G+ GA E+K FFK+ ++
Sbjct: 295 GKNGADEIKAHPFFKTIDFSS 315
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 91/302 (30%), Positives = 159/302 (52%), Gaps = 31/302 (10%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + +V+G+G FGEV +++ T ++YA K L K + KR + E+ +L + ++
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+ +L YA++ ++ L LV+ GGDL + D+ ARFY AE++ + +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM--ARFYIAEMVLAIHSIHQ 120
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR--VGTVGYMAPEVIDNE-- 291
+ V+RD KP+N+LLD GH+R++D G +++ + +V+ VGT Y++PE++
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 292 ---KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS-----CRF 343
KY DW+S G ++EM+ G+ PF + E ++ E++
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIMNHEERFQFPSHITDV 236
Query: 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW---KRLEAGLCDPPFVP 400
S++AK L + L+ R RLG + G + K+ FF+ +W + LEA P++P
Sbjct: 237 SEEAKDLIQRLICSRER-RLGQN----GIEDFKKHAFFEGIDWENIRNLEA-----PYIP 286
Query: 401 DV 402
DV
Sbjct: 287 DV 288
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 96/318 (30%), Positives = 168/318 (52%), Gaps = 27/318 (8%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + +V+G+G FGEV +++ K++A K L K + KR + E+ +L ++++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+ +L YA++ ++ L LV+ GGDL + D+AR FY AE++ ++ +H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR--FYLAEMVIAIDSVHQ 120
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR--VGTVGYMAPEVI---DN 290
+ V+RD KP+NIL+D GH+R++D G +++ E +V+ VGT Y++PE++ ++
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 291 EKYTYSP--DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS-----CRF 343
K Y P DW+S G ++EM+ G+ PF + E ++ E++
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIMNHKERFQFPAQVTDV 236
Query: 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403
S+DAK L + L+ S RL G+ G + KQ FF +W + C+ P++P+V
Sbjct: 237 SEDAKDLIRRLI-CSREHRL----GQNGIEDFKQHPFFTGIDWDNIRN--CEAPYIPEVS 289
Query: 404 R--DEVDRRVKEDAEKYS 419
D + V +D K S
Sbjct: 290 SPTDTSNFDVDDDCLKNS 307
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 71/252 (28%), Positives = 129/252 (51%), Gaps = 12/252 (4%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGESMVLIEKQILQKINS 173
+ + + +GKG FG+V + ++ GK+Y K+ L K+R+ L E +IL+K+N
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE---DALNEVKILKKLNH 58
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHI--YNMGGEPGFDIARARFYAAEVLCGLE 231
++ ++E K LC+V+ +GGDL I G+P F + + ++ L+
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP-FPEEQILDWFVQLCLALK 117
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLA-VEIPEGESVRGRVGTVGYMAPEVIDN 290
+LH +++RD KP+NI L G V++ D G++ V + + VGT Y++PE+ N
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350
+ Y Y D +S GC+++E+ + PF + + +K ++S + + L
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LELALKILKGQYPPIPSQYSSELRNL 234
Query: 351 CKALLKKSPRSR 362
+LL+K P R
Sbjct: 235 VSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 57/92 (61%), Positives = 72/92 (78%), Gaps = 3/92 (3%)
Query: 660 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 719
LGKGGFGEV ACQ+RATGK+YACKKL KKR+KKRKG ++EK+IL K++SRF+VSLAY
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 720 AYETKDALCLVLTII---DVMFTCVQPSETNP 748
A++TK LCLV+TI+ D+ + E NP
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP 92
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 79/274 (28%), Positives = 128/274 (46%), Gaps = 17/274 (6%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKL-EKKRIKKRKGESMVLIEKQILQKINSR 174
+VLG+G G V + + TGK+YA KK+ + RK +L E + L+ S
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK---QLLRELKTLRSCESP 59
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+VV A+ + + +VL M+GG L + +G P +A A ++L GL++LH
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYI---ARQILKGLDYLH 116
Query: 235 YI-GLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEK 292
+++RD KP N+L++ G V+I+D G++ + VGTV YM+PE I E
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY-SCRFSDDAKALC 351
Y+Y+ D +S G + E G+ PF + + + + FS + +
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236
Query: 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385
A L+K P+ R EL Q F K +
Sbjct: 237 SACLQKDPKKRPSAA-------ELLQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 3e-33
Identities = 102/340 (30%), Positives = 151/340 (44%), Gaps = 67/340 (19%)
Query: 116 FRMYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 174
F + LG G FGEVC AC+V T +YA K L KK + R + V E+ IL + ++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVD-THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE 61
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+VV L Y+++ KD L V+ + GGD+ + M P ARFY AE+ +E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPE---VLARFYIAELTLAIESVH 118
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEI---------PEGESVR----------- 274
+G ++RD KP+NIL+D GH++++D GL +G +R
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 275 ----------------------------GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLI 306
VGT Y+APEV+ + YT DW+S G ++
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 307 FEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCH 366
FEM+ GQ PF + +V + S +A L L S RL
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLC-CSAEERL--- 294
Query: 367 CGRYGARELKQAEFFK----STNWKRLEAGLCDPPFVPDV 402
GR GA ++K FF S++ + A P+VP +
Sbjct: 295 -GRNGADDIKAHPFFSEVDFSSDIRTQPA-----PYVPKI 328
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 51/76 (67%), Positives = 68/76 (89%)
Query: 660 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 719
LGKGGFGEVCA QV+ TGKMYACKKL+KKR+KK+ GE M L+EK+IL+K+NS F+V+LAY
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 720 AYETKDALCLVLTIID 735
A+E+K LCLV+++++
Sbjct: 61 AFESKTHLCLVMSLMN 76
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 73/222 (32%), Positives = 110/222 (49%), Gaps = 30/222 (13%)
Query: 102 KDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGES 159
+++Y ++ I G+G GEV RATGK A KK L K+ +
Sbjct: 18 RELYKNLEKI-----------GEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL----- 61
Query: 160 MVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDL----KFHIYNMGGEPGFD 215
++ E I++ +V +Y D L +V+ M+GG L + M EP
Sbjct: 62 -IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMN-EP--Q 117
Query: 216 IARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR- 274
IA + EVL GLE+LH +++RD K +NILL G V+++D G A ++ + +S R
Sbjct: 118 IA---YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174
Query: 275 GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
VGT +MAPEVI + Y D +S G + EM EG+ P+
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F++ + LGKG +G V + + + YA K+++ + +++ E V E +IL +N
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHPN 60
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGE----PGFDIARARFYAAEVLCGLE 231
++S A+ + LC+V+ GDL I + P +I R ++L GL+
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR---IFIQLLRGLQ 117
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNE 291
LH +++RD K NILL V+I DLG++ ++ + + ++GT YMAPEV
Sbjct: 118 ALHEQKILHRDLKSANILLVANDLVKIGDLGIS-KVLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 292 KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY---SCRFSDDAK 348
Y+Y D +S GCL++EM PF R D R K KY +S D +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFE------ARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230
Query: 349 ALCKALLKKSPRSRLGC 365
+++L+ P+ R C
Sbjct: 231 NFIRSMLQVKPKLRPNC 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 9/205 (4%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM--VLIEKQILQKINSRFVVS 178
++G+G FG V TG A K++ ++IK+ E++ ++ E +L+ + +V
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE---EALKSIMQEIDLLKNLKHPNIVK 63
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
+ ET D+L ++L G L+ I G P +A Y +VL GL +LH G+
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAV---YVYQVLQGLAYLHEQGV 120
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRVGTVGYMAPEVIDNEKYTYSP 297
++RD K NIL G V+++D G+A ++ + + VGT +MAPEVI+ + +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTAS 180
Query: 298 DWFSFGCLIFEMIEGQAPFRRRKEM 322
D +S GC + E++ G P+ M
Sbjct: 181 DIWSLGCTVIELLTGNPPYYDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 92/328 (28%), Positives = 160/328 (48%), Gaps = 15/328 (4%)
Query: 91 LEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATG-KMYACKKLEK 149
L++ + + + + Y+ F R LG G FG V + A K+ EK
Sbjct: 7 LQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEK 66
Query: 150 KRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 209
+I K+K V E++IL IN F V+L +++ + L LVL + GG+ +
Sbjct: 67 SKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK 126
Query: 210 GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269
P D+ FYAA+++ E+L + +VYRD KPEN+LLD G ++++D G A ++ +
Sbjct: 127 RFPN-DVGC--FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA-KVVD 182
Query: 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD 329
+ GT Y+APE++ N + + DW++ G I+E++ G PF + ++ +
Sbjct: 183 TRTYT-LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----IY 237
Query: 330 RRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389
+++ E + ++ K L K LL R G + GA+ +K+ +F + +W L
Sbjct: 238 QKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNL--KKGAQNVKEHPWFGNIDWVSL 295
Query: 390 EAGLCDPPFVPDVKR--DEVD-RRVKED 414
+ P+ P K D + RV+ED
Sbjct: 296 LHKNVEVPYKPKYKNVFDSSNFERVQED 323
|
Length = 340 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 83/321 (25%), Positives = 143/321 (44%), Gaps = 66/321 (20%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F +V+G+G FGEV Q + TG +YA K L K + +++ + + E+ IL + + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
VV + Y+++ K L L++ + GGD+ + + +FY AE + ++ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--------------------- 274
+G ++RD KP+N+LLD GHV++SD GL + +
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 275 ---------------GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF--- 316
VGT Y+APEV Y DW+S G +++EM+ G PF
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 317 ----RRRKEMVKRDEV----DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCG 368
RK M ++ + + + E A+ RF D++ +R+G +
Sbjct: 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSE------------NRIGSN-- 285
Query: 369 RYGARELKQAEFFKSTNWKRL 389
G E+K FF+ +W +
Sbjct: 286 --GVEEIKSHPFFEGVDWGHI 304
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
+ + LG+G FGEV +++ G A K L K + L E +I++K++
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL--KEDASEQQIEEFLREARIMRKLD 59
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
VV L ++ L +V+ M GGDL Y P ++ +A ++ G+E+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLL--SYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG--TVGYMAPEVIDN 290
L ++RD N L+ + V+ISD GL+ ++ + + R R G + +MAPE +
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 291 EKYTYSPDWFSFGCLIFEMIE-GQAPF 316
K+T D +SFG L++E+ G+ P+
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPY 204
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 85/321 (26%), Positives = 143/321 (44%), Gaps = 66/321 (20%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F +V+G+G FGEV Q + TG +YA K L K + +++ + E+ IL + +S +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
VV + Y+++ K L L++ + GGD+ + + +FY AE + ++ +H
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV---------------------- 273
+G ++RD KP+N+LLD GHV++SD GL + +
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 274 -------RGR-------VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF--- 316
R R VGT Y+APEV Y DW+S G +++EM+ G PF
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 317 ----RRRKEMVKRDEV----DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCG 368
+K M ++ + + + E A+ RF C+ R+G
Sbjct: 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFC------CEW------EHRIGAP-- 285
Query: 369 RYGARELKQAEFFKSTNWKRL 389
G E+K FF+ +W+ +
Sbjct: 286 --GVEEIKTNPFFEGVDWEHI 304
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 120 RVLGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ LG+G FGEV ++ G A K L K + L E +I++K++
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL--KEDASEQQIEEFLREARIMRKLDHPN 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V L ++ L +V+ M GGDL ++ + ++ +A ++ G+E+L
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLES 121
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG--TVGYMAPEVIDNEKY 293
++RD N L+ + V+ISD GL+ ++ + + + + G + +MAPE + K+
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181
Query: 294 TYSPDWFSFGCLIFEMIE-GQAPF 316
T D +SFG L++E+ G+ P+
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPY 205
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 7/205 (3%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 174
+++ +G+G G V + R TG+ A KK+ +R++ + L E + LQ
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHP 59
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+VV L + LV+ M DL + + E A+ + Y +L G+ ++H
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--GRVGTVGYMAPEVI-DNE 291
G+++RD KP N+L+ G ++I+D GLA E E +V T Y APE++
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 292 KYTYSPDWFSFGCLIFEMIEGQAPF 316
KY D ++ GC+ E++ G F
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLF 201
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 68/266 (25%), Positives = 118/266 (44%), Gaps = 43/266 (16%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLA 180
+GKG FG V + ++ GK+ K+++ + +++ + ++ E IL+++ +V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE-KQQLVSEVNILRELKHPNIV--- 62
Query: 181 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAE--------- 225
Y + L +V+ GGDL I + R Y E
Sbjct: 63 -RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC--------KKERKYIEEEFIWRILTQ 113
Query: 226 VLCGLEHLHYIG-----LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-RGRVGT 279
+L L H +++RD KP NI LD +V++ D GLA + S + VGT
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173
Query: 280 VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY 339
YM+PE +++ Y D +S GCLI+E+ PF R + ++ ++KE K+
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQLASKIKEG--KF 227
Query: 340 SC---RFSDDAKALCKALLKKSPRSR 362
R+S + + K++L P R
Sbjct: 228 RRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 6/197 (3%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
+G+G +G V + + TG++ A KK+ K R + L E ++L+++N ++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
+ K L LV M+ DL + + + Y ++L GL H G+++R
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLY-KLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSHGILHR 122
Query: 242 DCKPENILLDDYGHVRISDLGLAVEI-PEGESVRGRVGTVGYMAPEVIDNEK-YTYSPDW 299
D KPEN+L++ G ++++D GLA V T Y APE++ +K Y+ D
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDI 182
Query: 300 FSFGCLIFEMIEGQAPF 316
+S GC+ E++ + F
Sbjct: 183 WSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 78/274 (28%), Positives = 125/274 (45%), Gaps = 37/274 (13%)
Query: 102 KDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV 161
++ Y IQ I G G +G+V + ATG++ A K IK G+
Sbjct: 2 QEDYELIQRI-----------GSGTYGDVYKARDIATGELVAIKV-----IKLEPGDDFE 45
Query: 162 LIEKQI--LQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEP--GFDIA 217
+I+++I L++ +V+ +Y +D L +V+ GG L+ IY + P IA
Sbjct: 46 IIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIA 104
Query: 218 RARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR- 276
+ E L GL +LH G ++RD K NILL + G V+++D G++ ++ + R
Sbjct: 105 ---YVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161
Query: 277 VGTVGYMAPEVIDNEK---YTYSPDWFSFGCLIFEMIEGQAPF-----RRRKEMVKRDEV 328
+GT +MAPEV E+ Y D ++ G E+ E Q P R ++ +
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF 221
Query: 329 DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSR 362
+D EK+S F D K L K P+ R
Sbjct: 222 PPPKLKDKEKWSPVFHD----FIKKCLTKDPKKR 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE----SMVLIEKQILQKINSRFVV 177
LG+G +G V + + TG++ A KK I+ E S L E +L+++ +V
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKK-----IRLDNEEEGIPSTALREISLLKELKHPNIV 61
Query: 178 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG 237
L T+ L LV + DLK ++ + ++L GL + H
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLA--VEIPEGESVRGRVGTVGYMAPEVIDNEK-YT 294
+++RD KP+NIL++ G ++++D GLA IP V T+ Y APE++ K Y+
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH-EVVTLWYRAPEILLGSKHYS 177
Query: 295 YSPDWFSFGCLIFEMIEGQAPFR 317
+ D +S GC+ EMI G+ F
Sbjct: 178 TAVDIWSVGCIFAEMITGKPLFP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK--QILQKI 171
+ F + LG+G +G V + TG++ A K + + E + I K IL++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQEIIKEISILKQC 55
Query: 172 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARAR----------F 221
+S ++V +Y L +V+ G + DI +
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVS------------DIMKITNKTLTEEEIAA 103
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRV-GTV 280
+ L GLE+LH ++RD K NILL++ G +++D G++ ++ + + R V GT
Sbjct: 104 ILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTP 163
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
+MAPEVI Y D +S G EM EG+ P+
Sbjct: 164 FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 120 RVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFV 176
+ LG+G FGEV +++ A K L K + L E ++++K+ V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL--KEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 177 VSLAYAYETKDALCLVLTIMNGGDLKFHI------YNMGGEPGFDIARARFYAAEVLCGL 230
V L ++ L LVL M GGDL ++ + + + +A ++ G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---VGYMAPEV 287
E+L V+RD N L+ + V+ISD GL+ ++ + + R + G + +MAPE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 288 IDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ + +T D +SFG L++E+ G P+
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPY 208
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 70/259 (27%), Positives = 118/259 (45%), Gaps = 18/259 (6%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI--LQKIN 172
+R +LG G FG V G +A K++ + E++ +E++I L K+
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
+V +D L + L ++ GG L + G F R Y ++L GLE+
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS---FPEPVIRLYTRQILLGLEY 117
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNE- 291
LH V+RD K NIL+D G V+++D G+A ++ E + G+ +MAPEVI +
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 292 KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-----VKRDEVDRRVKEDAEKYSCRFSDD 346
Y + D +S GC + EM G+ P+ + + + + R + + + SD+
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH-------LSDE 230
Query: 347 AKALCKALLKKSPRSRLGC 365
AK L++ P R
Sbjct: 231 AKDFILKCLQRDPSLRPTA 249
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 36/72 (50%), Positives = 49/72 (68%)
Query: 660 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 719
LGKG FG+V + + TGK+YA K L+KK+I KRK L E+ IL +IN F+V L Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 720 AYETKDALCLVL 731
A++T++ L LVL
Sbjct: 61 AFQTEEKLYLVL 72
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 7e-23
Identities = 78/261 (29%), Positives = 117/261 (44%), Gaps = 32/261 (12%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGESM--VLIEKQILQKINSRFV 176
V+G G V A + A K+ LEK + S+ + E Q + + N V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT------SVDELRKEVQAMSQCNHPNV 61
Query: 177 VSLAYAYETKDALCLVLTIMNGG---DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
V ++ D L LV+ ++GG D+ Y GG IA EVL GLE+L
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA---TVLKEVLKGLEYL 118
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-----VGTVGYMAPEVI 288
H G ++RD K NILL + G V+I+D G++ + +G + VGT +MAPEV+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 289 DNEK-YTYSPDWFSFGCLIFEMIEGQAPFRRRKEM------VKRDEVDRRVKEDAEKYSC 341
+ Y + D +SFG E+ G AP+ + M ++ D D +KYS
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238
Query: 342 RFSDDAKALCKALLKKSPRSR 362
F + + L+K P R
Sbjct: 239 SF----RKMISLCLQKDPSKR 255
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 26/206 (12%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-R 174
+++ + LG G FG V + + TG++ A KK+ KK+ E M L E + L+K+N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYS-WEECMNLREVKSLRKLNEHP 58
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM----GGEPGFDIARARFYAAEVLCGL 230
+V L + D L V M G ++Y + G+P F + R ++L GL
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEG-----NLYQLMKDRKGKP-FSESVIRSIIYQILQGL 112
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR------VGTVGYMA 284
H+H G +RD KPEN+L+ V+I+D GLA EI R R V T Y A
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI------RSRPPYTDYVSTRWYRA 166
Query: 285 PEVIDNEKYTYSP-DWFSFGCLIFEM 309
PE++ SP D ++ GC++ E+
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 68/248 (27%), Positives = 121/248 (48%), Gaps = 6/248 (2%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + +GKG FG V +A ++YA K+++ ++ +R+ E + E ++L K++S +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREE-AIDEARVLAKLDSSY 60
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
++ ++ K L +V+ GDL + G P + RF+ ++L GL HLH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLHS 119
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEGESVRGRVGTVGYMAPEVIDNEKYT 294
+++RD K N+ LD Y +V+I DLG+A + VGT Y++PE+ +++ Y
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 295 YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354
D ++ G +++E G+ PF + ++ R V S +S L
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV---FPPVSQMYSQQLAQLIDQC 236
Query: 355 LKKSPRSR 362
L K R R
Sbjct: 237 LTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 9/213 (4%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMVLIEKQILQKINS 173
+R ++LG+G FG V C TG+ A K++ +K + + E Q+L+ +
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+V + L + + M GG +K + G R Y ++L G+E+L
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYL 120
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP----EGESVRGRVGTVGYMAPEVID 289
H +V+RD K NIL D G+V++ D G + + G ++ GT +M+PEVI
Sbjct: 121 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 290 NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
E Y D +S GC + EM+ + P+ + M
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 78/276 (28%), Positives = 119/276 (43%), Gaps = 26/276 (9%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGESMVLIEKQILQKIN 172
LG G G V R TGK+ A K + + I+K+ +L E IL K N
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-----ILRELDILHKCN 57
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDL-KFHIYNMGGEPGFDIARARFYAAEVLCGLE 231
S ++V A+ + + + M+GG L K G P + + A VL GL
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKI---AVAVLKGLT 114
Query: 232 HLH-YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVID 289
+LH +++RD KP NIL++ G +++ D G++ ++ S+ VGT YMAPE I
Sbjct: 115 YLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN--SLAKTFVGTSSYMAPERIQ 172
Query: 290 NEKYTYSPDWFSFGCLIFEMIEGQAPFR--RRKEMVKRDEVDRRVKEDAEKY-SCRFSDD 346
Y+ D +S G + E+ G+ P+ + + V E + S +FS D
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232
Query: 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
+ L K PR R EL + F K
Sbjct: 233 FQDFVNLCLIKDPRERPSYK-------ELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 76/277 (27%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 119 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVS 178
+ +G+G G VC ++TG+ A KK++ ++K++ ++ E I++ +V
Sbjct: 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 179 LAYAYETKDALCLVLTIMNGG---DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+ +Y D L +V+ + GG D+ H M E + A VL L LH
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLA------VLKALSFLHA 133
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLG----LAVEIPEGESVRGRVGTVGYMAPEVIDNE 291
G+++RD K ++ILL G V++SD G ++ E+P +S+ VGT +MAPEVI
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPEVISRL 190
Query: 292 KYTYSPDWFSFGCLIFEMIEGQAPFRRR---KEMVK-RDEVDRRVKEDAEKYSCRFSDDA 347
Y D +S G ++ EM++G+ P+ + M + RD + ++K + K S R
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRLRS-- 247
Query: 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384
+L + P R A EL F
Sbjct: 248 --FLDRMLVRDPAQ-------RATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 80/279 (28%), Positives = 119/279 (42%), Gaps = 38/279 (13%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGESMVLIEK--QILQKI 171
F + +GKG FGEV + T ++ A K LE+ + + I++ Q L +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE------DEIEDIQQEIQFLSQC 56
Query: 172 NSRFVVSLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
S ++ Y K + L +++ GG + G IA F EVL GL
Sbjct: 57 RSPYITKY-YGSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIA---FILREVLLGL 111
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVID 289
E+LH G ++RD K NILL + G V+++D G++ ++ S R VGT +MAPEVI
Sbjct: 112 EYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 290 NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV-----KEDAEKYSCR-F 343
Y D +S G E+ +G+ P M RV K + F
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIPKNNPPSLEGNKF 223
Query: 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
S K L K P+ R A+EL + +F K
Sbjct: 224 SKPFKDFVSLCLNKDPKERP-------SAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 122 LGKGGFGEVCACQVRATGKMYACK-----KLEKKRIKKRKGESMVLIEKQILQKINSRFV 176
+G G FG+V TG++ A K + K IK+ E ++L+ + +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEM------KVLELLKHPNL 61
Query: 177 VSLAYAYET-KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
V Y E ++ + + + +GG L+ + + D R Y ++L GL +LH
Sbjct: 62 VKY-YGVEVHREKVYIFMEYCSGGTLEELLEHGRIL---DEHVIRVYTLQLLEGLAYLHS 117
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEI-----PEGESVRGRVGTVGYMAPEVIDN 290
G+V+RD KP NI LD G +++ D G AV++ GE V+ GT YMAPEVI
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 291 EKYTY---SPDWFSFGCLIFEMIEGQAPF 316
K + D +S GC++ EM G+ P+
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPW 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLE-KKRIKKRKGESMVLIEKQILQKINS------ 173
++GKG +G V TG+M A K++E I R + K + +I +
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 174 -RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
V L + T++ L + L + GG + G F+ RF+ +VL GL +
Sbjct: 68 LNIVQYLGFE-TTEEYLSIFLEYVPGGSIG-SCLRTYGR--FEEQLVRFFTEQVLEGLAY 123
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLA---VEIPEGESVRGRVGTVGYMAPEVID 289
LH G+++RD K +N+L+D G +ISD G++ +I + + G+V +MAPEVI
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 290 NEKYTYSP--DWFSFGCLIFEMIEGQAPFRR 318
+ YS D +S GC++ EM G+ P+
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 63/216 (29%), Positives = 112/216 (51%), Gaps = 18/216 (8%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRI----KKRKGESMVLIEKQI--LQKINSR 174
++G G FG V ++G++ A K++E + K RK + + ++I L+++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+V + D L + L + GG + + N G F+ R + ++L GL +LH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLH 123
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRV--------GTVGYMAPE 286
G+++RD K NIL+D+ G ++ISD G++ ++ E S+ + G+V +MAPE
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
V+ YT D +S GCL+ EM+ G+ PF ++
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 69/296 (23%), Positives = 132/296 (44%), Gaps = 51/296 (17%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-EKQILQKINSRFVVSLA 180
+G+G +G+V + + TG++ A KK+ + +++G + I E ++LQK+ +V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 181 --YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
+ K ++ +V M+ DL + + + F ++ + Y ++L GL++LH G+
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVK--FTESQIKCYMKQLLEGLQYLHSNGI 121
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG---RVGTVGYMAPEVIDNE-KYT 294
++RD K NIL+++ G ++++D GLA + RV T+ Y PE++ +Y
Sbjct: 122 LHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 295 YSPDWFSFGCLIFEMIEGQAPFRRRKEM-----------------------------VKR 325
D +S GC++ E+ G+ F+ E+ +K
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 326 DEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381
+ +R E + A L LL P+ R+ A + Q E+F
Sbjct: 241 KKPYKRRL--REFFKHLIDPSALDLLDKLLTLDPKKRI-------SADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 81/272 (29%), Positives = 130/272 (47%), Gaps = 36/272 (13%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
+G+G G VC + TGK A KK++ ++ ++R+ ++ E I++ + VV +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRE---LLFNEVVIMRDYHHENVVDMYN 86
Query: 182 AYETKDALCLVLTIMNGG---DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
+Y D L +V+ + GG D+ H M E IA VL L +LH G+
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEE---QIATV---CLSVLRALSYLHNQGV 139
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAV----EIPEGESVRGRVGTVGYMAPEVIDNEKYT 294
++RD K ++ILL G +++SD G E+P+ +S+ VGT +MAPEVI Y
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL---VGTPYWMAPEVISRLPYG 196
Query: 295 YSPDWFSFGCLIFEMIEGQAPFRRRKEMVK----RDEVDRRVKEDAEKYSCRFSDDAKAL 350
D +S G ++ EMI+G+ P+ + RD + RVK+ S + S +
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD-----SHKVSSVLRGF 251
Query: 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
+L + P R A+EL Q F K
Sbjct: 252 LDLMLVREPSQRA-------TAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 8e-21
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGESMVLIEKQILQKI 171
+ + LG+G FGEV ++ G+ A K L K + L E I++K+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKL 58
Query: 172 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLE 231
+ +V L + L +V M GGDL + G + + A ++ G+E
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIAKGME 116
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---VGYMAPEVI 288
+L V+RD N L+ + V+ISD GL+ +I E + R R G + +MAPE +
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 289 DNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ K+T D +SFG L++E+ G+ P+
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPY 205
|
Length = 258 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 1e-20
Identities = 48/155 (30%), Positives = 87/155 (56%), Gaps = 7/155 (4%)
Query: 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI 171
+ + F + + + +G FG+V + + K+YA K ++K + + V E+ L
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 172 NSRFVVSLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGGEPGFDIARARFYAAEVLCG 229
S F+V L Y+ ++ + + LV+ + GGD+K HIY FD A Y +EV
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-----FDEEMAVKYISEVALA 116
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264
L++LH G+++RD KP+N+L+ + GH++++D GL+
Sbjct: 117 LDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 76/255 (29%), Positives = 121/255 (47%), Gaps = 24/255 (9%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGESMVLIEKQILQKINSRFVVS 178
LG G G V + TG + A K + K ++K+ +L E QI+ + S ++VS
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMHECRSPYIVS 67
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI-G 237
A+ ++ +C+ + M+ G L IY GG +I A V+ GL +L+ +
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSLD-RIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR 124
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEKYTYS 296
+++RD KP NIL++ G +++ D G++ E+ S+ VGT YM+PE I KYT
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN--SIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 297 PDWFSFGCLIFEMIEGQAPFRRRKE--------MVKRDEVDRRVKEDAEKY-SCRFSDDA 347
D +S G I E+ G+ PF M D + + V+E + S F +D
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL 242
Query: 348 KALCKALLKKSPRSR 362
+ A L K P R
Sbjct: 243 RDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 67/226 (29%), Positives = 114/226 (50%), Gaps = 16/226 (7%)
Query: 95 ENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 154
E R + + + + P TY + +G+G G VC V+++GK+ A KK++ ++ ++
Sbjct: 3 EQFRAALQMVVDPGDPRTY--LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR 60
Query: 155 RKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGG---DLKFHIYNMGGE 211
R+ ++ E I++ VV + +Y D L +V+ + GG D+ H M E
Sbjct: 61 RE---LLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEE 116
Query: 212 PGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEG 270
IA VL L LH G+++RD K ++ILL G V++SD G ++ E
Sbjct: 117 ---QIAAV---CLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170
Query: 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
+ VGT +MAPE+I Y D +S G ++ EM++G+ P+
Sbjct: 171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV---LIEKQILQKINSRFV 176
+ LG G F + TG + A K++ R + E +V E +++ ++N +
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 177 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI 236
+ + A L + M GG + + G F A Y ++L GL +LH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLHEN 122
Query: 237 GLVYRDCKPENILLDDYGH-VRISDLG----LAVEIPEGESVRGR-VGTVGYMAPEVIDN 290
+++RD K N+L+D G +RI+D G LA + +G+ +GT+ +MAPEV+
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQAPF 316
E+Y S D +S GC+I EM + P+
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 1e-19
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 8/204 (3%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K + Y +G+G G V ATG+ A K++ ++K+ + +++ E +++++ +
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKN 75
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+V+ ++ D L +V+ + GG L ++ E D A+ E L LE L
Sbjct: 76 PNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFL 131
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEGESVRGRVGTVGYMAPEVIDNEK 292
H +++RD K +N+LL G V+++D G +I PE VGT +MAPEV+ +
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPF 316
Y D +S G + EM+EG+ P+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 10/207 (4%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F++ + +GKG F V G++ A KK++ + K L E +L++++
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GGEPGFDIARARFYAAEVLCGLEHL 233
V+ ++ + L +VL + + GDL I + Y ++ LEH+
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLCSALEHM 122
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGL----AVEIPEGESVRGRVGTVGYMAPEVID 289
H +++RD KP N+ + G V++ DLGL + + S+ VGT YM+PE I
Sbjct: 123 HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIH 179
Query: 290 NEKYTYSPDWFSFGCLIFEMIEGQAPF 316
Y + D +S GCL++EM Q+PF
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 2/203 (0%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
FR+ + +G+G F EV G A KK++ + K + + E +L+++N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF-YAAEVLCGLEHLH 234
V+ ++ + L +VL + + GDL I + + + + Y ++ LEH+H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP-EGESVRGRVGTVGYMAPEVIDNEKY 293
+++RD KP N+ + G V++ DLGL + + VGT YM+PE I Y
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 294 TYSPDWFSFGCLIFEMIEGQAPF 316
+ D +S GCL++EM Q+PF
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 66/247 (26%), Positives = 122/247 (49%), Gaps = 11/247 (4%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
RV+GKG +GEV + R GK Y KKL + +R+ ++ E Q+L ++ +V+
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ-EAQLLSQLKHPNIVAY 64
Query: 180 AYAYETKDA-LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
++E +D L +V+ GGDL + G+ + ++ ++ L++LH +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMALQYLHEKHI 123
Query: 239 VYRDCKPENILLDDYGHVRISDLGLA-VEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSP 297
++RD K +N+ L +++ DLG+A V + + +GT YM+PE+ N+ Y Y
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKS 183
Query: 298 DWFSFGCLIFEMIEGQAPFRRR--KEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355
D ++ GC ++EM + F + +V R ++ ++ + YS + L +L
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGE----LIATML 238
Query: 356 KKSPRSR 362
K P R
Sbjct: 239 SKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 67/286 (23%), Positives = 121/286 (42%), Gaps = 53/286 (18%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMVLIEKQILQKINSRFV 176
V+G+G +G V C+ +ATG++ A KK + + +KK L E ++L+++ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKK-----TALREVKVLRQLRHENI 62
Query: 177 VSLAYAYETKDALCLVL-----TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLE 231
V+L A+ K L LV T++ + G R Y ++L +
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVERTLLELLEAS--------PGGLPPDAVRSYIWQLLQAIA 114
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--GRVGTVGYMAPEV-I 288
+ H +++RD KPENIL+ + G +++ D G A + + V T Y APE+ +
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 289 DNEKYTYSPDWFSFGCLIFEMIEGQAPF--------------------RRRKEMVKRDEV 328
+ Y D ++ GC++ E+++G+ F +E+ +
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234
Query: 329 DRRVK------ED--AEKYSCRFSDDAKALCKALLKKSPRSRLGCH 366
V + +Y + S A KA L+ P+ RL C
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCD 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 9e-19
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 11/216 (5%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGESMVLIEKQILQKIN 172
+R ++LG+G FG V C TG+ A K+++ + + K S + E Q+L+ +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 173 SRFVVSL--AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
+V + L + + M GG +K + G + R Y ++L G+
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGM 119
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP----EGESVRGRVGTVGYMAPE 286
+LH +V+RD K NIL D G+V++ D G + + G +R GT +M+PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
VI E Y D +S GC + EM+ + P+ + M
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+++VS +D++ LVL GG L HI P + R +AAE++ L+ L
Sbjct: 52 KYIVS-------EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR---WAAEMVVALDAL 101
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE---GESVRGRVGTVGYMAPEVIDN 290
H G+V RD P NILLDD GH++++ E+ + GE+V Y APEV
Sbjct: 102 HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGI 156
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350
+ T + DW+S G ++FE++ G+ + + E S++A++L
Sbjct: 157 SEETEACDWWSLGAILFELLTGKTLVECHPSGINT-HTTLNIPE-------WVSEEARSL 208
Query: 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFF 381
+ LL+ +P RLG G G ++K FF
Sbjct: 209 LQQLLQFNPTERLG--AGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 32/267 (11%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGESMVLIEKQILQKIN 172
LG+G G V C+++ TG ++A K + ++K+ +L E +I +
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ-----ILRELEINKSCK 57
Query: 173 SRFVVSL--AYAYETKDALCLVLTIMNGGDLKFHIY----NMGGEPGFDIARARFYAAEV 226
S ++V A+ E+ ++ + + GG L IY GG G + A V
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGK--IAESV 114
Query: 227 LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAP 285
L GL +LH +++RD KP NILL G V++ D G++ E+ S+ G GT YMAP
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--VNSLAGTFTGTSFYMAP 172
Query: 286 EVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKE----------MVKRDEVDRRVKED 335
E I + Y+ + D +S G + E+ + + PF E + +D
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL--KD 230
Query: 336 AEKYSCRFSDDAKALCKALLKKSPRSR 362
++S++ K K L+K P R
Sbjct: 231 EPGNGIKWSEEFKDFIKQCLEKDPTRR 257
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 8/204 (3%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K + + +G+G G V ATG+ A +++ ++ K++ +++ E ++++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---LIINEILVMRENKN 76
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+V+ +Y D L +V+ + GG L ++ E D + E L LE L
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEK 292
H +++RD K +NILL G V+++D G +I +S R VGT +MAPEV+ +
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPF 316
Y D +S G + EMIEG+ P+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 119 YRVLGK---GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR- 174
Y++LGK G F EV Q R TGK YA K + KK K + L E Q L++++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKS-LEQVNNLREIQALRRLSPHP 58
Query: 175 FVVSLA-YAYETKDA-LCLVLTIMNGGDLKFHIYNM--GGEPGFDIARARFYAAEVLCGL 230
++ L ++ K L LV +M+ ++Y + G + R + Y ++L L
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMDM-----NLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG---------RVGTVG 281
+H+H G+ +RD KPENIL+ D ++++D G S RG + T
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFG---------SCRGIYSKPPYTEYISTRW 163
Query: 282 YMAPE-VIDNEKYTYSPDWFSFGCLIFEMI 310
Y APE ++ + Y D ++ GC+ FE++
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 73/253 (28%), Positives = 109/253 (43%), Gaps = 20/253 (7%)
Query: 122 LGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
LGKG +G V R TG A K +LE K + +++E IL K S ++V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ----IIMELDILHKAVSPYIVDF 64
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGE-PGFDIARARFYAAEVLCGLEHL---HY 235
A+ + A+ + + M+ G L +Y G G R V+ GL+ L H
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVI------D 289
I ++RD KP N+L++ G V++ D G++ + + +G YMAPE I
Sbjct: 124 I--IHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 290 NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349
N YT D +S G I EM G+ P+ ++ V D +SDDA+
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQD 240
Query: 350 LCKALLKKSPRSR 362
L K P R
Sbjct: 241 FVAKCLNKIPNRR 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 8/204 (3%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K + + +G+G G V ATG+ A K++ ++ K++ +++ E ++++
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKE---LIINEILVMRENKH 75
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+V+ +Y D L +V+ + GG L + + G A R E L LE L
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQALEFL 131
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEGESVRGRVGTVGYMAPEVIDNEK 292
H +++RD K +NILL G V+++D G +I PE VGT +MAPEV+ +
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPF 316
Y D +S G + EM+EG+ P+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 2/203 (0%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F++ + +G+G F EV K A KK++ + K + E +L+++N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF-YAAEVLCGLEHLH 234
V+ ++ + L +VL + + GDL I + R + Y ++ +EH+H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP-EGESVRGRVGTVGYMAPEVIDNEKY 293
+++RD KP N+ + G V++ DLGL + + VGT YM+PE I Y
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 294 TYSPDWFSFGCLIFEMIEGQAPF 316
+ D +S GCL++EM Q+PF
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 6/242 (2%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
+G+G FG+ + + GK Y K++ ++ ++ E E +L + +V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREE-SRKEVAVLSNMKHPNIVQYQE 66
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
++E L +V+ GGDL I G F + + ++ L+H+H +++R
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVL-FPEDQILDWFVQICLALKHVHDRKILHR 125
Query: 242 DCKPENILLDDYGHVRISDLGLA-VEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWF 300
D K +NI L G +++ D G+A V E R +GT Y++PE+ +N Y D +
Sbjct: 126 DIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIW 185
Query: 301 SFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPR 360
+ GC+++EM + F ++ V + ++ S +S D + L L K++PR
Sbjct: 186 ALGCVLYEMCTLKHAFEAGN---MKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPR 242
Query: 361 SR 362
R
Sbjct: 243 DR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 9e-18
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 8/204 (3%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K + + +G+G G V ATG+ A K++ ++ K++ +++ E ++++ +
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE---LIINEILVMRENKN 75
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+V+ +Y D L +V+ + GG L ++ E D + E L L+ L
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFL 131
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEGESVRGRVGTVGYMAPEVIDNEK 292
H +++RD K +NILL G V+++D G +I PE VGT +MAPEV+ +
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPF 316
Y D +S G + EM+EG+ P+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVSL 179
VLGKG +G V A + +T A K++ ++ + L E+ L + R +V
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR----YVQPLHEEIALHSYLKHRNIVQY 70
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
+ + + + GG L + + G + FY ++L GL++LH +V
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 240 YRDCKPENILLDDY-GHVRISDLG----LAVEIPEGESVRGRVGTVGYMAPEVIDNEKYT 294
+RD K +N+L++ Y G V+ISD G LA P E+ GT+ YMAPEVID
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVIDKGPRG 187
Query: 295 YSP--DWFSFGCLIFEMIEGQAPF 316
Y D +S GC I EM G+ PF
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 21/200 (10%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-GESMVLI-EKQILQKINSRFVVSL 179
LG+G + V + + TG++ A KK++ K+ K G + + E ++LQ++ ++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC-------GLEH 232
+ K + LV M DL+ I + A++ GLE+
Sbjct: 68 LDVFGHKSNINLVFEFM-ETDLEKVIKDK---------SIVLTPADIKSYMLMTLRGLEY 117
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRVGTVGYMAPEVI-DN 290
LH +++RD KP N+L+ G ++++D GLA + +V T Y APE++
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGA 177
Query: 291 EKYTYSPDWFSFGCLIFEMI 310
Y D +S GC+ E++
Sbjct: 178 RHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 8/199 (4%)
Query: 119 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVS 178
Y +G+G G VC + + +G+ A K ++ ++ ++R+ ++ E I++ + VV
Sbjct: 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRE---LLFNEVVIMRDYQHQNVVE 82
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
+ +Y + L +++ + GG L ++ + + + VL L +LH G+
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQGV 138
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEKYTYSP 297
++RD K ++ILL G V++SD G +I + R VGT +MAPEVI Y
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 298 DWFSFGCLIFEMIEGQAPF 316
D +S G ++ EM++G+ P+
Sbjct: 199 DIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMY-ACKKL--------EKKRIKKRKGESMVLIEK 165
+ + LG G FG V + + G+ A K++ + KR + + +V
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 166 QILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA-- 223
I +++ +V + D L +V+ ++ G L H ++ E R +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIF 119
Query: 224 AEVLCGLEHLHYIG-LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGY 282
+++ L +LH +V+RD P NI+L + V I+D GLA + + VGT+ Y
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
PE++ NE Y D ++FGC++++M Q PF
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 66/213 (30%), Positives = 108/213 (50%), Gaps = 27/213 (12%)
Query: 118 MYRVLGK---GGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMVLIEKQILQK 170
Y LG G +G V C+ + TG++ A KK + K +KK + + E ++L++
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKK-----IAMREIRMLKQ 56
Query: 171 INSRFVVSLAYAYETKDALCLVL-----TIMNGGDLKFHIYNMGGEPGFDIARARFYAAE 225
+ +V+L + K L LV T+++ DL+ + G D +R R Y +
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLD--DLEKY------PNGLDESRVRKYLFQ 108
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRVGTVGYMA 284
+L G+E H +++RD KPENIL+ G V++ D G A + GE V T Y A
Sbjct: 109 ILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRA 168
Query: 285 PE-VIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
PE ++ + KY + D ++ GCL+ EM+ G+ F
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 11/215 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGESMVLIEKQILQKI-N 172
+R+ ++LG+G FG V C TG+ A K+++ + + K + + E Q+L+ + +
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 173 SRFVVSLAYAYETKD-ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLE 231
R V + + L + + M GG +K + + G R Y ++L G+
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVS 120
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP----EGESVRGRVGTVGYMAPEV 287
+LH +V+RD K NIL D G+V++ D G + + G ++ GT +M+PEV
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 288 IDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
I E Y D +S GC + EM+ + P+ + M
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKK----LEKKRIKKRKGESMVLIEKQILQKIN-SRFV 176
+G+G +G+V + + TGK+ A KK ++++ I L E +LQ ++ S ++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP-----PTALREISLLQMLSESIYI 63
Query: 177 VSLAYAYET-----KDALCLVLTIMNGGDLKFHIYNMGGEPG--FDIARARFYAAEVLCG 229
V L K +L LV ++ DLK + + G PG + + ++L G
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGHV-RISDLGL--AVEIPEGESVRGRVGTVGYMAPE 286
+ H H G+++RD KP+N+L+D + +I+DLGL A IP S + T+ Y APE
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPE 181
Query: 287 V-IDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
V + + Y+ D +S GC+ EM Q F
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 61/245 (24%), Positives = 115/245 (46%), Gaps = 8/245 (3%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
RV+G+G FG V C+ +A K+ K++ +++ K + + E Q+L+ ++ ++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSHPNIIEY 64
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
+ AL +V+ GG L +I D + ++L L H+H ++
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTKLIL 123
Query: 240 YRDCKPENILLDDYGHV-RISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPD 298
+RD K +NILLD + V +I D G++ + VGT Y++PE+ + + Y D
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSD 183
Query: 299 WFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK-YSCRFSDDAKALCKALLKK 357
++ GC+++E+ A +R E + ++ S R+S D + L ++L
Sbjct: 184 IWALGCVLYEL----ASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL 239
Query: 358 SPRSR 362
P R
Sbjct: 240 DPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 6e-17
Identities = 28/78 (35%), Positives = 47/78 (60%), Gaps = 2/78 (2%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + LG+G FG+V + + TGK+ A K ++KK+IKK + +L E +IL+K+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58
Query: 714 VVSLAYAYETKDALCLVL 731
+V L +E +D L LV+
Sbjct: 59 IVRLYDVFEDEDKLYLVM 76
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 57/202 (28%), Positives = 104/202 (51%), Gaps = 9/202 (4%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE-SMVLIEKQILQKINSRFVVSLA 180
LG+G + V + R TG++ A K++ + +G S + E +++++ +V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVY 240
T++ L LV M+ DLK ++ G D + + ++L G+ H +++
Sbjct: 65 DVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 241 RDCKPENILLDDYGHVRISDLGL--AVEIPEGESVRGRVGTVGYMAPEVI-DNEKYTYSP 297
RD KP+N+L++ G ++++D GL A IP + V T+ Y AP+V+ + Y+ S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPV-NTFSNEVVTLWYRAPDVLLGSRTYSTSI 182
Query: 298 DWFSFGCLIFEMIEGQAPFRRR 319
D +S GC++ EMI G+ F
Sbjct: 183 DIWSVGCIMAEMITGRPLFPGT 204
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 7e-17
Identities = 72/259 (27%), Positives = 125/259 (48%), Gaps = 25/259 (9%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + + +G G +G+V + TG++ A K IK GE +++++I+ + +
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKV-----IKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 176 VVSLAY--AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+AY +Y +D L + + GG L+ IY++ G ++ + + E L GL +L
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQ-DIYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEK 292
H G ++RD K NILL D GHV+++D G++ +I + R +GT +MAPEV E+
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 293 ---YTYSPDWFSFGCLIFEMIEGQA------PFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343
Y D ++ G E+ E Q P R M K + ++K+ ++
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM-----KW 237
Query: 344 SDDAKALCKALLKKSPRSR 362
S+ K L K+P+ R
Sbjct: 238 SNSFHHFVKMALTKNPKKR 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 11/215 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKL--EKKRIKKRKGESMVLIEKQILQKINS 173
+R+ ++LG+G FGEV C TG+ A K++ + + K + + E Q+L+ +
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 174 RFVVSLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLE 231
+V + L + + M GG +K + G R Y ++L G+
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQILQGVS 120
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP----EGESVRGRVGTVGYMAPEV 287
+LH +V+RD K NIL D G+V++ D G + I G ++ GT +M+PEV
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 288 IDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
I E Y D +S C + EM+ + P+ + M
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 16/234 (6%)
Query: 125 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 184
G FG+V + + T K++ K ++ K E MV L K N F+ L Y+
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAK--NFNAIEPMV----HQLMKDNPNFI-KLYYSVT 79
Query: 185 TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCK 244
T L++ + GDL F + E A + +++ L LH +++ D K
Sbjct: 80 TLKGHVLIMDYIKDGDL-FDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK 136
Query: 245 PENILLDDY-GHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFG 303
EN+L D + + D GL +I S GT+ Y +PE I Y S DW++ G
Sbjct: 137 LENVLYDRAKDRIYLCDYGL-CKIIGTPSCYD--GTLDYFSPEKIKGHNYDVSFDWWAVG 193
Query: 304 CLIFEMIEGQAPFRR-RKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLK 356
L +E++ G+ PF+ E + + + +R ++ S +A +++LK
Sbjct: 194 VLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV-SKNANDFVQSMLK 246
|
Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 27/217 (12%)
Query: 105 YNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK----KRIKKRKGESM 160
Y ++QP+ G G FG VC+ + + TG+ A KK+ K + KR
Sbjct: 12 YVDLQPV-----------GMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR----- 55
Query: 161 VLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARAR 220
E ++L+ + ++SL+ + + +T + G DL + + E F +
Sbjct: 56 TYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQF----IQ 111
Query: 221 FYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTV 280
++ ++L GL+++H G+V+RD KP NIL+++ ++I D GLA + + G V T
Sbjct: 112 YFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYVSTR 169
Query: 281 GYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPF 316
Y APE++ +KY D +S GC+ EM+EG+ F
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-16
Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEK--------KRIKKRKGESMVLIEKQILQKI 171
+ +G G +G VC+ + TG+ A KK+ KRI L E ++L+ +
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRI---------LREIKLLRHL 56
Query: 172 NSRFVVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
++ L + E + + +V +M DL I + +P +++ ++
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKS--PQP-LTDDHIQYFLYQI 112
Query: 227 LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA----VEIPEGESVRGRVGTVGY 282
L GL++LH +++RD KP NIL++ ++I D GLA + E + V T Y
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172
Query: 283 MAPEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
APE++ + +YT + D +S GC+ E++ + F
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 70/285 (24%), Positives = 131/285 (45%), Gaps = 44/285 (15%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKL-------EKKRIKKRKGESMVLIEKQIL 168
++ ++G+G +G V + TG++ A K + + I++ E +L + +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR---EVALLSQLRQS 59
Query: 169 QKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAA---- 224
Q N + +Y L +++ GG ++ + + G A Y +
Sbjct: 60 QPPN---ITKYYGSYLKGPRLWIIMEYAEGGSVRTLM-----KAG---PIAEKYISVIIR 108
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYM 283
EVL L+++H +G+++RD K NIL+ + G+V++ D G+A + + S R VGT +M
Sbjct: 109 EVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWM 168
Query: 284 APEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPFRR----RKEMVKRDEVDRRVKEDAEK 338
APEVI + + Y D +S G I+EM G P+ R M+ R++++
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNG-- 226
Query: 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383
+S + A L + P+ RL A EL ++++ K+
Sbjct: 227 ----YSKLLREFVAACLDEEPKERL-------SAEELLKSKWIKA 260
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 79/264 (29%), Positives = 127/264 (48%), Gaps = 22/264 (8%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + + +G G +G+V + TG++ A K IK G+ LI+++I +
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKI-----IKLEPGDDFSLIQQEIFMVKECKH 65
Query: 176 VVSLAY--AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+AY +Y +++ L + + GG L+ IY++ G P ++ A + E L GL +L
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQ-DIYHVTG-PLSELQIA-YVCRETLQGLAYL 122
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEK 292
H G ++RD K NILL D G V+++D G+A +I + R +GT +MAPEV EK
Sbjct: 123 HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 293 ---YTYSPDWFSFGCLIFEMIEGQA------PFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343
Y D ++ G E+ E Q P R M K + ++K D K+S F
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK-DKTKWSSTF 241
Query: 344 SDDAK-ALCKALLKKSPRSRLGCH 366
+ K +L K K+ RL H
Sbjct: 242 HNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 65/255 (25%), Positives = 125/255 (49%), Gaps = 19/255 (7%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGESMVLIEKQILQKINS 173
+ + + +G+G FG++ + ++ + K+ L K +K+++ +I +L K+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVI---LLAKMKH 58
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+V+ +++ L +V+ +GGDL I N F + + ++ GL+H+
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 234 HYIGLVYRDCKPENILLDDYGHV-RISDLGLAVEIPEG-ESVRGRVGTVGYMAPEVIDNE 291
H +++RD K +NI L G V ++ D G+A ++ + E VGT Y++PE+ N
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 292 KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY----SCRFSDDA 347
Y D +S GC+++E+ + PF + + + + V + + Y S FS D
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPF-------EGNNLHQLVLKICQGYFAPISPNFSRDL 230
Query: 348 KALCKALLKKSPRSR 362
++L L K SPR R
Sbjct: 231 RSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-- 163
+ +G G G V R TG++YA K + E V
Sbjct: 66 APSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH------EDTVRRQI 119
Query: 164 --EKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGF-DIARAR 220
E +IL+ +N VV ++ + ++L M+GG L+ ++ E D+AR
Sbjct: 120 CREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT--HIADEQFLADVAR-- 175
Query: 221 FYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ESVRGRVGT 279
++L G+ +LH +V+RD KP N+L++ +V+I+D G++ + + + VGT
Sbjct: 176 ----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGT 231
Query: 280 VGYMAPEVIDNE----KYT-YSPDWFSFGCLIFEMIEGQAPF 316
+ YM+PE I+ + Y Y+ D +S G I E G+ PF
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-16
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMVLIE----K 165
K ++ + +G G G VCA G A KKL + + KR +VL++ K
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 166 QILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAE 225
I+ +N V + + E + LV+ +M+ + + +M D R + +
Sbjct: 81 NIISLLN---VFTPQKSLEEFQDVYLVMELMDANLCQ--VIHME----LDHERMSYLLYQ 131
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAP 285
+LCG++HLH G+++RD KP NI++ ++I D GLA + V T Y AP
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191
Query: 286 EVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
EVI Y + D +S GC++ E+++G F+
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-16
Identities = 34/80 (42%), Positives = 56/80 (70%), Gaps = 3/80 (3%)
Query: 659 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR---FVV 715
++G+GGFGEV C+ TGKMYA K L+KKRIK ++GE++ L E+ +L +++ F+V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 716 SLAYAYETKDALCLVLTIID 735
++YA+ T D L +L +++
Sbjct: 61 CMSYAFHTPDKLSFILDLMN 80
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 8e-16
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 45/229 (19%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-----------EKQILQK 170
LG+G +G+V TGK+ A KK++ I + L+ E +I+ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC-- 228
I ++ L Y D + LV+ IM DLK + + + R ++V C
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLK-KVVD---------RKIRLTESQVKCIL 125
Query: 229 -----GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA---------------VEIP 268
GL LH ++RD P NI ++ G +I+D GLA +
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 269 EGESVRGRVGTVGYMAPEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
E + +V T+ Y APE++ EKY ++ D +S GC+ E++ G+ F
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 18/252 (7%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F +GKG FGEV T K+ A K ++ + + + + E +L + +S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED--IQQEITVLSQCDSPY 63
Query: 176 VVSLAYAYETKDALCLVLTIMNGG---DLKFHIYNMGGEPG-FDIARARFYAAEVLCGLE 231
V +Y L +++ + GG DL EPG D + E+L GL+
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--------EPGPLDETQIATILREILKGLD 115
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDN 290
+LH ++RD K N+LL ++G V+++D G+A ++ + + R VGT +MAPEVI
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350
Y D +S G E+ +G+ P E+ + K + +S K
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPP---HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF 232
Query: 351 CKALLKKSPRSR 362
+A L K P R
Sbjct: 233 VEACLNKEPSFR 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 9/194 (4%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
RVLGKG FGE + + K++ R+ + K L E IL + +++
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAY 64
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
+ + L + + NGG L + F+ +Y +++ + ++H G++
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 240 YRDCKPENILLDDYGHVRISDLGLA----VEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
+RD K NI L G +++ D G++ E E+V VGT YM+PE+ KY +
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV---VGTPYYMSPELCQGVKYNF 180
Query: 296 SPDWFSFGCLIFEM 309
D ++ GC+++E+
Sbjct: 181 KSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 35/80 (43%), Positives = 56/80 (70%), Gaps = 3/80 (3%)
Query: 659 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS---RFVV 715
++G+GGFGEV C+ TGKMYA K L+KKRIK ++GE++ L E+ +L +++ F+V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 716 SLAYAYETKDALCLVLTIID 735
+ YA+ T D LC +L +++
Sbjct: 61 CMTYAFHTPDKLCFILDLMN 80
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 58/214 (27%), Positives = 110/214 (51%), Gaps = 15/214 (7%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-EKQILQKINSRFVVSLA 180
LG+G + V + + GK+ A K + R+++ +G I E +L+ + +V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLLH 69
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG-FDIARARFYAAEVLCGLEHLHYIGLV 239
TK+ L LV ++ ++ M PG + + ++L GL ++H ++
Sbjct: 70 DIIHTKETLTLVFEYVHTDLCQY----MDKHPGGLHPENVKLFLFQLLRGLSYIHQRYIL 125
Query: 240 YRDCKPENILLDDYGHVRISDLGL--AVEIPEGESVRGRVGTVGYMAPEV-IDNEKYTYS 296
+RD KP+N+L+ D G ++++D GL A +P + V T+ Y P+V + + +Y+
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 297 PDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR 330
D + GC+ EMI+G A F K++ +D+++R
Sbjct: 185 LDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLER 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 10/242 (4%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
+GKG FGEV T ++ A K ++ + + + + E +L + +S +V
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED--IQQEITVLSQCDSPYVTKYYG 69
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
+Y L +++ + GG + G F IA E+L GL++LH ++R
Sbjct: 70 SYLKGTKLWIIMEYLGGGS-ALDLLRAGPFDEFQIATM---LKEILKGLDYLHSEKKIHR 125
Query: 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEKYTYSPDWF 300
D K N+LL + G V+++D G+A ++ + + R VGT +MAPEVI Y D +
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 301 SFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPR 360
S G E+ +G+ P +M + K + + FS K A L K P
Sbjct: 186 SLGITAIELAKGEPP---NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPS 242
Query: 361 SR 362
R
Sbjct: 243 FR 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 71/265 (26%), Positives = 125/265 (47%), Gaps = 31/265 (11%)
Query: 102 KDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKG 157
D Y +++ + G G +G VC+ R TG A KKL + + KR
Sbjct: 14 PDRYRDLKQV-----------GSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY 62
Query: 158 ESMVLIEKQILQKINSRFVVSLAYAYETKDALC---LVLTIMNGGDL-KFHIYNMGGEPG 213
+ L++ ++ N ++ + + D LV+ M G DL K + E
Sbjct: 63 RELRLLKH--MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSED- 118
Query: 214 FDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273
R +F ++L GL+++H G+++RD KP N+ +++ ++I D GLA + +
Sbjct: 119 ----RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--TDSEM 172
Query: 274 RGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV 332
G V T Y APEVI N YT + D +S GC++ EM+ G+ F+ + + E+ +
Sbjct: 173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232
Query: 333 KEDAEKYSCRF-SDDAKALCKALLK 356
++++ + S+DAK K L +
Sbjct: 233 GTPSKEFVQKLQSEDAKNYVKKLPR 257
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 67/250 (26%), Positives = 117/250 (46%), Gaps = 18/250 (7%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
LG G FG+V + + TG + A K +E K ++ + + MV IE IL N ++V L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYMVEIE--ILATCNHPYIVKLLG 76
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
A+ L +++ GG + + + + G + + ++L L++LH + +++R
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMKIIHR 134
Query: 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEK-----YTY 295
D K N+LL G ++++D G++ + + R +GT +MAPEV+ E Y Y
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEM---VKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352
D +S G + EM + + P M +K + + K+S F D K
Sbjct: 195 KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD----FLK 250
Query: 353 ALLKKSPRSR 362
L K P +R
Sbjct: 251 TALDKHPETR 260
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F+ +G+G +G V + + TG++ A KK+ + + S + E +L+++N
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 60
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEP--GFDIARARFYAAEVLCGLEHL 233
+V L T++ L LV ++ DLK M P G + + Y ++L GL
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKF---MDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG---RVGTVGYMAPEVIDN 290
H +++RD KP+N+L++ G ++++D GLA G VR V T+ Y APE++
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174
Query: 291 EKYTYSP-DWFSFGCLIFEMIEGQAPF 316
KY + D +S GC+ EM+ +A F
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACK--KLE-KKRIKKRKGESMVLIEKQILQKIN 172
F LG G G V R +G + A K LE K I+ + ++ E ++L + N
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQ-----IIRELKVLHECN 57
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
S ++V A+ + + + + M+GG L + G P + + L L
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEK 292
H I ++RD KP NIL++ G +++ D G++ ++ + + VGT YM+PE +
Sbjct: 118 KHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTH 174
Query: 293 YTYSPDWFSFGCLIFEMIEGQAP 315
YT D +S G + EM G+ P
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 42/230 (18%)
Query: 103 DIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK--------KRIKK 154
D Y + P+ G G +G+VC+ TG+ A KKL + KR +
Sbjct: 15 DRYQNLSPV-----------GSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63
Query: 155 RKGESMVLIEKQILQKINSRFVVSL------AYAYETKDALCLVLTIMNGGDLKFHIYNM 208
E ++L+ ++ V+ L A + E + LV +M G DL N+
Sbjct: 64 ---------ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL----NNI 109
Query: 209 GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268
+F ++L GL+++H G+++RD KP NI +++ ++I D GLA
Sbjct: 110 VKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--H 167
Query: 269 EGESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFR 317
+ + G V T Y APE++ N Y + D +S GC++ E++ G+ F
Sbjct: 168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 44/229 (19%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKL-----EKKRIKKRKGESMVLIEKQILQ 169
F + V+G+G +G+V + + TG++ A K + E++ IK+ E IL+
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---------EYNILR 57
Query: 170 KI-NSRFVVSLAYAYETKDALC------LVLTIMNGG---DLKFHIYNMGG---EPGFDI 216
K N + + A+ K+ LV+ + GG DL + G E I
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE--WI 115
Query: 217 ARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR 276
A + E L GL +LH +++RD K +NILL V++ D G++ ++ +S GR
Sbjct: 116 A---YILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGR 169
Query: 277 ----VGTVGYMAPEVI-----DNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
+GT +MAPEVI + Y D +S G E+ +G+ P
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 68/256 (26%), Positives = 116/256 (45%), Gaps = 24/256 (9%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
LG G FG+V Q + TG A K ++ I+ + ++E IL + +V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
AY ++ L +++ +GG L + + E G + R+ ++L L LH +++R
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR----VGTVGYMAPEVIDNEK----- 292
D K NILL G V+++D G++ + +S + +GT +MAPEV+ E
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSA---KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPFRRRKEM---VKRDEVDRRVKEDAEKYSCRFSDDAKA 349
Y Y D +S G + E+ + + P M +K + + + K+S F+D
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND---F 241
Query: 350 LCKALLKKSPRSRLGC 365
L L+K P R
Sbjct: 242 LKSCLVKD-PDDRPTA 256
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 63/248 (25%), Positives = 119/248 (47%), Gaps = 7/248 (2%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + RV+G+G FG Q + + YA K++ + +S E +L K+
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK--EAVLLAKMKHPN 59
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V+ ++E L +V+ +GGDL I G+ F + ++ G++H+H
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHE 118
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRVGTVGYMAPEVIDNEKYT 294
+++RD K +NI L G V++ D G A + G VGT Y+ PE+ +N Y
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 295 YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354
D +S GC+++E+ + PF+ ++ + + + + +S + ++L K +
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSW---KNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 355 LKKSPRSR 362
K++PRSR
Sbjct: 236 FKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKK----RIKKRKGESMVLIEKQILQK 170
++ +G G +G VC+ +GK A KK+ + KR L E +IL+
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKR-----TLRELKILRH 60
Query: 171 INSRFVVSLAYAYETKDALC----LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
++++ A +V+ +M DL I+ +P R++ ++
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIH--SDQP-LTEEHIRYFLYQL 116
Query: 227 LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-----VGTVG 281
L GL+++H +++RD KP N+L+++ +RI D G+A + + V T
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 282 YMAPEVI-DNEKYTYSPDWFSFGCLIFEMI 310
Y APE++ +YT + D +S GC+ EM+
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLA 180
VLGKG +G V C + G++ A K++E E E + LQ+ V L
Sbjct: 7 VLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEK----EYEKLQE-----EVDLL 56
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARA--RF----------YAAEVLC 228
+ + + + + T ++ D I+ M PG I+ RF Y ++L
Sbjct: 57 KSLKHVNIVQYLGTCLD--DNTISIF-MEFVPGGSISSILNRFGPLPEPVFCKYTKQILD 113
Query: 229 GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-------PEGESVRGRVGTVG 281
G+ +LH +V+RD K N++L G +++ D G A + ++ GT
Sbjct: 114 GVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
+MAPEVI+ Y D +S GC +FEM G+ P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 47/150 (31%), Positives = 72/150 (48%), Gaps = 5/150 (3%)
Query: 162 LIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF 221
LIE +LQ +N V+ + + C+VL + + I +A
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRP---LPIDQALI 161
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SVRGRVGTV 280
++L GL +LH +++RD K ENI ++D V I DLG A + P + G GTV
Sbjct: 162 IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTV 220
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
APEV+ +KY D +S G ++FEM+
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 28/251 (11%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
+GKG FGEV T ++ A K ++ + + + + E +L + +S ++
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED--IQQEITVLSQCDSPYITRYYG 69
Query: 182 AYETKDALCLVLTIMNGG---DLKFHIYNMGGEPG-FDIARARFYAAEVLCGLEHLHYIG 237
+Y L +++ + GG DL +PG + E+L GL++LH
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--------KPGPLEETYIATILREILKGLDYLHSER 121
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEKYTYS 296
++RD K N+LL + G V+++D G+A ++ + + R VGT +MAPEVI Y +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 297 PDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV-----KEDAEKYSCRFSDDAKALC 351
D +S G E+ +G+ P M RV K ++S K
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPM--------RVLFLIPKNSPPTLEGQYSKPFKEFV 233
Query: 352 KALLKKSPRSR 362
+A L K PR R
Sbjct: 234 EACLNKDPRFR 244
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACK------KLEKKRIKKRKGESMVLIEKQILQKINSR 174
+LG G G V T ++ A K +E ++ ++ E +IL K +S
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK--------QIMSELEILYKCDSP 59
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+++ A+ ++ + + M+GG L + P + R A V+ GL +L
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRI---AVAVVKGLTYLW 112
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYT 294
+ +++RD KP N+L++ G V++ D G++ ++ + + VGT YMAPE I E+Y
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA-KTYVGTNAYMAPERISGEQYG 171
Query: 295 YSPDWFSFGCLIFEMIEGQAPF 316
D +S G E+ G+ P+
Sbjct: 172 IHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 120 RVLGKGGFGEVCAC----QVRATGKMYACKKLEKKRIKKRKGESMVLI----EKQILQKI 171
+ LG+G FG+V C TG+ A K L GE E +IL+ +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL------NHSGEEQHRSDFEREIEILRTL 63
Query: 172 NSRFVVSLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCG 229
+ +V E +L L++ + G L+ Y ++ R +++++ G
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLR--DYLQRHRDQINLKRLLLFSSQICKG 121
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE---SVRG-RVGTVGYMAP 285
+++L ++RD NIL++ V+ISD GLA +PE + V+ + + AP
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 286 EVIDNEKYTYSPDWFSFGCLIFEM 309
E + K++ + D +SFG ++E+
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK----KRKGESMVLIE----KQILQKI 171
+ +G G G VCA TG+ A KKL + KR +VL++ K I+ +
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 172 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFH-IYNMGGEPGFDIARARFYAAEVLCGL 230
N V + + E + LV+ +M D + M D R + ++LCG+
Sbjct: 82 N---VFTPQKSLEEFQDVYLVMELM---DANLCQVIQMD----LDHERMSYLLYQMLCGI 131
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN 290
+HLH G+++RD KP NI++ ++I D GLA + V T Y APEVI
Sbjct: 132 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 191
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQAPF 316
Y + D +S GC++ EMI G F
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 6/209 (2%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + V+G+G +G V C+ + T ++ A KK + + E+ L E ++L+ +
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKET-TLRELKMLRTLKQEN 61
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V L A+ + L LV + L+ G P + R Y +++ + H
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP---EKVRSYIYQLIKAIHWCHK 118
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--GRVGTVGYMAPEVIDNEKY 293
+V+RD KPEN+L+ +++ D G A + EG + V T Y +PE++ Y
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
+ D +S GC++ E+ +GQ F E+
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + V+G G +G+V + TG++ A K ++ E + +E +L+K +
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHR 73
Query: 176 VVSLAYAYETK-------DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC 228
++ Y K D L LV+ G + + N G + E+L
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILR 132
Query: 229 GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEV 287
GL HLH +++RD K +N+LL + V++ D G++ ++ R +GT +MAPEV
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 192
Query: 288 IDNEK-----YTYSPDWFSFGCLIFEMIEGQAPF 316
I ++ Y Y D +S G EM EG P
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 27/273 (9%)
Query: 104 IYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI 163
I + P +G G G+V + + TG + A K++ +R ++ +L+
Sbjct: 5 IDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKEENKRILM 62
Query: 164 EKQILQKIN-SRFVVSL--AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARAR 220
+ ++ K + ++V + ++ +C+ L L I E DI
Sbjct: 63 DLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPE---DILGKM 119
Query: 221 FYAAEVLCGLEHLHYI----GLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR 276
A ++ LHY+ G+++RD KP NILLD G+V++ D G++ + + ++
Sbjct: 120 TVAI-----VKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS 174
Query: 277 VGTVGYMAPEVID----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV 332
G YMAPE ID N KY D +S G + E+ GQ P++ K EV ++
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---EVLTKI 231
Query: 333 KEDAE---KYSCRFSDDAKALCKALLKKSPRSR 362
++ + FS D + L K R R
Sbjct: 232 LQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKR 264
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGESMVLIEKQ 166
P Y + + +G G +G VC+ + TG+ A KKL + I ++ + + K
Sbjct: 14 PERYTSLKQ---VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH 70
Query: 167 ILQK--INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAA 224
+ + I V + A + + LV+ M K MG + ++
Sbjct: 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI----MGHP--LSEDKVQYLVY 124
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMA 284
++LCGL+++H G+++RD KP N+ +++ ++I D GLA + G V T Y A
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVTRWYRA 182
Query: 285 PEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFR 317
PEVI N Y + D +S GC++ EM+ G+ F+
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 20/221 (9%)
Query: 107 EIQPITYKTFRMYRVL---GKGGFGEVCACQVRATGKMYACKKLEK----KRIKKRKGES 159
EI T+ + Y+ L G G G VCA + A KKL + + KR
Sbjct: 14 EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE 73
Query: 160 MVLIE----KQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD 215
+VL++ K I+ +N V + + E + +V+ +M+ + + M D
Sbjct: 74 LVLMKCVNHKNIIGLLN---VFTPQKSLEEFQDVYIVMELMDANLCQ--VIQME----LD 124
Query: 216 IARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG 275
R + ++LCG++HLH G+++RD KP NI++ ++I D GLA +
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184
Query: 276 RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
V T Y APEVI Y + D +S GC++ EMI+G F
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 31/78 (39%), Positives = 53/78 (67%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + RV+GKG FG+VC Q R T KM+A K + K++ ++ VL E++ILQ++N F
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 714 VVSLAYAYETKDALCLVL 731
+V+L Y+++ ++ + LV+
Sbjct: 62 LVNLWYSFQDEENMYLVV 79
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 42/122 (34%), Positives = 59/122 (48%), Gaps = 6/122 (4%)
Query: 212 PGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271
PG + + L GL+ LH +V+RD KPENIL+ G V+++D GLA
Sbjct: 103 PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM 162
Query: 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR 331
++ V T+ Y APEV+ Y D +S GC+ EM FRR+ E D+
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM------FRRKPLFCGNSEADQL 216
Query: 332 VK 333
K
Sbjct: 217 GK 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGESMVLIEKQILQKINSRFVVS 178
+G G +G VC+ + A KKL + I R+ E ++L+ + V+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR----TYRELRLLKHMKHENVIG 78
Query: 179 L------AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
L A + E + + LV +M G DL N+ +F ++L GL++
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLM-GADLN----NIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN-E 291
+H G+++RD KP N+ +++ +RI D GLA + + + G V T Y APE++ N
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEMTGYVATRWYRAPEIMLNWM 191
Query: 292 KYTYSPDWFSFGCLIFEMIEGQAPF 316
Y + D +S GC++ E+++G+A F
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 52/199 (26%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-EKQILQKINSRFVVSLA 180
LG+G + V + + T + A K++ R++ +G I E +L+ + +V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVY 240
T+ L LV ++ DLK ++ N G + + + ++L GL + H +++
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYLDNCGNL--MSMHNVKIFMFQLLRGLSYCHKRKILH 126
Query: 241 RDCKPENILLDDYGHVRISDLGL--AVEIPEGESVRGRVGTVGYMAPEV-IDNEKYTYSP 297
RD KP+N+L+++ G ++++D GL A +P ++ V T+ Y P+V + + +Y+
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 298 DWFSFGCLIFEMIEGQAPF 316
D + GC+++EM G+ F
Sbjct: 186 DMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKL-----EKKRIKKRKGESMVLIEKQILQK 170
F + ++G G +G+V + TG++ A K + E++ IK+ E +L+K
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---------EINMLKK 58
Query: 171 INSRFVVSLAYAYETK-------DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
+ ++ Y K D L LV+ G + I N G +
Sbjct: 59 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYIC 117
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGY 282
E+L GL HLH +++RD K +N+LL + V++ D G++ ++ R +GT +
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 177
Query: 283 MAPEVI-----DNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
MAPEVI + Y + D +S G EM EG P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV----LIEKQILQKINSR--- 174
+G+G +G V + TG+ A KK ++ E + L E +L+++ S
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKK-----VRVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 175 -----FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCG 229
V + + L LV ++ DL ++ +PG + ++L G
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRG 119
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVID 289
++ LH +V+RD KP+NIL+ G V+I+D GLA ++ V T+ Y APEV+
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLL 179
Query: 290 NEKYTYSPDWFSFGCLIFEMIEGQAPFRRR 319
Y D +S GC+ E+ FRRR
Sbjct: 180 QSSYATPVDMWSVGCIFAEL------FRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 5e-13
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK----KRIKKRKGESMVLIEKQILQ 169
K ++ + +G G G VCA + A KKL + + KR +VL ++
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL-----MK 71
Query: 170 KINSRFVVSLAYAYETKDAL------CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
+N + ++SL + + +L LV+ +M+ + + M D R +
Sbjct: 72 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ--VIQME----LDHERMSYLL 125
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYM 283
++LCG++HLH G+++RD KP NI++ ++I D GLA + V T Y
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 284 APEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRR 319
APEVI Y + D +S GC++ EM+ + F R
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-EKQILQKINSRFVVSLA 180
LG+G + V R G++ A K + +K +G I E +L+ + +V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVY 240
TK+ L V M+ ++ I + GG +++ R + ++L GL ++H +++
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNV---RLFMFQLLRGLAYIHGQHILH 126
Query: 241 RDCKPENILLDDYGHVRISDLGLA--VEIPEGESVRGRVGTVGYMAPEVI-DNEKYTYSP 297
RD KP+N+L+ G ++++D GLA IP ++ V T+ Y P+V+ Y+ +
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIP-SQTYSSEVVTLWYRPPDVLLGATDYSSAL 185
Query: 298 DWFSFGCLIFEMIEGQAPF 316
D + GC+ EM++GQ F
Sbjct: 186 DIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 63/234 (26%), Positives = 115/234 (49%), Gaps = 29/234 (12%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-EKQILQKINSR 174
F + +G+G +G+V + + TG++ A KK+ +++G + I E +IL+++N R
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD--NEKEGFPITAIREIKILRQLNHR 66
Query: 175 FVVSLAYAYETKD----------ALCLVLTIMNGGDLKFHIYNMG----GEPGFDIARAR 220
+V+L K A LV M+ DL MG G F +
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DL------MGLLESGLVHFSEDHIK 119
Query: 221 FYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR---GRV 277
+ ++L GL + H ++RD K NILL++ G ++++D GLA + E R +V
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA-RLYNSEESRPYTNKV 178
Query: 278 GTVGYMAPE-VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR 330
T+ Y PE ++ E+Y + D +S GC++ E+ + F+ +E+ + + + R
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|188704 cd08750, RGS_GRK4, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase 4 (GRK4) | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-13
Identities = 23/54 (42%), Positives = 38/54 (70%), Gaps = 1/54 (1%)
Query: 492 EIIEHCKESLD-SGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYLQWKWLE 544
+++ C+ L+ + ++ELF +C V +L+G PF +Q+SM+F R+LQWKWLE
Sbjct: 73 DVVTECRLKLEENPSKELFEECTRVVHEYLSGEPFEAYQESMYFSRFLQWKWLE 126
|
The RGS domain is an essential part of the GRK4 (G protein-coupled receptor kinase4) proteins, which are membrane-associated serine/threonine protein kinases that phosphorylate G protein-coupled receptors (GPCRs) upon agonist stimulation. This phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events. GRK4 is a member of the GRK kinase family which includes three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. GRK4 plays a key role in regulating dopaminergic-mediated natriuresis and is associated with essential hypertension and/or salt-sensitive hypertension. GRK4 exists in four splice variants involved in hyperphosphorylation, desensitization, and internalization of two dopamine receptors (D1R and D3R). GRK4 also increases the expression of a key receptor of the renin-angiotensin system, the AT1R (angiotensin type 1 receptor). RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 132 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
LG G G V + +G + A +KL IK + ++ E Q+L + NS ++V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMA-RKLIHLEIKPAI-RNQIIRELQVLHECNSPYIVGFYG 70
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
A+ + + + + M+GG L + G P + + + L L H I ++R
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHR 128
Query: 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFS 301
D KP NIL++ G +++ D G++ ++ + + VGT YM+PE + Y+ D +S
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSDIWS 187
Query: 302 FGCLIFEMIEGQAP 315
G + EM G+ P
Sbjct: 188 MGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 28/78 (35%), Positives = 45/78 (57%), Gaps = 1/78 (1%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + R LG G FG V + + TGK+ A K L+K+ K +K + E +IL++++
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPN 59
Query: 714 VVSLAYAYETKDALCLVL 731
+V L A+E KD L LV+
Sbjct: 60 IVRLIDAFEDKDHLYLVM 77
|
Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM---VLIEKQILQKINSRFVVS 178
LG+G FGEV + TG++ A KK+ + + + L E +IL+K+ VV
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI----LMHNEKDGFPITALREIKILKKLKHPNVVP 71
Query: 179 L---AYAY-----ETKDALCLVLTIMNGGDLKFHIYNMGGEPG--FDIARARFYAAEVLC 228
L A + ++ +V M+ DL + N P ++ + Y ++L
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLE 126
Query: 229 GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI---------PEGESVR---GR 276
G+ +LH +++RD K NIL+D+ G ++I+D GLA G R
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 277 VGTVGYMAPEVIDNEK-YTYSPDWFSFGCLIFEMIEG 312
V T Y PE++ E+ YT + D + GC+ EM
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 68/228 (29%), Positives = 100/228 (43%), Gaps = 11/228 (4%)
Query: 99 LSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 158
LS K I + P T+ + +GKG +G+V + G A K L+ + E
Sbjct: 3 LSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE 62
Query: 159 SMVLIEKQILQKINSRFVVSLAYAYETK--DALCLVLTIMNGGDLKFHIYNM--GGEPGF 214
+ I K + N + Y + K D L LVL + NGG + + GE
Sbjct: 63 AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122
Query: 215 DIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274
+ A + E L GL+HLH ++RD K NILL G V++ D G++ ++ R
Sbjct: 123 EPIIA-YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 275 G-RVGTVGYMAPEVIDNEK-----YTYSPDWFSFGCLIFEMIEGQAPF 316
VGT +MAPEVI E+ Y D +S G E+ +G P
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-12
Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 39/243 (16%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKL-----EKKRIKKRKGESMVLIEKQILQKINSR 174
R++GKGG GEV + A KK+ E +KKR L E +I +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR-----FLREAKIAADLIHP 62
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGF--DIARARFYAA------EV 226
+V + D + + + G LK + ++ + ++A A ++
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 227 LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA------------VEIPEGES-- 272
+E++H G+++RD KP+NILL +G V I D G A +++ E
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 273 ----VRGR-VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRK--EMVKR 325
+ G+ VGT YMAPE + + S D ++ G ++++M+ P+RR+K ++ R
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242
Query: 326 DEV 328
D +
Sbjct: 243 DVI 245
|
Length = 932 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NS 173
T+ + +GKG +G+V + G + A K L+ + E+ E ILQ + N
Sbjct: 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA----EYNILQSLPNH 78
Query: 174 RFVVSLAYAYETKD-----ALCLVLTIMNGGDLKFHIYNM--GGEPGFDIARARFYAAEV 226
VV + D L LVL + NGG + + + G+ D A +
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGA 137
Query: 227 LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG-RVGTVGYMAP 285
L GL+HLH +++RD K NILL G V++ D G++ ++ R VGT +MAP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197
Query: 286 EVIDNE-KYTYSPD-----WFSFGCLIFEMIEGQAPF 316
EVI E +Y YS D W S G E+ +G P
Sbjct: 198 EVIACEQQYDYSYDARCDVW-SLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 51/199 (25%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-EKQILQKINSRFVVSLA 180
LG+G + V + + T + A K++ R++ +G I E +L+ + +V+L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVY 240
T+ +L LV ++ DLK ++ + G ++ + + ++L GL + H +++
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNS--INMHNVKLFLFQLLRGLNYCHRRKVLH 127
Query: 241 RDCKPENILLDDYGHVRISDLGL--AVEIPEGESVRGRVGTVGYMAPEV-IDNEKYTYSP 297
RD KP+N+L+++ G ++++D GL A IP ++ V T+ Y P++ + + Y+
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVVTLWYRPPDILLGSTDYSTQI 186
Query: 298 DWFSFGCLIFEMIEGQAPF 316
D + GC+ +EM G+ F
Sbjct: 187 DMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 52/199 (26%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-EKQILQKINSRFVVSLA 180
LG+G + V + + T + A K++ R++ +G I E +L+ + +V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVY 240
T +L LV ++ DLK ++ + G + + + ++L GL + H +++
Sbjct: 71 DIVHTDKSLTLVFEYLDK-DLKQYMDDCGNI--MSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 241 RDCKPENILLDDYGHVRISDLGL--AVEIPEGESVRGRVGTVGYMAPEV-IDNEKYTYSP 297
RD KP+N+L+++ G ++++D GL A +P ++ V T+ Y P+V + + +Y+
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 298 DWFSFGCLIFEMIEGQAPF 316
D + GC+ FEM G+ F
Sbjct: 187 DMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
+G+G FGEV + ++RA A K + K + L E +IL++ + +V L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK--FLQEARILKQYSHPNIVRLIG 60
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
K + +V+ ++ GGD + G P + G+E+L ++R
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKHCIHR 118
Query: 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG-----TVGYMAPEVIDNEKYTYS 296
D N L+ + ++ISD G++ E E + V G V + APE ++ +Y+
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 297 PDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVK 333
D +SFG L++E G P+ R+ +++ V+
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR 214
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 17/203 (8%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-EKQILQKINSRFVVSL 179
LG+G + V + + TG++ A K++ R++ +G I E +L+ + +V+L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
TK L LV ++ DLK ++ + GG G + R + ++L GL + H ++
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRRVL 125
Query: 240 YRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-----VGTVGYMAPEVI-DNEKY 293
+RD KP+N+L+ + G ++++D GLA +SV + V T+ Y P+V+ + +Y
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLA----RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 294 TYSPDWFSFGCLIFEMIEGQAPF 316
+ S D + GC+ +EM G+ F
Sbjct: 182 STSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 5/194 (2%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
LG G G V Q + +G + A +KL IK + ++ E Q+L + NS ++V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMA-RKLIHLEIKPAI-RNQIIRELQVLHECNSPYIVGFYG 70
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
A+ + + + + M+GG L + P + + L L H I ++R
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQI--MHR 128
Query: 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFS 301
D KP NIL++ G +++ D G++ ++ + + VGT YM+PE + Y+ D +S
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSDIWS 187
Query: 302 FGCLIFEMIEGQAP 315
G + E+ G+ P
Sbjct: 188 MGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|188679 cd08724, RGS_GRK-like, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase (GRK) | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 6e-12
Identities = 27/53 (50%), Positives = 35/53 (66%), Gaps = 1/53 (1%)
Query: 54 IIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYN 106
I +QQPIGRLLFRQFC E +P+ FLD I+ YE+ DE R ++IY+
Sbjct: 1 ICEQQPIGRLLFRQFC-ETRPELVPQIEFLDEIKEYEVAEDEERAKKAREIYD 52
|
The RGS domain is found in G protein-coupled receptor kinases (GRKs). These proteins play a key role in phosphorylation-dependent desensitization/resensitization of GPCRs (G protein-coupled receptors), intracellular trafficking, endocytosis, as well as in the modulation of important intracellular signaling cascades by GPCR. GRKs also modulate cellular response in phosphorylation-independent manner using their ability to interact with multiple signaling proteins involved in many essential cellular pathways. The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. Based on sequence homology the GRK family consists of three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 114 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 63/225 (28%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 116 FRMYRVLGKGGFGEVCA-CQVRA---TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI 171
+ RVLG+G FG+V C A TG+M A K L KR ++ S E IL+ +
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--KRECGQQNTSGWKKEINILKTL 63
Query: 172 NSRFVVSLAYAYETK--DALCLVLTIMNGGDLKFHI--YNMGGEPGFDIARARFYAAEVL 227
+V + L L++ + G L+ ++ + + +A+ +A ++
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLN------LAQLLLFAQQIC 117
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVG-----Y 282
G+ +LH ++RD N+LLD+ V+I D GLA +PEG RV G +
Sbjct: 118 EGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-RVREDGDSPVFW 176
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEMI----EGQAPFRRRKEMV 323
A E + K++Y+ D +SFG ++E++ Q+P ++ +EM+
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 29/74 (39%), Positives = 46/74 (62%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 717
++LGKG FG+V + +ATGK YA K L+K+ I + + L E ++LQ F+ +L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 718 AYAYETKDALCLVL 731
Y+++T D LC V+
Sbjct: 61 KYSFQTHDRLCFVM 74
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 38/80 (47%), Positives = 51/80 (63%), Gaps = 5/80 (6%)
Query: 402 VKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGKSHCLSIGLVMMLKLSVL 461
VKR+EVDRRVKED E+YS +FS+DAK++C+ LL K+P+ RLG C G +K +
Sbjct: 208 VKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLG---CRGNG-AAGVKQHPI 263
Query: 462 KKNVNLSVLNTVQI-PLFFP 480
KN+N L + P F P
Sbjct: 264 FKNINFKRLEANMLEPPFCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 53/195 (27%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--ESMVLIEKQILQKINSRFVVSL 179
+G+G +G V + + TG++ A KK+ R++ + S + E +L+++ +V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
+ L L+ ++ DLK ++ ++ D + Y ++L G+ H ++
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVL 123
Query: 240 YRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR---GRVGTVGYMAPEVI-DNEKYTY 295
+RD KP+N+L+D+ G ++++D GLA G VR V T+ Y APEV+ + +Y+
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 296 SPDWFSFGCLIFEMI 310
D +S G + EM
Sbjct: 182 PVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKK-----RIKKRKGESMVLIEKQILQKINSRFV 176
+G G +G VCA TG A KKL + K+ E +L + I V
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 177 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI 236
+ A + E + + LV +M G DL N+ +F ++L GL+++H
Sbjct: 85 FTPARSLEEFNDVYLVTHLM-GADLN----NIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139
Query: 237 GLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN-EKYTY 295
+++RD KP N+ +++ ++I D GLA + + G V T Y APE++ N Y
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQ 197
Query: 296 SPDWFSFGCLIFEMIEGQAPF 316
+ D +S GC++ E++ G+ F
Sbjct: 198 TVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGK--------------MYACKKLEKKRIKKRKGESMV 161
R+ LG+G FGEV C+ + + A K L K + +
Sbjct: 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARND--F 64
Query: 162 LIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDL-----------KFHIYNMGG 210
L E +I+ ++ + ++ L + D LC++ M GDL F N
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHAN--N 122
Query: 211 EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270
P IA + A ++ G+++L + V+RD N L+ ++ ++I+D G++ + G
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182
Query: 271 ESVR--GR-VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEM 309
+ R GR V + +MA E I K+T + D ++FG ++EM
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 21/215 (9%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM----VLIEKQ 166
I + ++ R LG G FGEV T + +K K +M L E Q
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPV---------AVKTLKPGTMDPKDFLAEAQ 53
Query: 167 ILQKINSRFVVSLAYAYETKDALCLVLT-IMNGGDLKFHIYNMGGEPGFDIARARFYAAE 225
I++K+ ++ L YA T + ++T +M G L ++ G + + AA+
Sbjct: 54 IMKKLRHPKLIQL-YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQ 111
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---VGY 282
V G+ +L ++RD N+L+ + +++D GLA I E R G + +
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKW 170
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
APE +++ D +SFG L+ E++ G+ P+
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 13/159 (8%)
Query: 164 EKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEP---GFDIARAR 220
E IL+ I+ R +++L +AY K +C+V+ DL ++ G P I R
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR- 193
Query: 221 FYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI---PEGESVRGRV 277
+L L +LH G+++RD K ENI LD+ + + D G A ++ P+ G
Sbjct: 194 -----LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
GT+ +PE++ + Y D +S G ++FEM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-KG-ESMVLIEKQILQKINSRFVVSL 179
+G+G +G V + R T ++ A K++ R+ +G S L E +L+++ + +V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
+ L LV + DLK + + G+ D + + ++L GL H ++
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDI--DPEIVKSFMFQLLKGLAFCHSHNVL 121
Query: 240 YRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR---GRVGTVGYMAPEVIDNEK-YTY 295
+RD KP+N+L++ G ++++D GLA G VR V T+ Y P+V+ K Y+
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 179
Query: 296 SPDWFSFGCLIFEMIEGQAP 315
S D +S GC+ E+ P
Sbjct: 180 SIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 120 RVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVS 178
RV+GKG FG V + + G+ C RI + L E I++ + V+S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 179 LAYAYETKDALCLV-LTIMNGGDLKFHIYNMGGEP------GFDIARARFYAAEVLCGLE 231
L + LV L M GDL+ I + P GF + A+ G+E
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAK--------GME 112
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE--SVRGRVGT---VGYMAPE 286
+L V+RD N +LD+ V+++D GLA +I + E SV G V +MA E
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 287 VIDNEKYTYSPDWFSFGCLIFE-MIEGQAPFR 317
+ +K+T D +SFG L++E M G P+
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLA 180
++G+G FG V + Y +K+ K IK L E ++ K++ + +V L
Sbjct: 13 IIGEGEFGAVLQGE-------YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL- 64
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVY 240
+ L +V+ +M+ G+L + G + + ++ +V G+E+L LV+
Sbjct: 65 LGVILHNGLYIVMELMSKGNL-VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH 123
Query: 241 RDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWF 300
RD NIL+ + G ++SD GLA G V V + APE + ++K++ D +
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVW 181
Query: 301 SFGCLIFEMIE-GQAPF 316
S+G L++E+ G+AP+
Sbjct: 182 SYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 61/249 (24%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
LG G FG+V Q + TG + A K ++ K ++ + ++E IL + +V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED---YMVEIDILASCDHPNIVKLLD 69
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241
A+ ++ L +++ GG + + + E + R + L L +LH +++R
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENKIIHR 127
Query: 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR---VGTVGYMAPEVI-----DNEKY 293
D K NIL G ++++D G++ + +++ R +GT +MAPEV+ + Y
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353
Y D +S G + EM + + P M ++ + + S R+S + K K
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPS-RWSSEFKDFLKK 244
Query: 354 LLKKSPRSR 362
L+K+ +R
Sbjct: 245 CLEKNVDAR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 13/215 (6%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLE-----KKRIKKRKGESMVLIEKQIL 168
K + + RVLG G G V + + G+ +A K ++ + + + E L+
Sbjct: 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFF 91
Query: 169 Q--KINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG--GEPGFDIARARFYAA 224
K + F E + LVL N GDL+ I + F A
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRT-FREHEAGLLFI 150
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA---VEIPEGESVRGRVGTVG 281
+VL + H+H +++RD K NILL G V++ D G + + R GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
Y+APE+ + Y+ D FS G L++E++ + PF
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF 245
|
Length = 496 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 25/42 (59%), Positives = 34/42 (80%)
Query: 402 VKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 443
VKR+EV+RRVKED E+YS +FS+ A+++C+ LL K P RLG
Sbjct: 208 VKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLG 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 31/80 (38%), Positives = 43/80 (53%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
F + LG G FG V + + +GK YA K L K +I K K VL EK+ILQ I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 712 RFVVSLAYAYETKDALCLVL 731
F+V+L +++ L LV+
Sbjct: 61 PFLVNLYGSFQDDSNLYLVM 80
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 27/73 (36%), Positives = 45/73 (61%)
Query: 659 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLA 718
V+G+G FGEV + + TG++YA K L K + KR + V E+ IL +S ++V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 719 YAYETKDALCLVL 731
Y+++ ++ L LV+
Sbjct: 68 YSFQDEEHLYLVM 80
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 183 YETKDALCLVLTIMNGGDLKFHIYNMGGEP-GFDIARARFYAAEVLCGLEHLHYIGLVYR 241
+++ D L L++ +GGDL I E F +++ L+ +H +++R
Sbjct: 134 FKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHR 193
Query: 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESV---RGRVGTVGYMAPEVIDNEKYTYSPD 298
D K NI L G +++ D G + + + S+ GT Y+APE+ + ++Y+ D
Sbjct: 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKAD 253
Query: 299 WFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKS 358
+S G +++E++ PF K +R+ + + + + + C S KAL LL K+
Sbjct: 254 MWSLGVILYELLTLHRPF---KGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKN 310
Query: 359 PRSRLGCHCGRYGARELKQAEFFK 382
P R ++L EF K
Sbjct: 311 PALRP-------TTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 40/120 (33%), Positives = 61/120 (50%), Gaps = 6/120 (5%)
Query: 211 EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270
EPG + ++L GL+ LH +V+RD KP+NIL+ G ++++D GLA
Sbjct: 104 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 163
Query: 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR 330
++ V T+ Y APEV+ Y D +S GC+ EM FRR+ +VD+
Sbjct: 164 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM------FRRKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 57/218 (26%), Positives = 108/218 (49%), Gaps = 27/218 (12%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGESMVLIEKQILQK 170
++ +G+G +G VC+ + TG A KK+ E + +R L E +IL++
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-----TLREIKILRR 59
Query: 171 INSRFVVSL-----AYAYETKDALCLVLTIMNGGDLKFHIY--NMGGEPGFDIARARFYA 223
++ + ++E+ + + +V +M DL I ++ + +++
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSND------HIQYFL 112
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA-VEIPEGESVRG---RVGT 279
++L GL+++H +++RD KP N+LL+ ++I D GLA + PE + V T
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 280 VGYMAPEVIDNEK-YTYSPDWFSFGCLIFEMIEGQAPF 316
Y APE++ N K YT + D +S GC++ EM+ + F
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 52/226 (23%), Positives = 99/226 (43%), Gaps = 30/226 (13%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM---VLIEKQILQKINSRFV 176
+ LG+G FG+V + K +K+ S +L E +L+++N V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 177 VSLAYAYETKDALCLVLT---------------------IMNGGDLKFHIYNMGGEPGFD 215
+ L A L L++ + + G+ + E
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 216 IARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-- 273
+ +A ++ G+++L + LV+RD N+L+ + ++ISD GL+ ++ E +S
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 274 --RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+GR+ V +MA E + + YT D +SFG L++E++ G P+
Sbjct: 186 RSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV--LIEKQILQKINSRFVVSL 179
+G+G +G V + +G++ A KK+ R+ + + L E +L + +V L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV---RMDNERDGIPISSLREITLLLNLRHPNIVEL 71
Query: 180 AYAYETK--DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG 237
K D++ LV+ DL + NM F ++ + ++L GL++LH
Sbjct: 72 KEVVVGKHLDSIFLVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLA--VEIPEGESVRGRVGTVGYMAPEVI-DNEKYT 294
+++RD K N+LL D G ++I+D GLA +P + +V T+ Y APE++ YT
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYT 187
Query: 295 YSPDWFSFGCLIFEMIEGQ 313
+ D ++ GC++ E++ +
Sbjct: 188 TAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 60/223 (26%), Positives = 107/223 (47%), Gaps = 15/223 (6%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
I ++ ++ + LG G FGEV K+ A K L+ + L E QI++K
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPES----FLEEAQIMKK 57
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
+ +V L YA +++ + +V M+ G L + + G + AA+V G+
Sbjct: 58 LRHDKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGM 115
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA--VEIPEGESVRGRVGTVGYMAPEVI 288
++ + ++RD + NIL+ D +I+D GLA +E E + +G + + APE
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 289 DNEKYTYSPDWFSFGCLIFEMI-EGQAPF-----RRRKEMVKR 325
++T D +SFG L+ E++ +G+ P+ R E V+R
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 9e-11
Identities = 66/252 (26%), Positives = 105/252 (41%), Gaps = 11/252 (4%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K F R +G G FG V + T ++ A KK+ + + ++ E + LQ+I
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+ Y + LV+ G + + +P ++ A L GL +L
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITHG-ALQGLAYL 141
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVI---DN 290
H +++RD K NILL + G V+++D G A S VGT +MAPEVI D
Sbjct: 142 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDE 198
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350
+Y D +S G E+ E + P M + + E S +SD +
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NESPTLQSNEWSDYFRNF 256
Query: 351 CKALLKKSPRSR 362
+ L+K P+ R
Sbjct: 257 VDSCLQKIPQDR 268
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 118 MYRVLGKGGFGEV---CACQVRA--TGKMYACKKL-EKKRIKKRKGESMVLIEKQILQKI 171
+ R LG+G FG V A V A K + E +++R L E ++++
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE---FLNEASVMKEF 66
Query: 172 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY----NMGGEPGFDI-ARARFY--AA 224
N VV L T +V+ +M GDLK ++ PG +F AA
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR---GRVGTVG 281
E+ G+ +L V+RD N ++ + V+I D G+ +I E + R + V
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEM 309
+MAPE + + +T D +SFG +++EM
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 30/75 (40%), Positives = 48/75 (64%), Gaps = 1/75 (1%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL-QKINSRFVVS 716
+V+GKG FG+V + +A GK YA K L+KK I K+K + ++ E+ +L + + F+V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 717 LAYAYETKDALCLVL 731
L Y+++T D L VL
Sbjct: 61 LHYSFQTADKLYFVL 75
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-10
Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 7/104 (6%)
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR--- 276
R+ ++L L+++H +++RD KP NILL+ V+++D GLA + E E
Sbjct: 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 277 ---VGTVGYMAPEV-IDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
V T Y APE+ + + +YT D +S GC++ EM+ G+ F
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMVLIEKQILQKINSRFVV 177
+G+G +G V C+ R TG++ A KK + IKK + L E ++L+++ +V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKK-----IALREIRMLKQLKHPNLV 63
Query: 178 SLAYAYETKDALCLVL-----TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
+L + K L LV T++N + N G P I + + + L +
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNELE-----KNPRGVPEHLIKKIIW---QTLQAVNF 115
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLA-VEIPEGESVRGRVGTVGYMAPEVI-DN 290
H ++RD KPENIL+ G +++ D G A + G+ V T Y APE++ +
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQA 314
+Y D ++ GC+ E++ GQ
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 223 AAEVLCGLEHLH-YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVG 281
A ++ LE+LH + +++RD KP N+L++ G V++ D G++ + + + G
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP 168
Query: 282 YMAPEVIDNEK----YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE 337
YMAPE I+ E Y D +S G + E+ G+ P+ K + ++ + V+E +
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ--QLKQVVEEPSP 226
Query: 338 KYSC-RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
+ +FS + + LKK+ + R Y EL Q FF+
Sbjct: 227 QLPAEKFSPEFQDFVNKCLKKNYKER-----PNY--PELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 57/224 (25%), Positives = 108/224 (48%), Gaps = 15/224 (6%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKM---YACKKLEKKRIKKRKGESMVLIEKQI 167
I ++ +V+G G FGEVC+ +++ GK A K L+ +K++ + L E I
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD--FLSEASI 58
Query: 168 LQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVL 227
+ + + ++ L + +V M G L + G+ F + + +
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--FTVIQLVGMLRGIA 116
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI---PEGE-SVRGRVGTVGYM 283
G+++L +G V+RD NIL++ ++SD GL+ + PE + RG + +
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176
Query: 284 APEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRD 326
APE I K+T + D +S+G +++E++ G+ P+ EM +D
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW---EMSNQD 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 116 FRMYRVLGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ + + LG+G +G VC+ + T + A KK+ + K+IL K
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITN------------VFSKKILAKRAL 49
Query: 174 RFVVSLAYAYETKDALCLV-LTIMNGGDLK-FHIYN-----------MGGEPGFDIARAR 220
R + L + K+ CL + I+ G+ ++Y G+P D A +
Sbjct: 50 RELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTD-AHFQ 108
Query: 221 FYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-----ESVRG 275
+ ++LCGL+++H +++RD KP N+L++ ++I D GLA E +
Sbjct: 109 SFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE 168
Query: 276 RVGTVGYMAPEV-IDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRR 319
V T Y APE+ + + YT + D +S GC++ E++ + F+ +
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 60/225 (26%), Positives = 112/225 (49%), Gaps = 17/225 (7%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
I ++ R+ LG+G FGEV T ++ A K L+ + L E Q+++K
Sbjct: 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA----FLQEAQVMKK 57
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG--FDIARARFYAAEVLC 228
+ +V L YA +++ + +V M+ G L + + GE G + + AA++
Sbjct: 58 LRHEKLVQL-YAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 229 GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE--SVRGRVGTVGYMAPE 286
G+ ++ + V+RD + NIL+ + +++D GLA I + E + +G + + APE
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 287 VIDNEKYTYSPDWFSFGCLIFEM-IEGQAPFRRRKEMVKRDEVDR 330
++T D +SFG L+ E+ +G+ P+ MV R+ +D+
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPY---PGMVNREVLDQ 215
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|188706 cd08752, RGS_GRK5, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase 5 (GRK5) | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-10
Identities = 24/64 (37%), Positives = 39/64 (60%), Gaps = 1/64 (1%)
Query: 480 PQAPEAVDVLSLEIIEHCKESL-DSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYL 538
P++P + + +++ +E L +ELF+ C +V +L G PF E+ DSM+F R+L
Sbjct: 60 PKSPVFIPQVGQDLVSQTEEKLLQKPCKELFSACTQSVHDYLRGEPFHEYLDSMYFDRFL 119
Query: 539 QWKW 542
QWKW
Sbjct: 120 QWKW 123
|
The RGS domain is an essential part of the GRK5 (G protein-coupled receptor kinase 5) protein, a membrane-associated serine/threonine protein kinases which phosphorylates G protein-coupled receptors (GPCRs) upon agonist stimulation. This phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events. GRK5 is a member of the GRK kinase family which include three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 123 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 3e-10
Identities = 58/238 (24%), Positives = 111/238 (46%), Gaps = 42/238 (17%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + + +G G FGEV + + T + + K + + +K+R+ +S ++IE +++++ +
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE-KSQLVIEVNVMRELKHKN 73
Query: 176 VVSLAYAYETK--DALCLVLTIMNGGDLKFHI---YNMGGE----PGFDIARARFYAAEV 226
+V + K L +++ + GDL +I Y M G+ DI R ++
Sbjct: 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR------QL 127
Query: 227 LCGLEHLHYIG-------LVYRDCKPENILLDD-YGHV----------------RISDLG 262
L L + H + +++RD KP+NI L H+ +I D G
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 263 LAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY--SPDWFSFGCLIFEMIEGQAPFRR 318
L+ I VGT Y +PE++ +E +Y D ++ GC+I+E+ G+ PF +
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 30/81 (37%), Positives = 51/81 (62%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
K F+ ++LGKG G V +++ TGK++A K L+KK + KR VL E++IL ++
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 712 RFVVSLAYAYETKDALCLVLT 732
F+ +L +++T+ LCLV+
Sbjct: 61 PFLPTLYASFQTETYLCLVMD 81
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 33/207 (15%)
Query: 122 LGKGGFGEVCACQVR----ATGKMYACKKLEKKRIKKRKGESMVLIEK--QILQKINSRF 175
LGKG FG V C+ TG++ A KKL+ E + E+ +IL+ +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDN 66
Query: 176 VV---SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
+V + Y+ + L LV+ + G L+ ++ D + YA+++ G+E+
Sbjct: 67 IVKYKGVCYS-AGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEY 123
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE----------GESVRGRVGTVGY 282
L V+RD NIL++ V+I D GL +P+ GES + +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES------PIFW 177
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEM 309
APE + K++ + D +SFG +++E+
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 16/226 (7%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
I ++ R+ LG+G FGEV T K+ A K L+ + L E QI++K
Sbjct: 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEA----FLQEAQIMKK 57
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
+ +V L YA +++ + +V M G L G + + AA++ G+
Sbjct: 58 LRHDKLVPL-YAVVSEEPIYIVTEFMGKGSL-LDFLKEGDGKYLKLPQLVDMAAQIADGM 115
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE--SVRGRVGTVGYMAPEVI 288
++ + ++RD + NIL+ D +I+D GLA I + E + +G + + APE
Sbjct: 116 AYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 289 DNEKYTYSPDWFSFGCLIFEMI-EGQAPFRRRKEMVKR---DEVDR 330
++T D +SFG L+ E++ +G+ P+ MV R ++V+R
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPY---PGMVNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 26/42 (61%), Positives = 33/42 (78%)
Query: 402 VKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 443
VKR+EVDRRV E E YS +FS++AK++CK LL K P+ RLG
Sbjct: 208 VKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLG 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 17/211 (8%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRKGESMVLIEKQILQKI 171
+VLG G FG V G+ A K L ++ K +L E ++ +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVMASV 66
Query: 172 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF-YAAEVLCGL 230
+ VV L + L+ +M G L ++ N G ++ + ++ G+
Sbjct: 67 DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIG---SQYLLNWCVQIAKGM 122
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV----RGRVGTVGYMAPE 286
+L LV+RD N+L+ HV+I+D GLA + E G+V + +MA E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV-PIKWMALE 181
Query: 287 VIDNEKYTYSPDWFSFGCLIFE-MIEGQAPF 316
I + YT+ D +S+G ++E M G P+
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 14/207 (6%)
Query: 122 LGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVS 178
LG G FG V A K L+++ I K E L E ++ +++ +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKE--FLREASVMAQLDHPCIVR 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L + + L LV+ + G L ++ P D+ A +V G+ +L
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYLESKHF 116
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-VRGRVG---TVGYMAPEVIDNEKYT 294
V+RD N+LL + +ISD G++ + G R + + APE I+ K++
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 295 YSPDWFSFGCLIFEMIE-GQAPFRRRK 320
D +S+G ++E G P+ K
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|188705 cd08751, RGS_GRK6, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase 6 (GRK6) | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-10
Identities = 20/66 (30%), Positives = 41/66 (62%), Gaps = 1/66 (1%)
Query: 480 PQAPEAVDVLSLEIIEHCKESLDSG-NRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYL 538
++ + + + +++ +C + L+ +ELF + + +L+ APF ++ DS++F R+L
Sbjct: 78 HKSEDYIPEVPRQLVTNCTQRLEQEPCKELFQELTKLIHDYLSVAPFADYLDSIYFNRFL 137
Query: 539 QWKWLE 544
QWKWLE
Sbjct: 138 QWKWLE 143
|
The RGS domain is an essential part of the GRK6 (G protein-coupled receptor kinase 6) protein which plays an important role in the regulating of dopamine, opioids, M3 muscarinic, and chemokine receptor signaling. GRK6 is a member of the GRK kinase family which includes three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. The RH domain of GRK6 does not have structural determinants that are required for binding G-alpha subunit, in contrast to GRK2 and many other RGS proteins. GRK6 is an important target for treatment of addiction and Parkinson disease. RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 145 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--ESMVLIEKQILQKINSRFVVSL 179
+G+G +G V + + TG++ A KK+ R++ S + E +L+++N +V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI---RLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
+++ L LV ++ DLK ++ + G D + Y ++L G+ + H ++
Sbjct: 64 LDVVHSENKLYLVFEFLDL-DLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 240 YRDCKPENILLDDYGHVRISDLGLA--VEIPEGESVRG---RVGTVGYMAPEVIDNEKYT 294
+RD KP+N+L+D G ++++D GLA +P VR V T+ Y APE++ +
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVP----VRTYTHEVVTLWYRAPEILLGSRQY 177
Query: 295 YSP-DWFSFGCLIFEMIEGQAPF 316
+P D +S GC+ EM+ + F
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM----VLIEKQ 166
+ +T ++ + LG G FGEV M K IK K SM L E
Sbjct: 3 VPRETLKLVKKLGAGQFGEVW---------MGYYNGHTKVAIKSLKQGSMSPEAFLAEAN 53
Query: 167 ILQKINSRFVVSLAYAYETKDALCLVLTIM-NGGDLKFHIYNMGGEPGFDIARARF--YA 223
+++++ +V L YA T++ + ++ M NG + F + G + + A
Sbjct: 54 LMKQLQHPRLVRL-YAVVTQEPIYIITEYMENGSLVDF----LKTPEGIKLTINKLIDMA 108
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA--VEIPEGESVRGRVGTVG 281
A++ G+ + ++RD + NIL+ + +I+D GLA +E E + G +
Sbjct: 109 AQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK 168
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ APE I+ +T D +SFG L+ E++ G+ P+
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 37/224 (16%)
Query: 122 LGKGGFGEVCACQV----------------RATGKMYACKKLEKKRIKKRKGESMVLIEK 165
LG+G FGEV C+V + + A K L K + + L E
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND--FLKEV 70
Query: 166 QILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLK----FHIYNMGGEPGFDIARAR- 220
+IL ++ ++ L +D LC++ M GDL H + E G D
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 221 -----------FYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269
A ++ G+++L + V+RD N L+ + ++I+D G++ +
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 270 GE--SVRGR-VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
G+ ++GR V + +MA E I K+T + D ++FG ++E++
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 19/226 (8%)
Query: 102 KDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESM 160
K I N+I K++++ ++G G FG V T + A KK L+ + K R
Sbjct: 54 KMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----- 108
Query: 161 VLIEKQILQKINSRFVVSLAYAYETKDA--------LCLVLTIMNGGDLKFHIYNMGGEP 212
E I++ +N ++ L Y T+ L +V+ + K+ +
Sbjct: 109 ---ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNH 165
Query: 213 GFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH-VRISDLGLAVEIPEGE 271
+ + Y+ ++ L ++H + +RD KP+N+L+D H +++ D G A + G+
Sbjct: 166 ALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
Query: 272 SVRGRVGTVGYMAPEV-IDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
+ + Y APE+ + YT D +S GC+I EMI G F
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 29/78 (37%), Positives = 49/78 (62%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 717
++LGKG FG+V + +A+GK YA K L+K+ I + + L E ++L+ F+ SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 718 AYAYETKDALCLVLTIID 735
Y+++TKD LC V+ ++
Sbjct: 61 KYSFQTKDRLCFVMEYVN 78
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 120 RVLGKGGFGEVCACQVR-----ATGKM-YACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
LG G FGEV +G + A K L K + K E L E ++ N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE--FLKEAHLMSNFNH 58
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM----GGEPGFDIARARFYAAEVLCG 229
+V L + +++ +M GGDL ++ + G P + +V G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGH-----VRISDLGLAVEIPEGE--SVRG-RVGTVG 281
+L + ++RD N L+ + G+ V+I D GLA +I + + G + V
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+MAPE + + K+T D +SFG L++E++ GQ P+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 13/208 (6%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K F R +G G FG V + T ++ A KK+ + + ++ E + LQ++
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 174 RFVVSL--AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLE 231
+ Y E L + + + D I + +P ++ A L GL
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASD----ILEVHKKPLQEVEIAAI-CHGALQGLA 129
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVI--- 288
+LH ++RD K NILL + G V+++D G A + S VGT +MAPEVI
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILAM 186
Query: 289 DNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
D +Y D +S G E+ E + P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 20/226 (8%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQI 167
I R LG+G FG+V ++ + + + K +K+ K + E ++
Sbjct: 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL 61
Query: 168 LQKINSRFVVSLAYAYETKDALCLVLTIMNGGDL-KFHIYNM------GGEPGFDIARAR 220
+ + +V L + C++ + GDL +F + N + +
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 221 FY------AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274
A ++ G+E+L V+RD N L+ + V+ISD GL+ +I + R
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 275 ---GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ V +M PE I K+T D +SFG +++E+ G P+
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 119 YRVLG---KGGFGEVCACQVRA-TGKMYA-------------CKKLEKKRIKKRKGESMV 161
+RV+ G FG++ C +RA T + A C++L KR+K ++
Sbjct: 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQ 209
Query: 162 LIEKQIL--QKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD---- 215
L E +IL ++N ++ + ++ T M F +Y+ + FD
Sbjct: 210 L-ENEILALGRLNHENILKIEEILRSEAN-----TYMITQKYDFDLYSFMYDEAFDWKDR 263
Query: 216 --IARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV--EIPEGE 271
+ + R ++LC +E++H L++RD K ENI L+ G + + D G A+ E
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
G VGTV +PE++ + Y D +S G ++ +M+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 57/241 (23%), Positives = 109/241 (45%), Gaps = 33/241 (13%)
Query: 117 RMYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
R LG+ FG++ + G ++ A K L+ ++ GE E ++ +++
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQ--EASLMAELH 65
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARAR------------ 220
+V L + +C++ +N GDL H + + P D+ +
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDL--HEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 221 ----FYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR 276
A ++ G+E+L V++D NIL+ + HV+ISDLGL+ EI + R +
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 277 VGT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF-----RRRKEMVKRDE 327
+ + +M PE I K++ D +SFG +++E+ G P+ + EMV++ +
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243
Query: 328 V 328
+
Sbjct: 244 L 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 16/227 (7%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-N 172
K ++ + +GKG FG+V R K+ K IK L E ++ ++ +
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGN-------KVAVKCIKNDATAQAFLAEASVMTQLRH 58
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
S V L E K L +V M G L ++ + G ++ +V +E+
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEY 117
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEK 292
L V+RD N+L+ + ++SD GL E + G++ V + APE + +K
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-GKL-PVKWTAPEALREKK 175
Query: 293 YTYSPDWFSFGCLIFEMIE-GQAPFRR--RKEMVKRDEVDRRVKEDA 336
++ D +SFG L++E+ G+ P+ R K++V R V++ K DA
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--VEKGYKMDA 220
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES-MVLIEKQILQKINSRFVVSLA 180
+G+G FGEV + + T ++ A KK+ + K+ G L E +ILQ + VV+L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNL- 76
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIAR------ARFYAAEV-------L 227
E +C K Y + D+A +F +E+ L
Sbjct: 77 --IE----ICRTKATPYNRY-KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA-----VEIPEGESVRGRVGTVGY 282
GL ++H +++RD K NIL+ G ++++D GLA + + RV T+ Y
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 283 MAPEVIDNEKYTYSP--DWFSFGCLIFEM 309
PE++ E+ Y P D + GC++ EM
Sbjct: 190 RPPELLLGER-DYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F +V+GKG FGEV Q + TGK+YA K L K + K+ + V E+ +L + +S +
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 714 VVSLAYAYETKDALCLVLTII---DVM 737
VVSL Y+++ L L++ + D+M
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLM 89
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 59/214 (27%), Positives = 110/214 (51%), Gaps = 19/214 (8%)
Query: 125 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV-LIEKQILQKINSRFVVSLAYAY 183
G +G V + + TG++ A KKL K K+++G + L E IL K+ +V++
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLKLQHPNIVTVK--- 70
Query: 184 E-----TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
E D + +V+ + DLK + M + F + + ++L G+ HLH +
Sbjct: 71 EVVVGSNLDKIYMVMEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNWI 127
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVI-DNEKYTYS 296
++RD K N+LL++ G ++I D GLA E + V T+ Y APE++ ++Y+ +
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTA 187
Query: 297 PDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR 330
D +S GC+ E++ + F + E+ D++++
Sbjct: 188 IDMWSVGCIFAELLTKKPLFPGKSEI---DQLNK 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 63/252 (25%), Positives = 103/252 (40%), Gaps = 11/252 (4%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K F R +G G FG V + ++ A KK+ + + ++ E + LQK+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+ Y + LV+ G + + +P ++ A L GL +L
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHG-ALQGLAYL 131
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVI---DN 290
H +++RD K NILL + G V++ D G A + VGT +MAPEVI D
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDE 188
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350
+Y D +S G E+ E + P M + + E S +S+ +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NESPALQSGHWSEYFRNF 246
Query: 351 CKALLKKSPRSR 362
+ L+K P+ R
Sbjct: 247 VDSCLQKIPQDR 258
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 25/80 (31%), Positives = 46/80 (57%), Gaps = 1/80 (1%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SR 712
F+ +++G+G F V + + T K YA K L+K+++ K K V IEK++L ++N
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 713 FVVSLAYAYETKDALCLVLT 732
++ L Y ++ ++ L VL
Sbjct: 63 GIIKLYYTFQDEENLYFVLE 82
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 26/78 (33%), Positives = 44/78 (56%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F M LG G FG V + + TG+ YA K L+K+ I K K V EK IL +++ F
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 714 VVSLAYAYETKDALCLVL 731
+V++ +++ ++ + +L
Sbjct: 80 IVNMMCSFQDENRVYFLL 97
|
Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 27/78 (34%), Positives = 49/78 (62%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F +V+G+G FGEV Q + TG +YA KKL K + +++ + V E+ IL + ++ +
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 714 VVSLAYAYETKDALCLVL 731
VV L Y+++ ++ L L++
Sbjct: 63 VVKLYYSFQDENYLYLIM 80
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 16/218 (7%)
Query: 124 KGGFGEVCACQVRATGKMYAC---KKLEKKRIK--KRKGESMVLIEKQILQKINSRFVVS 178
K GF + A G +AC K E IK +R G E IL+ IN ++
Sbjct: 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGG---TATEAHILRAINHPSIIQ 147
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L + CL+L DL ++ DI VL +++LH +
Sbjct: 148 LKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIE---RSVLRAIQYLHENRI 203
Query: 239 VYRDCKPENILLDDYGHVRISDLGLA---VEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
++RD K ENI ++ G V + D G A V+I + G GT+ APE++ + Y
Sbjct: 204 IHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY-GWAGTIATNAPELLARDPYGP 262
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK 333
+ D +S G ++FEM + + + DR++K
Sbjct: 263 AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK 300
|
Length = 391 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 47/193 (24%), Positives = 91/193 (47%), Gaps = 7/193 (3%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVL--IEKQILQKINSRFVVSL 179
LGKG FG V + + K L++ + + V E Q+L K++ +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHI--YNMGGEPGFDIARARFYAAEVLCGLEHLHYIG 237
++ +DA C++ G DL + G+ + + ++L G+ ++H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT-LSENQVCEWFIQLLLGVHYMHQRR 126
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLA-VEIPEGESVRGRVGTVGYMAPEVIDNEKYTYS 296
+++RD K +NI L + ++I D G++ + + + GT YM+PE + ++ Y
Sbjct: 127 ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185
Query: 297 PDWFSFGCLIFEM 309
D +S GC+++EM
Sbjct: 186 SDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 28/74 (37%), Positives = 45/74 (60%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 717
++LGKG FG+V + +ATG+ YA K L K+ I + + + E ++LQ F+ +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 718 AYAYETKDALCLVL 731
YA++T D LC V+
Sbjct: 61 KYAFQTHDRLCFVM 74
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 25/72 (34%), Positives = 40/72 (55%), Gaps = 2/72 (2%)
Query: 660 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 719
LG+GGFG V + + TGK A K ++K+ +L E +IL+K+N +V L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58
Query: 720 AYETKDALCLVL 731
+E ++ L LV+
Sbjct: 59 VFEDENHLYLVM 70
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|188704 cd08750, RGS_GRK4, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase 4 (GRK4) | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-09
Identities = 24/48 (50%), Positives = 32/48 (66%), Gaps = 1/48 (2%)
Query: 51 YSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRR 98
YS + D+QPIGRLLFRQFC + +P + FLD++ YE+ DE R
Sbjct: 2 YSSLCDKQPIGRLLFRQFC-DTRPTLKRCIEFLDAVAEYEVAPDEKRS 48
|
The RGS domain is an essential part of the GRK4 (G protein-coupled receptor kinase4) proteins, which are membrane-associated serine/threonine protein kinases that phosphorylate G protein-coupled receptors (GPCRs) upon agonist stimulation. This phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events. GRK4 is a member of the GRK kinase family which includes three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. GRK4 plays a key role in regulating dopaminergic-mediated natriuresis and is associated with essential hypertension and/or salt-sensitive hypertension. GRK4 exists in four splice variants involved in hyperphosphorylation, desensitization, and internalization of two dopamine receptors (D1R and D3R). GRK4 also increases the expression of a key receptor of the renin-angiotensin system, the AT1R (angiotensin type 1 receptor). RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 132 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 52/211 (24%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
I ++ ++ + LG G FGEV G K+ K +K +E+ L K
Sbjct: 3 IPRESIKLVKKLGAGQFGEVW------MGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMK 56
Query: 171 INSRFVVSLAYAYETKDALCLVLT--IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC 228
+ YA TK+ ++T + G L F + GG+ + + ++A++
Sbjct: 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGK--VLLPKLIDFSAQIAE 114
Query: 229 GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE--SVRGRVGTVGYMAPE 286
G+ ++ ++RD + N+L+ + +I+D GLA I + E + G + + APE
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
I+ +T D +SFG L++E++ G+ P+
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ F + R LG G FGEV + ++ A K L K K + E Q L+++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKIL--KSDDLLKQQDFQK-EVQALKRLRH 61
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+ ++SL + + ++ +M G L + + G+ +A A +V G+ +L
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYL 120
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLA------VEIPEGESVRGRVGTVGYMAPEV 287
++RD NIL+ + +++D GLA V + + + + APE
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-----PYKWTAPEA 175
Query: 288 IDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ ++ D +SFG L++EM GQ P+
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 49/217 (22%), Positives = 96/217 (44%), Gaps = 13/217 (5%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMVLIEKQILQKINSRFVV 177
+GKG FG+V ++ ++ A K + KRK L E +IL++ + +V
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRK----FLQEAEILKQYDHPNIV 55
Query: 178 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG 237
L K + +V+ ++ GG L + + + + + G+E+L
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN 113
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SVRGRVGT--VGYMAPEVIDNEKYT 294
++RD N L+ + ++ISD G++ E G +V + + + APE ++ +YT
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 295 YSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDR 330
D +S+G L++E G P+ R+ ++
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES 210
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 31/79 (39%), Positives = 49/79 (62%), Gaps = 1/79 (1%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVS 716
+V+GKG FG+V + +A K YA K L+KK I K+K E ++ E+ +L K + F+V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 717 LAYAYETKDALCLVLTIID 735
L ++++T D L VL I+
Sbjct: 61 LHFSFQTADKLYFVLDYIN 79
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-09
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPE-GESVRGR--- 276
+VL L H G+V+RD KP+NI++ H ++ D G+ +P ++
Sbjct: 86 LQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTR 145
Query: 277 ----VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQ 313
+GT Y APE + E T + D +++G + E + GQ
Sbjct: 146 TTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 17/247 (6%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
+G G FG V T ++ A KK+ + + ++ E + LQ++ +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 182 AYETKDALCLVLTIMNGGD---LKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
Y + LV+ G L+ H +P ++ A L GL +LH +
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAITHG-ALQGLAYLHSHNM 142
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVI---DNEKYTY 295
++RD K NILL + G V+++D G A + S VGT +MAPEVI D +Y
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYDG 199
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355
D +S G E+ E + P M + + + S ++D + L
Sbjct: 200 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NDSPTLQSNEWTDSFRGFVDYCL 257
Query: 356 KKSPRSR 362
+K P+ R
Sbjct: 258 QKIPQER 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEK 165
+ + + R LG G FGEV R A A K L + + ES L+E
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE--SCSEQDESDFLMEA 60
Query: 166 QILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLK-F--HIYNMGGEPG-FDIARARF 221
I+ K N + +V L + ++L +M GGDLK F P + F
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH---VRISDLGLAVEIPEGESVR--GR 276
A +V G ++L ++RD N LL G +I+D G+A +I R GR
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 277 -VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ + +M PE + +T D +SFG L++E+ G P+
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 28/74 (37%), Positives = 46/74 (62%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 717
++LGKG FG+V + +ATG+ YA K L+K+ I + + L E ++LQ F+ +L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 718 AYAYETKDALCLVL 731
Y+++T D LC V+
Sbjct: 61 KYSFQTHDRLCFVM 74
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 3/94 (3%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVS 716
+V+GKG FG+V + + GK YA K L+KK + RK + ++ E+ +L K + F+V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 717 LAYAYETKDALCLVLTIID--VMFTCVQPSETNP 748
L Y+++T + L VL ++ +F +Q + P
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP 94
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 26/78 (33%), Positives = 48/78 (61%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + +V+G+G FGEV +++ TG++YA K L K + KR + E+ +L + R+
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 714 VVSLAYAYETKDALCLVL 731
+ +L YA++ ++ L LV+
Sbjct: 63 ITNLHYAFQDENNLYLVM 80
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 31/220 (14%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM----VLIEKQ 166
I ++ ++ R LG G FGEV T K+ +K K +M L E Q
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKV---------AVKTLKPGTMSPEAFLQEAQ 53
Query: 167 ILQKINSRFVVSLAYAYETK-DALCLVLTIMNGGDLKFHIYNMGG-----EPGFDIARAR 220
I++K+ +V L YA ++ + + +V M+ G L + + G D+A
Sbjct: 54 IMKKLRHDKLVQL-YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA--- 109
Query: 221 FYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT- 279
A++ G+ +L ++RD NIL+ + +I+D GLA I + E R G
Sbjct: 110 ---AQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGAK 165
Query: 280 --VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+ + APE + ++T D +SFG L+ E++ G+ P+
Sbjct: 166 FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 39/112 (34%), Positives = 54/112 (48%), Gaps = 12/112 (10%)
Query: 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK-STNWKRLEAGLCD---- 395
R SD A + K + R G Y A E+ Q E + S +W L L +
Sbjct: 134 VRISDLGLA-VELKGGKKIKGRAGTP--GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190
Query: 396 -PPFV---PDVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 443
PF V+++E+ RR E A +Y +FS +AK LC+ALL+K P RLG
Sbjct: 191 RSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLG 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 30/81 (37%), Positives = 48/81 (59%), Gaps = 3/81 (3%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR- 712
FR VLG+G FG+V + + TG++YA K L+K I R ++ EK+I + NS
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 713 --FVVSLAYAYETKDALCLVL 731
F+V+L ++T+D +C V+
Sbjct: 61 HPFLVNLFACFQTEDHVCFVM 81
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 24/71 (33%), Positives = 41/71 (57%)
Query: 660 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 719
+ KG +G V + ++TG +YA K ++K + ++ VL E+ IL + S +VV L Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 720 AYETKDALCLV 730
+++ K L LV
Sbjct: 61 SFQGKKNLYLV 71
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 33/82 (40%), Positives = 47/82 (57%), Gaps = 2/82 (2%)
Query: 654 FRMYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 712
F + LG G FGEVC AC+V T +YA K L KK + R + V E+ IL + ++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVD-THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE 61
Query: 713 FVVSLAYAYETKDALCLVLTII 734
+VV L Y+++ KD L V+ I
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYI 83
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|188706 cd08752, RGS_GRK5, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase 5 (GRK5) | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-08
Identities = 27/54 (50%), Positives = 33/54 (61%), Gaps = 1/54 (1%)
Query: 51 YSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDI 104
Y + D+QPIGRLLFRQFC E +P Y FLDS+ YE+ DE K+I
Sbjct: 1 YCSLCDKQPIGRLLFRQFC-ETRPGLECYIQFLDSVAEYEVTPDEKLGEKGKEI 53
|
The RGS domain is an essential part of the GRK5 (G protein-coupled receptor kinase 5) protein, a membrane-associated serine/threonine protein kinases which phosphorylates G protein-coupled receptors (GPCRs) upon agonist stimulation. This phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events. GRK5 is a member of the GRK kinase family which include three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 123 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181
+G+G +G V + R T + A KK+ ++ + S + E +L+++ +V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGF--DIARARFYAAEVLCGLEHLHYIGLV 239
++ L LV ++ DLK H M P F + + Y ++L G+ + H ++
Sbjct: 69 VVHSEKRLYLVFEYLDL-DLKKH---MDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124
Query: 240 YRDCKPENILLDDYGH-VRISDLGLAVEIPEGESVRG---RVGTVGYMAPEVIDNEKYTY 295
+RD KP+N+L+D + ++++D GLA G VR V T+ Y APE++ ++
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILLGSRHYS 182
Query: 296 SP-DWFSFGCLIFEMIEGQAPF 316
+P D +S GC+ EM+ + F
Sbjct: 183 TPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKL---------------EKKRIKKRKGESM 160
+++ V+GKG +G VC+ TG+ A KK+ E K ++ + +
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 161 VLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARAR 220
V I K I+ + R E KD + +V +M DL I +
Sbjct: 62 VEI-KHIMLPPSRR---------EFKD-IYVVFELM-ESDLHQVI---KANDDLTPEHHQ 106
Query: 221 FYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA----VEIPEGESVRGR 276
F+ ++L L+++H + +RD KP+NIL + ++I D GLA + P
Sbjct: 107 FFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166
Query: 277 VGTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPF 316
V T Y APE+ + KYT + D +S GC+ E++ G+ F
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|188702 cd08748, RGS_GRK1, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase 1 (GRK1) | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 20/65 (30%), Positives = 29/65 (44%)
Query: 478 FFPQAPEAVDVLSLEIIEHCKESLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRY 537
+ E L + + KE + +LF + + L A F F DSM+F R+
Sbjct: 74 LESSSKEFCAFLDAKAVARVKEDGNKVGDDLFKPLLRELLAHLEEAAFAPFLDSMYFLRF 133
Query: 538 LQWKW 542
LQWKW
Sbjct: 134 LQWKW 138
|
The RGS domain is found in G protein-coupled receptor kinases 1 (GRK1, also refered to as Rhodopsin kinase) which play a key role in phosphorylation of rhodopsin (Rho), a G protein-coupled receptor responsible for visual signal transduction in rod cell. GRK1 is a member of the GRK kinase family which includes three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. A few inactivation mutations in GRK1 have been found in patients with Oguchi disease, a stationary form of night blindness. RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 138 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 25/42 (59%), Positives = 33/42 (78%)
Query: 402 VKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 443
+KR+EV+R VKE E+YS +FS DA++LCK LL K P+ RLG
Sbjct: 208 IKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLG 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 30/81 (37%), Positives = 44/81 (54%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + LG G FGEVC + T +YA K L KK + R + V E+ IL + ++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 714 VVSLAYAYETKDALCLVLTII 734
VV L Y+++ KD L V+ I
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYI 83
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 28/228 (12%)
Query: 105 YNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK----KRIKKRKGESM 160
+ +Q IT LG+G FGEV + + + E K ++K K E++
Sbjct: 4 RSNLQEIT--------TLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENL 51
Query: 161 VLI---EKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLK-FHIYNMGGEPGFDI 216
E + +K++ + VV L + ++L + GDLK F +
Sbjct: 52 QSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKP 111
Query: 217 ARARFYAAEVLC-----GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271
LC G++HL V+RD N L+ V++S L L+ ++ E
Sbjct: 112 PPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171
Query: 272 --SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+R + + ++APE + + ++ D +SFG L++E+ +G+ PF
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 122 LGKGGFGEVCACQVRATGKM--YACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
LG G FG V + K A K L+ + K + E M E +I+ ++++ ++V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMR--EAEIMHQLDNPYIVRM 60
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
E +AL LV+ + +GG L + + G + ++ +V G+++L V
Sbjct: 61 IGVCEA-EALMLVMEMASGGPL--NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 240 YRDCKPENILLDDYGHVRISDLGLAVEIPEGES-VRGRVG---TVGYMAPEVIDNEKYTY 295
+RD N+LL + + +ISD GL+ + +S + R + + APE I+ K++
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 296 SPDWFSFGCLIFEMIE-GQAPFRRRK 320
D +S+G ++E GQ P+++ K
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMK 203
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 118 MYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
M R LG+G FG V + K A K + + + + E L E ++++ N
Sbjct: 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 67
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN----MGGEPGF---DIARARFYAAE 225
VV L +++ +M GDLK ++ + M P + + A E
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR-GRVG--TVGY 282
+ G+ +L+ V+RD N ++ + V+I D G+ +I E + R G G V +
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEM 309
M+PE + + +T D +SFG +++E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM----VLIEKQ 166
I ++ ++ + LG G FGEV M K K +K K SM L E
Sbjct: 3 IPRESLKLEKKLGAGQFGEVW---------MATYNKHTKVAVKTMKPGSMSVEAFLAEAN 53
Query: 167 ILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF--YAA 224
+++ + +V L +A TK+ + ++ M G L + + + G + ++A
Sbjct: 54 VMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSL---LDFLKSDEGSKQPLPKLIDFSA 109
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV--RGRVGTVGY 282
++ G+ + ++RD + NIL+ +I+D GLA I + E G + +
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
APE I+ +T D +SFG L+ E++ G+ P+
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 10/200 (5%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
+ LG G FG V + RA K+ A K + + + E + E +++ K++ +V L
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQL 64
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
+ L +V M G L ++ G+ D+ + +V G+E+L +
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLS--MCQDVCEGMEYLERNSFI 122
Query: 240 YRDCKPENILLDDYGHVRISDLGLAVEIPEGE--SVRGRVGTVGYMAPEVIDNEKYTYSP 297
+RD N L+ G V++SD G+ + + E S G V + PEV + KY+
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 298 DWFSFGCLIFEMI-EGQAPF 316
D +SFG L++E+ EG+ PF
Sbjct: 183 DVWSFGVLMWEVFTEGKMPF 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 3/87 (3%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + +G G FGEVC + T +YA K L K + R + V E+ IL + ++ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 714 VVSLAYAYETKDALCLVLTII---DVM 737
VV L Y+++ KD L V+ I D+M
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMM 89
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 17/217 (7%)
Query: 116 FRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
F + R+LGKG FG V Q+++ + + A K L K I L E +++ +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 173 SRFVVSL---AYAYETKDAL---CLVLTIMNGGDL-KFHIYNMGGEPGFDIARARF--YA 223
V+ L + K L ++L M GDL F + + GE F + +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---V 280
++ G+E+L ++RD N +L++ V ++D GL+ +I G+ R + V
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFE-MIEGQAPF 316
++A E + + YT D ++FG ++E M GQ P+
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 48/222 (21%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE---SMVLIEKQILQKI 171
+ +L +G FG + + K +++ K +K E +++L E +L +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDE-KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 172 NSRFVVSLAYA-YETKDALCLVLTIMNGGDLKFHIYN--MGGEPGFDIARAR---FYAAE 225
+ + ++ + + E + ++ MN G+LK + +G + A +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-P---------EGESVRG 275
+ CG+ +LH G++++D N ++D+ V+I+D L+ ++ P E V+
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK- 184
Query: 276 RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+MA E + N++Y+ + D +SFG L++E++ GQ P+
Sbjct: 185 ------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 38/117 (32%), Positives = 58/117 (49%), Gaps = 13/117 (11%)
Query: 654 FRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRI-KKRKGESMVLIEKQILQKI 709
F + RVLG G +G+V + GK+YA K L+K I +K K E+Q+L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 710 NSR-FVVSLAYAYETKDALCLVLTIID--VMFTCVQPSETNPCCFPFRRKEVVVVAA 763
F+V+L YA++T L L+L ++ +FT + E F EV V A
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH------FTESEVRVYIA 112
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 5e-08
Identities = 20/58 (34%), Positives = 35/58 (60%)
Query: 660 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 717
LG GGFG V +V++ + +A K ++K+ I + + + EK+IL++ N F+V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 28/79 (35%), Positives = 50/79 (63%), Gaps = 1/79 (1%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVS 716
+V+GKG FG+V + ++ G YA K L+KK I K+K ++ ++ E+ +L K + F+V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 717 LAYAYETKDALCLVLTIID 735
L Y+++T + L VL ++
Sbjct: 61 LHYSFQTAEKLYFVLDYVN 79
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 120 RVLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFV 176
+V+G G FGEV ++ G+ A K L+ +K++ + L E I+ + + +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD--FLSEASIMGQFSHHNI 68
Query: 177 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI 236
+ L ++ M G L ++ + GE F + + G+++L +
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYLSDM 126
Query: 237 GLVYRDCKPENILLDDYGHVRISDLGLA---VEIPEGE-SVRGRVGTVGYMAPEVIDNEK 292
V+RD NIL++ ++SD GL+ + PEG + G + + APE I K
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 293 YTYSPDWFSFGCLIFE-MIEGQAPF 316
+T + D +SFG +++E M G+ P+
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 32/99 (32%), Positives = 59/99 (59%), Gaps = 2/99 (2%)
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA-VEIPEGESVRGRVG 278
+++ ++L GL+++H +++RD KP N+LL+ ++I D GLA +G+ + V
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV 170
Query: 279 TVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPF 316
T Y APE++ N +YT + D +S GC+ E++ + F
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 26/76 (34%), Positives = 45/76 (59%)
Query: 660 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 719
+GKG FG+V + R T ++YA K + K I R + L E+ +L ++N F+V L +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 720 AYETKDALCLVLTIID 735
++++ + L LVL I+
Sbjct: 61 SFQSPEKLYLVLAFIN 76
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 29/80 (36%), Positives = 47/80 (58%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
K F + ++G+G FGEV + +ATG +YA K ++K + ++ S E+ IL NS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 712 RFVVSLAYAYETKDALCLVL 731
++ L YA++ KD L LV+
Sbjct: 61 PWIPQLQYAFQDKDNLYLVM 80
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 31/80 (38%), Positives = 47/80 (58%), Gaps = 8/80 (10%)
Query: 658 RVLGKGGFGEVCACQVRAT-----GKMYACKKLEKKRI-KKRKGESMVLIEKQILQKINS 711
+VLGKGG+G+V QVR GK++A K L+K I + +K + E+ IL+ +
Sbjct: 2 KVLGKGGYGKVF--QVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH 59
Query: 712 RFVVSLAYAYETKDALCLVL 731
F+V L YA++T L L+L
Sbjct: 60 PFIVDLIYAFQTGGKLYLIL 79
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-KGESMVLIEKQILQKINSRFVVSLA 180
+GKG FG+V Y +K+ K +K L E ++ + +V L
Sbjct: 14 IGKGEFGDVML-------GDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLL 66
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARAR-----------FYAAEVLCG 229
+ L +V M G L D R+R +A +V G
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSL------------VDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVID 289
+E+L V+RD N+L+ + ++SD GLA E +G+ G++ V + APE +
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS-GKL-PVKWTAPEALR 172
Query: 290 NEKYTYSPDWFSFGCLIFEMIE-GQAPFRR--RKEMVKRDEVDRR 331
+K++ D +SFG L++E+ G+ P+ R K++V E R
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR 217
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 121 VLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVV 177
V+G G FGEVC +++ GK A K L+ +K++ + L E I+ + + ++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD--FLSEASIMGQFDHPNII 68
Query: 178 SLAYAYETKDALCLVLT-IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI 236
L TK +++T M G L + G+ F + + + G+++L +
Sbjct: 69 HLE-GVVTKSRPVMIITEFMENGALDSFLRQNDGQ--FTVIQLVGMLRGIAAGMKYLSEM 125
Query: 237 GLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVG------YMAPEVIDN 290
V+RD NIL++ ++SD GL+ + + S ++G + APE I
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 291 EKYTYSPDWFSFGCLIFE-MIEGQAPF 316
K+T + D +S+G +++E M G+ P+
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 51/203 (25%), Positives = 81/203 (39%), Gaps = 12/203 (5%)
Query: 122 LGKGGFGEVC-ACQVRATGKMY--ACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVS 178
LG G FG V + GK+ A K L K K L E I+ ++ ++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCL--KSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L Y L +V + G L F I+ YA ++ G+ +L
Sbjct: 61 L-YGVVLTHPLMMVTELAPLGSL-LDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEIPEGE----SVRGRVGTVGYMAPEVIDNEKYT 294
++RD NILL V+I D GL +P+ E + APE + ++
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 295 YSPDWFSFGCLIFEMIE-GQAPF 316
++ D + FG ++EM G+ P+
Sbjct: 179 HASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 35/95 (36%), Positives = 58/95 (61%), Gaps = 3/95 (3%)
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA-VEIP-EGESVRGRVGTVGY 282
++L GL++LH G+++RD KP N+L++ ++I D GLA VE P E + + V T Y
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 283 MAPEVIDNEK-YTYSPDWFSFGCLIFEMIEGQAPF 316
APE++ + YT + D +S GC+ E++ + F
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 38/127 (29%), Positives = 69/127 (54%), Gaps = 21/127 (16%)
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILL----DDYGHVRISDLGLA-------VEIPEGESV 273
++L G+ +LH +++RD KP NIL+ + G V+I DLGLA + + + V
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 274 RGRVGTVGYMAPEVIDNEK-YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK------RD 326
V T+ Y APE++ + YT + D ++ GC+ E++ + F+ R+ +K RD
Sbjct: 176 ---VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 327 EVDRRVK 333
+++R +
Sbjct: 233 QLERIFE 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 230 LEHL-HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVI 288
L +L + +++RD KP NILLD G++++ D G++ ++ + + G YMAPE I
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179
Query: 289 D---NEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
D + Y D +S G ++E+ G+ P+
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 48/217 (22%), Positives = 100/217 (46%), Gaps = 16/217 (7%)
Query: 121 VLGKGGFGEVC--ACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVS 178
+LGKG FGEV + + + CK+ + +K + L E +IL++ + +V
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIVK 56
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
L + + +V+ ++ GGD F + + + +A + G+ +L
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGD--FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG----TVGYMAPEVIDNEKYT 294
++RD N L+ + ++ISD G++ + E + + G + + APE ++ +Y+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 295 YSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDR 330
D +S+G L++E G P+ R++V++
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK 209
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 53/215 (24%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 134 QVRATG-KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192
Q+ TG M AC+++ +++ K +++ ++K L + + V L + Y D ++
Sbjct: 35 QIEGTGISMSACREI--ALLRELKHPNVIALQKVFLSHSDRK--VWLLFDYAEHDLWHII 90
Query: 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAA--EVLCGLEHLHYIGLVYRDCKPENILL 250
KFH + + + R+ + ++L G+ +LH +++RD KP NIL+
Sbjct: 91 ---------KFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 141
Query: 251 ----DDYGHVRISDLGLA----VEIPEGESVRGRVGTVGYMAPEVIDNEK-YTYSPDWFS 301
+ G V+I+D+G A + + V T Y APE++ + YT + D ++
Sbjct: 142 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201
Query: 302 FGCLIFEMIEGQAPFRRRKEMVK------RDEVDR 330
GC+ E++ + F R+E +K D++DR
Sbjct: 202 IGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|188703 cd08749, RGS_GRK7, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase 7 (GRK7) | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 20/53 (37%), Positives = 29/53 (54%)
Query: 489 LSLEIIEHCKESLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYLQWK 541
LS ++ CK + + E+ K FL G PFT+FQ S F+ ++LQWK
Sbjct: 85 LSGDVATKCKAATEKDFEEVVGQAKDETKEFLQGKPFTDFQTSPFYDKFLQWK 137
|
The RGS domain is an essential part of the GRK7 (G protein-coupled receptor kinases 7) proteins which together with GRK1 (Rhodopsin kinase) have been implicated in the shutoff of the photoresponse and adaptation to changing light conditions via rod and cone opsin phosphorylation. GRK7 is a member of the GRK kinase family which includes three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. GRK7 is expressed in all vertebrate cones except that of mice and rats, which do not have the gene for GRK7. Lack of either GRK7 or both GRK1 and GRK7 in human leads to a vision defect called Enhanced S Cone syndrome. RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 139 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ------------ 169
LG+G FGEV C+ K ++K G VL+ ++L+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKF-----MDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 170 ---KINSRF----VVSLAYAYETKDALCLVLTIMNGGDL-KFHIYNMGGEPGFD------ 215
KI SR ++ L T D LC++ M GDL +F + E
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 216 -IARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274
+ F A ++ G+++L + V+RD N L+ ++I+D G++ + G+ R
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187
Query: 275 --GR-VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
GR V + +M+ E I K+T + D ++FG ++E++
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 134 QVRATG-KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192
Q+ TG M AC+++ +++ K +++ ++K L + + V L + Y D ++
Sbjct: 35 QIEGTGISMSACREI--ALLRELKHPNVISLQKVFLSHADRK--VWLLFDYAEHDLWHII 90
Query: 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAA--EVLCGLEHLHYIGLVYRDCKPENILL 250
KFH + + + R + ++L G+ +LH +++RD KP NIL+
Sbjct: 91 ---------KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 141
Query: 251 ----DDYGHVRISDLGLA----VEIPEGESVRGRVGTVGYMAPEVIDNEK-YTYSPDWFS 301
+ G V+I+D+G A + + V T Y APE++ + YT + D ++
Sbjct: 142 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201
Query: 302 FGCLIFEMIEGQAPFRRRKEMVK------RDEVDR 330
GC+ E++ + F R+E +K D++DR
Sbjct: 202 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 44/119 (36%), Positives = 65/119 (54%), Gaps = 11/119 (9%)
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEGESVR---GRV 277
Y+ +V G+E L ++RD NILL + V+I D GLA +I + + VR R+
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRD-EVDRRVKE 334
+ +MAPE I + YT D +SFG L++E+ G +P+ VK D E RR+KE
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKE 297
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMY---ACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ +V+G G FGEVC +++ GK A K L+ K++ + L E I+ + +
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD--FLTEASIMGQFDH 64
Query: 174 RFVVSLAYAYETKDALCLVLT-IMNGGDLKFHIYNMGGE--PGFDIARARFYAAEVLCGL 230
++ L TK +++T M G L + G+ G + R A+ G+
Sbjct: 65 PNIIRL-EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIAS----GM 119
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA--VEIPEGE-SVRGRVGTVGYMAPEV 287
++L + V+RD NIL++ ++SD GL+ +E E + +G + + APE
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179
Query: 288 IDNEKYTYSPDWFSFGCLIFE-MIEGQAPF 316
I K+T + D +SFG +++E M G+ P+
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 116 FRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
++ ++LG+G FG V Q+ + A K ++ + E L E ++ +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEF-LSEAACMKDFD 59
Query: 173 SRFVVSL------AYAYETKDALCLVLTIMNGGDLKFHIYNM--GGEP-GFDIARARFYA 223
V+ L A + + ++L M GDL + GG P + +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR-GRVGT--V 280
++ G+E+L ++RD N +L + V ++D GL+ +I G+ R GR+ V
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFE-MIEGQAPF 316
++A E + + YT D ++FG ++E GQ P+
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKK-RIKKRKGES-------MVLIEKQILQKINS 173
LG G FG V MY KK EK +K K ++ +L E ++Q++++
Sbjct: 3 LGSGNFGTV-------KKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDL-KFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
++V + E ++ LV+ + G L KF N +V G+++
Sbjct: 56 PYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKH----VTEKNITELVHQVSMGMKY 110
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT----VGYMAPEVI 288
L V+RD N+LL + +ISD GL+ + E+ V + APE +
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 289 DNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRK 320
+ K++ D +SFG L++E GQ P++ K
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 118 MYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK-------QILQK 170
+ R LG+G FG V + + E + K ES L E+ +++
Sbjct: 10 LLRELGQGSFGMV----YEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 65
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY-------NMGGEPGFDIARARFYA 223
VV L +V+ +M GDLK ++ N G P + A
Sbjct: 66 FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR-GRVG--TV 280
AE+ G+ +L+ V+RD N ++ V+I D G+ +I E + R G G V
Sbjct: 126 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEM 309
+MAPE + + +T S D +SFG +++E+
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 4/85 (4%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR-FVVS 716
+VLGKG FG+V +++ T ++YA K L+K I + + EK++L F+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 717 LAYAYETKDALCLVLTII---DVMF 738
L ++TKD L V+ + D+MF
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMF 85
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 25/78 (32%), Positives = 45/78 (57%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
K F++ +G+GG+G+V + + TG++ A K+++K + K VL E+ IL S
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 712 RFVVSLAYAYETKDALCL 729
++V L YA++ + L L
Sbjct: 61 EWLVKLLYAFQDDEYLYL 78
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|188705 cd08751, RGS_GRK6, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase 6 (GRK6) | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 23/54 (42%), Positives = 34/54 (62%), Gaps = 1/54 (1%)
Query: 45 LALYVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRR 98
+L Y + ++QPIGRLLFRQFC +P+ + FLD++ YE+ DE R+
Sbjct: 13 QSLERDYHSLCERQPIGRLLFRQFC-ATRPELSRCVAFLDAVAEYEVTPDEKRK 65
|
The RGS domain is an essential part of the GRK6 (G protein-coupled receptor kinase 6) protein which plays an important role in the regulating of dopamine, opioids, M3 muscarinic, and chemokine receptor signaling. GRK6 is a member of the GRK kinase family which includes three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. The RH domain of GRK6 does not have structural determinants that are required for binding G-alpha subunit, in contrast to GRK2 and many other RGS proteins. GRK6 is an important target for treatment of addiction and Parkinson disease. RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 145 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 6/100 (6%)
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEGESVR---GRV 277
Y+ +V G+E L ++RD NILL + V+I D GLA +I + + VR R+
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ +MAPE I ++ YT D +SFG L++E+ G +P+
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRKGESMVLIEKQILQKI 171
+ +VLG G FG V G+ A K L + K E +L E ++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE--ILDEAYVMAGV 66
Query: 172 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLE 231
S +V L T + LV +M G L ++ G + ++ G+
Sbjct: 67 GSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLN--WCVQIAKGMS 123
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLA--VEIPEGE--SVRGRVGTVGYMAPEV 287
+L + LV+RD N+L+ HV+I+D GLA ++I E E + G+V + +MA E
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PIKWMALES 182
Query: 288 IDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
I + ++T+ D +S+G ++E++ G P+
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 25/80 (31%), Positives = 46/80 (57%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
+ F + +V+G+G FGEV + +++ ++YA K L K + KR + E+ I+ NS
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 712 RFVVSLAYAYETKDALCLVL 731
++V L YA++ L +V+
Sbjct: 103 EWIVQLHYAFQDDKYLYMVM 122
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 38/133 (28%), Positives = 71/133 (53%), Gaps = 7/133 (5%)
Query: 191 LVLTIMNGGDL-KFHIYN-MGGEPGFDIARARF-YAAEVLCGLEHLHYIGLVYRDCKPEN 247
++L M GDL F +Y+ +G P + + + ++ G+E+L ++RD N
Sbjct: 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARN 142
Query: 248 ILLDDYGHVRISDLGLAVEIPEGESVR-GRVGT--VGYMAPEVIDNEKYTYSPDWFSFGC 304
+L++ +V ++D GL+ +I G+ R GR+ V ++A E + + YT D +SFG
Sbjct: 143 CMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGV 202
Query: 305 LIFEM-IEGQAPF 316
++E+ GQ P+
Sbjct: 203 TMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 6/100 (6%)
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEGESVR---GRV 277
Y+ +V G+E L ++RD NILL + V+I D GLA +I + + VR R+
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ +MAPE I ++ YT D +SFG L++E+ G +P+
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 18/78 (23%), Positives = 38/78 (48%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ +G G FG V + R + YA K + + + K E V EK++L++++ F
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 714 VVSLAYAYETKDALCLVL 731
++ L + + L +++
Sbjct: 63 IIRLFWTEHDQRFLYMLM 80
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 55/221 (24%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 122 LGKGGFGEVCACQVRATGK-------MYACKKLEKKRIKKRKGESMVLIEKQILQKINS- 173
LG+G FG+V + K A K L+ +K + ++ E ++++ I
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD--LVSEMEMMKMIGKH 80
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN---MGGEPGFDIARAR----FYAAEV 226
+ +++L A L +++ + G+L+ ++ G E +DIAR + V
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 227 LC------GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE----GESVRGR 276
C G+E+L ++RD N+L+ + ++I+D GLA ++ ++ GR
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR 200
Query: 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ V +MAPE + + YT+ D +SFG L++E+ G +P+
Sbjct: 201 L-PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 31/99 (31%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 223 AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE----GESVRGRVG 278
A +V G+E+L ++RD N+L+ + ++I+D GLA ++ ++ GR+
Sbjct: 140 AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL- 198
Query: 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
V +MAPE + + YT+ D +SFG L++E+ G +P+
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 5/87 (5%)
Query: 654 FRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRI-KKRKGESMVLIEKQILQKI 709
F + +VLG G +G+V + + +GK+YA K L+K I +K K E+Q+L+ I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 710 -NSRFVVSLAYAYETKDALCLVLTIID 735
S F+V+L YA++T L L+L I+
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYIN 88
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 24/78 (30%), Positives = 47/78 (60%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + +V+G+G FGEV +++ T ++YA K L K + KR + E+ +L + ++
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 714 VVSLAYAYETKDALCLVL 731
+ +L YA++ ++ L LV+
Sbjct: 63 ITTLHYAFQDENYLYLVM 80
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 14/152 (9%)
Query: 164 EKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFH--IYNMGGEPGFDIARARF 221
E ++L++++ V++L CLVL K+ +Y G + A+
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLP-------KYRSDLYTYLGARLRPLGLAQV 262
Query: 222 YAA--EVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV---RGR 276
A ++L ++++H G+++RD K EN+L++ + + D G A S G
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFE 308
GTV APEV+ + YT S D +S G +IFE
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 223 AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE----GESVRGRVG 278
A +V G+E+L ++RD N+L+ + ++I+D GLA +I ++ GR+
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL- 204
Query: 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
V +MAPE + + YT+ D +SFG L++E+ G +P+
Sbjct: 205 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 26/56 (46%), Positives = 35/56 (62%)
Query: 215 DIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270
DI + +VL GL LH IG+V+RD KPEN+L+ G V+I D G AV++ G
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 52/231 (22%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI---- 171
F++ +LG+G FG+V R K Y K+ + K + IE Q ++K+
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKR-KEYCAVKIVRNVPKYTRDAK---IEIQFMEKVRQAD 186
Query: 172 -NSRFVVSLAYAYETKDA--LCLVLT---------IMNGGDLKFHIYNMGGEPGFDIARA 219
RF + Y + +C+V+ IM G H + +A+
Sbjct: 187 PADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFS-HRH---------LAQI 236
Query: 220 RFYAAEVLCGLEHLHY-IGLVYRDCKPENILLD----------------DYGHVRISDLG 262
F L++ H + L++ D KPENIL++ D VRI DLG
Sbjct: 237 IFQTG---VALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293
Query: 263 LAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQ 313
+ E S V T Y +PEV+ + YS D +S GC+I+E+ G+
Sbjct: 294 GCCD--ERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 30/85 (35%), Positives = 47/85 (55%), Gaps = 4/85 (4%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVS 716
RVLGKG FG+V +++ +G++YA K L+K I + + EK+IL N F+
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 717 LAYAYETKDALCLVLTII---DVMF 738
L ++T D L V+ + D+MF
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMF 85
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|188679 cd08724, RGS_GRK-like, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase (GRK) | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-06
Identities = 16/58 (27%), Positives = 30/58 (51%), Gaps = 1/58 (1%)
Query: 480 PQAPEAVDVLSLEIIEHCKESLDSGNR-ELFNDCMAAVKTFLAGAPFTEFQDSMFFYR 536
++ S + +EH +E+L+ +LF + + +L GAPF +F +S +F R
Sbjct: 57 KESLAHSHEFSKDAVEHVQENLEKEVPKDLFQPYIEEIHDYLRGAPFQKFLESDYFTR 114
|
The RGS domain is found in G protein-coupled receptor kinases (GRKs). These proteins play a key role in phosphorylation-dependent desensitization/resensitization of GPCRs (G protein-coupled receptors), intracellular trafficking, endocytosis, as well as in the modulation of important intracellular signaling cascades by GPCR. GRKs also modulate cellular response in phosphorylation-independent manner using their ability to interact with multiple signaling proteins involved in many essential cellular pathways. The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. Based on sequence homology the GRK family consists of three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 114 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 118 MYRVLGKGGFGEV----CACQVRATGKMY-ACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
+ R LG+G FG+V C KM A K L+ + RK E ++L +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQ 65
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG--------GEP-----GFDIARA 219
+V D L +V M GDL + G G+P +++
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG- 278
A+++ G+ +L V+RD N L+ V+I D G++ ++ + R VG
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR--VGG 183
Query: 279 ----TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ +M PE I K+T D +SFG +++E+ G+ P+
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 121 VLGKGGFGEVCACQVRATG-KMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RFVVS 178
V+G+G FG+V +++ G +M A K K+ K E ++L K+ +++
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-ELEVLCKLGHHPNIIN 72
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYN---MGGEPGFDIARAR----------FYAAE 225
L A E + L L + G+L + + +P F IA + +AA+
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-----RGRVGTV 280
V G+++L ++RD NIL+ + +I+D GL+ G+ V GR+ V
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRL-PV 187
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+MA E ++ YT + D +S+G L++E++ G P+
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 17/72 (23%), Positives = 33/72 (45%), Gaps = 1/72 (1%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 717
+LG+G FG V + TG++ A K +E + + E+ + E +IL + +V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA-LEREIRILSSLQHPNIVRY 64
Query: 718 AYAYETKDALCL 729
+ ++ L
Sbjct: 65 YGSERDEEKNTL 76
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRKGESMVLIEKQILQKI 171
F+ +VLG G FG V G+ A K+L + K E +L E ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE--ILDEAYVMASV 66
Query: 172 NSRFVVSLAYAYETKDALCLVLTIMNGGDL----KFHIYNMGGEPGFDIARARFYAAEVL 227
++ V L T + L+ +M G L + H N+G + + + ++
Sbjct: 67 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN------WCVQIA 119
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA----VEIPEGESVRGRVGTVGYM 283
G+ +L LV+RD N+L+ HV+I+D GLA + E + G+V + +M
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV-PIKWM 178
Query: 284 APEVIDNEKYTYSPDWFSFGCLIFE-MIEGQAPF 316
A E I + YT+ D +S+G ++E M G P+
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMVLIEKQILQKINSRFVVSLA 180
LG G FG V GK + K IK+ E + E +++ K++ +V L
Sbjct: 12 LGTGQFGVV------KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLY 65
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVY 240
+ + +V M+ G L ++ G F ++ +V G+ +L ++
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 241 RDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---VGYMAPEVIDNEKYTYSP 297
RD N L+DD G V++SD GL+ + + E VG+ V + PEV+ K++
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 298 DWFSFGCLIFEMIE-GQAPFRR 318
D ++FG L++E+ G+ P+ R
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 5/159 (3%)
Query: 164 EKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
E Q++ K++ +V L + +CLV M G L ++ G+ F
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMC 106
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE--SVRGRVGTVG 281
+V G+ +L +++RD N L+ + V++SD G+ + + + S G V
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK 166
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPFRRR 319
+ +PEV KY+ D +SFG L++E+ EG+ P+ R
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 26/74 (35%), Positives = 42/74 (56%), Gaps = 3/74 (4%)
Query: 660 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI---NSRFVVS 716
+GKG FG+V + + T ++YA K L KK I +K + + E+ IL + S F+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 717 LAYAYETKDALCLV 730
L ++++T L LV
Sbjct: 61 LKFSFQTDSDLYLV 74
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 24/71 (33%), Positives = 40/71 (56%), Gaps = 1/71 (1%)
Query: 662 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVSLAYA 720
KG FG V + R+TG +A K L+K + + + V E+ I+ + S +V L Y+
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 721 YETKDALCLVL 731
+++KD L LV+
Sbjct: 66 FQSKDYLYLVM 76
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + +V+G+G FGEV + ++T K+YA K L K + KR + E+ I+ NS +
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 714 VVSLAYAYETKDALCLVL 731
VV L YA++ L +V+
Sbjct: 105 VVQLFYAFQDDRYLYMVM 122
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 32/110 (29%), Positives = 58/110 (52%), Gaps = 6/110 (5%)
Query: 219 ARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHV-RISDLGLAVEIPEGESVRGR- 276
AR + ++L GL+++H +++RD KP N+ ++ V +I D GLA + S +G
Sbjct: 116 ARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175
Query: 277 ---VGTVGYMAPE-VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
+ T Y +P ++ YT + D ++ GC+ EM+ G+ F E+
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 4/99 (4%)
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA--VEIPEGE-SVRGRVG 278
+ ++ G+ +L LV+RD N+L+ HV+I+D GLA +E E E + G
Sbjct: 114 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
Query: 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ +MA E I K+T+ D +S+G I+E++ G P+
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 25/81 (30%), Positives = 47/81 (58%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F +V+G+G FGEV Q + TG +YA K L K + +++ + + E+ IL + + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 714 VVSLAYAYETKDALCLVLTII 734
VV + Y+++ K L L++ +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFL 83
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 26/81 (32%), Positives = 47/81 (58%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F +V+G+G FGEV Q + TG +YA K L K + +++ + E+ IL + +S +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 714 VVSLAYAYETKDALCLVLTII 734
VV + Y+++ K L L++ +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFL 83
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 31/101 (30%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 223 AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE--SVRGRVGTV 280
++V +E+L G ++RD N L+ + V++SD GLA + + + S +G V
Sbjct: 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV 165
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPFRRRK 320
+ PEV D +++ D +SFG L++E+ EG+ P+ R
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 17/42 (40%), Positives = 26/42 (61%)
Query: 402 VKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 443
V+ E+ +R+ D+ Y +FS +K+ C+ALL K P RLG
Sbjct: 204 VENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLG 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 19/98 (19%)
Query: 658 RVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 712
+VLG+G FG+V VR G++YA K L+K +K R +E+ IL ++N
Sbjct: 2 KVLGQGSFGKVFL--VRKITGPDAGQLYAMKVLKKATLKVRD-RVRTKMERDILAEVNHP 58
Query: 713 FVVSLAYAYETKDALCLVLTII-----------DVMFT 739
F+V L YA++T+ L L+L + +VMFT
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT 96
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 39/116 (33%), Positives = 64/116 (55%), Gaps = 14/116 (12%)
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHV-RISDLGLAVEIPEGES---VRGRV 277
++++V G++ L ++RD N+LL D G V +I D GLA +I +S V+G
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTD-GRVAKICDFGLARDI-MNDSNYVVKGNA 274
Query: 278 G-TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF------RRRKEMVKR 325
V +MAPE I + YT D +S+G L++E+ G++P+ + +MVKR
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR 330
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 48.2 bits (113), Expect = 1e-05
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-R 712
+R+ R LG+G FGEV + R K+ A K L KK K K L E QIL +N
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 713 FVVSLAYAYETKDALCLVLTIID 735
+V L ++ + +L LV+ +D
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVD 81
|
Length = 384 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 23/78 (29%), Positives = 47/78 (60%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + +V+G+G FGEV +++ K++A K L K + KR + E+ +L ++++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 714 VVSLAYAYETKDALCLVL 731
+ +L YA++ ++ L LV+
Sbjct: 63 ITTLHYAFQDENNLYLVM 80
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 4/79 (5%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKL-EKKRIKKRKGESMVLIEKQILQKINSR 712
+VLG+G G V + + TGK+YA KK+ + RK +L E + L+ S
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK---QLLRELKTLRSCESP 59
Query: 713 FVVSLAYAYETKDALCLVL 731
+VV A+ + + +VL
Sbjct: 60 YVVKCYGAFYKEGEISIVL 78
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 122 LGKGGFGEV----CACQVRATGKMY-ACKKLEKKRIKKRKGESMVLIEKQILQKINSRFV 176
LG+G FG+V C + KM A K L++ R+ E ++L + + +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQHI 69
Query: 177 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGG-----EPGFDIARARF-------YAA 224
V L +V M GDL + + G G D+A + A+
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--GRVG-TVG 281
++ G+ +L + V+RD N L+ V+I D G++ +I + R GR +
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+M PE I K+T D +SFG +++E+ G+ P+
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 32/223 (14%)
Query: 118 MYRVLGKGGFGEV--------CACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ 169
+ R LG+G FG+V C Q + + A K L+ RK E ++L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKI---LVAVKTLKDASDNARKDFHR---EAELLT 62
Query: 170 KINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG--------GEPGFDIARARF 221
+ +V D L +V M GDL + G G ++ +++
Sbjct: 63 NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122
Query: 222 Y--AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG- 278
A ++ G+ +L V+RD N L+ + V+I D G++ ++ + RVG
Sbjct: 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY--RVGG 180
Query: 279 ----TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ +M PE I K+T D +S G +++E+ G+ P+
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT-- 279
++ +V G+E L V+RD N+L+ + V+I D GLA +I + + T
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 280 -VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ +MAPE I N YT D +SFG L++E+ G P+
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 35/101 (34%), Positives = 57/101 (56%), Gaps = 8/101 (7%)
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHV-RISDLGLAVEIPEGESVR----GR 276
+A +V G+E L ++RD N+L+ + HV +I+D GLA +I + R GR
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTE-DHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFE-MIEGQAPF 316
+ V +MAPE + + YT+ D +SFG L++E G +P+
Sbjct: 196 L-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 31/99 (31%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 223 AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE----GESVRGRVG 278
A +V G+E+L ++RD N+L+ + ++I+D GLA + + ++ GR+
Sbjct: 140 AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL- 198
Query: 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
V +MAPE + + YT+ D +SFG L++E+ G +P+
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 654 FRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRI-KKRKGESMVLIEKQILQ 707
F + +VLG G +G+V VR TGK+YA K L+K + +K K E+ +L+
Sbjct: 2 FELLKVLGTGAYGKVFL--VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE 59
Query: 708 KI-NSRFVVSLAYAYETKDALCLVLTIID--VMFT 739
+ S F+V+L YA++T+ L L+L + MFT
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFT 94
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|188703 cd08749, RGS_GRK7, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase 7 (GRK7) | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 19/56 (33%), Positives = 32/56 (57%), Gaps = 1/56 (1%)
Query: 51 YSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYN 106
+ + +QQPIG+ LFR F A P+Y FLD ++N+EL + + + ++I
Sbjct: 17 FESLCEQQPIGKRLFRDFLAT-VPEYTVAADFLDDVQNWELAEEAAKDKARQNIIA 71
|
The RGS domain is an essential part of the GRK7 (G protein-coupled receptor kinases 7) proteins which together with GRK1 (Rhodopsin kinase) have been implicated in the shutoff of the photoresponse and adaptation to changing light conditions via rod and cone opsin phosphorylation. GRK7 is a member of the GRK kinase family which includes three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. GRK7 is expressed in all vertebrate cones except that of mice and rats, which do not have the gene for GRK7. Lack of either GRK7 or both GRK1 and GRK7 in human leads to a vision defect called Enhanced S Cone syndrome. RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 139 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 4/99 (4%)
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT-- 279
+ +V G+E L V+RD N+LL V+I D GLA +I + + T
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 280 -VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
V +MAPE I + YT D +S+G L++E+ G P+
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 9/205 (4%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMVLI-EKQILQKINSRF- 175
+ LG G FG+V K A K+ K +K E L+ E +I+ + +
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V+L A + ++ GDL + E + ++ +V G+ L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDL-LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES--VRGRVG-TVGYMAPEVIDNEK 292
++RD N+LL V+I D GLA +I + V+G V +MAPE I N
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219
Query: 293 YTYSPDWFSFGCLIFEMIE-GQAPF 316
YT+ D +S+G L++E+ G P+
Sbjct: 220 YTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 29/85 (34%), Positives = 47/85 (55%), Gaps = 4/85 (4%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVS 716
+VLGKG FG+V +++ T ++YA K L+K I + + EK+IL F+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 717 LAYAYETKDALCLVLTII---DVMF 738
L ++TKD L V+ + D+MF
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMF 85
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 22/94 (23%), Positives = 43/94 (45%), Gaps = 15/94 (15%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK--QILQKI 709
+ F + LG+G +G V + TG++ A K + + E + I K IL++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQEIIKEISILKQC 55
Query: 710 NSRFVVSLAYAYETKDALCLVL------TIIDVM 737
+S ++V +Y L +V+ ++ D+M
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM 89
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 24/78 (30%), Positives = 43/78 (55%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F +++ G +G V + + T + +A KK+ K+ + R V +E+ IL + F
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 714 VVSLAYAYETKDALCLVL 731
VVS+ ++ETK LC+V+
Sbjct: 63 VVSMFCSFETKRHLCMVM 80
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 4e-05
Identities = 24/80 (30%), Positives = 45/80 (56%), Gaps = 5/80 (6%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGESMVLIEKQILQKINS 711
+ + + +GKG FG+V + ++ GK+Y K+ L K+R+ L E +IL+K+N
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE---DALNEVKILKKLNH 58
Query: 712 RFVVSLAYAYETKDALCLVL 731
++ ++E K LC+V+
Sbjct: 59 PNIIKYYESFEEKGKLCIVM 78
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES--VRGRVG- 278
++ +V G+ L ++RD NILL +I D GLA +I + V+G
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
V +MAPE I N YT+ D +S+G L++E+ G +P+
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 121 VLGKGGFGEVCACQVRATG-KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR-FVVS 178
V+G+G FG+V ++ G KM A K+ K+ + E ++L K+ +++
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAG-ELEVLCKLGHHPNIIN 67
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYN---MGGEPGFDIARARF----------YAAE 225
L A E + L + + G+L + + +P F +A++
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-----RGRVGTV 280
V G+++L ++RD N+L+ + +I+D GL+ GE V GR+ V
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVYVKKTMGRL-PV 182
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+MA E ++ YT D +SFG L++E++ G P+
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 37/135 (27%), Positives = 57/135 (42%), Gaps = 32/135 (23%)
Query: 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV---- 332
+GT Y+APE++ + + + DW++ G +FE + G PF DE ++V
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPF--------NDETPQQVFQNI 592
Query: 333 -------KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385
E EK S +A+ + LL P R G +ELKQ F +
Sbjct: 593 LNRDIPWPEGEEK----LSVNAQNAIEILLTMDPTKRA-------GLKELKQHPLFHGVD 641
Query: 386 WKRLEAGLCDPPFVP 400
W+ L PF+P
Sbjct: 642 WENL--QNQTMPFIP 654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 25/78 (32%), Positives = 44/78 (56%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + +V+G+G FGEV + +++ K+YA K L K + KR + E+ I+ NS +
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 714 VVSLAYAYETKDALCLVL 731
VV L A++ L +V+
Sbjct: 105 VVQLFCAFQDDKYLYMVM 122
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 49/204 (24%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 120 RVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGESMVL---IEKQILQKIN 172
R LG+G FG+V C+ TG+ A K L K G + + E +IL+ +
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-----KPESGGNHIADLKKEIEILRNLY 64
Query: 173 SRFVVSLA--YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
+V + + + L++ + G LK ++ + ++ + YA ++ G+
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGM 122
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE---SVRGRVGT-VGYMAPE 286
++L V+RD N+L++ V+I D GL I + +V+ + + V + APE
Sbjct: 123 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMI 310
+ K+ + D +SFG ++E++
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGE-------SVRGR 276
+VL L+++H G ++R K +ILL G V +S L +V I G+ +
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 277 VGTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPF 316
V + +++PEV+ + Y D +S G E+ G PF
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR- 712
F VLGKG FG+V + + T ++YA K L+K I + ++EK++L + +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVL-ALPGKP 60
Query: 713 -FVVSLAYAYETKDALCLVLTII---DVMF 738
F+ L ++T D L V+ + D+M+
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 90
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 21/76 (27%), Positives = 39/76 (51%), Gaps = 1/76 (1%)
Query: 660 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 719
+G+G +G V + + TG++ A KK+ K R + L E ++L+++N ++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 720 AYETKDALCLVLTIID 735
+ K L LV +D
Sbjct: 66 VFRHKGDLYLVFEFMD 81
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 27/97 (27%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR---GRVGTV 280
++ G+E L +V++D N+L+ D +V+ISDLGL E+ + + + +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+M+PE I K++ D +S+G +++E+ G P+
Sbjct: 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 25/78 (32%), Positives = 43/78 (55%), Gaps = 3/78 (3%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + +GKGGFGEV + + TGK A K + +++ ++ + ++ E QIL+K
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCKHPN 58
Query: 714 VVSLAYAYETKDALCLVL 731
+V +Y KD L +V+
Sbjct: 59 IVKYYGSYLKKDELWIVM 76
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214613 smart00315, RGS, Regulator of G protein signalling domain | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 17/62 (27%), Positives = 32/62 (51%), Gaps = 3/62 (4%)
Query: 478 FFPQAPEAVDVLSLEIIEHCKESLDSG--NRELFNDCMAAVKTFLAGAPFTEFQDSMFFY 535
P AP+ V++ S ++ E +E+L+S +LF++ V L F F +S ++
Sbjct: 58 LSPNAPKEVNLDS-DLREKIEENLESEEPPPDLFDEAQREVYELLEKDSFPRFLESDYYL 116
Query: 536 RY 537
R+
Sbjct: 117 RF 118
|
RGS family members are GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. Length = 118 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 121 VLGKGGFGEVCACQVRATG-KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR-FVVS 178
V+G+G FG+V +++ G +M A K K+ K E ++L K+ +++
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-ELEVLCKLGHHPNIIN 60
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYN---MGGEPGFDIARAR------------FYA 223
L A E + L L + G+L + + +P F A A +A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF--AIANSTASTLSSQQLLHFA 118
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-----RGRVG 278
A+V G+++L ++RD NIL+ + +I+D GL+ G+ V GR+
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRL- 173
Query: 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
V +MA E ++ YT + D +S+G L++E++ G P+
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 59/279 (21%), Positives = 109/279 (39%), Gaps = 42/279 (15%)
Query: 122 LGKGGFGEVCACQV---------------RATG-KMYACKKLEKKRIKKRKGESMVLIEK 165
LG+G FGEV C+ A + A K L + + L E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED--FLKEV 70
Query: 166 QILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAE 225
+IL +++ + L LC+++ M GDL + E ++ +
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 226 VL--------CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE--SVRG 275
L G+ +L + V+RD N L+ ++I+D G++ + + V+G
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG 190
Query: 276 R-VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEV-DRRVK 333
R + +MA E + K+T D ++FG ++E++ R + + + D++V
Sbjct: 191 RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT----LCREQPY---EHLTDQQVI 243
Query: 334 EDAEKYSCRFSDDAKALCKALLKKSPRS--RLGCHCGRY 370
E+A + F DD + + P+ L C R
Sbjct: 244 ENAGHF---FRDDGRQIYLPRPPNCPKDIYELMLECWRR 279
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 3e-04
Identities = 18/58 (31%), Positives = 28/58 (48%), Gaps = 8/58 (13%)
Query: 396 PPFVPDVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG-------KSH 446
PPF R E+ ++ +D ++ S +A+ L LL+K P RLG K+H
Sbjct: 191 PPF-YAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 1/87 (1%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATG-KMYACKKLEKKRIKKRKGESMVLIEKQILQ 707
+ Y+ F R LG G FG V + A K+ EK +I K+K V E++IL
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN 86
Query: 708 KINSRFVVSLAYAYETKDALCLVLTII 734
IN F V+L +++ + L LVL +
Sbjct: 87 YINHPFCVNLYGSFKDESYLYLVLEFV 113
|
Length = 340 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 4/99 (4%)
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP--EGESVRGRVGT 279
+ ++ G+ +L +V+R+ NILL V+I+D G+A + + + T
Sbjct: 114 WCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 280 -VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ +MA E I +YT+ D +S+G ++EM+ G P+
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 26/98 (26%), Positives = 50/98 (51%), Gaps = 3/98 (3%)
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT-- 279
Y+ ++ L +L V+RD N+L+ V++ D GL+ + + + G
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 280 VGYMAPEVIDNEKYTYSPDWFSFGCLIFE-MIEGQAPF 316
+ +MAPE I+ ++T + D + FG ++E ++ G PF
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 42/203 (20%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 118 MYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVV 177
M LG G +GEV + A K L++ ++ + L E ++++I +V
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLV 65
Query: 178 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG 237
L + ++ M G+L ++ + + + A ++ +E+L
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 124
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---VGYMAPEVIDNEKYT 294
++RD N L+ + V+++D GL+ + G++ G + + APE + K++
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 295 YSPDWFSFGCLIFEMIE-GQAPF 316
D ++FG L++E+ G +P+
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 25/85 (29%), Positives = 46/85 (54%), Gaps = 4/85 (4%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVS 716
+VLGKG FG+V +++ G+ +A K L+K + ++EK++L + F+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 717 LAYAYETKDALCLVLTII---DVMF 738
L ++TK+ L V+ + D+MF
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMF 85
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL-QKINS 711
F VLGKG FG+V + + T ++YA K L+K + + ++EK++L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 712 RFVVSLAYAYETKDALCLVLTII---DVMF 738
F+ L ++T D L V+ + D+M+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMY 90
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 7e-04
Identities = 21/82 (25%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 660 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-GESMVLI-EKQILQKINSRFVVSL 717
LG+G + V + + TG++ A KK++ K+ K G + + E ++LQ++ ++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 718 AYAYETKDALCLVLTIIDVMFT 739
+ K + LV + M T
Sbjct: 68 LDVFGHKSNINLVF---EFMET 86
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.001
Identities = 22/79 (27%), Positives = 35/79 (44%), Gaps = 8/79 (10%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGESMVLIEKQILQKINS 711
++ +G+G GEV RATGK A KK L K+ + ++ E I++
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL------IINEILIMKDCKH 74
Query: 712 RFVVSLAYAYETKDALCLV 730
+V +Y D L +V
Sbjct: 75 PNIVDYYDSYLVGDELWVV 93
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 24/70 (34%), Positives = 40/70 (57%), Gaps = 10/70 (14%)
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILLDD-YGHVRISDLGLAVEIPEGESVRGRVGTVGYM 283
++L L+ LH G+V+RD KP+NI+ + G +I DLG A ++ RVG + Y+
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADL--------RVG-INYI 313
Query: 284 APEVIDNEKY 293
E + + +Y
Sbjct: 314 PKEFLLDPRY 323
|
Length = 566 |
| >gnl|CDD|216023 pfam00615, RGS, Regulator of G protein signaling domain | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 12/61 (19%), Positives = 25/61 (40%), Gaps = 2/61 (3%)
Query: 478 FFPQAPEAVDVLSLEIIEHCKESL-DSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYR 536
P +P ++ L + E +E+L + +LF++ V + + F S + R
Sbjct: 58 LAPDSPSEIN-LDSDTREKIEENLEKQPSPDLFDEAQEEVYDLMEKDSYPRFLKSPLYLR 116
Query: 537 Y 537
Sbjct: 117 L 117
|
RGS family members are GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. Length = 117 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 46/211 (21%), Positives = 84/211 (39%), Gaps = 30/211 (14%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVS--- 178
+G G FG+V G+ + + +K+ + + + LQ++ ++
Sbjct: 3 IGNGWFGKVL------LGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPN 56
Query: 179 ----LAYAYETKDALCLVLTIMNGGDLKFHIYN----MGGEPGFDIARARFYAAEVLCGL 230
L E+ L LVL GDLK ++ + + D+ + A EV GL
Sbjct: 57 VLQCLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGL 113
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEG--ESVRGRVGTVGYMAPEV 287
LH ++ D N L V+I D GLA+E PE + + ++APE+
Sbjct: 114 LWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 288 IDN-------EKYTYSPDWFSFGCLIFEMIE 311
++ + T + +S G ++E+
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 4/93 (4%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSR 712
F VLGKG FG+V + + T ++YA K L+K + + ++EK++L
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 713 FVVSLAYAYETKDALCLVLTII---DVMFTCVQ 742
F+ L ++T D L V+ + D+M+ Q
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ 94
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 18/65 (27%), Positives = 32/65 (49%), Gaps = 1/65 (1%)
Query: 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 712
+++ +G+G G V + R TG+ A KK+ +R++ + L E + LQ
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHP 59
Query: 713 FVVSL 717
+VV L
Sbjct: 60 YVVKL 64
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 37/179 (20%), Positives = 76/179 (42%), Gaps = 17/179 (9%)
Query: 150 KRIKKRKGESMVLI---EKQI--LQKINSRFVVSL-AYAYETKDALC---LVLTIMNGGD 200
+ KK VLI E +I L++I+S ++ + + + D L L+L G
Sbjct: 49 RTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGY 108
Query: 201 LKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH-YIGLVYRDCKPENILLDDYGHVRIS 259
L+ + E A + GL +L+ Y Y++ + L+ + ++I
Sbjct: 109 LREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI- 164
Query: 260 DLGLAVEIPEGESVRGRVGTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPF 316
+ +E V + Y + +++++ +YT D +S G +++E+ G+ PF
Sbjct: 165 -ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222
|
Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 24/85 (28%), Positives = 46/85 (54%), Gaps = 4/85 (4%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL-QKINSRFVVS 716
RV+G+G + +V +++ T ++YA K ++K+ + + V EK + Q N F+V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 717 LAYAYETKDALCLVLTII---DVMF 738
L ++T+ L V+ + D+MF
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMF 85
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.003
Identities = 17/35 (48%), Positives = 21/35 (60%), Gaps = 3/35 (8%)
Query: 657 YRVLGK---GGFGEVCACQVRATGKMYACKKLEKK 688
Y++LGK G F EV Q R TGK YA K ++K
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH 35
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|188704 cd08750, RGS_GRK4, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase 4 (GRK4) | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 16/25 (64%), Positives = 20/25 (80%), Gaps = 1/25 (4%)
Query: 7 YSYIIDQQPIGRLLFRQFCAEAKPQ 31
YS + D+QPIGRLLFRQFC + +P
Sbjct: 2 YSSLCDKQPIGRLLFRQFC-DTRPT 25
|
The RGS domain is an essential part of the GRK4 (G protein-coupled receptor kinase4) proteins, which are membrane-associated serine/threonine protein kinases that phosphorylate G protein-coupled receptors (GPCRs) upon agonist stimulation. This phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events. GRK4 is a member of the GRK kinase family which includes three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. GRK4 plays a key role in regulating dopaminergic-mediated natriuresis and is associated with essential hypertension and/or salt-sensitive hypertension. GRK4 exists in four splice variants involved in hyperphosphorylation, desensitization, and internalization of two dopamine receptors (D1R and D3R). GRK4 also increases the expression of a key receptor of the renin-angiotensin system, the AT1R (angiotensin type 1 receptor). RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 132 |
| >gnl|CDD|188706 cd08752, RGS_GRK5, Regulator of G protein signaling domain (RGS) found in G protein-coupled receptor kinase 5 (GRK5) | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 17/29 (58%), Positives = 20/29 (68%), Gaps = 1/29 (3%)
Query: 7 YSYIIDQQPIGRLLFRQFCAEAKPQYHKY 35
Y + D+QPIGRLLFRQFC E +P Y
Sbjct: 1 YCSLCDKQPIGRLLFRQFC-ETRPGLECY 28
|
The RGS domain is an essential part of the GRK5 (G protein-coupled receptor kinase 5) protein, a membrane-associated serine/threonine protein kinases which phosphorylates G protein-coupled receptors (GPCRs) upon agonist stimulation. This phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events. GRK5 is a member of the GRK kinase family which include three major subfamilies: the GRK4 subfamily (GRK4, GRK5 and GRK6), the rhodopsin kinase or visual GRK subfamily (GRK1 and GRK7), and the beta-adrenergic receptor kinases subfamily (GRK2/GRK3). The RGS domain of the GRKs has very little sequence similarity with the canonical RGS domain of the RGS proteins and therefore is often refered to as the RH (RGS Homology) domain. RGS proteins regulate many aspects of embryonic development such as glial differentiation, embryonic axis formation, skeletal and muscle development, cell migration during early embryogenesis, as well as apoptosis, cell proliferation, and modulation of cardiac development. Length = 123 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 21/209 (10%)
Query: 120 RVLGKGGFGEV----CACQVRATGKMY-ACKKLEKKRIKKRKGESMVLIEKQILQKINSR 174
R LG+G FG+V C K A K L K E ++L
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAELLTNFQHE 68
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDL---------KFHIYNMGGEPGFDIARARFY--A 223
+V D +V M GDL P ++ ++ A
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR---GRVGTV 280
++ G+ +L V+RD N L+ V+I D G++ ++ + R + +
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEM 309
+M PE I K+T D +SFG +++E+
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.004
Identities = 20/75 (26%), Positives = 40/75 (53%), Gaps = 5/75 (6%)
Query: 659 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM--VLIEKQILQKINSRFVVS 716
++G+G FG V TG A K++ ++IK+ E++ ++ E +L+ + +V
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE---EALKSIMQEIDLLKNLKHPNIVK 63
Query: 717 LAYAYETKDALCLVL 731
+ ET D+L ++L
Sbjct: 64 YIGSIETSDSLYIIL 78
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214613 smart00315, RGS, Regulator of G protein signalling domain | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.004
Identities = 17/53 (32%), Positives = 32/53 (60%), Gaps = 5/53 (9%)
Query: 57 QQPIGRLLFRQFCAEAKPQYHKYNV-FLDSIENYELEMDENRRLST-KDIYNE 107
PIGRLLFR+F E++ N+ F ++E ++ D+ R++ ++IY++
Sbjct: 7 SDPIGRLLFREFL-ESEFSEE--NLEFWLAVEEFKKAEDDEERIAKAREIYDK 56
|
RGS family members are GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. Length = 118 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 767 | |||
| KOG0986|consensus | 591 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0614|consensus | 732 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0595|consensus | 429 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0583|consensus | 370 | 100.0 | ||
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0593|consensus | 396 | 100.0 | ||
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| KOG2345|consensus | 302 | 100.0 | ||
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG4278|consensus | 1157 | 99.98 | ||
| KOG0664|consensus | 449 | 99.97 | ||
| KOG0984|consensus | 282 | 99.97 | ||
| KOG1152|consensus | 772 | 99.97 | ||
| KOG0576|consensus | 829 | 99.97 | ||
| KOG1025|consensus | 1177 | 99.97 | ||
| KOG1290|consensus | 590 | 99.97 | ||
| KOG1167|consensus | 418 | 99.97 | ||
| KOG2052|consensus | 513 | 99.97 | ||
| KOG0200|consensus | 609 | 99.96 | ||
| KOG3653|consensus | 534 | 99.96 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0606|consensus | 1205 | 99.96 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0986|consensus | 591 | 99.95 | ||
| KOG1345|consensus | 378 | 99.95 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0590|consensus | 601 | 99.93 | ||
| KOG1024|consensus | 563 | 99.92 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164|consensus | 322 | 99.91 | ||
| KOG0590|consensus | 601 | 99.88 | ||
| KOG1163|consensus | 341 | 99.87 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG4158|consensus | 598 | 99.87 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG1165|consensus | 449 | 99.86 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG0598|consensus | 357 | 99.85 | ||
| KOG0616|consensus | 355 | 99.84 | ||
| KOG0606|consensus | 1205 | 99.84 | ||
| KOG1240|consensus | 1431 | 99.83 | ||
| KOG0605|consensus | 550 | 99.83 | ||
| KOG0595|consensus | 429 | 99.82 | ||
| KOG0690|consensus | 516 | 99.81 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG1166|consensus | 974 | 99.78 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG1035|consensus | 1351 | 99.76 | ||
| KOG0195|consensus | 448 | 99.76 | ||
| KOG0694|consensus | 694 | 99.76 | ||
| KOG0615|consensus | 475 | 99.74 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0610|consensus | 459 | 99.73 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| KOG0611|consensus | 668 | 99.72 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG1033|consensus | 516 | 99.71 | ||
| KOG0575|consensus | 592 | 99.7 | ||
| KOG0592|consensus | 604 | 99.7 | ||
| KOG0580|consensus | 281 | 99.7 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG0591|consensus | 375 | 99.65 | ||
| KOG0581|consensus | 364 | 99.65 | ||
| KOG0612|consensus | 1317 | 99.64 | ||
| KOG1023|consensus | 484 | 99.62 | ||
| KOG0608|consensus | 1034 | 99.62 | ||
| KOG0583|consensus | 370 | 99.61 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG0588|consensus | 786 | 99.61 | ||
| KOG0032|consensus | 382 | 99.6 | ||
| KOG0696|consensus | 683 | 99.6 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG0194|consensus | 474 | 99.58 | ||
| KOG0586|consensus | 596 | 99.57 | ||
| KOG0695|consensus | 593 | 99.57 | ||
| KOG0597|consensus | 808 | 99.56 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.55 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.55 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.55 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.55 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.54 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.53 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.53 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.51 | |
| KOG4717|consensus | 864 | 99.49 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.49 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.49 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.49 | |
| KOG0585|consensus | 576 | 99.48 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.47 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.45 | |
| KOG0601|consensus | 524 | 99.45 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.45 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.44 | |
| KOG0589|consensus | 426 | 99.44 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.44 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.44 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.43 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.43 | |
| KOG0614|consensus | 732 | 99.42 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.42 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.42 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.42 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.41 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.41 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.41 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.41 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.41 | |
| KOG0593|consensus | 396 | 99.41 | ||
| KOG0600|consensus | 560 | 99.4 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.4 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.4 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.39 |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-112 Score=897.19 Aligned_cols=425 Identities=68% Similarity=1.182 Sum_probs=408.3
Q ss_pred hhhhhccceeeeeccCcchhHHHHHHHhhhcccccccccccccccchhhcccccccCChHHH------------------
Q psy11874 43 FTLALYVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDI------------------ 104 (767)
Q Consensus 43 ~~~~~~~~~~~~~~~~p~g~~lf~~f~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~------------------ 104 (767)
+..+++++|+++|++|||||+||++|| ++.|.+.++..|++.+.+|+...++.+.....++
T Consensus 45 Lr~~~e~~f~sl~~~QpIGrlLFr~Fc-~~~~~~~~~i~Fl~~v~eYE~~~~~~r~~~~~~i~~~~l~~~~~~~~~~~s~ 123 (591)
T KOG0986|consen 45 LRDSLELTFESLCEKQPIGRLLFRDFC-ENRPELRPAIEFLEEVKEYEKADDDERKDKARQILDAYLMKELLACLPQFSS 123 (591)
T ss_pred HHHhhcccHHHHhccCcHHHHHHHHHH-hcCchhhhHHHHHHHHHHHhcCCcccchhhHHHHHHHHhhccccccCCCcch
Confidence 678899999999999999999999999 5599999999999999999987765543322111
Q ss_pred ----------------------------------------------------hhhcCcccCCCeEEEeEEeecCcEEEEE
Q psy11874 105 ----------------------------------------------------YNEIQPITYKTFRMYRVLGKGGFGEVCA 132 (767)
Q Consensus 105 ----------------------------------------------------~~~~~~i~~~~y~~~~~LG~G~fG~Vy~ 132 (767)
|.+.++++.++|+..++||+||||+||.
T Consensus 124 ~~~v~~~~~~l~~~~~~~lf~~~~~~~~~~L~~~pF~~f~~S~yf~rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~a 203 (591)
T KOG0986|consen 124 KDLVTHVQEHLLEKPPKDLFQPLARAICAYLRGDPFQEFLESDYFTRFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCA 203 (591)
T ss_pred hhhhHHHhhhccccCchhhhHHHHHHHHHHhccchHhHhHHHHHHHHHHHHHHHHhhhccccceeeeEEEecccccceeE
Confidence 7788999999999999999999999999
Q ss_pred EEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCCCC
Q psy11874 133 CQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEP 212 (767)
Q Consensus 133 a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~ 212 (767)
|+.+.||++||+|++.|+++++++++.++++|.+||++++++|||.|.++|++++.+||||+.|+||||.+||++.+ ++
T Consensus 204 cqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g-~~ 282 (591)
T KOG0986|consen 204 CQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHG-NP 282 (591)
T ss_pred EEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccC-CC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999986 58
Q ss_pred CCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcccccccccccCCcceecCCC
Q psy11874 213 GFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEK 292 (767)
Q Consensus 213 ~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ 292 (767)
+|++.++++|++||++||+|||+.+||||||||+|||||++|||+|+|+|||..++.++...+++||++|||||++.++.
T Consensus 283 gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~ 362 (591)
T KOG0986|consen 283 GFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV 362 (591)
T ss_pred CCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccH
Q psy11874 293 YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGA 372 (767)
Q Consensus 293 ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a 372 (767)
|++++|||||||+||||+.|+.||+..++++.++++.+++.++..+|+..||+++++||+.+|++||++|+||++ .|+
T Consensus 363 Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg--~ga 440 (591)
T KOG0986|consen 363 YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRG--EGA 440 (591)
T ss_pred ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCC--cCc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999997 589
Q ss_pred HHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhhhhhcccCCChhHHHHHHHHhhcCCCCcCCCCccchhhH
Q psy11874 373 RELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGKSHCLSIGL 452 (767)
Q Consensus 373 ~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (767)
+++++||||+++||.+|++|+++|||+|+
T Consensus 441 ~evk~HpfFk~lnw~rleagml~PPfiPd--------------------------------------------------- 469 (591)
T KOG0986|consen 441 QEVKEHPFFKDLNWRRLEAGMLEPPFIPD--------------------------------------------------- 469 (591)
T ss_pred chhhhCcccccCCHhHHhccCCCCCCCCC---------------------------------------------------
Confidence 99999999999999999999999999999
Q ss_pred HHHHHHhhhhhccccccccccccccCCCCCccchhhhhHHHHHhhhcccccCCcchhhhhHHHHHhhhcCCCccccchhh
Q psy11874 453 VMMLKLSVLKKNVNLSVLNTVQIPLFFPQAPEAVDVLSLEIIEHCKESLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSM 532 (767)
Q Consensus 453 ~~~~~~s~~kk~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (767)
T Consensus 470 -------------------------------------------------------------------------------- 469 (591)
T KOG0986|consen 470 -------------------------------------------------------------------------------- 469 (591)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hHHHHhhhhhcccceeeeeeeecccccCCCceeecCCccCccccccccceecCCCChHHHhhhccCCcccccccccchhh
Q psy11874 533 FFYRYLQWKWLEHHFLYVEVFTHGVYCSQPHAVYAKDVLDIEQFSTVKGVTLDTTDDSFYSKFNTGSVSIPWQNEMIETE 612 (767)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~f~~~f~tg~v~~~~~~e~ie~~ 612 (767)
|+|||||||+|||||||||||.+|++|.+||++|+||+|||||||||+||+
T Consensus 470 -----------------------------p~aVyakDv~DIeqFs~VKGV~ld~~D~~fy~~F~tg~vsipWQnE~~ET~ 520 (591)
T KOG0986|consen 470 -----------------------------PGAVYAKDVLDIEQFSTVKGVKLDDTDTDFYKNFATGSVSIPWQNEMIETE 520 (591)
T ss_pred -----------------------------ccccchhhhhhhhhcccccceecccccHHHHHhccCCcccchHHHHHHHhh
Confidence 999999999999999999999999999999999999999999999999999
Q ss_pred hhhhccccCCCCCCCCCCc
Q psy11874 613 CFKELNVFGENNTPSSDVM 631 (767)
Q Consensus 613 cf~eln~~~~~~~~s~dl~ 631 (767)
||.++|++.+++..++|..
T Consensus 521 ~f~elnv~~~~~~~~~d~~ 539 (591)
T KOG0986|consen 521 CFEELNVFGDDGAKNPDLR 539 (591)
T ss_pred hHHHhhccccccccCcchh
Confidence 9999999999998888776
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-70 Score=571.93 Aligned_cols=303 Identities=39% Similarity=0.703 Sum_probs=277.7
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|+++++||+|+||+||+++.+.|++.||+|+++|+.+...+...++..|..||.+++|||||+|++.|++.+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc-C
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-P 268 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~-~ 268 (767)
|||+||++||+|..||++.+ .|++..+++|+++|++||.|||++|||||||||||||||.+||++|+|||||+.. .
T Consensus 101 ylVld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999999999876 7999999999999999999999999999999999999999999999999999854 4
Q ss_pred CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc-cccCCCCcHHH
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA-EKYSCRFSDDA 347 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~-~~~~~~~s~~~ 347 (767)
.+..+.+.|||+.|||||++.+.+|+.++||||||+++|||++|.+||.+.+.. ++.+.|.... ...+..+|.++
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----~~~~~I~~~k~~~~p~~ls~~a 253 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----KMYDKILKGKLPLPPGYLSEEA 253 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----HHHHHHhcCcCCCCCccCCHHH
Confidence 445677789999999999999999999999999999999999999999988653 4445555555 44455699999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhhhhhcccCC
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEKYSCRF 422 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~~~~~~~~~ 422 (767)
+|++++||++||++|+| +..++.+|++||||+++||+.+.++.+.|||.|.+.+.+..+++..+...++...
T Consensus 254 rdll~~LL~rdp~~RLg---~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~~~~ 325 (357)
T KOG0598|consen 254 RDLLKKLLKRDPRQRLG---GPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYTVDY 325 (357)
T ss_pred HHHHHHHhccCHHHhcC---CCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccHHHHhccccC
Confidence 99999999999999998 3357999999999999999999999999999999999998888888777665433
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-66 Score=524.38 Aligned_cols=290 Identities=33% Similarity=0.610 Sum_probs=271.7
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
..+++|+.+++||.|+||.|.+++.+.+|..||+|++++..+.+.++.++..+|+.+|+.+.|||+++|++.|.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 67889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||++||.|..++++.+ +|++..+++|++||++||+|||+++|+||||||||||||.+|++||+|||+|+.+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999999876 7999999999999999999999999999999999999999999999999999998655
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
+.+.||||.|+|||++..++|+.++|||||||++|||+.|.+||.+.+. ..+.+.|......+|+.+|++++||
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~~fs~~~kdL 271 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPSYFSSDAKDL 271 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCcccCHHHHHH
Confidence 6788999999999999999999999999999999999999999999876 4566777888999999999999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCC-CCCchhHHhhh
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP-DVKRDEVDRRV 411 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P-~~~~~~~~~~~ 411 (767)
|++||++|-++|.|+.. +|.++|+.||||++++|+.+.++.++||++| .+......+++
T Consensus 272 l~~LL~vD~t~R~gnlk--nG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnf 331 (355)
T KOG0616|consen 272 LKKLLQVDLTKRFGNLK--NGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNF 331 (355)
T ss_pred HHHHHhhhhHhhhcCcC--CCccccccCcccccccHHHHhhccccCCCCCccccCCcccccc
Confidence 99999999999999764 5799999999999999999999999999998 44444443333
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-65 Score=565.15 Aligned_cols=305 Identities=37% Similarity=0.655 Sum_probs=283.5
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCC
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKD 187 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~ 187 (767)
.++++++|.++++||+|+||+|++|..+.+++.||||+++|..+..+...+..+.|++|+...+ |||+++|+..|++++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4688999999999999999999999999999999999999999999999999999999999986 999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
++|+||||++|||+ .++.+.+ .|++.++++|+++|+.||.|||++||||||||.+|||||.+||+||+|||+++..
T Consensus 443 ~l~fvmey~~Ggdm-~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDL-MHHIHTD---VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred eEEEEEEecCCCcE-EEEEecc---cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999999995 3444333 7999999999999999999999999999999999999999999999999999976
Q ss_pred C-CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 268 P-EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 268 ~-~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
. .+..+.+.||||.|||||++.+..|+.++|||||||+|||||.|.+||.+.++ +++...|..+...||..+|.+
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE----ee~FdsI~~d~~~yP~~ls~e 594 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE----EEVFDSIVNDEVRYPRFLSKE 594 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCCCCCCCcccHH
Confidence 5 56678899999999999999999999999999999999999999999999876 568888999999999999999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhhhhhcccCCC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEKYSCRFS 423 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~~~~~~~~~~ 423 (767)
+.+++++||++||++|+|+.+ .++++|++||||++|||..|+++.++|||+|.+++.++.+++.++..+-.+..+
T Consensus 595 a~~il~~ll~k~p~kRLG~~e--~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt 669 (694)
T KOG0694|consen 595 AIAIMRRLLRKNPEKRLGSGE--RDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALT 669 (694)
T ss_pred HHHHHHHHhccCcccccCCCC--CCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCCccC
Confidence 999999999999999999865 579999999999999999999999999999999999888888877766555444
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-64 Score=545.93 Aligned_cols=299 Identities=33% Similarity=0.598 Sum_probs=264.5
Q ss_pred hhhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe
Q psy11874 105 YNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 184 (767)
Q Consensus 105 ~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 184 (767)
...+..+..++|+++++||+||||+||+|+.+.||..||||+++|+.+..+++..+++.|..||...++|+||+||++|+
T Consensus 132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred HhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 44455678999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
+++++||||||++|||+..+|.+.+ .+++..+++|+++++.|++.||+.|+|||||||+|+|||..||+||+|||||
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeecccccc
Confidence 9999999999999999999999876 7999999999999999999999999999999999999999999999999999
Q ss_pred cccCC----------------------C--C------------------------cccccccccccCCcceecCCCCCCC
Q psy11874 265 VEIPE----------------------G--E------------------------SVRGRVGTVGYMAPEVIDNEKYTYS 296 (767)
Q Consensus 265 ~~~~~----------------------~--~------------------------~~~~~~GT~~Y~APEvl~~~~ys~~ 296 (767)
+-+.. . . ...+.+|||.|||||++.+.+|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 52210 0 0 0113479999999999999999999
Q ss_pred CccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHH
Q psy11874 297 PDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELK 376 (767)
Q Consensus 297 ~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil 376 (767)
+||||||||+||||.|.+||.+.+.......+...-.....+-...+|++|+|||.+||. ||++|+|. .|++||+
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~----~G~~EIK 443 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS----KGAEEIK 443 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc----ccHHHHh
Confidence 999999999999999999999987766555554433322222234678999999999999 99999993 3699999
Q ss_pred hCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhh
Q psy11874 377 QAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKE 413 (767)
Q Consensus 377 ~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~ 413 (767)
+||||++++|+.|... +|||+|.+.+.++..+|..
T Consensus 444 ~HPfF~~v~W~~l~~~--~apfvP~v~~~~DT~yFdd 478 (550)
T KOG0605|consen 444 KHPFFKGVDWDHLREM--PAPFVPQVNSELDTQYFDD 478 (550)
T ss_pred cCCccccCCcchhhcC--CCCCCCCCCCccccccccc
Confidence 9999999999999874 5999999998887777653
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-62 Score=498.49 Aligned_cols=303 Identities=37% Similarity=0.674 Sum_probs=282.8
Q ss_pred hcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 107 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
....++.++|+.+++||+|.||+|-+|+.+.||+.||||+++|..+..+....+.+.|.++|+..+|||+..|-+.|++.
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 34567899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+.+|+||||.+||+|..||.+.+ .|+++++++|-++|+.||.|||+++|||||||.+|+|||.+||+||+||||++.
T Consensus 241 drlCFVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh
Confidence 99999999999999999998754 799999999999999999999999999999999999999999999999999985
Q ss_pred -cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 267 -IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 267 -~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
+..+..+.+.||||.|+|||++....|+.++|||.+||++|||++|+.||.+.+. +.+...|......+|..+|+
T Consensus 318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----~kLFeLIl~ed~kFPr~ls~ 393 (516)
T KOG0690|consen 318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----EKLFELILMEDLKFPRTLSP 393 (516)
T ss_pred cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch----hHHHHHHHhhhccCCccCCH
Confidence 4566778899999999999999999999999999999999999999999988743 55677788888999999999
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhhhhhc
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEKY 418 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~~~~~ 418 (767)
+++.|+..||.+||.+|+| +|..+|.||.+|+||+++||+.+..+.+.|||.|.+.++.+.+.+.++....
T Consensus 394 eAktLLsGLL~kdP~kRLG--gGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q 464 (516)
T KOG0690|consen 394 EAKTLLSGLLKKDPKKRLG--GGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQ 464 (516)
T ss_pred HHHHHHHHHhhcChHhhcC--CCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhcc
Confidence 9999999999999999999 4457899999999999999999999999999999999988888887766543
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-58 Score=501.94 Aligned_cols=276 Identities=35% Similarity=0.603 Sum_probs=254.4
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l 189 (767)
.+.++|.+.+.||.|+|++|++|+.+.+++.||+|++.|+-+.+.+-...+.+|..+|.+| .||.|++|+..|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 4568999999999999999999999999999999999999999988899999999999999 899999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+|+||+++|+|..+|.+.| .|++..+++|++||+.||+|||++|||||||||||||||.+|+++|+|||.|+.+..
T Consensus 150 YFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999999987 799999999999999999999999999999999999999999999999999987643
Q ss_pred CCc------------c--cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc
Q psy11874 270 GES------------V--RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED 335 (767)
Q Consensus 270 ~~~------------~--~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~ 335 (767)
... . .+.+||..|.+||+|.....++++|+|+||||||+|+.|.+||++.++ ..+.++|..-
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yliFqkI~~l 302 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLIFQKIQAL 302 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHHHHHHHHh
Confidence 211 1 457999999999999999999999999999999999999999999876 3466777778
Q ss_pred ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 336 AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 336 ~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
...++..+++.++|||+++|..||.+|+| +++|++||||.+++|+.|... -+|++.|.
T Consensus 303 ~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt-------~~qIk~HpFF~~Vdw~nlw~~-~PP~l~py 360 (604)
T KOG0592|consen 303 DYEFPEGFPEDARDLIKKLLVRDPSDRLT-------SQQIKAHPFFEGVDWENLWQQ-TPPKLQPY 360 (604)
T ss_pred cccCCCCCCHHHHHHHHHHHccCcccccc-------HHHHhhCcccccCChhhhhhc-CCCcccCC
Confidence 88999999999999999999999999999 899999999999999997664 34555554
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-58 Score=488.73 Aligned_cols=284 Identities=36% Similarity=0.624 Sum_probs=252.8
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++++.||.|.-|+||+|+.+.++..+|||++.|..+..++...++..|.+||+.++|||++.||..|++.+..
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 45678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|||||||+||||....+++ ....|++..+++|+++++.||+|||-+||||||||||||||.++|||.|+||.|+.....
T Consensus 153 cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999998877776 456899999999999999999999999999999999999999999999999999843210
Q ss_pred ---------------------------------C-C-----------------------cccccccccccCCcceecCCC
Q psy11874 270 ---------------------------------G-E-----------------------SVRGRVGTVGYMAPEVIDNEK 292 (767)
Q Consensus 270 ---------------------------------~-~-----------------------~~~~~~GT~~Y~APEvl~~~~ 292 (767)
. . ...+.+||-+|+|||++.+.+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 012347999999999999999
Q ss_pred CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC--CCcHHHHHHHHHhcccCcCccCCCCCCcc
Q psy11874 293 YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC--RFSDDAKALCKALLKKSPRSRLGCHCGRY 370 (767)
Q Consensus 293 ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~--~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~ 370 (767)
++.++|||+|||+|||||.|..||.+.+.. +...+|...+..++. .+|..|+|||++||.+||++|+||.-
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~----~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~r--- 384 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKR--- 384 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCch----hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcccc---
Confidence 999999999999999999999999998654 445556666666653 57899999999999999999999874
Q ss_pred cHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCC
Q psy11874 371 GARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403 (767)
Q Consensus 371 ~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~ 403 (767)
||+||++||||+++||.-+. -..||++|...
T Consensus 385 GA~eIK~HpFF~gVnWaLir--~~~PP~iP~~~ 415 (459)
T KOG0610|consen 385 GAAEIKRHPFFEGVNWALIR--CARPPEIPKPV 415 (459)
T ss_pred chHHhhcCccccCCChhhee--ccCCCcCCCcc
Confidence 69999999999999999433 37899999853
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-58 Score=480.07 Aligned_cols=298 Identities=37% Similarity=0.676 Sum_probs=274.0
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCe
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDA 188 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~ 188 (767)
.+...+|..+.+||+|+||+|.+|..+.|...||||+++|..+......+..+.|.++|... +.|++++|+..|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 46678999999999999999999999999999999999999988888889999999999876 56899999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc-
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI- 267 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~- 267 (767)
+|+||||++||||.++|++.+ .|.+..|.+||++|+.||=+||++||||||||.+|||||.+|||||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999999999987 7999999999999999999999999999999999999999999999999999863
Q ss_pred CCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
-.+.++.+.||||.|+|||++.-.+|+.++||||+||+||||+.|++||.+.++ .++.+.|.+....||..+|.+|
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE----~elF~aI~ehnvsyPKslSkEA 577 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQAIMEHNVSYPKSLSKEA 577 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHccCcCcccccHHH
Confidence 455667889999999999999999999999999999999999999999999866 5677788888899999999999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhhhh
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAE 416 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~~~ 416 (767)
.++|+.+|.+.|.+|+||.. .+-++|+.||||+.|+|++++++.++|||.|.++......++..-..
T Consensus 578 v~ickg~ltK~P~kRLGcg~--~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft 644 (683)
T KOG0696|consen 578 VAICKGLLTKHPGKRLGCGP--EGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFT 644 (683)
T ss_pred HHHHHHHhhcCCccccCCCC--ccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHh
Confidence 99999999999999999865 67899999999999999999999999999999866554444444333
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-57 Score=474.38 Aligned_cols=265 Identities=27% Similarity=0.378 Sum_probs=234.2
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhh----hHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK----GESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~----~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
..+.|.+.+.||+|+||.|-+|..+.||+.||||++++....... ....+.+|++||++|+||+||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346789999999999999999999999999999999887655422 3334689999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC---CCEEEeecCcc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY---GHVRISDLGLA 264 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~---g~vkL~DFGla 264 (767)
..|+|||||.||+|.+.+-..+ .+.+...+.|+.|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999999998765 78899999999999999999999999999999999999766 78999999999
Q ss_pred cccCCCCcccccccccccCCcceecCCCC---CCCCccccchhhHHHHhcCCCCCCCchhhh-hhhhhhhhhhccccccC
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDNEKY---TYSPDWFSFGCLIFEMIEGQAPFRRRKEMV-KRDEVDRRVKEDAEKYS 340 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~y---s~~~DvwSlGviLyElltG~~PF~~~~~~~-~~~~i~~~i~~~~~~~~ 340 (767)
+...++..+.+.||||.|.|||++.++++ ..++|+||+||+||-+|+|.+||....... ..+++.+.-....+.++
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 99988888999999999999999977654 347799999999999999999998765543 34455555455556677
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
..+|+++++||++||..||++|++ ++|+++||||+...-
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s-------~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPS-------ADEALNHPWFKDAPC 445 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcC-------HHHHhcChhhhcccc
Confidence 889999999999999999999999 999999999998763
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-55 Score=482.26 Aligned_cols=256 Identities=29% Similarity=0.507 Sum_probs=242.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
.+|...+.||+|||+.||.+++..+|..||+|++.++.+.+....+.+.+|++|.+.|+|||||+++.+|++.+++|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Cc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~ 272 (767)
|+|..|+|..++.+++ .++|.+|+.|+.||+.||.|||+++|||||||..|+||+++.+|||+|||||..+... +.
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 9999999998888554 7999999999999999999999999999999999999999999999999999998744 67
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
..+.||||.|+|||++...++++.+||||+||+||-||.|+|||... ..+++.++|.......|..+|.+|+|||.
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk----~vkety~~Ik~~~Y~~P~~ls~~A~dLI~ 250 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK----TVKETYNKIKLNEYSMPSHLSAEAKDLIR 250 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc----hHHHHHHHHHhcCcccccccCHHHHHHHH
Confidence 88999999999999999999999999999999999999999999776 45667778888888899999999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+||++||.+||+ +++|+.|+||++
T Consensus 251 ~lL~~~P~~Rps-------l~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 251 KLLRPNPSERPS-------LDEVLDHPFFKS 274 (592)
T ss_pred HHhcCCcccCCC-------HHHHhcCHhhhC
Confidence 999999999999 999999999943
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-55 Score=449.82 Aligned_cols=322 Identities=31% Similarity=0.594 Sum_probs=286.5
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeC
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETK 186 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~ 186 (767)
.+.+.+++|+++++||+|+|++|.++++++|.+.||+|+++|.-+........+..|+.+..+. +||++|-|+..|+++
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 4567889999999999999999999999999999999999998888888888899999999885 799999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
..+++|.||++||||.+|+++++ .++++.+++|.++|+.||.|||++||||||||.+|+|+|..||+||+|+|.++.
T Consensus 324 srlffvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999999999999876 799999999999999999999999999999999999999999999999999986
Q ss_pred -cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCC----chhhhhhhhhhhhhhccccccCC
Q psy11874 267 -IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRR----RKEMVKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 267 -~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~----~~~~~~~~~i~~~i~~~~~~~~~ 341 (767)
+.++..+.+.||||.|+|||++.+..|++++|||+|||+++||+.|+.||.- +.+.....-+.+.|++.+...|.
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr 480 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR 480 (593)
T ss_pred CCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc
Confidence 4667778899999999999999999999999999999999999999999952 22223334567888888999999
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhhhhhcccC
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEKYSCR 421 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~~~~~~~~ 421 (767)
.+|-.+..+++..|++||.+|+||+.. .|..+++.||||++++|+.++++.+-|||.|.+..+-...++....+.-...
T Consensus 481 slsvkas~vlkgflnkdp~erlgc~~~-~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~q 559 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERLGCRPQ-TGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQ 559 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhcCCCcc-cchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccCCcc
Confidence 999999999999999999999999863 5899999999999999999999999999999998866655555544444555
Q ss_pred CChhHHHHHHHH
Q psy11874 422 FSDDAKALCKAL 433 (767)
Q Consensus 422 ~~~~~~~~~~~~ 433 (767)
.++|.+.....+
T Consensus 560 ltpdd~d~i~ri 571 (593)
T KOG0695|consen 560 LTPDDEDAIKRI 571 (593)
T ss_pred cCCCCHHHHHhc
Confidence 566555554443
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=510.21 Aligned_cols=289 Identities=33% Similarity=0.621 Sum_probs=260.6
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++|+++++||+|+||+|..++++.|++.||||+++|-.+.++.....|..|..||..-+++.||+|+++|++.+++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 45589999999999999999999999999999999999988888888889999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+|||||+||||-.++.+.. .+++..|++|+++|+.||.-||++|.|||||||+|||||..|||||+|||.+-....+
T Consensus 152 lVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999998875 6999999999999999999999999999999999999999999999999999888766
Q ss_pred Ccc--cccccccccCCcceec----C-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC--C
Q psy11874 271 ESV--RGRVGTVGYMAPEVID----N-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS--C 341 (767)
Q Consensus 271 ~~~--~~~~GT~~Y~APEvl~----~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~--~ 341 (767)
+.. ...+|||.|++||++. + +.|+..+||||+||++|||+.|..||+...-..++..|..- .....+| .
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--k~~l~FP~~~ 306 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--KESLSFPDET 306 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch--hhhcCCCccc
Confidence 554 4468999999999994 2 56999999999999999999999999998776666655432 2233444 4
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhh
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRV 411 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~ 411 (767)
.+|+++++||.++|. +|+.|+| |+|+++++.||||.+++|..+.. ..||++|++.++.+.++|
T Consensus 307 ~VSeeakdLI~~ll~-~~e~RLg----rngiedik~HpFF~g~~W~~iR~--~~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALLC-DREVRLG----RNGIEDIKNHPFFEGIDWDNIRE--SVPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred ccCHHHHHHHHHHhc-Chhhhcc----cccHHHHHhCccccCCChhhhhh--cCCCCCCcCCCCCccccc
Confidence 689999999999998 8999998 67899999999999999988876 569999999998887777
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-53 Score=449.09 Aligned_cols=284 Identities=77% Similarity=1.283 Sum_probs=256.8
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|+..+.||+|+||.||+|.++.+|+.||+|.+.+...........+.+|+.+|++++|++|+++.+++.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999988766655566678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~ 274 (767)
||+||+|..++.... ...+++..+..++.||+.||+|||+.||+||||||+|||+++++.++|+|||++.....+....
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence 999999998887643 3468999999999999999999999999999999999999999999999999998876555556
Q ss_pred ccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHh
Q psy11874 275 GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~l 354 (767)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+...+......++..+|+++.+||++|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence 67899999999999999999999999999999999999999988765545555666666666677888999999999999
Q ss_pred cccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 355 L~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
|+.||.+||++.+ .+++++++||||.+++|+++++++++|||.|+
T Consensus 240 l~~~P~~R~~~~~--~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 240 LTKNPKERLGCRG--NGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred hhcCHHHhcCCCC--CCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 9999999999765 47999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=441.28 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=232.7
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC-e
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD-A 188 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-~ 188 (767)
.++.++.+.++.||+|+.|+||+|+++.|++.||+|++... .+......+.+|++|++..+|||||.+|++|..+. .
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 35667889999999999999999999999999999999332 24445667899999999999999999999999999 5
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
++++||||+||+|...+...+ .++|.....++.+|++||.|||+ ++||||||||+|||++..|.|||||||.|..+
T Consensus 153 isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 999999999999999988765 69999999999999999999995 99999999999999999999999999999988
Q ss_pred CCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCch--hhhhhhhhhhhhhccccccCCC-Cc
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRK--EMVKRDEVDRRVKEDAEKYSCR-FS 344 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~--~~~~~~~i~~~i~~~~~~~~~~-~s 344 (767)
.+. ...+.+||..|||||.+.+..|+.++||||||+++.||++|+.||.... .....+.+...+.+.++..|.. +|
T Consensus 230 vnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 230 VNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS 308 (364)
T ss_pred hhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence 665 5678999999999999999999999999999999999999999997751 1223333444444577788886 99
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+++++||..||++||.+|++ ++++++|||++..
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s-------~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPS-------AKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHHHHHHhcCCcccCCC-------HHHHhcCHHHhhc
Confidence 99999999999999999998 9999999999864
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-52 Score=454.71 Aligned_cols=298 Identities=33% Similarity=0.572 Sum_probs=260.8
Q ss_pred hhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 106 ~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
+.+..+...-|..++.||-|+||+|++++...|...||+|.+.|+.+..+++..++..|..||....++.||+||+.|++
T Consensus 621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred HHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 34455677889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
++.+|+||||++|||+..+|.+++ .|.|+.+++|++++.||+++.|.+|+|||||||+|||||.+|||||+||||++
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc
Confidence 999999999999999999999987 79999999999999999999999999999999999999999999999999995
Q ss_pred cc---------CCCC----------------------------------cccccccccccCCcceecCCCCCCCCccccc
Q psy11874 266 EI---------PEGE----------------------------------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSF 302 (767)
Q Consensus 266 ~~---------~~~~----------------------------------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSl 302 (767)
-+ .++. .....+||+.|+|||++...+|+..+||||.
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 32 1110 0113479999999999999999999999999
Q ss_pred hhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 303 GCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 303 GviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
|||||||+.|++||...........+...-......+...+|++|.++|.+|.. +++.|+| +.++++|+.||||+
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLG----kng~d~vKaHpfFk 932 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLG----KNGADQVKAHPFFK 932 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhc----ccchhhhhcCcccc
Confidence 999999999999998876554444443333333445567899999999999865 9999999 35699999999999
Q ss_pred CCChhhHhcCCCCCCCCCCCCchhHHhhhhh
Q psy11874 383 STNWKRLEAGLCDPPFVPDVKRDEVDRRVKE 413 (767)
Q Consensus 383 ~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~ 413 (767)
.|+|..|.. ...|++|.++...+.++|..
T Consensus 933 gIDfsslRk--q~ApYIP~ItHptDTSNFdp 961 (1034)
T KOG0608|consen 933 GIDFSSLRK--QRAPYIPRITHPTDTSNFDP 961 (1034)
T ss_pred ccchHhhhh--ccCCcCccccCCCccccCCc
Confidence 999999654 56789999998877776654
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=456.84 Aligned_cols=302 Identities=30% Similarity=0.526 Sum_probs=282.6
Q ss_pred HhhhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEE
Q psy11874 104 IYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAY 183 (767)
Q Consensus 104 ~~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 183 (767)
...+...+.+.+++.+..||-||||.|=+++.+.....+|+|+++|..+...++.+++..|..||...++|+||+||-.|
T Consensus 410 ~~~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 410 FAEEFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred HHhhhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 34466678889999999999999999999999876667999999999999999999999999999999999999999999
Q ss_pred eeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 184 ETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 184 ~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
.+..++|++||-|-||+|+..++.++ .|++..+++|++.++.|++|||++|||||||||||.|||.+|.+||.|||+
T Consensus 490 rd~kyvYmLmEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhh
Confidence 99999999999999999999999876 799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 264 AVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 264 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
|+.+..+..+.+.||||.|.|||++.+++++.++|+||||+++|||++|.+||.+.+.+..++.+.+.+. ...+|..+
T Consensus 567 AKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid--~i~~Pr~I 644 (732)
T KOG0614|consen 567 AKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID--KIEFPRRI 644 (732)
T ss_pred HHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh--hhhccccc
Confidence 9999999999999999999999999999999999999999999999999999999999888888877664 34567899
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhh
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVK 412 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~ 412 (767)
+..+.+||++|-..+|.+|+|+.. +|..||++|.||.++||+.|.++.+.|||+|.+....+.++|.
T Consensus 645 ~k~a~~Lik~LCr~~P~ERLG~~~--~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd 711 (732)
T KOG0614|consen 645 TKTATDLIKKLCRDNPTERLGYQK--GGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFD 711 (732)
T ss_pred chhHHHHHHHHHhcCcHhhhcccc--CChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhcc
Confidence 999999999999999999999765 6899999999999999999999999999999998877666554
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=436.25 Aligned_cols=283 Identities=37% Similarity=0.664 Sum_probs=247.1
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGG 199 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG 199 (767)
++||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|++++||||+++++.+.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998776555555667889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC-CCCccccccc
Q psy11874 200 DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP-EGESVRGRVG 278 (767)
Q Consensus 200 ~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~-~~~~~~~~~G 278 (767)
+|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+... .+......+|
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 9998887654 68999999999999999999999999999999999999999999999999997642 2233445689
Q ss_pred ccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccC
Q psy11874 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKS 358 (767)
Q Consensus 279 T~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~d 358 (767)
|+.|+|||++.+..|+.++|+|||||++|||++|..||.+.+.. .+...+......++..+++++++||++||.+|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence 99999999999999999999999999999999999999776432 23334444556677889999999999999999
Q ss_pred cCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhh
Q psy11874 359 PRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRV 411 (767)
Q Consensus 359 P~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~ 411 (767)
|++||+... .++.++++||||++++|..+..+.+.||+.|.+......+.+
T Consensus 234 P~~R~~~~~--~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (323)
T cd05571 234 PKQRLGGGP--EDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYF 284 (323)
T ss_pred HHHcCCCCC--CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhc
Confidence 999996432 369999999999999999999999999999987765544443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=425.01 Aligned_cols=284 Identities=76% Similarity=1.301 Sum_probs=254.5
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.++||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999987666555556678889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~ 274 (767)
|++||+|..++.... ...+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++..........
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence 999999998887643 3468999999999999999999999999999999999999999999999999998776555555
Q ss_pred ccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHh
Q psy11874 275 GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~l 354 (767)
..+||+.|+|||++.+..++.++|+||+||++|||++|..||.+.+.....+.+...+......++..+++.+++||.+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 66899999999999988999999999999999999999999988766555555555566666667778999999999999
Q ss_pred cccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 355 L~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
|..||++||++.+ .+++++++||||...+|.++.+++.+|||.|+
T Consensus 240 l~~~P~~R~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05605 240 LTKDPGFRLGCRG--EGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284 (285)
T ss_pred ccCCHHHhcCCCC--CCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence 9999999998764 47999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=437.01 Aligned_cols=288 Identities=30% Similarity=0.509 Sum_probs=252.9
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCC-cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATG-KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
..+..++|++.+.||+|+||.||+|+++.++ ..||+|++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4466789999999999999999999977665 789999998776655556677889999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+||||++||+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999999997654 6899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
... ..+.+||+.|||||++.+..++.++|||||||++|||++|.+||.+.+... +.+.+......++..+++++
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~i~~~~~~~p~~~~~~~ 255 (340)
T PTZ00426 182 DTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----IYQKILEGIIYFPKFLDNNC 255 (340)
T ss_pred CCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----HHHHHhcCCCCCCCCCCHHH
Confidence 432 345689999999999999999999999999999999999999998765432 33344445556778899999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhH
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEV 407 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~ 407 (767)
+++|++||+.||++|++.. +.+++++++||||++++|..+..+.+.+|+.|.......
T Consensus 256 ~~li~~~l~~dp~~R~~~~--~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~ 313 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNL--KKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFD 313 (340)
T ss_pred HHHHHHHcccCHHHcCCCC--CCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCCcc
Confidence 9999999999999998632 357999999999999999999999999999999765443
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=427.69 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=230.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
..+|.+.+.||+|+||+||+|+++.++..||||.+.++.+ ..+..+.+..|++||+.++|||||.|+++.++.+.+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999998876 456677889999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC------CCEEEeecCcccc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY------GHVRISDLGLAVE 266 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~------g~vkL~DFGla~~ 266 (767)
||||+||||..+|++.+ .+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999999999986 79999999999999999999999999999999999999764 4589999999999
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc---ccccCCCC
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED---AEKYSCRF 343 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~---~~~~~~~~ 343 (767)
+.++....+.||+|-|||||++....|+.++|+||+|++||+|++|++||...+..+ +..++... .+..+..+
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e----L~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE----LLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH----HHHHHhccccccCchhhhc
Confidence 998888889999999999999999999999999999999999999999998775433 33333333 23345577
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+....+|+..+|+++|..|.+ ..+-..|++...
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~-------~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRIS-------FEDFFDHPFLAA 273 (429)
T ss_pred cCchhhhhhHHHhcCccccCc-------hHHhhhhhhccc
Confidence 888999999999999999988 778888888755
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=432.74 Aligned_cols=285 Identities=33% Similarity=0.591 Sum_probs=251.0
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
.....++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|++++||||+++++++.+.+.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 33456899999999999999999999999999999999987765555566778999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+||||++||+|..++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999999998754 68999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.. ++.+.+......++..+++.++
T Consensus 170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~~p~~~~~~~~ 243 (329)
T PTZ00263 170 DR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIYEKILAGRLKFPNWFDGRAR 243 (329)
T ss_pred CC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCCcCCCCCCCHHHH
Confidence 43 23467999999999999999999999999999999999999999876443 2334444555667778999999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCc
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKR 404 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~ 404 (767)
+||++||++||.+|+++.. .+++++++||||++.+|..+..+.+.+|+.+.+..
T Consensus 244 ~li~~~L~~dP~~R~~~~~--~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 297 (329)
T PTZ00263 244 DLVKGLLQTDHTKRLGTLK--GGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKS 297 (329)
T ss_pred HHHHHHhhcCHHHcCCCCC--CCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCC
Confidence 9999999999999998532 46999999999999999999988888887776543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-50 Score=429.10 Aligned_cols=284 Identities=32% Similarity=0.559 Sum_probs=251.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++........+....+.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999999999999999998765555556677889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||++||+|..++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--T 155 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--c
Confidence 9999999999998754 6899999999999999999999999999999999999999999999999999876432 3
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ++.+.+......++..+++.+++||++
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~li~~ 231 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----GIYEKILAGKLEFPRHLDLYAKDLIKK 231 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCcCCCccCCHHHHHHHHH
Confidence 3467999999999999999999999999999999999999999876543 233444445556777889999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHH
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVD 408 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~ 408 (767)
||+.||.+|+++.. .+++++++||||+.++|..+......||+.|.+..+...
T Consensus 232 ~l~~dp~~R~~~~~--~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 284 (291)
T cd05612 232 LLVVDRTRRLGNMK--NGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDT 284 (291)
T ss_pred HcCCCHHHccCCcc--CCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCcccc
Confidence 99999999998543 479999999999999999999999999999987655443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=420.41 Aligned_cols=278 Identities=55% Similarity=1.008 Sum_probs=244.5
Q ss_pred EeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCH
Q psy11874 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDL 201 (767)
Q Consensus 122 LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L 201 (767)
||+|+||+||+|.++.+|+.||+|++.+...........+..|+.++++++|+||+++.+++.+++.+|+|||||+||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999877665555566788899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-ccccccc
Q psy11874 202 KFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-VRGRVGT 279 (767)
Q Consensus 202 ~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-~~~~~GT 279 (767)
..++.... ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........ .....||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 98886532 234689999999999999999999999999999999999999999999999999987654432 3345799
Q ss_pred cccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCc
Q psy11874 280 VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSP 359 (767)
Q Consensus 280 ~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP 359 (767)
+.|+|||++.+..++.++|+|||||++|||++|+.||...........+...+......++..+|+++.+++.+||+.||
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 240 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP 240 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence 99999999999999999999999999999999999998765443444455555555566777899999999999999999
Q ss_pred CccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 360 RSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 360 ~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
++||+..+ .+++++++||||++++|..++++.++|||.|.
T Consensus 241 ~~R~~~~~--~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~ 280 (280)
T cd05608 241 EKRLGFRD--GNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280 (280)
T ss_pred HHhcCCCC--CCHHHHhcChhhhcCCHhHHhhccCCCCCCCC
Confidence 99998654 47999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=426.11 Aligned_cols=284 Identities=38% Similarity=0.710 Sum_probs=247.2
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC-CceeEEEEEEeeCCeEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l~lV~ 193 (767)
+|++.+.||+|+||.||+|+.+.+++.||+|++.+...........+..|.+++..+.| ++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999987765555566778889999999976 46889999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC-CCCc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP-EGES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~-~~~~ 272 (767)
||++||+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.... ....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 9999999999887654 68999999999999999999999999999999999999999999999999987532 2233
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.. ++...+......++..++++++++|+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~li~ 233 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQSIMEHNVSYPKSLSKEAVSICK 233 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 44567999999999999999999999999999999999999999876543 33344445556677889999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhH
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEV 407 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~ 407 (767)
+||.+||.+|+++.. .+.+++++||||+.++|.++..+.+.||+.|.+.....
T Consensus 234 ~~l~~~P~~R~~~~~--~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (324)
T cd05587 234 GLLTKHPAKRLGCGP--TGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRS 286 (324)
T ss_pred HHhhcCHHHcCCCCC--CCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcch
Confidence 999999999998543 35799999999999999999999899999998755433
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=435.58 Aligned_cols=260 Identities=28% Similarity=0.500 Sum_probs=235.6
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh--hhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGESMVLIEKQILQKIN-SRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~ 187 (767)
...+.|++.+.||+|+||+|+.|.+..+|..||+|+++++..... ...+.+.+|+.++++++ ||||++++.++.+.+
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345789999999999999999999999999999998877643322 34556778999999999 999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC-CCEEEeecCcccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY-GHVRISDLGLAVE 266 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~-g~vkL~DFGla~~ 266 (767)
.+|+||||+.||+|.+++.+.+ .+.+..++.++.||+.|++|||++||+||||||||||+|.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999999854 78999999999999999999999999999999999999999 9999999999998
Q ss_pred c-CCCCcccccccccccCCcceecCCC-CC-CCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 I-PEGESVRGRVGTVGYMAPEVIDNEK-YT-YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~-~~~~~~~~~~GT~~Y~APEvl~~~~-ys-~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
. ..+....+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+. ..+.+.+......+|..+
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----~~l~~ki~~~~~~~p~~~ 246 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV----PNLYRKIRKGEFKIPSYL 246 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH----HHHHHHHhcCCccCCCCc
Confidence 8 4667788999999999999999987 86 889999999999999999999988543 345555778888899999
Q ss_pred -cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 344 -SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 344 -s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
|+++++||.+||..||.+|++ +.+|+.||||+..
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t-------~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRIT-------LLEILEHPWFQKE 281 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCC-------HHHHhhChhhccC
Confidence 999999999999999999998 9999999999974
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=426.76 Aligned_cols=285 Identities=38% Similarity=0.653 Sum_probs=247.5
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
++||+|+||.||+|+++.+++.||+|++.+...........+..|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999877655555666788899999876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-CCcccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~-~~~~~~~~ 277 (767)
|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .......+
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 99998887654 689999999999999999999999999999999999999999999999999876432 23344567
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhccc
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~ 357 (767)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.. ++...+......++..++++++++|++||++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHhcCCCCCCCCCCHHHHHHHHHHccc
Confidence 999999999999999999999999999999999999999876543 3334445555667778999999999999999
Q ss_pred CcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhh
Q psy11874 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVK 412 (767)
Q Consensus 358 dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~ 412 (767)
||++|+++.+ ..+.+++++||||++++|..+..+.+.||+.|.+...+..+++.
T Consensus 234 dP~~R~~~~~-~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (320)
T cd05590 234 NPTMRLGSLT-LGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFD 287 (320)
T ss_pred CHHHCCCCCC-CCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcC
Confidence 9999999643 23569999999999999999999999999999987655544443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=432.34 Aligned_cols=275 Identities=30% Similarity=0.560 Sum_probs=233.4
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.++.+++|+||+++++.+++...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998776555556677889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-- 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-- 271 (767)
|||+||+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999998754 68999999999999999999999999999999999999999999999999997543211
Q ss_pred ----------------------------------cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCC
Q psy11874 272 ----------------------------------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317 (767)
Q Consensus 272 ----------------------------------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~ 317 (767)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0124579999999999999999999999999999999999999998
Q ss_pred CchhhhhhhhhhhhhhccccccC--CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCC
Q psy11874 318 RRKEMVKRDEVDRRVKEDAEKYS--CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCD 395 (767)
Q Consensus 318 ~~~~~~~~~~i~~~i~~~~~~~~--~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~ 395 (767)
+.+.......+... .....++ ..+|++++++|.+|+. +|.+|++ |.+++||++||||++++|+.+..+...
T Consensus 238 ~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~----r~~~~ei~~hp~f~~~~~~~~~~~~~~ 310 (363)
T cd05628 238 SETPQETYKKVMNW--KETLIFPPEVPISEKAKDLILRFCC-EWEHRIG----APGVEEIKTNPFFEGVDWEHIRERPAA 310 (363)
T ss_pred CCCHHHHHHHHHcC--cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCC----CCCHHHHhCCCCCCCCCHHHHHhCCCC
Confidence 76543333322211 0112233 2478999999999885 7888876 346999999999999999999877555
Q ss_pred CCC
Q psy11874 396 PPF 398 (767)
Q Consensus 396 pp~ 398 (767)
+|+
T Consensus 311 ~~~ 313 (363)
T cd05628 311 IPI 313 (363)
T ss_pred CCc
Confidence 553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=424.01 Aligned_cols=280 Identities=38% Similarity=0.696 Sum_probs=246.3
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+|++.+.||+|+||.||+|+++.+++.||+|++.+..............|..++..+ +|++|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999876655555566678888888887 5799999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-CCc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~-~~~ 272 (767)
||++||+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||++..... ...
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 9999999998887654 689999999999999999999999999999999999999999999999999976432 223
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.. .+...+......++..++++++++|.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~li~ 233 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEHNVAYPKSMSKEAVAICK 233 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 44567999999999999999999999999999999999999999876543 33344445556677889999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~ 403 (767)
+||++||++|+++.. .+..++++||||+.++|..+..+.+.||+.|...
T Consensus 234 ~~l~~~p~~R~~~~~--~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (323)
T cd05616 234 GLMTKHPGKRLGCGP--EGERDIKEHAFFRYIDWEKLERKEVQPPYKPKAC 282 (323)
T ss_pred HHcccCHHhcCCCCC--CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC
Confidence 999999999999643 4689999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=434.84 Aligned_cols=288 Identities=33% Similarity=0.573 Sum_probs=240.6
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
.|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+|++++|||||++++.+.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68999999999999999999999999999999988766556667788999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC----
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG---- 270 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~---- 270 (767)
||+||+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999987654 6899999999999999999999999999999999999999999999999997532100
Q ss_pred --------------------------------------------CcccccccccccCCcceecCCCCCCCCccccchhhH
Q psy11874 271 --------------------------------------------ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLI 306 (767)
Q Consensus 271 --------------------------------------------~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviL 306 (767)
....+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 001234799999999999999999999999999999
Q ss_pred HHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 307 FEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 307 yElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
|||++|++||.+.+.......+..............+|++++++|.+|+ .+|.+|++ +.+++++++||||++++|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~----~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG----KNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC----CCCHHHHhcCCCcCCcCh
Confidence 9999999999876543322222211111111223468999999999987 59999998 346999999999999999
Q ss_pred hhHhcCCCCCCCCCCCCchhHHhhh
Q psy11874 387 KRLEAGLCDPPFVPDVKRDEVDRRV 411 (767)
Q Consensus 387 ~~l~~~~~~pp~~P~~~~~~~~~~~ 411 (767)
..... ...+|+.|.+........+
T Consensus 314 ~~~~~-~~~~~~~~~~~~~~~~~~~ 337 (382)
T cd05625 314 SSDLR-QQSAPYIPKITHPTDTSNF 337 (382)
T ss_pred HHHHh-cCCCCccCcCCCcchhhhc
Confidence 87654 4678999998765544443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=426.21 Aligned_cols=282 Identities=36% Similarity=0.644 Sum_probs=245.7
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGG 199 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG 199 (767)
++||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|+.++||||+++++.+.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998766555556677889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-CCccccccc
Q psy11874 200 DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRVG 278 (767)
Q Consensus 200 ~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~-~~~~~~~~G 278 (767)
+|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .......+|
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 9998887653 689999999999999999999999999999999999999999999999999976432 223345679
Q ss_pred ccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccC
Q psy11874 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKS 358 (767)
Q Consensus 279 T~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~d 358 (767)
|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ++...+......++..+++++++||++||.+|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEDIKFPRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH----HHHHHhccCCccCCCCCCHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999999999999775432 23334444555677889999999999999999
Q ss_pred cCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhh
Q psy11874 359 PRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRR 410 (767)
Q Consensus 359 P~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~ 410 (767)
|++|++... .++.++++||||.+.+|..+....+.||+.|.+........
T Consensus 234 P~~R~~~~~--~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (328)
T cd05593 234 PNKRLGGGP--DDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRY 283 (328)
T ss_pred HHHcCCCCC--CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhh
Confidence 999997433 47999999999999999999999899999998766544433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=426.68 Aligned_cols=288 Identities=33% Similarity=0.622 Sum_probs=248.5
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
+.||+|+||+||+|+.+.+++.||+|++.+...........+.+|..++.++ +||||+.+++++++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999887665555667788999999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC-CCCcccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP-EGESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~-~~~~~~~~~ 277 (767)
|+|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... ........+
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 99998887654 69999999999999999999999999999999999999999999999999997532 233345678
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhh---hhhhhhhhhhhccccccCCCCcHHHHHHHHHh
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM---VKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~---~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~l 354 (767)
||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+.+.+......++..+|..+.++|++|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999999999999643221 12233445555556667788999999999999
Q ss_pred cccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhh
Q psy11874 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRV 411 (767)
Q Consensus 355 L~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~ 411 (767)
|.+||++|+++.. ..+.+++++||||+.++|..+..+.+.||+.|.+..+.....+
T Consensus 238 L~~dP~~R~~~~~-~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (327)
T cd05617 238 LNKDPKERLGCQP-QTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENF 293 (327)
T ss_pred hccCHHHcCCCCC-CCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcchhhc
Confidence 9999999999753 2468999999999999999999999999999998665444444
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=427.11 Aligned_cols=284 Identities=33% Similarity=0.641 Sum_probs=244.5
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
++||+|+||.||+|+++.+++.||+|++.+...........+..|..++.++ +||||+++++++.+.+.+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999877655555566788999999998 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc-CCCCcccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEGESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~-~~~~~~~~~~ 277 (767)
|+|..++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.. ..+......+
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 99998887653 6999999999999999999999999999999999999999999999999999753 2333345568
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhh-----hhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-----VKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~-----~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||...... .....+.+.+.......+..+++++.++|+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999999999999999999999999999999999632211 112233444555566677889999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhH
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEV 407 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~ 407 (767)
+||++||.+|+++... .+++++++||||++++|..+....+.||+.|.+.....
T Consensus 238 ~~L~~dP~~R~~~~~~-~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (329)
T cd05588 238 GFLNKDPKERLGCHPQ-TGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRD 291 (329)
T ss_pred HHhccCHHHcCCCCCC-CCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcch
Confidence 9999999999996532 46999999999999999999988888999998765443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=422.56 Aligned_cols=278 Identities=38% Similarity=0.715 Sum_probs=244.4
Q ss_pred EeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCH
Q psy11874 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDL 201 (767)
Q Consensus 122 LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L 201 (767)
||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+|.+++||||+++++++.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876655555667788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Cccccccccc
Q psy11874 202 KFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ESVRGRVGTV 280 (767)
Q Consensus 202 ~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~~~~~~GT~ 280 (767)
..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++..... ......+||+
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 99987654 6899999999999999999999999999999999999999999999999999754322 2334567999
Q ss_pred ccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcC
Q psy11874 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPR 360 (767)
Q Consensus 281 ~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~ 360 (767)
.|+|||++.+..++.++|||||||++|||++|..||.+.+. .++.+.+......++..++++++++|.+||..||.
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 233 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----NEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPT 233 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----HHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHH
Confidence 99999999999999999999999999999999999987643 33444555566677888999999999999999999
Q ss_pred ccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhh
Q psy11874 361 SRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRR 410 (767)
Q Consensus 361 ~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~ 410 (767)
+||+.. ++.++++||||++.+|..+......||+.|.+.......+
T Consensus 234 ~R~~~~----~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (312)
T cd05585 234 RRLGYN----GAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSN 279 (312)
T ss_pred HcCCCC----CHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhh
Confidence 999853 4999999999999999999998899999988765443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=425.83 Aligned_cols=282 Identities=37% Similarity=0.649 Sum_probs=244.3
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGG 199 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG 199 (767)
++||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.++++++||||+++++.+.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765555555667788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-CCccccccc
Q psy11874 200 DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRVG 278 (767)
Q Consensus 200 ~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~-~~~~~~~~G 278 (767)
+|..++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........|
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 9998887653 689999999999999999999999999999999999999999999999999876422 223345679
Q ss_pred ccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccC
Q psy11874 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKS 358 (767)
Q Consensus 279 T~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~d 358 (767)
|+.|+|||++.+..++.++|+|||||++|||++|..||.+.+... ....+......++..++++++++|.+||.+|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~~~~~~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILMEEIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCCCCCCCCCHHHHHHHHHHccCC
Confidence 999999999999999999999999999999999999997765432 2233333445567789999999999999999
Q ss_pred cCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhh
Q psy11874 359 PRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRR 410 (767)
Q Consensus 359 P~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~ 410 (767)
|.+|++... .++.++++||||.+++|..+..+.+.||+.|.+......+.
T Consensus 234 P~~R~~~~~--~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (323)
T cd05595 234 PKQRLGGGP--SDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRY 283 (323)
T ss_pred HHHhCCCCC--CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhh
Confidence 999996432 46999999999999999999998889999998766554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=431.19 Aligned_cols=286 Identities=31% Similarity=0.577 Sum_probs=239.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998776555556677889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES- 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~- 272 (767)
||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999987654 699999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCC
Q psy11874 273 --------------------------------------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQA 314 (767)
Q Consensus 273 --------------------------------------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~ 314 (767)
..+.+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 112469999999999999999999999999999999999999
Q ss_pred CCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCC
Q psy11874 315 PFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLC 394 (767)
Q Consensus 315 PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~ 394 (767)
||.+.+.......+..............+|+++++||++||. +|.+|++. .+++++++||||++++|..+.. .
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~----~~~~~ll~h~~~~~~~~~~~~~--~ 310 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN----NGVNEIKSHPFFKGVDWEHIRE--R 310 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC----CCHHHHhcCCCcCCCCHHHHhh--c
Confidence 998765433322222111111111123579999999999997 99999983 4699999999999999998765 4
Q ss_pred CCCCCCCCCchhHHh
Q psy11874 395 DPPFVPDVKRDEVDR 409 (767)
Q Consensus 395 ~pp~~P~~~~~~~~~ 409 (767)
.||++|.+.......
T Consensus 311 ~~~~~~~~~~~~~~~ 325 (364)
T cd05599 311 PAPIIPELKSITDTS 325 (364)
T ss_pred CCCCCCCCCCchhhh
Confidence 678888876544433
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=424.62 Aligned_cols=279 Identities=38% Similarity=0.663 Sum_probs=243.9
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
++||+|+||.||+|+++.+|+.||+|++.+...........+..|.+++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999877655555666788899999876 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-CCcccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~-~~~~~~~~ 277 (767)
|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .......+
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 99998887654 689999999999999999999999999999999999999999999999999976432 22344567
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhccc
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~ 357 (767)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+... +...+......++..+++++.++|++||++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~----~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD----LFESILHDDVLYPVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCCCCCCHHHHHHHHHHhcc
Confidence 9999999999999999999999999999999999999998775433 333444455566778899999999999999
Q ss_pred CcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCch
Q psy11874 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRD 405 (767)
Q Consensus 358 dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~ 405 (767)
||++|++|.....+++++++||||.+++|..+..+...||+.|.....
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTK 281 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCc
Confidence 999999876544479999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=433.29 Aligned_cols=279 Identities=34% Similarity=0.620 Sum_probs=236.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||+||+|..+.+|+.||+|++.+...........+.+|+.++++++|||||++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998766555556677889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-- 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-- 271 (767)
||++||+|..++.+.+ .+++..++.++.|++.||+|||+.||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999999987654 68999999999999999999999999999999999999999999999999996331100
Q ss_pred ----------c------------------------------------ccccccccccCCcceecCCCCCCCCccccchhh
Q psy11874 272 ----------S------------------------------------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCL 305 (767)
Q Consensus 272 ----------~------------------------------------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGvi 305 (767)
. ....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 012469999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC--CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 306 IFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC--RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 306 LyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~--~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+|||++|.+||.+.........+.... ....++. .+|.++++||.+||. +|.+|++ |.++.++++||||++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~----r~~~~~~l~hp~~~~ 310 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWR--ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG----RGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccC--CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC----CCCHHHHhcCCCcCC
Confidence 999999999998765433222222111 1122232 578999999999997 9999986 356999999999999
Q ss_pred CChhhHhcCCCCCCCCCCCCc
Q psy11874 384 TNWKRLEAGLCDPPFVPDVKR 404 (767)
Q Consensus 384 i~w~~l~~~~~~pp~~P~~~~ 404 (767)
++|..+. .+.+|++|.+..
T Consensus 311 ~~~~~~~--~~~~~~~~~~~~ 329 (377)
T cd05629 311 VDWDTIR--QIRAPFIPQLKS 329 (377)
T ss_pred CCHHHHc--cCCCCcccCCCC
Confidence 9999885 467899998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=414.63 Aligned_cols=284 Identities=74% Similarity=1.248 Sum_probs=248.2
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||+|+||.||+|.++.+++.||+|.+.+...........+.+|+.++++++|++++.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999987665555555678889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~ 274 (767)
|++||+|.+++...+ ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.....+....
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence 999999999887643 3468999999999999999999999999999999999999999999999999998766555545
Q ss_pred ccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHh
Q psy11874 275 GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~l 354 (767)
...||+.|+|||++.+..++.++|+||+||++|+|++|..||......................++..+++++++||.+|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence 56899999999999999999999999999999999999999987543322222222223333456677899999999999
Q ss_pred cccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 355 L~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
|+.||++|+|+.+ .+++|+++||||+.++|.++..++..|||.|+
T Consensus 240 l~~~p~~R~s~~~--~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05630 240 LCKDPKERLGCQG--GGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284 (285)
T ss_pred hhcCHHHccCCCC--CchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence 9999999999765 36999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=422.66 Aligned_cols=282 Identities=38% Similarity=0.647 Sum_probs=244.2
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHH---HhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL---QKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL---~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|++++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999999999999999999877655555556677777766 466899999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-CC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GE 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~-~~ 271 (767)
|||++||+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 9999999998877542 589999999999999999999999999999999999999999999999999875432 22
Q ss_pred cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
.....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+... +...+......++..+++++.++|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~----~~~~i~~~~~~~p~~~~~~~~~li 232 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE----VFDSIVNDEVRYPRFLSREAISIM 232 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCCCCCHHHHHHH
Confidence 3445679999999999999999999999999999999999999998765432 333444445567778999999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhH
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEV 407 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~ 407 (767)
.+||++||++||+... .+++++++||||++++|..+..+.+.||+.|.+.....
T Consensus 233 ~~~L~~dP~~R~~~~~--~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d 286 (324)
T cd05589 233 RRLLRRNPERRLGSGE--KDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPED 286 (324)
T ss_pred HHHhhcCHhHcCCCCC--CCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcch
Confidence 9999999999998654 47999999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=423.64 Aligned_cols=282 Identities=33% Similarity=0.642 Sum_probs=242.5
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
+.||+|+||.||+|+++.+++.||+|++.+...........+.+|..++.++ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999877655555566788899998876 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC-CCCcccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP-EGESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~-~~~~~~~~~ 277 (767)
|+|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++... ........+
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 99998887653 68999999999999999999999999999999999999999999999999997642 223344568
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchh-----hhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKE-----MVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~-----~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.+.+......+|..++.+++++|+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 99999999999999999999999999999999999999953211 1112233444555566778889999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCch
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRD 405 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~ 405 (767)
+||++||++|+++.. ..+++++++||||++++|..+..+.+.||+.|.+...
T Consensus 238 ~~L~~dP~~R~~~~~-~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 289 (329)
T cd05618 238 SFLNKDPKERLGCHP-QTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGE 289 (329)
T ss_pred HHhcCCHHHcCCCCC-CCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCc
Confidence 999999999999643 2458999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=411.49 Aligned_cols=284 Identities=77% Similarity=1.284 Sum_probs=255.1
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|+..+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+|++++|+||+.+.+.+.+++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999987766655556678889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~ 274 (767)
|++||+|..++...+ ...+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++..........
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence 999999998887653 3469999999999999999999999999999999999999999999999999998765544445
Q ss_pred ccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHh
Q psy11874 275 GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~l 354 (767)
...||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.........+...+......++..+++++.+|+.+|
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 56899999999999989999999999999999999999999987766555556666666666677788999999999999
Q ss_pred cccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 355 L~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
|+.||++||++.+ .+++++++||||++++|.++++++..|||+|.
T Consensus 240 l~~~P~~R~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 240 LTKDPKQRLGCQE--EGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284 (285)
T ss_pred ccCCHhHcCCCcc--cChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence 9999999999875 57999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=421.03 Aligned_cols=279 Identities=32% Similarity=0.612 Sum_probs=240.4
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998776555556677889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||++||+|..++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..... ..
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--cc
Confidence 9999999999997654 689999999999999999999999999999999999999999999999999986644 33
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc-ccccC---CCCcHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED-AEKYS---CRFSDDAKA 349 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~-~~~~~---~~~s~~~~d 349 (767)
...+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+....... .+... ..+|+++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 45679999999999999999999999999999999999999998765433333222111100 11111 256899999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~ 406 (767)
||.+||..+|.+|++ ++++++||||++++|..+. ...||++|.+....
T Consensus 236 li~~~l~~~~~rr~s-------~~~ll~h~~~~~~~~~~~~--~~~~~~~~~~~~~~ 283 (333)
T cd05600 236 LITKLINDPSRRFGS-------LEDIKNHPFFKEVDWNELR--ELKPPFVPELESEI 283 (333)
T ss_pred HHHHHhhChhhhcCC-------HHHHHhCcccCCCCHHHHh--hCCCCCCCCCCCcc
Confidence 999999999999998 9999999999999999887 57889999876543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-51 Score=403.29 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=235.5
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.|++..+||+|.|+.|++|.++.||+.||+|+++.+.+... +.+.+.+|++|-+.|+|||||+|...+......|+|+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 568888999999999999999999999999999988877665 6677899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC---CCCCEEEeecCcccccCCC
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD---DYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld---~~g~vkL~DFGla~~~~~~ 270 (767)
|+|.||+|.+-|-.+. .+++..+..++.||+.||.|+|.+||||||+||+|+||- ..--+||+|||+|..+..+
T Consensus 90 e~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred ecccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 9999999988887653 689999999999999999999999999999999999995 3345899999999999977
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
....+++|||+|||||++...+|+.++||||.||+||-||.|.+||.+.+.....+.+.+.-...+..+++.+|+++++|
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 77888999999999999999999999999999999999999999999976555555555554555566778999999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+++||..||++|++ |.|.++|||.++-
T Consensus 247 vrrML~~dP~kRIt-------a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 247 IRRMLTVNPKKRIT-------ADEALKHPWICNR 273 (355)
T ss_pred HHHHhccChhhhcc-------HHHHhCCchhcch
Confidence 99999999999998 9999999999874
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=426.49 Aligned_cols=275 Identities=29% Similarity=0.572 Sum_probs=234.1
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|+.+.+|+.||+|++.+...........+.+|+.++.+++||||+++++.+++++.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998766555556677889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-- 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-- 271 (767)
|||+||+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|+++|+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999987654 68999999999999999999999999999999999999999999999999987543211
Q ss_pred ----------------------------------cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCC
Q psy11874 272 ----------------------------------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317 (767)
Q Consensus 272 ----------------------------------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~ 317 (767)
...+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0123579999999999999999999999999999999999999998
Q ss_pred CchhhhhhhhhhhhhhccccccCC--CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCC
Q psy11874 318 RRKEMVKRDEVDRRVKEDAEKYSC--RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCD 395 (767)
Q Consensus 318 ~~~~~~~~~~i~~~i~~~~~~~~~--~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~ 395 (767)
+.+.......+... .....++. .+|+++++||.+|+. ||.+|++. .+++++++||||++++|..+..+...
T Consensus 238 ~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~----~~~~ei~~hp~f~~~~~~~~~~~~~~ 310 (360)
T cd05627 238 SETPQETYRKVMNW--KETLVFPPEVPISEKAKDLILRFCT-DSENRIGS----NGVEEIKSHPFFEGVDWGHIRERPAA 310 (360)
T ss_pred CCCHHHHHHHHHcC--CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCC----CCHHHHhcCCCCCCCCHHHHhcCCCC
Confidence 76543332222211 11122332 478999999999875 99999983 35999999999999999999887666
Q ss_pred CCC
Q psy11874 396 PPF 398 (767)
Q Consensus 396 pp~ 398 (767)
+|+
T Consensus 311 ~~~ 313 (360)
T cd05627 311 IPI 313 (360)
T ss_pred CCc
Confidence 554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=411.41 Aligned_cols=276 Identities=56% Similarity=1.067 Sum_probs=239.0
Q ss_pred EeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCH
Q psy11874 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDL 201 (767)
Q Consensus 122 LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L 201 (767)
||+|+||.||+|+.+.+|+.||+|.+.++..........+..|++++++++||||+++++.++++..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999877665555556677899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcccccccccc
Q psy11874 202 KFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVG 281 (767)
Q Consensus 202 ~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~ 281 (767)
.+++...+ ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.............||+.
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 98887653 33589999999999999999999999999999999999999999999999999987765544455679999
Q ss_pred cCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc-CCCCcHHHHHHHHHhcccCcC
Q psy11874 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY-SCRFSDDAKALCKALLKKSPR 360 (767)
Q Consensus 282 Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~-~~~~s~~~~dLi~~lL~~dP~ 360 (767)
|+|||++.+..++.++|+||+||++|||++|..||..........++.+......... ...+++++++||++||++||+
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence 9999999988899999999999999999999999987654433444444443333222 246899999999999999999
Q ss_pred ccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 361 SRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 361 ~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
+||++.+ ..++++.||||+.++|.+++.+..+|||.|+
T Consensus 240 ~R~~~~~---~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~ 277 (277)
T cd05607 240 DRLGSRE---KNDDPRKHEFFKTINFPRLEAGLIPPPFVPD 277 (277)
T ss_pred hCCCCcc---chhhhhcChhhcCCCHHHHhcCcCCCCCCCC
Confidence 9999543 2588999999999999999999999999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=419.48 Aligned_cols=280 Identities=37% Similarity=0.702 Sum_probs=245.2
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+|+..++||+|+||.||+|+++.+|+.||+|++.+...........+..|..++..+. |++|+++++.+.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998776555555667888999998886 577889999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Cc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~ 272 (767)
||++||+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ..
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 9999999999987654 6999999999999999999999999999999999999999999999999999764332 22
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
....+||+.|+|||++.+..++.++|+||+||++|||++|.+||.+.+.. .+.+.+......++..+++++++++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~~p~~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSIMEHNVSYPKSLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 34567999999999999999999999999999999999999999876543 23344444555677889999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~ 403 (767)
+||++||.+|+++.. .+.+++++||||+.++|..+..+.+.||+.|...
T Consensus 234 ~~l~~~p~~R~~~~~--~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~ 282 (323)
T cd05615 234 GLMTKHPSKRLGCGP--EGERDIREHAFFRRIDWDKLENREIQPPFKPKVC 282 (323)
T ss_pred HHcccCHhhCCCCCC--CCHHHHhcCcccCCCCHHHHhcCCCCcCccCccC
Confidence 999999999999653 4689999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=434.01 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=238.6
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
+.+-|++.+.||+|+-|.|-+|++..||+..|||++.+..-........+.+|+-||+.++||||++||++|+++.++||
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 45779999999999999999999999999999999988754444556678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
|+||++||.|++++...| ++++.++..++.||+.|+.|+|..+|+||||||||+|||..++|||+|||+|..-.++.
T Consensus 90 vlEyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999999999877 79999999999999999999999999999999999999999999999999999888888
Q ss_pred cccccccccccCCcceecCCCCC-CCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEKYT-YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~ys-~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
...+.||+|.|.|||++.+.+|+ .++||||.|||||.||+|+.||.+.+... +...++.+....|..+|++|.||
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~----LLlKV~~G~f~MPs~Is~eaQdL 242 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV----LLLKVQRGVFEMPSNISSEAQDL 242 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH----HHHHHHcCcccCCCcCCHHHHHH
Confidence 88999999999999999999985 89999999999999999999998775543 44455566677889999999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
|.+||.+||++|++ .+||++|||+....
T Consensus 243 Lr~ml~VDp~~RiT-------~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 243 LRRMLDVDPSTRIT-------TEEILKHPFLSGYT 270 (786)
T ss_pred HHHHhccCcccccc-------HHHHhhCchhhcCC
Confidence 99999999999998 99999999998754
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=427.37 Aligned_cols=281 Identities=32% Similarity=0.518 Sum_probs=233.5
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
.|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+|++++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999988766666667788999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC---
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE--- 271 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~--- 271 (767)
|++||+|..++.+.+ .+++..++.+++||+.||+|||+.||+||||||+|||++.+|++||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999987754 68999999999999999999999999999999999999999999999999975431100
Q ss_pred ---------------------------------------------cccccccccccCCcceecCCCCCCCCccccchhhH
Q psy11874 272 ---------------------------------------------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLI 306 (767)
Q Consensus 272 ---------------------------------------------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviL 306 (767)
...+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 01235799999999999999999999999999999
Q ss_pred HHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhccc--CcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 307 FEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK--SPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 307 yElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~--dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
|||++|.+||...+.......+..............+|+++++||.+||.. +|..|++ ++++++||||+++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~-------~~~~l~hp~f~~~ 311 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG-------ADDIKAHPFFSEV 311 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCC-------HHHHhcCcccCCC
Confidence 999999999987654322222211111111112235899999999997754 3444766 9999999999999
Q ss_pred ChhhHhcCCCCCCCCCCCCchh
Q psy11874 385 NWKRLEAGLCDPPFVPDVKRDE 406 (767)
Q Consensus 385 ~w~~l~~~~~~pp~~P~~~~~~ 406 (767)
+|..... ...+|+.|.+....
T Consensus 312 ~~~~~~~-~~~~~~~p~~~~~~ 332 (381)
T cd05626 312 DFSSDIR-TQPAPYVPKISHPM 332 (381)
T ss_pred ChhHHhh-cCCCCccCcCCCcc
Confidence 9998664 46788999865543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=419.86 Aligned_cols=280 Identities=36% Similarity=0.662 Sum_probs=242.9
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGG 199 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG 199 (767)
+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|.++++.++||||+++++.+.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998776555555667788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCcccccC-CCCcccccc
Q psy11874 200 DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLAVEIP-EGESVRGRV 277 (767)
Q Consensus 200 ~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~-~~~~~~~~~ 277 (767)
+|..++.+.+ .+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||++.... ........+
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 9998887643 68999999999999999999997 799999999999999999999999999997543 223344567
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhccc
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~ 357 (767)
||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+. ..+...+......++..+++++.+||++||++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILMEEIRFPRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----HHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhc
Confidence 99999999999999999999999999999999999999977643 23334444455567788999999999999999
Q ss_pred CcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHH
Q psy11874 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVD 408 (767)
Q Consensus 358 dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~ 408 (767)
||++|++... .++.++++||||+++.|.....+...||+.|........
T Consensus 234 dP~~R~~~~~--~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (325)
T cd05594 234 DPKQRLGGGP--DDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDT 282 (325)
T ss_pred CHHHhCCCCC--CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchh
Confidence 9999996432 469999999999999999999888889998876554433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=417.45 Aligned_cols=288 Identities=38% Similarity=0.683 Sum_probs=246.0
Q ss_pred CeEEEeEEeecCcEEEEEEEEc---cCCcEEEEEEechhhhhh-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKK-RKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l 189 (767)
+|++.+.||+|+||.||+|+.. .+|+.||+|++.+..... ......+..|..+|+++ +|++|+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998864 578999999997754432 23445678899999999 589999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||++||+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999987654 689999999999999999999999999999999999999999999999999986543
Q ss_pred CC--cccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 270 GE--SVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 270 ~~--~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
.. .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........+...+......++..+++.
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 32 23346799999999999765 4889999999999999999999999765443344455555555666777789999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhH
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEV 407 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~ 407 (767)
++++|.+||+.||++|++... .+++++++||||++.+|..+....+.||+.|.......
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~--~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGP--QGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELD 296 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCC--CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcch
Confidence 999999999999999997542 36999999999999999999988899999998665433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=417.99 Aligned_cols=279 Identities=38% Similarity=0.719 Sum_probs=240.5
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHh-cCCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
++||+|+||.||+|.++.+++.||+|++.+..............|..++.. .+||||+++++++.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999987655444455566778877775 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Ccccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~~~~~~ 277 (767)
|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...... ......+
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 99998887654 6899999999999999999999999999999999999999999999999999765332 2334567
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhccc
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~ 357 (767)
||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.. ++...+......++..+++++.+||.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----ELFDSILNDRPHFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCHHHHHHHHHHccC
Confidence 999999999999999999999999999999999999999876543 3333444455667778999999999999999
Q ss_pred CcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhh
Q psy11874 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRV 411 (767)
Q Consensus 358 dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~ 411 (767)
||++|++ .++++++||||+.++|..+..+...||+.|..........+
T Consensus 234 ~P~~R~~------~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (316)
T cd05592 234 DPTKRLG------VDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNF 281 (316)
T ss_pred CHHHcCC------ChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhc
Confidence 9999998 25799999999999999999999999999987654444433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=421.38 Aligned_cols=283 Identities=27% Similarity=0.403 Sum_probs=242.0
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC--Ce
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK--DA 188 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~ 188 (767)
...+.|+.++.||+|+||.||+|++..||++||+|++..... +......+.+|+.||++|+||||++|.+....+ ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 455789999999999999999999999999999999976542 344556688999999999999999999988776 68
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|||+|||+ -||.-++.+. ...|++.+++.|+.||+.||+|||++||+|||||.+|||||++|.+||+|||||+.+.
T Consensus 193 iYlVFeYMd-hDL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 193 IYLVFEYMD-HDLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEEeccc-chhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999999998 5888877763 3479999999999999999999999999999999999999999999999999999665
Q ss_pred CCC--cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC----
Q psy11874 269 EGE--SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC---- 341 (767)
Q Consensus 269 ~~~--~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~---- 341 (767)
... ..+..+-|.+|.|||++.+ ..|+.++|+||.||||.||++|++.|.++++..+.+.|.+......+.+|.
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 443 4678899999999999987 479999999999999999999999999999998888887766555555443
Q ss_pred ---------------------CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCC
Q psy11874 342 ---------------------RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400 (767)
Q Consensus 342 ---------------------~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P 400 (767)
.+++.+.+|+..||..||.+|.+ |.++++|+||.... -..+|+-+|
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t-------A~~aL~seyF~t~p------~~~~p~~Lp 416 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT-------ASSALQSEYFTTEP------LPCDPSSLP 416 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc-------HHHHhcCcccccCC------CCCCcccCC
Confidence 25789999999999999999988 99999999995532 335666677
Q ss_pred C-CCchhHHhh
Q psy11874 401 D-VKRDEVDRR 410 (767)
Q Consensus 401 ~-~~~~~~~~~ 410 (767)
. ....|.+..
T Consensus 417 ~y~~s~E~~~K 427 (560)
T KOG0600|consen 417 KYPPSHELDAK 427 (560)
T ss_pred CCCcchhHHHH
Confidence 6 233444443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=416.56 Aligned_cols=277 Identities=38% Similarity=0.727 Sum_probs=239.6
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHh-cCCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
++||+|+||.||+|+++.+|+.||+|++.+..............|..++.. .+||||+++++++.+++.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999987654444455667778888876 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Ccccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~~~~~~ 277 (767)
|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++...... ......+
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 99999887653 6899999999999999999999999999999999999999999999999998754322 2344567
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhccc
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~ 357 (767)
||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.. ++.+.+......++..++.++++||++||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----ELFESIRVDTPHYPRWITKESKDILEKLFER 233 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCCCCCHHHHHHHHHHccC
Confidence 999999999999999999999999999999999999999876543 3334444455667778999999999999999
Q ss_pred CcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHh
Q psy11874 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDR 409 (767)
Q Consensus 358 dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~ 409 (767)
||++|++ ..+++++||||++++|..+..+.++||+.|.........
T Consensus 234 dP~~R~~------~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (316)
T cd05620 234 DPTRRLG------VVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYS 279 (316)
T ss_pred CHHHcCC------ChHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhh
Confidence 9999998 246899999999999999999999999999876554433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=426.71 Aligned_cols=284 Identities=33% Similarity=0.566 Sum_probs=238.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|++++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998776655556677889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC---
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG--- 270 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~--- 270 (767)
||++||+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999997754 6899999999999999999999999999999999999999999999999998532100
Q ss_pred -----------------------------------------CcccccccccccCCcceecCCCCCCCCccccchhhHHHH
Q psy11874 271 -----------------------------------------ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEM 309 (767)
Q Consensus 271 -----------------------------------------~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEl 309 (767)
......+||+.|||||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 001234799999999999999999999999999999999
Q ss_pred hcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhH
Q psy11874 310 IEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389 (767)
Q Consensus 310 ltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l 389 (767)
++|+.||.+.........+..............+++++.++|.+|+ .+|.+|++. .++.++++||||+.++|..+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~----~t~~ell~h~~~~~~~~~~~ 312 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK----NGADEIKAHPFFKGIDFASL 312 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC----CCHHHHhCCCCcCCCCHHHH
Confidence 9999999876543332222211111112223468999999999987 599999962 25999999999999999988
Q ss_pred hcCCCCCCCCCCCCchh
Q psy11874 390 EAGLCDPPFVPDVKRDE 406 (767)
Q Consensus 390 ~~~~~~pp~~P~~~~~~ 406 (767)
. ....+|++|.+....
T Consensus 313 ~-~~~~~~~~~~~~~~~ 328 (376)
T cd05598 313 I-RRQKAPYIPKITHPT 328 (376)
T ss_pred h-hcCCCCCCCcCCCcc
Confidence 7 456788888865543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=425.93 Aligned_cols=289 Identities=30% Similarity=0.550 Sum_probs=244.0
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35567999999999999999999999999999999999876655555566678899999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||++||+|..++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999999888653 488999999999999999999999999999999999999999999999999987643
Q ss_pred CCc--ccccccccccCCcceecCC----CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC--
Q psy11874 270 GES--VRGRVGTVGYMAPEVIDNE----KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC-- 341 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~~~----~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~-- 341 (767)
... ....+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+.......+.... ....++.
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~ 272 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK--NSLTFPDDI 272 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--CcCCCCCcC
Confidence 322 2356799999999998653 47899999999999999999999998876543333332211 1122333
Q ss_pred CCcHHHHHHHHHhcccCcCc--cCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhh
Q psy11874 342 RFSDDAKALCKALLKKSPRS--RLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRV 411 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~--Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~ 411 (767)
.+|.++++||++||+.+|.+ |++ ++++++||||++.+|.........+|++|....+...+.+
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s-------~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 337 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNG-------VDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNF 337 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCC-------HHHHhcCcccCCCChhhHHhcCCCcCccCcCCCcchhhhc
Confidence 57999999999999988876 766 9999999999999999887777889999987665544443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=429.65 Aligned_cols=254 Identities=29% Similarity=0.458 Sum_probs=234.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|.+++.||+|+||.||+|+.+.|.+.||||.+.|.. ...+....+.+|++|++.++|||||.++++|++..++++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 57889999999999999999999999999999998764 34456777999999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||+.| +|..+|...+ .++|+.++.++.+++.||.|||+.+|+|||+||.|||++..|++|+||||+|+....+...
T Consensus 81 e~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 99997 9999998865 7999999999999999999999999999999999999999999999999999988776554
Q ss_pred -cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 274 -RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 274 -~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
+...|||-|||||++.+..|+..+|+||||||+|||.+|++||.... ..++.+.|..++..+|...|.++++|++
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s----i~~Lv~~I~~d~v~~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS----ITQLVKSILKDPVKPPSTASSSFVNFLQ 232 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH----HHHHHHHHhcCCCCCcccccHHHHHHHH
Confidence 44579999999999999999999999999999999999999998763 3556778888999999999999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
.+|.+||.+|++ +.+++.|||.++
T Consensus 233 gLL~kdP~~Rlt-------W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 233 GLLIKDPAQRLT-------WTDLLGHPFWKG 256 (808)
T ss_pred HHhhcChhhccc-------HHHHhcChHHhh
Confidence 999999999999 999999999886
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=415.89 Aligned_cols=281 Identities=37% Similarity=0.695 Sum_probs=240.8
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHh-cCCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
+.||+|+||+||+|+++.+++.||+|++.+..............|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999987654444445567778888876 4999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Ccccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~~~~~~ 277 (767)
|+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 99999987643 6899999999999999999999999999999999999999999999999999754322 2334567
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhccc
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~ 357 (767)
||+.|+|||++.+..++.++|+||+||++|||++|..||.+.+.. ++.+.+......++..++.+++++|.+||++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQSIRMDNPCYPRWLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCccCCHHHHHHHHHHhcc
Confidence 999999999999999999999999999999999999999876543 3333344444556778999999999999999
Q ss_pred CcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhh
Q psy11874 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKE 413 (767)
Q Consensus 358 dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~ 413 (767)
||++||++ .+++++||||+.++|..+..+..+||+.|.++......++..
T Consensus 234 ~P~~R~~~------~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (316)
T cd05619 234 EPERRLGV------KGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDK 283 (316)
T ss_pred CHhhcCCC------hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcCh
Confidence 99999992 358999999999999999999999999998766555444433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=424.36 Aligned_cols=290 Identities=32% Similarity=0.568 Sum_probs=241.4
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 44578999999999999999999999999999999998765555555667888999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+|||||+||+|..++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|......
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 999999999999988653 4889999999999999999999999999999999999999999999999999876433
Q ss_pred Cc--ccccccccccCCcceecCCC----CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC--C
Q psy11874 271 ES--VRGRVGTVGYMAPEVIDNEK----YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC--R 342 (767)
Q Consensus 271 ~~--~~~~~GT~~Y~APEvl~~~~----ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~--~ 342 (767)
.. ..+.+||+.|||||++.+.. ++.++||||+||++|||++|.+||.+.+.......+.... ....++. .
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~ 273 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK--NSLNFPEDVE 273 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cccCCCCccc
Confidence 22 23567999999999997543 7899999999999999999999998776543333332211 1122333 5
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRV 411 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~ 411 (767)
++..++++|.+||. ++.+|++ |.+++++++||||++..|.........+|+.|.+.......++
T Consensus 274 ~s~~~~~li~~~L~-~~~~r~~----R~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 337 (370)
T cd05621 274 ISKHAKNLICAFLT-DREVRLG----RNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNF 337 (370)
T ss_pred CCHHHHHHHHHHcc-CchhccC----CCCHHHHhcCcccCCCCcChHhcCCCCCCcCCCCCCcchhhhc
Confidence 69999999999998 5555554 3459999999999998887776667789999987665544443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=420.16 Aligned_cols=284 Identities=33% Similarity=0.595 Sum_probs=242.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+..|+.+|..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998876655566777889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-- 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-- 271 (767)
||++||+|..++.+.+ .+++..++.++.||+.||+|||+.||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999999999998753 68999999999999999999999999999999999999999999999999998665433
Q ss_pred ----------------------------cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh
Q psy11874 272 ----------------------------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV 323 (767)
Q Consensus 272 ----------------------------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~ 323 (767)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2234579999999999999999999999999999999999999998776433
Q ss_pred hhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCC
Q psy11874 324 KRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403 (767)
Q Consensus 324 ~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~ 403 (767)
....+..............+++++++||.+||. ||.+|++ +++++++||||++++|.... ...||++|.+.
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~------s~~~ll~hp~~~~~~~~~~~--~~~~~~~~~~~ 308 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLG------SFEEIKSHPFFKGIDWENLR--ETKPPFVPELS 308 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCC------CHHHHhcCCCcCCCCHHHHh--hCCCCcCCCCC
Confidence 333332211111111223469999999999997 9999998 59999999999999999887 45688999876
Q ss_pred chhHHh
Q psy11874 404 RDEVDR 409 (767)
Q Consensus 404 ~~~~~~ 409 (767)
......
T Consensus 309 ~~~~~~ 314 (350)
T cd05573 309 SPLDTS 314 (350)
T ss_pred Cchhhh
Confidence 654433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=415.92 Aligned_cols=283 Identities=39% Similarity=0.699 Sum_probs=245.2
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
+.||+|+||+||+|.++.+++.||+|++.+...........+.+|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999887655555666778899999888 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-CCcccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~-~~~~~~~~ 277 (767)
|+|..++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .......+
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 99998887654 689999999999999999999999999999999999999999999999999975322 22334567
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhccc
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~ 357 (767)
||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.. .+...+......++..+++++++||++||.+
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----ELFQSILEDEVRYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----HHHHHHHcCCCCCCCcCCHHHHHHHHHHccC
Confidence 999999999999999999999999999999999999999876542 3333444455566778999999999999999
Q ss_pred CcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhh
Q psy11874 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRV 411 (767)
Q Consensus 358 dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~ 411 (767)
||++||++.. ..+.++++||||++++|..+....+.||+.|.+.......++
T Consensus 234 dP~~R~s~~~--~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (318)
T cd05570 234 NPEKRLGCLP--TGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNF 285 (318)
T ss_pred CHHHcCCCCC--CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhc
Confidence 9999999533 345999999999999999999999999999998765544433
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=414.67 Aligned_cols=276 Identities=39% Similarity=0.677 Sum_probs=238.3
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHH-HHHhcCCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQ-ILQKINSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
++||+|+||+||+|+++.+|+.||+|++.+...........+..|.. +++.++||||+++++.+.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998766554444455666655 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-CCcccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~-~~~~~~~~ 277 (767)
|+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .......+
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 99999887653 689999999999999999999999999999999999999999999999999976432 22334567
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhccc
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~ 357 (767)
||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.. ++...+.......+..+++++.++|++||++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA----EMYDNILNKPLRLKPNISVSARHLLEGLLQK 233 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence 999999999999999999999999999999999999999876432 3334444445566677899999999999999
Q ss_pred CcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCch
Q psy11874 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRD 405 (767)
Q Consensus 358 dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~ 405 (767)
||.+||+... .+.++++||||++++|..+....+.+|+.|.+...
T Consensus 234 ~p~~R~~~~~---~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05575 234 DRTKRLGAKD---DFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGP 278 (323)
T ss_pred CHHhCCCCCC---CHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCc
Confidence 9999999653 58999999999999999999988999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=421.25 Aligned_cols=290 Identities=32% Similarity=0.550 Sum_probs=242.3
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34568999999999999999999999999999999999876655555566788899999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||++||+|..++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 9999999999999888653 488999999999999999999999999999999999999999999999999987654
Q ss_pred CCc--ccccccccccCCcceecCCC----CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 270 GES--VRGRVGTVGYMAPEVIDNEK----YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~~~~----ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
... ....+||+.|||||++.+.. ++.++|||||||++|||++|.+||.+.+.......+..............+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 274 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCC
Confidence 322 23567999999999996543 789999999999999999999999887654333333322111111223468
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHH
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVD 408 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~ 408 (767)
|+.++++|.+||. +|..|++ |.+++++++||||++..|.....+...+|++|.+......
T Consensus 275 s~~~~~li~~~L~-~~~~r~~----r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (371)
T cd05622 275 SKEAKNLICAFLT-DREVRLG----RNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDT 334 (371)
T ss_pred CHHHHHHHHHHcC-ChhhhcC----CCCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCCCcchh
Confidence 9999999999998 7777776 3569999999999998887766677788999986554433
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-49 Score=399.53 Aligned_cols=260 Identities=23% Similarity=0.395 Sum_probs=222.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.|+.+.++|+|+||.||+|+++.||+.||||++.-.. ......+-+++|+++|++++|+|+|.|..+|..+..++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46888999999999999999999999999999985432 22334456899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC-CCCc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP-EGES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~-~~~~ 272 (767)
|||+..-| .-|.+. ..+.+.+.++.|+.|++.|+.|+|++++||||||||||||+.+|.+||||||+|+.+. .++.
T Consensus 81 E~~dhTvL-~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDHTVL-HELERY--PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecchHHH-HHHHhc--cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 99986544 445443 2379999999999999999999999999999999999999999999999999999887 6777
Q ss_pred ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc-------------
Q psy11874 273 VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK------------- 338 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~------------- 338 (767)
++.++.|.+|+|||.+.+ ..|+.++||||+||++.||++|.+.|.+..+.++...+......-.+.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 888999999999999987 789999999999999999999999999988766554433322111100
Q ss_pred --------------cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 339 --------------YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 339 --------------~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
-.+.+|.-+.||+++||..||++|++ +++++.||||.++
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s-------c~qll~H~yFd~~ 290 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS-------CEQLLHHPYFDGF 290 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc-------HHHHhcChHHHHH
Confidence 01245778999999999999999999 8999999999554
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=413.55 Aligned_cols=278 Identities=37% Similarity=0.644 Sum_probs=238.9
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHH-HHHhcCCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQ-ILQKINSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
+.||+|+||+||+|.++.+|+.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765544444555666665 56779999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-CCcccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~-~~~~~~~~ 277 (767)
|+|..++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .......+
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 99998887643 689999999999999999999999999999999999999999999999999975432 22344567
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhccc
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~ 357 (767)
||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.. ++.+.+.......+...+..+.++|++||++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----EMYDNILHKPLVLRPGASLTAWSILEELLEK 233 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----HHHHHHHcCCccCCCCCCHHHHHHHHHHhcc
Confidence 999999999999999999999999999999999999999876533 2333444444555667899999999999999
Q ss_pred CcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhH
Q psy11874 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEV 407 (767)
Q Consensus 358 dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~ 407 (767)
||.+||+.+ .+..++++||||+..+|..+..+.+.||+.|.......
T Consensus 234 ~p~~R~~~~---~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T cd05604 234 DRQRRLGAK---EDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDD 280 (325)
T ss_pred CHHhcCCCC---CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcch
Confidence 999999965 36899999999999999999999899999998655433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=409.38 Aligned_cols=280 Identities=37% Similarity=0.639 Sum_probs=239.5
Q ss_pred EeEEeecCcEEEEEEEEc---cCCcEEEEEEechhhhh-hhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 119 YRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIK-KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 119 ~~~LG~G~fG~Vy~a~~~---~tg~~~AiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
++.||+|+||.||+|+.. .+|+.||+|++.+.... .......+.+|+.+|+.++||||+++++.+.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 47899999999876543 23344567889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Ccc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ESV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~~ 273 (767)
|++||+|..++.+.+ .+.+..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ...
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 999999999987654 5889999999999999999999999999999999999999999999999999754332 233
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
...+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+... ....+......++..+++++++||++
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----TIDKILKGKLNLPPYLTPEARDLLKK 233 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 45679999999999999999999999999999999999999998765433 23333344456677889999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhH
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEV 407 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~ 407 (767)
||++||++|++... .+++++++||||+..+|..+....+.||+.|.....+.
T Consensus 234 ~l~~~p~~R~~~~~--~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (323)
T cd05584 234 LLKRNPSSRLGAGP--GDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEED 285 (323)
T ss_pred HcccCHhHcCCCCC--CCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcch
Confidence 99999999996543 46999999999999999999998899998887654433
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=386.46 Aligned_cols=262 Identities=27% Similarity=0.408 Sum_probs=242.6
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
...++++|++.+.||+|-||.||+|+.+.++-.+|+|++.|+.+........+.+|++|-+.|+||||+++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 34567899999999999999999999999999999999999999888888899999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+||++||.++|+|...|.... ...+++..+..|+.|++.||.|+|..+||||||||+|+|++..|.+||+|||.+...+
T Consensus 97 iyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999999998543 3469999999999999999999999999999999999999999999999999998876
Q ss_pred CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
. ..-.+.|||..|.|||+..+..++..+|+|++|++.||++.|.+||.+.. ..+..++|......+|..+|.+++
T Consensus 176 ~-~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~----~~etYkrI~k~~~~~p~~is~~a~ 250 (281)
T KOG0580|consen 176 S-NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS----HSETYKRIRKVDLKFPSTISGGAA 250 (281)
T ss_pred C-CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh----hHHHHHHHHHccccCCcccChhHH
Confidence 3 34567899999999999999999999999999999999999999997765 455667777778888999999999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
|+|.+||.++|.+|+. ..|++.|||...
T Consensus 251 dlI~~ll~~~p~~r~~-------l~~v~~hpwI~a 278 (281)
T KOG0580|consen 251 DLISRLLVKNPIERLA-------LTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHhccCcccccc-------HHHHhhhHHHHh
Confidence 9999999999999998 999999999754
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=402.08 Aligned_cols=249 Identities=26% Similarity=0.423 Sum_probs=216.2
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEE-EEeeCCe-
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY-AYETKDA- 188 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~~~~~~~- 188 (767)
.+..+|+++++||+|+||+||+|+...+|+.+|.|.+.-..+ ..+..+....|+.+|++|+|||||+.++ .|...+.
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 345689999999999999999999999999999999985433 4445667888999999999999999988 5555444
Q ss_pred EEEEEEeccCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHhHHHHHHH--CC--cccccCCcceEEeCCCCCEEEeecCc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGG-EPGFDIARARFYAAEVLCGLEHLHY--IG--LVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~-~~~l~~~~~~~~~~qIl~aL~yLH~--~~--IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
++||||+|.+|||..+|+.... ...+++..++.|+.|++.||.++|+ .+ |+||||||.||+|+.+|.+||+||||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 9999999999999999987432 4579999999999999999999999 55 99999999999999999999999999
Q ss_pred ccccCCCCc-ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc-cccC-
Q psy11874 264 AVEIPEGES-VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA-EKYS- 340 (767)
Q Consensus 264 a~~~~~~~~-~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~-~~~~- 340 (767)
++.+....+ ..+.+|||.||+||++...+|+.++||||+||++|||+.-++||.+++- .++.+.|.... ++.|
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~----~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL----LSLCKKIEQGDYPPLPD 250 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH----HHHHHHHHcCCCCCCcH
Confidence 999876544 4678999999999999999999999999999999999999999999854 34444454432 3355
Q ss_pred CCCcHHHHHHHHHhcccCcCccCC
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
..+|.++..||..|+..||+.||+
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCC
Confidence 678999999999999999999998
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=409.91 Aligned_cols=277 Identities=37% Similarity=0.651 Sum_probs=237.5
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHH-HHHhcCCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQ-ILQKINSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998765544444445555554 56889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-CCcccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~-~~~~~~~~ 277 (767)
|+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..... .......+
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 99999887653 688999999999999999999999999999999999999999999999999976432 22344567
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhccc
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~ 357 (767)
||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+... +...+.......+..++++++++|++||++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILNKPLQLKPNITNSARHLLEGLLQK 233 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----HHHHHHhCCcCCCCCCCHHHHHHHHHHccc
Confidence 9999999999999999999999999999999999999998765433 233333444556678999999999999999
Q ss_pred CcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchh
Q psy11874 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406 (767)
Q Consensus 358 dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~ 406 (767)
||.+|++..+ ...++++|+||..++|..+....+.||+.|.+....
T Consensus 234 ~p~~R~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (325)
T cd05602 234 DRTKRLGAKD---DFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPN 279 (325)
T ss_pred CHHHCCCCCC---CHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcc
Confidence 9999999654 588999999999999999999889999988865543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=412.08 Aligned_cols=285 Identities=33% Similarity=0.565 Sum_probs=239.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.+++.++|+||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998876555556677889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||++||+|..++.+.. ..+++..+..++.||+.||.|||+.+|+||||||+|||++.+|.+||+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999999999998752 26899999999999999999999999999999999999999999999999999876544332
Q ss_pred --cccccccccCCcceec------CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 274 --RGRVGTVGYMAPEVID------NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 274 --~~~~GT~~Y~APEvl~------~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
....||+.|+|||++. +..++.++|||||||++|||++|..||...........+..............+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 2347999999999986 45688999999999999999999999977654333332222111111111235799
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhh
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRR 410 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~ 410 (767)
++++||++||. ||.+||+ ++++++||||+.++|..+.. ..||+.|.+........
T Consensus 239 ~~~~li~~ll~-~p~~R~t-------~~~l~~h~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 293 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLG-------YEGLCCHPFFSKIDWNNIRN--SLPPFVPTLKSDDDTSN 293 (330)
T ss_pred HHHHHHHHHcc-ChhhCCC-------HHHHhCCCCcCCCCHHHHhh--CCCCccCcCCCcchhhh
Confidence 99999999998 9999999 99999999999999998875 56888888766544333
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=418.19 Aligned_cols=260 Identities=32% Similarity=0.491 Sum_probs=240.6
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lV 192 (767)
..|++.+.||+|.||.||+|+.+.||+.||+|.+.+...........+.+|+.||+++. |||||.++++|++.+.+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 57999999999999999999999999999999999988776666778999999999998 99999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC----CCCEEEeecCcccccC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD----YGHVRISDLGLAVEIP 268 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~----~g~vkL~DFGla~~~~ 268 (767)
||++.||+|.+.|... .+++..+..++.||+.|+.|||+.||+||||||||+|+.. ++.+|++|||+|....
T Consensus 115 mEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999876 3999999999999999999999999999999999999963 3579999999999988
Q ss_pred CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
.+......+||+.|+|||++....|+..+|+||+||++|.|++|.+||.+..+......+.+.-......+++.+|..++
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ak 270 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAK 270 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHH
Confidence 87778889999999999999999999999999999999999999999999987777776666655566677888999999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
++|+.||..||.+|++ |.++++|||+++.
T Consensus 271 d~i~~ll~~dp~~R~t-------a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 271 DFIRKLLEFDPRKRLT-------AAQALQHPWIKSI 299 (382)
T ss_pred HHHHHhcccCcccCCC-------HHHHhcCccccCC
Confidence 9999999999999998 9999999998775
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=406.03 Aligned_cols=276 Identities=37% Similarity=0.644 Sum_probs=237.5
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHH-HHHhcCCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQ-ILQKINSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
++||+|+||.||+|+++.+|+.||+|++.+...........+..|.. +++.++||||+++++.+.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998776544444555666654 67889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-CCcccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~-~~~~~~~~ 277 (767)
|+|..++.+.. .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..... .......+
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 99988887643 689999999999999999999999999999999999999999999999999875422 22334567
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhccc
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 357 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~ 357 (767)
||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+.. .+...+......++...+.++.++|.+||++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----QMYDNILHKPLQLPGGKTVAACDLLVGLLHK 233 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----HHHHHHhcCCCCCCCCCCHHHHHHHHHHccC
Confidence 999999999999999999999999999999999999999876532 2334444555666778899999999999999
Q ss_pred CcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCch
Q psy11874 358 SPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRD 405 (767)
Q Consensus 358 dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~ 405 (767)
||.+|++.. .++.++++||||..++|..+....+.||+.|.....
T Consensus 234 ~p~~R~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (321)
T cd05603 234 DQRRRLGAK---ADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGP 278 (321)
T ss_pred CHhhcCCCC---CCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCc
Confidence 999999954 358899999999999999999888889988875543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=409.92 Aligned_cols=277 Identities=39% Similarity=0.657 Sum_probs=235.1
Q ss_pred EeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc---CCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI---NSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 122 LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
||+|+||+||+|+++.+|+.||+|++.+..............|..++.+. +||||++++..+.+.+.+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999876655544555566788888766 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-CCcccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRV 277 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~-~~~~~~~~ 277 (767)
|+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..... .......+
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 99998887654 689999999999999999999999999999999999999999999999999976432 23344568
Q ss_pred cccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC-CCcHHHHHHHHHhc
Q psy11874 278 GTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC-RFSDDAKALCKALL 355 (767)
Q Consensus 278 GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~-~~s~~~~dLi~~lL 355 (767)
||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+... +.+.+......++. .++++++++|++||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~li~~~L 233 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----MYRNIAFGKVRFPKNVLSDEGRQFVKGLL 233 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----HHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 99999999998754 58999999999999999999999998765432 22333333333333 57999999999999
Q ss_pred ccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHH
Q psy11874 356 KKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVD 408 (767)
Q Consensus 356 ~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~ 408 (767)
.+||.+||++. .++.++++||||++.+|..+....+.||+.|.+......
T Consensus 234 ~~~P~~R~~~~---~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (330)
T cd05586 234 NRNPQHRLGAH---RDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDV 283 (330)
T ss_pred CCCHHHCCCCC---CCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcch
Confidence 99999999854 369999999999999999999999999999987654433
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=388.51 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=230.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhh-----hhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCC
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~-----~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 187 (767)
+.|+-.++||+|..+.|-+|.++.||+.+|+|++....... ....+....|+.||+++ -||+|+.|.++|++..
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45667789999999999999999999999999986533221 12234567899999997 6999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+++|+|.|+.|.|.++|...- .+++.+++.+++|++.|++|||.++||||||||+|||+|++.++||+|||+|+.+
T Consensus 97 F~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999999998643 6999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccccccccccCCcceec------CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC
Q psy11874 268 PEGESVRGRVGTVGYMAPEVID------NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~------~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~ 341 (767)
..++..+..||||+|+|||.+. ..+|+..+|+||+|||||.||.|.+||..++.......+.+.-.....+-|.
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence 9999999999999999999994 3579999999999999999999999999887655444444444444445567
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.+|..++|||.+||+.||++|++ ++|+++||||..+
T Consensus 254 dis~~~KdLIsrlLqVdp~~Rit-------ake~LaHpff~q~ 289 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTKRIT-------AKEALAHPFFIQI 289 (411)
T ss_pred hccccHHHHHHHHHeeCchhccc-------HHHHhcChHHHHH
Confidence 89999999999999999999998 9999999999765
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=414.19 Aligned_cols=260 Identities=28% Similarity=0.391 Sum_probs=231.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCC-eEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKD-ALC 190 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~-~l~ 190 (767)
.++|.+++.||.|+||.||+|+.+.+|..||||+++++... -.+..-+||++.|++++ |||||+|.+++.+.+ .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 46899999999999999999999999999999999876533 34556789999999999 999999999998888 999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+|||||+ .+|..++..+ +..|++..++.|+.||+.||+|+|.+|+.||||||||||+.....|||+|||||+.+...
T Consensus 87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 9999998 6898888776 457999999999999999999999999999999999999999999999999999999888
Q ss_pred CcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc----------
Q psy11874 271 ESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY---------- 339 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~---------- 339 (767)
...+.++.|.+|+|||++.. .-|+.++|+||+|||++|+.+-++.|.|.++.++...+...+.+.....
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 88899999999999999854 6799999999999999999999999999998877766655443332221
Q ss_pred ----------------CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 340 ----------------SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 340 ----------------~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.+..++++.++|.+||..||.+||+ |+++++||||+.-
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT-------A~~al~~pffq~~ 297 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT-------ASQALQHPFFQVG 297 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc-------HHHHhcCcccccc
Confidence 1235899999999999999999999 9999999999864
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=407.81 Aligned_cols=260 Identities=31% Similarity=0.529 Sum_probs=222.7
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh-----------hhHHHHHHHHHHHHhcCCCceeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----------KGESMVLIEKQILQKINSRFVVS 178 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~-----------~~~~~~~~E~~iL~~l~hp~Iv~ 178 (767)
...+++|++.+.||+|.||.|-+|++..+|+.||||++.|+..... ...+.+.+|+.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3567899999999999999999999999999999999988765432 22457899999999999999999
Q ss_pred EEEEEeeC--CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCE
Q psy11874 179 LAYAYETK--DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHV 256 (767)
Q Consensus 179 l~~~~~~~--~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~v 256 (767)
|+.+..+. +.+|||+|||..|.+...=. ..+.+++.+++.|+.+++.||+|||.+|||||||||+|+||+++|++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 99999874 68999999999998853211 12348999999999999999999999999999999999999999999
Q ss_pred EEeecCcccccCCC------CcccccccccccCCcceecCCC----CCCCCccccchhhHHHHhcCCCCCCCchhhhhhh
Q psy11874 257 RISDLGLAVEIPEG------ESVRGRVGTVGYMAPEVIDNEK----YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD 326 (767)
Q Consensus 257 kL~DFGla~~~~~~------~~~~~~~GT~~Y~APEvl~~~~----ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~ 326 (767)
||+|||.+.....+ ......+|||.|||||...++. -+.+.||||+||+||.|+.|+.||.+..+.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---- 325 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---- 325 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----
Confidence 99999999876332 2234478999999999987632 357889999999999999999999887654
Q ss_pred hhhhhhhccccccCCC--CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 327 EVDRRVKEDAEKYSCR--FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 327 ~i~~~i~~~~~~~~~~--~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
++...|.+.+..+|.. ++++++|||.+||.+||++|++ ..+|+.|||...
T Consensus 326 ~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~-------l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 326 ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRIT-------LPDIKLHPWVTR 377 (576)
T ss_pred HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheee-------hhhheecceecc
Confidence 4556667777777754 7999999999999999999998 899999999754
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=404.44 Aligned_cols=275 Identities=38% Similarity=0.680 Sum_probs=237.4
Q ss_pred eEEeecCcEEEEEEEE---ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEec
Q psy11874 120 RVLGKGGFGEVCACQV---RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIM 196 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~---~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~ 196 (767)
+.||+|+||.||++.. +.+|+.||+|++.+..... .....+.+|+.+|++++||||+++++++.+.+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 6799999999999886 3578999999998765432 23445678999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Ccccc
Q psy11874 197 NGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ESVRG 275 (767)
Q Consensus 197 ~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~~~~ 275 (767)
+||+|..++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .....
T Consensus 81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 9999999887643 6899999999999999999999999999999999999999999999999999865443 23445
Q ss_pred cccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhc
Q psy11874 276 RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355 (767)
Q Consensus 276 ~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL 355 (767)
.+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+... ....+......++..+++++++||++||
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~i~~~~~~~p~~~~~~~~~li~~~l 233 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE----TMTMILKAKLGMPQFLSPEAQSLLRALF 233 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH----HHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 679999999999999999999999999999999999999998765432 2233334445567788999999999999
Q ss_pred ccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCc
Q psy11874 356 KKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKR 404 (767)
Q Consensus 356 ~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~ 404 (767)
++||++||++.+ ...+++++||||++++|..+......||+.|....
T Consensus 234 ~~~P~~R~~a~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (318)
T cd05582 234 KRNPANRLGAGP--DGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGR 280 (318)
T ss_pred hcCHhHcCCCCC--CCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCC
Confidence 999999999643 35899999999999999999998899999887644
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=402.74 Aligned_cols=257 Identities=30% Similarity=0.459 Sum_probs=217.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC--eEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD--ALCL 191 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~l~l 191 (767)
.++...+.||+|+||.||++.+..+|..+|+|.+..... . ..+.+.+|+.+|.+++|||||+.++...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--P-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--h-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 457788999999999999999999999999999876521 1 1566889999999999999999999765555 6999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC-CCCEEEeecCcccccCC-
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-YGHVRISDLGLAVEIPE- 269 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-~g~vkL~DFGla~~~~~- 269 (767)
.|||++||+|.+++.+.++ .+++..++.|++||+.||+|||++|||||||||+|||++. +|.+||+|||+|+....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999999998764 6999999999999999999999999999999999999999 79999999999987653
Q ss_pred ---CCcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhh-hhhccccccCCCCc
Q psy11874 270 ---GESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR-RVKEDAEKYSCRFS 344 (767)
Q Consensus 270 ---~~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~-~i~~~~~~~~~~~s 344 (767)
........||+.|||||++.+. ..+.++|+|||||++.||+||.+||.... .....+.. ......+.+|..+|
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~~~~~~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--EEAEALLLIGREDSLPEIPDSLS 249 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--chHHHHHHHhccCCCCCCCcccC
Confidence 1223457899999999999852 33459999999999999999999997631 11122222 12223457888999
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+++++|+.+||.+||++||+ |+++++|||.++.
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpt-------a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPT-------AEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHHHHHhhcCcccCcC-------HHHHhhChhhhcc
Confidence 99999999999999999999 9999999999774
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=392.80 Aligned_cols=277 Identities=65% Similarity=1.167 Sum_probs=245.9
Q ss_pred EeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCH
Q psy11874 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDL 201 (767)
Q Consensus 122 LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L 201 (767)
||+|+||+||+|..+.+|+.||+|.+.++..........+.+|+.+|++++||||+++++.+...+..|+||||++||+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999877655555666778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcccccccccc
Q psy11874 202 KFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVG 281 (767)
Q Consensus 202 ~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~ 281 (767)
.+++.+... ..+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||++.............|+..
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 999987542 4689999999999999999999999999999999999999999999999999987655444455678999
Q ss_pred cCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCc
Q psy11874 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRS 361 (767)
Q Consensus 282 Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~ 361 (767)
|+|||++.+..++.++|+|||||++|+|++|+.||...........+...+......++..++++++++|.+||+.||++
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence 99999998888999999999999999999999999876554444555555566666677788999999999999999999
Q ss_pred cCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 362 RLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 362 Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
||++.+ .++.++++||||++++|.++.+....|||.|+
T Consensus 240 R~~~~~--~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~ 277 (277)
T cd05577 240 RLGCRG--GSADEVREHPLFKDLNWRRLEAGMLEPPFIPD 277 (277)
T ss_pred ccCCCc--ccHHHHHhChhhhcCChhhhhcCCCCCCCCCC
Confidence 998654 37999999999999999999999999999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=401.83 Aligned_cols=282 Identities=30% Similarity=0.581 Sum_probs=233.4
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+..|..++..++|+||+++++++.+.+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765555555666888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||++||+|..++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999997643 26899999999999999999999999999999999999999999999999999876543322
Q ss_pred --cccccccccCCcceecC-----CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-ccccccCCCCcH
Q psy11874 274 --RGRVGTVGYMAPEVIDN-----EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK-EDAEKYSCRFSD 345 (767)
Q Consensus 274 --~~~~GT~~Y~APEvl~~-----~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~~~~~s~ 345 (767)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+..... ...+.....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 23579999999999865 4688999999999999999999999987654333322221110 001111234689
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCc
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKR 404 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~ 404 (767)
+++++|.+||..++ +|++ +.+++++++||||++++|..+.. ..+|++|+...
T Consensus 239 ~~~~li~~ll~~~~-~~~~----~~~~~~~~~h~~f~~~~~~~~~~--~~~~~~p~~~~ 290 (331)
T cd05624 239 EAKDLIQRLICSRE-RRLG----QNGIEDFKKHAFFEGIDWENIRN--LEAPYIPDVSS 290 (331)
T ss_pred HHHHHHHHHccCch-hhcC----CCCHHHHhcCCCcCCCCHHHHhh--CCCCccCCCCC
Confidence 99999999998654 5655 24699999999999999998854 67888887544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=426.68 Aligned_cols=408 Identities=31% Similarity=0.510 Sum_probs=331.0
Q ss_pred EEeecCcEEEEEEEE---ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeEEEEEEec
Q psy11874 121 VLGKGGFGEVCACQV---RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCLVLTIM 196 (767)
Q Consensus 121 ~LG~G~fG~Vy~a~~---~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lV~E~~ 196 (767)
++|.|+||.|+++.- ...|+.||+|++.+.....+... ....|..++..++ ||++|++++.|+++..+++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999997643 35689999999998877655444 6677999999997 999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccccc
Q psy11874 197 NGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR 276 (767)
Q Consensus 197 ~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~ 276 (767)
.||+|..++.+.. .+++....+|.++++.|++++|+.+|+|||+|++||+++.+||+++.|||+++..-..+..
T Consensus 80 rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred ccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 9999998887654 7899999999999999999999999999999999999999999999999999876554332
Q ss_pred ccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcc
Q psy11874 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLK 356 (767)
Q Consensus 277 ~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~ 356 (767)
|||..|||||+++ ++..++||||+|++++||++|..||.. ++.++|.......|..++..+++++..|+.
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCchhhhHHHHHHHHHHHh
Confidence 9999999999998 789999999999999999999999977 466677777788899999999999999999
Q ss_pred cCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhhhhhcccCCChhHHHHHHHHhhc
Q psy11874 357 KSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKK 436 (767)
Q Consensus 357 ~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (767)
++|.+|+++.. .++.++++|+||..|+|..+.++...|||.|.+..+....++.++....
T Consensus 224 r~p~nrLg~~~--~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~------------------ 283 (612)
T KOG0603|consen 224 RNPENRLGAGP--DGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQ------------------ 283 (612)
T ss_pred hCHHHHhccCc--chhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccC------------------
Confidence 99999999643 5799999999999999999999999999999987765554444333222
Q ss_pred CCCCcCCCCccchhhHHHHHHHhhhhhccccccccccccccCCCCCccchhhhhHHHHHhhhcccccCCc-chhhhhHHH
Q psy11874 437 SPRSRLGKSHCLSIGLVMMLKLSVLKKNVNLSVLNTVQIPLFFPQAPEAVDVLSLEIIEHCKESLDSGNR-ELFNDCMAA 515 (767)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~s~~kk~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 515 (767)
.|.-+|--|.. ++. .+|
T Consensus 284 --------------------------------------~P~dsp~~~~~------------------~s~~~if------ 301 (612)
T KOG0603|consen 284 --------------------------------------VPADSPLLSAS------------------GSDHTIF------ 301 (612)
T ss_pred --------------------------------------CcccCCCCCCC------------------ccccchh------
Confidence 22222221110 111 111
Q ss_pred HHhhhcCCCccccchhhhHHHHhhhhhcccceeeeeeeecccccCCCceeecCCccCccccccccceecCCCChHHHhhh
Q psy11874 516 VKTFLAGAPFTEFQDSMFFYRYLQWKWLEHHFLYVEVFTHGVYCSQPHAVYAKDVLDIEQFSTVKGVTLDTTDDSFYSKF 595 (767)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~f~~~f 595 (767)
+|.||..+-
T Consensus 302 -----~g~sfva~~------------------------------------------------------------------ 310 (612)
T KOG0603|consen 302 -----SGPSFVAPG------------------------------------------------------------------ 310 (612)
T ss_pred -----cCCCccChH------------------------------------------------------------------
Confidence 122221110
Q ss_pred ccCCcccccccccchhhhhhhccccCCCCCCCCCCcccCCCCCCCCCCCCCCCCCCCCceeeeecccCCccceeEEEEcc
Q psy11874 596 NTGSVSIPWQNEMIETECFKELNVFGENNTPSSDVMFTSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRA 675 (767)
Q Consensus 596 ~tg~v~~~~~~e~ie~~cf~eln~~~~~~~~s~dl~~~s~~~~~~ks~~f~~~~~~~~y~~~~~LG~GsfG~V~l~~~k~ 675 (767)
+++. +. ..-..++|++...+|.|+||.|..|.++.
T Consensus 311 ------------il~~------------~~---------------------~~~~~~~y~~~~~~~~gs~s~~~~~~~~~ 345 (612)
T KOG0603|consen 311 ------------VLED------------AV---------------------TAPFTESYEFREELGEGSFSAVKYCESSP 345 (612)
T ss_pred ------------Hhhc------------cc---------------------cCCcchhhccccccCCCCccceeeeeccc
Confidence 0000 00 00123578888889999999999999999
Q ss_pred CCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCEEEEEEeccCCccccccccccCCCC
Q psy11874 676 TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVLTIIDVMFTCVQPSETNPCC 750 (767)
Q Consensus 676 tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~~~ 750 (767)
|++.+|+|+|.+.. ....+|+.++... +||||+++++.+.+..++|+|||++.||.|.+.+.....++
T Consensus 346 t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~ 414 (612)
T KOG0603|consen 346 TDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC 414 (612)
T ss_pred cccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH
Confidence 99999999999862 2455677777666 89999999999999999999999999999999997766544
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=400.65 Aligned_cols=281 Identities=30% Similarity=0.604 Sum_probs=232.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|+.+.+++.||+|++.+...........+..|+.++..++|+||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998765555555566888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES- 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~- 272 (767)
||++||+|..++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999997643 2689999999999999999999999999999999999999999999999999976543322
Q ss_pred -ccccccccccCCcceec-----CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc-cccccCCCCcH
Q psy11874 273 -VRGRVGTVGYMAPEVID-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE-DAEKYSCRFSD 345 (767)
Q Consensus 273 -~~~~~GT~~Y~APEvl~-----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~~~~~s~ 345 (767)
....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+.......+...... ..+.....+|+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 22357999999999986 346899999999999999999999999876543333333221110 01122245799
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCC
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~ 403 (767)
++++||++||..++ +|++ |.+++++++||||.+++|..+.. ..+|++|...
T Consensus 239 ~~~~li~~ll~~~~-~r~~----r~~~~~~~~h~~f~~~~~~~~~~--~~~~~~~~~~ 289 (332)
T cd05623 239 DAKDLIRRLICSRE-HRLG----QNGIEDFKQHPFFTGIDWDNIRN--CEAPYIPEVS 289 (332)
T ss_pred HHHHHHHHHccChh-hhcC----CCCHHHHhCCCCcCCCCHHHHhh--CCCCccCCCC
Confidence 99999999998644 4544 34699999999999999999875 5677888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=399.89 Aligned_cols=285 Identities=31% Similarity=0.605 Sum_probs=235.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|+.+.+++.||+|++.+...........+.+|..++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766555556667888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||++||+|..++.+.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999997642 36899999999999999999999999999999999999999999999999999776543322
Q ss_pred --cccccccccCCcceecC-----CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-ccccccCCCCcH
Q psy11874 274 --RGRVGTVGYMAPEVIDN-----EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK-EDAEKYSCRFSD 345 (767)
Q Consensus 274 --~~~~GT~~Y~APEvl~~-----~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~~~~~s~ 345 (767)
...+||+.|||||++.+ ..++.++||||+||++|||++|+.||.+.+.......+..... .........+|+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 23469999999999863 4578899999999999999999999987654333332221110 011112235799
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhH
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEV 407 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~ 407 (767)
+++++|++||.. |.+|++ |.+++++++||||.+.+|..+.. ..||+.|.......
T Consensus 239 ~~~~li~~ll~~-~~~r~~----r~~~~~~l~hp~~~~~~~~~~~~--~~~~~~~~~~~~~~ 293 (331)
T cd05597 239 EAKDLIRRLICS-PETRLG----RNGLQDFKDHPFFEGIDWDNIRN--STAPYVPEVSSPTD 293 (331)
T ss_pred HHHHHHHHHccC-cccccC----CCCHHHHhcCCCCCCCCHHHHhh--CCCCccCcCCCcch
Confidence 999999999975 666654 34599999999999999999875 46788887655433
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=387.42 Aligned_cols=276 Identities=25% Similarity=0.349 Sum_probs=237.1
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--CCeE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--KDAL 189 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 189 (767)
..+.|+.++.|++|+||.||+|+++.|+..||+|+++.+. .+...--..++|+.+|.+++|||||.+-.+..- -+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3467999999999999999999999999999999997664 122233457899999999999999999887754 4679
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+|||||+ -||...+.+++ ..|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||||+.+..
T Consensus 153 y~VMe~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeeHHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99999998 69999999875 4799999999999999999999999999999999999999999999999999998866
Q ss_pred C-CcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCC-----
Q psy11874 270 G-ESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR----- 342 (767)
Q Consensus 270 ~-~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~----- 342 (767)
. ...+..+-|.+|.|||++.+. .|+.++|+||+|||+.||+++++.|.+..+..+...+.+....+....++.
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 5 335667899999999998774 699999999999999999999999999999888877776665444433322
Q ss_pred -----------------------CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCC
Q psy11874 343 -----------------------FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFV 399 (767)
Q Consensus 343 -----------------------~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~ 399 (767)
+|+...+|+..||..||.+|++ |+|.|+|+||++.. .-++|-+.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t-------A~~~L~h~~F~e~P------~p~~P~~~ 376 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT-------AEDGLKHEYFRETP------LPIDPSMF 376 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc-------HHHhhcccccccCC------CCCChhhc
Confidence 4688999999999999999998 99999999999864 23566677
Q ss_pred CCCCc
Q psy11874 400 PDVKR 404 (767)
Q Consensus 400 P~~~~ 404 (767)
|....
T Consensus 377 Pt~P~ 381 (419)
T KOG0663|consen 377 PTWPA 381 (419)
T ss_pred CCCcc
Confidence 76543
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=376.13 Aligned_cols=261 Identities=26% Similarity=0.346 Sum_probs=228.4
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
.+|...+.||+|.||.||+|++..||+.||+|++.....+. .-...+++|++.|+.++|+||+.|.++|-..+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46888899999999999999999999999999998764322 22346899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES- 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~- 272 (767)
|||+ .||...|++. ...++..+++.|+.+++.||+|||++.|+||||||+|+|++++|.+||+|||+|+.+.....
T Consensus 81 Efm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred Eecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9998 6998888774 34799999999999999999999999999999999999999999999999999998764433
Q ss_pred ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC----------
Q psy11874 273 VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC---------- 341 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~---------- 341 (767)
....+-|.+|.|||.+.| ..|+..+|+||.|||+.||+-|.+-|.+.++.++...+.+...+..+..|+
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 333488999999999876 569999999999999999999999999999888877777666555444332
Q ss_pred --------------CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 342 --------------RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 342 --------------~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
..|+++.||+.+||..||.+|++ |+|+++|+||++..
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit-------a~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT-------ASQALKHPYFKSLP 288 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhccc-------HHHHhcchhhhcCC
Confidence 23688999999999999999999 99999999999854
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=409.95 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=226.8
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
...|.....||+|+.|.||.|....+++.||+|.+...... -.+.+++|+.+|+..+|+|||+++..|--++.++.|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 45689999999999999999999999999999999876433 345689999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
||||+||+|.+.+... .++|.++..++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||++.++.....
T Consensus 349 MEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999999888764 599999999999999999999999999999999999999999999999999998877664
Q ss_pred -ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 273 -VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 273 -~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
-.+.+|||.|||||++....|+.++||||||+++.||+.|.+||-..+.......+ ..-.......+..+|+.++||+
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-a~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-hhcCCCCcCCccccCHHHHHHH
Confidence 45678999999999999999999999999999999999999999876543222222 2223334455789999999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
.+||+.||.+|++ |.|||+||||+.
T Consensus 504 ~~cL~~dv~~Ras-------A~eLL~HpFl~~ 528 (550)
T KOG0578|consen 504 DRCLVVDVEQRAS-------AKELLEHPFLKM 528 (550)
T ss_pred HHHhhcchhcCCC-------HHHHhcChhhhh
Confidence 9999999999998 999999999954
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=385.07 Aligned_cols=279 Identities=37% Similarity=0.627 Sum_probs=247.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.+..+++.+|+|++.+......+....+.+|++++++++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998776655566777899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||++||+|..++...+ .+++..+..++.||+.||.|||+.||+||||+|+|||++.+|.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--T 155 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--C
Confidence 9999999999987754 6899999999999999999999999999999999999999999999999999876544 3
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ....+.+......++..+++.++++|++
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~ 231 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQIYEKILEGKVRFPSFFSPDAKDLIRN 231 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCccCCccCCHHHHHHHHH
Confidence 445799999999999888899999999999999999999999976653 2233333444556677889999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~ 403 (767)
||..||.+|++... .+++|+++||||+.++|..+....+.+|+.|...
T Consensus 232 ~l~~~p~~R~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (290)
T cd05580 232 LLQVDLTKRLGNLK--NGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVK 279 (290)
T ss_pred HccCCHHHccCccc--CCHHHHHcCcccccCCHHHHhhccCCCCccCCCC
Confidence 99999999996432 4699999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=388.23 Aligned_cols=266 Identities=27% Similarity=0.395 Sum_probs=229.1
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
..++..++|++..+||.|.-++||+|+...++..||||+++.++... ....+.+|++.|+.++||||++++..|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 45677799999999999999999999999999999999998876543 3678999999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+++||.||.+|++.+.+...- ..+++|..+..+.++++.||.|||++|-||||||+.|||||++|.|||+|||.+..+
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999888753 347999999999999999999999999999999999999999999999999988654
Q ss_pred CC-CCcc----cccccccccCCcceec--CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc---
Q psy11874 268 PE-GESV----RGRVGTVGYMAPEVID--NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE--- 337 (767)
Q Consensus 268 ~~-~~~~----~~~~GT~~Y~APEvl~--~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~--- 337 (767)
-. +... .+.+|||.|||||++. ..+|+.++||||||++..||.+|+.||.....+. .+...+.+.++
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk---vLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK---VLLLTLQNDPPTLL 253 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH---HHHHHhcCCCCCcc
Confidence 33 2221 4568999999999964 3579999999999999999999999997765432 22333333333
Q ss_pred ------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 338 ------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 338 ------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
.-...++...+.+|..||.+||++||+ |+++++|+||+...-
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt-------AskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT-------ASKLLKHAFFKKAKS 301 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCC-------HHHHhccHHHhhccc
Confidence 112357889999999999999999999 999999999998643
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=383.39 Aligned_cols=260 Identities=23% Similarity=0.395 Sum_probs=221.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee-----CCe
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-----KDA 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~~ 188 (767)
..|..++.||+|+||.|+.|.++.||+.||+|++... +...-...+.++|+++|+.++|+||+.+.+++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4566689999999999999999999999999998643 3455567789999999999999999999999866 357
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+|+|+|+ .||...|.... .++...+.+++.||++||.|+|+.+|+||||||.|+|++.+..+||+|||||+...
T Consensus 101 vYiV~elMe-tDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eEEehhHHh-hHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 999999994 78888887643 59999999999999999999999999999999999999999999999999999885
Q ss_pred C---CCcccccccccccCCccee-cCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc-------
Q psy11874 269 E---GESVRGRVGTVGYMAPEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE------- 337 (767)
Q Consensus 269 ~---~~~~~~~~GT~~Y~APEvl-~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~------- 337 (767)
. ....+.++.|.+|.|||++ ....|+.++||||+|||+.||++|++.|.+.+...+...+...+.....
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 4 3445778999999999997 4578999999999999999999999999988765544433222211110
Q ss_pred --------------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 338 --------------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 338 --------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
...+..++.|.||+++||..||.+|+| |+|+++|||+....
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit-------a~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT-------AEEALAHPYLAPYH 317 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC-------HHHHhcChhhhhhc
Confidence 112356899999999999999999999 99999999998754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=386.53 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=214.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||.|+||.||+|.++.+++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 468999999999999999999999999999999986543 222344577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
|||++| +|..++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 82 ~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 999985 8988887643 357899999999999999999999999999999999999999999999999997654322
Q ss_pred cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc--------------
Q psy11874 272 SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA-------------- 336 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~-------------- 336 (767)
......||+.|+|||++.+ ..++.++|+||+||++|+|++|++||.+.+.......+.+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2345678999999999865 5689999999999999999999999987654433322222111000
Q ss_pred ------------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 337 ------------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 337 ------------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
......+++++++||++||+.||.+||+ ++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t-------~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS-------AEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC-------HHHHhcCCCC
Confidence 0012356889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=387.82 Aligned_cols=256 Identities=25% Similarity=0.443 Sum_probs=234.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
.+|++.+.||+|+||+|-+|.....|+.||||.+.|..++.....-++.+|++||+.|+||||+.+|.+|++++.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 57999999999999999999999999999999999999999888889999999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||..||+|.+++...+ .+++.+++.+++||++|+.|+|.++++|||||.+|||||.++++||+||||+..+......
T Consensus 133 EYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 9999999999999876 7999999999999999999999999999999999999999999999999999999888888
Q ss_pred cccccccccCCcceecCCCCC-CCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYT-YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys-~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
.++||+|-|.+||++++.+|. ..+|-|||||+||.|..|..||.+.+-+ .+.+.|......- +.-+.++.-||+
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----~lvrQIs~GaYrE-P~~PSdA~gLIR 284 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----RLVRQISRGAYRE-PETPSDASGLIR 284 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----HHHHHhhcccccC-CCCCchHHHHHH
Confidence 999999999999999999985 8899999999999999999999998653 3444444443322 245668999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
.||..||++|.+ ..||-.|=|. ||.
T Consensus 285 wmLmVNP~RRAT-------ieDiAsHWWv---Nwg 309 (668)
T KOG0611|consen 285 WMLMVNPERRAT-------IEDIASHWWV---NWG 309 (668)
T ss_pred HHHhcCcccchh-------HHHHhhhhee---ecc
Confidence 999999999987 9999999884 664
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=384.36 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=214.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|+++.+++.||+|++..... .......+.+|+.++++++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999876532 2233456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-- 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-- 271 (767)
||++++.|....... ..+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 999998776544332 368999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc-----------------
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE----------------- 334 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~----------------- 334 (767)
......||+.|+|||++.+..++.++|+|||||++|||++|++||.+.+.......+......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 233457999999999999989999999999999999999999999876543222211111000
Q ss_pred -----------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 335 -----------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 335 -----------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
....+...+|+++++||++||++||++||+ ++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s-------~~~~l~hp~f 287 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL-------TEQCLNHPAF 287 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC-------HHHHhcCCCC
Confidence 000112347889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=386.44 Aligned_cols=262 Identities=24% Similarity=0.404 Sum_probs=213.1
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|+.+.+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 689999999999999999999999999999999865432 222345778999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Cc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~ 272 (767)
||++ ++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ..
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9996 57777776542 36899999999999999999999999999999999999999999999999999754322 22
Q ss_pred ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhh-hhhhhhhhhhccc--------------
Q psy11874 273 VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV-KRDEVDRRVKEDA-------------- 336 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~-~~~~i~~~i~~~~-------------- 336 (767)
.....||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+..... ....+........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 345678999999999865 468899999999999999999999998754321 1111111000000
Q ss_pred -ccc-------------CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 337 -EKY-------------SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 337 -~~~-------------~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
..+ ...+++++++|+++||+.||++||+ ++|+++||||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s-------~~~~l~h~~f~~~~~~ 297 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS-------AQAALSHEYFSDLPPR 297 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC-------HHHHhcCcccccCChh
Confidence 000 0124678999999999999999999 9999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=377.68 Aligned_cols=274 Identities=45% Similarity=0.851 Sum_probs=227.6
Q ss_pred EEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHh---cCCCceeEEEEEEeeCCeEEEEEEecc
Q psy11874 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK---INSRFVVSLAYAYETKDALCLVLTIMN 197 (767)
Q Consensus 121 ~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~---l~hp~Iv~l~~~~~~~~~l~lV~E~~~ 197 (767)
+||+|+||.||+|....+|+.+|+|.+.+.............+|..+++. .+||+|+.+++.+.+.+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999977654433334445555554444 479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcccccc
Q psy11874 198 GGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRV 277 (767)
Q Consensus 198 gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~ 277 (767)
||+|..++...+ .+++..+..++.|++.||+|||+.+|+||||||+|||+++++.++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcC
Confidence 999998887654 58999999999999999999999999999999999999999999999999997654332 23457
Q ss_pred cccccCCcceec-CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcc
Q psy11874 278 GTVGYMAPEVID-NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLK 356 (767)
Q Consensus 278 GT~~Y~APEvl~-~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~ 356 (767)
||+.|+|||.+. +..++.++|+||+||++|+|++|..||...... ....+.+.........+..++++++++|++||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-CHHHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence 999999999986 466899999999999999999999999765322 122333333334455667889999999999999
Q ss_pred cCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 357 KSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 357 ~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
+||++|++|.. .+++++++||||++++|.+.......||.+|.
T Consensus 236 ~~p~~R~~~~~--~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 278 (279)
T cd05633 236 RDVSKRLGCLG--RGAQEVKEHVFFKGIDWQQVYLQKYPPPLIPP 278 (279)
T ss_pred CCHHHhcCCCC--CCHHHHHhCccccCCCHhHHhcCCCCCCCCCC
Confidence 99999998765 57999999999999999998877777777664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=389.53 Aligned_cols=259 Identities=22% Similarity=0.432 Sum_probs=236.5
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+-|.+.+.||+|-|+.|-+|++-.||.+||+|++.|..+... ...++..|++.|+.+.|||||+||.+..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 458888999999999999999999999999999998876443 3456888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe-CCCCCEEEeecCcccccCCCCc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL-DDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl-d~~g~vkL~DFGla~~~~~~~~ 272 (767)
|+-+||||.++|.+.. .++.++.++.|++||+.|+.|+|+..+|||||||||+++ ..-|-|||+|||++..+..++.
T Consensus 97 ELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 9999999999998864 489999999999999999999999999999999999987 5679999999999999999999
Q ss_pred ccccccccccCCcceecCCCCC-CCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYT-YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys-~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
..+.||+..|-|||++.+..|+ +++||||||||||-|.+|++||...++.+ ....|.......|..+|.+|+|||
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----TLTmImDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----TLTMIMDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----hhhhhhcccccCchhhhHHHHHHH
Confidence 9999999999999999999998 67899999999999999999998766543 344556667788899999999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
..||..||.+|.+ .++|..|+|.+.++-
T Consensus 251 ~sMLvRdPkkRAs-------lEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 251 QSMLVRDPKKRAS-------LEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHhcCchhhcc-------HHHHhccccccCCCC
Confidence 9999999999988 999999999999863
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=376.74 Aligned_cols=263 Identities=26% Similarity=0.387 Sum_probs=225.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCc-eeEEEEEEeeCC-----
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF-VVSLAYAYETKD----- 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~~~~~~----- 187 (767)
..|+.++.||+|+||+||+|+.+.+|+.||+|++....-. ...-..+.+|+.+|+.++|+| ||+|++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4566778899999999999999999999999998765321 223456799999999999999 999999999887
Q ss_pred -eEEEEEEeccCCCHHHHHHhcCCC-CCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 188 -ALCLVLTIMNGGDLKFHIYNMGGE-PGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 188 -~l~lV~E~~~gG~L~~~l~~~~~~-~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
.+++|+||+. -||..++...... .+.+...++.++.||+.||+|||+++|+||||||.||||++.|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 8999999997 6999999886532 467888999999999999999999999999999999999999999999999999
Q ss_pred ccCCC-CcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC--
Q psy11874 266 EIPEG-ESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC-- 341 (767)
Q Consensus 266 ~~~~~-~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~-- 341 (767)
..... ......++|.+|.|||++.+. .|+..+||||+|||++||+++++.|.+..+..+...+.+....+.+..|+
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 77633 346677899999999999886 79999999999999999999999999998877766666655444333221
Q ss_pred ------------------------CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 342 ------------------------RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 342 ------------------------~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
..++++.+++.+||+.+|.+|++ |+.++.||||....
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S-------a~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS-------AKGALTHPYFSELP 309 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC-------HHHHhcChhhcccc
Confidence 12358999999999999999998 99999999999874
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=379.83 Aligned_cols=256 Identities=30% Similarity=0.432 Sum_probs=218.5
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC-----CeE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----DAL 189 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~l 189 (767)
.|+..+++|.|+||.||+|....+++.+|||++-.+.- .-.+|.+||+++.|||||+|.++|... -.+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 58889999999999999999999999999998754321 123599999999999999999988642 257
Q ss_pred EEEEEeccCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC-CCEEEeecCccccc
Q psy11874 190 CLVLTIMNGGDLKFHIYNM-GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY-GHVRISDLGLAVEI 267 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~-~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~-g~vkL~DFGla~~~ 267 (767)
.||||||+ .+|...+... ..+..++.-.++.|+.||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 89999999 5888888742 113468889999999999999999999999999999999999966 89999999999999
Q ss_pred CCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc--------c
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE--------K 338 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~--------~ 338 (767)
..++...++..|..|+|||.+.+ +.|+.+.||||.||++.||+-|++.|.+.+...+..++.+.+..+.. .
T Consensus 177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 98888888999999999999876 67999999999999999999999999998877776665543322111 1
Q ss_pred -----------------cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 339 -----------------YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 339 -----------------~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
+....++++.+|+.++|+.+|.+|++ |.|+++||||..+.
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~-------~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS-------ALEALAHPFFDELR 313 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC-------HHHHhcchhhHHhh
Confidence 23456899999999999999999998 99999999998753
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=402.45 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=213.0
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC---
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK--- 186 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--- 186 (767)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.+|++++|||||+++++|...
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 345578999999999999999999999999999999885432 2235699999999999999998877442
Q ss_pred -----CeEEEEEEeccCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-CEEEe
Q psy11874 187 -----DALCLVLTIMNGGDLKFHIYNM-GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-HVRIS 259 (767)
Q Consensus 187 -----~~l~lV~E~~~gG~L~~~l~~~-~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-~vkL~ 259 (767)
..+++||||+++ +|..++... .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 257899999985 565555432 2234689999999999999999999999999999999999999665 69999
Q ss_pred ecCcccccCCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc---
Q psy11874 260 DLGLAVEIPEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED--- 335 (767)
Q Consensus 260 DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~--- 335 (767)
|||+|+....+.......||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.........+.+.....
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9999998766555566789999999999865 469999999999999999999999998775443333322211100
Q ss_pred ----------------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 336 ----------------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 336 ----------------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
...++...|+++++||.+||++||.+||+ +.|+++||||.++.+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t-------a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN-------PIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC-------HHHHhCChhHHhhhc
Confidence 01133457889999999999999999999 999999999988754
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=383.96 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=211.1
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC-----CeE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----DAL 189 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~l 189 (767)
+|++.+.||+|+||.||+|.++.+|+.||+|++.... ........+.+|+.+|++++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999986532 1223345678999999999999999999887543 358
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+|||||. ++|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 99999995 68988887643 689999999999999999999999999999999999999999999999999976432
Q ss_pred CCc----ccccccccccCCcceecC--CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhh-------------
Q psy11874 270 GES----VRGRVGTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR------------- 330 (767)
Q Consensus 270 ~~~----~~~~~GT~~Y~APEvl~~--~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~------------- 330 (767)
... ....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.......+..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 211 234579999999999866 6789999999999999999999999977543221111100
Q ss_pred ----------hhhcc-c---cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 331 ----------RVKED-A---EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 331 ----------~i~~~-~---~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
.+... . .......++++.++|.+||+.||++||+ ++|+++||||+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt-------~~e~l~hp~f~~~~~ 298 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT-------AEEALADPYFKGLAK 298 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC-------HHHHhcCchhhhcCc
Confidence 00000 0 0111346788999999999999999998 999999999998764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=387.02 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=213.0
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcE-EEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC-e
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKM-YACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD-A 188 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~-~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-~ 188 (767)
+......+.+.||+|+||+||++.++ |.. +|+|++......... ...+.+|+.+|.+++|||||++++++.... .
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 33445566677999999999999997 556 999999876654444 778999999999999999999999999887 7
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC-cccccCCcceEEeCCCC-CEEEeecCcccc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG-LVYRDCKPENILLDDYG-HVRISDLGLAVE 266 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~-IvHrDLKPeNILld~~g-~vkL~DFGla~~ 266 (767)
+++|||||++|+|..++... ....+++..+..++.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+|+.
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 99999999999999999874 2347999999999999999999999999 99999999999999998 999999999987
Q ss_pred cCCC-CcccccccccccCCcceec--CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 IPEG-ESVRGRVGTVGYMAPEVID--NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~~~~-~~~~~~~GT~~Y~APEvl~--~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
.... .......||+.|||||++. ...|+.++||||||++||||+||..||.+.........+. .....+..+...
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~--~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV--VGGLRPPIPKEC 271 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hcCCCCCCCccC
Confidence 6554 3344478999999999999 5699999999999999999999999998876522222221 133445566679
Q ss_pred cHHHHHHHHHhcccCcCccCCCC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCH 366 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~ 366 (767)
++.+.+|+..|+..||+.||++.
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ 294 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFL 294 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHH
Confidence 99999999999999999999943
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=383.52 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=219.3
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++|++.+.||+|+||.||+|++..+|..+|+|.+.... .......+.+|+++|++++||||+++++++.+.+.++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 44679999999999999999999999999999999987542 2233456889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC-CcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI-GLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~-~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
+||||++||+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EEeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999999987654 589999999999999999999986 699999999999999999999999999986643
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhh--------------------
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD-------------------- 329 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~-------------------- 329 (767)
. ......||+.|+|||++.+..++.++|+|||||++|||++|+.||...+.......+.
T Consensus 157 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred c-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 3 2345679999999999999999999999999999999999999996543221111000
Q ss_pred ----------------------hhhh-cccccc-CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 330 ----------------------RRVK-EDAEKY-SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 330 ----------------------~~i~-~~~~~~-~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
..+. ...... ...+++++++||.+||++||++||+ +++|++||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt-------~~ell~h~~~~~~~ 308 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD-------LKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC-------HHHHhcChHHhhcc
Confidence 0000 011111 1247899999999999999999999 99999999998744
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=387.56 Aligned_cols=274 Identities=25% Similarity=0.390 Sum_probs=220.6
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC------
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------ 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 186 (767)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 478999999999999999999999999999999987543 2233445678899999999999999999987643
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
..+|+||||+++ +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 358999999975 66666643 478899999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc-----------
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED----------- 335 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~----------- 335 (767)
...........||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+...+...
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 655444556789999999999999999999999999999999999999998765443333222211100
Q ss_pred -------cc--------------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 336 -------AE--------------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 336 -------~~--------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
.+ ......++++++||.+||+.||.+||+ ++++++||||.. |..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t-------~~e~L~hp~~~~--~~~ 326 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS-------VDEALQHPYINV--WYD 326 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCC-------HHHHhcCccccc--ccC
Confidence 00 011123568999999999999999999 999999999974 544
Q ss_pred HhcCCCCCCCCCCC
Q psy11874 389 LEAGLCDPPFVPDV 402 (767)
Q Consensus 389 l~~~~~~pp~~P~~ 402 (767)
.......||.+|+.
T Consensus 327 ~~~~~~~~~~~~~~ 340 (364)
T cd07875 327 PSEAEAPPPKIPDK 340 (364)
T ss_pred cccCCCCCCCCCCc
Confidence 44444455555553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=372.48 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=210.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEcc-CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc---CCCceeEEEEEEe-----
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI---NSRFVVSLAYAYE----- 184 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~----- 184 (767)
++|++.+.||+|+||.||+|++.. +|+.+|+|++...... ........+|..+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 4788999998654322 22233456677777765 6999999999875
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
....+++||||++ |+|..++.... ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 3457999999997 68988887643 345899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc---------
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED--------- 335 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~--------- 335 (767)
.............||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.........+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 87655544556679999999999998999999999999999999999999998776544333332211100
Q ss_pred --------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 336 --------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 336 --------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.......+++.+++|+.+||+.||++||+ +.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s-------~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS-------AYSALSHPYF 290 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC-------HHHHhcCCCC
Confidence 01122457889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=385.47 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=211.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC-----
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----- 187 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 187 (767)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 478999999999999999999999999999999986542 22334556788999999999999999999986543
Q ss_pred -eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 188 -ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 188 -~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
.+|+||||+++ +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 58999999986 45555532 478899999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-------------
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK------------- 333 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~------------- 333 (767)
...........||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+.+...
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 6554445567899999999999999999999999999999999999999987654322211111100
Q ss_pred -----cccc--------------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 334 -----EDAE--------------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 334 -----~~~~--------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
.... ......++++++||.+||..||++||+ ++|+++||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t-------~~e~l~hp~~~~ 320 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS-------VDEALRHPYITV 320 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCC-------HHHHhcCchhhh
Confidence 0000 011124678999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=388.02 Aligned_cols=255 Identities=27% Similarity=0.359 Sum_probs=227.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
..|+.+..||+|+||.||+|.+..|++.||+|++..... ....+.+..|+.+|.+++++||.++|+.|..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 468888999999999999999999999999999987653 334567888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES- 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~- 272 (767)
|||.||++.+.+.... .+++..+..++.+++.||.|||.++.+|||||+.|||+..+|.+||+|||+|.++.....
T Consensus 91 ey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999999887643 458889999999999999999999999999999999999999999999999988766544
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
..+.+|||.|||||++.+..|+.++||||||++.|||++|.+|+...+.+. -+.-..+..++.+...+|+.+++|+.
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---vlflIpk~~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---VLFLIPKSAPPRLDGDFSPPFKEFVE 244 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---EEEeccCCCCCccccccCHHHHHHHH
Confidence 367899999999999999999999999999999999999999998876532 22222344556666789999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
.||.+||+.||+ |.++++|+|.+.
T Consensus 245 ~CL~k~P~~Rps-------A~~LLKh~FIk~ 268 (467)
T KOG0201|consen 245 ACLDKNPEFRPS-------AKELLKHKFIKR 268 (467)
T ss_pred HHhhcCcccCcC-------HHHHhhhHHHHh
Confidence 999999999999 999999999987
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=368.06 Aligned_cols=273 Identities=45% Similarity=0.846 Sum_probs=226.5
Q ss_pred EEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHH---HHHhcCCCceeEEEEEEeeCCeEEEEEEecc
Q psy11874 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQ---ILQKINSRFVVSLAYAYETKDALCLVLTIMN 197 (767)
Q Consensus 121 ~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~---iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~ 197 (767)
+||+|+||.||+|.+..+|+.||+|.+.++.............|.. +++..+||+|+.+.+.+.+.+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999998765543333333444444 4445689999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcccccc
Q psy11874 198 GGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRV 277 (767)
Q Consensus 198 gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~ 277 (767)
||+|..++.+.+ .+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASV 156 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcC
Confidence 999998887643 68999999999999999999999999999999999999999999999999997654322 23457
Q ss_pred cccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcc
Q psy11874 278 GTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLK 356 (767)
Q Consensus 278 GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~ 356 (767)
||..|+|||++.+ ..++.++|+||+||++|+|++|+.||...... ................+..+|+++.+++.+||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-chHHHHHHhhccCCCCCCcCCHHHHHHHHHHhh
Confidence 9999999999874 46899999999999999999999999765322 122233334444455666789999999999999
Q ss_pred cCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCC
Q psy11874 357 KSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400 (767)
Q Consensus 357 ~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P 400 (767)
.+|.+|+.|.. .++.++++||||+.++|..+.....+||.+|
T Consensus 236 ~~p~~R~~~~~--~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 277 (278)
T cd05606 236 RDVNRRLGCLG--RGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP 277 (278)
T ss_pred cCHHhccCCCC--CCHHHHHhCccccCCCchHhhhcccCCCCCC
Confidence 99999997653 4699999999999999999988776666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=374.66 Aligned_cols=279 Identities=37% Similarity=0.635 Sum_probs=236.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|....+++.||+|.+.+...........+..|..++++++|++|+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998776555456677899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES- 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~- 272 (767)
||+.|++|..++.... ...+++..+..++.||+.||.|||+.|++||||||+||+++.+|.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 9999999999887542 34689999999999999999999999999999999999999999999999999875432211
Q ss_pred -----------------------------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh
Q psy11874 273 -----------------------------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV 323 (767)
Q Consensus 273 -----------------------------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~ 323 (767)
.....||..|+|||++.+..++.++|+|||||++|+|++|..||.+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 113468999999999999899999999999999999999999998765433
Q ss_pred hhhhhhhhhhccccccCC--CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 324 KRDEVDRRVKEDAEKYSC--RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 324 ~~~~i~~~i~~~~~~~~~--~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
....+. .....++. .++++++++|.+||.+||++||+.. .+++++++||||++++|..+.. -.||.+|.
T Consensus 240 ~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~---~~~~~ll~~~~~~~~~~~~~~~--~~~~~~~~ 310 (316)
T cd05574 240 TFSNIL----KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK---RGAAEIKQHPFFRGVNWALIRH--TTPPIIPR 310 (316)
T ss_pred HHHHHh----cCCccCCCccccCHHHHHHHHHHccCCHhHCCCch---hhHHHHHcCchhhcCChhhccc--CCCCCCCC
Confidence 332222 22222332 3689999999999999999999955 3599999999999999998877 45776665
Q ss_pred C
Q psy11874 402 V 402 (767)
Q Consensus 402 ~ 402 (767)
+
T Consensus 311 ~ 311 (316)
T cd05574 311 P 311 (316)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=385.10 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=213.5
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
...++|+..+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+|+.++|+||+++++++...+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34578889999999999999999999999999999986432 2233456889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+|||||+||+|... ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 149 lv~e~~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 149 VLLEFMDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEecCCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 99999999998532 13567888899999999999999999999999999999999999999999999876433
Q ss_pred C-cccccccccccCCcceecC-----CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCc
Q psy11874 271 E-SVRGRVGTVGYMAPEVIDN-----EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFS 344 (767)
Q Consensus 271 ~-~~~~~~GT~~Y~APEvl~~-----~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s 344 (767)
. ......||+.|+|||++.. ...+.++|||||||++|||++|+.||...........+...........+..++
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS 301 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence 2 2345679999999999843 234578999999999999999999997433221112222222233344556789
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
+++++||.+||..||++||+ +.|+++||||....
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt-------~~ell~hp~~~~~~ 335 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWS-------AMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHHHccCChhhCcC-------HHHHhcCcccccCC
Confidence 99999999999999999998 99999999998853
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=368.09 Aligned_cols=257 Identities=24% Similarity=0.341 Sum_probs=210.0
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc---CCCceeEEEEEEee-----C
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI---NSRFVVSLAYAYET-----K 186 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~-----~ 186 (767)
+|++.+.||+|+||+||+|+++.+|+.||+|.+..... .......+.+|+.+++.+ +||||+++++++.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 48899999999999999999999999999999865432 122223455677777665 79999999998864 3
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
..+++|||++++ +|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 568999999984 8888887643 34589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc-----------
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED----------- 335 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~----------- 335 (767)
...........||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.........+...+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 655444455678999999999999999999999999999999999999997765443333322211000
Q ss_pred ------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 336 ------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 336 ------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.......+++.++++|.+||++||++||+ +.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS-------AFRALQHPFF 288 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC-------HHHHhcCCCC
Confidence 00122357888999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=387.62 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=233.5
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe-EEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA-LCL 191 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-l~l 191 (767)
.+.|..++++|+|+||.+++++++..++.|++|++...+...+. ...+.+|..+++++.|||||...+.|..++. +|+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 46899999999999999999999999999999999887665543 3478899999999999999999999998888 999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
||+||+||+|...|.... ...|+++.+..|+.||+.|+.|||+++|+|||||+.||++..++.|||+|||+|+......
T Consensus 82 vm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999998875 4579999999999999999999999999999999999999999999999999999987766
Q ss_pred -cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 272 -SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 272 -~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
...+.+|||.||+||++.+.+|+.++|+|||||++|||++-+++|.+.+.......+.+.. ....+..+|.+++.+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---YSPLPSMYSSELRSL 237 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc---CCCCCccccHHHHHH
Confidence 5677899999999999999999999999999999999999999999886544333333322 356778899999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
|+.||.++|..||+ |.+++.+|.....
T Consensus 238 v~~~l~~~P~~RPs-------a~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPS-------ALELLRRPHLLRY 264 (426)
T ss_pred HHHHhhcCCccCCC-------HHHHhhChhhhhH
Confidence 99999999999999 9999999887643
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=388.21 Aligned_cols=256 Identities=22% Similarity=0.274 Sum_probs=209.9
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
..+..++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|++++|||||+++++|..+..
T Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 87 AGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred cccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 34566889999999999999999999999999999997532 235789999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
.|+|||++. ++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred eEEEEecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999999996 68888876643 68999999999999999999999999999999999999999999999999997543
Q ss_pred CC--CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhh-------hhhhhhhhhhhccc---
Q psy11874 269 EG--ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-------VKRDEVDRRVKEDA--- 336 (767)
Q Consensus 269 ~~--~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~-------~~~~~i~~~i~~~~--- 336 (767)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .....+.+.....+
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 22 2233567999999999999999999999999999999999999887543210 00111111000000
Q ss_pred -------------------ccc---------CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 337 -------------------EKY---------SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 337 -------------------~~~---------~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
... ...++.++.+||.+||+.||++||+ |+|+++||||+++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt-------a~elL~hp~f~~~ 382 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS-------AEALLDFAAFQDI 382 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC-------HHHHhcChhhccC
Confidence 000 0124678999999999999999999 9999999999875
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=363.00 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=225.6
Q ss_pred CCeEEE-eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEee----CC
Q psy11874 114 KTFRMY-RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYET----KD 187 (767)
Q Consensus 114 ~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~----~~ 187 (767)
++|.+- ++||-|-.|.|..|.++.||+.+|+|++... ..+.+|+++.-.. .|||||+++++|++ ..
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 456554 6899999999999999999999999998543 2356677765554 69999999998764 57
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC---CCCEEEeecCcc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD---YGHVRISDLGLA 264 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~---~g~vkL~DFGla 264 (767)
.+.+|||.|+||+|...|+.++ ...|+|.++..++.||..|+.|||+++|.||||||||+|... +..+||+|||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 8999999999999999999875 456999999999999999999999999999999999999964 456899999999
Q ss_pred cccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC----
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS---- 340 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~---- 340 (767)
+.........+.|-||.|.|||++..++|+.++|+||+||++|-||+|.+||++.+.......+.++|......+|
T Consensus 212 K~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW 291 (400)
T KOG0604|consen 212 KETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW 291 (400)
T ss_pred cccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence 9887767788899999999999999999999999999999999999999999998877777778888888877775
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
..+|++++|+|++||..+|++|++ .++++.|||..+-
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRlT-------I~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERLT-------IEEVMDHPWINQY 328 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhhee-------HHHhhcCchhccc
Confidence 467999999999999999999998 9999999998764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=373.53 Aligned_cols=260 Identities=22% Similarity=0.373 Sum_probs=215.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|.++.+++.+|+|.+..... ......+.+|+.++++++||||+++++++.+++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4789999999999999999999999999999999865432 22334577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
|||+++ +|..++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 999985 7877776643 358899999999999999999999999999999999999999999999999997653322
Q ss_pred cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc--------------
Q psy11874 272 SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA-------------- 336 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~-------------- 336 (767)
......+|+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+.......+.+......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2334578999999999865 5689999999999999999999999987654333332222111000
Q ss_pred ------------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 337 ------------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 337 ------------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
......+++++++||.+||+.||.+|++ ++|+++||||+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-------~~e~l~h~~~~~~ 292 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS-------AEEAMKHAYFRSL 292 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC-------HHHHhcChhhhhc
Confidence 0111357889999999999999999998 9999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=363.58 Aligned_cols=281 Identities=38% Similarity=0.678 Sum_probs=237.5
Q ss_pred CeEEEeEEeecCcEEEEEEEEc---cCCcEEEEEEechhhhhh-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKK-RKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l 189 (767)
+|++.+.||+|+||.||.|... .+|+.||+|++....... ......+.+|+.+|+++ +|+||+++++.++....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 478999999987654322 23445678899999999 589999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999997653 588999999999999999999999999999999999999999999999999987644
Q ss_pred CCc--ccccccccccCCcceecC--CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 270 GES--VRGRVGTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~~--~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+...+......++..+++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence 322 234568999999999865 3578899999999999999999999975443333444555555555566778899
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCC
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P 400 (767)
.+.+++.+||..||++|+++.. .++++++.||||..++|+.+.+...++||.|
T Consensus 238 ~~~~ll~~~l~~~p~~R~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (290)
T cd05613 238 LAKDIIQRLLMKDPKKRLGCGP--SDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290 (290)
T ss_pred HHHHHHHHHhcCCHHHhcCCCC--CCHHHHHcCcccccCCHHHHhhccCCCCCCC
Confidence 9999999999999999997643 4699999999999999999988877777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.15 Aligned_cols=277 Identities=32% Similarity=0.577 Sum_probs=232.6
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.++.+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998765444455567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-- 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-- 271 (767)
||++||+|..++.+.+ .+++..+..++.|++.||.|||+.+|+||||||+||+++.+|.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999997754 58999999999999999999999999999999999999999999999999986321100
Q ss_pred --------------cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc
Q psy11874 272 --------------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE 337 (767)
Q Consensus 272 --------------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~ 337 (767)
......|+..|+|||.+.+..++.++|+|||||++|||++|..||.+.... ++...+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~~~~~~~~~ 233 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELFGQVISDDI 233 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccc
Confidence 011235788999999998889999999999999999999999999865432 22222222221
Q ss_pred cc---CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCC
Q psy11874 338 KY---SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403 (767)
Q Consensus 338 ~~---~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~ 403 (767)
.+ ...++++++++|.+||++||++||++. ++.++++||||...+|..+...+ ++++|.+.
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~----~~~~ll~~~~~~~~~~~~~~~~~--~~~~~~~~ 296 (305)
T cd05609 234 EWPEGDEALPADAQDLISRLLRQNPLERLGTG----GAFEVKQHRFFLGLDWNGLLRQK--AEFIPQLE 296 (305)
T ss_pred CCCCccccCCHHHHHHHHHHhccChhhccCcc----CHHHHHhCccccCCCHHHHhhcC--CCCCCCCC
Confidence 22 235789999999999999999999964 49999999999999999977543 46677753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=364.24 Aligned_cols=279 Identities=38% Similarity=0.694 Sum_probs=236.7
Q ss_pred CeEEEeEEeecCcEEEEEEEEc---cCCcEEEEEEechhhhhh-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKK-RKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l 189 (767)
+|++.+.||+|+||.||+|+.. .+++.||+|.+.+..... ......+.+|..++.++ +||+|+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 467899999987654322 23445678899999999 599999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||++||+|..++.... .+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999999887643 589999999999999999999999999999999999999999999999999976544
Q ss_pred CCc--ccccccccccCCcceecCCC--CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 270 GES--VRGRVGTVGYMAPEVIDNEK--YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~~~~--ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
... .....|++.|+|||.+.+.. ++.++|+||||+++|||++|..||..........++.+.+.......+..++.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence 322 22346899999999987654 78899999999999999999999965443333344444455555566777899
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCC
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P 400 (767)
++++++.+||+.||++||++. ++.++++||||++++|..+.++...|||.|
T Consensus 238 ~l~~li~~~l~~~p~~R~t~~----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 288 (288)
T cd05583 238 EARDFIQKLLEKDPKKRLGAN----GADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288 (288)
T ss_pred HHHHHHHHHhcCCHhhccCcc----hHHHHhcCcccccCCHHHHhhhccCCCCCC
Confidence 999999999999999999965 499999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=358.31 Aligned_cols=255 Identities=30% Similarity=0.517 Sum_probs=215.2
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEe
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
|++.+.||+|+||+||+|....+++.||+|++......... .....+|..++++++||||+++++++.+.+.+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999877544333 22345599999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc-CCCCccc
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEGESVR 274 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~-~~~~~~~ 274 (767)
+++++|..++...+ .+++..+..++.||+.||.+||+.||+||||||+||+++.++.++|+|||.+... .......
T Consensus 80 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 80 CPGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp ETTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999998543 6899999999999999999999999999999999999999999999999999763 2334455
Q ss_pred ccccccccCCcceec-CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc---ccccCCCCcHHHHHH
Q psy11874 275 GRVGTVGYMAPEVID-NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED---AEKYSCRFSDDAKAL 350 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~-~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~---~~~~~~~~s~~~~dL 350 (767)
...||+.|+|||++. +..++.++|+||||+++|+|++|..||...+.......+.+..... ........++.+.++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 678999999999998 8889999999999999999999999998763222222222221111 111112234899999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
|.+||+.||++||+ +.++++||||
T Consensus 237 i~~~l~~~p~~R~~-------~~~l~~~~~~ 260 (260)
T PF00069_consen 237 IKKMLSKDPEQRPS-------AEELLKHPWF 260 (260)
T ss_dssp HHHHSSSSGGGSTT-------HHHHHTSGGG
T ss_pred HHHHccCChhHCcC-------HHHHhcCCCC
Confidence 99999999999999 9999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=381.99 Aligned_cols=260 Identities=23% Similarity=0.320 Sum_probs=214.1
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC-----eE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD-----AL 189 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~l 189 (767)
+|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+|+.++|+||+++++++.+.+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999999999999999986432 22233456889999999999999999999998876 89
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||+. ++|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999997 57877776543 689999999999999999999999999999999999999999999999999986543
Q ss_pred CC--cccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-------------
Q psy11874 270 GE--SVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK------------- 333 (767)
Q Consensus 270 ~~--~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~------------- 333 (767)
.. ......+|+.|+|||++.+. .++.++||||+||++|||++|++||.+.+.......+.....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 32 23345789999999998774 589999999999999999999999987665433322221100
Q ss_pred ------ccc---------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 334 ------EDA---------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 334 ------~~~---------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
... .......++++.+||.+||+.||++||+ +.|+++||||++..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t-------~~e~l~hp~~~~~~~ 296 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS-------AADALAHPYLDEGRL 296 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC-------HHHHhcCHhhCCCcc
Confidence 000 0123456889999999999999999999 999999999998653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=374.89 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=217.1
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++|++.+.||+|+||.||+|.++.+|..+|+|.+.... .......+.+|+++|++++||||+++++++.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34578999999999999999999999999999999986542 2233456889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC-CcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI-GLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~-~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
+||||++||+|.+++.+.+ .+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999999997654 588999999999999999999975 799999999999999999999999999976533
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhh----------------------
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDE---------------------- 327 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~---------------------- 327 (767)
. ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...........
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred h-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 2 23445799999999999998999999999999999999999999975432211100
Q ss_pred ------------------hhhhh-hccccccC-CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 328 ------------------VDRRV-KEDAEKYS-CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 328 ------------------i~~~i-~~~~~~~~-~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+...+ .......+ ..+++++++|+.+||++||++||+ +.|+++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt-------~~ell~h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD-------LKQLMVHAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcC-------HHHHhhCHHHhcC
Confidence 00001 11111111 246789999999999999999999 9999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=377.28 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=211.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC------
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------ 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 186 (767)
.++|++.+.||+|+||.||+|.+..+++.+|+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4689999999999999999999999999999999865432 223345677899999999999999999988654
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
..+|+||||+++ +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999985 56555543 488999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc------------
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE------------ 334 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~------------ 334 (767)
...........||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+......
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 65554455678999999999999999999999999999999999999999876543322221111100
Q ss_pred ------c--------------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 335 ------D--------------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 335 ------~--------------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
. ....+...+.++++||.+||..||++||+ ++|+++||||..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps-------~~ell~hp~~~~ 316 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS-------VDEALQHPYINV 316 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC-------HHHHhcCcchhc
Confidence 0 00111224678899999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.05 Aligned_cols=259 Identities=34% Similarity=0.608 Sum_probs=225.2
Q ss_pred EeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCH
Q psy11874 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDL 201 (767)
Q Consensus 122 LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L 201 (767)
||.|+||.||+|.+..+++.+|+|++.+...........+.+|+.++++++||||+++++.+.+++.+|+||||++||+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999877655555667899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcccccccccc
Q psy11874 202 KFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVG 281 (767)
Q Consensus 202 ~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~ 281 (767)
..++.+.. .+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.............|++.
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 99997653 589999999999999999999999999999999999999999999999999987765543445678999
Q ss_pred cCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh--ccccccCCCCcHHHHHHHHHhcccCc
Q psy11874 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK--EDAEKYSCRFSDDAKALCKALLKKSP 359 (767)
Q Consensus 282 Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~~~~~s~~~~dLi~~lL~~dP 359 (767)
|+|||.+.+..++.++|+||+||++|+|++|..||...... ..++.+.+. .....++...+++++++|.+||..||
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 99999998888999999999999999999999999776521 122222222 33455666678999999999999999
Q ss_pred CccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 360 RSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 360 ~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
++|+++.. .+++|+++||||++.+|+
T Consensus 236 ~~R~~~~~--~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 236 EERLGNLK--GGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred hhCcCCcc--cCHHHHhcChhhhCCCCC
Confidence 99998533 359999999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=357.18 Aligned_cols=258 Identities=37% Similarity=0.590 Sum_probs=214.9
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHH-HhcCCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL-QKINSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
+.||.|+||.||+|....+|+.||+|.+.+..............|..++ ...+|+|++++++.+...+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999999999999999999766544333334445565554 456899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG 278 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~G 278 (767)
|+|..++...+ .+++..+..++.||+.||.|||+.+|+||||+|+||+++.++.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCC
Confidence 99999987654 589999999999999999999999999999999999999999999999999876533 234568
Q ss_pred ccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccC
Q psy11874 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKS 358 (767)
Q Consensus 279 T~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~d 358 (767)
++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..............+++++.++|.+||+.|
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 99999999998888999999999999999999999999776543333222222222222333467899999999999999
Q ss_pred cCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 359 PRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 359 P~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
|++||++. +++|++.||||++++|+
T Consensus 236 p~~R~~~~----~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 236 PAKRLGAN----GYQEIKSHPFFKSINWD 260 (260)
T ss_pred HHHccCCC----cHHHHHcChHhhcCCCC
Confidence 99999853 48999999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=383.60 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=216.0
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-C-----CceeEEEEEEeeCCe
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-S-----RFVVSLAYAYETKDA 188 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-h-----p~Iv~l~~~~~~~~~ 188 (767)
+|+++++||+|+||+|-+|.+..|++.||||+++.+. ........|+.||..++ | -|+|+++++|..+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 6899999999999999999999999999999997642 34456778999999997 3 489999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC--CEEEeecCcccc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG--HVRISDLGLAVE 266 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g--~vkL~DFGla~~ 266 (767)
+|||+|++. -+|.++|+... ..+++...++.++.||+.||..||+.||||+|||||||||.+.+ .|||+|||.|..
T Consensus 263 lciVfELL~-~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999996 79999998864 56799999999999999999999999999999999999997544 699999999988
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc-----------
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED----------- 335 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~----------- 335 (767)
.... ..+++.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.++.++...+.+.+...
T Consensus 341 ~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~ 418 (586)
T KOG0667|consen 341 ESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA 418 (586)
T ss_pred cCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence 6543 348889999999999999999999999999999999999999999887765543222211000
Q ss_pred -------------------------------------ccccCC-----------CCcHHHHHHHHHhcccCcCccCCCCC
Q psy11874 336 -------------------------------------AEKYSC-----------RFSDDAKALCKALLKKSPRSRLGCHC 367 (767)
Q Consensus 336 -------------------------------------~~~~~~-----------~~s~~~~dLi~~lL~~dP~~Rl~~~~ 367 (767)
....|. .-.....|+|++||..||.+|++
T Consensus 419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t--- 495 (586)
T KOG0667|consen 419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT--- 495 (586)
T ss_pred ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC---
Confidence 000110 01245789999999999999998
Q ss_pred CcccHHHHHhCCCCCCCC
Q psy11874 368 GRYGARELKQAEFFKSTN 385 (767)
Q Consensus 368 ~~~~a~eil~HpfF~~i~ 385 (767)
+.++++||||....
T Consensus 496 ----p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 496 ----PAQALNHPFLTGTS 509 (586)
T ss_pred ----HHHHhcCccccccc
Confidence 99999999999654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=390.77 Aligned_cols=261 Identities=25% Similarity=0.366 Sum_probs=220.4
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC-----
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----- 187 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 187 (767)
.++|++.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+|..++|+|+++++..+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 46899999999999999999999999999999998765432 234556788999999999999999988775432
Q ss_pred ---eEEEEEEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 188 ---ALCLVLTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 188 ---~l~lV~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
.+++||||++||+|..++.... ....+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 4789999999999999987642 234689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC---CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC
Q psy11874 264 AVEIPEG---ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS 340 (767)
Q Consensus 264 a~~~~~~---~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~ 340 (767)
++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...... ..........+
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~---~~~~~~~~~~~ 266 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH---KTLAGRYDPLP 266 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHhcCCCCCCC
Confidence 9765432 22345679999999999999999999999999999999999999998764322221 11222233456
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
..+++++.+++.+||+.||.+||+ +.++++|||++..
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs-------~~ell~~p~~~~~ 303 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPS-------SSKLLNMPICKLF 303 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcC-------HHHHHhCHHHHHh
Confidence 788999999999999999999999 9999999998864
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=363.66 Aligned_cols=262 Identities=22% Similarity=0.382 Sum_probs=215.4
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||.||+|.++.+++.||+|.+.... .......+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc--ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 4578999999999999999999999999999999986542 22233457789999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
||||++ ++|...+...+ ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred EEeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 999998 58888887643 358899999999999999999999999999999999999999999999999997654322
Q ss_pred -cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc--------------
Q psy11874 272 -SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED-------------- 335 (767)
Q Consensus 272 -~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~-------------- 335 (767)
......+++.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.......+.+.....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 2334568999999999865 458899999999999999999999998765432222221111000
Q ss_pred ------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 336 ------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 336 ------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
.......+++++++||.+||+.||.+||+ ++|+++||||+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t-------~~eil~h~~f~~~~ 293 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS-------AEEAMKHPYFHCLG 293 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC-------HHHHhcCccccccc
Confidence 00112357889999999999999999998 99999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=389.23 Aligned_cols=258 Identities=21% Similarity=0.345 Sum_probs=219.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccC-CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
..|.+.+.||+|+||.||+|....+ +..+|+|.+... .......+.+|+.+|+.++|||||++++.+.+.+.+|+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 4599999999999999999998877 788999976433 223345678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 193 LTIMNGGDLKFHIYNM-GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~-~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
|||++||+|..++... .....+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+|+......
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999888653 223358999999999999999999999999999999999999999999999999998765432
Q ss_pred c---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 272 S---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 272 ~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+ ........+..++++++
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV---LYGKYDPFPCPVSSGMK 300 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCCCCCCccCCHHHH
Confidence 2 34457999999999999999999999999999999999999999776543222222 12223345667899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+||.+||.+||++||+ +++++.|||++.+
T Consensus 301 ~li~~~L~~dP~~Rps-------~~~~l~~~~~~~~ 329 (478)
T PTZ00267 301 ALLDPLLSKNPALRPT-------TQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHhccChhhCcC-------HHHHHhCHHHHHH
Confidence 9999999999999999 9999999998754
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.12 Aligned_cols=258 Identities=35% Similarity=0.686 Sum_probs=226.4
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||.|+||.||+|.+..+++.||+|.+.+...........+.+|++++++++||||+++++.+.+.+.+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48899999999999999999999999999999987766555567788999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~ 274 (767)
|++|++|..++.... .+++..+..++.||+.||.|||+++++|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 999999999987653 68999999999999999999999999999999999999999999999999998776554445
Q ss_pred ccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHh
Q psy11874 275 GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~l 354 (767)
...|+..|+|||++.+..++.++|+|||||++|+|++|..||...... ....+...........+..+++++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 567999999999998888999999999999999999999999876532 1223333333345566778899999999999
Q ss_pred cccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 355 LKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 355 L~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
|..||.+|+++. .+|+++||||
T Consensus 237 l~~~p~~R~~~~-----~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDN-----LKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCcc-----HHHHhcCCCC
Confidence 999999999921 3999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=352.03 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=218.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh--hhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
++|++.+.||+|++|.||.|....+++.+|+|.+...... .......+.+|+.++++++||||+++++++.+.+.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999999999999999998654322 12234568889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
||||++|++|..++...+ .+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999987754 58899999999999999999999999999999999999999999999999997654322
Q ss_pred cc----cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 272 SV----RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 272 ~~----~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
.. ....|+..|+|||++.+..++.++|+|||||++|||++|+.||............ ........++..+++++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 236 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI--ATQPTNPQLPSHVSPDA 236 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH--hccCCCCCCCccCCHHH
Confidence 11 2356889999999999988999999999999999999999999765433222211 11222344567789999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.++|.+||.++|.+||+ +.++++||||
T Consensus 237 ~~li~~~l~~~p~~Rpt-------~~~ll~~~~~ 263 (263)
T cd06625 237 RNFLRRTFVENAKKRPS-------AEELLRHFFV 263 (263)
T ss_pred HHHHHHHhhcCcccCCC-------HHHHhhCCCC
Confidence 99999999999999998 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=370.68 Aligned_cols=257 Identities=25% Similarity=0.334 Sum_probs=207.8
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYA 182 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 182 (767)
+++..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+|.++ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 4566789999999999999999999853 346789999986432 223345688999999999 89999999998
Q ss_pred EeeC-CeEEEEEEeccCCCHHHHHHhcCC---------------------------------------------------
Q psy11874 183 YETK-DALCLVLTIMNGGDLKFHIYNMGG--------------------------------------------------- 210 (767)
Q Consensus 183 ~~~~-~~l~lV~E~~~gG~L~~~l~~~~~--------------------------------------------------- 210 (767)
+... ..+++||||++||+|.+++.....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8764 468999999999999999875321
Q ss_pred --------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc---ccccccc
Q psy11874 211 --------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES---VRGRVGT 279 (767)
Q Consensus 211 --------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~---~~~~~GT 279 (767)
...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... .....+|
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 12478889999999999999999999999999999999999999999999999986543322 1233467
Q ss_pred cccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhc-cccccCCCCcHHHHHHHHHhccc
Q psy11874 280 VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKE-DAEKYSCRFSDDAKALCKALLKK 357 (767)
Q Consensus 280 ~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~-~~~~~~~~~s~~~~dLi~~lL~~ 357 (767)
+.|+|||++.+..++.++|||||||++|||++ |..||.+..... .+...+.. .....+...++++++|+.+||..
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFCQRLKDGTRMRAPENATPEIYRIMLACWQG 316 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHhcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 89999999999999999999999999999997 999997754321 12222221 22334567889999999999999
Q ss_pred CcCccCCCCCCcccHHHHHh
Q psy11874 358 SPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 358 dP~~Rl~~~~~~~~a~eil~ 377 (767)
||++||+ +.++++
T Consensus 317 dp~~RPs-------~~el~~ 329 (338)
T cd05102 317 DPKERPT-------FSALVE 329 (338)
T ss_pred ChhhCcC-------HHHHHH
Confidence 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=373.45 Aligned_cols=257 Identities=24% Similarity=0.372 Sum_probs=210.6
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC------C
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------D 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------~ 187 (767)
++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+|++++||||+++++++... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 679999999999999999999999999999999875432 223345577899999999999999999887543 4
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
..|++|+++ |++|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 579999998 78998776532 5999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc-----------
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED----------- 335 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~----------- 335 (767)
... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 169 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred CCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 443 345679999999999876 578999999999999999999999997754332222221110000
Q ss_pred --------c--------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 336 --------A--------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 336 --------~--------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
. .......++.+.+||.+||..||.+||+ +.++++||||....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s-------~~ell~hp~~~~~~ 305 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS-------ASEALAHPYFSQYH 305 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC-------HHHHhcCcchhccC
Confidence 0 0011245778999999999999999999 99999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=387.81 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=203.1
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC------CceeEEEEEEee
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS------RFVVSLAYAYET 185 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h------p~Iv~l~~~~~~ 185 (767)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ........|+.+++.++| .++++++.+|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3478999999999999999999999999999999986432 122334557777777654 458899888876
Q ss_pred C-CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCC---------
Q psy11874 186 K-DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYG--------- 254 (767)
Q Consensus 186 ~-~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g--------- 254 (767)
. .++|+|||++ |++|.+++.+.+ .+++..+..++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 5 5799999998 678888887654 68999999999999999999998 5999999999999998766
Q ss_pred -------CEEEeecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhh
Q psy11874 255 -------HVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDE 327 (767)
Q Consensus 255 -------~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~ 327 (767)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.......
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred ccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 499999999865322 23456899999999999999999999999999999999999999987654332222
Q ss_pred hhhhhhccccc-------------------------------------cC-CCCcHHHHHHHHHhcccCcCccCCCCCCc
Q psy11874 328 VDRRVKEDAEK-------------------------------------YS-CRFSDDAKALCKALLKKSPRSRLGCHCGR 369 (767)
Q Consensus 328 i~~~i~~~~~~-------------------------------------~~-~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~ 369 (767)
+.+.....+.. .. ...++.+.|||.+||+.||++||+
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----- 431 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN----- 431 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC-----
Confidence 21111000000 00 011456789999999999999999
Q ss_pred ccHHHHHhCCCCCCC
Q psy11874 370 YGARELKQAEFFKST 384 (767)
Q Consensus 370 ~~a~eil~HpfF~~i 384 (767)
++|+++||||...
T Consensus 432 --a~e~L~Hp~~~~~ 444 (467)
T PTZ00284 432 --ARQMTTHPYVLKY 444 (467)
T ss_pred --HHHHhcCcccccc
Confidence 9999999999864
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=373.67 Aligned_cols=259 Identities=30% Similarity=0.448 Sum_probs=222.4
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGG 199 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG 199 (767)
++||+|.||+||-|.++.||+.||+|+++|-++.. +++..+.+|+.||++++||.||.|...|++.+.++.|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 79999999999999999999999999999988754 4568899999999999999999999999999999999999985
Q ss_pred CHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC---CCEEEeecCcccccCCCCccccc
Q psy11874 200 DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY---GHVRISDLGLAVEIPEGESVRGR 276 (767)
Q Consensus 200 ~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~---g~vkL~DFGla~~~~~~~~~~~~ 276 (767)
|...+|.... ..++++....+++.||+.||.|||-+||+|+|||||||||.+. -.+||||||+|+.+.+...-++.
T Consensus 648 DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV 726 (888)
T KOG4236|consen 648 DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV 726 (888)
T ss_pred hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence 5555555432 3479999999999999999999999999999999999999643 46999999999999887777788
Q ss_pred ccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcc
Q psy11874 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLK 356 (767)
Q Consensus 277 ~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~ 356 (767)
+|||.|+|||++.+++|+.+.|+||.|||+|--|+|..||....+ ..+++...-...+..-|..+|++|.|||..||+
T Consensus 727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~eis~~AidlIn~LLq 804 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSEISPEAIDLINNLLQ 804 (888)
T ss_pred cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhhcCHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999954322 222332222223334456789999999999999
Q ss_pred cCcCccCCCCCCcccHHHHHhCCCCCCC-ChhhHh
Q psy11874 357 KSPRSRLGCHCGRYGARELKQAEFFKST-NWKRLE 390 (767)
Q Consensus 357 ~dP~~Rl~~~~~~~~a~eil~HpfF~~i-~w~~l~ 390 (767)
..-.+|.+ .+..+.|||+++- -|..|.
T Consensus 805 Vkm~kRys-------vdk~lsh~Wlq~yq~w~DLR 832 (888)
T KOG4236|consen 805 VKMRKRYS-------VDKSLSHPWLQDYQTWLDLR 832 (888)
T ss_pred HHHHHhcc-------hHhhccchhhhcchHHHHHH
Confidence 99999988 9999999999984 365553
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=372.76 Aligned_cols=255 Identities=25% Similarity=0.328 Sum_probs=206.6
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+...+|++.+.||+|+||.||+|....+++.||+|+..+.. ...|..++++++||||+++++++......|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 34467999999999999999999999999999999854332 346999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+|||++. |+|..++.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 134 lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9999996 57888776643 36899999999999999999999999999999999999999999999999999765444
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCC-CCCchhh---------hhhhhhhhhhhccccccC
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAP-FRRRKEM---------VKRDEVDRRVKEDAEKYS 340 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~P-F~~~~~~---------~~~~~i~~~i~~~~~~~~ 340 (767)
.......||+.|+|||++.+..++.++|||||||++|||+++..| |...... .....+.......+..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 444556799999999999999999999999999999999985544 4332111 000011111110011111
Q ss_pred ------------------------------CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 341 ------------------------------CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 341 ------------------------------~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
..++.++.+||.+||+.||++||+ |.|+++||||+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt-------a~e~l~hp~f~~~ 357 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS-------AEEILNYPMFAQL 357 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC-------HHHHhcCchhccC
Confidence 145778889999999999999999 9999999999874
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=356.69 Aligned_cols=266 Identities=24% Similarity=0.383 Sum_probs=221.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.+.|++.+.||+|+||.||+|++..+++.+|+|.+... .......+.+|+.++++++||||+++++.+...+.+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 46799999999999999999999999999999998654 233455678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
|||++||+|..++.+.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++.......
T Consensus 88 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999999988776543 368999999999999999999999999999999999999999999999999987643321
Q ss_pred cccccccccccCCcceec-----CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 272 SVRGRVGTVGYMAPEVID-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~-----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
......|++.|+|||++. ...++.++|+|||||++|||++|.+||...+.......+.. ........+..++.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 244 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPPTLSQPSKWSME 244 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc-CCCccCCCCcccCHH
Confidence 223456899999999984 34578899999999999999999999976543222211111 111112234567899
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhc
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEA 391 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~ 391 (767)
+.++|.+||..||++||+ ++++++||||..++|.+...
T Consensus 245 ~~~li~~~l~~~p~~Rp~-------~~~il~~~~~~~~~~~~~~~ 282 (292)
T cd06644 245 FRDFLKTALDKHPETRPS-------AAQLLEHPFVSSVTSNRPLR 282 (292)
T ss_pred HHHHHHHHhcCCcccCcC-------HHHHhcCccccccccchhHH
Confidence 999999999999999998 99999999999999887443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=354.97 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=213.1
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.++||+|+||.||+|.+..+++.||+|.+.+.. .......+.+|+.++++++||||+++++.+.+.+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36888999999999999999999999999999986542 2233456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||++||+|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.+|.++|+|||++...... ..
T Consensus 79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~ 150 (279)
T cd06619 79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IA 150 (279)
T ss_pred ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cc
Confidence 999999996431 4788899999999999999999999999999999999999999999999999866433 23
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhh---hhhhhhhhhc-ccccc-CCCCcHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK---RDEVDRRVKE-DAEKY-SCRFSDDAK 348 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~---~~~i~~~i~~-~~~~~-~~~~s~~~~ 348 (767)
...+||+.|+|||++.+..++.++|+|||||++|+|++|..||........ .....+.+.. ..... ....+++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 456899999999999999999999999999999999999999965322111 1111111111 11122 235788999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
+++.+||..||++||+ ++++++||||+..+
T Consensus 231 ~li~~~l~~~P~~Rp~-------~~eil~~~~~~~~~ 260 (279)
T cd06619 231 HFITQCMRKQPKERPA-------PENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHhhCChhhCCC-------HHHHhcCccccccc
Confidence 9999999999999998 99999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=375.23 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=212.7
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEc--cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
..+|++.+.||+|+||.||+|... .+++.+|+|.+.... ...+|+.+|++++|||||++++++.....+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 357999999999999999999864 356889999875432 2457999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+|||++. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 163 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999996 6888888543 36899999999999999999999999999999999999999999999999999766543
Q ss_pred Cc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhh---hhhhhhhhccccc------
Q psy11874 271 ES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKR---DEVDRRVKEDAEK------ 338 (767)
Q Consensus 271 ~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~---~~i~~~i~~~~~~------ 338 (767)
.. .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....... ..+.+.+......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 22 23457999999999999999999999999999999999999999765432111 1111111100000
Q ss_pred -------------------c-----CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHh
Q psy11874 339 -------------------Y-----SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLE 390 (767)
Q Consensus 339 -------------------~-----~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~ 390 (767)
. ...++.++.++|++||..||++||+ +.|+++||||+..+|..+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps-------a~e~l~~p~f~~~~~~~~~ 387 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS-------AQDILSLPLFTKEPINLLN 387 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC-------HHHHhhCchhhccchhhhc
Confidence 0 1235778999999999999999999 9999999999999887664
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=354.25 Aligned_cols=258 Identities=23% Similarity=0.337 Sum_probs=211.6
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||.|++|.||+|.++.+|+.||+|++..... .......+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58899999999999999999999999999999865432 22234567889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-cc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~ 273 (767)
|++ |+|..++........+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++....... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 998 6888888765444568999999999999999999999999999999999999999999999999997653322 22
Q ss_pred cccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-------------------
Q psy11874 274 RGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK------------------- 333 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~------------------- 333 (767)
....+++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+...........+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 34467999999998865 4578999999999999999999999986543222111111000
Q ss_pred ------ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 334 ------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 334 ------~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.........++++++++|++||..||++||+ +.+|+.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt-------~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS-------AKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC-------HHHHhcCCCC
Confidence 0001113357899999999999999999998 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=357.37 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=218.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++++.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.++++++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 36889999999999999999999999999999886431 2223456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
||++|++|..++........+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.++|+|||++...... .
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-L 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-c
Confidence 999999998888764223368999999999999999999997 59999999999999999999999999999766432 2
Q ss_pred ccccccccccCCcceecCC------CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNE------KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~------~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
.....|++.|+|||++.+. .++.++|+|||||++|+|++|..||...........+...........+..++++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 3345689999999998543 3588999999999999999999999765433222223222333445566679999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+.+|+.+||..+|++||+ ++++++||||...
T Consensus 238 ~~~li~~~l~~~p~~Rp~-------~~~l~~~~~~~~~ 268 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPT-------YAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHHcccCcccCCC-------HHHHhcChhhhhc
Confidence 999999999999999999 9999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=350.81 Aligned_cols=266 Identities=28% Similarity=0.444 Sum_probs=225.0
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
+.||+|+|+.|--|....||+.||+|++.|.. ......+.+|++++.+. .|+||+.|+++|++++..|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 67999999999999999999999999998763 33456789999999998 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC---EEEeecCcccccCCCC----
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH---VRISDLGLAVEIPEGE---- 271 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~---vkL~DFGla~~~~~~~---- 271 (767)
|.|..||.++. .|++.++..++.+|+.||.+||.+||.||||||+|||-.+..+ ||||||.|........
T Consensus 161 GplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 161 GPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred chHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99999999875 7999999999999999999999999999999999999976554 7999998875443221
Q ss_pred ----cccccccccccCCcceec-----CCCCCCCCccccchhhHHHHhcCCCCCCCchh-----------hhhhhhhhhh
Q psy11874 272 ----SVRGRVGTVGYMAPEVID-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKE-----------MVKRDEVDRR 331 (767)
Q Consensus 272 ----~~~~~~GT~~Y~APEvl~-----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~-----------~~~~~~i~~~ 331 (767)
...+.+|+..|||||++. ...|+..+|.||||||||-||+|.+||.+.-. ..-.+.+...
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 134578999999999973 35699999999999999999999999965421 1234556777
Q ss_pred hhccccccC----CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 332 VKEDAEKYS----CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 332 i~~~~~~~~----~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
|++....+| ..+|.+++|+|+.||.+|+.+|++ |.++++|||++.+.- +...-.|+.+-.
T Consensus 318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls-------a~~vlnhPw~~~~~~---ekalptp~v~~r 381 (463)
T KOG0607|consen 318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS-------AAQVLNHPWVQRCAP---EKALPTPQVLQR 381 (463)
T ss_pred HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh-------hhhccCCccccccch---hccCCCCccccc
Confidence 777766665 468999999999999999999999 999999999998753 344445555544
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=362.92 Aligned_cols=250 Identities=25% Similarity=0.340 Sum_probs=195.5
Q ss_pred EeEEeecCcEEEEEEEEc--cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--CCeEEEEEE
Q psy11874 119 YRVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--KDALCLVLT 194 (767)
Q Consensus 119 ~~~LG~G~fG~Vy~a~~~--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~lV~E 194 (767)
.+.||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.+|++++||||+++++++.. ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999976 4678999999865422 2346789999999999999999998854 567999999
Q ss_pred eccCCCHHHHHHhcC------CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe----CCCCCEEEeecCcc
Q psy11874 195 IMNGGDLKFHIYNMG------GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL----DDYGHVRISDLGLA 264 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~------~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl----d~~g~vkL~DFGla 264 (767)
|+. ++|..++.... ....+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 997 57877765421 12258999999999999999999999999999999999999 46689999999999
Q ss_pred cccCCCC----cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhh---------hhhhhh
Q psy11874 265 VEIPEGE----SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK---------RDEVDR 330 (767)
Q Consensus 265 ~~~~~~~----~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~---------~~~i~~ 330 (767)
....... ......||+.|+|||++.+ ..++.++|+||+||++|||++|++||....+... ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 8654321 2345678999999999876 4689999999999999999999999975433111 000100
Q ss_pred hhhcc----------------------------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHH
Q psy11874 331 RVKED----------------------------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELK 376 (767)
Q Consensus 331 ~i~~~----------------------------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil 376 (767)
..... ........++++.+||.+||+.||.+|++ ++|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t-------~~e~l 312 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT-------SEQAM 312 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC-------HHHHh
Confidence 00000 00001123567999999999999999999 99999
Q ss_pred hCCCC
Q psy11874 377 QAEFF 381 (767)
Q Consensus 377 ~HpfF 381 (767)
+||||
T Consensus 313 ~hp~f 317 (317)
T cd07868 313 QDPYF 317 (317)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=347.23 Aligned_cols=256 Identities=29% Similarity=0.415 Sum_probs=217.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||.|+||+||+|....++..+|+|++....... ....+.+|+.+|+.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999999899999999987554322 4567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
|+++|++|..++.+......+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999987543346899999999999999999999999999999999999999999999999999766543221
Q ss_pred -----cccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC-----CC
Q psy11874 274 -----RGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS-----CR 342 (767)
Q Consensus 274 -----~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~-----~~ 342 (767)
....|+..|+|||++... .++.++|+|||||++|+|++|+.||...+.......... .....+. ..
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 235 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---NDPPSLETGADYKK 235 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---CCCCCcCCcccccc
Confidence 334689999999998776 789999999999999999999999976654322222221 1222221 36
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
+++++.+++.+||.+||++||+ +.+|++||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~-------~~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPT-------AEELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcC-------HHHHhhCCCC
Confidence 7899999999999999999998 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=372.70 Aligned_cols=262 Identities=25% Similarity=0.372 Sum_probs=236.2
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
.....|.+.+.||+|.|++|.+|.+..||..||||.++|....... .....+|++||..++|||||+|+.+.++...+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 3457899999999999999999999999999999999888665443 334888999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||+.||++.+++.+.+ ...+..++.++.|+++|++|||+++|||||||++||||+.+.++||+|||++..+..+
T Consensus 132 lV~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999999986 5677999999999999999999999999999999999999999999999999999888
Q ss_pred CcccccccccccCCcceecCCCCC-CCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYT-YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys-~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
....+.||++.|.|||++.+..|+ ..+|+||+|++||-|+.|..||.+.+-+ ++..+........+-.+|.++++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk----~Lr~rvl~gk~rIp~~ms~dce~ 284 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK----ELRPRVLRGKYRIPFYMSCDCED 284 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc----cccchheeeeecccceeechhHH
Confidence 888999999999999999998875 8899999999999999999999887543 44445555556667788999999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
||+++|..+|.+|++ .+++..|+|.....-.
T Consensus 285 lLrk~lvl~Pskr~~-------~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 285 LLRKFLVLNPSKRGP-------CDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHHhhccCccccCC-------HHHhhhhcccchhhhh
Confidence 999999999999988 8999999998765444
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=349.07 Aligned_cols=254 Identities=35% Similarity=0.617 Sum_probs=218.9
Q ss_pred EeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCH
Q psy11874 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDL 201 (767)
Q Consensus 122 LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L 201 (767)
||+|+||.||+|.+..+|+.+|+|.+.+...........+.+|+.++++++||||+++++.+.+++..|+||||++||+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999877655556677889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC---------c
Q psy11874 202 KFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE---------S 272 (767)
Q Consensus 202 ~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~---------~ 272 (767)
..++.+.+ .+++..+..++.||+.||.|||+.+++||||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99998754 68999999999999999999999999999999999999999999999999987654331 1
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCC--CcHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR--FSDDAKAL 350 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~--~s~~~~dL 350 (767)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||........ ...+.......+.. +++.+.++
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI----FQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCcCCCccccCCHHHHHH
Confidence 2335688999999999888899999999999999999999999976653322 22222222333333 48999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
+.+||+.+|++||+++. +.++++||||++++|
T Consensus 234 i~~~l~~~p~~Rpt~~~----~~~~l~~~~~~~~~~ 265 (265)
T cd05579 234 ISKLLVPDPEKRLGAKS----IEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHhcCCHhhcCCCcc----HHHHhcCccccCCCC
Confidence 99999999999999543 699999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=351.93 Aligned_cols=257 Identities=24% Similarity=0.361 Sum_probs=213.1
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.++++++|+||+++++++.....+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999865431 2223445788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-c
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-S 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~ 272 (767)
||++++.|...+.... .+++..+..++.||+.||+|||+.||+||||||+||+++.+|.++|+|||++....... .
T Consensus 80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 9999998877765432 58999999999999999999999999999999999999999999999999998765543 2
Q ss_pred ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc-----------------
Q psy11874 273 VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE----------------- 334 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~----------------- 334 (767)
.....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.........+......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 334568999999999866 56889999999999999999999999876543222221111000
Q ss_pred ---cc-------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 335 ---DA-------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 335 ---~~-------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.. ......++..+.+||.+||..+|++||+ +.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~-------~~eil~~~~f 286 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS-------CEELLEHPYF 286 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC-------HHHHhcCCCC
Confidence 00 0112356889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=357.91 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=214.6
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|++..+|..+|+|.+.... .......+.+|++++++++||||+++++.+.+.+.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999986432 2233456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
||++||+|..++.+.+ .+++..+..++.||+.||.|||+ .+++||||||+|||++.++.++|+|||++...... .
T Consensus 79 ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 154 (308)
T ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-c
Confidence 9999999999997653 68999999999999999999997 69999999999999999999999999999765432 2
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhh----------------------
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR---------------------- 330 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~---------------------- 330 (767)
....+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 3456799999999999888899999999999999999999999965432211110100
Q ss_pred ----------hh-hccccccC-CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 331 ----------RV-KEDAEKYS-CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 331 ----------~i-~~~~~~~~-~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
.+ ....+..+ ..++.++++|+.+||..||++||+ +.++++||||.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt-------~~~ll~~~~~~~ 292 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD-------LKELTKHPFIKR 292 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC-------HHHHhcChhhhh
Confidence 00 00011111 236889999999999999999999 999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=350.29 Aligned_cols=262 Identities=23% Similarity=0.364 Sum_probs=213.1
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHH-HHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI-LQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|.+.+.... .....+..|..+ ++.++||||+++++++...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 4799999999999999999999999999999998765321 223345556664 6667999999999999999999999
Q ss_pred EEeccCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHhHHHHHHHC-CcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 193 LTIMNGGDLKFHIYNM-GGEPGFDIARARFYAAEVLCGLEHLHYI-GLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~-~~~~~l~~~~~~~~~~qIl~aL~yLH~~-~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
|||++ |+|...+... .....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 6787777653 2234689999999999999999999997 9999999999999999999999999999876544
Q ss_pred CcccccccccccCCcceecC----CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC-CCCcH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDN----EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS-CRFSD 345 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~----~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~-~~~s~ 345 (767)
.......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||..... ..+.+...........+ ..+|+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPSPQLPAEKFSP 235 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCCCCCCccccCH
Confidence 33344578999999999864 4578999999999999999999999965322 11222222222223332 35789
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
+++++|.+||..+|++||+ ++++++||||+...+.
T Consensus 236 ~l~~li~~~l~~~p~~Rp~-------~~~il~~~~~~~~~~~ 270 (283)
T cd06617 236 EFQDFVNKCLKKNYKERPN-------YPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHHHHHHccCChhhCcC-------HHHHhcCchhhhcccc
Confidence 9999999999999999999 9999999999987654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=347.24 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=216.1
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh------hhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
+|.+.+.||+|+||.||+|.+..+++.||+|.+...... .......+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999999989999999988654332 12234568889999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
.++||||++|++|..++...+ .+++..+..++.|++.||+|||+.|++||||+|+||++++++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999999997654 58899999999999999999999999999999999999999999999999998765
Q ss_pred CCCc-------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC
Q psy11874 269 EGES-------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 269 ~~~~-------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~ 341 (767)
.... .....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+... .+...........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~ 234 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIFKIGENASPEIPS 234 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHHHHhccCCCcCCc
Confidence 3211 123458999999999998899999999999999999999999997654322 222222222344566
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.++..+.++|++||+.||.+||+ +.++++||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~-------~~~il~~~~~ 267 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPT-------AAELLKHPFL 267 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcC-------HHHHhhCCCC
Confidence 78999999999999999999998 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=343.19 Aligned_cols=255 Identities=24% Similarity=0.417 Sum_probs=215.5
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee-CCeEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-KDALCLVL 193 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lV~ 193 (767)
+|++.+.||+|++|.||+|.++.+++.||+|++...... ......+.+|..++++++|+|++++++.+.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 489999999999999999999999999999998765432 2334567889999999999999999988864 44689999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-c
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-S 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~ 272 (767)
||++|++|..++.... ...+++.++..++.|++.||++||+.||+||||||+||+++.++.++|+|||++....... .
T Consensus 80 e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred cccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 9999999999987643 2358999999999999999999999999999999999999999999999999997664322 2
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
.....|++.|+|||++.+..++.++|+||+||++|+|++|..||...+.......+ ........+..+++++.+++.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI---IEGKLPPMPKDYSPELGELIA 235 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HhcCCCCCccccCHHHHHHHH
Confidence 33457899999999999999999999999999999999999999765432221111 122223445678999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
+||+.||++||+ +.++++||||
T Consensus 236 ~~l~~~p~~Rp~-------~~~~l~~~~~ 257 (257)
T cd08223 236 TMLSKRPEKRPS-------VKSILRQPYI 257 (257)
T ss_pred HHhccCcccCCC-------HHHHhcCCCC
Confidence 999999999998 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=342.11 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=219.2
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|.+.+.||+|++|.||+|..+.+|+.||+|.+...... ......+.+|+.++++++||||+++++.+.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588999999999999999999999999999998765433 3345568889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-c
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-V 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-~ 273 (767)
|++|++|..++.... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 999999999998752 34689999999999999999999999999999999999999999999999999987654432 3
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+ ........+..+++++.+++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI---IRGVFPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HcCCCCCCccccCHHHHHHHHH
Confidence 3457899999999999999999999999999999999999999776532222221 2222334445788999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
||+.+|++||+ +.++++|||.
T Consensus 236 ~l~~~p~~Rp~-------~~~ll~~~~~ 256 (256)
T cd08529 236 CLTKDYRQRPD-------TFQLLRNPSL 256 (256)
T ss_pred HccCCcccCcC-------HHHHhhCCCC
Confidence 99999999999 9999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=376.10 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=221.4
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
.++++..||.|+||+||+|+.+.++-..|-|++.-+ .....+.++-|+.||..+.||+||+|+++|...+.++++.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 355678899999999999999999999999998644 44456678889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC-CCCcc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP-EGESV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~-~~~~~ 273 (767)
||.||-....+...+ ..+++.++..++.|++.||.|||+++|||||||..|||+.-+|.|+|+|||.+.... ....-
T Consensus 110 FC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 999999998888765 379999999999999999999999999999999999999999999999999985432 22334
Q ss_pred cccccccccCCcceec-----CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc--cCCCCcHH
Q psy11874 274 RGRVGTVGYMAPEVID-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK--YSCRFSDD 346 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~-----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~--~~~~~s~~ 346 (767)
.++.|||+|||||++. ..+|++++||||||++|.||..+.+|....+.+-.. .+.-+..++. .|..+|..
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl---lKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---LKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH---HHHhhcCCCcccCcchhhhH
Confidence 5678999999999984 468999999999999999999999998776553322 2222333333 36789999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
.+||+++||.+||..||+ +.+|++||||.+++-.
T Consensus 265 F~DfLk~cL~Knp~~Rp~-------aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPP-------AAQLLKHPFVQNAPSN 298 (1187)
T ss_pred HHHHHHHHHhcCCccCCC-------HHHHhhCcccccCCcc
Confidence 999999999999999998 9999999999987643
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=351.77 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=217.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||.|+||.||+|.++.+++.+|+|.+... .......+.+|+.++++++||||+++++.+.++..+|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 5789999999999999999999989999999998643 2334456888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-c
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-S 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~ 272 (767)
||++||+|..++.+.+ ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... .
T Consensus 82 e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 9999999999887643 268999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccccccccCCcceec-----CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 273 VRGRVGTVGYMAPEVID-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~-----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
.....||+.|+|||++. ...++.++|+|||||++|+|++|.+||...........+... .......+..++.++
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS-EPPTLDQPSKWSSSF 238 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC-CCCCcCCcccCCHHH
Confidence 33457999999999984 345778999999999999999999999776433222222111 111122345688999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
.++|.+||..+|.+||+ +.++++||||++...
T Consensus 239 ~~li~~~l~~~p~~Rps-------~~~il~~~~~~~~~~ 270 (280)
T cd06611 239 NDFLKSCLVKDPDDRPT-------AAELLKHPFVSDQSD 270 (280)
T ss_pred HHHHHHHhccChhhCcC-------HHHHhcChhhcccch
Confidence 99999999999999998 999999999988643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=361.18 Aligned_cols=259 Identities=21% Similarity=0.313 Sum_probs=207.6
Q ss_pred EEeEEeec--CcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEe
Q psy11874 118 MYRVLGKG--GFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 118 ~~~~LG~G--~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
++++||+| +||+||+|..+.+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 7899999999999999999998765332 23345677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC----
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE---- 271 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~---- 271 (767)
+++|+|.+++.... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.++++|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 81 MAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred cCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999999987643 2358999999999999999999999999999999999999999999999998764432111
Q ss_pred ----cccccccccccCCcceecC--CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh-hh-----------
Q psy11874 272 ----SVRGRVGTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR-VK----------- 333 (767)
Q Consensus 272 ----~~~~~~GT~~Y~APEvl~~--~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~-i~----------- 333 (767)
......++..|+|||++.+ ..|+.++|||||||++|||++|..||............... +.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0122357888999999975 46899999999999999999999999754322111110000 00
Q ss_pred ------------------------------ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 334 ------------------------------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 334 ------------------------------~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
.....+...+++++++|+.+||+.||++||+ ++++++||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt-------~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS-------ASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC-------HHHHhcChhhhh
Confidence 0000112245789999999999999999999 999999999987
Q ss_pred CC
Q psy11874 384 TN 385 (767)
Q Consensus 384 i~ 385 (767)
+.
T Consensus 313 ~~ 314 (327)
T cd08227 313 IK 314 (327)
T ss_pred cc
Confidence 63
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=348.88 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=211.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|++..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 357888999999999999999999999999999986542 22334577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
|||+++|+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999999999887654 68999999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccCCcceec---CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh-hhccccccCCCCcHHH
Q psy11874 272 SVRGRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR-VKEDAEKYSCRFSDDA 347 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~---~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~-i~~~~~~~~~~~s~~~ 347 (767)
......||+.|+|||++. +..++.++|+|||||++|+|++|..||............... ...........++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 123457999999999984 456889999999999999999999999765432221111111 1111111122578899
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCC
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEF 380 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~Hpf 380 (767)
.++|.+||..+|++||+ +++|++|||
T Consensus 242 ~~li~~~l~~~P~~R~~-------~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPT-------AEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcC-------HHHHhcCCC
Confidence 99999999999999998 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=352.45 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=218.5
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
..+|++.+.||.|+||.||+|....+++.||+|.+..... .....+.+|+.+++.++|+||+++++.+......|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 3689999999999999999999999999999999876532 2345678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
|||++||+|..++.+. .+++.++..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999999988653 478999999999999999999999999999999999999999999999999876543322
Q ss_pred -ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 273 -VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 273 -~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|..||.............. ........+..+++.+.+++
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li 250 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIFRDFL 250 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCCCCCccccCHHHHHHH
Confidence 2345799999999999988899999999999999999999999977654222211111 11112233456889999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.+||.+||++||+ +.++++||||...
T Consensus 251 ~~~l~~~p~~Rpt-------~~eil~~~~~~~~ 276 (296)
T cd06654 251 NRCLDMDVEKRGS-------AKELLQHQFLKIA 276 (296)
T ss_pred HHHCcCCcccCcC-------HHHHhhChhhhcc
Confidence 9999999999998 9999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=349.67 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=214.1
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEe
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
|++.+.||+|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 577889999999999999999999999999986542 23345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-ccc
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SVR 274 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~~ 274 (767)
++||+|..++.+.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... ...
T Consensus 84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 99999988876532 368999999999999999999999999999999999999999999999999997653322 233
Q ss_pred ccccccccCCcceec-----CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 275 GRVGTVGYMAPEVID-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~-----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
...||+.|+|||++. +..++.++|+||+||++|||++|.+||...+.......+... .......+..++.++++
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSEFKD 240 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-CCCCCCCccccCHHHHH
Confidence 457999999999983 455788999999999999999999999776543222222111 11122334568899999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+|.+||.+||.+||+ ++++++||||+..
T Consensus 241 li~~~l~~~p~~Rp~-------~~~il~~~~~~~~ 268 (282)
T cd06643 241 FLKKCLEKNVDARWT-------TTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHccCChhhCcC-------HHHHhcCCCEecc
Confidence 999999999999999 9999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.52 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=207.8
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||+|+||.||+|.++.+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+.+.+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999999999999999999999999865432 22234567789999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-cc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~ 273 (767)
|++ ++|..++.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 80 YCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred cCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 997 47777776533 258999999999999999999999999999999999999999999999999998654332 23
Q ss_pred cccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchh-hhhhhhhhhhhhc----------------c
Q psy11874 274 RGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKE-MVKRDEVDRRVKE----------------D 335 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~-~~~~~~i~~~i~~----------------~ 335 (767)
....+++.|+|||++.+. .++.++|+|||||++|+|++|..||..... ......+.+.... .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 345689999999998664 478999999999999999999888643322 1111111111000 0
Q ss_pred c---------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 336 A---------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 336 ~---------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
. ......+|+++++||.+||..||.+||+ ++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t-------~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS-------AEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC-------HHHHhcCCCC
Confidence 0 0112357899999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=351.70 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=219.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||.|+||.||+|.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++.+...+.+|+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 57999999999999999999999999999999986543 223456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES- 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~- 272 (767)
||++||+|..++... .+++.++..++.|++.||.|||++|++||||||+||+++.+|.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999999988653 589999999999999999999999999999999999999999999999999886644332
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+... .......+..+++.++++|.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 250 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSPIFRDFLN 250 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcccCCcccCCHHHHHHHH
Confidence 23457899999999999888999999999999999999999999876543222222111 11122345568899999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+||..||++||+ +.++++||||+..
T Consensus 251 ~~l~~dp~~Rpt-------~~~il~~~~~~~~ 275 (296)
T cd06655 251 RCLEMDVEKRGS-------AKELLQHPFLKLA 275 (296)
T ss_pred HHhhcChhhCCC-------HHHHhhChHhhhc
Confidence 999999999998 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=346.23 Aligned_cols=256 Identities=25% Similarity=0.343 Sum_probs=212.2
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||.||+|....+|+.||+|++.... ......+.+|+.++++++||||+++++.+..++.+++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3468999999999999999999999999999999986442 2234467789999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999999887643 68999999999999999999999999999999999999999999999999998764332
Q ss_pred -cccccccccccCCcceec---CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh-hhccccccCCCCcHH
Q psy11874 272 -SVRGRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR-VKEDAEKYSCRFSDD 346 (767)
Q Consensus 272 -~~~~~~GT~~Y~APEvl~---~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~-i~~~~~~~~~~~s~~ 346 (767)
......|++.|+|||.+. ...++.++|+||+||++|||++|..||...........+... ...........++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 223457899999999984 455788999999999999999999999654332211111111 111111122457899
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEF 380 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~Hpf 380 (767)
+.++|++||..+|++||+ +++|++|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~-------~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPT-------AERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcC-------HHHHhcCCC
Confidence 999999999999999999 999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=391.27 Aligned_cols=267 Identities=22% Similarity=0.366 Sum_probs=219.4
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--C
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--K 186 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~ 186 (767)
.+...++|++++.||+|+||+||+|.++.++..+|+|++....... .....+..|+.+|++++|||||+++++|.+ .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3445679999999999999999999999999999999987654322 335668889999999999999999998854 4
Q ss_pred CeEEEEEEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHC-------CcccccCCcceEEeCC------
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYI-------GLVYRDCKPENILLDD------ 252 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~-------~IvHrDLKPeNILld~------ 252 (767)
..+||||||+++|+|..+|.... ....+++..++.++.||+.||.|||+. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 57999999999999999987632 123689999999999999999999985 4999999999999964
Q ss_pred -----------CCCEEEeecCcccccCCCCcccccccccccCCcceecC--CCCCCCCccccchhhHHHHhcCCCCCCCc
Q psy11874 253 -----------YGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPFRRR 319 (767)
Q Consensus 253 -----------~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~--~~ys~~~DvwSlGviLyElltG~~PF~~~ 319 (767)
.+.+||+|||++............+||+.|+|||++.+ ..++.++|||||||+||||++|..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 34589999999987755544455679999999999854 45889999999999999999999999765
Q ss_pred hhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 320 KEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 320 ~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
+... .+...+...........+.++.+||..||..+|.+||+ +.+++.|||++.+..
T Consensus 247 ~~~~---qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPS-------a~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 247 NNFS---QLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPS-------ALQCLGYQIIKNVGP 303 (1021)
T ss_pred CcHH---HHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcC-------HHHHhccHHHhhcCC
Confidence 4322 22222222222222457899999999999999999999 999999999998754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=351.10 Aligned_cols=251 Identities=16% Similarity=0.187 Sum_probs=206.4
Q ss_pred ccCCCeEEE--eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee---
Q psy11874 111 ITYKTFRMY--RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--- 185 (767)
Q Consensus 111 i~~~~y~~~--~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--- 185 (767)
++.++++.. ..||+|++|.||+|.. +|+.||+|++.+.........+.+.+|+.+|++++|||||++++++.+
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 333444444 6899999999999998 699999999976543333335667899999999999999999999877
Q ss_pred -CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 186 -KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 186 -~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
...+++||||++||+|..++.+.+ .+++.....++.|++.||.|||+ .+++||||||+|||++++|.+||+|||+
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccch
Confidence 457999999999999999997653 68899999999999999999998 5999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCcceecC--CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC
Q psy11874 264 AVEIPEGESVRGRVGTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 264 a~~~~~~~~~~~~~GT~~Y~APEvl~~--~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~ 341 (767)
+...... .....||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+.......+.. .......+.
T Consensus 170 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~ 245 (283)
T PHA02988 170 EKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN--KNNSLKLPL 245 (283)
T ss_pred Hhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--cCCCCCCCC
Confidence 9865432 234578999999999976 6899999999999999999999999987654322222211 122334455
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
..++++++|+.+||+.||++||+ ++++++
T Consensus 246 ~~~~~l~~li~~cl~~dp~~Rps-------~~ell~ 274 (283)
T PHA02988 246 DCPLEIKCIVEACTSHDSIKRPN-------IKEILY 274 (283)
T ss_pred cCcHHHHHHHHHHhcCCcccCcC-------HHHHHH
Confidence 68999999999999999999999 777764
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=344.02 Aligned_cols=255 Identities=23% Similarity=0.359 Sum_probs=213.8
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhh---hhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI---KKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~---~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
+|++.+.||+|+||+||+|.. .+|+.+|+|.+..+.. ........+.+|+.+|++++|+||+++.+++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 477889999999999999987 4899999999865421 122334568889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG- 270 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~- 270 (767)
||||++||+|..++.+.+ .+++..+..++.|++.||+|||+.+|+|+||+|+||++++++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999999997654 5889999999999999999999999999999999999999999999999999765321
Q ss_pred ------CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCc
Q psy11874 271 ------ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFS 344 (767)
Q Consensus 271 ------~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s 344 (767)
.......||..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+. .........+..++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 235 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFS 235 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-hccCCCCCCCCCCC
Confidence 11234568999999999999999999999999999999999999997654322221111 11112234566789
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
+++.++|.+||.++|++||+ +.++++||||
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~-------~~~~l~~~~~ 265 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPS-------ALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHHhcCCcccCCC-------HHHHhcCCCC
Confidence 99999999999999999998 9999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=346.22 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=210.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeC------
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETK------ 186 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~------ 186 (767)
+.|++.+.||+|+||.||+|....+++.||+|.+.... .....+.+|+.++.++ +|+||+++.+.+...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46888899999999999999999999999999986542 2345678899999998 799999999998753
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
..+|+||||+++|+|..++.... ...+++..+..++.|++.||.|||+++|+||||||+||++++++.++|+|||++..
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 56899999999999999987643 33589999999999999999999999999999999999999999999999999986
Q ss_pred cCCC-CcccccccccccCCcceec-----CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC
Q psy11874 267 IPEG-ESVRGRVGTVGYMAPEVID-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS 340 (767)
Q Consensus 267 ~~~~-~~~~~~~GT~~Y~APEvl~-----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~ 340 (767)
.... .......|++.|+|||++. +..|+.++|+||+||++|||++|..||.............. .......+
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~ 238 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--NPAPRLKS 238 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--CCCCCCCC
Confidence 5432 2234467999999999986 34688999999999999999999999976543222221111 11111223
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
..++.++++|+.+||..||.+||+ +++++.||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt-------~~~il~~~~~ 272 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPT-------TEQLMKHPFI 272 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCC-------HHHHhhCCCC
Confidence 467899999999999999999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=342.48 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=217.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|..+.+++.||+|.+..... ...+.+|++++++++||||+++++.+.+...+|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3689999999999999999999999999999999865422 56788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
+||++|++|.+++...+ ..+++..+..++.|++.||.|||+.+|+||||+|+||++++++.++|+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred EecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999999987643 368999999999999999999999999999999999999999999999999998765443
Q ss_pred cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...........+.. ........+..++.++.++|
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-KPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc-CCCCCCCchhhcCHHHHHHH
Confidence 22345689999999999999999999999999999999999999976543222211111 11111223345788999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.+||+.||++||+ +.++++||||
T Consensus 234 ~~~l~~~P~~Rps-------~~~il~~~~~ 256 (256)
T cd06612 234 KKCLVKDPEERPS-------AIQLLQHPFI 256 (256)
T ss_pred HHHHhcChhhCcC-------HHHHhcCCCC
Confidence 9999999999999 9999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=347.22 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=218.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||.|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++|+||+++.+.+.+...+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46888999999999999999999999999999986543 2233456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Cc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~ 272 (767)
||++|++|..++... .+++..+..++.|++.||.|||+.+++||||+|+||+++++|.++|+|||+++..... ..
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 999999999988753 6899999999999999999999999999999999999999999999999999877544 22
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCC-CcHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR-FSDDAKALC 351 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~-~s~~~~dLi 351 (767)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+. .......+.. +++++.+++
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP---KNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh---hcCCCCCcccccCHHHHHHH
Confidence 344578999999999998889999999999999999999999997655332222221 1222333334 889999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.+||..+|++||+ ++++++||||++.
T Consensus 232 ~~~l~~~p~~Rpt-------~~~il~~~~~~~~ 257 (274)
T cd06609 232 SLCLNKDPKERPS-------AKELLKHKFIKKA 257 (274)
T ss_pred HHHhhCChhhCcC-------HHHHhhChhhcCC
Confidence 9999999999998 9999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=347.19 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=205.8
Q ss_pred CCeEEEeEE--eecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHh-cCCCceeEEEEEEeeCCeEE
Q psy11874 114 KTFRMYRVL--GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 114 ~~y~~~~~L--G~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+.|++.+.+ |+|+||.||+|..+.+|..||+|.+.+...... |..+... .+||||+++++.+...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 355566655 999999999999999999999999876532211 2222222 27999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-CEEEeecCcccccCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-HVRISDLGLAVEIPE 269 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-~vkL~DFGla~~~~~ 269 (767)
+||||++||+|..++.+.. .+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999999999987653 689999999999999999999999999999999999999998 999999999976543
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh-hhhhhhhhhhccccccCCCCcHHHH
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV-KRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~-~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
. ....||+.|+|||++.+..++.++|+||+||++|+|++|..||....... ....+.... ......+..+|+.++
T Consensus 163 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 163 P---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNAN 238 (267)
T ss_pred C---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHH
Confidence 2 23468999999999999999999999999999999999999997553322 122222222 333345567899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
++|.+||+.||.+|++ +++++++||||++
T Consensus 239 ~li~~~l~~~p~~R~~------~~~~~l~h~~~~~ 267 (267)
T PHA03390 239 DFVQSMLKYNINYRLT------NYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHhccChhhCCc------hHHHHhcCCcccC
Confidence 9999999999999997 3699999999975
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=341.58 Aligned_cols=260 Identities=29% Similarity=0.450 Sum_probs=222.5
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|++|.||+|++..+|+.||+|++...... .....+.+|+.++.+++|+|++++++.+...+.+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4689999999999999999999999999999998765322 34567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
||++|++|..++.+.. .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999998753 68999999999999999999999 9999999999999999999999999999987654433
Q ss_pred c-cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCC-CcHHHHHH
Q psy11874 273 V-RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR-FSDDAKAL 350 (767)
Q Consensus 273 ~-~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~-~s~~~~dL 350 (767)
. ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.........+.............+.. ++..+.++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 2 255789999999999998999999999999999999999999977642111111112222233344455 88999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
|.+||..+|++||+ +.++++||||+.++
T Consensus 236 i~~~l~~~p~~R~~-------~~~ll~~~~~~~~~ 263 (264)
T cd06623 236 ISACLQKDPKKRPS-------AAELLQHPFIKKAD 263 (264)
T ss_pred HHHHccCChhhCCC-------HHHHHhCHHHHhcc
Confidence 99999999999999 99999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=361.29 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=210.7
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC------
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------ 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 186 (767)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.++++++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3689999999999999999999999999999999865421 223344577899999999999999999988644
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
...|+||||+. |+|...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 35799999997 478777653 388999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc----------
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA---------- 336 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~---------- 336 (767)
...........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 7555444556789999999999999999999999999999999999999976654322222211100000
Q ss_pred --------c--------------cc-------CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 337 --------E--------------KY-------SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 337 --------~--------------~~-------~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
. .+ +...++.++++|.+||+.||++||+ +.|+++||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~eiL~~~~~~~ 316 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS-------VDDALQHPYINV 316 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC-------HHHHhcChhHhh
Confidence 0 00 1134667899999999999999999 999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=346.40 Aligned_cols=257 Identities=28% Similarity=0.401 Sum_probs=214.2
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||.|+||.||+|.+..+|+.||+|++...... ......+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 588999999999999999999999999999998765432 2334568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--c
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE--S 272 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~--~ 272 (767)
|+ |++|..++.+.. ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....... .
T Consensus 80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 99 999999887643 368999999999999999999999999999999999999999999999999998765443 2
Q ss_pred ccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc----------------
Q psy11874 273 VRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED---------------- 335 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~---------------- 335 (767)
.....||..|+|||++.+. .++.++||||+||++|||++|.+||.+.........+.......
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 3445799999999998654 46899999999999999999999997665432222221111000
Q ss_pred ----------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 336 ----------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 336 ----------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
........+.++.++|++||..||++||+ ++++++||||.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~-------~~~~l~h~~~~ 286 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS-------AAEALRHPYFT 286 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC-------HHHHhhCcCcC
Confidence 00112345789999999999999999999 99999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=344.35 Aligned_cols=258 Identities=25% Similarity=0.387 Sum_probs=216.6
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhh---hhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
+|+..+.||+|+||.||+|....+|+.+|+|++....... ......+.+|+.++++++|+||+++++.+.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999999999999999987543221 2235678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-CEEEeecCcccccCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-HVRISDLGLAVEIPEG 270 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-~vkL~DFGla~~~~~~ 270 (767)
||||++|++|.+++.+.+ .+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999999997654 688999999999999999999999999999999999998876 5899999999776432
Q ss_pred Cc-----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh-hhccccccCCCCc
Q psy11874 271 ES-----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR-VKEDAEKYSCRFS 344 (767)
Q Consensus 271 ~~-----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~-i~~~~~~~~~~~s 344 (767)
.. .....||..|+|||++.+..++.++|+||+||++|+|++|..||...........+.+. ........+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 12346899999999998889999999999999999999999999755432222222111 1122344556789
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
+++.+++.+||..+|++||+ +.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~-------~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPP-------SRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcC-------HHHHhcCcccC
Confidence 99999999999999999998 99999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.27 Aligned_cols=255 Identities=23% Similarity=0.409 Sum_probs=218.5
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||+|+||.||.+....+|+.||+|.+....... .....+.+|+.++++++||||+++.+.+...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 5889999999999999999999999999999987654432 234568889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-c
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-V 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-~ 273 (767)
|++|++|..++.... ...+++..+..++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++........ .
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 80 YCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred cCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 999999999887643 23578999999999999999999999999999999999999999999999999976644322 2
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..... ...+.......+..++.++.++|.+
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV---LKIIRGSYPPVSSHYSYDLRNLVSQ 235 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH---HHHhcCCCCCCcccCCHHHHHHHHH
Confidence 2346899999999999888999999999999999999999999765432222 2222333334566789999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
||+.+|++||+ +.++++||||
T Consensus 236 ~l~~~p~~Rp~-------~~~vl~~~~~ 256 (256)
T cd08218 236 LFKRNPRDRPS-------VNSILEKNFI 256 (256)
T ss_pred HhhCChhhCcC-------HHHHhhCcCC
Confidence 99999999999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.17 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=215.7
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEcc-----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 184 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 184 (767)
.+..++|++.+.||+|+||.||+|..+. .+..||+|.+.... .......+.+|..+++.++||||+++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4456789999999999999999997653 35689999876442 2223345788999999999999999999999
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCC-------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEE
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGG-------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVR 257 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~-------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vk 257 (767)
+.+..|+||||++||+|..++.+.+. .+.++...+..++.||+.||.|||+++|+||||||+|||+++++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999999976432 23457788899999999999999999999999999999999999999
Q ss_pred EeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhh
Q psy11874 258 ISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVK 333 (767)
Q Consensus 258 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~ 333 (767)
|+|||+++....... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+..... +...+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~ 235 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLKFVM 235 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH
Confidence 999999976543222 112345778999999998899999999999999999998 789997654322 222222
Q ss_pred -ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh------CCCCCCCCh
Q psy11874 334 -EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ------AEFFKSTNW 386 (767)
Q Consensus 334 -~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~------HpfF~~i~w 386 (767)
......+...++.+++++.+||+.||++||+ +.++++ ||||++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-------~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 236 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT-------FLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcC-------HHHHHHHHHhhcCCCCCCCCC
Confidence 2223345567899999999999999999999 667665 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=352.04 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=218.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||.|+||.||+|....+|+.||+|.+..... .....+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 689999999999999999999999999999999865432 23456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES- 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~- 272 (767)
||++||+|..++.+. .+++..+..++.|++.||.|||+.||+||||||+|||++.+|.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 999999999988653 578999999999999999999999999999999999999999999999999976644332
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.. ........+..+++.+++|+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCCCCCccccCHHHHHHHH
Confidence 2345789999999999999999999999999999999999999976543221111111 111122234568899999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+||..||++||+ ++++++||||+..
T Consensus 251 ~~l~~~p~~Rps-------~~~il~~~~~~~~ 275 (297)
T cd06656 251 RCLEMDVDRRGS-------AKELLQHPFLKLA 275 (297)
T ss_pred HHccCChhhCcC-------HHHHhcCchhccc
Confidence 999999999998 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.53 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=212.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh--hhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--CCeE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMVLIEKQILQKINSRFVVSLAYAYET--KDAL 189 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 189 (767)
.+|+..+.||+|+||.||+|.+..+|+.||+|++...... ..+....+.+|+.++++++||||+++++.+.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688999999999999999999999999999998654321 22344568889999999999999999998876 3678
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
+++|||++|++|..++.+.+ .+++.....++.||+.||+|||+.+|+||||||+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 99999999999999997654 588999999999999999999999999999999999999999999999999976532
Q ss_pred C----CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 270 G----ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 270 ~----~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
. .......|+..|+|||.+.+..++.++|+||+||++|||++|+.||............ ........++..+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 236 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI--ATQPTNPQLPSHISE 236 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH--hcCCCCCCCchhcCH
Confidence 1 1123346899999999999988999999999999999999999999765432222111 111123444567889
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
.++++| +||..+|++||+ ++||++||||+
T Consensus 237 ~~~~li-~~~~~~p~~Rp~-------~~eil~hp~~~ 265 (266)
T cd06651 237 HARDFL-GCIFVEARHRPS-------AEELLRHPFAQ 265 (266)
T ss_pred HHHHHH-HHhcCChhhCcC-------HHHHhcCcccc
Confidence 999999 566689999998 99999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.66 Aligned_cols=263 Identities=25% Similarity=0.344 Sum_probs=213.8
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC--CeE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK--DAL 189 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l 189 (767)
..++|++.+.||.|+||.||+|.++.+|+.||+|++...... ........+|+.++++++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 357899999999999999999999999999999998654322 12233456799999999999999999998755 579
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
++||||+.+ +|...+.... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999999974 7888877643 3689999999999999999999999999999999999999999999999999987654
Q ss_pred CC-cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc----------
Q psy11874 270 GE-SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE---------- 337 (767)
Q Consensus 270 ~~-~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~---------- 337 (767)
.. ......+++.|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+.......+.........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 32 2333456889999999865 56899999999999999999999999876654433333221110000
Q ss_pred ----------c------cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 338 ----------K------YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 338 ----------~------~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
. ....+++++.++|.+||..||++||+ ++++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t-------~~~il~h~~f~~~~ 297 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT-------AEEALESSYFKEKP 297 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC-------HHHHhcChhhccCC
Confidence 0 01235889999999999999999999 99999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=372.64 Aligned_cols=252 Identities=24% Similarity=0.255 Sum_probs=204.7
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
...|.+.+.||+|+||.||+|.+..+++.||+|.... ....+|+++|++++|+|||++++++...+..|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3479999999999999999999999999999996422 2246799999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
||++. |+|..++.... ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.......
T Consensus 239 ~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 239 LPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99996 68888876542 2689999999999999999999999999999999999999999999999999986543322
Q ss_pred ---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh----hhhhhhhhhhccc---ccc---
Q psy11874 273 ---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV----KRDEVDRRVKEDA---EKY--- 339 (767)
Q Consensus 273 ---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~----~~~~i~~~i~~~~---~~~--- 339 (767)
....+||+.|+|||++.+..++.++|||||||+||||++|..|+....... ...++.+.+.... ..+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 224579999999999999999999999999999999999886653321100 0011111111000 000
Q ss_pred ----------------------------CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 340 ----------------------------SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 340 ----------------------------~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
...++.++.+||.+||+.||.+||+ +.|+++||||++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs-------a~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS-------AAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC-------HHHHhhCcccCC
Confidence 0135678999999999999999999 999999999975
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=338.53 Aligned_cols=255 Identities=23% Similarity=0.373 Sum_probs=219.7
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||+|+||.||+|....+++.+|+|.+...... ......+.+|+.+|++++||||+++++.+...+.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 488999999999999999999999999999998765432 2345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-CEEEeecCcccccCCCCcc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-HVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-~vkL~DFGla~~~~~~~~~ 273 (767)
|++|++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 999999999997653 23589999999999999999999999999999999999998654 5799999999887665544
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+ ........+..+++++++++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI---MSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH---HhcCCCCCCCCcCHHHHHHHHH
Confidence 5567999999999999888999999999999999999999999776543222222 2222334556789999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
||..||++||+ +.++++||||
T Consensus 236 ~l~~~p~~Rpt-------~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQ-------LSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCC-------HHHHhhCCCC
Confidence 99999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.65 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=212.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhh--hhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC--CeE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGESMVLIEKQILQKINSRFVVSLAYAYETK--DAL 189 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l 189 (767)
++|++.+.||+|+||.||.|.+..+|+.||+|.+..... ........+.+|+.++++++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999999864321 1223456788899999999999999999988763 578
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
++||||++||+|.+++.+.. .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 99999999999999987653 578999999999999999999999999999999999999999999999999976532
Q ss_pred C----CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 270 G----ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 270 ~----~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
. .......||..|+|||++.+..++.++|+|||||++|||++|+.||............. ........+..++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 236 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA--TQPTNPVLPPHVSD 236 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh--cCCCCCCCchhhCH
Confidence 1 11233568999999999988889999999999999999999999997653322221111 11112334567888
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
.+.++|.+||. +|++||+ ++++++|||++
T Consensus 237 ~~~~~i~~~l~-~p~~Rp~-------~~~il~~~~~~ 265 (265)
T cd06652 237 HCRDFLKRIFV-EAKLRPS-------ADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHHhc-ChhhCCC-------HHHHhcCcccC
Confidence 99999999995 9999999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=349.24 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=212.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++.+..... .....+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999999999999986643322 33456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-c
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-S 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~ 272 (767)
||+++++|..+..... .+++..+..++.||+.||.|||+.||+||||+|+||++++++.++|+|||++....... .
T Consensus 80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred ecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 9999999987765432 58999999999999999999999999999999999999999999999999998764432 2
Q ss_pred ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc-----------------
Q psy11874 273 VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE----------------- 334 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~----------------- 334 (767)
.....|+..|+|||++.+ ..++.++|+|||||++|||++|.+||...........+......
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 344568999999999865 45788999999999999999999999765432211111110000
Q ss_pred ----------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 335 ----------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 335 ----------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
......+.++..+.+|+.+||..+|++||+ +.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~-------~~~il~~~~~ 286 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS-------SSQLLHHEFF 286 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh-------HHHHhcCCCC
Confidence 000113467889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.00 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=215.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||.|+||.||+|....+++.+|+|.+..... .....+.+|+.++++++||||+++++.+.+.+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 689999999999999999999999999999999875432 24567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-c
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-S 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~ 272 (767)
||++|++|..++.... ..+++..+..++.|++.||.|||+.+|+||||||+||+++++|.++|+|||++....... .
T Consensus 80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 9999999999887642 368999999999999999999999999999999999999999999999999998765432 2
Q ss_pred ccccccccccCCcceecCC---CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh-hccccccCCCCcHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNE---KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV-KEDAEKYSCRFSDDAK 348 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~---~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i-~~~~~~~~~~~s~~~~ 348 (767)
.....|+..|+|||++.+. .++.++|+|||||++|+|++|.+||...+.......+.... ...........+.++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 3345789999999999776 88999999999999999999999997765332222221110 1111112335678899
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEF 380 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~Hpf 380 (767)
+++++||..+|.+||+ +.+++.|||
T Consensus 238 ~li~~~l~~~p~~Rpt-------~~~il~~~~ 262 (262)
T cd06613 238 DFIKKCLTKDPKKRPT-------ATKLLQHPF 262 (262)
T ss_pred HHHHHHcCCChhhCCC-------HHHHhcCCC
Confidence 9999999999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.03 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=221.7
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
-|.++..||+|+||.||+|.++.+|..+|+|.+... ...+.+..|+.||+++.+|+||++|+.|-....+++|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 477889999999999999999999999999997543 346678999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-c
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-V 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-~ 273 (767)
||..|+..+.++.++ ..+++.++..++...+.||+|||...-||||||..||||+.+|+.||+|||.|-++.+... -
T Consensus 109 YCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 999999999887754 4799999999999999999999999999999999999999999999999999987755432 3
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc--CCCCcHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY--SCRFSDDAKALC 351 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~--~~~~s~~~~dLi 351 (767)
++..|||.|||||++..-+|+.++|+||||++..||..|++||.+.+.+ ..+.-.-.+.++.+ |..+|.+..|++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence 4567999999999999999999999999999999999999999877643 22221112223333 456899999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
++||.++|++|-+ |.++++|||.++..
T Consensus 264 ~~CLiK~PE~R~T-------A~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 264 RSCLIKKPEERKT-------ALRLCEHTFIKNAP 290 (502)
T ss_pred HHHhcCCHHHHHH-------HHHHhhhhhhcCCC
Confidence 9999999999977 99999999999853
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.33 Aligned_cols=257 Identities=24% Similarity=0.428 Sum_probs=207.9
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||.|++|.||+|..+.+|+.||+|.+..... ......+.+|+.++++++|+||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999865431 12233467899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
|||+++ +|..++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++.......
T Consensus 82 ~e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 999985 9998887653 268999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhh-hhhhhhhhhhhc---------------
Q psy11874 272 SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-VKRDEVDRRVKE--------------- 334 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~-~~~~~i~~~i~~--------------- 334 (767)
......+++.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.... .....+.+....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1223457899999999865 56899999999999999999999999765421 111111100000
Q ss_pred -----------cccccCCCCc--HHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 335 -----------DAEKYSCRFS--DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 335 -----------~~~~~~~~~s--~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
........++ .++.+++.+||+.+|++||+ +.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps-------~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS-------AAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC-------HHHHhcCCCC
Confidence 0000112344 88999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.64 Aligned_cols=255 Identities=22% Similarity=0.388 Sum_probs=219.1
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|+.+++||.|+||.||.++...+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 5899999999999999999999999999999987654333 334567899999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-cc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~ 273 (767)
|++||+|..++.... ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 999999999987653 3468999999999999999999999999999999999999999999999999998764433 23
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
....||+.|+|||++.+..++.++|+|||||++|||++|..||...........+. .......+..++.++.++|.+
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV---QGNYTPVVSVYSSELISLVHS 235 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---cCCCCCCccccCHHHHHHHHH
Confidence 45679999999999988889999999999999999999999997754433222222 122223345678999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
||.++|.+||+ +.++++|||+
T Consensus 236 ~l~~~p~~R~s-------~~~ll~~~~l 256 (256)
T cd08221 236 LLQQDPEKRPT-------ADEVLDQPLL 256 (256)
T ss_pred HcccCcccCCC-------HHHHhhCcCC
Confidence 99999999998 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.08 Aligned_cols=256 Identities=20% Similarity=0.301 Sum_probs=205.7
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEcc----------------CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCc
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRA----------------TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~----------------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~ 175 (767)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|.+++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 45789999999999999999998642 34579999986542 2234556889999999999999
Q ss_pred eeEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCC----------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcc
Q psy11874 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGG----------------EPGFDIARARFYAAEVLCGLEHLHYIGLV 239 (767)
Q Consensus 176 Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~----------------~~~l~~~~~~~~~~qIl~aL~yLH~~~Iv 239 (767)
|+++++++.+.+..|+||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999999999999999999999999998865321 12467888999999999999999999999
Q ss_pred cccCCcceEEeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc--CCC
Q psy11874 240 YRDCKPENILLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE--GQA 314 (767)
Q Consensus 240 HrDLKPeNILld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt--G~~ 314 (767)
||||||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999987644332 223456889999999988899999999999999999986 667
Q ss_pred CCCCchhhhhhhhhhhhhh----ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHH
Q psy11874 315 PFRRRKEMVKRDEVDRRVK----EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELK 376 (767)
Q Consensus 315 PF~~~~~~~~~~~i~~~i~----~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil 376 (767)
||...+.......+..... ......+...++.+.+|+.+||..||++||+ +++|.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-------~~~i~ 299 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS-------FSDIH 299 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC-------HHHHH
Confidence 8876543322222211111 1111234567899999999999999999999 77774
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.03 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=211.3
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|+..+.||.|+||.||+|.+..+|+.||+|++..... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48899999999999999999999999999999865432 22234568889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-cc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~ 273 (767)
|++ ++|..++.... ...+++..+..++.||+.||+|||+.+++||||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 80 FLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred ccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 996 68888886643 3468999999999999999999999999999999999999999999999999997654332 23
Q ss_pred cccccccccCCcceecCCC-CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc------------------
Q psy11874 274 RGRVGTVGYMAPEVIDNEK-YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE------------------ 334 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~-ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~------------------ 334 (767)
....+++.|+|||++.+.. ++.++|+|||||++|||++|+.||...++......+.+....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3446789999999987644 688999999999999999999999776543222221111100
Q ss_pred -------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 335 -------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 335 -------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
........++++++++|.+||+.||++||+ ++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt-------~~~~l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS-------AKAALAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC-------HHHHhcCCCC
Confidence 001112357889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=350.33 Aligned_cols=264 Identities=22% Similarity=0.352 Sum_probs=214.0
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~l 191 (767)
.++|+..+.||+|+||.||++.++.+|+.+|+|.+.+.... .....+.+|+.++.++. |+||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 35677788999999999999999999999999998765322 34456788999999996 9999999999999999999
Q ss_pred EEEeccCCCHHHH---HHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC-CcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 192 VLTIMNGGDLKFH---IYNMGGEPGFDIARARFYAAEVLCGLEHLHYI-GLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 192 V~E~~~gG~L~~~---l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~-~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
+|||+.+ +|..+ +... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++...
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EEecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9999874 44433 2222 124689999999999999999999974 9999999999999999999999999999876
Q ss_pred CCCCcccccccccccCCcceecCC---CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc----C
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDNE---KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY----S 340 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~~---~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~----~ 340 (767)
..........||+.|+|||++.+. .++.++|+||+||++|+|++|++||..... ..+.+.+......... +
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCCCcCC
Confidence 544333445789999999999765 689999999999999999999999976542 2222222222221122 2
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhH
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l 389 (767)
..+++++.+|+.+||++||++||+ +++|++||||+...|...
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt-------~~~i~~~~~~~~~~~~~~ 278 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPK-------YKELLEHPFIKDYEERNV 278 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcC-------HHHHhcChhhhchhhcch
Confidence 347899999999999999999999 999999999998765543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=349.97 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=215.1
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh--hhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
+|++.+.||+|+||.||+|..+.+|+.||+|.+...... .......+..|+.++++++|+||+++++++.+.+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999999999999999766443 122344567899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
|||+ +|+|..++.+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 899999887643 358999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc---------------
Q psy11874 272 SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED--------------- 335 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~--------------- 335 (767)
......+++.|+|||.+.+ ..++.++|+|||||++|||++|.+||.+.........+.+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 2334467899999999854 467899999999999999999999887765433322222111000
Q ss_pred ---------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 336 ---------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 336 ---------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
........+.++.++|.+||.+||++||+ +.|++.||||++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s-------~~e~l~~~~~~~~ 288 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT-------ARQALEHPYFSND 288 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC-------HHHHhhCccccCC
Confidence 00112345789999999999999999998 9999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.66 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=194.3
Q ss_pred EeEEeecCcEEEEEEEEcc--CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe--eCCeEEEEEE
Q psy11874 119 YRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE--TKDALCLVLT 194 (767)
Q Consensus 119 ~~~LG~G~fG~Vy~a~~~~--tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~l~lV~E 194 (767)
.+.||+|+||+||+|+.+. +++.||+|.+.... ....+.+|+.+|++++||||+++++++. ....+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 3689999999999999764 56899999986542 2234678999999999999999999885 4568999999
Q ss_pred eccCCCHHHHHHhcC------CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe----CCCCCEEEeecCcc
Q psy11874 195 IMNGGDLKFHIYNMG------GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL----DDYGHVRISDLGLA 264 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~------~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl----d~~g~vkL~DFGla 264 (767)
|+.+ +|...+.... ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.+|.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9975 6766664321 12348899999999999999999999999999999999999 56789999999999
Q ss_pred cccCCCC----cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhh---------hhhhh
Q psy11874 265 VEIPEGE----SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKR---------DEVDR 330 (767)
Q Consensus 265 ~~~~~~~----~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~---------~~i~~ 330 (767)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||....+.... ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 8664332 1334578999999999876 45899999999999999999999999754322110 00000
Q ss_pred h-----------hhc-----------------------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHH
Q psy11874 331 R-----------VKE-----------------------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELK 376 (767)
Q Consensus 331 ~-----------i~~-----------------------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil 376 (767)
. +.. .........+..+.+||.+||+.||.+||+ ++|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t-------~~e~l 312 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT-------SEQAL 312 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccC-------HHHHh
Confidence 0 000 000011234567899999999999999999 99999
Q ss_pred hCCCC
Q psy11874 377 QAEFF 381 (767)
Q Consensus 377 ~HpfF 381 (767)
+||||
T Consensus 313 ~hp~f 317 (317)
T cd07867 313 QDPYF 317 (317)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=348.05 Aligned_cols=259 Identities=27% Similarity=0.376 Sum_probs=217.1
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||+||+|....+|+.||+|++.... .......+.+|+++++.++||||+++++.+...+.+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4568999999999999999999999999999999986542 23345678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
||||++||+|..++...+ .+++..+..++.+++.||.|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999998887643 58999999999999999999997 69999999999999999999999999998765332
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh--------hhhhhhhhhhccccccCC-
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV--------KRDEVDRRVKEDAEKYSC- 341 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~--------~~~~i~~~i~~~~~~~~~- 341 (767)
.....+||..|+|||++.+..++.++|+|||||++|+|++|..||....... ....+...+.......+.
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 2234579999999999988899999999999999999999999997654320 011111112222222222
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
.++.++.+|+.+||.+||++||+ +.|+++||||..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt-------~~e~~~~~~~~~ 271 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPT-------PQQLCAMPPFIQ 271 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcC-------HHHHhcCccccc
Confidence 37889999999999999999999 999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=362.80 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=212.4
Q ss_pred hhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 106 ~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
...+.+....+.+.+.||+|-||+|+.|.++. ...+|+|.+.... ...+.+++|++||.+|+|++||+|++++..
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS----MSPEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc----cChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 34455666677888999999999999999973 3488999986543 234567899999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
++.+|||||||+.|+|.++|+.. ....+...+...+++||++||+||+++++|||||...||||++++.+||+|||||+
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccc
Confidence 88999999999999999999983 34579999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCccc--ccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 266 EIPEGESVR--GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 266 ~~~~~~~~~--~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
...++.... +..-...|.|||.+....++.+||||||||+||||+| |+.||.+....+..+.+.+ .....-|..
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~---GyRlp~P~~ 428 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER---GYRLPRPEG 428 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc---cCcCCCCCC
Confidence 655544322 2223678999999999999999999999999999998 9999988765444443333 233445678
Q ss_pred CcHHHHHHHHHhcccCcCccCCC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGC 365 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~ 365 (767)
+|+++-++...|+..+|++|||+
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF 451 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTF 451 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCH
Confidence 99999999999999999999994
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.75 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=210.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCe----
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDA---- 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~---- 188 (767)
++|++.+.||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++++. ||||+++++.+...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 469999999999999999999999999999999865432 2223456788999999995 5999999999987666
Q ss_pred -EEEEEEeccCCCHHHHHHhcCC--CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC-CCCEEEeecCcc
Q psy11874 189 -LCLVLTIMNGGDLKFHIYNMGG--EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-YGHVRISDLGLA 264 (767)
Q Consensus 189 -l~lV~E~~~gG~L~~~l~~~~~--~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-~g~vkL~DFGla 264 (767)
.|+||||+++ +|..++..... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999996 78888765432 235899999999999999999999999999999999999998 899999999999
Q ss_pred cccCCC-CcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc-------
Q psy11874 265 VEIPEG-ESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED------- 335 (767)
Q Consensus 265 ~~~~~~-~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~------- 335 (767)
...... .......+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.........+.+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 765332 22233467899999998865 567999999999999999999999998765433332222211100
Q ss_pred -----------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 336 -----------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 336 -----------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
.......+++++.+||.+||..||.+||+ ++|++.||||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~-------~~eil~~~~~~ 295 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS-------AKAALTHPYFD 295 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC-------HHHHhcCCCcC
Confidence 00111357899999999999999999998 99999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=343.73 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=214.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|++++++++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999865432 2334467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-- 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-- 271 (767)
||++++.|...+.+. ..+++..+..++.||+.||.|||+.+++||||+|+||++++++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 999988776655443 258999999999999999999999999999999999999999999999999998765543
Q ss_pred cccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh------------------
Q psy11874 272 SVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV------------------ 332 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i------------------ 332 (767)
......|+..|+|||++.+. .++.++|+||||+++|+|++|++||.+.........+....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 33456789999999999887 88999999999999999999999997654322111110000
Q ss_pred ----------hccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 333 ----------KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 333 ----------~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
......++..+++++++||++||..+|++||+ ++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-------~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT-------CDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc-------HHHHhcCCCC
Confidence 00011234456899999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=342.76 Aligned_cols=257 Identities=26% Similarity=0.355 Sum_probs=209.7
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEe-----eC
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYE-----TK 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~-----~~ 186 (767)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++. +.
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 478999999999999999999999999999999875432 1234567899999999 6999999999873 45
Q ss_pred CeEEEEEEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
+.+++||||++||+|...+.... ....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 67999999999999998876431 23468899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC-cccccccccccCCcceecC-----CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 266 EIPEGE-SVRGRVGTVGYMAPEVIDN-----EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 266 ~~~~~~-~~~~~~GT~~Y~APEvl~~-----~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
...... ......||+.|+|||++.. ..++.++||||+||++|||++|..||...+........... .......
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 251 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN-PPPTLHQ 251 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc-CCCcccC
Confidence 764332 2234579999999999853 45889999999999999999999999765432222111111 1111223
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
+..++.++.+++.+||+.||++||+ +.|+++||||
T Consensus 252 ~~~~~~~~~~li~~~l~~~p~~Rps-------~~ell~~~~~ 286 (286)
T cd06638 252 PELWSNEFNDFIRKCLTKDYEKRPT-------VSDLLQHVFI 286 (286)
T ss_pred CCCcCHHHHHHHHHHccCCcccCCC-------HHHHhhcccC
Confidence 4456889999999999999999999 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=342.42 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=205.6
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeC--CeEEEE
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETK--DALCLV 192 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~--~~l~lV 192 (767)
|++.+.||+|+||.||+|..+.+++.||+|++.+... .. ......+|+.++.++. |+|++++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999865421 11 2223457888999885 99999999999988 899999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
|||++| +|...+.... ..+++..+..++.||+.||+|||+.||+||||||+||+++. |.+||+|||++........
T Consensus 79 ~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 79 FELMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EecCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 999984 7777776542 36899999999999999999999999999999999999999 9999999999987755444
Q ss_pred ccccccccccCCcceec-CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc--------------c--
Q psy11874 273 VRGRVGTVGYMAPEVID-NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE--------------D-- 335 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~-~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~--------------~-- 335 (767)
.....+|+.|+|||++. +..++.++|+|||||++|||++|.+||.+.+.......+...... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 44567899999999864 455789999999999999999999999876543222111110000 0
Q ss_pred ---------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 336 ---------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 336 ---------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.......+|.+++++|.+||.+||++||+ ++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~-------~~~~l~~~~~ 282 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT-------AKQALRHPYF 282 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccC-------HHHHhhCCCC
Confidence 00112356899999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=343.87 Aligned_cols=258 Identities=28% Similarity=0.413 Sum_probs=217.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|+..+.||.|+||.||+|.++.+++.+|+|.+..... ......+.+|+.++++++||||+++++.+...+.+++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468888999999999999999999999999999876532 234566888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
||++|++|..++.... ..+++..+..++.|++.||.|||+ .|++||||||+||+++++|.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999999987753 368999999999999999999999 9999999999999999999999999999876543222
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchh--hhhhhhhhhhhhccccccCCC-CcHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKE--MVKRDEVDRRVKEDAEKYSCR-FSDDAKA 349 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~--~~~~~~i~~~i~~~~~~~~~~-~s~~~~d 349 (767)
....|+..|+|||.+.+..++.++|+|||||++|+|++|..||..... ......+...........+.. +++++++
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 226789999999999999999999999999999999999999965421 111112222222223333433 8899999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+|.+||..||++||+ +.+++.||||+.
T Consensus 236 li~~~l~~~p~~Rpt-------~~~ll~~~~~~~ 262 (265)
T cd06605 236 FVNLCLIKDPRERPS-------YKELLEHPFIKK 262 (265)
T ss_pred HHHHHcCCCchhCcC-------HHHHhhCchhhc
Confidence 999999999999999 999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=336.60 Aligned_cols=255 Identities=28% Similarity=0.438 Sum_probs=217.0
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh--hhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
+|+..+.||+|+||+||+|....++..||+|.+...... .......+.+|+.+++.++|+||+++++.+.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 367789999999999999999989999999998654321 223456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
|||++|++|..++.+.+ .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 99999999999987653 588999999999999999999999999999999999999999999999999987655444
Q ss_pred ccccccccccCCcceecCCC-CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEK-YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~-ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
.....|++.|+|||.+.... ++.++|+|||||++|+|++|..||.............. .......+..+++++++++
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--SKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--cccCCCcCCCcCHHHHHHH
Confidence 45567999999999987766 89999999999999999999999976543222211111 1223345667899999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.+||+.+|++||+ +.+++.|||+
T Consensus 236 ~~~l~~~p~~Rp~-------~~~~l~~~~~ 258 (258)
T cd06632 236 LKCLQRDPSLRPT-------AAELLEHPFV 258 (258)
T ss_pred HHHhhcCcccCcC-------HHHHhcCCCC
Confidence 9999999999998 9999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=342.27 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=209.9
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEee------
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYET------ 185 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~------ 185 (767)
.+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|..++.++ +|+||+++++.+..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 368999999999999999999999999999999986542 2234577899999998 79999999998853
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
.+.+|+||||+++|+|..++.... ...+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||++.
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 568999999999999999887653 2358899999999999999999999999999999999999999999999999987
Q ss_pred ccCCC-CcccccccccccCCcceec-----CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 266 EIPEG-ESVRGRVGTVGYMAPEVID-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 266 ~~~~~-~~~~~~~GT~~Y~APEvl~-----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
..... .......|++.|+|||++. +..++.++|+|||||++|||++|..||...........+.+. ......
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~ 247 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--PPPKLK 247 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC--CCCCCc
Confidence 65432 2234467999999999985 356888999999999999999999999765432222211111 011112
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
...++.++.+||.+||..||.+||+ +.+|++||||
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rp~-------~~ell~~~~~ 282 (282)
T cd06636 248 SKKWSKKFIDFIEGCLVKNYLSRPS-------TEQLLKHPFI 282 (282)
T ss_pred ccccCHHHHHHHHHHhCCChhhCcC-------HHHHhcCCCC
Confidence 2357899999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=361.98 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=209.3
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccCC-----cEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEE
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY 181 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 181 (767)
.+.+..++|++.+.||+|+||.||+|.+..+| +.||+|++..... ......+.+|+.+|+.+ +|+|||++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 34466678999999999999999999875444 5899999865432 22345688899999999 8999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCC---------------------------------------------------
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGG--------------------------------------------------- 210 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~--------------------------------------------------- 210 (767)
++...+.+|+|||||++|+|.+++.....
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 99999999999999999999999865311
Q ss_pred ----------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc-
Q psy11874 211 ----------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV- 273 (767)
Q Consensus 211 ----------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~- 273 (767)
...+++..++.++.||+.||.|||++||+||||||+|||+++++++||+|||+++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 124788999999999999999999999999999999999999999999999999876443221
Q ss_pred --cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 274 --RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 274 --~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
....+++.|||||++.+..++.++|||||||++|||++ |..||.............. .......+...+++++++
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK--RGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH--cccCccCCCCCCHHHHHH
Confidence 12235678999999988899999999999999999997 9999977543222211111 111223445678999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
|.+||+.||++||+ +.++.+
T Consensus 348 i~~cl~~dp~~RPs-------~~~l~~ 367 (374)
T cd05106 348 MKMCWNLEPTERPT-------FSQISQ 367 (374)
T ss_pred HHHHcCCChhhCcC-------HHHHHH
Confidence 99999999999999 777654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.81 Aligned_cols=253 Identities=18% Similarity=0.226 Sum_probs=209.1
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEc---cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
+..++|++.+.||+|+||.||+|.++ ..+..+|+|.+.... .......+.+|+.++.+++||||+++++++..++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34568999999999999999999875 346799999987542 2233456889999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+||||++||+|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999999987643 36899999999999999999999999999999999999999999999999988654
Q ss_pred CCCCcc--cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCc
Q psy11874 268 PEGESV--RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFS 344 (767)
Q Consensus 268 ~~~~~~--~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s 344 (767)
...... ....++..|+|||++.+..++.++|+|||||++|||++ |..||...........+.+. .....+..++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~ 234 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG---FRLPAPRNCP 234 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---CCCCCCCCCC
Confidence 332211 12345688999999999999999999999999999775 99999876543322222211 1233456788
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
..+.+++.+||+.+|++||+ +++|++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~-------~~~i~~ 260 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPR-------FSQIHS 260 (266)
T ss_pred HHHHHHHHHHcCCCchhCCC-------HHHHHH
Confidence 99999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=336.65 Aligned_cols=255 Identities=26% Similarity=0.442 Sum_probs=217.3
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--CCeEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--KDALCLV 192 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~lV 192 (767)
+|++.+.||.|+||.||+|.+..+|+.+|+|.+...... ......+..|+.++++++||||+++++.+.. +..+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 588999999999999999999999999999998765432 3335568889999999999999999987754 4578999
Q ss_pred EEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHH-----HCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 193 LTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLH-----YIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH-----~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
|||+++++|..++.... ....+++..++.++.||+.||.||| +.+|+||||||+||++++++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999999987642 2346899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCc-ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc-cccccCCCCc
Q psy11874 267 IPEGES-VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE-DAEKYSCRFS 344 (767)
Q Consensus 267 ~~~~~~-~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~~~~~s 344 (767)
...... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||....... +.+.+.. .....+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~ 235 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ----LASKIKEGKFRRIPYRYS 235 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH----HHHHHhcCCCCCCccccC
Confidence 765443 345679999999999998889999999999999999999999998765322 2222222 2234566788
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.++.+++.+||..+|++||+ +.+|++|||+
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~-------~~~il~~~~~ 265 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPS-------TEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHccCCcccCCC-------HHHHhhCCCC
Confidence 99999999999999999999 9999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=341.69 Aligned_cols=258 Identities=26% Similarity=0.350 Sum_probs=211.0
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeC-----
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETK----- 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~----- 186 (767)
.++|++.+.||+|+||.||+|....+|+.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 378999999999999999999999999999999986532 1234567899999998 899999999998754
Q ss_pred CeEEEEEEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
+.+|+||||++||+|..++.... ....+++..++.++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 36899999999999998886421 23368999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC-cccccccccccCCcceecCC-----CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 266 EIPEGE-SVRGRVGTVGYMAPEVIDNE-----KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 266 ~~~~~~-~~~~~~GT~~Y~APEvl~~~-----~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
...... ......|+..|+|||++... .++.++|+|||||++|||++|++||...+.......+.+.. ......
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 255 (291)
T cd06639 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP-PPTLLH 255 (291)
T ss_pred hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC-CCCCCc
Confidence 764432 22345789999999998543 36899999999999999999999997664432222221111 111122
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
+..++..++++|.+||+.+|++||+ +.++++||||+
T Consensus 256 ~~~~~~~l~~li~~~l~~~p~~Rps-------~~~il~~~~~~ 291 (291)
T cd06639 256 PEKWCRSFNHFISQCLIKDFEARPS-------VTHLLEHPFIK 291 (291)
T ss_pred ccccCHHHHHHHHHHhhcChhhCcC-------HHHHhcCcccC
Confidence 4457789999999999999999999 99999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=335.34 Aligned_cols=250 Identities=25% Similarity=0.405 Sum_probs=212.9
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||.|+||.||+|+++.+++.||+|.+.... .....+.+.+|..++++++|+||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5889999999999999999999999999999986543 22345567889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-c
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-V 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-~ 273 (767)
|++||+|..++.... ...+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||++........ .
T Consensus 79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 79 YCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred eCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 999999998887543 33589999999999999999999999999999999999999999999999999976643322 2
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+ ........+..++..+++||.+
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV---CQGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH---hcCCCCCCCcccCHHHHHHHHH
Confidence 3457999999999999889999999999999999999999999876543222222 1222334556788999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHh
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
||++||++||+ +.+++.
T Consensus 235 ~l~~~P~~Rp~-------~~~il~ 251 (255)
T cd08219 235 MFKRNPRSRPS-------ATTILS 251 (255)
T ss_pred HHhCCcccCCC-------HHHHhh
Confidence 99999999999 888875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=341.98 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=211.9
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||.|++|.||+|++..+|+.||+|++..... ......+.+|+.++++++|+||+++++.+.+.+.+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58899999999999999999999999999999875432 2234557789999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-cc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~ 273 (767)
|++| +|..++...+....+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||++....... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9985 888888765544568999999999999999999999999999999999999999999999999997654322 22
Q ss_pred cccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh-----------h---c----
Q psy11874 274 RGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV-----------K---E---- 334 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i-----------~---~---- 334 (767)
....+|+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+.+.. . .
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 34568999999999865 457899999999999999999999998765433222221110 0 0
Q ss_pred -------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 335 -------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 335 -------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
....+.+..++.+++++.+||+.||.+||+ +.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~-------~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS-------AHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC-------HHHHhcCCCC
Confidence 000112346789999999999999999998 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=337.89 Aligned_cols=257 Identities=26% Similarity=0.340 Sum_probs=210.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.+.....||+|+||.||+|.++.++..||+|.+.... ......+.+|+.++++++|+||+++++++...+..++|+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34444578999999999999999999999999986543 233456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC-CCCEEEeecCcccccCCCCc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-YGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-~g~vkL~DFGla~~~~~~~~ 272 (767)
||++|++|..++.........++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 99999999999986432212388889999999999999999999999999999999986 67999999999976543322
Q ss_pred -ccccccccccCCcceecCC--CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 273 -VRGRVGTVGYMAPEVIDNE--KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 273 -~~~~~GT~~Y~APEvl~~~--~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
.....|++.|+|||++.+. .++.++|+||+||++|+|++|.+||........ .............++..+++++++
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHhhhhhhccCCCCCcccCHHHHH
Confidence 2344689999999998654 388999999999999999999999965432111 111111223334566778999999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
++.+||..+|++||+ +.+++.||||
T Consensus 244 li~~~l~~~p~~Rpt-------~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRAS-------AHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCC-------HHHHHhCCCC
Confidence 999999999999998 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.42 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=213.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|+.+.+|+.||+|.+........+....+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999999999999999987654444555667888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 194 TIMNGGDLKFHIYNMGG-EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~-~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
||+++|+|..++..... ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988865322 23578999999999999999999999999999999999999999999999999987654322
Q ss_pred -ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc--cccccCCCCcHHHHH
Q psy11874 273 -VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE--DAEKYSCRFSDDAKA 349 (767)
Q Consensus 273 -~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~~~~~s~~~~d 349 (767)
.....|++.|+|||.+.+..++.++|+||+||++|||++|..||...... ...+...+.. .....+...+..+.+
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 23456899999999998888999999999999999999999999654321 1122222221 111122357789999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++.+||..+|++||+ +.++++
T Consensus 240 li~~cl~~~p~~Rp~-------~~~vl~ 260 (267)
T cd08228 240 LVSMCIYPDPDQRPD-------IGYVHQ 260 (267)
T ss_pred HHHHHCCCCcccCcC-------HHHHHH
Confidence 999999999999999 788775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.56 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=212.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC--CeEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK--DALCL 191 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~l 191 (767)
++|++.+.||.|+||.||+|.++.+++.+|+|.+...... ......+.+|+.++++++||||+++++++... +.+|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 5799999999999999999999999999999998755432 22334567899999999999999999998877 89999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG- 270 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~- 270 (767)
||||+++ +|...+.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 84 v~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999984 8988887643 26899999999999999999999999999999999999999999999999999876554
Q ss_pred CcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh----------------
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK---------------- 333 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~---------------- 333 (767)
.......+++.|+|||++.+. .++.++|+|||||++|+|++|.+||...........+.....
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 223445689999999998654 468999999999999999999999987654333222221110
Q ss_pred -----------ccccccCCC-CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 334 -----------EDAEKYSCR-FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 334 -----------~~~~~~~~~-~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.....++.. +++.++++|++||+.||++||+ +.|+++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-------~~ell~~~~f 293 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS-------AEDALKHPYF 293 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC-------HHHHhcCCCC
Confidence 001112222 5889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=339.06 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=211.2
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhh-------hhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-------RKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~-------~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
+|.+.+.||.|+||.||+|....+|+.+|+|.+....... ....+.+..|+.++++++|||++++++.+...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4788899999999999999999999999999886432211 112346778999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
..++||||++||+|..++.+.+ .+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 9999999999999999987753 6899999999999999999999999999999999999999999999999999765
Q ss_pred CCCC---cccccccccccCCcceecCCC--CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc--cccccC
Q psy11874 268 PEGE---SVRGRVGTVGYMAPEVIDNEK--YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE--DAEKYS 340 (767)
Q Consensus 268 ~~~~---~~~~~~GT~~Y~APEvl~~~~--ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~~ 340 (767)
.... ......|+..|+|||++.... ++.++|+||||+++|+|++|..||..........++...... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 4321 123456899999999987654 889999999999999999999999655432222221111100 111122
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
..++.++++++.+||.++|++||+ ++++++||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps-------~~~il~~~~~ 272 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPT-------ARELLQHPFI 272 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCC-------HHHHhhCCCC
Confidence 356899999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=382.24 Aligned_cols=150 Identities=31% Similarity=0.531 Sum_probs=139.0
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..++||||+++++.+...+.+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999876655555567788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
|||+.||+|..++...+ .+++..++.|+.||+.||.|||+.+||||||||+|||++.+|++||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999987654 58899999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=334.91 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=214.9
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|.+.+.||+|+||.||+|....+++.||+|.+...... ......+.+|+.++++++|+||+++++.+.+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 488899999999999999999999999999998766433 3466788999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc--
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-- 272 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-- 272 (767)
|+++++|.+++.+.. .+++..+..++.|++.||.|||+.||+||||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 999999999987643 578999999999999999999999999999999999999999999999999987654322
Q ss_pred ---ccccccccccCCcceecCCC---CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCC--Cc
Q psy11874 273 ---VRGRVGTVGYMAPEVIDNEK---YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR--FS 344 (767)
Q Consensus 273 ---~~~~~GT~~Y~APEvl~~~~---ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~--~s 344 (767)
.....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||........ .............+.. .+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 234 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFHVGAGHKPPIPDSLQLS 234 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHHHhcCCCCCCCcccccC
Confidence 12356899999999997766 89999999999999999999999975432111 1111111222333433 48
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
+.+.++|.+||+.+|.+||+ +.+++.|||+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~-------~~~i~~~~~~ 264 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPT-------ASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHHccCCcccCCC-------HHHHhcCCCC
Confidence 99999999999999999998 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.17 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=213.0
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCC-----cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
++.++|++.+.||+|+||.||+|.....+ +.+|+|.+.... .......+.+|+.++++++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 45578999999999999999999987655 789999986442 22334568889999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD 252 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~ 252 (767)
....|++|||+++|+|.+++..... ...+++..+..++.||+.||.|||+.||+||||||+||++++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 9999999999999999999976422 135888999999999999999999999999999999999999
Q ss_pred CCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhh
Q psy11874 253 YGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEV 328 (767)
Q Consensus 253 ~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i 328 (767)
++.++|+|||++........ .....+|+.|+|||.+.+..++.++|+|||||++|||++ |..||.+.........+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999976543321 234467899999999988899999999999999999998 99999876543322222
Q ss_pred hhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 329 DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 329 ~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.. ......+..+++++.+|+.+||+.||.+||+ +++|++|
T Consensus 240 ~~---~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~-------~~~i~~~ 279 (283)
T cd05048 240 RS---RQLLPCPEDCPARVYALMIECWNEIPARRPR-------FKDIHTR 279 (283)
T ss_pred Hc---CCcCCCcccCCHHHHHHHHHHccCChhhCcC-------HHHHHHH
Confidence 21 1223345678999999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=342.32 Aligned_cols=258 Identities=35% Similarity=0.608 Sum_probs=222.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lV 192 (767)
++|.+.+.||+|+||.||+|..+.+|+.||+|++.+...........+.+|..++++++ ||||+++++.+.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998766555555677888999999998 99999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
||+++|++|..++.+.+ .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+|.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999998754 69999999999999999999999999999999999999999999999999997654322
Q ss_pred --------------------cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh
Q psy11874 272 --------------------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR 331 (767)
Q Consensus 272 --------------------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~ 331 (767)
......|+..|+|||++.+..++.++|+|||||++++|++|..||........ .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~ 233 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT----FQK 233 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH----HHH
Confidence 11234588999999999888899999999999999999999999987654222 223
Q ss_pred hhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 332 VKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 332 i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
+......++..+++.+.++|.+||+.||++||++.. +.+++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~---~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNE---GYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCccc---CHHHHhcCCCC
Confidence 333444566788999999999999999999999321 23999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.76 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=208.0
Q ss_pred CeEEEeEEeecCcEEEEEEEEcc--CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC--CeEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK--DALC 190 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~--tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~ 190 (767)
.|++.+.||+|+||.||+|..+. +|+.||+|.+.+...........+.+|+.++++++||||+++++++.+. +.+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999999875433344455678899999999999999999999988 8899
Q ss_pred EEEEeccCCCHHHHHHhcCC--CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC----CCCEEEeecCcc
Q psy11874 191 LVLTIMNGGDLKFHIYNMGG--EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD----YGHVRISDLGLA 264 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~--~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~----~g~vkL~DFGla 264 (767)
+||||+++ +|...+..... ...+++..+..++.||+.||.|||+.+|+||||||+|||++. +|.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999985 66666654321 226899999999999999999999999999999999999999 999999999999
Q ss_pred cccCCCCc----ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhh---------hhhhhh
Q psy11874 265 VEIPEGES----VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK---------RDEVDR 330 (767)
Q Consensus 265 ~~~~~~~~----~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~---------~~~i~~ 330 (767)
........ .....+|+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+...... ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86543321 234568999999998866 4589999999999999999999999976544320 000000
Q ss_pred hhh----------------------ccccccC-----------CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 331 RVK----------------------EDAEKYS-----------CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 331 ~i~----------------------~~~~~~~-----------~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+. .....++ ...+.++.++|.+||+.||++||+ ++++++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps-------~~eil~ 312 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT-------AEEALE 312 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC-------HHHHhc
Confidence 000 0000001 156788999999999999999999 999999
Q ss_pred CCCC
Q psy11874 378 AEFF 381 (767)
Q Consensus 378 HpfF 381 (767)
||||
T Consensus 313 ~~~f 316 (316)
T cd07842 313 HPYF 316 (316)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=359.28 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=207.6
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEE-----ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAY 183 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~ 183 (767)
.+..++|++.+.||+|+||.||+|+. ..++..||+|++.... .......+.+|+.+|..+ +|||||++++++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34556899999999999999999974 3467799999986432 223345688999999999 899999999999
Q ss_pred eeCCeEEEEEEeccCCCHHHHHHhcCC-----------------------------------------------------
Q psy11874 184 ETKDALCLVLTIMNGGDLKFHIYNMGG----------------------------------------------------- 210 (767)
Q Consensus 184 ~~~~~l~lV~E~~~gG~L~~~l~~~~~----------------------------------------------------- 210 (767)
.+.+..++|||||+||+|..++.....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999999999999875321
Q ss_pred -------------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 211 -------------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 211 -------------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 1247888999999999999999999999999999999999999999999999998764432
Q ss_pred c---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhcc-ccccCCCCcHH
Q psy11874 272 S---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKED-AEKYSCRFSDD 346 (767)
Q Consensus 272 ~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~-~~~~~~~~s~~ 346 (767)
. .....++..|+|||++.+..++.++|||||||++|||++ |..||......... .+.+... ....+...+.+
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF---YKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH---HHHHHhCccCCCCCCCCHH
Confidence 2 112345678999999999999999999999999999997 89999765332211 1112211 12234456889
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++||.+||..||++||+ +.+|++
T Consensus 346 l~~li~~cl~~dP~~RPs-------~~eil~ 369 (375)
T cd05104 346 MYDIMKSCWDADPLKRPT-------FKQIVQ 369 (375)
T ss_pred HHHHHHHHccCChhHCcC-------HHHHHH
Confidence 999999999999999999 888775
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=346.29 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=208.3
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcE--EEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKM--YACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~--~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 187 (767)
+..++|++.+.||+|+||.||+|.++.+|.. +|+|.+... ........+.+|+.++.++ +|+||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 5568999999999999999999999888765 477765432 2234456678899999999 8999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG 254 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g 254 (767)
..|+||||++||+|..++...+. ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 99999999999999999976431 23578999999999999999999999999999999999999999
Q ss_pred CEEEeecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhh
Q psy11874 255 HVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVK 333 (767)
Q Consensus 255 ~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~ 333 (767)
.+||+|||++.............++..|+|||++.+..++.++|+|||||++|||++ |..||.+.+...... .+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~~ 237 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KLP 237 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH----HHh
Confidence 999999999864322211222335678999999988889999999999999999998 999997654432222 222
Q ss_pred cc-ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 334 ED-AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 334 ~~-~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.. ....+..+++++.+|+.+||+.+|++||+ +++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~-------~~~il~~ 276 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPS-------FAQILVS 276 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcC-------HHHHHHH
Confidence 11 22334567899999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=342.70 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=212.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|++|.||+|.++.+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 679999999999999999999999999999999865432 2223456778999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC-CCCEEEeecCcccccCCCC-
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-YGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-~g~vkL~DFGla~~~~~~~- 271 (767)
||++ ++|..++.... ...+++..+..++.||+.||+|||+++|+||||+|+||+++. ++.+||+|||++.......
T Consensus 81 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 81 EYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred eccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 9996 57877776543 234688999999999999999999999999999999999985 5579999999997654322
Q ss_pred cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc---------------
Q psy11874 272 SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED--------------- 335 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~--------------- 335 (767)
......|++.|+|||++.+ ..++.++|+||+||++|+|++|.+||..........++.......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 2334568999999999866 457899999999999999999999997664432222221111000
Q ss_pred ----------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 336 ----------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 336 ----------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
.......+++++++++.+||+.+|++||+ +.++++||||++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps-------~~~~l~~~~~~~~~ 291 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT-------ARAALEHEYFKDLG 291 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC-------HHHHhcCchHhHHh
Confidence 00112457899999999999999999998 99999999998753
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=336.54 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=211.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCC----
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD---- 187 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~---- 187 (767)
.++|++.+.||.|+||.||+|.++.+++.+|+|++..... ....+.+|+.+++++ +|+||+++++.+.+..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4789999999999999999999999999999999865432 235688899999999 7999999999997644
Q ss_pred --eEEEEEEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 188 --ALCLVLTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 188 --~l~lV~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
.+|+||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 5999999999999998887532 1346899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-ccccccccccCCcceecC-----CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc
Q psy11874 265 VEIPEGES-VRGRVGTVGYMAPEVIDN-----EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK 338 (767)
Q Consensus 265 ~~~~~~~~-~~~~~GT~~Y~APEvl~~-----~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~ 338 (767)
........ .....|++.|+|||++.. ..++.++|+|||||++|+|++|.+||...........+..... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~ 239 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP-PTLK 239 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC-CCCC
Confidence 76543322 334568999999999853 3578899999999999999999999976543322222221111 1111
Q ss_pred cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 339 ~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.+..+++++++||.+||..||++||+ ++++++|||+
T Consensus 240 ~~~~~~~~~~~li~~~l~~dp~~Rpt-------~~~ll~~~~~ 275 (275)
T cd06608 240 SPENWSKKFNDFISECLIKNYEQRPF-------MEELLEHPFI 275 (275)
T ss_pred chhhcCHHHHHHHHHHhhcChhhCcC-------HHHHhcCCCC
Confidence 22347889999999999999999999 9999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=341.88 Aligned_cols=257 Identities=26% Similarity=0.357 Sum_probs=218.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
..|+..+.||.|+||.||+|.+..++..+|+|.+..... ......+.+|+.++++++||||+++++.+.+.+..|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 357788999999999999999999999999999875432 233466888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES- 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~- 272 (767)
||++||+|.+++... .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 82 EYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred ecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 999999999988642 588999999999999999999999999999999999999999999999999977644332
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
.....++..|+|||++.+..++.++|+|||||++|||++|.+||...........+ ........+..++.++.+++.
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI---PKNNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh---hcCCCCCCchhhhHHHHHHHH
Confidence 23346899999999998888999999999999999999999999765432222111 112233444567889999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
+||..+|++||+ +.++++||||.....
T Consensus 235 ~~l~~~p~~Rp~-------~~~il~~~~~~~~~~ 261 (277)
T cd06640 235 ACLNKDPSFRPT-------AKELLKHKFIVKNAK 261 (277)
T ss_pred HHcccCcccCcC-------HHHHHhChHhhhcch
Confidence 999999999998 999999999977643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=343.05 Aligned_cols=258 Identities=25% Similarity=0.320 Sum_probs=205.9
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC-----
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----- 187 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 187 (767)
.++|++.+.||+|+||.||+|..+.+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3689999999999999999999999999999999865432 2222335678999999999999999999887653
Q ss_pred ---eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 188 ---ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 188 ---~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
..++||||+. ++|...+.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4699999997 47877776542 35899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-----ccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc--
Q psy11874 265 VEIPEGES-----VRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA-- 336 (767)
Q Consensus 265 ~~~~~~~~-----~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~-- 336 (767)
........ .....++..|+|||++.+. .++.++|+|||||++|||++|.+||.+.+.......+........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 76543221 2345688999999988664 478999999999999999999999977654322222211110000
Q ss_pred -------------cc------------c-CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 337 -------------EK------------Y-SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 337 -------------~~------------~-~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.. + +...++.+++||.+||..||++||+ ++++++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t-------~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID-------ADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC-------HHHHhcCCCC
Confidence 00 0 1123678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=380.79 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=204.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|++++++++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999997654333344567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCC--------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 194 TIMNGGDLKFHIYNMGG--------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~--------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
||++||+|..++.+... ....++..+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||+|.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999999875311 1235667788999999999999999999999999999999999999999999997
Q ss_pred ccCCCC-------------------cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhh
Q psy11874 266 EIPEGE-------------------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD 326 (767)
Q Consensus 266 ~~~~~~-------------------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~ 326 (767)
...... .....+||+.|||||++.+..++.++|||||||++|||++|..||........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki-- 239 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI-- 239 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh--
Confidence 652110 01124699999999999999999999999999999999999999976543211
Q ss_pred hhhhhhhcccccc--CCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 327 EVDRRVKEDAEKY--SCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 327 ~i~~~i~~~~~~~--~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
........+... ...+++.+.+++.+||..||++|++
T Consensus 240 -~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 240 -SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS 278 (932)
T ss_pred -hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcC
Confidence 111111111111 2367899999999999999999998
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.94 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=213.5
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEe
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
|.....||+|+||.||++....+++.||+|.+.... ......+.+|+.++++++|+||+++++.+...+..|+||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 444577999999999999999999999999986532 23345688899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-ccc
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SVR 274 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~~ 274 (767)
++|++|..++... .+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++....... ...
T Consensus 101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 9999999887542 58899999999999999999999999999999999999999999999999997653322 233
Q ss_pred ccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHh
Q psy11874 275 GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~l 354 (767)
...||+.|+|||++.+..++.++|+|||||++|||++|..||...........+.. ............+..+.+++.+|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCccccccccCHHHHHHHHHH
Confidence 45789999999999888999999999999999999999999976544322222211 11112222345788999999999
Q ss_pred cccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 355 L~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
|..||++||+ ++++++||||+...
T Consensus 256 l~~~P~~Rpt-------~~~il~~~~~~~~~ 279 (292)
T cd06658 256 LVREPSQRAT-------AQELLQHPFLKLAG 279 (292)
T ss_pred ccCChhHCcC-------HHHHhhChhhhccC
Confidence 9999999998 99999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=362.55 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=218.2
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGG 199 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG 199 (767)
-+||+|+||+||.|+++.|....|||.+.-+ .....+-+..|+.+.++++|.|||+..+.+..++.+-+.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 4899999999999999999999999998543 2334455778999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC-CCCCEEEeecCcccccCC-CCcccccc
Q psy11874 200 DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD-DYGHVRISDLGLAVEIPE-GESVRGRV 277 (767)
Q Consensus 200 ~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld-~~g~vkL~DFGla~~~~~-~~~~~~~~ 277 (767)
+|..++...=+.-.-.+..+-+|.+||+.||.|||++.|||||||-+|+|++ -.|.+||+|||.++++.. +..+.+..
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 9999998764433448899999999999999999999999999999999997 468999999999987643 34466788
Q ss_pred cccccCCcceecCC--CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhc
Q psy11874 278 GTVGYMAPEVIDNE--KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355 (767)
Q Consensus 278 GT~~Y~APEvl~~~--~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL 355 (767)
||..|||||++..+ +|+.++|||||||++.||.||++||.....- +.....-......++.|..+|.+|+.+|.+|+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-qAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-QAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-hHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 99999999999654 6999999999999999999999999654321 11112223445567788899999999999999
Q ss_pred ccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 356 KKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 356 ~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
..||..||+ |.++++.||++.-
T Consensus 817 epd~~~R~s-------A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 817 EPDPCDRPS-------AKDLLQDPFLQHN 838 (1226)
T ss_pred CCCcccCcc-------HHHhccCcccccC
Confidence 999999999 9999999999874
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.11 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=205.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|..+.+|+.||+|.+..... ......+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 689999999999999999999999999999999865432 223345678999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Cc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~ 272 (767)
||+. ++|...+.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||+++..... ..
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 9996 66766665432 25788899999999999999999999999999999999999999999999999764332 22
Q ss_pred ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhh-hhhhhhhhh--------------ccc
Q psy11874 273 VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK-RDEVDRRVK--------------EDA 336 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~-~~~i~~~i~--------------~~~ 336 (767)
.....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+...... ..++...+. ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 334568999999999875 4588999999999999999999999976543111 111100000 000
Q ss_pred cc------------cC--CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 337 EK------------YS--CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 337 ~~------------~~--~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.. .+ ...++++.+++.+||..||++||+ ++|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t-------~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS-------AQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC-------HHHHhcCCCC
Confidence 00 00 012678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=371.99 Aligned_cols=269 Identities=20% Similarity=0.282 Sum_probs=202.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCC-cEEEEE--------------EechhhhhhhhhHHHHHHHHHHHHhcCCCcee
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATG-KMYACK--------------KLEKKRIKKRKGESMVLIEKQILQKINSRFVV 177 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-~~~AiK--------------~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv 177 (767)
.++|++++.||+|+||+||+|..+... ...+.| .+.+...........+.+|+.+|++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999999876432 222222 11111111222345678999999999999999
Q ss_pred EEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCC--CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC
Q psy11874 178 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGG--EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH 255 (767)
Q Consensus 178 ~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~--~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~ 255 (767)
++++++.+.+..|+|++++. ++|..++..... ........++.++.||+.||.|||++|||||||||+|||++.+|.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999996 567666654321 123456778899999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCC-CCCch--hhhhhhhhhh
Q psy11874 256 VRISDLGLAVEIPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAP-FRRRK--EMVKRDEVDR 330 (767)
Q Consensus 256 vkL~DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~P-F~~~~--~~~~~~~i~~ 330 (767)
+||+|||+|..+..... ....+||+.|+|||++.+..|+.++|||||||++|||++|..| +.... ......++..
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 99999999987654332 2346799999999999999999999999999999999998764 43221 1111111111
Q ss_pred hhhcccccc----------------------------CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 331 RVKEDAEKY----------------------------SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 331 ~i~~~~~~~----------------------------~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
.+......+ ...++.++.++|.+||+.||.+||+ |.|+++||||.
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps-------a~elL~hp~f~ 458 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG-------AAELLALPLFS 458 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC-------HHHHhhChhhh
Confidence 111000000 1135678889999999999999999 99999999999
Q ss_pred CCChhhH
Q psy11874 383 STNWKRL 389 (767)
Q Consensus 383 ~i~w~~l 389 (767)
..+++.+
T Consensus 459 ~~~~~~~ 465 (501)
T PHA03210 459 AEEEEEI 465 (501)
T ss_pred cCCchHH
Confidence 8776654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.63 Aligned_cols=255 Identities=23% Similarity=0.411 Sum_probs=216.5
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||+|+||.||+|..+.+|+.+|+|.+....... .....+.+|+.++++++|+||+++++.+.+.+..|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4889999999999999999999999999999987654322 334567889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC-EEEeecCcccccCCCCc-
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH-VRISDLGLAVEIPEGES- 272 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~-vkL~DFGla~~~~~~~~- 272 (767)
|++|++|..++.... ...+++..+..++.|++.||.|||+.+|+|+||||+||++++++. ++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 80 YCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred cCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 999999999987653 235799999999999999999999999999999999999998865 69999999977654322
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
.....|++.|+|||++.+..++.++|+|||||++|||++|..||...+....... ............++.+++++|.
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK---ICQGYFAPISPNFSRDLRSLIS 235 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH---HhcccCCCCCCCCCHHHHHHHH
Confidence 2334689999999999888899999999999999999999999976643322222 2222223344567899999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
+||..+|++||+ ++++++||||
T Consensus 236 ~~l~~~p~~Rpt-------~~~ll~~~~~ 257 (257)
T cd08225 236 QLFKVSPRDRPS-------ITSILKRPFL 257 (257)
T ss_pred HHhccChhhCcC-------HHHHhhCCCC
Confidence 999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=337.39 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=213.4
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|+.+.+|+.+|+|.+.+...........+.+|+.+++.++||||+++++.+...+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57889999999999999999999999999999987655545555667889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 194 TIMNGGDLKFHIYNMGG-EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~-~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
||++|++|..++..... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998875322 34689999999999999999999999999999999999999999999999999877654332
Q ss_pred -ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc--ccccCCCCcHHHHH
Q psy11874 273 -VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED--AEKYSCRFSDDAKA 349 (767)
Q Consensus 273 -~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~~~~~s~~~~d 349 (767)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.... .....+.+... ....+..+++.+++
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 23457999999999999889999999999999999999999999765331 12222222211 11123457899999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHH
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELK 376 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil 376 (767)
+|.+||..||++||+ +++|+
T Consensus 240 li~~~l~~~p~~Rpt-------~~~i~ 259 (267)
T cd08229 240 LVNMCINPDPEKRPD-------ITYVY 259 (267)
T ss_pred HHHHhcCCCcccCCC-------HHHHH
Confidence 999999999999999 77654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.37 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=213.9
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
.|...+.||+|++|.||+|....+++.+|+|++.... ......+.+|+.+++.++||||+++++.+...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4556789999999999999999999999999985432 2234557889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-c
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-V 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-~ 273 (767)
|++|++|.+++... .+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++........ .
T Consensus 97 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 97 FLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred ccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence 99999999988762 589999999999999999999999999999999999999999999999999876543322 2
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
....|++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.......+... .......+..+++.+.+++.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHHH
Confidence 3456999999999998888999999999999999999999999765433222222111 111111233478999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
||+.+|++||+ +.++++||||++.
T Consensus 252 ~l~~~p~~Rpt-------~~~il~~~~~~~~ 275 (285)
T cd06648 252 MLVRDPAQRAT-------AAELLNHPFLAKA 275 (285)
T ss_pred HcccChhhCcC-------HHHHccCcccccC
Confidence 99999999998 9999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=339.73 Aligned_cols=254 Identities=19% Similarity=0.293 Sum_probs=210.6
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEcc-----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
..++|.+.+.||+|+||.||+|.... +++.||+|.+.... .......+.+|+++|++++|+||+++++.+...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34678999999999999999998753 46899999986542 222456788999999999999999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCC-----------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGG-----------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH 255 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~-----------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~ 255 (767)
...++||||++||+|..++...+. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 999999999999999999976532 235788999999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhh
Q psy11874 256 VRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRR 331 (767)
Q Consensus 256 vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~ 331 (767)
++|+|||++........ .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-- 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-- 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--
Confidence 99999999976533221 223456789999999999999999999999999999998 999997665433222222
Q ss_pred hhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 332 VKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 332 i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.......+...+..+++++.+||..||++||+ ++|+++
T Consensus 239 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~-------~~eil~ 276 (280)
T cd05049 239 -QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRIN-------IKDIHE 276 (280)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCC-------HHHHHH
Confidence 11222334578899999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=350.54 Aligned_cols=257 Identities=23% Similarity=0.344 Sum_probs=207.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC-----Ce
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----DA 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~ 188 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|.+.... .......+.+|+.++++++|+||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 68999999999999999999999999999999986421 223445677899999999999999999876543 46
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+||||+. ++|..++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 899999997 5887776542 58999999999999999999999999999999999999999999999999997654
Q ss_pred CCCc----ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh----------
Q psy11874 269 EGES----VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK---------- 333 (767)
Q Consensus 269 ~~~~----~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~---------- 333 (767)
.... .....||+.|+|||++.+ ..++.++|+||+||++|+|++|++||.+.+.......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3221 223578999999998754 5689999999999999999999999976543221111111000
Q ss_pred -c---------c-------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 334 -E---------D-------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 334 -~---------~-------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
. . ........++++.+++.+||+.||++||+ +.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt-------~~e~l~hp~~~~~ 298 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT-------VEEALAHPYLEQY 298 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC-------HHHHhcCcccccc
Confidence 0 0 00012346788999999999999999998 9999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.42 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=210.2
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEc----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVR----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+..++|++.+.||+|+||.||+|... .+++.+|+|.+.... .......+.+|+.++++++||||+++++.+...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 34578999999999999999999863 356899999986532 223345688899999999999999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCC--------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGG--------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD 252 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~--------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~ 252 (767)
+..|+||||+++|+|..++..... ...+++..+..++.||+.||+|||++||+||||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 999999999999999999864321 224788999999999999999999999999999999999999
Q ss_pred CCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhh
Q psy11874 253 YGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEV 328 (767)
Q Consensus 253 ~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i 328 (767)
++.+||+|||+++....... .....++..|+|||++.+..++.++|+|||||++|||++ |.+||.+.......+.+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999987643321 233456788999999988889999999999999999998 99999776432222222
Q ss_pred hhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 329 DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 329 ~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.. ......+..+++.+++++.+||+.||++||+ +.+|+++
T Consensus 240 ~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~-------~~~i~~~ 279 (283)
T cd05090 240 RK---RQLLPCSEDCPPRMYSLMTECWQEGPSRRPR-------FKDIHTR 279 (283)
T ss_pred Hc---CCcCCCCCCCCHHHHHHHHHHcccCcccCcC-------HHHHHHH
Confidence 11 1223345678999999999999999999999 7777664
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=364.17 Aligned_cols=244 Identities=32% Similarity=0.486 Sum_probs=212.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHh-cCCCceeEEEEEEeeCCeEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~l~l 191 (767)
...|++...+|.|+||.|-.|.++.+++.+|+|++.+..- ...+|..++.. -+||||+++.+.+.+..+.|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence 5678899999999999999999999999999999977621 12336655554 489999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe-CCCCCEEEeecCcccccCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL-DDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl-d~~g~vkL~DFGla~~~~~~ 270 (767)
|||+++||.|...+.... .+. ..+..+++||+.|+.|||++|||||||||+|||+ ++.|+++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999999988887653 344 7888899999999999999999999999999999 69999999999999987655
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
..+.+-|..|.|||++....|+.++||||||++||+||+|+.||...... .++..++.... +...+|++|+||
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~--~s~~vS~~AKdL 542 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK--FSECVSDEAKDL 542 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc--cccccCHHHHHH
Confidence 45667899999999999999999999999999999999999999876543 34555554333 337899999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
|++||+.||.+||+ +++++.||||
T Consensus 543 l~~LL~~dP~~Rl~-------~~~i~~h~w~ 566 (612)
T KOG0603|consen 543 LQQLLQVDPALRLG-------ADEIGAHPWF 566 (612)
T ss_pred HHHhccCChhhCcC-------hhhhccCcch
Confidence 99999999999999 9999999999
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.16 Aligned_cols=251 Identities=20% Similarity=0.301 Sum_probs=209.6
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.++++++|+||+++++.+.+.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 456789999999999999999999975 567899999765322 245688899999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
++||||++||+|..++.... ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999999987643 33688999999999999999999999999999999999999999999999999987654
Q ss_pred CCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 270 GES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
... .....++..|+|||++.+..++.++|+|||||++|+|++ |..||...........+.. .........++.+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 232 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR---GYRMPRMENCPDE 232 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHH
Confidence 322 123346778999999988889999999999999999998 9999977644332322221 1222334568899
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHH
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELK 376 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil 376 (767)
+.+++.+||..+|++||+ ++++.
T Consensus 233 ~~~li~~~l~~~p~~Rp~-------~~~i~ 255 (261)
T cd05072 233 LYDIMKTCWKEKAEERPT-------FDYLQ 255 (261)
T ss_pred HHHHHHHHccCCcccCcC-------HHHHH
Confidence 999999999999999999 66664
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=349.86 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=211.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC-----Ce
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----DA 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~ 188 (767)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 47999999999999999999999999999999986542 2233345677899999999999999999887654 35
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+||||+. ++|..++...+ .+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 899999996 68888876543 69999999999999999999999999999999999999999999999999998765
Q ss_pred CC-CcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh---------------
Q psy11874 269 EG-ESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR--------------- 331 (767)
Q Consensus 269 ~~-~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~--------------- 331 (767)
.. .......||..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+.......+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 43 22344578999999998865 56899999999999999999999999765422111111100
Q ss_pred --------hhc----cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 332 --------VKE----DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 332 --------i~~----~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
+.. ........++++++++|++||+.||++||+ ++++++||||+.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps-------~~ell~h~~~~~~~ 298 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT-------VEEALAHPYLASLH 298 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC-------HHHHHcCcchhhhc
Confidence 000 001123467899999999999999999998 99999999998763
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=342.56 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=217.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||.|+||.||++....+++.||+|.+.... ......+.+|+.++++++||||+++++.+...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 368999999999999999999998899999999986432 23345688899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
+||++||+|..++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999999988753 478999999999999999999999999999999999999999999999999876543322
Q ss_pred -ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 273 -VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 273 -~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.. ........+..++..++++|
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCCCCCccccCHHHHHHH
Confidence 2345689999999999888899999999999999999999999977644222111111 01111122345788999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
.+||..+|++||+ +++++.||||+..+
T Consensus 250 ~~~l~~~p~~Rp~-------~~~il~h~~~~~~~ 276 (293)
T cd06647 250 NRCLEMDVEKRGS-------AKELLQHPFLKIAK 276 (293)
T ss_pred HHHccCChhhCcC-------HHHHhcCHHHhcCc
Confidence 9999999999998 99999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.15 Aligned_cols=248 Identities=22% Similarity=0.289 Sum_probs=207.0
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|+.+ ++..+|+|.+..... ....+.+|+.+|++++||||+++++++...+.+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 467999999999999999999886 456899998764432 234678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
|||++||+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||++++++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999999999887643 2589999999999999999999999999999999999999999999999999986543322
Q ss_pred c--cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 273 V--RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 273 ~--~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
. ....++..|+|||++.+..++.++|+|||||++|||++ |+.||...+.......+.+ ......+...+..+.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~ 232 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR---GFRLYRPKLASMTVYE 232 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---CCCCCCCCCCCHHHHH
Confidence 2 22345678999999998899999999999999999999 9999977654333332222 1222335567889999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++.+||..+|++||+ ++++++
T Consensus 233 li~~c~~~~p~~Rps-------~~~l~~ 253 (256)
T cd05114 233 VMYSCWHEKPEGRPT-------FAELLR 253 (256)
T ss_pred HHHHHccCCcccCcC-------HHHHHH
Confidence 999999999999999 888764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.01 Aligned_cols=256 Identities=20% Similarity=0.284 Sum_probs=208.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEcc-----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
+..++|++.+.||+|+||.||+|.++. ++..+|+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 455789999999999999999998653 35789999985432 22234457889999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCC-------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEE
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGG-------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRI 258 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~-------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL 258 (767)
.+..++||||+++|+|.+++.+... ...+++..+..++.|++.||.|||+.|++||||||+|||+++++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999999876432 123678889999999999999999999999999999999999999999
Q ss_pred eecCcccccCCCCcc---cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhc
Q psy11874 259 SDLGLAVEIPEGESV---RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKE 334 (767)
Q Consensus 259 ~DFGla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~ 334 (767)
+|||++......... ....+++.|+|||++.+..++.++|+|||||++|||++ |..||.+.+.......+ ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~ 237 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV---MEG 237 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HcC
Confidence 999999765433221 12356789999999998899999999999999999998 78999766443222211 122
Q ss_pred cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 335 DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 335 ~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.....+...++.+++++.+||+.||++||+ +.|++++
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-------~~e~l~~ 274 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPS-------FLEIISS 274 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcC-------HHHHHHH
Confidence 223445678899999999999999999999 7887753
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=329.49 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=218.8
Q ss_pred hcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEee
Q psy11874 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYET 185 (767)
Q Consensus 107 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~ 185 (767)
+.++...++.+.+..||.|+-|.|++++++.+|...|+|.+.+.. +....++++..+.++.+.+ +|+||+.+++|.+
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 344566778889999999999999999999999999999997654 3444567888888877765 8999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
+..+.+.||.|.. -+..++.+.. ..++|..+-.+...++.||.||-+ ++|||||+||+|||+|+.|++||||||.|
T Consensus 163 n~dV~IcMelMs~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 163 NTDVFICMELMST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred CchHHHHHHHHHH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccc
Confidence 9999999999953 3444454433 258888888999999999999995 68999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCcceec---CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-ccccccC
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK-EDAEKYS 340 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~---~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~~ 340 (767)
-.+-+....+...|.+.|||||.+. ...|+..+||||||++|+||.||+.||.+.+.. .+ +...+. +.++.++
T Consensus 240 GrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe-~ltkvln~ePP~L~ 316 (391)
T KOG0983|consen 240 GRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FE-VLTKVLNEEPPLLP 316 (391)
T ss_pred ceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HH-HHHHHHhcCCCCCC
Confidence 8887766666678999999999994 457999999999999999999999999886542 12 222233 2333333
Q ss_pred --CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 341 --CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 341 --~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
..||++..+|+..||++|+.+||. ..++++|||++..
T Consensus 317 ~~~gFSp~F~~fv~~CL~kd~r~RP~-------Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 317 GHMGFSPDFQSFVKDCLTKDHRKRPK-------YNKLLEHPFIKRY 355 (391)
T ss_pred cccCcCHHHHHHHHHHhhcCcccCcc-------hHHHhcCcceeec
Confidence 359999999999999999999998 8899999999864
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.40 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=213.1
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC---CCceeEEEEEEeeCCeEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN---SRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~~~l~l 191 (767)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.++++++ |||++++++++..++..|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4778899999999999999999999999999986542 2233456778999999997 9999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
||||++|++|..++... .+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999999887642 58999999999999999999999999999999999999999999999999998765443
Q ss_pred c-ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC-CCcHHHH
Q psy11874 272 S-VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC-RFSDDAK 348 (767)
Q Consensus 272 ~-~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~-~~s~~~~ 348 (767)
. .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+.. ......+. .++.++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 232 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---SKPPRLEDNGYSKLLR 232 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---CCCCCCCcccCCHHHH
Confidence 2 334579999999999865 4578999999999999999999999976543222211111 11222332 3788999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+++.+||+.||++||+ +.+++.||||++.
T Consensus 233 ~~i~~~l~~~p~~R~~-------~~~il~~~~~~~~ 261 (277)
T cd06917 233 EFVAACLDEEPKERLS-------AEELLKSKWIKAH 261 (277)
T ss_pred HHHHHHcCCCcccCcC-------HHHHhhChHhhcc
Confidence 9999999999999998 9999999999775
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.80 Aligned_cols=252 Identities=19% Similarity=0.273 Sum_probs=211.7
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+...+|++.+.||+|+||.||+|..+.+++.+|+|.+.... .....+.+|+.++++++|+||+++++.+...+.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 44567999999999999999999999999999999986432 23456888999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.|++||||||+|||+++++.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 79 IITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999999987643 345899999999999999999999999999999999999999999999999999876543
Q ss_pred Ccc--cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 271 ESV--RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 271 ~~~--~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+.. ......+...++++
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 234 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---GYRMERPEGCPPKV 234 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---CCCCCCCCCCCHHH
Confidence 221 12234678999999999999999999999999999998 9999977543322222221 12334566789999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+++.+||..||++||+ +.++++
T Consensus 235 ~~li~~cl~~~p~~Rp~-------~~~l~~ 257 (263)
T cd05052 235 YELMRACWQWNPSDRPS-------FAEIHQ 257 (263)
T ss_pred HHHHHHHccCCcccCCC-------HHHHHH
Confidence 99999999999999999 777654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.29 Aligned_cols=261 Identities=25% Similarity=0.365 Sum_probs=212.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--CCeEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--KDALCL 191 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~l 191 (767)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|++++++++||||+++++.+.+ .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 478999999999999999999999999999999875422 2345668889999999999999999998865 347999
Q ss_pred EEEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
||||++||+|.+++.... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 999999999988876432 2345899999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhh-hhhhhhhhhhhc-cccccC------CC
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-VKRDEVDRRVKE-DAEKYS------CR 342 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~-~~~~~i~~~i~~-~~~~~~------~~ 342 (767)
. .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ....+....+.. .....+ ..
T Consensus 159 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd06621 159 L-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237 (287)
T ss_pred c-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence 2 22346889999999999999999999999999999999999999765220 011111111111 111111 24
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+++.+.+++.+||..||++||+ +.|++.||||++.
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt-------~~eil~~~~~~~~ 272 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPT-------PWDMLEHPWIKAQ 272 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCC-------HHHHHhCcccccc
Confidence 5788999999999999999999 9999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=336.55 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=215.9
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
-|++.+.||+|+||.||+|.+..++..+|+|.+..... ......+.+|+.++++++||||+++++.+..++..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 47788999999999999999998999999999865432 2334568889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-c
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-V 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-~ 273 (767)
|++||+|..++.+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.++|+|||++........ .
T Consensus 83 ~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 83 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 99999999888642 589999999999999999999999999999999999999999999999999976644321 2
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. .......+..++.++.+++.+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP---KNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh---cCCCCCCCcccCHHHHHHHHH
Confidence 33568999999999988889999999999999999999999997654322222211 112233455678999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
||..+|.+||+ +.++++||||...
T Consensus 236 ~l~~~p~~Rp~-------~~~~l~~~~~~~~ 259 (277)
T cd06641 236 CLNKEPSFRPT-------AKELLKHKFIVRF 259 (277)
T ss_pred HccCChhhCcC-------HHHHHhCHHHhhh
Confidence 99999999998 9999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=345.17 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=213.7
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
.|+....||+|+||.||+|....+++.||+|.+..... .....+.+|+.+++.++||||+++++.+...+..|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 34456689999999999999999999999999865432 234567889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-cc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~ 273 (767)
|++|++|..++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 99 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 99 FLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred cCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 99999999877542 58999999999999999999999999999999999999999999999999997654332 23
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
....|++.|+|||++.+..++.++|+|||||++|||++|..||...........+.. ........+..+++++.+++.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCCCccccCCCCHHHHHHHHH
Confidence 346799999999999988999999999999999999999999976543222222111 1111122334678999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
||+.+|++||+ +.++++||||.+.
T Consensus 254 ~l~~~P~~Rps-------~~~ll~~~~~~~~ 277 (297)
T cd06659 254 MLTREPQERAT-------AQELLDHPFLLQT 277 (297)
T ss_pred HhcCCcccCcC-------HHHHhhChhhccC
Confidence 99999999998 9999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.90 Aligned_cols=256 Identities=22% Similarity=0.274 Sum_probs=212.3
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccC-----CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRAT-----GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 184 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 184 (767)
++..++|++.+.||+|+||.||+|..+.. ++.+|+|.+.... .......+.+|+.+|..++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 35567899999999999999999998754 4899999986442 2233456788999999999999999999999
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCC-------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEE
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGG-------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVR 257 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~-------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vk 257 (767)
.....++||||+++|+|..++..... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.+|.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 99999999999999999999976432 12368889999999999999999999999999999999999999999
Q ss_pred EeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhh
Q psy11874 258 ISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVK 333 (767)
Q Consensus 258 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~ 333 (767)
|+|||+++....... .....+|..|+|||.+.+..++.++|+|||||++|||++ |..||.+.........+. .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~ 236 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI---D 236 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh---c
Confidence 999999976544322 233457889999999988889999999999999999998 999997654432222221 2
Q ss_pred ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 334 EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 334 ~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
......+..++.++.+++.+||+.+|++||+ +.++++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-------~~~l~~ 273 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPT-------FLEIVS 273 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCC-------HHHHHH
Confidence 2234456678999999999999999999998 777764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=326.20 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=220.5
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC--CeEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK--DALCLV 192 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~lV 192 (767)
+|...+.||+|++|.||+|..+.+++.+++|++...... ......+.+|+.++++++||||+++++.+... +.+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 478889999999999999999999999999998765432 34566788999999999999999999999988 899999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
+||++|++|.+++.+.. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 99999999999998754 789999999999999999999999999999999999999999999999999988766543
Q ss_pred ---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh-hccccccCCCCcHHHH
Q psy11874 273 ---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV-KEDAEKYSCRFSDDAK 348 (767)
Q Consensus 273 ---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i-~~~~~~~~~~~s~~~~ 348 (767)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....+.... ......++..++..++
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccccCCCcCCCcccCHHHH
Confidence 3456799999999999888899999999999999999999999977651 111111111 1233455667899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
++|.+||..||++||+ +.++++||||
T Consensus 235 ~~i~~~l~~~p~~Rp~-------~~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRRDPKKRPT-------ADELLQHPFL 260 (260)
T ss_pred HHHHHhCcCChhhCCC-------HHHHhhCCCC
Confidence 9999999999999998 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=331.15 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=213.6
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhh--hhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC--CeE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK--DAL 189 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l 189 (767)
.+|++.+.||+|+||.||+|.++.+|+.||+|.+.... .........+.+|+.++++++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875432 11223445788899999999999999999998764 568
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
++||||++|++|..++.+.+ .+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 99999999999999987654 588999999999999999999999999999999999999999999999999986532
Q ss_pred C----CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh-hccccccCCCCc
Q psy11874 270 G----ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV-KEDAEKYSCRFS 344 (767)
Q Consensus 270 ~----~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i-~~~~~~~~~~~s 344 (767)
. .......|+..|+|||++.+..++.++|+|||||++|+|++|++||....... .+.+.. ......++..++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~p~~~~ 235 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---AIFKIATQPTKPMLPDGVS 235 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---HHHHHHcCCCCCCCCcccC
Confidence 1 12234568999999999998889999999999999999999999997654322 222222 222345677899
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
+.+.++|.+||. +|..||+ +.+++.|||.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~-------~~~~~~~~~~ 264 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPT-------AEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHHhc-CcccCcc-------HHHHhcCCCC
Confidence 999999999999 6799998 9999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.77 Aligned_cols=249 Identities=43% Similarity=0.746 Sum_probs=218.9
Q ss_pred EeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCH
Q psy11874 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDL 201 (767)
Q Consensus 122 LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L 201 (767)
||.|+||.||.|....+++.+|+|.+.+...........+..|+.++++++||||+++++.+++++..|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999887666656677889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Cccccccccc
Q psy11874 202 KFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ESVRGRVGTV 280 (767)
Q Consensus 202 ~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~~~~~~GT~ 280 (767)
.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......|+.
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 99998754 5899999999999999999999999999999999999999999999999999876543 2344567899
Q ss_pred ccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcC
Q psy11874 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPR 360 (767)
Q Consensus 281 ~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~ 360 (767)
.|+|||.+.+...+.++|+||||+++|+|++|..||..... .++.+.+......++..+++.+.+++++||..||+
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~ 233 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPT 233 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence 99999999888899999999999999999999999976643 23333344455667778899999999999999999
Q ss_pred ccCCCCCCcccHHHHHhCCCC
Q psy11874 361 SRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 361 ~Rl~~~~~~~~a~eil~HpfF 381 (767)
+||+..+ ++++++||||
T Consensus 234 ~R~~~~~----~~~l~~~~~f 250 (250)
T cd05123 234 KRLGSGG----AEEIKAHPFF 250 (250)
T ss_pred hCCCccc----HHHHHhCCCC
Confidence 9999321 4999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=326.38 Aligned_cols=253 Identities=28% Similarity=0.445 Sum_probs=220.4
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|++++++++|+|++++.+++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 488999999999999999999999999999999776543 2345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-c
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-V 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-~ 273 (767)
|++|++|.+++.+.+ .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 80 YAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred cCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 999999999987753 689999999999999999999999999999999999999999999999999987755433 2
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
....|+..|+|||.+.+..++.++|+||+|+++|+|++|..||......... ...........+..+++.+++++.+
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL---FRIVQDDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHhccCCCCCCCCCCHHHHHHHHH
Confidence 3456899999999998888999999999999999999999999765432222 2222333445667789999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
||..+|++||+ +.+++.||||
T Consensus 234 ~l~~~p~~R~~-------~~~~l~~~~~ 254 (254)
T cd06627 234 CFQKDPNLRPT-------AKQLLKHPWI 254 (254)
T ss_pred HHhCChhhCcC-------HHHHhcCCCC
Confidence 99999999998 9999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=329.95 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=213.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|....+|+.||+|.+.............+.+|++++++++|++++++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999999999999999987655444455667889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 194 TIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
||++||+|..++.+.. ....+++.++..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 9999999999887532 23458999999999999999999999999999999999999999999999999997654432
Q ss_pred cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc-cccccCC-CCcHHHHH
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE-DAEKYSC-RFSDDAKA 349 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~~~-~~s~~~~d 349 (767)
......|++.|+|||.+.+..++.++|+|||||++|+|++|..||..... ....+...+.. .....+. .++.++++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence 23345789999999999999999999999999999999999999965432 11112222111 1122333 67889999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+|.+||..+|++||+ +.+|++
T Consensus 240 ~i~~cl~~~p~~Rp~-------~~~il~ 260 (267)
T cd08224 240 LVSRCINPDPEKRPD-------ISYVLQ 260 (267)
T ss_pred HHHHHcCCCcccCCC-------HHHHHH
Confidence 999999999999999 666653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.58 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=214.7
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
.|+..+.||+|+||.||+|.+..+|..+|+|.+..... ......+.+|+.++++++||||+++++.+...+..|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 46677889999999999999999999999999865432 2234568889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-c
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-V 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-~ 273 (767)
|++||+|..++... .+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++........ .
T Consensus 83 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 83 YLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 99999999887542 589999999999999999999999999999999999999999999999999977654322 2
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
....|+..|+|||++.+..++.++|+|||||++|||++|..||...........+ ............+.++.++|.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI---PKNSPPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh---hcCCCCCCCcccCHHHHHHHHH
Confidence 3346899999999999989999999999999999999999999755432221111 1111223344678899999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
||..+|++||+ +.++++||||....
T Consensus 236 ~l~~~p~~Rp~-------~~~il~~~~~~~~~ 260 (277)
T cd06642 236 CLNKDPRFRPT-------AKELLKHKFITRYT 260 (277)
T ss_pred HccCCcccCcC-------HHHHHHhHHHHHHh
Confidence 99999999998 99999999987643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=340.74 Aligned_cols=254 Identities=25% Similarity=0.314 Sum_probs=211.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.|++.+.||+|+||.||+|....+|+.||+|++.............+.+|+.+++.++||||+++.+.+.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56999999999999999999999999999999986554333444566889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||++ |+|...+.... ..+++..+..++.||+.||.|||+.||+||||+|+||+++++|.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 9998 56666665432 25899999999999999999999999999999999999999999999999999765432
Q ss_pred cccccccccCCcceec---CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc-CCCCcHHHHH
Q psy11874 274 RGRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY-SCRFSDDAKA 349 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~---~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~-~~~~s~~~~d 349 (767)
....|++.|+|||++. ...++.++|||||||++|||++|.+||.+.+.......+. ....... +..++.++++
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh---cCCCCCCCchhhCHHHHH
Confidence 3456899999999984 4568899999999999999999999997765432222111 1111121 2357889999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+|.+||..||++||+ +.+++.||||..
T Consensus 246 li~~~l~~~p~~Rp~-------~~~il~~~~~~~ 272 (307)
T cd06607 246 FVDSCLQKIPQDRPS-------SEELLKHRFVLR 272 (307)
T ss_pred HHHHHhcCChhhCcC-------HHHHhcChhhcc
Confidence 999999999999999 999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.30 Aligned_cols=248 Identities=20% Similarity=0.308 Sum_probs=205.4
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
++.++|.+.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 44578999999999999999999863 356789999986542 2345568899999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCC----------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGG----------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH 255 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~----------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~ 255 (767)
.+.+++||||+++|+|..++...+. ...+++..+..++.||+.||+|||++||+||||||+|||+++++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 9999999999999999999976531 124899999999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhh
Q psy11874 256 VRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRR 331 (767)
Q Consensus 256 vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~ 331 (767)
++|+|||++........ .....+++.|+|||++.+..++.++|+|||||++|+|++ |.+||...........+.
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~-- 236 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-- 236 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--
Confidence 99999999986543322 123346789999999999999999999999999999998 999997664322222221
Q ss_pred hhccccccCCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 332 VKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 332 i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
.......+..++.++.+|+.+||+.||.+||+
T Consensus 237 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 268 (288)
T cd05093 237 -QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLN 268 (288)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 11223344568899999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.12 Aligned_cols=259 Identities=23% Similarity=0.357 Sum_probs=210.4
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee----CCeE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET----KDAL 189 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~l 189 (767)
++|++.+.||.|+||.||+|..+.+|+.||+|++..... .......+.+|+.+|++++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 579999999999999999999999999999999875432 22345567789999999999999999988753 4579
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||+. |+|..++...+ .+++..+..++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999996 68888876543 589999999999999999999999999999999999999999999999999976533
Q ss_pred CCc-----ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh------------
Q psy11874 270 GES-----VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR------------ 331 (767)
Q Consensus 270 ~~~-----~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~------------ 331 (767)
... .....|+..|+|||++.+ ..++.++|+|||||++|||++|++||.+.+.......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 221 234578999999999865 56899999999999999999999999765432211111100
Q ss_pred --------hhcc--c-----cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 332 --------VKED--A-----EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 332 --------i~~~--~-----~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+... . .......+++++++|++||+.+|++||+ ++++++||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt-------~~~~l~~~~~~~~ 300 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT-------VEQALQHPFLAQY 300 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC-------HHHHHhChhhhhc
Confidence 0000 0 0112456899999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=323.80 Aligned_cols=251 Identities=31% Similarity=0.493 Sum_probs=215.8
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||+|++|.||+|....+|+.+++|++..... .....+.+|+.++++++|++++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58889999999999999999999999999999876543 345678889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~ 274 (767)
|++|++|...+.... ..+++..+..++.|++.||.+||+.|++||||+|+||++++++.++|+|||.+..........
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence 999999998887642 368999999999999999999999999999999999999999999999999998776554334
Q ss_pred ccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC--CCCcHHHHHHHH
Q psy11874 275 GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS--CRFSDDAKALCK 352 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~--~~~s~~~~dLi~ 352 (767)
...|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......... ......+ ..++..+.++|.
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCcccccCHHHHHHHH
Confidence 56789999999999888899999999999999999999999977643222222211 2222222 234889999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEF 380 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~Hpf 380 (767)
+||+.||++||+ +.++++|||
T Consensus 233 ~~l~~~p~~R~t-------~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPT-------AEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCC-------HHHHhcCCC
Confidence 999999999998 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=333.62 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=210.5
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc---CCCceeEEEEEEeeCCe----
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI---NSRFVVSLAYAYETKDA---- 188 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~~~~---- 188 (767)
|++.+.||+|+||.||+|+++.+|+.||+|.+..... .......+.+|+.+++++ +|+|++++++.+.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6789999999999999999998999999999875432 222233466788777666 69999999999988876
Q ss_pred -EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 189 -LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 189 -l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
++++|||+++ +|..++.... ...+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999985 7988887643 235899999999999999999999999999999999999999999999999999887
Q ss_pred CCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc------------
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED------------ 335 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~------------ 335 (767)
..........+++.|+|||++.+..++.++|+|||||++|+|++|.+||.+.........+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 65544455568999999999999999999999999999999999999998766543333332211100
Q ss_pred -----------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 336 -----------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 336 -----------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.......+++.+.++|.+||+.||++||+ ++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-------~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS-------AFEALQHPYF 287 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC-------HHHHhcCcCC
Confidence 00011235688999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.07 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=210.6
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEe
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
|++.+.||.|++|.||+|.++.+|+.||+|++..... .......+.+|+.++++++|||++++++++.+.+..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 5778999999999999999999999999999876532 223345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-ccc
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SVR 274 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~~ 274 (767)
++ ++|..++.... ...+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++....... ...
T Consensus 80 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 80 LD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred cC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 96 68988887653 2358999999999999999999999999999999999999999999999999997654322 223
Q ss_pred ccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh--------------------
Q psy11874 275 GRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK-------------------- 333 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~-------------------- 333 (767)
...+++.|+|||++.+. .++.++|+|||||++|+|++|.+||...+.......+.+...
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34678999999988664 578999999999999999999999976654322222111100
Q ss_pred -----ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 334 -----EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 334 -----~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.........++.++.++|.+||+.||++||+ ++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt-------~~~il~~~~~ 283 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS-------AKAALQHPYF 283 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC-------HHHHhcCCCC
Confidence 0111223467899999999999999999998 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.77 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=216.2
Q ss_pred hhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 106 ~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
.+.++|..+....++-||+|+.|.||+|+.+ +..||||+++.- -..+++-|++|+||||+.+.++|..
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecC
Confidence 3456677777777888999999999999987 789999987421 1237888999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
...+|||||||..|.|...|+... ..+......+..+|+.||.|||.+.|||||||.-||||..+..|||+|||.++
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred CceeEEeeeccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchH
Confidence 999999999999999999998754 68889999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 266 EIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 266 ~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
...+-.+...++||..|||||++.+++.+.++|||||||+|||||||..||.+.+......-+-.++ .....|...++
T Consensus 261 e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNs--L~LpvPstcP~ 338 (904)
T KOG4721|consen 261 ELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNS--LHLPVPSTCPD 338 (904)
T ss_pred hhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCc--ccccCcccCch
Confidence 9877766778999999999999999999999999999999999999999997765433222221111 12345678899
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhCC
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAE 379 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~Hp 379 (767)
.++-|+++||+..|..||+ +.+|+.|=
T Consensus 339 GfklL~Kqcw~sKpRNRPS-------Frqil~Hl 365 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPS-------FRQILLHL 365 (904)
T ss_pred HHHHHHHHHHhcCCCCCcc-------HHHHHHHH
Confidence 9999999999999999999 88998883
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=347.29 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=210.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC------
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD------ 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~------ 187 (767)
++|++.+.||+|+||.||+|....+|+.||+|++.+.. ........+.+|+.+|++++||||+++++++....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 67999999999999999999999999999999986542 22333456788999999999999999999987654
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
..|+||||+ |++|..++... .+++..++.++.||+.||.|||+.||+||||||+||+++.+|.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 469999999 78998877642 5899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh-----------hh--
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR-----------VK-- 333 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~-----------i~-- 333 (767)
... .....+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+... +.
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 169 DSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred ccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 432 334568999999999866 45889999999999999999999999866432222211110 00
Q ss_pred --------------ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 334 --------------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 334 --------------~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.........+++++.++|.+||..||++||+ +.+++.||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t-------~~~~l~~~~~~~~ 304 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT-------AAEALAHPYFEEF 304 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC-------HHHHhcCccHhhh
Confidence 0001122467889999999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.01 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=202.3
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGG 199 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG 199 (767)
+.||+|+||.||+|+++.+|+.+|+|.+.... .......+.+|++++++++||||+++++++...+..|+||||++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999875432 2334456889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccc---cc
Q psy11874 200 DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR---GR 276 (767)
Q Consensus 200 ~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~---~~ 276 (767)
+|.+++.+.+ ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9999987643 358999999999999999999999999999999999999999999999999997654322111 11
Q ss_pred ccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhc
Q psy11874 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355 (767)
Q Consensus 277 ~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL 355 (767)
.++..|+|||.+.+..++.++|+|||||++|||++ |.+||...........+.. ......+...+..+.+|+.+||
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ---GVRLPCPELCPDAVYRLMERCW 233 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc---CCCCCCcccCCHHHHHHHHHHc
Confidence 23567999999999899999999999999999997 9999976544322222222 1223445677899999999999
Q ss_pred ccCcCccCCCCCCcccHHHHHh
Q psy11874 356 KKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 356 ~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
..||++||+ ++++++
T Consensus 234 ~~~p~~Rps-------~~~~~~ 248 (252)
T cd05084 234 EYDPGQRPS-------FSTVHQ 248 (252)
T ss_pred CCChhhCcC-------HHHHHH
Confidence 999999999 777753
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=307.14 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=221.2
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
.|.-.+.||+|+||+|++|+.+.|+..||+|.+....- ....-..+++|+-+|+.+.|.|||+|++....++.+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 45667889999999999999999999999999876532 23345678999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-cc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~ 273 (767)
||. .+|..+.....+ .++.+.++.++.|++.||.++|+++++||||||.|.||+.+|.+||+|||+|+.+...- ..
T Consensus 82 ~cd-qdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred Hhh-HHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 997 688888876543 68999999999999999999999999999999999999999999999999998775432 34
Q ss_pred cccccccccCCcceecCC-CCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCC----------
Q psy11874 274 RGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSC---------- 341 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~---------- 341 (767)
...+-|.+|.+|.++.+. -|+.+.|+||.|||+.|+.. |++.|.+.+-..+...+.+......+..++
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 556789999999999775 48999999999999999984 899999988777777666655443333221
Q ss_pred ---------------CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 342 ---------------RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 342 ---------------~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.++..-+||++++|..+|.+|++ |++.++||||.+.
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qris-------aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS-------AEAALQHPYFSDF 289 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC-------HHHHhcCcccccc
Confidence 23556899999999999999998 9999999999874
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.76 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=210.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEcc-----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
+..++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|..++++++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 344679999999999999999999987 78899999875432 22334568889999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCC----CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC---CEEE
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGG----EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG---HVRI 258 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~----~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g---~vkL 258 (767)
.+..++||||++||+|..++...+. ...+++..+..++.||+.||+|||+++++||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999999977532 12589999999999999999999999999999999999998765 5999
Q ss_pred eecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhc
Q psy11874 259 SDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKE 334 (767)
Q Consensus 259 ~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~ 334 (767)
+|||+++....... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+ ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~---~~~ 237 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV---TGG 237 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HcC
Confidence 99999987633221 112234578999999998899999999999999999997 99999875433222211 112
Q ss_pred cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 335 DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 335 ~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.....+..++..+.+++.+||+.+|++||+ +.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps-------~~~vl~~ 274 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPN-------FATILER 274 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcC-------HHHHHHH
Confidence 233456678999999999999999999999 8898876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=333.01 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=210.7
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC--CeEEEEE
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK--DALCLVL 193 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~lV~ 193 (767)
|++.+.||.|+||.||+|....+|+.+|+|++.... ........+.+|+.++++++|+|++++++++... +.+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999999999999999997664 2233345678899999999999999999999988 8999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-- 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-- 271 (767)
||+++ +|..++.+.. ..+++..+..++.||+.||+|||+.|++|+||||+||+++++|.++|+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 99984 8888876542 368999999999999999999999999999999999999999999999999998765443
Q ss_pred cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc--------------
Q psy11874 272 SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA-------------- 336 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~-------------- 336 (767)
......++..|+|||.+.+ ..++.++|+|||||++|||++|..||...+.......+........
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2334567899999998764 4688999999999999999999999987654433333222111000
Q ss_pred -------------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 337 -------------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 337 -------------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
..+....++++.+++.+||..+|.+||+ +.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~-------~~~~l~~~~~ 287 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS-------ADQALQHEYF 287 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC-------HHHHhhCcCC
Confidence 0011123889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=342.00 Aligned_cols=253 Identities=23% Similarity=0.268 Sum_probs=207.1
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcE----EEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+...+|++.+.||+|+||.||+|++..+|.. ||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 4557899999999999999999998766654 8999986432 233445688899999999999999999988765
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
..++|+||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++.
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 5789999999999999987643 3588899999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcc---cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 267 IPEGESV---RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 267 ~~~~~~~---~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+........ +.. .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~--~~~~~~~~~~ 235 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILE--KGERLPQPPI 235 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHh--CCCCCCCCCC
Confidence 6543321 22345778999999999999999999999999999997 999997754322111 111 1112233456
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.+.++.+++.+||..||++||+ +.+++.+
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps-------~~~l~~~ 264 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPK-------FRELIIE 264 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcC-------HHHHHHH
Confidence 7889999999999999999999 7777765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=347.67 Aligned_cols=259 Identities=28% Similarity=0.391 Sum_probs=205.7
Q ss_pred cccCChHHHhhhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCc
Q psy11874 96 NRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175 (767)
Q Consensus 96 ~~~~~~~~~~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~ 175 (767)
.+.++..++...+ ++|..-+.||+||||.||+|... +|..+|||++....... ...+.+|+.+|.+++|||
T Consensus 62 ~~~fs~~el~~AT-----~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~N 132 (361)
T KOG1187|consen 62 LRSFSYDELRKAT-----NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPN 132 (361)
T ss_pred cceeeHHHHHHHH-----hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcC
Confidence 3446667776665 67888899999999999999986 45999999876543221 345999999999999999
Q ss_pred eeEEEEEEeeCC-eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC---cccccCCcceEEeC
Q psy11874 176 VVSLAYAYETKD-ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG---LVYRDCKPENILLD 251 (767)
Q Consensus 176 Iv~l~~~~~~~~-~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~---IvHrDLKPeNILld 251 (767)
+|+|+|+|.+.+ ..+||+|||++|+|.++|...... .++|.....||.+++.||+|||+.. ||||||||+|||||
T Consensus 133 lv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 133 LVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred cccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 999999999988 599999999999999999886533 7899999999999999999999854 99999999999999
Q ss_pred CCCCEEEeecCcccccCC-CCccccc-ccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchh--hhhhhh
Q psy11874 252 DYGHVRISDLGLAVEIPE-GESVRGR-VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKE--MVKRDE 327 (767)
Q Consensus 252 ~~g~vkL~DFGla~~~~~-~~~~~~~-~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~--~~~~~~ 327 (767)
++.+.||+|||+|+..+. .....+. .||.+|+|||++..+..+.++|||||||+|.||++|+.|...... .....+
T Consensus 212 ~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~ 291 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE 291 (361)
T ss_pred CCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence 999999999999977765 4444444 899999999999989999999999999999999999988864321 110000
Q ss_pred -hhhhhhcc------ccccC-CCCc--HH---HHHHHHHhcccCcCccCC
Q psy11874 328 -VDRRVKED------AEKYS-CRFS--DD---AKALCKALLKKSPRSRLG 364 (767)
Q Consensus 328 -i~~~i~~~------~~~~~-~~~s--~~---~~dLi~~lL~~dP~~Rl~ 364 (767)
....+... .+.+. ...+ .. +..+...|++.+|.+||+
T Consensus 292 w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~ 341 (361)
T KOG1187|consen 292 WAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPT 341 (361)
T ss_pred HHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcC
Confidence 00111110 11111 2223 22 456778999999999999
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=346.06 Aligned_cols=271 Identities=25% Similarity=0.392 Sum_probs=214.4
Q ss_pred HHhhhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEE
Q psy11874 103 DIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYA 182 (767)
Q Consensus 103 ~~~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 182 (767)
++....+.+. ++|.+.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 82 (342)
T cd07879 5 EVNKTVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDV 82 (342)
T ss_pred hhhhhhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhhe
Confidence 3333444443 579999999999999999999999999999999875432 22234457889999999999999999998
Q ss_pred EeeC------CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCE
Q psy11874 183 YETK------DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHV 256 (767)
Q Consensus 183 ~~~~------~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~v 256 (767)
+... ...|+||||+. ++|..++. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~ 156 (342)
T cd07879 83 FTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCEL 156 (342)
T ss_pred ecccccCCCCceEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 8754 35699999997 46765442 258999999999999999999999999999999999999999999
Q ss_pred EEeecCcccccCCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh---
Q psy11874 257 RISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV--- 332 (767)
Q Consensus 257 kL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i--- 332 (767)
+|+|||++..... ......||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+.......+....
T Consensus 157 kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (342)
T cd07879 157 KILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 234 (342)
T ss_pred EEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999999976533 2334578999999999866 468999999999999999999999998765332222111100
Q ss_pred ----------------h--------ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 333 ----------------K--------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 333 ----------------~--------~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
. .......+..++++.+||.+||+.||++||+ +++++.||||+...+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~-------~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT-------ATEALEHPYFDSFRDAD 307 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC-------HHHHhcCcchhhccccc
Confidence 0 0000112346788999999999999999998 99999999999986544
Q ss_pred Hh
Q psy11874 389 LE 390 (767)
Q Consensus 389 l~ 390 (767)
.+
T Consensus 308 ~~ 309 (342)
T cd07879 308 EE 309 (342)
T ss_pred cc
Confidence 33
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=324.58 Aligned_cols=256 Identities=27% Similarity=0.500 Sum_probs=219.7
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ......+.+|++++++++|+|++++.+.+...+..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 588999999999999999999999999999998765432 2344567889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-c
Q psy11874 195 IMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-S 272 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~ 272 (767)
+++|++|..++.+.. ....+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 999999999998742 12479999999999999999999999999999999999999999999999999998765443 2
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
.....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+........ ........+..++.++.+++.
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI---LKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH---hcCCCCCCCCCCCHHHHHHHH
Confidence 33457899999999998888999999999999999999999999766432222222 222234455678999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
+||..+|++||+ +.++++||||
T Consensus 237 ~~l~~~p~~Rp~-------~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPS-------IAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcC-------HHHHhcCCCC
Confidence 999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.32 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=216.5
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC-----eE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD-----AL 189 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~l 189 (767)
+|++.+.||.|+||.||+|+...+|+.||+|++.+.. ........+.+|+.+++.++|+||+++.+++...+ .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5889999999999999999999999999999987542 12334566888999999999999999999988775 89
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||++ ++|...+.+.. .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999998 58888876543 699999999999999999999999999999999999999999999999999987655
Q ss_pred CC----cccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc--------
Q psy11874 270 GE----SVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA-------- 336 (767)
Q Consensus 270 ~~----~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~-------- 336 (767)
.. ......+|+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+.......+........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 43 23445789999999999887 899999999999999999999999987765433332222111000
Q ss_pred -------------------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 337 -------------------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 337 -------------------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
......+++++.++|.+||+++|++||+ ++++++||||+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt-------~~~ll~~~~~~~~~ 296 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT-------ADEALAHPYLAQLH 296 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC-------HHHHHhCccHHhhc
Confidence 0112347889999999999999999999 99999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=336.20 Aligned_cols=263 Identities=24% Similarity=0.376 Sum_probs=212.4
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeC
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETK 186 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~ 186 (767)
...+..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+.... .....+..|..++.+.. ||||+++++++.+.
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 3456778999999999999999999999999999999998754321 22345566777676664 99999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
..+|+||||+. ++|...+.... ..+++..+..++.||+.||.|||+ .||+||||+|+||++++++.++|+|||++.
T Consensus 87 ~~~~~v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 87 SDVFICMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred CeEEEEeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 99999999986 57776665533 268999999999999999999997 599999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCcceecCCC----CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC-
Q psy11874 266 EIPEGESVRGRVGTVGYMAPEVIDNEK----YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS- 340 (767)
Q Consensus 266 ~~~~~~~~~~~~GT~~Y~APEvl~~~~----ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~- 340 (767)
............|++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...... .+.+.+.........+
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQEEPPSLPP 241 (296)
T ss_pred hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcCCCCCCCC
Confidence 765544444456889999999997554 889999999999999999999999653221 1111111111112222
Q ss_pred -CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 341 -CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 341 -~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
..+++++++|+.+||..||++||+ ++++++||||...
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~-------~~~il~~~~~~~~ 279 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPK-------YRELLQHPFIRRY 279 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCC-------HHHHhcChhhhcc
Confidence 247899999999999999999999 9999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=346.74 Aligned_cols=258 Identities=24% Similarity=0.306 Sum_probs=207.5
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEcc-----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYA 182 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 182 (767)
+++..++|++.++||+|+||.||+|.... +++.||+|++.... .......+..|+.++.++ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 45566789999999999999999997543 45899999986432 223345678899999999 89999999998
Q ss_pred Eee-CCeEEEEEEeccCCCHHHHHHhcCC---------------------------------------------------
Q psy11874 183 YET-KDALCLVLTIMNGGDLKFHIYNMGG--------------------------------------------------- 210 (767)
Q Consensus 183 ~~~-~~~l~lV~E~~~gG~L~~~l~~~~~--------------------------------------------------- 210 (767)
+.. ...++++|||++||+|...+.....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 765 4679999999999999988865321
Q ss_pred -------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc---cccccccc
Q psy11874 211 -------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES---VRGRVGTV 280 (767)
Q Consensus 211 -------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~ 280 (767)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+..... .....++.
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 12578999999999999999999999999999999999999999999999999987643322 12345678
Q ss_pred ccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhc-cccccCCCCcHHHHHHHHHhcccC
Q psy11874 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKE-DAEKYSCRFSDDAKALCKALLKKS 358 (767)
Q Consensus 281 ~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~-~~~~~~~~~s~~~~dLi~~lL~~d 358 (767)
.|+|||++.+..++.++|||||||++|||++ |..||.+........ ..+.. .....+...++++.+++.+||+.+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 316 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC---RRLKEGTRMRAPEYATPEIYSIMLDCWHNN 316 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH---HHHhccCCCCCCccCCHHHHHHHHHHccCC
Confidence 8999999999999999999999999999997 999997643322111 11111 122234567899999999999999
Q ss_pred cCccCCCCCCcccHHHHHhC
Q psy11874 359 PRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 359 P~~Rl~~~~~~~~a~eil~H 378 (767)
|++||+ +.++++|
T Consensus 317 p~~RPs-------~~ell~~ 329 (337)
T cd05054 317 PEDRPT-------FSELVEI 329 (337)
T ss_pred hhhCcC-------HHHHHHH
Confidence 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=336.68 Aligned_cols=253 Identities=19% Similarity=0.257 Sum_probs=205.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCc--EEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGK--MYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~ 190 (767)
++|++.++||+|+||.||+|..+.+|. .+|+|.+... ........+.+|+.++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999887765 4688877532 2233455688899999999 7999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEE
Q psy11874 191 LVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVR 257 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vk 257 (767)
+||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 99999999999999976421 12488999999999999999999999999999999999999999999
Q ss_pred EeecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccc
Q psy11874 258 ISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDA 336 (767)
Q Consensus 258 L~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~ 336 (767)
|+|||++.............++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+.. ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~---~~~ 236 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GYR 236 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---CCC
Confidence 999999865332211112233567999999998899999999999999999997 9999977654322222221 112
Q ss_pred cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 337 EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 337 ~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
...+..+++++++|+.+||..+|.+||+ ++++.+.
T Consensus 237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~-------~~~i~~~ 271 (297)
T cd05089 237 MEKPRNCDDEVYELMRQCWRDRPYERPP-------FAQISVQ 271 (297)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcC-------HHHHHHH
Confidence 3345578999999999999999999999 7887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=328.79 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=208.7
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccC---CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
..++|++.+.||+|+||.||+|.++.+ ...+|+|.+.... .......+.+|+.++++++||||+++++.+...+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 346899999999999999999998754 4689999986543 22334567889999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
.++||||++||+|..++....+ .+++..+..++.|++.||.|||+++|+||||||+|||+++++.++|+|||++....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999999876432 68999999999999999999999999999999999999999999999999998774
Q ss_pred CCC-cc--cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhc-cccccCCCC
Q psy11874 269 EGE-SV--RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKE-DAEKYSCRF 343 (767)
Q Consensus 269 ~~~-~~--~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~-~~~~~~~~~ 343 (767)
... .. ....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||....... +...+.. .....+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~ 233 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD----VIKAVEDGYRLPPPMDC 233 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH----HHHHHHcCCCCCCCCCC
Confidence 221 11 12345678999999999999999999999999999998 999996654322 2222222 122334567
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
++.+.+++.+||+.+|++||+ +++++++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~-------~~ei~~~ 261 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPT-------FSQIVST 261 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcC-------HHHHHHH
Confidence 899999999999999999999 7887653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=329.40 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=205.5
Q ss_pred eEEEeEEeecCcEEEEEEEEccC---CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe----
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA---- 188 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~---- 188 (767)
|.+.+.||+|+||.||.|....+ +..||+|++..... .......+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56789999999999999997653 48899999875432 22345668899999999999999999998765544
Q ss_pred --EEEEEEeccCCCHHHHHHhcC---CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 189 --LCLVLTIMNGGDLKFHIYNMG---GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 189 --l~lV~E~~~gG~L~~~l~~~~---~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
.++||||+++|+|..++.... ....+++..+..++.|++.||.|||+.+|+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 899999999999998886542 123689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcc---cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 264 AVEIPEGESV---RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 264 a~~~~~~~~~---~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
++........ ....++..|+|||++.+..++.++|||||||++|||++ |.+||.+.........+ ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~ 236 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL---RHGNRLKQ 236 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCCCCCC
Confidence 9876443221 12345778999999988999999999999999999999 99999776543222222 22233445
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+..+++++.+++.+||+.||++||+ +.+++++
T Consensus 237 ~~~~~~~~~~li~~~l~~~p~~Rp~-------~~e~~~~ 268 (273)
T cd05035 237 PEDCLDELYDLMYSCWRADPKDRPT-------FTKLREV 268 (273)
T ss_pred CcCCCHHHHHHHHHHcCCChhhCcC-------HHHHHHH
Confidence 6778999999999999999999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=340.69 Aligned_cols=278 Identities=23% Similarity=0.378 Sum_probs=214.8
Q ss_pred CeEEEeEEeecCcEEEEEEEEccC--CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEee----CC
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYET----KD 187 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~t--g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~----~~ 187 (767)
+|++.+.||+|+||.||+|....+ ++.||+|++.... ........+.+|+.+++++ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999988 9999999986432 2223345678899999999 59999999886432 25
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|++++++. ++|...+.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 6899999986 68988886543 6899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCc-----ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh---------
Q psy11874 268 PEGES-----VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV--------- 332 (767)
Q Consensus 268 ~~~~~-----~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i--------- 332 (767)
..... .....||+.|+|||++.+ ..++.++|+||+||++|+|++|.+||...+.......+....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43221 233579999999998755 578999999999999999999999997654322111111100
Q ss_pred --------------hc----cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhH-hcCC
Q psy11874 333 --------------KE----DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL-EAGL 393 (767)
Q Consensus 333 --------------~~----~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l-~~~~ 393 (767)
.. .........+..+++++.+||+.||++||+ +.+++.||||+. |... ....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t-------~~~ll~~~~~~~--~~~~~~~~~ 306 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS-------VEEALEHPYLAI--WHDPDDEPV 306 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC-------HHHHhcChhhhh--hcCcccccc
Confidence 00 001112345889999999999999999998 999999999975 3322 2223
Q ss_pred CCCCCCCCCCchh
Q psy11874 394 CDPPFVPDVKRDE 406 (767)
Q Consensus 394 ~~pp~~P~~~~~~ 406 (767)
+..|+-|++.+++
T Consensus 307 ~~~~~~~~~~~~~ 319 (332)
T cd07857 307 CQKPFDFSFESED 319 (332)
T ss_pred ccccccCCccccc
Confidence 5555656655443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.71 Aligned_cols=256 Identities=21% Similarity=0.291 Sum_probs=210.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCC-----cEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEe
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYE 184 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~ 184 (767)
+..++|++.+.||+|+||.||+|..+..+ ..+|+|.+.... .......+.+|+.++.++ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 45578999999999999999999987543 789999987542 223345688899999999 8999999999999
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcC-------------CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMG-------------GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD 251 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~-------------~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld 251 (767)
..+.+++||||+++|+|..++.... ....+++..+..++.||+.||.|||+.+|+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 9999999999999999999987531 233589999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhh
Q psy11874 252 DYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDE 327 (767)
Q Consensus 252 ~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~ 327 (767)
+++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999987654322 122345678999999989999999999999999999997 9999977654332222
Q ss_pred hhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 328 VDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 328 i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+... .....+...+.++.+|+.+||..||++||+ +.+++++
T Consensus 247 ~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-------~~eil~~ 287 (293)
T cd05053 247 LKEG---YRMEKPQNCTQELYHLMRDCWHEVPSQRPT-------FKQLVED 287 (293)
T ss_pred HHcC---CcCCCCCCCCHHHHHHHHHHcccCcccCcC-------HHHHHHH
Confidence 2211 122345567899999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.18 Aligned_cols=260 Identities=30% Similarity=0.424 Sum_probs=219.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.|+..+.||.|+||.||+|.+..+++.+|+|++..... ....+.+|++++++++|+|++++++.+...+..|+|+
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 568889999999999999999998999999999875432 4566888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-c
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-S 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~ 272 (767)
||++|++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.+|.++|+|||++....... .
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 9999999999998753 368999999999999999999999999999999999999999999999999987654332 2
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..... .....+..++.+++++|.
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCcchhhCCHHHHHHHH
Confidence 2344688999999999888899999999999999999999999976544322222211111 111122347889999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
+||+.+|.+||+ +.+++.||||+...|.
T Consensus 252 ~~l~~~p~~Rpt-------~~~il~~~~~~~~~~~ 279 (286)
T cd06614 252 KCLVKDPEKRPS-------AEELLQHPFLKKACPK 279 (286)
T ss_pred HHhccChhhCcC-------HHHHhhChHhhccCch
Confidence 999999999998 9999999999996654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=342.78 Aligned_cols=260 Identities=29% Similarity=0.407 Sum_probs=210.2
Q ss_pred CCeE-EEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhh-----------hHHHHHHHHHHHHhcCCCceeEEEE
Q psy11874 114 KTFR-MYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-----------GESMVLIEKQILQKINSRFVVSLAY 181 (767)
Q Consensus 114 ~~y~-~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~-----------~~~~~~~E~~iL~~l~hp~Iv~l~~ 181 (767)
++|. +.+.||.|+||+||+|.++.+|+.||+|++......... ....+.+|+.++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 457899999999999999999999999998654322210 1124678999999999999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeec
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDL 261 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DF 261 (767)
++...+..|+||||++ |+|..++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 68988887643 6899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCC---------------CcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhh
Q psy11874 262 GLAVEIPEG---------------ESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKR 325 (767)
Q Consensus 262 Gla~~~~~~---------------~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~ 325 (767)
|++...... .......+++.|+|||++.+. .++.++|+|||||++|||++|.+||.+.+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999765411 112234578899999998764 4789999999999999999999999877654333
Q ss_pred hhhhhhhhcccc------------------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 326 DEVDRRVKEDAE------------------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 326 ~~i~~~i~~~~~------------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
..+......... ......++++.++|.+||..+|++||+ ++|++.||||
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s-------~~~~l~~~~~ 316 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS-------AKEALKHEYF 316 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC-------HHHHhcCccc
Confidence 322221111100 012345889999999999999999998 9999999999
Q ss_pred CCC
Q psy11874 382 KST 384 (767)
Q Consensus 382 ~~i 384 (767)
+.-
T Consensus 317 ~~~ 319 (335)
T PTZ00024 317 KSD 319 (335)
T ss_pred CCC
Confidence 864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=344.01 Aligned_cols=256 Identities=24% Similarity=0.365 Sum_probs=208.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC------C
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------D 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------~ 187 (767)
++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.++++++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 689999999999999999999999999999999875422 223345677899999999999999999988643 4
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
..|++++++ |++|..++... .+++..+..++.||+.||.|||++||+||||||+||+++++|.+||+|||++...
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 578999887 78998777542 5899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-------------
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK------------- 333 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~------------- 333 (767)
.. ......||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+.+...
T Consensus 171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 171 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred cc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 33 2334578999999999866 5688999999999999999999999976543322222111100
Q ss_pred ------ccc--------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 334 ------EDA--------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 334 ------~~~--------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
... .......+++++++|.+||+.||.+|++ +.++++||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-------~~e~l~h~~f~~~ 306 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT-------AAQALAHAYFAQY 306 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC-------HHHHhcChhhhhc
Confidence 000 0011235889999999999999999998 9999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=351.23 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=205.2
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccC-----CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEE
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRAT-----GKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAY 181 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~ 181 (767)
...+..++|++.+.||+|+||.||+|.+... +..||+|++.... .....+.+++|+.+|.++. |||||++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3445668899999999999999999987543 3579999986542 2233457889999999996 999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCC---------------------------------------------------
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGG--------------------------------------------------- 210 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~--------------------------------------------------- 210 (767)
++.+.+.+|+|||||+||+|.+++.....
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 99999999999999999999998865321
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceE
Q psy11874 211 ------------------------------------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248 (767)
Q Consensus 211 ------------------------------------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNI 248 (767)
...+++..+..++.||+.||.|||+.+|+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 12478888999999999999999999999999999999
Q ss_pred EeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhh
Q psy11874 249 LLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVK 324 (767)
Q Consensus 249 Lld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~ 324 (767)
|++.++.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999986543322 223457889999999999999999999999999999997 9999976432211
Q ss_pred hhhhhhhhhc-cccccCCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 325 RDEVDRRVKE-DAEKYSCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 325 ~~~i~~~i~~-~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
+...+.. .....+..++.++.+++.+||+.||++||+
T Consensus 349 ---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 386 (400)
T cd05105 349 ---FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPS 386 (400)
T ss_pred ---HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcC
Confidence 1111211 123345578899999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=325.24 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=210.2
Q ss_pred eEEeecCcEEEEEEEEccC---CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEec
Q psy11874 120 RVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIM 196 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~ 196 (767)
+.||+|+||.||+|..... +..||+|.+....... ....+.+|+.+++.++|+||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8999999987654322 4567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCC------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 197 NGGDLKFHIYNMGG------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 197 ~gG~L~~~l~~~~~------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||+|..++..... ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999987521 247899999999999999999999999999999999999999999999999999877554
Q ss_pred C---cccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 271 E---SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 271 ~---~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
. ......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...........+.. ......+..+|++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 235 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK---GYRLPKPEYCPDE 235 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCCccCChH
Confidence 2 2334568899999999988899999999999999999999 6999987644322222221 2333456678999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+.+++.+||..||++||+ +.++++|
T Consensus 236 ~~~li~~~l~~~p~~Rps-------~~~l~~~ 260 (262)
T cd00192 236 LYELMLSCWQLDPEDRPT-------FSELVER 260 (262)
T ss_pred HHHHHHHHccCCcccCcC-------HHHHHHh
Confidence 999999999999999999 8888865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=385.99 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=221.1
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEe
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
+.-...||.|.||.||-|....||...|+|-+...... .+....+.+|..+|..++|||+|+.|++=.+.+.++|.|||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 55667899999999999999999999999998765544 55666788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC----
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE---- 271 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~---- 271 (767)
|.||+|.+.+...+ ..++...+.|..|++.|+.|||++|||||||||+||+|+.+|.+|++|||.|+.+....
T Consensus 1316 C~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred hccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999999988754 57888899999999999999999999999999999999999999999999998876543
Q ss_pred -cccccccccccCCcceecC---CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 272 -SVRGRVGTVGYMAPEVIDN---EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 272 -~~~~~~GT~~Y~APEvl~~---~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
.....+|||.|||||++.+ ++..-+.|||||||++.||+||+.||...+. ...-+.+--....+.+|..+|++.
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhHHHhHHhccCCCCCchhhhHhH
Confidence 2345689999999999965 4577899999999999999999999965432 222233333445667788899999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+|||..||..||++|.+ +.||+.|.|=+.
T Consensus 1471 ~dFle~Cl~~dP~~Rw~-------~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWT-------ASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHHHhcCchhhhH-------HHHHHHhhcccc
Confidence 99999999999999977 999999998654
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=326.09 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=218.4
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+|++.+.||.|+||.||+|+++.+|+.+|+|.+.+..... .....+.+|+.++++++|+||+++.+.+.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5889999999999999999999999999999987654332 334567789999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 195 IMNGGDLKFHIYNMGG-EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~-~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
|++|++|..++.+... ...+++..+..++.|++.||.|||+.|++||||+|+||++++++.+||+|||++...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~ 158 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA 158 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence 9999999998876321 346899999999999999999999999999999999999999999999999999877554 33
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.. ......+..++.++++++.+
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR---GKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCCCCchhhCHHHHHHHHH
Confidence 446789999999999999999999999999999999999999977654322222211 22233445788999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
||..+|++||+ +.++++||+.
T Consensus 236 ~l~~~p~~Rp~-------~~~~l~~p~~ 256 (256)
T cd08530 236 MLQVKPKLRPN-------CDKILASPAV 256 (256)
T ss_pred HcCCCcccCCC-------HHHHhcCCCC
Confidence 99999999999 9999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=331.46 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=206.4
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCc----EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
++.++|++.+.||+|+||+||+|.+..+|. .||+|++.... .......+.+|..+++.++||||+++++.+..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 456789999999999999999999887776 48999986442 22334568889999999999999999998875
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
...+++|||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 45789999999999999987642 3689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcc---cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 267 IPEGESV---RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 267 ~~~~~~~---~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
....... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+.. ......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~ 235 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK---GERLPQPPI 235 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---CCcCCCCcc
Confidence 6543221 22345778999999999999999999999999999998 9999976543222221111 112233456
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+.++.++|.+||..||++||+ +.+++.
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~-------~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPR-------FRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcC-------HHHHHH
Confidence 8899999999999999999999 778774
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=344.10 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=207.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC-------
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------- 186 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------- 186 (767)
++|++.+.||.|+||.||+|..+.+|+.||+|++..... .....+.+|+.++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 689999999999999999999999999999999865432 3456688899999999999999998776543
Q ss_pred -------CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC-CCCEEE
Q psy11874 187 -------DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-YGHVRI 258 (767)
Q Consensus 187 -------~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-~g~vkL 258 (767)
..+|+||||++ ++|...+... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 46899999997 5888777532 5899999999999999999999999999999999999984 567899
Q ss_pred eecCcccccCCCCc----ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh-
Q psy11874 259 SDLGLAVEIPEGES----VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV- 332 (767)
Q Consensus 259 ~DFGla~~~~~~~~----~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i- 332 (767)
+|||++........ .....||..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......+....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999976532211 123468999999998754 568899999999999999999999997665432222111100
Q ss_pred ------------------h-------ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 333 ------------------K-------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 333 ------------------~-------~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
. .........++.++++|+.+||+.||.+||+ +.++++||||+...+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~ell~h~~~~~~~~ 308 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT-------AEEALMHPYMSCYSC 308 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC-------HHHHhCCCccccccC
Confidence 0 0001122357889999999999999999998 999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.02 Aligned_cols=257 Identities=19% Similarity=0.306 Sum_probs=208.3
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCC----------------cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCc
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATG----------------KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg----------------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~ 175 (767)
..++|++.+.||+|+||.||+|....++ ..+|+|.+..... ......+.+|++++++++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3468999999999999999999876544 5689999875532 234567889999999999999
Q ss_pred eeEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCC--------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcce
Q psy11874 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGG--------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPEN 247 (767)
Q Consensus 176 Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~--------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeN 247 (767)
|+++++++..++..++|||++++++|..++.+... ...+++..+..++.|++.||.|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99999999999999999999999999999976531 1258999999999999999999999999999999999
Q ss_pred EEeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc--CCCCCCCchhh
Q psy11874 248 ILLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE--GQAPFRRRKEM 322 (767)
Q Consensus 248 ILld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt--G~~PF~~~~~~ 322 (767)
|+++.++.++|+|||++........ .....+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999976543321 223457889999999988889999999999999999998 77888665433
Q ss_pred hhhhhhhhhhh----ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 323 VKRDEVDRRVK----EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 323 ~~~~~i~~~i~----~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
........... ......+..+++++.+++.+||+.||++||+ +.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-------~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT-------FREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC-------HHHHHH
Confidence 22222211100 0111223456899999999999999999999 888854
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=335.38 Aligned_cols=255 Identities=20% Similarity=0.271 Sum_probs=209.5
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccC-----CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT-----GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
+...+|++.+.||+|+||.||+|.+..+ ++.+|+|++.... .......+.+|..++.+++||||+++++++.+
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456788899999999999999987643 5889999987542 22234567889999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD 252 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~ 252 (767)
.+.+++++||+++++|..++..... ...+++..+..++.|++.||.|||++||+||||||+|||+++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 9999999999999999999864211 124788889999999999999999999999999999999999
Q ss_pred CCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhh
Q psy11874 253 YGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEV 328 (767)
Q Consensus 253 ~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i 328 (767)
++.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.......+.+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999886643322 223456789999999988889999999999999999998 88999776543322222
Q ss_pred hhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 329 DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 329 ~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.. ......+..+++.+.+|+.+||+.+|.+||+ +++|++
T Consensus 240 ~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~-------~~~i~~ 278 (283)
T cd05091 240 RN---RQVLPCPDDCPAWVYTLMLECWNEFPSRRPR-------FKDIHS 278 (283)
T ss_pred Hc---CCcCCCCCCCCHHHHHHHHHHhCCCcccCCC-------HHHHHH
Confidence 21 2223456778999999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=327.91 Aligned_cols=249 Identities=21% Similarity=0.286 Sum_probs=206.8
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
..+|++.+.||+|+||.||+|.++ ++..+|+|++.+... ....+.+|+.++++++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 357889999999999999999886 577899999865432 234577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
|||++|++|.+++..... .+++..+..++.||+.||.|||+.||+||||||+||+++++|.+||+|||+++...+...
T Consensus 78 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 78 TEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred EecCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999999999876432 689999999999999999999999999999999999999999999999999976543322
Q ss_pred c--cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 273 V--RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 273 ~--~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
. ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+.. ......+...++++.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 232 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA---GYRLYRPKLAPTEVYT 232 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc---CCcCCCCCCCCHHHHH
Confidence 1 12234567999999999999999999999999999998 8999976544333222221 1123345568999999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
++.+||..+|++||+ +.++++.
T Consensus 233 li~~cl~~~p~~Rpt-------~~~~l~~ 254 (256)
T cd05059 233 IMYSCWHEKPEDRPA-------FKKLLSQ 254 (256)
T ss_pred HHHHHhcCChhhCcC-------HHHHHHH
Confidence 999999999999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=335.16 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=210.0
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC----
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD---- 187 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~---- 187 (767)
..++|++.+.||+|+||.||+|..+.+|+.||+|++..... .......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34689999999999999999999999999999999875432 2223345678999999999999999999987655
Q ss_pred ------eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeec
Q psy11874 188 ------ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDL 261 (767)
Q Consensus 188 ------~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DF 261 (767)
.+|+|+||+++ +|...+.+. ...+++..++.++.||+.||.|||+.||+||||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 89999999986 666666543 236899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCC--cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc-
Q psy11874 262 GLAVEIPEGE--SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE- 337 (767)
Q Consensus 262 Gla~~~~~~~--~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~- 337 (767)
|++....... ......+++.|+|||.+.+ ..++.++|+|||||++|||++|++||...+.......+.+.......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 9998764432 2233457889999998865 45789999999999999999999999866543333333222111100
Q ss_pred -------------------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 338 -------------------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 338 -------------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.....+++.+.+++.+||..||++||+ +.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~-------~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT-------AEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC-------HHHHhcCCCC
Confidence 112346899999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.19 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=208.0
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++|++.+.||+|++|.||+|... +++.||+|.+..... ....+.+|+.++++++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 45578999999999999999999975 467899999865432 2455788999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||++|++|.+++.... ...+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999999999987653 346899999999999999999999999999999999999999999999999999876533
Q ss_pred Ccc--cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 271 ESV--RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 271 ~~~--~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
... ....++..|+|||++.+..++.++|+|||||++|||++ |+.||.+.+.......+.. ......+...++++
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 233 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ---GYRMPCPPGCPKEL 233 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCCCcCCHHH
Confidence 211 11223458999999999999999999999999999999 9999987654333322222 11223455678999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHH
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELK 376 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil 376 (767)
.+++.+||+.+|++||+ ++++.
T Consensus 234 ~~li~~~l~~~P~~Rp~-------~~~l~ 255 (261)
T cd05068 234 YDIMLDCWKEDPDDRPT-------FETLQ 255 (261)
T ss_pred HHHHHHHhhcCcccCCC-------HHHHH
Confidence 99999999999999999 66665
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.22 Aligned_cols=253 Identities=20% Similarity=0.327 Sum_probs=207.7
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
++..+|.+.+.||+|+||.||+|+.. .++..+|+|.+..... .....+.+|+.++++++|+||+++++.+..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 34568999999999999999999864 3467799999865432 233567889999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD 252 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~ 252 (767)
.+..++||||++||+|.+++...+. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 9999999999999999999976431 124889999999999999999999999999999999999999
Q ss_pred CCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhh
Q psy11874 253 YGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEV 328 (767)
Q Consensus 253 ~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i 328 (767)
++.++|+|||++........ .....|++.|+|||++.+..++.++|+|||||++|||++ |..||.........+.+
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999976543321 223457889999999999999999999999999999998 99999765443222221
Q ss_pred hhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHH
Q psy11874 329 DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELK 376 (767)
Q Consensus 329 ~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil 376 (767)
. .......+..++..+.+++.+||++||++||+ +++++
T Consensus 239 ~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt-------~~~v~ 276 (291)
T cd05094 239 T---QGRVLERPRVCPKEVYDIMLGCWQREPQQRLN-------IKEIY 276 (291)
T ss_pred h---CCCCCCCCccCCHHHHHHHHHHcccChhhCcC-------HHHHH
Confidence 1 11222334567899999999999999999999 66664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=336.07 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=211.2
Q ss_pred EEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEec
Q psy11874 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIM 196 (767)
Q Consensus 117 ~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~ 196 (767)
.....||+|+||.||++..+.+|+.+|+|++... .......+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 3347899999999999999999999999997543 2233456888999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-cccc
Q psy11874 197 NGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SVRG 275 (767)
Q Consensus 197 ~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~~~ 275 (767)
++++|..++.+. .+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 999998877542 58999999999999999999999999999999999999999999999999987654332 2234
Q ss_pred cccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhc
Q psy11874 276 RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355 (767)
Q Consensus 276 ~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL 355 (767)
..||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.........+.... ..........++++.+++.+||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-CcccCCcccCCHHHHHHHHHHH
Confidence 568999999999988889999999999999999999999997754332222221111 1111122457889999999999
Q ss_pred ccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 356 KKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 356 ~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
..||.+||+ +.++++||||...
T Consensus 255 ~~~P~~R~~-------~~~ll~~~~~~~~ 276 (292)
T cd06657 255 VRDPAQRAT-------AAELLKHPFLAKA 276 (292)
T ss_pred hCCcccCcC-------HHHHhcChHHhcc
Confidence 999999999 9999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=345.59 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=210.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe-----
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA----- 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~----- 188 (767)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++|||++++.+++...+.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 679999999999999999999999999999999865422 22334567789999999999999999888766554
Q ss_pred -EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 189 -LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 189 -l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
+|+|+||+ |++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||+++++|.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 99999999 57998888652 5899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc-----------
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED----------- 335 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~----------- 335 (767)
... .....+|..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......+.......
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred ccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 443 345578999999999865 467899999999999999999999997665432222211110000
Q ss_pred ----------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 336 ----------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 336 ----------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.......+++++.++|.+||..||++||+ +.+|++||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt-------~~ell~h~~~~~~ 304 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT-------AAEALAHPYLAEY 304 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC-------HHHHhcCCCcccc
Confidence 00112346899999999999999999998 9999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=350.79 Aligned_cols=253 Identities=24% Similarity=0.300 Sum_probs=217.9
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
-|.-++.||.|+||.||-|++..|...||||+++-.--.....-..++.|+..|++++|||+|.+-++|-.....+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46667899999999999999999999999999875533333344568999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~ 274 (767)
||- |+-.+.+.-.. .++-+.++..++.+.+.||.|||+++.||||||..||||++.|.|||+|||.|....+ .+
T Consensus 107 YCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---An 180 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---AN 180 (948)
T ss_pred HHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hh
Confidence 997 56666665543 3688999999999999999999999999999999999999999999999999976543 56
Q ss_pred ccccccccCCcceec---CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC-CCCcHHHHHH
Q psy11874 275 GRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS-CRFSDDAKAL 350 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~---~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~-~~~s~~~~dL 350 (767)
+++|||.|||||++. .+.|+-++||||||++..||...+||+.+.+.+.. +...-.++.+.++ ..+|...++|
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA---LYHIAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH---HHHHHhcCCCCCCCchhHHHHHHH
Confidence 789999999999984 46799999999999999999999999988776543 3333444555554 5789999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+..||++-|.+||+ .++++.|+|...
T Consensus 258 vd~CLqKipqeRpt-------se~ll~H~fv~R 283 (948)
T KOG0577|consen 258 VDSCLQKIPQERPT-------SEELLKHRFVLR 283 (948)
T ss_pred HHHHHhhCcccCCc-------HHHHhhcchhcc
Confidence 99999999999999 999999999764
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=318.73 Aligned_cols=258 Identities=29% Similarity=0.358 Sum_probs=212.6
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee---
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--- 185 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--- 185 (767)
-.|+.++|++.+.||.|||+.||+++...+++.||+|++.-. ..++.+.+++|++..++++||||++++++...
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 346668999999999999999999999999999999998654 34567789999999999999999999776533
Q ss_pred --CCeEEEEEEeccCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHhHHHHHHHCC--cccccCCcceEEeCCCCCEEEee
Q psy11874 186 --KDALCLVLTIMNGGDLKFHIYNMGG-EPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLDDYGHVRISD 260 (767)
Q Consensus 186 --~~~l~lV~E~~~gG~L~~~l~~~~~-~~~l~~~~~~~~~~qIl~aL~yLH~~~--IvHrDLKPeNILld~~g~vkL~D 260 (767)
+...||+++|...|+|.+.+.+... +..+++.++..|+.+|+.||++||+.. ..||||||.|||+.+.+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 3459999999999999999988643 336899999999999999999999998 99999999999999999999999
Q ss_pred cCcccccCCCCc----------ccccccccccCCcceecC---CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhh
Q psy11874 261 LGLAVEIPEGES----------VRGRVGTVGYMAPEVIDN---EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDE 327 (767)
Q Consensus 261 FGla~~~~~~~~----------~~~~~GT~~Y~APEvl~~---~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~ 327 (767)
||.++..+-.-. ......|..|.|||.+.- ...+.++|||||||+||+|+.|..||...-+ .-..
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--~GgS 250 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--QGGS 250 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--cCCe
Confidence 999976532110 112347999999999954 4567999999999999999999999954322 1122
Q ss_pred hhhhhhccccccC--CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 328 VDRRVKEDAEKYS--CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 328 i~~~i~~~~~~~~--~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+.-.+.+....+| ..+|+.+.++|+.||+.||.+||+ +.+++.+
T Consensus 251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~-------i~~ll~~ 296 (302)
T KOG2345|consen 251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPT-------IPELLSK 296 (302)
T ss_pred EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCC-------HHHHHHH
Confidence 2223344444444 358999999999999999999999 7787754
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.00 Aligned_cols=253 Identities=19% Similarity=0.319 Sum_probs=208.0
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
...+|...+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+++++.++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3467889999999999999999753 357789999876542 23455688999999999999999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCC------------CCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGE------------PGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG 254 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~------------~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g 254 (767)
+..++||||+++|+|..++...+.. ..+++..+..++.||+.||+|||+.||+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 9999999999999999999865321 2478999999999999999999999999999999999999999
Q ss_pred CEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhh
Q psy11874 255 HVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDR 330 (767)
Q Consensus 255 ~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~ 330 (767)
.++|+|||++........ .....+++.|+|||.+.+..++.++|+|||||++|||++ |.+||...........+
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-- 237 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-- 237 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH--
Confidence 999999999976543321 122345789999999999999999999999999999998 99999765443222222
Q ss_pred hhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 331 RVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 331 ~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
........+..+++.+.+|+.+||+.||++||+ +++|++
T Consensus 238 -~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~-------~~~l~~ 276 (280)
T cd05092 238 -TQGRELERPRTCPPEVYAIMQGCWQREPQQRMV-------IKDIHS 276 (280)
T ss_pred -HcCccCCCCCCCCHHHHHHHHHHccCChhhCCC-------HHHHHH
Confidence 122223445678899999999999999999999 677653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=329.13 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=210.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
..+|++.+.||.|+||.||+|..+. ++.+|+|.+..... .....+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4579999999999999999999987 89999999876532 2344578899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
|||+++|+|.+++.+.. ...+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999998753 33589999999999999999999999999999999999999999999999999987644322
Q ss_pred -ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 273 -VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 273 -~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
.....++..|+|||++.+..++.++|+|||||++|+|++ |+.||...........+. .......+...++.+.++
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---AGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---hCCcCCCCCCCCHHHHHH
Confidence 223456788999999988899999999999999999998 899997665332222222 122234456789999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+.+||+.||.+||+ +.++.+
T Consensus 237 i~~~l~~~p~~Rpt-------~~~l~~ 256 (261)
T cd05148 237 MLECWAAEPEDRPS-------FKALRE 256 (261)
T ss_pred HHHHcCCCchhCcC-------HHHHHH
Confidence 99999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=343.48 Aligned_cols=256 Identities=19% Similarity=0.247 Sum_probs=202.8
Q ss_pred eEEeec--CcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEecc
Q psy11874 120 RVLGKG--GFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMN 197 (767)
Q Consensus 120 ~~LG~G--~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~ 197 (767)
..||+| +||+||+|++..+|+.||+|++....... ...+.+.+|+.+++.++||||++++++|..++.+|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 99999999999999999999987543222 334678889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-c---
Q psy11874 198 GGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-V--- 273 (767)
Q Consensus 198 gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-~--- 273 (767)
+|+|..++.+.. ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.++++|||.+........ .
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999999888753 33589999999999999999999999999999999999999999999999986543322111 0
Q ss_pred ----cccccccccCCcceecCC--CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh----------------
Q psy11874 274 ----RGRVGTVGYMAPEVIDNE--KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR---------------- 331 (767)
Q Consensus 274 ----~~~~GT~~Y~APEvl~~~--~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~---------------- 331 (767)
....++..|+|||++.+. .++.++|+||+||++|+|++|.+||...............
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 112356779999999763 5789999999999999999999999765332111110000
Q ss_pred -------------------------hhcc--ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 332 -------------------------VKED--AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 332 -------------------------i~~~--~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.... ....+..+++.+++|+++||+.||++||+ ++++++||||+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt-------a~e~l~~~~~~~~ 314 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS-------ASSLLSHAFFKQV 314 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC-------HHHHhhCHHHHHH
Confidence 0000 00112346788999999999999999999 9999999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.91 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=207.3
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||.||.|.... +..+|+|.+..... ....+.+|+.++++++||||+++++++...+.+++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 34689999999999999999998753 45699999865432 23568889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
||||+++|+|.+++..... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 77 v~e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999999999876432 68999999999999999999999999999999999999999999999999997664433
Q ss_pred cc--cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 272 SV--RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 272 ~~--~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
.. ....++..|+|||++.+..++.++|+|||||++|+|++ |..||...+.......+. .......+...++.++
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 231 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS---QGLRLYRPHLASEKVY 231 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh---cCCCCCCCCCCCHHHH
Confidence 21 12345678999999988889999999999999999998 999997654432222221 1122233456789999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+++.+||..||.+||+ +.+|+.+
T Consensus 232 ~li~~cl~~~p~~Rp~-------~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPT-------FQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCC-------HHHHHHh
Confidence 9999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.96 Aligned_cols=244 Identities=24% Similarity=0.323 Sum_probs=201.2
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++|++.+.||+|+||.||+|++..+ ..+|+|++.+... ....+.+|+.++++++||||+++++.+. .+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 4457899999999999999999998755 4699999875432 2345788999999999999999998875 45689
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+|+||||||+||++++++.++|+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999999997642 235799999999999999999999999999999999999999999999999999876543
Q ss_pred Ccc--cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 271 ESV--RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 271 ~~~--~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
... ....++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.........+.. ......+..++.++
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l 232 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESL 232 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc---CCCCCCccccCHHH
Confidence 321 23346778999999988899999999999999999999 8899977644322222211 11223345688999
Q ss_pred HHHHHHhcccCcCccCC
Q psy11874 348 KALCKALLKKSPRSRLG 364 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~ 364 (767)
.+++.+||++||++||+
T Consensus 233 ~~li~~~l~~~p~~Rp~ 249 (262)
T cd05071 233 HDLMCQCWRKEPEERPT 249 (262)
T ss_pred HHHHHHHccCCcccCCC
Confidence 99999999999999999
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.94 Aligned_cols=250 Identities=21% Similarity=0.277 Sum_probs=201.7
Q ss_pred EEEeEEeecCcEEEEEEEEccCCc--EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee------CCe
Q psy11874 117 RMYRVLGKGGFGEVCACQVRATGK--MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------KDA 188 (767)
Q Consensus 117 ~~~~~LG~G~fG~Vy~a~~~~tg~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~~~ 188 (767)
.+.+.||+|+||.||+|+...++. .+|+|.+..... .......+.+|..+++.++|+||+++++.+.. ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 467899999999999999987775 699998865422 33345678889999999999999999987643 235
Q ss_pred EEEEEEeccCCCHHHHHHhcC---CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMG---GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~---~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
.++|||||++|+|..++.... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 799999999999998875321 12358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcc---cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCC
Q psy11874 266 EIPEGESV---RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 266 ~~~~~~~~---~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~ 341 (767)
........ ....+++.|+|||++.+..++.++|+|||||++|||++ |..||.+.........+. .......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 237 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR---QGNRLKQPP 237 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---cCCCCCCCC
Confidence 76543321 22346788999999999999999999999999999999 899997654332222221 112234456
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.++..+.++|.+||..||++||+ +++|++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps-------~~~l~~ 266 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPS-------FETLRC 266 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcC-------HHHHHH
Confidence 78899999999999999999999 788765
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.02 Aligned_cols=236 Identities=23% Similarity=0.319 Sum_probs=196.1
Q ss_pred EEeecCcEEEEEEEE--ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 121 VLGKGGFGEVCACQV--RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 121 ~LG~G~fG~Vy~a~~--~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
.||+|+||.||+|.+ ..+++.+|+|++.... ........+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999965 4578999999986543 22334567888999999999999999998875 4568999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc----cc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES----VR 274 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~----~~ 274 (767)
|+|..++...+ .+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||++........ ..
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 99999987643 689999999999999999999999999999999999999999999999999987644322 12
Q ss_pred ccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 275 GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
...+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+.+.......+.. ......+...++++.++|.+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES---GERMECPQRCPPEMYDLMKL 233 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC---CCCCCCCCCCCHHHHHHHHH
Confidence 2345689999999988889999999999999999998 9999987654333222221 12234566789999999999
Q ss_pred hcccCcCccCC
Q psy11874 354 LLKKSPRSRLG 364 (767)
Q Consensus 354 lL~~dP~~Rl~ 364 (767)
||+.||++||+
T Consensus 234 ~~~~~p~~Rp~ 244 (257)
T cd05116 234 CWTYGVDERPG 244 (257)
T ss_pred HhccCchhCcC
Confidence 99999999999
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.67 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=211.5
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEe
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
|...+.||+|+||+||+|....+|+.||+|++.............+.+|+.+++.++|||++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999998765443444455678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcccc
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG 275 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~ 275 (767)
+. |+|...+.... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..... ...
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~ 176 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANS 176 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCC
Confidence 97 56766665532 2589999999999999999999999999999999999999999999999999865432 234
Q ss_pred cccccccCCcceec---CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 276 RVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 276 ~~GT~~Y~APEvl~---~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
..|+..|+|||++. +..++.++|+|||||++|+|++|.+||...+.......+... .........++..+++|+.
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCccccCHHHHHHHH
Confidence 57899999999984 456889999999999999999999999776543222222111 1111223457789999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
+||+++|.+||+ +.++++||||+..+
T Consensus 255 ~~l~~~P~~Rp~-------~~~~l~~~~~~~~~ 280 (313)
T cd06633 255 YCLQKIPQERPA-------SAELLRHDFVRRDR 280 (313)
T ss_pred HHccCChhhCcC-------HHHHhcCcccCCCc
Confidence 999999999999 99999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=335.03 Aligned_cols=258 Identities=25% Similarity=0.353 Sum_probs=205.7
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC------
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------ 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 186 (767)
.++|++.+.||.|+||.||+|.++.+|+.+|+|++....... .....+.+|++++++++||||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 579999999999999999999999999999999986553222 1233467899999999999999999877443
Q ss_pred --CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 187 --DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 187 --~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
..+++||||+.+ +|...+... ...+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 357999999975 676666543 236999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc------------ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh
Q psy11874 265 VEIPEGES------------VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR 331 (767)
Q Consensus 265 ~~~~~~~~------------~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~ 331 (767)
........ .....||+.|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+.......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 76543221 122357899999998865 45899999999999999999999999876554333322221
Q ss_pred hhccc--------------------------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 332 VKEDA--------------------------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 332 i~~~~--------------------------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
..... ......+++++.++|.+||+.||.+||+ +.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t-------~~ell~~~~f 311 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT-------ASDALEHPYF 311 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC-------HHHHhcCCCC
Confidence 11000 0011245678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.03 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=205.3
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++|++.+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.++++++|++++++++.+. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45578999999999999999999876 567799999876432 2345889999999999999999998875 45689
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||+++|+|..++.... ...+++..+..++.|++.||.|||+.+|+||||||+||++++++.++|+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999999987643 335899999999999999999999999999999999999999999999999999876443
Q ss_pred Cc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 271 ES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 271 ~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
.. .....++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+.......+.. ......+...+..+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 232 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER---GYRMPCPQDCPISL 232 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCCCcCCHHH
Confidence 22 122345678999999988889999999999999999999 9999977544332222221 22334456788999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHH
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELK 376 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil 376 (767)
.+|+.+||.++|++||+ ++++.
T Consensus 233 ~~li~~~l~~~p~~Rpt-------~~~l~ 254 (260)
T cd05070 233 HELMLQCWKKDPEERPT-------FEYLQ 254 (260)
T ss_pred HHHHHHHcccCcccCcC-------HHHHH
Confidence 99999999999999999 66664
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.58 Aligned_cols=257 Identities=21% Similarity=0.267 Sum_probs=209.8
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEE-----ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYA 182 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 182 (767)
.++..++|++.+.||+|+||.||+|.. ..++..+|+|.+.... .......+.+|+.+++++ +||||+++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 345567899999999999999999975 3356789999986542 223345688899999999 89999999999
Q ss_pred EeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecC
Q psy11874 183 YETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLG 262 (767)
Q Consensus 183 ~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFG 262 (767)
+...+.+|+||||++||+|..++.... ...+++.++..++.||+.||.|||+++|+||||||+|||++.++.++|+|||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999999987643 2348999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccc
Q psy11874 263 LAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEK 338 (767)
Q Consensus 263 la~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~ 338 (767)
++........ .....+++.|+|||++.+..++.++|+||+||++|||++ |..||.+............. .....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~--~~~~~ 264 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE--GYRMA 264 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc--CCcCC
Confidence 9986644322 122346788999999999999999999999999999998 99999776543222221111 11222
Q ss_pred cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 339 ~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+...++++.+++.+||.++|++||+ +.++++
T Consensus 265 ~~~~~~~~~~~li~~cl~~~p~~Rpt-------~~ell~ 296 (302)
T cd05055 265 QPEHAPAEIYDIMKTCWDADPLKRPT-------FKQIVQ 296 (302)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcC-------HHHHHH
Confidence 34467899999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.82 Aligned_cols=247 Identities=22% Similarity=0.311 Sum_probs=205.0
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEE-eeCCeE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAY-ETKDAL 189 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-~~~~~l 189 (767)
+..++|++.+.||+|+||.||+|... |..+|+|.+.... ....+.+|+.++++++|++++++++++ ...+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999999875 8889999985432 234678899999999999999999875 556789
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
++||||+++|+|.+++.+.. ...+++..+..++.||+.||+|||++||+||||||+||++++++.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999999999987653 33588999999999999999999999999999999999999999999999999976543
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
.. ....++..|+|||++.+..++.++|+|||||++|||++ |..||...........+.. ......+...++.++
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 229 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPVVY 229 (256)
T ss_pred cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---CCCCCCCCCCCHHHH
Confidence 32 23345678999999998899999999999999999997 9999976543222222211 122344567899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++.+||+.+|++||+ +.++++
T Consensus 230 ~li~~~l~~~p~~Rpt-------~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPS-------FLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcC-------HHHHHH
Confidence 9999999999999999 777754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.05 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=207.8
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEcc-------CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRA-------TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY 181 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 181 (767)
.+..++|.+.+.||+|+||.||+|++.. ++..+|+|.+.... .......+.+|+.+++++ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3445789999999999999999998753 23579999987542 223345678899999999 7999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceE
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNI 248 (767)
++...+..|+||||+++|+|..++..... ...+++..+..++.||+.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 99999999999999999999999976432 12488899999999999999999999999999999999
Q ss_pred EeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhh
Q psy11874 249 LLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVK 324 (767)
Q Consensus 249 Lld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~ 324 (767)
|++.++.+||+|||++........ .....+++.|+|||++.+..++.++|+|||||++|||++ |..||.+....
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-- 249 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 249 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--
Confidence 999999999999999976643221 112234578999999998889999999999999999998 88999765432
Q ss_pred hhhhhhhhhcc-ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 325 RDEVDRRVKED-AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 325 ~~~i~~~i~~~-~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++...+... ....+...+.++++|+.+||..+|++||+ +.++++
T Consensus 250 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-------~~evl~ 294 (307)
T cd05098 250 --ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT-------FKQLVE 294 (307)
T ss_pred --HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcC-------HHHHHH
Confidence 222222222 23445678999999999999999999999 677654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=337.25 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=200.3
Q ss_pred CcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCHHHHH
Q psy11874 126 GFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHI 205 (767)
Q Consensus 126 ~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l 205 (767)
++|.||.++...+|+.||+|++..... .......+.+|+.++++++|+||+++++++.+.+..+++|||+++|+|..++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 455666666777999999999876532 2345567899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--------cccccc
Q psy11874 206 YNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE--------SVRGRV 277 (767)
Q Consensus 206 ~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~--------~~~~~~ 277 (767)
.+.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.+|.++|+|||.+....... ......
T Consensus 91 ~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 91 KTHF-PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 8653 2358999999999999999999999999999999999999999999999999987553221 123345
Q ss_pred cccccCCcceecC--CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh------------------------
Q psy11874 278 GTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR------------------------ 331 (767)
Q Consensus 278 GT~~Y~APEvl~~--~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~------------------------ 331 (767)
++..|+|||++.+ ..++.++|+||+||++|||++|..||..........+....
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 7889999999865 46889999999999999999999999765432111110000
Q ss_pred ------hhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 332 ------VKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 332 ------i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
...........+++++.+|+.+||..||++||+ ++++++||||+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt-------~~~ll~~p~~~~~ 301 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS-------ASQLLNHSFFKQC 301 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC-------HHHHhcCchHhhh
Confidence 000111122345678999999999999999999 9999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.08 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=211.6
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEe
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
|+..+.||+|+||.||+|+...+++.||+|++.... ........+..|+.++++++|+|++++++++.+.+.+++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 567889999999999999999999999999997654 2233345677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-ccc
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SVR 274 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~~ 274 (767)
++ ++|..++.+.. ..+++..+..++.|++.||.|||+.||+||||+|+||++++++.++|+|||++....... ...
T Consensus 80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 98 58999998753 368999999999999999999999999999999999999999999999999998764432 233
Q ss_pred ccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc------------------
Q psy11874 275 GRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED------------------ 335 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~------------------ 335 (767)
...++..|+|||.+.+. .++.++|+|||||++|||++|.+||.+.........+.......
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 44578899999998766 88999999999999999999999998765433322222111000
Q ss_pred -------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 336 -------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 336 -------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.....+.++.++.++|.+||..||++||+ +.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~-------~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS-------AKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCC-------HHHHhhCcCC
Confidence 00111235789999999999999999998 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=348.21 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=215.3
Q ss_pred hhhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCc---E-EEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEE
Q psy11874 105 YNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGK---M-YACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLA 180 (767)
Q Consensus 105 ~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~-~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 180 (767)
-...+.+..++-.+.+.||+|+||+||+|..+..+. . ||+|....+....+.....+++|.++|++++|||||++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 344566777888888999999999999999886533 4 899998764445566778899999999999999999999
Q ss_pred EEEeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEee
Q psy11874 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISD 260 (767)
Q Consensus 181 ~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~D 260 (767)
|+...+..+++|||+|+||+|.++|.+.++ .++..+...++.+.++||+|||++++|||||-.+|+|++.++.+||+|
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCc
Confidence 999999999999999999999999998653 589999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCccc-ccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccc
Q psy11874 261 LGLAVEIPEGESVR-GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEK 338 (767)
Q Consensus 261 FGla~~~~~~~~~~-~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~ 338 (767)
||||+......... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+.+....+..+.. ......
T Consensus 306 FGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~--~~~r~~ 383 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK--NGYRMP 383 (474)
T ss_pred cccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh--cCccCC
Confidence 99997654222222 1224678999999999999999999999999999998 8999998866544443311 122234
Q ss_pred cCCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 339 YSCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 339 ~~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
.+...+.++..++.+|+..||+.|++
T Consensus 384 ~~~~~p~~~~~~~~~c~~~~p~~R~t 409 (474)
T KOG0194|consen 384 IPSKTPKELAKVMKQCWKKDPEDRPT 409 (474)
T ss_pred CCCCCHHHHHHHHHHhccCChhhccC
Confidence 45577889999999999999999999
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.45 Aligned_cols=234 Identities=28% Similarity=0.402 Sum_probs=197.6
Q ss_pred cCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCHHHH
Q psy11874 125 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFH 204 (767)
Q Consensus 125 G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~ 204 (767)
|.||.||+|+++.+|+.||+|.+.+... ..+|...+....||||+++++.+.+.+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999866431 23355555566799999999999999999999999999999999
Q ss_pred HHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcccccccccccCC
Q psy11874 205 IYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMA 284 (767)
Q Consensus 205 l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~A 284 (767)
+.+.. .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... .....++..|+|
T Consensus 76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFL---NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCA 150 (237)
T ss_pred HHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccC
Confidence 87653 5899999999999999999999999999999999999999999999999988765432 234567888999
Q ss_pred cceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 285 PEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 285 PEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
||.+.+..++.++|+||+||++|||++|..||...... +. .......+..+++.++++|.+||++||++|++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 222 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----IN---THTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc---cccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence 99998888999999999999999999999998543211 00 01112345678999999999999999999999
Q ss_pred CCCCcccHHHHHhCCCC
Q psy11874 365 CHCGRYGARELKQAEFF 381 (767)
Q Consensus 365 ~~~~~~~a~eil~HpfF 381 (767)
... .+++++++||||
T Consensus 223 ~~~--~~~~~~~~h~~~ 237 (237)
T cd05576 223 AGV--AGVEDIKSHPFF 237 (237)
T ss_pred CCc--cchHHHHcCCCC
Confidence 543 468999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.56 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=211.1
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEe
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
|++.+.||.|++|.||+|....+|+.+|+|.+...... ......+.+|+.+|++++|++|+++++.+.+++.+++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 56788999999999999999999999999998765332 23455678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-ccc
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SVR 274 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~~ 274 (767)
+++ +|...+.... ..+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||.+....... ...
T Consensus 80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 985 8877776643 368999999999999999999999999999999999999999999999999998775543 233
Q ss_pred ccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc------------------
Q psy11874 275 GRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED------------------ 335 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~------------------ 335 (767)
...++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+.......+.......
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 45688999999998776 78999999999999999999999997765432222211111000
Q ss_pred --------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 336 --------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 336 --------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
.......++.+++++|.+||.+||.+||+ +.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~-------~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT-------AEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC-------HHHHhhCCCC
Confidence 00112346889999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.52 Aligned_cols=251 Identities=21% Similarity=0.329 Sum_probs=206.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCC---cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
..+|++.+.||+|+||.||+|.++.++ ..+|+|.+..... ......+.+|+.++++++||||+++++.+.+++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 467999999999999999999987554 3799999865421 23345688899999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||++||+|..++.... ..+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999999997653 3589999999999999999999999999999999999999999999999999987654
Q ss_pred CCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCc
Q psy11874 270 GES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFS 344 (767)
Q Consensus 270 ~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s 344 (767)
... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||...........+.+ ......+...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 235 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE---GYRLPAPMDCP 235 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC---CCcCCCCCCCC
Confidence 322 112234678999999998899999999999999999886 9999976643322222221 11223345678
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+.+.+++.+||+++|.+||+ +.++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~-------~~~i~~ 261 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPK-------FEQIVS 261 (267)
T ss_pred HHHHHHHHHHcccCchhCCC-------HHHHHH
Confidence 99999999999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=324.56 Aligned_cols=253 Identities=19% Similarity=0.270 Sum_probs=207.4
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCc---EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
+..++|+..+.||+|+||.||+|....+++ .+|+|.+.... .......+.+|+.++++++||||+++.+++.+.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 445689999999999999999999876665 79999986542 1223456788999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
..|+||||+++|+|..++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999999987643 36899999999999999999999999999999999999999999999999999766
Q ss_pred CCCCcc----cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 268 PEGESV----RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 268 ~~~~~~----~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
...... .....++.|+|||++.+..++.++|+|||||++|||++ |..||...+.......+.. ......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~ 234 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND---GFRLPAPMD 234 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc---CCCCCCCCC
Confidence 433211 11223567999999988899999999999999999997 9999976544322222221 112233446
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+.++.+++.+||..+|++||+ ++++++
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~-------~~~i~~ 262 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPR-------FVDIVN 262 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcC-------HHHHHH
Confidence 7899999999999999999999 677654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=349.51 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=211.3
Q ss_pred hcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 107 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+.|.|..+...+...||+|+||+||+|.+-. .||||+++....... ..+.|.+|+.+|++-+|.||+-+.|++...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 5567888889999999999999999999964 499999987765444 778899999999999999999999998887
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
.. .+|+.+|+|.+|..||+-.. ..|++...+.|+.||+.||.|||.++|||||||..||+|++++.|||+||||+..
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 76 99999999999999998754 4799999999999999999999999999999999999999999999999999954
Q ss_pred ---cCCCCcccccccccccCCcceecC---CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-cccccc
Q psy11874 267 ---IPEGESVRGRVGTVGYMAPEVIDN---EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK-EDAEKY 339 (767)
Q Consensus 267 ---~~~~~~~~~~~GT~~Y~APEvl~~---~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~ 339 (767)
...........|...|||||++.. .+|++.+|||||||++|||++|..||...+.....-.+-+... .+....
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 222333455678999999999954 4799999999999999999999999985544333322323221 122233
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
....+.++++|+..|+..++++||.
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~ 642 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPL 642 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCcc
Confidence 4566789999999999999999999
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=322.77 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=207.2
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++.+.||+|+||.||+|..+ +++.||+|.+..... ....+.+|+.++++++|+||+++++.+. .+..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 345678999999999999999999865 678899999875432 2346888999999999999999998764 5679
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++.....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999999887643 34689999999999999999999999999999999999999999999999999977653
Q ss_pred CCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 270 GES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
... .....++..|+|||++....++.++|+|||||++|||++ |.+||.+.+.......+.. ......+...+.+
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 231 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER---GYRMPRPDNCPEE 231 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc---CCCCCCCCCCCHH
Confidence 322 223456789999999998899999999999999999998 9999976654322222211 1122345667899
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+.+++.+||..+|++||+ ++++++
T Consensus 232 ~~~li~~~l~~~p~~Rp~-------~~~l~~ 255 (260)
T cd05067 232 LYELMRLCWKEKPEERPT-------FEYLRS 255 (260)
T ss_pred HHHHHHHHccCChhhCCC-------HHHHHH
Confidence 999999999999999999 777654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=327.24 Aligned_cols=255 Identities=29% Similarity=0.418 Sum_probs=209.5
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeEEEEEE
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
|++.+.||.|+||+||+|....+++.+|+|.+...... .......+|+..+.+++ |+||+++++.+.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999999999999998655321 22334567999999999 9999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~ 274 (767)
|+ +|+|..++.... ...+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++..........
T Consensus 79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence 99 789988887653 2468999999999999999999999999999999999999999999999999998776554445
Q ss_pred ccccccccCCcceec-CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh--------------------
Q psy11874 275 GRVGTVGYMAPEVID-NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK-------------------- 333 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~-~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~-------------------- 333 (767)
...|+..|+|||++. +..++.++|+||||++++||++|.+||...........+.....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 567899999999884 45689999999999999999999999976644322211111000
Q ss_pred ------ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 334 ------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 334 ------~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
..........+++++++|.+||+.||++||+ +.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt-------~~ei~~~~~~ 283 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT-------ASQALQHPYF 283 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC-------HHHHhhCCCC
Confidence 0001111233688999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=342.42 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=206.9
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDAL 189 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l 189 (767)
+.-..|++++.||+||.+.||++... ....||+|++.... ........+.+|+..|.++. |.+||+|+++-.+++.+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 44567999999999999999999875 45677777664432 24456778999999999995 79999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+|||+=+ .||..+|..... ....-.+++|..||+.|+.++|++||||.||||.|+|+=. |.+||+|||.|..+..
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEeeccc-ccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 99999865 699888887643 2232388999999999999999999999999999999875 9999999999998877
Q ss_pred CCc---ccccccccccCCcceecCCC-----------CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc
Q psy11874 270 GES---VRGRVGTVGYMAPEVIDNEK-----------YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED 335 (767)
Q Consensus 270 ~~~---~~~~~GT~~Y~APEvl~~~~-----------ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~ 335 (767)
+.+ ..+.+||+.||+||.+.... .+.++||||||||||+|+.|++||...... ..-...|.+.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~---~aKl~aI~~P 588 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ---IAKLHAITDP 588 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---HHHHHhhcCC
Confidence 654 23468999999999995432 458899999999999999999999664321 1112233333
Q ss_pred --ccccCCCCcHH-HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 336 --AEKYSCRFSDD-AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 336 --~~~~~~~~s~~-~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
..+|+..-+.. +.++.+.||..||.+|++ +.++|+|||..-+
T Consensus 589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~s-------i~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWS-------IPELLQHPFLQIQ 633 (677)
T ss_pred CccccccCCCCchHHHHHHHHHHhcCcccCCC-------cHHHhcCcccccc
Confidence 23455443444 999999999999999999 8999999998653
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=324.34 Aligned_cols=251 Identities=20% Similarity=0.321 Sum_probs=207.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCc---EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.++|++.+.||+|+||.||+|..+.+|+ .||+|.+.... .......+..|+.++++++||||+++.+.+.++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4679999999999999999999987765 69999986542 233456688999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
++||||++||+|..++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 81 MIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999999887643 3689999999999999999999999999999999999999999999999999876544
Q ss_pred CCccc---ccc---cccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 270 GESVR---GRV---GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 270 ~~~~~---~~~---GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
..... ... ++..|+|||.+.+..++.++|+|||||++|||++ |..||...+.......+. .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~~~~~~~~~~ 235 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---QDYRLPPPMD 235 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cCCcCCCccc
Confidence 32211 111 2457999999999999999999999999999886 999997765432222221 1112233456
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+..+.+++.+||.++|++||+ +++|++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~-------~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPK-------FGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcC-------HHHHHH
Confidence 7899999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=326.15 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=198.9
Q ss_pred eEEEeEEeecCcEEEEEEEE----ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--CCeE
Q psy11874 116 FRMYRVLGKGGFGEVCACQV----RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--KDAL 189 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~----~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 189 (767)
|++.+.||+|+||+||++.. ..++..+|+|.+.... .......+.+|+.+|++++||||+++++++.. ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 48999999999999988754 3568899999986542 12234567889999999999999999998765 3468
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
++||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||+++++.++|+|||++.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999998753 489999999999999999999999999999999999999999999999999987654
Q ss_pred CCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhh-----------hhhhhhh-h
Q psy11874 270 GES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKR-----------DEVDRRV-K 333 (767)
Q Consensus 270 ~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~-----------~~i~~~i-~ 333 (767)
+.. .....++..|+|||++.+..++.++|||||||++|||++|..||......... ..+...+ .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 332 11234567899999998888999999999999999999999998653221000 0000000 0
Q ss_pred ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 334 EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 334 ~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
......+..++..+.+++.+||+.||++||+ ++++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-------~~~i~~ 276 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPT-------FRSLIP 276 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCC-------HHHHHH
Confidence 1112234567899999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=333.09 Aligned_cols=254 Identities=25% Similarity=0.310 Sum_probs=211.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.|+..+.||+|+||.||+|.+..+|..+|+|++.............+.+|+.++++++|||++++++++.+.+..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45888999999999999999999999999999987654333344567888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||++| +|.+.+.... ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..... .
T Consensus 105 e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~ 178 (317)
T cd06635 105 EYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---A 178 (317)
T ss_pred eCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---c
Confidence 99985 7766665432 2589999999999999999999999999999999999999999999999999875533 2
Q ss_pred cccccccccCCcceec---CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc-ccCCCCcHHHHH
Q psy11874 274 RGRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE-KYSCRFSDDAKA 349 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~---~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~-~~~~~~s~~~~d 349 (767)
....|++.|+|||++. ...++.++|+|||||++|||++|..||...........+ ...... .....+++.+++
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---HhccCCCCCCccccHHHHH
Confidence 3457899999999973 456889999999999999999999999765432222222 111111 223457889999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
++.+||+.+|.+||+ +.++++|||+..
T Consensus 256 li~~~l~~~p~~Rpt-------~~~il~~~~~~~ 282 (317)
T cd06635 256 FVDSCLQKIPQDRPT-------SEELLKHMFVLR 282 (317)
T ss_pred HHHHHccCCcccCcC-------HHHHHhChhhhc
Confidence 999999999999998 999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=338.32 Aligned_cols=259 Identities=27% Similarity=0.382 Sum_probs=209.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeC--CeE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETK--DAL 189 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~--~~l 189 (767)
.++|++.+.||+|+||.||+|.+..+|+.+|+|++.+.. ........+.+|+.+++++ +||||+++++++... ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 367999999999999999999999999999999986532 2223344567899999999 999999999988653 468
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||++ ++|..++... .+++..+..++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99999998 5898887653 578899999999999999999999999999999999999999999999999986543
Q ss_pred CC------cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh----------
Q psy11874 270 GE------SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV---------- 332 (767)
Q Consensus 270 ~~------~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i---------- 332 (767)
.. ......||+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 32 2233568999999998754 568899999999999999999999997654332211111110
Q ss_pred -------------hc----cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 333 -------------KE----DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 333 -------------~~----~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.. ........++.++.++|.+||+.||++||+ +.++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps-------~~~il~~~~~~~~ 301 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT-------AEEALEHPYVAQF 301 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC-------HHHHhhChhhhhh
Confidence 00 001112336889999999999999999999 9999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=332.33 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=207.6
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEcc-------CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRA-------TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY 181 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 181 (767)
.+..++|.+.+.||+|+||.||+|+... .+..+|+|.+.... .......+.+|+.+++++ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3455789999999999999999998642 35679999986542 233455688899999999 6999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceE
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNI 248 (767)
++...+.+|+||||+++|+|..++..... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 99999999999999999999999976421 23588999999999999999999999999999999999
Q ss_pred EeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhh
Q psy11874 249 LLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVK 324 (767)
Q Consensus 249 Lld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~ 324 (767)
|++.++.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999986643221 122234568999999998899999999999999999999 8999977643322
Q ss_pred hhhhhhhhhcc-ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 325 RDEVDRRVKED-AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 325 ~~~i~~~i~~~-~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.. .+... ....+...+.++++++.+||..||++||+ +.++++
T Consensus 246 ~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-------~~~ll~ 288 (314)
T cd05099 246 FK----LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPT-------FKQLVE 288 (314)
T ss_pred HH----HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcC-------HHHHHH
Confidence 22 22221 22345677889999999999999999999 677664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=330.54 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=205.2
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccC--------------CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCcee
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRAT--------------GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVV 177 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t--------------g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv 177 (767)
..++|++.+.||+|+||.||+|....+ ...||+|.+.... .......+.+|++++++++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 446899999999999999999987543 2359999986542 223445688999999999999999
Q ss_pred EEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCC---------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceE
Q psy11874 178 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGG---------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248 (767)
Q Consensus 178 ~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~---------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNI 248 (767)
++++++...+..++||||++|++|.+++..... ...+++..+..++.|++.||.|||+.|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999999999999999999999999999865321 12468889999999999999999999999999999999
Q ss_pred EeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc--CCCCCCCchhhh
Q psy11874 249 LLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE--GQAPFRRRKEMV 323 (767)
Q Consensus 249 Lld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt--G~~PF~~~~~~~ 323 (767)
|+++++.+||+|||++........ .....+++.|+|||++.+..++.++|+|||||++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999976543322 122345789999999988899999999999999999988 678887654332
Q ss_pred hhhhhhhhhh----ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 324 KRDEVDRRVK----EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 324 ~~~~i~~~i~----~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
....+..... ......+...++.+++|+.+||..||++||+ +++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-------~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT-------FNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcC-------HHHHHH
Confidence 2222211110 0111224457899999999999999999999 677653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=321.35 Aligned_cols=242 Identities=21% Similarity=0.315 Sum_probs=199.8
Q ss_pred eEEeecCcEEEEEEEEccCC---cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEec
Q psy11874 120 RVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIM 196 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~ 196 (767)
+.||+|+||.||+|.+..++ ..+|+|.+...... .....+.+|+.+++++.|+||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876655 89999998766443 34567888999999999999999999776 45689999999
Q ss_pred cCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc---
Q psy11874 197 NGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV--- 273 (767)
Q Consensus 197 ~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~--- 273 (767)
++|+|.+++.+.. .+++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 9999999998754 6899999999999999999999999999999999999999999999999999876443321
Q ss_pred -cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 274 -RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 274 -~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
....++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+.......+. .......+...++.++++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li 231 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE---SGERLPRPEECPQEIYSIM 231 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---cCCcCCCCCCCCHHHHHHH
Confidence 11224568999999998999999999999999999998 999997664432222221 1122345567889999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+||..+|++||+ +.++++
T Consensus 232 ~~cl~~~p~~Rp~-------~~~l~~ 250 (257)
T cd05060 232 LSCWKYRPEDRPT-------FSELES 250 (257)
T ss_pred HHHhcCChhhCcC-------HHHHHH
Confidence 9999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=320.77 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=209.1
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
++..++|++.+.||+|+||.||+|... +++.+|+|.+..... ....+.+|+.++++++|+||+++++.+.+...+
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 456689999999999999999999976 567899999875432 235688899999999999999999999998999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
++||||+++++|..++.... ...+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++.....
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999999997653 33689999999999999999999999999999999999999999999999999987654
Q ss_pred CCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 270 GES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
... .....++..|+|||.+.+..++.++|+||+||++|+|++ |+.||.+.........+.. ......+...+++
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 232 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER---GYRMPRPPNCPEE 232 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHH
Confidence 221 112235678999999998899999999999999999998 9999977644332222221 1123334567899
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHH
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELK 376 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil 376 (767)
+.+++.+||+.+|++||+ ++++.
T Consensus 233 ~~~~i~~~l~~~p~~Rp~-------~~~l~ 255 (261)
T cd05034 233 LYDLMLQCWDKDPEERPT-------FEYLQ 255 (261)
T ss_pred HHHHHHHHcccCcccCCC-------HHHHH
Confidence 999999999999999999 66665
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=334.82 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=208.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee-CCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-KDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lV 192 (767)
++|++.+.||.|+||.||+|....+|+.||+|++.+.. ........+..|+.++++++||||+++.++|.. .+..|+|
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 67999999999999999999999999999999986542 222344567789999999999999999999865 5689999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
|||+ +++|..++... .+++..+..++.||+.||.|||+.+|+||||+|.|||+++++.++|+|||++..... .
T Consensus 89 ~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~ 161 (328)
T cd07856 89 TELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--Q 161 (328)
T ss_pred eehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--C
Confidence 9999 56888777542 478888999999999999999999999999999999999999999999999976533 2
Q ss_pred ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh--------------------
Q psy11874 273 VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR-------------------- 331 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~-------------------- 331 (767)
.....+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...........+.+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 334578999999999865 67899999999999999999999999765432111110000
Q ss_pred ---hhc-c---ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 332 ---VKE-D---AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 332 ---i~~-~---~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
... . .......++++++++|++||+.+|++||+ +++++.||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t-------~~ell~~~~~~~~ 294 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS-------AAEALAHPYLAPY 294 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC-------HHHHhcCCccccc
Confidence 000 0 00112357889999999999999999998 9999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=330.57 Aligned_cols=256 Identities=20% Similarity=0.300 Sum_probs=209.4
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEc-------cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY 181 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~-------~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 181 (767)
.+..++|.+.+.||+|+||.||+|++. .++..+|+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 355678999999999999999999853 234689999986542 223345688899999999 8999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceE
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNI 248 (767)
.+......|+||||+++|+|..++.+... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 99999999999999999999999987432 13478888999999999999999999999999999999
Q ss_pred EeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhh
Q psy11874 249 LLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVK 324 (767)
Q Consensus 249 Lld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~ 324 (767)
|++.++.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 999999999999999987654322 223346788999999988899999999999999999998 889997664332
Q ss_pred hhhhhhhhhcc-ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 325 RDEVDRRVKED-AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 325 ~~~i~~~i~~~-~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+...+... ....+...+.++++|+.+||..+|++||+ +.++++.
T Consensus 248 ---~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-------~~e~l~~ 292 (304)
T cd05101 248 ---LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPT-------FKQLVED 292 (304)
T ss_pred ---HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCC-------HHHHHHH
Confidence 22222221 22334568899999999999999999998 7777653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=321.86 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=204.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++|++.+.||+|+||.||+|....+ ..+|+|.+..... ....+.+|+.++++++|+|++++++.+. .+..+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 4456799999999999999999998655 4699998765432 2356788999999999999999998875 45689
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999999999997643 335889999999999999999999999999999999999999999999999999766443
Q ss_pred Cc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 271 ES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 271 ~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
.. .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.........+.. ......+..++..+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 232 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER---GYRMPCPQGCPESL 232 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCcccCHHH
Confidence 22 123346788999999988889999999999999999999 9999987654332222221 12233455788999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++++++||.+||++||+ ++++++
T Consensus 233 ~~li~~~l~~~p~~Rp~-------~~~i~~ 255 (260)
T cd05069 233 HELMKLCWKKDPDERPT-------FEYIQS 255 (260)
T ss_pred HHHHHHHccCCcccCcC-------HHHHHH
Confidence 99999999999999998 666653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=339.74 Aligned_cols=257 Identities=25% Similarity=0.326 Sum_probs=205.8
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEE-----ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAY 183 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~ 183 (767)
.++.++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .......+.+|+.+|.++ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 45567899999999999999999984 3567899999986542 223345688899999999 689999999887
Q ss_pred ee-CCeEEEEEEeccCCCHHHHHHhcCC----------------------------------------------------
Q psy11874 184 ET-KDALCLVLTIMNGGDLKFHIYNMGG---------------------------------------------------- 210 (767)
Q Consensus 184 ~~-~~~l~lV~E~~~gG~L~~~l~~~~~---------------------------------------------------- 210 (767)
.. ...+++||||++||+|.+++.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 65 4568999999999999999875321
Q ss_pred ------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc---ccc
Q psy11874 211 ------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES---VRG 275 (767)
Q Consensus 211 ------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~---~~~ 275 (767)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12367888899999999999999999999999999999999999999999999976533221 122
Q ss_pred cccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhh-ccccccCCCCcHHHHHHHHH
Q psy11874 276 RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVK-EDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 276 ~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~-~~~~~~~~~~s~~~~dLi~~ 353 (767)
..+++.|+|||++.+..++.++|+|||||++|+|++ |..||........ +...+. ......+...++++.+++..
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGTRMRAPDYTTPEMYQTMLD 317 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH---HHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 345678999999988899999999999999999996 9999976532211 111111 12223345578899999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
||..||++||+ +.+|++|
T Consensus 318 cl~~~p~~Rps-------~~eil~~ 335 (343)
T cd05103 318 CWHGEPSQRPT-------FSELVEH 335 (343)
T ss_pred HccCChhhCcC-------HHHHHHH
Confidence 99999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=319.60 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=209.1
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++|++.+.||+|+||.||+|... |+.+|+|.+..... ....+.+|+.++++++|+||+++++.+.+.+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 44578999999999999999999875 88999999865532 4566888999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 9999999999999987653 235899999999999999999999999999999999999999999999999999876433
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
.. ...++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+.. ......+..+++.+.+
T Consensus 156 ~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 156 QD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK---GYRMEAPEGCPPEVYK 230 (256)
T ss_pred cc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc---CCCCCCccCCCHHHHH
Confidence 22 3345678999999988889999999999999999997 9999977644322222221 1123345568899999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+|.+||..+|++||+ +.++++
T Consensus 231 li~~~l~~~p~~Rp~-------~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPT-------FKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcC-------HHHHHH
Confidence 999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=321.01 Aligned_cols=245 Identities=22% Similarity=0.296 Sum_probs=203.7
Q ss_pred eEEeecCcEEEEEEEEcc-CC--cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEec
Q psy11874 120 RVLGKGGFGEVCACQVRA-TG--KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIM 196 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~-tg--~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~ 196 (767)
+.||+|++|.||+|.+.. ++ ..+|+|.+...... .....+.+|+.++++++||||+++++.+.. ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 33 36999999776543 456678899999999999999999999988 8999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc----
Q psy11874 197 NGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES---- 272 (767)
Q Consensus 197 ~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~---- 272 (767)
++|+|..++.+... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999999987542 4689999999999999999999999999999999999999999999999999987654321
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
.....++..|+|||.+.+..++.++|+|||||++|||++ |..||...+.......+.. .......+...+..+.+++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li 234 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK--EGERLERPEACPQDIYNVM 234 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--cCCcCCCCccCCHHHHHHH
Confidence 123457889999999999999999999999999999998 9999976544332222221 1122233456789999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+||..+|++||+ ++++++
T Consensus 235 ~~~l~~~p~~Rps-------~~~~~~ 253 (257)
T cd05040 235 LQCWAHNPADRPT-------FAALRE 253 (257)
T ss_pred HHHCCCCcccCCC-------HHHHHH
Confidence 9999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=325.78 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=202.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcE----EEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+..++|++.+.||+|+||+||+|.+..+|.. +|+|.+.... .......+..|..++++++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 4557899999999999999999999877764 6777764321 1223345777888999999999999999875 4
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
...++++||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 56889999999999999997643 2589999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 267 IPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 267 ~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
...... .....|+..|+|||.+.+..++.++|+|||||++|||++ |..||.+.........+. .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~ 235 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---KGERLAQPQI 235 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---CCCcCCCCCC
Confidence 643322 223457789999999998899999999999999999998 999997764322211111 1112223445
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+.++.+++.+|+..||++||+ +.|+++
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps-------~~el~~ 263 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPT-------FKELAN 263 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcC-------HHHHHH
Confidence 6789999999999999999999 777754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=345.49 Aligned_cols=258 Identities=22% Similarity=0.271 Sum_probs=209.9
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEE
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAY 181 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~ 181 (767)
.+.+..++|.+.+.||+|+||.||+|.++ .+++.||+|++.... .......+.+|+.+|.++. |||||++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 35566678999999999999999999964 346789999997542 2223346889999999997 999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCC---------------------------------------------------
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGG--------------------------------------------------- 210 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~--------------------------------------------------- 210 (767)
++.+.+.+++||||++||+|.+++...+.
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 99999999999999999999999975321
Q ss_pred --------------------------------------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcc
Q psy11874 211 --------------------------------------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPE 246 (767)
Q Consensus 211 --------------------------------------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPe 246 (767)
...+++..+..++.||+.||.|||+.+|+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 124677888999999999999999999999999999
Q ss_pred eEEeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhh
Q psy11874 247 NILLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEM 322 (767)
Q Consensus 247 NILld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~ 322 (767)
|||+++++.+||+|||+++....... .....|++.|+|||.+.+..++.++|+|||||++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986533221 223467889999999998889999999999999999998 89999764332
Q ss_pred hhhhhhhhhhh-ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 323 VKRDEVDRRVK-EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 323 ~~~~~i~~~i~-~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
... ...+. ......+...+.++.+|+.+||..+|.+||+ +++|++
T Consensus 349 ~~~---~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs-------~~ell~ 394 (401)
T cd05107 349 EQF---YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD-------FSQLVH 394 (401)
T ss_pred HHH---HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcC-------HHHHHH
Confidence 221 11111 1123345678999999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=324.30 Aligned_cols=246 Identities=20% Similarity=0.284 Sum_probs=197.6
Q ss_pred eEEeecCcEEEEEEEEccCCc--EEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEEEEec
Q psy11874 120 RVLGKGGFGEVCACQVRATGK--MYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVLTIM 196 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV~E~~ 196 (767)
++||+|+||.||+|+...+|. .+|+|.+... ........+.+|+.++.++ +||||+++++.+...+.+++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988876 4588877532 1233445688899999999 8999999999999999999999999
Q ss_pred cCCCHHHHHHhcC-------------CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 197 NGGDLKFHIYNMG-------------GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 197 ~gG~L~~~l~~~~-------------~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
++|+|.+++.... ....+++..+..++.|++.||+|||+.|++||||||+|||+++++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997642 123478999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 264 AVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 264 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
+..............+..|+|||++.+..++.++|+|||||++|||++ |..||.+.+.......+.. ......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~ 235 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GYRLEKPLN 235 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC---CCCCCCCCc
Confidence 864322111112234678999999988899999999999999999997 9999976543222222211 112233456
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+.++.+++.+||..||.+||+ ++++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps-------~~~il~ 263 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPS-------FAQILV 263 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCC-------HHHHHH
Confidence 7889999999999999999999 777654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=331.51 Aligned_cols=255 Identities=24% Similarity=0.301 Sum_probs=211.1
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.|...+.||+|+||.||+|+.+.++..+|+|.+.............+.+|+.+++.++|+|++++.+++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45777889999999999999999999999999986543333344456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||+. |+|...+.... ..+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9997 57777665432 35899999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccCCcceec---CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc-cCCCCcHHHHH
Q psy11874 274 RGRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK-YSCRFSDDAKA 349 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~---~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~-~~~~~s~~~~d 349 (767)
....||+.|+|||.+. ...++.++|||||||++|+|++|..||...+.......+.+ ..... ....++..+++
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NESPALQSGHWSEYFRN 245 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh---cCCCCcCcccccHHHHH
Confidence 3456899999999974 35688999999999999999999999976543222222211 11111 23467899999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
||++||.++|++||+ ++++++|||+...
T Consensus 246 li~~cl~~~P~~Rp~-------~~~ll~~~~~~~~ 273 (308)
T cd06634 246 FVDSCLQKIPQDRPT-------SEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHhhCCcccCCC-------HHHHhhCcccccc
Confidence 999999999999999 9999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=327.53 Aligned_cols=256 Identities=20% Similarity=0.342 Sum_probs=204.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEcc----------------CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCce
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRA----------------TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFV 176 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~----------------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 176 (767)
.++|++.+.||+|+||.||+|.... ++..+|+|++.... .......+.+|+.+|++++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4679999999999999999986432 34579999986542 23344568899999999999999
Q ss_pred eEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCCC--------CCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceE
Q psy11874 177 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGE--------PGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248 (767)
Q Consensus 177 v~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~--------~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNI 248 (767)
+++++++...+..|+||||++||+|..++.+.... ..+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999999999999764321 2367889999999999999999999999999999999
Q ss_pred EeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc--CCCCCCCchhhh
Q psy11874 249 LLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE--GQAPFRRRKEMV 323 (767)
Q Consensus 249 Lld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt--G~~PF~~~~~~~ 323 (767)
|++.++.++|+|||++........ .....+++.|+|||+..+..++.++|+|||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986644321 122345678999999888889999999999999999998 788997654332
Q ss_pred hhhhhhhhhh----ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 324 KRDEVDRRVK----EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 324 ~~~~i~~~i~----~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.......... ......+..+++.+.+|+.+||+.||++||+ +++|.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~-------~~~i~~ 292 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS-------FQEIHA 292 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCC-------HHHHHH
Confidence 2221111110 1111223467899999999999999999999 666643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=327.12 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=207.3
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEcc-----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
+..++|++.+.||+|+||.||+|.... ++..||+|.+.... .......+.+|+.++++++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 345789999999999999999999753 67899999986542 12334568889999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCC-------------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGG-------------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPE 246 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~-------------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPe 246 (767)
.+.+|+||||+++|+|..++..... ...+++..+..++.||+.||.|||+.+++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 9999999999999999999975321 234788889999999999999999999999999999
Q ss_pred eEEeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhh
Q psy11874 247 NILLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEM 322 (767)
Q Consensus 247 NILld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~ 322 (767)
|||++.++.++|+|||++........ .....+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876543321 122345678999999998999999999999999999997 88899765432
Q ss_pred hhhhhhhhhhhcc-ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 323 VKRDEVDRRVKED-AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 323 ~~~~~i~~~i~~~-~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
. +...+... ....+..++.++.+||.+||+.||++||+ +.|+++
T Consensus 240 ~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-------~~el~~ 284 (288)
T cd05050 240 E----VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPS-------FASINR 284 (288)
T ss_pred H----HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCC-------HHHHHH
Confidence 2 22222211 22234567899999999999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.82 Aligned_cols=256 Identities=22% Similarity=0.372 Sum_probs=211.4
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh--hhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
+|.+.+.||+|+||.||+|.+..++..+++|++...... .......+..|..++++++||||+++++.+.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 488999999999999999999888777877776543322 122334567799999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 193 LTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
|||+++++|..++.... ....+++..+..++.|++.||.|||+.|++|+||||+||++++ +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 99999999998886532 2346899999999999999999999999999999999999975 679999999997664432
Q ss_pred c-ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 272 S-VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 272 ~-~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
. .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||........ ............+..++.++.++
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV---VLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHcCCCCCCcchhcHHHHHH
Confidence 2 3345689999999999888899999999999999999999999976543221 12222223344456788999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
|.+||..||++||+ +.++++||||
T Consensus 237 i~~~l~~~p~~Rp~-------~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPS-------AAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcC-------HHHHhhCCCC
Confidence 99999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.15 Aligned_cols=236 Identities=22% Similarity=0.316 Sum_probs=193.5
Q ss_pred EEeecCcEEEEEEEEc--cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 121 VLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 121 ~LG~G~fG~Vy~a~~~--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
.||+|+||.||+|.++ .++..+|+|++.... .....+.+.+|+.++++++||||+++++.++ .+..++||||++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999775 456679999986542 2334556889999999999999999999876 4578999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc----cc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES----VR 274 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~----~~ 274 (767)
|+|..++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 79 GPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999887532 3689999999999999999999999999999999999999999999999999976544322 11
Q ss_pred ccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 275 GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
...+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+.........+. .......+...++++.++|.+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE---QGKRLDCPAECPPEMYALMKD 233 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH---CCCCCCCCCCCCHHHHHHHHH
Confidence 1234678999999988889999999999999999996 999997764432222221 112234456778999999999
Q ss_pred hcccCcCccCC
Q psy11874 354 LLKKSPRSRLG 364 (767)
Q Consensus 354 lL~~dP~~Rl~ 364 (767)
||..||++||+
T Consensus 234 c~~~~~~~Rp~ 244 (257)
T cd05115 234 CWIYKWEDRPN 244 (257)
T ss_pred HcCCChhhCcC
Confidence 99999999999
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=322.21 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=208.9
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccC-----CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRAT-----GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
..++|++.+.||+|+||.||+|+.+.+ .+.+|+|.+.... .......+.+|++++++++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 346899999999999999999997643 5789999876532 222345688899999999999999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCC------CCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEee
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGE------PGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISD 260 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~------~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~D 260 (767)
+..|+||||+++|+|..++...... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999999765422 1589999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCC--cccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccc-
Q psy11874 261 LGLAVEIPEGE--SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDA- 336 (767)
Q Consensus 261 FGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~- 336 (767)
||++....... ......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||....... +...+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~~~~~~~ 236 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRLQAGKL 236 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH----HHHHHHcCCc
Confidence 99987543221 2234467888999999988889999999999999999998 889996654322 222222111
Q ss_pred -cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 337 -EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 337 -~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
...+..+++.+.+++.+||+.+|++||+ +.+++++
T Consensus 237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~-------~~~~l~~ 272 (275)
T cd05046 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPS-------FSELVSA 272 (275)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCC-------HHHHHHH
Confidence 2234568899999999999999999998 8888763
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.65 Aligned_cols=245 Identities=20% Similarity=0.308 Sum_probs=203.2
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
++..++|++.+.||+|+||.||+|... .+..+|+|.+.... .....+.+|+.++++++|+||+++++.+.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 466789999999999999999999865 56679999886532 224567889999999999999999999887 789
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999999997643 33578899999999999999999999999999999999999999999999999976644
Q ss_pred CCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 270 GES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
... .....++..|+|||++....++.++|+|||||++|+|++ |..||.+.+.......+.. ......+...+.+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 231 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER---GYRMPRPENCPEE 231 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC---CCCCCCcccCCHH
Confidence 322 223346778999999988889999999999999999998 9999987643322222211 1122334578899
Q ss_pred HHHHHHHhcccCcCccCC
Q psy11874 347 AKALCKALLKKSPRSRLG 364 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~ 364 (767)
+.+++.+||.++|++||+
T Consensus 232 ~~~~i~~~l~~~p~~Rp~ 249 (260)
T cd05073 232 LYNIMMRCWKNRPEERPT 249 (260)
T ss_pred HHHHHHHHcccCcccCcC
Confidence 999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.38 Aligned_cols=249 Identities=21% Similarity=0.289 Sum_probs=206.6
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
..+|++.+.||.|+||.||+|.+. ++..+|+|.+..... ....+.+|++++++++||+++++++.+......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 357999999999999999999885 477899999865432 234578899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
|||++||+|.+++.... ..++++.+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999999987643 2578999999999999999999999999999999999999999999999999976543321
Q ss_pred --ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 273 --VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 273 --~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
.....++..|+|||.+.+..++.++|+|||||++|||++ |..||...........+... .....+...++.+.+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 232 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG---FRLYKPRLASQSVYE 232 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC---CCCCCCCCCCHHHHH
Confidence 122345678999999988899999999999999999998 99999766543322222211 122224457899999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
|+.+||..+|++||+ +.+++++
T Consensus 233 l~~~~l~~~p~~Rp~-------~~~~l~~ 254 (256)
T cd05112 233 LMQHCWKERPEDRPS-------FSLLLHQ 254 (256)
T ss_pred HHHHHcccChhhCCC-------HHHHHHh
Confidence 999999999999999 8888763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=333.48 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=209.1
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccC-------CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRAT-------GKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY 181 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-------g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 181 (767)
.+...+|++.+.||+|+||.||+|++... +..+|+|.+.... .......+.+|+.+++++ +||||+++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 44556899999999999999999986532 2378999876432 223456788899999999 8999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceE
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNI 248 (767)
.+...+.+++||||+++|+|.+++..... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 99999999999999999999999976431 23478888999999999999999999999999999999
Q ss_pred EeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhh
Q psy11874 249 LLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVK 324 (767)
Q Consensus 249 Lld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~ 324 (767)
|++.++.+||+|||+++....... .....++..|+|||++.+..++.++|+|||||++|||++ |..||.+......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999987644322 122334678999999999999999999999999999998 8999977643322
Q ss_pred hhhhhhhhhc-cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 325 RDEVDRRVKE-DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 325 ~~~i~~~i~~-~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
. +.+.. .....+...+.++.+++.+||..+|++||+ +.+++++
T Consensus 246 ~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-------~~ell~~ 289 (334)
T cd05100 246 F----KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPT-------FKQLVED 289 (334)
T ss_pred H----HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcC-------HHHHHHH
Confidence 2 22222 222345567899999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=324.67 Aligned_cols=254 Identities=20% Similarity=0.290 Sum_probs=203.4
Q ss_pred CCeEEEeEEeecCcEEEEEEEE----ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC--C
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQV----RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK--D 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~----~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~ 187 (767)
..|++.+.||+|+||.||.|.. +.+++.||+|.+.... .......+.+|+.++++++||||+++.+++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4678999999999999999985 4578999999986442 233345688999999999999999999988775 6
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
..++||||++||+|..++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..+
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 7899999999999999986542 25899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhh-----------hhhhhhhhhh
Q psy11874 268 PEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-----------VKRDEVDRRV 332 (767)
Q Consensus 268 ~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~-----------~~~~~i~~~i 332 (767)
..... .....|+..|+|||++.+..++.++|+|||||++|||++|..|+...... .........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 54322 12345778899999998888999999999999999999988765332110 0000011111
Q ss_pred h-ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 333 K-EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 333 ~-~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
. ......+..+++.+.+|+.+||+.||++||+ +++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-------~~~il~~ 279 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTT-------FQNLIEG 279 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCCcccCcC-------HHHHHHH
Confidence 1 1122334568999999999999999999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.35 Aligned_cols=243 Identities=21% Similarity=0.351 Sum_probs=200.8
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGG 199 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG 199 (767)
++||+|+||.||+|... +++.+|+|.+.... .......+.+|+.++++++||||+++++.+...+..++||||++||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 68899999986542 2223446888999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc--cccc
Q psy11874 200 DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV--RGRV 277 (767)
Q Consensus 200 ~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~--~~~~ 277 (767)
+|..++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......... ....
T Consensus 78 ~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 78 DFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 9999887543 35789999999999999999999999999999999999999999999999999765433221 1224
Q ss_pred cccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcc
Q psy11874 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLK 356 (767)
Q Consensus 278 GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~ 356 (767)
+++.|+|||++.+..++.++|+|||||++|+|++ |..||...........+.. ......+..++.++.+++.+||.
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~ 232 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK---GYRMSCPQKCPDDVYKVMQRCWD 232 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHcc
Confidence 5678999999988889999999999999999998 9999976644322222221 12233456788999999999999
Q ss_pred cCcCccCCCCCCcccHHHHHh
Q psy11874 357 KSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 357 ~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+|++||+ +.++.+
T Consensus 233 ~~p~~Rp~-------~~~l~~ 246 (250)
T cd05085 233 YKPENRPK-------FSELQK 246 (250)
T ss_pred cCcccCCC-------HHHHHH
Confidence 99999999 777764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.94 Aligned_cols=246 Identities=22% Similarity=0.264 Sum_probs=204.5
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCc----EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+...+|++.+.||+|+||.||+|..+.+|. .+|+|.+.+... ......+.+|+.++++++||||+++++.+.+
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345789999999999999999999887765 689998865532 3345568889999999999999999999887
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
...++||||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+.+|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 78999999999999999998753 2589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccc---ccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 267 IPEGESVR---GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 267 ~~~~~~~~---~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
........ ...++..|+|||.+....++.++|+|||||++|||++ |..||.+.........+.. ......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK---GERLPQPPI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC---CCCCCCCCC
Confidence 65433211 1224678999999988899999999999999999998 9999987654322222221 122344556
Q ss_pred CcHHHHHHHHHhcccCcCccCC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
.+.++.+++.+||..||++||+
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~ 257 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPT 257 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCC
Confidence 7899999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.24 Aligned_cols=243 Identities=20% Similarity=0.309 Sum_probs=203.1
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCC
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGG 199 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG 199 (767)
+.||.|+||.||+|.... ++.||+|.+...... .....+.+|+.++++++|+||+++++++.+.+..++||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999987 999999998665332 34556888999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc---ccc
Q psy11874 200 DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV---RGR 276 (767)
Q Consensus 200 ~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~---~~~ 276 (767)
+|..++.... ..+++..+..++.+++.||.|||+++++||||||+|||++.++.++|+|||++.....+... ...
T Consensus 78 ~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 78 SLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9999987643 25789999999999999999999999999999999999999999999999999865432211 122
Q ss_pred ccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhc
Q psy11874 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355 (767)
Q Consensus 277 ~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL 355 (767)
.++..|+|||++.+..++.++|+|||||++|||++ |..||...........+.. ......+...+.++.+++.+||
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l 232 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES---GYRMPAPQLCPEEIYRLMLQCW 232 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc---CCCCCCCccCCHHHHHHHHHHh
Confidence 34678999999988899999999999999999998 8999977654322222211 1123345678899999999999
Q ss_pred ccCcCccCCCCCCcccHHHHHh
Q psy11874 356 KKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 356 ~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
..+|.+||+ +.++++
T Consensus 233 ~~~p~~Rp~-------~~ell~ 247 (251)
T cd05041 233 AYDPENRPS-------FSEIYN 247 (251)
T ss_pred ccChhhCcC-------HHHHHH
Confidence 999999998 888875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.83 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=203.7
Q ss_pred CeEEEeEEeecCcEEEEEEEEcc-----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
+|++.+.||+|+||.||+|.... ....+|+|.+.+... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47888999999999999998753 236789998865432 22345688899999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCC---------------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceE
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGG---------------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~---------------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNI 248 (767)
++||||+++|+|..++..... ...+++..+..++.|++.||+|||+.+|+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999999875321 12478899999999999999999999999999999999
Q ss_pred EeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhh
Q psy11874 249 LLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVK 324 (767)
Q Consensus 249 Lld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~ 324 (767)
|+++++.+||+|||++........ .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+......
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999976533221 122346788999999988889999999999999999998 9999977644322
Q ss_pred hhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 325 RDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 325 ~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+.+... .....+...+.++++++.+||+.+|++||+ ++++++
T Consensus 239 ~~~~~~~---~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~-------~~~i~~ 281 (290)
T cd05045 239 FNLLKTG---YRMERPENCSEEMYNLMLTCWKQEPDKRPT-------FADISK 281 (290)
T ss_pred HHHHhCC---CCCCCCCCCCHHHHHHHHHHccCCcccCCC-------HHHHHH
Confidence 2222111 122335678899999999999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=354.63 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=207.2
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEE-ee---
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAY-ET--- 185 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~-~~--- 185 (767)
+...++++.++|.+|||+.||+|+....|+.||+|++--. +......+.+|+.+|++|. |+|||.+++.. ..
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3345678999999999999999999988899999998544 4556778999999999997 99999999932 11
Q ss_pred ---CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC--cccccCCcceEEeCCCCCEEEee
Q psy11874 186 ---KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLDDYGHVRISD 260 (767)
Q Consensus 186 ---~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~--IvHrDLKPeNILld~~g~vkL~D 260 (767)
.-.++|.||||.||.|-+++..+. ..+|++.+++.|+.+++.|+.+||... |||||||-|||||+.+|+.||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rl-q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRL-QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHH-hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 135899999999999999987654 346999999999999999999999998 99999999999999999999999
Q ss_pred cCcccccCCCC-cc---------cccccccccCCccee---cCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhh
Q psy11874 261 LGLAVEIPEGE-SV---------RGRVGTVGYMAPEVI---DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDE 327 (767)
Q Consensus 261 FGla~~~~~~~-~~---------~~~~GT~~Y~APEvl---~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~ 327 (767)
||.|+..-... .. -...-|+.|+|||++ .+.+.+.++|||+|||+||-|+....||.....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99996532221 11 112469999999998 578899999999999999999999999976532
Q ss_pred hhhhhhccccccCC--CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 328 VDRRVKEDAEKYSC--RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 328 i~~~i~~~~~~~~~--~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
-.|......+|+ ..|..+++||+.||+.||.+||. +-+++.+
T Consensus 264 --laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPn-------I~Qv~~~ 307 (738)
T KOG1989|consen 264 --LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPN-------IYQVLEE 307 (738)
T ss_pred --eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCC-------HHHHHHH
Confidence 134455555554 78999999999999999999998 6676643
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.10 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=201.0
Q ss_pred CCCeEEEeEEeecCcEEEEEEEE----ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--C
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQV----RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--K 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~----~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~ 186 (767)
.++|++.+.||+|+||.||+|.. ..+++.||+|.+.... ......+.+|++++++++||||+++.+++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 35899999999999999999984 4578999999986542 3345568899999999999999999987643 4
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
..+++||||++||+|..++.+.. ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++..
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 57899999999999999987643 2589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcc----cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhh------------hhhhh
Q psy11874 267 IPEGESV----RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKR------------DEVDR 330 (767)
Q Consensus 267 ~~~~~~~----~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~------------~~i~~ 330 (767)
....... ....++..|+|||++.+..++.++|+|||||++|||++|..|+......... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 6543321 1122445699999999889999999999999999999988776443211000 00001
Q ss_pred hhh-ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 331 RVK-EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 331 ~i~-~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+. ......+..++.++.+|+.+||..+|++||+ +++|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt-------~~ei~~ 278 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS-------FSELAL 278 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCC-------HHHHHH
Confidence 111 1111234567899999999999999999999 888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.13 Aligned_cols=255 Identities=19% Similarity=0.283 Sum_probs=207.7
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEcc----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee-
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET- 185 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~- 185 (767)
+..++|++.++||+|+||.||+|.+.. ++..+|+|.+... ........+.+|..++++++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999876 3688999987643 233445678899999999999999999997655
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCC-----CCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEee
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGE-----PGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISD 260 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~-----~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~D 260 (767)
....+++++|+++|+|..++...... ..+++..+..++.||+.||+|||+.+++||||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 57899999999999999998764322 4589999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCcc---cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccc
Q psy11874 261 LGLAVEIPEGESV---RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDA 336 (767)
Q Consensus 261 FGla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~ 336 (767)
||+++........ ....++..|+|||++.+..++.++|||||||++|||++ |.+||...+.......+.. ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~ 237 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD---GYR 237 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc---CCC
Confidence 9999865433221 22346778999999998899999999999999999998 9999976544322221111 112
Q ss_pred cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 337 EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 337 ~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
...+..+++++.+++.+||..||++||+ +.++++
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps-------~~~~~~ 271 (280)
T cd05043 238 LAQPINCPDELFAVMACCWALDPEERPS-------FSQLVQ 271 (280)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCC-------HHHHHH
Confidence 2334567899999999999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=322.63 Aligned_cols=238 Identities=19% Similarity=0.261 Sum_probs=195.3
Q ss_pred eEEeecCcEEEEEEEEccCCc-------EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 120 RVLGKGGFGEVCACQVRATGK-------MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~-------~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
+.||+|+||.||+|..+.++. .+|+|.+.... ....+.+..|..+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999999876554 38888875432 23445678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC--------EEEeecCcc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH--------VRISDLGLA 264 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~--------vkL~DFGla 264 (767)
|||+++|+|..++...+ ..+++..+..++.||+.||+|||+.||+||||||+|||++.++. ++++|||++
T Consensus 78 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred EecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999999987653 26899999999999999999999999999999999999987765 699999998
Q ss_pred cccCCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcC-CCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEG-QAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG-~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
...... ....|++.|+|||++.+ ..++.++|+|||||++|||++| .+||......... ........++..
T Consensus 156 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 227 (258)
T cd05078 156 ITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-----QFYEDRHQLPAP 227 (258)
T ss_pred cccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-----HHHHccccCCCC
Confidence 765332 23568899999999976 4589999999999999999998 4676554332211 122233455666
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+.++.+|+.+||+.||++||+ +++|++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps-------~~~il~ 255 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPS-------FRAIIR 255 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCC-------HHHHHH
Confidence 7889999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.83 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=208.4
Q ss_pred eEEEeEEeecCcEEEEEEEEccCC----cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
+++.+.||.|+||.||+|....++ ..+|+|.+..... ......+..|+.+++.++|+||+++++.+.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 356789999999999999998776 9999999865432 2245678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
+|||++|++|..++..... ..+++..+..++.|++.||.|||+.+++||||||+||++++++.++|+|||++.......
T Consensus 79 i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999999876532 128999999999999999999999999999999999999999999999999998765543
Q ss_pred cccc--cccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 272 SVRG--RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 272 ~~~~--~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
.... ..+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||...+.......+.. ......+...+.++.
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 234 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK---GYRLPKPENCPPEIY 234 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---CCCCCCCCcCCHHHH
Confidence 2221 337889999999988889999999999999999998 8999976543322222221 122334456899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++.+||..||++||+ +.++++
T Consensus 235 ~~i~~~l~~~p~~Rpt-------~~~ll~ 256 (258)
T smart00219 235 KLMLQCWAEDPEDRPT-------FSELVE 256 (258)
T ss_pred HHHHHHCcCChhhCcC-------HHHHHh
Confidence 9999999999999999 888875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.84 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=200.7
Q ss_pred EEEeEEeecCcEEEEEEEEc----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 117 RMYRVLGKGGFGEVCACQVR----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 117 ~~~~~LG~G~fG~Vy~a~~~----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
++.+.||.|+||.||+|.+. ..+..|++|.++.. ........+.+|++++++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999998 45688999999542 2333467789999999999999999999999988889999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
|||+++|+|.++|.... ...+++.....++.||+.||.|||+++|+|+||+|+|||+++++.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999998862 34689999999999999999999999999999999999999999999999999987733222
Q ss_pred ---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 273 ---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 273 ---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
.....+...|+|||.+.+..++.++||||||+++|||++ |+.||...+.......+. .......+..++..+.
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK---QGQRLPIPDNCPKDIY 235 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH---TTEETTSBTTSBHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccceeccchhHHHH
Confidence 233457889999999988889999999999999999999 789997764433222221 2223344567899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++.+||..||++||+ +++|++
T Consensus 236 ~li~~C~~~~p~~RPs-------~~~i~~ 257 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPS-------FQEILQ 257 (259)
T ss_dssp HHHHHHT-SSGGGS---------HHHHHH
T ss_pred HHHHHHcCCChhhCcC-------HHHHHh
Confidence 9999999999999999 788764
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.33 Aligned_cols=252 Identities=20% Similarity=0.283 Sum_probs=205.9
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccC---CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
+..++|.+.+.||+|+||.||+|.+..+ ...+|+|....... ....+.+.+|+.++++++||||+++++++.+ +
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3456799999999999999999987644 45799998765431 2344578889999999999999999998876 4
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
..|+||||+++|+|..++.+.. ..+++..+..++.|++.||+|||+.|++||||||+|||++.++.++|+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 5789999999999999997643 35899999999999999999999999999999999999999999999999999866
Q ss_pred CCCCcc--cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCc
Q psy11874 268 PEGESV--RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFS 344 (767)
Q Consensus 268 ~~~~~~--~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s 344 (767)
...... ....+++.|+|||.+.+..++.++|+|||||++|||++ |..||...........+. .......+..++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE---NGERLPMPPNCP 234 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---cCCcCCCCCCCC
Confidence 443221 12234578999999988899999999999999999986 999997765432222221 122334556789
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+.+.+++.+||..+|++||+ +.+++.
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt-------~~~~~~ 260 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPR-------FTELKA 260 (270)
T ss_pred HHHHHHHHHHcCCChhhCcC-------HHHHHH
Confidence 99999999999999999998 777664
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.82 Aligned_cols=248 Identities=22% Similarity=0.246 Sum_probs=192.1
Q ss_pred eEEeecCcEEEEEEEEcc--CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEecc
Q psy11874 120 RVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMN 197 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~--tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~ 197 (767)
+.||+|+||.||+|.... ....+|+|.+.... .......+++|+.+++.++||||+++++.+.+...+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997543 34578888775432 22334567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCC--CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc---
Q psy11874 198 GGDLKFHIYNMGG--EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES--- 272 (767)
Q Consensus 198 gG~L~~~l~~~~~--~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~--- 272 (767)
+|+|.+++..... ....++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999999977532 12356788899999999999999999999999999999999999999999999875433221
Q ss_pred ccccccccccCCcceecC-------CCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhh--hccccccCCC
Q psy11874 273 VRGRVGTVGYMAPEVIDN-------EKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRV--KEDAEKYSCR 342 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~-------~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i--~~~~~~~~~~ 342 (767)
.....+++.|+|||++.. ..++.++|||||||++|||++ |..||................ ....+..+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 123456788999999743 456889999999999999999 888997654332222221111 1112233456
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++...+++..|+ .||++||+ +++|++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt-------~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPT-------AEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccC-------HHHHHH
Confidence 8899999999998 59999999 666553
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.91 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=200.6
Q ss_pred eEEeecCcEEEEEEEEccCC------cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 120 RVLGKGGFGEVCACQVRATG------KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.||+|+||.||+|+.+..+ +.+|+|.+.+.. .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46999999999999986544 789999886542 1233456888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcC----CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-----CEEEeecCcc
Q psy11874 194 TIMNGGDLKFHIYNMG----GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-----HVRISDLGLA 264 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~----~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-----~vkL~DFGla 264 (767)
||++||+|..++.+.. ....+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999999997642 123578999999999999999999999999999999999999887 8999999999
Q ss_pred cccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccC
Q psy11874 265 VEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYS 340 (767)
Q Consensus 265 ~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~ 340 (767)
........ .....++..|+|||++.+..++.++|+|||||++|||++ |..||...+.......+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~~~~~~ 235 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT---AGGRLQKP 235 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh---cCCccCCc
Confidence 76543322 123356789999999999999999999999999999998 999997654322222111 12223445
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
..+|+.+.++|.+||.++|++||+ ++++++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~-------~~~i~~ 265 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPT-------FDRIQE 265 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCC-------HHHHHH
Confidence 678899999999999999999999 777654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.74 Aligned_cols=239 Identities=18% Similarity=0.245 Sum_probs=192.2
Q ss_pred eEEeecCcEEEEEEEEccC------------CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 120 RVLGKGGFGEVCACQVRAT------------GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~t------------g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
+.||+|+||.||+|..... ...+|+|.+.... ......+..|..+++.++||||+++++++.++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999986422 3368889876542 233446778899999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC-------EEEee
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH-------VRISD 260 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~-------vkL~D 260 (767)
..++||||+++|+|..++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. ++++|
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999999988887543 35899999999999999999999999999999999999987664 89999
Q ss_pred cCcccccCCCCcccccccccccCCcceec-CCCCCCCCccccchhhHHHHh-cCCCCCCCchhhhhhhhhhhhhhccccc
Q psy11874 261 LGLAVEIPEGESVRGRVGTVGYMAPEVID-NEKYTYSPDWFSFGCLIFEMI-EGQAPFRRRKEMVKRDEVDRRVKEDAEK 338 (767)
Q Consensus 261 FGla~~~~~~~~~~~~~GT~~Y~APEvl~-~~~ys~~~DvwSlGviLyEll-tG~~PF~~~~~~~~~~~i~~~i~~~~~~ 338 (767)
||++..... .....||..|+|||++. +..++.++|||||||++|||+ +|..||........ . ........
T Consensus 156 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~-~~~~~~~~ 227 (262)
T cd05077 156 PGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----E-RFYEGQCM 227 (262)
T ss_pred CCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----H-HHHhcCcc
Confidence 999876532 23456889999999986 567899999999999999998 58899876533211 1 11111222
Q ss_pred cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 339 ~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.....++++.+|+.+||+.||.+||+ +.+|+++
T Consensus 228 ~~~~~~~~~~~li~~cl~~dp~~Rp~-------~~~il~~ 260 (262)
T cd05077 228 LVTPSCKELADLMTHCMNYDPNQRPF-------FRAIMRD 260 (262)
T ss_pred CCCCChHHHHHHHHHHcCCChhhCcC-------HHHHHHh
Confidence 23345788999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.28 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=203.3
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
++.++|++.+.||+|+||.||++.. +++.+|+|.+.... ....+.+|+.++++++|||++++++.+... ..+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY 74 (254)
T ss_pred ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence 3457899999999999999999874 68899999985432 234678899999999999999999988654 589
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||++||+|..++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 9999999999999987653 335899999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
......+..|+|||.+.+..++.++|+|||||++|||++ |.+||...........+.+. .....+..+++.+++
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 228 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVYV 228 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC---CCCCCCCcCCHHHHH
Confidence 222345678999999988899999999999999999997 99999776543333322221 122334568899999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++.+||+.+|++||+ +++++.
T Consensus 229 li~~~l~~~p~~Rp~-------~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPS-------FHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcC-------HHHHHH
Confidence 999999999999998 666654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.97 Aligned_cols=247 Identities=23% Similarity=0.240 Sum_probs=192.8
Q ss_pred eEEeecCcEEEEEEEEc--cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEecc
Q psy11874 120 RVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMN 197 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~ 197 (767)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.++++++||||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 3567899999865432 2233468889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCC--CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc---
Q psy11874 198 GGDLKFHIYNMGG--EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES--- 272 (767)
Q Consensus 198 gG~L~~~l~~~~~--~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~--- 272 (767)
||+|.+++..... ....++..+..++.|++.||+|||+.+++||||||+||+++.+++++|+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999999976432 22467778889999999999999999999999999999999999999999999975433321
Q ss_pred ccccccccccCCcceecCC-------CCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhh--hhccccccCCC
Q psy11874 273 VRGRVGTVGYMAPEVIDNE-------KYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRR--VKEDAEKYSCR 342 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~-------~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~--i~~~~~~~~~~ 342 (767)
.....|++.|+|||++.+. .++.++|+|||||++|||++ |..||............... .....+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 1234578899999998642 35789999999999999996 99999765432221111110 01111222235
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHH
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELK 376 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil 376 (767)
.++...+++++|+ .+|++||+ +++|.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt-------~~~l~ 264 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPS-------AEEVH 264 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCC-------HHHHH
Confidence 6889999999998 68999999 77775
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=325.85 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=211.7
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC--C----ceeEEEEEEeeC
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS--R----FVVSLAYAYETK 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p----~Iv~l~~~~~~~ 186 (767)
.++|.+.+.+|+|+||.|..|.++.++..+|+|+++.. .+..+.++.|+++|+++++ | -+|.+.++|+-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 47899999999999999999999999999999998543 2345567889999999943 2 378888999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC---------------
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD--------------- 251 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld--------------- 251 (767)
++.|+|+|.| |-++.+.+.+.+ ...|+...++.++.|++.++++||+.+++|-||||||||+-
T Consensus 164 ghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 9999999999 458999998754 45799999999999999999999999999999999999982
Q ss_pred -----CCCCEEEeecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhh
Q psy11874 252 -----DYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD 326 (767)
Q Consensus 252 -----~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~ 326 (767)
.+..|+|+|||.|+...+.. .+.+.|..|.|||++.+-+++..+||||+||||+|+.+|...|......+..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL- 318 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL- 318 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH-
Confidence 13468999999998765443 5678999999999999999999999999999999999999999877643333
Q ss_pred hhhhhhhccccc------------------cCCC----------------------C---cHHHHHHHHHhcccCcCccC
Q psy11874 327 EVDRRVKEDAEK------------------YSCR----------------------F---SDDAKALCKALLKKSPRSRL 363 (767)
Q Consensus 327 ~i~~~i~~~~~~------------------~~~~----------------------~---s~~~~dLi~~lL~~dP~~Rl 363 (767)
.+.++|..+.+. ++.. - -.++.||+++||..||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 233344332211 0000 0 13578899999999999999
Q ss_pred CCCCCcccHHHHHhCCCCCCC
Q psy11874 364 GCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 364 ~~~~~~~~a~eil~HpfF~~i 384 (767)
+ +.|++.||||+..
T Consensus 399 T-------l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 399 T-------LREALSHPFFARL 412 (415)
T ss_pred c-------HHHHhcCHHhhcC
Confidence 9 9999999999864
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.20 Aligned_cols=248 Identities=28% Similarity=0.403 Sum_probs=201.9
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC------e
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD------A 188 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~------~ 188 (767)
.+..-+.||+||||.||+++++.||..+|+|.+++.. .....+...+|++||++++|+|||++.++=++.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4556688999999999999999999999999997754 3445667788999999999999999998776654 5
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC--CCCC--EEEeecCcc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD--DYGH--VRISDLGLA 264 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld--~~g~--vkL~DFGla 264 (767)
..+|||||+||||...+.+-..-.++++.+.+.+...++.||.|||++||+||||||.||++- .+|. -||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 689999999999999998765566899999999999999999999999999999999999983 3343 599999999
Q ss_pred cccCCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh-----------
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV----------- 332 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i----------- 332 (767)
+.++++....+.+||+.|++||++.+ ..|+..+|.|||||++|+++||..||..........++.-.+
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 99999998999999999999999984 889999999999999999999999995443221111111111
Q ss_pred ----hcccc------ccCCCCcHH----HHHHHHHhcccCcCccCC
Q psy11874 333 ----KEDAE------KYSCRFSDD----AKALCKALLKKSPRSRLG 364 (767)
Q Consensus 333 ----~~~~~------~~~~~~s~~----~~dLi~~lL~~dP~~Rl~ 364 (767)
.+++. +++..+++. ...++..+|..+|.+|-+
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 11111 123334433 445788899999999973
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=318.70 Aligned_cols=259 Identities=25% Similarity=0.337 Sum_probs=210.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--------
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-------- 185 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-------- 185 (767)
+.|+-...||+|.||+||+|+.+.+|+.||+|++-...- +...-...++|++||+.+.|+|++.++..+.+
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 456777889999999999999999999999987643211 22334467899999999999999999877654
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
...+|+|+++|+ -||.-.+.+. ..+++..++..++.+++.||.|+|++.|+|||+||+|+||+.+|.+||+|||+|+
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 245999999998 5898888775 3479999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCc-----ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 266 EIPEGES-----VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 266 ~~~~~~~-----~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
.+...+. .+.++-|.+|++||.+.+ ..|+.+.|+|+.||++.||.+|.+.|.+..+..+...+...........
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 6543322 345677999999999877 4699999999999999999999999998877655443332221111111
Q ss_pred CC-------------------------------CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 340 SC-------------------------------RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 340 ~~-------------------------------~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
|+ .-++++.||+.+||..||.+|+. ++++++|.||..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~-------ad~alnh~~F~k 320 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID-------ADQALNHDFFWK 320 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc-------hHhhhchhhhhc
Confidence 11 11468999999999999999998 999999999965
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=314.50 Aligned_cols=244 Identities=25% Similarity=0.292 Sum_probs=194.1
Q ss_pred eEEeecCcEEEEEEEEcc---CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe-eCCeEEEEEEe
Q psy11874 120 RVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE-TKDALCLVLTI 195 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~---tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~~l~lV~E~ 195 (767)
+.||+|+||.||+|.+.. ++..+|+|.+... ........+.+|..+++.++||||+++++++. .++..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998753 3468999987532 12233556788999999999999999999765 45668999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc---
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES--- 272 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~--- 272 (767)
+++|+|..++.+.. ...++..+..++.||+.||.|||+.+|+||||||+|||+++++.+||+|||++........
T Consensus 79 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 79 MKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999999987643 2467788889999999999999999999999999999999999999999999976543211
Q ss_pred --ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 273 --VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 273 --~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
.....+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+.......+ ........+..+++.+.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 233 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL---LQGRRLLQPEYCPDPLYE 233 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---hcCCCCCCCCcCCHHHHH
Confidence 123346788999999988899999999999999999999 56777655432222222 111223334567899999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++.+||..+|++||+ +.++++
T Consensus 234 li~~cl~~~p~~Rp~-------~~~il~ 254 (262)
T cd05058 234 VMLSCWHPKPEMRPT-------FSELVS 254 (262)
T ss_pred HHHHHcCCChhhCCC-------HHHHHH
Confidence 999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.92 Aligned_cols=263 Identities=25% Similarity=0.324 Sum_probs=207.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCC----cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee-CCe
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-KDA 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~ 188 (767)
..|+..+.||+|+||.||+|..+.++ +.||+|+++...- .......+.+|+.+++.++||||+.|..+|-+ +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 57999999999999999999766553 4799999865421 11223458899999999999999999998877 788
Q ss_pred EEEEEEeccCCCHHHHHHhcC--CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC----CCEEEeecC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMG--GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY----GHVRISDLG 262 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~--~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~----g~vkL~DFG 262 (767)
++|++||.+ -||...|.-.+ ....++...++.++.||+.|+.|||++=|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999999998 58887776432 23458888999999999999999999999999999999999877 899999999
Q ss_pred cccccCCCC----cccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhh---------hh
Q psy11874 263 LAVEIPEGE----SVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD---------EV 328 (767)
Q Consensus 263 la~~~~~~~----~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~---------~i 328 (767)
+|+.+.+.- +....+-|.+|.|||.+.+. .|+.+.|+||+|||+.||++-.+.|.+..++.... .+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 998765431 12344679999999999875 69999999999999999999999997765443221 11
Q ss_pred hhhhhccccc---------------------cCCC------------CcHHHHHHHHHhcccCcCccCCCCCCcccHHHH
Q psy11874 329 DRRVKEDAEK---------------------YSCR------------FSDDAKALCKALLKKSPRSRLGCHCGRYGAREL 375 (767)
Q Consensus 329 ~~~i~~~~~~---------------------~~~~------------~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~ei 375 (767)
.+.......+ +... -++.+.+|+.+||+.||.+|++ |++.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt-------a~qA 334 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT-------AEQA 334 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc-------HHHH
Confidence 1111111111 1111 2567999999999999999998 9999
Q ss_pred HhCCCCCCCC
Q psy11874 376 KQAEFFKSTN 385 (767)
Q Consensus 376 l~HpfF~~i~ 385 (767)
++|+||+.-.
T Consensus 335 leh~yF~~d~ 344 (438)
T KOG0666|consen 335 LEHPYFTEDP 344 (438)
T ss_pred hcccccccCC
Confidence 9999998753
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=316.48 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=205.8
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEcc----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--C
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--K 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~ 186 (767)
..+|++.+.||+|+||.||+|.... +++.+|+|.+...... .....+.+|+.+++.+.|+||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 3578889999999999999999653 4899999998765332 345678999999999999999999998877 6
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
...++||||+++|+|..++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 68999999999999999997653 2589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcc----cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhh-----------hhhhhhh
Q psy11874 267 IPEGESV----RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK-----------RDEVDRR 331 (767)
Q Consensus 267 ~~~~~~~----~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~-----------~~~i~~~ 331 (767)
....... ....++..|+|||.+.+..++.++|+|||||++|||++|..||........ ...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 7533221 123456679999999888999999999999999999999999865422110 1111111
Q ss_pred hhc-cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 332 VKE-DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 332 i~~-~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+.. .....+...+.++.+++.+||..+|++||+ +.||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt-------~~ei~~ 278 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPS-------FADLIL 278 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCC-------HHHHHH
Confidence 111 112223456789999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=340.02 Aligned_cols=252 Identities=22% Similarity=0.400 Sum_probs=212.0
Q ss_pred EEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh-hhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe--EEEEE
Q psy11874 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA--LCLVL 193 (767)
Q Consensus 117 ~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~--l~lV~ 193 (767)
+...+||+|+|-+||+|.+..+|..||--.++...+. .....+.+..|+.+|+.|+|||||++|++|.+... +-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4557899999999999999999999997665544433 34456789999999999999999999999987655 88999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC--cccccCCcceEEeC-CCCCEEEeecCcccccCCC
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLD-DYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~--IvHrDLKPeNILld-~~g~vkL~DFGla~~~~~~ 270 (767)
|+|..|+|+.|+.+.+ ..+...++.|++||+.||.|||++. |||||||.+||+|+ ..|.|||+|+|||+.....
T Consensus 123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999999876 6889999999999999999999985 99999999999997 5699999999999876443
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc--cccCCCCcHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA--EKYSCRFSDDAK 348 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~--~~~~~~~s~~~~ 348 (767)
......|||.|||||+.. +.|+..+||||||.++.||+|+..||.--. ...++.+++..+. ..+..--.++++
T Consensus 200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~---n~AQIYKKV~SGiKP~sl~kV~dPevr 274 (632)
T KOG0584|consen 200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT---NPAQIYKKVTSGIKPAALSKVKDPEVR 274 (632)
T ss_pred -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC---CHHHHHHHHHcCCCHHHhhccCCHHHH
Confidence 234468999999999996 889999999999999999999999995432 2233444443332 223333478999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+||.+||.. .+.||+ |.|+|+||||..-
T Consensus 275 ~fIekCl~~-~~~R~s-------a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 275 EFIEKCLAT-KSERLS-------AKELLKDPFFDED 302 (632)
T ss_pred HHHHHHhcC-chhccC-------HHHHhhChhhccc
Confidence 999999998 999999 9999999999874
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=322.58 Aligned_cols=253 Identities=23% Similarity=0.258 Sum_probs=204.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCc----EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+..++|+..+.||+|+||.||+|++..+|. .+|+|.+..... ......+.+|..++++++||||+++++.+...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 456789999999999999999999987776 468888764422 22334578899999999999999999988764
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
..++++||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++.
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 4789999999999999887643 2588999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 267 IPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 267 ~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
...... .....++..|+|||++.+..++.++|+|||||++|||++ |..||.+........ +... ......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~--~~~~~~~~~ 235 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEK--GERLPQPPI 235 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHC--CCCCCCCCC
Confidence 643322 223346789999999998999999999999999999997 999997654322211 1111 112223456
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.+.++.+++.+|+..+|++||+ ++++++.
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~-------~~~l~~~ 264 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPK-------FKELAAE 264 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcC-------HHHHHHH
Confidence 7889999999999999999999 7777663
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=314.97 Aligned_cols=254 Identities=23% Similarity=0.385 Sum_probs=206.8
Q ss_pred CeEEEeEEeecCcEEEEEEEEcc-CCcEEEEEEechhhhh-------hhhhHHHHHHHHHHHHh-cCCCceeEEEEEEee
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIK-------KRKGESMVLIEKQILQK-INSRFVVSLAYAYET 185 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~-tg~~~AiK~l~k~~~~-------~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~ 185 (767)
+|++.+.||+|+||.||+|.... +++.+|+|.+...... .......+.+|..++.+ ++||||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 6899999988643221 22234456778888875 799999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
.+..++||||++|++|.+++.... ....+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999998875431 23468999999999999999999996 7899999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 264 AVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 264 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
+.............|+..|+|||.+.+..++.++|+||||+++|+|++|.+||...+.......+..... .+.....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 238 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY--EPLPEGMY 238 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC--CcCCcccC
Confidence 9876555444556799999999999988899999999999999999999999976543322222221111 11112357
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++++.+++.+||+.||++||+ +.|+..
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~-------~~e~~~ 265 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPD-------IIQVSA 265 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCC-------HHHHHH
Confidence 899999999999999999999 666654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=317.12 Aligned_cols=238 Identities=18% Similarity=0.262 Sum_probs=191.6
Q ss_pred EEeecCcEEEEEEEEccC------------------------CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCce
Q psy11874 121 VLGKGGFGEVCACQVRAT------------------------GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFV 176 (767)
Q Consensus 121 ~LG~G~fG~Vy~a~~~~t------------------------g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 176 (767)
.||+|+||.||+|....+ ...+|+|++.... ......+.+|..++++++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999986432 2468899886542 2234457788999999999999
Q ss_pred eEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC--
Q psy11874 177 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-- 254 (767)
Q Consensus 177 v~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-- 254 (767)
+++++++.+.+..++||||++||+|..++.+.. ..+++..+..++.||+.||+|||+++|+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999998886532 3688999999999999999999999999999999999997654
Q ss_pred -----CEEEeecCcccccCCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHh-cCCCCCCCchhhhhhhh
Q psy11874 255 -----HVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMI-EGQAPFRRRKEMVKRDE 327 (767)
Q Consensus 255 -----~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyEll-tG~~PF~~~~~~~~~~~ 327 (767)
.++|+|||++...... ....+++.|+|||.+.+ ..++.++|+|||||++|||+ +|..||......... .
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~ 232 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-R 232 (274)
T ss_pred cCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-H
Confidence 3899999998654322 23467889999998865 56899999999999999995 799999765432211 1
Q ss_pred hhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 328 VDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 328 i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
. .......+...++++.++|.+||+.+|++||+ +++|+++
T Consensus 233 ~----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-------~~~il~~ 272 (274)
T cd05076 233 F----YEKKHRLPEPSCKELATLISQCLTYEPTQRPS-------FRTILRD 272 (274)
T ss_pred H----HHhccCCCCCCChHHHHHHHHHcccChhhCcC-------HHHHHHh
Confidence 1 11222344456789999999999999999998 8888764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=312.45 Aligned_cols=236 Identities=20% Similarity=0.283 Sum_probs=192.5
Q ss_pred eEEeecCcEEEEEEEEccCC----------cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 120 RVLGKGGFGEVCACQVRATG----------KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg----------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
+.||+|+||.||+|.+..++ ..+++|.+..... ....+.+|..+|++++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46999999999999998777 3577887654321 15678889999999999999999999888 778
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-------CEEEeecC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-------HVRISDLG 262 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-------~vkL~DFG 262 (767)
++||||+++|+|..++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999999886532 689999999999999999999999999999999999999888 89999999
Q ss_pred cccccCCCCcccccccccccCCcceecCC--CCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 263 LAVEIPEGESVRGRVGTVGYMAPEVIDNE--KYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 263 la~~~~~~~~~~~~~GT~~Y~APEvl~~~--~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
++..... .....++..|+|||++.+. .++.++|+|||||++|||++ |..||......... .... .....
T Consensus 154 ~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-~~~~----~~~~~ 225 (259)
T cd05037 154 IPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-RFYQ----DQHRL 225 (259)
T ss_pred ccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-HHHh----cCCCC
Confidence 9987543 2234678899999999776 78999999999999999999 68888665422111 1111 11222
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+...+..+.++|.+||..+|.+||+ +.++++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt-------~~~il~ 256 (259)
T cd05037 226 PMPDCAELANLINQCWTYDPTKRPS-------FRAILR 256 (259)
T ss_pred CCCCchHHHHHHHHHhccChhhCCC-------HHHHHH
Confidence 2333489999999999999999999 778764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=358.14 Aligned_cols=253 Identities=29% Similarity=0.422 Sum_probs=202.9
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee-------
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------- 185 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------- 185 (767)
..+|+.+++||+||||.||+|+++-+|..||||++..+. ..+....+.+|+..|.+|+|||||++|.+|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 368999999999999999999999999999999997764 44556678999999999999999998866521
Q ss_pred ------------------------------------------------C-------------------------------
Q psy11874 186 ------------------------------------------------K------------------------------- 186 (767)
Q Consensus 186 ------------------------------------------------~------------------------------- 186 (767)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHH
Q psy11874 187 ---------------------------------DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233 (767)
Q Consensus 187 ---------------------------------~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yL 233 (767)
..+|+-||||+.-.|.+.+.+.... -....++.+++||++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 2378999999988787777664311 14788899999999999999
Q ss_pred HHCCcccccCCcceEEeCCCCCEEEeecCcccccC-------------------CCCcccccccccccCCcceecCCC--
Q psy11874 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP-------------------EGESVRGRVGTVGYMAPEVIDNEK-- 292 (767)
Q Consensus 234 H~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~-------------------~~~~~~~~~GT~~Y~APEvl~~~~-- 292 (767)
|++|||||||||.||+||++++|||+|||+|+... +....++.+||.-|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999998621 011234578999999999997654
Q ss_pred -CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC----CCCcHHHHHHHHHhcccCcCccCCCCC
Q psy11874 293 -YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS----CRFSDDAKALCKALLKKSPRSRLGCHC 367 (767)
Q Consensus 293 -ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~----~~~s~~~~dLi~~lL~~dP~~Rl~~~~ 367 (767)
|+.++|+||||++++||+ .||.-.- .+..+...+.....+.+ ..--+....+|+.||+.||++|||
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~---yPF~TsM---ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt--- 864 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEML---YPFGTSM---ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT--- 864 (1351)
T ss_pred cccchhhhHHHHHHHHHHh---ccCCchH---HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC---
Confidence 999999999999999999 4564432 23333333333333322 222356788999999999999999
Q ss_pred CcccHHHHHhCCCCC
Q psy11874 368 GRYGARELKQAEFFK 382 (767)
Q Consensus 368 ~~~~a~eil~HpfF~ 382 (767)
|.|+|++.||-
T Consensus 865 ----A~eLL~s~llp 875 (1351)
T KOG1035|consen 865 ----ATELLNSELLP 875 (1351)
T ss_pred ----HHHHhhccCCC
Confidence 99999999885
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=323.22 Aligned_cols=279 Identities=22% Similarity=0.334 Sum_probs=224.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEec--hh--hhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe-eCC
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLE--KK--RIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE-TKD 187 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~--k~--~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~ 187 (767)
.++|-++.+||+|||++||+|-+....+.+|||+-. |. .-++.+...++.+|.+|.+.|.||-||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 357889999999999999999999889999999843 22 1223445667899999999999999999999996 456
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC--cccccCCcceEEeC---CCCCEEEeecC
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLD---DYGHVRISDLG 262 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~--IvHrDLKPeNILld---~~g~vkL~DFG 262 (767)
.+|-|+|||+|.||.++|.... .+++.+++.|+.||+.||.||.+.. |||-||||.||||- ..|.+||+|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 7999999999999999998865 6899999999999999999999764 99999999999994 45789999999
Q ss_pred cccccCCCCc--------ccccccccccCCcceecC----CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhh
Q psy11874 263 LAVEIPEGES--------VRGRVGTVGYMAPEVIDN----EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR 330 (767)
Q Consensus 263 la~~~~~~~~--------~~~~~GT~~Y~APEvl~~----~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~ 330 (767)
|++....+.. +....||.+|++||.+.- .+.+.++||||+|||+|.++.|+.||...-.....-+-..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 9987754322 334579999999998732 3578999999999999999999999977644333222222
Q ss_pred hhhccccccC--CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 331 RVKEDAEKYS--CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 331 ~i~~~~~~~~--~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
.+......+| +.+|+++++||++||+..-+.|.. ..++-.||+|...--....+|-+..|-+|.
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~D-------V~qLA~dpyllPh~rrs~s~gs~~~a~i~~ 764 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRID-------VQQLACDPYLLPHIRRSVSTGSPAGAAIAS 764 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhh-------HHHHccCccccchhhhccccCCCccccccC
Confidence 2233333444 468999999999999999999976 999999999987544444555544444443
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=354.21 Aligned_cols=256 Identities=25% Similarity=0.356 Sum_probs=218.5
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCc-----EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 184 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 184 (767)
.+..+.-++.+.||+|.||+||.|+...... .||+|.+.+. .+...+..+++|..+|++++|||||+|++++-
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 3566788899999999999999999875432 3888888553 45667788999999999999999999999999
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCC----CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEee
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGG----EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISD 260 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~----~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~D 260 (767)
+....++++|||.||||..+|++.+. ...++..+...++.+|++|++||++++.|||||..+|+||+....|||+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999999998632 34689999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCcccc--c-ccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccc
Q psy11874 261 LGLAVEIPEGESVRG--R-VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDA 336 (767)
Q Consensus 261 FGla~~~~~~~~~~~--~-~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~ 336 (767)
||+|+.+...+.++. . .-...|||||.+....++.++|||||||+|||+++ |..||.+.+..+.... -.....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~---~~~ggR 922 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD---VLEGGR 922 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH---HHhCCc
Confidence 999996655443322 1 23578999999999999999999999999999998 9999988765433332 233346
Q ss_pred cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 337 EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 337 ~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
...|..+++.+.+++.+|++.+|++||+ ...|++
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~-------F~~i~~ 956 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPS-------FRTIVE 956 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCcc-------HHHHHh
Confidence 6777889999999999999999999999 666665
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.17 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=201.1
Q ss_pred eEEEeEEeecCcEEEEEEEEcc---CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC-----
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----- 187 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~---tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 187 (767)
|++.++||+|+||.||+|..+. +++.+|+|++..+.. .....+.+.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 5678899999999999998653 578999999865432 2334566889999999999999999999886532
Q ss_pred -eEEEEEEeccCCCHHHHHHhcC---CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 188 -ALCLVLTIMNGGDLKFHIYNMG---GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 188 -~l~lV~E~~~gG~L~~~l~~~~---~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
..+++++|+++|+|..++.... ....+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 3588999999999988875432 122478899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 264 AVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 264 a~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
++....+.. .....+++.|++||.+.+..++.++|+|||||++|||++ |.+||.+.+.......+. .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~ 236 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI---KGNRLKQ 236 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH---cCCcCCC
Confidence 987644322 122346788999999999899999999999999999999 899997664322221111 1222333
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+...++.+.+++.+||+.+|++||+ +.++++
T Consensus 237 ~~~~~~~~~~l~~~~l~~~p~~Rps-------~~~~~~ 267 (273)
T cd05074 237 PPDCLEDVYELMCQCWSPEPKCRPS-------FQHLRD 267 (273)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcC-------HHHHHH
Confidence 4567899999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=346.07 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=215.0
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEcc-----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEE
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYA 182 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 182 (767)
...++..+.+..+.||+|+||+||+|+... ....||||.++.+. .......|.+|+++|..++|||||+|+|+
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 345677888999999999999999998653 34789999997653 33355679999999999999999999999
Q ss_pred EeeCCeEEEEEEeccCCCHHHHHHhcCC-----------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC
Q psy11874 183 YETKDALCLVLTIMNGGDLKFHIYNMGG-----------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD 251 (767)
Q Consensus 183 ~~~~~~l~lV~E~~~gG~L~~~l~~~~~-----------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld 251 (767)
+..++.+|+|+|||..|||..+|...++ .+.++..+.+.+|.||+.||+||-++.+|||||-..|+||.
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG 637 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence 9999999999999999999999986532 12388899999999999999999999999999999999999
Q ss_pred CCCCEEEeecCcccccCCCCcccc---cccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhh
Q psy11874 252 DYGHVRISDLGLAVEIPEGESVRG---RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDE 327 (767)
Q Consensus 252 ~~g~vkL~DFGla~~~~~~~~~~~---~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~ 327 (767)
++-.|||+||||++.+-..+.++. ..-...|||||.+...+||.++||||+||+|||+++ |..||.+... ++
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----~E 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----QE 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----HH
Confidence 999999999999987655443322 234679999999999999999999999999999997 9999988754 34
Q ss_pred hhhhhhccc-cccCCCCcHHHHHHHHHhcccCcCccCCCC
Q psy11874 328 VDRRVKEDA-EKYSCRFSDDAKALCKALLKKSPRSRLGCH 366 (767)
Q Consensus 328 i~~~i~~~~-~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~ 366 (767)
+.+.+.... ..-|+..+.++.+|...|++.+|++||+++
T Consensus 714 VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~ 753 (774)
T KOG1026|consen 714 VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFK 753 (774)
T ss_pred HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence 444444333 445678999999999999999999999943
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=314.37 Aligned_cols=255 Identities=18% Similarity=0.121 Sum_probs=190.9
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccC---CcEEEEEEechhhhhh--h------hhHHHHHHHHHHHHhcCCCceeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKK--R------KGESMVLIEKQILQKINSRFVVSL 179 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~~AiK~l~k~~~~~--~------~~~~~~~~E~~iL~~l~hp~Iv~l 179 (767)
+..++|++.+.||+|+||.||+|+...+ +..+|+|+........ . ........+...+..+.|++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3446899999999999999999999887 6778888643221100 0 001112334455667799999999
Q ss_pred EEEEeeCC----eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC
Q psy11874 180 AYAYETKD----ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH 255 (767)
Q Consensus 180 ~~~~~~~~----~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~ 255 (767)
++...... ..+++|+++. .++...+.... .+++..+..++.|++.||+|||+.+|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 98765543 4577888775 45665555432 3678889999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCC--------cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhh-h-
Q psy11874 256 VRISDLGLAVEIPEGE--------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK-R- 325 (767)
Q Consensus 256 vkL~DFGla~~~~~~~--------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~-~- 325 (767)
++|+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||++|.+||.+...... .
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999997653221 12234699999999999999999999999999999999999999976632111 1
Q ss_pred ---hhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 326 ---DEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 326 ---~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+...++...... ....++.+.++++.|++.+|++||+ .++|++
T Consensus 245 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~-------~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIK-IKNANKFIYDFIECVTKLSYEEKPD-------YDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhc-cCCCCHHHHHHHHHHHhCCCCCCCC-------HHHHHH
Confidence 1122333322222 3456889999999999999999999 777764
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=310.18 Aligned_cols=247 Identities=17% Similarity=0.224 Sum_probs=191.6
Q ss_pred EEeecCcEEEEEEEEccC--CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 121 VLGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 121 ~LG~G~fG~Vy~a~~~~t--g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
.||+|+||.||+|+...+ ...+++|.+.... .......+.+|..+++.++||||+++++.+.+....|+||||++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 599999999999976433 2456677665432 223456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCC-CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC---ccc
Q psy11874 199 GDLKFHIYNMGG-EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE---SVR 274 (767)
Q Consensus 199 G~L~~~l~~~~~-~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~---~~~ 274 (767)
|+|..++.+... ....++..+..++.||+.||+|||+.+|+||||||+|||++.++.++|+|||++....... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 999999976432 2346777888999999999999999999999999999999999999999999986432211 123
Q ss_pred ccccccccCCcceecC-------CCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhh--ccccccCCCCc
Q psy11874 275 GRVGTVGYMAPEVIDN-------EKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVK--EDAEKYSCRFS 344 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~-------~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~--~~~~~~~~~~s 344 (767)
..+|++.|+|||++.. ..++.++|||||||++|||++ |..||...........+..... ...+..+..++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS 239 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence 4578999999999843 245789999999999999996 6778876544333332221111 11123344678
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+.+.+++..|+ .+|++||+ +++|++
T Consensus 240 ~~~~~l~~~c~-~~P~~Rp~-------~~~i~~ 264 (268)
T cd05086 240 ERWYEVLQFCW-LSPEKRAT-------AEEVHR 264 (268)
T ss_pred HHHHHHHHHHh-hCcccCCC-------HHHHHH
Confidence 99999999999 68999999 777754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.32 Aligned_cols=264 Identities=22% Similarity=0.346 Sum_probs=216.9
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHH-hcCCCceeEEEEEEeeCC
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVSLAYAYETKD 187 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~~~ 187 (767)
.+++.++.+-+..||.|+||+|++-.++.+|+..|+|.+..... .+...+++.|.+... .-+.||||++|++.-.++
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 44566677778899999999999999999999999999976543 344566777877554 457899999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhc--CCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNM--GGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~--~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
..++.||+|. .+|..+.... -....++|...-.++...+.||.||-+ .+|||||+||+|||||..|.|||||||.+
T Consensus 137 dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 137 DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 9999999997 5665433221 123468898888999999999999985 68999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCcceec--CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC--
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVID--NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS-- 340 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~--~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~-- 340 (767)
-++.+.-..+.-+|...|||||.+. +.+|+.++|+||||++|||+.||..|+++.+. ..+++.+.+..+++.+.
T Consensus 216 GqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 216 GQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred HhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCc
Confidence 8775544445567999999999994 45699999999999999999999999988765 45556555555555442
Q ss_pred ---CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 341 ---CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 341 ---~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
-.+|..++.+|.-||.+|-+.||. .++++.+||++.-
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpk-------y~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPK-------YDDLKKFPFYRMY 333 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcc-------hhhhhcCchhhhh
Confidence 237899999999999999999999 8899999999763
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=335.09 Aligned_cols=259 Identities=26% Similarity=0.390 Sum_probs=224.0
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEee---
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYET--- 185 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--- 185 (767)
+...+.|+++.+||+|.+|.||+++.+.+|+..|+|++.... ...+.+..|..||+.. +|||++.+||+|.-
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 344578999999999999999999999999999999986542 3445677789999886 68999999999854
Q ss_pred --CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 186 --KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 186 --~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
.+.++||||||.||+..+++.+.. ...+.|+.+..|+.+++.||.|||...++|||||-.|||++.+|.|||+|||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 468999999999999999998876 55799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-cccccccccccCCcceecC-----CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc
Q psy11874 264 AVEIPEGE-SVRGRVGTVGYMAPEVIDN-----EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE 337 (767)
Q Consensus 264 a~~~~~~~-~~~~~~GT~~Y~APEvl~~-----~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~ 337 (767)
+.++.... ...+.+|||.|||||++.. ..|+..+|+||||++..||..|.+|+.+.... ..+.....++++
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---raLF~IpRNPPP 246 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPRNPPP 246 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---hhhccCCCCCCc
Confidence 98875542 2456789999999999953 35788999999999999999999999887653 334444555555
Q ss_pred cc--CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 338 KY--SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 338 ~~--~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
++ |..++++..++|..||.+|-.+||+ ..++++|||.+.
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~-------~~~ll~hpFi~e 287 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPS-------TEELLKHPFITE 287 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcc-------hhhhccCCcccc
Confidence 54 5688999999999999999999999 899999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=343.54 Aligned_cols=263 Identities=19% Similarity=0.214 Sum_probs=183.7
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccC----CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEE---
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRAT----GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYA--- 182 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~--- 182 (767)
....++|++.+.||+|+||.||+|.+..+ +..||+|++..... .+...+| .+....+.+++.+...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 35678999999999999999999999988 99999998754211 1111111 1112222222222111
Q ss_pred ---EeeCCeEEEEEEeccCCCHHHHHHhcCC-----------------CCCCCHHHHHHHHHHHHhHHHHHHHCCccccc
Q psy11874 183 ---YETKDALCLVLTIMNGGDLKFHIYNMGG-----------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRD 242 (767)
Q Consensus 183 ---~~~~~~l~lV~E~~~gG~L~~~l~~~~~-----------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrD 242 (767)
......+++||||+++|+|.+++..... ........+..++.||+.||.|||+++|+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2456789999999999999988875321 01122345678999999999999999999999
Q ss_pred CCcceEEeCC-CCCEEEeecCcccccCCCCc--ccccccccccCCcceecCC----------------------CCCCCC
Q psy11874 243 CKPENILLDD-YGHVRISDLGLAVEIPEGES--VRGRVGTVGYMAPEVIDNE----------------------KYTYSP 297 (767)
Q Consensus 243 LKPeNILld~-~g~vkL~DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~~----------------------~ys~~~ 297 (767)
|||+|||++. ++.+||+|||+|+.+..+.. ....+||+.|||||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 68999999999986644322 3456899999999976332 234566
Q ss_pred ccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh----------hccc--------cccCCCCcHHHHHHHHHhcccCc
Q psy11874 298 DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV----------KEDA--------EKYSCRFSDDAKALCKALLKKSP 359 (767)
Q Consensus 298 DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i----------~~~~--------~~~~~~~s~~~~dLi~~lL~~dP 359 (767)
||||+||+||||+++..|+..... ......... .... .......+..+++||.+||++||
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLI--QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHH--HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999999998776543211 111100000 0000 00111123456799999999999
Q ss_pred CccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 360 RSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 360 ~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
++||+ ++++++||||++.++..
T Consensus 439 ~kR~t-------a~e~L~Hpff~~~~~~~ 460 (566)
T PLN03225 439 RQRIS-------AKAALAHPYFDREGLLG 460 (566)
T ss_pred ccCCC-------HHHHhCCcCcCCCCccc
Confidence 99999 99999999999987753
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.73 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=217.9
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC------
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------ 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 186 (767)
..+|.-++.+|.|+- .|..|-+..+++.+|+|++... .........+.+|..++..++|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 357888999999998 8889999999999999998877 44556677889999999999999999999998543
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
...|+|||+|. ++|...+.. .++-..+..+..|+++|++|||+.||+||||||+||++..++.+||.|||+|+.
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 46899999997 688887773 478889999999999999999999999999999999999999999999999988
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc--------
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK-------- 338 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~-------- 338 (767)
....-..+.++.|..|.|||++.+..|...+||||+||++.||++|...|.+.+...+...+.+...+..+.
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred cCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 766655677899999999999999999999999999999999999999998876655444333322221111
Q ss_pred -------------------cCC-----------CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 339 -------------------YSC-----------RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 339 -------------------~~~-----------~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
+|+ .-+..++|++.+||..||++|.+ ++++|+|||++ -|
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris-------v~daL~HPY~~--vw 316 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS-------VDDALRHPYIK--VW 316 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc-------HHHHhcCCeee--ee
Confidence 111 12457999999999999999998 99999999999 46
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=322.35 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=214.9
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC------CceeEEEEEEe
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS------RFVVSLAYAYE 184 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h------p~Iv~l~~~~~ 184 (767)
+--+.|.+....|+|-||+|..|.+...|..||||++....+.... -+.|++||++|+. .++++|+-.|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~Kt----Gl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKT----GLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhh----hhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 3447899999999999999999999999999999999877654333 4679999999963 47999999999
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-CEEEeecCc
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-HVRISDLGL 263 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-~vkL~DFGl 263 (767)
.++++|||+|-+. -+|...|...|.+.++....++.|+.|+..||.+|-..||+|.||||.|||+++.. .+||||||.
T Consensus 505 hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 9999999999886 68999999999899999999999999999999999999999999999999999765 469999999
Q ss_pred ccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC---
Q psy11874 264 AVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS--- 340 (767)
Q Consensus 264 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~--- 340 (767)
|..+.+++ ++.+.-+..|.|||++.+-+|++..|+||+||+||||.||+..|.+......... ..+...++|
T Consensus 584 A~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl----~me~KGk~p~Km 658 (752)
T KOG0670|consen 584 ASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL----FMELKGKFPNKM 658 (752)
T ss_pred cccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH----HHHhcCCCcHHH
Confidence 98887665 4556678899999999999999999999999999999999999987643221110 000000000
Q ss_pred --------------------------------------------------CCC-------cHHHHHHHHHhcccCcCccC
Q psy11874 341 --------------------------------------------------CRF-------SDDAKALCKALLKKSPRSRL 363 (767)
Q Consensus 341 --------------------------------------------------~~~-------s~~~~dLi~~lL~~dP~~Rl 363 (767)
..+ -..+++|+.+||..||++|+
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 001 24688999999999999999
Q ss_pred CCCCCcccHHHHHhCCCCCC
Q psy11874 364 GCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 364 ~~~~~~~~a~eil~HpfF~~ 383 (767)
+ +.++|+||||..
T Consensus 739 t-------~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 739 T-------VNQALKHPFITE 751 (752)
T ss_pred C-------HHHHhcCCcccC
Confidence 8 899999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=327.19 Aligned_cols=266 Identities=24% Similarity=0.281 Sum_probs=193.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEc----------------cCCcEEEEEEechhhhhh-----------hhhHHHHHH
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVR----------------ATGKMYACKKLEKKRIKK-----------RKGESMVLI 163 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~----------------~tg~~~AiK~l~k~~~~~-----------~~~~~~~~~ 163 (767)
+..++|++.++||+|+||.||+|... ..++.||+|++....... ....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45789999999999999999999752 245689999986432111 111233456
Q ss_pred HHHHHHhcCCCce-----eEEEEEEee--------CCeEEEEEEeccCCCHHHHHHhcCC--------------------
Q psy11874 164 EKQILQKINSRFV-----VSLAYAYET--------KDALCLVLTIMNGGDLKFHIYNMGG-------------------- 210 (767)
Q Consensus 164 E~~iL~~l~hp~I-----v~l~~~~~~--------~~~l~lV~E~~~gG~L~~~l~~~~~-------------------- 210 (767)
|..++.+++|.++ +++.++|.. +...+|||||+++|+|.+++....+
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 8888888877654 556565542 4568999999999999998875321
Q ss_pred -CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccccc--ccccccCCcce
Q psy11874 211 -EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR--VGTVGYMAPEV 287 (767)
Q Consensus 211 -~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~--~GT~~Y~APEv 287 (767)
...+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.....+...... .+|+.|+|||+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 113467788999999999999999999999999999999999999999999999765443332222 35899999999
Q ss_pred ecCCC--------------------CC--CCCccccchhhHHHHhcCCC-CCCCchhhhhh----h---hhhhhhhcccc
Q psy11874 288 IDNEK--------------------YT--YSPDWFSFGCLIFEMIEGQA-PFRRRKEMVKR----D---EVDRRVKEDAE 337 (767)
Q Consensus 288 l~~~~--------------------ys--~~~DvwSlGviLyElltG~~-PF~~~~~~~~~----~---~i~~~i~~~~~ 337 (767)
+.... |+ ...|+||+||++|+|++|.. ||......... . ...+.......
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 85432 22 24799999999999999885 77542211100 0 01111111121
Q ss_pred --ccCCCCcHHHHHHHHHhcccCc---CccCCCCCCcccHHHHHhCCCCCC
Q psy11874 338 --KYSCRFSDDAKALCKALLKKSP---RSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 338 --~~~~~~s~~~~dLi~~lL~~dP---~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
......++.++||+.+||.++| .+|+| ++|+|+||||..
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlS-------a~eaL~Hp~f~~ 505 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLS-------VGQALSHRFFLP 505 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCC-------HHHHhCCCCcCC
Confidence 2235678999999999999876 67988 999999999965
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=290.39 Aligned_cols=241 Identities=38% Similarity=0.607 Sum_probs=206.1
Q ss_pred CcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCHHHHH
Q psy11874 126 GFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHI 205 (767)
Q Consensus 126 ~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l 205 (767)
+||.||+|....+|+.+|+|++........ ...+.+|++.+++++|++|+++.+.+......++++|++++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999998999999999876543221 567888999999999999999999999999999999999999999998
Q ss_pred HhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcccccccccccCCc
Q psy11874 206 YNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAP 285 (767)
Q Consensus 206 ~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~AP 285 (767)
.... .+++..+..++.+++.+|.+||+.+|+|+||+|.||++++++.++|+|||.+.............|+..|+||
T Consensus 79 ~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRG---RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAP 155 (244)
T ss_pred Hhcc---CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCH
Confidence 7653 3899999999999999999999999999999999999999999999999999887665455567799999999
Q ss_pred ceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCC---CcHHHHHHHHHhcccCcCcc
Q psy11874 286 EVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR---FSDDAKALCKALLKKSPRSR 362 (767)
Q Consensus 286 Evl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~---~s~~~~dLi~~lL~~dP~~R 362 (767)
|.+.+..++.++|+||+|+++|+|++|..||...... ..+.+............ ++.++.+++.+||..+|++|
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---LELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9998888999999999999999999999999763221 22222222222222221 88999999999999999999
Q ss_pred CCCCCCcccHHHHHhCCCC
Q psy11874 363 LGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 363 l~~~~~~~~a~eil~HpfF 381 (767)
|+ +.++++||||
T Consensus 233 p~-------~~~~~~~~~~ 244 (244)
T smart00220 233 LT-------AEEALQHPFF 244 (244)
T ss_pred cC-------HHHHhhCCCC
Confidence 98 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=288.44 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=208.8
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeC--CeE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETK--DAL 189 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~--~~l 189 (767)
.++|++.+.+|+|.+++|+.|....++..+++|+++..+- ..+.+|+.||+.+. ||||++|++...+. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk------kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK------KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH------HHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4789999999999999999999999999999999965432 33788999999998 99999999998775 457
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC-CCCEEEeecCcccccC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-YGHVRISDLGLAVEIP 268 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-~g~vkL~DFGla~~~~ 268 (767)
.||+||+++.|...... .++.-.++.|+.|++.||.|+|++||+|||+||.|++||. .-.++|+|+|||....
T Consensus 111 aLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 89999999988865443 4788899999999999999999999999999999999995 4579999999999999
Q ss_pred CCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCC-Cchhhhhhhhhhhhh---------hcc--
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFR-RRKEMVKRDEVDRRV---------KED-- 335 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~-~~~~~~~~~~i~~~i---------~~~-- 335 (767)
.+...+-++.+..|-.||.+.. ..|+++.|+|||||++..|+..+-||. +.+.-.+.-.+.+.. ..-
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 9888888999999999999855 679999999999999999999998874 332222211111100 000
Q ss_pred --cccc--------------------CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 336 --AEKY--------------------SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 336 --~~~~--------------------~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.+.+ ....++++.||+.++|..|-.+||+ |+|.+.||||..+
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT-------akEam~HpyF~~~ 328 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT-------AKEAMAHPYFAPV 328 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc-------hHHHhcCchHHHH
Confidence 0000 0124799999999999999999999 9999999999875
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=315.08 Aligned_cols=248 Identities=22% Similarity=0.290 Sum_probs=213.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccC-C--cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT-G--KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-g--~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
|..++..+++.||+|+||.|++|.+... | ..||||.+....... ....|++|..+|.+|+|+|+++||++..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 5566788889999999999999998753 3 478999997664432 45679999999999999999999999988 6
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+.+|||++++|+|.+.|.+ .....|-......|+.||+.||.||.+++.|||||-..|+||-....|||+||||.+.+
T Consensus 184 p~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 78999999999999999998 34557899999999999999999999999999999999999999999999999999998
Q ss_pred CCCCccccc----ccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 268 PEGESVRGR----VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 268 ~~~~~~~~~----~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
..++..... .-...|+|||.++...++.++|+|++||+||||++ |.-||.+.......+.+.. .....-+..
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~---~erLpRPk~ 339 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA---GERLPRPKY 339 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc---cccCCCCCC
Confidence 777654322 23568999999999999999999999999999997 8899999877665555542 233445668
Q ss_pred CcHHHHHHHHHhcccCcCccCCC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGC 365 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~ 365 (767)
+|+++.++++.|+..+|++||++
T Consensus 340 csedIY~imk~cWah~paDRptF 362 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTF 362 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccH
Confidence 89999999999999999999994
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.82 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=208.3
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
++..+...+.+.||+|-||+|.+|+... +..||+|+++... .......+..|+++|.+++|||||.|.++|..++.+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 3455667888999999999999999863 6999999997654 333456799999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+|+|||++|||..++...... ...-.....++.||+.||+||.+.++|||||.|.|+|+|.++++||+|||+|+.+-.
T Consensus 611 cmI~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999999999886422 245556677999999999999999999999999999999999999999999998766
Q ss_pred CCccc---ccccccccCCcceecCCCCCCCCccccchhhHHHHh--cCCCCCCCchhhhhhhhhhhhhhccc----cccC
Q psy11874 270 GESVR---GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI--EGQAPFRRRKEMVKRDEVDRRVKEDA----EKYS 340 (767)
Q Consensus 270 ~~~~~---~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEll--tG~~PF~~~~~~~~~~~i~~~i~~~~----~~~~ 340 (767)
++... ..+-...|||||.+..++++.++|+|+||+++||++ +...||......+..++......... ...|
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 65432 235578999999999999999999999999999987 58889976655433333322222111 2235
Q ss_pred CCCcHHHHHHHHHhcccCcCccCC
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
.-++..+.+++-.|+..+-++||+
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPs 793 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPS 793 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCC
Confidence 678999999999999999999999
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=315.35 Aligned_cols=256 Identities=20% Similarity=0.327 Sum_probs=217.6
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccCC---cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 184 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 184 (767)
..+|..+...+.++||.|.||+||.|+.+..| ..||||.++... ..++...|+.|..||.++.||||++|.++..
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 34566678889999999999999999999777 479999986543 4455667999999999999999999999999
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
....+.+|.|||++|+|+.+|+...+ .|+..+..-+.+.|+.||.||-++|.|||||...|||++.+-.+|++||||+
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 99999999999999999999998754 5999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-ccccc-c--ccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 265 VEIPEGES-VRGRV-G--TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 265 ~~~~~~~~-~~~~~-G--T~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
+.+.++.. ..+.. | ...|.|||.+...+++.++||||+|++|||.++ |..||......+..+.+.+.. ..+-
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy---RLPp 855 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY---RLPP 855 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc---CCCC
Confidence 98765542 22222 2 578999999999999999999999999999885 999998876544444443322 2334
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
|-..+..+..|...|+++|-.+||. .++|..
T Consensus 856 PmDCP~aL~qLMldCWqkdR~~RP~-------F~qiV~ 886 (996)
T KOG0196|consen 856 PMDCPAALYQLMLDCWQKDRNRRPK-------FAQIVS 886 (996)
T ss_pred CCCCcHHHHHHHHHHHHHHhhcCCC-------HHHHHH
Confidence 5588999999999999999999999 566554
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=319.70 Aligned_cols=246 Identities=27% Similarity=0.379 Sum_probs=197.3
Q ss_pred eEEEeEEeecCcEE-EEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEEE
Q psy11874 116 FRMYRVLGKGGFGE-VCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 116 y~~~~~LG~G~fG~-Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
|.--+++|.|+-|+ ||+|... |+.||||.+-. .....+.+|+..|+.- +|||||+.|+.-++...+|+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 44557889999985 8999985 88999998733 3455688999999987 6999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCC-CCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC---CC--CEEEeecCccccc
Q psy11874 194 TIMNGGDLKFHIYNMGGE-PGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD---YG--HVRISDLGLAVEI 267 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~-~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~---~g--~vkL~DFGla~~~ 267 (767)
|.|. -+|.+++...+.. ....-...+....|++.||+|||+.+||||||||.||||+. +| .++|+|||+++.+
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9998 6999999874111 11111455788999999999999999999999999999975 44 5789999999998
Q ss_pred CCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcC-CCCCCCchhhhhhhhhhhhhhcccccc---
Q psy11874 268 PEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEG-QAPFRRRKEMVKRDEVDRRVKEDAEKY--- 339 (767)
Q Consensus 268 ~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG-~~PF~~~~~~~~~~~i~~~i~~~~~~~--- 339 (767)
..+.+ ..+..||-+|+|||++....-+.++|||||||++|..++| ..||.+.-+.+ .+|.......
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~------~NIl~~~~~L~~L 735 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ------ANILTGNYTLVHL 735 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh------hhhhcCccceeee
Confidence 77654 3345799999999999998888999999999999999885 89997764321 1222222221
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
.+.-..+|+|||.+||..+|..||+ |.+++.||||-+
T Consensus 736 ~~~~d~eA~dLI~~ml~~dP~~RPs-------a~~VL~HPlFW~ 772 (903)
T KOG1027|consen 736 EPLPDCEAKDLISRMLNPDPQLRPS-------ATDVLNHPLFWD 772 (903)
T ss_pred ccCchHHHHHHHHHhcCCCcccCCC-------HHHHhCCCccCC
Confidence 1111228999999999999999999 999999999965
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=303.34 Aligned_cols=255 Identities=18% Similarity=0.282 Sum_probs=211.0
Q ss_pred CeEEEeEEeecCcEEEEEEEEccC----CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRAT----GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~t----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
...+.++||.|-||.||.|.+..- .-.||+|.-+.+. .....+.++.|..||++++|||||+|+|++.+. ..+
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 344557899999999999987533 3468888875542 334467799999999999999999999999865 589
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+|||+++-|.|..+|+... ..++......|+.||+.||.|||+.+.|||||...|||+.+...|||+||||++.+.+.
T Consensus 467 ivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 9999999999999998764 36889999999999999999999999999999999999999999999999999998777
Q ss_pred Cccccccc--ccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 271 ESVRGRVG--TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 271 ~~~~~~~G--T~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
..+....| ...|||||-++-..++.++|||-|||++||++. |..||.+-...+. +...-.....+.|+.+++.+
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---I~~iEnGeRlP~P~nCPp~L 621 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---IGHIENGERLPCPPNCPPAL 621 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce---EEEecCCCCCCCCCCCChHH
Confidence 65554444 568999999999999999999999999999986 9999988643221 22222345567788999999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
..|..+|+..+|.+||.+.+-.....+|++
T Consensus 622 YslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999999999996542233444444
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=338.30 Aligned_cols=239 Identities=18% Similarity=0.223 Sum_probs=187.3
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
.|...++||+|+||.||+|+.+.+|+.||+|++..... ....|++++++++|||||++++++.+.+..|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 45667899999999999999999999999999864321 11246889999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHH---HCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH---YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH---~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
||+||+|.+++. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 999999999985 3788999999999999999999 6699999999999999999988876 666543322
Q ss_pred cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh-hhhhhhhh---------hhccc----c
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV-KRDEVDRR---------VKEDA----E 337 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~-~~~~i~~~---------i~~~~----~ 337 (767)
.....||+.|||||++.+..|+.++|||||||++|||++|+.||....... ...+..+. +.... .
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 123478999999999999999999999999999999999999995432110 00000000 00000 0
Q ss_pred ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 338 KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 338 ~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
........++.+++.+|++.||++||+ ++|+++
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt-------~~evl~ 946 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPC-------ANDVLK 946 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcC-------HHHHHH
Confidence 001112235778999999999999999 777764
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=298.80 Aligned_cols=251 Identities=18% Similarity=0.262 Sum_probs=215.3
Q ss_pred hcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 107 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+.|++...+......||.|.||.||.|.++.-.--+|+|.++-+ ....+.|+.|..+|+.++|||+|+|.++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 44556667788889999999999999999998899999998543 34567899999999999999999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
..+|||+|||..|+|.++|+... ...++.-..+.++.||..||+||..+++|||||...|+|+.++..||++||||++.
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999999998864 33567777788899999999999999999999999999999999999999999998
Q ss_pred cCCCCccccccc---ccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 267 IPEGESVRGRVG---TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 267 ~~~~~~~~~~~G---T~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
...+. ++.-.| ...|.|||-+.-..++.++|||+|||+|||+.| |-.||.+.+..+.+..+.+... -.-|..
T Consensus 415 MtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR---M~~PeG 490 (1157)
T KOG4278|consen 415 MTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR---MDGPEG 490 (1157)
T ss_pred hcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc---ccCCCC
Confidence 76543 333333 678999999999999999999999999999997 9999999866544444433322 334678
Q ss_pred CcHHHHHHHHHhcccCcCccCCCC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCH 366 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~ 366 (767)
+++....|...|++.+|+.||++.
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFa 514 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFA 514 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHH
Confidence 999999999999999999999953
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-33 Score=284.16 Aligned_cols=258 Identities=23% Similarity=0.341 Sum_probs=208.3
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC-----eE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD-----AL 189 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~l 189 (767)
+.+--+.||-|+||.||.+.+..+|+.+|+|++... ..+....+.+.+|.++|.-.+|.||+...+..+-.. .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 344568999999999999999999999999998543 334445567899999999999999999988776542 57
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|.|+|+|. .||...|-.- ..++.+.++-+..||++||.|||+.||+||||||.|.|++++..+||||||+|+....
T Consensus 133 YV~TELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 88899986 5776666542 3689999999999999999999999999999999999999999999999999987655
Q ss_pred CCc--ccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc----------
Q psy11874 270 GES--VRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA---------- 336 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~---------- 336 (767)
++. ++..+-|-.|.|||++.+. .|+.++||||.|||+.||+..+..|...+..++.+.+.....+..
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 443 4456789999999999874 699999999999999999999999988776655544333221111
Q ss_pred ---------cccC-----------CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 337 ---------EKYS-----------CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 337 ---------~~~~-----------~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.+.| ..-..++.+++.++|..||.+|.+ .++.+.|++....
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris-------~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS-------VEEALQHRYLEEG 349 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc-------Hhhhccccccccc
Confidence 0101 122357889999999999999998 8999999998764
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=264.61 Aligned_cols=224 Identities=22% Similarity=0.349 Sum_probs=178.0
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHh-cCCCceeEEEEEEeeCCeEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~l~ 190 (767)
..++..-+..||+|++|.|-+-++..+|+..|+|.+...- ..+.....++|..+..+ ..+|++|++|+++.+...++
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 3355666778999999999999999999999999986542 23344567778876555 57899999999999999999
Q ss_pred EEEEeccCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 191 LVLTIMNGGDLKFHIYNM-GGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~-~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+.||.|. .+|..+..+. ......+|..+-.++..++.||.|||+ ..|||||+||+||||+.+|++|+||||.+-.+.
T Consensus 122 IcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred EeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9999997 5665444331 223468899999999999999999996 589999999999999999999999999998775
Q ss_pred CCCcccccccccccCCcceec----CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC
Q psy11874 269 EGESVRGRVGTVGYMAPEVID----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS 340 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~ 340 (767)
+.-..+-..|.-.|||||.+. +..|+.++|+||||+++.||.+++.||..... ..+++.+-+.+..+.++
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t--pF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT--PFQQLKQVVEEPSPQLP 274 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC--HHHHHHHHhcCCCCCCc
Confidence 543333367899999999984 35799999999999999999999999976543 33444444444444443
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=295.71 Aligned_cols=204 Identities=30% Similarity=0.452 Sum_probs=182.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh-----hhHHHHHHHHHHHHhcC---CCceeEEEEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----KGESMVLIEKQILQKIN---SRFVVSLAYA 182 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~-----~~~~~~~~E~~iL~~l~---hp~Iv~l~~~ 182 (767)
-...+|..++.||.|+||.|++|.++.+...|++|.+.|.++... .....+-.|++||..++ |+||+++.++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 345679999999999999999999999999999999999886432 22334667999999998 9999999999
Q ss_pred EeeCCeEEEEEEe-ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeec
Q psy11874 183 YETKDALCLVLTI-MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDL 261 (767)
Q Consensus 183 ~~~~~~l~lV~E~-~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DF 261 (767)
|++++++||+||- -+|.||.++|... +.++|.++..++.||+.|++|||++||||||||-||+.+|.+|-+||+||
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 9999999999997 4678999999765 47999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCcccccccccccCCcceecCCCC-CCCCccccchhhHHHHhcCCCCCCC
Q psy11874 262 GLAVEIPEGESVRGRVGTVGYMAPEVIDNEKY-TYSPDWFSFGCLIFEMIEGQAPFRR 318 (767)
Q Consensus 262 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y-s~~~DvwSlGviLyElltG~~PF~~ 318 (767)
|.|.....+ .....+||.+|.|||++.+.+| +..-|||+||++||.++....||+.
T Consensus 715 gsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999877654 4567899999999999999887 5778999999999999999999864
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=300.25 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=218.0
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|+++..+|+|+||.||+|+++.+++..|+|+++... ....+.+..|+-+++..+|||||.+++.|-..+.+++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 478999999999999999999999999999999987543 33455567799999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-C
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-E 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~ 271 (767)
||||.||+|.+..+-.+ .+++.++...+++.+.||.|||++|-+|||||-.|||+++.|.+||+|||.+.++... .
T Consensus 91 MEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 99999999987655443 7999999999999999999999999999999999999999999999999998766432 1
Q ss_pred cccccccccccCCccee---cCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhh-hhhccccccCCCCcHHH
Q psy11874 272 SVRGRVGTVGYMAPEVI---DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR-RVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl---~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~-~i~~~~~~~~~~~s~~~ 347 (767)
.-.++.|||.|||||+. ...+|...+|+|++|++..|+-.-++|......+.....+.+ .......+-...+++..
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 23456899999999997 467899999999999999999999998766554332222211 11111222345789999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.+|++.+|.++|.+||+ ++.+++|||...-
T Consensus 248 h~fvK~altknpKkRpt-------aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPT-------AEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHhcCCCccCCC-------hhhheeceeeccc
Confidence 99999999999999999 9999999999865
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=296.10 Aligned_cols=244 Identities=23% Similarity=0.241 Sum_probs=204.7
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCc----EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
..+..++||+|+||+||+|.+-..|+ +||+|++.... ..+.-..++.|..+|.+++|||+++|.+++.... +-
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 34567899999999999999876654 68888876543 3344567899999999999999999999998877 99
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
||++||++|.|.++++..+. .+-....+.|..||++||.|||.+++|||||-..|||+..-.++||+|||+|+.+..+
T Consensus 774 lvtq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999999998653 5777888999999999999999999999999999999999999999999999987665
Q ss_pred Cc-ccc--cccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 271 ES-VRG--RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 271 ~~-~~~--~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
.. ... ..-.+.|||-|.+....|+.++||||+||++||++| |..|+.+....+....+.. ......|+..+-+
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~---geRLsqPpiCtiD 928 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK---GERLSQPPICTID 928 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc---cccCCCCCCccHH
Confidence 43 222 223678999999999999999999999999999998 9999988754333322221 2234567788999
Q ss_pred HHHHHHHhcccCcCccCCCC
Q psy11874 347 AKALCKALLKKSPRSRLGCH 366 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~ 366 (767)
+.-++.+||..|+..||+++
T Consensus 929 Vy~~mvkCwmid~~~rp~fk 948 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFK 948 (1177)
T ss_pred HHHHHHHHhccCcccCccHH
Confidence 99999999999999999954
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=273.59 Aligned_cols=134 Identities=26% Similarity=0.401 Sum_probs=114.4
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-----C---CceeEEEEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-----S---RFVVSLAYA 182 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----h---p~Iv~l~~~ 182 (767)
+.-++|.+.++||-|-|++||+|.+..+.+.||+|+.+... ...+.++.|+++|++++ | ..||+|++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 34478999999999999999999999999999999986432 34456888999999984 3 369999999
Q ss_pred Eee----CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEe
Q psy11874 183 YET----KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILL 250 (767)
Q Consensus 183 ~~~----~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILl 250 (767)
|.. +.++|+|+|++ |-+|..+|.... -.+++...++.|+.||+.||.|||+ .||||-||||+|||+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 975 56999999999 456777776543 4579999999999999999999996 599999999999998
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=277.17 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=201.6
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEcc---CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCe
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDA 188 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~ 188 (767)
.+.|.+.+.||.|+|+.||++.+.. .++.||+|.+.... ...++.+|+++|..+. +.||+++.+.+..++.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4679999999999999999999887 78899999986543 3456889999999984 7899999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC-CCCEEEeecCccccc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-YGHVRISDLGLAVEI 267 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-~g~vkL~DFGla~~~ 267 (767)
.++||||++.-+-.+++. .++...++.|+..++.||.++|.+|||||||||.|+|.+. .+.-.|.|||||...
T Consensus 110 v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 999999999888777665 3678999999999999999999999999999999999984 567899999999621
Q ss_pred C-----------------C--CC---------------c-----------ccccccccccCCcceecC-CCCCCCCcccc
Q psy11874 268 P-----------------E--GE---------------S-----------VRGRVGTVGYMAPEVIDN-EKYTYSPDWFS 301 (767)
Q Consensus 268 ~-----------------~--~~---------------~-----------~~~~~GT~~Y~APEvl~~-~~ys~~~DvwS 301 (767)
. . +. . ...+.||++|.|||++.. ..-+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 0 0 00 0 012369999999999865 45689999999
Q ss_pred chhhHHHHhcCCCCCCCchhhh-hhh---------------hhh--------------------------hhhhc-----
Q psy11874 302 FGCLIFEMIEGQAPFRRRKEMV-KRD---------------EVD--------------------------RRVKE----- 334 (767)
Q Consensus 302 lGviLyElltG~~PF~~~~~~~-~~~---------------~i~--------------------------~~i~~----- 334 (767)
.|||+.-+++++.||....... ... ... ..+..
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 9999999999999994322110 000 000 00000
Q ss_pred -cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 335 -DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 335 -~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
......+.++..+.||+.+||+.||.+|+| |++.|+||||...+
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRit-------AEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRIT-------AEDALKHPFFDEAD 388 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhccc-------HHHHhcCcCCcchh
Confidence 111122345679999999999999999998 99999999998543
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=273.24 Aligned_cols=241 Identities=28% Similarity=0.364 Sum_probs=187.8
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHh--cCCCceeEEEEEEeeC---
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK--INSRFVVSLAYAYETK--- 186 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~~~~~--- 186 (767)
.-.+..+.+.||+|.||+||+|.++ |..||||++.. ..+....+|.+|.+. |+|+||+.++++=...
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s------rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS------RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecc------cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 3467889999999999999999998 99999999843 345667778888876 5999999998764332
Q ss_pred -CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC--------CcccccCCcceEEeCCCCCEE
Q psy11874 187 -DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI--------GLVYRDCKPENILLDDYGHVR 257 (767)
Q Consensus 187 -~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~--------~IvHrDLKPeNILld~~g~vk 257 (767)
+.++||.+|-+.|+|.++|.+. .++.+....++..+++||+|||.. .|.|||||..|||+..+|.+-
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 3699999999999999999875 589999999999999999999953 499999999999999999999
Q ss_pred EeecCcccccCCCCc-----ccccccccccCCcceecCCC----CC--CCCccccchhhHHHHhc----------CCCCC
Q psy11874 258 ISDLGLAVEIPEGES-----VRGRVGTVGYMAPEVIDNEK----YT--YSPDWFSFGCLIFEMIE----------GQAPF 316 (767)
Q Consensus 258 L~DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~----ys--~~~DvwSlGviLyEllt----------G~~PF 316 (767)
|+|+|||........ .+.++||..|||||++...- +. ..+||||||.++||++. -++||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 999999987655422 45679999999999995432 11 45899999999999984 24688
Q ss_pred CCchhhhh-hhhhhhhhhc--cccccCCCC-c-H---HHHHHHHHhcccCcCccCC
Q psy11874 317 RRRKEMVK-RDEVDRRVKE--DAEKYSCRF-S-D---DAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 317 ~~~~~~~~-~~~i~~~i~~--~~~~~~~~~-s-~---~~~dLi~~lL~~dP~~Rl~ 364 (767)
.+.-..+. .+++.+-+.. ..+..|..+ | + .+-.|++.|+..||.-|++
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT 492 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH
Confidence 65433222 2333332222 122333322 2 2 3456789999999999998
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=296.33 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=208.2
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEcc-------CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEE
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRA-------TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSL 179 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 179 (767)
.+++..++..+.+.||+|+||.|++|.... ....||+|.+...... .....+..|+.+|..+ .|+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence 344555666777899999999999997541 1457999998765433 5667889999999998 69999999
Q ss_pred EEEEeeCCeEEEEEEeccCCCHHHHHHhcC-----CC--------CCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcc
Q psy11874 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMG-----GE--------PGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPE 246 (767)
Q Consensus 180 ~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~-----~~--------~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPe 246 (767)
.+++..+..+++|+||+..|+|..+++..+ .. ..++......++.||+.||+||++.++|||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998865 01 13889999999999999999999999999999999
Q ss_pred eEEeCCCCCEEEeecCcccccCCCCccc--cccc--ccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchh
Q psy11874 247 NILLDDYGHVRISDLGLAVEIPEGESVR--GRVG--TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKE 321 (767)
Q Consensus 247 NILld~~g~vkL~DFGla~~~~~~~~~~--~~~G--T~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~ 321 (767)
|||+..+..+||+|||+|+......... ...| ...|||||.+....|+.++||||+||+||||++ |..||.+...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999999765544432 2233 345999999999999999999999999999998 9999987321
Q ss_pred hhhhhhhhhhhhcc-ccccCCCCcHHHHHHHHHhcccCcCccCCCC
Q psy11874 322 MVKRDEVDRRVKED-AEKYSCRFSDDAKALCKALLKKSPRSRLGCH 366 (767)
Q Consensus 322 ~~~~~~i~~~i~~~-~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~ 366 (767)
..++.+.+..+ ....|...++++.++.+.|++.+|++||++.
T Consensus 528 ---~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~ 570 (609)
T KOG0200|consen 528 ---TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFS 570 (609)
T ss_pred ---HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence 22233333333 3456778899999999999999999999943
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=277.31 Aligned_cols=242 Identities=22% Similarity=0.306 Sum_probs=187.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHh--cCCCceeEEEEEEeeCC---
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK--INSRFVVSLAYAYETKD--- 187 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~~~~~~--- 187 (767)
....+++.+||+|.||.||+|+.. ++.||||++... ..+.+.+|..|.+. +.|+||++++++-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 345667899999999999999985 699999998543 34567788888776 68999999998876665
Q ss_pred -eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC---------CcccccCCcceEEeCCCCCEE
Q psy11874 188 -ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI---------GLVYRDCKPENILLDDYGHVR 257 (767)
Q Consensus 188 -~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~---------~IvHrDLKPeNILld~~g~vk 257 (767)
.+.||++|-+.|+|.++|... ..+|.....++..|+.||+|||+. .|+|||||..||||.+++++.
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 899999999999999999876 589999999999999999999963 599999999999999999999
Q ss_pred EeecCcccccCCCCc---ccccccccccCCcceecCCC-CC-----CCCccccchhhHHHHhcCCC------------CC
Q psy11874 258 ISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEK-YT-----YSPDWFSFGCLIFEMIEGQA------------PF 316 (767)
Q Consensus 258 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~-ys-----~~~DvwSlGviLyElltG~~------------PF 316 (767)
|+|||||..+..+.. ....+||..|||||++.+.- .. ...||||+|.+||||++.-. ||
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 999999988765543 34478999999999996532 21 45799999999999997433 33
Q ss_pred CCc-hhhhhhhhhhhhh--hccccccCCC-----CcHHHHHHHHHhcccCcCccCCCC
Q psy11874 317 RRR-KEMVKRDEVDRRV--KEDAEKYSCR-----FSDDAKALCKALLKKSPRSRLGCH 366 (767)
Q Consensus 317 ~~~-~~~~~~~~i~~~i--~~~~~~~~~~-----~s~~~~dLi~~lL~~dP~~Rl~~~ 366 (767)
... ...-..+++...+ ....+.++.. --..+++.|..|+..||+-|+|+.
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 210 0000112222211 1122233321 234688999999999999999954
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=243.92 Aligned_cols=212 Identities=34% Similarity=0.522 Sum_probs=188.5
Q ss_pred EeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCH
Q psy11874 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDL 201 (767)
Q Consensus 122 LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L 201 (767)
||+|++|.||+|....+|+.+++|++....... ....+.+|+.+++.+.|++++++++++......+++||+++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987654322 346788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC-CCCEEEeecCcccccCCCC-cccccccc
Q psy11874 202 KFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-YGHVRISDLGLAVEIPEGE-SVRGRVGT 279 (767)
Q Consensus 202 ~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-~g~vkL~DFGla~~~~~~~-~~~~~~GT 279 (767)
..++.... ..+++..+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......++
T Consensus 79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence 99987642 25899999999999999999999999999999999999999 8999999999998765432 13345688
Q ss_pred cccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccC
Q psy11874 280 VGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKS 358 (767)
Q Consensus 280 ~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~d 358 (767)
..|++||.+... .++.++|+||+|+++++| +.+.+++.+||..|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhCC
Confidence 999999999877 889999999999999999 58899999999999
Q ss_pred cCccCCCCCCcccHHHHHhCC
Q psy11874 359 PRSRLGCHCGRYGARELKQAE 379 (767)
Q Consensus 359 P~~Rl~~~~~~~~a~eil~Hp 379 (767)
|++||+ ++++++|+
T Consensus 202 p~~R~~-------~~~l~~~~ 215 (215)
T cd00180 202 PEKRPS-------AKEILEHL 215 (215)
T ss_pred cccCcC-------HHHHhhCC
Confidence 999998 89998875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=297.37 Aligned_cols=254 Identities=29% Similarity=0.536 Sum_probs=203.7
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
..+|+.+|.|..|++|.||.++++.|.+.+|+ +++|+.+.-++ ||.....|++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilRn----------ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILRN----------ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhhc----------cccccCCccee---------------
Confidence 47899999999999999999999999999999 55555432221 66667778877
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
||=...+.+.+. ++. +++.|++|||+.||+|||+||+|.||..-|++|++|||+++......
T Consensus 136 ------gDc~tllk~~g~---lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGP---LPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ------chhhhhcccCCC---Ccc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 566666666542 332 23789999999999999999999999999999999999986432110
Q ss_pred ---------------cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc
Q psy11874 272 ---------------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA 336 (767)
Q Consensus 272 ---------------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~ 336 (767)
.-...||||.|+|||++..++|+..+|||++|+|+||.+.|..||.+....+ +...+..+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee----lfg~visd~ 274 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE----LFGQVISDD 274 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH----HHhhhhhhh
Confidence 0123489999999999999999999999999999999999999999985543 333333333
Q ss_pred cccC---CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhh
Q psy11874 337 EKYS---CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKE 413 (767)
Q Consensus 337 ~~~~---~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~ 413 (767)
..++ ..++++++++|.+||+.+|..|++- .++-++++|+||+.++|..|..++ .+|+|.+..++....|..
T Consensus 275 i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt----~ga~evk~h~ff~~LDw~~llRqk--aefvpql~~eddtsyfdT 348 (1205)
T KOG0606|consen 275 IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGT----GGALEVKQHGFFQLLDWKSLLRQK--AEFVPQLESEDDTSYFDT 348 (1205)
T ss_pred ccccccCcCCCHHHHHHHHHHHHhChHhhccc----chhhhhhhccceeecccchhhhhh--ccccccccccccchhhcc
Confidence 3333 4678999999999999999999984 369999999999999999888765 679999888887777766
Q ss_pred hhhhcc
Q psy11874 414 DAEKYS 419 (767)
Q Consensus 414 ~~~~~~ 419 (767)
..++|.
T Consensus 349 Rs~Ryh 354 (1205)
T KOG0606|consen 349 RSDRYH 354 (1205)
T ss_pred cchhee
Confidence 666663
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=248.40 Aligned_cols=199 Identities=36% Similarity=0.577 Sum_probs=177.7
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEe
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
|.+.+.||.|++|.||+|....+++.+|+|.+...... .....+.+|+..+++++|+|++++++.+...+..++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56789999999999999999988999999999765433 2456788899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--cc
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE--SV 273 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~--~~ 273 (767)
+++++|..++..... .+++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++....... ..
T Consensus 79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 79 CEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 999999999887541 18899999999999999999999999999999999999999999999999998776543 34
Q ss_pred cccccccccCCccee-cCCCCCCCCccccchhhHHHHhcCCCCCCC
Q psy11874 274 RGRVGTVGYMAPEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPFRR 318 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl-~~~~ys~~~DvwSlGviLyElltG~~PF~~ 318 (767)
....++..|++||.+ ....++.++|+||||+++++|++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 456789999999998 677788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-29 Score=264.40 Aligned_cols=157 Identities=59% Similarity=0.980 Sum_probs=145.7
Q ss_pred HHHHHhhhcccccC-CcchhhhhHHHHHhhhcCCCccccchhhhHHHHhhhhhcccceeeeeeeecccccCCCceeecCC
Q psy11874 491 LEIIEHCKESLDSG-NRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYLQWKWLEHHFLYVEVFTHGVYCSQPHAVYAKD 569 (767)
Q Consensus 491 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 569 (767)
..++.||++.|..+ .+.||.+|++++++||+|+||.+|++||||+|||||||+|. .
T Consensus 124 ~~~v~~~~~~l~~~~~~~lf~~~~~~~~~~L~~~pF~~f~~S~yf~rFlQWK~lE~-q---------------------- 180 (591)
T KOG0986|consen 124 KDLVTHVQEHLLEKPPKDLFQPLARAICAYLRGDPFQEFLESDYFTRFLQWKWLEL-Q---------------------- 180 (591)
T ss_pred hhhhHHHhhhccccCchhhhHHHHHHHHHHhccchHhHhHHHHHHHHHHHHHHHHh-h----------------------
Confidence 67899999999666 99999999999999999999999999999999999999992 1
Q ss_pred ccCccccccccceecCCCChHHHhhhccCCcccccccccchhhhhhhccccCCCCCCCCCCcccCCCCCCCCCCCCCCCC
Q psy11874 570 VLDIEQFSTVKGVTLDTTDDSFYSKFNTGSVSIPWQNEMIETECFKELNVFGENNTPSSDVMFTSVPPSETNPSCFPQPI 649 (767)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~f~~~f~tg~v~~~~~~e~ie~~cf~eln~~~~~~~~s~dl~~~s~~~~~~ks~~f~~~~ 649 (767)
++
T Consensus 181 ------------------------------------------------------------------------------pv 182 (591)
T KOG0986|consen 181 ------------------------------------------------------------------------------PV 182 (591)
T ss_pred ------------------------------------------------------------------------------hc
Confidence 24
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
+.+.|..-++||+|+||.|+-|+.+.||+.||+|.+.|.++..+.--...++|..||+.++.||||.|-++|+|.+.|||
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 55678889999999999999999999999999999999988777777789999999999999999999999999999999
Q ss_pred EEeccCCccccccccccCC
Q psy11874 730 VLTIIDVMFTCVQPSETNP 748 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~ 748 (767)
||..|+||||.-+|-+.+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~ 281 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN 281 (591)
T ss_pred EEEeecCCceeEEeeccCC
Confidence 9999999999999987774
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-29 Score=250.42 Aligned_cols=239 Identities=26% Similarity=0.382 Sum_probs=188.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEE-EEeeCCeEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY-AYETKDALCL 191 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~-~~~~~~~l~l 191 (767)
+.|.+.+.||.|.||.+-+|.++.++..+++|.+.+..... ..+.+|...--.| .|.||+.-|+ +|++.+.+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~----~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQ----ADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhH----HHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 56889999999999999999999999999999997765433 3466676654444 5889998765 6899999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC--CCCCEEEeecCcccccCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD--DYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld--~~g~vkL~DFGla~~~~~ 269 (767)
+|||++.|||..-+.. .++-|.....+++|+++||+|||+.++||||||.+||||- +...|||||||+++....
T Consensus 100 ~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999999876644 3688999999999999999999999999999999999993 345799999999876432
Q ss_pred CCcccccccccccCCcceec---CCC--CCCCCccccchhhHHHHhcCCCCCCCchhhhhh----hhhhhhhhccccccC
Q psy11874 270 GESVRGRVGTVGYMAPEVID---NEK--YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKR----DEVDRRVKEDAEKYS 340 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~---~~~--ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~----~~i~~~i~~~~~~~~ 340 (767)
.....--+..|.|||+.. ++. ..+++|+|.||+++|.+++|.+||.....+... .....+.....+...
T Consensus 176 --tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 176 --TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred --eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 222333577899999873 333 468999999999999999999999754333222 122222222333444
Q ss_pred CCCcHHHHHHHHHhcccCcCcc
Q psy11874 341 CRFSDDAKALCKALLKKSPRSR 362 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~R 362 (767)
..+|+.+..+.++-|..+|++|
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred cccCHHHHHHHHHhcCCccccc
Confidence 5789999999999999999998
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=298.66 Aligned_cols=199 Identities=17% Similarity=0.224 Sum_probs=148.6
Q ss_pred cCC-CceeEEEEEE-------eeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCccccc
Q psy11874 171 INS-RFVVSLAYAY-------ETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRD 242 (767)
Q Consensus 171 l~h-p~Iv~l~~~~-------~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrD 242 (767)
++| +||++++++| .....++++||++ +++|..+|... ...+++.+++.++.||+.||.|||++||+|||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 345 5777888877 2234688889988 56999999753 23599999999999999999999999999999
Q ss_pred CCcceEEeCCC-------------------CCEEEeecCcccccCCCC-----------------cccccccccccCCcc
Q psy11874 243 CKPENILLDDY-------------------GHVRISDLGLAVEIPEGE-----------------SVRGRVGTVGYMAPE 286 (767)
Q Consensus 243 LKPeNILld~~-------------------g~vkL~DFGla~~~~~~~-----------------~~~~~~GT~~Y~APE 286 (767)
|||+||||+.. +.+||+|||+++...... .....+||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999999654 455666666665321100 001246899999999
Q ss_pred eecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCC
Q psy11874 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCH 366 (767)
Q Consensus 287 vl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~ 366 (767)
++.+..|+.++|||||||+||||++|.+|+..... ....+..... +... ..-.+.+.+++.+||.+||.+||+
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~L~~~P~~Rps-- 258 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVL--PPQI-LLNWPKEASFCLWLLHPEPSCRPS-- 258 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhc--Chhh-hhcCHHHHHHHHHhCCCChhhCcC--
Confidence 99999999999999999999999999999864322 1111211111 1111 112456789999999999999999
Q ss_pred CCcccHHHHHhCCCCCCC
Q psy11874 367 CGRYGARELKQAEFFKST 384 (767)
Q Consensus 367 ~~~~~a~eil~HpfF~~i 384 (767)
+.|+++||||...
T Consensus 259 -----~~eil~h~~~~~~ 271 (793)
T PLN00181 259 -----MSELLQSEFINEP 271 (793)
T ss_pred -----hHHHhhchhhhhh
Confidence 9999999999764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-25 Score=230.76 Aligned_cols=258 Identities=35% Similarity=0.495 Sum_probs=205.0
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCC-ceeEEEEEEeeCCeEEEEEE
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR-FVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~~~~~~~l~lV~E 194 (767)
|.+.+.||.|+||.||++.+. ..+|+|.+.............+.+|..+++.+.|+ +++++...+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999987 88999999877654444577789999999999998 79999999988888999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-CEEEeecCcccccCCCC--
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-HVRISDLGLAVEIPEGE-- 271 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-~vkL~DFGla~~~~~~~-- 271 (767)
++.|++|...+........++...+..++.|++.+++|+|+.+++|||+||+||+++..+ .++++|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999996665432112589999999999999999999999999999999999999988 79999999998654433
Q ss_pred -----cccccccccccCCcceecC---CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc-c---
Q psy11874 272 -----SVRGRVGTVGYMAPEVIDN---EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK-Y--- 339 (767)
Q Consensus 272 -----~~~~~~GT~~Y~APEvl~~---~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~-~--- 339 (767)
......||..|+|||.+.+ ..++...|+||+|++++++++|..||...............+...... .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2356789999999999987 578999999999999999999999987665310011122222222111 1
Q ss_pred -CCCC----cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 340 -SCRF----SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 340 -~~~~----s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
.... +..+.+++..++..+|..|.+ ..+...+++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~-------~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLS-------SSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCC-------HHHHhhchHhhC
Confidence 1111 257999999999999999988 556666644433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=226.17 Aligned_cols=163 Identities=20% Similarity=0.202 Sum_probs=130.0
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccccccc
Q psy11874 199 GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG 278 (767)
Q Consensus 199 G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~G 278 (767)
|+|.+++...+ ..+++.+++.++.||+.||.|||+++ ||+|||++.++.+++ ||++....... ..|
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g 66 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRV 66 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCC
Confidence 78999997643 36999999999999999999999998 999999999999999 99997654422 368
Q ss_pred ccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh-hhhhhhhhhhcccc---ccCCCCcH--HHHHHHH
Q psy11874 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV-KRDEVDRRVKEDAE---KYSCRFSD--DAKALCK 352 (767)
Q Consensus 279 T~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~-~~~~i~~~i~~~~~---~~~~~~s~--~~~dLi~ 352 (767)
|+.|||||++.+..|+.++|||||||++|||++|..||....... ....+......... ..+..+++ ++++++.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999999999999999999999999999999999997654321 11222211111100 11123344 6999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
+||..||.+||+ +.++++|+|+.
T Consensus 147 ~cl~~~p~~Rp~-------~~~ll~~~~~~ 169 (176)
T smart00750 147 VCASRLPQRREA-------ANHYLAHCRAL 169 (176)
T ss_pred HHHhcccccccC-------HHHHHHHHHHH
Confidence 999999999999 99999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=269.79 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=207.0
Q ss_pred EEEeEEeecCcEEEEEEEEccCCcEEEEEEechh---hhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKK---RIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 117 ~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~---~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
...+++|.|++|.|+.+......+.++.|..... ....++....+..|.-+-..++|||++.....+......+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4668999999999988888877777777765421 1122222223566777788899999987766666665555669
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-- 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-- 271 (767)
|||++ ||...+...+ .++..++..++.|++.|+.|||++||.||||||+|+++..+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 9998887753 58889999999999999999999999999999999999999999999999997543321
Q ss_pred ---cccccccccccCCcceecCCCCCC-CCccccchhhHHHHhcCCCCCCCchhhhh-----hhhhhhhhhccccccCCC
Q psy11874 272 ---SVRGRVGTVGYMAPEVIDNEKYTY-SPDWFSFGCLIFEMIEGQAPFRRRKEMVK-----RDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 272 ---~~~~~~GT~~Y~APEvl~~~~ys~-~~DvwSlGviLyElltG~~PF~~~~~~~~-----~~~i~~~i~~~~~~~~~~ 342 (767)
...+.+|+..|+|||++.+..|+. .+|+||.|++++.|++|+.||......++ .......+..........
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 245678999999999999999974 68999999999999999999965543322 122233444445555677
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
++...+.+|.+||+.||.+|.+ +++|++.+||+.+.=
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~t-------i~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRIT-------IEQILNDEWIRSIEC 593 (601)
T ss_pred chhhHHHHHHHHccCChhheec-------HHHHhhChHhhhcce
Confidence 8999999999999999999988 999999999999863
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=232.61 Aligned_cols=247 Identities=19% Similarity=0.285 Sum_probs=197.3
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCc-----EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEE-ee
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAY-ET 185 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-~~ 185 (767)
...++++..++-+|.||.||.|.++.... .+-+|.++.. .+.-+...++.|.-.|..+.|||+.++.++. ++
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 34568888999999999999998774332 2333433222 1334566788899999999999999998876 45
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcC-----CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEee
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMG-----GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISD 260 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~-----~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~D 260 (767)
.+..+.++.+++-|+|+.++...+ .....+-.+...++.|+++|++|||++||||.||...|.+||+.-.+||+|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence 567888999999999999998322 233467778889999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCcc---cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhcc-
Q psy11874 261 LGLAVEIPEGESV---RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKED- 335 (767)
Q Consensus 261 FGla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~- 335 (767)
=.|++.+-+.+.. ...-....||+||.+.+..|+.++|+|||||+||||+| |+.|+...+. .++...++++
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP----fEm~~ylkdGy 515 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP----FEMEHYLKDGY 515 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH----HHHHHHHhccc
Confidence 9999876443321 11224678999999999999999999999999999998 9999976654 3444444433
Q ss_pred ccccCCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 336 AEKYSCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 336 ~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
....|-+.++++..+..-|+..+|++||+
T Consensus 516 RlaQP~NCPDeLf~vMacCWallpeeRPs 544 (563)
T KOG1024|consen 516 RLAQPFNCPDELFTVMACCWALLPEERPS 544 (563)
T ss_pred eecCCCCCcHHHHHHHHHHHhcCcccCCC
Confidence 34456789999999999999999999999
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=238.81 Aligned_cols=166 Identities=20% Similarity=0.180 Sum_probs=131.0
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEcc-CCcEEEEEEechhhh--hhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRI--KKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~~AiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+.|++.+.||+|+||+||+|+++. +|..+|+|++..... ........+.+|+++|++++|+|++..+..+ +..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCc
Confidence 4689999999999999999999886 688889998753311 1222355688999999999999998533322 458
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccC-CcceEEeCCCCCEEEeecCcccccC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDC-KPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDL-KPeNILld~~g~vkL~DFGla~~~~ 268 (767)
|+|||||+|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.++|+|||+|+.+.
T Consensus 94 ~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 94 GLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 99999999999962 211 11 1457889999999999999999999 9999999999999999999998664
Q ss_pred CCCc---------ccccccccccCCcceecCC
Q psy11874 269 EGES---------VRGRVGTVGYMAPEVIDNE 291 (767)
Q Consensus 269 ~~~~---------~~~~~GT~~Y~APEvl~~~ 291 (767)
.... ..+.++++.|+|||++...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 4321 2345789999999999543
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-23 Score=224.83 Aligned_cols=245 Identities=21% Similarity=0.248 Sum_probs=189.9
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCC-cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC----CCceeEEEEEE-eeCCe
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATG-KMYACKKLEKKRIKKRKGESMVLIEKQILQKIN----SRFVVSLAYAY-ETKDA 188 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg-~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~----hp~Iv~l~~~~-~~~~~ 188 (767)
.|.+.+.||+|+||.||.|.+..++ +.+|+|......... ...+..|..+|..+. .+++..++... .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998775 689999875542111 114667888888886 36889999888 57888
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC-----CCEEEeecCc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY-----GHVRISDLGL 263 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~-----g~vkL~DFGl 263 (767)
-|+||+.+ |-+|.++..... ...|+...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99999988 689988776654 5689999999999999999999999999999999999999865 3589999999
Q ss_pred cc--ccCCCC--------c-ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh
Q psy11874 264 AV--EIPEGE--------S-VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV 332 (767)
Q Consensus 264 a~--~~~~~~--------~-~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i 332 (767)
|+ ...... . .....||..|+++.+..+...+...|+||++.++.||+.|..||.+........++.+..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 321111 1 123459999999999999999999999999999999999999997765433333332222
Q ss_pred hccccc-cCCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 333 KEDAEK-YSCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 333 ~~~~~~-~~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
...... .....+.+..++...+-..+...+|.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pd 286 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPD 286 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCC
Confidence 211111 22334567777777777778888887
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-24 Score=252.49 Aligned_cols=262 Identities=26% Similarity=0.352 Sum_probs=207.5
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEc-cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALC 190 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~-~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~ 190 (767)
...|.+.+.||+|+|+.|-.+... .+...+|+|.+.... ........+..|..+-..++ |+|++++++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 356888889999999999887764 345667777776553 23334444555777777777 999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHH-HCCcccccCCcceEEeCCCC-CEEEeecCcccccC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH-YIGLVYRDCKPENILLDDYG-HVRISDLGLAVEIP 268 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH-~~~IvHrDLKPeNILld~~g-~vkL~DFGla~~~~ 268 (767)
+++++..||++..-+... .....+...+..+..|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|....
T Consensus 98 ~~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999999998877321 2225777888899999999999999 99999999999999999999 99999999998775
Q ss_pred C-CCc---cccccc-ccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh-hccccccCC
Q psy11874 269 E-GES---VRGRVG-TVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV-KEDAEKYSC 341 (767)
Q Consensus 269 ~-~~~---~~~~~G-T~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i-~~~~~~~~~ 341 (767)
. ... ....+| ++.|+|||...+. ......|+||.|+++.-|++|..|+...........-.... .......+.
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 5 222 345688 9999999999885 45688999999999999999999996654433221111111 111244567
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
.++..+.+++.++|..+|+.|.+ .+++..+||+..
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s-------~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLS-------IEELKLDNWLSS 291 (601)
T ss_pred cCChhhhhcccccccCCchhccc-------cccccccccccc
Confidence 88999999999999999999998 788999999877
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-22 Score=197.39 Aligned_cols=246 Identities=19% Similarity=0.252 Sum_probs=189.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC-CceeEEEEEEeeCCeE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RFVVSLAYAYETKDAL 189 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l 189 (767)
+..+.|++++.||+|+||.+|.|....+|..||+|+-+.+ .....+..|..+.+.+++ ..|..+..+..++.+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 4567899999999999999999999999999999985433 123347779999999987 6788888888889999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC---CCEEEeecCcccc
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY---GHVRISDLGLAVE 266 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~---g~vkL~DFGla~~ 266 (767)
.+|||++ |-+|.+++.-. ...|+...+.-++-|++.-++|+|.++.|||||||+|.|..-+ ..+-|+|||||+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 9999998 67887766543 2379999999999999999999999999999999999998643 3478999999987
Q ss_pred cCCCCc--------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhh---hhhhh-hhhc
Q psy11874 267 IPEGES--------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKR---DEVDR-RVKE 334 (767)
Q Consensus 267 ~~~~~~--------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~---~~i~~-~i~~ 334 (767)
..+..+ -....||..|.+--...+..-+...|+=|+|.+|..+..|..||.+.....+. +.+.+ .+..
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 654322 12347999999988887777889999999999999999999999887654332 22222 1222
Q ss_pred cccccCCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 335 DAEKYSCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 335 ~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
....+-..+|.+..-.+.-|-..--++-|.
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 223334567777666666554443334343
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-22 Score=203.24 Aligned_cols=173 Identities=15% Similarity=0.121 Sum_probs=136.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHH------HHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM------VLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~------~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
.++|++.++||.|+||.||++.. ++..+|+|.+..+.......... +.+|++.+.+++|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47899999999999999999765 47789999997654333333233 57899999999999999998886643
Q ss_pred --------CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEE
Q psy11874 187 --------DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRI 258 (767)
Q Consensus 187 --------~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL 258 (767)
+..+|||||++|.+|.+.. .+++. ...+++.+|..||+.|++|||+||+||+++.+| ++|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 3589999999999997652 23332 356999999999999999999999999999989 999
Q ss_pred eecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHh
Q psy11874 259 SDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310 (767)
Q Consensus 259 ~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEll 310 (767)
+|||.+.......... .++....|+.++|+||||+++.-+.
T Consensus 176 iDfg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 9999887654332211 1344556788999999999876554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=199.32 Aligned_cols=143 Identities=17% Similarity=0.111 Sum_probs=111.4
Q ss_pred EeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhh-----------------------hHHHHHHHHHHHHhcCCCc
Q psy11874 119 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-----------------------GESMVLIEKQILQKINSRF 175 (767)
Q Consensus 119 ~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~-----------------------~~~~~~~E~~iL~~l~hp~ 175 (767)
...||+|+||.||+|... +|+.||+|++......... ......+|..+|.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 8999999999765321111 0123456999999998777
Q ss_pred eeEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHH-HHCCcccccCCcceEEeCCCC
Q psy11874 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL-HYIGLVYRDCKPENILLDDYG 254 (767)
Q Consensus 176 Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yL-H~~~IvHrDLKPeNILld~~g 254 (767)
+...... .... .++||||++|++|...+...+ .+++..+..++.|++.+|.+| |+.||+||||||+|||++ ++
T Consensus 81 v~~p~~~-~~~~-~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 81 IPCPEPI-LLKS-HVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCcEE-EecC-CEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 6433222 2222 389999999988765543322 689999999999999999999 799999999999999998 48
Q ss_pred CEEEeecCcccccC
Q psy11874 255 HVRISDLGLAVEIP 268 (767)
Q Consensus 255 ~vkL~DFGla~~~~ 268 (767)
.++|+|||+|....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=211.05 Aligned_cols=267 Identities=22% Similarity=0.306 Sum_probs=191.8
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCc-----------------------------------EEEEEEechhhhh
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGK-----------------------------------MYACKKLEKKRIK 153 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----------------------------------~~AiK~l~k~~~~ 153 (767)
+.+++++|++...||+|.-..||.|....+|. +.|+|.+-.-...
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 34678999999999999999999998765321 2345543211111
Q ss_pred hhhhHHHHHH----H------------HHH--HHh--------cCCCceeEEEEEEee----------------------
Q psy11874 154 KRKGESMVLI----E------------KQI--LQK--------INSRFVVSLAYAYET---------------------- 185 (767)
Q Consensus 154 ~~~~~~~~~~----E------------~~i--L~~--------l~hp~Iv~l~~~~~~---------------------- 185 (767)
.+...+++ | ... .+. -+|||||++..+|.+
T Consensus 232 --s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 232 --SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred --CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 11111111 1 100 011 269999999988755
Q ss_pred -----CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe--CCCC--CE
Q psy11874 186 -----KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL--DDYG--HV 256 (767)
Q Consensus 186 -----~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl--d~~g--~v 256 (767)
...+|+||.-.+ .+|..++-.+. .+....+-+++|+++|+.|||++||.|||||.+|||+ |+++ .+
T Consensus 310 ~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~L 384 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQL 384 (598)
T ss_pred cccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEE
Confidence 246899999886 58888887653 5667778899999999999999999999999999998 4554 46
Q ss_pred EEeecCcccccCCC-------CcccccccccccCCcceecCCCC------CCCCccccchhhHHHHhcCCCCCCCchhhh
Q psy11874 257 RISDLGLAVEIPEG-------ESVRGRVGTVGYMAPEVIDNEKY------TYSPDWFSFGCLIFEMIEGQAPFRRRKEMV 323 (767)
Q Consensus 257 kL~DFGla~~~~~~-------~~~~~~~GT~~Y~APEvl~~~~y------s~~~DvwSlGviLyElltG~~PF~~~~~~~ 323 (767)
.|+|||++-.-... ......-|.-.-||||+....+- -.++|.|+.|.+.||+++...||+++.++.
T Consensus 385 VvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~ 464 (598)
T KOG4158|consen 385 VVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML 464 (598)
T ss_pred EEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe
Confidence 88999987532221 11223457888999999864331 257899999999999999999999866532
Q ss_pred hhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 324 KRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 324 ~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
.. ....-....+..++.+++.+++++..+|+.||++|++-. -|..+++--.|..-+|-.
T Consensus 465 L~--~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~----iAANvl~LsLw~~~~~vk 523 (598)
T KOG4158|consen 465 LD--TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN----IAANVLNLSLWRMGEDVK 523 (598)
T ss_pred ec--hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc----HHHhHHHHHHhcCchHHH
Confidence 21 111223445677889999999999999999999999943 478888888777777743
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=207.97 Aligned_cols=237 Identities=24% Similarity=0.324 Sum_probs=153.8
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC-----------CceeEEEEE-
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-----------RFVVSLAYA- 182 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-----------p~Iv~l~~~- 182 (767)
.+...+.||.|++|.||.+++..||+.+|+|+............+.+.+|.-....+.+ .+++.+--.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45678999999999999999999999999999865543344445555555544444322 233332111
Q ss_pred -------EeeCC--------eEEEEEEeccCCCHHHHHHh---cCCC-CCCCHHHHHHHHHHHHhHHHHHHHCCcccccC
Q psy11874 183 -------YETKD--------ALCLVLTIMNGGDLKFHIYN---MGGE-PGFDIARARFYAAEVLCGLEHLHYIGLVYRDC 243 (767)
Q Consensus 183 -------~~~~~--------~l~lV~E~~~gG~L~~~l~~---~~~~-~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDL 243 (767)
+.... +.+++|+-+. +||...+.- .... ..+.......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11111 3478888885 788877553 2211 11222333455689999999999999999999
Q ss_pred CcceEEeCCCCCEEEeecCcccccCCCCcccccccccccCCcceecC--------CCCCCCCccccchhhHHHHhcCCCC
Q psy11874 244 KPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN--------EKYTYSPDWFSFGCLIFEMIEGQAP 315 (767)
Q Consensus 244 KPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~--------~~ys~~~DvwSlGviLyElltG~~P 315 (767)
||+|++++.+|.+.|+||+....... .......+..|.+||.... -.++.+.|.|+||+++|.|.+|..|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 99999999999999999998776533 2222455688999998743 2478899999999999999999999
Q ss_pred CCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCcc
Q psy11874 316 FRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSR 362 (767)
Q Consensus 316 F~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~R 362 (767)
|........... ....-..+++..++||.+||+.||.+|
T Consensus 250 f~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 976543222211 111122688999999999999999988
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=202.14 Aligned_cols=201 Identities=21% Similarity=0.312 Sum_probs=171.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lV 192 (767)
-.|++.+.||.|+||+.+.|...-++..||||.-..+. ..-.+..|.+..+.|. .+.|...|++.+.+.+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 47999999999999999999999999999999753321 2234666888888875 48999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-----CEEEeecCccccc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-----HVRISDLGLAVEI 267 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-----~vkL~DFGla~~~ 267 (767)
||++ |-+|.++..-.+ ..|+...+..+|.|++.-++|+|++..|+|||||+|+||...| .|.|+|||+|+..
T Consensus 103 idLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 9998 678887776554 3799999999999999999999999999999999999997544 4899999999987
Q ss_pred CCCCc--------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhh
Q psy11874 268 PEGES--------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322 (767)
Q Consensus 268 ~~~~~--------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~ 322 (767)
.+..+ ..+..||..||+-....+..-+..-|+=|||-++...|.|..||.+.+..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 65443 23456999999999988999999999999999999999999999877543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=193.91 Aligned_cols=189 Identities=16% Similarity=0.151 Sum_probs=144.3
Q ss_pred EEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh-hhHHHHHHHHHHHHhcCC-CceeEEEEEEeeCCeEEEEEE
Q psy11874 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-KGESMVLIEKQILQKINS-RFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 117 ~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~-~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l~lV~E 194 (767)
.+...|++|+||+|+.+.. .+..++.+.+.-...... -....+.+|+++|+++.| +++++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4568899999999997765 577888777755433222 122357899999999954 789998875 45799999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccC-CcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDC-KPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDL-KPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
|+.|.+|...+.. . ...++.|++.+|+++|++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 79 YLAGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eecCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9999998643211 1 1346789999999999999999999 799999999999999999999865543310
Q ss_pred --------------cccccccccCCcceecCC-CCC-CCCccccchhhHHHHhcCCCCCCCchh
Q psy11874 274 --------------RGRVGTVGYMAPEVIDNE-KYT-YSPDWFSFGCLIFEMIEGQAPFRRRKE 321 (767)
Q Consensus 274 --------------~~~~GT~~Y~APEvl~~~-~ys-~~~DvwSlGviLyElltG~~PF~~~~~ 321 (767)
.-...++.|++|+.-.-. ..+ ...+|++.|+-+|.++|+..|+.+.++
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 112368889999865322 233 667999999999999999999877654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.5e-21 Score=191.68 Aligned_cols=144 Identities=19% Similarity=0.119 Sum_probs=113.0
Q ss_pred EeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhh-----------------------hHHHHHHHHHHHHhcCCCc
Q psy11874 119 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-----------------------GESMVLIEKQILQKINSRF 175 (767)
Q Consensus 119 ~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~-----------------------~~~~~~~E~~iL~~l~hp~ 175 (767)
.+.||+|+||.||+|.+. +|+.||+|++......... ......+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999998765211000 0123457999999999988
Q ss_pred eeEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCC
Q psy11874 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYG 254 (767)
Q Consensus 176 Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g 254 (767)
+.....+.... .||||||++|+++........ .++...+..++.|++.+|.+||+ .||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~---~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV---PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhc---cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 75443333222 489999999986544322222 57888999999999999999999 9999999999999999 89
Q ss_pred CEEEeecCcccccCC
Q psy11874 255 HVRISDLGLAVEIPE 269 (767)
Q Consensus 255 ~vkL~DFGla~~~~~ 269 (767)
.++|+|||+|.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=207.38 Aligned_cols=109 Identities=31% Similarity=0.464 Sum_probs=102.8
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
..+.+||+++++||+|+||+|++|+++.|++.||||+|+|+.+...+.++++.+|..||..++|||||+|+++|||.++|
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
|||+||+.||+|+.+|++.+.+.+..++-
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arf 129 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARF 129 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHH
Confidence 99999999999999999998877664443
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-21 Score=198.30 Aligned_cols=108 Identities=23% Similarity=0.355 Sum_probs=102.8
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
.+++||+++++||.||||+|.+|+++.+|..||||+++|.++.+.++++|+.+|++||+.+.|||+|+|+++|++.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 67889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
|||||++||+|++++++.+++.++-++-
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arF 148 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARF 148 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHH
Confidence 9999999999999999988877765544
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.3e-22 Score=229.47 Aligned_cols=286 Identities=25% Similarity=0.360 Sum_probs=235.5
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
..+.+.+.+.+-+-+|++|.++.+.-..+|...+.|...+.........+.+..+..++-..++|.++.....+.....+
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 45678899999999999999999999889988888887665554555556666677777777889999888878888899
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
+||++|.+||+|...+++.+ ..+.+-++.++..+..++++||+..++|||++|.|+|...+|+.+++|||+......
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999999999888765 688888999999999999999999999999999999999999999999984422100
Q ss_pred ---------------------CC-----------cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCC
Q psy11874 270 ---------------------GE-----------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317 (767)
Q Consensus 270 ---------------------~~-----------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~ 317 (767)
.. ......||+.|.|||.+.+......+|||++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 00 0112369999999999999999999999999999999999999998
Q ss_pred CchhhhhhhhhhhhhhccccccC---CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCC
Q psy11874 318 RRKEMVKRDEVDRRVKEDAEKYS---CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLC 394 (767)
Q Consensus 318 ~~~~~~~~~~i~~~i~~~~~~~~---~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~ 394 (767)
.... +.+.+.+......++ ...+..+++++..+|..+|.+|++.. ++.+++.||||+.++|+.|..+.
T Consensus 1037 a~tp----q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~----~~~e~k~~~~~~~~~~~~l~~q~- 1107 (1205)
T KOG0606|consen 1037 AETP----QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK----GAAEVKGHPFFQDVDWENLALQK- 1107 (1205)
T ss_pred Ccch----hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc----cccccccCCccCCCCcccccccc-
Confidence 7644 445555555555544 46799999999999999999999954 47899999999999999998765
Q ss_pred CCCCCCCCCchhHH
Q psy11874 395 DPPFVPDVKRDEVD 408 (767)
Q Consensus 395 ~pp~~P~~~~~~~~ 408 (767)
.+|+|.....+..
T Consensus 1108 -~~~~p~~~s~~dt 1120 (1205)
T KOG0606|consen 1108 -AEFVPQPESTQDT 1120 (1205)
T ss_pred -CccCCCCCCCCcc
Confidence 4577775543333
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-21 Score=227.22 Aligned_cols=240 Identities=21% Similarity=0.282 Sum_probs=183.6
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhh-hhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-IKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~-~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++...+.||++.|=+|.+|+++. |. +++|++-+.. ..........+.|++ ....++||++.+.-+-.+....|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 67788999999999999999863 44 8999986543 222233333444555 66779999999988888888999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc--cCCCC
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE--IPEGE 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~--~~~~~ 271 (767)
+|.. -+|.+.|..+ +-+...+-+.|+.|++.||..+|..||+|+|||.|||||..-+.+.|+||..-+. ++++.
T Consensus 101 qyvk-hnLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHh-hhhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9997 5788888654 4678888999999999999999999999999999999999999999999987643 33332
Q ss_pred c------ccccccccccCCcceecCC----------C-CCCCCccccchhhHHHHhc-CCCCCCCc-------hhhhhhh
Q psy11874 272 S------VRGRVGTVGYMAPEVIDNE----------K-YTYSPDWFSFGCLIFEMIE-GQAPFRRR-------KEMVKRD 326 (767)
Q Consensus 272 ~------~~~~~GT~~Y~APEvl~~~----------~-ys~~~DvwSlGviLyEllt-G~~PF~~~-------~~~~~~~ 326 (767)
. ..+...-..|+|||.+... . .+++-||||+||++.||++ |++||.-. ......+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e 256 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPE 256 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHH
Confidence 2 1222344689999998431 1 5678899999999999987 89999321 1112222
Q ss_pred hhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 327 EVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 327 ~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.+.+.| -+..++.+|..|++.||++|++ |++.|+.
T Consensus 257 ~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlS-------AedyL~~ 291 (1431)
T KOG1240|consen 257 QLLEKI----------EDVSLRNLILSMIQRDPSKRLS-------AEDYLQK 291 (1431)
T ss_pred HHHHhC----------cCccHHHHHHHHHccCchhccC-------HHHHHHh
Confidence 222222 1347999999999999999999 9998886
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.8e-21 Score=208.15 Aligned_cols=109 Identities=28% Similarity=0.451 Sum_probs=102.9
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
+++++||+++++||+|+||.||+|+.+.||..||||+++|..+...+++++++.|..||...++|+||+||++||+.++|
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
||||||++|||+.++|.+.+.+.+..++-
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arf 245 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARF 245 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHH
Confidence 99999999999999999888776665544
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-20 Score=198.21 Aligned_cols=113 Identities=20% Similarity=0.217 Sum_probs=105.4
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
..++|++.+.||+|+||+||+++|+.++..+|||.|.+.++ ..+.++.+..|+.||+.++|||||+|+++.++++.+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 46799999999999999999999999999999999999875 66778899999999999999999999999999999999
Q ss_pred EEeccCCccccccccccCCCChhhhHHHHHHhhh
Q psy11874 730 VLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVAA 763 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a~ 763 (767)
|||||+||||.++|++++...+...+.-+.++|+
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~ 120 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLAS 120 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHH
Confidence 9999999999999999998888888887777765
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=193.79 Aligned_cols=117 Identities=32% Similarity=0.502 Sum_probs=106.5
Q ss_pred CCCCCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe
Q psy11874 644 CFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 723 (767)
Q Consensus 644 ~f~~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~ 723 (767)
....+++++||+++++||+|+||+|.+|+.|.||+.||||+++|+-+..+..+.+.+.|-++|+..+|||+..|.++||+
T Consensus 160 ~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 160 KRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 34457899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCEEEEEEeccCCccccccccccCCCChh---hhHHHHHH
Q psy11874 724 KDALCLVLTIIDVMFTCVQPSETNPCCFP---FRRKEVVV 760 (767)
Q Consensus 724 ~~~lylVmEy~~gG~L~~~l~~~~~~~~~---~~~~~v~~ 760 (767)
++++|+||||++||+|+.+|.+.+.+.++ ++-++|+.
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvs 279 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVS 279 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHH
Confidence 99999999999999999999887766554 44445543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=181.55 Aligned_cols=135 Identities=15% Similarity=0.041 Sum_probs=107.8
Q ss_pred EEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-----CCCceeEEEEEEeeCC---eE
Q psy11874 118 MYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-----NSRFVVSLAYAYETKD---AL 189 (767)
Q Consensus 118 ~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~~~---~l 189 (767)
-.+.||+|+||.||. +..++.. +||++.... ......+.+|+.+++.+ +||||++++++++++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999995 7666665 699886542 22345689999999999 6799999999999974 43
Q ss_pred E-EEEEe--ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHH-HHHHHCCcccccCCcceEEeCC----CCCEEEeec
Q psy11874 190 C-LVLTI--MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL-EHLHYIGLVYRDCKPENILLDD----YGHVRISDL 261 (767)
Q Consensus 190 ~-lV~E~--~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL-~yLH~~~IvHrDLKPeNILld~----~g~vkL~DF 261 (767)
+ +|||| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 4 78999 5689999999653 36655 35678888888 9999999999999999999974 347999995
Q ss_pred Ccc
Q psy11874 262 GLA 264 (767)
Q Consensus 262 Gla 264 (767)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-19 Score=213.07 Aligned_cols=194 Identities=23% Similarity=0.356 Sum_probs=159.7
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC---CCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN---SRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~~ 187 (767)
+....|.+-+.||+|+||+||.|.... |+.+|+|+-.... ...+..=.+++.+|+ -+-|..+..++.-.+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~------~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN------PWEFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC------ceeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 445679999999999999999999986 9999999854432 112222334555555 134555566666677
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC-------CCCCEEEee
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD-------DYGHVRISD 260 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld-------~~g~vkL~D 260 (767)
.-+||+||.+.|+|.+++.. ...+++..+.+++.|++.-+++||..+|||+||||+|.||. +.--++|+|
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred cceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 88999999999999998874 34799999999999999999999999999999999999994 233589999
Q ss_pred cCcccc---cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCC
Q psy11874 261 LGLAVE---IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQA 314 (767)
Q Consensus 261 FGla~~---~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~ 314 (767)
||.|.. ++++......++|-.+-.+|+..|..+++.+|.|.|..++|-||.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999954 456666777889999999999999999999999999999999999974
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=181.17 Aligned_cols=146 Identities=20% Similarity=0.130 Sum_probs=113.7
Q ss_pred CeEEEeEEeecCcEEEEEEE-EccCCcEEEEEEechhhhhhh-----------------h----hHHHHHHHHHHHHhcC
Q psy11874 115 TFRMYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKKRIKKR-----------------K----GESMVLIEKQILQKIN 172 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~-~~~tg~~~AiK~l~k~~~~~~-----------------~----~~~~~~~E~~iL~~l~ 172 (767)
.|.+.+.||+|+||.||+|. +..+|+.||+|++........ . ....+.+|..++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 667899999999875421100 0 1123568999999997
Q ss_pred CCc--eeEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC-cccccCCcceEE
Q psy11874 173 SRF--VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG-LVYRDCKPENIL 249 (767)
Q Consensus 173 hp~--Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~-IvHrDLKPeNIL 249 (767)
+.. +.+.+.. . ..++||||++|++|....... ..++...+..++.||+.+|.+||+.| |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 632 3344432 2 358999999998886554332 24666777899999999999999999 999999999999
Q ss_pred eCCCCCEEEeecCcccccC
Q psy11874 250 LDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 250 ld~~g~vkL~DFGla~~~~ 268 (767)
++ ++.++|+|||.|....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 8899999999987543
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-18 Score=201.60 Aligned_cols=203 Identities=19% Similarity=0.182 Sum_probs=151.9
Q ss_pred HHHHHHHHHHHHhcCCCceeEEEEEEeeCCe----EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHH
Q psy11874 158 ESMVLIEKQILQKINSRFVVSLAYAYETKDA----LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233 (767)
Q Consensus 158 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~----l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yL 233 (767)
......|...+.++.|+|++.++.+-..+.. +.+..+++++-++..+++..+ ..+.+.++.+..++++||.|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHH
Confidence 3445668888999999999998877644322 334457889999999998876 688999999999999999999
Q ss_pred HHCCcccccCCcc---eEEeCCCCCEEEe--ecCcccccCCCCcccccccccccCCcceecCCCCCCC--CccccchhhH
Q psy11874 234 HYIGLVYRDCKPE---NILLDDYGHVRIS--DLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYS--PDWFSFGCLI 306 (767)
Q Consensus 234 H~~~IvHrDLKPe---NILld~~g~vkL~--DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~--~DvwSlGviL 306 (767)
|+....|.-|... +--.+..+.+.++ ||+.+...++........-+..+.|||......+..+ .|+|.+|.++
T Consensus 303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 9997666665555 4445677778877 9999988877665555566778889999877766655 6999999999
Q ss_pred HHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 307 FEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 307 yElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
..+..|..+-... ..... -.+........+...+|+.-++++|++ +.+++.|||.+.
T Consensus 383 ~~~~~~~~i~~~~-------~~~~~------~l~~~~~~~~~d~~~~~~~~~~~~Rl~-------~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 383 LQLSQGEDISEKS-------AVPVS------LLDVLSTSELLDALPKCLDEDSEERLS-------ALELLTHPFLRF 439 (1351)
T ss_pred hhhhhcCcccccc-------cchhh------hhccccchhhhhhhhhhcchhhhhccc-------hhhhhhchhccc
Confidence 9999877543111 00000 111112226788899999999999998 999999999764
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.9e-19 Score=180.06 Aligned_cols=243 Identities=18% Similarity=0.226 Sum_probs=192.7
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++..++.+|...-.|+.|+|++. |.-++.|+++......+. ...+..|.-.|+-+.||||+.+.+++....++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~ri-srdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARI-SRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchhh-cchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 44556667788889999999999996 556777887665554433 234666888888899999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC--cccccCCcceEEeCCCCCEEEe--ecCcccc
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLDDYGHVRIS--DLGLAVE 266 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~--IvHrDLKPeNILld~~g~vkL~--DFGla~~ 266 (767)
++..||+-|+|...+.... ....+-.++..++.+|+.|+.|||+.. |----|....+++|++-+.+|+ |--++.+
T Consensus 264 ~isq~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred EeeeeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence 9999999999999998754 345788899999999999999999874 4445788999999999888775 3333222
Q ss_pred cCCCCcccccccccccCCcceecCCCCC---CCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYT---YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys---~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
..++.-.|.||+||.+...+-+ .++|+|||.+++|||.|...||.....++.-..+ ....-....|+.+
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki--aleglrv~ippgi 414 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI--ALEGLRVHIPPGI 414 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh--hhccccccCCCCc
Confidence 1234457999999999876543 6789999999999999999999876654333222 2334456788999
Q ss_pred cHHHHHHHHHhcccCcCccCCC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGC 365 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~ 365 (767)
|.....|++-|+..||.+||.+
T Consensus 415 s~hm~klm~icmnedpgkrpkf 436 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKF 436 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCc
Confidence 9999999999999999999983
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-18 Score=192.42 Aligned_cols=113 Identities=31% Similarity=0.490 Sum_probs=100.4
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCC
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 725 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~ 725 (767)
.++++++|.++++||+|+||+|+++..+.|++.||||+++|..+..++.++.++.|.+|+..+ +|||+++||.+|||.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 578999999999999999999999999999999999999999999999999999999999988 5999999999999999
Q ss_pred EEEEEEeccCCccccccccccCCCChh---hhHHHHHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFP---FRRKEVVV 760 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~---~~~~~v~~ 760 (767)
++|+||||+.|||+ .++++.+.+.++ ++.++|++
T Consensus 443 ~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l 479 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVL 479 (694)
T ss_pred eEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHH
Confidence 99999999999994 555555655554 44445544
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.5e-18 Score=182.32 Aligned_cols=111 Identities=20% Similarity=0.185 Sum_probs=96.2
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchh----hHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK----GESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~----~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
-+.|.+.+.||+|+||.|.+|.++.||+.||||+|.+.+..... ....+.+|++||++|+|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35689999999999999999999999999999999998754322 33457899999999999999999999999999
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
.||||||++||+|++++...+...+...+....++
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Ql 285 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQL 285 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHH
Confidence 99999999999999999988876666666554443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=168.43 Aligned_cols=137 Identities=21% Similarity=0.247 Sum_probs=114.1
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhh-----hhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
+.||+|++|.||+|.. +|..+++|+....... .......+.+|..++..+.|++++....++.+.+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 6788999986543221 11123457789999999999988777767777788999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
|++|++|...+.... . ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998886532 1 7788999999999999999999999999999999 78999999999865
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-18 Score=183.01 Aligned_cols=102 Identities=24% Similarity=0.362 Sum_probs=97.3
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
..+.+++|++++.||.|.-|+||||+.+.++..+|||+|+|+.+..++...++..|..||+.++|||++.||..|++++.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 46889999999999999999999999999999999999999998888889999999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccccCC
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNP 748 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~ 748 (767)
+|+|||||+||||+.+.+++..
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~ 173 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPG 173 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCC
Confidence 9999999999999999887754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.5e-17 Score=166.95 Aligned_cols=141 Identities=18% Similarity=0.080 Sum_probs=109.7
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh-------------------hhHHHHHHHHHHHHhcCCC-
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-------------------KGESMVLIEKQILQKINSR- 174 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~-------------------~~~~~~~~E~~iL~~l~hp- 174 (767)
.|.+.+.||+|+||.||+|... +|+.+|+|++........ ........|..++.++.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3778899999999999999875 899999998764321000 0112367789999999887
Q ss_pred -ceeEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC
Q psy11874 175 -FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY 253 (767)
Q Consensus 175 -~Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~ 253 (767)
.++..+. ....++||||++|++|...... .....++.+++.++.++|+.||+||||||+||+++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC
Confidence 4444443 2346999999999998654321 3456788999999999999999999999999999999
Q ss_pred CCEEEeecCcccccCC
Q psy11874 254 GHVRISDLGLAVEIPE 269 (767)
Q Consensus 254 g~vkL~DFGla~~~~~ 269 (767)
+.++|+|||++.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-18 Score=182.57 Aligned_cols=112 Identities=20% Similarity=0.259 Sum_probs=106.3
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
..|++.+.||+|+||+|.+|.+...|+.||+|.|+|.++.++.+.-++.|||+||..|+|||||.+|++|++.+++.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 57999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHHhhh
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVVVAA 763 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~~a~ 763 (767)
||+.||+|+++|..++.+.+.+++..+.++..
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvS 164 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVS 164 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHH
Confidence 99999999999999999999999887776543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.8e-17 Score=164.37 Aligned_cols=133 Identities=20% Similarity=0.151 Sum_probs=106.6
Q ss_pred EEeecCcEEEEEEEEccCCcEEEEEEechhhhh-----hhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEe
Q psy11874 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 121 ~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
.||+|+||.||+|.. +|..+++|........ .......+.+|.+++..+.|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 5789999986543211 112235677899999999987655444445566678999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
++|++|...+.... . .++.+++.+|.+||+.|++|||++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988775421 1 7889999999999999999999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.2e-18 Score=189.96 Aligned_cols=179 Identities=23% Similarity=0.341 Sum_probs=140.1
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
.++|+.|++|.-++|.++|.+.......++.....++.|+..|++| ++.+|||+||.||++..++.+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 4689999999999999999865555567888899999999999999 9999999999999999999999999999987
Q ss_pred cCCCC-------cccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccc
Q psy11874 267 IPEGE-------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEK 338 (767)
Q Consensus 267 ~~~~~-------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~ 338 (767)
..... ..+..+||..||+||.+.+..|+.++|+||||+||+|++. =..+|.... ....+..++.. +.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~r~g~ip--~~ 480 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---TLTDIRDGIIP--PE 480 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhhhcCCCC--hH
Confidence 76655 3455689999999999999999999999999999999996 333432211 11222222111 01
Q ss_pred cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 339 ~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
+... .+...+||.+||.+.|.+||+ +.+.--|+|.
T Consensus 481 ~~~d-~p~e~~ll~~lls~~p~~RP~-------~~~~~~~~~~ 515 (516)
T KOG1033|consen 481 FLQD-YPEEYTLLQQLLSPSPEERPS-------AIEVALHEFL 515 (516)
T ss_pred Hhhc-CcHHHHHHHHhcCCCcccCch-------HHHHhhhhhc
Confidence 1111 246678999999999999997 5566556553
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=3e-17 Score=183.08 Aligned_cols=111 Identities=25% Similarity=0.295 Sum_probs=105.5
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
..|+..+.||+|+|+.||.+++..||+.||+|+|.|..+.+..+++.+.+||+|.++|+|||||++|++|+|.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
|+|+.|+|..++++++...|++++..+.+++
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv 128 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIV 128 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHH
Confidence 9999999999999999999999998666543
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.1e-17 Score=181.67 Aligned_cols=109 Identities=26% Similarity=0.301 Sum_probs=102.3
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDA 726 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~ 726 (767)
+.+..||.+++.||+|+|++|++|+++.|++.||+|++.|..+..++.+.-+.+|..+|.+| .||.||+||..|||+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 67789999999999999999999999999999999999999999999999999999999999 89999999999999999
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
||+|||||++|||+++|++.|.+.+..++.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~ 178 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARF 178 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHH
Confidence 999999999999999999998866554443
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.3e-18 Score=168.17 Aligned_cols=117 Identities=20% Similarity=0.148 Sum_probs=108.0
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
...+++||++.+.||+|-||.||+++.++++-.+|+|++-|+.+...+..+++.||++|-..|+||||.++|++|.+..+
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 35778999999999999999999999999999999999999988777777889999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccc--ccCCCChhhhHHHHHHhhh
Q psy11874 727 LCLVLTIIDVMFTCVQPS--ETNPCCFPFRRKEVVVVAA 763 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~--~~~~~~~~~~~~~v~~~a~ 763 (767)
+|++|||+.+|+|+..|+ +.+.+.++.++.-+.++|.
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~ 135 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLAN 135 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHH
Confidence 999999999999999998 6677888888887777663
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=185.55 Aligned_cols=139 Identities=17% Similarity=0.138 Sum_probs=111.7
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhh-----hhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-----IKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~-----~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.|...+.||+|+||+||+|.+.. ..+++|+...+. .........+.+|.+++++++|++++....+..+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44667999999999999998753 344444432211 11122345678999999999999998887777777788
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
++||||++|++|..++. ....++.+++.+|.+||+.||+||||||+|||+ +++.++|+|||+|+..
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999988775 245688999999999999999999999999999 6789999999999754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=160.08 Aligned_cols=140 Identities=23% Similarity=0.199 Sum_probs=102.2
Q ss_pred EeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHH---------------------HHHHHHHHHHhcCCCc--
Q psy11874 119 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES---------------------MVLIEKQILQKINSRF-- 175 (767)
Q Consensus 119 ~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~---------------------~~~~E~~iL~~l~hp~-- 175 (767)
.+.||+|+||.||+|.+. +|+.||+|++............ ....|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 8999999998654322111111 1245677777765543
Q ss_pred eeEEEEEEeeCCeEEEEEEeccCCCHHHH-HHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCC
Q psy11874 176 VVSLAYAYETKDALCLVLTIMNGGDLKFH-IYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDY 253 (767)
Q Consensus 176 Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~-l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~ 253 (767)
+.+.++. ...++||||++|+.+... +.... .. ..+..++.+++.++.++|+ .+|+||||||+||+++ +
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence 4444432 236999999999654322 22111 11 6678899999999999999 9999999999999999 8
Q ss_pred CCEEEeecCcccccCC
Q psy11874 254 GHVRISDLGLAVEIPE 269 (767)
Q Consensus 254 g~vkL~DFGla~~~~~ 269 (767)
+.++|+|||.|.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 9999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.6e-18 Score=171.95 Aligned_cols=115 Identities=20% Similarity=0.238 Sum_probs=97.6
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeE-EEEeCC
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY-AYETKD 725 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~-~f~~~~ 725 (767)
.+.++.+|++++.||+|+||.||+|++..+|+.+|.|.|+-. ..+.+..+.+..|+.||++|+|||||++|+ .|..++
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 456788999999999999999999999999999999999954 467788899999999999999999999998 777666
Q ss_pred E-EEEEEeccCCccccccccccC----CCChhhhHHHHHHhh
Q psy11874 726 A-LCLVLTIIDVMFTCVQPSETN----PCCFPFRRKEVVVVA 762 (767)
Q Consensus 726 ~-lylVmEy~~gG~L~~~l~~~~----~~~~~~~~~~v~~~a 762 (767)
. ++||||||++|||...|++.+ .++++.-+..+++++
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~ 134 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLC 134 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHH
Confidence 5 999999999999999997654 345555555444443
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.5e-16 Score=164.54 Aligned_cols=107 Identities=21% Similarity=0.235 Sum_probs=95.8
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE-
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA- 726 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~- 726 (767)
.+++++.+.++.||+|+.|+|++|+|+.|++.||+|+|... .+....+++.+|++|++.++|||||++|++|.++..
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 46677999999999999999999999999999999999554 466778899999999999999999999999999995
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
++|+||||+||+|.+.++..++..|+.-..
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ 182 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGK 182 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHH
Confidence 999999999999999998877766655443
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.5e-17 Score=193.14 Aligned_cols=108 Identities=28% Similarity=0.377 Sum_probs=100.0
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..+||+++++||+|+||.|.+|+++.|++.||||+++|..+.++.....+..|..||...+.+.||.||++|||+++|
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 36678999999999999999999999999999999999999988888889999999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRR 755 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~ 755 (767)
|+||||++||||.++|.+....++..++
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~Ar 178 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWAR 178 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHH
Confidence 9999999999999999888865655443
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-15 Score=170.59 Aligned_cols=195 Identities=20% Similarity=0.267 Sum_probs=156.1
Q ss_pred HHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCc-ccccCCcc
Q psy11874 168 LQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL-VYRDCKPE 246 (767)
Q Consensus 168 L~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~I-vHrDLKPe 246 (767)
|+.+.|.|+.++++.+.+....+.|.+||..|+|.+.+.+. ...+++--...++++|+.||.|||...| .|+-|++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 45789999999999999999999999999999999999883 3467888888899999999999998766 99999999
Q ss_pred eEEeCCCCCEEEeecCcccccCCC---CcccccccccccCCcceecCCC-------CCCCCccccchhhHHHHhcCCCCC
Q psy11874 247 NILLDDYGHVRISDLGLAVEIPEG---ESVRGRVGTVGYMAPEVIDNEK-------YTYSPDWFSFGCLIFEMIEGQAPF 316 (767)
Q Consensus 247 NILld~~g~vkL~DFGla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~-------ys~~~DvwSlGviLyElltG~~PF 316 (767)
|.++|..-.+||+|||+....... .......-..-|.|||.+.+.. .+.+.|+||+|+++||+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998765321 1111122345689999997631 467799999999999999999999
Q ss_pred CCchhhhhhhhhhhhhhc-cccccCC------CCcHHHHHHHHHhcccCcCccCC
Q psy11874 317 RRRKEMVKRDEVDRRVKE-DAEKYSC------RFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 317 ~~~~~~~~~~~i~~~i~~-~~~~~~~------~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
..........++..++.. ....+.+ .+.+++..+++.|+..+|.+||+
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs 213 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPS 213 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCcc
Confidence 876554444555555554 2222211 34567999999999999999999
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.62 E-value=2e-16 Score=175.31 Aligned_cols=115 Identities=25% Similarity=0.338 Sum_probs=106.0
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
++.-.-|..++.||-|+||+|+||+...|...||||.+.|..+..++++.++..|..||...+.+.||+||++|+|.+.|
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 45556799999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
||||||++|||+.++|-+.+.+.|..++.-|+.++
T Consensus 705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAElt 739 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELT 739 (1034)
T ss_pred EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHH
Confidence 99999999999999999999988887776655443
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.7e-15 Score=167.87 Aligned_cols=115 Identities=19% Similarity=0.249 Sum_probs=102.0
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccch--hhHHHHHHHHHHHhhCC-CCceeeeeEEEEeCC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGESMVLIEKQILQKIN-SRFVVSLAYAYETKD 725 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~--~~~~~~~~Ei~IL~~l~-HpnIV~l~~~f~~~~ 725 (767)
...+.|++.+.||+|+||+|+++++..||..+|+|+++++..... ...+.+.+|+.+|+.+. ||||+++++++.+..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 567799999999999999999999999999999999988743322 35567889999999998 999999999999999
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHHhhh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVAA 763 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a~ 763 (767)
.+|+|||||.||+|+++|...++..+..++..+.+++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlis 131 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLIS 131 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHH
Confidence 99999999999999999998888888888877776653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.4e-15 Score=153.51 Aligned_cols=138 Identities=17% Similarity=0.186 Sum_probs=105.0
Q ss_pred eEEe-ecCcEEEEEEEEccCCcEEEEEEechhhhh----h------hhhHHHHHHHHHHHHhcCCCce--eEEEEEEeeC
Q psy11874 120 RVLG-KGGFGEVCACQVRATGKMYACKKLEKKRIK----K------RKGESMVLIEKQILQKINSRFV--VSLAYAYETK 186 (767)
Q Consensus 120 ~~LG-~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~----~------~~~~~~~~~E~~iL~~l~hp~I--v~l~~~~~~~ 186 (767)
.+|| .||.|+||.+... +..+++|.+....+. . ......+.+|..++.++.|++| +..+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 5677 7888889888764 788999988643221 1 1223467889999999998774 5666554332
Q ss_pred C----eEEEEEEeccC-CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeec
Q psy11874 187 D----ALCLVLTIMNG-GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDL 261 (767)
Q Consensus 187 ~----~l~lV~E~~~g-G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DF 261 (767)
. ..++|||+++| .+|..++... .+++.. +.+|+.+|.+||+.||+||||||+|||++.++.++|+||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 2 23599999998 6898877542 355543 568999999999999999999999999999999999999
Q ss_pred Cccccc
Q psy11874 262 GLAVEI 267 (767)
Q Consensus 262 Gla~~~ 267 (767)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 988653
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.8e-16 Score=172.54 Aligned_cols=113 Identities=21% Similarity=0.140 Sum_probs=103.5
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
-.++-|++++.||+|+-|.|.+|+|..||+.+|||+|.+..-........+.+||-||+.+.||||++||++|++..++|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 45678999999999999999999999999999999999984345566778999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
+|+||++||+||++|.++|++.++++..-++++
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QI 121 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQI 121 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHH
Confidence 999999999999999999999999988866654
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.3e-15 Score=166.94 Aligned_cols=110 Identities=25% Similarity=0.359 Sum_probs=98.1
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC-CCceeeeeEEEEeCCEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~-HpnIV~l~~~f~~~~~lylV 730 (767)
..|++.+.||+|+||.||+|+++.||+.||+|+|.|..+......+.+.+|+.||+++. |||||.++++|++.+.+|+|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 46999999999999999999999999999999999988766667789999999999998 99999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
||+|+||+|++.|.+. ...+..+...+.+++
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il 145 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQIL 145 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHH
Confidence 9999999999999776 356666666555443
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.3e-16 Score=166.42 Aligned_cols=116 Identities=26% Similarity=0.370 Sum_probs=105.3
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDA 726 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~ 726 (767)
.+...||.++.+||+||||+|.++..+.|.+.||+|+++|.-+.....++..+.|.+||... +-||+|.||.+|||-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 57788999999999999999999999999999999999999999999999999999999877 78899999999999999
Q ss_pred EEEEEeccCCccccccccccCCCChh---hhHHHHHHhhh
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFP---FRRKEVVVVAA 763 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~---~~~~~v~~~a~ 763 (767)
||+|||||.||||.-+|++.|.+-++ +++++|+.-+.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLF 464 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLF 464 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhh
Confidence 99999999999999999988876665 55666665443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.1e-15 Score=140.98 Aligned_cols=132 Identities=22% Similarity=0.130 Sum_probs=111.8
Q ss_pred EEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC--CceeEEEEEEeeCCeEEEEEEe
Q psy11874 118 MYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS--RFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 118 ~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
+.+.||+|+++.||++... ++.+++|....... ...+..|..+++.+.+ .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999985 47899999765422 3467889999999977 5899999888888899999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC---CcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI---GLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~---~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
++|+.+... +......++.+++.+|..||.. +++|+|++|+||+++..+.++++|||++..
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877532 4456677889999999999985 699999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.6e-15 Score=168.21 Aligned_cols=101 Identities=16% Similarity=0.194 Sum_probs=88.9
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCc---E-EEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGK---M-YACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 723 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~---~-~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~ 723 (767)
.+..++-.+.+.||+|+||.|++++.+..+. . ||+|.++.+....+.++..+++|.+||++++|||||++|++...
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 4667778888999999999999998876532 3 89999986443567788999999999999999999999999999
Q ss_pred CCEEEEEEeccCCccccccccccCC
Q psy11874 724 KDALCLVLTIIDVMFTCVQPSETNP 748 (767)
Q Consensus 724 ~~~lylVmEy~~gG~L~~~l~~~~~ 748 (767)
...+|||||+|+||+|.++|++.+.
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~ 257 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK 257 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC
Confidence 9999999999999999999988765
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.3e-15 Score=165.44 Aligned_cols=113 Identities=19% Similarity=0.161 Sum_probs=102.1
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
....+.|.+.++||+|.||+|.++++..||..||||+|+|..+ +....++..+|++||+.++|||||+||.+..+...+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 4567789999999999999999999999999999999999874 445566799999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|+||||+.||+++++|.++++..+.+++..+.+.
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~ 164 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQI 164 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHH
Confidence 9999999999999999999988887777765543
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.6e-15 Score=157.50 Aligned_cols=119 Identities=21% Similarity=0.381 Sum_probs=106.8
Q ss_pred CCCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeC
Q psy11874 646 PQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETK 724 (767)
Q Consensus 646 ~~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~ 724 (767)
+..+.+.||+++++||+|+|++|.+|++++|.+.||||+++|+-..+...+..+..|..+..+. +|||+|.||.+|++.
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 3468899999999999999999999999999999999999999888888899999999999887 899999999999999
Q ss_pred CEEEEEEeccCCccccccccccCCCCh---hhhHHHHHHhhhc
Q psy11874 725 DALCLVLTIIDVMFTCVQPSETNPCCF---PFRRKEVVVVAAF 764 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~~~~~~---~~~~~~v~~~a~~ 764 (767)
.++++|.||++||+|.-++++++..++ +++..+|++.+.|
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~f 366 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNF 366 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHH
Confidence 999999999999999999988766544 4667777765543
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-15 Score=166.76 Aligned_cols=105 Identities=19% Similarity=0.210 Sum_probs=95.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
+++|.+...||+|+||.||+++.|.|.+.||+|.|.|.. ..+++.+.+.+|++|++.++|||||.++++|++..++++|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 468999999999999999999999999999999999987 5667888999999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHH
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKE 757 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~ 757 (767)
.|||.| +|+.+|...+..++...++.
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~ 105 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAI 105 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHH
Confidence 999997 99999988777666655553
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.5e-14 Score=160.22 Aligned_cols=109 Identities=24% Similarity=0.349 Sum_probs=96.4
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++++.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.+|..++||||++++++|++...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999999866555566778999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|||+||+|.+++.+.+...+......+..
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~q 109 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAE 109 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHH
Confidence 99999999999987776666666554443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.5e-14 Score=159.97 Aligned_cols=109 Identities=26% Similarity=0.392 Sum_probs=95.4
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++++.||+|+||.||+|+++.+|+.||+|++++..+........+.+|+.+|+.++||||++++++|++.+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999999865555566778899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|||+||+|.+++.+.+.+.+......+.+
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~q 109 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAE 109 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHH
Confidence 99999999999977666555555544433
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.8e-14 Score=160.63 Aligned_cols=107 Identities=29% Similarity=0.371 Sum_probs=94.9
Q ss_pred CceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEe
Q psy11874 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 732 (767)
Q Consensus 653 ~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmE 732 (767)
.|++++.||+|+||+||+|+++.+++.||+|++.+..+......+.+.+|+.+|+.++|||||+++++|.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999998766666777889999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChhhhHHHHH
Q psy11874 733 IIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 733 y~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
||+||+|.+++.+.+...+...+..+.
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~ 108 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIA 108 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHH
Confidence 999999999997766655555444333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.7e-14 Score=160.34 Aligned_cols=107 Identities=27% Similarity=0.369 Sum_probs=94.1
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.||+.++||||+++++.|++.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765545556778999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
|||+||+|.+++.+.+...+...+..+
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~ 107 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYI 107 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHH
Confidence 999999999999877665555544433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.9e-14 Score=160.39 Aligned_cols=107 Identities=29% Similarity=0.374 Sum_probs=94.8
Q ss_pred CceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEe
Q psy11874 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 732 (767)
Q Consensus 653 ~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmE 732 (767)
.|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.||+.++|||||+++++|++.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999998765556677889999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChhhhHHHHH
Q psy11874 733 IIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 733 y~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
||+||+|.+++.+.+...+...+..+.
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~ 108 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIA 108 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHH
Confidence 999999999997766655555554443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.4e-14 Score=159.27 Aligned_cols=105 Identities=30% Similarity=0.410 Sum_probs=92.9
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+++|+.++|||||+++++|++.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765445566778999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
|||+||+|.+++.+.+.+.+...+.
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~ 105 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRF 105 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHH
Confidence 9999999999997766655555444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.3e-14 Score=155.31 Aligned_cols=108 Identities=24% Similarity=0.337 Sum_probs=95.8
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
..+++|++.+.||+|+||.||+|+++.+|+.||+|++++..+......+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 55789999999999999999999999999999999998876555566778999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
+|||||+||+|.+.+.+.+...+.....
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 122 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKF 122 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHH
Confidence 9999999999999998776655554443
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.3e-14 Score=154.94 Aligned_cols=109 Identities=23% Similarity=0.369 Sum_probs=95.4
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++++.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+|..++||||++++++|++.+.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765555566788999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|||+||+|.+++.+.+...+......+..
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~q 109 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAE 109 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHH
Confidence 99999999999987766565555544433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-14 Score=156.89 Aligned_cols=109 Identities=17% Similarity=0.183 Sum_probs=97.0
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
+=|++.+.||+|.|++|.+|+|.-||..||||+|+|.++ +.-...+++.|++.|+.++|||||+||++..++.++|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 458999999999999999999999999999999999885 4455679999999999999999999999999999999999
Q ss_pred eccCCcccccccccc-CCCChhhhHHHHHHh
Q psy11874 732 TIIDVMFTCVQPSET-NPCCFPFRRKEVVVV 761 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~-~~~~~~~~~~~v~~~ 761 (767)
|+-+||||+++|-++ .+.++..++..++++
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI 127 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQI 127 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHH
Confidence 999999999998665 456777777655544
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=152.22 Aligned_cols=111 Identities=26% Similarity=0.305 Sum_probs=96.3
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCC-cEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATG-KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 725 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg-~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~ 725 (767)
..+..++|++.+.||+|+||.||+|.++.++ ..+|+|++.+.........+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4577889999999999999999999987765 689999998876555566778999999999999999999999999999
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKE 757 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~ 757 (767)
.+|+|||||+||+|.+++.+.+...+......
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~ 136 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY 136 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHH
Confidence 99999999999999999987766555554443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.49 E-value=9.8e-14 Score=151.56 Aligned_cols=107 Identities=24% Similarity=0.355 Sum_probs=94.0
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++++.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+|..++||||+++++++++.+.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999999865444556678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
|||+||+|.+++.+.+...+......+
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~ 107 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYM 107 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHH
Confidence 999999999999776665555554433
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.1e-14 Score=150.87 Aligned_cols=106 Identities=17% Similarity=0.222 Sum_probs=92.9
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998765444456678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKE 757 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~ 757 (767)
||++||+|.+++.+.+...+......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~ 106 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFY 106 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHH
Confidence 99999999999987766555554443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.1e-13 Score=150.41 Aligned_cols=113 Identities=25% Similarity=0.293 Sum_probs=92.0
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccch-----------hhHHHHHHHHHHHhhCCCCcee
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----------KGESMVLIEKQILQKINSRFVV 715 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~-----------~~~~~~~~Ei~IL~~l~HpnIV 715 (767)
....++.|++++.||+|+||+|.||++..+++.||||++.|...... ...+.+.+||.||++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 45678899999999999999999999999999999999998664321 1246899999999999999999
Q ss_pred eeeEEEEeC--CEEEEEEeccCCccccccccccCCCChhhhHHHHH
Q psy11874 716 SLAYAYETK--DALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 716 ~l~~~f~~~--~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
+|+++..+. +++|||+|||+.|++...=.....+.+.+++..+.
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylr 217 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLR 217 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHH
Confidence 999999875 57999999999999865432222255666665544
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.6e-13 Score=150.00 Aligned_cols=107 Identities=26% Similarity=0.391 Sum_probs=91.8
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++++.||+|+||.||+++++.+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765455556677899999999999999999999999999999999
Q ss_pred eccCCcccccccccc-CCCChhhhHHHH
Q psy11874 732 TIIDVMFTCVQPSET-NPCCFPFRRKEV 758 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~-~~~~~~~~~~~v 758 (767)
||++||+|.+++.+. ....+......+
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~ 108 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYL 108 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHH
Confidence 999999999999653 334444444433
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-13 Score=152.45 Aligned_cols=108 Identities=25% Similarity=0.373 Sum_probs=93.2
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++.+.||+|+||.||+|+++.+|+.||+|++++.........+.+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 36678999999999999999999999999999999999876555555666788999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
|+|||||+||+|.+++... ...+.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~ 146 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-DIPEKWARF 146 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHH
Confidence 9999999999999988653 334444443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.7e-14 Score=157.96 Aligned_cols=256 Identities=22% Similarity=0.235 Sum_probs=197.3
Q ss_pred CCeEEEeEEee--cCcEEEEEEEE--ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCe
Q psy11874 114 KTFRMYRVLGK--GGFGEVCACQV--RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDA 188 (767)
Q Consensus 114 ~~y~~~~~LG~--G~fG~Vy~a~~--~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~ 188 (767)
..|.+.+-+|. |++|.||.+.. +.++..+|+|+-+.. ......-.+-++|.....++ .|++.++.+..++..+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 45677788999 99999999998 889999999983322 11122222334566666666 48999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHh----HHHHHHHCCcccccCCcceEEeCCC-CCEEEeecCc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC----GLEHLHYIGLVYRDCKPENILLDDY-GHVRISDLGL 263 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~----aL~yLH~~~IvHrDLKPeNILld~~-g~vkL~DFGl 263 (767)
+++-+|++. .+|..+..... .-++...+..+..+... ||.++|+.+|+|-|+||+||++..+ ..++++|||+
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 999999996 67777666543 24777888888888888 9999999999999999999999988 8899999999
Q ss_pred ccccCCCCccc------ccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc
Q psy11874 264 AVEIPEGESVR------GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE 337 (767)
Q Consensus 264 a~~~~~~~~~~------~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~ 337 (767)
...+.++.... ...|..-|++||.+ +.-++...|++|+|.++.+-.+|..++...... ...++.+.. .+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~--ip~ 345 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGY--IPL 345 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-Ccccccccc--Cch
Confidence 99887665211 12588899999988 456899999999999999999888776544110 111121111 334
Q ss_pred ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 338 KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 338 ~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
++-...+.+....+.+|+..+|-.|++ ++.+++|++....
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~-------~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLT-------AQILTALNVIHSK 385 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhH-------HHHHhccccccch
Confidence 455566778888999999999999998 8999999998853
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.3e-13 Score=151.48 Aligned_cols=107 Identities=24% Similarity=0.330 Sum_probs=92.2
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++.+.||+|+||.||+|+++.+++.||+|++++.........+.+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 45678999999999999999999999999999999998765545555667889999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
+|||||+||+|.+++... ...+.....
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~ 146 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKF 146 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHH
Confidence 999999999999998654 334444433
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.4e-13 Score=147.43 Aligned_cols=105 Identities=25% Similarity=0.367 Sum_probs=90.5
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++.+.||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..++||||+.++++|++.+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998755444555667889999999999999999999999999999999
Q ss_pred eccCCcccccccccc-CCCChhhhHH
Q psy11874 732 TIIDVMFTCVQPSET-NPCCFPFRRK 756 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~-~~~~~~~~~~ 756 (767)
|||+||+|.+++.+. +...+.....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~ 106 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARF 106 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHH
Confidence 999999999999763 3444444433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.6e-14 Score=153.85 Aligned_cols=101 Identities=20% Similarity=0.384 Sum_probs=90.6
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE-EEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA-LCL 729 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~-lyl 729 (767)
+++|+.++.+|+|+||.+++++|+..++.|++|.|...+.. ...++....|..+++++.|||||.++++|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t-~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT-EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC-chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 57899999999999999999999999999999999998754 4455689999999999999999999999998888 999
Q ss_pred EEeccCCccccccccccCCCChh
Q psy11874 730 VLTIIDVMFTCVQPSETNPCCFP 752 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~~~~~ 752 (767)
||+||+||+|.+.|.+.+...++
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~ 104 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFP 104 (426)
T ss_pred EEeecCCCCHHHHHHHHhhcccc
Confidence 99999999999999877643333
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.8e-13 Score=147.53 Aligned_cols=100 Identities=31% Similarity=0.440 Sum_probs=87.9
Q ss_pred eecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEeccCCc
Q psy11874 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIIDVM 737 (767)
Q Consensus 658 ~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmEy~~gG 737 (767)
+.||+|+||.||+|+++.+|+.||+|++++.............+|+.+|+.++||||++++++|++.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999999865555566778899999999999999999999999999999999999999
Q ss_pred cccccccccCCCChhhhHHH
Q psy11874 738 FTCVQPSETNPCCFPFRRKE 757 (767)
Q Consensus 738 ~L~~~l~~~~~~~~~~~~~~ 757 (767)
+|.+++.+.+...+......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~ 100 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFY 100 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHH
Confidence 99999977666555555443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.2e-13 Score=149.37 Aligned_cols=109 Identities=27% Similarity=0.373 Sum_probs=95.3
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+|..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999999876555566778999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|||+||+|.+++.+.+...+......+..
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~q 109 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAE 109 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHH
Confidence 99999999999977666555555544433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.6e-13 Score=149.89 Aligned_cols=107 Identities=27% Similarity=0.372 Sum_probs=92.4
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45668999999999999999999999999999999999876544555566788999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRR 755 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~ 755 (767)
|+|||||+||+|.+++... ...+....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~ 145 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-DVPEKWAR 145 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHH
Confidence 9999999999999988654 33444433
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.4e-13 Score=144.73 Aligned_cols=106 Identities=20% Similarity=0.191 Sum_probs=92.2
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++++.||+|+||.||+|+++.+|..+|+|++.... .....+.+.+|+++|+.++||||+++++++.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 44679999999999999999999999999999999998652 3345578999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
+||||++||+|.+++.+.+...+.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 107 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGK 107 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHH
Confidence 9999999999999997766555554444
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.6e-15 Score=159.84 Aligned_cols=120 Identities=23% Similarity=0.291 Sum_probs=109.2
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
.++.+.+++++.+||-|+||.|-+|+.+.....+|+|+|+|..+.+.++.+|+..|.+||..++.||||+||..|.+..+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 46788899999999999999999999888777899999999999999999999999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHH-Hhhhccc
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVV-VVAAFDF 766 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~-~~a~~~~ 766 (767)
+|+.||-|-||+|++.|+.++.+....++-.+. ++-||+|
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeY 535 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEY 535 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHH
Confidence 999999999999999999999887777776444 4456666
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.6e-13 Score=145.89 Aligned_cols=101 Identities=30% Similarity=0.416 Sum_probs=87.5
Q ss_pred eecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEeccCCc
Q psy11874 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIIDVM 737 (767)
Q Consensus 658 ~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmEy~~gG 737 (767)
+.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+|+.++||||++++++|.+.+.+|+|||||+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999999865545566778889999999999999999999999999999999999999
Q ss_pred cccccccccCCCChhhhHHHH
Q psy11874 738 FTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 738 ~L~~~l~~~~~~~~~~~~~~v 758 (767)
+|..++.+.+...+......+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~ 101 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYG 101 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHH
Confidence 999988776655555554433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.2e-13 Score=145.61 Aligned_cols=107 Identities=27% Similarity=0.342 Sum_probs=92.7
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++++.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 37999999999999999999999999999999999865444556677899999999999999999999999999999999
Q ss_pred eccCCcccccccccc-CCCChhhhHHHH
Q psy11874 732 TIIDVMFTCVQPSET-NPCCFPFRRKEV 758 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~-~~~~~~~~~~~v 758 (767)
|||+||+|.+++.+. +...+......+
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~ 108 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYL 108 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHH
Confidence 999999999999765 444555544433
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.6e-13 Score=145.65 Aligned_cols=102 Identities=21% Similarity=0.325 Sum_probs=88.4
Q ss_pred eecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCEEEEEEeccCC
Q psy11874 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVLTIIDV 736 (767)
Q Consensus 658 ~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~lylVmEy~~g 736 (767)
+.||+|+||.||+|+++.+++.||+|++++...........+.+|+.+++.+ +||||++++++|.+.+.+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999987655556677889999999998 799999999999999999999999999
Q ss_pred ccccccccccCCCChhhhHHHHH
Q psy11874 737 MFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 737 G~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
|+|.+++.+.+...+......+.
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~ 103 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSA 103 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHH
Confidence 99999887766666655554433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.41 E-value=8e-13 Score=143.91 Aligned_cols=107 Identities=24% Similarity=0.338 Sum_probs=91.8
Q ss_pred CceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCC-CceeeeeEEEEeCCEEEEEE
Q psy11874 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 653 ~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~H-pnIV~l~~~f~~~~~lylVm 731 (767)
+|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+..|++++..+.| ++|+.++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999998755555667788999999999965 56899999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
|||+||+|.+++...+...++.....+.
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~ 108 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAA 108 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHH
Confidence 9999999999997766656655554433
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.9e-13 Score=144.00 Aligned_cols=106 Identities=18% Similarity=0.175 Sum_probs=91.8
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++.+.||+|+||.||+++++.+|..+|+|++.... .....+.+.+|+++|+.++|||||+++++|.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34578999999999999999999999999999999998652 3345567899999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
+||||++||+|.+++.+.+...+.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 107 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGK 107 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHH
Confidence 9999999999999997766555554443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.2e-13 Score=144.34 Aligned_cols=100 Identities=30% Similarity=0.438 Sum_probs=87.0
Q ss_pred eecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEeccCCc
Q psy11874 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIIDVM 737 (767)
Q Consensus 658 ~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmEy~~gG 737 (767)
+.||+|+||.||+|+++.+|+.||+|++++.............+|+++++.++||||++++++|.+.+.+|+|||||+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999999876555556678889999999999999999999999999999999999999
Q ss_pred cccccccccCCCChhhhHHH
Q psy11874 738 FTCVQPSETNPCCFPFRRKE 757 (767)
Q Consensus 738 ~L~~~l~~~~~~~~~~~~~~ 757 (767)
+|.+++.+.+...+......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~ 100 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFY 100 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHH
Confidence 99998877666555544443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.4e-13 Score=144.65 Aligned_cols=100 Identities=31% Similarity=0.459 Sum_probs=87.3
Q ss_pred eecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEeccCCc
Q psy11874 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIIDVM 737 (767)
Q Consensus 658 ~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmEy~~gG 737 (767)
+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+++|+.++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999999866555566778899999999999999999999999999999999999999
Q ss_pred cccccccccCCCChhhhHHH
Q psy11874 738 FTCVQPSETNPCCFPFRRKE 757 (767)
Q Consensus 738 ~L~~~l~~~~~~~~~~~~~~ 757 (767)
+|.+.+.+.+...+......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~ 100 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFY 100 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHH
Confidence 99998876665555544443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.2e-13 Score=144.39 Aligned_cols=108 Identities=23% Similarity=0.326 Sum_probs=91.7
Q ss_pred CceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC-CCceeeeeEEEEeCCEEEEEE
Q psy11874 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 653 ~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~-HpnIV~l~~~f~~~~~lylVm 731 (767)
+|++.+.||+|+||.||+|+++.+|+.||+|++++.........+....|+.++..+. ||+|++++++|++.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999999865445556678889999998885 678889999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|||+||+|.+++.+.+.+.+......+..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~q 109 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAE 109 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHH
Confidence 99999999999877666666555544433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-13 Score=142.93 Aligned_cols=95 Identities=21% Similarity=0.347 Sum_probs=80.8
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
++.|+.+..+|+||||+|++|+++.||+.||+|...... .+....+-.+|||++|++++|||+|.|.++|....++|+|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 467999999999999999999999999999999987653 2344456688999999999999999999999999999999
Q ss_pred EeccCCccccccccccC
Q psy11874 731 LTIIDVMFTCVQPSETN 747 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~ 747 (767)
+|||+. ++.+.|.+..
T Consensus 80 FE~~dh-TvL~eLe~~p 95 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYP 95 (396)
T ss_pred eeecch-HHHHHHHhcc
Confidence 999986 4444555443
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.4e-13 Score=146.88 Aligned_cols=97 Identities=23% Similarity=0.301 Sum_probs=85.8
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC--
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-- 724 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~-- 724 (767)
.+...+.|+.++.||+|+||.||+|++..||+.||+|.|..+. .+.+...-+.|||.||++|+|||||+|.+...+.
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 3566789999999999999999999999999999999999876 4566778899999999999999999999998877
Q ss_pred CEEEEEEeccCCccccccccc
Q psy11874 725 DALCLVLTIIDVMFTCVQPSE 745 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~ 745 (767)
..+|||+|||+ -||.-++..
T Consensus 191 ~siYlVFeYMd-hDL~GLl~~ 210 (560)
T KOG0600|consen 191 GSIYLVFEYMD-HDLSGLLSS 210 (560)
T ss_pred ceEEEEEeccc-chhhhhhcC
Confidence 68999999998 477777644
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.40 E-value=7.9e-13 Score=143.20 Aligned_cols=98 Identities=28% Similarity=0.439 Sum_probs=85.9
Q ss_pred cccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEeccCCccc
Q psy11874 660 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIIDVMFT 739 (767)
Q Consensus 660 LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmEy~~gG~L 739 (767)
||+|+||.||+|+++.+++.||+|++++...........+.+|+.+|++++|||||+++++|.+.+.+|+|||||+||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876555556677889999999999999999999999999999999999999999
Q ss_pred cccccccCCCChhhhHHH
Q psy11874 740 CVQPSETNPCCFPFRRKE 757 (767)
Q Consensus 740 ~~~l~~~~~~~~~~~~~~ 757 (767)
.+++.+.+.+.+......
T Consensus 81 ~~~l~~~~~~~~~~~~~~ 98 (312)
T cd05585 81 FHHLQREGRFDLSRARFY 98 (312)
T ss_pred HHHHHhcCCCCHHHHHHH
Confidence 999977666555544443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-12 Score=143.34 Aligned_cols=105 Identities=24% Similarity=0.370 Sum_probs=90.2
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++.+.||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..++||||+.+++++++.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998765444555667889999999999999999999999999999999
Q ss_pred eccCCcccccccccc-CCCChhhhHH
Q psy11874 732 TIIDVMFTCVQPSET-NPCCFPFRRK 756 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~-~~~~~~~~~~ 756 (767)
|||+||+|.+++.+. +...+.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~ 106 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARF 106 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHH
Confidence 999999999999763 3444444433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.3e-12 Score=139.56 Aligned_cols=94 Identities=79% Similarity=1.152 Sum_probs=83.6
Q ss_pred CceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEe
Q psy11874 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 732 (767)
Q Consensus 653 ~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmE 732 (767)
.|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999987654444445667899999999999999999999999999999999
Q ss_pred ccCCcccccccccc
Q psy11874 733 IIDVMFTCVQPSET 746 (767)
Q Consensus 733 y~~gG~L~~~l~~~ 746 (767)
||+||+|.+++.+.
T Consensus 81 ~~~~~~L~~~~~~~ 94 (285)
T cd05605 81 LMNGGDLKFHIYNM 94 (285)
T ss_pred ccCCCcHHHHHHhc
Confidence 99999998887544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=2e-12 Score=146.60 Aligned_cols=143 Identities=20% Similarity=0.187 Sum_probs=98.4
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhh-------------------------------------hHHHHH
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-------------------------------------GESMVL 162 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~-------------------------------------~~~~~~ 162 (767)
+.||+|++|+||+|+.+ +|+.||||+........-. .+-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999985 7999999997543111000 001244
Q ss_pred HHHHHHHhcC-----CCceeEEEEEE-eeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHh-HHHHHHH
Q psy11874 163 IEKQILQKIN-----SRFVVSLAYAY-ETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC-GLEHLHY 235 (767)
Q Consensus 163 ~E~~iL~~l~-----hp~Iv~l~~~~-~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~-aL~yLH~ 235 (767)
+|...+.++. +++| .+-..+ ...+..+|||||++|++|.+....... +.+ ...++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHh
Confidence 5666666652 3332 222222 223456999999999999877653211 222 2335555555 4788999
Q ss_pred CCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 236 ~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
.|++|+|+||.||+++.+|.++|+|||++..++.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999977643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.6e-12 Score=141.59 Aligned_cols=106 Identities=25% Similarity=0.346 Sum_probs=90.9
Q ss_pred CceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCEEEEEE
Q psy11874 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 653 ~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~lylVm 731 (767)
||++++.||+|+||.||+|+++.+++.||+|++++.........+....|+.++..+ +||+|+.+++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999999986544555667788899999887 6899999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
||++||+|.+.+.+.+...+......+
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~ 107 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYA 107 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHH
Confidence 999999999998776665555444433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 767 | ||||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-112 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-31 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-112 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-32 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-77 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-21 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-77 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-21 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-77 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-21 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-77 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-21 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-57 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-57 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-57 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-57 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-44 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-43 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-43 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-43 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-43 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-43 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-43 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-43 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-43 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-43 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-42 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-42 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-41 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-41 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-41 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-41 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-40 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-40 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-40 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-40 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-40 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-40 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-40 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-39 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-38 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-38 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-37 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-37 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-37 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-36 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-36 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-36 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-36 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-36 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-36 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-36 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-36 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-35 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-35 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-35 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-35 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-35 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-35 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-35 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-35 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-35 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-35 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-35 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-35 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-35 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-35 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-35 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-35 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-35 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-35 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-35 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-35 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-35 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-35 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-35 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-35 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-35 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-35 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-35 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-35 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-35 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-35 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-35 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-35 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-35 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-35 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-35 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-35 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-35 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-35 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-34 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-34 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-34 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-34 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-34 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-34 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-34 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-34 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-33 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-33 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-33 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-33 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-31 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-30 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-30 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-30 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-30 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-30 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-30 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-29 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-29 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-29 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-29 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-29 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-29 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-29 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-29 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-29 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-29 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-29 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-29 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-29 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-29 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-29 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-29 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-28 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-27 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-27 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-22 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-19 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-19 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-19 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-19 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-19 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-18 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-18 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-18 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-18 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-18 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-18 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-17 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-17 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-17 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-17 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-17 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-17 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-17 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-17 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-17 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-17 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-16 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-14 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-14 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-12 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-12 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-12 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-12 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-12 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-12 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-12 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-12 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-12 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-12 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-10 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-05 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-05 |
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 491 bits (1266), Expect = e-166
Identities = 226/425 (53%), Positives = 283/425 (66%), Gaps = 29/425 (6%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMF-----------TLALYVRYS 52
+ Y + ++ PIGRLLFR+FC +P+ + + + +
Sbjct: 50 ERDYHSLCERNPIGRLLFREFC-ATRPELSRCVAFLDGVAEYEVTPDDKRKACGRNLTQN 108
Query: 53 YIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIY------- 105
++ P + Q + D + E ++ Y
Sbjct: 109 FLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFN 168
Query: 106 -------NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 158
E QP+T TFR YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE
Sbjct: 169 RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 228
Query: 159 SMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIAR 218
+M L EKQIL+K+NSRFVVSLAYAYETKDALCLVLT+MNGGDLKFHIY+MG + GF AR
Sbjct: 229 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEAR 287
Query: 219 ARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG 278
A FYAAE+ CGLE LH +VYRD KPENILLDD+GH+RISDLGLAV +PEG++++GRVG
Sbjct: 288 AVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK 338
TVGYMAPEV+ NE+YT+SPDW++ GCL++EMI GQ+PF++RK+ +KR+EV+R VKE E+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
Query: 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPF 398
YS RFS A++LC LL K P RLG C ARE+K+ FK N+KRL AG+ +PPF
Sbjct: 408 YSERFSPQARSLCSQLLCKDPAERLG--CRGGSAREVKEHPLFKKLNFKRLGAGMLEPPF 465
Query: 399 VPDVK 403
PD +
Sbjct: 466 KPDPQ 470
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-36
Identities = 79/95 (83%), Positives = 86/95 (90%), Gaps = 3/95 (3%)
Query: 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL 706
QP+T TFR YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE+M L EKQIL
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 707 QKINSRFVVSLAYAYETKDALCLVLTII---DVMF 738
+K+NSRFVVSLAYAYETKDALCLVLT++ D+ F
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-24
Identities = 53/113 (46%), Positives = 66/113 (58%), Gaps = 6/113 (5%)
Query: 534 FYRYLQWKWLEHHFLYVEVFTHGVYCSQPHAVYAKDVLDIEQFSTVKGVTLDTTDDSFYS 593
++ L +K L + P A+Y KDVLDIEQFSTVKGV L+ TD FY
Sbjct: 447 LFKKLNFKRLGAGM------LEPPFKPDPQAIYCKDVLDIEQFSTVKGVELEPTDQDFYQ 500
Query: 594 KFNTGSVSIPWQNEMIETECFKELNVFGENNTPSSDVMFTSVPPSETNPSCFP 646
KF TGSV IPWQNEM+ETECF+ELNVFG + + D+ + PP+
Sbjct: 501 KFATGSVPIPWQNEMVETECFQELNVFGLDGSVPPDLDWKGQPPAPPKKGLLQ 553
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 22/77 (28%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 480 PQAPEAVDVLSLEIIEHCKESLDSGN-RELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYL 538
P+ + + +++ +C + L+ G ++LF + +L+ APF ++ DS++F R+L
Sbjct: 112 HTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFL 171
Query: 539 QWKWLEHHFLYVEVFTH 555
QWKWLE + F
Sbjct: 172 QWKWLERQPVTKNTFRQ 188
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 26/51 (50%), Positives = 32/51 (62%), Gaps = 3/51 (5%)
Query: 396 PPFVPD---VKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 443
PF +KR+EV+R VKE E+YS RFS A++LC LL K P RLG
Sbjct: 383 SPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLG 433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 475 bits (1223), Expect = e-160
Identities = 179/425 (42%), Positives = 252/425 (59%), Gaps = 30/425 (7%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMF-----------TLALYVRYS 52
D+ + + +QPIG+ LF+QF Q+ L+ + A +R +
Sbjct: 55 DLGFEGMCLEQPIGKRLFQQFL-RTHEQHGPALQLWKDIEDYDTADDALRPQKAQALRAA 113
Query: 53 YIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSI------------ENYELEMDENRRLS 100
Y+ Q + +F + + + + R L
Sbjct: 114 YLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQ 173
Query: 101 TKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM 160
K + E QP+ F +RVLG+GGFGEV ACQ++ATGK+YACKKL KKR+KKRKG
Sbjct: 174 WK--WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG 231
Query: 161 VLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-GEPGFDIARA 219
++EK+IL K++SRF+VSLAYA+ETK LCLV+TIMNGGD+++HIYN+ PGF RA
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-VRGRVG 278
FY A+++ GLEHLH ++YRD KPEN+LLDD G+VRISDLGLAVE+ G++ +G G
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 279 TVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK 338
T G+MAPE++ E+Y +S D+F+ G ++EMI + PFR R E V+ E+ +RV E A
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411
Query: 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPF 398
Y +FS +K C+ALL+K P RLG G L+ F+ +W++LEAG+ PPF
Sbjct: 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDG--SCDGLRTHPLFRDISWRQLEAGMLTPPF 469
Query: 399 VPDVK 403
VPD +
Sbjct: 470 VPDSR 474
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-37
Identities = 58/95 (61%), Positives = 76/95 (80%), Gaps = 3/95 (3%)
Query: 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL 706
QP+ F +RVLG+GGFGEV ACQ++ATGK+YACKKL KKR+KKRKG ++EK+IL
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 707 QKINSRFVVSLAYAYETKDALCLVLTII---DVMF 738
K++SRF+VSLAYA+ETK LCLV+TI+ D+ +
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRY 274
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-20
Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 534 FYRYLQWKWLEHHFLYVEVFTHGVYCSQPHAVYAKDVLDIEQFSTVKGVTLDTTDDSFYS 593
+R + W+ LE L + VYAK++ D+ FSTVKGV + D F+
Sbjct: 451 LFRDISWRQLEAGMLTPP------FVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTEFFQ 504
Query: 594 KFNTGSVSIPWQNEMIETECFKELNVFGEN 623
+F +G+ IPWQ EMIET F +LNV+ +
Sbjct: 505 EFASGTCPIPWQEEMIETGVFGDLNVWRPD 534
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 27/76 (35%), Positives = 35/76 (46%), Gaps = 3/76 (3%)
Query: 480 PQAPEAVDVLSLEIIEHCKESLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYLQ 539
PQA L E + + LF + AV L APF EF DS++F R+LQ
Sbjct: 117 PQAQLFCSFLDAETVARARAGAG---DGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQ 173
Query: 540 WKWLEHHFLYVEVFTH 555
WKWLE + + F
Sbjct: 174 WKWLEAQPMGEDWFLD 189
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 21/51 (41%), Positives = 28/51 (54%), Gaps = 3/51 (5%)
Query: 396 PPFVPD---VKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 443
PF V+ E+ +RV E A Y +FS +K C+ALL+K P RLG
Sbjct: 387 GPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLG 437
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 460 bits (1186), Expect = e-153
Identities = 148/456 (32%), Positives = 229/456 (50%), Gaps = 50/456 (10%)
Query: 4 DVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMFTLALYVRYSYIIDQQPIGRL 63
+V + I Q +G LLFR FC + + + + Y + ++ R
Sbjct: 52 EVTFEKIFSQ-KLGYLLFRDFCLKHLEEAKPLVEFYEEIKK---YEKLETEEERLVCSRE 107
Query: 64 LFRQFCAEAKPQYHKY--------------------NVFLDSIE------------NYEL 91
+F + + ++F IE +
Sbjct: 108 IFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIE 167
Query: 92 EMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR 151
R K++ +T F ++R++G+GGFGEV C+ TGKMYA K L+KKR
Sbjct: 168 SDKFTRFCQWKNV-ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR 226
Query: 152 IKKRKGESMVLIEKQILQKINS---RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM 208
IK ++GE++ L E+ +L +++ F+V ++YA+ T D L +L +MNGGDL +H+
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH 286
Query: 209 GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268
G F A RFYAAE++ GLEH+H +VYRD KP NILLD++GHVRISDLGLA +
Sbjct: 287 GV---FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343
Query: 269 EGESVRGRVGTVGYMAPEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDE 327
+ + VGT GYMAPEV+ Y S DWFS GC++F+++ G +PFR+ K + E
Sbjct: 344 KKKP-HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHE 401
Query: 328 VDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387
+DR A + FS + ++L + LL++ RLGC GA+E+K++ FF+S +W+
Sbjct: 402 IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGR--GAQEVKESPFFRSLDWQ 459
Query: 388 RLEAGLCDPPFVPDVKRDEVDRRVKEDAEKYSCRFS 423
+ PP +P V+ D + +
Sbjct: 460 MVFLQKYPPPLIPPRGE--VNAADAFDIGSFDEEDT 493
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 5e-35
Identities = 38/98 (38%), Positives = 64/98 (65%), Gaps = 6/98 (6%)
Query: 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL 706
+T F ++R++G+GGFGEV C+ TGKMYA K L+KKRIK ++GE++ L E+ +L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 707 QKINS---RFVVSLAYAYETKDALCLVLTII---DVMF 738
+++ F+V ++YA+ T D L +L ++ D+ +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHY 281
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 27/107 (25%), Positives = 40/107 (37%), Gaps = 19/107 (17%)
Query: 350 LCKALLKKSPRSRLGCHCG--RYGARE--LKQAEFFKSTNWKRL-----E--AGLCDPPF 398
L KK P + G Y A E K + S +W L + G PF
Sbjct: 338 LACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH--SPF 391
Query: 399 VPD--VKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 443
+ E+DR A + FS + ++L + LL++ RLG
Sbjct: 392 RQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLG 438
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 20/60 (33%), Positives = 26/60 (43%), Gaps = 4/60 (6%)
Query: 562 PHAVYAKDVLDIEQFST--VKGVTLDTTDDSFYSKFNTGSVSIPWQNEMIETECFKELNV 619
V A D DI F KG+ L +D Y F ++S WQ E+ ET F +N
Sbjct: 474 RGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPL-TISERWQQEVAET-VFDTINA 531
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 18/69 (26%), Positives = 28/69 (40%), Gaps = 2/69 (2%)
Query: 480 PQAPEAVDVLSLEIIEHCKESL--DSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRY 537
+ S IEH + L +LF + + L G F +F +S F R+
Sbjct: 115 KELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRF 174
Query: 538 LQWKWLEHH 546
QWK +E +
Sbjct: 175 CQWKNVELN 183
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = 6e-99
Identities = 88/312 (28%), Positives = 159/312 (50%), Gaps = 13/312 (4%)
Query: 100 STKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES 159
S +++E + + + F + R +GKG FG+VC Q T KMYA K + K++ +R
Sbjct: 1 SMPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR 60
Query: 160 MVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARA 219
V E QI+Q + F+V+L Y+++ ++ + +V+ ++ GGDL++H+ F
Sbjct: 61 NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH---FKEETV 117
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT 279
+ + E++ L++L +++RD KP+NILLD++GHV I+D +A +P + GT
Sbjct: 118 KLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGT 177
Query: 280 VGYMAPEVIDNEK---YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA 336
YMAPE+ + K Y+++ DW+S G +E++ G+ P+ R E+ +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTV 236
Query: 337 EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDP 396
Y +S + +L K LL+ +P R +++ + NW + P
Sbjct: 237 VTYPSAWSQEMVSLLKKLLEPNPDQRFS------QLSDVQNFPYMNDINWDAVFQKRLIP 290
Query: 397 PFVPDVKRDEVD 408
F+P+ R D
Sbjct: 291 GFIPNKGRLNCD 302
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 4/98 (4%)
Query: 634 SVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 693
S+PP + + + F + R +GKG FG+VC Q T KMYA K + K++ +R
Sbjct: 1 SMPP----VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER 56
Query: 694 KGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
V E QI+Q + F+V+L Y+++ ++ + +V+
Sbjct: 57 NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 4e-94
Identities = 106/292 (36%), Positives = 165/292 (56%), Gaps = 10/292 (3%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F ++LGKG FG+V + +ATG+ YA K L K+ I + + + E ++LQ F
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+ +L YA++T D LC V+ NGG+L FH+ F RARFY AE++ LE+LH
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS 123
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYT 294
+VYRD K EN++LD GH++I+D GL E I +G +++ GT Y+APEV+++ Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 295 YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354
+ DW+ G +++EM+ G+ PF + + + + + ++ S +AK+L L
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPRTLSPEAKSLLAGL 239
Query: 355 LKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
LKK P+ RLG G A+E+ + FF S NW+ + PPF P V +
Sbjct: 240 LKKDPKQRLG--GGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 289
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 29/78 (37%), Positives = 46/78 (58%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F ++LGKG FG+V + +ATG+ YA K L K+ I + + + E ++LQ F
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 714 VVSLAYAYETKDALCLVL 731
+ +L YA++T D LC V+
Sbjct: 67 LTALKYAFQTHDRLCFVM 84
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 8e-04
Identities = 14/48 (29%), Positives = 24/48 (50%), Gaps = 1/48 (2%)
Query: 396 PPFVPDVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 443
PF + + + + + ++ S +AK+L LLKK P+ RLG
Sbjct: 203 LPF-YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 1e-93
Identities = 96/346 (27%), Positives = 180/346 (52%), Gaps = 16/346 (4%)
Query: 73 KPQYHKYNVFLDSIENYELEM-----DENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGF 127
+H Y++ ++ M +E ++T++ + + F + RV+G+G +
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSY 65
Query: 128 GEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR-FVVSLAYAYETK 186
+V +++ T ++YA + ++K+ + + V EK + ++ ++ F+V L ++T+
Sbjct: 66 AKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125
Query: 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPE 246
L V+ +NGGDL FH+ ARFY+AE+ L +LH G++YRD K +
Sbjct: 126 SRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLD 182
Query: 247 NILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCL 305
N+LLD GH++++D G+ E + G++ GT Y+APE++ E Y +S DW++ G L
Sbjct: 183 NVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 242
Query: 306 IFEMIEGQAPFRRRKEMVK-----RDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPR 360
+FEM+ G++PF D + + + E + S A ++ K+ L K P+
Sbjct: 243 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPK 302
Query: 361 SRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
RLGCH + G +++ FF++ +W +E PPF P++ +
Sbjct: 303 ERLGCH-PQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEF 347
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 20/111 (18%), Positives = 50/111 (45%), Gaps = 1/111 (0%)
Query: 622 ENNTPSSDVMFTSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYA 681
S + + + + F + RV+G+G + +V +++ T ++YA
Sbjct: 22 FQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYA 81
Query: 682 CKKLEKKRIKKRKGESMVLIEKQILQKINSR-FVVSLAYAYETKDALCLVL 731
+ ++K+ + + V EK + ++ ++ F+V L ++T+ L V+
Sbjct: 82 MRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 1e-93
Identities = 110/314 (35%), Positives = 162/314 (51%), Gaps = 10/314 (3%)
Query: 95 ENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 154
E+ + N + F RVLGKG FG+V +V+ TG +YA K L+K I +
Sbjct: 4 ESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ 63
Query: 155 RKGESMVLIEKQILQKINSR-FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG 213
+ EK+IL + F+ L ++T D L V+ +NGGDL FHI
Sbjct: 64 DDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--- 120
Query: 214 FDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGES 272
FD ARARFYAAE++ L LH G++YRD K +N+LLD GH +++D G+ E I G +
Sbjct: 121 FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV 332
GT Y+APE++ Y + DW++ G L++EM+ G APF E D++ +
Sbjct: 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAI 236
Query: 333 KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAG 392
D Y +DA + K+ + K+P RLG + G + + FFK +W +L
Sbjct: 237 LNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSL-TQGGEHAILRHPFFKEIDWAQLNHR 295
Query: 393 LCDPPFVPDVKRDE 406
+PPF P +K E
Sbjct: 296 QIEPPFRPRIKSRE 309
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 30/99 (30%), Positives = 44/99 (44%), Gaps = 1/99 (1%)
Query: 634 SVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 693
S + F RVLGKG FG+V +V+ TG +YA K L+K I +
Sbjct: 5 SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD 64
Query: 694 KGESMVLIEKQILQKINSR-FVVSLAYAYETKDALCLVL 731
+ EK+IL + F+ L ++T D L V+
Sbjct: 65 DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 6e-04
Identities = 13/48 (27%), Positives = 21/48 (43%), Gaps = 1/48 (2%)
Query: 396 PPFVPDVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 443
PF D++ + D Y +DA + K+ + K+P RLG
Sbjct: 222 APF-EAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLG 268
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 3e-93
Identities = 93/305 (30%), Positives = 166/305 (54%), Gaps = 11/305 (3%)
Query: 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL 168
P+ + F + RV+G+G + +V +++ T ++YA K ++K+ + + V EK +
Sbjct: 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVF 63
Query: 169 QKINSR-FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVL 227
++ ++ F+V L ++T+ L V+ +NGGDL FH+ ARFY+AE+
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEIS 120
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPE 286
L +LH G++YRD K +N+LLD GH++++D G+ E + G++ GT Y+APE
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK-----RDEVDRRVKEDAEKYSC 341
++ E Y +S DW++ G L+FEM+ G++PF D + + + E +
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240
Query: 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401
S A ++ K+ L K P+ RLGCH + G +++ FF++ +W +E PPF P+
Sbjct: 241 SLSVKAASVLKSFLNKDPKERLGCH-PQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPN 299
Query: 402 VKRDE 406
+ +
Sbjct: 300 ISGEF 304
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 24/96 (25%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL 706
P+ + F + RV+G+G + +V +++ T ++YA K ++K+ + + V EK +
Sbjct: 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVF 63
Query: 707 QKINSR-FVVSLAYAYETKDALCLVLTII---DVMF 738
++ ++ F+V L ++T+ L V+ + D+MF
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMF 99
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 5e-93
Identities = 110/297 (37%), Positives = 165/297 (55%), Gaps = 18/297 (6%)
Query: 116 FRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
F + +VLG+G FG+V V+ ++YA K L+K +K R +E+ IL +
Sbjct: 26 FELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVE 82
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
+N F+V L YA++T+ L L+L + GGDL + E F +FY AE+ L
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALAL 139
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVID 289
+HLH +G++YRD KPENILLD+ GH++++D GL+ E I + GTV YMAPEV++
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 290 NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349
+T S DW+SFG L+FEM+ G PF+ + R E + + S +A++
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGK----DRKETMTMILKAKLGMPQFLSPEAQS 255
Query: 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
L + L K++P +RLG G G E+K+ FF + +W +L PPF P R E
Sbjct: 256 LLRMLFKRNPANRLG--AGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPE 310
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 29/83 (34%), Positives = 47/83 (56%), Gaps = 8/83 (9%)
Query: 654 FRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 708
F + +VLG+G FG+V V+ ++YA K L+K +K R +E+ IL +
Sbjct: 26 FELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVE 82
Query: 709 INSRFVVSLAYAYETKDALCLVL 731
+N F+V L YA++T+ L L+L
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLIL 105
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 7e-93
Identities = 107/298 (35%), Positives = 164/298 (55%), Gaps = 18/298 (6%)
Query: 116 FRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESM-VLIEKQILQ 169
F + RVLGKGG+G+V QVR TGK++A K L+K I + ++ E+ IL+
Sbjct: 19 FELLRVLGKGGYGKVF--QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 170 KINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCG 229
++ F+V L YA++T L L+L ++GG+L + G F A FY AE+
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI---FMEDTACFYLAEISMA 133
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVI 288
L HLH G++YRD KPENI+L+ GHV+++D GL E I +G GT+ YMAPE++
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193
Query: 289 DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348
+ + DW+S G L+++M+ G PF R + ++ + + +A+
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGE----NRKKTIDKILKCKLNLPPYLTQEAR 249
Query: 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
L K LLK++ SRLG G A E++ FF+ NW+ L A +PPF P ++ +E
Sbjct: 250 DLLKKLLKRNAASRLG--AGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEE 305
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 38/100 (38%), Positives = 59/100 (59%), Gaps = 8/100 (8%)
Query: 638 SETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKK 692
SET+ + P+ I + F + RVLGKGG+G+V QVR TGK++A K L+K I +
Sbjct: 3 SETSVNRGPEKIRPECFELLRVLGKGGYGKVF--QVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 693 RKGESM-VLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
++ E+ IL+++ F+V L YA++T L L+L
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL 100
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 1e-92
Identities = 110/312 (35%), Positives = 167/312 (53%), Gaps = 11/312 (3%)
Query: 99 LSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 158
+S D + F VLGKG FG+V + + T ++YA K L+K + +
Sbjct: 5 VSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV 64
Query: 159 SMVLIEKQILQKINSR-FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIA 217
++EK++L F+ L ++T D L V+ +NGGDL +HI +G F
Sbjct: 65 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEP 121
Query: 218 RARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGR 276
A FYAAE+ GL L G++YRD K +N++LD GH++I+D G+ E I +G + +
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF 181
Query: 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA 336
GT Y+APE+I + Y S DW++FG L++EM+ GQAPF E DE+ + + E
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHN 237
Query: 337 EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDP 396
Y S +A A+CK L+ K P RLG CG G R++K+ FF+ +W++LE P
Sbjct: 238 VAYPKSMSKEAVAICKGLMTKHPGKRLG--CGPEGERDIKEHAFFRYIDWEKLERKEIQP 295
Query: 397 PFVPDVKRDEVD 408
P+ P +
Sbjct: 296 PYKPKACGRNAE 307
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 26/100 (26%), Positives = 47/100 (47%), Gaps = 1/100 (1%)
Query: 633 TSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 692
T+ S+ + + + F VLGKG FG+V + + T ++YA K L+K + +
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60
Query: 693 RKGESMVLIEKQILQKINSR-FVVSLAYAYETKDALCLVL 731
++EK++L F+ L ++T D L V+
Sbjct: 61 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 9e-04
Identities = 17/48 (35%), Positives = 23/48 (47%), Gaps = 1/48 (2%)
Query: 396 PPFVPDVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 443
PF DE+ + + E Y S +A A+CK L+ K P RLG
Sbjct: 219 APF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLG 265
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 2e-92
Identities = 116/347 (33%), Positives = 175/347 (50%), Gaps = 18/347 (5%)
Query: 71 EAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEV 130
E D + E + L T ++ + + + F + +VLG G +G+V
Sbjct: 11 EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKV 70
Query: 131 CACQVR-----ATGKMYACKKLEKKRI-KKRKGESMVLIEKQILQKINSR-FVVSLAYAY 183
VR TGK+YA K L+K I +K K E+Q+L+ I F+V+L YA+
Sbjct: 71 F--LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128
Query: 184 ETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDC 243
+T+ L L+L +NGG+L H+ F + Y E++ LEHLH +G++YRD
Sbjct: 129 QTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLGIIYRDI 185
Query: 244 KPENILLDDYGHVRISDLGLAVEIPEGESVRGR--VGTVGYMAPEVIDNEKYTYSP--DW 299
K ENILLD GHV ++D GL+ E E+ R GT+ YMAP+++ + DW
Sbjct: 186 KLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 245
Query: 300 FSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSP 359
+S G L++E++ G +PF E + E+ RR+ + Y S AK L + LL K P
Sbjct: 246 WSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDP 305
Query: 360 RSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
+ RLG CG A E+K+ FF+ NW L A PF P ++ +
Sbjct: 306 KKRLG--CGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDEL 350
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 9/117 (7%)
Query: 622 ENNTPSSDVMFTSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVR-----AT 676
+ ++ N + + + + F + +VLG G +G+V VR T
Sbjct: 24 DGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKV--FLVRKISGHDT 81
Query: 677 GKMYACKKLEKKRI-KKRKGESMVLIEKQILQKINSR-FVVSLAYAYETKDALCLVL 731
GK+YA K L+K I +K K E+Q+L+ I F+V+L YA++T+ L L+L
Sbjct: 82 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 6e-92
Identities = 111/372 (29%), Positives = 180/372 (48%), Gaps = 25/372 (6%)
Query: 51 YSYIIDQQPIGRLLFRQFCAE--------------AKPQYHKYNVFLDSIENYELEMDEN 96
++II ++ R F E K + +
Sbjct: 71 NTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSG 130
Query: 97 RRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 156
+ +T F ++LGKG FG+V + +ATG+ YA K L+K+ I +
Sbjct: 131 AEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD 190
Query: 157 GESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDI 216
+ L E ++LQ F+ +L Y+++T D LC V+ NGG+L FH+ E F
Sbjct: 191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSE 247
Query: 217 ARARFYAAEVLCGLEHLH-YIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVR 274
RARFY AE++ L++LH +VYRD K EN++LD GH++I+D GL E I +G +++
Sbjct: 248 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307
Query: 275 GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE 334
GT Y+APEV+++ Y + DW+ G +++EM+ G+ PF + +++ +
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILM 363
Query: 335 DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLC 394
+ ++ +AK+L LLKK P+ RLG G A+E+ Q FF W+ +
Sbjct: 364 EEIRFPRTLGPEAKSLLSGLLKKDPKQRLG--GGSEDAKEIMQHRFFAGIVWQHVYEKKL 421
Query: 395 DPPFVPDVKRDE 406
PPF P V +
Sbjct: 422 SPPFKPQVTSET 433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 33/117 (28%), Positives = 57/117 (48%)
Query: 615 KELNVFGENNTPSSDVMFTSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVR 674
K+ + S + E + + +T F ++LGKG FG+V + +
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK 170
Query: 675 ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
ATG+ YA K L+K+ I + + L E ++LQ F+ +L Y+++T D LC V+
Sbjct: 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 2e-91
Identities = 103/293 (35%), Positives = 152/293 (51%), Gaps = 12/293 (4%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL-QKINSR 174
F +V+GKG FG+V + +A YA K L+KK I K+K E ++ E+ +L + +
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
F+V L ++++T D L VL +NGG+L +H+ F RARFYAAE+ L +LH
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLH 156
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKY 293
+ +VYRD KPENILLD GH+ ++D GL E I + GT Y+APEV+ + Y
Sbjct: 157 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY 216
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353
+ DW+ G +++EM+ G PF R E+ + + ++ A+ L +
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNILNKPLQLKPNITNSARHLLEG 272
Query: 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
LL+K RLG E+K FF NW L PPF P+V
Sbjct: 273 LLQKDRTKRLGAKD---DFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPN 322
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 29/79 (36%), Positives = 47/79 (59%), Gaps = 1/79 (1%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL-QKINSR 712
F +V+GKG FG+V + +A YA K L+KK I K+K E ++ E+ +L + +
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 713 FVVSLAYAYETKDALCLVL 731
F+V L ++++T D L VL
Sbjct: 100 FLVGLHFSFQTADKLYFVL 118
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 4e-90
Identities = 91/297 (30%), Positives = 151/297 (50%), Gaps = 19/297 (6%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F++ R LG G FG V + R G+ YA K L+K+ + + K E+ +L + F
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
++ + ++ + +++ + GG+L + F A+FYAAEV LE+LH
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHS 124
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRV----GTVGYMAPEVIDNE 291
++YRD KPENILLD GH++I+D G A +P+ GT Y+APEV+ +
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTPDYIAPEVVSTK 178
Query: 292 KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351
Y S DW+SFG LI+EM+ G PF M + ++ ++ F++D K L
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----KTYEKILNAELRFPPFFNEDVKDLL 234
Query: 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVD 408
L+ + RLG + G ++K +FK W++L + + P+ P +++ + D
Sbjct: 235 SRLITRDLSQRLG--NLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGD 289
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 5e-16
Identities = 19/78 (24%), Positives = 39/78 (50%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F++ R LG G FG V + R G+ YA K L+K+ + + K E+ +L + F
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 714 VVSLAYAYETKDALCLVL 731
++ + ++ + +++
Sbjct: 68 IIRMWGTFQDAQQIFMIM 85
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 3e-89
Identities = 104/293 (35%), Positives = 162/293 (55%), Gaps = 15/293 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR- 174
F ++++LGKG FG+V + + T + +A K L+K + ++EK++L
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
F+ + ++TK+ L V+ +NGGDL +HI + FD++RA FYAAE++ GL+ LH
Sbjct: 79 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH 135
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKY 293
G+VYRD K +NILLD GH++I+D G+ E + GT Y+APE++ +KY
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 195
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353
+S DW+SFG L++EM+ GQ+PF + E +E+ ++ D Y +AK L
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNPFYPRWLEKEAKDLLVK 251
Query: 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
L + P RLG +++Q F+ NW+ LE DPPF P VK
Sbjct: 252 LFVREPEKRLGVR------GDIRQHPLFREINWEELERKEIDPPFRPKVKSPF 298
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 22/97 (22%), Positives = 45/97 (46%), Gaps = 1/97 (1%)
Query: 636 PPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 695
P + + F ++++LGKG FG+V + + T + +A K L+K +
Sbjct: 1 PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD 60
Query: 696 ESMVLIEKQILQKINSR-FVVSLAYAYETKDALCLVL 731
++EK++L F+ + ++TK+ L V+
Sbjct: 61 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 7e-04
Identities = 14/56 (25%), Positives = 21/56 (37%), Gaps = 6/56 (10%)
Query: 396 PPFVPDVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG-----KSH 446
PF +E+ ++ D Y +AK L L + P RLG + H
Sbjct: 216 SPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 277 bits (712), Expect = 1e-87
Identities = 88/288 (30%), Positives = 145/288 (50%), Gaps = 13/288 (4%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F+ ++LG+G F V + AT + YA K LEK+ I K V E+ ++ +++ F
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
V L + ++ + L L+ G+L +I +G FD RFY AE++ LE+LH
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG 148
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR---VGTVGYMAPEVIDNEK 292
G+++RD KPENILL++ H++I+D G A + VGT Y++PE++ +
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352
S D ++ GC+I++++ G PFR E + +++ + + +F A+ L +
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEY----LIFQKIIKLEYDFPEKFFPKARDLVE 264
Query: 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400
LL RLGC G LK FF+S W+ L PP +
Sbjct: 265 KLLVLDATKRLGCE-EMEGYGPLKAHPFFESVTWENLHQQ--TPPKLT 309
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 25/98 (25%), Positives = 45/98 (45%)
Query: 634 SVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 693
+ P P+ + F+ ++LG+G F V + AT + YA K LEK+ I K
Sbjct: 12 AGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE 71
Query: 694 KGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
V E+ ++ +++ F V L + ++ + L L
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 109
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 4e-87
Identities = 92/314 (29%), Positives = 156/314 (49%), Gaps = 11/314 (3%)
Query: 90 ELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK 149
E K F + LG G FG V + + +G YA K L+K
Sbjct: 17 EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 150 KRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 209
+++ K K L EK+ILQ +N F+V L ++++ L +V+ + GG++ H+ +G
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136
Query: 210 GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269
F ARFYAA+++ E+LH + L+YRD KPEN+L+D G+++++D G A +
Sbjct: 137 R---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD 329
GT +APE+I ++ Y + DW++ G LI+EM G PF + + ++
Sbjct: 194 RTWT--LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIY 247
Query: 330 RRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389
++ ++ FS D K L + LL+ R G + G ++K ++F +T+W +
Sbjct: 248 EKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFG--NLKNGVNDIKNHKWFATTDWIAI 305
Query: 390 EAGLCDPPFVPDVK 403
+ PF+P K
Sbjct: 306 YQRKVEAPFIPKFK 319
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 27/78 (34%), Positives = 44/78 (56%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + LG G FG V + + +G YA K L+K+++ K K L EK+ILQ +N F
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 714 VVSLAYAYETKDALCLVL 731
+V L ++++ L +V+
Sbjct: 103 LVKLEFSFKDNSNLYMVM 120
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 6e-87
Identities = 98/348 (28%), Positives = 158/348 (45%), Gaps = 33/348 (9%)
Query: 82 FLDSIEN--YELEMDENRR-LSTKDIYNEIQPITYKT---------FRMYRVLGKGGFGE 129
LD + EL E + D +PI + F + +V+G+G F E
Sbjct: 17 LLDLLLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSE 76
Query: 130 VCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189
V +++ TG++YA K + K + KR S E+ +L + R++ L +A++ ++ L
Sbjct: 77 VAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136
Query: 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENIL 249
LV+ GGDL + G ARFY AE++ ++ +H +G V+RD KP+NIL
Sbjct: 137 YLVMEYYVGGDLLTLLSKFGER--IPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL 194
Query: 250 LDDYGHVRISDLGLAVEIPEGESVRGR--VGTVGYMAPEVI-------DNEKYTYSPDWF 300
LD GH+R++D G +++ +VR VGT Y++PE++ Y DW+
Sbjct: 195 LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 301 SFGCLIFEMIEGQAPF--RRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKS 358
+ G +EM GQ PF E + V + ++A+ + LL
Sbjct: 255 ALGVFAYEMFYGQTPFYADSTAETYGK-IVHYKEHLSLPLVDEGVPEEARDFIQRLLCP- 312
Query: 359 PRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
P +RLG GA + + FF +W L PPF PD +
Sbjct: 313 PETRLGRG----GAGDFRTHPFFFGLDWDGLRD--SVPPFTPDFEGAT 354
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 24/78 (30%), Positives = 46/78 (58%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + +V+G+G F EV +++ TG++YA K + K + KR S E+ +L + R+
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 714 VVSLAYAYETKDALCLVL 731
+ L +A++ ++ L LV+
Sbjct: 123 ITQLHFAFQDENYLYLVM 140
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 2e-86
Identities = 86/316 (27%), Positives = 159/316 (50%), Gaps = 21/316 (6%)
Query: 102 KDIYNEIQPITYKT--FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES 159
K ++++ + F + +V+G+G FGEV +++ K++A K L K + KR +
Sbjct: 60 KPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA 119
Query: 160 MVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARA 219
E+ +L +S+++ +L YA++ + L LV+ GGDL + A
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR--LPEEMA 177
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR--V 277
RFY AE++ ++ +H + V+RD KP+NIL+D GH+R++D G +++ E +V+ V
Sbjct: 178 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 278 GTVGYMAPEVI-----DNEKYTYSPDWFSFGCLIFEMIEGQAPF--RRRKEMVKRDEVDR 330
GT Y++PE++ +Y DW+S G ++EM+ G+ PF E + ++
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-IMNH 296
Query: 331 RVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLE 390
+ + S++AK L + L+ RLG + G + K+ FF +W +
Sbjct: 297 KERFQFPTQVTDVSENAKDLIRRLICSREH-RLGQN----GIEDFKKHPFFSGIDWDNIR 351
Query: 391 AGLCDPPFVPDVKRDE 406
C+ P++P+V
Sbjct: 352 N--CEAPYIPEVSSPT 365
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 24/78 (30%), Positives = 46/78 (58%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + +V+G+G FGEV +++ K++A K L K + KR + E+ +L +S++
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 714 VVSLAYAYETKDALCLVL 731
+ +L YA++ + L LV+
Sbjct: 136 ITTLHYAFQDDNNLYLVM 153
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 3e-86
Identities = 108/295 (36%), Positives = 163/295 (55%), Gaps = 11/295 (3%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR- 174
F VLGKG FG+V + + T ++YA K L+K + + ++EK++L
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
F+ L ++T D L V+ +NGGDL +HI +G F A FYAAE+ GL L
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQ 459
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVE-IPEGESVRGRVGTVGYMAPEVIDNEKY 293
G++YRD K +N++LD GH++I+D G+ E I +G + + GT Y+APE+I + Y
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 519
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353
S DW++FG L++EM+ GQAPF E DE+ + + E Y S +A A+CK
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPKSMSKEAVAICKG 575
Query: 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVD 408
L+ K P RLG CG G R++K+ FF+ +W++LE PP+ P +
Sbjct: 576 LMTKHPGKRLG--CGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASGRNAE 628
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 3e-15
Identities = 29/134 (21%), Positives = 56/134 (41%), Gaps = 1/134 (0%)
Query: 599 SVSIPWQNEMIETECFKELNVFGENNTPSSDVMFTSVPPSETNPSCFPQPITYKTFRMYR 658
+V +P + E ++ + T+ S+ + + + F
Sbjct: 288 NVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLM 347
Query: 659 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR-FVVSL 717
VLGKG FG+V + + T ++YA K L+K + + ++EK++L F+ L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 718 AYAYETKDALCLVL 731
++T D L V+
Sbjct: 408 HSCFQTMDRLYFVM 421
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 1e-84
Identities = 102/324 (31%), Positives = 160/324 (49%), Gaps = 27/324 (8%)
Query: 95 ENRRLSTKDIYNEIQPITYKT--FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 152
+N KD N+I+ + K + + +V+G+G FGEV + ++T K+YA K L K +
Sbjct: 48 DNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM 107
Query: 153 KKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEP 212
KR + E+ I+ NS +VV L YA++ L +V+ M GGDL + N
Sbjct: 108 IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---- 163
Query: 213 GFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272
ARFY AEV+ L+ +H +G ++RD KP+N+LLD GH++++D G +++ +
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 273 VRGR--VGTVGYMAPEVIDNE----KYTYSPDWFSFGCLIFEMIEGQAPF--RRRKEMVK 324
VR VGT Y++PEV+ ++ Y DW+S G ++EM+ G PF
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 283
Query: 325 R---DEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381
+ + +D + S +AK L A L RLG + G E+K+ FF
Sbjct: 284 KIMNHKNSLTFPDDND-----ISKEAKNLICAFLTD-REVRLGRN----GVEEIKRHLFF 333
Query: 382 KSTNWKRLEAGLCDPPFVPDVKRD 405
K+ W P VPD+ D
Sbjct: 334 KNDQWAWETLRDTVAPVVPDLSSD 357
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + +V+G+G FGEV + ++T K+YA K L K + KR + E+ I+ NS +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 714 VVSLAYAYETKDALCLVL 731
VV L YA++ L +V+
Sbjct: 131 VVQLFYAFQDDRYLYMVM 148
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 3e-62
Identities = 67/275 (24%), Positives = 109/275 (39%), Gaps = 18/275 (6%)
Query: 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL 168
+ ++F+ LG G +GEV + + G++YA K+ + K + L E
Sbjct: 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSH 110
Query: 169 QKI-NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVL 227
+K+ V L A+E L L + G L+ H G A+ Y + L
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGA--SLPEAQVWGYLRDTL 167
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEV 287
L HLH GLV+ D KP NI L G ++ D GL VE+ + + G YMAPE+
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 288 IDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347
+ Y + D FS G I E+ + + R +++ S +
Sbjct: 228 L-QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQ-----LRQGYLPPEFTAGLSSEL 281
Query: 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
+++ +L+ P+ R A L +
Sbjct: 282 RSVLVMMLEPDPKLRA-------TAEALLALPVLR 309
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 23/99 (23%), Positives = 38/99 (38%), Gaps = 2/99 (2%)
Query: 634 SVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 693
S P+ ++F+ LG G +GEV + + G++YA K+ +
Sbjct: 39 ETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS-MSPFRGP 97
Query: 694 KGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVL 731
K + L E +K+ V L A+E L L
Sbjct: 98 KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-53
Identities = 72/288 (25%), Positives = 124/288 (43%), Gaps = 21/288 (7%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + R LGKG FG V + + + A K L K +++K E + E +I +
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
++ + + + + L+L G+L + G FD R+ + E+ L + H
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCHE 132
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
+++RD KPEN+L+ G ++I+D G +V P R GT+ Y+ PE+I+ + +
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHDE 191
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355
D + G L +E + G PF RR+ K+ SD +K L LL
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETH----RRIVNVDLKFPPFLSDGSKDLISKLL 247
Query: 356 KKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403
+ P RL + + + + K N +R+ PP +
Sbjct: 248 RYHPPQRL-------PLKGVMEHPWVK-ANSRRVL-----PPVYQSTQ 282
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 19/78 (24%), Positives = 36/78 (46%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + R LGKG FG V + + + A K L K +++K E + E +I +
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 714 VVSLAYAYETKDALCLVL 731
++ + + + + L+L
Sbjct: 76 ILRMYNYFHDRKRIYLML 93
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 6e-53
Identities = 68/274 (24%), Positives = 118/274 (43%), Gaps = 15/274 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + R LGKG FG V + + + + A K L K +++K E + E +I +
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
++ L + + L+L G + + + FD R Y E+ L + H
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHS 127
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
+++RD KPEN+LL G ++I+D G +V P GT+ Y+ PE+I+ +
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMHDE 186
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355
D +S G L +E + G+ PF E +R+ + ++ A+ L LL
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRVEFTFPDFVTEGARDLISRLL 242
Query: 356 KKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389
K +P R RE+ + + + + K
Sbjct: 243 KHNPSQRP-------MLREVLEHPWITANSSKPS 269
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 20/78 (25%), Positives = 36/78 (46%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + R LGKG FG V + + + + A K L K +++K E + E +I +
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 714 VVSLAYAYETKDALCLVL 731
++ L + + L+L
Sbjct: 71 ILRLYGYFHDATRVYLIL 88
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-48
Identities = 73/256 (28%), Positives = 129/256 (50%), Gaps = 7/256 (2%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
++ RVLGKG FGEV C+ + TG+ A K + K+++K++ + +L E Q+L++++
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
++ L +E K LV + GG+L I + F A +VL G+ ++
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYM 142
Query: 234 HYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN 290
H +V+RD KPEN+LL ++RI D GL+ + ++ ++GT Y+APEV+ +
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-H 201
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350
Y D +S G +++ ++ G PF E +V++ + S+ AK L
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 351 CKALLKKSPRSRLGCH 366
+ +L P R+
Sbjct: 262 IRKMLTYVPSMRISAR 277
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 26/80 (32%), Positives = 47/80 (58%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
++ RVLGKG FGEV C+ + TG+ A K + K+++K++ + +L E Q+L++++
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 712 RFVVSLAYAYETKDALCLVL 731
++ L +E K LV
Sbjct: 86 PNIMKLYEFFEDKGYFYLVG 105
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-48
Identities = 68/301 (22%), Positives = 115/301 (38%), Gaps = 44/301 (14%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F VLG+G FG+V + + YA KK+ K +L E +L +N ++
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST----ILSEVMLLASLNHQY 63
Query: 176 VVSLAYAY-------------ETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFY 222
VV A+ + K L + + G L I++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN--QQRDEYWRL 121
Query: 223 AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA---------------VEI 267
++L L ++H G+++RD KP NI +D+ +V+I D GLA
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 268 PEGESVRGRVGTVGYMAPEVIDNEK-YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD 326
+++ +GT Y+A EV+D Y D +S G + FEMI + R ++K+
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK- 240
Query: 327 EVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386
+ E + K + + L+ P R GAR L + + +
Sbjct: 241 -LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNK-------RPGARTLLNSGWLPVKHQ 292
Query: 387 K 387
Sbjct: 293 D 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 20/72 (27%), Positives = 32/72 (44%), Gaps = 4/72 (5%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F VLG+G FG+V + + YA KK+ K +L E +L +N ++
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST----ILSEVMLLASLNHQY 63
Query: 714 VVSLAYAYETKD 725
VV A+ +
Sbjct: 64 VVRYYAAWLERR 75
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 61/313 (19%), Positives = 113/313 (36%), Gaps = 48/313 (15%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI------------ 163
+R+ R L +G F ++ K YA KK EK ++K++ +
Sbjct: 33 YRIIRTLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 164 --EKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-----GEPGFDI 216
E QI+ I + + ++ D + ++ M + I
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 217 ARARFYAAEVLCGLEHLHYI-GLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG 275
+ VL ++H + +RD KP NIL+D G V++SD G + + + + ++G
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-IKG 209
Query: 276 RVGTVGYMAPEVIDNEKYTYSP--DWFSFGCLIFEMIEGQAPF---RRRKEMVKR----- 325
GT +M PE NE D +S G ++ M PF E+
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN 269
Query: 326 --------DEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377
+ + + + S++ K L+K+P R+ + + +
Sbjct: 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI-------TSEDALK 322
Query: 378 AEFFKSTNWKRLE 390
E+ TN + L
Sbjct: 323 HEWLADTNIEDLR 335
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 16/92 (17%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI------------ 701
+R+ R L +G F ++ K YA KK EK ++K++ +
Sbjct: 33 YRIIRTLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 702 --EKQILQKINSRFVVSLAYAYETKDALCLVL 731
E QI+ I + + ++ D + ++
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIY 122
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 4e-48
Identities = 59/248 (23%), Positives = 115/248 (46%), Gaps = 6/248 (2%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + +G+G FG+ + G+ Y K++ R+ ++ E E +L +
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE-SRREVAVLANMKHPN 84
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V ++E +L +V+ GGDL I G F + + ++ L+H+H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHD 143
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-RGRVGTVGYMAPEVIDNEKYT 294
+++RD K +NI L G V++ D G+A + + R +GT Y++PE+ +N+ Y
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 295 YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354
D ++ GC+++E+ + F + V + + S +S D ++L L
Sbjct: 204 NKSDIWALGCVLYELCTLKHAFEAGSMK---NLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 355 LKKSPRSR 362
K++PR R
Sbjct: 261 FKRNPRDR 268
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 15/78 (19%), Positives = 35/78 (44%), Gaps = 1/78 (1%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + +G+G FG+ + G+ Y K++ R+ ++ E E +L +
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE-SRREVAVLANMKHPN 84
Query: 714 VVSLAYAYETKDALCLVL 731
+V ++E +L +V+
Sbjct: 85 IVQYRESFEENGSLYIVM 102
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-47
Identities = 69/256 (26%), Positives = 122/256 (47%), Gaps = 8/256 (3%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ ++ + LG G +GEV C+ + T A K + K + S +L E +L+ ++
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDH 95
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
++ L +E K LV+ GG+L I + F+ A +VL G+ +L
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYL 152
Query: 234 HYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN 290
H +V+RD KPEN+LL + ++I D GL+ + ++ R+GT Y+APEV+
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-R 211
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350
+KY D +S G ++F ++ G PF + + +V++ S+ AK L
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 351 CKALLKKSPRSRLGCH 366
K +L+ + R+
Sbjct: 272 IKQMLQFDSQRRISAQ 287
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 20/80 (25%), Positives = 38/80 (47%), Gaps = 1/80 (1%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
+ ++ + LG G +GEV C+ + T A K + K + S +L E +L+ ++
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDH 95
Query: 712 RFVVSLAYAYETKDALCLVL 731
++ L +E K LV+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVM 115
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 50/301 (16%), Positives = 104/301 (34%), Gaps = 35/301 (11%)
Query: 85 SIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEV-----CACQVRATG 139
+ +Y + +L E Q + K ++ +LG+G F +V
Sbjct: 37 PVSSYPNTFEWQCKLPAIKPKTEFQ-LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95
Query: 140 KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGG 199
+ + K + + + + L+ + A+ ++ LV + + G
Sbjct: 96 QKFVLKVQKPANPWEFY---IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYG 152
Query: 200 DLKFHI--YNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL------- 250
L I Y E +A +L +E +H +++ D KP+N +L
Sbjct: 153 TLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212
Query: 251 ----DDYGHVRISDLGLAVEI---PEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFG 303
D + + DLG ++++ P+G + T G+ E++ N+ + Y D+F
Sbjct: 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVA 272
Query: 304 CLIFEMIEGQAPF-RRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSR 362
++ M+ G + K + + RR+ D +L
Sbjct: 273 ATVYCMLFGTYMKVKNEGGECKPEGLFRRLPH---------LDMWNEFFHVMLNIPDCHH 323
Query: 363 L 363
L
Sbjct: 324 L 324
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 11/89 (12%), Positives = 28/89 (31%), Gaps = 8/89 (8%)
Query: 648 PITYKTFRMYRVLGKGGFGEV-----CACQVRATGKMYACKKLEKKRIKKRKGESMVLIE 702
+ K ++ +LG+G F +V + + K + + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY---IGTQL 117
Query: 703 KQILQKINSRFVVSLAYAYETKDALCLVL 731
+ L+ + A+ ++ LV
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVG 146
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-46
Identities = 76/265 (28%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ + + +LGKG FGEV C+ R T + YA K + K K + +L E ++L+K++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDH 80
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARF---YAAEV-- 226
++ L E + +V + GG+L FD I R RF AA +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL------------FDEIIKRKRFSEHDAARIIK 128
Query: 227 --LCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTVG 281
G+ ++H +V+RD KPENILL + ++I D GL+ + ++ R+GT
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341
Y+APEV+ Y D +S G +++ ++ G PF + E V+
Sbjct: 189 YIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247
Query: 342 RFSDDAKALCKALLKKSPRSRLGCH 366
SDDAK L + +L P R+
Sbjct: 248 TISDDAKDLIRKMLTFHPSLRITAT 272
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 23/80 (28%), Positives = 41/80 (51%), Gaps = 1/80 (1%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
+ + + +LGKG FGEV C+ R T + YA K + K K + +L E ++L+K++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDH 80
Query: 712 RFVVSLAYAYETKDALCLVL 731
++ L E + +V
Sbjct: 81 PNIMKLFEILEDSSSFYIVG 100
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 62/267 (23%), Positives = 102/267 (38%), Gaps = 32/267 (11%)
Query: 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI 171
F+ ++G GGFG+V + R GK Y K+++ K + E + L K+
Sbjct: 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER-------EVKALAKL 61
Query: 172 NSRFVVSLAYAYETKDA----------------LCLVLTIMNGGDLKFHIYNMGGEPGFD 215
+ +V ++ D L + + + G L+ I GE D
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LD 120
Query: 216 IARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG 275
A ++ G++++H L+ RD KP NI L D V+I D GL +
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180
Query: 276 RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED 335
GT+ YM+PE I ++ Y D ++ G ++ E++ +
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT--------DLR 232
Query: 336 AEKYSCRFSDDAKALCKALLKKSPRSR 362
S F K L + LL K P R
Sbjct: 233 DGIISDIFDKKEKTLLQKLLSKKPEDR 259
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 18/76 (23%), Positives = 33/76 (43%), Gaps = 7/76 (9%)
Query: 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI 709
F+ ++G GGFG+V + R GK Y K+++ K + E + L K+
Sbjct: 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER-------EVKALAKL 61
Query: 710 NSRFVVSLAYAYETKD 725
+ +V ++ D
Sbjct: 62 DHVNIVHYNGCWDGFD 77
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 4e-45
Identities = 42/288 (14%), Positives = 79/288 (27%), Gaps = 40/288 (13%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI- 171
+ ++ L G V + + +A K R + ++
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 172 -----------------------NSRFVVSLAYAYETKDA--LCLVLTIMNGGDLKFHIY 206
+ L+ + L++ DL+
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFS 179
Query: 207 NMGGEPGFD----IARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLG 262
+ F I A+++ +L GLV+ P+N+ + G + + D+
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 263 LAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSP--DWFSFGCLIFEMIEGQAPFRRR- 319
G V Y E ++ T++ + + G I+ + PF
Sbjct: 240 ALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 320 ---KEMVKRDEVDRRVKEDAEKYSCR-FSDDAKALCKALLKKSPRSRL 363
K KR + + SC D K L L R RL
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 6/68 (8%), Positives = 15/68 (22%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 710
+ ++ L G V + + +A K R + ++
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 711 SRFVVSLA 718
Sbjct: 121 GESPEEAR 128
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-45
Identities = 64/303 (21%), Positives = 126/303 (41%), Gaps = 35/303 (11%)
Query: 98 RLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 157
L T+++Y + + + + + + +G GG +V + ++YA K + + +
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTL 70
Query: 158 ESMVLIEKQILQKIN--SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD 215
+S E L K+ S ++ L T + +V+ DL + D
Sbjct: 71 DS-YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS---ID 125
Query: 216 IARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG 275
+ Y +L + +H G+V+ D KP N L+ D G +++ D G+A ++ +
Sbjct: 126 PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVV 184
Query: 276 R---VGTVGYMAPEVIDN-----------EKYTYSPD-WFSFGCLIFEMIEGQAPFRRRK 320
+ VGTV YM PE I + K + D W S GC+++ M G+ PF++
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW-SLGCILYYMTYGKTPFQQII 243
Query: 321 EMVKRDEVDRRVKEDAE-KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAE 379
+ + + + + E ++ D + + K LK+ P+ R+ EL
Sbjct: 244 NQISK--LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-------SIPELLAHP 294
Query: 380 FFK 382
+ +
Sbjct: 295 YVQ 297
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 17/101 (16%), Positives = 38/101 (37%), Gaps = 4/101 (3%)
Query: 633 TSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 692
+ V N + + + + + +G GG +V + ++YA K + +
Sbjct: 9 SGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADN 67
Query: 693 RKGESMVLIEKQILQKIN--SRFVVSLAYAYETKDALCLVL 731
+ +S E L K+ S ++ L T + +V+
Sbjct: 68 QTLDS-YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-45
Identities = 65/253 (25%), Positives = 116/253 (45%), Gaps = 10/253 (3%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
FR+ + +G+G F EV G A KK++ + K + + E +L+++N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG-FDIARARFYAAEVLCGLEHLH 234
V+ ++ + L +VL + + GDL I + + Y ++ LEH+H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-RGRVGTVGYMAPEVIDNEKY 293
+++RD KP N+ + G V++ DLGL + VGT YM+PE I Y
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 213
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY----SCRFSDDAKA 349
+ D +S GCL++EM Q+PF K + + +++++ Y S +S++ +
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCKKIEQC--DYPPLPSDHYSEELRQ 269
Query: 350 LCKALLKKSPRSR 362
L + P R
Sbjct: 270 LVNMCINPDPEKR 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 21/99 (21%), Positives = 40/99 (40%), Gaps = 2/99 (2%)
Query: 633 TSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 692
P P + FR+ + +G+G F EV G A KK++ +
Sbjct: 15 QFQPQKALRPDMGYNTL--ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD 72
Query: 693 RKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
K + + E +L+++N V+ ++ + L +VL
Sbjct: 73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 7e-45
Identities = 75/306 (24%), Positives = 126/306 (41%), Gaps = 25/306 (8%)
Query: 74 PQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCAC 133
+H + + R I +++ R LG G +GEV C
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIG--------ESYFKVRKLGSGAYGEVLLC 55
Query: 134 QVRATGKMYACKKLEKKRIKK----------RKGESMVLIEKQILQKINSRFVVSLAYAY 183
+ + A K ++K + K K + E +L+ ++ ++ L +
Sbjct: 56 KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115
Query: 184 ETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDC 243
E K LV GG+L I N FD A ++L G+ +LH +V+RD
Sbjct: 116 EDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHNIVHRDI 172
Query: 244 KPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWF 300
KPENILL + +++I D GL+ + +R R+GT Y+APEV+ +KY D +
Sbjct: 173 KPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL-KKKYNEKCDVW 231
Query: 301 SFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPR 360
S G +++ ++ G PF + + +V++ SD+AK L K +L
Sbjct: 232 SCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYN 291
Query: 361 SRLGCH 366
R
Sbjct: 292 KRCTAE 297
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 26/123 (21%), Positives = 44/123 (35%), Gaps = 13/123 (10%)
Query: 622 ENNTPSSDVMFTSVPPSETNPSCFPQPITYKTFRMY---RVLGKGGFGEVCACQVRATGK 678
++ SS NP + + K Y R LG G +GEV C+ +
Sbjct: 3 HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHS 62
Query: 679 MYACKKLEKKRIKK----------RKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728
A K ++K + K K + E +L+ ++ ++ L +E K
Sbjct: 63 EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122
Query: 729 LVL 731
LV
Sbjct: 123 LVT 125
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-45
Identities = 65/265 (24%), Positives = 126/265 (47%), Gaps = 25/265 (9%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ + LGKG F V C + TG +A K + K++ R + + E +I +K+
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQH 64
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARFY---AAE--- 225
+V L + + + LV ++ GG+L F+ +AR + A+
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL------------FEDIVAREFYSEADASHCIQ 112
Query: 226 -VLCGLEHLHYIGLVYRDCKPENILLDDYG---HVRISDLGLAVEIPEGESVRGRVGTVG 281
+L + + H G+V+R+ KPEN+LL V+++D GLA+E+ + E+ G GT G
Sbjct: 113 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG 172
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341
Y++PEV+ + Y+ D ++ G +++ ++ G PF + ++ +
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232
Query: 342 RFSDDAKALCKALLKKSPRSRLGCH 366
+ +AK+L ++L +P+ R+
Sbjct: 233 TVTPEAKSLIDSMLTVNPKKRITAD 257
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 20/80 (25%), Positives = 36/80 (45%), Gaps = 1/80 (1%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
+ + LGKG F V C + TG +A K + K++ R + + E +I +K+
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQH 64
Query: 712 RFVVSLAYAYETKDALCLVL 731
+V L + + + LV
Sbjct: 65 PNIVRLHDSIQEESFHYLVF 84
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 65/266 (24%), Positives = 126/266 (47%), Gaps = 25/266 (9%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
+ + LGKG F V C + TG +A K + K++ R + + E +I +K+
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQ 86
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARFY---AAE-- 225
+V L + + + LV ++ GG+L F+ +AR + A+
Sbjct: 87 HPNIVRLHDSIQEESFHYLVFDLVTGGEL------------FEDIVAREFYSEADASHCI 134
Query: 226 --VLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTV 280
+L + + H G+V+R+ KPEN+LL V+++D GLA+E+ + E+ G GT
Sbjct: 135 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 194
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS 340
GY++PEV+ + Y+ D ++ G +++ ++ G PF + ++ +
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 254
Query: 341 CRFSDDAKALCKALLKKSPRSRLGCH 366
+ +AK+L ++L +P+ R+
Sbjct: 255 DTVTPEAKSLIDSMLTVNPKKRITAD 280
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 20/81 (24%), Positives = 36/81 (44%), Gaps = 1/81 (1%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 710
+ + LGKG F V C + TG +A K + K++ R + + E +I +K+
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQ 86
Query: 711 SRFVVSLAYAYETKDALCLVL 731
+V L + + + LV
Sbjct: 87 HPNIVRLHDSIQEESFHYLVF 107
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 3e-44
Identities = 58/296 (19%), Positives = 107/296 (36%), Gaps = 41/296 (13%)
Query: 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL 168
Q + + + +LG+G V + + TG ++A K + + + E ++L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVL 61
Query: 169 QKINSRFVVSL--AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
+K+N + +V L T L++ G L + G + +V
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 227 LCGLEHLHYIGLVYRDCKPENILL----DDYGHVRISDLGLAVEIPEGESVRGRVGTVGY 282
+ G+ HL G+V+R+ KP NI+ D +++D G A E+ + E GT Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 283 MAPEVID--------NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK- 333
+ P++ + +KY + D +S G + G PFR + + EV ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 334 --------------------EDAEKYSCRFSDDAKALCK----ALLKKSPRSRLGC 365
SC S + L +L+ G
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 17/87 (19%), Positives = 37/87 (42%), Gaps = 4/87 (4%)
Query: 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL 706
Q + + + +LG+G V + + TG ++A K + + + E ++L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVL 61
Query: 707 QKINSRFVVSL--AYAYETKDALCLVL 731
+K+N + +V L T L++
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIM 88
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 7e-44
Identities = 78/269 (28%), Positives = 127/269 (47%), Gaps = 34/269 (12%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ + + +LGKG FGEV C+ R T + YA K + K K + +L E ++L+K++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDH 80
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARF---YAAE--- 225
++ L E + +V + GG+L FD I R RF AA
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL------------FDEIIKRKRFSEHDAARIIK 128
Query: 226 -VLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTVG 281
V G+ ++H +V+RD KPENILL + ++I D GL+ + ++ R+GT
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA----E 337
Y+APEV+ Y D +S G +++ ++ G PF + E ++ +RV+
Sbjct: 189 YIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNE----YDILKRVETGKYAFDL 243
Query: 338 KYSCRFSDDAKALCKALLKKSPRSRLGCH 366
SDDAK L + +L P R+
Sbjct: 244 PQWRTISDDAKDLIRKMLTFHPSLRITAT 272
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 23/80 (28%), Positives = 41/80 (51%), Gaps = 1/80 (1%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
+ + + +LGKG FGEV C+ R T + YA K + K K + +L E ++L+K++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDH 80
Query: 712 RFVVSLAYAYETKDALCLVL 731
++ L E + +V
Sbjct: 81 PNIMKLFEILEDSSSFYIVG 100
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-44
Identities = 55/296 (18%), Positives = 105/296 (35%), Gaps = 41/296 (13%)
Query: 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL 168
Q + + + +LG+G V + + TG ++A K + + + E ++L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVL 61
Query: 169 QKINSRFVVSL--AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
+K+N + +V L T L++ G L + G + +V
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 227 LCGLEHLHYIGLVYRDCKPENILL----DDYGHVRISDLGLAVEIPEGESVRGRVGTVGY 282
+ G+ HL G+V+R+ KP NI+ D +++D G A E+ + E GT Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 283 MAPEVID--------NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE 334
+ P++ + +KY + D +S G + G PFR + + EV ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 335 -------------------------DAEKYSCRFSDDAKALCKALLKKSPRSRLGC 365
+ S + +L+ G
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 17/87 (19%), Positives = 37/87 (42%), Gaps = 4/87 (4%)
Query: 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL 706
Q + + + +LG+G V + + TG ++A K + + + E ++L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVL 61
Query: 707 QKINSRFVVSL--AYAYETKDALCLVL 731
+K+N + +V L T L++
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIM 88
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 9e-44
Identities = 74/303 (24%), Positives = 124/303 (40%), Gaps = 17/303 (5%)
Query: 71 EAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEV 130
+ Q NY+ + + + + ++ LG G FG V
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173
Query: 131 CACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190
RATG +A K + ++ V E Q + + +V+L A+E + +
Sbjct: 174 HRVTERATGNNFAAKFVMTPHESDKE---TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL 250
++ M+GG+L + + + A Y +V GL H+H V+ D KPENI+
Sbjct: 231 MIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 288
Query: 251 --DDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFE 308
+++ D GL + +SV+ GT + APEV + + Y D +S G L +
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348
Query: 309 MIEGQAPFRRRKEMVKRDEVDRRVKE-----DAEKYSCRFSDDAKALCKALLKKSPRSRL 363
++ G +PF + DE R VK D +S S+D K + LL P +R+
Sbjct: 349 LLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFS-GISEDGKDFIRKLLLADPNTRM 403
Query: 364 GCH 366
H
Sbjct: 404 TIH 406
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 5e-14
Identities = 23/114 (20%), Positives = 43/114 (37%), Gaps = 9/114 (7%)
Query: 624 NTPSSDVMFTSVPPSETNPSCFPQPITYKT------FRMYRVLGKGGFGEVCACQVRATG 677
+ + +PQP+ K + ++ LG G FG V RATG
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG 182
Query: 678 KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
+A K + ++ V E Q + + +V+L A+E + + ++
Sbjct: 183 NNFAAKFVMTPHESDKE---TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-43
Identities = 40/310 (12%), Positives = 86/310 (27%), Gaps = 59/310 (19%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV------------ 161
+T VLG+ + TG+ + +
Sbjct: 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 132
Query: 162 -------------LIEKQILQKINSRFVVSLAYAYETKDALCLVLTIM----NGGDLKFH 204
+ +++ + ++ + L N
Sbjct: 133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 192
Query: 205 IYNMGGEPGFDIARARFY-AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263
+ + + AR +V+ L LH+ GLV+ +P +I+LD G V ++
Sbjct: 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 264 AVEIPEGESVRGRVGTVGYMAPEVIDNE-----------KYTYSPDWFSFGCLIFEMIEG 312
V + G+ PE+ T+S D ++ G +I+ +
Sbjct: 253 LVRDGARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 313 QAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGA 372
P + + + + R K +AL + L+ RL
Sbjct: 310 DLPITKDAALGGSEWIFRSCK--------NIPQPVRALLEGFLRYPKEDRL-------LP 354
Query: 373 RELKQAEFFK 382
+ + ++
Sbjct: 355 LQAMETPEYE 364
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 9/85 (10%), Positives = 20/85 (23%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
+T VLG+ + TG+ + + E L+ +
Sbjct: 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 132
Query: 712 RFVVSLAYAYETKDALCLVLTIIDV 736
A + ++
Sbjct: 133 IKNQKQAKVHLRFIFPFDLVKDPQK 157
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 69/274 (25%), Positives = 124/274 (45%), Gaps = 36/274 (13%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES---MVLIEKQILQ 169
+ + LG G F V C+ ++TG YA K ++K++ + + + E IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 170 KINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IAR-------AR 220
++ V++L YE + + L+L +++GG+L FD + A
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGEL------------FDFLAQKESLSEEEAT 118
Query: 221 FYAAEVLCGLEHLHYIGLVYRDCKPENILL----DDYGHVRISDLGLAVEIPEGESVRGR 276
+ ++L G+ +LH + + D KPENI+L H+++ D GLA EI +G +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA 336
GT ++APE+++ E D +S G + + ++ G +PF + E + +
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANITSVS 234
Query: 337 EKYSCRF----SDDAKALCKALLKKSPRSRLGCH 366
+ F S+ AK + LL K R RL
Sbjct: 235 YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQ 268
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 21/84 (25%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES---MVLIEKQILQ 707
+ + LG G F V C+ ++TG YA K ++K++ + + + E IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 708 KINSRFVVSLAYAYETKDALCLVL 731
++ V++L YE + + L+L
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLIL 94
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 59/257 (22%), Positives = 103/257 (40%), Gaps = 8/257 (3%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
F R LG G FG+V + R++G K + K R + + E ++L+ ++
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDH 79
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG-FDIARARFYAAEVLCGLEH 232
++ + +E + +V+ GG+L I + +++ L +
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 233 LHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVID 289
H +V++D KPENIL + ++I D GLA E GT YMAPEV
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF- 198
Query: 290 NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349
T+ D +S G +++ ++ G PF + + + + + A
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-TYKEPNYAVECRPLTPQAVD 257
Query: 350 LCKALLKKSPRSRLGCH 366
L K +L K P R
Sbjct: 258 LLKQMLTKDPERRPSAA 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 9e-13
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 2/101 (1%)
Query: 631 MFTSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 690
M S + + Q F R LG G FG+V + R++G K + K R
Sbjct: 1 MHHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60
Query: 691 KKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
+ + E ++L+ ++ ++ + +E + +V+
Sbjct: 61 QVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 69/269 (25%), Positives = 120/269 (44%), Gaps = 36/269 (13%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
F + LG+G V C+ + T K YA K +KK + +V E +L +++
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKV-----LKKTVDKKIVRTEIGVLLRLSH 107
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARFY---AAE--- 225
++ L +ET + LVL ++ GG+L FD + + + AA+
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGEL------------FDRIVEKGYYSERDAADAVK 155
Query: 226 -VLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTVG 281
+L + +LH G+V+RD KPEN+L ++I+D GL+ + ++ GT G
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG 215
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341
Y APE++ Y D +S G + + ++ G PF + + RR+ +
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG---DQFMFRRILNCEYYFIS 272
Query: 342 RF----SDDAKALCKALLKKSPRSRLGCH 366
+ S +AK L + L+ P+ RL
Sbjct: 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTF 301
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 28/118 (23%), Positives = 44/118 (37%), Gaps = 12/118 (10%)
Query: 621 GENNTPSSDVMFTSVPPSETNPSCFPQPITYKT-------FRMYRVLGKGGFGEVCACQV 673
EN S T+ T I F + LG+G V C+
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74
Query: 674 RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
+ T K YA K +KK + +V E +L +++ ++ L +ET + LVL
Sbjct: 75 KGTQKPYALKV-----LKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-43
Identities = 77/298 (25%), Positives = 129/298 (43%), Gaps = 35/298 (11%)
Query: 85 SIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYAC 144
I +Y+ ++ + Q Y + + LG G FG V C +ATG+++
Sbjct: 22 KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81
Query: 145 KKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFH 204
K + + V E I+ +++ +++L A+E K + L+L ++GG+L
Sbjct: 82 KFINTPYPLDKY---TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL--- 135
Query: 205 IYNMGGEPGFD--IAR--------ARFYAAEVLCGLEHLHYIGLVYRDCKPENILL--DD 252
FD A Y + GL+H+H +V+ D KPENI+
Sbjct: 136 ---------FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK 186
Query: 253 YGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEG 312
V+I D GLA ++ E V+ T + APE++D E + D ++ G L + ++ G
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
Query: 313 QAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF----SDDAKALCKALLKKSPRSRLGCH 366
+PF + E + VK ++ S +AK K LL+K PR RL H
Sbjct: 247 LSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVH 300
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 24/102 (23%), Positives = 44/102 (43%), Gaps = 9/102 (8%)
Query: 636 PPSETNPSCFPQPITYKT------FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR 689
+ PQP+ K + + LG G FG V C +ATG+++ K +
Sbjct: 29 FYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY 88
Query: 690 IKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
+ V E I+ +++ +++L A+E K + L+L
Sbjct: 89 PLDKY---TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES---MVLIEKQILQ 169
+ M LG G F V C+ + TGK YA K ++K+R+ + + E IL+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 170 KINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IAR-------AR 220
+I +++L +E K + L+L +++GG+L FD + A
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL------------FDFLAEKESLTEDEAT 111
Query: 221 FYAAEVLCGLEHLHYIGLVYRDCKPENILL----DDYGHVRISDLGLAVEIPEGESVRGR 276
+ ++L G+ +LH + + D KPENI+L +++ D G+A +I G +
Sbjct: 112 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171
Query: 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE-- 334
GT ++APE+++ E D +S G + + ++ G +PF + E +
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVN 227
Query: 335 ---DAEKYSCRFSDDAKALCKALLKKSPRSRLGCH 366
D E +S S+ AK + LL K P+ R+
Sbjct: 228 YDFDEEYFS-NTSELAKDFIRRLLVKDPKRRMTIA 261
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 24/84 (28%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES---MVLIEKQILQ 707
+ M LG G F V C+ + TGK YA K ++K+R+ + + E IL+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 708 KINSRFVVSLAYAYETKDALCLVL 731
+I +++L +E K + L+L
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLIL 87
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-43
Identities = 38/307 (12%), Positives = 79/307 (25%), Gaps = 52/307 (16%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
+T VLG+ + TG+ + + E L+ +
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 173 SRFVVSLAYAYETKDALCLVLTIMN-----------------------------GGDLKF 203
A + ++
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 204 HIYNMGGEPGFDIARARFY-AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLG 262
+ + + AR +V+ L LH+ GLV+ +P +I+LD G V ++
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 263 LAVEIPEGESVRG--RVGTVGYMAPEVI-----DNEKYTYSPDWFSFGCLIFEMIEGQAP 315
V A ++ T++ D ++ G I+ + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 316 FRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGAREL 375
+ + + R K +AL + L+ RL +
Sbjct: 317 NTDDAALGGSEWIFRSCK--------NIPQPVRALLEGFLRYPKEDRL-------LPLQA 361
Query: 376 KQAEFFK 382
+ ++
Sbjct: 362 METPEYE 368
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 9/86 (10%), Positives = 20/86 (23%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 710
+T VLG+ + TG+ + + E L+ +
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 711 SRFVVSLAYAYETKDALCLVLTIIDV 736
A + ++
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQK 162
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 68/274 (24%), Positives = 124/274 (45%), Gaps = 36/274 (13%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES---MVLIEKQILQ 169
+ + LG G F V C+ ++TG YA K ++K++ + + + E IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 170 KINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IAR-------AR 220
++ +++L YE + + L+L +++GG+L FD + A
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL------------FDFLAQKESLSEEEAT 118
Query: 221 FYAAEVLCGLEHLHYIGLVYRDCKPENILL----DDYGHVRISDLGLAVEIPEGESVRGR 276
+ ++L G+ +LH + + D KPENI+L H+++ D GLA EI +G +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA 336
GT ++APE+++ E D +S G + + ++ G +PF + E + +
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANITAVS 234
Query: 337 EKYSCRF----SDDAKALCKALLKKSPRSRLGCH 366
+ F S+ AK + LL K R RL
Sbjct: 235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQ 268
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 20/84 (23%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES---MVLIEKQILQ 707
+ + LG G F V C+ ++TG YA K ++K++ + + + E IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 708 KINSRFVVSLAYAYETKDALCLVL 731
++ +++L YE + + L+L
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLIL 94
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 63/295 (21%), Positives = 121/295 (41%), Gaps = 35/295 (11%)
Query: 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK 165
NE + + + + + +G GG +V + ++YA K + + + +S E
Sbjct: 1 NECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDS-YRNEI 58
Query: 166 QILQKIN--SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
L K+ S ++ L T + +V+ DL + D + Y
Sbjct: 59 AYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS---IDPWERKSYW 114
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR---VGTV 280
+L + +H G+V+ D KP N L+ D G +++ D G+A ++ + + VGTV
Sbjct: 115 KNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 281 GYMAPEVIDN-----------EKYTYSPD-WFSFGCLIFEMIEGQAPFRRRKEMVKRDEV 328
YM PE I + K + D W S GC+++ M G+ PF++ + + +
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVW-SLGCILYYMTYGKTPFQQIINQISK--L 230
Query: 329 DRRVKEDAE-KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
+ + E ++ D + + K LK+ P+ R+ EL + +
Sbjct: 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-------SIPELLAHPYVQ 278
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 15/82 (18%), Positives = 34/82 (41%), Gaps = 4/82 (4%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN- 710
+ + + + +G GG +V + ++YA K + + + +S E L K+
Sbjct: 9 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDS-YRNEIAYLNKLQQ 66
Query: 711 -SRFVVSLAYAYETKDALCLVL 731
S ++ L T + +V+
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVM 88
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 34/276 (12%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK------RKGESMVLIEKQ 166
Y+ + +LG+G V C + T K YA K ++ ++ L E
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 167 ILQKINS-RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARFY- 222
IL+K++ ++ L YET LV +M G+L FD +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL------------FDYLTEKVTLSE 123
Query: 223 --AAEV----LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR 276
++ L + LH + +V+RD KPENILLDD +++++D G + ++ GE +R
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183
Query: 277 VGTVGYMAPEVI------DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR 330
GT Y+APE+I ++ Y D +S G +++ ++ G PF RK+M+ +
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 331 RVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCH 366
+ +SD K L L P+ R
Sbjct: 244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 7/88 (7%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK------RKGESMVLIEKQ 704
Y+ + +LG+G V C + T K YA K ++ ++ L E
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 705 ILQKINS-RFVVSLAYAYETKDALCLVL 731
IL+K++ ++ L YET LV
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVF 103
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-43
Identities = 64/296 (21%), Positives = 111/296 (37%), Gaps = 41/296 (13%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + LG+GGFG V + + YA K++ + + V+ E + L K+
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEHPG 64
Query: 176 VVSLAYAYETKDA------------LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
+V A+ K+ L + + + +LK + + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA-------------VEIPEG 270
++ +E LH GL++RD KP NI V++ D GL +P
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR 330
G+VGT YM+PE I Y++ D FS G ++FE++ PF + E R
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQME---RVRTLT 238
Query: 331 RVKE-DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385
V+ + + + +L SP R A + + F+ +
Sbjct: 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPME-------RPEAINIIENAVFEDLD 287
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 2/89 (2%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + LG+GGFG V + + YA K++ + + V+ E + L K+
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEHPG 64
Query: 714 VVSLAYAYETKDALCLVLTIIDVMFTCVQ 742
+V A+ K+ + ++ +Q
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQ 93
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 9e-43
Identities = 59/257 (22%), Positives = 109/257 (42%), Gaps = 15/257 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + +G G +G + ++ GK+ K+L+ + + + + +V E +L+++
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHPN 66
Query: 176 VVSL--AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG-FDIARARFYAAEVLCGLEH 232
+V T L +V+ GGDL I E D ++ L+
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 233 LHYIGL-----VYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-RGRVGTVGYMAPE 286
H ++RD KP N+ LD +V++ D GLA + S + VGT YM+PE
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA-EKYSCRFSD 345
++ Y D +S GCL++E+ PF + E+ +++E + R+SD
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREGKFRRIPYRYSD 242
Query: 346 DAKALCKALLKKSPRSR 362
+ + +L R
Sbjct: 243 ELNEIITRMLNLKDYHR 259
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 14/80 (17%), Positives = 36/80 (45%), Gaps = 3/80 (3%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + +G G +G + ++ GK+ K+L+ + + + + +V E +L+++
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHPN 66
Query: 714 VVSL--AYAYETKDALCLVL 731
+V T L +V+
Sbjct: 67 IVRYYDRIIDRTNTTLYIVM 86
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 73/270 (27%), Positives = 120/270 (44%), Gaps = 28/270 (10%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES---MVLIEKQILQ 169
+ LG G F V C+ ++TG YA K ++K+R K + + E IL+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 170 KINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARFY---AA 224
+I V++L YE K + L+L ++ GG+L FD + A
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGEL------------FDFLAEKESLTEEEAT 117
Query: 225 E----VLCGLEHLHYIGLVYRDCKPENILL----DDYGHVRISDLGLAVEIPEGESVRGR 276
E +L G+ +LH + + + D KPENI+L ++I D GLA +I G +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA 336
GT ++APE+++ E D +S G + + ++ G +PF + V E
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 337 EKYSCRFSDDAKALCKALLKKSPRSRLGCH 366
++Y S AK + LL K P+ R+
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 267
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 25/84 (29%), Positives = 40/84 (47%), Gaps = 3/84 (3%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES---MVLIEKQILQ 707
+ LG G F V C+ ++TG YA K ++K+R K + + E IL+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 708 KINSRFVVSLAYAYETKDALCLVL 731
+I V++L YE K + L+L
Sbjct: 70 EIQHPNVITLHEVYENKTDVILIL 93
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-42
Identities = 62/295 (21%), Positives = 120/295 (40%), Gaps = 35/295 (11%)
Query: 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK 165
NE + + + + + +G GG +V + ++YA K + + + +S E
Sbjct: 48 NECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDS-YRNEI 105
Query: 166 QILQKIN--SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
L K+ S ++ L T + +V+ DL + D + Y
Sbjct: 106 AYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS---IDPWERKSYW 161
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR---VGTV 280
+L + +H G+V+ D KP N L+ D G +++ D G+A ++ + + VG V
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 281 GYMAPEVIDN-----------EKYTYSPD-WFSFGCLIFEMIEGQAPFRRRKEMVKRDEV 328
YM PE I + K + D W S GC+++ M G+ PF++ + + +
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVW-SLGCILYYMTYGKTPFQQIINQISK--L 277
Query: 329 DRRVKEDAE-KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
+ + E ++ D + + K LK+ P+ R+ EL + +
Sbjct: 278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-------SIPELLAHPYVQ 325
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 16/101 (15%), Positives = 39/101 (38%), Gaps = 4/101 (3%)
Query: 633 TSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 692
T ++ + + + + + + +G GG +V + ++YA K + +
Sbjct: 37 TDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADN 95
Query: 693 RKGESMVLIEKQILQKIN--SRFVVSLAYAYETKDALCLVL 731
+ +S E L K+ S ++ L T + +V+
Sbjct: 96 QTLDS-YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 62/334 (18%), Positives = 119/334 (35%), Gaps = 66/334 (19%)
Query: 91 LEMDENRRLSTKDIYNEIQPIT--YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLE 148
+ + +++Y + + K + + +G+G +G V T + A K +
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 149 KKRIKKRKGES--MVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY 206
K +I++ + + E ++++K++ + L YE + +CLV+ + +GG L +
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 207 NMGGEPGFDIAR-------------------------------------ARFYAAEVLCG 229
+ A ++
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 230 LEHLHYIGLVYRDCKPENILL--DDYGHVRISDLGLAVEIP-----EGESVRGRVGTVGY 282
L +LH G+ +RD KPEN L + +++ D GL+ E E + + GT +
Sbjct: 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 283 MAPEVIDNEKYTYSP--DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS 340
+APEV++ +Y P D +S G L+ ++ G PF D
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF--------PGVNDADTISQVLNKK 292
Query: 341 CRF--------SDDAKALCKALLKKSPRSRLGCH 366
F S A+ L LL ++ R
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 18/82 (21%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES--MVLIEKQILQKI 709
K + + +G+G +G V T + A K + K +I++ + + E ++++K+
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 710 NSRFVVSLAYAYETKDALCLVL 731
+ + L YE + +CLV+
Sbjct: 86 HHPNIARLYEVYEDEQYICLVM 107
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 73/265 (27%), Positives = 119/265 (44%), Gaps = 16/265 (6%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM--VLIEKQILQK 170
+ + V+GKG F V C R TG+ +A K ++ + G S + E I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG-FDIARARFYAAEVLCG 229
+ +V L Y + L +V M+G DL F I + A A Y ++L
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 230 LEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPE-GESVRGRVGTVGYMAP 285
L + H +++RD KP +LL ++ V++ G+A+++ E G GRVGT +MAP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 286 EVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF-- 343
EV+ E Y D + G ++F ++ G PF KE + + + K + R
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQWS 257
Query: 344 --SDDAKALCKALLKKSPRSRLGCH 366
S+ AK L + +L P R+ +
Sbjct: 258 HISESAKDLVRRMLMLDPAERITVY 282
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 21/83 (25%), Positives = 34/83 (40%), Gaps = 2/83 (2%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM--VLIEKQILQK 708
+ + V+GKG F V C R TG+ +A K ++ + G S + E I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 709 INSRFVVSLAYAYETKDALCLVL 731
+ +V L Y + L +V
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVF 105
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 59/271 (21%), Positives = 109/271 (40%), Gaps = 38/271 (14%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
Y+ + + LG+G FG V C ++ K Y K ++ K + +V E IL
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIAR 59
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARFY----AAE- 225
R ++ L ++E+ + L ++ ++G D+ F+ A
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDI------------FERINTSAFELNEREIVSY 107
Query: 226 ---VLCGLEHLHYIGLVYRDCKPENILL--DDYGHVRISDLGLAVEIPEGESVRGRVGTV 280
V L+ LH + + D +PENI+ ++I + G A ++ G++ R
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE-----D 335
Y APEV ++ + + D +S G L++ ++ G PF ++ + D
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFD 223
Query: 336 AEKYSCRFSDDAKALCKALLKKSPRSRLGCH 366
E + S +A LL K +SR+
Sbjct: 224 EEAFK-EISIEAMDFVDRLLVKERKSRMTAS 253
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 20/81 (24%), Positives = 38/81 (46%), Gaps = 4/81 (4%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 710
Y+ + + LG+G FG V C ++ K Y K ++ K + +V E IL
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIAR 59
Query: 711 SRFVVSLAYAYETKDALCLVL 731
R ++ L ++E+ + L ++
Sbjct: 60 HRNILHLHESFESMEELVMIF 80
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 66/266 (24%), Positives = 117/266 (43%), Gaps = 36/266 (13%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR-FVVS 178
+ LG+G F V C ++TG+ YA K L+K+R + + +L E +L+ S V++
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVIN 93
Query: 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IAR---------ARFYAAEVL 227
L YE + L+L GG++ F + ++L
Sbjct: 94 LHEVYENTSEIILILEYAAGGEI------------FSLCLPELAEMVSENDVIRLIKQIL 141
Query: 228 CGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMA 284
G+ +LH +V+ D KP+NILL G ++I D G++ +I +R +GT Y+A
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLA 201
Query: 285 PEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF- 343
PE+++ + T + D ++ G + + ++ +PF E + + YS
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ----ETYLNISQVNVDYSEETF 257
Query: 344 ---SDDAKALCKALLKKSPRSRLGCH 366
S A ++LL K+P R
Sbjct: 258 SSVSQLATDFIQSLLVKNPEKRPTAE 283
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 2/75 (2%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR-FVVS 716
+ LG+G F V C ++TG+ YA K L+K+R + + +L E +L+ S V++
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVIN 93
Query: 717 LAYAYETKDALCLVL 731
L YE + L+L
Sbjct: 94 LHEVYENTSEIILIL 108
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-42
Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 36/269 (13%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ + + +G+G +GEV + T A KK+ K ++ E +I++ ++
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD---RFKQEIEIMKSLDH 65
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARF---YAAE--- 225
++ L +E + LV+ + GG+L F+ + + F AA
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGEL------------FERVVHKRVFRESDAARIMK 113
Query: 226 -VLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTVG 281
VL + + H + + +RD KPEN L +++ D GLA G+ +R +VGT
Sbjct: 114 DVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY 173
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA----E 337
Y++P+V+ Y D +S G +++ ++ G PF + EV +++E E
Sbjct: 174 YVSPQVL-EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTD----SEVMLKIREGTFTFPE 228
Query: 338 KYSCRFSDDAKALCKALLKKSPRSRLGCH 366
K S A++L + LL KSP+ R+
Sbjct: 229 KDWLNVSPQAESLIRRLLTKSPKQRITSL 257
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 16/80 (20%), Positives = 36/80 (45%), Gaps = 3/80 (3%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
+ + + +G+G +GEV + T A KK+ K ++ E +I++ ++
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD---RFKQEIEIMKSLDH 65
Query: 712 RFVVSLAYAYETKDALCLVL 731
++ L +E + LV+
Sbjct: 66 PNIIRLYETFEDNTDIYLVM 85
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 79/265 (29%), Positives = 127/265 (47%), Gaps = 28/265 (10%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
KTF VLG G F EV + R TGK++A K ++K +S + E +L+KI
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK---SPAFRDSSLENEIAVLKKIKH 65
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARFY---AAE--- 225
+V+L YE+ LV+ +++GG+L FD + R + A+
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGEL------------FDRILERGVYTEKDASLVIQ 113
Query: 226 -VLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTVG 281
VL +++LH G+V+RD KPEN+L ++ + I+D GL+ G + GT G
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPG 172
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341
Y+APEV+ + Y+ + D +S G + + ++ G PF E +++ E +
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD 232
Query: 342 RFSDDAKALCKALLKKSPRSRLGCH 366
S+ AK LL+K P R C
Sbjct: 233 DISESAKDFICHLLEKDPNERYTCE 257
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
KTF VLG G F EV + R TGK++A K ++K +S + E +L+KI
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK---SPAFRDSSLENEIAVLKKIKH 65
Query: 712 RFVVSLAYAYETKDALCLVL 731
+V+L YE+ LV+
Sbjct: 66 ENIVTLEDIYESTTHYYLVM 85
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-42
Identities = 70/293 (23%), Positives = 133/293 (45%), Gaps = 24/293 (8%)
Query: 86 IENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACK 145
+ + +++ + K + + M + LG G GEV R T K A +
Sbjct: 115 VFVFFDLTVDDQSVYPKALR--------DEYIMSKTLGSGACGEVKLAFERKTCKKVAIR 166
Query: 146 KLEKKRI-----KKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGD 200
+ K++ ++ V E +IL+K+N ++ + ++ +D +VL +M GG+
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGE 225
Query: 201 LKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL---DDYGHVR 257
L + A + Y ++L +++LH G+++RD KPEN+LL ++ ++
Sbjct: 226 LFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIK 282
Query: 258 ISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYT-YSP--DWFSFGCLIFEMIEGQA 314
I+D G + + E +R GT Y+APEV+ + Y+ D +S G ++F + G
Sbjct: 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
Query: 315 PFRR-RKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCH 366
PF R ++ +D++ + S+ A L K LL P++R
Sbjct: 343 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 395
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 25/112 (22%), Positives = 51/112 (45%), Gaps = 7/112 (6%)
Query: 625 TPSSDVMFTSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK 684
+ S + +F + + S +P+ + + M + LG G GEV R T K A +
Sbjct: 109 SLSRNKVFVFFDLTVDDQSVYPKALR-DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRI 167
Query: 685 LEKKRI-----KKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
+ K++ ++ V E +IL+K+N ++ + ++ +D +VL
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVL 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-42
Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 29/270 (10%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
Y + LG+G F C + + + +A K I KR E+ E L+
Sbjct: 10 YDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKI-----ISKRM-EANTQKEITALKLCE 63
Query: 173 S-RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLE 231
+V L + + LV+ ++NGG+L I F A + +++ +
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVS 120
Query: 232 HLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEI-PEGESVRGRVGTVGYMAPEV 287
H+H +G+V+RD KPEN+L +D ++I D G A P+ + ++ T+ Y APE+
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 288 IDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD---RRVKEDAEKYSCRF- 343
++ Y S D +S G +++ M+ GQ PF+ + +++K+ +S F
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG--DFS--FE 236
Query: 344 -------SDDAKALCKALLKKSPRSRLGCH 366
S +AK L + LL P RL
Sbjct: 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 710
Y + LG+G F C + + + +A K I KR E+ E L+
Sbjct: 10 YDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKI-----ISKRM-EANTQKEITALKLCE 63
Query: 711 S-RFVVSLAYAYETKDALCLVL 731
+V L + + LV+
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVM 85
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 71/278 (25%), Positives = 120/278 (43%), Gaps = 39/278 (14%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK-----QI 167
Y+ + V+G+G V C RATG +A K +E + + + E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 168 LQKI----NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARF 221
L+++ + +++L +YE+ + LV +M G+L FD +
Sbjct: 153 LRQVAGHPH---IITLIDSYESSSFMFLVFDLMRKGEL------------FDYLTEKVAL 197
Query: 222 Y---AAEV----LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274
+ L + LH +V+RD KPENILLDD +R+SD G + + GE +R
Sbjct: 198 SEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR 257
Query: 275 GRVGTVGYMAPEVIDNEKYT----YSP--DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEV 328
GT GY+APE++ Y D ++ G ++F ++ G PF R++++ +
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317
Query: 329 DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCH 366
+ + S K L LL+ P +RL
Sbjct: 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAE 355
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 25/116 (21%), Positives = 49/116 (42%), Gaps = 12/116 (10%)
Query: 625 TPSSDVMFTSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK 684
+ ++ F S+ P + P Y+ + V+G+G V C RATG +A K
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 685 LEKKRIKKRKGESMVLIEK-----QILQKI----NSRFVVSLAYAYETKDALCLVL 731
+E + + + E IL+++ + +++L +YE+ + LV
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPH---IITLIDSYESSSFMFLVF 179
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 71/296 (23%), Positives = 124/296 (41%), Gaps = 50/296 (16%)
Query: 97 RRLSTKDIYNEIQPIT---YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 153
+ + I ++ + + + +G G + C +AT +A K ++K +
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 154 KRKGESMVLIEKQILQK-INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEP 212
+ E +IL + +++L Y+ + +V +M GG+L
Sbjct: 62 PTE-------EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----------- 103
Query: 213 GFD-IARARFY----AAEVLC----GLEHLHYIGLVYRDCKPENILL----DDYGHVRIS 259
D I R +F+ A+ VL +E+LH G+V+RD KP NIL + +RI
Sbjct: 104 -LDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 260 DLGLAVEI-PEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRR 318
D G A ++ E + T ++APEV++ + Y + D +S G L++ M+ G PF
Sbjct: 163 DFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222
Query: 319 RKEMVKRDEVDRRVKEDAEKYSCRF--------SDDAKALCKALLKKSPRSRLGCH 366
+ +E+ R+ K+S SD AK L +L P RL
Sbjct: 223 GPDDTP-EEILARIGSG--KFS--LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 14/82 (17%), Positives = 32/82 (39%), Gaps = 8/82 (9%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-I 709
+ + +G G + C +AT +A K ++K + + E +IL +
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-------EIEILLRYG 73
Query: 710 NSRFVVSLAYAYETKDALCLVL 731
+++L Y+ + +V
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVT 95
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-41
Identities = 63/266 (23%), Positives = 122/266 (45%), Gaps = 26/266 (9%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ ++++ LGKG F V C G+ YA + K++ R + + E +I + +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-KLEREARICRLLKH 69
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARFY---AAE--- 225
+V L + + L+ ++ GG+L F+ +AR + A+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL------------FEDIVAREYYSEADASHCIQ 117
Query: 226 -VLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEI-PEGESVRGRVGTV 280
+L + H H +G+V+R+ KPEN+LL V+++D GLA+E+ E ++ G GT
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS 340
GY++PEV+ + Y D ++ G +++ ++ G PF + ++ +
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237
Query: 341 CRFSDDAKALCKALLKKSPRSRLGCH 366
+ +AK L +L +P R+
Sbjct: 238 DTVTPEAKDLINKMLTINPSKRITAA 263
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 17/80 (21%), Positives = 35/80 (43%), Gaps = 1/80 (1%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
+ ++++ LGKG F V C G+ YA + K++ R + + E +I + +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-KLEREARICRLLKH 69
Query: 712 RFVVSLAYAYETKDALCLVL 731
+V L + + L+
Sbjct: 70 PNIVRLHDSISEEGHHYLIF 89
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 71/277 (25%), Positives = 129/277 (46%), Gaps = 19/277 (6%)
Query: 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ 169
P + + + R LGKGGF + T +++A K + K + K + +E I +
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 170 KINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCG 229
+ + VV +E D + +VL + L AR+Y +++ G
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLG 127
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEGESVRGRVGTVGYMAPEVI 288
++LH +++RD K N+ L++ V+I D GLA ++ +GE + GT Y+APEV+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 187
Query: 289 DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC--RFSDD 346
+ +++ D +S GC+++ ++ G+ PF E R+K+ +YS +
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIKK--NEYSIPKHINPV 241
Query: 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383
A +L + +L+ P +R + EL EFF S
Sbjct: 242 AASLIQKMLQTDPTARPTIN-------ELLNDEFFTS 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 9e-09
Identities = 22/94 (23%), Positives = 41/94 (43%)
Query: 638 SETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES 697
++ P P + + + R LGKGGF + T +++A K + K + K
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 698 MVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
+ +E I + + + VV +E D + +VL
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 73/307 (23%), Positives = 135/307 (43%), Gaps = 20/307 (6%)
Query: 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI 167
+ P + + + R LGKGGF + T +++A K + K + K + +E I
Sbjct: 35 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 94
Query: 168 LQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVL 227
+ + + VV +E D + +VL + L AR+Y +++
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIV 151
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRV-GTVGYMAPE 286
G ++LH +++RD K N+ L++ V+I D GLA ++ + + GT Y+APE
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 211
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC--RFS 344
V+ + +++ D +S GC+++ ++ G+ PF E R+K++ +YS +
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIKKN--EYSIPKHIN 265
Query: 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS-TNWKRLEAGLCDPPFVPDVK 403
A +L + +L+ P +R + EL EFF S RL P +
Sbjct: 266 PVAASLIQKMLQTDPTARPTIN-------ELLNDEFFTSGYIPARLPITCLTIPPRFSIA 318
Query: 404 RDEVDRR 410
+D
Sbjct: 319 PSSLDPS 325
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 24/96 (25%), Positives = 43/96 (44%)
Query: 636 PPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 695
PP++ P P + + + R LGKGGF + T +++A K + K + K
Sbjct: 25 PPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ 84
Query: 696 ESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
+ +E I + + + VV +E D + +VL
Sbjct: 85 REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 69/258 (26%), Positives = 110/258 (42%), Gaps = 22/258 (8%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RFVVSL 179
VLG G G+V C R TG+ A K L ++ E + + +V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQASGGPHIVCI 87
Query: 180 AYAYET----KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
YE K L +++ M GG+L I G + F A ++ ++ LH
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHS 146
Query: 236 IGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEK 292
+ +RD KPEN+L + ++++D G A E + ++ T Y+APEV+ EK
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEK 205
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA----EKYSCRFSDDAK 348
Y S D +S G +++ ++ G PF + RR++ S+DAK
Sbjct: 206 YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAK 265
Query: 349 ALCKALLKKSPRSRLGCH 366
L + LLK P RL
Sbjct: 266 QLIRLLLKTDPTERLTIT 283
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 21/85 (24%), Positives = 31/85 (36%), Gaps = 13/85 (15%)
Query: 646 PQPITYKTFRMYR----VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI 701
P+P Y Y+ VLG G G+V C R TG+ A K L ++
Sbjct: 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-------- 70
Query: 702 EKQILQKINS-RFVVSLAYAYETKD 725
E + + +V + YE
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMH 95
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-40
Identities = 66/269 (24%), Positives = 124/269 (46%), Gaps = 37/269 (13%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 174
T +LG G FG+V C+ ATG A K ++ + +K ++ V E ++ +++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE---EVKNEISVMNQLDHA 146
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IAR--------ARFYAA 224
++ L A+E+K+ + LV+ ++GG+L FD I +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGEL------------FDRIIDESYNLTELDTILFMK 194
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILL--DDYGHVRISDLGLAVEIPEGESVRGRVGTVGY 282
++ G+ H+H + +++ D KPENIL D ++I D GLA E ++ GT +
Sbjct: 195 QICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEF 254
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE-----DAE 337
+APEV++ + ++ D +S G + + ++ G +PF + E + + E
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILACRWDLEDE 310
Query: 338 KYSCRFSDDAKALCKALLKKSPRSRLGCH 366
++ S++AK LL K R+
Sbjct: 311 EFQ-DISEEAKEFISKLLIKEKSWRISAS 338
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 22/79 (27%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 712
T +LG G FG+V C+ ATG A K ++ + +K ++ V E ++ +++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE---EVKNEISVMNQLDHA 146
Query: 713 FVVSLAYAYETKDALCLVL 731
++ L A+E+K+ + LV+
Sbjct: 147 NLIQLYDAFESKNDIVLVM 165
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-40
Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 31/270 (11%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
YK +VLG G G+V + T + +A K L+ +R E ++ + +
Sbjct: 63 YKVTS--QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRAS 112
Query: 173 S-RFVVSLAYAYET----KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVL 227
+V + YE + L +V+ ++GG+L I + G + F A +
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIG 171
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGH---VRISDLGLAVEIPEGESVRGRVGTVGYMA 284
+++LH I + +RD KPEN+L ++++D G A E S+ T Y+A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 285 PEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF- 343
PEV+ EKY S D +S G +++ ++ G PF + + R++ +Y F
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG--QYE--FP 287
Query: 344 -------SDDAKALCKALLKKSPRSRLGCH 366
S++ K L + LLK P R+
Sbjct: 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 317
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 18/77 (23%), Positives = 31/77 (40%), Gaps = 11/77 (14%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 710
YK +VLG G G+V + T + +A K L+ +R E ++ + +
Sbjct: 63 YKVTS--QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRAS 112
Query: 711 S-RFVVSLAYAYETKDA 726
+V + YE A
Sbjct: 113 QCPHIVRIVDVYENLYA 129
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 66/252 (26%), Positives = 118/252 (46%), Gaps = 13/252 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F++ +LGKG F V + TG A K ++KK + K V E +I ++
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 176 VVSLAYAY-ETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
++ L Y Y E + + LVL + + G++ ++ N F AR + +++ G+ +LH
Sbjct: 73 ILEL-YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQIITGMLYLH 129
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRV-GTVGYMAPEVIDNEKY 293
G+++RD N+LL +++I+D GLA ++ + GT Y++PE+ +
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC--RFSDDAKALC 351
D +S GC+ + ++ G+ PF +V Y S +AK L
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVK----NTLNKVV--LADYEMPSFLSIEAKDLI 243
Query: 352 KALLKKSPRSRL 363
LL+++P RL
Sbjct: 244 HQLLRRNPADRL 255
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 5e-06
Identities = 26/91 (28%), Positives = 43/91 (47%), Gaps = 4/91 (4%)
Query: 642 PSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI 701
+C + I + F++ +LGKG F V + TG A K ++KK + K V
Sbjct: 3 ATCIGEKI--EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 702 EKQILQKINSRFVVSLAYAY-ETKDALCLVL 731
E +I ++ ++ L Y Y E + + LVL
Sbjct: 61 EVKIHCQLKHPSILEL-YNYFEDSNYVYLVL 90
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 40/278 (14%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGESMVLIEKQI 167
+ M + LG G GEV R T K A K + K++ ++ V E +I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 168 LQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD--IARARFYAAE 225
L+K+N ++ + ++ +D +VL +M GG+L FD + R A
Sbjct: 69 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGEL------------FDKVVGNKRLKEAT 115
Query: 226 -------VLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRG 275
+L +++LH G+++RD KPEN+LL ++ ++I+D G + + E +R
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175
Query: 276 RVGTVGYMAPEVIDNEKYT-YSP--DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV 332
GT Y+APEV+ + Y+ D +S G ++F + G PF + + + ++
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR---TQVSLKDQI 232
Query: 333 KEDA----EKYSCRFSDDAKALCKALLKKSPRSRLGCH 366
+ S+ A L K LL P++R
Sbjct: 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 24/94 (25%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 643 SCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGES 697
S +P+ + + M + LG G GEV R T K A K + K++ ++
Sbjct: 2 SVYPKALR-DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 698 MVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
V E +IL+K+N ++ + ++ +D +VL
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAED-YYIVL 93
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 60/270 (22%), Positives = 91/270 (33%), Gaps = 34/270 (12%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSR 174
F +G G FG V C R G +YA K+ KK + E L E +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG-FDIARARFYAAEVLCGLEHL 233
VV A+ D + + NGG L I F A + +V GL ++
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 234 HYIGLVYRDCKPENILLDDYGH-------------------VRISDLGLAVEIPEGESVR 274
H + LV+ D KP NI + +I DLG I +
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE- 190
Query: 275 GRVGTVGYMAPEVIDNEKYTYSP--DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV 332
G ++A EV+ E YT+ P D F+ + + R + +
Sbjct: 191 --EGDSRFLANEVL-QENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE------IR 241
Query: 333 KEDAEKYSCRFSDDAKALCKALLKKSPRSR 362
+ + S + L K ++ P R
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERR 271
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 21/79 (26%), Positives = 29/79 (36%), Gaps = 2/79 (2%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSR 712
F +G G FG V C R G +YA K+ KK + E L E +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 713 FVVSLAYAYETKDALCLVL 731
VV A+ D + +
Sbjct: 72 HVVRYFSAWAEDDHMLIQN 90
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-39
Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 24/292 (8%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ M LG GGFG V + TG+ A K+ ++ K + +E QI++K+N
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKKLNHPN 73
Query: 176 VVSLAYAYETK------DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCG 229
VVS + D L + GGDL+ ++ G R +++
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGH---VRISDLGLAVEIPEGESVRGRVGTVGYMAPE 286
L +LH +++RD KPENI+L +I DLG A E+ +GE VGT+ Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPF----------RRRKEMVKRDEVDRRVKEDA 336
+++ +KYT + D++SFG L FE I G PF + +E V A
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253
Query: 337 EKYSCRFSDDAK--ALCKALLKKSPRSRLGCH-CGRYGARELKQAEFFKSTN 385
K+S + L++ + L H R + F++ +
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 23/84 (27%), Positives = 36/84 (42%), Gaps = 2/84 (2%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ M LG GGFG V + TG+ A K+ ++ K + +E QI++K+N
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKKLNHPN 73
Query: 714 VVSLAYAYETKDALCLVLTIIDVM 737
VVS + L + M
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAM 97
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 63/269 (23%), Positives = 104/269 (38%), Gaps = 24/269 (8%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K + + LG+GGF V + G YA K++ + R+ E + + N
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE---EAQREADMHRLFNH 85
Query: 174 RFVVSL-AYAYETKDA---LCLVLTIMNGGDLKFHIYNMGGEPG-FDIARARFYAAEVLC 228
++ L AY + A L+L G L I + + + + +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 229 GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA----------VEIPEGESVRGRVG 278
GLE +H G +RD KP NILL D G + DLG + + +
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 279 TVGYMAPEVIDNEKY---TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED 335
T+ Y APE+ + + D +S GC+++ M+ G+ P+ + K D V V+
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ--KGDSVALAVQNQ 263
Query: 336 AEK-YSCRFSDDAKALCKALLKKSPRSRL 363
S R S L +++ P R
Sbjct: 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRP 292
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 20/84 (23%), Positives = 34/84 (40%), Gaps = 7/84 (8%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
K + + LG+GGF V + G YA K++ + R+ E + + N
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE---EAQREADMHRLFNH 85
Query: 712 RFVVSL-AYAYETKDA---LCLVL 731
++ L AY + A L+L
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLL 109
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-37
Identities = 62/287 (21%), Positives = 111/287 (38%), Gaps = 31/287 (10%)
Query: 91 LEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 150
LE D+ ++ I +I F VLG G G + + + A K++ +
Sbjct: 7 LEQDDGDEETSVVIVGKIS------FCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPE 59
Query: 151 RIKKRKGESMVLIEKQILQKINS-RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 209
E + Q+L++ + V+ + + + + + L+ ++
Sbjct: 60 CFSFADRE----V--QLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112
Query: 210 GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH-----VRISDLGLA 264
+ GL HLH + +V+RD KP NIL+ ISD GL
Sbjct: 113 FAHLGLEPITLLQ--QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
Query: 265 VEIPEGES----VRGRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
++ G G GT G++APE++ E TY+ D FS GC+ + +I EG PF
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230
Query: 317 RRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRL 363
+ + + + + D A+ L + ++ P+ R
Sbjct: 231 GKSLQR-QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP 276
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 12/80 (15%), Positives = 29/80 (36%), Gaps = 8/80 (10%)
Query: 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS- 711
+F VLG G G + + + A K++ + E + Q+L++ +
Sbjct: 25 SFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADRE----V--QLLRESDEH 77
Query: 712 RFVVSLAYAYETKDALCLVL 731
V+ + + + +
Sbjct: 78 PNVIRYFCTEKDRQFQYIAI 97
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 60/288 (20%), Positives = 104/288 (36%), Gaps = 38/288 (13%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+G+G FGEV + + TG A KK+ + + E ++S
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPR 111
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V L A + + + ++ GG L + G RA +Y + L GLE+LH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLG-QLIKQMGC--LPEDRALYYLGQALEGLEYLHT 168
Query: 236 IGLVYRDCKPENILLDDYG-HVRISDLGLAVEIPEGESVRGR------VGTVGYMAPEVI 288
+++ D K +N+LL G + D G A+ + + GT +MAPEV+
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 289 DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM------VKRDEVDRRVKEDAEKYSCR 342
+ D +S C++ M+ G P+ + R +
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPS------- 281
Query: 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLE 390
+ + L+K P R A EL++ L+
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRA-------SAMELRRKVGKALQEVGGLK 322
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 17/98 (17%), Positives = 33/98 (33%), Gaps = 8/98 (8%)
Query: 634 SVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 693
+ + P + +G+G FGEV + + TG A KK+ + +
Sbjct: 40 VLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE 99
Query: 694 KGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
E ++S +V L A + + +
Sbjct: 100 --------ELVACAGLSSPRIVPLYGAVREGPWVNIFM 129
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 74/280 (26%), Positives = 105/280 (37%), Gaps = 42/280 (15%)
Query: 121 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RFVVSL 179
VLG+G V C T + YA K +EK + S V E ++L + R V+ L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEK---QPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
+E +D LV M GG + HI+ F+ A +V L+ LH G+
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKGIA 133
Query: 240 YRDCKPENILLDDYGH---VRISDLGLAVEIPEGESVR--------GRVGTVGYMAPEVI 288
+RD KPENIL + V+I D L I G+ YMAPEV+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 289 D-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE------ 337
+ Y D +S G +++ ++ G PF R +
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253
Query: 338 ---KYSCRF--------SDDAKALCKALLKKSPRSRLGCH 366
KY F S AK L LL + + RL
Sbjct: 254 QEGKYE--FPDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 23/74 (31%), Positives = 33/74 (44%), Gaps = 4/74 (5%)
Query: 659 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RFVVSL 717
VLG+G V C T + YA K +EK + S V E ++L + R V+ L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEK---QPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 718 AYAYETKDALCLVL 731
+E +D LV
Sbjct: 77 IEFFEEEDRFYLVF 90
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-36
Identities = 58/290 (20%), Positives = 110/290 (37%), Gaps = 50/290 (17%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-- 171
++LG G G V G+ A K++ + L+E ++L +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDD 67
Query: 172 --NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV--- 226
N V+ + T L + L + +L+ + + + + +
Sbjct: 68 HPN---VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 227 -LCGLEHLHYIGLVYRDCKPENILLD-------------DYGHVRISDLGLAVEIPEGES 272
G+ HLH + +++RD KP+NIL+ + + ISD GL ++ G+S
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 273 -----VRGRVGTVGYMAPEVIDN-------EKYTYSPDWFSFGCLIFEMI-EGQAPF--- 316
+ GT G+ APE+++ + T S D FS GC+ + ++ +G+ PF
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 317 RRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCH 366
R+ + R + E + +A L ++ P R
Sbjct: 244 YSRESNIIRGIFS--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 14/84 (16%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-- 709
++LG G G V G+ A K++ + L+E ++L +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDD 67
Query: 710 --NSRFVVSLAYAYETKDALCLVL 731
N V+ + T L + L
Sbjct: 68 HPN---VIRYYCSETTDRFLYIAL 88
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 70/284 (24%), Positives = 126/284 (44%), Gaps = 49/284 (17%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI------------ 163
+ + +GKG +G V YA K L KK++ ++ G
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 164 -----------EKQILQKINSRFVVSLAYAYE-----TKDALCLVLTIMNGGDLKFHIYN 207
E IL+K++ VV L E +D L +V ++N G + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKL---VEVLDDPNEDHLYMVFELVNQGPV-MEVPT 130
Query: 208 MGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267
+ +ARFY +++ G+E+LHY +++RD KP N+L+ + GH++I+D G++ E
Sbjct: 131 LKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 268 PEGESV-RGRVGTVGYMAPEVIDNEKYTYSP---DWFSFGCLIFEMIEGQAPFRRRKEMV 323
+++ VGT +MAPE + + +S D ++ G ++ + GQ PF + M
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM- 246
Query: 324 KRDEVDRRVKEDAEKYSC----RFSDDAKALCKALLKKSPRSRL 363
+ ++K ++D K L +L K+P SR+
Sbjct: 247 ---CLHSKIKSQ--ALEFPDQPDIAEDLKDLITRMLDKNPESRI 285
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 61/332 (18%), Positives = 118/332 (35%), Gaps = 37/332 (11%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK-----QILQK 170
+ LG G FG V + K K ++K+++ + + K IL +
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 171 INSRFVVSLAYAYETKDALCLVLTI-MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCG 229
+ ++ + +E + LV+ +G DL I D A + +++
Sbjct: 86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSA 142
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVID 289
+ +L +++RD K ENI++ + +++ D G A + G+ GT+ Y APEV+
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 290 NEKYTYSP-DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC--RFSDD 346
Y + +S G ++ ++ + PF E++ V+ S +
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPF---------CELEETVE---AAIHPPYLVSKE 250
Query: 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
+L LL+ P R +L W L D + + ++
Sbjct: 251 LMSLVSGLLQPVPER-------RTTLEKLVTDP------WVTQPVNLADYTWEEVFRVNK 297
Query: 407 VDRRVKEDAEKYSCRFSDDAKALCKALLKKSP 438
+ V A S A + L
Sbjct: 298 PESGVLSAASLEMGNRSLSDVAQAQELCGGEG 329
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 16/104 (15%), Positives = 35/104 (33%), Gaps = 5/104 (4%)
Query: 633 TSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 692
E + + + LG G FG V + K K ++K+++ +
Sbjct: 5 EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE 64
Query: 693 RKGESMVLIEK-----QILQKINSRFVVSLAYAYETKDALCLVL 731
+ K IL ++ ++ + +E + LV+
Sbjct: 65 DCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 10/212 (4%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMVLIEKQIL 168
I + + +G G FG V RA G A K L ++ + + L E I+
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVH----RAEWHGSDVAVKILMEQDFHAER-VNEFLREVAIM 88
Query: 169 QKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC 228
+++ +V A L +V ++ G L ++ G D R A +V
Sbjct: 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 229 GLEHLHYIG--LVYRDCKPENILLDDYGHVRISDLGLA-VEIPEGESVRGRVGTVGYMAP 285
G+ +LH +V+R+ K N+L+D V++ D GL+ ++ S + GT +MAP
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208
Query: 286 EVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
EV+ +E D +SFG +++E+ Q P+
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMVLIEK 165
+ I YK + V+G+G FG VC +A K A K++E + +K ++E
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVC----KAKWRAKDVAIKQIESESERK-----AFIVEL 52
Query: 166 QILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAE 225
+ L ++N +V L A + +CLV+ GG L ++ P + A A + +
Sbjct: 53 RQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 226 VLCGLEHLH---YIGLVYRDCKPENILLD-DYGHVRISDLGLAVEIPEGESVRGRVGTVG 281
G+ +LH L++RD KP N+LL ++I D G A +I + G+
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAA 168
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
+MAPEV + Y+ D FS+G +++E+I + PF
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 65/290 (22%), Positives = 121/290 (41%), Gaps = 26/290 (8%)
Query: 85 SIENYELEMDENRRLSTKDIYNE-IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYA 143
+E EL+ + +RL + + + F LG G G V + +G + A
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 144 CKKL-------EKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIM 196
K + + +I + E Q+L + NS ++V A+ + + + + M
Sbjct: 63 RKLIHLEIKPAIRNQIIR---------ELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113
Query: 197 NGGDLKFHIYNMGGE-PGFDIARARFYAAEVLCGLEHLHYIG-LVYRDCKPENILLDDYG 254
+GG L + G P + + + V+ GL +L +++RD KP NIL++ G
Sbjct: 114 DGGSLD-QVLKKAGRIPEQILGKV---SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 169
Query: 255 HVRISDLGLAVEIPEGESVRG-RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQ 313
+++ D G++ ++ +S+ VGT YM+PE + Y+ D +S G + EM G+
Sbjct: 170 EIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
Query: 314 APFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRL 363
P +V+ DA + R + L K + P +
Sbjct: 228 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI--LQKINSRFVV 177
VLGKG +G V A + + A K I +R + ++I + + + +V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIK-----EIPERDSRYSQPLHEEIALHKHLKHKNIV 82
Query: 178 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG 237
++ + + + + GG L + + G + FY ++L GL++LH
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 238 LVYRDCKPENILLDDY-GHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEKYTY 295
+V+RD K +N+L++ Y G ++ISD G + + GT+ YMAPE+ID Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 296 SP--DWFSFGCLIFEMIEGQAPF 316
D +S GC I EM G+ PF
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPF 225
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 47/272 (17%), Positives = 94/272 (34%), Gaps = 27/272 (9%)
Query: 126 GFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185
+++ + + ++ + + +++ V
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKP 245
K L + + + +LK + + ++ +E LH GL++RD KP
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192
Query: 246 ENILLDDYGHVRISDLGLA-------------VEIPEGESVRGRVGTVGYMAPEVIDNEK 292
NI V++ D GL +P + G+VGT YM+PE I
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE-DAEKYSCRFSDDAKALC 351
Y++ D FS G ++FE++ F + E R + V+ + +
Sbjct: 253 YSHKVDIFSLGLILFELL---YSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMV 306
Query: 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383
+ +L SP R A ++ + F++
Sbjct: 307 QDMLSPSPTERP-------EATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 16/72 (22%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + +G+GGFG V + + YA K++ + + + V+ E + L K+
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK--VMREVKALAKLEHPG 65
Query: 176 VVSLAYAYETKD 187
+V A+
Sbjct: 66 IVRYFNAWLETP 77
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 16/72 (22%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + +G+GGFG V + + YA K++ + + + V+ E + L K+
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK--VMREVKALAKLEHPG 65
Query: 714 VVSLAYAYETKD 725
+V A+
Sbjct: 66 IVRYFNAWLETP 77
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 71/269 (26%), Positives = 110/269 (40%), Gaps = 46/269 (17%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GESMVLIEKQILQKIN 172
+R+ +LGKGGFG V A A K + + R+ +E +L K+
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 173 SRF----VVSLAYAYETKDALCLVL-TIMNGGDLKFHIYNMGGEPGFD-IAR-------- 218
+ V+ L +ET++ LVL + DL FD I
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL------------FDYITEKGPLGEGP 140
Query: 219 ARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD-DYGHVRISDLGLAVEIPEGESVRGRV 277
+R + +V+ ++H H G+V+RD K ENIL+D G ++ D G + E
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD 199
Query: 278 GTVGYMAPEVIDNEKYTYSP-DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA 336
GT Y PE I +Y P +S G L+++M+ G PF R +E+++ +
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAE---------- 249
Query: 337 EKYSCR--FSDDAKALCKALLKKSPRSRL 363
S D AL + L P SR
Sbjct: 250 --LHFPAHVSPDCCALIRRCLAPKPSSRP 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 28/116 (24%), Positives = 42/116 (36%), Gaps = 15/116 (12%)
Query: 631 MFTSVPPSETNPSCFPQPITYKT--------FRMYRVLGKGGFGEVCACQVRATGKMYAC 682
M T P P P +R+ +LGKGGFG V A A
Sbjct: 2 MLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAI 61
Query: 683 KKLEKKRIKKRK---GESMVLIEKQILQKINSRF----VVSLAYAYETKDALCLVL 731
K + + R+ +E +L K+ + V+ L +ET++ LVL
Sbjct: 62 KVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 62/251 (24%), Positives = 113/251 (45%), Gaps = 12/251 (4%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + LG G FG+V + + TG A K L +++I+ + E Q L+
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
++ L T +V+ ++GG+L +I G + AR ++L +++ H
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHR 129
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
+V+RD KPEN+LLD + + +I+D GL+ + +GE +R G+ Y APEVI Y
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 189
Query: 296 SP-DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC--RFSDDAKALCK 352
D +S G +++ ++ G PF ++++ + + L
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDEHVPTLF----KKIRG--GVFYIPEYLNRSVATLLM 243
Query: 353 ALLKKSPRSRL 363
+L+ P R
Sbjct: 244 HMLQVDPLKRA 254
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 18/78 (23%), Positives = 33/78 (42%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + LG G FG+V + + TG A K L +++I+ + E Q L+
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 714 VVSLAYAYETKDALCLVL 731
++ L T +V+
Sbjct: 73 IIKLYQVISTPTDFFMVM 90
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 73/298 (24%), Positives = 122/298 (40%), Gaps = 27/298 (9%)
Query: 93 MDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 152
M + S ++ + F +GKG FGEV T K+ A K ++ +
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA 60
Query: 153 KKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEP 212
+ + + E +L + +S +V +Y L +++ + GG + G
Sbjct: 61 EDEIED--IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLD 117
Query: 213 GFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272
IA E+L GL++LH ++RD K N+LL ++G V+++D G+A ++ + +
Sbjct: 118 ETQIA---TILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174
Query: 273 VRGR-VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR 331
R VGT +MAPEVI Y D +S G E+ G+ P M +
Sbjct: 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--------K 226
Query: 332 V-----KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384
V K + +S K +A L K P R A+EL + +F
Sbjct: 227 VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP-------TAKELLKHKFILRN 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 64/251 (25%), Positives = 117/251 (46%), Gaps = 13/251 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+R+ + +GKG F +V + TG+ A K ++K ++ + + E +I++ +N
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ-KLFREVRIMKILNHPN 75
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGG--EPGFDIARARFYAAEVLCGLEHL 233
+V L ET+ L L++ +GG++ ++ G E AR +++ +++
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EARSKFRQIVSAVQYC 130
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKY 293
H +V+RD K EN+LLD +++I+D G + E G + G Y APE+ +KY
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 294 TYSP-DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352
D +S G +++ ++ G PF + R RV + S D + L K
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR----ERVLRGKYRIPFYMSTDCENLLK 246
Query: 353 ALLKKSPRSRL 363
L +P R
Sbjct: 247 RFLVLNPIKRG 257
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 20/78 (25%), Positives = 41/78 (52%), Gaps = 1/78 (1%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+R+ + +GKG F +V + TG+ A K ++K ++ + + E +I++ +N
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ-KLFREVRIMKILNHPN 75
Query: 714 VVSLAYAYETKDALCLVL 731
+V L ET+ L L++
Sbjct: 76 IVKLFEVIETEKTLYLIM 93
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 69/267 (25%), Positives = 112/267 (41%), Gaps = 44/267 (16%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM---VLIEKQILQKIN 172
+++ +LG GGFG V + + A K +EK RI V +E +L+K++
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 173 SRF--VVSLAYAYETKDALCLVLTIMNG-GDLKFHIYNMGGEPGFD-IAR--------AR 220
S F V+ L +E D+ L+L DL FD I AR
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDL------------FDFITERGALQEELAR 152
Query: 221 FYAAEVLCGLEHLHYIGLVYRDCKPENILLD-DYGHVRISDLGLAVEIPEGESVRGRVGT 279
+ +VL + H H G+++RD K ENIL+D + G +++ D G + + GT
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGT 211
Query: 280 VGYMAPEVIDNEKYTYSP-DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK 338
Y PE I +Y +S G L+++M+ G PF +E+++ +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG------------Q 259
Query: 339 YSCR--FSDDAKALCKALLKKSPRSRL 363
R S + + L + L P R
Sbjct: 260 VFFRQRVSSECQHLIRWCLALRPSDRP 286
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 28/108 (25%), Positives = 46/108 (42%), Gaps = 10/108 (9%)
Query: 634 SVPPSETNPSCFPQPITYKT-----FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 688
+ P + P K +++ +LG GGFG V + + A K +EK
Sbjct: 20 HMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 79
Query: 689 RIKKRKGESM---VLIEKQILQKINSRF--VVSLAYAYETKDALCLVL 731
RI V +E +L+K++S F V+ L +E D+ L+L
Sbjct: 80 RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 88/300 (29%), Positives = 133/300 (44%), Gaps = 45/300 (15%)
Query: 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMVLIEKQI 167
I + + V+G G V A + A K LEK + +L E Q
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM----DELLKEIQA 66
Query: 168 LQKINSRFVVSLAYAYETKDALCLVLTIMNGG---DLKFHIYNMGGEPG--FD---IARA 219
+ + + +VS ++ KD L LV+ +++GG D+ HI G D IA
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA-- 124
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR--- 276
EVL GLE+LH G ++RD K NILL + G V+I+D G++ + G +
Sbjct: 125 -TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 277 ---VGTVGYMAPEVIDNEK-YTYSPDWFSFGCLIFEMIEGQAPFRRRKEM------VKRD 326
VGT +MAPEV++ + Y + D +SFG E+ G AP+ + M ++ D
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243
Query: 327 ----EVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
E + KE +KY F +LC L+K P R A EL + +FF+
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFR-KMISLC---LQKDPEKRP-------TAAELLRHKFFQ 292
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 26/122 (21%), Positives = 45/122 (36%), Gaps = 12/122 (9%)
Query: 639 ETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGE 696
+ S P I + + V+G G V A + A K LEK +
Sbjct: 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM---- 57
Query: 697 SMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL------TIIDVMFTCVQPSETNPCC 750
+L E Q + + + +VS ++ KD L LV+ +++D++ V E
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 751 FP 752
Sbjct: 118 LD 119
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 65/302 (21%), Positives = 124/302 (41%), Gaps = 26/302 (8%)
Query: 90 ELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK 149
E ++ + + + + +G+G F V T A +L+
Sbjct: 3 ERNQQQDDIEELETKAVGMSN-DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61
Query: 150 KRIKKRKGESMVLIEKQILQKINS----RFVVSLAYAYETKDALCLVLTIMNGGDLKFHI 205
+++ K + + E ++L+ + RF S + K + LV +M G LK ++
Sbjct: 62 RKLTKSERQRFKE-EAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 206 YNMGGEPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLD-DYGHVRISDLG 262
I R + ++L GL+ LH +++RD K +NI + G V+I DLG
Sbjct: 121 KRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177
Query: 263 LAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
LA + + +GT +MAPE+ + EKY S D ++FG + EM + P+ +
Sbjct: 178 LAT-LKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA 235
Query: 323 VKRDEVDRRVKEDA--EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEF 380
++ RRV + + K + + ++++ R ++L F
Sbjct: 236 A---QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY-------SIKDLLNHAF 285
Query: 381 FK 382
F+
Sbjct: 286 FQ 287
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 69/307 (22%), Positives = 130/307 (42%), Gaps = 43/307 (14%)
Query: 95 ENRRLSTKDIYNEIQPITYKT-----FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK 149
++ ++ + ++ + + Y +G+G G VC + + +G+ A K ++
Sbjct: 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD- 79
Query: 150 KRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 209
++K++ ++ E I++ VV + +Y + L +++ + GG L I +
Sbjct: 80 --LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQV 136
Query: 210 GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269
IA VL L +LH G+++RD K ++ILL G V++SD G +I +
Sbjct: 137 RLNEEQIA---TVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193
Query: 270 GESVRG-RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEV 328
R VGT +MAPEVI Y D +S G ++ EM++G+ P+ +
Sbjct: 194 DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------ 247
Query: 329 DRRVK-----------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377
+ +++ K S D + +L + P+ R A+EL
Sbjct: 248 --QAMKRLRDSPPPKLKNSHKVSPVLRD----FLERMLVRDPQE-------RATAQELLD 294
Query: 378 AEFFKST 384
F T
Sbjct: 295 HPFLLQT 301
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 16/79 (20%), Positives = 37/79 (46%), Gaps = 3/79 (3%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
Y +G+G G VC + + +G+ A K ++ ++K++ ++ E I++
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQH 101
Query: 712 RFVVSLAYAYETKDALCLV 730
VV + +Y + L ++
Sbjct: 102 FNVVEMYKSYLVGEELWVL 120
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 65/303 (21%), Positives = 118/303 (38%), Gaps = 37/303 (12%)
Query: 97 RRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL-------EK 149
++ I + +G G G+V + R TG + A K++ E
Sbjct: 8 KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN 67
Query: 150 KRIKKRKGESMVLIEKQILQK-INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM 208
KRI + ++ K + ++V + T + + + +M K
Sbjct: 68 KRILM---------DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ 118
Query: 209 GGEPGFDIARARFYAAEVLCGLEHLHYI-GLVYRDCKPENILLDDYGHVRISDLGLAVEI 267
G P + + ++ L +L G+++RD KP NILLD+ G +++ D G++ +
Sbjct: 119 GPIPERILGKM---TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175
Query: 268 PEGESVRGRVGTVGYMAPEVIDNEK-----YTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
+ ++ G YMAPE ID Y D +S G + E+ GQ P++ K
Sbjct: 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235
Query: 323 VKRDEVDRRVKEDAEK--YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEF 380
+ + + ++E+ FS D ++ K L K R R +L + F
Sbjct: 236 F--EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP-------KYNKLLEHSF 286
Query: 381 FKS 383
K
Sbjct: 287 IKR 289
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 75/301 (24%), Positives = 130/301 (43%), Gaps = 43/301 (14%)
Query: 100 STKDIYNEIQPIT-----YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 154
S ++I +++ I K + + +G+G G V ATG+ A +++ +++
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQ 57
Query: 155 RKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGF 214
+ + +++ E ++++ + +V+ +Y D L +V+ + GG L +
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEG 116
Query: 215 DIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274
IA E L LE LH +++RD K +NILL G V+++D G +I +S R
Sbjct: 117 QIA---AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 275 G-RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK 333
VGT +MAPEV+ + Y D +S G + EMIEG+ P+ + R
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RAL 225
Query: 334 -----------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
++ EK S F D L+ R A+EL Q +F K
Sbjct: 226 YLIATNGTPELQNPEKLSAIFRD----FLNRCLEMDVEK-------RGSAKELLQHQFLK 274
Query: 383 S 383
Sbjct: 275 I 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 15/79 (18%), Positives = 40/79 (50%), Gaps = 3/79 (3%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
K + + +G+G G V ATG+ A +++ ++++ + +++ E ++++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKN 76
Query: 712 RFVVSLAYAYETKDALCLV 730
+V+ +Y D L +V
Sbjct: 77 PNIVNYLDSYLVGDELWVV 95
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-30
Identities = 66/280 (23%), Positives = 110/280 (39%), Gaps = 43/280 (15%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
R+ RVL +GGF V Q +G+ YA K+L +K + ++ E ++K++
Sbjct: 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSG 84
Query: 174 -----RFVVSLAYAYE---TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAE 225
+F + + E T A L+LT + G L + M +
Sbjct: 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 226 VLCGLEHLHYIG--LVYRDCKPENILLDDYGHVRISDLGLA-------------VEIPEG 270
++H+H +++RD K EN+LL + G +++ D G A
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 271 ESVRGRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDE 327
E R T Y PE+ID N D ++ GC+++ + Q PF D
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--------EDG 256
Query: 328 VDRRVKEDAEKYSC----RFSDDAKALCKALLKKSPRSRL 363
R+ KYS +L +A+L+ +P RL
Sbjct: 257 AKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 61/290 (21%), Positives = 113/290 (38%), Gaps = 53/290 (18%)
Query: 91 LEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 150
+ ++ I ++ YK +VLG G G+V + T + +A K L+
Sbjct: 2 PHVKSGLQIKKNAIIDD-----YKVTS--QVLGLGINGKVLQIFNKRTQEKFALKMLQDC 54
Query: 151 RIKKRKGESMVLIEKQILQKINS-RFVVSLAYAYET----KDALCLVLTIMNGGDLKFHI 205
+R E ++ + + +V + YE + L +V+ ++GG+L I
Sbjct: 55 PKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 206 YNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLG 262
+ G + F A + +++LH I + +RD KPEN+L ++++D G
Sbjct: 107 QDRGDQA-FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165
Query: 263 LAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
A E EKY S D +S G +++ ++ G PF +
Sbjct: 166 F--------------------AKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204
Query: 323 VKRDEVDRRVKEDAEKYS------CRFSDDAKALCKALLKKSPRSRLGCH 366
+ R++ +Y S++ K L + LLK P R+
Sbjct: 205 AISPGMKTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 15/86 (17%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 710
YK +VLG G G+V + T + +A K L+ +R E ++ + +
Sbjct: 19 YKVTS--QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRAS 68
Query: 711 S-RFVVSLAYAYET----KDALCLVL 731
+V + YE + L +V+
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVM 94
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 47/225 (20%), Positives = 91/225 (40%), Gaps = 19/225 (8%)
Query: 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-- 163
+ + + + +GKGGFG V ++ + A K L +
Sbjct: 11 SRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 164 --EKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF 221
E I+ +N +V L + +V+ + GDL + + +
Sbjct: 71 QREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLR 126
Query: 222 YAAEVLCGLEHLHYIG--LVYRDCKPENILLDDYG-----HVRISDLGLAVEIPEGESVR 274
++ G+E++ +V+RD + NI L +++D GL+ + SV
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--SVHSVS 184
Query: 275 GRVGTVGYMAPEVIDNEKYTYSP--DWFSFGCLIFEMIEGQAPFR 317
G +G +MAPE I E+ +Y+ D +SF +++ ++ G+ PF
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 63/255 (24%), Positives = 109/255 (42%), Gaps = 16/255 (6%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + +G G FG + + T ++ A K +E+ V E + +
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPN 77
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V T L +++ +GG+L I N G F ARF+ ++L G+ + H
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHS 134
Query: 236 IGLVYRDCKPENILLDD--YGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKY 293
+ + +RD K EN LLD ++I D G + + VGT Y+APEV+ ++Y
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEY 194
Query: 294 T-YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC----RFSDDAK 348
D +S G ++ M+ G PF +E + +R+ + KYS R S +
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL--SVKYSIPDDIRISPECC 252
Query: 349 ALCKALLKKSPRSRL 363
L + P +R+
Sbjct: 253 HLISRIFVADPATRI 267
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 17/98 (17%), Positives = 32/98 (32%), Gaps = 4/98 (4%)
Query: 634 SVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 693
P T P P + + +G G FG + + T ++ A K +E+
Sbjct: 2 DRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE 61
Query: 694 KGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
V E + + +V T L +++
Sbjct: 62 N----VQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 62/294 (21%), Positives = 112/294 (38%), Gaps = 34/294 (11%)
Query: 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK 165
+ T + + +G+G +G V + +G++ A KRI+ E +K
Sbjct: 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMA-----VKRIRSTVDEK---EQK 65
Query: 166 QILQKI-------NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG-FDIA 217
Q+L + + ++V A + + + +M+ KF+ Y
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125
Query: 218 RARFYAAEVLCGLEHLHYIG-LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR 276
+ L HL +++RD KP NILLD G++++ D G++ ++ + +
Sbjct: 126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD 185
Query: 277 VGTVGYMAPEVIDNEK----YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV 332
G YMAPE ID Y D +S G ++E+ G+ P+ + + D++ + V
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQVV 243
Query: 333 KEDA----EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
K D FS L K R +EL + F
Sbjct: 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP-------KYKELLKHPFIL 290
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 29/289 (10%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + + LG+G +GEV R T + A K ++ KR + E I + +N
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHEN 66
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
VV + L L +GG+L I G A+ + +++ G+ +LH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 123
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG---RVGTVGYMAPEVIDNEK 292
IG+ +RD KPEN+LLD+ +++ISD GLA R GT+ Y+APE++ +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 293 YTYSP-DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC----RFSDDA 347
+ P D +S G ++ M+ G+ P+ + + + E ++ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKK---TYLNPWKKIDSAP 238
Query: 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDP 396
AL +L ++P + R ++K+ ++ K L+ G P
Sbjct: 239 LALLHKILVENPSA-------RITIPDIKKDRWYN----KPLKKGAKRP 276
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 70/299 (23%), Positives = 127/299 (42%), Gaps = 29/299 (9%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + + LG+G +GEV R T + A K ++ KR + E I + +N
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHEN 66
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
VV + L L +GG+L I G A+ + +++ G+ +LH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 123
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG---RVGTVGYMAPEVIDNEK 292
IG+ +RD KPEN+LLD+ +++ISD GLA R GT+ Y+APE++ +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 293 YTYSP-DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC----RFSDDA 347
+ P D +S G ++ M+ G+ P+ + + + E ++ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKK---TYLNPWKKIDSAP 238
Query: 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
AL +L ++P + R ++K+ ++ K L+ G P +
Sbjct: 239 LALLHKILVENPSA-------RITIPDIKKDRWYN----KPLKKGAKRPRVTSGGVSES 286
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 77/285 (27%), Positives = 119/285 (41%), Gaps = 44/285 (15%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ F + LG+G +G V + TG++ A K+ + ++ E I+Q+ +S
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ-----VPVESDLQEIIKEISIMQQCDS 83
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGG---DLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
VV +Y L +V+ G D+ E +IA L GL
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED--EIA---TILQSTLKGL 138
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG-RVGTVGYMAPEVID 289
E+LH++ ++RD K NILL+ GH +++D G+A ++ + + R +GT +MAPEVI
Sbjct: 139 EYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 198
Query: 290 NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK-----------EDAEK 338
Y D +S G EM EG+ P+ M R E
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--------RAIFMIPTNPPPTFRKPEL 250
Query: 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383
+S F+D K L KSP R A +L Q F +S
Sbjct: 251 WSDNFTD----FVKQCLVKSPEQ-------RATATQLLQHPFVRS 284
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 71/308 (23%), Positives = 130/308 (42%), Gaps = 33/308 (10%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-GESMVLIEKQILQKINSR 174
+ M +LG+G +G+V T A K L+KK++++ GE+ V E Q+L+++ +
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 175 FVVSL--AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
V+ L E K + +V+ G + F + +A Y +++ GLE+
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK--RFPVCQAHGYFCQLIDGLEY 124
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRV----GTVGYMAPEVI 288
LH G+V++D KP N+LL G ++IS LG+A E + G+ + PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVA-EALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 289 DNEKYTYSP---DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR--F 343
+ T+S D +S G ++ + G PF + + + Y+
Sbjct: 184 NGLD-TFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------SYAIPGDC 236
Query: 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403
L K +L+ P R+ R+++Q +F+ K+ P P
Sbjct: 237 GPPLSDLLKGMLEYEPAK-------RFSIRQIRQHSWFR----KKHPPAEAPVPIPPSPD 285
Query: 404 RDEVDRRV 411
+ R +
Sbjct: 286 TKDRWRSM 293
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 23/81 (28%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-GESMVLIEKQILQKINSR 712
+ M +LG+G +G+V T A K L+KK++++ GE+ V E Q+L+++ +
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 713 FVVSL--AYAYETKDALCLVL 731
V+ L E K + +V+
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVM 87
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 74/326 (22%), Positives = 140/326 (42%), Gaps = 28/326 (8%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + LG G FG+V + TG A K L +++I+ + E Q L+
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
++ L T + +V+ ++GG+L +I G D +R ++L G+++ H
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHR 134
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
+V+RD KPEN+LLD + + +I+D GL+ + +GE +R G+ Y APEVI Y
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 194
Query: 296 SP-DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR--FSDDAKALCK 352
D +S G +++ ++ G PF +++ + + +L K
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFDDDHVPTLF----KKIC--DGIFYTPQYLNPSVISLLK 248
Query: 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVK 412
+L+ P R +++++ E+FK + L L P +D
Sbjct: 249 HMLQVDPMK-------RATIKDIREHEWFK----QDLPKYLFPED--PSYSSTMID---D 292
Query: 413 EDAEKYSCRFSDDAKALCKALLKKSP 438
E ++ +F + + L ++
Sbjct: 293 EALKEVCEKFECSEEEVLSCLYNRNH 318
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 18/78 (23%), Positives = 33/78 (42%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + LG G FG+V + TG A K L +++I+ + E Q L+
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 714 VVSLAYAYETKDALCLVL 731
++ L T + +V+
Sbjct: 78 IIKLYQVISTPSDIFMVM 95
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 64/251 (25%), Positives = 117/251 (46%), Gaps = 13/251 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + LG+G FG+V T + A K + ++ +KK V E L+ +
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
++ L T + +V+ GG+L +I R + +++C +E+ H
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHR 126
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
+V+RD KPEN+LLDD +V+I+D GL+ + +G ++ G+ Y APEVI+ + Y
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 296 SP-DWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC--RFSDDAKALCK 352
D +S G +++ M+ G+ PF ++V + Y S A++L +
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKVN--SCVYVMPDFLSPGAQSLIR 240
Query: 353 ALLKKSPRSRL 363
++ P R+
Sbjct: 241 RMIVADPMQRI 251
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 17/78 (21%), Positives = 33/78 (42%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + LG+G FG+V T + A K + ++ +KK V E L+ +
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 714 VVSLAYAYETKDALCLVL 731
++ L T + +V+
Sbjct: 71 IIKLYDVITTPTDIVMVI 88
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 53/304 (17%)
Query: 102 KDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV 161
+ + ++ P + + + LG G FG+V + + TG + A K I+ + E +
Sbjct: 9 EHVRRDLDP--NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKV-----IETKSEEELE 61
Query: 162 LIEK--QILQKINSRFVVSLAYAYETKDALCLVLTIMNGG---DLKFHIYNMGGEPGFDI 216
+IL + ++V L AY L +++ GG + + EP I
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP--QI 119
Query: 217 ARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR 276
++L L LH +++RD K N+L+ G +R++D G++ + + R
Sbjct: 120 Q---VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176
Query: 277 -VGTVGYMAPEVIDNEK-----YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR 330
+GT +MAPEV+ E Y Y D +S G + EM + + P M
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------- 228
Query: 331 RVK-----------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAE 379
RV K+S F D K L K+P + R A +L +
Sbjct: 229 RVLLKIAKSDPPTLLTPSKWSVEFRD----FLKIALDKNPET-------RPSAAQLLEHP 277
Query: 380 FFKS 383
F S
Sbjct: 278 FVSS 281
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 7/82 (8%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK--QILQKI 709
+ + + LG G FG+V + + TG + A K I+ + E + +IL
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKV-----IETKSEEELEDYIVEIEILATC 73
Query: 710 NSRFVVSLAYAYETKDALCLVL 731
+ ++V L AY L +++
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMI 95
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMVLIEKQIL 168
I + + +G G FG V + G + A K L ++ E +L
Sbjct: 21 IPDGQITVGQRIGSGSFGTVY----KGKWHGDV-AVKMLNVTAPTPQQ-LQAFKNEVGVL 74
Query: 169 QKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC 228
+K ++ Y T L +V G L H++ E F++ + A +
Sbjct: 75 RKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTAR 131
Query: 229 GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA---VEIPEGESVRGRVGTVGYMAP 285
G+++LH +++RD K NI L + V+I D GLA G++ +MAP
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 286 EVIDNE---KYTYSPDWFSFGCLIFEMIEGQAPFR 317
EVI + Y++ D ++FG +++E++ GQ P+
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 44/217 (20%), Positives = 84/217 (38%), Gaps = 18/217 (8%)
Query: 114 KTFRMYRVLGKG--GFGEVCACQVRATGKMYACKK--LEKKRIKKRKGESMVLIEKQILQ 169
+ + V+GKG V + + TG+ ++ LE + + + E + +
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC---SNEMVTFLQGELHVSK 81
Query: 170 KINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCG 229
N +V + + L +V + M G K + G + + VL
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMNELAIAYILQGVLKA 140
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--------GRVGTVG 281
L+++H++G V+R K +IL+ G V +S L + + + V +
Sbjct: 141 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 282 YMAPEVIDNEKYTYSP--DWFSFGCLIFEMIEGQAPF 316
+++PEV+ Y D +S G E+ G PF
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 30/286 (10%)
Query: 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ 169
+ LG+G +G V + +G++ A KRI+ +K++L
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMA-----VKRIRATVNSQ---EQKRLLM 54
Query: 170 KI-------NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFY 222
+ + F V+ A + + + + +M+ KF+ +
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 223 AAEVLCGLEHLHYIG-LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVG 281
A ++ LEHLH +++RD KP N+L++ G V++ D G++ + + + G
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP 174
Query: 282 YMAPEVIDNEK----YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA- 336
YMAPE I+ E Y+ D +S G + E+ + P+ ++ + V+E +
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQLKQVVEEPSP 232
Query: 337 EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
+ + +FS + LKK+ + R EL Q FF
Sbjct: 233 QLPADKFSAEFVDFTSQCLKKNSKERP-------TYPELMQHPFFT 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 23/221 (10%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT--GKMYACKKLEKKRIK-KRKGESMVLIEKQI 167
I + + ++G GGFG+V RA G A K + + V E ++
Sbjct: 4 IDFAELTLEEIIGIGGFGKVY----RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 168 LQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVL 227
+ +++L + LCLV+ GG L + +A ++
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIA 115
Query: 228 CGLEHLH---YIGLVYRDCKPENILLDDYGH--------VRISDLGLAVEIPEGESVRGR 276
G+ +LH + +++RD K NIL+ ++I+D GLA E +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-HRTTKMSA 174
Query: 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
G +MAPEVI ++ D +S+G L++E++ G+ PFR
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 55/206 (26%), Positives = 83/206 (40%), Gaps = 9/206 (4%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K F R +G G FG V + ++ A KK+ + + ++ E + LQK+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+ Y + LV+ G + +IA L GL +L
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYL 170
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEK- 292
H +++RD K NILL + G V++ D G A + S VGT +MAPEVI
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDE 227
Query: 293 --YTYSPDWFSFGCLIFEMIEGQAPF 316
Y D +S G E+ E + P
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPL 253
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 18/79 (22%), Positives = 31/79 (39%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
K F R +G G FG V + ++ A KK+ + + ++ E + LQK+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 712 RFVVSLAYAYETKDALCLV 730
+ Y + LV
Sbjct: 114 PNTIQYRGCYLREHTAWLV 132
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 40/216 (18%), Positives = 79/216 (36%), Gaps = 19/216 (8%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMVLIEKQIL 168
I +K L + GE+ + G K L+ + RK E L
Sbjct: 7 IDFKQLNFLTKLNENHSGELW----KGRWQGNDIVVKVLKVRDWSTRKSRD-FNEECPRL 61
Query: 169 QKINSRFVVSL--AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
+ + V+ + A L+ M G L ++ D ++A +A ++
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDM 120
Query: 227 LCGLEHLHYIG--LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMA 284
G+ LH + + ++++D+ RIS + GR+ ++A
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS----FQSPGRMYAPAWVA 176
Query: 285 PEVIDNEKYTYSP---DWFSFGCLIFEMIEGQAPFR 317
PE + + + D +SF L++E++ + PF
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 48/224 (21%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMVLIEKQIL 168
I ++ + ++GKG FG+V G++ A + ++ +R + + ++ E
Sbjct: 30 IPFEQLEIGELIGKGRFGQVY----HGRWHGEV-AIRLIDIERDNEDQLKA-FKREVMAY 83
Query: 169 QKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC 228
++ VV A + L ++ ++ G L + + + D+ + R A E++
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVK 141
Query: 229 GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA------VEIPEGESVRGRVGTVGY 282
G+ +LH G++++D K +N+ D+ G V I+D GL + +R + G + +
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 283 MAPEVI---------DNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
+APE+I D ++ D F+ G + +E+ + PF+
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 46/226 (20%), Positives = 81/226 (35%), Gaps = 38/226 (16%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI--LQKINS 173
++ V +G FG V Q+ + A K + + E ++ L +
Sbjct: 26 LQLLEVKARGRFGCVWKAQLL--NEYVAVKIF------PIQDKQSWQNEYEVYSLPGMKH 77
Query: 174 RFVVSLAYAYETKDA-----LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC 228
++ E + L L+ G L + A +
Sbjct: 78 ENILQF-IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMAR 132
Query: 229 GLEHLH----------YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV---RG 275
GL +LH + +RD K +N+LL + I+D GLA++ G+S G
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 276 RVGTVGYMAPEVIDNEKYTYSP-----DWFSFGCLIFEMIEGQAPF 316
+VGT YMAPEV++ D ++ G +++E+
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 50/221 (22%), Positives = 96/221 (43%), Gaps = 20/221 (9%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
VLGKG FG+ R TG++ K+L + + ++ L E ++++
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR---TFLKEVKVMRC 63
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
+ V+ L + + GG L+ I +M + + ++ +A ++ G+
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGM 121
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA---------------VEIPEGESVRG 275
+LH + +++RD N L+ + +V ++D GLA ++ P+ +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 276 RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
VG +MAPE+I+ Y D FSFG ++ E+I
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 86/357 (24%), Positives = 138/357 (38%), Gaps = 76/357 (21%)
Query: 93 MDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL----- 147
R L D+ P F + ++G G +G+V + TG++ A K +
Sbjct: 5 DSPARSLDEIDLSALRDP--AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62
Query: 148 EKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAY------ETKDALCLVLTIMNGG- 199
E++ IK+ E +L+K + R + + A+ D L LV+ G
Sbjct: 63 EEEEIKQ---------EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGS 113
Query: 200 --DL-KFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHV 256
DL K N E IA + E+L GL HLH +++RD K +N+LL + V
Sbjct: 114 VTDLIKNTKGNTLKEE--WIA---YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 168
Query: 257 RISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEK-----YTYSPDWFSFGCLIFEMI 310
++ D G++ ++ R +GT +MAPEVI ++ Y + D +S G EM
Sbjct: 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
Query: 311 EGQAPFRRRKEMVKRDEVDRRV-----KEDA-----EKYSCRFSDDAKALCKALLKKSPR 360
EG P M R + A +K+S +F C L K+
Sbjct: 229 EGAPPLCDMHPM--------RALFLIPRNPAPRLKSKKWSKKFQ-SFIESC---LVKNHS 276
Query: 361 SRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEK 417
R +L + F + + V +D +DR K+ EK
Sbjct: 277 QRP-------ATEQLMKHPFIRD---------QPNERQVRIQLKDHIDRTKKKRGEK 317
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 62/256 (24%), Positives = 108/256 (42%), Gaps = 47/256 (18%)
Query: 69 CAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFG 128
+Y Y E++ +E Y ++ + G+G +
Sbjct: 15 NTHRPREYWDY-------ESHVVEWGNQDD------YQLVRKL-----------GRGKYS 50
Query: 129 EVCACQVRATGKMYACKKL---EKKRIKKRKGESMVLIEKQILQKI-NSRFVVSL--AYA 182
EV + K L +KK+IK+ E +IL+ + +++L
Sbjct: 51 EVFEAINITNNEKVVVKILKPVKKKKIKR---------EIKILENLRGGPNIITLADIVK 101
Query: 183 YETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRD 242
LV +N D K + +DI RFY E+L L++ H +G+++RD
Sbjct: 102 DPVSRTPALVFEHVNNTDFKQLYQTL---TDYDI---RFYMYEILKALDYCHSMGIMHRD 155
Query: 243 CKPENILLD-DYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVI-DNEKYTYSPDWF 300
KP N+++D ++ +R+ D GLA G+ RV + + PE++ D + Y YS D +
Sbjct: 156 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMW 215
Query: 301 SFGCLIFEMIEGQAPF 316
S GC++ MI + PF
Sbjct: 216 SLGCMLASMIFRKEPF 231
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 66/252 (26%), Positives = 113/252 (44%), Gaps = 38/252 (15%)
Query: 87 ENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRAT---GKMYA 143
E+ E+ + + +R S E+Q + F +LG+GGFG+V + G + A
Sbjct: 8 EDPEVHLGQLKRFS----LRELQVAS-DNFSNKNILGRGGFGKV----YKGRLADGTLVA 58
Query: 144 CKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAY-ETKDALCLVLTIMNGGDLK 202
K+L+++R + + + +E ++ R ++ L + T LV M G +
Sbjct: 59 VKRLKEERTQGGELQFQTEVE--MISMAVHRNLLRL-RGFCMTPTERLLVYPYMANGSVA 115
Query: 203 FHIY-NMGGEPGFD------IAR--ARFYAAEVLCGLEHLH---YIGLVYRDCKPENILL 250
+ +P D IA AR GL +LH +++RD K NILL
Sbjct: 116 SCLRERPESQPPLDWPKRQRIALGSAR--------GLAYLHDHCDPKIIHRDVKAANILL 167
Query: 251 DDYGHVRISDLGLAVEIPEGES-VRGRV-GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFE 308
D+ + D GLA + ++ V V GT+G++APE + K + D F +G ++ E
Sbjct: 168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227
Query: 309 MIEGQAPFRRRK 320
+I GQ F +
Sbjct: 228 LITGQRAFDLAR 239
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 61/247 (24%), Positives = 107/247 (43%), Gaps = 35/247 (14%)
Query: 84 DSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYA 143
D++ + L E+ R+ +++ T F ++G G FG+V +R G A
Sbjct: 14 DALSSSYLVPFESYRVP----LVDLEEAT-NNFDHKFLIGHGVFGKVYKGVLR-DGAKVA 67
Query: 144 CKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLA-YAYETKDALCLVLTIMNGGDLK 202
K+ + +G E + L +VSL + E ++ + L+ M G+LK
Sbjct: 68 LKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDE-RNEMILIYKYMENGNLK 123
Query: 203 FHIYNMGGEPGF-----------DIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD 251
H+Y AR GL +LH +++RD K NILLD
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAAR----------GLHYLHTRAIIHRDVKSINILLD 173
Query: 252 DYGHVRISDLGLAVEIPEGES--VRGRV-GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFE 308
+ +I+D G++ + E + + V GT+GY+ PE + T D +SFG ++FE
Sbjct: 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 309 MIEGQAP 315
++ ++
Sbjct: 234 VLCARSA 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 54/240 (22%), Positives = 88/240 (36%), Gaps = 37/240 (15%)
Query: 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI 167
+Q + + +GKG +GEV + G+ A K + E E ++
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIF------SSRDEKSWFRETEL 53
Query: 168 LQKINSR------FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF 221
+ R F+ S + + L L+ G L ++ D
Sbjct: 54 YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLR 109
Query: 222 YAAEVLCGLEHLHY--------IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273
+ GL HLH + +RD K +NIL+ G I+DLGLAV + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 274 R-----GRVGTVGYMAPEVIDNE------KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
RVGT YMAPEV+D D ++FG +++E+ ++
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 57/237 (24%), Positives = 90/237 (37%), Gaps = 35/237 (14%)
Query: 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL 168
Q K +M + +GKG +GEV + R G+ A K E+ +
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQ----T 85
Query: 169 QKINSRFVVSLAYAYETKDA-----LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
+ ++ A + K L L+ G L ++ + D A
Sbjct: 86 VLMRHENILGF-IAADIKGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLA 140
Query: 224 AEVLCGLEHLH--------YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-- 273
+ GL HLH + +RD K +NIL+ G I+DLGLAV+ +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 274 ---RGRVGTVGYMAPEVID------NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKE 321
RVGT YM PEV+D + + D +SFG +++E+ +E
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMVLIEKQILQKINS 173
++ +V+G G FG V ++ +G++ A KK L+ KR K R E QI++K++
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 106
Query: 174 RFVVSLAYAYETKDA------LCLVLTIMNGGDLKFHI--YNMGGEPGFDIARARFYAAE 225
+V L Y + + L LVL + + Y+ + + + Y +
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQT-LPVIYVKLYMYQ 164
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLD-DYGHVRISDLGLAVEIPEGESVRGRVGTVGYMA 284
+ L ++H G+ +RD KP+N+LLD D +++ D G A ++ GE + + Y A
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 224
Query: 285 PEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
PE+I YT S D +S GC++ E++ GQ F
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 16/92 (17%)
Query: 645 FPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMVLIEK 703
PQ ++Y +V+G G FG V ++ +G++ A KK L+ KR K R E
Sbjct: 50 RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------EL 98
Query: 704 QILQKINSRFVVSLAYAY----ETKDALCLVL 731
QI++K++ +V L Y + E KD + L L
Sbjct: 99 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 45/247 (18%), Positives = 84/247 (34%), Gaps = 50/247 (20%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMVLIEKQI- 167
+ ++ ++G+G +G V + + + A K + EK I
Sbjct: 10 LDLDNLKLLELIGRGRYGAVY----KGSLDERPVAVKVF------SFANRQNFINEKNIY 59
Query: 168 -LQKINSRFVVSLAYAYETKDA------LCLVLTIMNGGDLKFHIYNMGGEPGFDIARAR 220
+ + + + + LV+ G L ++ D +
Sbjct: 60 RVPLMEHDNIARF-IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSC 114
Query: 221 FYAAEVLCGLEHLH---------YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271
A V GL +LH + +RD N+L+ + G ISD GL++ +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 272 SVR---------GRVGTVGYMAPEVIDN-------EKYTYSPDWFSFGCLIFEMIEGQAP 315
VR VGT+ YMAPEV++ E D ++ G + +E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 316 FRRRKEM 322
+ +
Sbjct: 235 LFPGESV 241
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 10/120 (8%)
Query: 198 GGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVR 257
G LK G+ +A A Y E+L L +LH IGLVY D KPENI+L + ++
Sbjct: 168 GQSLKRSK----GQK-LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLK 221
Query: 258 ISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
+ DLG I + GT G+ APE++ + D ++ G + +
Sbjct: 222 LIDLGAVSRINSFGYL---YGTPGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPTRN 277
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 56/238 (23%), Positives = 89/238 (37%), Gaps = 35/238 (14%)
Query: 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI 167
+Q +T + +GKG FGEV + R G+ A K + + E+ +
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEI----YQ 89
Query: 168 LQKINSRFVVSLAYAYETKDA-----LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFY 222
+ ++ A + KD L LV G L ++ +
Sbjct: 90 TVMLRHENILGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKL 144
Query: 223 AAEVLCGLEHLH--------YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV- 273
A GL HLH + +RD K +NIL+ G I+DLGLAV
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 274 ----RGRVGTVGYMAPEVIDNE------KYTYSPDWFSFGCLIFEMIEGQAPFRRRKE 321
RVGT YMAPEV+D+ + D ++ G + +E+ + ++
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 65/236 (27%), Positives = 98/236 (41%), Gaps = 32/236 (13%)
Query: 105 YNEIQPITYKTFR------MYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKG 157
+ E++ +T F +G+GGFG V V A KKL +
Sbjct: 17 FYELKNVT-NNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEEL 73
Query: 158 ESMVLIEKQILQKINSRFVVSLA-YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFD- 215
+ E +++ K +V L ++ + D LCLV M G L + + G P
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSD-GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 216 -----IAR--ARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268
IA+ A G+ LH ++RD K NILLD+ +ISD GLA
Sbjct: 133 HMRCKIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 269 EGES--VRGRV-GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKE 321
+ + R+ GT YMAPE + + T D +SFG ++ E+I G +E
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 9e-22
Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
+ Y+ + + +V+GKG FG+V + A K + ++ R+ E +IL+
Sbjct: 95 VAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEH 149
Query: 171 IN------SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAA 224
+ + V+ + + ++ +C+ ++ +L + + GF + R +A
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNL-YELIKKNKFQGFSLPLVRKFAH 207
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILLDDYGH--VRISDLGLAVEIPEGESVRGRVGTVGY 282
+L L+ LH +++ D KPENILL G +++ D G + E + V + + Y
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTYIQSRFY 265
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
APEVI +Y D +S GC++ E++ G
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 35/122 (28%), Positives = 55/122 (45%), Gaps = 5/122 (4%)
Query: 198 GGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVR 257
G DL + G RA ++ L+ H G +RD KPENIL+
Sbjct: 118 GVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAY 174
Query: 258 ISDLGLAVEIPEGE--SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAP 315
+ D G+A + + + VGT+ YMAPE TY D ++ C+++E + G P
Sbjct: 175 LVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
Query: 316 FR 317
++
Sbjct: 235 YQ 236
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 51/237 (21%), Positives = 94/237 (39%), Gaps = 32/237 (13%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMVLIEKQILQKINS- 173
+ + R LG G F V + A K ++ + E ++LQ++N
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 174 ----------RFVVSL----AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARA 219
++ L + + +V ++ G +L I G +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYV 133
Query: 220 RFYAAEVLCGLEHLH-YIGLVYRDCKPENILLDD------YGHVRISDLGLAVEIPEGES 272
+ + ++L GL+++H G+++ D KPEN+L++ ++I+DLG A E
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEH 191
Query: 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD 329
+ T Y +PEV+ + D +S CLIFE+I G F + + D
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 38/123 (30%), Positives = 64/123 (52%), Gaps = 5/123 (4%)
Query: 197 NGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHV 256
G L +I + G + A + ++L G++H H + +V+RD KP+NIL+D +
Sbjct: 94 EGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTL 150
Query: 257 RISDLGLAVEIPEGESVRGR--VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQA 314
+I D G+A + E + +GTV Y +PE E D +S G +++EM+ G+
Sbjct: 151 KIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
Query: 315 PFR 317
PF
Sbjct: 211 PFN 213
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 51/211 (24%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR- 174
+ + ++GKG FG+V R + A K ++ K+ + IE ++L+ +N
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHD 111
Query: 175 -----FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCG 229
++V L + ++ LCLV ++ +L + + G + R +A ++
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEML-SYNL-YDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 230 LEHLHY--IGLVYRDCKPENILLDDYGH--VRISDLGLAVEIPEGESVRGRVGTVGYMAP 285
L L + +++ D KPENILL + ++I D G + + G+ + + + Y +P
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQSRFYRSP 227
Query: 286 EVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
EV+ Y + D +S GC++ EM G+ F
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 8e-21
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMVLIEKQILQKI 171
++ + +G G G VCA + A KKL + + KR E +++ +
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR-----AYRELVLMKCV 81
Query: 172 NSRFVVSL------AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAE 225
N + ++ L + E + +V+ +M +L + M + R + +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLC-QVIQMELDH----ERMSYLLYQ 135
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAP 285
+LCG++HLH G+++RD KP NI++ ++I D GLA + V T Y AP
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 286 EVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
EVI Y + D +S GC++ EMI+G F
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-21
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMVLIE 164
E + I Y +V+G G FG V ++ + ++ A KK L+ KR K R E
Sbjct: 35 GEQREIAYTN---CKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNR--------E 82
Query: 165 KQILQKINSRFVVSLAYAYETKDA------LCLVLTIMNGGDLKFHIYNMGGEP-GFDIA 217
QI++ + VV L + + L LVL + + + +
Sbjct: 83 LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPML 141
Query: 218 RARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD-DYGHVRISDLGLAVEIPEGESVRGR 276
+ Y ++L L ++H IG+ +RD KP+N+LLD G +++ D G A + GE
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY 201
Query: 277 VGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPF 316
+ + Y APE+I YT + D +S GC++ E+++GQ F
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 33/125 (26%), Positives = 60/125 (48%), Gaps = 7/125 (5%)
Query: 197 NGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHV 256
+G L+ ++ G RA A+ L H G+++RD KP NI++ V
Sbjct: 99 DGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAV 155
Query: 257 RISDLGLAVEIPEGESVRGR----VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEG 312
++ D G+A I + + + +GT Y++PE + D +S GC+++E++ G
Sbjct: 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
Query: 313 QAPFR 317
+ PF
Sbjct: 216 EPPFT 220
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 4e-20
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMVLIEKQILQ 169
K ++ + +G G G VCA + A KKL + + KR E +++
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-----AYRELVLMK 116
Query: 170 KINSRFVVSL------AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
+N + ++SL E + LV+ +M +L I D R +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-----ELDHERMSYLL 170
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYM 283
++LCG++HLH G+++RD KP NI++ ++I D GLA + V T Y
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 230
Query: 284 APEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
APEVI Y + D +S GC++ EM+ + F
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 19/239 (7%)
Query: 93 MDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 152
M + +D+ E+ + + + R + G +G VCA V + G A K++
Sbjct: 2 MQAKGEAAMRDLIAELHAMQSP-YTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVS 59
Query: 153 KKRKGESM--------VLIEKQILQKINSRFVVSL-----AYAYETKDALCLVLTIMNGG 199
R + VL E ++L + ++ L + L LV +M
Sbjct: 60 DGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RT 118
Query: 200 DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRIS 259
DL I++ +++ +L GL LH G+V+RD P NILL D + I
Sbjct: 119 DLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176
Query: 260 DLGLAVEIPEGESVRGRVGTVGYMAPEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
D LA E + V Y APE++ + +T D +S GC++ EM +A FR
Sbjct: 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 50/208 (24%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-EKQILQKIN 172
+T+ LG+G + V + + T + A K++ R++ +G I E +L+ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 58
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
+V+L T+ +L LV ++ DLK ++ + G ++ + + ++L GL +
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN--IINMHNVKLFLFQLLRGLAY 115
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG---RVGTVGYMAPEVI- 288
H +++RD KP+N+L+++ G ++++D GLA + V T+ Y P+++
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAK--SIPTKTYDNEVVTLWYRPPDILL 173
Query: 289 DNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
+ Y+ D + GC+ +EM G+ F
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGRPLF 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 14/201 (6%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG-ESMVLIEKQILQKINSRFVVSLA 180
+G+G +G V C+ R TG++ A KK + + + L E ++L+++ +V+L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKF--LESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVY 240
+ K L LV + + + G + + L + H ++
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIH 125
Query: 241 RDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG---RVGTVGYMAPEVIDNEKYTYSP 297
RD KPENIL+ + +++ D G A + V T Y +PE++ + Y P
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLL--TGPSDYYDDEVATRWYRSPELLVGDT-QYGP 182
Query: 298 --DWFSFGCLIFEMIEGQAPF 316
D ++ GC+ E++ G +
Sbjct: 183 PVDVWAIGCVFAELLSGVPLW 203
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG-ESMVLIEKQILQKINSRFVVSLA 180
+G+G +G V C+ + TG++ A KK K + + + E ++L+++ +V+L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKF--LESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVY 240
+ K LV ++ + + G D + Y +++ G+ H +++
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIH 147
Query: 241 RDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-----VGTVGYMAPEVI-DNEKYT 294
RD KPENIL+ G V++ D G A + + G V T Y APE++ + KY
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTL----AAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 295 YSPDWFSFGCLIFEMIEGQAPF 316
+ D ++ GCL+ EM G+ F
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLF 225
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 53/251 (21%), Positives = 90/251 (35%), Gaps = 52/251 (20%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMVLIEK 165
E Y + + LG G FG VC +GK +A KK L+ R K R E
Sbjct: 3 ETSSKKYS---LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR--------EL 51
Query: 166 QILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARA------ 219
I++ ++ ++ L + T K N G
Sbjct: 52 DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111
Query: 220 --------------------------------RFYAAEVLCGLEHLHYIGLVYRDCKPEN 247
Y ++ + +H +G+ +RD KP+N
Sbjct: 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 248 ILLD-DYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVI-DNEKYTYSPDWFSFGCL 305
+L++ +++ D G A ++ E + + Y APE++ +YT S D +S GC+
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 306 IFEMIEGQAPF 316
E+I G+ F
Sbjct: 232 FGELILGKPLF 242
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 21/80 (26%), Positives = 35/80 (43%), Gaps = 9/80 (11%)
Query: 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMVLIEKQI 705
+ K + + + LG G FG VC +GK +A KK L+ R K R E I
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR--------ELDI 53
Query: 706 LQKINSRFVVSLAYAYETKD 725
++ ++ ++ L + T
Sbjct: 54 MKVLDHVNIIKLVDYFYTTG 73
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 78/314 (24%), Positives = 113/314 (35%), Gaps = 56/314 (17%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
+ F + R +G G FG V CQ K YA K + + IKK + IE IL+K
Sbjct: 33 LNNA-FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAK--IEADILKK 87
Query: 171 INSR-----FVVSLAYAYETKDALCLV--LTIMNGGD-LKFHIYNMGGEPGFDIARARFY 222
I + +V + D +CL+ + + + + YN GF I + Y
Sbjct: 88 IQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYN-----GFHIEDIKLY 142
Query: 223 AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTV-- 280
E+L L +L + L + D KPENILLDD + V + + T
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 281 ----G-----------------YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRR 319
G Y APEVI N + S D +SFGC++ E+ G FR
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262
Query: 320 --KEMVKRDE----------VDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHC 367
E + E + K + KY + D L S S
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKY---VNKDELKLAWPENASSINSIKHVKK 319
Query: 368 GRYGARELKQAEFF 381
+ +K F
Sbjct: 320 CLPLYKIIKHELFC 333
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 6e-19
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-GESMVLI----EKQILQKINSRF- 175
+G G +G V + +G A K + R+ G + I E +L+++ +
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 176 --VVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC 228
VV L + + + LV ++ DL+ ++ PG + + L
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-PGLPAETIKDLMRQFLR 131
Query: 229 GLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--GRVGTVGYMAPE 286
GL+ LH +V+RD KPENIL+ G V+++D GLA + V T+ Y APE
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVVVTLWYRAPE 189
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
V+ Y D +S GC+ EM + F E
Sbjct: 190 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 56/234 (23%), Positives = 91/234 (38%), Gaps = 39/234 (16%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
+ + + + LG+G FG+V C A GK K+ + K R+ +E +L+K
Sbjct: 17 LQER-YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA---ARLEINVLKK 72
Query: 171 INSR------FVVSLAYAYETKDALCLV--LTIMNGGD-LKFHIYNMGGEPGFDIARARF 221
I + V ++ + +C+ L N + LK + + + + R
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQ-----PYPLPHVRH 127
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH-------------------VRISDLG 262
A ++ L LH L + D KPENIL + +R++D G
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 263 LAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
A + E V T Y PEVI + D +S GC++FE G F
Sbjct: 188 SA--TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 53/225 (23%), Positives = 99/225 (44%), Gaps = 21/225 (9%)
Query: 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMVLIE 164
+E F++ R+ G+G FG V + ++TG A KK ++ R + R+ L
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-----LQI 69
Query: 165 KQILQKINSRFVVSLAYAYETKDA-------LCLVLTIMNGGDLKFHI--YNMGGEPGFD 215
Q L ++ +V L + T L +V+ + L Y
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVA-PP 127
Query: 216 IARARFYAAEVLCGLEHLHY--IGLVYRDCKPENILLDDY-GHVRISDLGLAVEIPEGES 272
+ + +++ + LH + + +RD KP N+L+++ G +++ D G A ++ E
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 273 VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPF 316
+ + Y APE+I + YT + D +S GC+ EM+ G+ F
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 13/214 (6%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGESMVLIEKQ 166
+ F+ +VLG G FG V G+ A K+L + K +L E
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAY 69
Query: 167 ILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
++ +++ V L + L+ +M G L ++ + ++
Sbjct: 70 VMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQI 126
Query: 227 LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---VGYM 283
G+ +L LV+RD N+L+ HV+I+D GLA + E G + +M
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 284 APEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
A E I + YT+ D +S+G ++E++ G P+
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-18
Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 12/207 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ +G+G FGEV + ++RA + A K + K + L E +IL++ +
Sbjct: 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK--FLQEARILKQYSHPN 173
Query: 176 VVSLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+V L T+ + +V+ ++ GGD + G + + G+E+L
Sbjct: 174 IVRL-IGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLE 230
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT----VGYMAPEVIDN 290
++RD N L+ + ++ISD G++ E +G G V + APE ++
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA-SGGLRQVPVKWTAPEALNY 289
Query: 291 EKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+Y+ D +SFG L++E G +P+
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPY 316
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 43/236 (18%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
++ + + + LG+G FG+V C G + K+ K + + E Q+L+
Sbjct: 12 LSAR-YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA---ARSEIQVLEH 67
Query: 171 INSR------FVVSLAYAYETKDALCLV--LTIMNGGD-LKFHIYNMGGEPGFDIARARF 221
+N+ V + +E +C+V L ++ D +K + + F + R
Sbjct: 68 LNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFL-----PFRLDHIRK 122
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH-------------------VRISDLG 262
A ++ + LH L + D KPENIL + +++ D G
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 263 LAVEIPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
A E S V R Y APEVI ++ D +S GC++ E G F
Sbjct: 183 SATYDDEHHSTLVSTRH----YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI-EKQILQKINSRFVVSLA 180
LG G + V + TG A K++ ++ +G I E +++++ +V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELKHENIVRLY 69
Query: 181 YAYETKDALCLVLTIMNGGDLKFHIYNMG---GEPGFDIARARFYAAEVLCGLEHLHYIG 237
T++ L LV M+ DLK ++ + G ++ +++ ++L GL H
Sbjct: 70 DVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG---RVGTVGYMAPEVIDNEKYT 294
+++RD KP+N+L++ G +++ D GLA G V V T+ Y AP+V+ + T
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLMGSR-T 185
Query: 295 YSP--DWFSFGCLIFEMIEGQAPF 316
YS D +S GC++ EMI G+ F
Sbjct: 186 YSTSIDIWSCGCILAEMITGKPLF 209
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 122 LGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRK-GESMVLI-EKQILQKINSRF--- 175
+G+G +G+V A ++ G+ A K++ R++ + G + I E +L+ + +
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 176 VVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
VV L + + L LV ++ DL ++ + EPG + ++L GL
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVP-EPGVPTETIKDMMFQLLRGL 133
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--GRVGTVGYMAPEVI 288
+ LH +V+RD KP+NIL+ G ++++D GLA + V T+ Y APEV+
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVL 191
Query: 289 DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM 322
Y D +S GC+ EM + FR ++
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 225
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 52/230 (22%), Positives = 96/230 (41%), Gaps = 30/230 (13%)
Query: 103 DIYNEIQPITYK--------TFRMYRVLGKGGFGEVCACQVRATGKMY----ACKKLEKK 150
DI +E +P T + R LG+G FG+V C+ G A K L
Sbjct: 2 DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--- 58
Query: 151 RIKKRKGESMV---LIEKQILQKINSRFVVSLAYA---YETKDALCLVLTIMNGGDLKFH 204
K G + + E +IL+ + +V + + + L++ + G LK +
Sbjct: 59 --KPESGGNHIADLKKEIEILRNLYHENIVKY-KGICTEDGGNGIKLIMEFLPSGSLKEY 115
Query: 205 IYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264
+ + ++ + YA ++ G+++L V+RD N+L++ V+I D GL
Sbjct: 116 LPKNKNK--INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
Query: 265 VEIPEGESV-RGRVGT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
I + + V + APE + K+ + D +SFG + E++
Sbjct: 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-GESMVLI-EKQILQKINSRFVVSL 179
+G+G +G V + R T ++ A K++ R+ G + E +L+++ + +V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
+ L LV + DLK + + G D + + ++L GL H ++
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 240 YRDCKPENILLDDYGHVRISDLGLA--VEIPEGESVRG---RVGTVGYMAPEVI-DNEKY 293
+RD KP+N+L++ G +++++ GLA IP VR V T+ Y P+V+ + Y
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIP----VRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 294 TYSPDWFSFGCLIFEMIEGQAPF 316
+ S D +S GC+ E+ P
Sbjct: 180 STSIDMWSAGCIFAELANAGRPL 202
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 44/216 (20%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV----- 161
+ + + + + LGKG FG V C+ E +KK + +
Sbjct: 6 QFEE---RHLKFLQQLGKGNFGSVEMCRYDPLQD----NTGEVVAVKKLQHSTEEHLRDF 58
Query: 162 LIEKQILQKINSRFVVSLAYA---YETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIAR 218
E +IL+ + +V + L L++ + G L+ ++ D +
Sbjct: 59 EREIEILKSLQHDNIVKY-KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIK 115
Query: 219 ARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-RGRV 277
Y +++ G+E+L ++RD NIL+++ V+I D GL +P+ + + +
Sbjct: 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 278 GT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
+ + APE + K++ + D +SFG +++E+
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
LG+G F V + + T ++ A KK L + K L E ++LQ+++ ++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
A+ K + LV M DL+ I + + + Y L GLE+LH ++
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHWIL 134
Query: 240 YRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG---RVGTVGYMAPEVIDNEKYTYS 296
+RD KP N+LLD+ G ++++D GLA G R +V T Y APE++ + Y
Sbjct: 135 HRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGAR-MYG 191
Query: 297 P--DWFSFGCLIFEMIEGQAPF 316
D ++ GC++ E++
Sbjct: 192 VGVDMWAVGCILAELLLRVPFL 213
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 48/248 (19%), Positives = 103/248 (41%), Gaps = 23/248 (9%)
Query: 75 QYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQ 134
+H ++ + + EN + +D + + + + + LGKG FG V C+
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSAFEDRDPT-QFEE---RHLKFLQQLGKGNFGSVEMCR 61
Query: 135 VRATGKMYACKKLEKKRIKKRKGESMV-----LIEKQILQKINSRFVVSLAYA---YETK 186
E +KK + + E +IL+ + +V +
Sbjct: 62 YDPLQD----NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY-KGVCYSAGR 116
Query: 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPE 246
L L++ + G L+ ++ D + Y +++ G+E+L ++RD
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 174
Query: 247 NILLDDYGHVRISDLGLAVEIPEGESV-RGRVGT---VGYMAPEVIDNEKYTYSPDWFSF 302
NIL+++ V+I D GL +P+ + + + + + APE + K++ + D +SF
Sbjct: 175 NILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSF 234
Query: 303 GCLIFEMI 310
G +++E+
Sbjct: 235 GVVLYELF 242
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMVLIEKQILQ 169
+ ++ +G G +G VCA TG A KKL + KR E ++L+
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-----TYRELRLLK 83
Query: 170 KINSRFVVSL------AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
+ V+ L A + E + + LV +M G DL + +F
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----LTDDHVQFLI 138
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYM 283
++L GL+++H +++RD KP N+ +++ ++I D GLA + + G V T Y
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTGYVATRWYR 196
Query: 284 APEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPF 316
APE++ N Y + D +S GC++ E++ G+ F
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 47/218 (21%), Positives = 85/218 (38%), Gaps = 16/218 (7%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGESMVL 162
+ R +VLG G FG V G+ K + + R+ V
Sbjct: 9 IFKE---TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVT 63
Query: 163 IEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFY 222
+ ++ +V L +L LV + G L H+ G +
Sbjct: 64 DHMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNW 120
Query: 223 AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT--- 279
++ G+ +L G+V+R+ N+LL V+++D G+A +P +
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 280 VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+ +MA E I KYT+ D +S+G ++E++ G P+
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 13/214 (6%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGESMVLIEKQ 166
+ F+ +VLG G FG V G+ A K+L + K +L E
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAY 69
Query: 167 ILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
++ +++ V L + L+ +M G L ++ + ++
Sbjct: 70 VMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQI 126
Query: 227 LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---VGYM 283
G+ +L LV+RD N+L+ HV+I+D GLA + E G + +M
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 284 APEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
A E I + YT+ D +S+G ++E++ G P+
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE---SMVLIEKQILQKINSRFVVS 178
+G+G FGEV + R TG+ A KK+ ++ K E L E +ILQ + VV+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV---LMENEK-EGFPITALREIKILQLLKHENVVN 80
Query: 179 L--------AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
L + K ++ LV DL + N+ F ++ + +L GL
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGL 137
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA--VEIPEGESVRG---RVGTVGYMAP 285
++H +++RD K N+L+ G ++++D GLA + + RV T+ Y P
Sbjct: 138 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 197
Query: 286 EVIDNEKYTYSP--DWFSFGCLIFEMIEGQAPF 316
E++ E+ Y P D + GC++ EM
Sbjct: 198 ELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIM 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 47/225 (20%), Positives = 92/225 (40%), Gaps = 32/225 (14%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL--EKKRIKKRKGESMVLIEKQILQKI 171
+ + LG GG G V + K A KK+ + K L E +I++++
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH-----ALREIKIIRRL 65
Query: 172 NSRFVVSL--------------AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIA 217
+ +V + + +++ +V M DL +
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLE----E 120
Query: 218 RARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-HVRISDLGLA----VEIPEGES 272
AR + ++L GL+++H +++RD KP N+ ++ ++I D GLA
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 273 VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPF 316
+ + T Y +P ++ + YT + D ++ GC+ EM+ G+ F
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.2 bits (199), Expect = 1e-16
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 19/203 (9%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-GESMVLI-EKQILQKINSRFVVSL 179
+G+G +G V Q G+ +A KK+ R++K G I E IL+++ +V L
Sbjct: 10 IGEGTYGVVYKAQNN-YGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
TK L LV ++ DLK + G G + A+ + ++L G+ + H ++
Sbjct: 66 YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 240 YRDCKPENILLDDYGHVRISDLGLA--VEIPEGESVRG---RVGTVGYMAPEVI-DNEKY 293
+RD KP+N+L++ G ++I+D GLA IP VR + T+ Y AP+V+ ++KY
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIP----VRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 294 TYSPDWFSFGCLIFEMIEGQAPF 316
+ + D +S GC+ EM+ G F
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLF 201
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 18/233 (7%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
+ LGKG FG V C+ G A K+L+ +++ E QIL+ ++
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD---FQREIQILKALH 82
Query: 173 SRFVVSLAYA---YETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCG 229
S F+V + +L LV+ + G L+ + D +R Y++++ G
Sbjct: 83 SDFIVKY-RGVSYGPGRQSLRLVMEYLPSGCLR--DFLQRHRARLDASRLLLYSSQICKG 139
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-RGRVGT---VGYMAP 285
+E+L V+RD NIL++ HV+I+D GLA +P + R + + AP
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 286 EVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPFRRRKEMVKRDEVDRRVKEDAE 337
E + + ++ D +SFG +++E+ E ++ +R V +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-GESMVLI-EKQILQKINSRFVVSL 179
+G+G +G V + G++ A K++ R+ G I E +L++++ +VSL
Sbjct: 29 VGEGTYGVVYKAKDS-QGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
++ L LV M DLK + G ++ + Y ++L G+ H H ++
Sbjct: 85 IDVIHSERCLTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 240 YRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG---RVGTVGYMAPEVI-DNEKYTY 295
+RD KP+N+L++ G ++++D GLA G VR V T+ Y AP+V+ ++KY+
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEM 322
S D +S GC+ EMI G+ F +
Sbjct: 200 SVDIWSIGCIFAEMITGKPLFPGVTDD 226
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMVLIEKQILQ 169
KT+ +G G +G VC+ + +G+ A KKL + + KR E +L+
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR-----AYRELLLLK 78
Query: 170 KINSRFVVSL------AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
+ V+ L A + LV+ M DL+ + E + ++
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEE-----KIQYLV 132
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYM 283
++L GL+++H G+V+RD KP N+ +++ ++I D GLA + G V T Y
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYR 190
Query: 284 APEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
APEVI Y + D +S GC++ EM+ G+ F+
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
R+ LG+G FGEV T ++ A K L+ + L E Q+++K+
Sbjct: 269 LRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA----FLQEAQVMKKLRHEK 323
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V L YA +++ + +V M+ G L + G+ + + AA++ G+ ++
Sbjct: 324 LVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER 381
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT--VGYMAPEVIDNEKY 293
+ V+RD + NIL+ + +++D GLA I + E + + + APE ++
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 294 TYSPDWFSFGCLIFEMI-EGQAPF 316
T D +SFG L+ E+ +G+ P+
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPY 465
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 61/272 (22%), Positives = 116/272 (42%), Gaps = 18/272 (6%)
Query: 53 YIIDQQPIGRL---LFRQFCA-EAKPQYHKYN-VFLDSIENYELEMDENRRLSTKDIYNE 107
Y I + G QF + + Y+ + L + + E
Sbjct: 121 YKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWE 180
Query: 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI 167
I ++ R+ LG+G FGEV T ++ A K L+ + L E Q+
Sbjct: 181 IPR---ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA----FLQEAQV 232
Query: 168 LQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVL 227
++K+ +V L YA +++ + +V M+ G L + G+ + + AA++
Sbjct: 233 MKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIA 290
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT--VGYMAP 285
G+ ++ + V+RD + NIL+ + +++D GLA I + E + + + AP
Sbjct: 291 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350
Query: 286 EVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
E ++T D +SFG L+ E+ +G+ P+
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMVLIEKQILQ 169
+R + +G G +G VC+ TG A KKL + + KR E ++L+
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-----AYRELRLLK 79
Query: 170 KINSRFVVSL------AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
+ V+ L + LV+ M G DL + + R +F
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGE----DRIQFLV 134
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYM 283
++L GL ++H G+++RD KP N+ +++ ++I D GLA + + G V T Y
Sbjct: 135 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRWYR 192
Query: 284 APEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
APEVI + +YT + D +S GC++ EMI G+ F+
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 52/241 (21%), Positives = 101/241 (41%), Gaps = 50/241 (20%)
Query: 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGESMVL 162
I F++ +LG+G +G VC+ + TG++ A KK+ +K R L
Sbjct: 3 KRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-----TL 57
Query: 163 IEKQILQKINSRFVVSL-----AYAYETKDALCLVLTIMNGGDL----------KFHIYN 207
E +IL+ ++++ ++E + + ++ +M DL HI
Sbjct: 58 REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHI-- 114
Query: 208 MGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA-VE 266
+++ + L ++ LH +++RD KP N+L++ +++ D GLA +
Sbjct: 115 ------------QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 267 IPEGESVRGRVGTVGYM----------APEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAP 315
G M APEV+ + KY+ + D +S GC++ E+ +
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222
Query: 316 F 316
F
Sbjct: 223 F 223
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV----LIEKQILQKI 171
++ + LG G FGEV K K +K K SM L E +++ +
Sbjct: 190 LKLEKKLGAGQFGEVWMAT---------YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL 240
Query: 172 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLE 231
+V L +A TK+ + ++ M G L + + G + + ++A++ G+
Sbjct: 241 QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMA 298
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---VGYMAPEVI 288
+ ++RD + NIL+ +I+D GLA I + E R G + + APE I
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAI 357
Query: 289 DNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+ +T D +SFG L+ E++ G+ P+
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPY 386
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGESMV---LIEKQ 166
+ + R LG+G FG+V T A K L K G E
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-----KADAGPQHRSGWKQEID 85
Query: 167 ILQKINSRFVVSLAYAYETKDA---LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
IL+ + ++ L LV+ + G L+ ++ +A+ +A
Sbjct: 86 ILRTLYHEHIIKY-KGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFA 140
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-RGRVGT--- 279
++ G+ +LH ++RD N+LLD+ V+I D GLA +PEG R R
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 280 VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
V + APE + K+ Y+ D +SFG ++E++
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV----L 162
E+ +T ++ LG G FGEV K+ A K L K SM L
Sbjct: 9 EVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL--------KQGSMSPDAFL 56
Query: 163 IEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFY 222
E +++++ + +V L YA T++ + ++ M G L + G I +
Sbjct: 57 AEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDM 114
Query: 223 AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT--- 279
AA++ G+ + ++RD + NIL+ D +I+D GLA I + E R G
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFP 173
Query: 280 VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+ + APE I+ +T D +SFG L+ E++ G+ P+
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 23/215 (10%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGESMVLIEKQILQKIN 172
+ +G+G +G VC+ A KK+ E + +R L E +IL +
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR-----TLREIKILLRFR 83
Query: 173 SRFVVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVL 227
++ + A E + +V +M DL + ++ ++L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT----QHLSNDHICYFLYQIL 138
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR----VGTVGYM 283
GL+++H +++RD KP N+LL+ ++I D GLA G V T Y
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 284 APEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFR 317
APE++ N + YT S D +S GC++ EM+ + F
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 122 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-GESMVLI-EKQILQKINSRFVVSL 179
LG+G +GEV T + A K++ R++ + G I E +L+++ R ++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
L L+ DLK ++ P + + + +++ G+ H +
Sbjct: 99 KSVIHHNHRLHLIFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRRCL 154
Query: 240 YRDCKPENILLD-----DYGHVRISDLGLA--VEIPEGESVRG---RVGTVGYMAPEVID 289
+RD KP+N+LL + ++I D GLA IP +R + T+ Y PE++
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP----IRQFTHEIITLWYRPPEILL 210
Query: 290 NEKYTYSP--DWFSFGCLIFEMIEGQAPFRRRKEM 322
+ YS D +S C+ EM+ F E+
Sbjct: 211 GSR-HYSTSVDIWSIACIWAEMLMKTPLFPGDSEI 244
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 48/218 (22%), Positives = 86/218 (39%), Gaps = 14/218 (6%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMY---ACKKLEKKRIKKRKGESMVLI 163
I K R+ LG G FG V + A A K L+ + + + +
Sbjct: 14 LIGE---KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 164 EKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
E + ++ R ++ L Y + +V + G L + F + YA
Sbjct: 71 EVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYA 127
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-RGRVGT--- 279
+V G+ +L ++RD N+LL V+I D GL +P+ + +
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 280 VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+ APE + ++++ D + FG ++EM GQ P+
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 54/268 (20%), Positives = 87/268 (32%), Gaps = 77/268 (28%)
Query: 119 YRVLGKGGFGE---VCACQVRATGKMYACKKLEKKRIKKR--KGESMVLIEKQILQKINS 173
Y V+ K G+G V K A K + K L E ++L+ + +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMK------VVKSAEHYTETALDEIRLLKSVRN 92
Query: 174 --------RFVVSLAYAYETKDA----LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF 221
VV L ++ +C+V ++ G L I + G + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQ-GLPLPCVKK 150
Query: 222 YAAEVLCGLEHLH-YIGLVYRDCKPENILL------------------------------ 250
+VL GL++LH +++ D KPENILL
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 251 -------------------DDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNE 291
+ V+I+DLG A + + T Y + EV+
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQTRQYRSLEVLIGS 268
Query: 292 KYTYSPDWFSFGCLIFEMIEGQAPFRRR 319
Y D +S C+ FE+ G F
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPH 296
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 58/254 (22%), Positives = 105/254 (41%), Gaps = 16/254 (6%)
Query: 74 PQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCAC 133
+ N++ +++ + + + + + V+G+G FG V
Sbjct: 49 KKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHG 108
Query: 134 QVRATGKMY---ACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL-AYAYETKDAL 189
+ A K L RI S L E I++ + V+SL ++ +
Sbjct: 109 TLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166
Query: 190 CLVLTIMNGGDLKFHIYNMGGEPGF-DIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248
+VL M GDL+ I N P D+ + +V G++ L V+RD N
Sbjct: 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFLASKKFVHRDLAARNC 223
Query: 249 LLDDYGHVRISDLGLAVEIPEGESVRGRVGTVG-----YMAPEVIDNEKYTYSPDWFSFG 303
+LD+ V+++D GLA ++ + E T +MA E + +K+T D +SFG
Sbjct: 224 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 283
Query: 304 CLIFEMIE-GQAPF 316
L++E++ G P+
Sbjct: 284 VLLWELMTRGAPPY 297
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 47/216 (21%), Positives = 95/216 (43%), Gaps = 14/216 (6%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMY---ACKKLEKKRIKKRKGESMVLI 163
EIQ + + R +G+G FG+V + A K + + + L
Sbjct: 11 EIQR---ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQ 65
Query: 164 EKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
E +++ + +V L T++ + +++ + G+L + + D+A YA
Sbjct: 66 EALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYA 122
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT--VG 281
++ L +L V+RD N+L+ V++ D GL+ + + + G +
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+MAPE I+ ++T + D + FG ++E++ G PF
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 22/222 (9%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV----- 161
EI P +V+G G FGEV + K + KK IK K
Sbjct: 40 EIHP---SCVTRQKVIGAGEFGEVY----KGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD 92
Query: 162 -LIEKQILQKINSRFVVSLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGGEPGFDIARA 219
L E I+ + + ++ L +K + ++ M G L + + F + +
Sbjct: 93 FLGEAGIMGQFSHHNIIRL-EGVISKYKPMMIITEYMENGALD--KFLREKDGEFSVLQL 149
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ESVRGRVG 278
+ G+++L + V+RD NIL++ ++SD GL+ + + E+ G
Sbjct: 150 VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 279 T---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+ + APE I K+T + D +SFG +++E++ G+ P+
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 14/217 (6%)
Query: 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMY---ACKKLEKKRIKKRKGESMVLIEKQ 166
+ V+G+G FG V + A K L RI S L E
Sbjct: 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGI 78
Query: 167 ILQKINSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAE 225
I++ + V+SL ++ + +VL M GDL+ I N P + + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQ 136
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVG---- 281
V G+++L V+RD N +LD+ V+++D GLA ++ + E T
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 282 -YMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+MA E + +K+T D +SFG L++E++ G P+
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 58/315 (18%), Positives = 116/315 (36%), Gaps = 19/315 (6%)
Query: 9 YIIDQQPIGRLLFRQFCAEAKPQYHKYNVLFLAMFTLALYVRYSYIIDQQPIGRLLFRQF 68
Y+ + ++ C + + ID
Sbjct: 238 YLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPA 297
Query: 69 CAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFG 128
+ + + E+ + +E + + + + LG G FG
Sbjct: 298 RITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIE-------LGCGNFG 350
Query: 129 EVCACQVRATGKMY--ACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186
V R K A K L K+ ++ ++ E QI+ ++++ ++V L
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYIVRL-IGVCQA 407
Query: 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPE 246
+AL LV+ + GG L + E ++ +V G+++L V+R+
Sbjct: 408 EALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKNFVHRNLAAR 465
Query: 247 NILLDDYGHVRISDLGLAVEIPEGESV-RGRVGT---VGYMAPEVIDNEKYTYSPDWFSF 302
N+LL + + +ISD GL+ + +S R + + APE I+ K++ D +S+
Sbjct: 466 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 525
Query: 303 GCLIFEMI-EGQAPF 316
G ++E + GQ P+
Sbjct: 526 GVTMWEALSYGQKPY 540
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 46/220 (20%), Positives = 95/220 (43%), Gaps = 22/220 (10%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKK-RIKKRKGESMV---- 161
I + + R+LG+G FGEV G K + +K K + +
Sbjct: 8 GIAR---EDVVLNRILGEGFFGEVYE------GVYTNHKGEKINVAVKTCKKDCTLDNKE 58
Query: 162 --LIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARA 219
+ E I++ ++ +V L ++ +++ + G+L Y + +
Sbjct: 59 KFMSEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG--HYLERNKNSLKVLTL 115
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT 279
Y+ ++ + +L I V+RD NIL+ V++ D GL+ I + + + V
Sbjct: 116 VLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 175
Query: 280 --VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+ +M+PE I+ ++T + D + F ++E++ G+ PF
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 27/250 (10%), Positives = 60/250 (24%), Gaps = 34/250 (13%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+R+ G + A + A ++ + + L L +I+
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
V + T+ +V + GG L+ + A + + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHR 147
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
G+ P + + G V + M
Sbjct: 148 AGVALSIDHPSRVRVSIDGDV-------------------VLAYPATMPDA-------NP 181
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD---DAKALCK 352
D G ++ ++ + P +R + + D A+
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 353 ALLKKSPRSR 362
++ R
Sbjct: 242 RSVQGDGGIR 251
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 5e-15
Identities = 47/216 (21%), Positives = 95/216 (43%), Gaps = 14/216 (6%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMY---ACKKLEKKRIKKRKGESMVLI 163
EIQ + + R +G+G FG+V + A K + + + L
Sbjct: 386 EIQR---ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQ 440
Query: 164 EKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYA 223
E +++ + +V L T++ + +++ + G+L + + D+A YA
Sbjct: 441 EALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYA 497
Query: 224 AEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT--VG 281
++ L +L V+RD N+L+ V++ D GL+ + + + G +
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+MAPE I+ ++T + D + FG ++E++ G PF
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 14/217 (6%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMY--ACKKLEKKRIKKRKGESMVLIE 164
++ + LG G FG V R K A K L K+ ++ ++ E
Sbjct: 5 FLKRDNLLIADI--ELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMRE 60
Query: 165 KQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAA 224
QI+ ++++ ++V L +AL LV+ + GG L H + +G ++
Sbjct: 61 AQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPL--HKFLVGKREEIPVSNVAELLH 117
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-RGRVGT---V 280
+V G+++L V+RD N+LL + + +ISD GL+ + +S R +
Sbjct: 118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177
Query: 281 GYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+ APE I+ K++ D +S+G ++E + GQ P+
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 51/219 (23%), Positives = 102/219 (46%), Gaps = 17/219 (7%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMY---ACKKLEKKRIKKRKGESMVLI 163
E+ + +V+G G FGEVC+ +++ K A K L+ +K++ + L
Sbjct: 41 ELDA---TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD--FLG 95
Query: 164 EKQILQKINSRFVVSLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFY 222
E I+ + + ++ L TK + +V M G L + + F + +
Sbjct: 96 EASIMGQFDHPNIIRL-EGVVTKSKPVMIVTEYMENGSLD--SFLRKHDAQFTVIQLVGM 152
Query: 223 AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ESVRGRVGT-- 279
+ G+++L +G V+RD NIL++ ++SD GL + + E+ G
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 280 -VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+ + +PE I K+T + D +S+G +++E++ G+ P+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 56/246 (22%), Positives = 86/246 (34%), Gaps = 50/246 (20%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK--------KRIKKRKGESMVLIEKQI 167
+ + ++G+G +G V + T K A KK+ + KRI L E I
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---------LREITI 78
Query: 168 LQKINSRFVVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFY 222
L ++ S +++ L D L +VL I DLK +
Sbjct: 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKT--PIF-LTEEHIKTI 134
Query: 223 AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA-------------VEIPE 269
+L G +H G+++RD KP N LL+ V++ D GLA
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 270 GESVRGRVGTVGYM----------APEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPFRR 318
E + APE+I E YT S D +S GC+ E++
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
Query: 319 RKEMVK 324
Sbjct: 255 DPTNRF 260
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 46/219 (21%), Positives = 93/219 (42%), Gaps = 23/219 (10%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV----L 162
E++ M LG G +GEV + A K L K ++M L
Sbjct: 9 EMER---TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTMEVEEFL 57
Query: 163 IEKQILQKINSRFVVSLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF 221
E ++++I +V L T++ ++ M G+L ++ + +
Sbjct: 58 KEAAVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLY 115
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT-- 279
A ++ +E+L ++RD N L+ + V+++D GL+ + G++ G
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKF 174
Query: 280 -VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+ + APE + K++ D ++FG L++E+ G +P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 42/209 (20%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV----LIEKQILQKI 171
M LG G +GEV + A +K K ++M L E ++++I
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVA--------VKTLKEDTMEVEEFLKEAAVMKEI 273
Query: 172 NSRFVVSLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
+V L T++ ++ M G+L ++ + + A ++ +
Sbjct: 274 KHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAM 331
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE--SVRGRVGTVGYMAPEVI 288
E+L ++R+ N L+ + V+++D GL+ + + G + + APE +
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 289 DNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
K++ D ++FG L++E+ G +P+
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMY---ACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ R+LGKG FG V Q++ + A K L K I L E +++ +
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDH 84
Query: 174 RFVVSL------AYAYETKDALCLVLTIMNGGDLK-FHIYNMGGEPGFDIARARF--YAA 224
V L + A ++L M GDL F + + GE F++ +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 225 EVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---VG 281
++ CG+E+L ++RD N +L + V ++D GL+ +I G+ R + V
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
++A E + + YT D ++FG ++E++ GQ P+
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 12/204 (5%)
Query: 120 RVLGKGGFGEVCACQVRATGKMY--ACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVV 177
+ LG G FG V + + A K L+ + + + L E ++Q++++ ++V
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL-LAEANVMQQLDNPYIV 81
Query: 178 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG 237
+ ++ LV+ + G L + Y +V G+++L
Sbjct: 82 RM-IGICEAESWMLVMEMAELGPL--NKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN 137
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV-RGRVGT---VGYMAPEVIDNEKY 293
V+RD N+LL + +ISD GL+ + E+ + + V + APE I+ K+
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 294 TYSPDWFSFGCLIFEMI-EGQAPF 316
+ D +SFG L++E GQ P+
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPY 221
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 55/240 (22%), Positives = 102/240 (42%), Gaps = 40/240 (16%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMVL 162
+ + + + + LGKG +G V R TG++ A KK+ + +R
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR-----TF 56
Query: 163 IEKQILQKINS-RFVVSL--AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARA 219
E IL +++ +V+L + + LV M DL I +
Sbjct: 57 REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA----NILEPVHK 111
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA------------VEI 267
++ +++ +++LH GL++RD KP NILL+ HV+++D GL+ + +
Sbjct: 112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 268 PEGESVRGRVGTVGYM----------APEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPF 316
E+ + APE++ + KYT D +S GC++ E++ G+ F
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 14/210 (6%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMY---ACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
RV+GKG FG V + + A K L RI + + L E +++ +N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNH 81
Query: 174 RFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
V++L + ++L M GDL I + P + + +V G+E+
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP--TVKDLISFGLQVARGMEY 139
Query: 233 LHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVG-----YMAPEV 287
L V+RD N +LD+ V+++D GLA +I + E + + A E
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 288 IDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+ ++T D +SFG L++E++ G P+
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 5e-14
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV----L 162
E++ + + + LG G FG V + + + A K + K SM
Sbjct: 4 ELKR---EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMI--------KEGSMSEDEFF 51
Query: 163 IEKQILQKINSRFVVSLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF 221
E Q + K++ +V Y +K+ + +V ++ G L ++ + G + ++
Sbjct: 52 QEAQTMMKLSHPKLVKF-YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLE 108
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT-- 279
+V G+ L ++RD N L+D V++SD G+ + + + V VGT
Sbjct: 109 MCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKF 167
Query: 280 -VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
V + APEV KY+ D ++FG L++E+ G+ P+
Sbjct: 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 50/219 (22%), Positives = 100/219 (45%), Gaps = 17/219 (7%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMY---ACKKLEKKRIKKRKGESMVLI 163
EI+ + +++G G GEVC ++R G+ A K L+ ++++ + L
Sbjct: 45 EIEA---SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD--FLS 99
Query: 164 EKQILQKINSRFVVSLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFY 222
E I+ + + ++ L T+ +V M G L + + F I +
Sbjct: 100 EASIMGQFDHPNIIRL-EGVVTRGRLAMIVTEYMENGSL--DTFLRTHDGQFTIMQLVGM 156
Query: 223 AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP-EGESVRGRVGT-- 279
V G+ +L +G V+RD N+L+D ++SD GL+ + + ++ G
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 280 -VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+ + APE I ++ + D +SFG +++E++ G+ P+
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 25/219 (11%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV----L 162
EI P K + LG G FG V + R + A K + K SM +
Sbjct: 20 EIDP---KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMI--------KEGSMSEDEFI 67
Query: 163 IEKQILQKINSRFVVSLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF 221
E +++ ++ +V L Y TK + ++ M G L Y F +
Sbjct: 68 EEAKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLL--NYLREMRHRFQTQQLLE 124
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT-- 279
+V +E+L ++RD N L++D G V++SD GL+ + + E VG+
Sbjct: 125 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKF 183
Query: 280 -VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
V + PEV+ K++ D ++FG L++E+ G+ P+
Sbjct: 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 29/219 (13%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV---LI 163
+ K ++ + +GKG FG+V G A +K K ++ L
Sbjct: 17 ALNM---KELKLLQTIGKGEFGDVMLG--DYRGNKVA--------VKCIKNDATAQAFLA 63
Query: 164 EKQILQKINSRFVVSLAYAYETKD--ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF 221
E ++ ++ +V L ++ L +V M G L ++ + G
Sbjct: 64 EASVMTQLRHSNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLK 121
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT-- 279
++ +V +E+L V+RD N+L+ + ++SD GL E +
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKL 176
Query: 280 -VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
V + APE + +K++ D +SFG L++E+ G+ P+
Sbjct: 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 57/247 (23%), Positives = 94/247 (38%), Gaps = 47/247 (19%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMVLIEKQILQKI 171
+ + ++G G +G VC + ++ A KK+ E KR +L E IL ++
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR-----ILREIAILNRL 109
Query: 172 NSRFVVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
N VV + E D L +VL I D K + +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNL 165
Query: 227 LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA--VEIPEGESVRGRVGTVG--- 281
L G++++H G+++RD KP N L++ V++ D GLA V+ PE + + +
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 282 -----------------------YMAPEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPFR 317
Y APE+I E YT + D +S GC+ E++
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 318 RRKEMVK 324
Sbjct: 286 AYHADRG 292
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 51/219 (23%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV----L 162
I P + +G G FG V K+ A K + + +M +
Sbjct: 4 VIDP---SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI--------REGAMSEEDFI 51
Query: 163 IEKQILQKINSRFVVSLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF 221
E +++ K++ +V L Y + A +CLV M G L ++ G F
Sbjct: 52 EEAEVMMKLSHPKLVQL-YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLG 108
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT-- 279
+V G+ +L +++RD N L+ + +++SD G+ + + + GT
Sbjct: 109 MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKF 167
Query: 280 -VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
V + +PEV +Y+ D +SFG L++E+ EG+ P+
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 29/231 (12%)
Query: 122 LGKGGFGEV--CACQVRATGKMYACKKLEKKRIKKRKGESMVLI-EKQILQKINSRFVVS 178
+G+G +G V + K YA K++E G SM E +L+++ V+S
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT------GISMSACREIALLRELKHPNVIS 82
Query: 179 L--AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV-------LCG 229
L + + L+ DL I + V L G
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANK-KPVQLPRGMVKSLLYQILDG 140
Query: 230 LEHLHYIGLVYRDCKPENILL----DDYGHVRISDLGLA----VEIPEGESVRGRVGTVG 281
+ +LH +++RD KP NIL+ + G V+I+D+G A + + V T
Sbjct: 141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200
Query: 282 YMAPEVI-DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR 331
Y APE++ YT + D ++ GC+ E++ + F R+E +K
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV---LIEKQILQKIN 172
++ + +GKG FG+V R K +K K ++ L E ++ ++
Sbjct: 195 LKLLQTIGKGEFGDVMLGDYRGN----------KVAVKCIKNDATAQAFLAEASVMTQLR 244
Query: 173 SRFVVSLAYA--YETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
+V L E K L +V M G L ++ + G ++ +V +
Sbjct: 245 HSNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAM 302
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN 290
E+L V+RD N+L+ + ++SD GL E + G++ V + APE +
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKL-PVKWTAPEALRE 360
Query: 291 EKYTYSPDWFSFGCLIFEMI-EGQAPF 316
+K++ D +SFG L++E+ G+ P+
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPY 387
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 16/215 (7%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV---LIEKQILQKINS 173
+ R LG G FGEV QV + ++ K + + E L+E I+ K N
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 174 RFVVSLAYAYETKDA-LCLVLTIMNGGDLK----FHIYNMGGEPGFDIARARFYAAEVLC 228
+ +V + +++ +M GGDLK + A ++ C
Sbjct: 93 QNIVRC-IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 229 GLEHLHYIGLVYRDCKPENILLDDYGH---VRISDLGLAVEIPEGESVRGRVGT---VGY 282
G ++L ++RD N LL G +I D G+A +I R V +
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
M PE +T D +SFG L++E+ G P+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 54/215 (25%), Positives = 85/215 (39%), Gaps = 16/215 (7%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV---LIEKQILQKINS 173
+ R LG G FGEV QV + ++ K + + E L+E I+ K N
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 174 RFVVSLAYAYETKDA-LCLVLTIMNGGDLK----FHIYNMGGEPGFDIARARFYAAEVLC 228
+ +V + ++L +M GGDLK + A ++ C
Sbjct: 134 QNIVRC-IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 229 GLEHLHYIGLVYRDCKPENILLDDYGH---VRISDLGLAVEIPEGESVRGRVGT---VGY 282
G ++L ++RD N LL G +I D G+A +I R V +
Sbjct: 193 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
M PE +T D +SFG L++E+ G P+
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 48/215 (22%), Positives = 92/215 (42%), Gaps = 16/215 (7%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV---LIEKQILQKINS 173
M R LG+G FG V + K ++ K + + L E ++++ N
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 174 RFVVSLAYAYETKDA-LCLVLTIMNGGDLK-------FHIYNMGGEPGFDIARARFYAAE 225
VV L ++ +++ +M GDLK + N +++ A E
Sbjct: 88 HHVVRL-LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---VGY 282
+ G+ +L+ V+RD N ++ + V+I D G+ +I E + R V +
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
M+PE + + +T D +SFG +++E+ + P+
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 46/215 (21%), Positives = 82/215 (38%), Gaps = 25/215 (11%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV-----LIEKQILQKI 171
+ LG+G FG+V + + +K K S E ++L +
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVA---VKALKEASESARQDFQREAELLTML 100
Query: 172 NSRFVVSLAYAYETKDA-LCLVLTIMNGGDLK------------FHIYNMGGEPGFDIAR 218
+ +V + T+ L +V M GDL + +
Sbjct: 101 QHQHIVRF-FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 219 ARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG 278
A++V G+ +L + V+RD N L+ V+I D G++ +I + R
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 219
Query: 279 T---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
T + +M PE I K+T D +SFG +++E+
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 46/215 (21%), Positives = 89/215 (41%), Gaps = 16/215 (7%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMY---ACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+ ++LG+G FG V ++ A K + K ++ L E ++ +
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 174 RFVVSL-----AYAYETKDALCLVLTIMNGGDLK-FHIYNMGGEPGFDIARARF--YAAE 225
V+ L + + ++L M GDL + +Y+ I + +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---VGY 282
+ G+E+L ++RD N +L D V ++D GL+ +I G+ R V +
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPF 316
+A E + + YT D ++FG ++E+ G P+
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR---IKKRKGESMV------LIEKQI 167
+ + LG+G FG+V V A K + +K K ++ + E ++
Sbjct: 72 VLGKPLGEGAFGQV----VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 127
Query: 168 LQKINS-RFVVSLAYAYETKDALCLVLTIMNGGDLK-----------FHIYNMGGEPGFD 215
++ I + +++L A L +++ + G+L+ + YN P
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 216 IARARF--YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273
++ A +V G+E+L ++RD N+L+ + ++I+D GLA +I +
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 274 RGRVGT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
+ V +MAPE + + YT+ D +SFG L++E+
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 49/216 (22%), Positives = 79/216 (36%), Gaps = 22/216 (10%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV---LIEKQILQKINS 173
+ LG G FG+V K A + K +K + + E ++L + +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 174 -RFVVSLAYAYETKDALCLVLTIMNGGDLK---------FHIYNMGGEPGFDIARARFY- 222
+V+L A ++ GDL F D A
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 223 -----AAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRV 277
+ +V G+ L ++RD NILL +I D GLA +I + +
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 278 GT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
V +MAPE I N YT+ D +S+G ++E+
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 43/228 (18%), Positives = 90/228 (39%), Gaps = 24/228 (10%)
Query: 104 IYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKK--RKGES 159
++++I+ + LG+G F ++ R G + E K + K R
Sbjct: 1 VFHKIRN---EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE 57
Query: 160 MVLIEKQILQKINSRFVVSLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGGEPGFDIAR 218
++ K++ + +V Y LV + G L Y + +I
Sbjct: 58 SFFEAASMMSKLSHKHLVLN-YGVCVCGDENILVQEFVKFGSLD--TYLKKNKNCINILW 114
Query: 219 ARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD--------DYGHVRISDLGLAVEIPEG 270
A ++ + L L++ + +NILL + +++SD G+++ +
Sbjct: 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 271 ESVRGRVGTVGYMAPEVIDNEK-YTYSPDWFSFGCLIFEMI-EGQAPF 316
+ ++ R + ++ PE I+N K + D +SFG ++E+ G P
Sbjct: 175 DILQER---IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 48/228 (21%), Positives = 86/228 (37%), Gaps = 37/228 (16%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMY-----ACKKLEKKRIKKRKGESMV-----LIEKQ 166
+ R LG+G FG+V + A K L K ++ E +
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--------KDPTLAARKDFQREAE 69
Query: 167 ILQKINSRFVVSLAYAYETKDA-LCLVLTIMNGGDLK-------------FHIYNMGGEP 212
+L + +V Y L +V M GDL +
Sbjct: 70 LLTNLQHEHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 213 GFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272
+++ A+++ G+ +L V+RD N L+ V+I D G++ ++ +
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 273 VRGRVGT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPF 316
R T + +M PE I K+T D +SFG +++E+ G+ P+
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 46/220 (20%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR---IKKRKGESMV------LIEKQI 167
+ + LG+G FG+V V A K ++ +K K ++ + E ++
Sbjct: 38 TLGKPLGEGAFGQV----VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 93
Query: 168 LQKINS-RFVVSLAYAYETKDALCLVLTIMNGGDLK-----------FHIYNMGGEPGFD 215
++ I + +++L A L +++ + G+L+ + Y++ P
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 216 IARARF--YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273
+ ++ G+E+L ++RD N+L+ + ++I+D GLA +I +
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 274 RGRVGT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
+ V +MAPE + + YT+ D +SFG L++E+
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 54/257 (21%), Positives = 96/257 (37%), Gaps = 24/257 (9%)
Query: 73 KPQYHKYNVFLDSIENYELEMDENRRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCA 132
KP+Y ++S E + +L + + E + + LG G FG+V
Sbjct: 9 KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKW-EFPR---NNLQFGKTLGAGAFGKVVE 64
Query: 133 CQVRATGKMYACKKLEKKRIKKRKGESMV---LIEKQILQKINS-RFVVSLAYAYETKDA 188
GK A K+ K +K + E +I+ + +V+L T
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNL-LGACTHGG 123
Query: 189 -LCLVLTIMNGGDLK---------FHIYNMGGEPGFDIARARF--YAAEVLCGLEHLHYI 236
+ ++ GDL + ++++V G+ L
Sbjct: 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK 183
Query: 237 GLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT---VGYMAPEVIDNEKY 293
++RD N+LL + +I D GLA +I + + V +MAPE I + Y
Sbjct: 184 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243
Query: 294 TYSPDWFSFGCLIFEMI 310
T D +S+G L++E+
Sbjct: 244 TVQSDVWSYGILLWEIF 260
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 46/220 (20%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR---IKKRKGESMV------LIEKQI 167
+ + LG+G FG+V V A K ++ +K K ++ + E ++
Sbjct: 84 TLGKPLGEGCFGQV----VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 139
Query: 168 LQKINS-RFVVSLAYAYETKDALCLVLTIMNGGDLK-----------FHIYNMGGEPGFD 215
++ I + +++L A L +++ + G+L+ + Y++ P
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 216 IARARF--YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273
+ ++ G+E+L ++RD N+L+ + ++I+D GLA +I +
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 274 RGRVGT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
+ V +MAPE + + YT+ D +SFG L++E+
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 46/214 (21%), Positives = 89/214 (41%), Gaps = 21/214 (9%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV---LIEKQILQKINS 173
R LG+ FG+V + + + K +K + + E + ++
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 174 RFVVSLAYAYETKDA-LCLVLTIMNGGDLK-------------FHIYNMGGEPGFDIARA 219
VV L TKD L ++ + + GDL + + +
Sbjct: 72 PNVVCL-LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT 279
A++ G+E+L +V++D N+L+ D +V+ISDLGL E+ + + +
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 280 ---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
+ +MAPE I K++ D +S+G +++E+
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 41/181 (22%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SR 174
+R+ R +G G FG++ A G+ A K E + K + IE +I + +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKH----PQLHIESKIYKMMQGGV 65
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+ ++ + D +V+ ++ G L+ + F + A +++ +E++H
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH 122
Query: 235 YIGLVYRDCKPENILLDDYGH---VRISDLGLAVE---------IPEGESVRGRVGTVGY 282
++RD KP+N L+ V I D GLA + IP E+ + GT Y
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN-KNLTGTARY 181
Query: 283 M 283
Sbjct: 182 A 182
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 27/221 (12%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV---LIEKQILQKINS 173
+ + LG+G FG+V + K +K+ S + L E +L+++N
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLK---------FHIYNMGGEPGFDIARARF--- 221
V+ L A L L++ G L+ Y G +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 222 ---------YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272
+A ++ G+++L + LV+RD NIL+ + ++ISD GL+ ++ E +S
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 273 VRGRVGT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
R V +MA E + + YT D +SFG L++E++
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 23/216 (10%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV---LIEKQILQKINS 173
++ + LG+G FG+V K C+ + K +K+ S + E +IL I
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 174 -RFVVSLAYAYETKDA--LCLVLTIMNGGDLK-------------FHIYNMGGEPGFDIA 217
VV+L TK L +++ G+L + +
Sbjct: 90 HLNVVNL-LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 218 RARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRV 277
Y+ +V G+E L ++RD NILL + V+I D GLA +I + +
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 278 GT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
+ +MAPE I + YT D +SFG L++E+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 38/183 (20%), Positives = 72/183 (39%), Gaps = 24/183 (13%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSR 174
+++ R +G+G FG + + A K E +R + E + + +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDA----PQLRDEYRTYKLLAGCT 66
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+ ++ Y + LV+ ++ G L+ + G + F + A ++L ++ +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIH 123
Query: 235 YIGLVYRDCKPENILLDDYGH-----VRISDLGLAVE---------IPEGESVRGRVGTV 280
LVYRD KP+N L+ + + D G+ IP E + GT
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK-KNLSGTA 182
Query: 281 GYM 283
YM
Sbjct: 183 RYM 185
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 44/189 (23%), Positives = 78/189 (41%), Gaps = 22/189 (11%)
Query: 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI 167
++P FR+ R +G G FGE+ T + A K E + K +L E +I
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKH----PQLLYESKI 55
Query: 168 LQKIN-SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
+ + + ++ + D LV+ ++ G L+ ++N + A ++
Sbjct: 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRK-LSLKTVLMLADQM 112
Query: 227 LCGLEHLHYIGLVYRDCKPENILLDDYGH---VRISDLGLAVE---------IPEGESVR 274
+ +E +H ++RD KP+N L+ V I D GLA + IP E+ +
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN-K 171
Query: 275 GRVGTVGYM 283
GT Y
Sbjct: 172 NLTGTARYA 180
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 29/222 (13%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV---LIEKQILQKINS 173
+VLG G FG+V K ++ K +K++ S + E +++ ++ S
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 174 -RFVVSLAYAYETKDA-LCLVLTIMNGGDLK---------FHIYNMGGEPGFDIARARF- 221
+V+L T + L+ GDL F + E +
Sbjct: 108 HENIVNL-LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 222 ----------YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271
+A +V G+E L + V+RD N+L+ V+I D GLA +I
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 272 SVRGRVGT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
+ R V +MAPE + YT D +S+G L++E+
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 24/183 (13%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSR 174
FR+ + +G G FGE+ + T + A K LE + + + +E + +++ +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRA----PQLHLEYRFYKQLGSGD 65
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+ + Y +VL ++ G L+ F + A +++ +E++H
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRT--FSLKTVLMIAIQLISRMEYVH 122
Query: 235 YIGLVYRDCKPENILLDDYGH-----VRISDLGLAVE---------IPEGESVRGRVGTV 280
L+YRD KPEN L+ G+ + I D LA E IP E + GT
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH-KSLTGTA 181
Query: 281 GYM 283
YM
Sbjct: 182 RYM 184
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 38/117 (32%), Positives = 60/117 (51%), Gaps = 7/117 (5%)
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT-- 279
Y+ +V G+E L ++RD NILL + V+I D GLA +I + +
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 280 -VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKE 334
+ +MAPE I + YT D +SFG L++E+ G +P+ + +E RR+KE
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRLKE 311
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 45/221 (20%), Positives = 81/221 (36%), Gaps = 27/221 (12%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV---LIEKQILQKINS 173
R +G+G FG V + + K +K+ M E ++ + ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLK---------------------FHIYNMGGEP 212
+V L +CL+ M GDL + G P
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 213 GFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272
A A +V G+ +L V+RD N L+ + V+I+D GL+ I +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 273 VRGRVGT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
+ + +M PE I +YT D +++G +++E+
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV------LIEKQILQK 170
+ V+G+G FG+V +++ G IK+ K + E ++L K
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAA------IKRMKEYASKDDHRDFAGELEVLCK 81
Query: 171 INS-RFVVSLAYAYETKDALCLVLTIMNGGDLK-FHIYNMGGEPGFDIARARF------- 221
+ +++L A E + L L + G+L F + E A A
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 222 -----YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR 276
+AA+V G+++L ++RD NIL+ + +I+D GL+ E +
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKK 198
Query: 277 VGT---VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
V +MA E ++ YT + D +S+G L++E++
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 31/203 (15%), Positives = 65/203 (32%), Gaps = 30/203 (14%)
Query: 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI 167
+ + + +++ + G + +T + + +K +K + + E+
Sbjct: 36 LTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNF 95
Query: 168 LQKINSRFVVSLAYAYETKDALC----------------LVLTIMNGGDLKFHIYNMGGE 211
Q+ V+ + L LVL + G L+ ++ +
Sbjct: 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPK 153
Query: 212 PGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL--DDYGHVRISDLGLA----- 264
A +L LE LH V+ + ENI + +D V ++ G A
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 265 ----VEIPEGESVRGRVGTVGYM 283
V EG G + ++
Sbjct: 214 SGKHVAYVEGSR-SPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 37/209 (17%), Positives = 72/209 (34%), Gaps = 43/209 (20%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMVLIE 164
+ + + + + +G GGFG + + A K+E + + E
Sbjct: 30 VLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQE------NGPLFSE 83
Query: 165 KQILQKINSRFVVSLAYAYETKDAL-------------------CLVLTIMNGGDLKFHI 205
+ Q++ + + + D L +V+ + G DL+ I
Sbjct: 84 LKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KI 141
Query: 206 YNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD--DYGHVRISDLGL 263
G F + +L LE++H V+ D K N+LL + V ++D GL
Sbjct: 142 SGQNGT--FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGL 199
Query: 264 A---------VEIPEGESVRGRVGTVGYM 283
+ + E +G GT+ +
Sbjct: 200 SYRYCPNGNHKQYQENPR-KGHNGTIEFT 227
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-07
Identities = 84/643 (13%), Positives = 166/643 (25%), Gaps = 203/643 (31%)
Query: 1 MFTDVRYSYIIDQQPI---GRLLFRQFCAEAKPQYHKYNVLFLAMFTLALYVRYSYIIDQ 57
+ + +II + LF ++ + K+ L + Y +++
Sbjct: 45 ILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF-------VEEVLRINYKFLMSP 97
Query: 58 QPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDI-----YNEIQPIT 112
+ + Y D + N +N+ + ++ Y +++
Sbjct: 98 -------IKTEQRQPSMMTRMYIEQRDRLYN------DNQVFAKYNVSRLQPYLKLRQAL 144
Query: 113 YKTFRMYRVL--GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
+ VL G G G+ A V + ++ K
Sbjct: 145 LELRPAKNVLIDGVLGSGK----TWVA---------------------LDVCLSYKVQCK 179
Query: 171 INSR-FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCG 229
++ + F ++L + VL ++ L + I + + +
Sbjct: 180 MDFKIFWLNLKNCNSPET----VLEMLQ--KLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVID 289
L L Y +C ++L + + + + +
Sbjct: 234 LRRL-LKSKPYENCL---LVLLN-----VQN------------------------AKAWN 260
Query: 290 NEKYTYSPDWFSFGC--LIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFS-DD 346
F+ C L+ R K++ + +S + D+
Sbjct: 261 A---------FNLSCKILLTT---------RFKQVTDFLSAATTTHISLDHHSMTLTPDE 302
Query: 347 AKALC-KAL---LKKSPRSRLGCH---CGRYGAR---ELKQAEFFKSTNWKRLEA--GLC 394
K+L K L + PR L + L + +K N +L
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS 362
Query: 395 ----DPP-----------FVPDVK-RDEVDRRVKEDAEKYSCRFSDDAKALC-KALLKKS 437
+P F P + + D K L +L++K
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM--VVVNKLHKYSLVEKQ 420
Query: 438 PRSRLGKSHCLSIGLVMMLKLSVLKKNVNL-----SVLNTVQIPLFFPQ---APEAVDVL 489
P K +SI + L + K N S+++ IP F P +D
Sbjct: 421 P-----KESTISI---PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY 472
Query: 490 SLE-IIEHCKESLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYLQWKWLEH--- 545
I H K LF +L +++LE
Sbjct: 473 FYSHIGHHLKNIEHPERMTLFRMV------------------------FLDFRFLEQKIR 508
Query: 546 HFLYVEVFTHGV------------YCSQPHAVYAKDVLDIEQF 576
H + + Y Y + V I F
Sbjct: 509 HDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 5e-07
Identities = 71/439 (16%), Positives = 136/439 (30%), Gaps = 99/439 (22%)
Query: 229 GLEHLHY--IGLVYR-------DCK-----PENILLD-DYGHVRISDLGLAVEIPEGESV 273
G Y I V+ DCK P++IL + H+ + + S
Sbjct: 12 GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHI--------IMSKDAVSG 63
Query: 274 RGRVGTVGYMAPE------VIDNEKYTYSPDWFSFGCLIFEMI--EGQAPFRRRKEMVKR 325
R+ E V + + Y + + I E + P + +++
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRINY--KF------LMSPIKTEQRQPSMMTRMYIEQ 115
Query: 326 DEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCH----CGRYGARELKQ---A 378
+ + KY+ L +ALL+ P + G K
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG-------KTWVAL 168
Query: 379 EFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSP 438
+ S +++ + F ++K V E +K + + + +
Sbjct: 169 DVCLS---YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHS--SNI 223
Query: 439 RSRLGKSHCLSIGLVMMLKLSVLKKNVNLSVLNTVQIPLFFPQAPEAVDVLSLEIIEHCK 498
+ R+ H + L +LK + L VL VQ +A + +L CK
Sbjct: 224 KLRI---HSIQAELRRLLKSKPYENC--LLVLLNVQNA-------KAWNAFNL----SCK 267
Query: 499 ESLDSGNRELFNDCMAAVKTFLA----GAPFTEFQ-DSMFFYRYLQWKWLEHHF--LYVE 551
L + +++ + AA T ++ T + S+ K+L+ L E
Sbjct: 268 ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL------KYLDCRPQDLPRE 321
Query: 552 VF-THGVYCSQPHAVYAKDVLDIEQFSTVKGVTLDTTDDSFYSKFNTGSVSIPWQNEMIE 610
V T+ S + + + V L T +S + E
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP--------AEY-- 371
Query: 611 TECFKELNVFGEN-NTPSS 628
+ F L+VF + + P+
Sbjct: 372 RKMFDRLSVFPPSAHIPTI 390
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 36/206 (17%), Positives = 68/206 (33%), Gaps = 34/206 (16%)
Query: 107 EIQPITYKTFRMYRVLGKGGFGEV-----CACQVRATGKMYACKKLEKKRIKKRKGESMV 161
I + +++ +G+GGFG + + + + K +E E
Sbjct: 28 IITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVK-VEPSDNGPLFTELKF 86
Query: 162 LIEKQILQKINS-------------RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM 208
++I ++ S + K +++ G DL+ IY
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEA 144
Query: 209 GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD--DYGHVRISDLGLA-- 264
+ F + +L LE++H V+ D K N+LL+ + V + D GLA
Sbjct: 145 NAKR-FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 265 -------VEIPEGESVRGRVGTVGYM 283
R GT+ +
Sbjct: 204 YCPEGVHKAYAADPK-RCHDGTIEFT 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 36/246 (14%), Positives = 66/246 (26%), Gaps = 63/246 (25%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM-----VLIEKQILQK 170
+ +G+G FGEV Q A A K + + G +L E I ++
Sbjct: 22 LQRCEKIGEGVFGEVF--QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 171 IN-----------------SRFVVSLAY----------------------AYETKDALCL 191
++ S V +Y + D L +
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH-YIGLVYRDCKPENILL 250
VL GG + +A A+ ++ L + +RD N+LL
Sbjct: 140 VLEFEFGGIDLEQM----RTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 251 DDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI 310
++ + + G + YT S + ++
Sbjct: 196 KKTSLKKLHYTLNGKSS--------TIPSCGLQVSII----DYTLSRLERDGIVVFCDVS 243
Query: 311 EGQAPF 316
+ F
Sbjct: 244 MDEDLF 249
|
| >1qzv_F Plant photosystem I: subunit PSAF; photosynthesis,plant photosynthetic reaction center, peripheral antenna; HET: CL1 PQN; 4.44A {Pisum sativum} SCOP: i.5.1.1 Length = 154 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 3e-04
Identities = 12/33 (36%), Positives = 19/33 (57%), Gaps = 5/33 (15%)
Query: 164 EKQILQKINSRFVVSLA-YAYETKDALCLVLTI 195
EKQ L+K+ + SL YA ++ AL + T+
Sbjct: 18 EKQALKKLQA----SLKLYADDSAPALAIKATM 46
|
| >1qzv_F Plant photosystem I: subunit PSAF; photosynthesis,plant photosynthetic reaction center, peripheral antenna; HET: CL1 PQN; 4.44A {Pisum sativum} SCOP: i.5.1.1 Length = 154 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 3e-04
Identities = 12/33 (36%), Positives = 19/33 (57%), Gaps = 5/33 (15%)
Query: 702 EKQILQKINSRFVVSLA-YAYETKDALCLVLTI 733
EKQ L+K+ + SL YA ++ AL + T+
Sbjct: 18 EKQALKKLQA----SLKLYADDSAPALAIKATM 46
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 767 | |||
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.86 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.83 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.8 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.79 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.77 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.76 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.75 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.74 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.73 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.73 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.72 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.69 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.68 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.66 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.64 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.63 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.63 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.62 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.62 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.62 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.62 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.62 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.61 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.61 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.6 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.6 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.59 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.59 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.57 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.56 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.56 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.56 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.56 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.55 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.55 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.54 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.53 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.53 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.53 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.53 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.52 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.51 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.51 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.51 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.5 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.5 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.5 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.5 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.49 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.49 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.49 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.49 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.49 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.49 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.48 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.48 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.48 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.47 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.47 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.47 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.47 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.47 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.47 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.47 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.46 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.46 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.46 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.46 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.46 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.46 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.46 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.46 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.45 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.45 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.45 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.44 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.44 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.44 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.44 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.44 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.43 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.43 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.43 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.43 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.43 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.43 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.43 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.42 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.42 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.42 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.42 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.42 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.41 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.41 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.41 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.41 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.4 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.4 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.4 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.4 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.4 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.4 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.4 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.39 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.39 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.39 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.39 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.39 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.39 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.39 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.38 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.38 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.38 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.38 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.37 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.37 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.37 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.37 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.37 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.36 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.36 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.36 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.36 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.36 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.36 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.36 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.35 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.35 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.35 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.35 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.35 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.34 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.34 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.34 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.34 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.34 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.34 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.34 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.34 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.33 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.33 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.33 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.33 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.33 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.33 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.33 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.32 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.32 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.32 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.32 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.32 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.32 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.31 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.31 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.31 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.31 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.31 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.31 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.31 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.31 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.31 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.3 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.3 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.29 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.29 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.29 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.29 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.29 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.29 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.29 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.29 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.29 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.28 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.28 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.28 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.28 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.28 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.27 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.27 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.27 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.27 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.27 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.26 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.25 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.25 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.25 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.24 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.24 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.24 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.24 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.24 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.23 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.23 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.23 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.23 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.23 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.23 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.22 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.22 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.22 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.21 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.21 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.21 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.21 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.21 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.21 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.21 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.2 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.2 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.2 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.2 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.2 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.2 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.2 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.19 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.19 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.18 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.18 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.18 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.17 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.17 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.16 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.16 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.16 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.16 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.16 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.16 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.16 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.15 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.15 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.14 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.14 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.13 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.12 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.07 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.07 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.06 |
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-76 Score=684.84 Aligned_cols=438 Identities=64% Similarity=1.112 Sum_probs=362.2
Q ss_pred hhhhhccceeeeeccCcchhHHHHHHHhhhcccccccccccccccchhhcccccccCChHHH------------------
Q psy11874 43 FTLALYVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLSTKDI------------------ 104 (767)
Q Consensus 43 ~~~~~~~~~~~~~~~~p~g~~lf~~f~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~------------------ 104 (767)
+..+++++|.++|++||||++||+||| .++|.+..+..||+.+++|+...++.+......+
T Consensus 45 l~~~~~~~~~~~~~~~~ig~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~ 123 (576)
T 2acx_A 45 LRLSLERDYHSLCERNPIGRLLFREFC-ATRPELSRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPR 123 (576)
T ss_dssp HHHHSCCCHHHHHTTSHHHHHHHHHHH-TTSHHHHHHHHHHHHHHHHHTSCTTTHHHHHHHHHHHHSCSSSCCSSTTCCH
T ss_pred HHhccccCHHHhhccCchhHHHHHHHH-hcCcchhHHHHHHHHHHhhhcccchhHHHHHHHHHHHhcCcccccccccCCH
Confidence 556689999999999999999999999 5679999999999999999986654432111000
Q ss_pred ---------------------------------------------------hhhcCcccCCCeEEEeEEeecCcEEEEEE
Q psy11874 105 ---------------------------------------------------YNEIQPITYKTFRMYRVLGKGGFGEVCAC 133 (767)
Q Consensus 105 ---------------------------------------------------~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a 133 (767)
+.+..++..++|++.++||+|+||.||+|
T Consensus 124 ~l~~~~~~~l~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~s~~~~~~~~~~~l~~~~~~~~~f~~~~~LG~G~fG~Vy~a 203 (576)
T 2acx_A 124 QLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCAC 203 (576)
T ss_dssp HHHHHHHHHHHHCCCTTTTHHHHHHHHHHHTTHHHHHHHTSHHHHHHHHHHHHHTSCCCGGGEEEEEEEEEETTEEEEEE
T ss_pred HHHHHHHHHHhcCchHHHHHHHHHHHHHhhccCcchhhcchhhhhhhhhhhhhhhcCccccceEEEEEEeeCCCEEEEEE
Confidence 11234577889999999999999999999
Q ss_pred EEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCCCCC
Q psy11874 134 QVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG 213 (767)
Q Consensus 134 ~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~ 213 (767)
+++.+|+.||+|++.+..+........+.+|+.+|++++|||||++++++++.+.+|+|||||+||+|..++...+ ...
T Consensus 204 ~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~-~~~ 282 (576)
T 2acx_A 204 QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-QAG 282 (576)
T ss_dssp EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSS-SCC
T ss_pred EECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcC-CCC
Confidence 9999999999999998887777778889999999999999999999999999999999999999999999998754 345
Q ss_pred CCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcccccccccccCCcceecCCCC
Q psy11874 214 FDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKY 293 (767)
Q Consensus 214 l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y 293 (767)
+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....+......+||+.|+|||++.+..|
T Consensus 283 l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~ 362 (576)
T 2acx_A 283 FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362 (576)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCC
Confidence 99999999999999999999999999999999999999999999999999998877666667899999999999999999
Q ss_pred CCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHH
Q psy11874 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGAR 373 (767)
Q Consensus 294 s~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~ 373 (767)
+.++|||||||++|||++|.+||.+.+......++.+.+......++..+|+++++||++||++||++|||+.. .+++
T Consensus 363 ~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~--~sa~ 440 (576)
T 2acx_A 363 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRG--GSAR 440 (576)
T ss_dssp SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSS--SHHH
T ss_pred CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCC--CCHH
Confidence 99999999999999999999999887665556667777777777888899999999999999999999998754 4799
Q ss_pred HHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhhhhhcccCCChhHHHHHHHHhhcCCCCcCCCCccchhhHH
Q psy11874 374 ELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGKSHCLSIGLV 453 (767)
Q Consensus 374 eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (767)
|+++||||++++|..+.++.+.|||+|.
T Consensus 441 eil~HpfF~~i~w~~l~~~~~~pp~~p~---------------------------------------------------- 468 (576)
T 2acx_A 441 EVKEHPLFKKLNFKRLGAGMLEPPFKPD---------------------------------------------------- 468 (576)
T ss_dssp HHHTSGGGTTCCHHHHHTTCSCCSCCCC----------------------------------------------------
T ss_pred HHHhChhhccCCHHHHhcCCCCCCCCCC----------------------------------------------------
Confidence 9999999999999999999999999997
Q ss_pred HHHHHhhhhhccccccccccccccCCCCCccchhhhhHHHHHhhhcccccCCcchhhhhHHHHHhhhcCCCccccchhhh
Q psy11874 454 MMLKLSVLKKNVNLSVLNTVQIPLFFPQAPEAVDVLSLEIIEHCKESLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSMF 533 (767)
Q Consensus 454 ~~~~~s~~kk~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (767)
T Consensus 469 -------------------------------------------------------------------------------- 468 (576)
T 2acx_A 469 -------------------------------------------------------------------------------- 468 (576)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HHHHhhhhhcccceeeeeeeecccccCCCceeecCCccCccccccccceecCCCChHHHhhhccCCcccccccccchhhh
Q psy11874 534 FYRYLQWKWLEHHFLYVEVFTHGVYCSQPHAVYAKDVLDIEQFSTVKGVTLDTTDDSFYSKFNTGSVSIPWQNEMIETEC 613 (767)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~f~~~f~tg~v~~~~~~e~ie~~c 613 (767)
|.++|++|+.|+++|++++|+.++.+|.+||++|++|++++|||+||+|++|
T Consensus 469 ----------------------------~~~~~~~~~~d~~~f~~~~~~~~~~~~~~~f~~f~~~~~~~~~~~e~~~~~~ 520 (576)
T 2acx_A 469 ----------------------------PQAIYCKDVLDIEQFSTVKGVELEPTDQDFYQKFATGSVPIPWQNEMVETEC 520 (576)
T ss_dssp ----------------------------CCCCCC-----------------CHHHHHHHHHHCCEECHHHHHHHHHHTTH
T ss_pred ----------------------------ccccccCCcccHhhccccCCCCCCccHHHHHhhhccCCCCcccchhhhhcch
Confidence 6678999999999999999999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCCCCcccCCCCCCCCCCC
Q psy11874 614 FKELNVFGENNTPSSDVMFTSVPPSETNPSC 644 (767)
Q Consensus 614 f~eln~~~~~~~~s~dl~~~s~~~~~~ks~~ 644 (767)
|+++|++..++..++|.++...++..++++.
T Consensus 521 ~~~l~~~~~~g~~~~d~~~~~~~~~~~~~~~ 551 (576)
T 2acx_A 521 FQELNVFGLDGSVPPDLDWKGQPPAPPKKGL 551 (576)
T ss_dssp HHHHHCBSSSCC-------------------
T ss_pred hhhhcccCCCCCCCCccccccCCCCCCCccc
Confidence 9999999999999999887654444445554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-75 Score=683.14 Aligned_cols=347 Identities=42% Similarity=0.767 Sum_probs=299.4
Q ss_pred ccceeeeeccCcchhHHHHHHHhhhcccccccccccccccchhh-cccccccCCh-------------------------
Q psy11874 48 YVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYEL-EMDENRRLST------------------------- 101 (767)
Q Consensus 48 ~~~~~~~~~~~p~g~~lf~~f~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~~~~------------------------- 101 (767)
++.|..|| .|||||+||++||....+.+..+..|++.+++|+. +.++.+....
T Consensus 52 ~~~~~~i~-~q~ig~~~f~~f~~~~~~~~~~~~~~~~~v~~~~~~~~~~~r~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 130 (689)
T 3v5w_A 52 EVTFEKIF-SQKLGYLLFRDFCLNHLEEARPLVEFYEEIKKYEKLETEEERVARSREIFDSYIMKELLACSHPFSKSATE 130 (689)
T ss_dssp CCSHHHHH-TSHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHTCCSHHHHHHHHHHHHTSHHHHHHHSSSSCCCHHHHH
T ss_pred ccccceec-CccHHHHHHHHHhcCcchhhhHHHHHHHHHHhhhccCchhhHHHHHHHHHHHhcchhhhhccCccchHHHH
Confidence 55666665 39999999999998888898889999999988873 2222110000
Q ss_pred ------------HHH---------------------------------hhhc-CcccCCCeEEEeEEeecCcEEEEEEEE
Q psy11874 102 ------------KDI---------------------------------YNEI-QPITYKTFRMYRVLGKGGFGEVCACQV 135 (767)
Q Consensus 102 ------------~~~---------------------------------~~~~-~~i~~~~y~~~~~LG~G~fG~Vy~a~~ 135 (767)
.++ +.+. .++++++|+++++||+|+||+||+|++
T Consensus 131 ~~~~~~~~~~~~~~lf~~~~~~~~~~l~~~~f~~~~~s~~~~r~~q~k~~e~~~~~slddf~i~k~LG~G~fG~V~la~~ 210 (689)
T 3v5w_A 131 HVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRK 210 (689)
T ss_dssp HHHHHHHTTCCCTTTTHHHHHHHHHHHTTHHHHHHHHSHHHHHHHHHHHHHTTCCCCGGGEEEEEEEEECSSEEEEEEEE
T ss_pred HHHHhhhhccCChHHHHHHHHHHHHHhccCcccccccChhHHHHHhccccccCCCCchHHeEEEEEEecccCeEEEEEEE
Confidence 000 2222 378999999999999999999999999
Q ss_pred ccCCcEEEEEEechhhhhhhhhHHHHHHHHH---HHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCCCC
Q psy11874 136 RATGKMYACKKLEKKRIKKRKGESMVLIEKQ---ILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEP 212 (767)
Q Consensus 136 ~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~---iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~ 212 (767)
+.||+.||||++.+..+........+.+|.. +++.++|||||+++++|++.+.+|||||||+||+|..+|.+.+
T Consensus 211 ~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~--- 287 (689)
T 3v5w_A 211 ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--- 287 (689)
T ss_dssp TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC---
T ss_pred CCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC---
Confidence 9999999999999988877777777777754 4556789999999999999999999999999999999998875
Q ss_pred CCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcccccccccccCCcceec-CC
Q psy11874 213 GFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVID-NE 291 (767)
Q Consensus 213 ~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~-~~ 291 (767)
.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...... ..+.+||+.|||||++. +.
T Consensus 288 ~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~ 366 (689)
T 3v5w_A 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGV 366 (689)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCC
Confidence 69999999999999999999999999999999999999999999999999998875543 45679999999999996 46
Q ss_pred CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCccc
Q psy11874 292 KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYG 371 (767)
Q Consensus 292 ~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~ 371 (767)
.|+.++|||||||+||||++|.+||.+.+... ..++.+.+......+|..+|+++++||.+||++||++|+|+.. .+
T Consensus 367 ~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~--~g 443 (689)
T 3v5w_A 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLG--RG 443 (689)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSS--ST
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCC--CC
Confidence 89999999999999999999999998765432 3456667777788889999999999999999999999999854 47
Q ss_pred HHHHHhCCCCCCCChhhHhcCCCCCCCCCCC
Q psy11874 372 ARELKQAEFFKSTNWKRLEAGLCDPPFVPDV 402 (767)
Q Consensus 372 a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~ 402 (767)
|+||++||||+++||..|.++.+.|||+|.+
T Consensus 444 a~ei~~HpfF~~idW~~l~~~~~~pP~~P~~ 474 (689)
T 3v5w_A 444 AQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 474 (689)
T ss_dssp HHHHTTSGGGTTCCHHHHHTTCSCCSCCCCT
T ss_pred HHHHhcCccccCCCHHHHHcCCCCcCccCCC
Confidence 9999999999999999999999999999983
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-71 Score=641.98 Aligned_cols=420 Identities=48% Similarity=0.864 Sum_probs=358.1
Q ss_pred hhhhhccceeeeeccCcchhHHHHHHHhhhcccccccccccccccchhhccccc---------------------ccCC-
Q psy11874 43 FTLALYVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDEN---------------------RRLS- 100 (767)
Q Consensus 43 ~~~~~~~~~~~~~~~~p~g~~lf~~f~~~~~~~~~~~~~~~d~~~~~~~~~~~~---------------------~~~~- 100 (767)
+..++.++|.++|.+||||++||+|||. +.+.+.....+++.++.++...++. ....
T Consensus 50 l~~~~~~d~~~~~~~~~ig~~~~~~f~~-t~~~~~~~~~~~~~i~e~~~~~~~~~~~~~~~l~~~~~~~~~~d~~~~~~~ 128 (543)
T 3c4z_A 50 LRESLDLGFEGMCLEQPIGKRLFQQFLR-THEQHGPALQLWKDIEDYDTADDALRPQKAQALRAAYLEPQAQLFCSFLDA 128 (543)
T ss_dssp HHHHSCCCHHHHHTSSHHHHHHHHHHHH-HCGGGHHHHHHHHHHHHHHTSCTTTHHHHHHHHHHHHTSTTCTTCCTTSCH
T ss_pred HHhccccCHHHhhccCcccHHHHHHHHh-cCCchhHHHHHHhhhhhhccCchhhHHHHHHHHHHHhhCchhhhhhccCCH
Confidence 4556899999999999999999999995 4577777666776666555211100 0000
Q ss_pred --------------h----HHH-------------------------hhhcCcccCCCeEEEeEEeecCcEEEEEEEEcc
Q psy11874 101 --------------T----KDI-------------------------YNEIQPITYKTFRMYRVLGKGGFGEVCACQVRA 137 (767)
Q Consensus 101 --------------~----~~~-------------------------~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~ 137 (767)
. .++ |.+.+++..++|++.++||+|+||+||+|+++.
T Consensus 129 ~~v~~v~~~~~~~l~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~ 208 (543)
T 3c4z_A 129 ETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKA 208 (543)
T ss_dssp HHHHHHHCC---CTTHHHHHHHHHHHTTHHHHHHHTSHHHHHHHHHHHHHTSCCCGGGEEEEEEEEECSSSEEEEEEETT
T ss_pred HHHhhhhcCCCchhhHHHHHHHHHhhhcCchHhhhhhhhhhhhhhhhhhhcccCChhheEEEEEEeeCCCeEEEEEEECC
Confidence 0 000 223356778999999999999999999999999
Q ss_pred CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCC-CCCCCH
Q psy11874 138 TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGG-EPGFDI 216 (767)
Q Consensus 138 tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~-~~~l~~ 216 (767)
+|+.||+|++.+...........+.+|+.+|++++||||+++++++++.+.+|+|||||+||+|..++.+.+. ...+++
T Consensus 209 tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e 288 (543)
T 3c4z_A 209 TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288 (543)
T ss_dssp TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCH
T ss_pred CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccH
Confidence 9999999999988777777778899999999999999999999999999999999999999999999987532 346999
Q ss_pred HHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-ccccccccccCCcceecCCCCCC
Q psy11874 217 ARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-VRGRVGTVGYMAPEVIDNEKYTY 295 (767)
Q Consensus 217 ~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-~~~~~GT~~Y~APEvl~~~~ys~ 295 (767)
..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....... ....+||+.|+|||++.+..|+.
T Consensus 289 ~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 368 (543)
T 3c4z_A 289 PRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368 (543)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCCh
Confidence 99999999999999999999999999999999999999999999999988765543 34568999999999999999999
Q ss_pred CCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHH
Q psy11874 296 SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGAREL 375 (767)
Q Consensus 296 ~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~ei 375 (767)
++|||||||++|||++|.+||.+.+......++.+.+......++..+|+++++||++||++||++|||+.+ .++++|
T Consensus 369 ~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~--~~a~ei 446 (543)
T 3c4z_A 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRD--GSCDGL 446 (543)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBT--TBSHHH
T ss_pred HHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcc--cCHHHH
Confidence 999999999999999999999887655455667777777777888899999999999999999999999764 479999
Q ss_pred HhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhhhhhcccCCChhHHHHHHHHhhcCCCCcCCCCccchhhHHHH
Q psy11874 376 KQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGKSHCLSIGLVMM 455 (767)
Q Consensus 376 l~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (767)
++||||++++|..+.++.+.|||+|.
T Consensus 447 ~~Hpff~~i~w~~l~~~~~~pp~~P~------------------------------------------------------ 472 (543)
T 3c4z_A 447 RTHPLFRDISWRQLEAGMLTPPFVPD------------------------------------------------------ 472 (543)
T ss_dssp HTSGGGTTCCHHHHHTTCSCCSCCCC------------------------------------------------------
T ss_pred HcCccccCCCHHHHHcCCCCCCCCCC------------------------------------------------------
Confidence 99999999999999999999999998
Q ss_pred HHHhhhhhccccccccccccccCCCCCccchhhhhHHHHHhhhcccccCCcchhhhhHHHHHhhhcCCCccccchhhhHH
Q psy11874 456 LKLSVLKKNVNLSVLNTVQIPLFFPQAPEAVDVLSLEIIEHCKESLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFY 535 (767)
Q Consensus 456 ~~~s~~kk~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (767)
T Consensus 473 -------------------------------------------------------------------------------- 472 (543)
T 3c4z_A 473 -------------------------------------------------------------------------------- 472 (543)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HHhhhhhcccceeeeeeeecccccCCCceeecCCccCccccccccceecCCCChHHHhhhccCCcccccccccchhhhhh
Q psy11874 536 RYLQWKWLEHHFLYVEVFTHGVYCSQPHAVYAKDVLDIEQFSTVKGVTLDTTDDSFYSKFNTGSVSIPWQNEMIETECFK 615 (767)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~f~~~f~tg~v~~~~~~e~ie~~cf~ 615 (767)
+..+|++|+.|+++|++++|+.++..|.+||++|++|++++|||+||+|++||+
T Consensus 473 --------------------------~~~~~~~~~~d~~~f~~~~~~~~~~~~~~~f~~f~~~~~~~~~~~~~~~~~~~~ 526 (543)
T 3c4z_A 473 --------------------------SRTVYAKNIQDVGAFSTVKGVAFEKADTEFFQEFASGTCPIPWQEEMIETGVFG 526 (543)
T ss_dssp --------------------------SSSCCSCC----CCCC---CCCCCHHHHHHHHHHCCEECHHHHHHHHHHTTHHH
T ss_pred --------------------------ccccccCCchhhhhccccCCCCCCcchhhHhhcCCCCCCChhHHHhhhccccHH
Confidence 556889999999999999999999999999999999999999999999999999
Q ss_pred hccccCCCCC
Q psy11874 616 ELNVFGENNT 625 (767)
Q Consensus 616 eln~~~~~~~ 625 (767)
++|++.+++.
T Consensus 527 ~~~~~~~~~~ 536 (543)
T 3c4z_A 527 DLNVWRPDGV 536 (543)
T ss_dssp HHTCSCC---
T ss_pred HhcCCCCCCc
Confidence 9999988764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-65 Score=547.03 Aligned_cols=273 Identities=32% Similarity=0.566 Sum_probs=248.3
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|+++++||+|+||+||+|+++.||+.||||++.+..+........+.+|+++|++++|||||+++++|++++.+|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 44689999999999999999999999999999999998887777778889999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
|||||+||||.+++.+.+ .+++.+++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 110 vmEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999998875 69999999999999999999999999999999999999999999999999999875332
Q ss_pred ---cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 272 ---SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 272 ---~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
...+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+. .++...+......+|..+|++++
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~~p~~~s~~~~ 262 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----GLIFAKIIKLEYDFPEKFFPKAR 262 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCTTCCHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCcccCHHHH
Confidence 34567999999999999999999999999999999999999999988754 34455566666778889999999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAG 392 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~ 392 (767)
+||++||++||++|||+.+ ..+..+|++||||+++||+.|...
T Consensus 263 dli~~lL~~dp~~R~t~~e-~~~~~~i~~Hp~F~~idw~~l~~~ 305 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESVTWENLHQQ 305 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGG-GTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred HHHHHHccCCHhHCcChHH-HcCCHHHHCCCCcCCCCHHHhcCC
Confidence 9999999999999999653 134678999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-65 Score=546.73 Aligned_cols=280 Identities=37% Similarity=0.661 Sum_probs=243.6
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEc---cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
+..++|++++.||+|+||+||+|++. .+++.||+|++.+...... ....+.+|+.+|++++|||||+++++|++.+
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 34468999999999999999999984 4689999999987654332 3346788999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+|||||+||+|.+++.+.+ .+++.+++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+..
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999999998865 6999999999999999999999999999999999999999999999999999875
Q ss_pred CCC-CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 268 PEG-ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 268 ~~~-~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
... ....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.. ++...+......+|..+|++
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~~~~~~~p~~~s~~ 252 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK----ETMTMILKAKLGMPQFLSPE 252 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCTTSCHH
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH----HHHHHHHcCCCCCCCcCCHH
Confidence 443 3456679999999999999999999999999999999999999999887543 34455556667788899999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P 400 (767)
+++||++||++||++|||+.. .+++|+++||||+++||+.+..+.+.|||+|
T Consensus 253 ~~~li~~~L~~dP~~R~ta~~--~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 253 AQSLLRMLFKRNPANRLGAGP--DGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp HHHHHHHHTCSSGGGSTTCST--TTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred HHHHHHHHcccCHHHCCCCCc--CCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 999999999999999999643 4689999999999999999999999999998
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=504.85 Aligned_cols=256 Identities=26% Similarity=0.408 Sum_probs=214.7
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
+++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|++++|||||++++++++++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999887776666677899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
|||| +|+|.+++.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 92 mEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 9999 689999998764 699999999999999999999999999999999999999999999999999988776666
Q ss_pred ccccccccccCCcceecCCCC-CCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKY-TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~y-s~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
..+.+||+.|||||++.+..| +.++|||||||++|||++|++||.+.+. .++.+.+......++..+|+++++||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li 243 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----PVLFKNISNGVYTLPKFLSPGAAGLI 243 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 677899999999999998886 5799999999999999999999987654 34555666667778889999999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
++||++||++||| ++|+++||||+.
T Consensus 244 ~~~L~~dP~~R~s-------~~eil~hpw~k~ 268 (275)
T 3hyh_A 244 KRMLIVNPLNRIS-------IHEIMQDDWFKV 268 (275)
T ss_dssp HHHSCSSGGGSCC-------HHHHHHCHHHHT
T ss_pred HHHccCChhHCcC-------HHHHHcCccccc
Confidence 9999999999998 999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=511.68 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=226.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.|++++.||+|+||+||+|+++.||+.||||++.+... ...+.+.+|+.+|++++|||||+++++|++++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 569999999999999999999999999999999976533 33456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Cc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~ 272 (767)
|||+||+|.+++.+. .+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... ..
T Consensus 151 Ey~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 151 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp CCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred eCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 999999999988763 5999999999999999999999999999999999999999999999999999987544 34
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
..+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.......+.... ......+..+|+++++||.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCCCSCGGGSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccccCCHHHHHHHH
Confidence 567899999999999999999999999999999999999999998876544333332211 1122344578999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+||++||++||| ++|+++||||++.
T Consensus 306 ~~L~~dP~~R~t-------a~e~l~Hp~~~~~ 330 (346)
T 4fih_A 306 RLLVRDPAQRAT-------AAELLKHPFLAKA 330 (346)
T ss_dssp HHSCSSTTTSCC-------HHHHTTCGGGGGC
T ss_pred HHcCCChhHCcC-------HHHHhcCHhhcCC
Confidence 999999999998 9999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=512.81 Aligned_cols=259 Identities=22% Similarity=0.389 Sum_probs=223.5
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+.+|++++|||||+++++|++++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999998765433 3456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
||||+||+|.++|...+ ...+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 102 mEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp EECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred EeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 99999999999997653 3458999999999999999999999999999999999999999999999999998775432
Q ss_pred cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
...+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+.......+. .......+..+|+++++||
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~---~~~~~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII---SGSFPPVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HTCCCCCCTTSCHHHHHHH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---cCCCCCCCccCCHHHHHHH
Confidence 2345689999999999999999999999999999999999999998876543333222 2233456678999999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
.+||++||++||+ ++|+++||||+.
T Consensus 258 ~~~L~~dP~~R~s-------~~e~l~hp~~~~ 282 (350)
T 4b9d_A 258 SQLFKRNPRDRPS-------VNSILEKGFIAK 282 (350)
T ss_dssp HHHTCSSGGGSCC-------HHHHHTSHHHHT
T ss_pred HHHccCChhHCcC-------HHHHhcCHHhhc
Confidence 9999999999998 999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-58 Score=512.85 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=227.0
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.+.|++++.||+|+||+||+|+++.||+.||||++.+... ...+.+.+|+.+|++++|||||+++++|.+.+.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 3569999999999999999999999999999999976532 3345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-C
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-E 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~ 271 (767)
||||+||+|.+++... .+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... .
T Consensus 227 mEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999999988753 5999999999999999999999999999999999999999999999999999887544 3
Q ss_pred cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
...+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.......+... .......+..+|+++++||
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli 381 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFL 381 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCSCTTSSCHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCcccccCCHHHHHHH
Confidence 456789999999999999999999999999999999999999999887654443333221 1122334567999999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.+||++||++||+ ++|+++||||+..
T Consensus 382 ~~~L~~dP~~R~t-------a~ell~Hp~~~~~ 407 (423)
T 4fie_A 382 DRLLVRDPAQRAT-------AAELLKHPFLAKA 407 (423)
T ss_dssp HHHSCSSTTTSCC-------HHHHTTCGGGGGC
T ss_pred HHHcCCChhHCcC-------HHHHhcCHHhcCC
Confidence 9999999999998 9999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-57 Score=504.62 Aligned_cols=311 Identities=30% Similarity=0.598 Sum_probs=269.0
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCC
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 187 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 187 (767)
..+..++|+++++||+|+||+||+|+++.+|+.||+|++.+...........+.+|..+|.++ +|||||+++++|++.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 456778999999999999999999999999999999999988766666677789999999887 8999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc-
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE- 266 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~- 266 (767)
.+|+|||||+||+|..++.+.+ .+++..++.|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999999998765 699999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhh-----hhhhhhhhhhhccccccCC
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-----VKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~-----~~~~~i~~~i~~~~~~~~~ 341 (767)
...+....+.+||+.|+|||++.+..|+.++|||||||++|||++|++||...... .....+.+.+......++.
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 33444566789999999999999999999999999999999999999999643221 1223455667777778889
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhhhhhcccC
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEKYSCR 421 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~~~~~~~~ 421 (767)
.+|+++++||++||++||++|||+.. ..+++||++||||++++|..+..+.+.|||+|.+.......++..+.+.-...
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~-~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~~ 362 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHP-QTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQ 362 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCST-TTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCCC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCC-CCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCCc
Confidence 99999999999999999999999742 13689999999999999999999999999999998877777766655444333
Q ss_pred CC
Q psy11874 422 FS 423 (767)
Q Consensus 422 ~~ 423 (767)
.+
T Consensus 363 ~~ 364 (396)
T 4dc2_A 363 LT 364 (396)
T ss_dssp CC
T ss_pred cC
Confidence 33
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-57 Score=483.43 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=217.2
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee----CCeEEE
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET----KDALCL 191 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~l~l 191 (767)
|++.+.||+|+||+||+|.++.+|..||+|++.+..... ...+.+.+|+.+|++++|||||+++++|++ ++.+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 477889999999999999999999999999998765433 345678999999999999999999999976 456999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC--cccccCCcceEEeCC-CCCEEEeecCcccccC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLDD-YGHVRISDLGLAVEIP 268 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~--IvHrDLKPeNILld~-~g~vkL~DFGla~~~~ 268 (767)
|||||+||+|.+++.+.+ .+++..++.|+.||+.||+|||++| ||||||||+||||+. +|++||+|||+|+...
T Consensus 107 vmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999998765 6999999999999999999999999 999999999999984 7999999999998643
Q ss_pred CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc--ccccCCCCcHH
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED--AEKYSCRFSDD 346 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~~~~~s~~ 346 (767)
.....+.+||+.|||||++.+ +|+.++|||||||+||||+||++||.+.+.. ..+.+.+... +..++...+++
T Consensus 184 -~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~ 258 (290)
T 3fpq_A 184 -ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp -TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHHHHHTTTCCCGGGGGCCCHH
T ss_pred -CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH---HHHHHHHHcCCCCCCCCccCCHH
Confidence 334567799999999999865 6999999999999999999999999765432 2233333322 23455678999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+++||.+||++||++||| ++|+++||||++
T Consensus 259 ~~~li~~~L~~dP~~R~s-------~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 259 VKEIIEGCIRQNKDERYS-------IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHSCSSGGGSCC-------HHHHHTSGGGC-
T ss_pred HHHHHHHHccCChhHCcC-------HHHHhcCccccC
Confidence 999999999999999998 999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-56 Score=486.95 Aligned_cols=294 Identities=36% Similarity=0.646 Sum_probs=262.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
++.++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|..+|++++||||+++++++++.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45689999999999999999999999999999999998877666667778999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC-C
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP-E 269 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~-~ 269 (767)
+||||++||+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+... .
T Consensus 82 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999999998764 69999999999999999999999999999999999999999999999999998643 3
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
+....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.. .+...+......++..+|+++++
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~ 234 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEIRFPRTLSPEAKS 234 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCTTSCHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCHHHHH
Confidence 34456778999999999999999999999999999999999999999876543 34444555566778889999999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKE 413 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~ 413 (767)
||.+||++||++|||+.. .+++|+++||||++++|..+..+.+.|||+|.+......+++..
T Consensus 235 li~~lL~~dP~~R~g~~~--~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~~ 296 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGP--SDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDD 296 (337)
T ss_dssp HHHHHTCSSTTTSTTCST--TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCH
T ss_pred HHHHHhhcCHHHhcCCCC--CCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhcccc
Confidence 999999999999998543 47999999999999999999999999999999877655555443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-57 Score=489.92 Aligned_cols=247 Identities=24% Similarity=0.292 Sum_probs=212.8
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||+||+|+++.||+.||||+++++.. ..+|+.+|++++|||||+++++|++++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34689999999999999999999999999999999976532 2469999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-CEEEeecCcccccCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-HVRISDLGLAVEIPEG 270 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-~vkL~DFGla~~~~~~ 270 (767)
|||||+||+|.++|.+.+ .+++.+++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+...
T Consensus 128 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999999998865 699999999999999999999999999999999999999988 6999999999877543
Q ss_pred Cc------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCc
Q psy11874 271 ES------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFS 344 (767)
Q Consensus 271 ~~------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s 344 (767)
.. ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.......+.... .....++..+|
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~s 283 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP-PPIREIPPSCA 283 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC-CGGGGSCTTSC
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC-CCchhcCccCC
Confidence 22 223579999999999999999999999999999999999999998765443333222211 11234677899
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++++||.+||++||++||+ ++||++
T Consensus 284 ~~~~~li~~~L~~dP~~R~s-------a~el~~ 309 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRAS-------AMELRR 309 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcC-------HHHHHH
Confidence 99999999999999999998 888854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=491.46 Aligned_cols=298 Identities=36% Similarity=0.644 Sum_probs=257.5
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCC
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 187 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 187 (767)
..+..++|++.++||+|+||+||+|+++.+|+.||+|++.+...........+.+|..+|+.+ +||||+++++++++.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 346678999999999999999999999999999999999988776667778899999999998 7999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+|||||+||+|..++.+.+ .+++..++.|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999998765 6999999999999999999999999999999999999999999999999999864
Q ss_pred CC-CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 268 PE-GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 268 ~~-~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
.. +....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.. ++...+......++..++++
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~~~~~~ 250 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED----DLFEAILNDEVVYPTWLHED 250 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCTTSCHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCHH
Confidence 33 33455678999999999999999999999999999999999999999887543 44455566667788889999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhh
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKED 414 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~ 414 (767)
+++||++||++||++||++.. ..+++++++||||++++|..+..+.+.|||+|.++......++..+
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~-~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~ 317 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLT-QGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPD 317 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGG-GTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHH
T ss_pred HHHHHHHHhhhCHHHccCCcc-cCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccccCcc
Confidence 999999999999999999621 1357999999999999999999999999999998776555555443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-56 Score=487.48 Aligned_cols=296 Identities=35% Similarity=0.660 Sum_probs=261.6
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCC
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 187 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 187 (767)
..+..++|++.++||+|+||+||+|+++.+|+.||+|++.+...........+.+|..+|..+ +||||+++++++++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 446778999999999999999999999999999999999988766666778889999999988 8999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+||||++||+|..++.+.+ .+++..++.|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999999998765 6999999999999999999999999999999999999999999999999999864
Q ss_pred C-CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 268 P-EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 268 ~-~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
. .+......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.. ++.+.+......++..+|++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~ 247 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEHNVAYPKSMSKE 247 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCTTSCHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH----HHHHHHHhCCCCCCCCCCHH
Confidence 3 333456678999999999999999999999999999999999999999876543 34455556667788899999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhh
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKED 414 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~ 414 (767)
+++||++||.+||++|||+.. .++++|++||||++++|..+..+.+.|||+|.+... ...++...
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~--~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~-~~~~f~~~ 312 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGP--EGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRF 312 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCST--THHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC---CHHHHH
T ss_pred HHHHHHHHhhcCHHHcCCCCC--CCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc-chhhccch
Confidence 999999999999999999753 579999999999999999999999999999998765 44555443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=482.03 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=206.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC------
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD------ 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~------ 187 (767)
++|++++.||+|+||+||+|+++.+|+.||+|++.... .....+.+.+|+.+|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 47999999999999999999999999999999997543 2334467899999999999999999999997654
Q ss_pred ------eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeec
Q psy11874 188 ------ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDL 261 (767)
Q Consensus 188 ------~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DF 261 (767)
.+|+|||||+||+|.+++...+.....++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 48999999999999999987654445677889999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCc-------------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhh
Q psy11874 262 GLAVEIPEGES-------------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEV 328 (767)
Q Consensus 262 Gla~~~~~~~~-------------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i 328 (767)
|+|+....... ..+.+||+.|||||++.+..|+.++|||||||++|||++ ||.+..+.. ..+
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~--~~~ 237 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV--RTL 237 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--HHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH--HHH
Confidence 99987654321 234589999999999999999999999999999999996 886543321 111
Q ss_pred hhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 329 DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 329 ~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
........+..+...++.+++||++||++||++||+ ++|+++||||++++|..
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps-------~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE-------AINIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCC-------HHHHHTSGGGCCC----
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcC-------HHHHhcCHhhCCCCCCC
Confidence 111111112223345678899999999999999999 99999999999999853
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=480.75 Aligned_cols=301 Identities=31% Similarity=0.615 Sum_probs=263.7
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCC
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 187 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 187 (767)
.++..++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..+|.++ +||||+++++++++.+
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 456778999999999999999999999999999999999887766666677889999999998 8999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+||||++||+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999999998764 6999999999999999999999999999999999999999999999999999864
Q ss_pred C-CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhh-----hhhhhhhhhhhccccccCC
Q psy11874 268 P-EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-----VKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 268 ~-~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~-----~~~~~i~~~i~~~~~~~~~ 341 (767)
. .+......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...... .....+.+.+......++.
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 240 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC
Confidence 3 334456678999999999999999999999999999999999999999653211 1223445556666677888
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhh
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKE 413 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~ 413 (767)
.+|+++++||++||++||++|||+.. ..+++++++||||++++|..+..+.+.|||.|.+.......++..
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~-~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~ 311 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHP-QTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDS 311 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCT-TTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCH
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCC-cCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCc
Confidence 99999999999999999999999642 236899999999999999999999999999999877555555443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=481.92 Aligned_cols=290 Identities=37% Similarity=0.668 Sum_probs=245.8
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCe
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDA 188 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~ 188 (767)
.+..++|++.++||+|+||.||+|+++.+|+.||+|++.+...........+.+|..+|..+ +||||+++++++++.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999999999999999999887766666677888999999987 99999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+||||++||+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 999999999999999998764 69999999999999999999999999999999999999999999999999998653
Q ss_pred CC-CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 269 EG-ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 269 ~~-~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.. ++.+.+......++..+|+++
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~ 245 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIRMDNPFYPRWLEKEA 245 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCTTSCHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHhCCCCCCcccCHHH
Confidence 32 3355678999999999999999999999999999999999999999876543 344455556667788899999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHH-HHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhh
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGAR-ELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKE 413 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~-eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~ 413 (767)
++||.+||.+||++||| +. +|++||||++++|+.+..+.+.|||+|.+.......++..
T Consensus 246 ~~li~~lL~~dp~~R~~-------~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~ 305 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLG-------VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDK 305 (345)
T ss_dssp HHHHHHHSCSSGGGSBT-------TBSCGGGSGGGTTCCHHHHHTTCSCC-----------------
T ss_pred HHHHHHHhcCCHhHcCC-------ChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcch
Confidence 99999999999999999 44 8999999999999999999999999999876655555543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-55 Score=485.23 Aligned_cols=293 Identities=35% Similarity=0.616 Sum_probs=247.1
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHH-HHhcCCCceeEEEEEEeeCCe
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI-LQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~~~~~~~ 188 (767)
.+..++|++.++||+|+||+||+|+++.+++.||+|++.+...........+.+|..+ ++.++||||+++++++++.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4566899999999999999999999999999999999988876666666777888887 577899999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+||||++||+|..++.+.+ .+++..++.|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999999998764 68999999999999999999999999999999999999999999999999998643
Q ss_pred -CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 269 -EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 269 -~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.. ++.+.+......++..+++++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~ 266 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----EMYDNILNKPLQLKPNITNSA 266 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH----HHHHHHHHSCCCCCSSSCHHH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHhcccCCCCCCCHHH
Confidence 334456778999999999999999999999999999999999999999877543 344455555667778899999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhh
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVK 412 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~ 412 (767)
++||++||++||.+||++.+ +++++++||||++++|..+.++.+.|||+|.+......+++.
T Consensus 267 ~~li~~lL~~dp~~R~~~~~---~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~ 328 (373)
T 2r5t_A 267 RHLLEGLLQKDRTKRLGAKD---DFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFD 328 (373)
T ss_dssp HHHHHHHTCSSGGGSTTTTT---THHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC--------
T ss_pred HHHHHHHcccCHHhCCCCCC---CHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcC
Confidence 99999999999999999753 589999999999999999999999999999988766555544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-55 Score=487.58 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=223.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee------CC
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------KD 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~~ 187 (767)
++|++++.||+|+||+||+|+++.||+.||||++.+... .......+++|+.+|++++|||||++++++.+ .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 579999999999999999999999999999999976532 23345678899999999999999999998764 36
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|||||||+ |+|..++.+.+ .+++.+++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 8999999996 67998887654 7999999999999999999999999999999999999999999999999999876
Q ss_pred CCC-----CcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc----
Q psy11874 268 PEG-----ESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE---- 337 (767)
Q Consensus 268 ~~~-----~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~---- 337 (767)
... ....+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+.......+.........
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 432 234567999999999998775 5699999999999999999999999988766555544433221111
Q ss_pred -----------------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhH
Q psy11874 338 -----------------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389 (767)
Q Consensus 338 -----------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l 389 (767)
...+.+|++++|||++||++||++||| |+|+++||||+...+..-
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t-------a~e~L~Hp~f~~~~~p~~ 356 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS-------AAAALRHPFLAKYHDPDD 356 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC-------HHHHTTSGGGTTTCCGGG
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC-------HHHHhcCHhhCcCCCCcc
Confidence 112457999999999999999999999 999999999998876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=469.67 Aligned_cols=283 Identities=32% Similarity=0.590 Sum_probs=254.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
++.++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|..+|+.++||||+++++++++.+.+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45689999999999999999999999999999999998877666667778899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||++||+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999999998754 6999999999999999999999999999999999999999999999999999876442
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
..+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+... ....+......++..+++++++|
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~p~~~~~~~~~l 233 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKILNAELRFPPFFNEDVKDL 233 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHCCCCCCTTSCHHHHHH
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCCCCCHHHHHH
Confidence 446789999999999999999999999999999999999999998765433 33444455567788899999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCc
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKR 404 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~ 404 (767)
|++||.+||++||++.. .+++++++||||++++|+.+..+.+.|||.|.+..
T Consensus 234 i~~lL~~dp~~R~~~~~--~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~ 285 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQ--NGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQ 285 (318)
T ss_dssp HHHHTCSCTTTCTTSST--TTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC--
T ss_pred HHHHhccCHHHcCCCcC--CCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCC
Confidence 99999999999997542 46999999999999999999999999999999764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=472.93 Aligned_cols=291 Identities=31% Similarity=0.591 Sum_probs=261.7
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
....++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|++++||||+++++++.+.+.+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 35668999999999999999999999999999999999887766666778899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||++||+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999999998765 699999999999999999999999999999999999999999999999999987654
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
. ..+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.. ++...+......++..+|+++++
T Consensus 194 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~p~~~~~~~~~ 267 (350)
T 1rdq_E 194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKIVSGKVRFPSHFSSDLKD 267 (350)
T ss_dssp C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCTTCCHHHHH
T ss_pred C--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCHHHHH
Confidence 3 34678999999999999999999999999999999999999999876543 34444555566778889999999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRV 411 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~ 411 (767)
||.+||++||++||++.. .++++|++||||++++|..+..+.+.|||+|.+.......++
T Consensus 268 li~~lL~~dp~~R~~~~~--~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f 327 (350)
T 1rdq_E 268 LLRNLLQVDLTKRFGNLK--NGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNF 327 (350)
T ss_dssp HHHHHSCSCTTTCTTSST--TTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTS
T ss_pred HHHHHhhcCHHhccCCcc--CCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCccccccc
Confidence 999999999999998543 569999999999999999999999999999998765544444
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-54 Score=478.16 Aligned_cols=287 Identities=29% Similarity=0.604 Sum_probs=260.5
Q ss_pred hcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 107 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
....+..++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|++++|||||+++++|.+.
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 44567788999999999999999999999999999999999888777777778899999999999999999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+.+|+||||++||+|..++...+ .+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|..
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence 99999999999999999998654 699999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCcccccccccccCCcceecC---CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDN---EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~---~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
........+.+||+.|+|||++.+ ..|+.++|||||||++|||++|..||...... ...++...+......++..+
T Consensus 165 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~p~~~ 243 (384)
T 4fr4_A 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-SSKEIVHTFETTVVTYPSAW 243 (384)
T ss_dssp CCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-CHHHHHHHHHHCCCCCCTTS
T ss_pred ccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhhcccCCCCcC
Confidence 877666778899999999999963 46899999999999999999999999765432 23344555566667788899
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVK 403 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~ 403 (767)
|+++.+||.+||++||++||+ +++++++||||++++|..+..+.+.|||+|...
T Consensus 244 s~~~~~li~~lL~~dP~~R~s------~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~ 297 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNPDQRFS------QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKG 297 (384)
T ss_dssp CHHHHHHHHHHSCSSGGGSCC------SHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCC
T ss_pred CHHHHHHHHHHhcCCHhHhcc------cHHHHHcChhhhcCCHHHHHhCCCCCCCCCCCC
Confidence 999999999999999999998 489999999999999999999999999999854
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-55 Score=488.12 Aligned_cols=295 Identities=32% Similarity=0.538 Sum_probs=253.5
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++.++||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|+.++|||||+++++|++.+.+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 35568999999999999999999999999999999999887766666667788999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+|||||+||+|..++.+. .+++..++.|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 145 ~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 9999999999999988764 589999999999999999999999999999999999999999999999999987755
Q ss_pred CCc--ccccccccccCCcceecCCC----CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 270 GES--VRGRVGTVGYMAPEVIDNEK----YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~~~~----ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
... ..+.+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+.......+...........+..+
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 300 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccc
Confidence 432 34678999999999997765 889999999999999999999999887665444444332211222223478
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhh
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKE 413 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~ 413 (767)
|+++++||++||+.+|.+ +| |.+++||++||||++++|..+..+.+.|||+|.+......+++.+
T Consensus 301 s~~~~~li~~lL~~~~~r-lg----R~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~ 365 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVR-LG----RNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDD 365 (410)
T ss_dssp CHHHHHHHHHHSSCGGGC-TT----SSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCC
T ss_pred cHHHHHHHHHHccChhhh-CC----CCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCC
Confidence 999999999999966665 32 234999999999999999999999999999999887666555543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=505.58 Aligned_cols=266 Identities=24% Similarity=0.369 Sum_probs=236.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
+++|++.+.||+|+||+||+|+++.||+.||+|++.+... ...+.+.+|+.+|++++|||||+++++|++.+.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999976532 2345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC--CCEEEeecCcccccCCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY--GHVRISDLGLAVEIPEG 270 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~--g~vkL~DFGla~~~~~~ 270 (767)
||||+||+|.++|.+.. ..+++.+++.|++||+.||+|||++||+||||||+|||++.+ |++||+|||+|+.+...
T Consensus 233 ~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999999986542 369999999999999999999999999999999999999854 89999999999998877
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.......+...........+..+|+++++|
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 77778899999999999999999999999999999999999999999887655444443332233344456799999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHh
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLE 390 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~ 390 (767)
|++||++||++||+ ++|+++||||+..+|....
T Consensus 391 i~~~L~~dp~~R~t-------~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 391 IRKLLLADPNTRMT-------IHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp HHTTSCSSGGGSCC-------HHHHHHSTTTSCCCCTTTT
T ss_pred HHHHccCChhHCcC-------HHHHhcCcCcCCCCCCCch
Confidence 99999999999998 9999999999999986543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=510.65 Aligned_cols=298 Identities=36% Similarity=0.668 Sum_probs=265.8
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCe
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDA 188 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~ 188 (767)
.+..++|+++++||+|+||+||+|+++.+|+.||+|++.+...........+.+|..+|..+ +||||+++++++++.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 45678999999999999999999999999999999999988776677778899999999987 79999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+||||++||+|..++.+.+ .+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999998865 69999999999999999999999999999999999999999999999999998643
Q ss_pred -CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 269 -EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 269 -~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
.+....+.+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+. .++.+.+......++..+|+++
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~ 569 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPKSMSKEA 569 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHSSCCCCCTTSCHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH----HHHHHHHHhCCCCCCccCCHHH
Confidence 33445677899999999999999999999999999999999999999988754 3455566666778888999999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhhhhh
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKEDAEK 417 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~~~~ 417 (767)
++||++||++||++|||+.. .+++||++||||++++|+.++++.+.|||+|.+.. ....++....+.
T Consensus 570 ~~li~~lL~~dP~~R~~~~~--~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~-~~~~~f~~~~~~ 636 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGP--EGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTR 636 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCST--THHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG-GGHHHHTTTTTS
T ss_pred HHHHHHHccCCHHHCCCCCC--CcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC-CchhhcCchhcc
Confidence 99999999999999999743 47899999999999999999999999999999876 555555554443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=474.32 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=209.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEc---cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l 189 (767)
+.|++.+.||+|+||+||+|+++ .+++.||+|++.+.. ....+.+|+++|+.+ +|||||+++++|++.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 67999999999999999999876 468899999986542 344578899999998 699999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC-CCEEEeecCcccccC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY-GHVRISDLGLAVEIP 268 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~-g~vkL~DFGla~~~~ 268 (767)
|+|||||+||+|.+++. .+++.+++.|+.||+.||+|||++|||||||||+|||++.+ |++||+|||+|+...
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 99999999999998873 48999999999999999999999999999999999999876 899999999997653
Q ss_pred CCC-----------------------------cccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCC
Q psy11874 269 EGE-----------------------------SVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRR 318 (767)
Q Consensus 269 ~~~-----------------------------~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~ 318 (767)
... ...+.+||+.|||||++.+. .|+.++||||+||++|||++|++||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 321 12346899999999999775 589999999999999999999999964
Q ss_pred chh-hhhhhhhhhh----------------------------------hhc----------------cccccCCCCcHHH
Q psy11874 319 RKE-MVKRDEVDRR----------------------------------VKE----------------DAEKYSCRFSDDA 347 (767)
Q Consensus 319 ~~~-~~~~~~i~~~----------------------------------i~~----------------~~~~~~~~~s~~~ 347 (767)
.+. ......+... +.. .....+..+|+++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 432 2221111110 000 0011234679999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
+|||++||++||++|+| |+|+++||||+++|
T Consensus 330 ~DLl~~lL~~dP~~R~t-------a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRIT-------AEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHTCSCTTTSCC-------HHHHHTSGGGTTC-
T ss_pred HHHHHHHCcCChhHCcC-------HHHHhcCcccCCCC
Confidence 99999999999999999 99999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=481.63 Aligned_cols=294 Identities=30% Similarity=0.558 Sum_probs=247.3
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
..+..++|++.++||+|+||+||+|+++.+|+.||+|++.+...........+.+|..+|.+++||||++++++|++.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 34567899999999999999999999999999999999988766666666778999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+|||||+||+|..++.+.+ ..+++..++.|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 999999999999999998753 269999999999999999999999999999999999999999999999999998876
Q ss_pred CCCc--ccccccccccCCcceec-------CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-ccccc
Q psy11874 269 EGES--VRGRVGTVGYMAPEVID-------NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK-EDAEK 338 (767)
Q Consensus 269 ~~~~--~~~~~GT~~Y~APEvl~-------~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~-~~~~~ 338 (767)
.... ....+||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+.......+..... ...+.
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence 5443 23468999999999997 45789999999999999999999999988765544444332111 11122
Q ss_pred cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhh
Q psy11874 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRV 411 (767)
Q Consensus 339 ~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~ 411 (767)
.+..+|+++++||++||. +|.+|+| +.+++|+++||||++++|+.+.. ..|||+|.+.......++
T Consensus 294 ~~~~~s~~~~dli~~lL~-~p~~Rlg----r~~~~ei~~Hpff~~i~w~~l~~--~~~p~~p~~~~~~d~~~f 359 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLC-PPETRLG----RGGAGDFRTHPFFFGLDWDGLRD--SVPPFTPDFEGATDTCNF 359 (412)
T ss_dssp ---CCCHHHHHHHHTTSS-CGGGCTT----TTTHHHHHTSGGGTTCCSTTSTT--SCCSCCCC-----CCSSC
T ss_pred cccCCCHHHHHHHHHHcC-ChhhcCC----CCCHHHHhcCCCcCCCCHHHHhh--cCCCCCCcCCCccccccc
Confidence 345799999999999999 9999997 34699999999999999999964 579999998765444444
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=479.87 Aligned_cols=292 Identities=27% Similarity=0.554 Sum_probs=248.6
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++.++||+|+||+||+|+++.+|+.||+|++.+...........+.+|..+|..++||||++++++|++.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 34567999999999999999999999999999999999887666655666688999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+|||||+||+|..++.+.. ..+++..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 99999999999999998742 3699999999999999999999999999999999999999999999999999987655
Q ss_pred CCc--ccccccccccCCcceec-----CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc-cccccCC
Q psy11874 270 GES--VRGRVGTVGYMAPEVID-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE-DAEKYSC 341 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~-----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~~~ 341 (767)
... ....+||+.|+|||++. ...|+.++|||||||++|||++|++||.+.+.......+...... ..+....
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 443 23468999999999997 567999999999999999999999999887655444444322111 1122234
Q ss_pred CCcHHHHHHHHHhcccCcCc--cCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhh
Q psy11874 342 RFSDDAKALCKALLKKSPRS--RLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVK 412 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~--Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~ 412 (767)
.+|+++++||++||..+|++ |++ ++|+++||||++++|+.+. .++|||+|.+.......++.
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~-------~~eil~Hpff~~i~w~~l~--~~~~p~~P~~~~~~d~~~fd 371 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNG-------IEDFKKHPFFSGIDWDNIR--NCEAPYIPEVSSPTDTSNFD 371 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTT-------THHHHTSGGGTTCCTTTGG--GSCCSCCCCCSSTTCCTTSC
T ss_pred cCCHHHHHHHHHHhcccccccCCCC-------HHHHhCCCccCCCCHHHHh--hCCCCCCCcCCCccchhhcC
Confidence 58999999999999987765 554 9999999999999999994 58899999987765555443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=456.41 Aligned_cols=259 Identities=19% Similarity=0.301 Sum_probs=218.4
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAY 183 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 183 (767)
+.|..++|.+.+.||+|+||+||+|+++ .+|..||||+++.. .....+.+.+|+++|++++|||||++++++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 4566789999999999999999999975 36889999999754 233456789999999999999999999999
Q ss_pred eeCCeEEEEEEeccCCCHHHHHHhcC----------CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC
Q psy11874 184 ETKDALCLVLTIMNGGDLKFHIYNMG----------GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY 253 (767)
Q Consensus 184 ~~~~~l~lV~E~~~gG~L~~~l~~~~----------~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~ 253 (767)
.+++.+|||||||+||+|.++|.+.+ ....+++.++..++.||+.||+|||+++||||||||+||||+++
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 99999999999999999999998642 23469999999999999999999999999999999999999999
Q ss_pred CCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhh
Q psy11874 254 GHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVD 329 (767)
Q Consensus 254 g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~ 329 (767)
+++||+|||+|+....... ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.......+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999987654332 223569999999999999999999999999999999998 999998865433322222
Q ss_pred hhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 330 RRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 330 ~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
.......|..+|+++.+|+.+||++||++||+ +++| |+|++
T Consensus 245 ---~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs-------~~~i--~~~L~ 285 (299)
T 4asz_A 245 ---QGRVLQRPRTCPQEVYELMLGCWQREPHMRKN-------IKGI--HTLLQ 285 (299)
T ss_dssp ---HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHH--HHHHH
T ss_pred ---cCCCCCCCccchHHHHHHHHHHcCCChhHCcC-------HHHH--HHHHH
Confidence 22334567789999999999999999999999 8888 34544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=478.86 Aligned_cols=297 Identities=35% Similarity=0.649 Sum_probs=249.0
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
..+..++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+|++++||||+++++++.+.+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 34667899999999999999999999999999999999988766555666778899999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
+|+|||||+||+|..++.+.+ .+++..++.++.||+.||+|||+ .||+||||||+|||++.+|++||+|||+|+..
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEEEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999999998764 69999999999999999999998 99999999999999999999999999999864
Q ss_pred CC-CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 268 PE-GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 268 ~~-~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.. .+...+......++..++++
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~p~~~~~~ 375 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEIRFPRTLGPE 375 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCTTSCHH
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHHhCCCCCCccCCHH
Confidence 33 33455678999999999999999999999999999999999999999876543 34444555566778889999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhhhh
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKED 414 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~~~ 414 (767)
+++||.+||++||++||+... .+++|+++||||++++|..+..+.+.|||.|.+......+++.++
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~--~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~~ 441 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGS--EDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEE 441 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCST--TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC---
T ss_pred HHHHHHHHcccCHHHhCCCCC--CCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcchh
Confidence 999999999999999996432 469999999999999999999999999999998776655555443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=453.74 Aligned_cols=293 Identities=35% Similarity=0.604 Sum_probs=238.9
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEc---cCCcEEEEEEechhhhhh-hhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKK-RKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
.+..++|++.+.||+|+||.||+|+.. .+|+.||+|++.+..... ......+.+|+.+|++++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 456689999999999999999999985 689999999998764332 2344567889999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
.+.+|+||||++||+|..++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999999998764 68999999999999999999999999999999999999999999999999997
Q ss_pred ccCCC-CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCc
Q psy11874 266 EIPEG-ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFS 344 (767)
Q Consensus 266 ~~~~~-~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s 344 (767)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+... +...+......++..++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~p~~~~ 245 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----TIDKILKCKLNLPPYLT 245 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCCCCTTSC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCCCCCCCCCC
Confidence 65333 33455689999999999999999999999999999999999999998765433 33344444556778899
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhh
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRV 411 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~ 411 (767)
+++++||.+||.+||++||++.. .+++++++||||++++|+.+.++.+.|||.|.+...+....+
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~--~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~ 310 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGP--GDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 310 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSST--TTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC----------
T ss_pred HHHHHHHHHHHhcCHhhccCCCC--CCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCChhhhhhc
Confidence 99999999999999999998653 369999999999999999999999999999997765544443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=456.58 Aligned_cols=257 Identities=20% Similarity=0.311 Sum_probs=213.0
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAY 183 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 183 (767)
+.+..++|.+.+.||+|+||+||+|+++ .+++.||||+++.. .....+.+.+|+++|++++|||||++++++
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4566788999999999999999999975 36899999999754 233456799999999999999999999999
Q ss_pred eeCCeEEEEEEeccCCCHHHHHHhcCC------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC
Q psy11874 184 ETKDALCLVLTIMNGGDLKFHIYNMGG------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD 251 (767)
Q Consensus 184 ~~~~~l~lV~E~~~gG~L~~~l~~~~~------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld 251 (767)
.+.+.+|||||||+||+|.+++.+.+. ...+++.++..++.||+.||.|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 999999999999999999999986532 23589999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhh
Q psy11874 252 DYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDE 327 (767)
Q Consensus 252 ~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~ 327 (767)
+++++||+|||+|+....... ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.......
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999987644332 234679999999999999999999999999999999998 9999987654333322
Q ss_pred hhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 328 VDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 328 i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+. .......|..+|+++.+|+.+||++||++||+ ++||+++
T Consensus 273 i~---~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs-------~~ei~~~ 313 (329)
T 4aoj_A 273 IT---QGRELERPRACPPEVYAIMRGCWQREPQQRHS-------IKDVHAR 313 (329)
T ss_dssp HH---HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCC-------HHHHHHH
T ss_pred HH---cCCCCCCcccccHHHHHHHHHHcCcChhHCcC-------HHHHHHH
Confidence 22 22345667889999999999999999999999 8888753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=451.53 Aligned_cols=256 Identities=23% Similarity=0.278 Sum_probs=207.3
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
.+++..+++++.+.||+|+||+||+|+++ ..+|||+++.... .....+.+.+|+.+|++++|||||++++++. ++
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KD 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CC
Confidence 35677889999999999999999999865 3589999865432 3344567999999999999999999999775 46
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|||||||+||+|.++|.... ..+++.++..++.||+.||+|||+++||||||||+||||++++++||+|||+|+..
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred eEEEEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 7999999999999999997643 36999999999999999999999999999999999999999999999999999876
Q ss_pred CCC---CcccccccccccCCcceecC---CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhh-hhhhc-ccccc
Q psy11874 268 PEG---ESVRGRVGTVGYMAPEVIDN---EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD-RRVKE-DAEKY 339 (767)
Q Consensus 268 ~~~---~~~~~~~GT~~Y~APEvl~~---~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~-~~i~~-~~~~~ 339 (767)
... ....+.+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.+......... +.... .....
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 432 22455689999999999964 468999999999999999999999998755432222221 11111 12244
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+..+|+++.+|+.+||++||++||+ ++||++
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs-------~~ei~~ 293 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPL-------FPQILS 293 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCC-------HHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcC-------HHHHHH
Confidence 5678999999999999999999999 666543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=451.58 Aligned_cols=259 Identities=20% Similarity=0.280 Sum_probs=219.0
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEE
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYA 182 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 182 (767)
..++..+++++.+.||+|+||+||+|++. .+++.||||+++... .....+.+.+|+.+|++++|||||+++++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 34567788999999999999999999964 467899999996542 23345679999999999999999999999
Q ss_pred EeeCCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEE
Q psy11874 183 YETKDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENIL 249 (767)
Q Consensus 183 ~~~~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNIL 249 (767)
+.+.+.+|||||||+||+|.++|..... ...+++..+..++.||+.||+|||+++||||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 9999999999999999999999976431 235899999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCcccccCCCC---cccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhh
Q psy11874 250 LDDYGHVRISDLGLAVEIPEGE---SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKR 325 (767)
Q Consensus 250 ld~~g~vkL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~ 325 (767)
|++++++||+|||+|+...... .....+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+.....
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998764332 2345689999999999999999999999999999999998 89999887654333
Q ss_pred hhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 326 DEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 326 ~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
..+.. ....+.|..+|+++.+|+.+||+.||++||+ ++||+++
T Consensus 258 ~~i~~---~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs-------~~ei~~~ 300 (308)
T 4gt4_A 258 EMIRN---RQVLPCPDDCPAWVYALMIECWNEFPSRRPR-------FKDIHSR 300 (308)
T ss_dssp HHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred HHHHc---CCCCCCcccchHHHHHHHHHHcCCChhHCcC-------HHHHHHH
Confidence 32221 2234567789999999999999999999999 8888764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=450.55 Aligned_cols=258 Identities=24% Similarity=0.310 Sum_probs=218.7
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccC-----CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC-CceeEEEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRAT-----GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RFVVSLAYA 182 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~ 182 (767)
+++..++|++.+.||+|+||+||+|.++.+ ++.||+|++.... .......+.+|+.+|.+++| ||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 467778999999999999999999998754 4689999987543 22335678999999999966 899999999
Q ss_pred Eee-CCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceE
Q psy11874 183 YET-KDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248 (767)
Q Consensus 183 ~~~-~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNI 248 (767)
+.+ .+.+|+|||||+||+|.++|.+... ...+++.++..|+.||+.||+|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 4679999999999999999986421 23589999999999999999999999999999999999
Q ss_pred EeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhh
Q psy11874 249 LLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVK 324 (767)
Q Consensus 249 Lld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~ 324 (767)
|+++++++||+|||+|+.+..+.. ..+.+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+...
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~- 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999987754432 334679999999999999999999999999999999998 999998764322
Q ss_pred hhhhhhhhhc-cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 325 RDEVDRRVKE-DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 325 ~~~i~~~i~~-~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.+.+.+.. .....|..+|+++.+|+.+||++||++||+ ++||++|
T Consensus 296 --~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt-------~~eil~~ 341 (353)
T 4ase_A 296 --EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT-------FSELVEH 341 (353)
T ss_dssp --HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred --HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcC-------HHHHHHH
Confidence 22222322 345567789999999999999999999999 9999887
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=443.17 Aligned_cols=268 Identities=25% Similarity=0.413 Sum_probs=236.4
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh---hhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+.|++.+.||+|+||.||+|.++.+|+.||+|++.+...... ...+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 579999999999999999999999999999999987654322 13467889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC----CEEEeecCcccc
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG----HVRISDLGLAVE 266 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g----~vkL~DFGla~~ 266 (767)
+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ ++||+|||+|..
T Consensus 92 lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999997643 699999999999999999999999999999999999998877 799999999998
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
...+......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+..........++..+|++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 248 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 87766667788999999999999999999999999999999999999999887654444444333222333445678999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhc
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEA 391 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~ 391 (767)
+++||.+||.+||++||+ ++|+++||||++++|.....
T Consensus 249 ~~~li~~~L~~dP~~R~t-------~~e~l~hp~~~~~~~~~~~~ 286 (361)
T 2yab_A 249 AKDFIRKLLVKETRKRLT-------IQEALRHPWITPVDTQQAMV 286 (361)
T ss_dssp HHHHHHHHSCSSTTTSCC-------HHHHHTSTTTSCSSHHHHHH
T ss_pred HHHHHHHHCCCChhHCcC-------HHHHhcCcCcCCCchhhhhh
Confidence 999999999999999999 99999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=434.53 Aligned_cols=260 Identities=24% Similarity=0.396 Sum_probs=233.9
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 45789999999999999999999999999999999977643 23345668899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
|||||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....+.
T Consensus 92 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999999999998765 69999999999999999999999999999999999999999999999999998887766
Q ss_pred cccccccccccCCcceecCCCCC-CCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEKYT-YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~ys-~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.. ++...+.......+..+|+++.+|
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----ELRERVLRGKYRIPFYMSTDCENL 244 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCCCCCHHHHHH
Confidence 67778999999999999888875 7899999999999999999999887543 344445555566777899999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
|++||+.||.+||+ ++|+++||||+...+
T Consensus 245 i~~~L~~dP~~R~t-------~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 245 LKRFLVLNPIKRGT-------LEQIMKDRWINAGHE 273 (328)
T ss_dssp HHHHCCSSTTTSCC-------HHHHTTCTTTTTTCT
T ss_pred HHHHCCCChhHCcC-------HHHHhcCHhhcCCCc
Confidence 99999999999999 999999999997654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=440.58 Aligned_cols=291 Identities=37% Similarity=0.659 Sum_probs=250.8
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEc---cCCcEEEEEEechhhhh-hhhhHHHHHHHHHHHHhc-CCCceeEEEEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIK-KRKGESMVLIEKQILQKI-NSRFVVSLAYAY 183 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~~AiK~l~k~~~~-~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~ 183 (767)
..+..++|++.+.||+|+||.||+|+.. .+|+.||+|++.+.... .......+.+|+.+|+++ +||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 4456689999999999999999999984 58999999999765432 223344567799999999 699999999999
Q ss_pred eeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 184 ETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 184 ~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
.+.+.+|+||||++||+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999999998764 699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC--cccccccccccCCcceecC--CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 264 AVEIPEGE--SVRGRVGTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 264 a~~~~~~~--~~~~~~GT~~Y~APEvl~~--~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
|+...... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+.+.+......+
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC
Confidence 98654332 2334679999999999975 4578999999999999999999999987655445555666666666778
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCc
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKR 404 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~ 404 (767)
+..+++.+++||.+||..||++||++.. .+++++++||||++++|..+..+.++|||.|.+..
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~--~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~ 348 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGP--RDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRD 348 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSST--TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCC--CCHHHHHcCcchhcCChhHhhhccCCCCCCCcccc
Confidence 8899999999999999999999997543 36999999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=422.77 Aligned_cols=268 Identities=27% Similarity=0.419 Sum_probs=233.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh---hhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+.|++.+.||+|+||.||+|.++.+|+.||+|++.+...... .....+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 569999999999999999999999999999999976543321 13567889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC----CEEEeecCcccc
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG----HVRISDLGLAVE 266 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g----~vkL~DFGla~~ 266 (767)
+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|..
T Consensus 91 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999987643 699999999999999999999999999999999999999888 899999999998
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...........+..+|+.
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (326)
T 2y0a_A 168 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247 (326)
T ss_dssp CCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHH
Confidence 76665566778999999999999999999999999999999999999999877654444333332222333344678999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhc
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEA 391 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~ 391 (767)
+++||.+||+.||++||+ ++++++||||+..+|.....
T Consensus 248 ~~~li~~~L~~dP~~Rpt-------~~e~l~hp~~~~~~~~~~~~ 285 (326)
T 2y0a_A 248 AKDFIRRLLVKDPKKRMT-------IQDSLQHPWIKPKDTQQALS 285 (326)
T ss_dssp HHHHHHHHSCSSGGGSCC-------HHHHHHSTTTSCCSHHHHHH
T ss_pred HHHHHHHHccCChhhCCC-------HHHHhcCCCccCCcchhhhh
Confidence 999999999999999999 99999999999998876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=427.43 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=231.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34579999999999999999999999999999999998876665556677899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||+ +|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....+
T Consensus 86 lv~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999999 689988888764 6999999999999999999999999999999999999999999999999999887776
Q ss_pred CcccccccccccCCcceecCCCC-CCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKY-TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~y-s~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... .+.+.+.......+..+|+++++
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP----NLFKKVNSCVYVMPDFLSPGAQS 237 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST----TCBCCCCSSCCCCCTTSCHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH----HHHHHHHcCCCCCcccCCHHHHH
Confidence 66677899999999999988776 68999999999999999999999775432 33344444455667789999999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
||++||+.||.+||+ ++|+++||||+.
T Consensus 238 li~~~L~~dP~~Rpt-------~~eil~hp~~~~ 264 (336)
T 3h4j_B 238 LIRRMIVADPMQRIT-------IQEIRRDPWFNV 264 (336)
T ss_dssp HHHTTSCSSGGGSCC-------HHHHTTCHHHHT
T ss_pred HHHHHcCCChhHCcC-------HHHHHhChhhcc
Confidence 999999999999999 999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=428.84 Aligned_cols=269 Identities=26% Similarity=0.390 Sum_probs=230.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV 192 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++.+... ...+|+++|.++ +||||+++++++.+.+.+|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 579999999999999999999999999999999976532 134588888887 799999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC----CCEEEeecCcccccC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY----GHVRISDLGLAVEIP 268 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~----g~vkL~DFGla~~~~ 268 (767)
||||+||+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||+.+. +.+||+|||+|....
T Consensus 95 ~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp ECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999998754 69999999999999999999999999999999999998433 359999999998765
Q ss_pred CC-CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc----cCCCC
Q psy11874 269 EG-ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK----YSCRF 343 (767)
Q Consensus 269 ~~-~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~----~~~~~ 343 (767)
.. ....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.... ...++...+...... ++..+
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-TPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-CHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-CHHHHHHHHccCCcccCccccccC
Confidence 43 3345678999999999998888999999999999999999999999764321 223344444333322 34678
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDV 402 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~ 402 (767)
|+++++||++||..||++||+ +.++++||||. +|..+....+.+|+.|..
T Consensus 251 s~~~~~li~~~L~~dP~~R~t-------~~~il~hp~~~--~~~~~~~~~~~~~~~p~~ 300 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLT-------AALVLRHPWIV--HWDQLPQYQLNRQDAPHL 300 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC-------HHHHTTSHHHH--TGGGSCCSCCCCCCCHHH
T ss_pred CHHHHHHHHHHCCCChhHCcC-------HHHHhcCCeec--CccccccccCCCccchhh
Confidence 999999999999999999999 99999999995 599998888888888764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=420.76 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=227.5
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|.++.+|+.||+|.+.... .....+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 368999999999999999999999999999999986432 2345678999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC--CCCEEEeecCcccccCCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD--YGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~--~g~vkL~DFGla~~~~~~ 270 (767)
||||+||+|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....+
T Consensus 80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999999986542 36899999999999999999999999999999999999987 799999999999988776
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
.......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+...........+..+|+++++|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 66667789999999999999889999999999999999999999998876544444443332222333345789999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
|.+||..||++||+ +.|+++||||++.
T Consensus 238 i~~~L~~dp~~Rpt-------~~e~l~hp~~~~~ 264 (321)
T 1tki_A 238 VDRLLVKERKSRMT-------ASEALQHPWLKQK 264 (321)
T ss_dssp HHTTSCSSGGGSCC-------HHHHHHSHHHHSC
T ss_pred HHHHcCCChhHCcC-------HHHHhcChhhccC
Confidence 99999999999999 9999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=437.56 Aligned_cols=275 Identities=25% Similarity=0.340 Sum_probs=211.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee-----CCe
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-----KDA 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~~ 188 (767)
++|++.+.||+|+||+||+|.++.+|+.||+|++.+.. ........+.+|+.+|++++|||||++++++.. ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 68999999999999999999999999999999986542 233445678899999999999999999999843 367
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+||||+. |+|..++.... .+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 999999985 78988887643 69999999999999999999999999999999999999999999999999998764
Q ss_pred CCC----------------------------cccccccccccCCccee-cCCCCCCCCccccchhhHHHHhc--------
Q psy11874 269 EGE----------------------------SVRGRVGTVGYMAPEVI-DNEKYTYSPDWFSFGCLIFEMIE-------- 311 (767)
Q Consensus 269 ~~~----------------------------~~~~~~GT~~Y~APEvl-~~~~ys~~~DvwSlGviLyEllt-------- 311 (767)
... .....+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 221 23456899999999986 56779999999999999999998
Q ss_pred ---CCCCCCCchh--------------------hhhhhhhhhhhh---------------------------ccccccCC
Q psy11874 312 ---GQAPFRRRKE--------------------MVKRDEVDRRVK---------------------------EDAEKYSC 341 (767)
Q Consensus 312 ---G~~PF~~~~~--------------------~~~~~~i~~~i~---------------------------~~~~~~~~ 341 (767)
|.+||.+... ......+...+. .......+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 7777765431 011111111000 00112234
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCC
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P 400 (767)
..++++.+||++||..||++||+ ++|+++||||++++|..++.....++..|
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t-------~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~ 419 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRIT-------INECLAHPFFKEVRIAEVETNATEKVRLP 419 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCC-------HHHHHHSGGGTTTCCGGGCCCCSSCCCCS
T ss_pred CCCHHHHHHHHHHhccCccccCC-------HHHHhcCHhhhhcCCCccCCCCCCCCCCC
Confidence 56999999999999999999999 99999999999999999887665555555
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=424.91 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=226.1
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999999999999999999766543 234567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC---CEEEeecCcccccCCC
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG---HVRISDLGLAVEIPEG 270 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g---~vkL~DFGla~~~~~~ 270 (767)
||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|......
T Consensus 108 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999887643 689999999999999999999999999999999999998654 5999999999887766
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+...........+..+|+++++|
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 65667789999999999999999999999999999999999999998876543333333222222223335689999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
|.+||++||++||+ ++++++||||.+.
T Consensus 265 i~~~L~~dP~~R~t-------~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 265 IDSMLTVNPKKRIT-------ADQALKVPWICNR 291 (362)
T ss_dssp HHHHSCSSGGGSCC-------HHHHTTSHHHHTH
T ss_pred HHHHcCCChhhCcC-------HHHHhcCcccCCC
Confidence 99999999999999 9999999999763
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=427.28 Aligned_cols=277 Identities=25% Similarity=0.353 Sum_probs=217.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCC--eE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKD--AL 189 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~--~l 189 (767)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.+.. ........+.+|+.+|.++. ||||+++++++...+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 478999999999999999999999999999999986542 23345567889999999997 999999999997654 79
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+|||||+ |+|...+... .+++..+..++.||+.||+|||+.||+||||||+|||++.+|++||+|||+|+....
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 99999998 5898888763 589999999999999999999999999999999999999999999999999986532
Q ss_pred C----------------------CcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhh
Q psy11874 270 G----------------------ESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD 326 (767)
Q Consensus 270 ~----------------------~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~ 326 (767)
. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 11344689999999999976 679999999999999999999999998877655444
Q ss_pred hhhhhhhcccc-------------------------------------------ccCCCCcHHHHHHHHHhcccCcCccC
Q psy11874 327 EVDRRVKEDAE-------------------------------------------KYSCRFSDDAKALCKALLKKSPRSRL 363 (767)
Q Consensus 327 ~i~~~i~~~~~-------------------------------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl 363 (767)
.+...+..... ..+...++++++||.+||+.||++||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 44322211100 01126789999999999999999999
Q ss_pred CCCCCcccHHHHHhCCCCCCC---ChhhHhcCCCCCCCCCCC
Q psy11874 364 GCHCGRYGARELKQAEFFKST---NWKRLEAGLCDPPFVPDV 402 (767)
Q Consensus 364 ~~~~~~~~a~eil~HpfF~~i---~w~~l~~~~~~pp~~P~~ 402 (767)
+ ++|+++||||+.+ +|+......+++||.|..
T Consensus 322 t-------~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
T 3oz6_A 322 S-------ANDALKHPFVSIFHNPNEEPNCDHIITIPINDNV 356 (388)
T ss_dssp C-------HHHHTTSTTTTTTCCGGGCCCCSSCCCCC-----
T ss_pred C-------HHHHhCCHHHHHhcCCccCCCCCCCCCCCccccc
Confidence 9 9999999997664 566556666777877754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=409.54 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=224.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 467999999999999999999999999999999987553 23345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
|||++||+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|........
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999998764 589999999999999999999999999999999999999999999999999987654433
Q ss_pred -ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 273 -VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 273 -~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.......+... .......+..+++.+++||
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 250 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFL 250 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-CSCCCSCGGGSCHHHHHHH
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCccccCHHHHHHH
Confidence 44568999999999999999999999999999999999999999876553333222211 1122334567899999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.+||+.||++||+ ++|+++||||+..
T Consensus 251 ~~~l~~dp~~Rps-------~~ell~h~~~~~~ 276 (297)
T 3fxz_A 251 NRCLEMDVEKRGS-------AKELLQHQFLKIA 276 (297)
T ss_dssp HHHSCSSTTTSCC-------HHHHTTCGGGGGC
T ss_pred HHHccCChhHCcC-------HHHHhhChhhccc
Confidence 9999999999999 9999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=410.83 Aligned_cols=263 Identities=25% Similarity=0.390 Sum_probs=218.9
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||+||+|++. +|+.||+|++..... .......+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 478999999999999999999985 699999999975532 233346688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-C
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-E 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~ 271 (767)
|||++| +|...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...... .
T Consensus 98 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 999985 7877776643 36999999999999999999999999999999999999999999999999999876533 2
Q ss_pred cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc--------------
Q psy11874 272 SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA-------------- 336 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~-------------- 336 (767)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+........
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 3445689999999999876 5689999999999999999999999987765544444333221111
Q ss_pred ------------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 337 ------------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 337 ------------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
......+++++++||.+||+.||++||+ ++|+++||||+++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS-------ARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC-------HHHHHTSGGGTTSCTT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC-------HHHHhcCcccccCCcc
Confidence 1123457899999999999999999999 9999999999998864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=435.99 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=211.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC------
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------ 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------ 186 (767)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.+.. ........+.+|+.+|+.++|||||++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 478999999999999999999999999999999997653 2334456788999999999999999999999654
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
..+|+|||||+|+ |...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 4689999999865 5555532 489999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc--------
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK-------- 338 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~-------- 338 (767)
..........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.......+.+........
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 766655667899999999999999999999999999999999999999999877655444443322111100
Q ss_pred -------------------cCCC-----------CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 339 -------------------YSCR-----------FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 339 -------------------~~~~-----------~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
++.. .++++++||.+||+.||++||+ ++|+++||||+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t-------a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS-------VDDALQHPYINV 361 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC-------HHHHHTSTTTGG
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC-------HHHHhcChhhhh
Confidence 0110 1678999999999999999999 999999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=432.96 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=225.5
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++.+..... .....+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999998765433 34566889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC---CCCCEEEeecCcccccCCC
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD---DYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld---~~g~vkL~DFGla~~~~~~ 270 (767)
|||+||+|.+.+...+ .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|......
T Consensus 90 E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999998764 699999999999999999999999999999999999998 5688999999999877544
Q ss_pred Cc-ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 271 ES-VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 271 ~~-~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
.. ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+...........+..+|+++++
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 246 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 33 35678999999999999999999999999999999999999999887655444444433333333344578999999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
||.+||+.||++||+ ++|+++||||++
T Consensus 247 li~~~L~~dP~~Rpt-------a~e~L~hp~~~~ 273 (444)
T 3soa_A 247 LINKMLTINPSKRIT-------AAEALKHPWISH 273 (444)
T ss_dssp HHHHHSCSSTTTSCC-------HHHHHHSCTTHH
T ss_pred HHHHHcCCChhHCCC-------HHHHhcCccccC
Confidence 999999999999999 999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=404.46 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=215.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 689999999999999999999999999999999976542 3334467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Cc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~ 272 (767)
||++| +|...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...... ..
T Consensus 81 e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 99986 5555555432 36999999999999999999999999999999999999999999999999999876533 23
Q ss_pred ccccccccccCCcceecCCC-CCCCCccccchhhHHHHhcCCCCC-CCchhhhhhhhhhhhhhccc--------------
Q psy11874 273 VRGRVGTVGYMAPEVIDNEK-YTYSPDWFSFGCLIFEMIEGQAPF-RRRKEMVKRDEVDRRVKEDA-------------- 336 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~-ys~~~DvwSlGviLyElltG~~PF-~~~~~~~~~~~i~~~i~~~~-------------- 336 (767)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+.......+.+......
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 44568999999999997765 899999999999999999888775 44433333333322111110
Q ss_pred -----------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 337 -----------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 337 -----------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
......+++++++||.+||+.||++||+ ++|+++||||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS-------AEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC-------HHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC-------HHHHhcCcccccC
Confidence 1122357899999999999999999999 9999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=419.94 Aligned_cols=265 Identities=26% Similarity=0.430 Sum_probs=224.6
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh--hhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
+.|++.+.||+|+||.||+|.++.+|+.||+|++.+...... ...+.+.+|+.+|++++||||+++++++.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 579999999999999999999999999999999977654332 235678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC---EEEeecCccccc
Q psy11874 192 VLTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH---VRISDLGLAVEI 267 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~---vkL~DFGla~~~ 267 (767)
|||||+||+|.+.+.... ....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999999988876542 2335899999999999999999999999999999999999987655 999999999887
Q ss_pred CCCCc-ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 268 PEGES-VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 268 ~~~~~-~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.... ....+...........+..+|++
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~ 262 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISES 262 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHHHHHHTCCCCCHHHHTTSCHH
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHHHHHcCCCCCCccccccCCHH
Confidence 65433 44568999999999999999999999999999999999999999876432 12222221111222233578999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
+++||.+||..||++||+ +.++++||||++.++
T Consensus 263 ~~~li~~~L~~dP~~R~s-------~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 263 AKDLVRRMLMLDPAERIT-------VYEALNHPWLKERDR 295 (351)
T ss_dssp HHHHHHHHTCSSTTTSCC-------HHHHHTSHHHHTHHH
T ss_pred HHHHHHHHCCCChhHCcC-------HHHHhcChhhcCCcc
Confidence 999999999999999999 999999999987654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=416.25 Aligned_cols=247 Identities=24% Similarity=0.283 Sum_probs=193.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC----eE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----AL 189 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~l 189 (767)
++|.+.+.||+|+||+||+|++ +|+.||||+++.... .......|+.++.+++|||||++++++.+.+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4688999999999999999987 589999999965431 1122345666677899999999999997654 68
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC--------CcccccCCcceEEeCCCCCEEEeec
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI--------GLVYRDCKPENILLDDYGHVRISDL 261 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~--------~IvHrDLKPeNILld~~g~vkL~DF 261 (767)
|||||||+||+|.++|.+. .++++.+..++.|++.||.|||++ +||||||||+|||||.+|++||+||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 9999999999999999764 589999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCCc-----ccccccccccCCcceecCC------CCCCCCccccchhhHHHHhcCCCCCCCchhhh-------
Q psy11874 262 GLAVEIPEGES-----VRGRVGTVGYMAPEVIDNE------KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV------- 323 (767)
Q Consensus 262 Gla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~------~ys~~~DvwSlGviLyElltG~~PF~~~~~~~------- 323 (767)
|+|+....... ....+||+.|||||++.+. .|+.++|||||||+||||+||.+||.......
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 99987654332 2345899999999999764 36789999999999999999988775432110
Q ss_pred ----hhhhhhhhhhcc--ccccCC-----CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 324 ----KRDEVDRRVKED--AEKYSC-----RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 324 ----~~~~i~~~i~~~--~~~~~~-----~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
..+.+.+.+... .+..|. ..++.+.+|+.+||+.||++||+ +.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt-------~~ei~~ 290 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT-------ALRIKK 290 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC-------HHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC-------HHHHHH
Confidence 111222222111 112222 13357889999999999999999 888875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=411.43 Aligned_cols=268 Identities=25% Similarity=0.417 Sum_probs=234.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh---hhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++.+...... .....+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 579999999999999999999999999999999976543221 13567889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC----CEEEeecCcccc
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG----HVRISDLGLAVE 266 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g----~vkL~DFGla~~ 266 (767)
+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999997643 689999999999999999999999999999999999999888 799999999988
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
...........||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+...........+..+|+.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence 77665566678999999999999999999999999999999999999999877654443333332222233344678999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhc
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEA 391 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~ 391 (767)
+++||.+||..||++||+ ++|+++||||++++|.....
T Consensus 249 ~~~li~~~l~~dp~~Rps-------~~e~l~hp~~~~~~~~~~~~ 286 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLT-------IQEALRHPWITPVDNQQAMV 286 (321)
T ss_dssp HHHHHHTTSCSSTTTSCC-------HHHHHHSTTTSCSSHHHHHH
T ss_pred HHHHHHHHcCCChhhCcC-------HHHHhcCccccCCCcccccc
Confidence 999999999999999999 99999999999999877654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=426.24 Aligned_cols=267 Identities=26% Similarity=0.331 Sum_probs=215.9
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC-----C
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----D 187 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~ 187 (767)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.+.. ........+.+|+.+|++++||||+++++++... +
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 368999999999999999999999999999999997542 2334556789999999999999999999999876 6
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+|||||+ |+|..++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 7999999997 59999887643 6999999999999999999999999999999999999999999999999999876
Q ss_pred CCCC-----------------------cccccccccccCCccee-cCCCCCCCCccccchhhHHHHhcC-----------
Q psy11874 268 PEGE-----------------------SVRGRVGTVGYMAPEVI-DNEKYTYSPDWFSFGCLIFEMIEG----------- 312 (767)
Q Consensus 268 ~~~~-----------------------~~~~~~GT~~Y~APEvl-~~~~ys~~~DvwSlGviLyElltG----------- 312 (767)
.... .....+||+.|+|||++ .+..|+.++|||||||++|||++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 4432 13567899999999986 566799999999999999999984
Q ss_pred CCCCCCchh-----------------hhhhhhhhhh--------------------hhccc-------cccCCCCcHHHH
Q psy11874 313 QAPFRRRKE-----------------MVKRDEVDRR--------------------VKEDA-------EKYSCRFSDDAK 348 (767)
Q Consensus 313 ~~PF~~~~~-----------------~~~~~~i~~~--------------------i~~~~-------~~~~~~~s~~~~ 348 (767)
.++|.+.+. ......+... +.... ....+.+|++++
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 444443321 0111111110 00000 011246899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhc
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEA 391 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~ 391 (767)
+||++||+.||++||+ ++|+++||||++++|...+.
T Consensus 340 dLl~~mL~~dP~~R~t-------a~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 340 NLLESMLKFNPNKRIT-------IDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp HHHHHHSCSSTTTSCC-------HHHHHTCGGGTTTCCTTTC-
T ss_pred HHHHHHhcCCcccCCC-------HHHHhcChhhhhccCcccCc
Confidence 9999999999999999 99999999999999998775
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=420.45 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=212.1
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||.||+|+++.+|+.||+|++.+... ....+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 34789999999999999999999999999999999975432 23457889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC--EEEeecCcccccCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH--VRISDLGLAVEIPE 269 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~--vkL~DFGla~~~~~ 269 (767)
||||++||+|..++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 94 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999999998765 6999999999999999999999999999999999999987765 99999999986555
Q ss_pred CCcccccccccccCCcceecCCCCCCC-CccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC--CCcHH
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYS-PDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC--RFSDD 346 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~-~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~--~~s~~ 346 (767)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........+.+.+.......+. .+|++
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 250 (361)
T 3uc3_A 171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence 444566789999999999988887655 899999999999999999998765544444444555444444443 57999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+++||.+||+.||++||+ ++|+++||||..
T Consensus 251 ~~~li~~~L~~dP~~Rps-------~~ell~hp~f~~ 280 (361)
T 3uc3_A 251 CCHLISRIFVADPATRIS-------IPEIKTHSWFLK 280 (361)
T ss_dssp HHHHHHHHSCSCTTTSCC-------HHHHHTSHHHHT
T ss_pred HHHHHHHHccCChhHCcC-------HHHHHhCcchhc
Confidence 999999999999999999 999999999954
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=422.65 Aligned_cols=262 Identities=28% Similarity=0.442 Sum_probs=227.6
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 3689999999999999999999999999999999875432 2334688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC--CCCEEEeecCcccccCCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD--YGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~--~g~vkL~DFGla~~~~~~ 270 (767)
||||+||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|......
T Consensus 127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999998886542 36999999999999999999999999999999999999974 578999999999988766
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+...........+..+|+++++|
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 65666789999999999999999999999999999999999999998876544444333322222333445789999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
|.+||+.||++||+ ++++++||||++..+
T Consensus 285 i~~~L~~dP~~Rpt-------~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 285 IKNLLQKEPRKRLT-------VHDALEHPWLKGDHS 313 (387)
T ss_dssp HHTTSCSSGGGSCC-------HHHHHTSTTTSSCCT
T ss_pred HHHHcCCChhHCcC-------HHHHhhCccccCCcc
Confidence 99999999999999 999999999998643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=435.03 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=234.4
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
..+..++|.+.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34567899999999999999999999999999999999988766555566789999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999999987643 69999999999999999999999999999999999999999999999999999887
Q ss_pred CCCcccccccccccCCcceecCCCC-CCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDNEKY-TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~~~y-s~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
.+....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+... +...+.......+..+++++
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~ 243 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT----LFKKICDGIFYTPQYLNPSV 243 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----HHHHHHTTCCCCCTTCCHHH
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----HHHHHhcCCcCCCccCCHHH
Confidence 6666677899999999999988776 689999999999999999999998765433 33444444555677899999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
++||++||+.||++||+ ++++++||||+.
T Consensus 244 ~~Li~~~L~~dP~~Rpt-------~~eil~hp~~~~ 272 (476)
T 2y94_A 244 ISLLKHMLQVDPMKRAT-------IKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHHTCSSTTTSCC-------HHHHHTCHHHHT
T ss_pred HHHHHHHcCCCchhCcC-------HHHHHhCHHhhh
Confidence 99999999999999999 999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=397.88 Aligned_cols=267 Identities=24% Similarity=0.405 Sum_probs=232.7
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 36899999999999999999999999999999999766542 33456688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC---EEEeecCcccccCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH---VRISDLGLAVEIPE 269 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~---vkL~DFGla~~~~~ 269 (767)
|||++||+|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999998888764 6999999999999999999999999999999999999986665 99999999988776
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..............+++++++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 66666678999999999999999999999999999999999999999887654444444333333333334578999999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLE 390 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~ 390 (767)
||.+||+.||++||+ ++|+++||||++..+..-.
T Consensus 241 li~~~l~~dp~~Rps-------~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 241 LIDSMLTVNPKKRIT-------ADQALKVPWICNRERVASA 274 (284)
T ss_dssp HHHHHSCSSTTTSCC-------HHHHTTSHHHHSCCCGGGS
T ss_pred HHHHHcccChhhCCC-------HHHHhcCccccCChhHHhH
Confidence 999999999999999 9999999999998765443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=401.90 Aligned_cols=260 Identities=26% Similarity=0.399 Sum_probs=214.5
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|++ .+|+.||+|++..... .......+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 6899999999875532 2233456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Cc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~ 272 (767)
||+++ +|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...... ..
T Consensus 80 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp ECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 99985 8988887643 36899999999999999999999999999999999999999999999999999876433 22
Q ss_pred ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc---------------
Q psy11874 273 VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA--------------- 336 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~--------------- 336 (767)
.....||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+.+......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 345679999999999976 4589999999999999999999999987765444333332211100
Q ss_pred ----------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 337 ----------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 337 ----------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
..+...+++++++||.+||+.||++||+ ++|+++||||++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT-------AKQALEHAYFKENN 288 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC-------HHHHHTSGGGGC--
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC-------HHHHhcCcchhhcC
Confidence 1123457999999999999999999999 99999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=404.52 Aligned_cols=274 Identities=22% Similarity=0.296 Sum_probs=216.6
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 3689999999999999999999999999999999865432 233456678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
|||++|++|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 81 ~e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999988876543 69999999999999999999999999999999999999999999999999998765332
Q ss_pred cccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc--------------
Q psy11874 272 SVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA-------------- 336 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~-------------- 336 (767)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.........+........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 2445689999999999976 6789999999999999999999999988765443333222111100
Q ss_pred -------------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCC
Q psy11874 337 -------------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPP 397 (767)
Q Consensus 337 -------------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp 397 (767)
......+|+++.+||.+||+.||++||+ ++|+++||||+++.|....+.....|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~ell~hp~f~~~~~~~~~~~~~~~~ 304 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT-------CEQLLHHPYFENIREIEDLAKEHDKP 304 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC-------HHHHHTSGGGTTCC------------
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC-------HHHHhcChHHHhccCHHHHHHhhccH
Confidence 0012467899999999999999999999 99999999999998876666554443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=399.19 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=229.7
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
.+...++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 45667899999999999999999999999999999999987766666667788999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
.++||||++||+|..++.+.. .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999999998764 69999999999999999999999999999999999999999999999999996654
Q ss_pred CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
... .....||+.|+|||++.+..++.++|+|||||++|+|++|..||....... ....+......++..++++++
T Consensus 161 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 235 (279)
T 3fdn_A 161 SSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRISRVEFTFPDFVTEGAR 235 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCCTTSCHHHH
T ss_pred ccc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH----HHHHHHhCCCCCCCcCCHHHH
Confidence 332 345679999999999999999999999999999999999999998765433 333344445566778999999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+||.+||+.||++||+ ++|+++||||++.
T Consensus 236 ~li~~~l~~~p~~Rps-------~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 236 DLISRLLKHNPSQRPM-------LREVLEHPWITAN 264 (279)
T ss_dssp HHHHHHCCSSGGGSCC-------HHHHHHCHHHHHH
T ss_pred HHHHHHhccChhhCCC-------HHHHhhCccccCC
Confidence 9999999999999999 9999999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=397.81 Aligned_cols=272 Identities=26% Similarity=0.408 Sum_probs=236.1
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
..+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++++++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 34567899999999999999999999999999999999987765555556778999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+||||++||+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999999998764 68999999999999999999999999999999999999999999999999997664
Q ss_pred CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
.. ......||+.|+|||++.+..++.++|+|||||++|+|++|..||........ ...+......++..++++++
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 2vgo_A 166 SL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET----HRRIVNVDLKFPPFLSDGSK 240 (284)
T ss_dssp SS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCCTTSCHHHH
T ss_pred cc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH----HHHHhccccCCCCcCCHHHH
Confidence 43 23456799999999999999999999999999999999999999987654332 23334444566778999999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
+||.+||..||.+||+ ++++++||||+.. ...+.||..+.
T Consensus 241 ~li~~~l~~~p~~Rps-------~~~ll~h~~~~~~------~~~~~p~~~~~ 280 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLP-------LKGVMEHPWVKAN------SRRVLPPVYQS 280 (284)
T ss_dssp HHHHHHSCSSGGGSCC-------HHHHHTCHHHHHH------CCCCCCCCC--
T ss_pred HHHHHHhhcCHhhCCC-------HHHHhhCHHHHhh------ccccCCCcccc
Confidence 9999999999999999 9999999999753 34455665554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=417.48 Aligned_cols=268 Identities=21% Similarity=0.296 Sum_probs=220.5
Q ss_pred cCCCeEEEeEEeec--CcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 112 TYKTFRMYRVLGKG--GFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 112 ~~~~y~~~~~LG~G--~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
..++|++.+.||+| +||.||+|+++.+|+.||+|++...... ......+.+|+.+|++++|||||++++++.+.+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 44789999999999 9999999999999999999999776432 34556788899999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+|||||+||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999998753 23699999999999999999999999999999999999999999999999999865422
Q ss_pred CC--------cccccccccccCCcceecC--CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh------
Q psy11874 270 GE--------SVRGRVGTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK------ 333 (767)
Q Consensus 270 ~~--------~~~~~~GT~~Y~APEvl~~--~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~------ 333 (767)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.............
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 21 1233479999999999987 6799999999999999999999999987554332222111000
Q ss_pred ------------------------------------ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 334 ------------------------------------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 334 ------------------------------------~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.....++..+++++++||.+||+.||++||+ ++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-------a~ell~ 333 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS-------ASTLLN 333 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCC-------HHHHTT
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC-------HHHHhc
Confidence 0011234568999999999999999999999 999999
Q ss_pred CCCCCCCChhh
Q psy11874 378 AEFFKSTNWKR 388 (767)
Q Consensus 378 HpfF~~i~w~~ 388 (767)
||||+++.|..
T Consensus 334 hp~f~~~~~~~ 344 (389)
T 3gni_B 334 HSFFKQIKRRA 344 (389)
T ss_dssp SGGGGGC---C
T ss_pred CHHHHHHhhcc
Confidence 99999988753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=408.65 Aligned_cols=268 Identities=23% Similarity=0.361 Sum_probs=209.9
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.... .......+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999999999999999987543 223345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcC---CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 193 LTIMNGGDLKFHIYNMG---GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~---~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|||++ |+|..++.... ....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99998 59988887642 123589999999999999999999999999999999999999999999999999987653
Q ss_pred C-CcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc------------
Q psy11874 270 G-ESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED------------ 335 (767)
Q Consensus 270 ~-~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~------------ 335 (767)
. ......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+.......
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 3 23445689999999999976 468999999999999999999999998876554443333221110
Q ss_pred ------------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHh
Q psy11874 336 ------------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLE 390 (767)
Q Consensus 336 ------------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~ 390 (767)
....+..+++++++||.+||+.||++||+ ++|+++||||++..|....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-------~~e~l~hp~f~~~~~~~~~ 306 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS-------AKQALHHPWFAEYYHHASM 306 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC-------HHHHTTSGGGGGGCC----
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC-------HHHHhCChhhhcccchhhc
Confidence 01122367899999999999999999999 9999999999998776443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=436.05 Aligned_cols=265 Identities=29% Similarity=0.463 Sum_probs=232.8
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35799999999999999999999999999999999877665556677899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe---CCCCCEEEeecCcccccCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl---d~~g~vkL~DFGla~~~~~ 269 (767)
|||+.||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999987654 69999999999999999999999999999999999999 5678999999999998877
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
.......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+.......+...........+..+|+++++
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 666667789999999999976 6999999999999999999999999887665444444333222233344578999999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
||++||++||++||+ ++++++||||+...++.
T Consensus 261 li~~~L~~dp~~R~s-------~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 261 LIRKMLTYVPSMRIS-------ARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp HHHHHTCSSGGGSCC-------HHHHHTSHHHHHHTC--
T ss_pred HHHHHCCCChhHCcC-------HHHHhhChhhccccccc
Confidence 999999999999999 99999999998866543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=410.84 Aligned_cols=265 Identities=20% Similarity=0.326 Sum_probs=213.6
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
...++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 446789999999999999999999999999999999975532 2233456778999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe-----CCCCCEEEeecCccc
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL-----DDYGHVRISDLGLAV 265 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl-----d~~g~vkL~DFGla~ 265 (767)
+||||++ |+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+|.
T Consensus 110 lv~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999998 49999988754 69999999999999999999999999999999999999 455569999999998
Q ss_pred ccCCC-CcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc-----
Q psy11874 266 EIPEG-ESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK----- 338 (767)
Q Consensus 266 ~~~~~-~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~----- 338 (767)
..... ......+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.........+..........
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 76533 234456789999999999774 58999999999999999999999998876554444333322111100
Q ss_pred ---------------------cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 339 ---------------------YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 339 ---------------------~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
.+..+++++++||.+||+.||++||+ ++|+++||||++.+|+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS-------AKNALEHPYFSHNDFD 328 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC-------HHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC-------HHHHhCCcccCCCCCC
Confidence 11227899999999999999999999 9999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=408.40 Aligned_cols=271 Identities=24% Similarity=0.354 Sum_probs=226.7
Q ss_pred CCeEEE-eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeEEE
Q psy11874 114 KTFRMY-RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 114 ~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~l 191 (767)
+.|.+. +.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++++. ||||+++++++.+.+.+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 457777 899999999999999999999999999976543 2234567889999999995 6999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC---CCCEEEeecCcccccC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD---YGHVRISDLGLAVEIP 268 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~---~g~vkL~DFGla~~~~ 268 (767)
||||++||+|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||++. +|.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999999998886532 346999999999999999999999999999999999999998 8999999999999876
Q ss_pred CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...........+..+++.++
T Consensus 186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 3lm5_A 186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLAT 265 (327)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHH
Confidence 66555667899999999999999999999999999999999999999988766544444444333334444567899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGL 393 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~ 393 (767)
+||.+||+.||++||+ ++++++||||++++|+.+....
T Consensus 266 ~li~~~L~~dP~~Rpt-------~~~ll~h~~~~~~~~~~~~~~~ 303 (327)
T 3lm5_A 266 DFIQSLLVKNPEKRPT-------AEICLSHSWLQQWDFENLFHPE 303 (327)
T ss_dssp HHHHHHSCSSGGGSCC-------HHHHTTCGGGCCCCTTCC----
T ss_pred HHHHHHcCCChhhCcC-------HHHHhCCHhhcccccccccCcc
Confidence 9999999999999999 9999999999999998765533
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=401.26 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=218.9
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhh--hhhHHHHHHHHHHHHhcC---CCceeEEEEEEeeC
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMVLIEKQILQKIN---SRFVVSLAYAYETK 186 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~--~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~ 186 (767)
..++|++.+.||+|+||+||+|+++.+|+.||+|++....... ......+.+|+.+++++. ||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3478999999999999999999999999999999987543211 112335667777777664 99999999999876
Q ss_pred C-----eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeec
Q psy11874 187 D-----ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDL 261 (767)
Q Consensus 187 ~-----~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DF 261 (767)
. .+++||||+. |+|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 5 6899999998 59999988754 335999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc----
Q psy11874 262 GLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE---- 337 (767)
Q Consensus 262 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~---- 337 (767)
|+|............+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+.........
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 9998876666666778999999999999999999999999999999999999999887765554444433221111
Q ss_pred -------------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 338 -------------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 338 -------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.....+++++.+||.+||+.||++||+ ++|+++||||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS-------AFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC-------HHHHHTSTTC---
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC-------HHHHhcCccccCC
Confidence 122467899999999999999999999 9999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=407.19 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=213.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC------
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD------ 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~------ 187 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++.... .....+.+.+|+.+|++++|||||++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 57999999999999999999999999999999997543 2334567899999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEEeccCCCHHHHHHhcCCCCCCCH
Q psy11874 188 ---------------------------------------------------ALCLVLTIMNGGDLKFHIYNMGGEPGFDI 216 (767)
Q Consensus 188 ---------------------------------------------------~l~lV~E~~~gG~L~~~l~~~~~~~~l~~ 216 (767)
.+++|||||+||+|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999988765556777
Q ss_pred HHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-------------cccccccccccC
Q psy11874 217 ARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-------------SVRGRVGTVGYM 283 (767)
Q Consensus 217 ~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-------------~~~~~~GT~~Y~ 283 (767)
..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... .....+||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 8899999999999999999999999999999999999999999999998775542 123457999999
Q ss_pred CcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-ccccccCCCCcHHHHHHHHHhcccCcCcc
Q psy11874 284 APEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK-EDAEKYSCRFSDDAKALCKALLKKSPRSR 362 (767)
Q Consensus 284 APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~~~~~s~~~~dLi~~lL~~dP~~R 362 (767)
|||++.+..++.++|||||||++|||++|..|+..... ....+. ...+..+...++++++||.+||+.||++|
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR------IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH------HHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH------HHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 99999999999999999999999999999888633221 111111 11122223457889999999999999999
Q ss_pred CCCCCCcccHHHHHhCCCCCCC
Q psy11874 363 LGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 363 l~~~~~~~~a~eil~HpfF~~i 384 (767)
|+ ++|+++||||+++
T Consensus 318 ps-------~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 318 PE-------ATDIIENAIFENL 332 (332)
T ss_dssp CC-------HHHHHHSTTCCCC
T ss_pred CC-------HHHHhhchhhhcC
Confidence 99 9999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=415.59 Aligned_cols=275 Identities=25% Similarity=0.383 Sum_probs=215.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC-----
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----- 187 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 187 (767)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 478999999999999999999999999999999997543 23334566889999999999999999999998765
Q ss_pred -eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 188 -ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 188 -~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
.+|+||||++| +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 79999999985 68777752 489999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc----------
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA---------- 336 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~---------- 336 (767)
..........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+.+......
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 7655445567899999999999999999999999999999999999999988765444333322211100
Q ss_pred --------ccc--------------C------CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 337 --------EKY--------------S------CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 337 --------~~~--------------~------~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
..+ + ...++++++||++||+.||++||+ ++|+++||||+.. ..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t-------~~e~l~hp~~~~~--~~ 327 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS-------VDEALQHPYINVW--YD 327 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC-------HHHHHHSHHHHTT--CC
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC-------HHHHhCCcchhhh--cC
Confidence 000 0 012678999999999999999999 9999999999864 33
Q ss_pred HhcCCCCCCCCCCCC
Q psy11874 389 LEAGLCDPPFVPDVK 403 (767)
Q Consensus 389 l~~~~~~pp~~P~~~ 403 (767)
.......||.+|+..
T Consensus 328 ~~~~~~~~~~~~~~~ 342 (371)
T 2xrw_A 328 PSEAEAPPPKIPDKQ 342 (371)
T ss_dssp HHHHTCCCCCCCTTT
T ss_pred ccccCCCCCCCCChh
Confidence 333345677777643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=411.04 Aligned_cols=258 Identities=26% Similarity=0.360 Sum_probs=205.4
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.+.|++.+.||+|+||.||+|+++.+++.||+|++.+.. ..+.+.+|+.+|++++||||+++++++.+.+.+++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 367999999999999999999999999999999987542 234577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC---CCCEEEeecCcccccCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD---YGHVRISDLGLAVEIPE 269 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~---~g~vkL~DFGla~~~~~ 269 (767)
|||++||+|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.....
T Consensus 127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999887643 6899999999999999999999999999999999999975 89999999999987765
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh-hhhhhhhhhhccccccCCCCcHHHH
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV-KRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~-~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+...........+..++++++
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence 555566789999999999999999999999999999999999999997654322 1112211111112233457899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
+||.+||..||++||+ +.++++||||.+..
T Consensus 284 ~li~~~L~~dP~~Rpt-------~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLT-------TFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHTTSCSSGGGSCC-------HHHHHHSTTTTSTT
T ss_pred HHHHHHccCChhhCcC-------HHHHhcCcccCCCc
Confidence 9999999999999999 99999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=393.94 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=224.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.++.++..+|+|++.+... .....+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999976532 33567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe---CCCCCEEEeecCcccccCCC
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl---d~~g~vkL~DFGla~~~~~~ 270 (767)
||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred eccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999999888764 68999999999999999999999999999999999999 88899999999999887766
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
.......||+.|+|||++.+. ++.++|+|||||++|+|++|..||...........+..............+++++++|
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHH
Confidence 666777899999999998654 9999999999999999999999998876544333333322222222234689999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
|.+||+.||++||+ +.++++||||++
T Consensus 242 i~~~l~~dp~~R~s-------~~~~l~h~~~~~ 267 (277)
T 3f3z_A 242 IRRLLTKSPKQRIT-------SLQALEHEWFEK 267 (277)
T ss_dssp HHHHTCSSTTTSCC-------HHHHTTSHHHHH
T ss_pred HHHHccCChhhCcC-------HHHHhcCHHHhc
Confidence 99999999999999 999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=418.58 Aligned_cols=262 Identities=24% Similarity=0.415 Sum_probs=222.1
Q ss_pred CeEE--EeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 115 TFRM--YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 115 ~y~~--~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.|.+ .+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3444 6789999999999999999999999999976532 3345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe--CCCCCEEEeecCcccccCCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL--DDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl--d~~g~vkL~DFGla~~~~~~ 270 (767)
||||+||+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++......
T Consensus 165 ~E~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EECCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 99999999998887642 258999999999999999999999999999999999999 67789999999999988766
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+...........+..+++++++|
T Consensus 243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 322 (373)
T 2x4f_A 243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF 322 (373)
T ss_dssp CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence 66666789999999999999999999999999999999999999998876554444443322222233345789999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
|.+||+.||.+||+ ++|+++||||++..|..
T Consensus 323 i~~~L~~dp~~Rps-------~~e~l~hp~~~~~~~~~ 353 (373)
T 2x4f_A 323 ISKLLIKEKSWRIS-------ASEALKHPWLSDHKLHS 353 (373)
T ss_dssp HHTTSCSSGGGSCC-------HHHHHHSHHHHCHHHHH
T ss_pred HHHHcCCChhhCCC-------HHHHhcCcCcCCCchhh
Confidence 99999999999999 99999999999987654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=392.15 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=203.9
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46899999999999999999999999999999999877655555567789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
|||+++|+|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 99999999999988642 368999999999999999999999999999999999999999999999999998765332
Q ss_pred cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
......||+.|+|||++.+..++.++|+|||||++|+|++|..||........ ...+.......+..+++++++||
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li 243 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----LNKVVLADYEMPSFLSIEAKDLI 243 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCCCTTSCHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----HHHHhhcccCCccccCHHHHHHH
Confidence 23456799999999999999999999999999999999999999976543222 22222233445677899999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.+||+.||++||+ ++++++||||.+.
T Consensus 244 ~~~l~~dp~~Rps-------~~~~l~h~~~~~~ 269 (278)
T 3cok_A 244 HQLLRRNPADRLS-------LSSVLDHPFMSRN 269 (278)
T ss_dssp HHHSCSSGGGSCC-------HHHHTTSTTTC--
T ss_pred HHHcccCHhhCCC-------HHHHhcCccccCC
Confidence 9999999999999 9999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=394.05 Aligned_cols=268 Identities=28% Similarity=0.416 Sum_probs=226.8
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh------hhhhHHHHHHHHHHHHhcC-CCceeEEEEEEee
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGESMVLIEKQILQKIN-SRFVVSLAYAYET 185 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~------~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~ 185 (767)
.++|++.+.||+|+||.||+|.++.+|+.||+|++...... .......+.+|+.+|+++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 47899999999999999999999999999999998754311 1223456789999999995 9999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
.+..++||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 999999999999999999998754 68999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCcceec------CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 266 EIPEGESVRGRVGTVGYMAPEVID------NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 266 ~~~~~~~~~~~~GT~~Y~APEvl~------~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
............||+.|+|||++. ...++.++|+|||||++|+|++|..||...+.......+...........
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc
Confidence 877666666778999999999985 45689999999999999999999999987655433333322222222222
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHh
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLE 390 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~ 390 (767)
+..+++++.+||.+||+.||++||+ ++++++||||++..|+.+.
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps-------~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 253 WDDYSDTVKDLVSRFLVVQPQKRYT-------AEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCC-------HHHHTTSGGGCTTC-----
T ss_pred ccccCHHHHHHHHHHccCCcccCCC-------HHHHHhChHhhhccchhhc
Confidence 3468999999999999999999999 9999999999999887654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=401.22 Aligned_cols=257 Identities=28% Similarity=0.483 Sum_probs=213.3
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh-----------------------hhHHHHHHHHHH
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----------------------KGESMVLIEKQI 167 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~-----------------------~~~~~~~~E~~i 167 (767)
+..++|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 456899999999999999999999999999999999976543221 123568899999
Q ss_pred HHhcCCCceeEEEEEEee--CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCc
Q psy11874 168 LQKINSRFVVSLAYAYET--KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKP 245 (767)
Q Consensus 168 L~~l~hp~Iv~l~~~~~~--~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKP 245 (767)
|++++||||+++++++.+ .+.+|+||||++||+|..++. ...+++..+..++.||+.||.|||++||+||||||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 999999999999999987 678999999999999976543 23699999999999999999999999999999999
Q ss_pred ceEEeCCCCCEEEeecCcccccCCCCc-ccccccccccCCcceecCCC---CCCCCccccchhhHHHHhcCCCCCCCchh
Q psy11874 246 ENILLDDYGHVRISDLGLAVEIPEGES-VRGRVGTVGYMAPEVIDNEK---YTYSPDWFSFGCLIFEMIEGQAPFRRRKE 321 (767)
Q Consensus 246 eNILld~~g~vkL~DFGla~~~~~~~~-~~~~~GT~~Y~APEvl~~~~---ys~~~DvwSlGviLyElltG~~PF~~~~~ 321 (767)
+|||++.+|.+||+|||+|........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999999987654432 34568999999999997765 37789999999999999999999987654
Q ss_pred hhhhhhhhhhhhcccccc--CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 322 MVKRDEVDRRVKEDAEKY--SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 322 ~~~~~~i~~~i~~~~~~~--~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
..... .+......+ ...+++++++||.+||+.||++||+ ++|+++||||+
T Consensus 246 ~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s-------~~e~l~hp~~~ 297 (298)
T 2zv2_A 246 MCLHS----KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIV-------VPEIKLHPWVT 297 (298)
T ss_dssp HHHHH----HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC-------HHHHTTCHHHH
T ss_pred HHHHH----HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCC-------HHHHhcCcccc
Confidence 33222 222222222 3468999999999999999999999 99999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=419.40 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=208.6
Q ss_pred CCCeEEE-eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHH-hcCCCceeEEEEEEee----C
Q psy11874 113 YKTFRMY-RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVSLAYAYET----K 186 (767)
Q Consensus 113 ~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~----~ 186 (767)
.++|.+. ++||+|+||+||+|.++.+|+.||+|++... ..+.+|+.++. ..+||||++++++|.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4678887 7999999999999999999999999998532 23567888874 4589999999999876 6
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC---CCCEEEeecCc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD---YGHVRISDLGL 263 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~---~g~vkL~DFGl 263 (767)
+.+|+|||||+||+|.+++...+ ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred cEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 78999999999999999998653 346999999999999999999999999999999999999997 78999999999
Q ss_pred ccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc----
Q psy11874 264 AVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY---- 339 (767)
Q Consensus 264 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~---- 339 (767)
|+...........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.......+...+......+
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 9887665556678899999999999999999999999999999999999999987654332222233333322222
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+..+|+++++||++||+.||++||+ ++++++||||.+
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt-------~~eil~hp~~~~ 327 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMT-------ITEFMNHPWIMQ 327 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCC-------HHHHHHSHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcC-------HHHHhcCccccC
Confidence 3568999999999999999999999 999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=428.59 Aligned_cols=260 Identities=29% Similarity=0.445 Sum_probs=224.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||+||+|.++.+|+.||+|++.+.... ......+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999999775432 334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC---CCCCEEEeecCcccccCCC
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD---DYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld---~~g~vkL~DFGla~~~~~~ 270 (767)
|||+||+|.+.+...+ .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|......
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999999888764 699999999999999999999999999999999999995 5567999999999887766
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+.......+...........+..+|+++++|
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 66667789999999999976 59999999999999999999999998876544444443332222333445789999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
|.+||+.||++||+ +.++++||||+...
T Consensus 257 i~~~L~~dp~~R~t-------~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 257 IRKMLTFHPSLRIT-------ATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHTCSSTTTSCC-------HHHHHHCHHHHHTC
T ss_pred HHHHcCCChhhCcC-------HHHHhcCHhhccCc
Confidence 99999999999999 99999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=407.03 Aligned_cols=259 Identities=25% Similarity=0.370 Sum_probs=216.6
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||+||+|+++.+|+.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999998755332 2234578899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
|||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999998886543 69999999999999999999999999999999999999999999999999998653322
Q ss_pred --cccccccccccCCcceecCCCC-CCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 272 --SVRGRVGTVGYMAPEVIDNEKY-TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 272 --~~~~~~GT~~Y~APEvl~~~~y-s~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||............... .......+..+++++.
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAPL 239 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT-TCTTSTTGGGSCHHHH
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-ccccCCccccCCHHHH
Confidence 2345689999999999987765 77899999999999999999999765542211111111 1111122356899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+||.+||..||++||+ ++|+++||||+..
T Consensus 240 ~li~~~L~~dP~~R~t-------~~eil~h~~~~~~ 268 (323)
T 3tki_A 240 ALLHKILVENPSARIT-------IPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHSCSSTTTSCC-------HHHHTTCTTTTCC
T ss_pred HHHHHHccCChhhCcC-------HHHHhhChhhccc
Confidence 9999999999999999 9999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=409.70 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=225.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh-----hhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----KGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~-----~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+...... .....+.+|+.+|++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 579999999999999999999999999999999987643222 133456779999999999999999999999999
Q ss_pred EEEEEEeccCC-CHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 189 LCLVLTIMNGG-DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 189 l~lV~E~~~gG-~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
+++||||+.+| +|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999777 9999887653 6999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCcccccccccccCCcceecCCCC-CCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDNEKY-TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~~~y-s~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .......+..+|++
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------VEAAIHPPYLVSKE 250 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------TTTCCCCSSCCCHH
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------HhhccCCCcccCHH
Confidence 77666667789999999999988876 78999999999999999999999764321 11223345568999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC------CChhhHhcC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS------TNWKRLEAG 392 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~------i~w~~l~~~ 392 (767)
+++||.+||+.||++||+ ++++++||||++ .+|+.+...
T Consensus 251 l~~li~~~L~~dP~~Rps-------~~ell~hp~~~~~~~~~~~~~~~~~~~ 295 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTT-------LEKLVTDPWVTQPVNLADYTWEEVFRV 295 (335)
T ss_dssp HHHHHHHHTCSSGGGSCC-------HHHHHHCTTTTCCCCGGGCCHHHHC--
T ss_pred HHHHHHHHccCChhhCcC-------HHHHhcCccccCCccccccCHHHHhhh
Confidence 999999999999999999 999999999975 567766553
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=396.78 Aligned_cols=266 Identities=26% Similarity=0.440 Sum_probs=225.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh---hhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++.+...... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999976544322 13567889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC----CEEEeecCcccc
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG----HVRISDLGLAVE 266 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g----~vkL~DFGla~~ 266 (767)
+||||++|++|..++.+.. .+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999998754 689999999999999999999999999999999999999877 899999999988
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
...........||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+...........+...++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 76655556678999999999999999999999999999999999999999887654433333322222223344678999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhH
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l 389 (767)
+++||.+||..||++||+ ++++++||||+.+.|...
T Consensus 242 ~~~li~~~l~~dp~~Rps-------~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMT-------IAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp HHHHHHTTSCSSGGGSCC-------HHHHHHCHHHHHHHHCCC
T ss_pred HHHHHHHHccCCHhHCcC-------HHHHHhCHHHHHHHHHhh
Confidence 999999999999999999 999999999998766543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=390.44 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=221.7
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.++++++||||+++++++.+.+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 35568999999999999999999999999999999999877655556667889999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999998764 589999999999999999999999999999999999999999999999999988766
Q ss_pred CCcccccccccccCCcceecCCCC-CCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKY-TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~y-s~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
........||+.|+|||++.+..+ +.++|+|||||++|+|++|..||...... .+...+.......+..+++++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~ 239 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP----TLFKKIRGGVFYIPEYLNRSVA 239 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCTTSCHHHH
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHhhcCcccCchhcCHHHH
Confidence 555566789999999999987765 68999999999999999999999776443 2333344444556778899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
++|.+||+.||++||+ ++++++||||++
T Consensus 240 ~li~~~l~~~p~~Rps-------~~~~l~h~~~~~ 267 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRAT-------IKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHHTCSSGGGSCC-------HHHHHHSHHHHT
T ss_pred HHHHHHccCChhhCCC-------HHHHHhChhhcc
Confidence 9999999999999999 999999999976
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=406.75 Aligned_cols=262 Identities=23% Similarity=0.376 Sum_probs=213.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++..... ......+.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 689999999999999999999999999999999865432 111223457999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-c
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-S 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~ 272 (767)
||++ |+|..++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....... .
T Consensus 80 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp ECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 9998 58888887753 368999999999999999999999999999999999999999999999999998654332 2
Q ss_pred ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc--------------
Q psy11874 273 VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE-------------- 337 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~-------------- 337 (767)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.+.......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 345679999999999876 67899999999999999999999999887665444444332221111
Q ss_pred ------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 338 ------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 338 ------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
.....+++++++||.+||+.||++||+ ++|+++||||.++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS-------AEDAMKHPFFLSLGER 291 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC-------HHHHTTSGGGGGGCST
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC-------HHHHhcChhhhhcccc
Confidence 122357899999999999999999999 9999999999987643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=409.21 Aligned_cols=267 Identities=23% Similarity=0.325 Sum_probs=220.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh--hhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
++|++.+.||+|+||.||+|.++.+++.||+|++.+.... .......+.+|+.+|++++||||+++++++.+.+..|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5799999999999999999999999999999999876543 23455678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcC-------------------------------------CCCCCCHHHHHHHHHHHHhHHHHHH
Q psy11874 192 VLTIMNGGDLKFHIYNMG-------------------------------------GEPGFDIARARFYAAEVLCGLEHLH 234 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~-------------------------------------~~~~l~~~~~~~~~~qIl~aL~yLH 234 (767)
|||||+||+|.+++.... ....+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 999999999998885210 0112467888999999999999999
Q ss_pred HCCcccccCCcceEEeCCCC--CEEEeecCcccccCCCC-----cccccccccccCCcceecC--CCCCCCCccccchhh
Q psy11874 235 YIGLVYRDCKPENILLDDYG--HVRISDLGLAVEIPEGE-----SVRGRVGTVGYMAPEVIDN--EKYTYSPDWFSFGCL 305 (767)
Q Consensus 235 ~~~IvHrDLKPeNILld~~g--~vkL~DFGla~~~~~~~-----~~~~~~GT~~Y~APEvl~~--~~ys~~~DvwSlGvi 305 (767)
++||+||||||+|||++.++ .+||+|||+|....... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99999999999999998777 89999999998653321 1345679999999999965 678999999999999
Q ss_pred HHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 306 IFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 306 LyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
+|||++|..||.+.........+..............+++++++||.+||+.||.+||+ +.++++||||++..
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-------~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD-------AMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC-------HHHHHHSHHHHTTS
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCC-------HHHHhcChhhccCh
Confidence 99999999999887655444444333222222333458999999999999999999999 99999999999876
Q ss_pred hh
Q psy11874 386 WK 387 (767)
Q Consensus 386 w~ 387 (767)
|.
T Consensus 339 ~~ 340 (345)
T 3hko_A 339 DK 340 (345)
T ss_dssp SC
T ss_pred Hh
Confidence 53
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=428.19 Aligned_cols=261 Identities=29% Similarity=0.409 Sum_probs=223.8
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh----------hhHHHHHHHHHHHHhcCCCceeEEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR----------KGESMVLIEKQILQKINSRFVVSLAYA 182 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~----------~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 182 (767)
.++|++.+.||+|+||+||+|.++.+++.||+|++.+...... .....+.+|+.+|++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3689999999999999999999999999999999987654321 345678899999999999999999999
Q ss_pred EeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC---CEEEe
Q psy11874 183 YETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG---HVRIS 259 (767)
Q Consensus 183 ~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g---~vkL~ 259 (767)
+.+.+.+|+|||||+||+|..++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999998764 699999999999999999999999999999999999999876 69999
Q ss_pred ecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 260 DLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 260 DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
|||+|............+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+.......+...........
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 999999887766667788999999999986 4699999999999999999999999988765444444333222222233
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+..+|+++++||++||+.||.+||+ ++|+++||||+..
T Consensus 271 ~~~~s~~~~~li~~~L~~dp~~R~t-------~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 271 WKNISDEAKELIKLMLTYDYNKRCT-------AEEALNSRWIKKY 308 (504)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCC-------HHHHHTSHHHHHT
T ss_pred cCCCCHHHHHHHHHHcCCChhHCCC-------HHHHhcCHhhhhc
Confidence 4678999999999999999999999 9999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=399.14 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=210.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV 192 (767)
++|++.+.||+|+||+||+|+++.+|+.||+|++....... ........|...+.++ +||||+++++++.+.+.+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999986543222 2333455566665555 999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~ 272 (767)
|||+ +|+|..++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 9999 679988888764 3699999999999999999999999999999999999999999999999999988766555
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||.+... ...+.... ....++..+++++.+||.
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGY--LPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTC--CCHHHHTTSCHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccC--CCcccccCCCHHHHHHHH
Confidence 566779999999999876 799999999999999999999777655432 12222211 123445678999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+||+.||++||+ ++|+++||||++
T Consensus 287 ~~L~~dP~~Rpt-------~~ell~hp~~~~ 310 (311)
T 3p1a_A 287 MMLEPDPKLRAT-------AEALLALPVLRQ 310 (311)
T ss_dssp HHSCSSTTTSCC-------HHHHHTSGGGSC
T ss_pred HHcCCChhhCcC-------HHHHHhCccccC
Confidence 999999999999 999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=420.74 Aligned_cols=267 Identities=27% Similarity=0.417 Sum_probs=214.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhh-----hhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~-----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
.++|++.+.||+|+||+||+|.++.+++.||+|++.+..... ......+.+|+.+|++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 368999999999999999999999999999999998765432 1222347889999999999999999998864 5
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC---CEEEeecCcc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG---HVRISDLGLA 264 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g---~vkL~DFGla 264 (767)
..|+|||||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 6899999999999988876543 699999999999999999999999999999999999997544 5999999999
Q ss_pred cccCCCCcccccccccccCCcceecC---CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhh-hhhhhhhhccccccC
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDN---EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKR-DEVDRRVKEDAEKYS 340 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~---~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~-~~i~~~i~~~~~~~~ 340 (767)
+...........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||......... ..+...........+
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 98766655667789999999999853 67888999999999999999999999765432222 222222222223344
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHh
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLE 390 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~ 390 (767)
..+++++++||.+||+.||++||+ ++|+++||||++.+|.+..
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps-------~~e~l~hp~~~~~~~~~~~ 412 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFT-------TEEALRHPWLQDEDMKRKF 412 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCC-------HHHHHHSGGGCCHHHHHHH
T ss_pred cccCHHHHHHHHHHccCChhHCcC-------HHHHhCCcccCChhHHHHH
Confidence 578999999999999999999999 9999999999998887654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=424.96 Aligned_cols=262 Identities=27% Similarity=0.420 Sum_probs=223.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.|++.+.||+|+||+||+|+++.+|..||+|++.+..... .....+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999998765433 23566889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC---CCCEEEeecCcccccCCC
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD---YGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~---~g~vkL~DFGla~~~~~~ 270 (767)
|||+||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|......
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999999888764 6999999999999999999999999999999999999976 455999999999887766
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.........+...........+..+|+++++|
T Consensus 193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 6667788999999999986 569999999999999999999999998876654444443333333333446789999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
|++||+.||.+||+ ++++++||||+...+.
T Consensus 272 i~~~L~~dp~~R~s-------~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 272 IKQMLQFDSQRRIS-------AQQALEHPWIKEMCSK 301 (494)
T ss_dssp HHHHTCSSTTTSCC-------HHHHHTCHHHHHHHHH
T ss_pred HHHHCCCChhhCcc-------HHHHhcCcccccCccc
Confidence 99999999999999 9999999999876443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=399.07 Aligned_cols=262 Identities=28% Similarity=0.426 Sum_probs=211.9
Q ss_pred CCeEEE-eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHh-cCCCceeEEEEEEeeCCeEEE
Q psy11874 114 KTFRMY-RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 114 ~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~l~l 191 (767)
+.|++. +.||+|+||.||+|.+..+|+.||+|++.+.. ......+.+|+.+|.+ .+||||+++++++.+.+.+|+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 578885 78999999999999999999999999997542 2345678899999998 479999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC---EEEeecCcccccC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH---VRISDLGLAVEIP 268 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~---vkL~DFGla~~~~ 268 (767)
||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999999998764 6899999999999999999999999999999999999998776 9999999997654
Q ss_pred CCC--------cccccccccccCCcceecC-----CCCCCCCccccchhhHHHHhcCCCCCCCchhhh-----------h
Q psy11874 269 EGE--------SVRGRVGTVGYMAPEVIDN-----EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV-----------K 324 (767)
Q Consensus 269 ~~~--------~~~~~~GT~~Y~APEvl~~-----~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~-----------~ 324 (767)
... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+..... .
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 221 1234569999999999975 568999999999999999999999997654211 0
Q ss_pred hhhhhhhhhccccccC----CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 325 RDEVDRRVKEDAEKYS----CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 325 ~~~i~~~i~~~~~~~~----~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
...+...+......++ ..+++++++||.+||+.||++||+ ++|+++||||++..|+.
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-------~~e~l~hp~~~~~~~~~ 306 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS-------AAQVLQHPWVQGCAPEN 306 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC-------HHHHHHSTTCC------
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC-------HHHHhcChhhcCCCCcc
Confidence 1222333333333332 468999999999999999999999 99999999999876643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=408.90 Aligned_cols=262 Identities=27% Similarity=0.380 Sum_probs=214.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC------C
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------D 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------~ 187 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++.... ........+.+|+.+|++++||||+++++++... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 68999999999999999999999999999999986543 2333456788999999999999999999999876 3
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+||||+ |++|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 569999999 88999988763 5899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc-----------
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED----------- 335 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~----------- 335 (767)
.. .....+||+.|+|||++.+ ..|+.++||||+||++|||++|++||.+.+.......+.+.....
T Consensus 179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 179 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 43 2456789999999999977 789999999999999999999999998876554443333221111
Q ss_pred ----------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHh
Q psy11874 336 ----------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLE 390 (767)
Q Consensus 336 ----------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~ 390 (767)
........++++.+||.+||..||++||+ ++++++||||+++.+...+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t-------~~e~l~hp~f~~~~~~~~~ 320 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT-------AGEALAHPYFESLHDTEDE 320 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC-------HHHHHHSGGGTTTC-----
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC-------HHHHhcChHHHhhcCCccC
Confidence 11223467999999999999999999999 9999999999998765443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=406.75 Aligned_cols=264 Identities=25% Similarity=0.301 Sum_probs=219.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee-------
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------- 185 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------- 185 (767)
.++|++.+.||+|+||.||+|+++.+|+.||+|++..... .......+.+|+.+|++++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4789999999999999999999999999999999866543 22334567889999999999999999999987
Q ss_pred -CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 186 -KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 186 -~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
.+.+|+||||++| +|...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4579999999985 7777776543 36999999999999999999999999999999999999999999999999999
Q ss_pred cccCCC-----CcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc
Q psy11874 265 VEIPEG-----ESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK 338 (767)
Q Consensus 265 ~~~~~~-----~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~ 338 (767)
...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+.+........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 876422 22345679999999999876 558999999999999999999999998876655444444332222222
Q ss_pred cCCC----------------------------CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 339 YSCR----------------------------FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 339 ~~~~----------------------------~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
.+.. .++++++||.+||+.||++||+ ++|+++||||++..+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID-------SDDALNHDFFWSDPMP 321 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC-------HHHHHTSGGGGSSSCC
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC-------HHHHhCCCCcCCCCCc
Confidence 2111 2788999999999999999999 9999999999886543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=397.52 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=220.4
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
.|+..+.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|+.+|++++||||+++++++...+.+++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888899999999999999999999999999986543 2345668899999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-cc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SV 273 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~ 273 (767)
|++||+|.+++.+. .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....... ..
T Consensus 123 ~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (321)
T 2c30_A 123 FLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198 (321)
T ss_dssp CCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred cCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc
Confidence 99999999988643 59999999999999999999999999999999999999999999999999998765443 23
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~ 353 (767)
...+||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+... .......+..+++++++||.+
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 277 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKNSHKVSPVLRDFLER 277 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCTTGGGSCHHHHHHHHH
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCcCccccCCHHHHHHHHH
Confidence 4568999999999999999999999999999999999999999876543333222211 111112234689999999999
Q ss_pred hcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 354 lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
||+.||++||+ ++++++||||....
T Consensus 278 ~l~~dp~~Rps-------~~ell~hp~~~~~~ 302 (321)
T 2c30_A 278 MLVRDPQERAT-------AQELLDHPFLLQTG 302 (321)
T ss_dssp HSCSSTTTSCC-------HHHHHTSGGGGGCC
T ss_pred HccCChhhCcC-------HHHHhcChhhccCC
Confidence 99999999999 99999999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=405.08 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=222.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh-----hhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCC
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 187 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... .......+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999999999999998654311 112245678899999999 8999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
..|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999999999998754 6999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCcccccccccccCCcceecC------CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDN------EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~------~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~ 341 (767)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...........+.
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 330 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 77666677889999999999853 368899999999999999999999998765443333332222222222235
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
..++++.+||.+||+.||++||+ ++++++||||+
T Consensus 331 ~~~~~~~~li~~~L~~dP~~Rps-------~~ell~hp~f~ 364 (365)
T 2y7j_A 331 DRSSTVKDLISRLLQVDPEARLT-------AEQALQHPFFE 364 (365)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCC-------HHHHHHSGGGC
T ss_pred cCCHHHHHHHHHHcCCChhHCcC-------HHHHhcCcccC
Confidence 78899999999999999999999 99999999996
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=412.42 Aligned_cols=262 Identities=26% Similarity=0.339 Sum_probs=215.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC-----
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----- 187 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 187 (767)
..+|++.++||+|+||.||+|++..+++ +|+|++.+.... ..+|+.+|+.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 3579999999999999999999987766 888877543211 236999999999999999999986543
Q ss_pred -eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC-CCCCEEEeecCccc
Q psy11874 188 -ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD-DYGHVRISDLGLAV 265 (767)
Q Consensus 188 -~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld-~~g~vkL~DFGla~ 265 (767)
.+|+||||++++.+............+++..++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||+|+
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 3899999999765544333222234799999999999999999999999999999999999999 79999999999999
Q ss_pred ccCCCCcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc---------
Q psy11874 266 EIPEGESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED--------- 335 (767)
Q Consensus 266 ~~~~~~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~--------- 335 (767)
....+......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+......++.+.....
T Consensus 191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 87666666678899999999998764 59999999999999999999999998876554444443321110
Q ss_pred ----------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhH
Q psy11874 336 ----------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389 (767)
Q Consensus 336 ----------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l 389 (767)
...++...++++++||.+||+.||++||+ +.|+++||||+++.|...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT-------AIEALCHPFFDELRTGEA 333 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC-------HHHHHTSGGGSTTTSSCC
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC-------HHHHhcChhhhhhccccc
Confidence 01133458899999999999999999999 999999999999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=390.49 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=213.1
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.++.+|+.+|+|++.+.. .......+.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 67999999999999999999999999999999997654 2334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe---CCCCCEEEeecCcccccCC
Q psy11874 194 TIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl---d~~g~vkL~DFGla~~~~~ 269 (767)
||++||+|.+.+.... ....+++..+..++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 9999999999886531 12469999999999999999999999999999999999999 5568899999999987766
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
........||+.|+|||++. ..++.++|+|||||++|+|++|..||.+.............. .........+++++.+
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 257 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE-PNYAVECRPLTPQAVD 257 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCC--CCCCHHHHH
T ss_pred cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC-cccccccCcCCHHHHH
Confidence 55556678999999999985 568999999999999999999999998765432222211111 0111112347899999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
||.+||+.||++||+ ++|+++||||++
T Consensus 258 li~~~L~~dP~~Rps-------~~e~l~hp~f~~ 284 (285)
T 3is5_A 258 LLKQMLTKDPERRPS-------AAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHTCSCTTTSCC-------HHHHHTSGGGGC
T ss_pred HHHHHccCChhhCcC-------HHHHhcCHHhhc
Confidence 999999999999999 999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=398.04 Aligned_cols=260 Identities=21% Similarity=0.320 Sum_probs=219.9
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC--e
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD--A 188 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~ 188 (767)
+..++|++.+.||+|+||+||+|+++.+|+.||+|++..... ......+.+|+.+|++++||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 345689999999999999999999999999999999976543 233566789999999999999999999998765 8
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe----CCCCCEEEeecCcc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL----DDYGHVRISDLGLA 264 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl----d~~g~vkL~DFGla 264 (767)
+|+||||++||+|..++........+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 89999999999999999876544459999999999999999999999999999999999999 88888999999999
Q ss_pred cccCCCCcccccccccccCCcceec--------CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVID--------NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA 336 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~--------~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~ 336 (767)
+............||+.|+|||++. +..++.++|||||||++|||++|..||..........++...+....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 9887766666778999999999986 57899999999999999999999999975443333333333332221
Q ss_pred c-------------------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCC
Q psy11874 337 E-------------------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAE 379 (767)
Q Consensus 337 ~-------------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~Hp 379 (767)
+ .++..+++.+.+||.+||+.||++||+ ++|+++||
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s-------~~ell~h~ 304 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG-------FDQFFAET 304 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC-------HHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc-------HHHhhhcc
Confidence 1 112234678999999999999999999 99999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=401.60 Aligned_cols=274 Identities=20% Similarity=0.326 Sum_probs=227.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC-----Ce
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----DA 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~ 188 (767)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+|++++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 58999999999999999999999999999999987532 233446788999999999999999999999765 47
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+||||++ |+|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999999998 5898888763 59999999999999999999999999999999999999999999999999998764
Q ss_pred CCCc----ccccccccccCCcceec-CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc--------
Q psy11874 269 EGES----VRGRVGTVGYMAPEVID-NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED-------- 335 (767)
Q Consensus 269 ~~~~----~~~~~GT~~Y~APEvl~-~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~-------- 335 (767)
.... ....+||+.|+|||++. +..++.++|||||||++|+|++|++||.+.+.......+.......
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 3322 24458999999999875 4558999999999999999999999998876554444333211111
Q ss_pred -------------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCC
Q psy11874 336 -------------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDP 396 (767)
Q Consensus 336 -------------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~p 396 (767)
.......+++++.+||.+||+.||++||+ ++|+++||||++. |.........+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~e~l~hp~~~~~-~~~~~~~~~~~ 331 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE-------VEQALAHPYLEQY-YDPSDEPIAEA 331 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC-------HHHHHTSGGGTTT-CCGGGSCCCSS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC-------HHHHhcCcchhhc-cCcccccCCCC
Confidence 01123567899999999999999999999 9999999999987 45445555667
Q ss_pred CCCCCC
Q psy11874 397 PFVPDV 402 (767)
Q Consensus 397 p~~P~~ 402 (767)
||.++.
T Consensus 332 ~~~~~~ 337 (364)
T 3qyz_A 332 PFKFDM 337 (364)
T ss_dssp CCCCC-
T ss_pred cCCccc
Confidence 776654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=404.07 Aligned_cols=254 Identities=26% Similarity=0.471 Sum_probs=196.8
Q ss_pred CeEEE---eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeEE
Q psy11874 115 TFRMY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALC 190 (767)
Q Consensus 115 ~y~~~---~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~ 190 (767)
+|++. +.||+|+||.||+|.++.+|+.||+|++.+. ......+|+.+++.+. ||||+++++++.+.+..|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 45554 7899999999999999999999999998653 2345678999999997 999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC---CEEEeecCccccc
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG---HVRISDLGLAVEI 267 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g---~vkL~DFGla~~~ 267 (767)
+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 83 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEECCCCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999998754 699999999999999999999999999999999999998766 8999999999866
Q ss_pred CCCC-cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh---hhhhhhhhhhccccccC---
Q psy11874 268 PEGE-SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV---KRDEVDRRVKEDAEKYS--- 340 (767)
Q Consensus 268 ~~~~-~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~---~~~~i~~~i~~~~~~~~--- 340 (767)
.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+... ...++...+......++
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 5432 3456789999999999999999999999999999999999999997654321 11233333433332222
Q ss_pred -CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 341 -CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 341 -~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
..+|+++++||.+||+.||++||+ ++++++||||++.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt-------~~ell~h~w~~~~ 277 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLK-------MSGLRYNEWLQDG 277 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCC-------TTTSTTCGGGCTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCC-------HHHHhcChhhccC
Confidence 468999999999999999999999 8899999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=390.72 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=230.1
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.++++++||||+++++++.+.+.++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34578999999999999999999999999999999998766555556677889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||++|++|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999999887754 6899999999999999999999999999999999999999999999999999876533
Q ss_pred -CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 271 -ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 271 -~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
.......||+.|+|||++.+..++.++|+|||||++|+|++|..||........ ...+.......+..+++.+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 244 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKNEYSIPKHINPVAAS 244 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCCTTSCHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhhccCCCccccCHHHHH
Confidence 234456799999999999999999999999999999999999999987654332 223334445567789999999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+|.+||+.||++||+ ++++++||||.+.
T Consensus 245 li~~~l~~~p~~Rps-------~~~ll~~~~~~~~ 272 (294)
T 2rku_A 245 LIQKMLQTDPTARPT-------INELLNDEFFTSG 272 (294)
T ss_dssp HHHHHTCSSGGGSCC-------GGGGGGSHHHHTS
T ss_pred HHHHHcccChhhCcC-------HHHHhhChheecC
Confidence 999999999999999 8999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=401.64 Aligned_cols=256 Identities=29% Similarity=0.417 Sum_probs=215.3
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-----CCceeEEEEEEeeC
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-----SRFVVSLAYAYETK 186 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----hp~Iv~l~~~~~~~ 186 (767)
..++|++.+.||+|+||.||+|++..+|+.||+|++... .........|..+++.+. ||||+++++++...
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 347899999999999999999999999999999998642 223445677999999986 99999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC--------------
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-------------- 252 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-------------- 252 (767)
+.+|+||||+ ||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 9999999999 899999998754 345999999999999999999999999999999999999975
Q ss_pred -----------CCCEEEeecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchh
Q psy11874 253 -----------YGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKE 321 (767)
Q Consensus 253 -----------~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~ 321 (767)
++.+||+|||+|...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 889999999999865432 3456899999999999999999999999999999999999999987655
Q ss_pred hhhhhhhhhhhhccc------------------------------------------cccCCCCcHHHHHHHHHhcccCc
Q psy11874 322 MVKRDEVDRRVKEDA------------------------------------------EKYSCRFSDDAKALCKALLKKSP 359 (767)
Q Consensus 322 ~~~~~~i~~~i~~~~------------------------------------------~~~~~~~s~~~~dLi~~lL~~dP 359 (767)
......+.......+ ..+....++.+.+||.+||+.||
T Consensus 265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 433332222111000 00011234788899999999999
Q ss_pred CccCCCCCCcccHHHHHhCCCCC
Q psy11874 360 RSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 360 ~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
++||+ ++|+++||||+
T Consensus 345 ~~Rpt-------a~elL~hp~f~ 360 (360)
T 3llt_A 345 TLRPS-------PAELLKHKFLE 360 (360)
T ss_dssp GGSCC-------HHHHTTSGGGC
T ss_pred hhCCC-------HHHHhcCcccC
Confidence 99999 99999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=413.95 Aligned_cols=260 Identities=26% Similarity=0.394 Sum_probs=214.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee------CC
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------KD 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~~ 187 (767)
.+|++.++||+|+||.||+|+++.+|+.||+|++.+... ...+|+++|++++|||||+++++|.. ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 479999999999999999999999999999999865421 13369999999999999999998854 22
Q ss_pred eEEEEEEeccCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC-CCEEEeecCccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNM-GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY-GHVRISDLGLAV 265 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~-~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~-g~vkL~DFGla~ 265 (767)
.+++||||+++ +|...+... .....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 47899999986 555555431 123479999999999999999999999999999999999999965 568999999999
Q ss_pred ccCCCCcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc---------
Q psy11874 266 EIPEGESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED--------- 335 (767)
Q Consensus 266 ~~~~~~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~--------- 335 (767)
....+......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+......++.+.....
T Consensus 206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 87666656677899999999999764 79999999999999999999999998876554444443321110
Q ss_pred ----------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 336 ----------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 336 ----------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
...++..+++++++||.+||..||.+||+ +.|+++||||+++.+..
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t-------~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT-------PLEACAHSFFDELRDPN 347 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC-------HHHHHTSGGGGGGGCTT
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC-------HHHHhCCHhhccccccc
Confidence 00123467899999999999999999999 99999999999876654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=402.29 Aligned_cols=266 Identities=24% Similarity=0.342 Sum_probs=216.8
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh--hhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
.++|++.+.||+|+||.||+|.++.+|+.||+|++........ .....+.+|+.++++++||||+++++++.+.+.++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 4689999999999999999999999999999999976433221 12346788999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||++| +|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 89 lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 99999986 8888876543 36889999999999999999999999999999999999999999999999999876433
Q ss_pred -CcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc-----------
Q psy11874 271 -ESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE----------- 337 (767)
Q Consensus 271 -~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~----------- 337 (767)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+.........
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 23455689999999999965 45899999999999999999999999887665444444332221111
Q ss_pred -------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 338 -------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 338 -------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
......++++++||.+||..||++||+ ++|+++||||++..|..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT-------ATQALKMKYFSNRPGPT 302 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC-------HHHHHTSGGGTSSSCCC
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC-------HHHHhcChhhhcCCCCC
Confidence 112456799999999999999999999 99999999999876654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=394.90 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=215.0
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEee--CCeE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYET--KDAL 189 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~--~~~l 189 (767)
.++|++.+.||+|+||.||+|++..+|+.||+|++... ....+.+|+.+|++++ ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 47899999999999999999999999999999998643 2355788999999997 9999999999988 6789
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-CEEEeecCcccccC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-HVRISDLGLAVEIP 268 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-~vkL~DFGla~~~~ 268 (767)
++||||++|++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|....
T Consensus 109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999988774 378999999999999999999999999999999999999777 89999999998877
Q ss_pred CCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhh-hhhhhhhhh---------hhccc-
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-VKRDEVDRR---------VKEDA- 336 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~-~~~~~i~~~---------i~~~~- 336 (767)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+... +....
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 6666667789999999999977 67999999999999999999999999543221 111111110 00000
Q ss_pred -----------------------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 337 -----------------------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 337 -----------------------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
...+..+++++++||.+||+.||++||+ ++|+++||||+++.|+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT-------AREAMEHPYFYTVVKD 329 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC-------HHHHHTSGGGTTCC--
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC-------HHHHhcCccHhhhccC
Confidence 0111237999999999999999999999 9999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=398.47 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=229.8
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 45689999999999999999999999999999999987765555566778899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG- 270 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~- 270 (767)
||||++|++|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 119 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999999887754 6999999999999999999999999999999999999999999999999999876533
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...+......++..+++.+.+|
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l 271 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKNEYSIPKHINPVAASL 271 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCCCTTSCHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHhcCCCCCCccCCHHHHHH
Confidence 234456799999999999999999999999999999999999999987654322 2333334455677899999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
|.+||+.||++||+ ++++++||||.+.
T Consensus 272 i~~~l~~dp~~Rps-------~~ell~~~~~~~~ 298 (335)
T 2owb_A 272 IQKMLQTDPTARPT-------INELLNDEFFTSG 298 (335)
T ss_dssp HHHHTCSSGGGSCC-------GGGGGGSHHHHTS
T ss_pred HHHHccCChhHCcC-------HHHHhcCccccCC
Confidence 99999999999999 8999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=392.40 Aligned_cols=257 Identities=30% Similarity=0.468 Sum_probs=221.4
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 579999999999999999999999999999999975432 22346788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe---CCCCCEEEeecCcccccCCC
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl---d~~g~vkL~DFGla~~~~~~ 270 (767)
||++||+|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 86 QLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999999988764 68999999999999999999999999999999999999 78899999999999765432
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|..||...........+...........+..+++++++|
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 241 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 3345679999999999999999999999999999999999999998775544333333332222334456789999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
|.+||..||++||+ ++++++||||++.
T Consensus 242 i~~~l~~dp~~Rps-------~~~~l~h~~~~~~ 268 (304)
T 2jam_A 242 ICHLLEKDPNERYT-------CEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHCSSTTTSCC-------HHHHHTSHHHHSS
T ss_pred HHHHcCCChhHCcC-------HHHHhcCccccCC
Confidence 99999999999999 9999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=400.25 Aligned_cols=261 Identities=22% Similarity=0.307 Sum_probs=216.7
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC----e
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----A 188 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~ 188 (767)
.++|++.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 478999999999999999999999999999999998765555555667889999999999999999999987654 3
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
.|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 599999999999999998764 69999999999999999999999999999999999999999999999999998764
Q ss_pred CCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCc
Q psy11874 269 EGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFS 344 (767)
Q Consensus 269 ~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s 344 (767)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+........................+|
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 4322 234579999999999999999999999999999999999999998776543333332222222333456789
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+++.+||.+||++||++||+ +.+++.|+|++.
T Consensus 248 ~~l~~li~~~l~~dP~~R~~-------~~~~l~~~l~~~ 279 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQ-------TAAEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCS-------SHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCHhhChh-------hHHHHHHHHHHH
Confidence 99999999999999999998 788889998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=407.78 Aligned_cols=259 Identities=21% Similarity=0.325 Sum_probs=215.8
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee------
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------ 185 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------ 185 (767)
..++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+|+.+|+.++|||||+++++|.+
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 34789999999999999999999999999999999865421 12369999999999999999999844
Q ss_pred --------------------------------CCeEEEEEEeccCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHhHHHH
Q psy11874 186 --------------------------------KDALCLVLTIMNGGDLKFHIYNM-GGEPGFDIARARFYAAEVLCGLEH 232 (767)
Q Consensus 186 --------------------------------~~~l~lV~E~~~gG~L~~~l~~~-~~~~~l~~~~~~~~~~qIl~aL~y 232 (767)
...+++|||||+ |+|...+... .....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 345999999999 5777666542 123469999999999999999999
Q ss_pred HHHCCcccccCCcceEEeC-CCCCEEEeecCcccccCCCCcccccccccccCCcceecCC-CCCCCCccccchhhHHHHh
Q psy11874 233 LHYIGLVYRDCKPENILLD-DYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMI 310 (767)
Q Consensus 233 LH~~~IvHrDLKPeNILld-~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyEll 310 (767)
||++||+||||||+|||++ .++.+||+|||+|+............||+.|+|||++.+. .|+.++||||+||++|||+
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 9999999999999999998 6899999999999987766666677899999999998765 4999999999999999999
Q ss_pred cCCCCCCCchhhhhhhhhhhhhhc-------------------------cccccCCCCcHHHHHHHHHhcccCcCccCCC
Q psy11874 311 EGQAPFRRRKEMVKRDEVDRRVKE-------------------------DAEKYSCRFSDDAKALCKALLKKSPRSRLGC 365 (767)
Q Consensus 311 tG~~PF~~~~~~~~~~~i~~~i~~-------------------------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~ 365 (767)
+|++||.+.+.......+.+.... ....++...|+++++||.+||+.||++||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t- 315 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN- 315 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC-
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC-
Confidence 999999887665444443322111 111245568999999999999999999999
Q ss_pred CCCcccHHHHHhCCCCCCCC
Q psy11874 366 HCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 366 ~~~~~~a~eil~HpfF~~i~ 385 (767)
+.|+++||||+++.
T Consensus 316 ------~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 316 ------PYEAMAHPFFDHLR 329 (383)
T ss_dssp ------HHHHHTSGGGHHHH
T ss_pred ------HHHHhcCHHHHHHH
Confidence 99999999998763
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=386.88 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=210.9
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
-.++|++.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 34789999999999999999999999999999999876554445556778999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
||||++||+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 89 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999999999998765 69999999999999999999999999999999999999999999999999998765432
Q ss_pred c--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhh-hhhhhccccccCCCCcHHHH
Q psy11874 272 S--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEV-DRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 272 ~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i-~~~i~~~~~~~~~~~s~~~~ 348 (767)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+........ ...........+..+++.+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 2 33457999999999999999999999999999999999999999876543322221 11112222344567899999
Q ss_pred HHHHHhcccCcCccCC
Q psy11874 349 ALCKALLKKSPRSRLG 364 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~ 364 (767)
++|.+||++||++||+
T Consensus 246 ~li~~~l~~dp~~R~~ 261 (294)
T 4eqm_A 246 NVILRATEKDKANRYK 261 (294)
T ss_dssp HHHHHHSCSSGGGSCS
T ss_pred HHHHHHhcCCHhHccc
Confidence 9999999999999996
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=397.56 Aligned_cols=264 Identities=28% Similarity=0.443 Sum_probs=217.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh-----hhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++.+.... .......+.+|+.+|++++||||+++++++...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999999765432 1122335788999999999999999999987765
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC---EEEeecCccc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH---VRISDLGLAV 265 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~---vkL~DFGla~ 265 (767)
.|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 899999999999998887543 6999999999999999999999999999999999999987665 9999999998
Q ss_pred ccCCCCcccccccccccCCcceec---CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhh-hhhhhhhhccccccCC
Q psy11874 266 EIPEGESVRGRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKR-DEVDRRVKEDAEKYSC 341 (767)
Q Consensus 266 ~~~~~~~~~~~~GT~~Y~APEvl~---~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~-~~i~~~i~~~~~~~~~ 341 (767)
............||+.|+|||++. ...++.++|||||||++|+|++|..||......... ..+...........+.
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence 876554445667999999999974 567899999999999999999999999765432221 1121111111223345
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
.+++++.+||.+||..||++||+ ++++++||||++.+|.+
T Consensus 246 ~~~~~~~~li~~~l~~dP~~Rps-------~~~~l~h~~~~~~~~~~ 285 (322)
T 2ycf_A 246 EVSEKALDLVKKLLVVDPKARFT-------TEEALRHPWLQDEDMKR 285 (322)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCC-------HHHHHTSGGGCCHHHHH
T ss_pred hcCHHHHHHHHHHcccCHhhCCC-------HHHHhhCcCcCCHHHHH
Confidence 78999999999999999999999 99999999999877653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=404.50 Aligned_cols=268 Identities=24% Similarity=0.347 Sum_probs=224.3
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
...+..++|++.+.||+|+||.||+|.++.+|+.||+|++.... .......+.+|+.+|++++||||+++++++.+.+
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 104 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 104 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence 44566789999999999999999999999999999999987642 2334567889999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC-CcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI-GLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~-~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
.+|+||||++||+|.+++.+.+ .+++..+..++.||+.||.|||+. ||+||||||+|||++.+|++||+|||++..
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEEEEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999999999998765 689999999999999999999996 999999999999999999999999999976
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhh-------------------
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDE------------------- 327 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~------------------- 327 (767)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......
T Consensus 182 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 182 LIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred cccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 5322 23456799999999999999999999999999999999999999976543221111
Q ss_pred -------------------hhhhhh-cccccc-CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 328 -------------------VDRRVK-EDAEKY-SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 328 -------------------i~~~i~-~~~~~~-~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
....+. ...... ...+|+++++||.+||+.||++||+ ++|+++||||++.+|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD-------LKQLMVHAFIKRSDA 333 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCC-------HHHHHTSHHHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCC-------HHHHhhChHhhcchH
Confidence 011111 111111 2357899999999999999999999 999999999998766
Q ss_pred hh
Q psy11874 387 KR 388 (767)
Q Consensus 387 ~~ 388 (767)
+.
T Consensus 334 ~~ 335 (360)
T 3eqc_A 334 EE 335 (360)
T ss_dssp SC
T ss_pred hh
Confidence 44
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=378.87 Aligned_cols=254 Identities=23% Similarity=0.285 Sum_probs=214.1
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV 192 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.++.++ +||||+++++++.+.+.+++|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 579999999999999999999999999999999876432 233456788899999999 999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC------------------
Q psy11874 193 LTIMNGGDLKFHIYNMGG-EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY------------------ 253 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~-~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~------------------ 253 (767)
|||++||+|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 999999999999976421 1368999999999999999999999999999999999999844
Q ss_pred -CCEEEeecCcccccCCCCcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh
Q psy11874 254 -GHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR 331 (767)
Q Consensus 254 -g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~ 331 (767)
+.+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+..... ...+.
T Consensus 170 ~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~-- 241 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIR-- 241 (289)
T ss_dssp CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHH--
T ss_pred ceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHH--
Confidence 47999999999876543 234699999999999765 567899999999999999999988765432 12221
Q ss_pred hhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 332 VKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 332 i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.......+..+++++.+||.+||+.||++||+ ++++++||||++.
T Consensus 242 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-------~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 242 -QGRLPRIPQVLSQEFTELLKVMIHPDPERRPS-------AMALVKHSVLLSA 286 (289)
T ss_dssp -TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCC-------HHHHHTCTTC---
T ss_pred -cCCCCCCCcccCHHHHHHHHHHhCCCcccCCC-------HHHHhhChHhhhh
Confidence 22334566789999999999999999999999 9999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=379.90 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=216.8
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee----CCe
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET----KDA 188 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~ 188 (767)
...|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+|++++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 35689999999999999999999999999999999765443 3345678899999999999999999999875 467
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC--cccccCCcceEEeC-CCCCEEEeecCccc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLD-DYGHVRISDLGLAV 265 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~--IvHrDLKPeNILld-~~g~vkL~DFGla~ 265 (767)
+|+||||++||+|.+++.+.+ .+++..+..++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999998764 6899999999999999999999999 99999999999998 88999999999997
Q ss_pred ccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc--cccccCCCC
Q psy11874 266 EIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE--DAEKYSCRF 343 (767)
Q Consensus 266 ~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~~~~~ 343 (767)
..... ......||+.|+|||++.+ .++.++|+|||||++|+|++|..||........ +...+.. .....+...
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~ 255 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHHHHTTTCCCGGGGGCC
T ss_pred ccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH---HHHHHhccCCccccCCCC
Confidence 65433 3345679999999998864 599999999999999999999999976443222 1122221 223345667
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
++++.+||.+||+.||++||+ ++++++||||++.
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps-------~~ell~h~~f~~~ 289 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNKDERYS-------IKDLLNHAFFQEE 289 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCC-------HHHHHTSGGGC--
T ss_pred CHHHHHHHHHHccCChhhCCC-------HHHHhhCcccccC
Confidence 899999999999999999999 9999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=398.05 Aligned_cols=267 Identities=24% Similarity=0.383 Sum_probs=219.1
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 35789999999999999999999999999999999865432 23334567889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG- 270 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~- 270 (767)
||||++|++|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 102 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999999988766543 6999999999999999999999999999999999999999999999999999876443
Q ss_pred CcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc---------------
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE--------------- 334 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~--------------- 334 (767)
.......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+......
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 234456799999999999775 7899999999999999999999999877654333322211110
Q ss_pred ------------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhH
Q psy11874 335 ------------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389 (767)
Q Consensus 335 ------------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l 389 (767)
........+++++.+||.+||+.||++||+ ++|+++||||+..+|...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-------~~ell~hp~f~~~~~~~~ 318 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF-------CAELLHHDFFQMDGFAER 318 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC-------GGGGGGSHHHHGGGHHHH
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC-------HHHHhcCchhccCChhhh
Confidence 001112367999999999999999999999 899999999998776543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=402.66 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=203.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC------C
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------D 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------~ 187 (767)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+|+.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 68999999999999999999999999999999986542 2333456788999999999999999999999754 6
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+|||++ |++|..++... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 689999999 68998888652 6999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc----------
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA---------- 336 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~---------- 336 (767)
... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+.+.+....
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 183 ADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred ccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 432 445689999999999977 6799999999999999999999999988766544443333211110
Q ss_pred -----------------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 337 -----------------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 337 -----------------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
.......++++++||.+||+.||++||+ ++++++||||+......
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t-------~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT-------AAQALAHAYFAQYHDPD 322 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC-------HHHHHTSGGGTTTCCGG
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC-------HHHHhcChhhhhccCCC
Confidence 1112356899999999999999999999 99999999999876554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=384.78 Aligned_cols=263 Identities=29% Similarity=0.436 Sum_probs=225.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+.... ......+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 36899999999999999999999999999999999765432 33456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC---CCEEEeecCcccccCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY---GHVRISDLGLAVEIPE 269 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~---g~vkL~DFGla~~~~~ 269 (767)
|||++|++|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999998887754 68999999999999999999999999999999999999764 4799999999988766
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
........||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+.+.......+...........+..+|+++.+
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred CCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 655566679999999999866 4899999999999999999999999887654333333222111122233578999999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
+|.+||..||++||+ ++++++||||++.+|+
T Consensus 256 li~~~l~~dp~~Rps-------~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 256 LIRKMLTFHPSLRIT-------ATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HHHHHTCSSGGGSCC-------HHHHHHSHHHHHHCCC
T ss_pred HHHHHcccChhhCcC-------HHHHhcCHHHhccccC
Confidence 999999999999999 9999999999876653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=380.42 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=217.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++..... ......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 579999999999999999999999999999999876542 234467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC--
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-- 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-- 271 (767)
||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999888653 368999999999999999999999999999999999999999999999999997654322
Q ss_pred -cccccccccccCCcceecCCCC-CCCCccccchhhHHHHhcCCCCCCCchhhhhh-hhhhhhhhccccccCCCCcHHHH
Q psy11874 272 -SVRGRVGTVGYMAPEVIDNEKY-TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKR-DEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 272 -~~~~~~GT~~Y~APEvl~~~~y-s~~~DvwSlGviLyElltG~~PF~~~~~~~~~-~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
......||+.|+|||++.+..+ +.++|+|||||++|+|++|..||......... ..... .......+..++++++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPL 239 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT--TCTTSTTGGGSCHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh--cccccCchhhcCHHHH
Confidence 2345679999999999987665 77899999999999999999999775432211 11111 0111122346899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+||.+||+.||++||+ ++|+++||||++.
T Consensus 240 ~li~~~l~~~p~~Rps-------~~~il~~~~~~~~ 268 (276)
T 2yex_A 240 ALLHKILVENPSARIT-------IPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHSCSSTTTSCC-------HHHHTTCTTTTCC
T ss_pred HHHHHHCCCCchhCCC-------HHHHhcCccccCh
Confidence 9999999999999999 9999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=396.71 Aligned_cols=268 Identities=24% Similarity=0.398 Sum_probs=228.0
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhH--------------HHHHHHHHHHHhcCCCc
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE--------------SMVLIEKQILQKINSRF 175 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~--------------~~~~~E~~iL~~l~hp~ 175 (767)
.+..++|++.+.||+|+||.||+|.+ +|+.||+|++........... ..+.+|+.++++++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34568999999999999999999998 899999999987654432222 67899999999999999
Q ss_pred eeEEEEEEeeCCeEEEEEEeccCCCHHHH------HHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceE
Q psy11874 176 VVSLAYAYETKDALCLVLTIMNGGDLKFH------IYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENI 248 (767)
Q Consensus 176 Iv~l~~~~~~~~~l~lV~E~~~gG~L~~~------l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNI 248 (767)
|+++++++.+.+.+|+||||++||+|.++ +... ....+++..+..++.||+.||.|||+ .||+||||||+||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 99999999999999999999999999887 4432 13479999999999999999999999 9999999999999
Q ss_pred EeCCCCCEEEeecCcccccCCCCcccccccccccCCcceecCC-CCCC-CCccccchhhHHHHhcCCCCCCCchhhhhhh
Q psy11874 249 LLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNE-KYTY-SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD 326 (767)
Q Consensus 249 Lld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~ys~-~~DvwSlGviLyElltG~~PF~~~~~~~~~~ 326 (767)
|++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|..||...... .
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---V 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---H
T ss_pred EEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---H
Confidence 9999999999999999876543 34556799999999999877 6666 999999999999999999999876541 2
Q ss_pred hhhhhhhccccccC-------------------CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 327 EVDRRVKEDAEKYS-------------------CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 327 ~i~~~i~~~~~~~~-------------------~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
++...+......++ ..+++++.+||.+||+.||++||+ ++|+++||||++.+|.
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-------~~e~l~hp~f~~~~~~ 332 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT-------SEDALKHEWLADTNIE 332 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC-------HHHHHTSGGGTTCCHH
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCC-------HHHHhcCccccCCCHH
Confidence 22223333333333 568999999999999999999999 9999999999999998
Q ss_pred hHhc
Q psy11874 388 RLEA 391 (767)
Q Consensus 388 ~l~~ 391 (767)
.+..
T Consensus 333 ~~~~ 336 (348)
T 2pml_X 333 DLRE 336 (348)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=394.65 Aligned_cols=256 Identities=24% Similarity=0.299 Sum_probs=218.5
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.|++.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999997654444445567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCcc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV 273 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~ 273 (767)
||++ |+|.+.+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---A 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---B
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---C
Confidence 9998 57877776543 3689999999999999999999999999999999999999999999999999987643 2
Q ss_pred cccccccccCCcceec---CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~---~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
...+||+.|+|||++. +..++.++|||||||++|||++|.+||.+.+.......+... ......+..+++.+++|
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEYFRNF 285 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCCCCCTTSCHHHHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCCCCCCHHHHHH
Confidence 3567999999999984 567899999999999999999999999876543332222211 11122345789999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
|.+||+.||++||+ ++++++||||...
T Consensus 286 i~~~l~~dP~~Rps-------~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 286 VDSCLQKIPQDRPT-------SEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHTCSSGGGSCC-------HHHHTTCHHHHSC
T ss_pred HHHHcccChhhCcC-------HHHHhhChhhhcc
Confidence 99999999999999 9999999999653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=405.46 Aligned_cols=257 Identities=21% Similarity=0.319 Sum_probs=215.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc------CCCceeEEEEEEeeC
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI------NSRFVVSLAYAYETK 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l------~hp~Iv~l~~~~~~~ 186 (767)
..+|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++.+ +|+||+++++.+...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 467999999999999999999999999999999996542 2334567788888877 677999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC--EEEeecCcc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH--VRISDLGLA 264 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~--vkL~DFGla 264 (767)
+.+|+||||+. |+|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999999996 68988887753 345999999999999999999999999999999999999999987 999999999
Q ss_pred cccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc-------
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE------- 337 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~------- 337 (767)
..... ...+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.......+.........
T Consensus 250 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 250 CYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp EETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred eecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 76543 344678999999999999999999999999999999999999999887654443333222111000
Q ss_pred ------------------------------------------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCc
Q psy11874 338 ------------------------------------------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGR 369 (767)
Q Consensus 338 ------------------------------------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~ 369 (767)
..+...++++++||.+||+.||++||+
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt----- 402 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT----- 402 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC-----
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC-----
Confidence 011234788999999999999999999
Q ss_pred ccHHHHHhCCCCCCC
Q psy11874 370 YGARELKQAEFFKST 384 (767)
Q Consensus 370 ~~a~eil~HpfF~~i 384 (767)
++|+++||||++.
T Consensus 403 --a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 403 --PGQALRHPWLRRR 415 (429)
T ss_dssp --HHHHHTSTTTC--
T ss_pred --HHHHhCChhhccC
Confidence 9999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=387.52 Aligned_cols=265 Identities=24% Similarity=0.353 Sum_probs=221.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEc-cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc---CCCceeEEEEEEe-----
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI---NSRFVVSLAYAYE----- 184 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~-~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~----- 184 (767)
++|++.+.||+|+||.||+|++. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 68999999999999999999995 678999999987543221 2223456788777766 8999999999987
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
....+++||||++ |+|..++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5678999999998 69999988753 335999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc----------
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE---------- 334 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~---------- 334 (767)
.............||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+......
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (326)
T 1blx_A 168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247 (326)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence 8765544455678999999999999999999999999999999999999999887654444333322110
Q ss_pred -------------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 335 -------------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 335 -------------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
....+...+++.+++||.+||..||++||+ +.++++||||++++|..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS-------AYSALSHPYFQDLERCK 307 (326)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC-------HHHHHTSGGGTTCCCCC
T ss_pred ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC-------HHHHhcCccccccchhh
Confidence 111234568999999999999999999999 99999999999987653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=384.01 Aligned_cols=263 Identities=21% Similarity=0.338 Sum_probs=203.8
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++.+.||+|+||.||+|++..+|+.||+|++..... ..........+...++.++||||+++++++.+.+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 3566899999999999999999999999999999999976532 222233344555568889999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHhHHHHHHHC-CcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 190 CLVLTIMNGGDLKFHIYNM-GGEPGFDIARARFYAAEVLCGLEHLHYI-GLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~-~~~~~l~~~~~~~~~~qIl~aL~yLH~~-~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
|+||||++| +|..++... .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999985 887776542 1234699999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCcccccccccccCCccee----cCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc-CCC
Q psy11874 268 PEGESVRGRVGTVGYMAPEVI----DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY-SCR 342 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl----~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~-~~~ 342 (767)
..........||+.|+|||++ .+..++.++|||||||++|+|++|..||..... ....+...+....... +..
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHHSCCCCCCTTT
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhccCCCCccccc
Confidence 665555556899999999996 566789999999999999999999999975332 1222222222222222 346
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+++++.+||.+||+.||++||+ ++++++||||+.
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt-------~~e~l~hp~f~~ 272 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPT-------YPELMQHPFFTL 272 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCC-------HHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHhhcChhhCcC-------HHHHHhCccccc
Confidence 8999999999999999999999 999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=408.05 Aligned_cols=263 Identities=15% Similarity=0.114 Sum_probs=202.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc--CCCceeEEE-------EEEe
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI--NSRFVVSLA-------YAYE 184 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~-------~~~~ 184 (767)
.+|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999887654555566778885555444 699988865 4444
Q ss_pred eC-----------------CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHH------HHHHHHHHhHHHHHHHCCcccc
Q psy11874 185 TK-----------------DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARA------RFYAAEVLCGLEHLHYIGLVYR 241 (767)
Q Consensus 185 ~~-----------------~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~------~~~~~qIl~aL~yLH~~~IvHr 241 (767)
.. ..+|+|||||+ |+|.+++...+. .+++... ..++.||+.||+|||++||+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 33 34899999999 899999987532 2344444 5667999999999999999999
Q ss_pred cCCcceEEeCCCCCEEEeecCcccccCCCCcccccccccccCCcceecC--CCCCCCCccccchhhHHHHhcCCCCCCCc
Q psy11874 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPFRRR 319 (767)
Q Consensus 242 DLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~--~~ys~~~DvwSlGviLyElltG~~PF~~~ 319 (767)
||||+|||++.+|.+||+|||+|+..... .....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999999876432 225567899999999987 77999999999999999999999999876
Q ss_pred hhhhhh--hhh-hhhhhccc--cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 320 KEMVKR--DEV-DRRVKEDA--EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 320 ~~~~~~--~~i-~~~i~~~~--~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
...... ... ........ ...+..+|+++++||.+||+.||++||+ ++++++||||+++.|..
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL-------PLEAMETPEFLQLQNEI 363 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC-------HHHHTTSHHHHHHHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC-------HHHHhcCHHHHHHHHHH
Confidence 432111 000 00001111 1223578999999999999999999999 99999999999988764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=397.09 Aligned_cols=272 Identities=26% Similarity=0.367 Sum_probs=221.4
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE----
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL---- 189 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l---- 189 (767)
++|.+.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 689999999999999999999999999999999976432 233456788999999999999999999999887665
Q ss_pred --EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 190 --CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 190 --~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
|+||||+. |+|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999998 57876652 24999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc-----------
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED----------- 335 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~----------- 335 (767)
... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 195 DAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred ccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 432 445689999999999977 789999999999999999999999998876544333332211110
Q ss_pred ----------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCC
Q psy11874 336 ----------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFV 399 (767)
Q Consensus 336 ----------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~ 399 (767)
....+..+++++++||.+||+.||++||+ ++|+++||||+.+.+...+. ....|+.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~ell~hp~f~~~~~~~~~~-~~~~~~~ 344 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT-------AAQALTHPFFEPFRDPEEET-EAQQPFD 344 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC-------HHHHHTSGGGTTTCCGGGCC-CCSSCCC
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC-------HHHHhcCcccccCCCccccc-ccccCcC
Confidence 11223467999999999999999999999 99999999999987665443 3445555
Q ss_pred CCC
Q psy11874 400 PDV 402 (767)
Q Consensus 400 P~~ 402 (767)
+.+
T Consensus 345 ~~~ 347 (371)
T 4exu_A 345 DSL 347 (371)
T ss_dssp CTT
T ss_pred cch
Confidence 543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=385.21 Aligned_cols=262 Identities=25% Similarity=0.402 Sum_probs=221.6
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhh-hhhHHHHHHHHHHHHhcCCCceeEEEEEE--eeCCeE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMVLIEKQILQKINSRFVVSLAYAY--ETKDAL 189 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~--~~~~~l 189 (767)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.+..... ......+.+|+.++++++||||+++++++ .+.+.+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999999999999999998765433 34566789999999999999999999998 455689
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||+++| |..++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9999999977 767776643 34699999999999999999999999999999999999999999999999999987643
Q ss_pred C---CcccccccccccCCcceecCCC--CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCc
Q psy11874 270 G---ESVRGRVGTVGYMAPEVIDNEK--YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFS 344 (767)
Q Consensus 270 ~---~~~~~~~GT~~Y~APEvl~~~~--ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s 344 (767)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.. ++...+.......+..++
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~i~~~~~~~~~~~~ 237 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY----KLFENIGKGSYAIPGDCG 237 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHCCCCCCSSSC
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH----HHHHHHhcCCCCCCCccC
Confidence 2 2234567999999999997654 377999999999999999999999876543 233344444556677899
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
+++.+||.+||..||++||+ ++++++||||++....
T Consensus 238 ~~l~~li~~~l~~dp~~Rps-------~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFS-------IRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCC-------HHHHHHSHHHHSCCCC
T ss_pred HHHHHHHHHHccCChhhCCC-------HHHHhcCcccccCCCC
Confidence 99999999999999999999 9999999999987543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=411.11 Aligned_cols=253 Identities=16% Similarity=0.153 Sum_probs=207.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHH---HHHHhcCCCceeEEE-------EE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK---QILQKINSRFVVSLA-------YA 182 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~---~iL~~l~hp~Iv~l~-------~~ 182 (767)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+ ++|++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999999999999999999866554555667788999 555666899999998 77
Q ss_pred EeeCCe-----------------EEEEEEeccCCCHHHHHHhcCCC----CCCCHHHHHHHHHHHHhHHHHHHHCCcccc
Q psy11874 183 YETKDA-----------------LCLVLTIMNGGDLKFHIYNMGGE----PGFDIARARFYAAEVLCGLEHLHYIGLVYR 241 (767)
Q Consensus 183 ~~~~~~-----------------l~lV~E~~~gG~L~~~l~~~~~~----~~l~~~~~~~~~~qIl~aL~yLH~~~IvHr 241 (767)
+++.+. .|+||||+ +|+|.+++...+.. ..+++..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 766543 89999999 68999999875311 113347888899999999999999999999
Q ss_pred cCCcceEEeCCCCCEEEeecCcccccCCCCcccccccccccCCcceecCC-----------CCCCCCccccchhhHHHHh
Q psy11874 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNE-----------KYTYSPDWFSFGCLIFEMI 310 (767)
Q Consensus 242 DLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-----------~ys~~~DvwSlGviLyEll 310 (767)
||||+|||++.+|.+||+|||+|+.... .....+| +.|+|||++.+. .|+.++|||||||++|||+
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 9999999999999999999999986433 3456678 999999999887 8999999999999999999
Q ss_pred cCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 311 EGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 311 tG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+|+.||.+.........+. ..+..+++++++||.+||+.||++||+ +.++++||||+++
T Consensus 308 tg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt-------~~e~l~hp~f~~~ 366 (377)
T 3byv_A 308 CADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLL-------PLQAMETPEYEQL 366 (377)
T ss_dssp HSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCC-------HHHHHTSHHHHHH
T ss_pred HCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCC-------HHHHhhChHHHHH
Confidence 9999997765432222221 223578999999999999999999999 9999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=391.25 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=217.9
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC-----C
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----D 187 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~ 187 (767)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+|++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 368999999999999999999999999999999986432 233455678899999999999999999987664 6
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
..|+||||+. |+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 8999999998 6898888763 5899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCc-----------ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc-
Q psy11874 268 PEGES-----------VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE- 334 (767)
Q Consensus 268 ~~~~~-----------~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~- 334 (767)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 43211 223578999999998754 77899999999999999999999999877643332222111100
Q ss_pred ---------------------------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 335 ---------------------------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 335 ---------------------------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
.....+..+++++++||.+||+.||++||+ ++++++||||++..|.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT-------AKEALEHPYLQTYHDP 315 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC-------HHHHHTSGGGTTTCCT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC-------HHHHhcCccccccCCc
Confidence 011223578999999999999999999999 9999999999998876
Q ss_pred hH
Q psy11874 388 RL 389 (767)
Q Consensus 388 ~l 389 (767)
..
T Consensus 316 ~~ 317 (353)
T 2b9h_A 316 ND 317 (353)
T ss_dssp TS
T ss_pred cc
Confidence 53
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=394.83 Aligned_cols=264 Identities=24% Similarity=0.314 Sum_probs=206.5
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe---
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA--- 188 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~--- 188 (767)
..++|++.+.||+|+||.||+|+++.+|+.||+|++.... .......+|++.+..++||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3478999999999999999999999999999999985532 223345678888899999999999999976433
Q ss_pred ----EEEEEEeccCCCHHHHHHh-cCCCCCCCHHHHHHHHHHHHhHHHHHH--HCCcccccCCcceEEeCC-CCCEEEee
Q psy11874 189 ----LCLVLTIMNGGDLKFHIYN-MGGEPGFDIARARFYAAEVLCGLEHLH--YIGLVYRDCKPENILLDD-YGHVRISD 260 (767)
Q Consensus 189 ----l~lV~E~~~gG~L~~~l~~-~~~~~~l~~~~~~~~~~qIl~aL~yLH--~~~IvHrDLKPeNILld~-~g~vkL~D 260 (767)
+++||||++|+ |...+.+ ......+++..+..++.||+.||.||| +.||+||||||+|||++. ++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 89999999975 4444332 233447899999999999999999999 999999999999999996 89999999
Q ss_pred cCcccccCCCCcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc---
Q psy11874 261 LGLAVEIPEGESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA--- 336 (767)
Q Consensus 261 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~--- 336 (767)
||+|.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.+......
T Consensus 176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 9999987766666677899999999998665 489999999999999999999999988766544444433211110
Q ss_pred -------------------------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 337 -------------------------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 337 -------------------------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
.......++++++||.+||+.||.+||+ ++|+++||||+++.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK-------PYEALCHPYFDELHDP 324 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC-------HHHHTTSGGGGGGGCT
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC-------HHHHhcCccccccCCc
Confidence 0112235789999999999999999999 9999999999987543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=384.30 Aligned_cols=263 Identities=24% Similarity=0.400 Sum_probs=217.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.+.|++.+.||+|+||.||+|.+..+|+.+|+|++.... ......+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 368999999999999999999999999999999986542 33456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-C
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-E 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~ 271 (767)
|||++||+|..++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++...... .
T Consensus 95 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 99999999999887643 36999999999999999999999999999999999999999999999999998643211 1
Q ss_pred cccccccccccCCccee-----cCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 272 SVRGRVGTVGYMAPEVI-----DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl-----~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
......||+.|+|||++ .+..++.++|+|||||++|+|++|..||...+.......+... .......+..++++
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 251 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLTPSKWSVE 251 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCSSGGGSCHH
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc-CCcccCCccccCHH
Confidence 12345799999999998 4677899999999999999999999999876543322222111 11111234568999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
+.+||.+||..||++||+ ++++++||||+++.|..
T Consensus 252 l~~li~~~l~~dp~~Rps-------~~~ll~h~~~~~~~~~~ 286 (302)
T 2j7t_A 252 FRDFLKIALDKNPETRPS-------AAQLLEHPFVSSITSNK 286 (302)
T ss_dssp HHHHHHHHSCSCTTTSCC-------HHHHTTSTTTTTCCCCH
T ss_pred HHHHHHHHcccChhhCCC-------HHHHhcChHHhhhccch
Confidence 999999999999999999 99999999999988754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=386.05 Aligned_cols=273 Identities=26% Similarity=0.383 Sum_probs=198.6
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
..+..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 34566899999999999999999999999999999999865532 2334567889999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhc-----CCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNM-----GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~-----~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
.++||||++||+|.+++... .....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999999998752 1123589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc------ccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc--
Q psy11874 264 AVEIPEGES------VRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE-- 334 (767)
Q Consensus 264 a~~~~~~~~------~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~-- 334 (767)
+........ .....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||..................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 976643321 234579999999999965 56899999999999999999999999876543322211111100
Q ss_pred ----cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHh
Q psy11874 335 ----DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLE 390 (767)
Q Consensus 335 ----~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~ 390 (767)
........+++++++||.+||+.||++||+ ++++++||||++..+..+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-------~~~ll~h~~~~~~~~~~~~ 300 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT-------AAELLRHKFFQKAKNKEFL 300 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCC-------HHHHHTSTTC---------
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcC-------HHHHhhChhhhcCCCCccc
Confidence 011233567899999999999999999999 9999999999988766543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=386.65 Aligned_cols=265 Identities=26% Similarity=0.359 Sum_probs=220.5
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||.||+|.++.+|+.||+|++.... ....+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3478999999999999999999999999999999986542 34568889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
||||++||+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++.......
T Consensus 102 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999999987543 368999999999999999999999999999999999999999999999999998765432
Q ss_pred -cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 272 -SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 272 -~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
......||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+... .......+..+++++.+|
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCSSGGGSCHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-CCcccCCcccCCHHHHHH
Confidence 234567999999999999999999999999999999999999999876543222211111 111122345679999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhc
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEA 391 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~ 391 (767)
|.+||..||.+||+ ++++++||||++..+.....
T Consensus 259 i~~~l~~dp~~Rpt-------~~~ll~~~~~~~~~~~~~~~ 292 (314)
T 3com_A 259 VKQCLVKSPEQRAT-------ATQLLQHPFVRSAKGVSILR 292 (314)
T ss_dssp HHHHTCSCTTTSCC-------HHHHTTSHHHHTCCCGGGGH
T ss_pred HHHHccCChhhCcC-------HHHHHhCHHHhcCCcchHHH
Confidence 99999999999999 99999999999887665443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=385.77 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=210.8
Q ss_pred hhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 106 ~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
.....+..++|++.+.||+|+||.||+|++ +|+.||+|++..... .......+.+|+.+|++++||||+++++++.+
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 334456778999999999999999999987 589999999876543 23345678899999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC--cccccCCcceEEeCCCCCEEEeecCc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~--IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
.+.+++||||++||+|.+++...+....+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999999986542234899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCC-cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 264 AVEIPEGE-SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 264 a~~~~~~~-~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
|+...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+. ........+..
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~ 263 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG--FKCKRLEIPRN 263 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH--HSCCCCCCCTT
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCcc
Confidence 97654332 2345679999999999999999999999999999999999999998765433322221 12334456778
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++++.+||.+||+.||.+||+ ++++++
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps-------~~~ll~ 291 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPS-------FATIMD 291 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcC-------HHHHHH
Confidence 9999999999999999999999 888876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=392.22 Aligned_cols=261 Identities=25% Similarity=0.312 Sum_probs=207.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh--------hhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--------KRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~--------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
++|++.+.||+|+||.||+|.+. +|+.||+|++...... .......+.+|+.+|++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 78999999999999999999986 4999999998654322 22234678999999999999999999999844
Q ss_pred -----CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEee
Q psy11874 186 -----KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISD 260 (767)
Q Consensus 186 -----~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~D 260 (767)
...+|+||||++ |+|...+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 347999999998 58877777542 3699999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc----
Q psy11874 261 LGLAVEIPEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED---- 335 (767)
Q Consensus 261 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~---- 335 (767)
||+|.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 999987665555566789999999999977 679999999999999999999999998876543333332211100
Q ss_pred ------------------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 336 ------------------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 336 ------------------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
........++.+.+||.+||+.||++||+ ++|+++||||+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS-------TEQALRHPYFESLF 324 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC-------HHHHHTSGGGTTTC
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC-------HHHHHcCchhhhcc
Confidence 11223467899999999999999999999 99999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=392.32 Aligned_cols=278 Identities=21% Similarity=0.243 Sum_probs=212.4
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcE----EEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
.+..++|++.+.||+|+||.||+|.+..+|+. +|+|.+.... .......+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 35668999999999999999999999988876 6666664332 2223345678999999999999999999886
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
.+..++||||++||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 456999999999999999997642 268999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCC
Q psy11874 266 EIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 266 ~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~ 341 (767)
....... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+. .......+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 240 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE---KGERLAQPQ 240 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH---TTCBCCCCT
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH---cCCCCCCCC
Confidence 7754432 234568889999999999999999999999999999999 999998765433222222 122344556
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh-------------------------CCCCCCCChhhHhcCCCCC
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ-------------------------AEFFKSTNWKRLEAGLCDP 396 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~-------------------------HpfF~~i~w~~l~~~~~~p 396 (767)
.+++++.+++.+||..||++||+ ++++++ +|.+.+++|..+....++|
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps-------~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 313 (325)
T 3kex_A 241 ICTIDVYMVMVKCWMIDENIRPT-------FKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEP 313 (325)
T ss_dssp TBCTTTTHHHHHHTCSCTTTSCC-------HHHHHHHHHHHTTSHHHHBCCCSSSSCCCBCCCCCCC-------------
T ss_pred cCcHHHHHHHHHHcCCChhhCcC-------HHHHHHHHHHHHhcchhhhccccCCCCCCCCCCccccchhhcccccccch
Confidence 78889999999999999999999 677654 5788888888888888888
Q ss_pred CCCCCC
Q psy11874 397 PFVPDV 402 (767)
Q Consensus 397 p~~P~~ 402 (767)
|+.|+.
T Consensus 314 ~~~~~~ 319 (325)
T 3kex_A 314 ELDLDL 319 (325)
T ss_dssp ------
T ss_pred hccCCc
Confidence 888773
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=388.18 Aligned_cols=280 Identities=21% Similarity=0.292 Sum_probs=203.8
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCc---EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
.+..++|++.+.||+|+||.||+|+++.++. .||+|++..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3556789999999999999999999887775 899999976533 233466788999999999999999999999887
Q ss_pred CeE------EEEEEeccCCCHHHHHHhcCC---CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEE
Q psy11874 187 DAL------CLVLTIMNGGDLKFHIYNMGG---EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVR 257 (767)
Q Consensus 187 ~~l------~lV~E~~~gG~L~~~l~~~~~---~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vk 257 (767)
+.. ++||||++||+|..++..... ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 665 999999999999999876431 22589999999999999999999999999999999999999999999
Q ss_pred EeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhh
Q psy11874 258 ISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVK 333 (767)
Q Consensus 258 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~ 333 (767)
|+|||+|........ .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+ ..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---~~ 254 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL---IG 254 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HT
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH---hc
Confidence 999999987654432 223457889999999999999999999999999999999 99999876554333222 22
Q ss_pred ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCC
Q psy11874 334 EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGL 393 (767)
Q Consensus 334 ~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~ 393 (767)
......+..+++++.+||.+||+.||++||++.+-....+++++|||+.+..+..+....
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~~~ 314 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINI 314 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------------
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCCCC
Confidence 233455678899999999999999999999854433457889999999987766655443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=387.79 Aligned_cols=270 Identities=22% Similarity=0.295 Sum_probs=217.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCC-cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCc------eeEEEEEEee
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATG-KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF------VVSLAYAYET 185 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~------Iv~l~~~~~~ 185 (767)
.++|++.+.||+|+||.||+|.+..++ +.||+|++.... .....+.+|+.++++++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 478999999999999999999998877 799999986432 23456778999999987665 9999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe---------------
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL--------------- 250 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl--------------- 250 (767)
.+.+|+||||+ +|+|...+.... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred CCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 99999999999 567767776643 2369999999999999999999999999999999999999
Q ss_pred ----CCCCCEEEeecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhh
Q psy11874 251 ----DDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD 326 (767)
Q Consensus 251 ----d~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~ 326 (767)
+.++.+||+|||+|...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 56789999999999865432 345689999999999999999999999999999999999999998765543332
Q ss_pred hhhhhhhcccc----------------------------------------ccCCCCcHHHHHHHHHhcccCcCccCCCC
Q psy11874 327 EVDRRVKEDAE----------------------------------------KYSCRFSDDAKALCKALLKKSPRSRLGCH 366 (767)
Q Consensus 327 ~i~~~i~~~~~----------------------------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~ 366 (767)
.+.......+. ......++++.+||.+||+.||++||+
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-- 327 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT-- 327 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC--
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC--
Confidence 22221110000 001122568999999999999999999
Q ss_pred CCcccHHHHHhCCCCCCCChhhHhcCCCCCC
Q psy11874 367 CGRYGARELKQAEFFKSTNWKRLEAGLCDPP 397 (767)
Q Consensus 367 ~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp 397 (767)
++|+++||||++++|+........+|
T Consensus 328 -----~~e~l~hp~f~~~~~~~~~~~~~~~p 353 (355)
T 2eu9_A 328 -----LAEALLHPFFAGLTPEERSFHTSRNP 353 (355)
T ss_dssp -----HHHHTTSGGGGGCCHHHHC-------
T ss_pred -----HHHHhcChhhcCCChhhccccccCCC
Confidence 99999999999999987765544433
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=376.58 Aligned_cols=261 Identities=26% Similarity=0.400 Sum_probs=210.6
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--------
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-------- 185 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-------- 185 (767)
++|++.+.||+|+||.||+|++..+|+.||+|++... ......+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 4799999999999999999999999999999998643 2334668899999999999999999998865
Q ss_pred -----CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEee
Q psy11874 186 -----KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISD 260 (767)
Q Consensus 186 -----~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~D 260 (767)
.+.+|+||||++||+|.+++...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 467899999999999999998643 3578899999999999999999999999999999999999999999999
Q ss_pred cCcccccCCC---------------CcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhh-h
Q psy11874 261 LGLAVEIPEG---------------ESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-V 323 (767)
Q Consensus 261 FGla~~~~~~---------------~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~-~ 323 (767)
||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++ ||...... .
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9999765422 123445799999999999765 68999999999999999998 55433221 1
Q ss_pred hhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHh
Q psy11874 324 KRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLE 390 (767)
Q Consensus 324 ~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~ 390 (767)
....+.......+..++...++.+++||.+||+.||++||+ ++++++||||+...++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-------~~~ll~h~~~~~~~~~~~~ 296 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG-------ARTLLNSGWLPVKHQDEVI 296 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCC-------HHHHHHSSCSCCCCHHHHH
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcC-------HHHHhCCCCcCCCChHHHH
Confidence 11222211122233345567788999999999999999999 9999999999988776543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=393.30 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=212.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CC-----ceeEEEEEEeeC
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SR-----FVVSLAYAYETK 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp-----~Iv~l~~~~~~~ 186 (767)
.++|++.+.||+|+||+||+|.++.+|+.||+|++.... .....+.+|+.+++.++ |+ +|+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 478999999999999999999999999999999997532 23455677888888875 44 599999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHH--HCCcccccCCcceEEeC--CCCCEEEeecC
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH--YIGLVYRDCKPENILLD--DYGHVRISDLG 262 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH--~~~IvHrDLKPeNILld--~~g~vkL~DFG 262 (767)
+.+|+||||++ |+|.+++.... ...+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 99999999997 59999988753 235999999999999999999999 57999999999999994 57889999999
Q ss_pred cccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc----
Q psy11874 263 LAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK---- 338 (767)
Q Consensus 263 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~---- 338 (767)
+|..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.......+..........
T Consensus 207 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (382)
T 2vx3_A 207 SSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284 (382)
T ss_dssp TCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred Cceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9987643 2446789999999999999999999999999999999999999998876554444333221111000
Q ss_pred ----------cCC----------------------------------------------CCcHHHHHHHHHhcccCcCcc
Q psy11874 339 ----------YSC----------------------------------------------RFSDDAKALCKALLKKSPRSR 362 (767)
Q Consensus 339 ----------~~~----------------------------------------------~~s~~~~dLi~~lL~~dP~~R 362 (767)
.+. ..++++++||.+||+.||++|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 364 (382)
T 2vx3_A 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364 (382)
T ss_dssp CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence 000 001478999999999999999
Q ss_pred CCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 363 LGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 363 l~~~~~~~~a~eil~HpfF~~i~w 386 (767)
|+ ++|+++||||++..|
T Consensus 365 pt-------a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 365 IQ-------PYYALQHSFFKKTAD 381 (382)
T ss_dssp CC-------HHHHTTSGGGCC---
T ss_pred CC-------HHHHhcCcccccCCC
Confidence 99 999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=391.14 Aligned_cols=257 Identities=22% Similarity=0.364 Sum_probs=211.0
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC--CceeEEEEEEeeCCe
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS--RFVVSLAYAYETKDA 188 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~~ 188 (767)
+..+.|++.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+|.+++| |||+++++++.+.+.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 44578999999999999999999884 699999999876542 23345678899999999987 999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+||| +.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ +|.+||+|||+|....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEEEEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999999 56789999998754 689999999999999999999999999999999999997 5889999999998765
Q ss_pred CCCc---ccccccccccCCcceecC-----------CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh-h
Q psy11874 269 EGES---VRGRVGTVGYMAPEVIDN-----------EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV-K 333 (767)
Q Consensus 269 ~~~~---~~~~~GT~~Y~APEvl~~-----------~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i-~ 333 (767)
.... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+...+ .
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~ 236 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDP 236 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHCT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHHhcC
Confidence 4332 235679999999999864 67889999999999999999999999764321 11111111 1
Q ss_pred ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 334 EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 334 ~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
.....++...++++.+||.+||+.||.+||+ +.++++||||+.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-------~~e~l~hp~~~~ 279 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS-------IPELLAHPYVQI 279 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC-------HHHHHTSHHHHS
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCC-------HHHHHhCccccc
Confidence 2233456677899999999999999999999 999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=383.79 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=210.7
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe--------
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE-------- 184 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-------- 184 (767)
.++|++.+.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 36899999999999999999999999999999998654 2344567889999999999999999999873
Q ss_pred ------eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC-CCCCEE
Q psy11874 185 ------TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD-DYGHVR 257 (767)
Q Consensus 185 ------~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld-~~g~vk 257 (767)
+.+.+|+||||++ |+|..++.+. .+++..++.++.||+.||+|||++||+||||||+|||++ +++.+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 4578999999998 6999888542 589999999999999999999999999999999999997 567999
Q ss_pred EeecCcccccCCC----CcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh
Q psy11874 258 ISDLGLAVEIPEG----ESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV 332 (767)
Q Consensus 258 L~DFGla~~~~~~----~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i 332 (767)
|+|||++...... .......||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+.......+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999876432 12344568999999999865 678999999999999999999999998876543333322211
Q ss_pred h--------------------------ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 333 K--------------------------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 333 ~--------------------------~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
. ......+..+++++++||.+||+.||++||+ ++++++||||+..+|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT-------AEEALSHPYMSIYSF 314 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC-------HHHHHTSHHHHTTCC
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC-------HHHHhCCcccccccC
Confidence 0 0011233568999999999999999999999 999999999999887
Q ss_pred hh
Q psy11874 387 KR 388 (767)
Q Consensus 387 ~~ 388 (767)
..
T Consensus 315 p~ 316 (320)
T 2i6l_A 315 PM 316 (320)
T ss_dssp --
T ss_pred cc
Confidence 64
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=388.19 Aligned_cols=271 Identities=26% Similarity=0.374 Sum_probs=219.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe-----
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA----- 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~----- 188 (767)
++|.+.+.||+|+||.||+|.++.+|+.||+|++.... ........+.+|+.+|++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 68999999999999999999999999999999997643 233345678899999999999999999999987654
Q ss_pred -EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 189 -LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 189 -l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
+|+||||+. |+|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 599999998 58876653 25899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc------------
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE------------ 334 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~------------ 334 (767)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.+....
T Consensus 177 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 177 DAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred CCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 432 345689999999999876 67899999999999999999999999887654333332221100
Q ss_pred ---------------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCC
Q psy11874 335 ---------------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFV 399 (767)
Q Consensus 335 ---------------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~ 399 (767)
.....+..+++++++||.+||+.||++||+ ++++++||||+...+...+. ....||.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-------~~e~l~hp~f~~~~~~~~~~-~~~~~~~ 326 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT-------AAQALTHPFFEPFRDPEEET-EAQQPFD 326 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC-------HHHHHTSGGGTTTCCGGGCC-CCSSCCC
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC-------HHHHhcCcchhhccCccccc-cCCCCCc
Confidence 011223467999999999999999999999 99999999999887654432 2344554
Q ss_pred CC
Q psy11874 400 PD 401 (767)
Q Consensus 400 P~ 401 (767)
+.
T Consensus 327 ~~ 328 (353)
T 3coi_A 327 DS 328 (353)
T ss_dssp CT
T ss_pred cc
Confidence 44
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=382.97 Aligned_cols=259 Identities=24% Similarity=0.318 Sum_probs=214.9
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEE-ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCC------ceeEEEEEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQV-RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR------FVVSLAYAY 183 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~-~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp------~Iv~l~~~~ 183 (767)
+-.++|++.+.||+|+||.||+|.+ +.+|+.||+|++.... .....+.+|+.+++.++|+ +++++++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 3347899999999999999999998 5689999999986432 2345678899999988765 499999999
Q ss_pred eeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC-----------
Q psy11874 184 ETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD----------- 252 (767)
Q Consensus 184 ~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~----------- 252 (767)
.+.+.+|+||||+ +|+|.+++...+ ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 9999999999999 899999988753 345899999999999999999999999999999999999987
Q ss_pred --------CCCEEEeecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhh
Q psy11874 253 --------YGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK 324 (767)
Q Consensus 253 --------~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~ 324 (767)
++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 678999999999875432 3456899999999999999999999999999999999999999987665433
Q ss_pred hhhhhhhhhccc----------------------------------------cccCCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 325 RDEVDRRVKEDA----------------------------------------EKYSCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 325 ~~~i~~~i~~~~----------------------------------------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
...+.+.....+ .......++++.+||.+||+.||++||+
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 332222111000 0001223578999999999999999999
Q ss_pred CCCCcccHHHHHhCCCCCCC
Q psy11874 365 CHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 365 ~~~~~~~a~eil~HpfF~~i 384 (767)
++|+++||||+.+
T Consensus 323 -------~~ell~hp~f~~~ 335 (339)
T 1z57_A 323 -------LREALKHPFFDLL 335 (339)
T ss_dssp -------HHHHTTSGGGGGG
T ss_pred -------HHHHhcCHHHHHH
Confidence 9999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=396.25 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=209.4
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC--------CCceeEEEEEEe
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN--------SRFVVSLAYAYE 184 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--------hp~Iv~l~~~~~ 184 (767)
.++|++.+.||+|+||+||+|++..+|+.||+|++.... .....+.+|+.+|++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 478999999999999999999999999999999996542 33456788999999985 788999999998
Q ss_pred ----eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC-CcccccCCcceEEeCCCC-----
Q psy11874 185 ----TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI-GLVYRDCKPENILLDDYG----- 254 (767)
Q Consensus 185 ----~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~-~IvHrDLKPeNILld~~g----- 254 (767)
+...+|+||||+ +|+|...+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 567899999999 566666666542 24699999999999999999999998 999999999999999876
Q ss_pred --------------------------------------------CEEEeecCcccccCCCCcccccccccccCCcceecC
Q psy11874 255 --------------------------------------------HVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN 290 (767)
Q Consensus 255 --------------------------------------------~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~ 290 (767)
.+||+|||+|...... ....+||+.|+|||++.+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC
Confidence 7999999999876433 445689999999999999
Q ss_pred CCCCCCCccccchhhHHHHhcCCCCCCCchhhh------hhhhhhhhhhc------------------------------
Q psy11874 291 EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV------KRDEVDRRVKE------------------------------ 334 (767)
Q Consensus 291 ~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~------~~~~i~~~i~~------------------------------ 334 (767)
..|+.++|||||||++|||++|..||...+... ....+......
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 999999999999999999999999997644211 11111110000
Q ss_pred --------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 335 --------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 335 --------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
....++...++++++||.+||+.||++||+ ++|+++||||++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~e~l~hp~~~~ 397 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT-------AAECLRHPWLNS 397 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC-------HHHHHTSGGGGC
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC-------HHHHhhCccccC
Confidence 000112234577899999999999999999 999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=379.97 Aligned_cols=254 Identities=20% Similarity=0.268 Sum_probs=213.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++|++.+.||+|+||+||+|.++.+|+.||+|++... .......+.+|+.+|++++||||+++++++.+.+.++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4557899999999999999999999999999999998543 3344567889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||++||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999999998743 36999999999999999999999999999999999999999999999999999876433
Q ss_pred Ccc---------------cccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc
Q psy11874 271 ESV---------------RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED 335 (767)
Q Consensus 271 ~~~---------------~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~ 335 (767)
... ...+||+.|+|||++.+..++.++|||||||++|||++|..||............. .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~ 240 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGFL 240 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhccc
Confidence 221 14579999999999999999999999999999999999999996543221111000 00111
Q ss_pred ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 336 AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 336 ~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
....+..+++++.+|+.+||+.||++||+ ++++++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps-------~~~l~~ 275 (310)
T 3s95_A 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPS-------FVKLEH 275 (310)
T ss_dssp HHTCCTTCCTTHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred cccCCCCCCHHHHHHHHHHccCChhhCcC-------HHHHHH
Confidence 12345678899999999999999999999 888876
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=381.77 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=214.6
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEee-----
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYET----- 185 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~----- 185 (767)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3578999999999999999999999999999999986532 2345688899999999 89999999999987
Q ss_pred -CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 186 -KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 186 -~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
.+.+|+||||++||+|.+++.... ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 568999999999999999998742 236899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-cccccccccccCCcceec-----CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc
Q psy11874 265 VEIPEGE-SVRGRVGTVGYMAPEVID-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK 338 (767)
Q Consensus 265 ~~~~~~~-~~~~~~GT~~Y~APEvl~-----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~ 338 (767)
....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||...+.......+... .....
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~ 254 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--PAPRL 254 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCCC
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccccC
Confidence 8764332 234567999999999996 567899999999999999999999999776543322222111 11122
Q ss_pred cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 339 ~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
.+..+++.+++||.+||..||.+||+ ++++++||||++..+.+
T Consensus 255 ~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~ll~hp~~~~~~~~~ 297 (326)
T 2x7f_A 255 KSKKWSKKFQSFIESCLVKNHSQRPA-------TEQLMKHPFIRDQPNER 297 (326)
T ss_dssp SCSCSCHHHHHHHHHHCCSSGGGSCC-------HHHHHTSHHHHCCTTHH
T ss_pred CccccCHHHHHHHHHHhccChhhCCC-------HHHHhhChHHhhCcccc
Confidence 24568999999999999999999999 99999999999876554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=377.64 Aligned_cols=262 Identities=26% Similarity=0.363 Sum_probs=217.4
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|....+||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 345555669999999999999999999999999986542 23345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC-CCCEEEeecCcccccCCCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-YGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-~g~vkL~DFGla~~~~~~~ 271 (767)
|||++||+|..++........+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999999999987654456789999999999999999999999999999999999987 8999999999998765432
Q ss_pred -cccccccccccCCcceecCC--CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 272 -SVRGRVGTVGYMAPEVIDNE--KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 272 -~~~~~~GT~~Y~APEvl~~~--~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
......||+.|+|||++.+. .++.++|+|||||++|+|++|..||........ ..............+..+++++.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 256 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMFKVHPEIPESMSAEAK 256 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHHHHHHHCCCCCCCTTSCHHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHHhhccccccccccccCCHHHH
Confidence 23456799999999999764 388999999999999999999999975433211 11111222334456678999999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
+||.+||+.||++||+ ++++++||||+...
T Consensus 257 ~li~~~l~~dp~~Rps-------~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 257 AFILKCFEPDPDKRAC-------ANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHTTCSSTTTSCC-------HHHHHTSGGGCC--
T ss_pred HHHHHHccCChhhCCC-------HHHHhcChhhhhcc
Confidence 9999999999999999 99999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=396.37 Aligned_cols=257 Identities=22% Similarity=0.368 Sum_probs=211.7
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC--CCceeEEEEEEeeCCeE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN--SRFVVSLAYAYETKDAL 189 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~~l 189 (767)
..++|++.+.||+|+||.||+|.+.. |+.||+|++..... .......+.+|+.+|+++. ||||+++++++.+.+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999999864 99999999976543 2334567889999999996 59999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||| +.+|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99999 67889999998754 689999999999999999999999999999999999996 58999999999987654
Q ss_pred CCc---ccccccccccCCcceecC-----------CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-c
Q psy11874 270 GES---VRGRVGTVGYMAPEVIDN-----------EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK-E 334 (767)
Q Consensus 270 ~~~---~~~~~GT~~Y~APEvl~~-----------~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~-~ 334 (767)
... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||....... ..+...+. .
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~~~~~~~ 284 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIIDPN 284 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHCTT
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--HHHHHHhCcc
Confidence 332 345689999999999865 468899999999999999999999997643211 11111111 1
Q ss_pred cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 335 DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 335 ~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
....++...++++++||.+||+.||++||+ ++|+++||||+..
T Consensus 285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-------~~ell~hp~~~~~ 327 (390)
T 2zmd_A 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRIS-------IPELLAHPYVQIQ 327 (390)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCC-------HHHHHTSHHHHSC
T ss_pred ccCCCCccchHHHHHHHHHHcccChhhCCC-------HHHHhhCcCcccc
Confidence 223455667899999999999999999999 9999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=375.20 Aligned_cols=261 Identities=22% Similarity=0.363 Sum_probs=220.2
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe--eCCeE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE--TKDAL 189 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~l 189 (767)
..++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+.++++++||||+++++++. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 347899999999999999999999999999999999765432 234567889999999999999999999874 46789
Q ss_pred EEEEEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCC-----cccccCCcceEEeCCCCCEEEeecCc
Q psy11874 190 CLVLTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIG-----LVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~-----IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
|+||||++||+|.+++.... ....+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999997643 1335899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCc-ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 264 AVEIPEGES-VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 264 a~~~~~~~~-~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
+........ .....||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.. ......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~ 239 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---GKFRRIPYR 239 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TCCCCCCTT
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh---cccccCCcc
Confidence 987654432 2345799999999999999999999999999999999999999987654332222221 222345668
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+++++.++|.+||+.||++||+ ++++++|+|+..
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps-------~~~ll~~~~~~~ 273 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPS-------VEEILENPLILE 273 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCC-------HHHHHTSTTCCG
T ss_pred cCHHHHHHHHHHcCCCcccCCC-------HHHHHhChhhhh
Confidence 8999999999999999999999 999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=377.32 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=222.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 569999999999999999999999999999999976542 234567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-c
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-S 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~ 272 (767)
||++||+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....... .
T Consensus 100 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 100 EYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp ECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 999999999988642 58999999999999999999999999999999999999999999999999998765443 2
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
.....||+.|+|||++.+..++.++|+|||||++|+|++|..||...........+. .......+..+++.+.+||.
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~ 252 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP---KNNPPTLEGNYSKPLKEFVE 252 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HSCCCCCCSSCCHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh---cCCCCCCccccCHHHHHHHH
Confidence 345679999999999999999999999999999999999999997765432222221 22334456688999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+||..||++||+ ++++++||||..
T Consensus 253 ~~l~~dp~~Rps-------~~~ll~~~~~~~ 276 (303)
T 3a7i_A 253 ACLNKEPSFRPT-------AKELLKHKFILR 276 (303)
T ss_dssp HHCCSSGGGSCC-------HHHHTTCHHHHH
T ss_pred HHcCCChhhCcC-------HHHHhhChhhhc
Confidence 999999999999 999999999965
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=390.32 Aligned_cols=257 Identities=19% Similarity=0.284 Sum_probs=217.4
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEc-------cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY 181 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~-------~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 181 (767)
.+..++|++.+.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+|+++ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 455689999999999999999999975 346689999997542 334456789999999999 8999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceE
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNI 248 (767)
++.+.+.+|+||||++||+|.+++...+. ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 99999999999999999999999987532 23589999999999999999999999999999999999
Q ss_pred EeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhh
Q psy11874 249 LLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVK 324 (767)
Q Consensus 249 Lld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~ 324 (767)
|++.+|++||+|||+|+....... .....||+.|+|||++.+..|+.++|||||||++|||++ |..||.+......
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999987654332 234567899999999999999999999999999999999 9999987654332
Q ss_pred hhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 325 RDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 325 ~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
...+.. ......+..+++++.+||.+||..||++||+ +.|++++
T Consensus 315 ~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-------~~ell~~ 358 (370)
T 2psq_A 315 FKLLKE---GHRMDKPANCTNELYMMMRDCWHAVPSQRPT-------FKQLVED 358 (370)
T ss_dssp HHHHHT---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred HHHHhc---CCCCCCCCCCCHHHHHHHHHHcCCChhhCcC-------HHHHHHH
Confidence 222221 2234456788999999999999999999999 8888763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=402.36 Aligned_cols=261 Identities=24% Similarity=0.324 Sum_probs=195.3
Q ss_pred CeEE-EeEEeecCcEEEEEEEEc--cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--CCeE
Q psy11874 115 TFRM-YRVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--KDAL 189 (767)
Q Consensus 115 ~y~~-~~~LG~G~fG~Vy~a~~~--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 189 (767)
.|++ .++||+|+||.||+|+++ .+++.||+|++..... ...+.+|+.+|++++|||||++++++.+ ...+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 4665 458999999999999977 5689999999865432 2357889999999999999999999954 7789
Q ss_pred EEEEEeccCCCHHHHHHhcC------CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe----CCCCCEEEe
Q psy11874 190 CLVLTIMNGGDLKFHIYNMG------GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL----DDYGHVRIS 259 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~------~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl----d~~g~vkL~ 259 (767)
|+||||+.| +|...+.... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999999984 7777775321 12248999999999999999999999999999999999999 778999999
Q ss_pred ecCcccccCCC----CcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhh---------hhh
Q psy11874 260 DLGLAVEIPEG----ESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM---------VKR 325 (767)
Q Consensus 260 DFGla~~~~~~----~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~---------~~~ 325 (767)
|||+|+..... ......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.... ...
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 99999876432 223456899999999999874 5899999999999999999999999765432 111
Q ss_pred hhhhhhhhcccc----------------------------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCccc
Q psy11874 326 DEVDRRVKEDAE----------------------------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYG 371 (767)
Q Consensus 326 ~~i~~~i~~~~~----------------------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~ 371 (767)
..+...+..... ......++++.+||.+||+.||++||+
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t------- 327 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT------- 327 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC-------
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC-------
Confidence 111111110000 011123788999999999999999999
Q ss_pred HHHHHhCCCCCCCChhh
Q psy11874 372 ARELKQAEFFKSTNWKR 388 (767)
Q Consensus 372 a~eil~HpfF~~i~w~~ 388 (767)
++|+++||||++..|..
T Consensus 328 a~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 328 SEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHHHHTSGGGTSSSCCC
T ss_pred HHHHhcChhhccCCCCc
Confidence 99999999999876654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=393.98 Aligned_cols=281 Identities=21% Similarity=0.273 Sum_probs=225.8
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEE-----EccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEE
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQ-----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYA 182 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~-----~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 182 (767)
...+..++|++.+.||+|+||.||+|+ ...+++.||+|++.... .......+.+|+.+|++++|||||+++++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 445667899999999999999999999 44578899999986432 23345568889999999999999999999
Q ss_pred EeeCCeEEEEEEeccCCCHHHHHHhcCC----CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC---C
Q psy11874 183 YETKDALCLVLTIMNGGDLKFHIYNMGG----EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG---H 255 (767)
Q Consensus 183 ~~~~~~l~lV~E~~~gG~L~~~l~~~~~----~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g---~ 255 (767)
+.+....|+|||||+||+|.+++...+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+| .
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 9999999999999999999999987642 23589999999999999999999999999999999999999655 4
Q ss_pred EEEeecCcccccCCC---CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhh
Q psy11874 256 VRISDLGLAVEIPEG---ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRR 331 (767)
Q Consensus 256 vkL~DFGla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~ 331 (767)
+||+|||+|+..... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-- 300 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-- 300 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH--
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--
Confidence 999999999754222 22344678999999999999999999999999999999998 999998775433332222
Q ss_pred hhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 332 VKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 332 i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
.......+..+++.+.+|+.+||+.||++||+ +++|++|.++-.-+...+.. .+++.+-|.
T Consensus 301 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-------~~eil~~l~~~~~~~~~~~~-~~p~~~~~~ 361 (367)
T 3l9p_A 301 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN-------FAIILERIEYCTQDPDVINT-ALPIEYGPL 361 (367)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHHHHHHHHCHHHHTC-CCCCC----
T ss_pred -cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcC-------HHHHHHHHHHHhhChhhccC-CCccccCCc
Confidence 12234456678999999999999999999999 99999998876555443332 334444443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=380.12 Aligned_cols=266 Identities=20% Similarity=0.273 Sum_probs=217.8
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~l 191 (767)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+|+.+++++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 3689999999999999999999999999999999865421 23477899999999 99999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC-----EEEeecCcccc
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH-----VRISDLGLAVE 266 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~-----vkL~DFGla~~ 266 (767)
||||+ ||+|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++. +||+|||+|+.
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99999 999999998752 36999999999999999999999999999999999999999887 99999999987
Q ss_pred cCCCCc--------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc---
Q psy11874 267 IPEGES--------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED--- 335 (767)
Q Consensus 267 ~~~~~~--------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~--- 335 (767)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.....+ ....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~-~~~~i~~~~~~ 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE-RYQKIGDTKRA 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH-HHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH-HHHHHHhhhcc
Confidence 644332 245689999999999999999999999999999999999999998754322221 12222111
Q ss_pred --ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh----------CCCCCCCChhhHhcCCCCCCC
Q psy11874 336 --AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ----------AEFFKSTNWKRLEAGLCDPPF 398 (767)
Q Consensus 336 --~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~----------HpfF~~i~w~~l~~~~~~pp~ 398 (767)
.......++ ++.+|+..||+.||.+||+ +++|++ .++...++|. .+.+.+|+
T Consensus 239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~-------~~~l~~~l~~~~~~~~~~~~~~~dw~---~~~~~~p~ 302 (330)
T 2izr_A 239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPD-------YDYLRKLFTDLFDRKGYMFDYEYDWI---GKQLPTPV 302 (330)
T ss_dssp SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCC-------HHHHHHHHHHHHHHTTCCCSCCCTTT---TSCCCCCC
T ss_pred CCHHHHhccCh-HHHHHHHHHHhCCCCCCCC-------HHHHHHHHHHHHHHcCCCCCCCccCC---CCCcCCCC
Confidence 112223355 9999999999999999999 555544 4455568887 34455565
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=381.97 Aligned_cols=255 Identities=20% Similarity=0.299 Sum_probs=214.2
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCc---EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
..+..++|++.+.||+|+||.||+|.++.+|+ .||+|++.... .......+.+|+.+|++++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34667899999999999999999999986654 59999997542 23345678899999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
.+.+|+||||++||+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999999999997643 369999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccC
Q psy11874 266 EIPEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYS 340 (767)
Q Consensus 266 ~~~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~ 340 (767)
....... .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.. ......+
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~---~~~~~~~ 276 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE---GYRLPAP 276 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT---TCCCCCC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc---CCCCCCC
Confidence 7654322 223456889999999998999999999999999999999 9999987655433333322 2234456
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
..+++++.+||.+||..||++||+ +++|++
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps-------~~eil~ 306 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPR-------FSQIVS 306 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CCcCHHHHHHHHHHccCChhhCcC-------HHHHHH
Confidence 688999999999999999999999 777764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=369.07 Aligned_cols=253 Identities=20% Similarity=0.272 Sum_probs=216.6
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
+.+..++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3456689999999999999999999987 578899999976432 23568899999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
.|+||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred eEEEEEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence 999999999999999997643 368999999999999999999999999999999999999999999999999998764
Q ss_pred CCC--cccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 269 EGE--SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 269 ~~~--~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
... ......||+.|+|||++.+..++.++|+|||||++|+|++ |..||...........+.. ......+...++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLAST 234 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---TCCCCCCTTSCH
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc---CccCCCCCcCCH
Confidence 432 1234567889999999999999999999999999999999 9999987655433333322 223344567899
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
++.+++.+||+.||++||+ ++++++|
T Consensus 235 ~~~~li~~~l~~~p~~Rps-------~~~ll~~ 260 (269)
T 4hcu_A 235 HVYQIMNHCWRERPEDRPA-------FSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred HHHHHHHHHccCCcccCcC-------HHHHHHH
Confidence 9999999999999999999 8888875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=386.68 Aligned_cols=258 Identities=23% Similarity=0.284 Sum_probs=215.0
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEE-----EccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQ-----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAY 183 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~-----~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~ 183 (767)
.+..++|++.+.||+|+||.||+|+ ...+++.||+|++.... .......+.+|+.+|.++ +|||||++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 4566899999999999999999999 45677999999997542 223356789999999999 789999999999
Q ss_pred eeCC-eEEEEEEeccCCCHHHHHHhcCC----------------------------------------------------
Q psy11874 184 ETKD-ALCLVLTIMNGGDLKFHIYNMGG---------------------------------------------------- 210 (767)
Q Consensus 184 ~~~~-~l~lV~E~~~gG~L~~~l~~~~~---------------------------------------------------- 210 (767)
.+.+ .+++||||++||+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8765 49999999999999999987532
Q ss_pred -----------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc---cccc
Q psy11874 211 -----------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES---VRGR 276 (767)
Q Consensus 211 -----------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~---~~~~ 276 (767)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|........ ....
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 11289999999999999999999999999999999999999999999999999987644322 3345
Q ss_pred ccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhc
Q psy11874 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355 (767)
Q Consensus 277 ~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL 355 (767)
.||+.|+|||++.+..++.++|||||||++|||++ |..||.+........... ........+..+++++.+++.+||
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l 333 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCW 333 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH--HHTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH--HcCCCCCCCCCCCHHHHHHHHHHc
Confidence 78999999999999999999999999999999998 999998765332221111 112234556778999999999999
Q ss_pred ccCcCccCCCCCCcccHHHHHhC
Q psy11874 356 KKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 356 ~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+.||++||+ +.++++|
T Consensus 334 ~~dP~~Rps-------~~ell~~ 349 (359)
T 3vhe_A 334 HGEPSQRPT-------FSELVEH 349 (359)
T ss_dssp CSSGGGSCC-------HHHHHHH
T ss_pred cCChhhCCC-------HHHHHHH
Confidence 999999999 8888875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=382.75 Aligned_cols=275 Identities=20% Similarity=0.254 Sum_probs=226.9
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 184 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 184 (767)
.+..++|++.+.||+|+||.||+|.++ .+++.||+|++.... .......+.+|+.++++++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 455678999999999999999999987 467899999997543 2233456889999999999999999999999
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCC-------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEE
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGG-------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVR 257 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~-------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vk 257 (767)
+.+..++||||++||+|.+++...+. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 99999999999999999999976421 13579999999999999999999999999999999999999999999
Q ss_pred EeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhh
Q psy11874 258 ISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVK 333 (767)
Q Consensus 258 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~ 333 (767)
|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+. .
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~ 255 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM---E 255 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH---T
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH---c
Confidence 999999986643322 233467999999999999999999999999999999999 899998765433222222 1
Q ss_pred ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC------CCCCCCChhhHhcCCCCC
Q psy11874 334 EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA------EFFKSTNWKRLEAGLCDP 396 (767)
Q Consensus 334 ~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H------pfF~~i~w~~l~~~~~~p 396 (767)
......+..+++++.+||.+||+.||++||+ +.++++| |+|+.++|.......+++
T Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~e~l~~L~~~~~~~~~~~~~~~~~~~~~~~ 317 (322)
T 1p4o_A 256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPS-------FLEIISSIKEEMEPGFREVSFYYSEENKLPE 317 (322)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHHHGGGSCTTHHHHCSTTSTTC----
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcC-------HHHHHHHHHHhhccCCcccccccccccCCCC
Confidence 2233456688999999999999999999999 8888876 888888777665554443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=384.74 Aligned_cols=268 Identities=26% Similarity=0.369 Sum_probs=224.6
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh---hhHHHHHHHHHHHHhcC--CCceeEEEEEEeeC
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKIN--SRFVVSLAYAYETK 186 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~ 186 (767)
..++|++.+.||+|+||.||+|.+..+|+.||+|++........ .....+.+|+.++++++ |+||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 35789999999999999999999999999999999977654321 12244667999999996 49999999999999
Q ss_pred CeEEEEEEeccC-CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC-CCCCEEEeecCcc
Q psy11874 187 DALCLVLTIMNG-GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD-DYGHVRISDLGLA 264 (767)
Q Consensus 187 ~~l~lV~E~~~g-G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld-~~g~vkL~DFGla 264 (767)
+..++|||++.+ ++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++ +++.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999986 89999998764 689999999999999999999999999999999999999 7899999999999
Q ss_pred cccCCCCcccccccccccCCcceecCCCC-CCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDNEKY-TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~y-s~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
...... ......||+.|+|||++.+..+ +.++|||||||++|||++|..||..... +......++..+
T Consensus 198 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------~~~~~~~~~~~~ 266 (320)
T 3a99_A 198 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQRV 266 (320)
T ss_dssp EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HHHCCCCCSSCC
T ss_pred cccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------hhcccccccccC
Confidence 877543 3445679999999999977665 6889999999999999999999976432 112233456778
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P 400 (767)
++++.+||.+||..||++||+ ++++++||||++..+..-.+....++..|
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps-------~~~ll~hp~~~~~~~~~~~~~~~~~~~~p 316 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPT-------FEEIQNHPWMQDVLLPQETAEIHLHSLSP 316 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHTSGGGSSCCCHHHHHHHHTC----
T ss_pred CHHHHHHHHHHccCChhhCcC-------HHHHhcCHhhcCccCccccccccccccCC
Confidence 999999999999999999999 99999999999987665444333333333
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=371.69 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=208.4
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
...++|++.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.++++++||||+++++++.+.+.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34589999999999999999999999999999999998765555555677889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||++|++|..++.+.+ .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999998764 6899999999999999999999999999999999999999999999999999776543
Q ss_pred C--cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 271 E--SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 271 ~--~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
. ......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+ ..........+..+|+++.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCTHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCHHHH
Confidence 2 233567999999999999999999999999999999999999999877543222212 1112223345677899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++|.+||+.||++||+ +++++++
T Consensus 267 ~li~~~l~~dP~~Rp~------s~~~l~~ 289 (309)
T 2h34_A 267 AVIARGMAKNPEDRYV------TCGDLSA 289 (309)
T ss_dssp HHHHHHTCSSGGGSCS------SHHHHHH
T ss_pred HHHHHhccCCHHHHHH------hHHHHHH
Confidence 9999999999999995 3777764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=364.89 Aligned_cols=252 Identities=20% Similarity=0.260 Sum_probs=215.5
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++.+.||+|+||.||+|.++ ++..||+|++..... ....+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456689999999999999999999886 577899999975432 235588999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
++||||++||+|.+++...+ ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999999999999998753 2589999999999999999999999999999999999999999999999999987655
Q ss_pred CCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 270 GES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
... .....||+.|+|||++.+..++.++|+|||||++|+|++ |..||...........+. .......+...+++
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 233 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS---QGHRLYRPHLASDT 233 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---TTCCCCCCTTSCHH
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH---cCCCCCCCCcChHH
Confidence 432 233457788999999999899999999999999999999 999998765433322222 22233445678999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+.++|.+||+.||++||+ ++++++|
T Consensus 234 l~~li~~~l~~~p~~Rps-------~~~ll~~ 258 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPT-------FQQLLSS 258 (268)
T ss_dssp HHHHHHHTTCSSGGGSCC-------HHHHHHH
T ss_pred HHHHHHHHcCCChhhCcC-------HHHHHHH
Confidence 999999999999999999 8888875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=366.89 Aligned_cols=246 Identities=16% Similarity=0.242 Sum_probs=208.0
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l 189 (767)
+..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++++ +|++++++++++.+....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 44578999999999999999999999999999999986432 233477899999999 799999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC-----EEEeecCcc
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH-----VRISDLGLA 264 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~-----vkL~DFGla 264 (767)
|+||||+ ||+|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+|. +||+|||+|
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999999 999999998753 25999999999999999999999999999999999999988776 999999999
Q ss_pred cccCCCCc--------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhh---hhhh-hh
Q psy11874 265 VEIPEGES--------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD---EVDR-RV 332 (767)
Q Consensus 265 ~~~~~~~~--------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~---~i~~-~i 332 (767)
........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...... .+.. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 87654322 244579999999999999999999999999999999999999998754322221 1111 11
Q ss_pred hccccccCCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 333 KEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 333 ~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
..........+++++.+|+.+||+.||++||+
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~ 270 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPD 270 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCC
Confidence 12223344578999999999999999999999
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=384.06 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=185.6
Q ss_pred CCCeEEEe-EEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee----CC
Q psy11874 113 YKTFRMYR-VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET----KD 187 (767)
Q Consensus 113 ~~~y~~~~-~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~ 187 (767)
.++|++.+ +||+|+||.||+|.++.+|+.||+|++..... ........++.+.||||+++++++.. +.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 36899965 79999999999999999999999999865321 11222334667899999999999977 55
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC---CCCEEEeecCcc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD---YGHVRISDLGLA 264 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~---~g~vkL~DFGla 264 (767)
.+++||||++||+|.+++...+ ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 6999999999999999998753 346999999999999999999999999999999999999976 455999999999
Q ss_pred cccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc----cccC
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA----EKYS 340 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~----~~~~ 340 (767)
...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...............+.... ...+
T Consensus 179 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 179 KETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp EEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred eecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 876533 33456799999999999888999999999999999999999999977654333222222222222 2223
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
..+++++++||.+||+.||++||+ ++++++||||++
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt-------~~ell~hp~~~~ 293 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLT-------ITQFMNHPWINQ 293 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCC-------HHHHHHSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcC-------HHHHhcCccccc
Confidence 578999999999999999999999 999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=381.44 Aligned_cols=266 Identities=20% Similarity=0.329 Sum_probs=195.6
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHH-HHHhcCCCceeEEEEEEeeCC
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQ-ILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
..+..++|++.+.||+|+||.||+|.++.+|+.||+|++..... ......+..|.. +++.++||||+++++++.+.+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 34667899999999999999999999999999999999975421 222334555555 777889999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhc--CCCCCCCHHHHHHHHHHHHhHHHHHHHC-CcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNM--GGEPGFDIARARFYAAEVLCGLEHLHYI-GLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~--~~~~~l~~~~~~~~~~qIl~aL~yLH~~-~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
..++||||++| +|..++... .....+++..+..++.|++.||.|||+. ||+||||||+|||++.+|.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999999985 777666531 1134689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCccee----cCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc-
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVI----DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY- 339 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl----~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~- 339 (767)
.............||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.. ...+..........+
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGDPPQLS 251 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSCCCCCC
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcCCCCCCC
Confidence 877655444555899999999999 4667899999999999999999999999765431 111212222222222
Q ss_pred ---CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 340 ---SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 340 ---~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
...+++++.+||.+||..||++||+ ++++++||||....+
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPK-------YKELLKHPFILMYEE 294 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCC-------HHHHTTSHHHHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcC-------HHHHHhChHHHHhHh
Confidence 2468999999999999999999999 999999999986543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=366.40 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=211.8
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhh----hHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK----GESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~----~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
.+..++|++.+.||+|+||.||+|++..+++.||+|++......... ....+.+|+.++++++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 45668999999999999999999999999999999998654432221 12578899999999999999999999987
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC--cccccCCcceEEeCCCCC-----EEE
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLDDYGH-----VRI 258 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~--IvHrDLKPeNILld~~g~-----vkL 258 (767)
.. ++||||++||+|...+.+.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++. +||
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred CC--eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 76 69999999999988887643 36999999999999999999999999 999999999999988887 999
Q ss_pred eecCcccccCCCCcccccccccccCCccee--cCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc
Q psy11874 259 SDLGLAVEIPEGESVRGRVGTVGYMAPEVI--DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA 336 (767)
Q Consensus 259 ~DFGla~~~~~~~~~~~~~GT~~Y~APEvl--~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~ 336 (767)
+|||+|..... ......||+.|+|||++ ....++.++|||||||++|+|++|..||....................
T Consensus 171 ~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 171 ADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp CCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred CCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 99999986443 34456899999999999 445678999999999999999999999976543222111111112233
Q ss_pred cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 337 EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 337 ~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
...+..+++++.+||.+||+.||++||+ ++++++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~ll~ 282 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPH-------FSYIVK 282 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcC-------HHHHHH
Confidence 4566788999999999999999999999 888765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=373.77 Aligned_cols=258 Identities=23% Similarity=0.287 Sum_probs=217.9
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAY 183 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 183 (767)
..+..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+|++++||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 3455688999999999999999999983 456899999997542 234456788999999999999999999999
Q ss_pred eeCCeEEEEEEeccCCCHHHHHHhcCC---------------------CCCCCHHHHHHHHHHHHhHHHHHHHCCccccc
Q psy11874 184 ETKDALCLVLTIMNGGDLKFHIYNMGG---------------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRD 242 (767)
Q Consensus 184 ~~~~~l~lV~E~~~gG~L~~~l~~~~~---------------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrD 242 (767)
.+.+.+|+||||++||+|.+++..... ...+++..+..++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999987542 12489999999999999999999999999999
Q ss_pred CCcceEEeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCC
Q psy11874 243 CKPENILLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRR 318 (767)
Q Consensus 243 LKPeNILld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~ 318 (767)
|||+|||++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654432 233467899999999999999999999999999999999 9999987
Q ss_pred chhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 319 RKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 319 ~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.........+.. ......+..+++++.+||.+||+.||++||+ ++++++|
T Consensus 256 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-------~~~l~~~ 305 (314)
T 2ivs_A 256 IPPERLFNLLKT---GHRMERPDNCSEEMYRLMLQCWKQEPDKRPV-------FADISKD 305 (314)
T ss_dssp CCGGGHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred CCHHHHHHHhhc---CCcCCCCccCCHHHHHHHHHHccCChhhCcC-------HHHHHHH
Confidence 654332222221 2234456788999999999999999999999 8888764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=386.19 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=211.5
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-----------CCceeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-----------SRFVVS 178 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv~ 178 (767)
++..++|++.+.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.++++++ ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 345679999999999999999999999999999999997543 23455778999999886 889999
Q ss_pred EEEEEeeCC----eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC-CcccccCCcceEEeC--
Q psy11874 179 LAYAYETKD----ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI-GLVYRDCKPENILLD-- 251 (767)
Q Consensus 179 l~~~~~~~~----~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~-~IvHrDLKPeNILld-- 251 (767)
+++++...+ .+++|||++ ||+|..++.... ...+++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence 999998654 899999999 899999998753 33599999999999999999999998 999999999999994
Q ss_pred ----CCCCEEEeecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhh-----
Q psy11874 252 ----DYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM----- 322 (767)
Q Consensus 252 ----~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~----- 322 (767)
..+.+||+|||+|...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999876432 34568999999999999999999999999999999999999999765321
Q ss_pred -hhhhhhhhhh--------------------------------------hccccccCCCCcHHHHHHHHHhcccCcCccC
Q psy11874 323 -VKRDEVDRRV--------------------------------------KEDAEKYSCRFSDDAKALCKALLKKSPRSRL 363 (767)
Q Consensus 323 -~~~~~i~~~i--------------------------------------~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl 363 (767)
.....+.... ......++...++++.+||.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 1111111110 0111123344578899999999999999999
Q ss_pred CCCCCcccHHHHHhCCCCCCC
Q psy11874 364 GCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 364 ~~~~~~~~a~eil~HpfF~~i 384 (767)
+ ++|+++||||++.
T Consensus 327 t-------~~ell~hp~f~~~ 340 (373)
T 1q8y_A 327 D-------AGGLVNHPWLKDT 340 (373)
T ss_dssp C-------HHHHHTCGGGTTC
T ss_pred C-------HHHHhhChhhhcc
Confidence 9 9999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=367.51 Aligned_cols=255 Identities=20% Similarity=0.267 Sum_probs=214.9
Q ss_pred hcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 107 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
..+.+..++|++.+.||+|+||.||+|.++ ++..||+|++..... ....+.+|+.++.+++||||+++++++.+.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 345567789999999999999999999886 678899999975432 235688999999999999999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+.+|+||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred CCeEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence 99999999999999999997643 2699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 IPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
...... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+... .....+...
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~ 246 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLA 246 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---CCCCCCTTC
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc---cCCCCCCcC
Confidence 644321 233457889999999998999999999999999999998 99999876654333333222 233445678
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
++.+.+||.+||+.||++||+ ++++++|
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps-------~~~ll~~ 274 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPT-------FKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCC-------HHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcC-------HHHHHHH
Confidence 999999999999999999999 8888875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.54 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=201.7
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhh-hhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
+..++|++.+.||+|+||.||+|.+. |+.||+|++....... ....+.+.+|..+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 55689999999999999999999974 8999999987654322 23456788999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC---cccccCCcceEEeCC--------CCCEEE
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG---LVYRDCKPENILLDD--------YGHVRI 258 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~---IvHrDLKPeNILld~--------~g~vkL 258 (767)
|+||||++||+|..++... .+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEEEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999888532 6999999999999999999999999 999999999999986 788999
Q ss_pred eecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc
Q psy11874 259 SDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK 338 (767)
Q Consensus 259 ~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~ 338 (767)
+|||++....... .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+.. ......
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~ 234 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM--NKLALP 234 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT--SCCCCC
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc--CCCCCC
Confidence 9999998765433 2356799999999999999999999999999999999999999987654333222211 222334
Q ss_pred cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 339 ~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.+..+++++.++|.+||+.||++||+ ++|+++|
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps-------~~e~l~~ 267 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRPS-------FTNILDQ 267 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcC-------HHHHHHH
Confidence 56788999999999999999999999 8888764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=377.93 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=215.9
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 184 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 184 (767)
.+..++|++.+.||+|+||.||+|++. .+++.||+|++.+.. .......+.+|+.+|++++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 456689999999999999999999997 456899999997543 2334567889999999999999999999999
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCC---------------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccC
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGG---------------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDC 243 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~---------------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDL 243 (767)
+.+.+|+||||++||+|.+++..... ...+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99999999999999999999987431 146899999999999999999999999999999
Q ss_pred CcceEEeCCCCCEEEeecCcccccCCCC---cccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCc
Q psy11874 244 KPENILLDDYGHVRISDLGLAVEIPEGE---SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRR 319 (767)
Q Consensus 244 KPeNILld~~g~vkL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~ 319 (767)
||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|+|||||++|||++ |..||.+.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 9999999999999999999998654332 2234568999999999999999999999999999999999 99999876
Q ss_pred hhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 320 KEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 320 ~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
........+. .......+..+++++.+||.+||+.||++||+ +.++++
T Consensus 281 ~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-------~~~~~~ 328 (343)
T 1luf_A 281 AHEEVIYYVR---DGNILACPENCPLELYNLMRLCWSKLPADRPS-------FCSIHR 328 (343)
T ss_dssp CHHHHHHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred ChHHHHHHHh---CCCcCCCCCCCCHHHHHHHHHHcccCcccCCC-------HHHHHH
Confidence 5433222222 12233456788999999999999999999999 777765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=387.68 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=216.8
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
.+.+..++|++.+.||+|+||.||+|.++.+|+.||+|++.... .......+.+|+.+|++++||||+++++++.+.+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 34566789999999999999999999999999999999986542 2233445788999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+|||||+||+|..++...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 9999999999999999998753 25899999999999999999999999999999999999999999999999999875
Q ss_pred CCCCcc---cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 268 PEGESV---RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 268 ~~~~~~---~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
..+... ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.. ......+..+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 340 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK---GGRLPCPELC 340 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT---TCCCCCCTTC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCC
Confidence 443221 12346788999999998899999999999999999998 9999987654433332222 2234456678
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++++.+|+.+||+.||++||+ ++++++
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps-------~~~i~~ 367 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPS-------FSTIYQ 367 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcC-------HHHHHH
Confidence 999999999999999999999 777764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=381.65 Aligned_cols=258 Identities=20% Similarity=0.279 Sum_probs=218.9
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccC-------CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRAT-------GKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLA 180 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-------g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~ 180 (767)
+.+..++|++.+.||+|+||.||+|++..+ +..||+|++.... .......+.+|+.+++++ +|||||+++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 345668999999999999999999997643 3689999987652 334456788999999999 999999999
Q ss_pred EEEeeCCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcce
Q psy11874 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPEN 247 (767)
Q Consensus 181 ~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeN 247 (767)
+++.+.+.+|+||||++||+|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 999999999999999999999999987542 2359999999999999999999999999999999999
Q ss_pred EEeCCCCCEEEeecCcccccCCCC---cccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhh
Q psy11874 248 ILLDDYGHVRISDLGLAVEIPEGE---SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMV 323 (767)
Q Consensus 248 ILld~~g~vkL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~ 323 (767)
||++.++.+||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998765432 2334568899999999999999999999999999999999 999998765433
Q ss_pred hhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 324 KRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 324 ~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
....+.. ......+..+++++.+||.+||+.||++||+ +++++++
T Consensus 302 ~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-------~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKE---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPT-------FKQLVED 346 (382)
T ss_dssp HHHHHHT---TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred HHHHHHc---CCCCCCCccCCHHHHHHHHHHcCCChhhCcC-------HHHHHHH
Confidence 2222221 2234456788999999999999999999999 8888874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=378.00 Aligned_cols=260 Identities=20% Similarity=0.260 Sum_probs=215.5
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYA 182 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 182 (767)
+.+..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+|.++ +||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4566789999999999999999999973 467799999997543 233456788999999999 99999999999
Q ss_pred EeeCCeEEEEEEeccCCCHHHHHHhcCCC--------------------CCCCHHHHHHHHHHHHhHHHHHHHCCccccc
Q psy11874 183 YETKDALCLVLTIMNGGDLKFHIYNMGGE--------------------PGFDIARARFYAAEVLCGLEHLHYIGLVYRD 242 (767)
Q Consensus 183 ~~~~~~l~lV~E~~~gG~L~~~l~~~~~~--------------------~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrD 242 (767)
+.+.+.+|+||||++||+|.+++...... ..+++..+..++.||+.||.|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 99999999999999999999999875321 2379999999999999999999999999999
Q ss_pred CCcceEEeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCC
Q psy11874 243 CKPENILLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRR 318 (767)
Q Consensus 243 LKPeNILld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~ 318 (767)
|||+|||++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999986644332 234568899999999999999999999999999999998 9999987
Q ss_pred chhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCC
Q psy11874 319 RKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAE 379 (767)
Q Consensus 319 ~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~Hp 379 (767)
............. ......+...++++.+||.+||..||.+||+ +.++++|-
T Consensus 278 ~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~l~~~l 329 (344)
T 1rjb_A 278 IPVDANFYKLIQN--GFKMDQPFYATEEIYIIMQSCWAFDSRKRPS-------FPNLTSFL 329 (344)
T ss_dssp CCCSHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHHH
T ss_pred CCcHHHHHHHHhc--CCCCCCCCCCCHHHHHHHHHHcCCCchhCcC-------HHHHHHHH
Confidence 6543222222211 1233445678999999999999999999999 88888754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=372.91 Aligned_cols=262 Identities=23% Similarity=0.370 Sum_probs=197.2
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++.+.||+|+||.||+|.++.+|+.||+|++...... ......+..+..+++.++||||+++++++.+.+.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 34567899999999999999999999999999999999765322 22233344555678889999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC-CcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI-GLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~-~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
|+||||+ ++.+........ ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEEEecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999999 556655554432 3689999999999999999999995 99999999999999999999999999998776
Q ss_pred CCCcccccccccccCCcceec-----CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC--C
Q psy11874 269 EGESVRGRVGTVGYMAPEVID-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS--C 341 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~-----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~--~ 341 (767)
.........||+.|+|||++. +..++.++|||||||++|+|++|..||...... ...+...........+ .
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 254 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVLQEEPPLLPGHM 254 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHHSCCCCCCSSS
T ss_pred CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHHhccCCCCCCccC
Confidence 555555668999999999994 567899999999999999999999999764321 1112222222222222 3
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.+++++.+||.+||..||.+||+ ++++++||||++.
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps-------~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPK-------YNKLLEHSFIKRY 290 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCC-------HHHHTTSHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcC-------HHHHhhCHHHHhc
Confidence 58999999999999999999999 9999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=369.75 Aligned_cols=256 Identities=20% Similarity=0.296 Sum_probs=208.5
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEE----EccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQ----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
.+..++|++.+.||+|+||.||+|+ ...+|+.||+|++... .......+.+|+.+|++++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4556899999999999999999999 5668999999998654 23345568899999999999999999999854
Q ss_pred --CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 186 --KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 186 --~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
...+++||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 456999999999999999998753 2589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhh------------hhh
Q psy11874 264 AVEIPEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK------------RDE 327 (767)
Q Consensus 264 a~~~~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~------------~~~ 327 (767)
|........ .....||+.|+|||++.+..++.++|||||||++|||++|..||........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987654322 2334578889999999999999999999999999999999999875432110 001
Q ss_pred hhhhh-hccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 328 VDRRV-KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 328 i~~~i-~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+...+ .......+..+++++.+|+.+||+.||++||+ ++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~el~~ 284 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS-------FRDLAL 284 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCC-------HHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCC-------HHHHHH
Confidence 11111 22234456788999999999999999999999 777764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=375.31 Aligned_cols=253 Identities=23% Similarity=0.271 Sum_probs=206.4
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEE----EEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~----AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+..++|++.+.||+|+||.||+|++..+|+.+ |+|.+.... .......+.+|+.++++++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45678999999999999999999998888765 777665332 334456789999999999999999999999876
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+ .++|+||+++|+|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 5 889999999999999998753 3699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 267 IPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 267 ~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
...... .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.. ......+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~ 243 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPI 243 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---TCCCCCCTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc---CCCCCCCcc
Confidence 654432 233457889999999999999999999999999999999 9999987654332222221 223345667
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.+.++.+++.+||+.||++||+ +.++++|
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps-------~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPK-------FRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCC-------HHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCC-------HHHHHHH
Confidence 8999999999999999999999 8888765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=382.49 Aligned_cols=281 Identities=15% Similarity=0.122 Sum_probs=208.7
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccC-----CcEEEEEEechhhhhh--------hhhHHHHHHHHHHHHhcCCCcee
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT-----GKMYACKKLEKKRIKK--------RKGESMVLIEKQILQKINSRFVV 177 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~~AiK~l~k~~~~~--------~~~~~~~~~E~~iL~~l~hp~Iv 177 (767)
+..++|++.+.||+|+||.||+|.++.+ ++.||+|++....... .........|...+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4457899999999999999999999765 5899999986543111 11122355677788889999999
Q ss_pred EEEEEEeeC----CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC--
Q psy11874 178 SLAYAYETK----DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD-- 251 (767)
Q Consensus 178 ~l~~~~~~~----~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld-- 251 (767)
++++++... ..+|+||||| ||+|..++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 999998764 5699999999 999999998742 3699999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCcccccCCCCc--------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh
Q psy11874 252 DYGHVRISDLGLAVEIPEGES--------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV 323 (767)
Q Consensus 252 ~~g~vkL~DFGla~~~~~~~~--------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~ 323 (767)
.++.+||+|||+|+....... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 899999999999976543321 133459999999999999999999999999999999999999998643221
Q ss_pred hhhh-hhhhhhccccc------cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHH----------hCCCCCCCCh
Q psy11874 324 KRDE-VDRRVKEDAEK------YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELK----------QAEFFKSTNW 386 (767)
Q Consensus 324 ~~~~-i~~~i~~~~~~------~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil----------~HpfF~~i~w 386 (767)
.... ........... ....+++++.+++..||..||++||+ +++|+ ..++-...+|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~-------~~~l~~~l~~~~~~~~~~~~~~~dw 341 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPL-------YENLRDILLQGLKAIGSKDDGKLDL 341 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCC-------HHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCC-------HHHHHHHHHHHHHHcCCCcCCccce
Confidence 1111 11111111111 12567999999999999999999999 55544 2466677899
Q ss_pred hhHhcCCCCCCCCCC
Q psy11874 387 KRLEAGLCDPPFVPD 401 (767)
Q Consensus 387 ~~l~~~~~~pp~~P~ 401 (767)
....++...+|..+.
T Consensus 342 ~~~~~~~~~~~~~~~ 356 (364)
T 3op5_A 342 SVVENGGLKAKTITK 356 (364)
T ss_dssp ---------------
T ss_pred EeccCCccchhhhhh
Confidence 998888877775544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=397.55 Aligned_cols=272 Identities=24% Similarity=0.317 Sum_probs=206.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l 189 (767)
+...+|++.++||+|+||+|+. ....+|+.||+|++.+... ..+.+|+.+|+++ +|||||++++++.+.+.+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 3445699999999999999764 3446899999999865432 2256799999999 799999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC---C--CCEEEeecCcc
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD---Y--GHVRISDLGLA 264 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~---~--g~vkL~DFGla 264 (767)
|+|||||+ |+|.+++.... ..+.+..+..++.||+.||.|||++||+||||||+|||++. + ..+||+|||+|
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99999997 59999987653 23555567789999999999999999999999999999953 2 35789999999
Q ss_pred cccCCCC----cccccccccccCCcceec---CCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccc
Q psy11874 265 VEIPEGE----SVRGRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDA 336 (767)
Q Consensus 265 ~~~~~~~----~~~~~~GT~~Y~APEvl~---~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~ 336 (767)
+....+. .....+||+.|+|||++. ...++.++|||||||++|||++ |..||......... .+........
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~~~~~~~ 249 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLGACSLDC 249 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTTCCCCTT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhccCCccc
Confidence 8775442 234567999999999997 4567889999999999999999 99999655332211 1111111111
Q ss_pred cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh---------hhHhcCCCCCCCCC
Q psy11874 337 EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW---------KRLEAGLCDPPFVP 400 (767)
Q Consensus 337 ~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w---------~~l~~~~~~pp~~P 400 (767)
.......+..+++||.+||+.||++||+ ++++++||||.+++| .+++....++|+++
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps-------~~evl~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPS-------AKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVK 315 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCC-------HHHHHTSTTTCCHHHHHHHHHHHHHHCSCSCSSCHHHH
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCC-------HHHHHhCccccChHHHHHHHHHHHHHhhcccccchHHH
Confidence 1112234667999999999999999999 999999999999988 33444445555544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=369.42 Aligned_cols=259 Identities=21% Similarity=0.259 Sum_probs=217.2
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEE-----ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYA 182 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 182 (767)
..+..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+|+++ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 345668999999999999999999985 4578899999997543 223356788999999999 99999999999
Q ss_pred EeeCCeEEEEEEeccCCCHHHHHHhcCC---------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcce
Q psy11874 183 YETKDALCLVLTIMNGGDLKFHIYNMGG---------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPEN 247 (767)
Q Consensus 183 ~~~~~~l~lV~E~~~gG~L~~~l~~~~~---------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeN 247 (767)
+.+.+..++||||++||+|.+++..... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 9999999999999999999999987542 1248999999999999999999999999999999999
Q ss_pred EEeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhh
Q psy11874 248 ILLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMV 323 (767)
Q Consensus 248 ILld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~ 323 (767)
||++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999987655432 234568899999999999999999999999999999998 999998765432
Q ss_pred hhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 324 KRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 324 ~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
........ ......+..+++++.+||.+||..||.+||+ +++++++
T Consensus 256 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPT-------FKQIVQL 301 (313)
T ss_dssp HHHHHHHH--TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred HHHHHhcc--CCCCCCcccCCHHHHHHHHHHcCCCchhCcC-------HHHHHHH
Confidence 22222211 1122335678999999999999999999999 8888763
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=391.30 Aligned_cols=258 Identities=21% Similarity=0.323 Sum_probs=213.9
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC--eE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD--AL 189 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~l 189 (767)
..++|++.+.||+|+||.||+|+++.+|+.||+|++..... ......+.+|+.+|++++||||+++++++...+ ..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 34689999999999999999999999999999999976543 233566789999999999999999999998765 78
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe----CCCCCEEEeecCccc
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL----DDYGHVRISDLGLAV 265 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl----d~~g~vkL~DFGla~ 265 (767)
|+|||||+||+|..++........+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 9999999999999999875544459999999999999999999999999999999999999 788889999999999
Q ss_pred ccCCCCcccccccccccCCcceecC--------CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc
Q psy11874 266 EIPEGESVRGRVGTVGYMAPEVIDN--------EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE 337 (767)
Q Consensus 266 ~~~~~~~~~~~~GT~~Y~APEvl~~--------~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~ 337 (767)
...........+||+.|+|||++.+ ..++.++|||||||++|||++|..||..........++...+....+
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 8776666667789999999999865 56788999999999999999999999754332222222222222111
Q ss_pred -------------------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 338 -------------------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 338 -------------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.++..+++.+.+++.+||+.||++|++ +++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s-------~~e~l~~ 303 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG-------FDQFFAE 303 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC-------HHHHHHH
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc-------HHHHHHH
Confidence 111234678899999999999999999 8887653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=367.60 Aligned_cols=249 Identities=19% Similarity=0.247 Sum_probs=210.2
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCC-------cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYA 182 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 182 (767)
.+..++|++.+.||+|+||.||+|.++.++ ..||+|++.+.. ....+.+.+|+.++++++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456689999999999999999999999877 479999986542 3345678899999999999999999999
Q ss_pred EeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC-------
Q psy11874 183 YETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH------- 255 (767)
Q Consensus 183 ~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~------- 255 (767)
+.+.+..++||||++||+|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 999999999999999999999998753 24899999999999999999999999999999999999998887
Q ss_pred -EEEeecCcccccCCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCC-CCCCCchhhhhhhhhhhhh
Q psy11874 256 -VRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQ-APFRRRKEMVKRDEVDRRV 332 (767)
Q Consensus 256 -vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~-~PF~~~~~~~~~~~i~~~i 332 (767)
+||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|. +||......... ..
T Consensus 159 ~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-----~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-----QF 230 (289)
T ss_dssp EEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----HH
T ss_pred eeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-----HH
Confidence 99999999976533 234568999999999987 77999999999999999999954 555444322111 12
Q ss_pred hccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 333 KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 333 ~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.......+...++++.+||.+||+.||++||+ ++++++|
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~ll~~ 269 (289)
T 4fvq_A 231 YEDRHQLPAPKAAELANLINNCMDYEPDHRPS-------FRAIIRD 269 (289)
T ss_dssp HHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCC-------HHHHHHH
T ss_pred hhccCCCCCCCCHHHHHHHHHHcCCChhHCcC-------HHHHHHH
Confidence 22334556677889999999999999999999 8888763
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=365.48 Aligned_cols=253 Identities=20% Similarity=0.290 Sum_probs=202.5
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccC---CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
.+..++|++.+.||+|+||.||+|.+..+ +..+|+|++.... .....+.+.+|+.++++++||||+++++++. .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 45567899999999999999999998754 5679999986542 2334566889999999999999999999884 5
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+..|+||||++||+|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred CccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 67899999999999999998653 3689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 IPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+. .......+..+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~ 242 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---NGERLPMPPNC 242 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCCCCCCTTC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH---cCCCCCCCCCC
Confidence 654432 223457889999999999999999999999999999996 999998765443332222 12234566789
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++++.++|.+||+.||++||+ ++++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps-------~~~l~~ 269 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPR-------FTELKA 269 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcC-------HHHHHH
Confidence 999999999999999999999 888775
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=364.64 Aligned_cols=254 Identities=19% Similarity=0.271 Sum_probs=219.0
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
+.+..++|++.+.||+|+||.||+|.++.+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3456689999999999999999999999999999999986532 234568899999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+||||++||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999998753 3469999999999999999999999999999999999999999999999999998765
Q ss_pred CCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 269 EGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 269 ~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
.... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.. ......+..+++
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 239 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPE 239 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TCCCCCCTTCCH
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---cCCCCCCCCCCH
Confidence 4432 234567899999999999999999999999999999999 9999987654433332222 223445678899
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++.+||.+||..||.+||+ ++++++
T Consensus 240 ~l~~li~~~l~~dp~~Rps-------~~~~~~ 264 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPS-------FAEIHQ 264 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHHHHHHHHhCCChhhCcC-------HHHHHH
Confidence 9999999999999999999 778764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=373.70 Aligned_cols=257 Identities=19% Similarity=0.290 Sum_probs=213.6
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEE--EEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeC
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMY--ACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETK 186 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~--AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~ 186 (767)
.+..++|++.+.||+|+||.||+|+++.+|..+ |+|.+.... .......+.+|+.+|+++ +||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 356689999999999999999999999999866 999886432 233455688999999999 999999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcC-------------CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMG-------------GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY 253 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~-------------~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~ 253 (767)
+.+|+||||++||+|.+++...+ ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 99999999999999999997642 12368999999999999999999999999999999999999999
Q ss_pred CCEEEeecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhh
Q psy11874 254 GHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRV 332 (767)
Q Consensus 254 g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i 332 (767)
+.+||+|||++.............+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus 179 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-- 256 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 256 (327)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG--
T ss_pred CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc--
Confidence 9999999999975443333344567899999999998889999999999999999998 9999987754333322222
Q ss_pred hccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 333 KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 333 ~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
......+..+++++.+||.+||..||++||+ ++++++|
T Consensus 257 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~ell~~ 294 (327)
T 1fvr_A 257 -GYRLEKPLNCDDEVYDLMRQCWREKPYERPS-------FAQILVS 294 (327)
T ss_dssp -TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred -CCCCCCCCCCCHHHHHHHHHHccCChhhCcC-------HHHHHHH
Confidence 1233455678999999999999999999999 8888874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=365.51 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=204.3
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.++++++||||+++++++.+.+.++
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34578999999999999999999999999999999997655445555677889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
+||||++||+|..++.... ....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999999887532 234689999999999999999999999999999999999999999999999999987644
Q ss_pred CCc-ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc--ccccCCCCcHH
Q psy11874 270 GES-VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED--AEKYSCRFSDD 346 (767)
Q Consensus 270 ~~~-~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~~~~~s~~ 346 (767)
... .....||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.... ...+...+... ....+..++++
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCcccccCHH
Confidence 322 34457999999999999999999999999999999999999999765321 11122222211 11123568999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+.+||.+||..||++||+ ++++++
T Consensus 267 l~~li~~~l~~dp~~Rps-------~~~il~ 290 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPD-------VTYVYD 290 (310)
T ss_dssp HHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHHHHHHHcCCChhhCCC-------HHHHHH
Confidence 999999999999999999 888876
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=372.39 Aligned_cols=251 Identities=28% Similarity=0.419 Sum_probs=209.5
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh---hhHHHHHHHHHHHHhc----CCCceeEEEEEEee
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKI----NSRFVVSLAYAYET 185 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l----~hp~Iv~l~~~~~~ 185 (767)
.++|++.+.||+|+||.||+|.++.+|+.||+|++........ .....+.+|+.++.++ +||||+++++++.+
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 4689999999999999999999999999999999976543221 1223456799999998 89999999999999
Q ss_pred CCeEEEEEEe-ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC-CCCCEEEeecCc
Q psy11874 186 KDALCLVLTI-MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD-DYGHVRISDLGL 263 (767)
Q Consensus 186 ~~~l~lV~E~-~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld-~~g~vkL~DFGl 263 (767)
.+..++|||+ +.|++|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++ .+|.+||+|||+
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999 89999999998764 589999999999999999999999999999999999999 889999999999
Q ss_pred ccccCCCCcccccccccccCCcceecCCCCC-CCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 264 AVEIPEGESVRGRVGTVGYMAPEVIDNEKYT-YSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 264 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys-~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
+...... ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||..... +......++..
T Consensus 187 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~~~~~~~~~~ 255 (312)
T 2iwi_A 187 GALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------ILEAELHFPAH 255 (312)
T ss_dssp CEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HHHTCCCCCTT
T ss_pred hhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------HhhhccCCccc
Confidence 9877543 34556799999999999776664 589999999999999999999976432 11223345678
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
+++++++||.+||+.||++||+ ++|+++||||+..
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps-------~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPS-------LEEILLDPWMQTP 290 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCC-------HHHHHHSTTTCC-
T ss_pred CCHHHHHHHHHHccCChhhCcC-------HHHHhcChhhcCc
Confidence 8999999999999999999999 9999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=361.60 Aligned_cols=261 Identities=19% Similarity=0.264 Sum_probs=209.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEE-EEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY-AYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~~~~~~~l~lV 192 (767)
++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+|..+++.++|++++..+. ++...+..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 689999999999999999999999999999998755432 224778999999999877665554 45778899999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe---CCCCCEEEeecCcccccCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl---d~~g~vkL~DFGla~~~~~ 269 (767)
|||+ ||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9999 999999987643 369999999999999999999999999999999999999 7899999999999987654
Q ss_pred CCc--------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhh----hhhhcccc
Q psy11874 270 GES--------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD----RRVKEDAE 337 (767)
Q Consensus 270 ~~~--------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~----~~i~~~~~ 337 (767)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+. ........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 322 234579999999999999999999999999999999999999998754332222211 11112222
Q ss_pred ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh----------CCCCCCCChhhH
Q psy11874 338 KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ----------AEFFKSTNWKRL 389 (767)
Q Consensus 338 ~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~----------HpfF~~i~w~~l 389 (767)
.....+|+++.+||.+||+.||++||+ ++++++ .++-...+|+.+
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt-------~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPD-------YSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCC-------HHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCC-------HHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 334678999999999999999999999 666655 455555666654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=358.03 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=214.9
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 455678999999999999999999986 678999999976532 235688999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 99999999999999998753 3689999999999999999999999999999999999999999999999999987643
Q ss_pred CCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 270 GES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 270 ~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
... .....||+.|+|||++.+..++.++|+|||||++|+|++ |..||...........+.. ......+...++.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~ 233 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLASTH 233 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---TCCCCCCTTSCHH
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc---CCcCCCCccCcHH
Confidence 321 234567889999999998999999999999999999999 9999987654333332222 1223445678999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+.+++.+||+.||++||+ +++++++
T Consensus 234 l~~li~~~l~~~p~~Rps-------~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPA-------FSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred HHHHHHHHccCChhhCcC-------HHHHHHH
Confidence 999999999999999999 8888753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=364.46 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=210.6
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEE----EccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQ----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+..+.|++.+.||+|+||.||+|+ ...+|+.||+|++.... .......+.+|+.+|++++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 445679999999999999999999 46789999999997653 333456788999999999999999999999876
Q ss_pred --CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 187 --DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 187 --~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
+.+++||||++||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 67999999999999999996653 26999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhh-----------hhhhhhh
Q psy11874 265 VEIPEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-----------VKRDEVD 329 (767)
Q Consensus 265 ~~~~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~-----------~~~~~i~ 329 (767)
........ .....||+.|+|||++.+..++.++|+|||||++|+|++|..|+...... .....+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 87755432 23456899999999999999999999999999999999999987543211 1111222
Q ss_pred hhh-hccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 330 RRV-KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 330 ~~i-~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
..+ .......+..+++++.+||.+||+.||++||+ ++++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTS-------FQNLIE 295 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCC-------HHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCC-------HHHHHH
Confidence 222 22234456788999999999999999999999 777764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=367.51 Aligned_cols=257 Identities=25% Similarity=0.318 Sum_probs=214.3
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEE-----ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAY 183 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~ 183 (767)
.+..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .......+.+|+.++.++ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 35568999999999999999999985 3567999999997643 223445688999999999 789999999998
Q ss_pred eeCC-eEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEE
Q psy11874 184 ETKD-ALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENIL 249 (767)
Q Consensus 184 ~~~~-~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNIL 249 (767)
...+ .+++||||++||+|..++..... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 8754 59999999999999999987542 112899999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhh
Q psy11874 250 LDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKR 325 (767)
Q Consensus 250 ld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~ 325 (767)
++.+|.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~- 259 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 259 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH-
Confidence 99999999999999987644332 234568999999999999999999999999999999998 9999977543222
Q ss_pred hhhhhhhh-ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 326 DEVDRRVK-EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 326 ~~i~~~i~-~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+...+. ......+..+++++.++|.+||+.||.+||+ ++++++|
T Consensus 260 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~ell~~ 304 (316)
T 2xir_A 260 --FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT-------FSELVEH 304 (316)
T ss_dssp --HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred --HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcC-------HHHHHHH
Confidence 111221 2233456678999999999999999999999 8898876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=356.37 Aligned_cols=252 Identities=18% Similarity=0.212 Sum_probs=212.5
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC--
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-- 186 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-- 186 (767)
..+..++|++.+.||+|+||.||+|++. |+.+|+|++...... ......+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 4566789999999999999999999985 899999999765322 23345688999999999999999999999887
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC--cccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~--IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
+.+++||||++||+|.+++.... ...+++..+..++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 78999999999999999998753 335899999999999999999999999 999999999999999999999999887
Q ss_pred cccCCCCcccccccccccCCcceecCCCCCC---CCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCC
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDNEKYTY---SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~---~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~ 341 (767)
.... .....||+.|+|||++.+..++. ++|||||||++|||++|..||.+.+.......+.. .......+.
T Consensus 161 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~ 234 (271)
T 3kmu_A 161 FSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL--EGLRPTIPP 234 (271)
T ss_dssp CTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH--SCCCCCCCT
T ss_pred eeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh--cCCCCCCCC
Confidence 5532 23457899999999998766555 79999999999999999999987654333222211 222345667
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+++++.++|.+||+.||++||+ ++++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps-------~~~il~ 263 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPK-------FDMIVP 263 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcC-------HHHHHH
Confidence 89999999999999999999999 788765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=383.54 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=213.5
Q ss_pred hhhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe
Q psy11874 105 YNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 184 (767)
Q Consensus 105 ~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 184 (767)
....+.+..++|++.+.||+|+||.||+|.++ |+.||+|++.... ..+.+.+|+.+|++++|||||++++++.
T Consensus 184 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 184 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp HHTTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 34456788899999999999999999999985 7899999987542 3456889999999999999999999987
Q ss_pred eCC-eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 185 TKD-ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 185 ~~~-~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
..+ .+|+|||||+||+|.+++...+ ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence 655 7999999999999999998764 33479999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 264 AVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 264 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
|+..... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.. ......+..
T Consensus 336 a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~---~~~~~~p~~ 410 (450)
T 1k9a_A 336 TKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDG 410 (450)
T ss_dssp CEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT---TCCCCCCTT
T ss_pred ccccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCc
Confidence 9865432 223468899999999999999999999999999999998 9999987654333332222 223455678
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++++.+||.+||+.||++||+ +.++++
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt-------~~~l~~ 438 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPT-------FLQLRE 438 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcC-------HHHHHH
Confidence 8999999999999999999999 666653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=371.26 Aligned_cols=259 Identities=20% Similarity=0.257 Sum_probs=216.2
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccCCc-----EEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEE
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY 181 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 181 (767)
...+..++|++.+.||+|+||.||+|.+..+|+ .||+|++.... .......+.+|+.+|+++ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 345667899999999999999999999987664 89999986543 223456788999999999 8999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCC-----------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGG-----------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL 250 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~-----------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl 250 (767)
++.+.+.+|+||||++||+|.+++..... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 99999999999999999999999976421 2358999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhh
Q psy11874 251 DDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRD 326 (767)
Q Consensus 251 d~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~ 326 (767)
+.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 9999999999999986543322 234567899999999999999999999999999999998 999998764332222
Q ss_pred hhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 327 EVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 327 ~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+... ......+...++++.+||.+||+.||.+||+ ++++++
T Consensus 278 ~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-------~~~l~~ 319 (333)
T 2i1m_A 278 KLVKD--GYQMAQPAFAPKNIYSIMQACWALEPTHRPT-------FQQICS 319 (333)
T ss_dssp HHHHH--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHHhc--CCCCCCCCCCCHHHHHHHHHHhccChhhCcC-------HHHHHH
Confidence 22211 1223345668999999999999999999999 888875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=360.81 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=213.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--------
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-------- 185 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-------- 185 (767)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 47999999999999999999999999999999986542 235679999999999999999998865
Q ss_pred --------CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEE
Q psy11874 186 --------KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVR 257 (767)
Q Consensus 186 --------~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vk 257 (767)
...+++||||++||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 456899999999999999997653 23689999999999999999999999999999999999999999999
Q ss_pred EeecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc
Q psy11874 258 ISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE 337 (767)
Q Consensus 258 L~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~ 337 (767)
|+|||++.............||+.|+|||++.+..++.++|+|||||++|+|++|..||..... ....+. ..
T Consensus 163 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------~~~~~~--~~ 234 (284)
T 2a19_B 163 IGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------FFTDLR--DG 234 (284)
T ss_dssp ECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH------HHHHHH--TT
T ss_pred ECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH------HHHHhh--cc
Confidence 9999999887766555667899999999999999999999999999999999999999854321 111111 12
Q ss_pred ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 338 KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 338 ~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
..+..+++++++||.+||..||++||+ +.++++|++.-
T Consensus 235 ~~~~~~~~~~~~li~~~l~~dp~~Rps-------~~e~l~~l~~~ 272 (284)
T 2a19_B 235 IISDIFDKKEKTLLQKLLSKKPEDRPN-------TSEILRTLTVW 272 (284)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCC-------HHHHHHHHHHH
T ss_pred cccccCCHHHHHHHHHHccCChhhCcC-------HHHHHHHHHHH
Confidence 345678999999999999999999999 99999987653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=369.04 Aligned_cols=257 Identities=19% Similarity=0.287 Sum_probs=215.1
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEc-------cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY 181 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~-------~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 181 (767)
.+..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++++ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 455689999999999999999999986 467899999997543 233456788999999999 9999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceE
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNI 248 (767)
++.+.+.+|+||||++||+|.+++..... ...+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 99999999999999999999999987532 12489999999999999999999999999999999999
Q ss_pred EeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhh
Q psy11874 249 LLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVK 324 (767)
Q Consensus 249 Lld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~ 324 (767)
|++.+|.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+......
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 999999999999999987655432 233467899999999998889999999999999999999 9999987654332
Q ss_pred hhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 325 RDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 325 ~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
...+.. ......+..+++++.++|.+||..||.+||+ +++++++
T Consensus 269 ~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~ell~~ 312 (334)
T 2pvf_A 269 FKLLKE---GHRMDKPANCTNELYMMMRDCWHAVPSQRPT-------FKQLVED 312 (334)
T ss_dssp HHHHHH---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred HHHHhc---CCCCCCCccCCHHHHHHHHHHccCChhhCcC-------HHHHHHH
Confidence 222221 2234456678999999999999999999999 8888763
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=367.47 Aligned_cols=259 Identities=22% Similarity=0.383 Sum_probs=210.2
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC--CCceeEEEEEEeeCC
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN--SRFVVSLAYAYETKD 187 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~ 187 (767)
.+..++|++.+.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.++.+++ ||||+++++++.+.+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 344567999999999999999999985 589999999976532 2334567889999999997 599999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+||| +.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+++ |.+||+|||++...
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999999 66889999998754 6899999999999999999999999999999999999975 89999999999876
Q ss_pred CCCCc---ccccccccccCCcceecC-----------CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh
Q psy11874 268 PEGES---VRGRVGTVGYMAPEVIDN-----------EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK 333 (767)
Q Consensus 268 ~~~~~---~~~~~GT~~Y~APEvl~~-----------~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~ 333 (767)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ..+...+.
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~ 254 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIID 254 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHHHC
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--HHHHHHHh
Confidence 54332 234579999999999865 468889999999999999999999997643221 11111111
Q ss_pred -ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 334 -EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 334 -~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.....++...++++.+||.+||+.||++||+ ++|+++||||+..
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~ell~h~~~~~~ 299 (313)
T 3cek_A 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS-------IPELLAHPYVQIQ 299 (313)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC-------HHHHHTSHHHHCC
T ss_pred cccccCCcccchHHHHHHHHHHccCCcccCcC-------HHHHhcCccccCC
Confidence 1223455667899999999999999999999 9999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=378.97 Aligned_cols=254 Identities=20% Similarity=0.313 Sum_probs=202.7
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEc---cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
.+..++|++.+.||+|+||.||+|+++ .++..||+|++.... .......+.+|+.+|++++||||+++++++.+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 455678999999999999999999987 467889999986542 233456789999999999999999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+.+|+||||++||+|..++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CceEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999999997643 3699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCC
Q psy11874 267 IPEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 267 ~~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~ 341 (767)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.. ......+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~---~~~~~~~~ 273 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE---GYRLPPPM 273 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT---TEECCCCT
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCc
Confidence 654321 122346789999999999999999999999999999998 9999987654333322222 12233456
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+++++.+|+.+||+.||++||+ ++++++
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs-------~~~i~~ 302 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPK-------FEQIVS 302 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred cccHHHHHHHHHHhCcChhhCcC-------HHHHHH
Confidence 78999999999999999999999 777764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.63 Aligned_cols=254 Identities=21% Similarity=0.272 Sum_probs=210.3
Q ss_pred CcccCCCeEEEe-EEeecCcEEEEEEEE--ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 109 QPITYKTFRMYR-VLGKGGFGEVCACQV--RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 109 ~~i~~~~y~~~~-~LG~G~fG~Vy~a~~--~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
..+..++|++.+ .||+|+||.||+|.+ ..+++.||+|++..... .......+.+|+.++++++||||+++++++ .
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 345567899998 999999999999954 56789999999976532 233456788999999999999999999998 5
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
.+..++||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 677999999999999999998753 59999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccC
Q psy11874 266 EIPEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYS 340 (767)
Q Consensus 266 ~~~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~ 340 (767)
....... .....||+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.......+.. ......+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~ 242 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCP 242 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCC
Confidence 7654432 122357899999999998889999999999999999999 9999987654332222221 2234456
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
..+++++.++|.+||+.||++||+ +.++++
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps-------~~~l~~ 272 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPG-------FAAVEL 272 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCC-------HHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcC-------HHHHHH
Confidence 788999999999999999999999 777764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=369.92 Aligned_cols=250 Identities=20% Similarity=0.232 Sum_probs=200.7
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC---
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD--- 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--- 187 (767)
+..++|++.+.||+|+||.||+|++. |+.||+|++.... .......+|+.+|++++|||||++++++.+..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 45578999999999999999999875 8999999996543 22334566899999999999999999998744
Q ss_pred -eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC----------CcccccCCcceEEeCCCCCE
Q psy11874 188 -ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI----------GLVYRDCKPENILLDDYGHV 256 (767)
Q Consensus 188 -~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~----------~IvHrDLKPeNILld~~g~v 256 (767)
.+|+||||++||+|..++... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred ceEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 489999999999999999764 499999999999999999999999 99999999999999999999
Q ss_pred EEeecCcccccCCCCc---ccccccccccCCcceecCC-----CCCCCCccccchhhHHHHhcCCCCCCCchhhhh----
Q psy11874 257 RISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNE-----KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK---- 324 (767)
Q Consensus 257 kL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~-----~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~---- 324 (767)
||+|||+|+....... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 9999999987654332 3346799999999999763 456788999999999999999999976533111
Q ss_pred --------hhhhhhhhhcc--ccccC-----CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 325 --------RDEVDRRVKED--AEKYS-----CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 325 --------~~~i~~~i~~~--~~~~~-----~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
...+...+... .+..+ ...++++.+||.+||+.||++||+ ++++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-------~~ell~ 311 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS-------AGCVGE 311 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcC-------HHHHHH
Confidence 11111111111 01111 122456999999999999999999 778765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.98 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=210.2
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEcc---CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
.+..++|++.+.||+|+||.||+|.+.. ++..||+|++.+.. .......+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 4566899999999999999999999764 34579999987653 233456788999999999999999999998754
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
..|+||||++||+|..++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred -CCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 5689999999999999998753 3589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 IPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
...... .....||+.|+|||++.+..++.++|+|||||++|+|++ |+.||...........+.. ......+..+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 239 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRLPKPDLC 239 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH---TCCCCCCTTC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc---CCCCCCCCCC
Confidence 654332 234467899999999998999999999999999999998 9999976544333222221 2233456678
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
++.+.++|.+||..||++||+ +.+++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps-------~~ell~~ 267 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPR-------FTELVCS 267 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcC-------HHHHHHH
Confidence 999999999999999999999 8888764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=369.90 Aligned_cols=266 Identities=21% Similarity=0.282 Sum_probs=216.7
Q ss_pred hcCcccCCCeEEEeEEeecCcEEEEEEE-----EccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEE
Q psy11874 107 EIQPITYKTFRMYRVLGKGGFGEVCACQ-----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAY 181 (767)
Q Consensus 107 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~-----~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 181 (767)
+...+..++|++.+.||+|+||.||+|+ ...+++.||+|++.... .......+.+|+.++++++||||+++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 3455667899999999999999999999 55678999999986432 2334556888999999999999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCC----CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC---C
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGG----EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY---G 254 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~----~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~---g 254 (767)
++.+.+..|+||||++||+|..++..... ...+++..+..++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 99999999999999999999999987542 1358999999999999999999999999999999999999944 4
Q ss_pred CEEEeecCcccccCCCC---cccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhh
Q psy11874 255 HVRISDLGLAVEIPEGE---SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDR 330 (767)
Q Consensus 255 ~vkL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~ 330 (767)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~- 259 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT- 259 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-
Confidence 69999999997653332 1234568999999999999999999999999999999998 999998765433222222
Q ss_pred hhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 331 RVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 331 ~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.......+..+++.+.+||.+||+.||.+||+ ++++++|.|+-.-
T Consensus 260 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 260 --SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN-------FAIILERIEYCTQ 304 (327)
T ss_dssp --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHHHHHHHH
T ss_pred --cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcC-------HHHHHHHHHHHhc
Confidence 12233456678999999999999999999999 9999999886543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=367.98 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=212.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEE----EccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe--
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQ----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE-- 184 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-- 184 (767)
+..++|++.+.||+|+||.||+|+ ...+|+.||+|++.... ......+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 456799999999999999999999 46789999999987542 334456889999999999999999999886
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
+.+.+|+||||++||+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred CCceEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 56779999999999999999987432 5899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhh-----------hhhhh
Q psy11874 265 VEIPEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK-----------RDEVD 329 (767)
Q Consensus 265 ~~~~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~-----------~~~i~ 329 (767)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 87654432 2334689999999999999999999999999999999999999976543211 01111
Q ss_pred hhh-hccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 330 RRV-KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 330 ~~i-~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
..+ .......+..+++++.+||.+||+.||++||+ ++++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-------~~ell~ 296 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS-------FSALGP 296 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcC-------HHHHHH
Confidence 111 12233456688999999999999999999999 777753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=368.54 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=205.9
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEE----EEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~----AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+..++|++.+.||+|+||.||+|.+..+|+.+ |+|.+... ........+.+|+.+|++++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 55689999999999999999999999888766 55555332 1334556788999999999999999999999876
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
. .++|++++.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred C-ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 5 889999999999999998753 3699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 267 IPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 267 ~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
...... .....||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.........+.. ......+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~ 243 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPI 243 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---TCCCCCCTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCCCCCcc
Confidence 644322 233457889999999999999999999999999999999 9999987655433322221 223445667
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++++.+||.+||..||.+||+ ++++++
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps-------~~ell~ 271 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPK-------FRELII 271 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcC-------HHHHHH
Confidence 8999999999999999999999 888876
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=391.28 Aligned_cols=255 Identities=18% Similarity=0.264 Sum_probs=218.9
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
.+.+..++|++.+.||+|+||.||+|.++.++..||+|++.... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 34566788999999999999999999999999999999987542 23566889999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+|||||+||+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred cEEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999999998753 346899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCc
Q psy11874 268 PEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFS 344 (767)
Q Consensus 268 ~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s 344 (767)
..... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+.. ......+..++
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 445 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCP 445 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TCCCCCCTTCC
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCC
Confidence 54322 223457889999999998999999999999999999999 9999987654333322222 22334567889
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++.+||.+||+.||++||+ +++|++
T Consensus 446 ~~l~~li~~cl~~dP~~RPs-------~~el~~ 471 (495)
T 1opk_A 446 EKVYELMRACWQWNPSDRPS-------FAEIHQ 471 (495)
T ss_dssp HHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHHHHHHHHHcCcChhHCcC-------HHHHHH
Confidence 99999999999999999999 788764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=359.21 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=213.2
Q ss_pred ccCCCeEEEe-EEeecCcEEEEEEEEc--cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYR-VLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~-~LG~G~fG~Vy~a~~~--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
+..++|.+.+ .||+|+||.||+|.++ .++..||+|++.... .......+.+|+.++++++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 4456788887 9999999999999864 468899999997642 234456788999999999999999999999 456
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+++||||++||+|..++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 7999999999999999987542 36999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 268 PEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 268 ~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
..... .....||+.|+|||++.+..++.++|+|||||++|||++ |..||...........+.. ......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~ 237 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPE 237 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---TCCCCCCTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc---CCcCCCCCC
Confidence 54332 223457899999999998899999999999999999998 9999987654333222221 223456678
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAE 379 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~Hp 379 (767)
+++++.++|.+||..||++||+ +.++++|.
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps-------~~~l~~~l 267 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPD-------FLTVEQRM 267 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCC-------HHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcC-------HHHHHHHH
Confidence 9999999999999999999999 88988764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=363.84 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=202.6
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 189 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 189 (767)
.+..++|++.+.||+|+||.||+|++. ++.||+|++... .....+.+|+.+|++++||||+++++++.+ ..
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 74 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PV 74 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence 456689999999999999999999985 789999998643 234568899999999999999999998774 48
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH---CCcccccCCcceEEeCCCCC-EEEeecCccc
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY---IGLVYRDCKPENILLDDYGH-VRISDLGLAV 265 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~---~~IvHrDLKPeNILld~~g~-vkL~DFGla~ 265 (767)
|+||||++||+|.+++......+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 9999999999999999876544468999999999999999999999 89999999999999998887 7999999997
Q ss_pred ccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 266 EIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 266 ~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...............+..+++
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (307)
T 2eva_A 155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-FRIMWAVHNGTRPPLIKNLPK 231 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-HHHHHHHHTTCCCCCBTTCCH
T ss_pred ccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-HHHHHHHhcCCCCCcccccCH
Confidence 65432 334579999999999999999999999999999999999999997543211 111111222333455667899
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+.+|+.+||+.||++||+ ++++++
T Consensus 232 ~l~~li~~~l~~dp~~Rps-------~~ell~ 256 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPS-------MEEIVK 256 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHHHHHHHHhcCChhhCcC-------HHHHHH
Confidence 9999999999999999999 888876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.28 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=214.0
Q ss_pred hhhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe
Q psy11874 105 YNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 184 (767)
Q Consensus 105 ~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 184 (767)
|.+.+.+..++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+|++++||||+++++++.
T Consensus 4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 44556677789999999999999999999975 67789999986543 23456889999999999999999999886
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
. +..++||||++||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 79 ~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 79 Q-EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred C-CCcEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 4 56899999999999999886532 125899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCC
Q psy11874 265 VEIPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 265 ~~~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~ 341 (767)
........ .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.. ......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~ 233 (279)
T 1qpc_A 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GYRMVRPD 233 (279)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCCT
T ss_pred ccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc---ccCCCCcc
Confidence 87754432 233457889999999998889999999999999999999 9999987654333322222 22334456
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+++++.+|+.+||..||++||+ ++++++
T Consensus 234 ~~~~~l~~li~~~l~~~p~~Rps-------~~~l~~ 262 (279)
T 1qpc_A 234 NCPEELYQLMRLCWKERPEDRPT-------FDYLRS 262 (279)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred cccHHHHHHHHHHhccChhhCCC-------HHHHHH
Confidence 78999999999999999999999 777764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=354.96 Aligned_cols=250 Identities=19% Similarity=0.255 Sum_probs=205.8
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEE-EEEeeCCeEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLA-YAYETKDALCL 191 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~-~~~~~~~~l~l 191 (767)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+|..+++.++|++++..+ .++...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 368999999999999999999999999999999986543 223578899999999987755544 44577888999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe---CCCCCEEEeecCcccccC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl---d~~g~vkL~DFGla~~~~ 268 (767)
||||+ ||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99999 899999997543 369999999999999999999999999999999999999 588999999999998765
Q ss_pred CCCc--------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhh---hhhhhh-hhhccc
Q psy11874 269 EGES--------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK---RDEVDR-RVKEDA 336 (767)
Q Consensus 269 ~~~~--------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~---~~~i~~-~i~~~~ 336 (767)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...... ...+.. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 4432 2455799999999999999999999999999999999999999986433211 111111 112222
Q ss_pred cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 337 EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 337 ~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
...+..+|+++.+||.+||+.||++||+ ++++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPD-------YSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCC-------HHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCC-------HHHHHH
Confidence 3344678999999999999999999999 666654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.92 Aligned_cols=249 Identities=25% Similarity=0.335 Sum_probs=198.0
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHh--cCCCceeEEEEEEee--
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK--INSRFVVSLAYAYET-- 185 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~~~~-- 185 (767)
.+..++|++.+.||+|+||+||+|++ +|+.||+|++.... .....+|.+++.. ++||||+++++++.+
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34457899999999999999999987 69999999986542 3345567777776 899999999998654
Q ss_pred --CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHH--------HCCcccccCCcceEEeCCCCC
Q psy11874 186 --KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH--------YIGLVYRDCKPENILLDDYGH 255 (767)
Q Consensus 186 --~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH--------~~~IvHrDLKPeNILld~~g~ 255 (767)
...+|+||||++||+|.+++... .+++..+..++.||+.||.||| +.||+||||||+|||++.++.
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred CCCceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence 35699999999999999999543 6999999999999999999999 999999999999999999999
Q ss_pred EEEeecCcccccCCCCc-----ccccccccccCCcceecCC------CCCCCCccccchhhHHHHhcC----------CC
Q psy11874 256 VRISDLGLAVEIPEGES-----VRGRVGTVGYMAPEVIDNE------KYTYSPDWFSFGCLIFEMIEG----------QA 314 (767)
Q Consensus 256 vkL~DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~------~ys~~~DvwSlGviLyElltG----------~~ 314 (767)
+||+|||+|........ ....+||+.|+|||++.+. .++.++|||||||++|||++| ..
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 99999999976544332 2334799999999999876 455789999999999999999 88
Q ss_pred CCCCchhhhhh-hhhhhhhhc--ccccc-----CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 315 PFRRRKEMVKR-DEVDRRVKE--DAEKY-----SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 315 PF~~~~~~~~~-~~i~~~i~~--~~~~~-----~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
||......... ..+...... ..... +...++++.+|+.+||+.||++||+ ++++++
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-------~~~i~~ 295 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT-------ALRIKK 295 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC-------HHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC-------HHHHHH
Confidence 98654322111 111111111 11111 2235678999999999999999999 888775
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=384.62 Aligned_cols=283 Identities=18% Similarity=0.233 Sum_probs=220.9
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC-CceeEEEEEEeeCCeE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RFVVSLAYAYETKDAL 189 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l 189 (767)
...++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|..+++.+.| ++++.+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 345789999999999999999999999999999998765432 2247789999999987 5666677777888999
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEe---CCCCCEEEeecCcccc
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL---DDYGHVRISDLGLAVE 266 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILl---d~~g~vkL~DFGla~~ 266 (767)
|+||||+ ||+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 79 ~lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 9999999 999999998643 369999999999999999999999999999999999999 6889999999999987
Q ss_pred cCCCCc--------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhh----hhhhc
Q psy11874 267 IPEGES--------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD----RRVKE 334 (767)
Q Consensus 267 ~~~~~~--------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~----~~i~~ 334 (767)
...... ....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.........+. .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 654432 125679999999999999999999999999999999999999998754422222111 11122
Q ss_pred cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHH---HHhCCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 335 DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARE---LKQAEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 335 ~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~e---il~HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
........+++++.+||..||..||++||++..-..-.++ -..|+|+..++|..+......+|..|.
T Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p~ 305 (483)
T 3sv0_A 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAPP 305 (483)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC----------
T ss_pred cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCCC
Confidence 2233446789999999999999999999993221111111 234899999999999877666555543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=371.59 Aligned_cols=256 Identities=22% Similarity=0.261 Sum_probs=209.5
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||.||+|.++ +|+.||+|++.... ......+.+|+.+|++++||||+++++++.+.+.+++|
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 478999999999999999999964 79999999986542 23456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 193 LTIMNGGDLKFHIYNMGG-EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~-~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
|||++||+|.+++..... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998865432 2358999999999999999999999999999999999999999999999999998654322
Q ss_pred ---cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhh---hhh--------hc--c
Q psy11874 272 ---SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD---RRV--------KE--D 335 (767)
Q Consensus 272 ---~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~---~~i--------~~--~ 335 (767)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+........... ... .. .
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence 2234569999999999998999999999999999999999999997654322111100 000 00 0
Q ss_pred ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCC
Q psy11874 336 AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAE 379 (767)
Q Consensus 336 ~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~Hp 379 (767)
....+...+..+.+++.+||+.||++||+ ++|+++|.
T Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps-------~~ell~~L 310 (321)
T 2qkw_B 274 ADKIRPESLRKFGDTAVKCLALSSEDRPS-------MGDVLWKL 310 (321)
T ss_dssp TTCSCHHHHHHHHHHHHHHTCSSGGGSCC-------HHHHHHHH
T ss_pred ccccCHHHHHHHHHHHHHHcCCCcccCcC-------HHHHHHHH
Confidence 01122234677899999999999999999 88988653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=373.03 Aligned_cols=240 Identities=17% Similarity=0.244 Sum_probs=198.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEE-----EEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC---CCceeEEEEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCAC-----QVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN---SRFVVSLAYA 182 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a-----~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~ 182 (767)
+..++|++.+.||+|+||.||+| ....+++.||+|++... ....+.+|..+++.++ |+||+.++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 45578999999999999999999 46778999999998653 2345677888888887 8999999999
Q ss_pred EeeCCeEEEEEEeccCCCHHHHHHhcC--CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC--------
Q psy11874 183 YETKDALCLVLTIMNGGDLKFHIYNMG--GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-------- 252 (767)
Q Consensus 183 ~~~~~~l~lV~E~~~gG~L~~~l~~~~--~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-------- 252 (767)
+...+..|+|||||+||+|.+++.... ....+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999999997532 2346999999999999999999999999999999999999998
Q ss_pred ---CCCEEEeecCcccccC---CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhh
Q psy11874 253 ---YGHVRISDLGLAVEIP---EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD 326 (767)
Q Consensus 253 ---~g~vkL~DFGla~~~~---~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~ 326 (767)
++.+||+|||+|+... ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 8999999999996543 33345567899999999999999999999999999999999999999965432110
Q ss_pred hhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 327 EVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 327 ~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
.+ ...... ...++...+++..||+.+|.+|+.
T Consensus 294 ~~----~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 294 KP----EGLFRR--LPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp EE----CSCCTT--CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred ee----chhccc--cCcHHHHHHHHHHHcCCCCCCcch
Confidence 00 000111 134778999999999999999977
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=384.58 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=213.8
Q ss_pred hcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 107 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
..+.+..++|++.+.||+|+||.||+|.++ ++..||+|++.... ...+.+.+|+.+|++++|||||++++++. .
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 345677789999999999999999999986 57889999997543 23567899999999999999999999886 6
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+.+|+|||||+||+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred CccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 67999999999999999997542 22588999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 IPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
...... .....+|+.|+|||++....++.++|||||||++|||++ |..||.+.........+.+. .....+..+
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~ 410 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---YRMPRPENC 410 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT---CCCCCCTTS
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCC
Confidence 654321 223457889999999998999999999999999999999 99999876544333333222 233446678
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++++.+|+.+||..||++||+ +++|++
T Consensus 411 ~~~l~~li~~cl~~dp~~RPt-------~~~i~~ 437 (454)
T 1qcf_A 411 PEELYNIMMRCWKNRPEERPT-------FEYIQS 437 (454)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcC-------HHHHHH
Confidence 999999999999999999999 777653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=365.05 Aligned_cols=256 Identities=19% Similarity=0.267 Sum_probs=208.0
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCC----cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 184 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 184 (767)
..+..++|++.+.||+|+||.||+|.++.++ ..||+|++.... .......+.+|+.++++++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3466789999999999999999999987653 469999987542 2234456889999999999999999999999
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
+.+.+++||||++||+|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 9999999999999999999997643 36999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 265 VEIPEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 265 ~~~~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
........ .....||+.|+|||++.+..++.++|||||||++|||++ |..||...........+.. ......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~---~~~~~~ 271 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFRLPT 271 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---TCCCCC
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC---CCcCCC
Confidence 87654321 223356889999999999999999999999999999998 9999977654332222221 123344
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+..+++++.+||.+||+.||++||+ +.+++++
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rps-------~~~l~~~ 303 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRPK-------FADIVSI 303 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCC-------HHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhhCcC-------HHHHHHH
Confidence 5678999999999999999999999 7777653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=358.95 Aligned_cols=256 Identities=24% Similarity=0.316 Sum_probs=199.8
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
..++..++|++.+.||+|+||.||+|++. ..+|+|++..... .......+.+|+.+|++++||||++++++ ...+
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccCC
Confidence 44567789999999999999999999864 3599999865532 33445678899999999999999999985 4566
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+++||||++||+|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred ccEEEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 7999999999999999886543 36999999999999999999999999999999999999999999999999999765
Q ss_pred CCC---CcccccccccccCCcceec---CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhh-h-hcccccc
Q psy11874 268 PEG---ESVRGRVGTVGYMAPEVID---NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR-V-KEDAEKY 339 (767)
Q Consensus 268 ~~~---~~~~~~~GT~~Y~APEvl~---~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~-i-~~~~~~~ 339 (767)
... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.+........+.... . .......
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence 432 2234457999999999986 567888999999999999999999999876543322222211 1 1112234
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
...+++++++||.+||+.||++||+ ++++++
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps-------~~ell~ 281 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPS-------FPRILA 281 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCCC-------HHHHHH
Confidence 4578999999999999999999999 788765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=361.17 Aligned_cols=257 Identities=20% Similarity=0.264 Sum_probs=204.7
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEcc---CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
+..++|++.+.||+|+||.||+|.... ++..||+|++..... .......+.+|+.++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 455789999999999999999998875 566999999875532 2334566889999999999999999999998755
Q ss_pred -----eEEEEEEeccCCCHHHHHHhcC---CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEe
Q psy11874 188 -----ALCLVLTIMNGGDLKFHIYNMG---GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRIS 259 (767)
Q Consensus 188 -----~l~lV~E~~~gG~L~~~l~~~~---~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~ 259 (767)
..++||||+++|+|..++.... ....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 4599999999999999986431 23469999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhcc
Q psy11874 260 DLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKED 335 (767)
Q Consensus 260 DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~ 335 (767)
|||++........ .....||+.|+|||++.+..++.++|+|||||++|+|++ |.+||.+.........+. ...
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~ 266 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL---HGH 266 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TTC
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH---cCC
Confidence 9999987654322 223457899999999999999999999999999999999 999998765443333222 222
Q ss_pred ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 336 AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 336 ~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
....+..+++++.+||.+||..||++||+ +.++++|
T Consensus 267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~l~~~ 302 (313)
T 3brb_A 267 RLKQPEDCLDELYEIMYSCWRTDPLDRPT-------FSVLRLQ 302 (313)
T ss_dssp CCCCBTTCCHHHHHHHHHTTCSSGGGSCC-------HHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhhCcC-------HHHHHHH
Confidence 34556788999999999999999999999 8888763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=383.40 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=195.5
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV 192 (767)
+.|.+.++||+|+||+||.+. ..+|+.||+|++.... ...+.+|+.+|+++ +|||||++++++.+.+.+|+|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 557778999999999998754 4689999999986532 34567899999886 899999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCC----CCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC-------------CC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEP----GFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY-------------GH 255 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~----~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~-------------g~ 255 (767)
||||+ |+|.+++...+... ..++..+..++.||+.||+|||++||+||||||+|||++.+ ++
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99996 69999998653211 11333457899999999999999999999999999999754 48
Q ss_pred EEEeecCcccccCCCCc-----ccccccccccCCcceecC-------CCCCCCCccccchhhHHHHhc-CCCCCCCchhh
Q psy11874 256 VRISDLGLAVEIPEGES-----VRGRVGTVGYMAPEVIDN-------EKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEM 322 (767)
Q Consensus 256 vkL~DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~-------~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~ 322 (767)
+||+|||+|+....+.. ....+||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987755432 234579999999999965 678999999999999999999 99999765332
Q ss_pred hhhhhhhhhhhcccc-c--cCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 323 VKRDEVDRRVKEDAE-K--YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 323 ~~~~~i~~~i~~~~~-~--~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
. ..+......... . ....+++++++||.+||+.||++||+ +.++++||||.+.
T Consensus 247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-------~~eil~hp~f~~~ 302 (434)
T 2rio_A 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT-------AMKVLRHPLFWPK 302 (434)
T ss_dssp H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC-------HHHHHTSGGGSCH
T ss_pred H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCC-------HHHHHhCCccCCc
Confidence 1 112211111110 0 11235689999999999999999999 9999999999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=362.86 Aligned_cols=256 Identities=23% Similarity=0.295 Sum_probs=207.0
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe----eC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE----TK 186 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~----~~ 186 (767)
+..++|++.+.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.++++++||||+++++++. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 4567899999999999999999999999999999998653 2334566889999999999999999999986 34
Q ss_pred CeEEEEEEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
...++||||++||+|..++.... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 58999999999999999987632 13469999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCc----------ccccccccccCCcceecCCC---CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh
Q psy11874 266 EIPEGES----------VRGRVGTVGYMAPEVIDNEK---YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV 332 (767)
Q Consensus 266 ~~~~~~~----------~~~~~GT~~Y~APEvl~~~~---ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i 332 (767)
....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ .+...+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~ 260 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALAV 260 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHHh
Confidence 6532111 12346899999999997654 68999999999999999999999964322111 111111
Q ss_pred h-ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 333 K-EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 333 ~-~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
. ......+..+++++.+||.+||+.||.+||+ ++++++|
T Consensus 261 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~ll~~ 300 (317)
T 2buj_A 261 QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPH-------IPLLLSQ 300 (317)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred hccCCCCccccCCHHHHHHHHHHhhcChhhCCC-------HHHHHHH
Confidence 1 1122334578999999999999999999999 8898874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=371.35 Aligned_cols=256 Identities=15% Similarity=0.145 Sum_probs=201.2
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEcc---CCcEEEEEEechhhhh--------hhhhHHHHHHHHHHHHhcCCCceeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIK--------KRKGESMVLIEKQILQKINSRFVVSL 179 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~~AiK~l~k~~~~--------~~~~~~~~~~E~~iL~~l~hp~Iv~l 179 (767)
+..++|++.+.||+|+||.||+|.+.. ++..+|+|++...... .......+.+|..+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345789999999999999999999987 7899999998754311 11122346778999999999999999
Q ss_pred EEEEee----CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-
Q psy11874 180 AYAYET----KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG- 254 (767)
Q Consensus 180 ~~~~~~----~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g- 254 (767)
++++.+ ...+|+||||+ ||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 999988 78999999999 999999987654 699999999999999999999999999999999999998877
Q ss_pred -CEEEeecCcccccCCCC--------cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh-h
Q psy11874 255 -HVRISDLGLAVEIPEGE--------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV-K 324 (767)
Q Consensus 255 -~vkL~DFGla~~~~~~~--------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~-~ 324 (767)
.+||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+..... .
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 99999999997664321 1244579999999999999999999999999999999999999996532211 1
Q ss_pred hhhhhhhhhcccc----cc--CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 325 RDEVDRRVKEDAE----KY--SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 325 ~~~i~~~i~~~~~----~~--~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
............. .. ...++++++++|.+||..||++||+ +++|++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~l~~ 321 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN-------YQALKK 321 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC-------HHHHHH
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCC-------HHHHHH
Confidence 1111111111111 11 1278999999999999999999999 777765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=354.77 Aligned_cols=249 Identities=23% Similarity=0.274 Sum_probs=206.0
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCc---EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeE-E
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL-C 190 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l-~ 190 (767)
.|++.+.||+|+||.||+|.+..+++ .+|+|++... ......+.+.+|+.++++++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57788999999999999999866554 8999998653 2334456788999999999999999999999877665 9
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||+.||+|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999997643 36899999999999999999999999999999999999999999999999999865432
Q ss_pred C-----cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCC-CCCCCchhhhhhhhhhhhhhccccccCCCCc
Q psy11874 271 E-----SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQ-APFRRRKEMVKRDEVDRRVKEDAEKYSCRFS 344 (767)
Q Consensus 271 ~-----~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~-~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s 344 (767)
. ......||+.|+|||++.+..++.++|||||||++|+|++|. +||...+.......+. .......+..++
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 254 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA---QGRRLPQPEYCP 254 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH---TTCCCCCCTTCC
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh---cCCCCCCCccch
Confidence 2 233456899999999999999999999999999999999955 5555443322222221 222344566789
Q ss_pred HHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 345 DDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 345 ~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++.+|+.+||+.||.+||+ ++++++
T Consensus 255 ~~l~~li~~~l~~~p~~Rps-------~~~ll~ 280 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPT-------FRVLVG 280 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHHHHHHHHHccCChhhCcC-------HHHHHH
Confidence 99999999999999999999 777765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.63 Aligned_cols=259 Identities=25% Similarity=0.342 Sum_probs=208.7
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 3478999999999999999999854 7999999999765422 223358899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHhHHHHHHHC---CcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 192 VLTIMNGGDLKFHIYNMGG-EPGFDIARARFYAAEVLCGLEHLHYI---GLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~-~~~l~~~~~~~~~~qIl~aL~yLH~~---~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
||||++||+|.+++..... ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 9999999999999987542 33599999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhh----h-hhhhhhhhcc-----
Q psy11874 268 PEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK----R-DEVDRRVKED----- 335 (767)
Q Consensus 268 ~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~----~-~~i~~~i~~~----- 335 (767)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ . ..+.......
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTS
T ss_pred CcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhh
Confidence 53322 3445699999999999888899999999999999999999999953221100 0 0000000000
Q ss_pred -----ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCC
Q psy11874 336 -----AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEF 380 (767)
Q Consensus 336 -----~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~Hpf 380 (767)
...++...++.+.+++.+||+.||++||+ ++++++|-.
T Consensus 265 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-------~~ell~~L~ 307 (326)
T 3uim_A 265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK-------MSEVVRMLE 307 (326)
T ss_dssp SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCC-------HHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHhCcCCccCCC-------HHHHHHHhc
Confidence 01112233578999999999999999999 899988754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=359.72 Aligned_cols=253 Identities=25% Similarity=0.314 Sum_probs=206.4
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhh-hhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~-~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
|...+.||+|+||.||+|.. +++.+|+|++..... ........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 34458999999999999986 588999999865432 223345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc--
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-- 272 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~-- 272 (767)
|++||+|.+++........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999999998654455799999999999999999999999999999999999999999999999999987654322
Q ss_pred -ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc-----------ccccC
Q psy11874 273 -VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED-----------AEKYS 340 (767)
Q Consensus 273 -~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~-----------~~~~~ 340 (767)
.....||+.|+|||++.+ .++.++|+|||||++|+|++|.+||...........+...+... ....+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 234579999999999865 58999999999999999999999997765433222222221111 11122
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
...++.+.+++.+||..||.+||+ +++++++
T Consensus 270 ~~~~~~l~~li~~cl~~~p~~Rps-------~~~l~~~ 300 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEKKNKRPD-------IKKVQQL 300 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSTTTSCC-------HHHHHHH
T ss_pred hHHHHHHHHHHHHHcCCCcccCcC-------HHHHHHH
Confidence 234678999999999999999999 8888753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=364.10 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=192.0
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEe-----
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYE----- 184 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~----- 184 (767)
+...+|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.++.++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 44468999999999999999999999999999999985542 233456888999999996 999999999983
Q ss_pred ---eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC--cccccCCcceEEeCCCCCEEEe
Q psy11874 185 ---TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLDDYGHVRIS 259 (767)
Q Consensus 185 ---~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~--IvHrDLKPeNILld~~g~vkL~ 259 (767)
....+++||||++ |+|.+++........+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 4456899999997 789888876433446999999999999999999999999 9999999999999999999999
Q ss_pred ecCcccccCCCCcc-------------cccccccccCCccee---cCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh
Q psy11874 260 DLGLAVEIPEGESV-------------RGRVGTVGYMAPEVI---DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV 323 (767)
Q Consensus 260 DFGla~~~~~~~~~-------------~~~~GT~~Y~APEvl---~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~ 323 (767)
|||++......... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 99999876543221 145699999999998 56778999999999999999999999997653321
Q ss_pred hhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCC
Q psy11874 324 KRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAE 379 (767)
Q Consensus 324 ~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~Hp 379 (767)
+.... .....+...++.+.+||.+||+.||++||+ ++|+++|-
T Consensus 261 ----~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-------~~e~l~~l 303 (337)
T 3ll6_A 261 ----IVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLS-------IAEVVHQL 303 (337)
T ss_dssp -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCC-------HHHHHHHH
T ss_pred ----hhcCc--ccCCcccccchHHHHHHHHHccCChhhCcC-------HHHHHHHH
Confidence 11111 112223466788999999999999999998 99999873
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=355.75 Aligned_cols=251 Identities=23% Similarity=0.260 Sum_probs=206.0
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccC---CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEE-eeCCe
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAY-ETKDA 188 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-~~~~~ 188 (767)
...|++.+.||+|+||.||+|.+..+ +..+|+|.+.... .......+.+|..++++++||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 35799999999999999999997643 3468999986532 334456788999999999999999999985 55678
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
.|+||||++||+|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred eEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 999999999999999997643 368999999999999999999999999999999999999999999999999998664
Q ss_pred CCCc-----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 269 EGES-----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 269 ~~~~-----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
.... .....||+.|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+.......+. .......+..
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 256 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---QGRRLLQPEY 256 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH---TTCCCCCCTT
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh---cCCCCCCCcc
Confidence 4321 234568899999999999999999999999999999999 667776654433222222 2223344567
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++++.+++.+||+.||++||+ ++++++
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps-------~~ell~ 284 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPS-------FSELVS 284 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcC-------HHHHHH
Confidence 8999999999999999999999 777765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=358.23 Aligned_cols=235 Identities=24% Similarity=0.417 Sum_probs=195.2
Q ss_pred CCCeEEE-eEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHH-HhcCCCceeEEEEEEee----C
Q psy11874 113 YKTFRMY-RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL-QKINSRFVVSLAYAYET----K 186 (767)
Q Consensus 113 ~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~~~~----~ 186 (767)
.++|.+. ++||+|+||.||+|.++.+|+.||+|++... ..+.+|+.++ +..+||||+++++++.+ .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 3678887 8899999999999999999999999998542 2456788888 56799999999999987 7
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC---CCCEEEeecCc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD---YGHVRISDLGL 263 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~---~g~vkL~DFGl 263 (767)
..+|+||||++||+|..++.... ...+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred ceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 78999999999999999998753 346999999999999999999999999999999999999998 78999999999
Q ss_pred ccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC---
Q psy11874 264 AVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS--- 340 (767)
Q Consensus 264 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~--- 340 (767)
|.... +..|+.++|||||||++|||++|..||.+.........+...+......++
T Consensus 167 a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 167 AKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp CEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 86542 244778999999999999999999999876543333223333332222222
Q ss_pred -CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 341 -CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 341 -~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
..+++++++||.+||+.||++||+ ++|+++||||++.
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps-------~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMT-------ITEFMNHPWIMQS 263 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCC-------HHHHHTSHHHHTG
T ss_pred cccCCHHHHHHHHHHcccChhhCCC-------HHHHhcChhhccc
Confidence 568999999999999999999999 9999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=368.90 Aligned_cols=248 Identities=15% Similarity=0.152 Sum_probs=203.0
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccC--------CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeE------
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRAT--------GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVS------ 178 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~t--------g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~------ 178 (767)
.++|++.+.||+|+||.||+|++..+ ++.||+|++.+. ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47899999999999999999999874 899999998654 34778999999999999987
Q ss_pred ---------EEEEEee-CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceE
Q psy11874 179 ---------LAYAYET-KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENI 248 (767)
Q Consensus 179 ---------l~~~~~~-~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNI 248 (767)
+++++.. .+.+|+||||+ ||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 5666665 78999999999 999999998752 23699999999999999999999999999999999999
Q ss_pred EeCCCC--CEEEeecCcccccCCCCc--------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCC
Q psy11874 249 LLDDYG--HVRISDLGLAVEIPEGES--------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRR 318 (767)
Q Consensus 249 Lld~~g--~vkL~DFGla~~~~~~~~--------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~ 318 (767)
|++.++ .+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 999999999976543221 2345799999999999999999999999999999999999999987
Q ss_pred ch-hhhhhhhhhhhhhccccccC------CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 319 RK-EMVKRDEVDRRVKEDAEKYS------CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 319 ~~-~~~~~~~i~~~i~~~~~~~~------~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.. ..................+. ..+++++.+||.+||..||++||+ ++++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPP-------YAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCC-------HHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCC-------HHHHHH
Confidence 54 21122222222222222222 256899999999999999999999 777654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=354.06 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=203.7
Q ss_pred hhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 106 ~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
.....+..++|++.+.||+|+||.||+|.+. |+.||+|++.... ..+.+.+|+.++++++||||+++++++.+
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3345567789999999999999999999874 8999999986542 34568899999999999999999998754
Q ss_pred C-CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 186 K-DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 186 ~-~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
. +.+|+||||++||+|.+++...+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred CCCceEEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccc
Confidence 4 57999999999999999997653 123789999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
...... .....+|+.|+|||++.+..++.++|+|||||++|+|++ |..||...........+.. ......+..+
T Consensus 165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 239 (278)
T 1byg_A 165 KEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGC 239 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT---TCCCCCCTTC
T ss_pred cccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---CCCCCCcccC
Confidence 865433 234468999999999999999999999999999999998 9999987654333222221 2234456788
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++.+.++|.+||+.||++||+ +.++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps-------~~~l~~ 266 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPS-------FLQLRE 266 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCCC-------HHHHHH
Confidence 999999999999999999999 777664
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=357.72 Aligned_cols=255 Identities=22% Similarity=0.307 Sum_probs=203.2
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEcc-CCc--EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRA-TGK--MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~-tg~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
+..++|++.+.||+|+||.||+|++.. +++ .||+|++.............+.+|+.++++++||||+++++++.+.+
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 445789999999999999999998753 333 69999997765555556678899999999999999999999998765
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 899999999999999998753 25899999999999999999999999999999999999999999999999999877
Q ss_pred CCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 268 PEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 268 ~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
..... .....||+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.......+... ......+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--GERLPRPED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--CCCCCCCTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc--CCCCCCCcC
Confidence 54432 223468889999999998889999999999999999999 99999877554333322211 112334567
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++++.++|.+||..||++||+ ++++++
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps-------~~~l~~ 277 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPT-------FVALRD 277 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcC-------HHHHHH
Confidence 8999999999999999999999 888876
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=360.02 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=208.7
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEc----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVR----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-- 185 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-- 185 (767)
..+.|++.+.||+|+||.||+|.++ .+|+.||+|++.... .......+.+|+.+|++++||||+++++++.+
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 3344699999999999999888653 478999999997652 23445678899999999999999999999988
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
...+++||||++||+|.+++.+. .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 46899999999999999998764 48999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh-----------hhhhhhh
Q psy11874 266 EIPEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV-----------KRDEVDR 330 (767)
Q Consensus 266 ~~~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~-----------~~~~i~~ 330 (767)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 8765432 234568899999999999899999999999999999999999997653211 0111111
Q ss_pred hhh-ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 331 RVK-EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 331 ~i~-~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.+. ......+..+++++.+||.+||+.||++||+ ++++++
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-------~~ell~ 303 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPT-------FENLIP 303 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcC-------HHHHHH
Confidence 111 2233456678999999999999999999999 788774
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=379.15 Aligned_cols=254 Identities=23% Similarity=0.304 Sum_probs=208.8
Q ss_pred hcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 107 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
..+.+..++|++.+.||+|+||.||+|.++. +..||+|++..... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 3455777899999999999999999999974 56799999976432 24568899999999999999999999876
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+.+|+|||||+||+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred CceEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 67999999999999999997532 22589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 IPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.. ......+..+
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~---~~~~~~~~~~ 406 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPEC 406 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCCTTS
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCC
Confidence 654322 233457889999999999999999999999999999999 9999987654333333222 2233456788
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++.+.+|+.+||+.||++||+ +++|++
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt-------~~~l~~ 433 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPT-------FEYLQA 433 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcC-------HHHHHH
Confidence 999999999999999999999 777765
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=357.54 Aligned_cols=247 Identities=28% Similarity=0.369 Sum_probs=196.5
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc--CCCceeEEEEEEeeC----
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI--NSRFVVSLAYAYETK---- 186 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~~~~~~---- 186 (767)
.++|++.+.||+|+||.||+|+++ |+.||+|++.... .....+|.+++..+ +||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 368999999999999999999985 8999999985432 23345566666554 999999999999887
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC--------CcccccCCcceEEeCCCCCEEE
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI--------GLVYRDCKPENILLDDYGHVRI 258 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~--------~IvHrDLKPeNILld~~g~vkL 258 (767)
..+|+||||++||+|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7899999999999999999764 599999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCCc-----ccccccccccCCcceecCCCCCCC------CccccchhhHHHHhcC----------CCCCC
Q psy11874 259 SDLGLAVEIPEGES-----VRGRVGTVGYMAPEVIDNEKYTYS------PDWFSFGCLIFEMIEG----------QAPFR 317 (767)
Q Consensus 259 ~DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~ys~~------~DvwSlGviLyElltG----------~~PF~ 317 (767)
+|||+|........ ....+||+.|+|||++.+..++.. +|||||||++|||++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999977644332 124579999999999988777766 9999999999999999 67775
Q ss_pred Cchhhhh-hhhhhhhh--hccccccC-----CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 318 RRKEMVK-RDEVDRRV--KEDAEKYS-----CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 318 ~~~~~~~-~~~i~~~i--~~~~~~~~-----~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
....... ...+...+ ......++ ..+++++.+|+.+||+.||++||+ ++++++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-------~~ell~~ 325 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT-------ALRVKKT 325 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC-------HHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC-------HHHHHHH
Confidence 4322111 11111111 11112222 245678999999999999999999 8888764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=368.94 Aligned_cols=251 Identities=23% Similarity=0.261 Sum_probs=199.1
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCC---cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe-eCCeE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE-TKDAL 189 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~~l 189 (767)
..|++.+.||+|+||.||+|.+..++ ..+|+|.+... ........+.+|..+|++++||||+++++++. ..+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35889999999999999999986443 46899998643 23345567899999999999999999999864 45688
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+||||++||+|..++.+.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999999999997643 3689999999999999999999999999999999999999999999999999986643
Q ss_pred CCc-----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 270 GES-----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 270 ~~~-----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
... .....||+.|+|||++.+..++.++|||||||++|||++ |.+||...+.......+. .......+..+
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~---~~~~~~~p~~~ 321 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---QGRRLLQPEYC 321 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH---TTCCCCCCTTC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH---cCCCCCCCCCC
Confidence 321 233467889999999999999999999999999999999 788887665433222222 12233445678
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
++.+.+++.+||..||++||+ +++++++
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs-------~~ell~~ 349 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPS-------FSELVSR 349 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcC-------HHHHHHH
Confidence 999999999999999999999 7887753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=402.44 Aligned_cols=278 Identities=28% Similarity=0.346 Sum_probs=223.6
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee------
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------ 185 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------ 185 (767)
..++|++.+.||+|+||.||+|.++.+|+.||+|++.... .......+.+|+.+|++++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 3478999999999999999999999999999999986542 33445678899999999999999999998765
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC---EEEeecC
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH---VRISDLG 262 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~---vkL~DFG 262 (767)
.+..|+|||||+||+|..++........+++..++.++.||+.||.|||+.||+||||||+|||++.+|. +||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 6788999999999999999987655556999999999999999999999999999999999999997775 9999999
Q ss_pred cccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhh----------hhhhh
Q psy11874 263 LAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDE----------VDRRV 332 (767)
Q Consensus 263 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~----------i~~~i 332 (767)
++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+......... .....
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 99988766666677899999999999999999999999999999999999999976422111000 00000
Q ss_pred h----------ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCC
Q psy11874 333 K----------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400 (767)
Q Consensus 333 ~----------~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P 400 (767)
. ......+..+++.+.+||.+||..||++||+ ++++++||||+. +..+....+-++|.+
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT-------a~elL~hp~F~~--l~~iL~~kil~~f~~ 318 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT-------DPQNPNVGCFQA--LDSILSLKLLSVMNM 318 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C-------CTTCCCCTTHHH--HHHHHCCCEEECCCS
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC-------HHHHhcCHHHHH--HHHHHhccccccccc
Confidence 0 0011123346789999999999999999999 789999999987 556666665555544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=389.13 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=205.2
Q ss_pred CCeEEE-eEEeecCcEEEEEEEE--ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 114 KTFRMY-RVLGKGGFGEVCACQV--RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 114 ~~y~~~-~~LG~G~fG~Vy~a~~--~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+.+.+. +.||+|+||.||+|.+ +.+++.||||++.... ........+.+|+.+|++++|||||++++++.+ +.++
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence 344443 4899999999999955 4667899999997653 233445679999999999999999999999875 4589
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+|||||+||+|.+++...+ .+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 446 lv~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEEccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 9999999999999997653 6899999999999999999999999999999999999999999999999999877544
Q ss_pred Cc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 271 ES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 271 ~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
.. .....||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.+.......+.. ......+..+++
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---~~~~~~p~~~~~ 599 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPR 599 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCCTTCCH
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCH
Confidence 32 223457899999999999999999999999999999998 9999988765433333322 223455678999
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++.+||.+||+.||++||+ +++|++
T Consensus 600 ~l~~li~~cl~~dP~~RPs-------~~~l~~ 624 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPG-------FAAVEL 624 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCC-------HHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcC-------HHHHHH
Confidence 9999999999999999999 777653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=376.42 Aligned_cols=247 Identities=18% Similarity=0.144 Sum_probs=195.6
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh-----hhhhHHHHHHHHHHHHhcC---------CCceeE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMVLIEKQILQKIN---------SRFVVS 178 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~---------hp~Iv~ 178 (767)
.++|++.+.||+|+||+||+|++ +|+.||+|++.+.... .......+.+|+.+|+.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46788999999999999999998 6899999999876432 2233467888999999886 777777
Q ss_pred EEEEEe------------------------------eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHh
Q psy11874 179 LAYAYE------------------------------TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC 228 (767)
Q Consensus 179 l~~~~~------------------------------~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~ 228 (767)
+.+.+. +.+.+|+|||||+||++...+.+ ..+++..++.++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence 766643 26889999999999977666643 25899999999999999
Q ss_pred HHHHHH-HCCcccccCCcceEEeCCCC--------------------CEEEeecCcccccCCCCcccccccccccCCcce
Q psy11874 229 GLEHLH-YIGLVYRDCKPENILLDDYG--------------------HVRISDLGLAVEIPEGESVRGRVGTVGYMAPEV 287 (767)
Q Consensus 229 aL~yLH-~~~IvHrDLKPeNILld~~g--------------------~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEv 287 (767)
||+||| ++||+||||||+|||++.+| .+||+|||+|+..... ..+||+.|||||+
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGG
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhh
Confidence 999999 99999999999999999887 8999999999876543 4589999999999
Q ss_pred ecCCCCCCCCccccchhh-HHHHhcCCCCCCCchhh-hhhhhhhhhhhc---cccccCCCCcHHHHHHHHHhcccCcCcc
Q psy11874 288 IDNEKYTYSPDWFSFGCL-IFEMIEGQAPFRRRKEM-VKRDEVDRRVKE---DAEKYSCRFSDDAKALCKALLKKSPRSR 362 (767)
Q Consensus 288 l~~~~ys~~~DvwSlGvi-LyElltG~~PF~~~~~~-~~~~~i~~~i~~---~~~~~~~~~s~~~~dLi~~lL~~dP~~R 362 (767)
+.+.. +.++||||+|++ .+++++|..||.+.... .....+...... .....+..+|+++++||++||++|
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 98776 899999998777 78899999999543210 011111111111 111223457899999999999977
Q ss_pred CCCCCCcccHHHHH-hCCCCC
Q psy11874 363 LGCHCGRYGARELK-QAEFFK 382 (767)
Q Consensus 363 l~~~~~~~~a~eil-~HpfF~ 382 (767)
+ |+|++ +||||+
T Consensus 324 -s-------a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 -S-------ATDLLCQHSLFK 336 (336)
T ss_dssp -S-------HHHHHHHCGGGC
T ss_pred -C-------HHHHHhcCCCcC
Confidence 5 99999 999995
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.87 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=195.1
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHH--HHhcCCCceeEEEEEEee-
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI--LQKINSRFVVSLAYAYET- 185 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~i--L~~l~hp~Iv~l~~~~~~- 185 (767)
..+..++|++.+.||+|+||.||+|+. +|+.||+|++.... ......|..+ +..++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 356779999999999999999999976 68999999986542 1223334444 456899999999975543
Q ss_pred ----CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC---------CcccccCCcceEEeCC
Q psy11874 186 ----KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI---------GLVYRDCKPENILLDD 252 (767)
Q Consensus 186 ----~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~---------~IvHrDLKPeNILld~ 252 (767)
...+|+||||++||+|.+++... ..++..+..++.||+.||.|||+. ||+||||||+|||++.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 34689999999999999999765 368999999999999999999999 9999999999999999
Q ss_pred CCCEEEeecCcccccCCCC---------cccccccccccCCcceecC-------CCCCCCCccccchhhHHHHhcCCCCC
Q psy11874 253 YGHVRISDLGLAVEIPEGE---------SVRGRVGTVGYMAPEVIDN-------EKYTYSPDWFSFGCLIFEMIEGQAPF 316 (767)
Q Consensus 253 ~g~vkL~DFGla~~~~~~~---------~~~~~~GT~~Y~APEvl~~-------~~ys~~~DvwSlGviLyElltG~~PF 316 (767)
+|.+||+|||+|....... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 9999999999998764322 1234579999999999976 45667899999999999999997776
Q ss_pred CCchhhhhhh--------------hhhhhh--hccccccCCC------CcHHHHHHHHHhcccCcCccCCCCCCcccHHH
Q psy11874 317 RRRKEMVKRD--------------EVDRRV--KEDAEKYSCR------FSDDAKALCKALLKKSPRSRLGCHCGRYGARE 374 (767)
Q Consensus 317 ~~~~~~~~~~--------------~i~~~i--~~~~~~~~~~------~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~e 374 (767)
.......... .+...+ ......++.. .++++.+||.+||+.||++||+ ++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-------~~e 308 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT-------AQX 308 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCC-------HHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcc-------hHH
Confidence 4332211100 000000 1111222222 3458999999999999999999 888
Q ss_pred H------HhCCCCCC
Q psy11874 375 L------KQAEFFKS 383 (767)
Q Consensus 375 i------l~HpfF~~ 383 (767)
+ +.++|-++
T Consensus 309 ~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 309 AEERMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHHHHCCCC-
T ss_pred HHHHHHHHHHHHHhc
Confidence 7 44566554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=357.02 Aligned_cols=256 Identities=20% Similarity=0.295 Sum_probs=210.6
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEE----ccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQV----RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~----~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
.+..++|++.+.||+|+||.||+|+. ..+|+.||+|++... .......+.+|+.+|++++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 34557899999999999999999994 568999999998754 23345678899999999999999999999876
Q ss_pred CC--eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 186 KD--ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 186 ~~--~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
.+ .+++||||++||+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 54 7899999999999999998753 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhh------------hhhh
Q psy11874 264 AVEIPEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV------------KRDE 327 (767)
Q Consensus 264 a~~~~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~------------~~~~ 327 (767)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|..||....... ....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 987754432 223457888999999998889999999999999999999999986542110 0011
Q ss_pred hhhhhh-ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 328 VDRRVK-EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 328 i~~~i~-~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+...+. ......+..+++++.+||.+||..||++||+ +.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-------~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS-------FRDLAL 315 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCC-------HHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcC-------HHHHHH
Confidence 111111 1223446678999999999999999999999 777764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=386.83 Aligned_cols=246 Identities=21% Similarity=0.305 Sum_probs=203.0
Q ss_pred ccCCCeEEEe-EEeecCcEEEEEEEEcc--CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYR-VLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~-~LG~G~fG~Vy~a~~~~--tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
+..+++.+.+ .||+|+||.||+|.++. ++..||+|++.... .....+.+.+|+.+|++++|||||++++++.+ +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 3445677776 89999999999998863 56789999997642 33356678999999999999999999999976 5
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+|||||+||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred CeEEEEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 6999999999999999987542 36999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 268 PEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 268 ~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
..... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+.. ......+..
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---~~~~~~p~~ 563 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPE 563 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT---TCCCCCCTT
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCCCCCCc
Confidence 54332 122346789999999999999999999999999999998 9999987655433332222 223455678
Q ss_pred CcHHHHHHHHHhcccCcCccCC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
+++++.+|+.+||..||++||+
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs 585 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPD 585 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCC
T ss_pred CCHHHHHHHHHHcCCChhHCcC
Confidence 9999999999999999999999
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=381.17 Aligned_cols=254 Identities=23% Similarity=0.304 Sum_probs=213.3
Q ss_pred hcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 107 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
..+.+..++|++.+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|+.+|++++|||||++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3456777899999999999999999999974 56799999976432 24568899999999999999999999876
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+.+|+|||||+||+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred ccceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 67999999999999999997532 12589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 IPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
...... .....+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.........+.+ ......+..+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~---~~~~~~~~~~ 489 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPEC 489 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT---TCCCCCCTTC
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCC
Confidence 654321 223457889999999999999999999999999999999 9999987654333333222 1223445678
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++++.+||.+||+.||++||+ +++|++
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt-------~~~l~~ 516 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPT-------FEYLQA 516 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcC-------HHHHHH
Confidence 999999999999999999999 777765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.05 Aligned_cols=246 Identities=26% Similarity=0.350 Sum_probs=200.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHh--cCCCceeEEEEEEeeCC----
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK--INSRFVVSLAYAYETKD---- 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~~~~~~---- 187 (767)
++|++.+.||+|+||.||+|++ +|+.||+|++... ....+.+|.+++.. ++||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 5799999999999999999998 5999999998643 23456788999988 79999999999998876
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHH--------HCCcccccCCcceEEeCCCCCEEEe
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH--------YIGLVYRDCKPENILLDDYGHVRIS 259 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH--------~~~IvHrDLKPeNILld~~g~vkL~ 259 (767)
.+|+||||++||+|.+++.+. .+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred eeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 899999999999999999764 5899999999999999999999 8999999999999999999999999
Q ss_pred ecCcccccCCCCc-----ccccccccccCCcceecCCC------CCCCCccccchhhHHHHhcC----------CCCCCC
Q psy11874 260 DLGLAVEIPEGES-----VRGRVGTVGYMAPEVIDNEK------YTYSPDWFSFGCLIFEMIEG----------QAPFRR 318 (767)
Q Consensus 260 DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~------ys~~~DvwSlGviLyElltG----------~~PF~~ 318 (767)
|||++........ .....||+.|+|||++.+.. ++.++|||||||++|||++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 9999987654432 24457999999999997653 33689999999999999999 788866
Q ss_pred chhhh-hhhhhhhhhhcc--ccccC-----CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 319 RKEMV-KRDEVDRRVKED--AEKYS-----CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 319 ~~~~~-~~~~i~~~i~~~--~~~~~-----~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
..... ....+...+... ....+ ...++.+.+|+.+||+.||++||+ ++++++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-------~~~i~~~ 330 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT-------ALRIKKT 330 (342)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC-------HHHHHHH
T ss_pred cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC-------HHHHHHH
Confidence 43211 112222222111 11122 133468999999999999999999 8888765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=373.01 Aligned_cols=253 Identities=15% Similarity=0.134 Sum_probs=198.3
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC-Cc----------eeE---
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RF----------VVS--- 178 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~----------Iv~--- 178 (767)
...|...++||+|+||+||+|++..+|+.||||++...........+.+.+|..+++.+.| ++ ++.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3468899999999999999999999999999999875443344456678899999999987 21 111
Q ss_pred --------EEEEEee-----CCeEEEEEEeccCCCHHHHHHhc----CCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccc
Q psy11874 179 --------LAYAYET-----KDALCLVLTIMNGGDLKFHIYNM----GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241 (767)
Q Consensus 179 --------l~~~~~~-----~~~l~lV~E~~~gG~L~~~l~~~----~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHr 241 (767)
+...+.. ...++++|+++ +|+|.+++... .....+++..+..++.||+.||+|||++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111 23467788776 58999888522 112347888899999999999999999999999
Q ss_pred cCCcceEEeCCCCCEEEeecCcccccCCCCcccccccccccCCccee----------cCCCCCCCCccccchhhHHHHhc
Q psy11874 242 DCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVI----------DNEKYTYSPDWFSFGCLIFEMIE 311 (767)
Q Consensus 242 DLKPeNILld~~g~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl----------~~~~ys~~~DvwSlGviLyEllt 311 (767)
||||+|||++.+|.+||+|||+|+..... ....+| +.|+|||++ .+..|+.++|||||||++|||++
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999999999875433 456678 999999999 55668899999999999999999
Q ss_pred CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 312 GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 312 G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
|+.||...+.......+ . .....+|+++++||.+||+.||++||+ +.++++||||+.+
T Consensus 313 g~~Pf~~~~~~~~~~~~----~----~~~~~~~~~~~~li~~~l~~dP~~Rpt-------~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWI----F----RSCKNIPQPVRALLEGFLRYPKEDRLL-------PLQAMETPEYEQL 370 (413)
T ss_dssp SSCCCCTTGGGSCSGGG----G----SSCCCCCHHHHHHHHHHTCSSGGGSCC-------HHHHTTSHHHHHH
T ss_pred CCCCCCCcchhhhHHHH----H----hhcccCCHHHHHHHHHHccCChhhCcC-------HHHHHhCHHHHHH
Confidence 99999876543222211 1 122467899999999999999999999 9999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=381.10 Aligned_cols=253 Identities=20% Similarity=0.290 Sum_probs=209.7
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccC---CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
.+..++|++.+.||+|+||.||+|.++.+ +..+|+|++.... .....+.+.+|+.+|++++||||+++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 35567899999999999999999998754 5679999986532 2334467889999999999999999999885 4
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+.+|+||||++||+|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred CceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 66899999999999999998643 3589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 IPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
...... .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+. .......+..+
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~---~~~~~~~~~~~ 617 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---NGERLPMPPNC 617 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---HTCCCCCCTTC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---cCCCCCCCccc
Confidence 654432 223457889999999999999999999999999999997 999998765433332222 22334567789
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++.+.+||.+||..||++||+ +.++++
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs-------~~el~~ 644 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPR-------FTELKA 644 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcC-------HHHHHH
Confidence 999999999999999999999 778764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=353.47 Aligned_cols=256 Identities=19% Similarity=0.253 Sum_probs=205.7
Q ss_pred hhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 106 ~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
.....+..++|++.+.||+|+||.||+|.+.. .+|+|++..... .......+.+|+.++++++||||+++++++.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 34566778999999999999999999999864 499999876432 22233456779999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
.+.+++||||++||+|..++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++ +|.+||+|||++.
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred CCceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999999999999987642 3689999999999999999999999999999999999998 6899999999987
Q ss_pred ccCCC------CcccccccccccCCcceecC---------CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhh
Q psy11874 266 EIPEG------ESVRGRVGTVGYMAPEVIDN---------EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR 330 (767)
Q Consensus 266 ~~~~~------~~~~~~~GT~~Y~APEvl~~---------~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~ 330 (767)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 257 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 54321 22334569999999999864 4578899999999999999999999987654433322222
Q ss_pred hhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 331 RVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 331 ~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.. ........+++++.+||.+||..||++||+ ++++++
T Consensus 258 ~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-------~~~l~~ 295 (319)
T 2y4i_B 258 GM--KPNLSQIGMGKEISDILLFCWAFEQEERPT-------FTKLMD 295 (319)
T ss_dssp TC--CCCCCCSSCCTTHHHHHHHHHCSSTTTSCC-------HHHHHH
T ss_pred CC--CCCCCcCCCCHHHHHHHHHHhcCChhhCcC-------HHHHHH
Confidence 11 111122367889999999999999999999 788775
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.87 Aligned_cols=228 Identities=13% Similarity=0.072 Sum_probs=190.6
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|..++.+++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 33468999999999999999999999999999999998765444455577899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||++||+|.+++.+ +....++..++.||+.||+|||++||+||||||+|||++.+|.+||+++
T Consensus 108 lv~e~~~g~~L~~~l~~-----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~--------- 173 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP--------- 173 (286)
T ss_dssp EEEECCCEEEHHHHHTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSC---------
T ss_pred EEEEecCCCCHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEec---------
Confidence 99999999999999843 2466678899999999999999999999999999999999999999844
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc---cccccCCCCcHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE---DAEKYSCRFSDDA 347 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~---~~~~~~~~~s~~~ 347 (767)
+|++| ++.++|||||||++|||++|+.||.+.+.........+.+.. ........+++++
T Consensus 174 ----------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 174 ----------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ----------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred ----------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 34443 789999999999999999999999876543222111111111 1223456789999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++||.+||++||++| + ++++++
T Consensus 237 ~~li~~~l~~dP~~R-s-------~~el~~ 258 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-S-------ASTLLN 258 (286)
T ss_dssp HHHHHHHHCTTSSCC-C-------HHHHHH
T ss_pred HHHHHHHcccCCccC-C-------HHHHHH
Confidence 999999999999999 8 778775
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=377.67 Aligned_cols=242 Identities=25% Similarity=0.326 Sum_probs=200.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEcc-CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe---
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA--- 188 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~--- 188 (767)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++.... .......+.+|+.+|.+++|||||++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 4789999999999999999999986 79999999986532 23345568899999999999999999999987665
Q ss_pred --EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 189 --LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 189 --l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
.|+|||||+||+|..++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++.
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999876643 58999999999999999999999999999999999999984 999999999987
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
.... ...+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+....... .. ......++.
T Consensus 231 ~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~--------~~--~~~~~~~~~ 296 (681)
T 2pzi_A 231 INSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------ED--DPVLKTYDS 296 (681)
T ss_dssp TTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC--------TT--CHHHHHCHH
T ss_pred cccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc--------cc--ccccccCHH
Confidence 6543 456799999999998665 488999999999999999999998764221100 00 001124678
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+.+||.+||++||++||+ ..+.+.|+|+.-
T Consensus 297 l~~li~~~l~~dP~~R~~-------~~~~l~~~l~~~ 326 (681)
T 2pzi_A 297 YGRLLRRAIDPDPRQRFT-------TAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHHTCSSGGGSCS-------SHHHHHHHHHHH
T ss_pred HHHHHhhhccCChhhCCC-------HHHHHHHHHHHH
Confidence 999999999999999998 567777887653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=319.02 Aligned_cols=190 Identities=17% Similarity=0.123 Sum_probs=139.3
Q ss_pred eEEeecCcEEEEEEEEccCCcEEEEEEechhhhh-------hhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCCeEEE
Q psy11874 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-------KRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~-------~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~l 191 (767)
...+.|++|.+..++...+|+.||||++.+.... .....+.+.+|+++|+++ .|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 4467888999888888889999999999764321 122345689999999999 79999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
||||++||+|.++|.+.+ .+++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999999999999998764 46654 478999999999999999999999999999999999999999998775443
Q ss_pred -cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCC
Q psy11874 272 -SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPF 316 (767)
Q Consensus 272 -~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF 316 (767)
...+.+||++|||||++.+ .+..++|+||+|+++++|.+|..|+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 3456789999999999976 4678899999999999998776655
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=283.58 Aligned_cols=172 Identities=32% Similarity=0.515 Sum_probs=148.5
Q ss_pred hHHHHHhhhcccc--cCCcchhhhhHHHHHhhhcCCCccccchhhhHHHHhhhhhcccceeeeeeeecccccCCCceeec
Q psy11874 490 SLEIIEHCKESLD--SGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYLQWKWLEHHFLYVEVFTHGVYCSQPHAVYA 567 (767)
Q Consensus 490 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 567 (767)
+...+++|++.++ ....+||++|+.+++.||.|+||.+|++|++|.||+||||++.+.
T Consensus 125 ~~~~~~~~~~~~~~~~~~~~lf~~~~~~~~~~l~~~~f~~~~~s~~~~r~~q~k~~e~~~-------------------- 184 (689)
T 3v5w_A 125 SKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNI-------------------- 184 (689)
T ss_dssp CHHHHHHHHHHHHTTCCCTTTTHHHHHHHHHHHTTHHHHHHHHSHHHHHHHHHHHHHTTC--------------------
T ss_pred chHHHHHHHHhhhhccCChHHHHHHHHHHHHHhccCcccccccChhHHHHHhccccccCC--------------------
Confidence 3467788888774 455899999999999999999999999999999999999998221
Q ss_pred CCccCccccccccceecCCCChHHHhhhccCCcccccccccchhhhhhhccccCCCCCCCCCCcccCCCCCCCCCCCCCC
Q psy11874 568 KDVLDIEQFSTVKGVTLDTTDDSFYSKFNTGSVSIPWQNEMIETECFKELNVFGENNTPSSDVMFTSVPPSETNPSCFPQ 647 (767)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~d~~f~~~f~tg~v~~~~~~e~ie~~cf~eln~~~~~~~~s~dl~~~s~~~~~~ks~~f~~ 647 (767)
T Consensus 185 -------------------------------------------------------------------------------- 184 (689)
T 3v5w_A 185 -------------------------------------------------------------------------------- 184 (689)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHH---HHHhhCCCCceeeeeEEEEeC
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK---QILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei---~IL~~l~HpnIV~l~~~f~~~ 724 (767)
+++++||+++++||+|+||+||+|+++.||+.||||+|++..+........+.+|. .+++.++|||||+|+++|++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 36788999999999999999999999999999999999988765555566666664 555677999999999999999
Q ss_pred CEEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 725 DALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
+++|||||||+||+|+++|.+.+.+.+..++..++++
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qI 301 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHH
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHH
Confidence 9999999999999999999988887877776655444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-28 Score=278.61 Aligned_cols=185 Identities=17% Similarity=0.103 Sum_probs=147.2
Q ss_pred EEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh-----hhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 117 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 117 ~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
...+.||+|+||.||+|. ..++.+|+|+...+... .....+.+.+|+++|++++||||+++..++.+.+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 345789999999999994 45889999986543322 22234568999999999999999965555557777899
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
|||||+||+|.+++.. +..++.||+.||+|||++||+||||||+|||++. ++||+|||+|+......
T Consensus 417 VmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999988764 4679999999999999999999999999999999 99999999999876543
Q ss_pred c--------ccccccccccCCcceecC--CCCCCCCccccchhhHHHHhcCCCCC
Q psy11874 272 S--------VRGRVGTVGYMAPEVIDN--EKYTYSPDWFSFGCLIFEMIEGQAPF 316 (767)
Q Consensus 272 ~--------~~~~~GT~~Y~APEvl~~--~~ys~~~DvwSlGviLyElltG~~PF 316 (767)
. ..+.+||+.|||||++.. ..|+..+|+||.++-..+.+.++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2 135689999999999977 67888899999999888888877776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.1e-25 Score=232.59 Aligned_cols=160 Identities=16% Similarity=0.152 Sum_probs=126.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh---------------hhHHHHHHHHHHHHhcCCCceeE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---------------KGESMVLIEKQILQKINSRFVVS 178 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~---------------~~~~~~~~E~~iL~~l~hp~Iv~ 178 (767)
..|.+.+.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|..+|++++| ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CC
Confidence 3567779999999999999999 8899999999865432111 134568899999999994 55
Q ss_pred EEEEEeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEE
Q psy11874 179 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRI 258 (767)
Q Consensus 179 l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL 258 (767)
+...+.. +..|+|||||+||+|.. +. . .....++.||+.||.|||++||+||||||+|||++ +|.+||
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEE
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEE
Confidence 5555544 45699999999999976 31 1 23457999999999999999999999999999999 999999
Q ss_pred eecCcccccCCCCcccccccccccCCcceecC----------CCCCCCCcccc
Q psy11874 259 SDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN----------EKYTYSPDWFS 301 (767)
Q Consensus 259 ~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~----------~~ys~~~DvwS 301 (767)
+|||+|+. +..++|||++.+ ..|+..+|+|.
T Consensus 234 ~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 234 IDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999863 456789999854 45666667664
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=5.3e-22 Score=213.22 Aligned_cols=115 Identities=21% Similarity=0.281 Sum_probs=104.8
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
+...+||++++.||+|+||+||+|+++.||+.||||+|++..+.+....+.+.+|++||+.++|||||++|++|++.+.+
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45678999999999999999999999999999999999988766667788999999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
|||||||+||+|+++|++.+.+.+..++..+.+++
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~ 142 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHH
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHH
Confidence 99999999999999999888888887777655543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=5.6e-21 Score=221.60 Aligned_cols=177 Identities=54% Similarity=0.897 Sum_probs=152.2
Q ss_pred CCCCccchhhhhHHHHHhhhccccc-CCcchhhhhHHHHHhhhcCCCccccchhhhHHHHhhhhhcccceeeeeeeeccc
Q psy11874 479 FPQAPEAVDVLSLEIIEHCKESLDS-GNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYLQWKWLEHHFLYVEVFTHGV 557 (767)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (767)
-|+.+...+....+++++|...|+. +.+.+|.++...+..+|.++||.+|.+|.+|.||+||+|++..
T Consensus 111 ~~~~~~~~~~v~~~l~~~~~~~l~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~s~~~~~~~~~~~l~~~----------- 179 (576)
T 2acx_A 111 SHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQ----------- 179 (576)
T ss_dssp CSSSCCSSTTCCHHHHHHHHHHHHHCCCTTTTHHHHHHHHHHHTTHHHHHHHTSHHHHHHHHHHHHHTS-----------
T ss_pred CcccccccccCCHHHHHHHHHHHhcCchHHHHHHHHHHHHHhhccCcchhhcchhhhhhhhhhhhhhhc-----------
Confidence 3455556666778889999999976 4689999999999999999999999999999999999988721
Q ss_pred ccCCCceeecCCccCccccccccceecCCCChHHHhhhccCCcccccccccchhhhhhhccccCCCCCCCCCCcccCCCC
Q psy11874 558 YCSQPHAVYAKDVLDIEQFSTVKGVTLDTTDDSFYSKFNTGSVSIPWQNEMIETECFKELNVFGENNTPSSDVMFTSVPP 637 (767)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~f~~~f~tg~v~~~~~~e~ie~~cf~eln~~~~~~~~s~dl~~~s~~~ 637 (767)
T Consensus 180 -------------------------------------------------------------------------------- 179 (576)
T 2acx_A 180 -------------------------------------------------------------------------------- 179 (576)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCCCCCCCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeee
Q psy11874 638 SETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 717 (767)
Q Consensus 638 ~~~ks~~f~~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l 717 (767)
++..++|++++.||+|+||+||+|+++.+|+.||+|++.+..+......+.+.+|+.+|+.++|||||++
T Consensus 180 ----------~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l 249 (576)
T 2acx_A 180 ----------PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249 (576)
T ss_dssp ----------CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ----------CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeE
Confidence 1345689999999999999999999999999999999998766555667789999999999999999999
Q ss_pred eEEEEeCCEEEEEEeccCCccccccccccCC--CChhhhHH
Q psy11874 718 AYAYETKDALCLVLTIIDVMFTCVQPSETNP--CCFPFRRK 756 (767)
Q Consensus 718 ~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~--~~~~~~~~ 756 (767)
+++|++.+.+|||||||+||+|.+++...+. +.+.....
T Consensus 250 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~ 290 (576)
T 2acx_A 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290 (576)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHH
T ss_pred EEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHH
Confidence 9999999999999999999999999876543 34444433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.82 E-value=2.8e-20 Score=214.78 Aligned_cols=159 Identities=50% Similarity=0.850 Sum_probs=137.7
Q ss_pred chhhhhHHHHHhhhcccccCCcchhhhhHHHHHhhhcCCCccccchhhhHHHHhhhhhcccceeeeeeeecccccCCCce
Q psy11874 485 AVDVLSLEIIEHCKESLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYLQWKWLEHHFLYVEVFTHGVYCSQPHA 564 (767)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (767)
++...+-+.+.+|++. ....+|.++++++..++.++||.+|++|.+|.||+||+|++.
T Consensus 122 ~~~~~~~~~v~~v~~~---~~~~l~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------- 179 (543)
T 3c4z_A 122 FCSFLDAETVARARAG---AGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEA------------------- 179 (543)
T ss_dssp CCTTSCHHHHHHHHCC------CTTHHHHHHHHHHHTTHHHHHHHTSHHHHHHHHHHHHHT-------------------
T ss_pred hhccCCHHHHhhhhcC---CCchhhHHHHHHHHHhhhcCchHhhhhhhhhhhhhhhhhhhc-------------------
Confidence 4444555667777666 456699999999999999999999999999999999999871
Q ss_pred eecCCccCccccccccceecCCCChHHHhhhccCCcccccccccchhhhhhhccccCCCCCCCCCCcccCCCCCCCCCCC
Q psy11874 565 VYAKDVLDIEQFSTVKGVTLDTTDDSFYSKFNTGSVSIPWQNEMIETECFKELNVFGENNTPSSDVMFTSVPPSETNPSC 644 (767)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~d~~f~~~f~tg~v~~~~~~e~ie~~cf~eln~~~~~~~~s~dl~~~s~~~~~~ks~~ 644 (767)
T Consensus 180 -------------------------------------------------------------------------------- 179 (543)
T 3c4z_A 180 -------------------------------------------------------------------------------- 179 (543)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 645 FPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 645 f~~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
..+..++|++++.||+|+||+||+|+++.+|+.||+|++.+..+......+.+.+|+++|+.++|||||+++++|++.
T Consensus 180 --~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 257 (543)
T 3c4z_A 180 --QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK 257 (543)
T ss_dssp --SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred --ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC
Confidence 114467899999999999999999999999999999999987655556678899999999999999999999999999
Q ss_pred CEEEEEEeccCCccccccccccC
Q psy11874 725 DALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+|+|||||+||+|.++|...+
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~ 280 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVD 280 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSS
T ss_pred CEEEEEEEeccCCCHHHHHHHhh
Confidence 99999999999999999986643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.6e-20 Score=193.94 Aligned_cols=140 Identities=19% Similarity=0.052 Sum_probs=109.0
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcE--EEEEEechhhhhh---------------------hhhHHHHHHHHHHHHhcC
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKM--YACKKLEKKRIKK---------------------RKGESMVLIEKQILQKIN 172 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~--~AiK~l~k~~~~~---------------------~~~~~~~~~E~~iL~~l~ 172 (767)
|++.+.||+|+||.||+|.+..+|+. ||+|++....... ......+.+|..+|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999778999 9999875432110 011235788999999998
Q ss_pred CCce--eEEEEEEeeCCeEEEEEEeccC-C----CHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHH-HCCcccccCC
Q psy11874 173 SRFV--VSLAYAYETKDALCLVLTIMNG-G----DLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH-YIGLVYRDCK 244 (767)
Q Consensus 173 hp~I--v~l~~~~~~~~~l~lV~E~~~g-G----~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH-~~~IvHrDLK 244 (767)
|+++ +.++.. +..+|||||+.+ | +|...... .++..+..++.||+.||.||| +.||+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 8753 333332 356899999942 4 66554332 234567889999999999999 9999999999
Q ss_pred cceEEeCCCCCEEEeecCccccc
Q psy11874 245 PENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 245 PeNILld~~g~vkL~DFGla~~~ 267 (767)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=198.47 Aligned_cols=109 Identities=15% Similarity=0.196 Sum_probs=88.6
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
++++|++++.||+|+||+||+|+++.+|+.||||+|++..+ .....+.+.+|++||++++|||||++|++|++++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 46799999999999999999999999999999999998764 44567889999999999999999999999999999999
Q ss_pred EEeccCCccccccccccCC--CChhhhHHHHH
Q psy11874 730 VLTIIDVMFTCVQPSETNP--CCFPFRRKEVV 759 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~--~~~~~~~~~v~ 759 (767)
|||||+||+|+++|...+. ..+......+.
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~ 132 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHH
Confidence 9999999999999975543 34444444333
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=191.91 Aligned_cols=112 Identities=18% Similarity=0.198 Sum_probs=92.6
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
.+++|++++.||+|+||+||+|+++.||+.||+|+|++..+.+....+.+.+|+++|+.++|||||+++++|++.+.+||
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 36799999999999999999999999999999999998876666677889999999999999999999999999999999
Q ss_pred EEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 730 VLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
||||| +|+|+++|.+.+.+.+......+.+++
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~ 122 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQII 122 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHH
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHH
Confidence 99999 789999998888888887777666554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-19 Score=193.39 Aligned_cols=113 Identities=26% Similarity=0.361 Sum_probs=92.4
Q ss_pred CCCCCceeeeecccCCccceeEEEEc---cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 725 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k---~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~ 725 (767)
...++|++++.||+|+||+||+|++. .+++.||+|+|++..+.. .....+.+|++||++++|||||++|++|++++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 45679999999999999999999985 478899999999876433 33447889999999999999999999999999
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
.+|||||||+||+|+++|.+.+.+.+..+...+.+++
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~ 136 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 136 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Confidence 9999999999999999999888878777776655543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=6.4e-19 Score=191.99 Aligned_cols=106 Identities=20% Similarity=0.282 Sum_probs=92.4
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
..|++++.||+|+||+||+|+++.||+.||||+|++... ...+.+.+|+.||+.++|||||++|++|++.+.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 469999999999999999999999999999999987542 34457889999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|||+||+|.+++.+ +.+.+...+..+.++
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi 179 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAV 179 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHH
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHH
Confidence 99999999999865 456666666655444
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.5e-18 Score=193.75 Aligned_cols=106 Identities=20% Similarity=0.293 Sum_probs=91.9
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
..|++++.||+|+||+||+|+++.||+.||||+|++.. ....+.+.+|+.||+.++|||||++|++|++.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT---CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 47999999999999999999999999999999998754 234457899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|||+||+|.++++. +.+.+......+.++
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qi 256 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAV 256 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHH
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHH
Confidence 99999999999864 455666665544443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2e-18 Score=187.40 Aligned_cols=106 Identities=15% Similarity=0.018 Sum_probs=93.8
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
...++|++.+.||+|+||+||+|+++.||+.||||+|+++.. ..+|+.+|+.++|||||++|++|++.+.+|
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456789999999999999999999999999999999987542 246999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
||||||+||+|.++|++.+.+.+......+.+++
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~ 160 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHH
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHH
Confidence 9999999999999998888877777766555543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.73 E-value=5.9e-18 Score=180.29 Aligned_cols=107 Identities=14% Similarity=0.149 Sum_probs=92.5
Q ss_pred ceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe----CCEEEE
Q psy11874 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET----KDALCL 729 (767)
Q Consensus 654 y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~----~~~lyl 729 (767)
|++.+.||+|+||+||+|+++.+|+.||+|++.+... .....+.+.+|++||++++|||||++|++|++ .+.+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 4778899999999999999999999999999987663 44567789999999999999999999999986 356999
Q ss_pred EEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 730 VLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|||||+||+|.++|.+.+.+.+......+.++
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi 138 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHH
Confidence 99999999999999888777777666555443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5e-18 Score=181.78 Aligned_cols=96 Identities=20% Similarity=0.239 Sum_probs=83.5
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC------
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD------ 725 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~------ 725 (767)
+||++++.||+|+||+||+|+++.+|+.||+|+|++.. .....+.+.+|+++|++++|||||++|++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 58999999999999999999999999999999998753 3455678999999999999999999999998655
Q ss_pred ------EEEEEEeccCCccccccccccCCC
Q psy11874 726 ------ALCLVLTIIDVMFTCVQPSETNPC 749 (767)
Q Consensus 726 ------~lylVmEy~~gG~L~~~l~~~~~~ 749 (767)
.+|||||||+||+|.++|...+..
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~ 112 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTI 112 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSG
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCC
Confidence 489999999999999999876553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.4e-17 Score=178.37 Aligned_cols=98 Identities=18% Similarity=0.207 Sum_probs=84.0
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEc-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAY 721 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k-----~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f 721 (767)
..+..++|.+.+.||+|+||+||+|+++ .+|+.||+|+++.. .....+.+.+|++||++++|||||++++++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 3466789999999999999999999875 46889999999864 345667899999999999999999999999
Q ss_pred EeCCEEEEEEeccCCccccccccccC
Q psy11874 722 ETKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 722 ~~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
.+.+.+|||||||+||+|.++|++.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~ 110 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHG 110 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTS
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcC
Confidence 99999999999999999999997643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.1e-17 Score=181.46 Aligned_cols=109 Identities=17% Similarity=0.263 Sum_probs=93.6
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC------C
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------D 725 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~------~ 725 (767)
++|++++.||+|+||+||+|+++.||+.||||+|++.. ......+.+.+|++||+.++|||||++++++.+. +
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46999999999999999999999999999999998764 3445567889999999999999999999998653 6
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
.+|||||||+ |+|+++|.+.+.+.+...+..+.+++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil 168 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLL 168 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHH
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHH
Confidence 7999999996 78999998888877777766555543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.68 E-value=7.9e-17 Score=187.44 Aligned_cols=109 Identities=19% Similarity=0.227 Sum_probs=94.4
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
.+++|++++.||+|+||+||+|+++.||+.||+|+|.+.. ....+.+.+|+.||+.++|||||+|+++|++.+.+||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4679999999999999999999999999999999998753 3456788999999999999999999999999999999
Q ss_pred EEeccCCcccccccccc-CCCChhhhHHHHHHh
Q psy11874 730 VLTIIDVMFTCVQPSET-NPCCFPFRRKEVVVV 761 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~-~~~~~~~~~~~v~~~ 761 (767)
|||||+||+|+++|... +.+.+......+.++
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi 264 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 264 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHH
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHH
Confidence 99999999999998644 455666655554443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=7.9e-17 Score=174.76 Aligned_cols=97 Identities=15% Similarity=0.175 Sum_probs=85.3
Q ss_pred CCCCCCceeeeecccCCccceeEEEEc-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 722 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k-----~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~ 722 (767)
.+...||.+.+.||+|+||+||+|+++ .+|+.||||+++.. .....+.+.+|++||++++|||||++++++.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 456679999999999999999999875 46889999999763 4456678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCccccccccccC
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+.+|||||||+||+|.++|.+.+
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~ 138 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHG 138 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSS
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcC
Confidence 9999999999999999999987643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1e-16 Score=176.55 Aligned_cols=141 Identities=14% Similarity=0.130 Sum_probs=102.7
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh---------------h----hHHHHHHHHHHHHhcCCCce
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---------------K----GESMVLIEKQILQKINSRFV 176 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~---------------~----~~~~~~~E~~iL~~l~hp~I 176 (767)
|++.+.||.|+||.||+|... +|+.||+|++.......+ . ....+..|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999985 799999999754321100 0 01123467788888865544
Q ss_pred eEEEEEEeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC--
Q psy11874 177 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-- 254 (767)
Q Consensus 177 v~l~~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-- 254 (767)
.-. ..+.... .+|||||++|++|.... +.+.+..++.||+.+|.+||+.|||||||||.|||++++|
T Consensus 176 ~vp-~p~~~~~-~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PVP-EPIAQSR-HTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SCC-CEEEEET-TEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCC-eeeeccC-ceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 221 1122222 37999999999885321 1223456789999999999999999999999999998877
Q ss_pred --------CEEEeecCcccccC
Q psy11874 255 --------HVRISDLGLAVEIP 268 (767)
Q Consensus 255 --------~vkL~DFGla~~~~ 268 (767)
.+.|+||+-+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 38999999887643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=171.63 Aligned_cols=97 Identities=16% Similarity=0.133 Sum_probs=83.5
Q ss_pred CCCCCCceeeeecccCCccceeEEEEc-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 722 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k-----~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~ 722 (767)
.+..+++++++.||+|+||+||+++.. .+++.||||+++... .....+.+.+|+.+|++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 467789999999999999999999864 467899999997642 3445678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCcccccccccc
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~ 746 (767)
+.+.+|||||||+||+|.++|..+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~ 123 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMR 123 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTT
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhh
Confidence 999999999999999999999654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.64 E-value=2.7e-16 Score=170.97 Aligned_cols=112 Identities=29% Similarity=0.408 Sum_probs=99.4
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+++++|++++.||+|+||+||+|+++.+|+.||+|++++.........+++.+|+++|+.++||||++++++|++.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 56789999999999999999999999999999999999876555667788999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+|||||+||+|.+++.+.+.+.+......+..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~q 113 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAE 113 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHH
Confidence 99999999999999987776666655554433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.63 E-value=5.2e-16 Score=167.30 Aligned_cols=112 Identities=19% Similarity=0.299 Sum_probs=99.0
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+++++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|+.++|||||+++++|++.+.+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 56789999999999999999999999999999999999876555566788999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+|||||+||+|.+++.+.+...+......+..
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~q 114 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE 114 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHH
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHH
Confidence 99999999999999987776666655554433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=5e-16 Score=170.01 Aligned_cols=114 Identities=27% Similarity=0.375 Sum_probs=97.9
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCC
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 725 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~ 725 (767)
..+.+++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+++|+.+ +|||||+++++|++.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 357889999999999999999999999999999999999987655667778899999999988 7999999999999999
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
.+|||||||+||+|.+++.+.+.+.+......+..
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~q 132 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 132 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHH
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHH
Confidence 99999999999999999988777666665554443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.8e-16 Score=172.88 Aligned_cols=115 Identities=18% Similarity=0.332 Sum_probs=98.0
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCC
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 725 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~ 725 (767)
..+.+++|+++++||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|.++ +|||||+++++|++.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 357789999999999999999999999999999999999988766666777899999999887 8999999999999999
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
.+|||||||+||+|.+++.+.+.+.+...+..+..+
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi 162 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHH
Confidence 999999999999999999887776666665544443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=7.3e-16 Score=170.72 Aligned_cols=114 Identities=25% Similarity=0.393 Sum_probs=101.1
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
..+.+++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.++|||||+++++|++.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 45778999999999999999999999999999999999998765566677899999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+|+|||||.||+|.+++.+.+.+.+......+..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~q 123 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE 123 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHH
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHH
Confidence 9999999999999999987766666655554433
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=6.9e-16 Score=165.63 Aligned_cols=109 Identities=16% Similarity=0.038 Sum_probs=87.7
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..+++++.+.||+|+||+||+++++. .+|||+++... ......+.+.+|+.+|++++|||||++++++ +.+.+
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~-~~~~~ 106 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYM-TKDNL 106 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ECCeE
Confidence 4677899999999999999999998653 58999998654 3455678899999999999999999999976 45679
Q ss_pred EEEEeccCCcccccccccc-CCCChhhhHHHHHHh
Q psy11874 728 CLVLTIIDVMFTCVQPSET-NPCCFPFRRKEVVVV 761 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~-~~~~~~~~~~~v~~~ 761 (767)
|||||||+||+|.++|... +.+.+......+..+
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qi 141 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQT 141 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHH
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHH
Confidence 9999999999999999654 344554444444333
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=166.72 Aligned_cols=113 Identities=20% Similarity=0.351 Sum_probs=100.4
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDA 726 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~ 726 (767)
++.+++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|+.+ +|||||+++++|++.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 46788999999999999999999999999999999999988766667788899999999988 89999999999999999
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+|+|||||+||+|.+++.+.+.+.+......+..
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~q 118 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE 118 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHH
Confidence 9999999999999999987776666655554433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=6.5e-16 Score=168.56 Aligned_cols=113 Identities=19% Similarity=0.304 Sum_probs=97.5
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDA 726 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~ 726 (767)
++.+++|++.+.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|..+ +|||||+++++|++.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 57788999999999999999999999999999999999987655556678899999999987 99999999999999999
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+|+|||||+||+|.+++.+.+.+.+......+..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~q 126 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE 126 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHH
Confidence 9999999999999999987777666655554443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.61 E-value=1.2e-15 Score=166.57 Aligned_cols=114 Identities=25% Similarity=0.381 Sum_probs=100.4
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
...+++|++++.||+|+||.||+|+++.+|+.||+|++++.........+.+.+|+++|+.++|||||+++++|++.+.+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 35678999999999999999999999999999999999987655556778899999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|+|||||+||+|.+++.+.+.+.+......+..+
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi 150 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHH
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHH
Confidence 9999999999999999877776666655544443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-15 Score=163.72 Aligned_cols=113 Identities=19% Similarity=0.201 Sum_probs=99.4
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
...+++|++++.||+|+||.||+|+++.+|+.||+|++.+... .....+.+.+|+++|+.++||||+++++++.+.+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 4567899999999999999999999999999999999988653 445667899999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|+|||||+||+|.+++...+...+......+..+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi 123 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHH
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHH
Confidence 9999999999999999877776766666555444
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=168.04 Aligned_cols=113 Identities=28% Similarity=0.418 Sum_probs=88.6
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHH-HhhCCCCceeeeeEEEEeCC
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI-LQKINSRFVVSLAYAYETKD 725 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~I-L~~l~HpnIV~l~~~f~~~~ 725 (767)
..+..++|++++.||+|+||+||+|+++.+|+.||+|++++..+.......++.+|+.+ ++.++|||||+++++|++.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 35778999999999999999999999999999999999998876666677788999998 57789999999999999999
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
.+|||||||+||+|.+++.+.+.+.+...+..+.
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ 146 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAA 146 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHH
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHH
Confidence 9999999999999999998777666665554433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1e-15 Score=167.46 Aligned_cols=115 Identities=22% Similarity=0.326 Sum_probs=98.6
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCC
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 725 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~ 725 (767)
..+.+++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+++|..+ +||||++++++|++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 357789999999999999999999999999999999999987655566778899999999988 8999999999999999
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
.+|||||||+||+|.+++.+.+.+.+......+..+
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi 130 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 130 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHH
Confidence 999999999999999999877776666655544433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.4e-15 Score=169.97 Aligned_cols=110 Identities=24% Similarity=0.340 Sum_probs=96.0
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|..++|||||+++++|++.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 55679999999999999999999999999999999999866555566778999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccC-CCChhhhHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETN-PCCFPFRRKEV 758 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~-~~~~~~~~~~v 758 (767)
||||||+||+|.++|.+.+ .+.+...+..+
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~ 168 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHH
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHH
Confidence 9999999999999997654 44555444433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=9.1e-16 Score=171.38 Aligned_cols=109 Identities=27% Similarity=0.350 Sum_probs=94.5
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|+.++|||||+++++|++.+.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 55679999999999999999999999999999999999865555555667899999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
||||||+||+|.+++.+. ...+...+..+
T Consensus 146 lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~ 174 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNY-DVPEKWARFYT 174 (410)
T ss_dssp EEECCCTTEEHHHHHHHC-CCCHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHcC-CCCHHHHHHHH
Confidence 999999999999998653 44555544433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=3e-15 Score=168.56 Aligned_cols=111 Identities=23% Similarity=0.356 Sum_probs=95.6
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|..++|||||+++++|++.+.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 55679999999999999999999999999999999999865545555667899999999999999999999999999999
Q ss_pred EEEeccCCcccccccccc-CCCChhhhHHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSET-NPCCFPFRRKEVV 759 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~-~~~~~~~~~~~v~ 759 (767)
||||||+||+|.++|.+. +.+.+...+..+.
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~ 182 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA 182 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHH
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHH
Confidence 999999999999999763 4555555544333
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=4.5e-15 Score=162.98 Aligned_cols=102 Identities=16% Similarity=0.213 Sum_probs=85.8
Q ss_pred CCceeeeecccCCccceeEEEEc---cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k---~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~l 727 (767)
+.|++.+.||+|+||+||+|+++ .+++.||+|++.+.. ....+.+|+++|+.+ +|||||+++++|++.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 46999999999999999999986 467899999987642 335688999999998 799999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|||||||+||+|.++++ .+.+...+..+.++
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~ql 126 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNL 126 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHH
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHH
Confidence 99999999999999984 34555555544443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.56 E-value=7e-15 Score=167.30 Aligned_cols=116 Identities=16% Similarity=0.132 Sum_probs=101.4
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
..+..++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 35778899999999999999999999999999999999988654444566789999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
+|+|||||+||+|.+++.+.+...+......+..++
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~ 126 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHH
Confidence 999999999999999998777766666665554443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=4e-15 Score=162.84 Aligned_cols=96 Identities=19% Similarity=0.235 Sum_probs=82.2
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCC-----cEEEEEEeecccccchhhHHHHHHHHHHHhhCCC-CceeeeeEEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RFVVSLAYAYE 722 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg-----~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~H-pnIV~l~~~f~ 722 (767)
+..++|++.+.||+|+||+||+|+++.++ +.||+|+++... .....+.+.+|+.+|.++.| ||||++++++.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 55679999999999999999999987653 689999998653 34556789999999999955 99999999986
Q ss_pred e-CCEEEEEEeccCCcccccccccc
Q psy11874 723 T-KDALCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 723 ~-~~~lylVmEy~~gG~L~~~l~~~ 746 (767)
+ .+.+|||||||+||+|.++|++.
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~ 163 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSK 163 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHT
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhc
Confidence 5 46799999999999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=8.6e-15 Score=160.68 Aligned_cols=111 Identities=18% Similarity=0.232 Sum_probs=95.3
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccch---hhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~---~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+.|++++.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3579999999999999999999999999999999998653221 1357899999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|+|||||+||+|.+++...+.+.+......+..+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi 124 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHH
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHH
Confidence 9999999999999999877766666665554444
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=6.7e-15 Score=157.71 Aligned_cols=90 Identities=18% Similarity=0.140 Sum_probs=73.6
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC----EE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----AL 727 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~----~l 727 (767)
.+|.+.+.||+|+||+||++++ +|+.||||+++... .......+|+.++.+++|||||++++++.+.+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 3688999999999999999986 68999999997642 11222345666667889999999999998654 69
Q ss_pred EEEEeccCCccccccccccC
Q psy11874 728 CLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~ 747 (767)
|||||||+||+|.++|++.+
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~~ 96 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRYT 96 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCC
T ss_pred EEEecCCCCCcHHHHHHhCC
Confidence 99999999999999997643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.54 E-value=2e-14 Score=152.37 Aligned_cols=97 Identities=12% Similarity=-0.027 Sum_probs=88.6
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44467999999999999999999999999999999998876555566788999999999999999999999999999999
Q ss_pred EEEeccCCccccccccc
Q psy11874 729 LVLTIIDVMFTCVQPSE 745 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~ 745 (767)
+|||||+||+|.+++++
T Consensus 108 lv~e~~~g~~L~~~l~~ 124 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT 124 (286)
T ss_dssp EEEECCCEEEHHHHHTT
T ss_pred EEEEecCCCCHHHHHhc
Confidence 99999999999999854
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.53 E-value=3.2e-14 Score=155.87 Aligned_cols=109 Identities=13% Similarity=0.057 Sum_probs=94.4
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
...++|++++.||+|+||.||+|+++.+|+.||+|++.+... ..+.+.+|+.+++.++|||||++++++.+.+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 445789999999999999999999999999999999986532 2356889999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
+|||||+||+|.+++...+.+.+......+..+
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql 125 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQL 125 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHH
Confidence 999999999999999877776666665554444
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.3e-14 Score=151.97 Aligned_cols=112 Identities=16% Similarity=0.098 Sum_probs=97.3
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+-.++|++++.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 33468999999999999999999999999999999998765455566788999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+|||||+||+|.+++.+.+...+......+..
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~q 119 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQ 119 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHH
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHH
Confidence 99999999999999987776666555554433
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.53 E-value=2.1e-14 Score=157.52 Aligned_cols=109 Identities=17% Similarity=0.203 Sum_probs=95.2
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++.+.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999999999999999987653 4456678999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|||+||+|++.+...+...+......+..+
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi 137 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQI 137 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHH
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHH
Confidence 999999999999877666665555544443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.6e-14 Score=153.97 Aligned_cols=109 Identities=18% Similarity=0.097 Sum_probs=91.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
+++|++++.||+|+||.||+|+++.+|+.||+|++..... ....+.+.+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999986532 23346788999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
||||+||+|.+++...+...+......+..+
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi 114 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHH
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHH
Confidence 9999999999999877666666555544443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.2e-14 Score=157.87 Aligned_cols=112 Identities=17% Similarity=0.105 Sum_probs=97.0
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
..+++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45679999999999999999999999999999999998765444445578999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
+||||+ +|+|.+++...+...+......+..+
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi 117 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHH
Confidence 999999 78999999877776666666554444
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.9e-14 Score=155.22 Aligned_cols=114 Identities=29% Similarity=0.398 Sum_probs=88.7
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEc---cCCcEEEEEEeeccccc-chhhHHHHHHHHHHHhhCCCCceeeeeEEEE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIK-KRKGESMVLIEKQILQKINSRFVVSLAYAYE 722 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k---~tg~~~AvK~i~k~~~~-~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~ 722 (767)
..+..++|++++.||+|+||.||+|++. .+|+.||+|++++..+. .......+.+|+.+|+.++|||||+++++|.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3567789999999999999999999986 68999999999876532 2334567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+.+.+|+|||||+||+|.+++.+.+...+......+..
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~q 129 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHH
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHH
Confidence 99999999999999999999987776665555544433
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.4e-14 Score=161.55 Aligned_cols=109 Identities=15% Similarity=0.212 Sum_probs=94.1
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|+.+|+.++|||||+++++|.+.+.+|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999998663 3455678999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|||+||+|++.+...+...+......+..+
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qi 119 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQI 119 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHH
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHH
Confidence 999999999999877776666665555444
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.51 E-value=2.8e-14 Score=149.49 Aligned_cols=114 Identities=18% Similarity=0.168 Sum_probs=98.4
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
.+..+++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 35678899999999999999999999999999999999987654444556788999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+|+||||++||+|.+.+...+...+......+..
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~q 117 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHH
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHH
Confidence 9999999999999999987666555555444433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=4.2e-14 Score=152.42 Aligned_cols=110 Identities=24% Similarity=0.273 Sum_probs=93.8
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccch---hhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~---~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+.|++.+.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 569999999999999999999999999999999987653221 13578999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
+|||||+||+|.+++...+...+......+..+
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi 123 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQI 123 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHH
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHH
Confidence 999999999999999776666665555544443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.2e-14 Score=163.63 Aligned_cols=114 Identities=28% Similarity=0.409 Sum_probs=88.8
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
..+..++|++++.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 35678899999999999999999999999999999999998765555667788999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+|||||||+||+|.+++.+.+.+.+......+..
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~q 256 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHH
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHH
Confidence 9999999999999999987776666555554433
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.9e-14 Score=156.93 Aligned_cols=95 Identities=22% Similarity=0.389 Sum_probs=84.5
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccch--hhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~--~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
+.|++.+.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 579999999999999999999999999999999986543221 245789999999999999999999999999999999
Q ss_pred EEeccCCcccccccccc
Q psy11874 730 VLTIIDVMFTCVQPSET 746 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~ 746 (767)
|||||+||+|.+.+.+.
T Consensus 104 v~e~~~g~~L~~~l~~~ 120 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKR 120 (351)
T ss_dssp EEECCSSCBHHHHHHHH
T ss_pred EEeCCCCCCHHHHHHHh
Confidence 99999999999887644
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.50 E-value=2.6e-14 Score=169.45 Aligned_cols=115 Identities=22% Similarity=0.326 Sum_probs=99.2
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCC
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 725 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~ 725 (767)
..+.+++|++++.||+|+||+||+|+++.+|+.||||++++..+......+.+.+|+.+|..+ +||||+.++++|++.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 357789999999999999999999999999999999999987655666778899999999988 8999999999999999
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
.+|||||||+||+|.++|.+.+.+.+......+..+
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi 451 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHH
Confidence 999999999999999999887776666665544443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.49 E-value=8.2e-14 Score=150.02 Aligned_cols=106 Identities=21% Similarity=0.269 Sum_probs=90.3
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.++|++.+.||+|+||.||+|+++.+|+.||+|++... ......+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 36899999999999999999999999999999999753 23456788999999999999999999999999999999
Q ss_pred EeccCCccccccccccC-CCChhhhHHHHHH
Q psy11874 731 LTIIDVMFTCVQPSETN-PCCFPFRRKEVVV 760 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~-~~~~~~~~~~v~~ 760 (767)
||||+||+|.+++...+ ...+......+..
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~q 110 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQ 110 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHH
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHH
Confidence 99999999999997653 3444444444333
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.49 E-value=5.3e-14 Score=160.94 Aligned_cols=111 Identities=19% Similarity=0.178 Sum_probs=91.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccch----------hhHHHHHHHHHHHhhCCCCceeeeeEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR----------KGESMVLIEKQILQKINSRFVVSLAYA 720 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~----------~~~~~~~~Ei~IL~~l~HpnIV~l~~~ 720 (767)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4689999999999999999999999999999999987653221 345788999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 721 YETKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 721 f~~~~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|.+.+.+|+|||||+||+|.+.+...+...+......+..+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi 155 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHH
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHH
Confidence 99999999999999999999999877776666665554444
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=4.3e-14 Score=160.68 Aligned_cols=111 Identities=24% Similarity=0.309 Sum_probs=97.7
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+|++++|||||+++++|.+.+.+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35799999999999999999999999999999999887655556678899999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
||||.||+|.+.+...+...+......+..+
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi 135 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQV 135 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHH
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHH
Confidence 9999999999999877776666555544443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.49 E-value=7.9e-14 Score=153.76 Aligned_cols=108 Identities=11% Similarity=0.093 Sum_probs=93.1
Q ss_pred CCCCceeeeecccC--CccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 650 TYKTFRMYRVLGKG--GFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 650 ~~~~y~~~~~LG~G--sfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
..++|++++.||+| +||.||+|+++.+|+.||+|++.+.. ......+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 45689999999999 99999999999999999999998765 3445677889999999999999999999999999999
Q ss_pred EEEEeccCCcccccccccc--CCCChhhhHHHH
Q psy11874 728 CLVLTIIDVMFTCVQPSET--NPCCFPFRRKEV 758 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~--~~~~~~~~~~~v 758 (767)
|+|||||+||+|.+++... +...+......+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 134 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL 134 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHH
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHH
Confidence 9999999999999998765 344444444433
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=5.8e-14 Score=146.55 Aligned_cols=114 Identities=17% Similarity=0.124 Sum_probs=97.6
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
..+..++|++.+.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 35677899999999999999999999999999999999987654444556789999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+|+||||++||+|.+++...+...+......+..
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~q 119 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ 119 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHH
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHH
Confidence 9999999999999999977666555554444443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=8.9e-14 Score=148.09 Aligned_cols=105 Identities=17% Similarity=0.158 Sum_probs=91.1
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++.+.||+|+||.||+|+++.+|+.+|+|++... .....+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 5567999999999999999999999999999999998653 4566778999999999999999999999999999999
Q ss_pred EEEeccCCcccccccccc-CCCChhhhHH
Q psy11874 729 LVLTIIDVMFTCVQPSET-NPCCFPFRRK 756 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~-~~~~~~~~~~ 756 (767)
+|||||+||+|.+++... +...+.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 112 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVS 112 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHH
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHH
Confidence 999999999999999763 3334433333
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=146.22 Aligned_cols=108 Identities=17% Similarity=0.186 Sum_probs=89.0
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
+++|++++.||+|+||.||+|+++.+|+.||+|++.... ......+.+.+|+.+|+.++|||||++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 468999999999999999999999999999999998765 3445567889999999999999999999999999999999
Q ss_pred EeccCCccccccccc-cCCCChhhhHHHHHH
Q psy11874 731 LTIIDVMFTCVQPSE-TNPCCFPFRRKEVVV 760 (767)
Q Consensus 731 mEy~~gG~L~~~l~~-~~~~~~~~~~~~v~~ 760 (767)
||||+| +|.+.+.. .+...+......+..
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~q 109 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHH
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHH
Confidence 999986 45555543 445555555444433
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.48 E-value=5.7e-14 Score=147.55 Aligned_cols=113 Identities=18% Similarity=0.158 Sum_probs=97.5
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+.+++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 46788999999999999999999999999999999999876544444557889999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|+||||++||+|.+++.+.+...+......+..
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~q 122 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHH
Confidence 999999999999999987766555555544433
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.48 E-value=7.3e-14 Score=149.32 Aligned_cols=96 Identities=18% Similarity=0.223 Sum_probs=83.7
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC-----
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----- 725 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~----- 725 (767)
+++|++++.||+|+||.||+|+++.+|+.||+|+++... .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 357999999999999999999999999999999998653 3445678999999999999999999999986653
Q ss_pred ----------------------------------------------------EEEEEEeccCCccccccccccCC
Q psy11874 726 ----------------------------------------------------ALCLVLTIIDVMFTCVQPSETNP 748 (767)
Q Consensus 726 ----------------------------------------------------~lylVmEy~~gG~L~~~l~~~~~ 748 (767)
.+|+|||||+||+|.+++.+...
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 38999999999999999976654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-13 Score=145.69 Aligned_cols=111 Identities=20% Similarity=0.209 Sum_probs=96.9
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
..++|++.+.||+|+||.||+|+++.+|+.+|+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 45689999999999999999999999999999999988765556677889999999999999999999999999999999
Q ss_pred EEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 730 VLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|||||+||+|.+++...+...+......+..
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~q 123 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQ 123 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHH
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHH
Confidence 9999999999999877666555555544443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.47 E-value=4.5e-14 Score=153.66 Aligned_cols=104 Identities=13% Similarity=0.135 Sum_probs=89.5
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~lyl 729 (767)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++... ...+|+.+|.++ +|||||+++++|++.+.+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3579999999999999999999999999999999987542 235788888888 89999999999999999999
Q ss_pred EEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 730 VLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|||||+||+|.+++.+.+.+.+......+..+
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi 125 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTI 125 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH
Confidence 99999999999999877776666655544443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=6.7e-14 Score=148.77 Aligned_cols=104 Identities=16% Similarity=0.174 Sum_probs=89.0
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 357999999999999999999999999999999998653 23456789999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHH
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
||||+||+|.+++.+. ...+......+
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~ 122 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVC 122 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHH
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHH
Confidence 9999999999998654 33444444433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=6.4e-14 Score=159.86 Aligned_cols=109 Identities=19% Similarity=0.181 Sum_probs=89.3
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
+.|++++.||+|+||.||+|+++.+|..+|+|++.+... .......+.+|+.+|+.++|||||+++++|.+.+.+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 469999999999999999999999999999999987653 2334567899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|||+||+|.+.+.+.+...+......+..+
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi 145 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQV 145 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHH
Confidence 999999999999877766666555544443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-14 Score=159.94 Aligned_cols=98 Identities=18% Similarity=0.238 Sum_probs=87.6
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++.+.||+|+||.||+|+++.+|+.||+|+++.. ......+.+.+|+++|+.++|||||++++++.+.+.+
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 45677999999999999999999999999999999999764 2344556788999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccC
Q psy11874 728 CLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~ 747 (767)
|+|||||+||+|.++++..+
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~ 207 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEG 207 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHG
T ss_pred EEEEEcCCCCCHHHHHHhcC
Confidence 99999999999999997654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=5.2e-14 Score=160.22 Aligned_cols=110 Identities=24% Similarity=0.285 Sum_probs=95.7
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+|+.++|||||++++++.+.+.+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4679999999999999999999999999999999987542 334567899999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
||||+||+|.+.+...+...+......+..+
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi 130 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQV 130 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHH
Confidence 9999999999999877776666665554443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-13 Score=150.28 Aligned_cols=110 Identities=17% Similarity=0.165 Sum_probs=95.7
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++++.||+|+||.||+|+++.+|+.||+|++.... .....+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 355678999999999999999999999999999999998752 445667899999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
|+|||||+||+|.+++.+.+...+......+.
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ 138 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 138 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHH
T ss_pred EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHH
Confidence 99999999999999998776655555544433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=3.6e-14 Score=151.52 Aligned_cols=111 Identities=15% Similarity=0.070 Sum_probs=94.3
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC----E
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----A 726 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~----~ 726 (767)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.............+.+|+.+++.++|||||++++++.+.. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 468999999999999999999999999999999998865555566778999999999999999999999988654 3
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
+|+|||||+||+|.+++...+...+......+..+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi 125 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHH
Confidence 59999999999999999877666666555544433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-13 Score=145.96 Aligned_cols=111 Identities=23% Similarity=0.295 Sum_probs=86.0
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccc-----------------------hhhHHHHHHHHH
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----------------------RKGESMVLIEKQ 704 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~-----------------------~~~~~~~~~Ei~ 704 (767)
.+.+++|++.+.||+|+||.||+|+++.+|+.||+|++.+..... ....+.+.+|+.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 356789999999999999999999999999999999998764321 122456889999
Q ss_pred HHhhCCCCceeeeeEEEEe--CCEEEEEEeccCCccccccccccCCCChhhhHHHHH
Q psy11874 705 ILQKINSRFVVSLAYAYET--KDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 705 IL~~l~HpnIV~l~~~f~~--~~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
+|+.++||||+++++++.+ .+.+|+|||||+||+|.+++.. +...+......+.
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~ 144 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQ 144 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHH
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHH
Confidence 9999999999999999987 5789999999999999987643 3445544444433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.7e-13 Score=143.56 Aligned_cols=110 Identities=17% Similarity=0.195 Sum_probs=95.1
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3689999999999999999999999999999999987653 445567889999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
||||+||+|.+.+...+...+......+..+
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i 114 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQI 114 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHH
Confidence 9999999999998776665555555444433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=148.56 Aligned_cols=112 Identities=20% Similarity=0.200 Sum_probs=97.9
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
...++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 44578999999999999999999999999999999999876556667788999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+|||||+||+|.+++...+...+......+..
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~q 149 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQ 149 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHH
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHH
Confidence 99999999999999877666565555544443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-13 Score=145.44 Aligned_cols=109 Identities=19% Similarity=0.252 Sum_probs=92.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
+++|++++.||+|+||.||+|+++.+|+.||+|++.... ......+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 468999999999999999999999999999999997654 3344567788999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
||||+||+|.+++...+...+......+..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~ 110 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQ 110 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHH
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHH
Confidence 999999999988876666555555544433
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-13 Score=146.11 Aligned_cols=112 Identities=16% Similarity=0.212 Sum_probs=95.2
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
..+++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 44689999999999999999999999999999999998765445555678999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+||||++||+|.+++...+...+......+..
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~q 142 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQ 142 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHH
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHH
Confidence 99999999999999987666555554444433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.46 E-value=2.4e-13 Score=141.73 Aligned_cols=108 Identities=19% Similarity=0.093 Sum_probs=92.7
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.++|++++.||+|+||.||+|+++.+|+.||+|+++... .....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG--CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc--chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 357999999999999999999999999999999998653 234557889999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|||++||+|.+++.......+......+..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 113 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHH
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHH
Confidence 999999999999977666555554444433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.45 E-value=2.9e-13 Score=149.88 Aligned_cols=106 Identities=20% Similarity=0.278 Sum_probs=90.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.++|++++.||+|+||.||+|.++.+|+.+|+|++.+.. ......+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999998743 33456789999999999999999999999999999999
Q ss_pred EeccCCccccccccccC-CCChhhhHHHHH
Q psy11874 731 LTIIDVMFTCVQPSETN-PCCFPFRRKEVV 759 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~-~~~~~~~~~~v~ 759 (767)
||||+||+|.+++...+ .+.+......+.
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~ 156 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMR 156 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHH
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHH
Confidence 99999999999987553 344444444333
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.5e-13 Score=143.80 Aligned_cols=109 Identities=22% Similarity=0.201 Sum_probs=92.6
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
.+++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 35689999999999999999999999999999999987654444456789999999999999999999999999999999
Q ss_pred EEeccCCcccccccccc-CCCChhhhHHHH
Q psy11874 730 VLTIIDVMFTCVQPSET-NPCCFPFRRKEV 758 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~-~~~~~~~~~~~v 758 (767)
|||||++|+|.+++... +...+......+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 118 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFM 118 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHH
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHH
Confidence 99999999999998764 334444444333
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.45 E-value=2.4e-13 Score=155.30 Aligned_cols=96 Identities=18% Similarity=0.176 Sum_probs=87.0
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+...+|++.+.||+|+||.||+++++.++..||+|+++... ...+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 466788999999999999999999999999999999998643 2356789999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccC
Q psy11874 728 CLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~ 747 (767)
|||||||+||+|.++|+..+
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~ 311 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECN 311 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSC
T ss_pred EEEEEccCCCCHHHHHHhcC
Confidence 99999999999999997644
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.4e-13 Score=148.45 Aligned_cols=112 Identities=14% Similarity=0.203 Sum_probs=90.1
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
...+++|++++.||+|+||.||+|+++.+|+.||+|+++... ......+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 456789999999999999999999999999999999998654 2334456778999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|+|||||+ |+|.+++...+...+......+..+
T Consensus 109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql 141 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQL 141 (329)
T ss_dssp EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHH
T ss_pred EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHH
Confidence 99999998 5999999877666665555544443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.7e-13 Score=146.89 Aligned_cols=109 Identities=19% Similarity=0.244 Sum_probs=92.1
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccch---hhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~---~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+.|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3579999999999999999999999999999999987643221 1357789999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
|+|||||+||+|.+++...+...+......+.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ 122 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIK 122 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHH
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHH
Confidence 99999999999999997766544444444333
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.44 E-value=2.4e-13 Score=151.93 Aligned_cols=110 Identities=18% Similarity=0.186 Sum_probs=89.7
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccc-----hhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGESMVLIEKQILQKINSRFVVSLAYAYETKD 725 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~-----~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~ 725 (767)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.+..... ......+.+|+.+|++++|||||++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 368999999999999999999999999999999998765321 122235789999999999999999999985 55
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
.+|+|||||+||+|.+++...+...+......+..+
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi 248 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHH
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHH
Confidence 689999999999999999877766666555544443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.3e-13 Score=143.42 Aligned_cols=92 Identities=18% Similarity=0.281 Sum_probs=84.3
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++.+.||+|+||.||+|+++.+|+.+|+|++.+.. .....+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 57999999999999999999999999999999998764 2344678899999999999999999999999999999999
Q ss_pred eccCCccccccccc
Q psy11874 732 TIIDVMFTCVQPSE 745 (767)
Q Consensus 732 Ey~~gG~L~~~l~~ 745 (767)
|||+||+|.+.+..
T Consensus 100 e~~~~~~L~~~l~~ 113 (285)
T 3is5_A 100 ETCEGGELLERIVS 113 (285)
T ss_dssp CCCSCCBHHHHHHH
T ss_pred EeCCCCcHHHHHHh
Confidence 99999999998854
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=3e-13 Score=143.86 Aligned_cols=97 Identities=22% Similarity=0.272 Sum_probs=87.1
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
..+++|++.+.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 45679999999999999999999999999999999998765555667788999999999999999999999999999999
Q ss_pred EEEeccCCccccccccc
Q psy11874 729 LVLTIIDVMFTCVQPSE 745 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~ 745 (767)
+||||++||+|.+++..
T Consensus 109 lv~e~~~~~~L~~~l~~ 125 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKH 125 (310)
T ss_dssp EEEECCCSCBHHHHHHH
T ss_pred EEEecCCCCCHHHHHHH
Confidence 99999999999998864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=2.6e-13 Score=141.64 Aligned_cols=108 Identities=20% Similarity=0.178 Sum_probs=91.1
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~lylV 730 (767)
++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL-AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC-TTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc-cccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57999999999999999999999999999999998754 2334566788999999999 999999999999999999999
Q ss_pred EeccCCcccccccccc----CCCChhhhHHHHHH
Q psy11874 731 LTIIDVMFTCVQPSET----NPCCFPFRRKEVVV 760 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~----~~~~~~~~~~~v~~ 760 (767)
||||+||+|.+++... +...+......+..
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~q 123 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHH
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHH
Confidence 9999999999999764 33444444443333
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.43 E-value=2.6e-13 Score=142.08 Aligned_cols=109 Identities=23% Similarity=0.298 Sum_probs=92.9
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccch---hhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~---~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 469999999999999999999999999999999987653222 23578899999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+||||++||+|.+++...+...+......+..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 116 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQ 116 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHH
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHH
Confidence 99999999999999977666555555444443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.5e-13 Score=145.30 Aligned_cols=96 Identities=18% Similarity=0.231 Sum_probs=84.6
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC--EE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD--AL 727 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~--~l 727 (767)
.-+.|++.+.||+|+||.||+|+++.+|+.||+|+++... .....+.+.+|+.+|+.++||||+++++++.+.+ .+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG--GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 3467999999999999999999999999999999998653 2334567889999999999999999999998765 89
Q ss_pred EEEEeccCCccccccccccC
Q psy11874 728 CLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~ 747 (767)
|+|||||+||+|.+++...+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~ 104 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPS 104 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGG
T ss_pred EEEEeCCCCCCHHHHHHHhc
Confidence 99999999999999997654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.43 E-value=3.2e-13 Score=143.95 Aligned_cols=106 Identities=23% Similarity=0.212 Sum_probs=90.6
Q ss_pred CCceee-eecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCEEEE
Q psy11874 652 KTFRMY-RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 652 ~~y~~~-~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~lyl 729 (767)
+.|++. +.||+|+||.||+|+++.+|+.||+|++.+.. ....+.+.+|+.+|.++ +||||+++++++.+.+.+|+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 578885 78999999999999999999999999998752 34456889999999985 79999999999999999999
Q ss_pred EEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 730 VLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|||||+||+|.+++.+.+...+......+..
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~q 119 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRRHFNELEASVVVQD 119 (316)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHH
T ss_pred EEEcCCCCcHHHHHhccCCCCHHHHHHHHHH
Confidence 9999999999999987766565555554443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=2.5e-13 Score=141.89 Aligned_cols=107 Identities=16% Similarity=0.153 Sum_probs=92.4
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
+.|++.+.||+|+||.||+|+++.++..+|+|++.+.. ....+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 46999999999999999999999999999999998753 234568899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|||+||+|.+++...+...+......+..+
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i 115 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDV 115 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHH
Confidence 999999999998776665555555444433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.1e-13 Score=146.94 Aligned_cols=110 Identities=16% Similarity=0.189 Sum_probs=91.4
Q ss_pred CCCCCCCCCceeeeecccCCccceeEEEEccCCc---EEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEE
Q psy11874 645 FPQPITYKTFRMYRVLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAY 721 (767)
Q Consensus 645 f~~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~---~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f 721 (767)
+...+..++|++.+.||+|+||.||+++++.+|+ .||+|+++... .....+.+.+|+.+|+.++|||||++++++
T Consensus 42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 119 (325)
T 3kul_A 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVV 119 (325)
T ss_dssp -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3346777899999999999999999999987665 59999998652 445567899999999999999999999999
Q ss_pred EeCCEEEEEEeccCCcccccccccc-CCCChhhhHH
Q psy11874 722 ETKDALCLVLTIIDVMFTCVQPSET-NPCCFPFRRK 756 (767)
Q Consensus 722 ~~~~~lylVmEy~~gG~L~~~l~~~-~~~~~~~~~~ 756 (767)
.+.+.+|+|||||+||+|.+++... +...+.....
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 155 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG 155 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHH
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHH
Confidence 9999999999999999999999654 3444444333
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=2.4e-13 Score=145.44 Aligned_cols=97 Identities=18% Similarity=0.187 Sum_probs=86.3
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++.+.||+|+||.||+|++ +|+.||+|++.+.. ......+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC-CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 35667999999999999999999976 68899999998765 3445567899999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccC
Q psy11874 728 CLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~ 747 (767)
|+|||||+||+|.+++.+.+
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~ 129 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSG 129 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTT
T ss_pred EEEEecCCCCcHHHHHhhcC
Confidence 99999999999999997654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=5e-13 Score=143.92 Aligned_cols=111 Identities=18% Similarity=0.292 Sum_probs=93.6
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
..+++|++++.||+|+||.||+|+++.+|+.||+|++.... ......+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 34679999999999999999999999999999999997654 33445567889999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+||||++||.|.+++...+...+......+..
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 132 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHH
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHH
Confidence 99999999999888765555555555444433
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.8e-13 Score=147.57 Aligned_cols=106 Identities=23% Similarity=0.248 Sum_probs=85.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.+.|++.+.||+|+||.||+|+++.+++.||+|++++.. ..+.+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 467999999999999999999999999999999998642 235678999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
||||+||+|.+++...+...+......+..+
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi 157 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQI 157 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHH
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHH
Confidence 9999999999999877665555555544443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.7e-13 Score=146.35 Aligned_cols=93 Identities=20% Similarity=0.349 Sum_probs=84.3
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeeccccc--chhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~--~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
++|++.+.||+|+||.||+|+++.+++.||+|++.+..+. .....+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5799999999999999999999999999999999876432 34556789999999999999999999999999999999
Q ss_pred EEeccCCcccccccc
Q psy11874 730 VLTIIDVMFTCVQPS 744 (767)
Q Consensus 730 VmEy~~gG~L~~~l~ 744 (767)
|||||+||+|.+++.
T Consensus 106 v~e~~~gg~L~~~l~ 120 (345)
T 3hko_A 106 VMELCHGGHLLDKLN 120 (345)
T ss_dssp EEECCCSCBHHHHEE
T ss_pred EEeCCCCCcHHHHHH
Confidence 999999999999885
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.42 E-value=3.7e-13 Score=145.06 Aligned_cols=103 Identities=15% Similarity=0.157 Sum_probs=88.2
Q ss_pred Cceee---eecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC-CCceeeeeEEEEeCCEEE
Q psy11874 653 TFRMY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALC 728 (767)
Q Consensus 653 ~y~~~---~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~-HpnIV~l~~~f~~~~~ly 728 (767)
+|++. +.||+|+||.||+|+++.+|+.||+|++.+. ......+|+.+|+.+. |||||+++++|.+.+.+|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 56664 7899999999999999999999999999763 2356789999999996 999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
+|||||+||+|.+++.+.+...+......+..+
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi 115 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKL 115 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHH
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHH
Confidence 999999999999999877766666655544443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.42 E-value=3.3e-13 Score=143.22 Aligned_cols=106 Identities=27% Similarity=0.291 Sum_probs=89.1
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++++.. ....+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 57999999999999999999999999999999998643 223457889999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|||+||+|.+.+...+...+......+..
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~q 114 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQ 114 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHH
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHH
Confidence 99999999999877666555555544443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=2.8e-13 Score=142.34 Aligned_cols=106 Identities=15% Similarity=0.140 Sum_probs=90.2
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCC-------cEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYA 720 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg-------~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~ 720 (767)
.+..++|++.+.||+|+||.||+|+++.++ ..||+|++.+. .....+.+.+|+.+|+.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 356679999999999999999999999887 47999999764 34556789999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCccccccccccCC-CChhhhHH
Q psy11874 721 YETKDALCLVLTIIDVMFTCVQPSETNP-CCFPFRRK 756 (767)
Q Consensus 721 f~~~~~lylVmEy~~gG~L~~~l~~~~~-~~~~~~~~ 756 (767)
+.+.+..|+|||||+||+|.+++.+.+. ..+.....
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 117 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHH
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHH
Confidence 9999999999999999999999976543 44444333
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=4.4e-13 Score=140.02 Aligned_cols=96 Identities=14% Similarity=0.239 Sum_probs=85.6
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe--CCEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--KDAL 727 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~--~~~l 727 (767)
..++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.+|+.++||||+++++++.+ .+.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 35789999999999999999999999999999999987653 44566789999999999999999999998854 6789
Q ss_pred EEEEeccCCcccccccccc
Q psy11874 728 CLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~ 746 (767)
|+|||||+||+|.+++...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~ 101 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKG 101 (279)
T ss_dssp EEEEECCTTEEHHHHHHHH
T ss_pred EEEEeCCCCCCHHHHHHhh
Confidence 9999999999999998654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=5.5e-13 Score=140.71 Aligned_cols=111 Identities=23% Similarity=0.229 Sum_probs=92.7
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeeccccc------chhhHHHHHHHHHHHhhCC-CCceeeeeEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGESMVLIEKQILQKIN-SRFVVSLAYAYE 722 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~------~~~~~~~~~~Ei~IL~~l~-HpnIV~l~~~f~ 722 (767)
-.++|++.+.||+|+||.||+|+++.+|+.||+|+++..... .....+.+.+|+.+|+++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357899999999999999999999999999999999865311 1234567889999999995 999999999999
Q ss_pred eCCEEEEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+.+.+|+||||++||+|.+++...+...+......+..
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~q 132 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHH
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHH
Confidence 99999999999999999999987666555555444443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.41 E-value=2.5e-13 Score=143.49 Aligned_cols=97 Identities=21% Similarity=0.262 Sum_probs=84.8
Q ss_pred CCCCCCceeeeecccCCccceeEEE----EccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQ----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 723 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~----~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~ 723 (767)
.+..++|++++.||+|+||.||+|+ +..+|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4667899999999999999999999 5678999999999864 44566789999999999999999999999865
Q ss_pred C--CEEEEEEeccCCccccccccccC
Q psy11874 724 K--DALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 724 ~--~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
. ..+|+|||||+||+|.+++...+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~ 108 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHK 108 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCG
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcc
Confidence 3 56999999999999999997654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.40 E-value=4.9e-13 Score=146.89 Aligned_cols=98 Identities=16% Similarity=0.198 Sum_probs=86.3
Q ss_pred CCCCCCceeeeecccCCccceeEEEEc-------cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY 719 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k-------~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~ 719 (767)
.+..++|++.+.||+|+||.||+|++. .++..||+|+++.. ......+.+.+|+.+|+.+ +|||||++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 356689999999999999999999975 34568999999865 3455677899999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCccccccccccC
Q psy11874 720 AYETKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 720 ~f~~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
++.+.+.+|+|||||+||+|.++|...+
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 182 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARR 182 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTC
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhC
Confidence 9999999999999999999999997654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=2.9e-13 Score=140.29 Aligned_cols=98 Identities=14% Similarity=0.064 Sum_probs=86.4
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC--C
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK--D 725 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~--~ 725 (767)
.+..++|++.+.||+|+||.||+|+++ |+.+|+|++.... ......+.+.+|+.+|+.++||||+++++++.+. +
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 466789999999999999999999985 8899999998764 3345567899999999999999999999999887 7
Q ss_pred EEEEEEeccCCccccccccccCC
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNP 748 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~ 748 (767)
.+|+|||||+||+|.+++.+.+.
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~ 105 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTN 105 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSS
T ss_pred CeEeeecccCCCcHHHHHhhccc
Confidence 89999999999999999976553
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=4e-13 Score=147.37 Aligned_cols=98 Identities=23% Similarity=0.194 Sum_probs=84.4
Q ss_pred CCCCCCceeeeecccCCccceeEEE-----EccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQ-----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 722 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~-----~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~ 722 (767)
.+..++|++++.||+|+||+||+|+ +..+++.||+|+++.. ........+.+|+.+|+.++|||||++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4566799999999999999999999 5567889999999754 23455567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCccccccccccC
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+.+|+|||||+||+|.+++...+
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~ 169 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETR 169 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHS
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhc
Confidence 9999999999999999999997654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=5.1e-13 Score=140.60 Aligned_cols=109 Identities=23% Similarity=0.277 Sum_probs=93.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+... .....+.+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3589999999999999999999999999999999987642 344567899999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|||++||+|.+.+...+...+......+..
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~q 129 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQ 129 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHH
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHH
Confidence 999999999999876666555554444333
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=5e-13 Score=148.03 Aligned_cols=95 Identities=18% Similarity=0.228 Sum_probs=84.3
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC--EEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD--ALC 728 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~--~ly 728 (767)
-+.|++.+.||+|+||.||+|+++.+|+.||+|++.... .....+.+.+|+.+|+.++|||||++++++.+.+ .+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG--GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 457999999999999999999999999999999998653 2334567889999999999999999999998765 789
Q ss_pred EEEeccCCccccccccccC
Q psy11874 729 LVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~ 747 (767)
+|||||+||+|.+++....
T Consensus 86 lv~e~~~~g~L~~~l~~~~ 104 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPS 104 (396)
T ss_dssp EEECCCTTEEHHHHTTSGG
T ss_pred EEEecCCCCCHHHHHHhhh
Confidence 9999999999999997654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.40 E-value=8.8e-13 Score=138.86 Aligned_cols=107 Identities=14% Similarity=0.146 Sum_probs=91.2
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe----CCEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET----KDAL 727 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~----~~~l 727 (767)
..|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+|+.++||||++++++|.+ ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 358999999999999999999999999999999987653 45567789999999999999999999999976 4569
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
|+|||||+||+|.+++.+.+...+......+.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 136 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 136 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHH
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHH
Confidence 99999999999999998766655555544333
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=9e-13 Score=139.32 Aligned_cols=107 Identities=19% Similarity=0.212 Sum_probs=85.7
Q ss_pred CCCCCCceeeeecccCCccceeEEE----EccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQ----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 723 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~----~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~ 723 (767)
.+....|++++.||+|+||.||+|+ +..+|+.||+|++.... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 3555679999999999999999999 57789999999998653 34456789999999999999999999999987
Q ss_pred C--CEEEEEEeccCCcccccccccc-CCCChhhhHH
Q psy11874 724 K--DALCLVLTIIDVMFTCVQPSET-NPCCFPFRRK 756 (767)
Q Consensus 724 ~--~~lylVmEy~~gG~L~~~l~~~-~~~~~~~~~~ 756 (767)
. +.+|+|||||+||+|.+++... +...+.....
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 130 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHH
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHH
Confidence 7 6799999999999999999544 3344444433
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=4.2e-13 Score=143.82 Aligned_cols=108 Identities=20% Similarity=0.216 Sum_probs=85.8
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~-----~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+.... .......+.+|+.+|+.++||||+++++++.+.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999999875421 1223345889999999999999999999997665
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+|+||||++||+|.+++...+...+......+..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~q 122 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHH
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHH
Confidence 8999999999999999877666555555444433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.39 E-value=8e-13 Score=138.73 Aligned_cols=97 Identities=18% Similarity=0.171 Sum_probs=87.6
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++.+.||+|+||.||+|+++.+++.+|+|++... ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 45677999999999999999999999999999999999754 33567889999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCC
Q psy11874 728 CLVLTIIDVMFTCVQPSETNP 748 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~ 748 (767)
|+|||||+||+|.+++...+.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~ 105 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNR 105 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCT
T ss_pred EEEEEcCCCCcHHHHHHhccc
Confidence 999999999999999976443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.39 E-value=5.3e-13 Score=143.76 Aligned_cols=97 Identities=15% Similarity=0.193 Sum_probs=86.4
Q ss_pred CCCCCCceeeeecccCCccceeEEEEc-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 722 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k-----~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~ 722 (767)
.+..++|++++.||+|+||.||+|+++ .+++.||+|++++.. .....+.+.+|+.+|+.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 456689999999999999999999998 456899999998653 3455678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCcccccccccc
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~ 746 (767)
+.+.+|+|||||+||+|.+++...
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~ 144 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSM 144 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHT
T ss_pred cCCceEEEEecCCCCcHHHHHHHh
Confidence 999999999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=3.1e-13 Score=146.37 Aligned_cols=110 Identities=15% Similarity=0.160 Sum_probs=92.7
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccch-----hhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----KGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~-----~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
++|++++.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+|+.++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 579999999999999999999999999999999998653222 234567889999999999999999999999999
Q ss_pred EEEEEeccCCc-cccccccccCCCChhhhHHHHHHh
Q psy11874 727 LCLVLTIIDVM-FTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 727 lylVmEy~~gG-~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
+|+||||+.+| +|.+++.+.+...+......+..+
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi 139 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHH
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHH
Confidence 99999999776 999999877666666655544443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.39 E-value=6e-13 Score=140.24 Aligned_cols=105 Identities=20% Similarity=0.205 Sum_probs=86.7
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
+++|++++.||+|+||.||+|++ .+|+.||+|++.... ......+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSS-GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccc-cccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 36899999999999999999998 678999999998654 2334456788999999999999999999999999999999
Q ss_pred EeccCCcccccccccc-CCCChhhhHHHH
Q psy11874 731 LTIIDVMFTCVQPSET-NPCCFPFRRKEV 758 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~-~~~~~~~~~~~v 758 (767)
|||+++ +|.+++... +...+......+
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~ 106 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFL 106 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHH
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHH
Confidence 999985 888888654 344444444333
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.39 E-value=8.1e-13 Score=138.49 Aligned_cols=108 Identities=15% Similarity=0.103 Sum_probs=86.4
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
-.+..++|++++.||+|+||.||+++++ ++..||+|++..... ..+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 3577789999999999999999999876 567899999986542 23568899999999999999999999999999
Q ss_pred EEEEEeccCCcccccccccc-CCCChhhhHHHHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSET-NPCCFPFRRKEVV 759 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~-~~~~~~~~~~~v~ 759 (767)
+|+|||||+||+|.+++... +...+......+.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 127 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 127 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHH
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHH
Confidence 99999999999999998763 3444444444333
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.39 E-value=8e-13 Score=142.77 Aligned_cols=92 Identities=21% Similarity=0.333 Sum_probs=82.1
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhh--------------HHHHHHHHHHHhhCCCCce
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--------------ESMVLIEKQILQKINSRFV 714 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~--------------~~~~~~Ei~IL~~l~HpnI 714 (767)
...++|++.+.||+|+||.||+|++ +|+.||+|++.......... .+.+.+|+.+|+.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 4567999999999999999999998 89999999998764322211 2789999999999999999
Q ss_pred eeeeEEEEeCCEEEEEEeccCCcccccc
Q psy11874 715 VSLAYAYETKDALCLVLTIIDVMFTCVQ 742 (767)
Q Consensus 715 V~l~~~f~~~~~lylVmEy~~gG~L~~~ 742 (767)
+++++++.+.+.+|+|||||+||+|.++
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 133 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKF 133 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHH
Confidence 9999999999999999999999999999
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=4.2e-13 Score=143.81 Aligned_cols=93 Identities=19% Similarity=0.245 Sum_probs=69.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.++|++++.||+|+||.||+|+++.+|+.||+|+++... .....+.+.+|+.+|+.++|||||++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999999999999999998653 334456788999999999999999999999999999999
Q ss_pred EeccCCcccccccccc
Q psy11874 731 LTIIDVMFTCVQPSET 746 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~ 746 (767)
||||+ |+|.+++...
T Consensus 82 ~e~~~-~~L~~~l~~~ 96 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSR 96 (317)
T ss_dssp EECCC-CBHHHHHHHH
T ss_pred EEecC-CCHHHHHHhc
Confidence 99998 6898888643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.38 E-value=4.7e-13 Score=150.97 Aligned_cols=109 Identities=20% Similarity=0.201 Sum_probs=81.8
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC-----C
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----D 725 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~-----~ 725 (767)
.++|++++.||+|+||+||+|+++.+|+.||+|++.+.. ......+.+.+|+.+|+.++|||||+++++|.+. +
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 368999999999999999999999999999999997653 3455667899999999999999999999999543 5
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
.+|+||||+. |+|.++++..+.+.+...+..+..+
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi 165 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNL 165 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHH
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHH
Confidence 7999999985 7999999776666665555544433
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=6e-13 Score=141.36 Aligned_cols=98 Identities=21% Similarity=0.207 Sum_probs=86.4
Q ss_pred CCCCCCceeeeecccCCccceeEEEEc-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 722 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k-----~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~ 722 (767)
.+..++|++.+.||+|+||.||+|++. .+++.||+|++.... .....+.+.+|+.+|+.++|||||++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 355678999999999999999999984 456899999998652 4556778999999999999999999999999
Q ss_pred eCCEEEEEEeccCCccccccccccC
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+.+|+|||||+||+|.+++...+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~ 121 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESR 121 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTT
T ss_pred cCCceEEEEeecCCCCHHHHHHHHh
Confidence 9999999999999999999997654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=4.7e-13 Score=145.25 Aligned_cols=97 Identities=21% Similarity=0.253 Sum_probs=84.2
Q ss_pred CCCCCceeeeecccCCccceeEEE-----EccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQ-----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYE 722 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~-----~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~ 722 (767)
+..++|++.+.||+|+||.||+|+ +..+++.||+|++++.. .....+.+.+|+.+|+.+ +|||||++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 556799999999999999999999 56677999999998653 345567899999999999 8999999999998
Q ss_pred eCC-EEEEEEeccCCccccccccccC
Q psy11874 723 TKD-ALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 723 ~~~-~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+ .+|+|||||+||+|.+++....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~ 122 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKR 122 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTT
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcc
Confidence 765 4999999999999999997654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.37 E-value=6e-13 Score=146.45 Aligned_cols=100 Identities=17% Similarity=0.231 Sum_probs=87.2
Q ss_pred CCCCCCCCceeeeecccCCccceeEEEEc---cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE
Q psy11874 646 PQPITYKTFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 722 (767)
Q Consensus 646 ~~~~~~~~y~~~~~LG~GsfG~V~l~~~k---~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~ 722 (767)
...+..++|++.+.||+|+||.||+++++ .++..||+|+++... .....+.+.+|+.+|++++|||||++++++.
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34567789999999999999999999987 567789999998652 4456678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCccccccccccC
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+.+|+|||||+||+|.+++.+.+
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~ 141 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHD 141 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTT
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCC
Confidence 9999999999999999999997654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.37 E-value=4.1e-13 Score=146.53 Aligned_cols=113 Identities=31% Similarity=0.419 Sum_probs=94.1
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEc---cCCcEEEEEEeeccccc-chhhHHHHHHHHHHHhhC-CCCceeeeeEEE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIK-KRKGESMVLIEKQILQKI-NSRFVVSLAYAY 721 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k---~tg~~~AvK~i~k~~~~-~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f 721 (767)
..+.+++|++++.||+|+||.||+|++. .+|+.||+|++++.... .....+.+.+|+.+|+.+ +||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3567789999999999999999999985 58999999999875432 223445678899999999 799999999999
Q ss_pred EeCCEEEEEEeccCCccccccccccCCCChhhhHHHHH
Q psy11874 722 ETKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 722 ~~~~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
.+.+.+|||||||+||+|.+++...+...+......+.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 166 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG 166 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHH
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHH
Confidence 99999999999999999999998766655555544443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.4e-12 Score=143.42 Aligned_cols=91 Identities=24% Similarity=0.379 Sum_probs=76.1
Q ss_pred Ccee--eeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 653 TFRM--YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 653 ~y~~--~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.|.+ .+.||+|+||.||+|+++.+|+.||+|+++... ....+.+.+|+.+|+.++|||||++++++.+.+.+|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3444 678999999999999999999999999998753 24556889999999999999999999999999999999
Q ss_pred EeccCCcccccccccc
Q psy11874 731 LTIIDVMFTCVQPSET 746 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~ 746 (767)
||||+||+|.+++...
T Consensus 165 ~E~~~~~~L~~~l~~~ 180 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDE 180 (373)
T ss_dssp EECCTTCEEHHHHHHT
T ss_pred EeCCCCCcHHHHHHhc
Confidence 9999999999988654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.4e-12 Score=135.87 Aligned_cols=94 Identities=17% Similarity=0.210 Sum_probs=83.0
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++.+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 55679999999999999999999987 467799999987542 2357899999999999999999999999999999
Q ss_pred EEEeccCCccccccccccC
Q psy11874 729 LVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~ 747 (767)
+|||||+||+|.+++....
T Consensus 82 lv~e~~~~~~L~~~l~~~~ 100 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQR 100 (269)
T ss_dssp EEEECCTTCBHHHHHHTTT
T ss_pred EEEEeCCCCcHHHHHHhcC
Confidence 9999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=140.90 Aligned_cols=103 Identities=16% Similarity=0.211 Sum_probs=87.1
Q ss_pred CceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEe
Q psy11874 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 732 (767)
Q Consensus 653 ~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmE 732 (767)
.|+..+.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|+.+|+.++|||||++++++.+.+.+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4788889999999999999999999999999998643 3345678899999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChhhhHHHHH
Q psy11874 733 IIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 733 y~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
|++||+|.+++.+. ...+......+.
T Consensus 123 ~~~~~~L~~~l~~~-~l~~~~~~~i~~ 148 (321)
T 2c30_A 123 FLQGGALTDIVSQV-RLNEEQIATVCE 148 (321)
T ss_dssp CCCSCBHHHHHTTC-CCCHHHHHHHHH
T ss_pred cCCCCCHHHHHHhc-CCCHHHHHHHHH
Confidence 99999999988643 344444444333
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=4.3e-13 Score=141.51 Aligned_cols=96 Identities=19% Similarity=0.213 Sum_probs=67.7
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++.+.||+|+||.||+|+++.+|+.||+|++.... .....+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 466789999999999999999999999999999999997653 234456788999999999999999999999999999
Q ss_pred EEEEeccCCccccccccc
Q psy11874 728 CLVLTIIDVMFTCVQPSE 745 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~ 745 (767)
|+||||++||+|.+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~ 106 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKH 106 (303)
T ss_dssp EEEEECCTTCBHHHHHHH
T ss_pred EEEehhccCCchHHHHHH
Confidence 999999999999998863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=140.20 Aligned_cols=97 Identities=18% Similarity=0.270 Sum_probs=83.7
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEE--EEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMY--ACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 725 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~--AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~ 725 (767)
+..++|++.+.||+|+||.||+|+++.+|..+ |+|.++.. ......+.+.+|+.+|+++ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 66789999999999999999999999999865 99998754 2344556789999999999 9999999999999999
Q ss_pred EEEEEEeccCCccccccccccC
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~ 747 (767)
.+|+|||||+||+|.+++...+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~ 121 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSR 121 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTC
T ss_pred ceEEEEecCCCCCHHHHHHhcc
Confidence 9999999999999999997654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-12 Score=137.75 Aligned_cols=105 Identities=21% Similarity=0.253 Sum_probs=86.5
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.+.|++++.||+|+||.||+|+++.+|+.+|+|++... .....+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 35799999999999999999999999999999999764 334567889999999999999999999999999999999
Q ss_pred EeccCCcccccccccc-CCCChhhhHHHH
Q psy11874 731 LTIIDVMFTCVQPSET-NPCCFPFRRKEV 758 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~-~~~~~~~~~~~v 758 (767)
||||+||+|.+++... +...+......+
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 123 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVC 123 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHH
Confidence 9999999999888653 334444444433
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-12 Score=137.31 Aligned_cols=94 Identities=21% Similarity=0.294 Sum_probs=80.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
+++|++++.||+|+||.||+|+++.+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 80 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCc-cchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEE
Confidence 578999999999999999999999999999999998654 2334456788999999999999999999999999999999
Q ss_pred EeccCCcccccccccc
Q psy11874 731 LTIIDVMFTCVQPSET 746 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~ 746 (767)
|||++ |+|.+++...
T Consensus 81 ~e~~~-~~L~~~~~~~ 95 (299)
T 2r3i_A 81 FEFLH-QDLKKFMDAS 95 (299)
T ss_dssp EECCS-EEHHHHHHHT
T ss_pred EEccc-CCHHHHHHhh
Confidence 99998 6999988655
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1e-12 Score=147.33 Aligned_cols=109 Identities=19% Similarity=0.179 Sum_probs=92.1
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC-----C
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----D 725 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~-----~ 725 (767)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ......+.+.+|+.+|+.++|||||++++++.+. +
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 468999999999999999999999999999999998653 3445667899999999999999999999999876 6
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
.+|+|||||+ |+|.++++..+.+.+......+.++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi 138 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNL 138 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHH
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHH
Confidence 7999999997 6999999876666665555544443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.7e-12 Score=137.51 Aligned_cols=104 Identities=18% Similarity=0.172 Sum_probs=89.3
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
+.|++++.||+|+||.||+|+++.+|+.||+|++.... .....+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT--CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 46999999999999999999999999999999998764 2345678999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHH
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
||++||+|.+++.. +...+......+
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~ 125 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATIL 125 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHH
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHH
Confidence 99999999999864 344444444333
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=139.71 Aligned_cols=106 Identities=16% Similarity=0.181 Sum_probs=84.0
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
--.++|++++.||+|+||.||+|+++ +|+.||+|++.... ......+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 44578999999999999999999985 58999999998654 33445678899999999999999999999999999999
Q ss_pred EEEeccCCccccccccccC-CCChhhhHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETN-PCCFPFRRKE 757 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~-~~~~~~~~~~ 757 (767)
+|||||+| +|.+.+...+ ...+......
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~ 124 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIY 124 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHH
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHH
Confidence 99999985 7877775543 3444444433
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.2e-12 Score=135.37 Aligned_cols=106 Identities=16% Similarity=0.158 Sum_probs=86.4
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhh----HHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG----ESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~----~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
+..++|++.+.||+|+||.||+|+++.+++.||+|++.......... .+.+.+|+.+|+.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 55678999999999999999999999999999999997654322221 26789999999999999999999999776
Q ss_pred CEEEEEEeccCCccccccccccC-CCChhhhHH
Q psy11874 725 DALCLVLTIIDVMFTCVQPSETN-PCCFPFRRK 756 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~~-~~~~~~~~~ 756 (767)
. ++||||++||+|.+.+...+ ...+.....
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 126 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLR 126 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHH
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHH
Confidence 6 79999999999998886543 334443333
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-13 Score=149.52 Aligned_cols=110 Identities=16% Similarity=0.137 Sum_probs=84.0
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHhhCC---------CCce
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMVLIEKQILQKIN---------SRFV 714 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~-----~~~~~~~~~~Ei~IL~~l~---------HpnI 714 (767)
+..++|++++.||+|+||+||+|++ +|+.||+|++.+.... .....+.+.+|+.+|+.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4567899999999999999999988 7899999999976421 2334578899999999886 6666
Q ss_pred eeeeEEE-----------------Ee-------------CCEEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 715 VSLAYAY-----------------ET-------------KDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 715 V~l~~~f-----------------~~-------------~~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|++++++ .+ .+.+|||||||+||++.+.+.+ +...+......+.++
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQL 170 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHH
Confidence 6665553 33 7889999999999998888754 444555555544444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.35 E-value=1.7e-12 Score=139.91 Aligned_cols=98 Identities=16% Similarity=0.206 Sum_probs=84.8
Q ss_pred CCCCCCceeeeecccCCccceeEEEEc-------cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY 719 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k-------~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~ 719 (767)
.+..++|++.+.||+|+||.||+|++. .++..||+|+++... .....+.+.+|+.+|+.+ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 355689999999999999999999986 467899999998653 445667899999999999 9999999999
Q ss_pred EEEeCCEEEEEEeccCCccccccccccC
Q psy11874 720 AYETKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 720 ~f~~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
++.+.+.+|+|||||+||+|.+++...+
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 136 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARR 136 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTS
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhc
Confidence 9999999999999999999999997654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-12 Score=138.75 Aligned_cols=94 Identities=19% Similarity=0.218 Sum_probs=81.6
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE----eC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE----TK 724 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~----~~ 724 (767)
+..++|++.+.||+|+||.||+|+++.+|+.||+|++... .....+.+.+|+.+++.++||||+++++++. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 4456899999999999999999999999999999999763 3456678899999999999999999999987 34
Q ss_pred CEEEEEEeccCCccccccccc
Q psy11874 725 DALCLVLTIIDVMFTCVQPSE 745 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~ 745 (767)
..+|+|||||++|+|.+++.+
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~ 123 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIER 123 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHH
T ss_pred ceeEEEEEeCCCCcHHHHHHH
Confidence 579999999999999999865
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.9e-12 Score=137.87 Aligned_cols=104 Identities=22% Similarity=0.272 Sum_probs=87.0
Q ss_pred CCceee-eecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCEEEE
Q psy11874 652 KTFRMY-RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 652 ~~y~~~-~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~lyl 729 (767)
+.|.+. +.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|+.+|+.+ +||||++++++|.+.+.+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEE-TTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 357777 89999999999999999999999999998765 2334467889999999999 57999999999999999999
Q ss_pred EEeccCCcccccccccc--CCCChhhhHH
Q psy11874 730 VLTIIDVMFTCVQPSET--NPCCFPFRRK 756 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~--~~~~~~~~~~ 756 (767)
|||||+||+|.+++... +...+.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 135 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIR 135 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHH
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHH
Confidence 99999999999998654 3334443333
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-12 Score=135.22 Aligned_cols=106 Identities=14% Similarity=0.086 Sum_probs=87.8
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++++.||+|+||.||+|+++ ++..||+|+++.... ..+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 356679999999999999999999776 567799999986542 235689999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCC-CChhhhHHHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNP-CCFPFRRKEV 758 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~-~~~~~~~~~v 758 (767)
|+|||||+||+|.+++...+. ..+......+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 110 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC 110 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHH
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHH
Confidence 999999999999999976543 4444444433
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.34 E-value=3.9e-12 Score=143.58 Aligned_cols=93 Identities=16% Similarity=0.225 Sum_probs=81.7
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++.+.||+|+||.||+++++. +..||+|+++... ...+.+.+|+.+|+.++|||||++++++. .+.+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 5667899999999999999999998864 6789999998643 23568999999999999999999999886 6679
Q ss_pred EEEEeccCCcccccccccc
Q psy11874 728 CLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~ 746 (767)
|||||||++|+|.++|+..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~ 276 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSD 276 (454)
T ss_dssp EEEECCCTTCBHHHHHHSH
T ss_pred EEEEeecCCCcHHHHHHhc
Confidence 9999999999999999754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.3e-12 Score=135.87 Aligned_cols=107 Identities=17% Similarity=0.154 Sum_probs=82.2
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccc-hhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~-~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
+..++|++.+.||+|+||.||+|++. |+.+|+|++....... ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45679999999999999999999874 8899999998754222 23457889999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
|+|||||+||+|.+++.. +...+......+
T Consensus 82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~ 111 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWA 111 (271)
T ss_dssp EEEEECCTTEEHHHHHTS-SCCCHHHHHHHH
T ss_pred EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHH
Confidence 999999999999988854 344444444433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.6e-12 Score=143.28 Aligned_cols=104 Identities=19% Similarity=0.243 Sum_probs=78.8
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC-CCceeeeeEEEEeCC--EE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKD--AL 727 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~-HpnIV~l~~~f~~~~--~l 727 (767)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+.. ......+.+.+|+.+|+.+. |||||+++++|.+.+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 468999999999999999999999999999999997653 34556678899999999997 999999999998654 79
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKE 757 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~ 757 (767)
|+|||||+ |+|.+.++. +...+......
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i 114 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYV 114 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHH
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHH
Confidence 99999998 689888865 34344444433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.9e-12 Score=139.05 Aligned_cols=98 Identities=22% Similarity=0.190 Sum_probs=81.8
Q ss_pred CCCCCCceeeeecccCCccceeEEE-----EccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQ-----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 722 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~-----~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~ 722 (767)
.+..++|++++.||+|+||.||+|+ +..+++.||+|++... ........+.+|+.+|+.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4566899999999999999999999 5678899999999754 23455667899999999999999999999999
Q ss_pred eCCEEEEEEeccCCccccccccccC
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+.+|+|||||+||+|.+++...+
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~ 128 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETR 128 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTS
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhc
Confidence 9999999999999999999997654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.34 E-value=1.7e-12 Score=144.13 Aligned_cols=103 Identities=17% Similarity=0.159 Sum_probs=83.0
Q ss_pred CCCCCceee-eecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhh-CCCCceeeeeEEEEe---
Q psy11874 649 ITYKTFRMY-RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSRFVVSLAYAYET--- 723 (767)
Q Consensus 649 ~~~~~y~~~-~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~-l~HpnIV~l~~~f~~--- 723 (767)
..+++|.+. +.||+|+||+||+|+++.+|+.||+|+++.. ....+|+.++.+ .+|||||+++++|.+
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 345788887 7899999999999999999999999999742 256789998744 589999999999986
Q ss_pred -CCEEEEEEeccCCccccccccccCC--CChhhhHHHHH
Q psy11874 724 -KDALCLVLTIIDVMFTCVQPSETNP--CCFPFRRKEVV 759 (767)
Q Consensus 724 -~~~lylVmEy~~gG~L~~~l~~~~~--~~~~~~~~~v~ 759 (767)
.+.+|||||||+||+|.++|...+. +.+......+.
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ 168 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 168 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHH
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHH
Confidence 6789999999999999999976543 44444444433
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.9e-12 Score=139.60 Aligned_cols=104 Identities=18% Similarity=0.136 Sum_probs=87.2
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
..|++++.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 35999999999999999999999999999999998765444556678999999999999999999999999999999999
Q ss_pred eccCCcccccccccc-CCCChhhhHH
Q psy11874 732 TIIDVMFTCVQPSET-NPCCFPFRRK 756 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~-~~~~~~~~~~ 756 (767)
|||. |+|.+.+... +...+.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~ 158 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAA 158 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHH
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHH
Confidence 9998 6787777533 3344443333
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-12 Score=139.45 Aligned_cols=94 Identities=18% Similarity=0.199 Sum_probs=83.4
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
..++|++.+.||+|+||.||+|+++ +|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 4578999999999999999999864 6899999998764 23456788999999999999999999999999999999
Q ss_pred EEeccCCccccccccccC
Q psy11874 730 VLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~ 747 (767)
|||||+||+|.+++...+
T Consensus 113 v~e~~~~~~L~~~l~~~~ 130 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSD 130 (321)
T ss_dssp EEECCTTCBTGGGSSSSC
T ss_pred EEEcCCCCcHHHHHhccC
Confidence 999999999999996554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.2e-12 Score=138.94 Aligned_cols=98 Identities=15% Similarity=0.130 Sum_probs=86.1
Q ss_pred CCCCCCceeeeecccCCccceeEEEE-----ccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAY 721 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~-----k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f 721 (767)
.+..++|++.+.||+|+||.||+|++ ..+++.||+|++.... .....+.+.+|+.+|+.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 35567899999999999999999985 4577899999998653 344567899999999999 999999999999
Q ss_pred EeCCEEEEEEeccCCccccccccccC
Q psy11874 722 ETKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 722 ~~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
.+.+.+|+|||||+||+|.+++...+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~ 122 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKR 122 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTT
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcc
Confidence 99999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.8e-12 Score=141.22 Aligned_cols=98 Identities=16% Similarity=0.195 Sum_probs=85.9
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccC-------CcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRAT-------GKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY 719 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~t-------g~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~ 719 (767)
.+..++|++.+.||+|+||.||+|++..+ +..||+|+++.. ......+.+.+|+.+|+.+ +|||||++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 45667999999999999999999997643 357999999865 3455667899999999999 9999999999
Q ss_pred EEEeCCEEEEEEeccCCccccccccccC
Q psy11874 720 AYETKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 720 ~f~~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
++.+.+.+|+|||||+||+|.+++...+
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 170 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARR 170 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTC
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhc
Confidence 9999999999999999999999997654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.33 E-value=2.2e-12 Score=135.69 Aligned_cols=92 Identities=25% Similarity=0.348 Sum_probs=82.1
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe--------
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-------- 723 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~-------- 723 (767)
++|++++.||+|+||.||+|+++.+|+.||+|++... ....+.+.+|+.+|+.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 4799999999999999999999999999999999753 3456788999999999999999999999865
Q ss_pred -----CCEEEEEEeccCCccccccccccC
Q psy11874 724 -----KDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 724 -----~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
.+.+|+|||||+||+|.+++...+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 110 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN 110 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc
Confidence 467999999999999999997543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.5e-12 Score=139.75 Aligned_cols=103 Identities=14% Similarity=0.051 Sum_probs=84.0
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC---
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD--- 725 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~--- 725 (767)
+..++|++.+.||+|+||.||+|++. |+.||+|++.... .......+|+.+|+.++|||||++++++.+..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 56679999999999999999999875 7999999997542 33445677999999999999999999998754
Q ss_pred -EEEEEEeccCCccccccccccCCCChhhhHHHH
Q psy11874 726 -ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 726 -~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
.+|+|||||+||+|.++++.. ...+......+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~ 127 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIA 127 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHH
T ss_pred ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHH
Confidence 589999999999999999654 34444444433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.2e-12 Score=136.01 Aligned_cols=103 Identities=18% Similarity=0.182 Sum_probs=82.4
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
..++|++++.||+|+||.||+|+++.+|+.||+|++.... ..+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3568999999999999999999999999999999998642 34578899999999999999999999999999999
Q ss_pred EEeccCCcccccccccc-CCCChhhhHHH
Q psy11874 730 VLTIIDVMFTCVQPSET-NPCCFPFRRKE 757 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~-~~~~~~~~~~~ 757 (767)
|||||+||+|.+++... +...+......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i 130 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATI 130 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHH
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHH
Confidence 99999999999998633 34444444333
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.33 E-value=2.5e-12 Score=140.94 Aligned_cols=110 Identities=20% Similarity=0.233 Sum_probs=91.5
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCC
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 725 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~-----~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~ 725 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++...... .....+.+.+|+.+|+.+ +||||+++++++.+.+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 4699999999999999999999999999999999865311 112346788999999999 8999999999999999
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
.+|+|||||+||+|.+++...+...+......+..+
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi 209 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSL 209 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHH
Confidence 999999999999999999776665555555444443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.6e-12 Score=140.25 Aligned_cols=97 Identities=16% Similarity=0.206 Sum_probs=82.5
Q ss_pred CCCCCceeeeecccCCccceeEEEEc-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYE 722 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k-----~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~ 722 (767)
+..++|++.+.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 55679999999999999999999973 456789999998642 344567899999999999 9999999999999
Q ss_pred eCCEEEEEEeccCCccccccccccC
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+.+|+|||||+||+|.+++...+
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~ 144 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKR 144 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTT
T ss_pred eCCccEEEEecCCCCcHHHHHhhcc
Confidence 9999999999999999999997653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.9e-12 Score=137.58 Aligned_cols=106 Identities=22% Similarity=0.210 Sum_probs=88.2
Q ss_pred CCCCCceeeeecccCCccceeEEE----EccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE--
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQ----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE-- 722 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~----~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~-- 722 (767)
+..++|++++.||+|+||.||+|+ +..+|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 556789999999999999999999 4678999999999864 3455678999999999999999999999987
Q ss_pred eCCEEEEEEeccCCccccccccccC-CCChhhhHHH
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETN-PCCFPFRRKE 757 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~-~~~~~~~~~~ 757 (767)
+.+.+|+|||||+||+|.+++...+ ...+......
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i 132 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 132 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHH
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHH
Confidence 4567999999999999999997643 3444444433
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.32 E-value=4e-12 Score=143.45 Aligned_cols=93 Identities=22% Similarity=0.234 Sum_probs=80.6
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++.+.||+|+||.||++.++.+ ..||+|+++.... ..+.+.+|+.+|+.++|||||++++++.+ +.+
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 45667899999999999999999998764 5699999986532 24578999999999999999999999865 779
Q ss_pred EEEEeccCCcccccccccc
Q psy11874 728 CLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~ 746 (767)
|||||||+||+|.++|+..
T Consensus 254 ~iv~e~~~~gsL~~~l~~~ 272 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGE 272 (452)
T ss_dssp EEEECCCTTCBHHHHHSHH
T ss_pred EEEehhhcCCCHHHHHHhc
Confidence 9999999999999999753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3.7e-12 Score=137.02 Aligned_cols=102 Identities=15% Similarity=0.077 Sum_probs=85.5
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~lylV 730 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++..... .+.+.+|+.+|+.+ +||||+++++++.+.+.+|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 579999999999999999999999999999999976431 23578999999999 999999999999999999999
Q ss_pred EeccCCcccccccccc-CCCChhhhHHHHH
Q psy11874 731 LTIIDVMFTCVQPSET-NPCCFPFRRKEVV 759 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~-~~~~~~~~~~~v~ 759 (767)
|||| ||+|.+++... +.+.+......+.
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~ 112 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAI 112 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHH
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHH
Confidence 9999 99999998754 3444444444333
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=7.6e-13 Score=142.23 Aligned_cols=103 Identities=17% Similarity=0.211 Sum_probs=82.9
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
+++|++++.||+|+||.||+|+++.+|+.||+|++.... .......+.+|+.+|+.++|||||++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc--ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 468999999999999999999999999999999997643 222223456899999999999999999999999999999
Q ss_pred EeccCCccccccccccCC-CChhhhHH
Q psy11874 731 LTIIDVMFTCVQPSETNP-CCFPFRRK 756 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~-~~~~~~~~ 756 (767)
||||+ |+|.+++...+. ..+.....
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~ 104 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKL 104 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHH
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHH
Confidence 99998 589888876543 33333333
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=4.6e-12 Score=134.28 Aligned_cols=103 Identities=17% Similarity=0.166 Sum_probs=84.8
Q ss_pred CCCCCceee-eecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHH-hhCCCCceeeeeEEEEe---
Q psy11874 649 ITYKTFRMY-RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQIL-QKINSRFVVSLAYAYET--- 723 (767)
Q Consensus 649 ~~~~~y~~~-~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL-~~l~HpnIV~l~~~f~~--- 723 (767)
..+++|.+. +.||+|+||.||+|+++.+|+.||+|+++.. ....+|+.++ +.++||||++++++|.+
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 446789988 7899999999999999999999999999752 2567899988 55699999999999987
Q ss_pred -CCEEEEEEeccCCccccccccccC--CCChhhhHHHHH
Q psy11874 724 -KDALCLVLTIIDVMFTCVQPSETN--PCCFPFRRKEVV 759 (767)
Q Consensus 724 -~~~lylVmEy~~gG~L~~~l~~~~--~~~~~~~~~~v~ 759 (767)
...+|+|||||+||+|.+++...+ ...+......+.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ 124 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHH
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHH
Confidence 778999999999999999997654 344444444333
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3.8e-12 Score=138.04 Aligned_cols=109 Identities=24% Similarity=0.244 Sum_probs=86.7
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe------
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------ 723 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~------ 723 (767)
.+++|++++.||+|+||.||+|+++.+|+.||+|++.... ........+.+|+.+|+.++||||+++++++.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSS-CSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 3579999999999999999999999999999999997764 233445678899999999999999999999987
Q ss_pred --CCEEEEEEeccCCcccccccccc-CCCChhhhHHHHHH
Q psy11874 724 --KDALCLVLTIIDVMFTCVQPSET-NPCCFPFRRKEVVV 760 (767)
Q Consensus 724 --~~~lylVmEy~~gG~L~~~l~~~-~~~~~~~~~~~v~~ 760 (767)
.+.+|+|||||+| +|.+.+... +...+......+..
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~q 132 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHH
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHH
Confidence 4579999999985 666666543 34444444444433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=3.5e-12 Score=137.67 Aligned_cols=109 Identities=16% Similarity=0.113 Sum_probs=88.7
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCC----cEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 722 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg----~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~ 722 (767)
..+...+|++.+.||+|+||.||+|+++.++ ..||+|+++... .......+.+|+.+|+.++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3466779999999999999999999987654 469999998653 3455667899999999999999999999999
Q ss_pred eCCEEEEEEeccCCcccccccccc-CCCChhhhHHH
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSET-NPCCFPFRRKE 757 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~-~~~~~~~~~~~ 757 (767)
+.+.+|+|||||+||+|.+++... +...+......
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i 152 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 152 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHH
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHH
Confidence 999999999999999999998754 33444443333
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3e-12 Score=134.95 Aligned_cols=110 Identities=16% Similarity=0.171 Sum_probs=87.4
Q ss_pred CCCCCceeee-ecccCCccceeEEE--EccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC
Q psy11874 649 ITYKTFRMYR-VLGKGGFGEVCACQ--VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 725 (767)
Q Consensus 649 ~~~~~y~~~~-~LG~GsfG~V~l~~--~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~ 725 (767)
+...+|++.+ .||+|+||.||+|. .+.+++.||+|+++... ......+.+.+|+.+++.++||||+++++++ ..+
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 4456899998 99999999999994 46678999999998754 3344567899999999999999999999999 567
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
.+|+||||++||+|.+++...+...+......+..
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~q 125 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHH
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHH
Confidence 78999999999999999987665555544444333
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=2.6e-12 Score=140.96 Aligned_cols=105 Identities=18% Similarity=0.185 Sum_probs=81.2
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC-----
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----- 725 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~----- 725 (767)
.+.|++++.||+|+||.||+|+++.+|+.||+|++.+.. ......+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 367999999999999999999999999999999997653 34455678899999999999999999999998763
Q ss_pred -EEEEEEeccCCccccccccccCCCChhhhHHHH
Q psy11874 726 -ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 726 -~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
.+|+||||+ |++|.++++. +...+......+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~ 134 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLV 134 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHH
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHH
Confidence 469999999 8999998865 344444444433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.31 E-value=5.7e-12 Score=137.01 Aligned_cols=95 Identities=26% Similarity=0.358 Sum_probs=84.5
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC-----CCceeeeeEEEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-----SRFVVSLAYAYE 722 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~-----HpnIV~l~~~f~ 722 (767)
.+-.++|++++.||+|+||.||+|+++.+|+.||+|++++. ....+...+|+.+|+.+. |||||+++++|.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 34557899999999999999999999999999999999753 344567788999999996 999999999999
Q ss_pred eCCEEEEEEeccCCccccccccccC
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+.+|+||||| ||+|.+++.+.+
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~ 130 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNN 130 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcC
Confidence 999999999999 999999997654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.31 E-value=2.4e-12 Score=137.71 Aligned_cols=98 Identities=20% Similarity=0.190 Sum_probs=73.9
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCc---EEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~---~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
.+..++|++.+.||+|+||.||+|+++.++. .||+|+++... ......+.+.+|+.+|+.++||||+++++++.+.
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI-IASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc-cCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3556789999999999999999999988775 89999998754 2345577899999999999999999999999887
Q ss_pred CEE------EEEEeccCCcccccccccc
Q psy11874 725 DAL------CLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 725 ~~l------ylVmEy~~gG~L~~~l~~~ 746 (767)
+.. |+|||||+||+|.+++...
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~ 125 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLAS 125 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHH
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhh
Confidence 765 9999999999999998543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.9e-12 Score=144.16 Aligned_cols=92 Identities=21% Similarity=0.358 Sum_probs=80.2
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC------
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------ 724 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~------ 724 (767)
.++|++++.||+|+||+||+|+++.+|+.||+|++.+.. ......+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 468999999999999999999999999999999998763 3455677899999999999999999999999765
Q ss_pred CEEEEEEeccCCcccccccc
Q psy11874 725 DALCLVLTIIDVMFTCVQPS 744 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~ 744 (767)
..+|||||||+|| |.+.+.
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~ 158 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ 158 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT
T ss_pred CeEEEEEeCCCCC-HHHHHh
Confidence 4689999999865 666654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.31 E-value=5e-12 Score=132.63 Aligned_cols=96 Identities=13% Similarity=0.227 Sum_probs=78.3
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++++.||+|+||.||+|+++.+|+.||+|++.... ......+...+|..+++.++||||+++++++.+.+.+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 356789999999999999999999999999999999998653 2233344455566668888999999999999999999
Q ss_pred EEEEeccCCccccccccc
Q psy11874 728 CLVLTIIDVMFTCVQPSE 745 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~ 745 (767)
|+|||||+ |+|.+++..
T Consensus 82 ~lv~e~~~-~~l~~~l~~ 98 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQ 98 (290)
T ss_dssp EEEEECCS-EEHHHHHHH
T ss_pred EEEEehhc-cchHHHHHH
Confidence 99999998 477776643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.7e-12 Score=136.85 Aligned_cols=97 Identities=16% Similarity=0.187 Sum_probs=86.0
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCc-----EEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAY 721 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~-----~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f 721 (767)
.+..++|++.+.||+|+||.||+|++..+|+ .+|+|++.... .....+.+.+|+.+|+.+ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4566899999999999999999999987764 79999998653 345567899999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCcccccccccc
Q psy11874 722 ETKDALCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 722 ~~~~~lylVmEy~~gG~L~~~l~~~ 746 (767)
.+.+.+|+|||||+||+|.+++...
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRK 144 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHH
T ss_pred ecCCceEEEEecCCCCcHHHHHHHh
Confidence 9999999999999999999998654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.3e-12 Score=132.35 Aligned_cols=103 Identities=16% Similarity=0.139 Sum_probs=86.7
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++.+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 45678999999999999999999986 578899999987542 2357899999999999999999999999999999
Q ss_pred EEEeccCCccccccccccC-CCChhhhHH
Q psy11874 729 LVLTIIDVMFTCVQPSETN-PCCFPFRRK 756 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~-~~~~~~~~~ 756 (767)
+||||++||+|.+++...+ ...+.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 108 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLG 108 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHH
Confidence 9999999999999997653 334443333
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=5.3e-12 Score=132.76 Aligned_cols=95 Identities=14% Similarity=0.125 Sum_probs=82.4
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
...++|.....||+|+||.||+|+++.+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 34455666679999999999999999999999999998642 344567899999999999999999999999999999
Q ss_pred EEEeccCCcccccccccc
Q psy11874 729 LVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~ 746 (767)
+||||++||+|.+++...
T Consensus 96 lv~e~~~~~~L~~~l~~~ 113 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSK 113 (295)
T ss_dssp EEEECCSEEEHHHHHHHT
T ss_pred EEEEeCCCCCHHHHHHhh
Confidence 999999999999998754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.30 E-value=4.1e-12 Score=132.72 Aligned_cols=88 Identities=20% Similarity=0.314 Sum_probs=78.6
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe--------
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-------- 723 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~-------- 723 (767)
++|++++.||+|+||.||+|+++.+|+.||+|++.... +.+.+|+.+|+.++||||+++++++.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 57999999999999999999999999999999998642 246789999999999999999999865
Q ss_pred --------CCEEEEEEeccCCcccccccccc
Q psy11874 724 --------KDALCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 724 --------~~~lylVmEy~~gG~L~~~l~~~ 746 (767)
...+|+|||||+||+|.+++...
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 114 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc
Confidence 45699999999999999999654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=4.7e-12 Score=132.78 Aligned_cols=97 Identities=14% Similarity=0.169 Sum_probs=82.7
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccC---CcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~t---g~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
.+..++|++.+.||+|+||.||+|+++.+ +..+|+|++... ......+.+.+|+.+|+.++||||+++++++ +.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEE-cc
Confidence 35567899999999999999999998764 457999998764 2345567899999999999999999999998 45
Q ss_pred CEEEEEEeccCCccccccccccC
Q psy11874 725 DALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+|+|||||+||+|.+++...+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~ 110 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRK 110 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT
T ss_pred CccEEEEecCCCCCHHHHHHhcC
Confidence 67899999999999999997554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.29 E-value=4.6e-12 Score=142.89 Aligned_cols=94 Identities=18% Similarity=0.268 Sum_probs=82.6
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC-E
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD-A 726 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~-~ 726 (767)
.+..++|++.+.||+|+||.||++.++ |+.||+|+++... ..+.+.+|+.+|++++|||||++++++.+.+ .
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 466789999999999999999999875 7899999997642 3567899999999999999999999987665 7
Q ss_pred EEEEEeccCCccccccccccCC
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNP 748 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~ 748 (767)
+|||||||+||+|.+++++.+.
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~ 283 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGR 283 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCT
T ss_pred eEEEEEecCCCcHHHHHHhcCC
Confidence 9999999999999999976654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=3.1e-12 Score=135.37 Aligned_cols=94 Identities=23% Similarity=0.281 Sum_probs=78.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccc-hhhHHHHHHHHHHHhhCCCCceeeeeEEEE--eCCEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMVLIEKQILQKINSRFVVSLAYAYE--TKDAL 727 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~-~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~--~~~~l 727 (767)
.++|++.+.||+|+||.||+|.++.+|+.+|+|++.+..... ....+.+.+|+.+|+.++||||+++++++. +.+.+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999999999999998764322 245678999999999999999999999984 45679
Q ss_pred EEEEeccCCccccccccc
Q psy11874 728 CLVLTIIDVMFTCVQPSE 745 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~ 745 (767)
|+|||||++| |.+.+..
T Consensus 84 ~lv~e~~~~~-l~~~~~~ 100 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDS 100 (305)
T ss_dssp EEEEECCSEE-HHHHHHH
T ss_pred EEEehhccCC-HHHHHHh
Confidence 9999999987 6666654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=7.5e-12 Score=133.84 Aligned_cols=94 Identities=21% Similarity=0.262 Sum_probs=83.4
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEe----
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYET---- 723 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~---- 723 (767)
...+.|++++.||+|+||.||+|+++.+|+.||+|++.... ...+.+.+|+.+++.+ +||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34568999999999999999999999999999999997643 2346788999999999 89999999999987
Q ss_pred --CCEEEEEEeccCCcccccccccc
Q psy11874 724 --KDALCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 724 --~~~lylVmEy~~gG~L~~~l~~~ 746 (767)
.+.+|+|||||+||+|.+++...
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~ 121 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT 121 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc
Confidence 56899999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.29 E-value=2.7e-12 Score=136.38 Aligned_cols=97 Identities=21% Similarity=0.259 Sum_probs=83.5
Q ss_pred CCCCCceeeeecccCCccceeEEEE-----ccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYE 722 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~-----k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~ 722 (767)
+..++|++.+.||+|+||.||+|++ ..+++.||+|++.+.. .....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 4567899999999999999999985 4577899999998753 344567889999999999 7999999999988
Q ss_pred eCC-EEEEEEeccCCccccccccccC
Q psy11874 723 TKD-ALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 723 ~~~-~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+ .+|+|||||+||+|.+++...+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~ 127 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKR 127 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCT
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcc
Confidence 755 5999999999999999997654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=6.6e-12 Score=133.30 Aligned_cols=103 Identities=17% Similarity=0.145 Sum_probs=80.8
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE--------
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE-------- 722 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~-------- 722 (767)
.++|++++.||+|+||.||+|+++.+|+.||+|++... +....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 35899999999999999999999999999999999764 3456678899999999999999999999873
Q ss_pred ------eCCEEEEEEeccCCccccccccccCCCChhhhHHHH
Q psy11874 723 ------TKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 723 ------~~~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
+.+.+|+||||++ |+|.+++.. +...+......+
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~ 126 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFM 126 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHH
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHH
Confidence 4478999999998 699998864 344444444433
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1.4e-12 Score=139.66 Aligned_cols=97 Identities=24% Similarity=0.309 Sum_probs=82.0
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++.+.||+|+||.||+|++ .+|+.||+|++..... ......+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC--chHHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 4567899999999999999999974 4689999999987542 222336889999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCC
Q psy11874 729 LVLTIIDVMFTCVQPSETNP 748 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~ 748 (767)
+|||||+||+|.+++.....
T Consensus 104 lv~e~~~~~~L~~~l~~~~~ 123 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPE 123 (326)
T ss_dssp EEEECCTTCBHHHHHHCCST
T ss_pred EEEEeccCCCHHHHHHhccc
Confidence 99999999999999976543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=7.7e-12 Score=135.47 Aligned_cols=108 Identities=13% Similarity=0.070 Sum_probs=90.0
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCC--CceeeeeEEEEeCCEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS--RFVVSLAYAYETKDAL 727 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~H--pnIV~l~~~f~~~~~l 727 (767)
.-..|++++.||+|+||.||+|.+ .+++.||+|++.... ......+.+.+|+.+|+.++| |||+++++++.+.+.+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 345799999999999999999987 468999999998764 344556788999999999976 9999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
||||| +.+|+|.+++.+.+...+......+..
T Consensus 85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~q 116 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKN 116 (343)
T ss_dssp EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHH
T ss_pred EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHH
Confidence 99999 678999999987766565555444433
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=4.5e-12 Score=135.71 Aligned_cols=101 Identities=21% Similarity=0.188 Sum_probs=83.1
Q ss_pred CceeeeecccCCccceeEEEE----ccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe--CCE
Q psy11874 653 TFRMYRVLGKGGFGEVCACQV----RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--KDA 726 (767)
Q Consensus 653 ~y~~~~~LG~GsfG~V~l~~~----k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~--~~~ 726 (767)
.|++++.||+|+||.||++.. ..+|+.||+|++++. ......+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 359999999999999988764 457899999999875 344566789999999999999999999999998 468
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
+|+|||||++|+|.+++.+.+ ..+.....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~ 138 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS-IGLAQLLL 138 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC-CCHHHHHH
T ss_pred EEEEEecccCCcHHHHHhhCC-CCHHHHHH
Confidence 999999999999999997654 34444433
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.28 E-value=3.9e-12 Score=135.81 Aligned_cols=96 Identities=17% Similarity=0.197 Sum_probs=84.7
Q ss_pred CCCCCceeeeecccCCccceeEEEEc-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 723 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k-----~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~ 723 (767)
+..++|++.+.||+|+||.||+|+++ .+++.||+|++.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 45578999999999999999999887 467899999998653 33455678999999999999999999999999
Q ss_pred CCEEEEEEeccCCcccccccccc
Q psy11874 724 KDALCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 724 ~~~lylVmEy~~gG~L~~~l~~~ 746 (767)
.+.+|+|||||+||+|.+++...
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~ 122 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSL 122 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHH
T ss_pred CCccEEEEEeCCCCcHHHHHHHh
Confidence 99999999999999999998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.28 E-value=1e-12 Score=144.34 Aligned_cols=100 Identities=9% Similarity=-0.053 Sum_probs=82.0
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHH---HHHhhCCCCceeeee-------EE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK---QILQKINSRFVVSLA-------YA 720 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei---~IL~~l~HpnIV~l~-------~~ 720 (767)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+ ++|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35799999999999999999999999999999999976555566778899999 455566899999998 77
Q ss_pred EEeCCE-----------------EEEEEeccCCccccccccccCCCCh
Q psy11874 721 YETKDA-----------------LCLVLTIIDVMFTCVQPSETNPCCF 751 (767)
Q Consensus 721 f~~~~~-----------------lylVmEy~~gG~L~~~l~~~~~~~~ 751 (767)
+.+.+. .||||||| +|+|.+++.+.+...+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~ 198 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS 198 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc
Confidence 776643 89999999 6899999976554333
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=6e-12 Score=135.13 Aligned_cols=96 Identities=21% Similarity=0.267 Sum_probs=82.9
Q ss_pred CCCCCceeeeecccCCccceeEEE----EccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQ----VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~----~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
+..++|++++.||+|+||.||+|+ +..+|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 556789999999999999999998 4678999999999863 345567899999999999999999999998765
Q ss_pred C--EEEEEEeccCCccccccccccC
Q psy11874 725 D--ALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 725 ~--~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+ .+|+||||++||+|.+++...+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~ 139 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK 139 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc
Confidence 4 7899999999999999997653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=7.8e-12 Score=138.34 Aligned_cols=106 Identities=14% Similarity=0.089 Sum_probs=88.8
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC--CCceeeeeEEEEeCCEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN--SRFVVSLAYAYETKDAL 727 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~--HpnIV~l~~~f~~~~~l 727 (767)
...+|++++.||+|+||+||+|.++. |+.||+|++.+.. ......+.+.+|+.+|+.+. |||||++++++.+.+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccc-ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999998865 8999999998765 34556778999999999996 59999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
||||| +.+|+|.+++.+.+...+......+
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~ 161 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYW 161 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHH
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHH
Confidence 99999 6789999999877665554444433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=7.3e-12 Score=144.45 Aligned_cols=93 Identities=22% Similarity=0.234 Sum_probs=80.7
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++.+.||+|+||.||+++++.+ ..||+|+++.... ..+.+.+|+.+|+.++|||||++++++.+ +.+
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 46677899999999999999999998764 5699999986532 24578999999999999999999998865 779
Q ss_pred EEEEeccCCcccccccccc
Q psy11874 728 CLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~ 746 (767)
|||||||+||+|.++|+..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~ 355 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGE 355 (535)
T ss_dssp EEEECCCTTEEHHHHHSHH
T ss_pred eEeeehhcCCcHHHHHhhc
Confidence 9999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.27 E-value=1e-11 Score=136.19 Aligned_cols=92 Identities=18% Similarity=0.335 Sum_probs=81.3
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC-----
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----- 725 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~----- 725 (767)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ......+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 468999999999999999999999999999999998754 34456678899999999999999999999998765
Q ss_pred -EEEEEEeccCCcccccccc
Q psy11874 726 -ALCLVLTIIDVMFTCVQPS 744 (767)
Q Consensus 726 -~lylVmEy~~gG~L~~~l~ 744 (767)
.+|+|||||+| +|.+.+.
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~ 121 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ 121 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH
T ss_pred cceEEEEEcCCC-CHHHHHh
Confidence 89999999985 6878775
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=9e-12 Score=133.05 Aligned_cols=106 Identities=20% Similarity=0.175 Sum_probs=83.6
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~lyl 729 (767)
.++|++++.||+|+||+||+|+++.+|+.||+|++..... .........+|+..+..+ +|||||++++++.+.+.+|+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3679999999999999999999999999999999876542 333444556666666555 99999999999999999999
Q ss_pred EEeccCCccccccccccC-CCChhhhHHHH
Q psy11874 730 VLTIIDVMFTCVQPSETN-PCCFPFRRKEV 758 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~-~~~~~~~~~~v 758 (767)
||||| +|+|.+.+...+ ...+......+
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~ 163 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYL 163 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHH
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHH
Confidence 99999 678988886554 34444444333
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.27 E-value=8.9e-12 Score=136.79 Aligned_cols=105 Identities=17% Similarity=0.181 Sum_probs=79.5
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC------C
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------D 725 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~------~ 725 (767)
++|++++.||+|+||.||+|.++.+|+.||+|++.+.. ......+.+.+|+.+|+.++|||||+++++|... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 68999999999999999999999999999999997653 3445567889999999999999999999999764 5
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
.+|+||||+ ||+|.+++.. +...+......+.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~ 139 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIY 139 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHH
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHH
Confidence 689999999 7999998865 3444444444333
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=1.5e-11 Score=129.35 Aligned_cols=107 Identities=18% Similarity=0.175 Sum_probs=85.8
Q ss_pred CCCCCceeee-ecccCCccceeEEEEc--cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC
Q psy11874 649 ITYKTFRMYR-VLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 725 (767)
Q Consensus 649 ~~~~~y~~~~-~LG~GsfG~V~l~~~k--~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~ 725 (767)
+..++|.+.. .||+|+||.||+|.++ .++..||+|+++.. ......+.+.+|+.+|+.++||||+++++++. .+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence 4557888887 9999999999999864 56789999999875 24456778999999999999999999999994 56
Q ss_pred EEEEEEeccCCccccccccccC-CCChhhhHHHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETN-PCCFPFRRKEV 758 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~-~~~~~~~~~~v 758 (767)
.+|+||||++||+|.+++...+ ...+......+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 116 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 116 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHH
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHH
Confidence 6999999999999999986443 34444443333
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.5e-11 Score=130.82 Aligned_cols=96 Identities=16% Similarity=0.162 Sum_probs=78.3
Q ss_pred CCCCCCceeeeecccCCccceeEEEEcc---CCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~---tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
.+..++|++.+.||+|+||.||+|+.+. ++..||+|+++... ......+.+.+|+.+|+.++||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 4566789999999999999999998875 56689999998654 3445567899999999999999999999999876
Q ss_pred C-----EEEEEEeccCCcccccccc
Q psy11874 725 D-----ALCLVLTIIDVMFTCVQPS 744 (767)
Q Consensus 725 ~-----~lylVmEy~~gG~L~~~l~ 744 (767)
+ ..|+||||+++|+|.+++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~ 133 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLL 133 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHH
T ss_pred cccCCcccEEEEecccCCCHHHHHH
Confidence 5 3599999999999999884
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.3e-11 Score=131.19 Aligned_cols=111 Identities=15% Similarity=0.130 Sum_probs=84.5
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeeccccc--chhhHHHHHHHHHHHhhCC---CCceeeeeEEEEe
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMVLIEKQILQKIN---SRFVVSLAYAYET 723 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~--~~~~~~~~~~Ei~IL~~l~---HpnIV~l~~~f~~ 723 (767)
+..++|++++.||+|+||.||+|+++.+|+.||+|++...... .........+|+.+++.+. ||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3456899999999999999999999999999999999864321 1122356778888887774 9999999999988
Q ss_pred CC-----EEEEEEeccCCccccccccccCC--CChhhhHHHHHH
Q psy11874 724 KD-----ALCLVLTIIDVMFTCVQPSETNP--CCFPFRRKEVVV 760 (767)
Q Consensus 724 ~~-----~lylVmEy~~gG~L~~~l~~~~~--~~~~~~~~~v~~ 760 (767)
.. .+|+||||++ |+|.+++..... ..+......+..
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~q 128 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQ 128 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHH
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHH
Confidence 66 6999999998 599999876654 444444444333
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-11 Score=136.13 Aligned_cols=86 Identities=21% Similarity=0.281 Sum_probs=72.2
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe-------
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------- 723 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~------- 723 (767)
.++|++++.||+|+||.||+|+++.+|+.||+|++..... ...+|+.+|+.++|||||+++++|.+
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 4689999999999999999999999999999999976431 22479999999999999999999954
Q ss_pred -------------------------------CCEEEEEEeccCCcccccccc
Q psy11874 724 -------------------------------KDALCLVLTIIDVMFTCVQPS 744 (767)
Q Consensus 724 -------------------------------~~~lylVmEy~~gG~L~~~l~ 744 (767)
...+|+|||||+ |+|.+.+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~ 129 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLK 129 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHH
Confidence 345999999998 57766664
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=8.5e-12 Score=136.22 Aligned_cols=91 Identities=13% Similarity=0.134 Sum_probs=77.5
Q ss_pred CCCCCceeeeecccCCccceeEE-----EEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC---CCceeeeeEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCAC-----QVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN---SRFVVSLAYA 720 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~-----~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~---HpnIV~l~~~ 720 (767)
+..++|++.+.||+|+||.||+| .+..+++.||+|+++... ...+.+|+.+++.++ ||||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 45578999999999999999999 577889999999997642 346778888888886 9999999999
Q ss_pred EEeCCEEEEEEeccCCccccccccc
Q psy11874 721 YETKDALCLVLTIIDVMFTCVQPSE 745 (767)
Q Consensus 721 f~~~~~lylVmEy~~gG~L~~~l~~ 745 (767)
+.+.+.+|||||||+||+|.+++..
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~ 160 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINL 160 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHH
T ss_pred eecCCCcEEEEeccCCCcHHHHHHH
Confidence 9999999999999999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.4e-12 Score=136.98 Aligned_cols=113 Identities=23% Similarity=0.194 Sum_probs=82.9
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccch---hhHHHHHHHHHHHhhC----CCCceeeeeEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKI----NSRFVVSLAYA 720 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~---~~~~~~~~Ei~IL~~l----~HpnIV~l~~~ 720 (767)
..-.++|++.+.||+|+||.||+|+++.+|+.||+|++........ .....+.+|+.++..+ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3445789999999999999999999999999999999987643221 1233466899999998 89999999999
Q ss_pred EEeCCEEEEEEec-cCCccccccccccCCCChhhhHHHHHH
Q psy11874 721 YETKDALCLVLTI-IDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 721 f~~~~~lylVmEy-~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+.+.+..|+|||| +.||+|.+++.+.+...+......+..
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~q 147 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ 147 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHH
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHH
Confidence 9999999999999 799999999987666555555544433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-11 Score=131.57 Aligned_cols=89 Identities=17% Similarity=0.213 Sum_probs=80.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC-CCceeeeeEEEEe--CCEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYET--KDAL 727 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~-HpnIV~l~~~f~~--~~~l 727 (767)
.++|++++.||+|+||.||+|+++.+|+.||+|+++... .+.+.+|+.+|+.+. ||||+++++++.+ ...+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 468999999999999999999999999999999997532 357889999999996 9999999999998 6789
Q ss_pred EEEEeccCCccccccccc
Q psy11874 728 CLVLTIIDVMFTCVQPSE 745 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~ 745 (767)
|+||||++||+|.++++.
T Consensus 109 ~lv~e~~~~~~l~~~~~~ 126 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT 126 (330)
T ss_dssp EEEEECCCCCCHHHHGGG
T ss_pred EEEEeccCchhHHHHHHh
Confidence 999999999999988754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=6.6e-12 Score=136.15 Aligned_cols=107 Identities=19% Similarity=0.242 Sum_probs=80.0
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccc--hhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~--~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
.++|++++.||+|+||.||+|+++.+|+.||+|++....... ....+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 468999999999999999999999999999999998643221 122356889999999999999999999999999999
Q ss_pred EEEeccCCccccccccccC-CCChhhhHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETN-PCCFPFRRKEV 758 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~-~~~~~~~~~~v 758 (767)
+|||||+| +|.+.+...+ ...+......+
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~ 118 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYM 118 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHH
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHH
Confidence 99999986 7888776543 33444444333
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2.2e-11 Score=130.51 Aligned_cols=94 Identities=13% Similarity=0.265 Sum_probs=79.2
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHH-HHhhCCCCceeeeeEEEEeCCE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQ-ILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~-IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
.+..++|++++.||+|+||.||+|.++.+|+.||+|++.... .........+|+. +++.++||||+++++++.+.+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 466789999999999999999999999999999999998753 3344455666666 7778899999999999999999
Q ss_pred EEEEEeccCCcccccccc
Q psy11874 727 LCLVLTIIDVMFTCVQPS 744 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~ 744 (767)
+|+|||||+| +|.+++.
T Consensus 96 ~~lv~e~~~~-~l~~~~~ 112 (327)
T 3aln_A 96 CWICMELMST-SFDKFYK 112 (327)
T ss_dssp EEEEECCCSE-EHHHHHH
T ss_pred eEEEEeecCC-ChHHHHH
Confidence 9999999985 7766664
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.23 E-value=1.3e-11 Score=130.12 Aligned_cols=95 Identities=16% Similarity=0.085 Sum_probs=81.1
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
..+.-++|++.+.||+|+||.||++++.. .+|+|+++... ......+.+.+|+.+|+.++||||++++++ ...+.
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccCCc
Confidence 45677899999999999999999997643 59999998654 345567789999999999999999999994 56677
Q ss_pred EEEEEeccCCcccccccccc
Q psy11874 727 LCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~ 746 (767)
+++|||||+||+|.+++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~ 113 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHAS 113 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC
T ss_pred cEEEEEecCCCcHHHHHhhc
Confidence 99999999999999998544
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.23 E-value=9.8e-12 Score=130.44 Aligned_cols=107 Identities=19% Similarity=0.191 Sum_probs=78.2
Q ss_pred CCCCCceeeeecccCCccceeEEEEcc-CCc--EEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRA-TGK--MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 725 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~-tg~--~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~ 725 (767)
+..++|++.+.||+|+||.||+|++.. +++ .||+|+++..........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 456789999999999999999998754 333 69999998765445566788999999999999999999999998765
Q ss_pred EEEEEEeccCCcccccccccc-CCCChhhhHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSET-NPCCFPFRRK 756 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~-~~~~~~~~~~ 756 (767)
+++||||+++|+|.+++... +...+.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 125 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHH
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHH
Confidence 89999999999999998754 3334444433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.23 E-value=1.3e-11 Score=132.82 Aligned_cols=106 Identities=19% Similarity=0.209 Sum_probs=79.4
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEE----EEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 723 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~----AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~ 723 (767)
.+..++|++++.||+|+||.||+|+++.+|+.+ |+|.+... ......+.+.+|+.+|+.++|||||++++++.+
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 356678999999999999999999999888765 66666543 233455789999999999999999999999987
Q ss_pred CCEEEEEEeccCCccccccccccC-CCChhhhHH
Q psy11874 724 KDALCLVLTIIDVMFTCVQPSETN-PCCFPFRRK 756 (767)
Q Consensus 724 ~~~lylVmEy~~gG~L~~~l~~~~-~~~~~~~~~ 756 (767)
.+ .++||||+.+|+|.+++...+ ...+.....
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~ 121 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHH
Confidence 65 789999999999999987643 334443333
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=6.6e-12 Score=134.86 Aligned_cols=106 Identities=18% Similarity=0.130 Sum_probs=83.4
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcE----EEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 723 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~----~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~ 723 (767)
.+..++|++++.||+|+||.||+|+++.+|+. +|+|++.... .....+.+.+|+.+++.++|||||++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 35567999999999999999999999998876 5666654331 2233456788999999999999999999886
Q ss_pred CCEEEEEEeccCCcccccccccc-CCCChhhhHH
Q psy11874 724 KDALCLVLTIIDVMFTCVQPSET-NPCCFPFRRK 756 (767)
Q Consensus 724 ~~~lylVmEy~~gG~L~~~l~~~-~~~~~~~~~~ 756 (767)
.+.+|+||||+.||+|.+++... +...+.....
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 119 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHH
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHH
Confidence 46689999999999999998764 3444444443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=134.93 Aligned_cols=103 Identities=13% Similarity=0.129 Sum_probs=85.5
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC-----CE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----DA 726 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~-----~~ 726 (767)
++|++++.||+|+||.||+|+++.+|+.||+|++... ......+.+.+|+.+|+.++||||+++++++.+. ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4799999999999999999999999999999999864 2345567889999999999999999999999765 47
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
+|+||||++ |+|.+++... ...+......+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~ 134 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ-HLSNDHICYFL 134 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC-CCCHHHHHHHH
T ss_pred EEEEEcccC-cCHHHHHHhC-CCCHHHHHHHH
Confidence 999999998 5899888653 34444444333
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.9e-11 Score=125.60 Aligned_cols=139 Identities=13% Similarity=-0.018 Sum_probs=111.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lV 192 (767)
..|++...+|.|+.+.||++... |..+++|+...... .....+.+|..+|+.+. +..+.++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 57899999999999999999753 78999999865321 12234788999999985 56788899999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-------------------------------------
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY------------------------------------- 235 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~------------------------------------- 235 (767)
||+++|.+|...+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999875421 112234678899999999998
Q ss_pred ----------------------CCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 236 ----------------------IGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 236 ----------------------~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876566799999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.4e-11 Score=128.91 Aligned_cols=105 Identities=16% Similarity=0.134 Sum_probs=85.1
Q ss_pred CCCCCCceeeeecccCCccceeEEEEcc---CCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~---tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
.+..++|++.+.||+|+||.||+|++.. ++..||+|++.+.. .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 3566799999999999999999998654 34579999998753 34556789999999999999999999999875
Q ss_pred CEEEEEEeccCCccccccccccCC-CChhhhH
Q psy11874 725 DALCLVLTIIDVMFTCVQPSETNP-CCFPFRR 755 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~~~-~~~~~~~ 755 (767)
+..|+||||++||+|.+++.+.+. ..+....
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~ 116 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLV 116 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHH
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHH
Confidence 457999999999999999976542 3443333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.5e-11 Score=129.44 Aligned_cols=92 Identities=20% Similarity=0.156 Sum_probs=79.7
Q ss_pred CceeeeecccCCccceeEEEEccCCc---EEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE-E
Q psy11874 653 TFRMYRVLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL-C 728 (767)
Q Consensus 653 ~y~~~~~LG~GsfG~V~l~~~k~tg~---~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l-y 728 (767)
.|++.+.||+|+||.||+|++..+++ .+|+|++... ......+.+.+|+.+|+.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46778999999999999999876654 7999999764 3445677899999999999999999999999877765 9
Q ss_pred EEEeccCCcccccccccc
Q psy11874 729 LVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~ 746 (767)
+||||+.+|+|.+++...
T Consensus 100 ~v~e~~~~~~L~~~~~~~ 117 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP 117 (298)
T ss_dssp EEECCCTTCBHHHHHHCT
T ss_pred EEEecccCCCHHHHHhcc
Confidence 999999999999999763
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.6e-11 Score=133.15 Aligned_cols=112 Identities=7% Similarity=-0.062 Sum_probs=83.4
Q ss_pred CCCCCceeeeecccCCccceeEEEEcc---CCcEEEEEEeecccccch--------hhHHHHHHHHHHHhhCCCCceeee
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKR--------KGESMVLIEKQILQKINSRFVVSL 717 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~---tg~~~AvK~i~k~~~~~~--------~~~~~~~~Ei~IL~~l~HpnIV~l 717 (767)
+..++|++.+.||+|+||.||+|+++. ++..+|+|++.+...... -....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 445789999999999999999999987 788999999987531111 112346789999999999999999
Q ss_pred eEEEEe----CCEEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 718 AYAYET----KDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 718 ~~~f~~----~~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
++++.+ ...+|+||||| ||+|.+++...+.+.+......+..+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi 160 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRM 160 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHH
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHH
Confidence 999998 78899999999 99999999877665555554444433
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.4e-11 Score=128.10 Aligned_cols=101 Identities=16% Similarity=0.137 Sum_probs=79.3
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhh--CCCCceeeeeEEEEe---
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK--INSRFVVSLAYAYET--- 723 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~--l~HpnIV~l~~~f~~--- 723 (767)
...++|++.+.||+|+||.||++++ +|+.||+|++... ......+|.+++.. ++||||+++++++.+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 3457899999999999999999987 6899999998753 23455667777766 799999999998654
Q ss_pred -CCEEEEEEeccCCccccccccccCCCChhhhHHHH
Q psy11874 724 -KDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 724 -~~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
...+|+|||||+||+|.++++.. ...+......+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~ 111 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIV 111 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTC-CBCHHHHHHHH
T ss_pred CCceeEEehhhccCCCHHHHHhhc-ccCHHHHHHHH
Confidence 35699999999999999999543 44444444433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.1e-11 Score=127.05 Aligned_cols=106 Identities=10% Similarity=0.022 Sum_probs=88.3
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCCEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~~l 727 (767)
+..++|++.+.||+|+||.||+|+++.+|+.||+|++.... ..+.+.+|+.+++.+ +||||+++++++.+...+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 44568999999999999999999999999999999997543 223578999999999 899999999999999999
Q ss_pred EEEEeccCCccccccccccC-CCChhhhHHHHHH
Q psy11874 728 CLVLTIIDVMFTCVQPSETN-PCCFPFRRKEVVV 760 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~-~~~~~~~~~~v~~ 760 (767)
|+||||+ ||+|.+++...+ ...+......+..
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~q 114 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQ 114 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHH
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHH
Confidence 9999999 999999997654 3444444443333
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.4e-11 Score=142.42 Aligned_cols=105 Identities=18% Similarity=0.183 Sum_probs=83.5
Q ss_pred CCCCCceeee-ecccCCccceeEEEEcc--CCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC
Q psy11874 649 ITYKTFRMYR-VLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 725 (767)
Q Consensus 649 ~~~~~y~~~~-~LG~GsfG~V~l~~~k~--tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~ 725 (767)
+..+++.+.+ .||+|+||.||++..+. ++..||+|++++.. .....+.+.+|+++|+.++|||||++++++.+ +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 3445666666 89999999999998764 55679999998752 34567789999999999999999999999976 5
Q ss_pred EEEEEEeccCCccccccccccC-CCChhhhHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETN-PCCFPFRRK 756 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~-~~~~~~~~~ 756 (767)
.+|||||||+||+|.++|...+ ...+.....
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~ 440 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHH
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHH
Confidence 6999999999999999986543 334444333
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=2.2e-11 Score=143.32 Aligned_cols=106 Identities=17% Similarity=0.180 Sum_probs=84.3
Q ss_pred Cceee-eecccCCccceeEEEE--ccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 653 TFRMY-RVLGKGGFGEVCACQV--RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 653 ~y~~~-~~LG~GsfG~V~l~~~--k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
.+.+. +.||+|+||.||++.+ +.+++.||+|+++... ......+.+.+|+.+|+.++|||||++++++.+ +.+||
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 4899999999999954 5677899999998753 344556789999999999999999999999865 55899
Q ss_pred EEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 730 VLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|||||+||+|.++|...+...+......+..
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~q 477 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 477 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHH
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHH
Confidence 9999999999999977666555544444333
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.1e-11 Score=129.65 Aligned_cols=93 Identities=17% Similarity=0.255 Sum_probs=79.2
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC-CE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-DA 726 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~-~~ 726 (767)
.+..++|++.+.||+|+||.||++++ +|+.||+|+++... ..+.+.+|+.+++.++||||+++++++.+. +.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 36678999999999999999999987 48899999997542 456789999999999999999999987554 47
Q ss_pred EEEEEeccCCccccccccccC
Q psy11874 727 LCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~ 747 (767)
+|+||||++||+|.+++.+.+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~ 110 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRG 110 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHH
T ss_pred eEEEEecCCCCCHHHHHHhcc
Confidence 999999999999999987653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.21 E-value=1.9e-11 Score=127.63 Aligned_cols=92 Identities=16% Similarity=0.233 Sum_probs=79.3
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++++.||+|+||.||+|++. ++..+|+|++.... ...+.+.+|+.+|+.++||||+++++++. .+.+|
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 44578999999999999999999875 56789999997643 23467899999999999999999999886 45689
Q ss_pred EEEeccCCcccccccccc
Q psy11874 729 LVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~ 746 (767)
+||||++||+|.+++...
T Consensus 84 ~v~e~~~~~~L~~~l~~~ 101 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP 101 (279)
T ss_dssp EEEECCTTCBHHHHTTSH
T ss_pred EEEecCCCCCHHHHHhcC
Confidence 999999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=4.1e-11 Score=127.37 Aligned_cols=107 Identities=14% Similarity=0.233 Sum_probs=76.0
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
...+++|++++.||+|+||.||+|+++.+|+.||+|++.... ......+.+..+..+++.++||||+++++++.+.+.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 456789999999999999999999999999999999998764 2223334455556678888999999999999999999
Q ss_pred EEEEeccCCccccccccc-cCCCChhhhHH
Q psy11874 728 CLVLTIIDVMFTCVQPSE-TNPCCFPFRRK 756 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~-~~~~~~~~~~~ 756 (767)
|+||||+ ++.+..+... .+...+.....
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~ 128 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGK 128 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHH
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHH
Confidence 9999999 4544444433 23334443333
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=1.9e-11 Score=132.17 Aligned_cols=105 Identities=18% Similarity=0.245 Sum_probs=85.9
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC-----C
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----D 725 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~-----~ 725 (767)
.++|++.+.||+|+||.||+|+++.+|+.||+|++... ........+.+|+.+|+.++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 36899999999999999999999999999999999754 2344566788999999999999999999988764 6
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
.+|+||||+. |+|.+++.. +...+......+.
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ 119 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIY 119 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHH
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHH
Confidence 7999999998 689888865 3444444444333
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.4e-11 Score=144.13 Aligned_cols=104 Identities=15% Similarity=0.169 Sum_probs=83.5
Q ss_pred CCCCCceeeeecccCCccceeEEEEcc-CCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE-
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA- 726 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~-tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~- 726 (767)
+..++|++.+.||+|+||.||++.++. +|+.||+|++... ......+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 334789999999999999999999986 7899999999764 234556678999999999999999999999987765
Q ss_pred ----EEEEEeccCCccccccccccCCCChhhhHH
Q psy11874 727 ----LCLVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 727 ----lylVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
+|||||||+||+|.+.+.. ...+.....
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~ 186 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIA 186 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHH
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHH
Confidence 7999999999999988754 334444333
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.9e-11 Score=131.30 Aligned_cols=103 Identities=18% Similarity=0.202 Sum_probs=85.2
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE-----
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA----- 726 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~----- 726 (767)
++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.. ......+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 57999999999999999999999999999999998754 344556788999999999999999999999987754
Q ss_pred -EEEEEeccCCccccccccccCCCChhhhHHHH
Q psy11874 727 -LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 727 -lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
+|+||||++ |+|.+.+.. ...+......+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~ 132 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLV 132 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHH
T ss_pred eEEEEecccc-CCHHHHhcC--CCCHHHHHHHH
Confidence 599999998 689888753 23444444333
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.5e-11 Score=129.76 Aligned_cols=105 Identities=20% Similarity=0.240 Sum_probs=84.4
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC-CCceeeeeEEEE-----
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYE----- 722 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~-HpnIV~l~~~f~----- 722 (767)
+.-.+|++.+.||+|+||.||+|+++.+|+.||+|++... .....+.+.+|+.+|+.+. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 3345799999999999999999999999999999999654 3455678899999999995 999999999994
Q ss_pred ---eCCEEEEEEeccCCccccccccc---cCCCChhhhHHH
Q psy11874 723 ---TKDALCLVLTIIDVMFTCVQPSE---TNPCCFPFRRKE 757 (767)
Q Consensus 723 ---~~~~lylVmEy~~gG~L~~~l~~---~~~~~~~~~~~~ 757 (767)
....+|+|||||+ |+|.+++.. .+...+......
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i 141 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKI 141 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHH
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHH
Confidence 4456999999996 789888754 233444444433
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.20 E-value=1.8e-11 Score=129.19 Aligned_cols=94 Identities=19% Similarity=0.146 Sum_probs=78.6
Q ss_pred CCceeeeecccCCccceeEEEEccCC---cEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEE-EeCCEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAY-ETKDAL 727 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg---~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f-~~~~~l 727 (767)
..|++.+.||+|+||.||+|++..++ ..+|+|.+... ......+.+.+|+.+|++++||||+++++++ .+.+..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 46999999999999999999976543 46899998764 3455677899999999999999999999985 556789
Q ss_pred EEEEeccCCccccccccccC
Q psy11874 728 CLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~ 747 (767)
|+|||||+||+|.+++...+
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~ 122 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNET 122 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTT
T ss_pred EEEEeCCCCCCHHHHHHhcc
Confidence 99999999999999996543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.9e-11 Score=130.30 Aligned_cols=90 Identities=27% Similarity=0.403 Sum_probs=78.3
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++.+.||+|+||.||++++. ++.||+|++... ...+.+.+|+++|++++|||||++++++.+ .+|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45678999999999999999999874 788999998643 345678999999999999999999998864 479
Q ss_pred EEEeccCCccccccccccC
Q psy11874 729 LVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~ 747 (767)
+|||||+||+|.+++...+
T Consensus 76 lv~e~~~~~~L~~~l~~~~ 94 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAE 94 (307)
T ss_dssp EEEECCTTCBHHHHHHCSS
T ss_pred EEEEcCCCCCHHHHHhccC
Confidence 9999999999999997654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.20 E-value=2.5e-11 Score=133.05 Aligned_cols=103 Identities=19% Similarity=0.211 Sum_probs=85.5
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE----
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL---- 727 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l---- 727 (767)
++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.. ......+.+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 58999999999999999999999999999999998754 3445567889999999999999999999999887765
Q ss_pred --EEEEeccCCccccccccccCCCChhhhHHHH
Q psy11874 728 --CLVLTIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 728 --ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
|+||||+. |+|.+.+.. ...+......+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~ 150 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLV 150 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--CCCHHHHHHHH
T ss_pred eEEEEEcccc-ccHHHHhhc--CCCHHHHHHHH
Confidence 99999998 688877743 23444444433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.9e-11 Score=130.25 Aligned_cols=105 Identities=19% Similarity=0.220 Sum_probs=84.6
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEE----EEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~----AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
+..++|++++.||+|+||.||+|+++.+|+.+ |+|.+... ......+.+.+|+.+|+.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 55679999999999999999999999998766 55555432 2334567899999999999999999999999876
Q ss_pred CEEEEEEeccCCccccccccccC-CCChhhhHH
Q psy11874 725 DALCLVLTIIDVMFTCVQPSETN-PCCFPFRRK 756 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~~-~~~~~~~~~ 756 (767)
+ .++||||+.+|+|.+++...+ ...+.....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~ 121 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHH
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHH
Confidence 5 899999999999999987643 344444433
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=2.6e-11 Score=132.85 Aligned_cols=105 Identities=18% Similarity=0.227 Sum_probs=84.3
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC--------CCceeeeeEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN--------SRFVVSLAYAYE 722 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~--------HpnIV~l~~~f~ 722 (767)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+. ....+.+.+|+.+|+.+. ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 47899999999999999999999999999999999753 345567899999999985 888999999998
Q ss_pred ----eCCEEEEEEeccCCcccccccccc--CCCChhhhHHHHHH
Q psy11874 723 ----TKDALCLVLTIIDVMFTCVQPSET--NPCCFPFRRKEVVV 760 (767)
Q Consensus 723 ----~~~~lylVmEy~~gG~L~~~l~~~--~~~~~~~~~~~v~~ 760 (767)
+...+|+||||| +|+|.+.+.+. +...+......+.+
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~q 154 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQ 154 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHH
Confidence 566899999999 56676766544 23444444444433
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.18 E-value=1.9e-11 Score=131.11 Aligned_cols=111 Identities=23% Similarity=0.206 Sum_probs=91.4
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccch---hhHHHHHHHHHHHhhCC--CCceeeeeEEEEeC
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKIN--SRFVVSLAYAYETK 724 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~---~~~~~~~~Ei~IL~~l~--HpnIV~l~~~f~~~ 724 (767)
..++|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.+. ||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 35689999999999999999999999999999999987653221 12345678999999996 59999999999999
Q ss_pred CEEEEEEeccCC-ccccccccccCCCChhhhHHHHHH
Q psy11874 725 DALCLVLTIIDV-MFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 725 ~~lylVmEy~~g-G~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+.+|+|||++.+ |+|.+++...+...+......+..
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~q 157 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHH
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHH
Confidence 999999999986 999999987666565555544433
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=3.4e-11 Score=128.19 Aligned_cols=108 Identities=14% Similarity=0.100 Sum_probs=89.6
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC--CCceeeeeEEEEeCC
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN--SRFVVSLAYAYETKD 725 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~--HpnIV~l~~~f~~~~ 725 (767)
.+...+|++++.||+|+||.||+|+++ +|+.||+|++.... ......+.+.+|+.+|+.+. ||||+++++++.+.+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 345567999999999999999999885 48999999998754 34456678999999999996 599999999999999
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEV 758 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v 758 (767)
.+|+||| +.+|+|.+++...+...+......+
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~ 133 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYW 133 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHH
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHH
Confidence 9999999 6789999999876665554444433
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=8.4e-12 Score=132.88 Aligned_cols=109 Identities=14% Similarity=0.128 Sum_probs=89.1
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
..+..++|++.+.||+|+||.||+++++. .+|+|+++... ......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIER-DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCS-CCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCC-CCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 35778899999999999999999998865 39999998654 233344567899999999999999999999999999
Q ss_pred EEEEEeccCCccccccccccC-CCChhhhHHHHH
Q psy11874 727 LCLVLTIIDVMFTCVQPSETN-PCCFPFRRKEVV 759 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~-~~~~~~~~~~v~ 759 (767)
+|+|||||+||+|.+++...+ ...+......+.
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 137 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQ 137 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHH
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHH
Confidence 999999999999999997654 344444444333
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=2.1e-11 Score=133.42 Aligned_cols=95 Identities=11% Similarity=-0.017 Sum_probs=70.4
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC--CCCceeeee-------EEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI--NSRFVVSLA-------YAYE 722 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l--~HpnIV~l~-------~~f~ 722 (767)
.+|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+ +|||||+++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4699999999999999999999999999999999987654556677888896555544 699988765 5554
Q ss_pred eC-----------------CEEEEEEeccCCccccccccccC
Q psy11874 723 TK-----------------DALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 723 ~~-----------------~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
.. ..+|||||||+ |+|.+++...+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 182 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD 182 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc
Confidence 43 34899999999 89999997653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=5.5e-12 Score=148.19 Aligned_cols=96 Identities=25% Similarity=0.218 Sum_probs=81.7
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe------
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------ 723 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~------ 723 (767)
..++|++.+.||+|+||.||+|+++.+|+.||+|++... ......+.+.+|+.+|+.++|||||++++++.+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 357899999999999999999999999999999999765 245566789999999999999999999998765
Q ss_pred CCEEEEEEeccCCccccccccccC
Q psy11874 724 KDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 724 ~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
.+..|+|||||+||+|.+++...+
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~ 113 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFE 113 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSS
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcc
Confidence 677899999999999999987644
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=4.9e-11 Score=128.89 Aligned_cols=101 Identities=21% Similarity=0.209 Sum_probs=77.9
Q ss_pred CCCCceeee-ecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHH-HHHhhCCCCceeeeeEEEEe----
Q psy11874 650 TYKTFRMYR-VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK-QILQKINSRFVVSLAYAYET---- 723 (767)
Q Consensus 650 ~~~~y~~~~-~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei-~IL~~l~HpnIV~l~~~f~~---- 723 (767)
-.++|++.+ .||+|+||.||+|+++.+|+.||+|++.... ...+|+ ..++.+.||||++++++|.+
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--------HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 357899965 6999999999999999999999999997532 122333 34566799999999999987
Q ss_pred CCEEEEEEeccCCccccccccccC--CCChhhhHHHH
Q psy11874 724 KDALCLVLTIIDVMFTCVQPSETN--PCCFPFRRKEV 758 (767)
Q Consensus 724 ~~~lylVmEy~~gG~L~~~l~~~~--~~~~~~~~~~v 758 (767)
...+|+|||||+||+|.+++.+.+ ...+......+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~ 134 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHH
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHH
Confidence 556999999999999999997654 33444444433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=3.9e-11 Score=127.09 Aligned_cols=91 Identities=23% Similarity=0.147 Sum_probs=78.4
Q ss_pred ceeeeecccCCccceeEEEEccCCcEEEEEEeecccc-cchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEe
Q psy11874 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 732 (767)
Q Consensus 654 y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~-~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmE 732 (767)
|...+.||+|+||.||+|.. +++.+|+|++..... ......+.+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 45568999999999999975 688999999976432 233456789999999999999999999999999999999999
Q ss_pred ccCCcccccccccc
Q psy11874 733 IIDVMFTCVQPSET 746 (767)
Q Consensus 733 y~~gG~L~~~l~~~ 746 (767)
|++||+|.+++...
T Consensus 111 ~~~~~~L~~~l~~~ 124 (307)
T 2nru_A 111 YMPNGSLLDRLSCL 124 (307)
T ss_dssp CCTTCBHHHHHHTG
T ss_pred ecCCCcHHHHHHhc
Confidence 99999999988643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=5.5e-11 Score=127.09 Aligned_cols=94 Identities=22% Similarity=0.372 Sum_probs=81.7
Q ss_pred CCCCCceeeeecccCCccceeEEEE-ccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCc------eeeeeEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQV-RATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF------VVSLAYAY 721 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~-k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~Hpn------IV~l~~~f 721 (767)
+-.++|++.+.||+|+||.||+|.+ +.+|+.||+|+++.. ....+.+.+|+.+++.++|++ |++++++|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 3456899999999999999999998 568899999999753 344567889999999887665 99999999
Q ss_pred EeCCEEEEEEeccCCccccccccccC
Q psy11874 722 ETKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 722 ~~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
.+.+.+|+||||| +|+|.+++...+
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~ 111 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENG 111 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcC
Confidence 9999999999999 899999997665
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.16 E-value=5e-11 Score=127.78 Aligned_cols=98 Identities=21% Similarity=0.168 Sum_probs=78.6
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC--CCCceeeeeEEEEeC---
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI--NSRFVVSLAYAYETK--- 724 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l--~HpnIV~l~~~f~~~--- 724 (767)
..++|++.+.||+|+||.||+|+++ |+.||+|++.... .....+|..++..+ +||||+++++++.+.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3468999999999999999999875 8999999986532 23455666666655 999999999999988
Q ss_pred -CEEEEEEeccCCccccccccccCCCChhhhHH
Q psy11874 725 -DALCLVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 725 -~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
..+|+|||||+||+|.++++.. ...+.....
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~ 138 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLK 138 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHH
T ss_pred CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHH
Confidence 7899999999999999999654 334444333
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.16 E-value=5.6e-11 Score=128.87 Aligned_cols=85 Identities=24% Similarity=0.250 Sum_probs=62.6
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE--
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA-- 726 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~-- 726 (767)
..+++|++.+.||+|+||.||+|+++.+|+.||+|++.+.. .......+|++.+..++|||||+++++|.+.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 45679999999999999999999999999999999987643 223356778888899999999999999976543
Q ss_pred -----EEEEEeccCCc
Q psy11874 727 -----LCLVLTIIDVM 737 (767)
Q Consensus 727 -----lylVmEy~~gG 737 (767)
+|+|||||+|+
T Consensus 96 ~~~~~~~lv~e~~~~~ 111 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT 111 (360)
T ss_dssp TTCEEEEEEEECCSCB
T ss_pred ccceeEEEEeeccccc
Confidence 89999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.16 E-value=4.9e-11 Score=130.17 Aligned_cols=111 Identities=7% Similarity=-0.065 Sum_probs=82.5
Q ss_pred CCCCCceeeeecccCCccceeEEEEccC-----CcEEEEEEeecccccch--------hhHHHHHHHHHHHhhCCCCcee
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRAT-----GKMYACKKLEKKRIKKR--------KGESMVLIEKQILQKINSRFVV 715 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~t-----g~~~AvK~i~k~~~~~~--------~~~~~~~~Ei~IL~~l~HpnIV 715 (767)
...++|++.+.||+|+||.||+|.++.+ ++.||+|++........ ........|+.++..++|||||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4456899999999999999999999875 58899999986531111 1112345677788888999999
Q ss_pred eeeEEEEeC----CEEEEEEeccCCcccccccccc-CCCChhhhHHHHHH
Q psy11874 716 SLAYAYETK----DALCLVLTIIDVMFTCVQPSET-NPCCFPFRRKEVVV 760 (767)
Q Consensus 716 ~l~~~f~~~----~~lylVmEy~~gG~L~~~l~~~-~~~~~~~~~~~v~~ 760 (767)
++++++.+. ..+||||||| ||+|.+++... +.+.+......+..
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~q 160 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLR 160 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHH
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHH
Confidence 999999875 5699999999 99999999765 34444444443333
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.16 E-value=3.7e-11 Score=128.30 Aligned_cols=94 Identities=17% Similarity=0.222 Sum_probs=78.3
Q ss_pred CCceeeeecccCCccceeEEEEc-cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC---CCCceeeeeEEEE-----
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI---NSRFVVSLAYAYE----- 722 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k-~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l---~HpnIV~l~~~f~----- 722 (767)
++|++++.||+|+||.||+|++. .+|+.||+|++..... .......+.+|+.+++.+ .||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc-cccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 68999999999999999999996 6789999999986542 223334567888888777 8999999999997
Q ss_pred eCCEEEEEEeccCCccccccccccC
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+...+|+||||++ |+|.+++....
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~ 113 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVP 113 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcc
Confidence 5678999999998 69999987654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=4.4e-11 Score=128.59 Aligned_cols=96 Identities=21% Similarity=0.185 Sum_probs=80.5
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhh--CCCCceeeeeEEEEeCC----
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK--INSRFVVSLAYAYETKD---- 725 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~--l~HpnIV~l~~~f~~~~---- 725 (767)
++|++.+.||+|+||.||++++ +|+.||+|++... ....+.+|+++++. ++||||+++++++.+.+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 6899999999999999999987 5899999999753 23467889999988 79999999999999876
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRK 756 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~ 756 (767)
.+|+||||++||+|.+++.+. ...+.....
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~ 143 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIK 143 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC-CBCHHHHHH
T ss_pred eeEEEEeecCCCcHHHHHhcc-CccHHHHHH
Confidence 899999999999999999654 334444333
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=7.1e-11 Score=126.76 Aligned_cols=93 Identities=14% Similarity=0.184 Sum_probs=73.7
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHH--HhhCCCCceeeeeEEEEe--
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI--LQKINSRFVVSLAYAYET-- 723 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~I--L~~l~HpnIV~l~~~f~~-- 723 (767)
.+.+++|++++.||+|+||.||+++. +|+.||+|++.... ......|..+ +..++||||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 36788999999999999999999965 78999999997542 2234445555 455899999999986643
Q ss_pred ---CCEEEEEEeccCCccccccccccCC
Q psy11874 724 ---KDALCLVLTIIDVMFTCVQPSETNP 748 (767)
Q Consensus 724 ---~~~lylVmEy~~gG~L~~~l~~~~~ 748 (767)
...+|+|||||+||+|.+++...+.
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 108 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLHTS 108 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHCCB
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhccc
Confidence 2368999999999999999965543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.14 E-value=3.4e-11 Score=132.44 Aligned_cols=94 Identities=19% Similarity=0.135 Sum_probs=79.5
Q ss_pred CCceeeeecccCCccceeEEEEccCC---cEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE-eCCEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE-TKDAL 727 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg---~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~-~~~~l 727 (767)
..|++.+.||+|+||.||+|+...++ ..+|+|+++.. ......+.+.+|+.+|+.++|||||++++++. ..+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35889999999999999999986543 46899998753 34566788999999999999999999999864 55688
Q ss_pred EEEEeccCCccccccccccC
Q psy11874 728 CLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~ 747 (767)
|+|||||+||+|.++++..+
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~ 186 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNET 186 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTT
T ss_pred EEEEECCCCCCHHHHHhhcc
Confidence 99999999999999997654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=2.4e-11 Score=131.89 Aligned_cols=101 Identities=10% Similarity=-0.016 Sum_probs=81.4
Q ss_pred CCCceeeeecccCCccceeEEEEccC--------CcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceee------
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRAT--------GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVS------ 716 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~t--------g~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~------ 716 (767)
-++|++.+.||+|+||.||+|+++.| ++.||+|++.+. +.+.+|+.+|+.++|||||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 46899999999999999999999985 889999999864 26789999999999999998
Q ss_pred ---------eeEEEEe-CCEEEEEEeccCCcccccccccc--CCCChhhhHHHHHH
Q psy11874 717 ---------LAYAYET-KDALCLVLTIIDVMFTCVQPSET--NPCCFPFRRKEVVV 760 (767)
Q Consensus 717 ---------l~~~f~~-~~~lylVmEy~~gG~L~~~l~~~--~~~~~~~~~~~v~~ 760 (767)
+++++.. .+.+|+||||| ||+|.+++... +...+......+..
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~q 167 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACR 167 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHH
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHH
Confidence 5677766 78999999999 99999999765 44455544444433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=1.1e-10 Score=130.66 Aligned_cols=104 Identities=18% Similarity=0.327 Sum_probs=85.6
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC------CCCceeeeeEEEEe
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI------NSRFVVSLAYAYET 723 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l------~HpnIV~l~~~f~~ 723 (767)
...+|++++.||+|+||.||+|+++.+|+.||+|+++.. ....+.+.+|+++|+.+ +||||++++++|..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 346799999999999999999999999999999999753 33456778899998887 67899999999999
Q ss_pred CCEEEEEEeccCCccccccccccCC--CChhhhHHHH
Q psy11874 724 KDALCLVLTIIDVMFTCVQPSETNP--CCFPFRRKEV 758 (767)
Q Consensus 724 ~~~lylVmEy~~gG~L~~~l~~~~~--~~~~~~~~~v 758 (767)
.+.+|+|||||. |+|.+++...+. +.+......+
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~ 206 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFA 206 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHH
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHH
Confidence 999999999996 689998876543 3444444433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=7.6e-11 Score=128.16 Aligned_cols=104 Identities=16% Similarity=0.158 Sum_probs=81.8
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccc--------cchhhHHHHHHHHHHHhhCCCCceeeeeEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--------KKRKGESMVLIEKQILQKINSRFVVSLAYAYE 722 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~--------~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~ 722 (767)
.++|++.+.||+|+||.||+|.+.. |+.||+|++..... .+....+.+.+|+.+|+.++||||++++++|.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 3589999999999999999998865 89999999976432 12233478999999999999999999999995
Q ss_pred e-----CCEEEEEEeccCCccccccccccC-CCChhhhHH
Q psy11874 723 T-----KDALCLVLTIIDVMFTCVQPSETN-PCCFPFRRK 756 (767)
Q Consensus 723 ~-----~~~lylVmEy~~gG~L~~~l~~~~-~~~~~~~~~ 756 (767)
+ ...+|+|||||+ |+|.+.+...+ ...+.....
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~ 138 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQY 138 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHH
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHH
Confidence 4 347999999998 68888876543 334444333
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=9.5e-11 Score=138.46 Aligned_cols=97 Identities=13% Similarity=0.163 Sum_probs=82.5
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccC---CcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~t---g~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
.+..++|++.+.||+|+||.||+|.++.+ +..+|+|+++.. ......+.+.+|+.+|+.++|||||++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 35567899999999999999999998754 467999998764 24455678999999999999999999999984 5
Q ss_pred CEEEEEEeccCCccccccccccC
Q psy11874 725 DALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+|+|||||+||+|.++++..+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~ 485 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRK 485 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTT
T ss_pred CceEEEEEcCCCCcHHHHHHhcc
Confidence 67999999999999999997543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.11 E-value=9.5e-11 Score=127.55 Aligned_cols=95 Identities=17% Similarity=0.207 Sum_probs=82.5
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC-----------CCceee
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-----------SRFVVS 716 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~-----------HpnIV~ 716 (767)
.+..++|++.+.||+|+||.||+|+++.+|+.||+|++.+. ....+.+.+|+.+++.+. ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 35567899999999999999999999999999999999754 234567889999999886 899999
Q ss_pred eeEEEEeCC----EEEEEEeccCCccccccccccC
Q psy11874 717 LAYAYETKD----ALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 717 l~~~f~~~~----~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+++++...+ .+++||||+ ||+|.+++....
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~ 124 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE 124 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh
Confidence 999998765 899999999 999999987643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.7e-10 Score=118.70 Aligned_cols=135 Identities=12% Similarity=-0.026 Sum_probs=100.1
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCc--eeEEEEEEeeCCeEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF--VVSLAYAYETKDALCL 191 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~~~~~~~l~l 191 (767)
.++.+..+.+.|+.+.||++.. .+|..+++|..... ....+.+|..+|+.+.+.. +.+++++..+.+..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 4566655545666799999965 46788999997543 1234677999999886544 5668888888888999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC----------------------------------
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG---------------------------------- 237 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~---------------------------------- 237 (767)
||||++|.+|. .. ..+. ..++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~~------~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 93 LLGEVPGQDLL--SS------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEECCSSEETT--TS------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEecCCcccC--cC------cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 99999999883 11 1222 245677778888888643
Q ss_pred ------------------------cccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 238 ------------------------LVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 238 ------------------------IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
++|+|++|.|||+++++.+.|+|||.|..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.07 E-value=9.7e-11 Score=130.82 Aligned_cols=86 Identities=24% Similarity=0.339 Sum_probs=71.6
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC------
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------ 724 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~------ 724 (767)
..+|++.+.||+|+||.||+|+++.+|+.||+|++.+... ...+|+.+|+.++|||||+++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 3479999999999999999999999999999999976431 234799999999999999999998642
Q ss_pred CEEEEEEeccCCcccccccc
Q psy11874 725 DALCLVLTIIDVMFTCVQPS 744 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~ 744 (767)
..+++||||+++ +|.+.+.
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~ 144 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVAR 144 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHH
T ss_pred eeEEeehhcccc-cHHHHHH
Confidence 247899999986 5655553
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.07 E-value=1.3e-10 Score=128.76 Aligned_cols=86 Identities=20% Similarity=0.260 Sum_probs=67.9
Q ss_pred Ccee-eeecccCCccceeEEEEc--cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe--CCEE
Q psy11874 653 TFRM-YRVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--KDAL 727 (767)
Q Consensus 653 ~y~~-~~~LG~GsfG~V~l~~~k--~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~--~~~l 727 (767)
.|++ .+.||+|+||.||+|+++ .+++.||+|++..... ...+.+|+.+|+.++|||||+++++|.+ ...+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 4666 568999999999999987 5689999999976532 2467899999999999999999999965 6789
Q ss_pred EEEEeccCCcccccccc
Q psy11874 728 CLVLTIIDVMFTCVQPS 744 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~ 744 (767)
|+|||||+ |+|.+.+.
T Consensus 96 ~lv~e~~~-~~l~~~~~ 111 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIK 111 (405)
T ss_dssp EEEEECCS-EEHHHHHH
T ss_pred EEEEeCCC-CCHHHHHH
Confidence 99999997 57888775
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.07 E-value=3.5e-10 Score=118.83 Aligned_cols=102 Identities=16% Similarity=0.105 Sum_probs=80.8
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeee-EEEEeCCEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLA-YAYETKDALCLV 730 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~-~~f~~~~~lylV 730 (767)
++|++.+.||+|+||.||+|+++.+|+.||+|++..... .+.+.+|+.+++.+.|++++..+ .++.+.+.+|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 579999999999999999999999999999999876431 23688999999999888765544 455778899999
Q ss_pred EeccCCcccccccccc-CCCChhhhHHHHH
Q psy11874 731 LTIIDVMFTCVQPSET-NPCCFPFRRKEVV 759 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~-~~~~~~~~~~~v~ 759 (767)
|||+ ||+|.+++... +...+......+.
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~ 112 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLAD 112 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHH
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHH
Confidence 9999 99999998643 3344444444333
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=2.8e-10 Score=125.04 Aligned_cols=105 Identities=23% Similarity=0.350 Sum_probs=85.3
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC-CC-----ceeeeeEEEEe
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SR-----FVVSLAYAYET 723 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~-Hp-----nIV~l~~~f~~ 723 (767)
-.++|++.+.||+|+||.||+|+++.+|+.||+|+++.. ......+.+|+++++.+. |+ +|++++++|.+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 357899999999999999999999999999999999753 234567888999998884 55 49999999999
Q ss_pred CCEEEEEEeccCCccccccccccC--CCChhhhHHHHH
Q psy11874 724 KDALCLVLTIIDVMFTCVQPSETN--PCCFPFRRKEVV 759 (767)
Q Consensus 724 ~~~lylVmEy~~gG~L~~~l~~~~--~~~~~~~~~~v~ 759 (767)
.+.+|+|||||+ |+|.+++.... ...+......+.
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~ 164 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQ 164 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHH
Confidence 999999999996 59999987653 334444444333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 767 | ||||
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-69 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-15 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-04 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-68 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-16 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-66 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-12 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-66 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-13 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-66 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-14 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-64 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-13 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-61 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-14 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-60 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-12 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-60 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-14 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-58 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-09 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-13 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-12 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-12 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-56 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-14 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-56 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-14 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-14 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-55 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-10 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-12 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-12 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-11 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-08 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-08 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-08 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-12 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-50 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-10 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-10 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-09 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-09 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-10 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-11 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-08 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-12 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-09 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-12 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-11 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-10 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-06 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-09 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-08 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-09 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-12 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-05 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-08 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-10 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-07 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-41 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-08 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-07 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-09 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-08 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-08 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-08 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-08 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-05 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-39 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-10 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-11 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-08 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-10 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-06 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-07 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-11 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-06 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 | |
| d1omwa1 | 157 | a.91.1.1 (A:29-185) G-protein coupled receptor kin | 5e-12 | |
| d1omwa1 | 157 | a.91.1.1 (A:29-185) G-protein coupled receptor kin | 4e-06 |
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 229 bits (584), Expect = 7e-69
Identities = 127/302 (42%), Positives = 186/302 (61%), Gaps = 11/302 (3%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK---QI 167
+T F ++R++G+GGFGEV C+ TGKMYA K L+KKRIK ++GE++ L E+ +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 168 LQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVL 227
+ + F+V ++YA+ T D L +L +MNGGDL +H+ G F A RFYAAE++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEII 117
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEV 287
GLEH+H +VYRD KP NILLD++GHVRISDLGLA + + + VGT GYMAPEV
Sbjct: 118 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEV 176
Query: 288 I-DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346
+ Y S DWFS GC++F+++ G +PFR+ K + E+DR A + FS +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEIDRMTLTMAVELPDSFSPE 235
Query: 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
++L + LL++ RLG C GA+E+K++ FF+S +W+ + PP +P
Sbjct: 236 LRSLLEGLLQRDVNRRLG--CLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVN 293
Query: 407 VD 408
Sbjct: 294 AA 295
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 74.4 bits (182), Expect = 8e-15
Identities = 36/90 (40%), Positives = 60/90 (66%), Gaps = 3/90 (3%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEK---QI 705
+T F ++R++G+GGFGEV C+ TGKMYA K L+KKRIK ++GE++ L E+ +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 706 LQKINSRFVVSLAYAYETKDALCLVLTIID 735
+ + F+V ++YA+ T D L +L +++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMN 90
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.0 bits (98), Expect = 2e-04
Identities = 20/63 (31%), Positives = 26/63 (41%), Gaps = 4/63 (6%)
Query: 558 YCSQPHAVYAKDVLDIEQFS--TVKGVTLDTTDDSFYSKFNTGSVSIPWQNEMIETECFK 615
V A D DI F KG+ L +D Y F ++S WQ E+ ET F
Sbjct: 285 LIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPL-TISERWQQEVAET-VFD 342
Query: 616 ELN 618
+N
Sbjct: 343 TIN 345
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 3e-68
Identities = 88/288 (30%), Positives = 145/288 (50%), Gaps = 13/288 (4%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F+ ++LG+G F V + AT + YA K LEK+ I K V E+ ++ +++ F
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
V L + ++ + L L+ G+L +I +G FD RFY AE++ LE+LH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG 126
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEK 292
G+++RD KPENILL++ H++I+D G A + VGT Y++PE++ +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352
S D ++ GC+I++++ G PFR E + +++ + + +F A+ L +
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEY----LIFQKIIKLEYDFPEKFFPKARDLVE 242
Query: 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400
LL RLGC G LK FF+S W+ L PP +
Sbjct: 243 KLLVLDATKRLGCE-EMEGYGPLKAHPFFESVTWENLHQQ--TPPKLT 287
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.7 bits (191), Expect = 3e-16
Identities = 24/86 (27%), Positives = 43/86 (50%)
Query: 646 PQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI 705
P+ + F+ ++LG+G F V + AT + YA K LEK+ I K V E+ +
Sbjct: 2 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 706 LQKINSRFVVSLAYAYETKDALCLVL 731
+ +++ F V L + ++ + L L
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGL 87
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 1e-66
Identities = 105/293 (35%), Positives = 163/293 (55%), Gaps = 15/293 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSR 174
F ++++LGKG FG+V + + T + +A K L+K + ++EK++L
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
F+ + ++TK+ L V+ +NGGDL +HI + FD++RA FYAAE++ GL+ LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH 120
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR-VGTVGYMAPEVIDNEKY 293
G+VYRD K +NILLD GH++I+D G+ E G++ GT Y+APE++ +KY
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKA 353
+S DW+SFG L++EM+ GQ+PF + E E+ ++ D Y +AK L
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIRMDNPFYPRWLEKEAKDLLVK 236
Query: 354 LLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
L + P RLG +++Q F+ NW+ LE DPPF P VK
Sbjct: 237 LFVREPEKRLGV------RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPF 283
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (158), Expect = 7e-12
Identities = 21/79 (26%), Positives = 42/79 (53%), Gaps = 1/79 (1%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK-INSR 712
F ++++LGKG FG+V + + T + +A K L+K + ++EK++L
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 713 FVVSLAYAYETKDALCLVL 731
F+ + ++TK+ L V+
Sbjct: 64 FLTHMFCTFQTKENLFFVM 82
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 219 bits (560), Expect = 4e-66
Identities = 91/293 (31%), Positives = 151/293 (51%), Gaps = 11/293 (3%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F++ R LG G FG V + R G+ YA K L+K+ + + K E+ +L + F
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
++ + ++ + +++ + GG+L + P A+FYAAEV LE+LH
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV---AKFYAAEVCLALEYLHS 122
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
++YRD KPENILLD GH++I+D G A +P + GT Y+APEV+ + Y
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355
S DW+SFG LI+EM+ G PF M + ++ ++ F++D K L L+
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTM----KTYEKILNAELRFPPFFNEDVKDLLSRLI 236
Query: 356 KKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVD 408
+ RLG + G ++K +FK W++L + + P+ P +++ + D
Sbjct: 237 TRDLSQRLG--NLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGD 287
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 69.4 bits (169), Expect = 2e-13
Identities = 22/111 (19%), Positives = 46/111 (41%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F++ R LG G FG V + R G+ YA K L+K+ + + K E+ +L + F
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 714 VVSLAYAYETKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVAAF 764
++ + ++ + +++ I+ ++ P + V
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA 116
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 8e-66
Identities = 106/297 (35%), Positives = 165/297 (55%), Gaps = 10/297 (3%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
+T F ++LGKG FG+V + +ATG+ YA K L K+ I + + + E ++LQ
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
F+ +L YA++T D LC V+ NGG+L FH+ F RARFY AE++ L
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSAL 118
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEGESVRGRVGTVGYMAPEVID 289
E+LH +VYRD K EN++LD GH++I+D GL E +G +++ GT Y+APEV++
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 290 NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349
+ Y + DW+ G +++EM+ G+ PF + + + + ++ S +AK+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEIRFPRTLSPEAKS 234
Query: 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
L LLKK P+ RLG G A+E+ + FF S NW+ + PPF P V +
Sbjct: 235 LLAGLLKKDPKQRLG--GGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 289
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (173), Expect = 9e-14
Identities = 29/81 (35%), Positives = 46/81 (56%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 708
+T F ++LGKG FG+V + +ATG+ YA K L K+ I + + + E ++LQ
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 709 INSRFVVSLAYAYETKDALCL 729
F+ +L YA++T D LC
Sbjct: 62 TRHPFLTALKYAFQTHDRLCF 82
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 2e-64
Identities = 67/270 (24%), Positives = 117/270 (43%), Gaps = 15/270 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + R LGKG FG V + + + + A K L K +++K E + E +I +
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
++ L + + L+L G + + + FD R Y E+ L + H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS 124
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
+++RD KPEN+LL G ++I+D G +V P GT+ Y+ PE+I+ +
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEGRMHDE 183
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355
D +S G L +E + G+ PF E +R+ + ++ A+ L LL
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRVEFTFPDFVTEGARDLISRLL 239
Query: 356 KKSPRSRLGCHCGRYGARELKQAEFFKSTN 385
K +P R RE+ + + + +
Sbjct: 240 KHNPSQ-------RPMLREVLEHPWITANS 262
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.8 bits (168), Expect = 2e-13
Identities = 20/82 (24%), Positives = 36/82 (43%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + R LGKG FG V + + + + A K L K +++K E + E +I +
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 714 VVSLAYAYETKDALCLVLTIID 735
++ L + + L+L
Sbjct: 68 ILRLYGYFHDATRVYLILEYAP 89
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 208 bits (529), Expect = 3e-61
Identities = 73/321 (22%), Positives = 127/321 (39%), Gaps = 24/321 (7%)
Query: 103 DIYNEI--QPITYKT------FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 154
DI+ + QP+ K + ++ LG G FG V RATG +A K +
Sbjct: 7 DIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66
Query: 155 RKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGF 214
++ V E Q + + +V+L A+E + + ++ M+GG+L + +
Sbjct: 67 KE---TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KM 121
Query: 215 DIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILL--DDYGHVRISDLGLAVEIPEGES 272
A Y +V GL H+H V+ D KPENI+ +++ D GL + +S
Sbjct: 122 SEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
Query: 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV 332
V+ GT + APEV + + Y D +S G L + ++ G +PF + V
Sbjct: 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 241
Query: 333 KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAG 392
+ S+D K + LL P + R + + + N ++
Sbjct: 242 WNMDDSAFSGISEDGKDFIRKLLLADPNT-------RMTIHQALEHPWLTPGNAPGRDSQ 294
Query: 393 LCDPPFVPDVKRDEVDRRVKE 413
+ P RD + +
Sbjct: 295 I--PSSRYTKIRDSIKTKYDA 313
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 71.3 bits (174), Expect = 9e-14
Identities = 23/93 (24%), Positives = 41/93 (44%), Gaps = 9/93 (9%)
Query: 645 FPQPITYKT------FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM 698
+PQP+ K + ++ LG G FG V RATG +A K + ++
Sbjct: 13 YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE---T 69
Query: 699 VLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
V E Q + + +V+L A+E + + ++
Sbjct: 70 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (525), Expect = 1e-60
Identities = 90/291 (30%), Positives = 154/291 (52%), Gaps = 11/291 (3%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F + LG G FG V + + +G YA K L+K+++ K K L EK+ILQ +N F
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V L ++++ L +V+ + GG++ H+ +G F ARFYAA+++ E+LH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS 159
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTY 295
+ L+YRD KPEN+L+D G+++++D G A + GT +APE+I ++ Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKGYNK 217
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALL 355
+ DW++ G LI+EM G PF + + ++ ++ ++ FS D K L + LL
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273
Query: 356 KKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406
+ R G + G ++K ++F +T+W + + PF+P K
Sbjct: 274 QVDLTKRFGNL--KNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPG 322
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 66.0 bits (160), Expect = 5e-12
Identities = 27/77 (35%), Positives = 43/77 (55%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F + LG G FG V + + +G YA K L+K+++ K K L EK+ILQ +N F
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 714 VVSLAYAYETKDALCLV 730
+V L ++++ L +V
Sbjct: 103 LVKLEFSFKDNSNLYMV 119
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 206 bits (524), Expect = 1e-60
Identities = 81/328 (24%), Positives = 144/328 (43%), Gaps = 29/328 (8%)
Query: 102 KDIYNE--IQPITYKT------FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 153
+DI+ + QP+ K + + LG G FG V C +ATG+++ K +
Sbjct: 9 EDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL 68
Query: 154 KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG 213
+ V E I+ +++ +++L A+E K + L+L ++GG+L I
Sbjct: 69 DKY---TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--K 123
Query: 214 FDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD--DYGHVRISDLGLAVEIPEGE 271
A Y + GL+H+H +V+ D KPENI+ + V+I D GLA ++ E
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183
Query: 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR 331
V+ T + APE++D E + D ++ G L + ++ G +PF ++ V R
Sbjct: 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 243
Query: 332 VKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEA 391
E E S +AK K LL+K PR R + + + K + L
Sbjct: 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRK-------RLTVHDALEHPWLKG-DHSNL-- 293
Query: 392 GLCDPPFVPDVKRDEVDRRVKEDAEKYS 419
+P + +++ +++KE +
Sbjct: 294 ----TSRIPSSRYNKIRQKIKEKYADWP 317
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 73.9 bits (181), Expect = 1e-14
Identities = 24/92 (26%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 646 PQPITYKT------FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV 699
PQP+ K + + LG G FG V C +ATG+++ K + + V
Sbjct: 17 PQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TV 73
Query: 700 LIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
E I+ +++ +++L A+E K + L+L
Sbjct: 74 KNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 1e-58
Identities = 112/319 (35%), Positives = 169/319 (52%), Gaps = 14/319 (4%)
Query: 97 RRLSTKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQ---VRATGKMYACKKLEKKRI- 152
L T ++ + + + F + +VLG G +G+V + TGK+YA K L+K I
Sbjct: 7 HELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66
Query: 153 KKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGE 211
+K K E+Q+L+ I S F+V+L YA++T+ L L+L +NGG+L H+
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--- 123
Query: 212 PGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI--PE 269
F + Y E++ LEHLH +G++YRD K ENILLD GHV ++D GL+ E E
Sbjct: 124 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183
Query: 270 GESVRGRVGTVGYMAPEVIDNEKYTYSP--DWFSFGCLIFEMIEGQAPFRRRKEMVKRDE 327
E GT+ YMAP+++ + DW+S G L++E++ G +PF E + E
Sbjct: 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 243
Query: 328 VDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387
+ RR+ + Y S AK L + LL K P+ RLG CG A E+K+ FF+ NW
Sbjct: 244 ISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLG--CGPRDADEIKEHLFFQKINWD 301
Query: 388 RLEAGLCDPPFVPDVKRDE 406
L A PF P ++ +
Sbjct: 302 DLAAKKVPAPFKPVIRDEL 320
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.3 bits (140), Expect = 1e-09
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 5/99 (5%)
Query: 638 SETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQ---VRATGKMYACKKLEKKRI-KKR 693
N + + + + F + +VLG G +G+V + TGK+YA K L+K I +K
Sbjct: 10 RTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA 69
Query: 694 KGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCLVL 731
K E+Q+L+ I S F+V+L YA++T+ L L+L
Sbjct: 70 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-58
Identities = 71/291 (24%), Positives = 127/291 (43%), Gaps = 25/291 (8%)
Query: 100 STKDIYNEIQPITY-----KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 154
S ++I +++ I K + + +G+G G V ATG+ A +++ ++ K
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60
Query: 155 RKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGF 214
++ +++ E ++++ + +V+ +Y D L +V+ + GG L + E
Sbjct: 61 KE---LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCM 113
Query: 215 DIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274
D + E L LE LH +++RD K +NILL G V+++D G +I +S R
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 275 G-RVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK 333
VGT +MAPEV+ + Y D +S G + EMIEG+ P+ + +
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIAT 230
Query: 334 EDAEKYSC--RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
+ + S + L R A+EL Q +F K
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEK-------RGSAKELLQHQFLK 274
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.5 bits (167), Expect = 4e-13
Identities = 16/80 (20%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
K + + +G+G G V ATG+ A +++ ++ K++ +++ E ++++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---LIINEILVMRENKN 76
Query: 712 RFVVSLAYAYETKDALCLVL 731
+V+ +Y D L +V+
Sbjct: 77 PNIVNYLDSYLVGDELWVVM 96
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-57
Identities = 67/316 (21%), Positives = 121/316 (38%), Gaps = 54/316 (17%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F LG G G V + +G + A K + + K + ++ E Q+L + NS +
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V A+ + + + + M+GG L + G + V+ GL +L
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 236 I-GLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYT 294
+++RD KP NIL++ G +++ D G++ ++ + + VGT YM+PE + Y+
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYS 181
Query: 295 YSPDWFSFGCLIFEMIEGQAPFR------------------------------------- 317
D +S G + EM G+ P
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 318 --RRKEMVKRDEVDRRVKEDAEKY-SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARE 374
R M + +D V E K S FS + + L K+P R ++
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-------DLKQ 294
Query: 375 LKQAEFFKSTNWKRLE 390
L F K ++ + ++
Sbjct: 295 LMVHAFIKRSDAEEVD 310
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.8 bits (165), Expect = 1e-12
Identities = 17/78 (21%), Positives = 34/78 (43%), Gaps = 2/78 (2%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F LG G G V + +G + A K + + K + ++ E Q+L + NS +
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 714 VVSLAYAYETKDALCLVL 731
+V A+ + + + +
Sbjct: 66 IVGFYGAFYSDGEISICM 83
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 4e-57
Identities = 62/280 (22%), Positives = 120/280 (42%), Gaps = 19/280 (6%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + LG G FG+V Q + T + A K ++ K ++ + ++E IL +
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE---DYMVEIDILASCDHPN 70
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V L A+ ++ L +++ GG + + + ++ + + L L +LH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD 128
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG-RVGTVGYMAPEVI-----D 289
+++RD K NIL G ++++D G++ + R +GT +MAPEV+
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 290 NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349
+ Y Y D +S G + EM E + P M ++ + + R+S + K
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-AKSEPPTLAQPSRWSSNFKD 247
Query: 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389
K L+K+ + R+ +L Q F + K +
Sbjct: 248 FLKKCLEKNVDA-------RWTTSQLLQHPFVTVDSNKPI 280
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.8 bits (160), Expect = 3e-12
Identities = 18/78 (23%), Positives = 38/78 (48%), Gaps = 3/78 (3%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + LG G FG+V Q + T + A K ++ K ++ + ++E IL +
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE---DYMVEIDILASCDHPN 70
Query: 714 VVSLAYAYETKDALCLVL 731
+V L A+ ++ L +++
Sbjct: 71 IVKLLDAFYYENNLWILI 88
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-56
Identities = 76/291 (26%), Positives = 131/291 (45%), Gaps = 18/291 (6%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM---VLIEKQILQKIN 172
+ LG G F V C+ ++TG YA K ++K+R K + + E IL++I
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
V++L YE K + L+L ++ GG+L + A + ++L G+ +
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 128
Query: 233 LHYIGLVYRDCKPENILLDDYG----HVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVI 288
LH + + + D KPENI+L D ++I D GLA +I G + GT ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 289 DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348
+ E D +S G + + ++ G +PF + V E ++Y S AK
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR-LEAGLCDPPF 398
+ LL K P+ R ++ Q + K + ++ L + P F
Sbjct: 249 DFIRRLLVKDPKK-------RMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.9 bits (173), Expect = 5e-14
Identities = 26/106 (24%), Positives = 45/106 (42%), Gaps = 3/106 (2%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM---VLIEKQILQKIN 710
+ LG G F V C+ ++TG YA K ++K+R K + + E IL++I
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 711 SRFVVSLAYAYETKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRK 756
V++L YE K + L+L ++ +E +
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (490), Expect = 3e-56
Identities = 78/301 (25%), Positives = 136/301 (45%), Gaps = 18/301 (5%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ VLG G F EV + + T K+ A K + KK ++ + E + E +L KI
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPN 68
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V+L YE+ L L++ +++GG+L I G + A +VL +++LH
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHD 125
Query: 236 IGLVYRDCKPENILL---DDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEK 292
+G+V+RD KPEN+L D+ + ISD GL+ G + GT GY+APEV+ +
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 293 YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352
Y+ + D +S G + + ++ G PF + +++ + E Y SD AK +
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245
Query: 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVK 412
L++K P R+ + Q + +K++ + K
Sbjct: 246 HLMEKDPEK-------RFTCEQALQHPWIAGDTALDKNI---HQSVSEQIKKNFAKSKWK 295
Query: 413 E 413
+
Sbjct: 296 Q 296
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 71.2 bits (174), Expect = 5e-14
Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 2/78 (2%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ VLG G F EV + + T K+ A K + KK ++ + E + E +L KI
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPN 68
Query: 714 VVSLAYAYETKDALCLVL 731
+V+L YE+ L L++
Sbjct: 69 IVALDDIYESGGHLYLIM 86
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (490), Expect = 3e-56
Identities = 69/308 (22%), Positives = 112/308 (36%), Gaps = 27/308 (8%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K F R +G G FG V + ++ A KK+ + + ++ E + LQK+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 174 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHL 233
+ Y + LV+ G + L GL +L
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYL 131
Query: 234 HYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVI---DN 290
H +++RD K NILL + G V++ D G A + S VGT +MAPEVI D
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDE 188
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350
+Y D +S G E+ E + P M + + E S +S+ +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NESPALQSGHWSEYFRNF 246
Query: 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRR 410
+ L+K P+ R + L + F P + D+ + D
Sbjct: 247 VDSCLQKIPQDRP-------TSEVLLKHRFVLRER---------PPTVIMDLIQRTKDAV 290
Query: 411 VKEDAEKY 418
+ D +Y
Sbjct: 291 RELDNLQY 298
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 71.6 bits (175), Expect = 5e-14
Identities = 18/80 (22%), Positives = 32/80 (40%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
K F R +G G FG V + ++ A KK+ + + ++ E + LQK+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 712 RFVVSLAYAYETKDALCLVL 731
+ Y + LV+
Sbjct: 75 PNTIQYRGCYLREHTAWLVM 94
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 190 bits (483), Expect = 1e-55
Identities = 76/283 (26%), Positives = 124/283 (43%), Gaps = 23/283 (8%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM------VLIEKQ 166
Y+ + +LG+G V C + T K YA K ++ E + L E
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 167 ILQKINS-RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAE 225
IL+K++ ++ L YET LV +M G+L ++ R
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRA 118
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAP 285
+L + LH + +V+RD KPENILLDD +++++D G + ++ GE +R GT Y+AP
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 286 EVI------DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY 339
E+I ++ Y D +S G +++ ++ G PF RK+M+ + +
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238
Query: 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
+SD K L L P+ RY A E FF+
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQK-------RYTAEEALAHPFFQ 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 59.3 bits (143), Expect = 4e-10
Identities = 23/88 (26%), Positives = 36/88 (40%), Gaps = 7/88 (7%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM------VLIEKQ 704
Y+ + +LG+G V C + T K YA K ++ E + L E
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 705 ILQKINS-RFVVSLAYAYETKDALCLVL 731
IL+K++ ++ L YET LV
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVF 89
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-55
Identities = 56/274 (20%), Positives = 108/274 (39%), Gaps = 20/274 (7%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + +G G +G + ++ GK+ K+L+ + + + + M++ E +L+++
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNLLRELKHPN 64
Query: 176 VVSLAYAY--ETKDALCLVLTIMNGGDLKFHIYNMGGEPG-FDIARARFYAAEVLCGLEH 232
+V T L +V+ GGDL I E D ++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 233 LHYIG-----LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVG-TVGYMAPE 286
H +++RD KP N+ LD +V++ D GLA + S T YM+PE
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346
++ Y D +S GCL++E+ PF + + + + + R+SD+
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIREGKFRRIPYRYSDE 241
Query: 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEF 380
+ +L R E+ +
Sbjct: 242 LNEIITRMLNLKDYH-------RPSVEEILENPL 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.0 bits (158), Expect = 4e-12
Identities = 14/80 (17%), Positives = 37/80 (46%), Gaps = 3/80 (3%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + +G G +G + ++ GK+ K+L+ + + + + M++ E +L+++
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNLLRELKHPN 64
Query: 714 VVSLAYAY--ETKDALCLVL 731
+V T L +V+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVM 84
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 7e-55
Identities = 66/271 (24%), Positives = 122/271 (45%), Gaps = 17/271 (6%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + + LG+G +GEV R T + A K ++ KR + E I + +N
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHEN 64
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
VV + L L +GG+L I G A+ + +++ G+ +LH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR---GRVGTVGYMAPEVIDNEK 292
IG+ +RD KPEN+LLD+ +++ISD GLA R GT+ Y+APE++ +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 293 Y-TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351
+ D +S G ++ M+ G+ P+ + + + + D + K+ + AL
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
+L ++P + R ++K+ ++
Sbjct: 241 HKILVENPSA-------RITIPDIKKDRWYN 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.4 bits (159), Expect = 3e-12
Identities = 19/78 (24%), Positives = 31/78 (39%), Gaps = 2/78 (2%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + + LG+G +GEV R T + A K ++ KR + E I + +N
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHEN 64
Query: 714 VVSLAYAYETKDALCLVL 731
VV + L L
Sbjct: 65 VVKFYGHRREGNIQYLFL 82
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 9e-54
Identities = 65/307 (21%), Positives = 122/307 (39%), Gaps = 21/307 (6%)
Query: 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 172
Y+ + + LG+G FG V C ++ K Y K ++ K + +V E IL
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILNIAR 59
Query: 173 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
R ++ L ++E+ + L ++ ++G D+ I E + Y +V L+
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQF 117
Query: 233 LHYIGLVYRDCKPENILLD--DYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDN 290
LH + + D +PENI+ ++I + G A ++ G++ R Y APEV +
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350
+ + + D +S G L++ ++ G PF + + E+ S +A
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRR 410
LL K +S R A E Q + K +++E + +K
Sbjct: 238 VDRLLVKERKS-------RMTASEALQHPWLK----QKIER--VSTKVIRTLKHRRYYHT 284
Query: 411 VKEDAEK 417
+ +
Sbjct: 285 LIKKDLN 291
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.9 bits (155), Expect = 2e-11
Identities = 20/80 (25%), Positives = 38/80 (47%), Gaps = 4/80 (5%)
Query: 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN 710
Y+ + + LG+G FG V C ++ K Y K ++ K + +V E IL
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILNIAR 59
Query: 711 SRFVVSLAYAYETKDALCLV 730
R ++ L ++E+ + L ++
Sbjct: 60 HRNILHLHESFESMEELVMI 79
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-52
Identities = 65/276 (23%), Positives = 120/276 (43%), Gaps = 25/276 (9%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ +G+G F V T A +L+ +++ K + + E ++L+ +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPN 69
Query: 176 VVSLAYAYET----KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLE 231
+V ++E+ K + LV +M G LK ++ I R + ++L GL+
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQ 126
Query: 232 HLHYIG--LVYRDCKPENILLDD-YGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVI 288
LH +++RD K +NI + G V+I DLGLA + + +GT +MAPE+
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMY 185
Query: 289 DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA--EKYSCRFSDD 346
EKY S D ++FG + EM + P+ E ++ RRV + +
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYPYS---ECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
K + + ++++ RY ++L FF+
Sbjct: 242 VKEIIEGCIRQNKDE-------RYSIKDLLNHAFFQ 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (129), Expect = 2e-08
Identities = 15/82 (18%), Positives = 34/82 (41%), Gaps = 5/82 (6%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ +G+G F V T A +L+ +++ K + + E ++L+ +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPN 69
Query: 714 VVSLAYAYET----KDALCLVL 731
+V ++E+ K + LV
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVT 91
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-52
Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 28/275 (10%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVS 178
+VLG G G+V + T + +A K L+ +R E ++ + +V
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 69
Query: 179 LAYAYET----KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+ YE + L +V+ ++GG+L I + G + F A + +++LH
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLH 128
Query: 235 YIGLVYRDCKPENILLDDY---GHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNE 291
I + +RD KPEN+L ++++D G A E S+ T Y+APEV+ E
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 292 KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC----RFSDDA 347
KY S D +S G +++ ++ G PF + + R++ ++ S++
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248
Query: 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
K L + LLK P R+ E +
Sbjct: 249 KMLIRNLLKTEPTQRM-------TITEFMNHPWIM 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.9 bits (129), Expect = 3e-08
Identities = 17/79 (21%), Positives = 32/79 (40%), Gaps = 13/79 (16%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVS 716
+VLG G G+V + T + +A K L+ +R E ++ + +V
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 69
Query: 717 LAYAYET----KDALCLVL 731
+ YE + L +V+
Sbjct: 70 IVDVYENLYAGRKCLLIVM 88
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 6e-51
Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 15/260 (5%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
I + + +G G FG V + A K L + E +L+K
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTP-QQLQAFKNEVGVLRK 60
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
++ Y T L +V G L H++ + + F++ + A + G+
Sbjct: 61 TRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 117
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE---SVRGRVGTVGYMAPEV 287
++LH +++RD K NI L + V+I D GLA G++ +MAPEV
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 288 I---DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRR--KEMVKRDEVDRRVKEDAEKYSCR 342
I D Y++ D ++FG +++E++ GQ P+ ++ + + D K
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 343 FSDDAKALCKALLKKSPRSR 362
K L LKK R
Sbjct: 238 CPKAMKRLMAECLKKKRDER 257
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (125), Expect = 7e-08
Identities = 16/83 (19%), Positives = 26/83 (31%), Gaps = 5/83 (6%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 708
I + + +G G FG V + A K L + E +L+K
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTP-QQLQAFKNEVGVLRK 60
Query: 709 INSRFVVSLAYAYETKDALCLVL 731
++ Y T L +V
Sbjct: 61 TRHVNILLF-MGYSTAPQLAIVT 82
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 176 bits (446), Expect = 2e-50
Identities = 60/285 (21%), Positives = 109/285 (38%), Gaps = 24/285 (8%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ + +LG GG EV + + A K L + E Q +N
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 176 VVSLAYAYETKDA----LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLE 231
+V++ E + +V+ ++G L+ ++ G RA A+ L
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALN 125
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR----VGTVGYMAPEV 287
H G+++RD KP NI++ V++ D G+A I + + + +GT Y++PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 288 IDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347
+ D +S GC+++E++ G+ PF + + R S D
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAG 392
A+ L K+P +R A E++ R+ G
Sbjct: 246 DAVVLKALAKNPENRYQT------AAEMRAD-------LVRVHNG 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 65.9 bits (160), Expect = 2e-12
Identities = 15/81 (18%), Positives = 28/81 (34%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + +LG GG EV + + A K L + E Q +N
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 714 VVSLAYAYETKDALCLVLTII 734
+V++ E + + I+
Sbjct: 69 IVAVYDTGEAETPAGPLPYIV 89
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-50
Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 27/275 (9%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKIN 172
+++ +LG GGFG V + + A K +EK RI + V +E +L+K++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 173 SRF--VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
S F V+ L +E D+ L+L F G AR + +VL +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 123
Query: 231 EHLHYIGLVYRDCKPENILLD-DYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVID 289
H H G+++RD K ENIL+D + G +++ D G + + GT Y PE I
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 182
Query: 290 NEKY-TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348
+Y S +S G L+++M+ G PF +E+++ R+ R S + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ----------RVSSECQ 232
Query: 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383
L + L P R E++ + +
Sbjct: 233 HLIRWCLALRPSD-------RPTFEEIQNHPWMQD 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (145), Expect = 2e-10
Identities = 25/83 (30%), Positives = 42/83 (50%), Gaps = 5/83 (6%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKIN 710
+++ +LG GGFG V + + A K +EK RI + V +E +L+K++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 711 SRF--VVSLAYAYETKDALCLVL 731
S F V+ L +E D+ L+L
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLIL 88
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 55/254 (21%), Positives = 99/254 (38%), Gaps = 15/254 (5%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
+ K ++ + +GKG FG+V G A K ++ + L E ++ +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVM--LGDYRGNKVAVKCIKNDATAQA-----FLAEASVMTQ 56
Query: 171 INSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCG 229
+ +V L E K L +V M G L ++ + G ++ +V
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEA 115
Query: 230 LEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVID 289
+E+L V+RD N+L+ + ++SD GL E + V + APE +
Sbjct: 116 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALR 173
Query: 290 NEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348
+K++ D +SFG L++E+ G+ P+ R V++ K DA
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG---CPPAVY 230
Query: 349 ALCKALLKKSPRSR 362
+ K R
Sbjct: 231 EVMKNCWHLDAAMR 244
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.5 bits (141), Expect = 6e-10
Identities = 18/84 (21%), Positives = 33/84 (39%), Gaps = 8/84 (9%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 708
+ K ++ + +GKG FG+V G A K ++ + L E ++ +
Sbjct: 4 LNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQA-----FLAEASVMTQ 56
Query: 709 INSRFVVSL-AYAYETKDALCLVL 731
+ +V L E K L +V
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVT 80
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-47
Identities = 50/255 (19%), Positives = 104/255 (40%), Gaps = 13/255 (5%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
I K + LG G FG V + R A K +++ + + + + E +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDE----FIEEAKVMMN 55
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
++ +V L + + ++ M G L ++ M F + +V +
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 113
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--GRVGTVGYMAPEVI 288
E+L ++RD N L++D G V++SD GL+ + + E G V + PEV+
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 289 DNEKYTYSPDWFSFGCLIFEMI-EGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347
K++ D ++FG L++E+ G+ P+ R + + + ++ S+
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL---ASEKV 230
Query: 348 KALCKALLKKSPRSR 362
+ + + R
Sbjct: 231 YTIMYSCWHEKADER 245
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (139), Expect = 1e-09
Identities = 14/83 (16%), Positives = 33/83 (39%), Gaps = 5/83 (6%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 708
I K + LG G FG V + R A K +++ + + + + E +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDE----FIEEAKVMMN 55
Query: 709 INSRFVVSLAYAYETKDALCLVL 731
++ +V L + + ++
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIIT 78
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-47
Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 32/295 (10%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
I ++ R+ LG+G FGEV T + A K L+ + L E Q+++K
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA----FLQEAQVMKK 68
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
+ +V L YA +++ + +V M+ G L + G+ + + AA++ G+
Sbjct: 69 LRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGM 126
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--GRVGTVGYMAPEVI 288
++ + V+RD + NIL+ + +++D GLA I + E G + + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 289 DNEKYTYSPDWFSFGCLIFEMI-EGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347
++T D +SFG L+ E+ +G+ P+ D+V+R + +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP---ECPESL 243
Query: 348 KALCKALLKKSPRSRLGCHCGRYGARELKQA--EFFKSTNWKRLEAGLCDPPFVP 400
L +K P R L+ ++F ST +P + P
Sbjct: 244 HDLMCQCWRKEPEE-------RPTFEYLQAFLEDYFTST----------EPQYQP 281
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (132), Expect = 8e-09
Identities = 24/118 (20%), Positives = 47/118 (39%), Gaps = 8/118 (6%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 708
I ++ R+ LG+G FGEV T + A K L+ + L E Q+++K
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA----FLQEAQVMKK 68
Query: 709 INSRFVVSLAYAYETKDALCLVLTIID--VMFTCVQPSETNPCCFPFRRKEVVVVAAF 764
+ +V L YA +++ + +V + + ++ P +A+
Sbjct: 69 LRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 8e-47
Identities = 62/288 (21%), Positives = 114/288 (39%), Gaps = 22/288 (7%)
Query: 102 KDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMV 161
K + + + +T ++ LG G FGEV A K L++ +
Sbjct: 1 KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDA----F 55
Query: 162 LIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF 221
L E +++++ + +V L YA T++ + ++ M G L + G I +
Sbjct: 56 LAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLD 113
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--GRVGT 279
AA++ G+ + ++RD + NIL+ D +I+D GLA I + E G
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 280 VGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE-K 338
+ + APE I+ +T D +SFG L+ E++ EV + ++
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMV 230
Query: 339 YSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA--EFFKST 384
++ L + K+ P R L+ +FF +T
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRP-------TFDYLRSVLEDFFTAT 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.1 bits (140), Expect = 8e-10
Identities = 18/83 (21%), Positives = 37/83 (44%), Gaps = 6/83 (7%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 708
+ +T ++ LG G FGEV A K L++ + L E ++++
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDA----FLAEANLMKQ 64
Query: 709 INSRFVVSLAYAYETKDALCLVL 731
+ + +V L YA T++ + ++
Sbjct: 65 LQHQRLVRL-YAVVTQEPIYIIT 86
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (420), Expect = 1e-46
Identities = 56/272 (20%), Positives = 111/272 (40%), Gaps = 20/272 (7%)
Query: 101 TKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKG 157
++ EI ++ +V+G G FGEVC+ ++ GK + K +K K
Sbjct: 16 VREFAKEIDI---SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAI--KTLKSGYTEKQ 70
Query: 158 ESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIA 217
L E I+ + + V+ L + ++ M G L + G+ F +
Sbjct: 71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ--FTVI 128
Query: 218 RARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES----- 272
+ + G+++L + V+RD NIL++ ++SD GL+ + + S
Sbjct: 129 QLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188
Query: 273 -VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPFRRRKEMVKRDEVDR 330
G + + APE I K+T + D +S+G +++E++ G+ P+ +M +D ++
Sbjct: 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMTNQDVINA 245
Query: 331 RVKEDAEKYSCRFSDDAKALCKALLKKSPRSR 362
++ L +K R
Sbjct: 246 IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 63.6 bits (154), Expect = 2e-11
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 5/90 (5%)
Query: 645 FPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGESMVLI 701
F + I ++ +V+G G FGEVC+ ++ GK + K +K K L
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAI--KTLKSGYTEKQRRDFLS 76
Query: 702 EKQILQKINSRFVVSLAYAYETKDALCLVL 731
E I+ + + V+ L + ++
Sbjct: 77 EASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 5e-46
Identities = 54/250 (21%), Positives = 96/250 (38%), Gaps = 15/250 (6%)
Query: 120 RVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVV 177
+ LG G FG V + K A K L K + +L E ++Q++++ ++V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 178 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG 237
+ ++ LV+ + G L ++ +V G+++L
Sbjct: 72 RM-IGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 127
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR----GRVGTVGYMAPEVIDNEKY 293
V+RD N+LL + +ISD GL+ + E+ V + APE I+ K+
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 294 TYSPDWFSFGCLIFEMI-EGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352
+ D +SFG L++E GQ P+R K + K + + L
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLEKGERMGCPAGCPREMYDLMN 244
Query: 353 ALLKKSPRSR 362
+R
Sbjct: 245 LCWTYDVENR 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (128), Expect = 3e-08
Identities = 17/76 (22%), Positives = 33/76 (43%), Gaps = 4/76 (5%)
Query: 658 RVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVV 715
+ LG G FG V + K A K L K + +L E ++Q++++ ++V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 716 SLAYAYETKDALCLVL 731
+ ++ LV+
Sbjct: 72 RM-IGICEAESWMLVM 86
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 9e-46
Identities = 60/292 (20%), Positives = 111/292 (38%), Gaps = 38/292 (13%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--ESMVLIEKQILQKINSRFVV 177
LG+G F V + + T ++ A KK++ + K L E ++LQ+++ ++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 178 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG 237
L A+ K + LV M N + + Y L GLE+LH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 238 LVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ESVRGRVGTVGYMAPEVIDNEK-YTY 295
+++RD KP N+LLD+ G ++++D GLA + +V T Y APE++ + Y
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 296 SPDWFSFGCLIFEMIEGQAPFRRRKEM------------------------VKRDEVDRR 331
D ++ GC++ E++ ++
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 332 VKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383
DD L + L +P +R+ A + + ++F +
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI-------TATQALKMKYFSN 285
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.9 bits (157), Expect = 6e-12
Identities = 19/108 (17%), Positives = 44/108 (40%), Gaps = 2/108 (1%)
Query: 658 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--ESMVLIEKQILQKINSRFVV 715
LG+G F V + + T ++ A KK++ + K L E ++LQ+++ ++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 716 SLAYAYETKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVAA 763
L A+ K + LV ++ + + + +++
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 111
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 8e-45
Identities = 49/255 (19%), Positives = 93/255 (36%), Gaps = 13/255 (5%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
I + +G G FG V A K + + + + + E +++ K
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEED----FIEEAEVMMK 56
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
++ +V L + +CLV M G L ++ F +V G+
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGM 114
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES--VRGRVGTVGYMAPEVI 288
+L +++RD N L+ + +++SD G+ + + + G V + +PEV
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 289 DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR-FSDDA 347
+Y+ D +SFG L++E+ + EV + Y R S
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRLYKPRLASTHV 231
Query: 348 KALCKALLKKSPRSR 362
+ K+ P R
Sbjct: 232 YQIMNHCWKERPEDR 246
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (138), Expect = 1e-09
Identities = 15/83 (18%), Positives = 30/83 (36%), Gaps = 5/83 (6%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 708
I + +G G FG V A K + + + + + E +++ K
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEED----FIEEAEVMMK 56
Query: 709 INSRFVVSLAYAYETKDALCLVL 731
++ +V L + +CLV
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVF 79
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-44
Identities = 66/297 (22%), Positives = 125/297 (42%), Gaps = 37/297 (12%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
F+ +G+G +G V + + TG++ A KK+ + + S + E +L+++N
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V L T++ L LV ++ KF + G + + Y ++L GL H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFCHS 120
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEI-PEGESVRGRVGTVGYMAPEVIDNEKY- 293
+++RD KP+N+L++ G ++++D GLA + V T+ Y APE++ KY
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEM-------------------------VKRDEV 328
+ + D +S GC+ EM+ +A F E+ +
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 329 DRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385
+ ++D K +D ++L +L P R+ A+ FF+
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI-------SAKAALAHPFFQDVT 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.7 bits (159), Expect = 4e-12
Identities = 20/77 (25%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
F+ +G+G +G V + + TG++ A KK+ + + S + E +L+++N
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 62
Query: 714 VVSLAYAYETKDALCLV 730
+V L T++ L LV
Sbjct: 63 IVKLLDVIHTENKLYLV 79
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-44
Identities = 70/335 (20%), Positives = 131/335 (39%), Gaps = 48/335 (14%)
Query: 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR 174
++ +V+G G FG V ++ +G++ A KK+ + + K + E QI++K++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73
Query: 175 FVVSLAYAYETKDA------LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLC 228
+V L Y + + L LVL + + + + + + Y ++
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 229 GLEHLHYIGLVYRDCKPENILLD-DYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAP-E 286
L ++H G+ +RD KP+N+LLD D +++ D G A ++ GE + + Y AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM------------------------ 322
+ YT S D +S GC++ E++ GQ F +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 323 -VKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381
+ + + + R +A ALC LL+ +P +RL E FF
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL-------TPLEACAHSFF 306
Query: 382 KSTNWKRLE-AGLCDPPFVPDVKRDEVDRRVKEDA 415
++ D P + + E+
Sbjct: 307 DELRDPNVKLPNGRDTPALFNFTTQELSSNPPLAT 341
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (150), Expect = 7e-11
Identities = 24/106 (22%), Positives = 49/106 (46%), Gaps = 10/106 (9%)
Query: 632 FTSVPPSETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 691
T+V + PQ ++Y + V+G G FG V ++ +G++ A KK+ + +
Sbjct: 3 VTTVVATPGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 59
Query: 692 KRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIIDVM 737
K + E QI++K++ +V L Y + + + + V+
Sbjct: 60 KNR-------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (401), Expect = 3e-44
Identities = 45/255 (17%), Positives = 100/255 (39%), Gaps = 11/255 (4%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
+ M LG G +GEV + A K L++ ++ + L E ++++
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKE 69
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGL 230
I +V L + ++ M G+L ++ + + A ++ +
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAM 128
Query: 231 EHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR--GRVGTVGYMAPEVI 288
E+L ++RD N L+ + V+++D GL+ + G + + APE +
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 289 DNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE-KYSCRFSDDA 347
K++ D ++FG L++E+ ++ +V +++D + +
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDYRMERPEGCPEKV 245
Query: 348 KALCKALLKKSPRSR 362
L +A + +P R
Sbjct: 246 YELMRACWQWNPSDR 260
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 60.5 bits (146), Expect = 1e-10
Identities = 15/81 (18%), Positives = 30/81 (37%), Gaps = 4/81 (4%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 708
+ M LG G +GEV + A K L++ ++ + L E ++++
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKE 69
Query: 709 INSRFVVSLAYAYETKDALCL 729
I +V L + +
Sbjct: 70 IKHPNLVQLLGVCTREPPFYI 90
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 6e-44
Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 15/248 (6%)
Query: 122 LGKGGFGEVCACQVRATGK--MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
LG G FG V R K A K L K+ ++ ++ E QI+ ++++ ++V L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 180 AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLV 239
+AL LV+ + GG L + E ++ +V G+++L V
Sbjct: 75 -IGVCQAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 240 YRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR----GRVGTVGYMAPEVIDNEKYTY 295
+RD N+LL + + +ISD GL+ + +S + + APE I+ K++
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 296 SPDWFSFGCLIFEMI-EGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKAL 354
D +S+G ++E + GQ P+++ K +++ + + + AL
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE---CPPELYALMSDC 248
Query: 355 LKKSPRSR 362
R
Sbjct: 249 WIYKWEDR 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (116), Expect = 1e-06
Identities = 21/74 (28%), Positives = 35/74 (47%), Gaps = 5/74 (6%)
Query: 660 LGKGGFGEVCACQVRATGK--MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 717
LG G FG V R K A K L K+ ++ ++ E QI+ ++++ ++V L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 718 AYAYETKDALCLVL 731
+AL LV+
Sbjct: 75 -IGVCQAEALMLVM 87
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 8e-44
Identities = 54/292 (18%), Positives = 106/292 (36%), Gaps = 32/292 (10%)
Query: 100 STKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES 159
+ Y+ + +VLG G FG+V K ++ K +K++ S
Sbjct: 23 FREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS 82
Query: 160 M---VLIEKQILQKINS-RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGG----- 210
++ E +++ ++ S +V+L A + L+ GDL ++ +
Sbjct: 83 EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 142
Query: 211 ---------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH 255
+A +V G+E L + V+RD N+L+
Sbjct: 143 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 202
Query: 256 VRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-E 311
V+I D GLA +I + V +MAPE + YT D +S+G L++E+
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262
Query: 312 GQAPFRRRKEMVKRDEVDRRVKEDAE-KYSCRFSDDAKALCKALLKKSPRSR 362
G P+ + ++ + +++ + ++ R R
Sbjct: 263 GVNPYPGIPVD---ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (136), Expect = 3e-09
Identities = 17/87 (19%), Positives = 36/87 (41%), Gaps = 4/87 (4%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM---VLIEKQI 705
+ +VLG G FG+V K ++ K +K++ S ++ E ++
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 706 LQKINS-RFVVSLAYAYETKDALCLVL 731
+ ++ S +V+L A + L+
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIF 120
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 1e-43
Identities = 52/276 (18%), Positives = 96/276 (34%), Gaps = 33/276 (11%)
Query: 116 FRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
R +G+G FG V + M A K L+++ ++ E ++ +
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAE 72
Query: 171 INSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG--------------------- 209
++ +V L +CL+ M GDL + +M
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 210 GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269
G P A A +V G+ +L V+RD N L+ + V+I+D GL+ I
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 270 GESVR---GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRD 326
+ + + +M PE I +YT D +++G +++E+ M +
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--YYGMAHEE 250
Query: 327 EVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSR 362
+ + + L + K P R
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.2 bits (124), Expect = 9e-08
Identities = 15/83 (18%), Positives = 31/83 (37%), Gaps = 7/83 (8%)
Query: 654 FRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 708
R +G+G FG V + M A K L+++ ++ E ++ +
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAE 72
Query: 709 INSRFVVSLAYAYETKDALCLVL 731
++ +V L +CL+
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLF 95
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-43
Identities = 55/260 (21%), Positives = 97/260 (37%), Gaps = 13/260 (5%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMVLIEKQI 167
I K R+ LG G FG V + A A K L+ + + + + E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 168 LQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVL 227
+ ++ R ++ L Y + +V + G L + G F + YA +V
Sbjct: 65 MHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVA 121
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESV----RGRVGTVGYM 283
G+ +L ++RD N+LL V+I D GL +P+ + R +
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 284 APEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342
APE + ++++ D + FG ++EM GQ P+ ++D+ + C
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC- 240
Query: 343 FSDDAKALCKALLKKSPRSR 362
D + P R
Sbjct: 241 -PQDIYNVMVQCWAHKPEDR 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (139), Expect = 1e-09
Identities = 18/86 (20%), Positives = 32/86 (37%), Gaps = 4/86 (4%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMVLIEKQI 705
I K R+ LG G FG V + A A K L+ + + + + E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 706 LQKINSRFVVSLAYAYETKDALCLVL 731
+ ++ R ++ L Y + +V
Sbjct: 65 MHSLDHRNLIRL-YGVVLTPPMKMVT 89
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 48/266 (18%), Positives = 101/266 (37%), Gaps = 16/266 (6%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQK 170
+ + + V+G+G FG+V +++ G K + E ++L K
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 171 I-NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM-------------GGEPGFDI 216
+ + +++L A E + L L + G+L +
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 217 ARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR 276
+ +AA+V G+++L ++RD NIL+ + +I+D GL+
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 277 VGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA 336
V +MA E ++ YT + D +S+G L++E++ M + ++ +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYEKLPQGYR 244
Query: 337 EKYSCRFSDDAKALCKALLKKSPRSR 362
+ D+ L + ++ P R
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYER 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (157), Expect = 8e-12
Identities = 18/91 (19%), Positives = 39/91 (42%), Gaps = 2/91 (2%)
Query: 642 PSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI 701
P+ +P + + + V+G+G FG+V +++ G K +
Sbjct: 1 PTIYPV-LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG 59
Query: 702 EKQILQKI-NSRFVVSLAYAYETKDALCLVL 731
E ++L K+ + +++L A E + L L +
Sbjct: 60 ELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 1e-42
Identities = 62/305 (20%), Positives = 117/305 (38%), Gaps = 42/305 (13%)
Query: 116 FRMYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS- 173
+ +G+G +G+V + ++ G+ A K++ + + + + E +L+ + +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 174 --RFVVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
VV L + + L LV ++ + EPG + ++
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQL 125
Query: 227 LCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPE 286
L GL+ LH +V+RD KP+NIL+ G ++++D GLA ++ V T+ Y APE
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 287 VIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-----------------------V 323
V+ Y D +S GC+ EM + FR ++ +
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 324 KRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383
R + + EK+ + K L L +P R+ A +F+
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-------SAYSALSHPYFQD 298
Query: 384 TNWKR 388
+
Sbjct: 299 LERCK 303
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (103), Expect = 3e-05
Identities = 12/76 (15%), Positives = 31/76 (40%), Gaps = 5/76 (6%)
Query: 654 FRMYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS- 711
+ +G+G +G+V + ++ G+ A K++ + + + + E +L+ + +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 712 --RFVVSLAYAYETKD 725
VV L
Sbjct: 68 EHPNVVRLFDVCTVSR 83
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 57/316 (18%), Positives = 112/316 (35%), Gaps = 20/316 (6%)
Query: 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK--KRIKKRKGESMVLIEK 165
++ + F+ +VLG G FG V G+ K + K +L E
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 166 QILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAE 225
++ +++ V L T + L+ +M G L ++ + +
Sbjct: 63 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQ 119
Query: 226 VLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR---GRVGTVGY 282
+ G+ +L LV+RD N+L+ HV+I+D GLA + E G + +
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 283 MAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341
MA E I + YT+ D +S+G ++E++ G P+ +++ +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI-- 237
Query: 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARE-LKQAEFFKSTNWKRLEAGLCDPPFVP 400
+ D + S R RE + + + L + +P
Sbjct: 238 -CTIDVYMIMVKCWMIDADS-------RPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289
Query: 401 DVKRDEVDRRVKEDAE 416
R + ++ +
Sbjct: 290 SPTDSNFYRALMDEED 305
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.4 bits (130), Expect = 2e-08
Identities = 16/79 (20%), Positives = 27/79 (34%), Gaps = 2/79 (2%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK--KRIKKRKGESMVLIEKQILQKINS 711
F+ +VLG G FG V G+ K + K +L E ++ +++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 712 RFVVSLAYAYETKDALCLV 730
V L T +
Sbjct: 71 PHVCRLLGICLTSTVQLIT 89
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 64/310 (20%), Positives = 112/310 (36%), Gaps = 53/310 (17%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ +G+G FGEV + R TG+ A KK+ + +K L E +ILQ +
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHEN 70
Query: 176 VVSLAYAYETKDA--------LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVL 227
VV+L TK + + LV + F ++ + +L
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLL 127
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES-----VRGRVGTVGY 282
GL ++H +++RD K N+L+ G ++++D GLA ++ RV T+ Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 283 MAPEVIDNEK-YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR----------- 330
PE++ E+ Y D + GC++ EM + E + + +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 331 -----------------RVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGAR 373
+ K + A L LL P R+ +
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-------DSD 300
Query: 374 ELKQAEFFKS 383
+ +FF S
Sbjct: 301 DALNHDFFWS 310
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.8 bits (141), Expect = 7e-10
Identities = 23/72 (31%), Positives = 34/72 (47%), Gaps = 1/72 (1%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ +G+G FGEV + R TG+ A KK+ + +K L E +ILQ +
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHEN 70
Query: 714 VVSLAYAYETKD 725
VV+L TK
Sbjct: 71 VVNLIEICRTKA 82
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-41
Identities = 48/251 (19%), Positives = 98/251 (39%), Gaps = 10/251 (3%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK-KRIKKRKGESMVLIEKQILQKINSR 174
+ R +G+G FG+V + ++ K L E +++ +
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+V L T++ + +++ + G+L+ + D+A YA ++ L +L
Sbjct: 69 HIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLE 125
Query: 235 YIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGR--VGTVGYMAPEVIDNEK 292
V+RD N+L+ V++ D GL+ + + + + +MAPE I+ +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 293 YTYSPDWFSFGCLIFEMI-EGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351
+T + D + FG ++E++ G PF+ K D + R + +L
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENGERLPMPPNCPPTLYSLM 242
Query: 352 KALLKKSPRSR 362
P R
Sbjct: 243 TKCWAYDPSRR 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.8 bits (118), Expect = 5e-07
Identities = 12/79 (15%), Positives = 30/79 (37%), Gaps = 2/79 (2%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEK-KRIKKRKGESMVLIEKQILQKINSR 712
+ R +G+G FG+V + ++ K L E +++ +
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 713 FVVSLAYAYETKDALCLVL 731
+V L T++ + +++
Sbjct: 69 HIVKL-IGVITENPVWIIM 86
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 152 bits (385), Expect = 1e-41
Identities = 70/310 (22%), Positives = 122/310 (39%), Gaps = 58/310 (18%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SR 174
+++ R LG+G + EV + K L+ + KK + E +IL+ +
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLRGGP 90
Query: 175 FVVSLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEH 232
+++LA + LV +N D K RFY E+L L++
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDY 144
Query: 233 LHYIGLVYRDCKPENILLD-DYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEV-IDN 290
H +G+++RD KP N+++D ++ +R+ D GLA G+ RV + + PE+ +D
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 291 EKYTYSPDWFSFGCLIFEMIEGQAPF---------------------------------- 316
+ Y YS D +S GC++ MI + PF
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 317 RRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELK 376
R +++ R R + + S +A LL+ +SRL ARE
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-------TAREAM 317
Query: 377 QAEFFKSTNW 386
+ +F +
Sbjct: 318 EHPYFYTVVK 327
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 52.5 bits (125), Expect = 9e-08
Identities = 16/79 (20%), Positives = 33/79 (41%), Gaps = 7/79 (8%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SR 712
+++ R LG+G + EV + K L+ + KK + E +IL+ +
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLRGGP 90
Query: 713 FVVSLAYAYETKDALCLVL 731
+++LA + + L
Sbjct: 91 NIITLADIVKDPVSRTPAL 109
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 8e-41
Identities = 60/271 (22%), Positives = 104/271 (38%), Gaps = 15/271 (5%)
Query: 101 TKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKG 157
+ + + + + V+G+G FG V + A K L RI
Sbjct: 14 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGE 71
Query: 158 ESMVLIEKQILQKINSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDI 216
S L E I++ + V+SL ++ + +VL M GDL+ I N P +
Sbjct: 72 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TV 129
Query: 217 ARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE----- 271
+ +V G++ L V+RD N +LD+ V+++D GLA ++ + E
Sbjct: 130 KDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRR 331
+ G V +MA E + +K+T D +SFG L++E++ AP D
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL 247
Query: 332 VKEDAEKYSCRFSDDAKALCKALLKKSPRSR 362
++ D + R
Sbjct: 248 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (117), Expect = 7e-07
Identities = 20/78 (25%), Positives = 31/78 (39%), Gaps = 6/78 (7%)
Query: 658 RVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFV 714
V+G+G FG V + A K L RI S L E I++ + V
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 715 VSL-AYAYETKDALCLVL 731
+SL ++ + +VL
Sbjct: 91 LSLLGICLRSEGSPLVVL 108
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-40
Identities = 58/327 (17%), Positives = 115/327 (35%), Gaps = 42/327 (12%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ +G+G +G VC+ A KK+ + + L E +IL +
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
++ + + + + +Y + ++ ++L GL+++H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 127
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG----RVGTVGYMAPEVIDNE 291
+++RD KP N+LL+ ++I D GLA G V T Y APE++ N
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 292 -KYTYSPDWFSFGCLIFEMIEGQAPF---------------------------RRRKEMV 323
YT S D +S GC++ EM+ + F K
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 324 KRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383
+ + K + A L +L +P R+ + + +
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-------EVEQALAHPYLEQ 300
Query: 384 TNWKRLEAGLCDPPFVPDVKRDEVDRR 410
+ + + + PF D++ D++ +
Sbjct: 301 -YYDPSDEPIAEAPFKFDMELDDLPKE 326
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 5e-09
Identities = 12/81 (14%), Positives = 27/81 (33%), Gaps = 2/81 (2%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ +G+G +G VC+ A KK+ + + L E +IL +
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 714 VVSLAYAYETKDALCLVLTII 734
++ + + +
Sbjct: 68 IIGINDIIRAPTIEQMKDVYL 88
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 4e-40
Identities = 54/280 (19%), Positives = 113/280 (40%), Gaps = 18/280 (6%)
Query: 98 RLSTKDIYNEIQ-PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR- 155
S D+Y + + + M R LG+G FG V + K ++ K + +
Sbjct: 3 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 62
Query: 156 --KGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG 213
+ L E ++++ N VV L +++ +M GDLK ++ ++
Sbjct: 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 214 -------FDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266
+++ A E+ G+ +L+ V+RD N ++ + V+I D G+ +
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 267 IPEGESVR---GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEG-QAPFRRRKEM 322
I E + R + V +M+PE + + +T D +SFG +++E+ + P++
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242
Query: 323 VKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSR 362
+ ++ D L + + +P+ R
Sbjct: 243 ---QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMR 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.1 bits (129), Expect = 2e-08
Identities = 20/124 (16%), Positives = 43/124 (34%), Gaps = 9/124 (7%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQI 705
+ + M R LG+G FG V + K ++ K + + + L E +
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 706 LQKINSRFVVSLAYAYETKDALCLVL------TIIDVMFTCVQPSETNPCCFPFRRKEVV 759
+++ N VV L +++ + + + NP P +++
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 760 VVAA 763
+A
Sbjct: 137 QMAG 140
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-40
Identities = 52/266 (19%), Positives = 101/266 (37%), Gaps = 19/266 (7%)
Query: 106 NEIQPITYKTFRMYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGESMV 161
EI P +V+G G FGEV ++ + A K L+ +K++ +
Sbjct: 2 TEIHP---SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--F 56
Query: 162 LIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARF 221
L E I+ + + ++ L + ++ M G L + GE F + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVG 114
Query: 222 YAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR----GRV 277
+ G+++L + V+RD NIL++ ++SD GL+ + + G
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 278 GTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE 337
+ + APE I K+T + D +SFG +++E++ EV + + +
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVMKAINDGFR 231
Query: 338 -KYSCRFSDDAKALCKALLKKSPRSR 362
L ++ R
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.1 bits (124), Expect = 8e-08
Identities = 19/98 (19%), Positives = 39/98 (39%), Gaps = 15/98 (15%)
Query: 638 SETNPSCFPQPITYKTFRMYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKR 693
+E +PSC +V+G G FGEV ++ + A K L+ +K+
Sbjct: 2 TEIHPSCV---------TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ 52
Query: 694 KGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731
+ + L E I+ + + ++ L + ++
Sbjct: 53 RVD--FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 1e-39
Identities = 44/262 (16%), Positives = 91/262 (34%), Gaps = 22/262 (8%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+R+ R +G G FG++ A G+ A K + + IE +I + +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-----ECVKTKHPQLHIESKIYKMMQGGV 63
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+ + +++ + G L+ + F + A +++ +E++H
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 121
Query: 236 IGLVYRDCKPENIL---LDDYGHVRISDLGLAVEIPEGESV--------RGRVGTVGYMA 284
++RD KP+N L V I D GLA + + + + GT Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 285 PEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR----RVKEDAEKYS 340
+ + D S G ++ G P++ K KR + +R ++ E
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 341 CRFSDDAKALCKALLKKSPRSR 362
+ + +
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDK 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.9 bits (126), Expect = 5e-08
Identities = 13/77 (16%), Positives = 28/77 (36%), Gaps = 5/77 (6%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+R+ R +G G FG++ A G+ A K + + IE +I + +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-----ECVKTKHPQLHIESKIYKMMQGGV 63
Query: 714 VVSLAYAYETKDALCLV 730
+ + ++
Sbjct: 64 GIPTIRWCGAEGDYNVM 80
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 56/285 (19%), Positives = 97/285 (34%), Gaps = 25/285 (8%)
Query: 101 TKDIYNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES- 159
T+ Y+ + LG G FG+V K A + K +K +
Sbjct: 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE 69
Query: 160 --MVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGG------ 210
++ E ++L + N +V+L A ++ GDL +
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 211 ---------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDL 261
E D+ ++ +V G+ L ++RD NILL +I D
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
Query: 262 GLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRR 318
GLA +I + V +MAPE I N YT+ D +S+G ++E+ +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249
Query: 319 RKEMVKRDEVDRRVKEDAE-KYSCRFSDDAKALCKALLKKSPRSR 362
+ + + +KE + + K P R
Sbjct: 250 GMPV--DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (129), Expect = 2e-08
Identities = 18/99 (18%), Positives = 34/99 (34%), Gaps = 8/99 (8%)
Query: 641 NPSCFPQP----ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 696
+P+ P + LG G FG+V K A + K +K
Sbjct: 8 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 67
Query: 697 S---MVLIEKQILQKI-NSRFVVSLAYAYETKDALCLVL 731
+ ++ E ++L + N +V+L A ++
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-39
Identities = 59/274 (21%), Positives = 103/274 (37%), Gaps = 24/274 (8%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES---MVLIEKQI 167
++ + LG+G FG+V K C+ + K +K+ S ++ E +I
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 168 LQKINSRFVVSL--AYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPG------------ 213
L I V + L +++ G+L ++ + E
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 214 -FDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES 272
+ Y+ +V G+E L ++RD NILL + V+I D GLA +I +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 273 ---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD 329
+ +MAPE I + YT D +SFG L++E+ A ++ +E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC 247
Query: 330 RRVKEDAE-KYSCRFSDDAKALCKALLKKSPRSR 362
RR+KE + + + P R
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 281
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 1e-05
Identities = 17/88 (19%), Positives = 34/88 (38%), Gaps = 4/88 (4%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES----MVLIEKQ 704
++ + LG+G FG+V K C+ + K +K+ S ++ K
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 705 ILQKINSRFVVSLAYAYETKDALCLVLT 732
++ + VV+L A +V+
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIV 97
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-39
Identities = 73/344 (21%), Positives = 130/344 (37%), Gaps = 60/344 (17%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
K ++ + +G G G VCA + A KKL + + + E +++ +N
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 174 RFVVSLAYAYETKDA------LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVL 227
+ ++SL + + + LV+ +M+ + + D R + ++L
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQML 129
Query: 228 CGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEV 287
CG++HLH G+++RD KP NI++ ++I D GLA + V T Y APEV
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 288 IDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEM-----------------------VK 324
I Y + D +S GC++ EM+ + F R +
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 325 RDEVDRRVKEDAEKYSCRF---------------SDDAKALCKALLKKSPRSRLGCHCGR 369
R+ V+ R K + F + A+ L +L P R+
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI------ 303
Query: 370 YGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVKE 413
+ Q + W PP + D + DE + ++E
Sbjct: 304 -SVDDALQHPYIN--VWYDPAEVEAPPPQIYDKQLDEREHTIEE 344
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.5 bits (148), Expect = 1e-10
Identities = 18/89 (20%), Positives = 36/89 (40%), Gaps = 1/89 (1%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
K ++ + +G G G VCA + A KKL + + + E +++ +N
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 712 RFVVSLAYAYETKDALCLVLTIIDVMFTC 740
+ ++SL + + L + VM
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELM 104
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-39
Identities = 78/344 (22%), Positives = 133/344 (38%), Gaps = 56/344 (16%)
Query: 107 EIQPITYK---TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLI 163
E+ ++ +R + +G G +G VC+ TG A KKL + + +
Sbjct: 8 EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-AYR 66
Query: 164 EKQILQKINSRFVVSLAYAYETKDALCLVLTIM----NGGDLKFHIYNMGGEPGFDIARA 219
E ++L+ + V+ L + + L G + R
Sbjct: 67 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRI 123
Query: 220 RFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGT 279
+F ++L GL ++H G+++RD KP N+ +++ ++I D GLA + + G V T
Sbjct: 124 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVT 181
Query: 280 VGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR-------- 330
Y APEVI N +YT + D +S GC++ EMI G+ F+ + + E+ +
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 331 -------------------RVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYG 371
K+D S A L + +L R+
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-------T 294
Query: 372 ARELKQAEFFKSTNWKRLEAGLCDPPFVP--DVKRDEVDRRVKE 413
A E +F+S + D P V D D+VDR + E
Sbjct: 295 AGEALAHPYFESLHDT------EDEPQVQKYDDSFDDVDRTLDE 332
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (155), Expect = 2e-11
Identities = 19/89 (21%), Positives = 34/89 (38%), Gaps = 1/89 (1%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
+R + +G G +G VC+ TG A KKL + + + E ++L+ +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMRH 76
Query: 712 RFVVSLAYAYETKDALCLVLTIIDVMFTC 740
V+ L + + L VM
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM 105
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (361), Expect = 9e-39
Identities = 65/294 (22%), Positives = 120/294 (40%), Gaps = 39/294 (13%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ +G+G +G V Q G+ +A KK+ ++ + S + E IL+++
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSN 61
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V L TK L LV ++ K GG + A+ + ++L G+ + H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE-GESVRGRVGTVGYMAPEVI-DNEKY 293
+++RD KP+N+L++ G ++I+D GLA + T+ Y AP+V+ ++KY
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR----------------------- 330
+ + D +S GC+ EM+ G F E + + R
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 331 --RVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
E + + L +LK P R+ A++ + +FK
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-------TAKQALEHAYFK 285
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 54.9 bits (131), Expect = 1e-08
Identities = 21/109 (19%), Positives = 42/109 (38%), Gaps = 2/109 (1%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ +G+G +G V Q G+ +A KK+ ++ + S + E IL+++
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSN 61
Query: 714 VVSLAYAYETKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762
+V L TK L LV +D + + ++ +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL 110
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 1e-37
Identities = 58/295 (19%), Positives = 110/295 (37%), Gaps = 39/295 (13%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
+ +G+G +G V + R T ++ A K++ + S L E +L+++ +
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS-ALREICLLKELKHKN 62
Query: 176 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY 235
+V L + L LV + K+ G D + + ++L GL H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHS 119
Query: 236 IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRG-RVGTVGYMAPEVIDNEK-Y 293
+++RD KP+N+L++ G +++++ GLA V T+ Y P+V+ K Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 294 TYSPDWFSFGCLIFEMIEGQAPFRRRKEMV--------------------------KRDE 327
+ S D +S GC+ E+ P ++ +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 328 VDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382
+ + + L + LLK +P R+ A E Q +F
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-------SAEEALQHPYFS 287
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.4 bits (145), Expect = 2e-10
Identities = 19/103 (18%), Positives = 37/103 (35%), Gaps = 1/103 (0%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ +G+G +G V + R T ++ A K++ + S L E +L+++ +
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS-ALREICLLKELKHKN 62
Query: 714 VVSLAYAYETKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRK 756
+V L + L LV D S +
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS 105
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-37
Identities = 56/278 (20%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKM-------YACKKLEKKRIKKRKGESMVLI 163
+ + + LG+G FG+V + K A K L+ +K S ++
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLIS 67
Query: 164 EKQILQKINS-RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGG------------ 210
E ++++ I + +++L A L +++ + G+L+ ++
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 211 -EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269
E A +V G+E+L ++RD N+L+ + ++I+D GLA +I
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 270 GESVR---GRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMI-EGQAPFRRRKEMVKR 325
+ + V +MAPE + + YT+ D +SFG L++E+ G +P+ V
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY----PGVPV 243
Query: 326 DEVDRRVKEDAE-KYSCRFSDDAKALCKALLKKSPRSR 362
+E+ + +KE +++ + + P R
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.2 bits (111), Expect = 4e-06
Identities = 17/91 (18%), Positives = 38/91 (41%), Gaps = 10/91 (10%)
Query: 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKM-------YACKKLEKKRIKKRKGESMVLI 701
+ + + LG+G FG+V + K A K L+ + K S ++
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLIS 67
Query: 702 EKQILQKINS-RFVVSLAYAYETKDALCLVL 731
E ++++ I + +++L A L +++
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIV 98
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 134 bits (339), Expect = 8e-36
Identities = 38/265 (14%), Positives = 88/265 (33%), Gaps = 26/265 (9%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR- 174
+++ R +G+G FG + + A K +R + E + + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAPQLRDEYRTYKLLAGCT 61
Query: 175 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLH 234
+ ++ Y + LV+ ++ F + A ++L ++ +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH 118
Query: 235 YIGLVYRDCKPENILLDDY-----GHVRISDLGLAVEIPEGES--------VRGRVGTVG 281
LVYRD KP+N L+ + + D G+ + + + GT
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR----RVKEDAE 337
YM+ + + D + G + + G P++ K + + +R +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 338 KYSCRFSDDAKALCKALLKKSPRSR 362
+ F ++ + +
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.6 bits (120), Expect = 3e-07
Identities = 12/104 (11%), Positives = 32/104 (30%), Gaps = 6/104 (5%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR- 712
+++ R +G+G FG + + A K +R + E + + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAPQLRDEYRTYKLLAGCT 61
Query: 713 FVVSLAYAYETKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRK 756
+ ++ Y + LV+ ++ +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM 105
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 59/323 (18%), Positives = 115/323 (35%), Gaps = 47/323 (14%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 175
++ +G G +G VCA TG A KKL + + E ++L+ +
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHEN 78
Query: 176 VVSLAYAYETKDALC----LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLE 231
V+ L + +L + L G +I +F ++L GL+
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLK 135
Query: 232 HLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNE 291
++H +++RD KP N+ +++ ++I D GLA + + G V T Y APE++ N
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNW 193
Query: 292 K-YTYSPDWFSFGCLIFEMIEGQAPFRRRKEM---------------------------V 323
Y + D +S GC++ E++ G+ F +
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 324 KRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383
+ + K + + A L + +L R+ A + +F
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-------TAAQALAHAYFA- 305
Query: 384 TNWKRLEAGLCDPPFVPDVKRDE 406
+ + P+ + +
Sbjct: 306 -QYHDPDDEPVADPYDQSFESRD 327
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.6 bits (151), Expect = 6e-11
Identities = 20/105 (19%), Positives = 34/105 (32%), Gaps = 1/105 (0%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
++ +G G +G VCA TG A KKL + + E ++L+ +
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHEN 78
Query: 714 VVSLAYAYETKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEV 758
V+ L + +L + V C V
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-34
Identities = 58/291 (19%), Positives = 102/291 (35%), Gaps = 51/291 (17%)
Query: 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 173
+T + +GKG FGEV + + G+ A K + + E E +
Sbjct: 3 RTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFRE----AEIYQTVMLRH 56
Query: 174 RFVVSLAYAYETKDA----LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCG 229
++ A + L LV G L ++ + A G
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASG 112
Query: 230 LEHLHYI--------GLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-----SVRGR 276
L HLH + +RD K +NIL+ G I+DLGLAV + R
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 277 VGTVGYMAPEVIDNE------KYTYSPDWFSFGCLIFEMIEGQAPFRRRK---------- 320
VGT YMAPEV+D+ + D ++ G + +E+ + +
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
Query: 321 ------EMVKRDEVDRRVKEDAEK--YSCRFSDDAKALCKALLKKSPRSRL 363
E +++ +++++ + SC + + + +RL
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (112), Expect = 3e-06
Identities = 15/83 (18%), Positives = 29/83 (34%), Gaps = 6/83 (7%)
Query: 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS 711
+T + +GKG FGEV + + G+ A K + + E E +
Sbjct: 3 RTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREERSWFRE----AEIYQTVMLRH 56
Query: 712 RFVVSLAYAYETKDALCLVLTII 734
++ A + L ++
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLV 79
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (295), Expect = 2e-29
Identities = 54/327 (16%), Positives = 107/327 (32%), Gaps = 65/327 (19%)
Query: 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQI-------L 168
+ + R LG G F V + A K + ++ E + + +++
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 169 QKINSRFVVSLAYAYET--KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEV 226
+ + ++ L + + + +V+ G+ + G + + + ++
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 227 LCGLEHLHY-IGLVYRDCKPENILLDDYGH----VRISDLGLAVEIPEGESVRGRVGTVG 281
L GL+++H G+++ D KPEN+L++ ++I L E + T
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 282 YMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD------------ 329
Y +PEV+ + D +S CLIFE+I G F + + D
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254
Query: 330 --------------------------------RRVKEDAEKYSCRFSDDAKALCKALLKK 357
V + K+S + + +L+
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314
Query: 358 SPRSRLGCHCGRYGARELKQAEFFKST 384
PR R A L + K T
Sbjct: 315 DPRKRA-------DAGGLVNHPWLKDT 334
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 50.4 bits (119), Expect = 4e-07
Identities = 13/65 (20%), Positives = 23/65 (35%), Gaps = 4/65 (6%)
Query: 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF 713
+ + R LG G F V + A K + ++ E E ++LQ++N
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDAD 70
Query: 714 VVSLA 718
Sbjct: 71 NTKED 75
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.9 bits (165), Expect = 1e-13
Identities = 21/149 (14%), Positives = 47/149 (31%), Gaps = 3/149 (2%)
Query: 120 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSL 179
+++G+G V C K + +K + + R +
Sbjct: 6 KLMGEGKESAVFNC-YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 180 AYAYETKDALCLVLTIM-NGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGL 238
A + L + G + + + + +L + ++ G+
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGI 124
Query: 239 VYRDCKPENILLDDYGHVRISDLGLAVEI 267
V+ D N+L+ + G I D +VE+
Sbjct: 125 VHGDLSQYNVLVSEEGIWII-DFPQSVEV 152
|
| >d1omwa1 a.91.1.1 (A:29-185) G-protein coupled receptor kinase 2, N-terminal domain {Cow (Bos taurus) [TaxId: 9913]} Length = 157 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Regulator of G-protein signaling, RGS superfamily: Regulator of G-protein signaling, RGS family: Regulator of G-protein signaling, RGS domain: G-protein coupled receptor kinase 2, N-terminal domain species: Cow (Bos taurus) [TaxId: 9913]
Score = 62.3 bits (151), Expect = 5e-12
Identities = 17/69 (24%), Positives = 26/69 (37%), Gaps = 2/69 (2%)
Query: 478 FFPQAPEAVDVLSLEIIEHCKE--SLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFY 535
+ S IEH + +LF + + L G F +F +S F
Sbjct: 85 IMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFT 144
Query: 536 RYLQWKWLE 544
R+ QWK +E
Sbjct: 145 RFCQWKNVE 153
|
| >d1omwa1 a.91.1.1 (A:29-185) G-protein coupled receptor kinase 2, N-terminal domain {Cow (Bos taurus) [TaxId: 9913]} Length = 157 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Regulator of G-protein signaling, RGS superfamily: Regulator of G-protein signaling, RGS family: Regulator of G-protein signaling, RGS domain: G-protein coupled receptor kinase 2, N-terminal domain species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.3 bits (107), Expect = 4e-06
Identities = 16/52 (30%), Positives = 26/52 (50%), Gaps = 1/52 (1%)
Query: 57 QQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYELEMDENRRLS-TKDIYNE 107
Q +G LLFR FC + + F + I+ YE E RL +++I++
Sbjct: 32 SQKLGYLLFRDFCLKHLEEAKPLVEFYEEIKKYEKLETEEERLVCSREIFDT 83
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 767 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.8 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.79 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.79 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.78 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.76 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.75 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.75 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.75 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.74 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.74 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.74 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.73 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.73 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.73 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.72 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.72 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.72 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.71 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.71 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.71 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.69 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.69 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.65 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.64 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.64 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.63 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.62 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.61 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.61 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.61 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.61 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.59 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.59 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.58 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.58 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.57 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.56 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.56 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.55 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.55 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.54 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.54 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.53 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.53 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.53 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.53 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.53 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.52 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.51 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.5 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.5 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.49 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.48 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.48 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.47 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.43 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.41 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.39 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.38 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.36 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.28 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 98.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 98.54 | |
| d1omwa1 | 157 | G-protein coupled receptor kinase 2, N-terminal do | 98.41 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.38 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.08 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 92.95 | |
| d1omwa1 | 157 | G-protein coupled receptor kinase 2, N-terminal do | 91.96 | |
| d2jm5a1 | 132 | Regulator of G-protein signaling 18, RGS18 {Human | 91.32 | |
| d1fqia_ | 138 | RGS9, RGS domain {Cow (Bos taurus) [TaxId: 9913]} | 87.19 | |
| d1cmza_ | 128 | Galpha interacting protein, GaIP {Human (Homo sapi | 83.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 81.33 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-64 Score=543.83 Aligned_cols=293 Identities=36% Similarity=0.648 Sum_probs=266.7
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+++++|+++++||+|+||.||+|+++.||+.||||++.+...........+.+|+.+|++++|||||+++++|++.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 67889999999999999999999999999999999999887777777888999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC-
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE- 269 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~- 269 (767)
+|||||+||+|..++.+.+ .+++..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 82 iv~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999999998865 699999999999999999999999999999999999999999999999999987644
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHH
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKA 349 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~d 349 (767)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+. .++.+.+......+|..+|+++++
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~d 234 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPRTLSPEAKS 234 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH----HHHHHHHhcCCCCCCccCCHHHHH
Confidence 3445668999999999999999999999999999999999999999988754 345556666677888999999999
Q ss_pred HHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhhhh
Q psy11874 350 LCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRRVK 412 (767)
Q Consensus 350 Li~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~~ 412 (767)
||++||++||++|+++.. .+++|+++||||++++|..+..+.+.||+.|.+.......++.
T Consensus 235 li~~~L~~dP~~R~~~~~--~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~ 295 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGP--SDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295 (337)
T ss_dssp HHHHHTCSSTTTSTTCST--TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSC
T ss_pred HHHhhccCCchhhccccc--ccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcC
Confidence 999999999999998643 4699999999999999999999999999999887655444443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-61 Score=517.99 Aligned_cols=284 Identities=32% Similarity=0.598 Sum_probs=255.6
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
++++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 45789999999999999999999999999999999988877666777889999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
|||||+||+|..++.... .+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999999999888765 6899999999999999999999999999999999999999999999999999887543
Q ss_pred cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.. ++...+......++..+|++++++|
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~li 232 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----KTYEKILNAELRFPPFFNEDVKDLL 232 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH----HHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 44678999999999999999999999999999999999999999886543 3444555566677889999999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchh
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~ 406 (767)
.+||.+||.+|+++. +.+++++++||||++++|+++..+.++||+.|.+...+
T Consensus 233 ~~~L~~dp~~R~~~~--r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~ 285 (316)
T d1fota_ 233 SRLITRDLSQRLGNL--QNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQ 285 (316)
T ss_dssp HHHTCSCTTTCTTSS--TTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC----
T ss_pred HHHhhhCHHhccccc--hhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCc
Confidence 999999999998743 35799999999999999999999999999999865543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-60 Score=522.17 Aligned_cols=289 Identities=44% Similarity=0.810 Sum_probs=254.1
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHH---HHHHHhcCCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIE---KQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E---~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
+++++|++.++||+|+||+||+|+++.||+.||||++.+..+........+.+| +.+++.++|||||+++++|.+.+
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 467899999999999999999999999999999999988877666666666665 55666778999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+|||||+||+|..+|.+.+ .+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+..
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999999998765 6899999999999999999999999999999999999999999999999999887
Q ss_pred CCCCcccccccccccCCcceec-CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 268 PEGESVRGRVGTVGYMAPEVID-NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~-~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
.... ....+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.+.. ...++.+.+......++..+|++
T Consensus 158 ~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~ 235 (364)
T d1omwa3 158 SKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEIDRMTLTMAVELPDSFSPE 235 (364)
T ss_dssp SSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-CHHHHHHHSSSCCCCCCSSSCHH
T ss_pred CCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccCCCCCCCCCCHH
Confidence 6543 45668999999999996 467999999999999999999999999876543 23345556666677778899999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchh
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDE 406 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~ 406 (767)
+++||.+||++||++||++.. .+|+|+++||||++++|..+..+.++||++|......
T Consensus 236 ~~~li~~~L~~dP~~R~t~~~--~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~~~ 293 (364)
T d1omwa3 236 LRSLLEGLLQRDVNRRLGCLG--RGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVN 293 (364)
T ss_dssp HHHHHHHHTCSSTTTSTTTSS--STHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC---
T ss_pred HHHHHHHHcccCHHHhCCCcc--cCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCCCC
Confidence 999999999999999999754 4699999999999999999999999999999765433
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-60 Score=520.74 Aligned_cols=288 Identities=31% Similarity=0.600 Sum_probs=260.1
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
..+++|++++.||+|+||+||+|+++.||+.||||++.+.........+.+++|+.+|++++|||||++++++.+.+.++
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 44679999999999999999999999999999999998887777777788999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+||||+.||+|..++.+.+ .+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cccccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999999998865 6999999999999999999999999999999999999999999999999999987543
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
..+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.. .+...+.......+..+|+++++|
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~l 268 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKIVSGKVRFPSHFSSDLKDL 268 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH----HHHHHHhcCCCCCCccCCHHHHHH
Confidence 34678999999999999999999999999999999999999999876543 344455566667788999999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHh
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDR 409 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~ 409 (767)
|++||.+||.+|+.. .|.++++|++||||++++|..+..+.+.|||+|.+.......
T Consensus 269 i~~~L~~dP~kR~~~--~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s 325 (350)
T d1rdqe_ 269 LRNLLQVDLTKRFGN--LKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTS 325 (350)
T ss_dssp HHHHSCSCTTTCTTS--STTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCT
T ss_pred HHHHhhhCHHhcccc--ccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhh
Confidence 999999999999752 235799999999999999999999999999999977654433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=508.50 Aligned_cols=279 Identities=32% Similarity=0.572 Sum_probs=245.0
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|++++|||||+++++|++++.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 34689999999999999999999999999999999998877666677889999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
|||||+||+|..++...+ .+++..++.++.||+.||+|||++|||||||||+|||++++|++||+|||+|+.+....
T Consensus 86 vmEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999999988765 69999999999999999999999999999999999999999999999999998775332
Q ss_pred ---cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 272 ---SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 272 ---~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
...+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.. ++.+.+......++..+|++++
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~ 238 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----LIFQKIIKLEYDFPEKFFPKAR 238 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHTTCCCCCTTCCHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH----HHHHHHHcCCCCCCccCCHHHH
Confidence 234568999999999999999999999999999999999999999887543 3444555566677889999999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVP 400 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P 400 (767)
+||++||++||++|||+.+ .....+|++||||++++|++|... .||-+|
T Consensus 239 ~li~~~L~~dP~~R~t~~e-~~~~~~i~~Hpff~~i~w~~l~~~--~pP~l~ 287 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESVTWENLHQQ--TPPKLT 287 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGG-GTCHHHHHTSGGGTTCCCTTGGGS--CCCCCC
T ss_pred HHHHHHccCCHhHCcCHHH-HcCCHHHHcCCccCCCCHHHhhcC--CCCCCC
Confidence 9999999999999999643 124567999999999999999875 455454
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-60 Score=511.51 Aligned_cols=284 Identities=37% Similarity=0.674 Sum_probs=244.8
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHH-hcCCCceeEEEEEEeeCCeEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
+++|++.++||+|+||+||+|+++.||+.||||++.+.........+.+.+|..++. .++|||||++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 368999999999999999999999999999999998877666666777888888776 6899999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
|||||+||+|..++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++++|++||+|||+|+......
T Consensus 81 vmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999999998765 68999999999999999999999999999999999999999999999999998765433
Q ss_pred -cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 272 -SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 272 -~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.. ++.+.+......++..+|+++++|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~~~~~~~p~~~s~~~~dl 233 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIRMDNPFYPRWLEKEAKDL 233 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCccCCHHHHHH
Confidence 344578999999999999999999999999999999999999999887543 345555666777888999999999
Q ss_pred HHHhcccCcCccCCCCCCcccH-HHHHhCCCCCCCChhhHhcCCCCCCCCCCCCchhHHhh
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGA-RELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRDEVDRR 410 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a-~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~~~~~~ 410 (767)
|++||++||++||+ + .++++||||++++|+.+..+.++||++|.+......++
T Consensus 234 i~~~L~~dP~~R~s-------~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~ 287 (320)
T d1xjda_ 234 LVKLFVREPEKRLG-------VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSN 287 (320)
T ss_dssp HHHHSCSSGGGSBT-------TBSCGGGSGGGTTCCHHHHHTTCSCC--------------
T ss_pred HHHhcccCCCCCcC-------HHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhh
Confidence 99999999999999 5 37999999999999999999999999998766433333
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-59 Score=487.19 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=235.5
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
.++++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|++++|||||++++++.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 34678999999999999999999999999999999999887777777788999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~ 270 (767)
+|||||+||+|..++.+.+ .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 83 ivmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999999998765 6999999999999999999999999999999999999999999999999999876544
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
.....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.. ++.+.+......+|..+|+++++|
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~l 234 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRVEFTFPDFVTEGARDL 234 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCccCCHHHHHH
Confidence 345678999999999999999999999999999999999999999876543 344455556667788899999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
|.+||++||++||+ ++|+++||||++
T Consensus 235 i~~~L~~dp~~R~t-------~~eil~hp~~~~ 260 (263)
T d2j4za1 235 ISRLLKHNPSQRPM-------LREVLEHPWITA 260 (263)
T ss_dssp HHHHTCSSGGGSCC-------HHHHHTCHHHHH
T ss_pred HHHHccCCHhHCcC-------HHHHHcCcCcCC
Confidence 99999999999998 999999999964
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-58 Score=487.51 Aligned_cols=273 Identities=27% Similarity=0.408 Sum_probs=232.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhh---hhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+.|++.+.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++++|||||+++++|++.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 569999999999999999999999999999999987654332 23567899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC----CEEEeecCcccc
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG----HVRISDLGLAVE 266 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g----~vkL~DFGla~~ 266 (767)
+|||||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|..
T Consensus 90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999998765 699999999999999999999999999999999999998777 599999999998
Q ss_pred cCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
...+....+..||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+.......+...........+..+|++
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHH
Confidence 87776677788999999999999999999999999999999999999999987665544444433333334455689999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDP 396 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~p 396 (767)
+++||++||++||++||+ ++|+++||||+..+|.........|
T Consensus 247 ~~~li~~~L~~dP~~R~s-------~~eil~hp~~~~~~~~~~l~~~~~~ 289 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMT-------IQDSLQHPWIKPKDTQQALSSAWSH 289 (293)
T ss_dssp HHHHHHTTSCSSGGGSCC-------HHHHHHSTTTCC-------------
T ss_pred HHHHHHHHccCChhHCcC-------HHHHhcCcccCCCChhHhhccCCCC
Confidence 999999999999999999 9999999999999998765554443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-57 Score=487.35 Aligned_cols=258 Identities=29% Similarity=0.441 Sum_probs=209.9
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.|++.+.||+|+||+||+|+++.+|+.||+|++.+..... ....+.+|+.+|++++|||||++++++++++.+|+||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999998765432 2356789999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC---CCCCEEEeecCcccccCCC
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD---DYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld---~~g~vkL~DFGla~~~~~~ 270 (767)
|||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||+. ++|++||+|||+|+....+
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999998654 699999999999999999999999999999999999994 5789999999999987766
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.......+.+.........+..+|+++++|
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 66677899999999999999999999999999999999999999998876554444444333333344456899999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
|.+||++||++||| ++|+++||||++
T Consensus 244 i~~~L~~dP~~R~s-------~~eil~hp~~~~ 269 (307)
T d1a06a_ 244 IRHLMEKDPEKRFT-------CEQALQHPWIAG 269 (307)
T ss_dssp HHHHSCSSGGGSCC-------HHHHHHSTTTTS
T ss_pred HHHHccCCHhHCcC-------HHHHhcCHhhCC
Confidence 99999999999998 999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=479.18 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=218.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+.... ...+.+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 36899999999999999999999999999999999765432 2335688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
||||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++++|++||+|||+|+......
T Consensus 82 mEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999999886543 69999999999999999999999999999999999999999999999999998764332
Q ss_pred --cccccccccccCCcceecCCCC-CCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 272 --SVRGRVGTVGYMAPEVIDNEKY-TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 272 --~~~~~~GT~~Y~APEvl~~~~y-s~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
...+.+||+.|||||++.+..| +.++|||||||++|||++|++||.............. ........+..+|++++
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-EKKTYLNPWKKIDSAPL 237 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH-TTCTTSTTGGGSCHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh-cCCCCCCccccCCHHHH
Confidence 2455789999999999988776 5789999999999999999999976544322211111 11112222357899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+||++||++||++||+ ++|+++||||+.
T Consensus 238 ~li~~~L~~dP~~R~t-------~~eil~hpwf~~ 265 (271)
T d1nvra_ 238 ALLHKILVENPSARIT-------IPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHSCSSTTTSCC-------HHHHTTCTTTTC
T ss_pred HHHHHHcCCChhHCcC-------HHHHhcCHhhCc
Confidence 9999999999999998 999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-57 Score=479.32 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=224.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++++.||+|+||+||+|+++.+|+.||+|++.+... ...+.+.+|+.+|++++|||||+++++|.+.+.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 579999999999999999999999999999999976532 23467899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-c
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-S 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~ 272 (767)
|||+||+|..++.+. .+++.+++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+.... .
T Consensus 97 Ey~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 999999999877653 59999999999999999999999999999999999999999999999999998875443 3
Q ss_pred ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 273 VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.......+... .......+..+|+++++||.
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-CSCCCSSGGGSCHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC-CCCCCCCcccCCHHHHHHHH
Confidence 45678999999999999999999999999999999999999999876654333222211 11223445678999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
+||++||++||+ ++|+++||||+.
T Consensus 252 ~~L~~dP~~R~s-------~~eil~Hp~~~~ 275 (293)
T d1yhwa1 252 RCLDMDVEKRGS-------AKELLQHQFLKI 275 (293)
T ss_dssp HHTCSSTTTSCC-------HHHHTTCGGGGG
T ss_pred HHccCChhHCcC-------HHHHhcCHhhCC
Confidence 999999999998 999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-56 Score=489.11 Aligned_cols=265 Identities=25% Similarity=0.367 Sum_probs=233.1
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
+++|++.+.||+|+||+||+|+++.+|+.||+|++.+... ...+.+.+|+.+|++++|||||++++++++++.+|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3689999999999999999999999999999999976532 2346788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC--CCCCEEEeecCcccccCCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD--DYGHVRISDLGLAVEIPEG 270 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld--~~g~vkL~DFGla~~~~~~ 270 (767)
||||+||+|.+++.+.. ..+++..++.++.||+.||+|||++|||||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 102 mE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999999886543 2699999999999999999999999999999999999995 4689999999999988777
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.......+...........+..+|+++++|
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 76777899999999999999999999999999999999999999998876544444443332223334445789999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhH
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l 389 (767)
|.+||++||++||| ++|+++||||+..+|...
T Consensus 260 i~~~L~~dP~~R~t-------~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 260 IRKLLLADPNTRMT-------IHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp HHHHCCSSGGGSCC-------HHHHHHSTTTSCTTCCSC
T ss_pred HHHHccCChhHCcC-------HHHHhcCcccCCCCCCCc
Confidence 99999999999998 999999999999887543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-57 Score=489.50 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=223.2
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 190 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 190 (767)
+..++|++++.||+|+||+||+|+++.||+.||+|++.+.. .......+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 44578999999999999999999999999999999997642 2334567899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 191 LVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 191 lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
+|||||+||+|..++.+.+ .+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999999998765 69999999999999999999997 5999999999999999999999999999987643
Q ss_pred CCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhh---------------------
Q psy11874 270 GESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEV--------------------- 328 (767)
Q Consensus 270 ~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i--------------------- 328 (767)
. ...+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+........
T Consensus 158 ~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp H-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred C-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2 234678999999999999999999999999999999999999999775432211000
Q ss_pred -----------------hhhhh-ccccccC-CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 329 -----------------DRRVK-EDAEKYS-CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 329 -----------------~~~i~-~~~~~~~-~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
...+. ...+..+ ..+|++++|||.+||+.||++||| |+|+++||||++.+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-------a~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD-------LKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCC-------HHHHHTSHHHHHHHHSC
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcC-------HHHHhhCHhhCcCCccc
Confidence 00000 1111111 246899999999999999999999 99999999999877643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-56 Score=479.92 Aligned_cols=292 Identities=37% Similarity=0.662 Sum_probs=255.7
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEE---ccCCcEEEEEEechhhhh-hhhhHHHHHHHHHHHHhcCC-CceeEEEEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQV---RATGKMYACKKLEKKRIK-KRKGESMVLIEKQILQKINS-RFVVSLAYAY 183 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~---~~tg~~~AiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~ 183 (767)
..+.+++|++++.||+|+||+||+|.+ +.+|+.||+|++++.... .....+.+.+|+++|++++| |||+++++++
T Consensus 19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 345678999999999999999999987 447999999999876543 23345668889999999977 8999999999
Q ss_pred eeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCc
Q psy11874 184 ETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGL 263 (767)
Q Consensus 184 ~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGl 263 (767)
.+...+++|||||.||+|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ccCCceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999999999998875 678999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc--ccccccccccCCcceecCC--CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 264 AVEIPEGES--VRGRVGTVGYMAPEVIDNE--KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 264 a~~~~~~~~--~~~~~GT~~Y~APEvl~~~--~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
|+....... ..+..||+.|+|||.+.+. .++.++|||||||+||||++|..||.+.+.......+.+........+
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~ 255 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCC
Confidence 987644322 3456899999999999654 468899999999999999999999988877666777777666677778
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhHhcCCCCCCCCCCCCch
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRLEAGLCDPPFVPDVKRD 405 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l~~~~~~pp~~P~~~~~ 405 (767)
+..+|+++++||++||.+||++||++.. .+|+|+++||||++++|..+..+.++||++|.+..+
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~--~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~ 319 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGP--RDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDE 319 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSST--TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-
T ss_pred cccCCHHHHHHHHHHcccCHHHcCCCCc--ccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCC
Confidence 8889999999999999999999998642 469999999999999999999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.3e-56 Score=483.17 Aligned_cols=259 Identities=28% Similarity=0.440 Sum_probs=230.1
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++++.||+|+||+||+|+++.+|+.||+|++.+... .....+.+|+.+|++++|||||+++++|.+++.+|+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999976532 23456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeC--CCCCEEEeecCcccccCCCC
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLD--DYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld--~~g~vkL~DFGla~~~~~~~ 271 (767)
|||+||+|.+++...+ ..+++.+++.++.||+.||+|||++|||||||||+||||+ .+|++||+|||+|+....+.
T Consensus 106 E~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 106 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999999988776543 3699999999999999999999999999999999999998 67899999999999988777
Q ss_pred cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHH
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALC 351 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi 351 (767)
...+..||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.......+.+.........+..+|+++++||
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 77778999999999999999999999999999999999999999988766544444443333333445567999999999
Q ss_pred HHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 352 KALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 352 ~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
++||++||.+||+ ++|+++||||++.
T Consensus 264 ~~~L~~dp~~R~s-------~~eil~Hp~~~~~ 289 (352)
T d1koba_ 264 KNLLQKEPRKRLT-------VHDALEHPWLKGD 289 (352)
T ss_dssp HTTSCSSGGGSCC-------HHHHHTSTTTSSC
T ss_pred HHHccCChhHCcC-------HHHHhcCHhhCCC
Confidence 9999999999999 9999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-56 Score=470.39 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=221.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
+.|++++.||+|+||+||+|+++.+|+.||+|++.+.. ....+.+.+|+++|++++|||||++++++.+.+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46999999999999999999999999999999997652 334566889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-Cc
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-ES 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~~ 272 (767)
|||+||+|..++.+.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... ..
T Consensus 89 Ey~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 9999999999887653 26999999999999999999999999999999999999999999999999999765332 22
Q ss_pred ccccccccccCCcceec-----CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHH
Q psy11874 273 VRGRVGTVGYMAPEVID-----NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDA 347 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~-----~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~ 347 (767)
..+.+||+.|||||++. +..|+.++|||||||++|||++|++||.+.+.......+.... ......+..+|+++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE-PPTLAQPSRWSSNF 245 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC-CCCCSSGGGSCHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCccccCCHHH
Confidence 34578999999999983 5568999999999999999999999998776543333222211 11223356789999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
++||++||++||++||+ ++|+++||||+.
T Consensus 246 ~~li~~~L~~dp~~R~t-------~~ell~hp~~~~ 274 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWT-------TSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHSCSSTTTSCC-------HHHHTTSGGGCC
T ss_pred HHHHHHHccCChhHCcC-------HHHHhcCcccCC
Confidence 99999999999999999 999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-56 Score=465.69 Aligned_cols=256 Identities=22% Similarity=0.390 Sum_probs=211.8
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee--CCeEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--KDALCL 191 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~l 191 (767)
++|++.+.||+|+||+||+|+++.||+.||+|++.+.... ....+.+.+|+++|++++|||||++++++.+ .+.+|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 6899999999999999999999999999999999876543 3345678899999999999999999999865 466999
Q ss_pred EEEeccCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHhHHHHHHHCC-----cccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 192 VLTIMNGGDLKFHIYNMG-GEPGFDIARARFYAAEVLCGLEHLHYIG-----LVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~-~~~~l~~~~~~~~~~qIl~aL~yLH~~~-----IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
|||||+||+|.+++.+.. ....+++..++.++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999987532 1346999999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCc-ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc-cccccCCCC
Q psy11874 266 EIPEGES-VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE-DAEKYSCRF 343 (767)
Q Consensus 266 ~~~~~~~-~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~~~~~ 343 (767)
....+.. ..+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+... +...+.. .....+..+
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCCCCCTTS
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH----HHHHHHcCCCCCCCccc
Confidence 8765433 456789999999999999999999999999999999999999998765533 3333332 233566789
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
|+++++||++||+.||++||+ ++|+++|||.
T Consensus 239 s~~l~~li~~~L~~dp~~Rps-------~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPS-------VEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcC-------HHHHHhCCcC
Confidence 999999999999999999999 9999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=456.69 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=215.6
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee----CCeEEE
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET----KDALCL 191 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~l~l 191 (767)
|++.+.||+|+||+||+|+++.+|+.||+|++....... ...+.+.+|+++|++++|||||++++++.+ +..+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 477789999999999999999999999999998765432 345678899999999999999999999875 456899
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCC--cccccCCcceEEeC-CCCCEEEeecCcccccC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIG--LVYRDCKPENILLD-DYGHVRISDLGLAVEIP 268 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~--IvHrDLKPeNILld-~~g~vkL~DFGla~~~~ 268 (767)
|||||+||+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+||||||+|||++ ++|.+||+|||+|+...
T Consensus 90 vmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999998764 6999999999999999999999999 99999999999996 58999999999998653
Q ss_pred CCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc--ccccCCCCcHH
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED--AEKYSCRFSDD 346 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~~~~~s~~ 346 (767)
. ....+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.... .++.+.+... +..++...+++
T Consensus 167 ~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 167 A-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp T-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHHHHHTTTCCCGGGGGCCCHH
T ss_pred C-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH---HHHHHHHHcCCCCcccCccCCHH
Confidence 3 33456789999999999865 5999999999999999999999999764322 2233333322 23455678999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
+++||.+||++||++||+ ++|+++||||+
T Consensus 242 ~~~li~~~l~~dp~~R~s-------~~ell~Hp~fk 270 (270)
T d1t4ha_ 242 VKEIIEGCIRQNKDERYS-------IKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHSCSSGGGSCC-------HHHHHTSGGGC
T ss_pred HHHHHHHHccCCHhHCcC-------HHHHhCCcccC
Confidence 999999999999999998 99999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-54 Score=458.62 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=227.5
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhh------hhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeC
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK------RKGESMVLIEKQILQKIN-SRFVVSLAYAYETK 186 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~------~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~ 186 (767)
++|++.+.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999999999999999997754322 223446889999999997 99999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+.+|+|||||+||||.++|...+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999998765 699999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCcccccccccccCCcceec------CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVID------NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS 340 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~------~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~ 340 (767)
+..+......+||+.|+|||++. ...|+.++||||+||++|||++|+.||.+.+.......+...-.......+
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 87766667788999999999985 345789999999999999999999999987654444333332222222334
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
..+|+++++||++||++||++||+ ++|+++||||+.
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s-------~~eil~h~~~~~ 275 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYT-------AEEALAHPFFQQ 275 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCC-------HHHHTTSGGGCT
T ss_pred ccCCHHHHHHHHHHccCChhHCcC-------HHHHHcCHHHHH
Confidence 479999999999999999999999 999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-55 Score=469.70 Aligned_cols=253 Identities=24% Similarity=0.304 Sum_probs=221.4
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEE
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 194 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E 194 (767)
.|+.++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987765555666779999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCccc
Q psy11874 195 IMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGESVR 274 (767)
Q Consensus 195 ~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~~~ 274 (767)
||+||+|..++...+ .+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BC
T ss_pred ecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CC
Confidence 999999977766543 699999999999999999999999999999999999999999999999999987543 34
Q ss_pred ccccccccCCcceecC---CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc-ccCCCCcHHHHHH
Q psy11874 275 GRVGTVGYMAPEVIDN---EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE-KYSCRFSDDAKAL 350 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~---~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~-~~~~~~s~~~~dL 350 (767)
..+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+.......+ ...... ..+..+|+++++|
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i---~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCSCTTSCHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH---HhCCCCCCCCCCCCHHHHHH
Confidence 5689999999999864 46899999999999999999999999876543322222 222222 2345689999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
|.+||++||++||+ ++|+++||||..
T Consensus 247 i~~~L~~dP~~Rpt-------~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 247 VDSCLQKIPQDRPT-------SEVLLKHRFVLR 272 (309)
T ss_dssp HHHHTCSSGGGSCC-------HHHHTTCHHHHS
T ss_pred HHHHCcCChhHCcC-------HHHHHhCHHhcC
Confidence 99999999999999 999999999965
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=466.96 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=226.9
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
.++|++.+.||+|+||+||+|.++.||+.||+|++.++.. ....+.+|+++|++++|||||+++++|++.+.+|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3689999999999999999999999999999999976532 234678999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCC--CCEEEeecCcccccCCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDY--GHVRISDLGLAVEIPEG 270 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~--g~vkL~DFGla~~~~~~ 270 (767)
||||+||+|..++...+ ..+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 99999999999987643 258999999999999999999999999999999999999854 58999999999988776
Q ss_pred CcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHH
Q psy11874 271 ESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKAL 350 (767)
Q Consensus 271 ~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dL 350 (767)
......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+.+.........+..+|+++++|
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 66677889999999999999999999999999999999999999998876654444443322222333345789999999
Q ss_pred HHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 351 CKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 351 i~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
|++||.+||++||+ ++|+++||||+.
T Consensus 238 i~~~L~~dp~~R~s-------~~eil~hp~~~~ 263 (321)
T d1tkia_ 238 VDRLLVKERKSRMT-------ASEALQHPWLKQ 263 (321)
T ss_dssp HHTTSCSSGGGSCC-------HHHHHHSHHHHS
T ss_pred HHHHccCChhHCcC-------HHHHhcCHhhcc
Confidence 99999999999998 999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=457.54 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=213.7
Q ss_pred EEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhh--hHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEe
Q psy11874 118 MYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTI 195 (767)
Q Consensus 118 ~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~--~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~ 195 (767)
.+++||+|+||+||+|+++.+|+.||||++.+....... ....+.+|+.+|++++|||||++++++.+++++|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 578999999999999999999999999999765443222 245688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-ccc
Q psy11874 196 MNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE-SVR 274 (767)
Q Consensus 196 ~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~-~~~ 274 (767)
|.||++...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...... ...
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 998877655443 2368999999999999999999999999999999999999999999999999998765443 345
Q ss_pred ccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc-----------------
Q psy11874 275 GRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA----------------- 336 (767)
Q Consensus 275 ~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~----------------- 336 (767)
+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.......+.+......
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 6789999999999865 4689999999999999999999999988776554444433221111
Q ss_pred -------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 337 -------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 337 -------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
......+|+++++||++||+.||++||| |+|+++||||++..
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s-------a~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT-------ATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC-------HHHHHTSGGGTSSS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC-------HHHHhCCHhhCCCC
Confidence 0112357899999999999999999999 99999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-54 Score=465.01 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=218.3
Q ss_pred CCCeEEEe-EEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEee----C
Q psy11874 113 YKTFRMYR-VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYET----K 186 (767)
Q Consensus 113 ~~~y~~~~-~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~----~ 186 (767)
.++|+++. +||+|+||+||+|+++.||+.||||++++. ..+.+|+.++.++ +|||||+++++|++ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 46899875 699999999999999999999999998643 2466799987654 89999999999976 4
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC---CCCEEEeecCc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD---YGHVRISDLGL 263 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~---~g~vkL~DFGl 263 (767)
..+|+|||||+||+|.++|.+.+ ...+++.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 67999999999999999998653 346999999999999999999999999999999999999985 56799999999
Q ss_pred ccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccC---
Q psy11874 264 AVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYS--- 340 (767)
Q Consensus 264 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~--- 340 (767)
|+...........+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+.......+...+......++
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 99887777777889999999999999999999999999999999999999999887655444555555544444443
Q ss_pred -CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 341 -CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 341 -~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
..+|+++++||++||++||++||+ ++|+++||||.+
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s-------~~eil~hp~~~~ 277 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMT-------ITEFMNHPWIMQ 277 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCC-------HHHHHHSHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhHCcC-------HHHHHcCHHhhC
Confidence 358999999999999999999999 999999999965
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=450.16 Aligned_cols=263 Identities=25% Similarity=0.389 Sum_probs=217.2
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
+++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+++|++++|||||++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 3689999999999999999999999999999999976532 233456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCC-C
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEG-E 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~-~ 271 (767)
|||+.|+.+....... ..++++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..... .
T Consensus 80 ~e~~~~~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred EeecCCchhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9999876554433332 347999999999999999999999999999999999999999999999999999877543 3
Q ss_pred cccccccccccCCcceecCCC-CCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccc--------------
Q psy11874 272 SVRGRVGTVGYMAPEVIDNEK-YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDA-------------- 336 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~~-ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~-------------- 336 (767)
......||+.|+|||++.... ++.++|+||+||++|+|++|+.||.+.+.......+.+......
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 345668999999999987765 57899999999999999999999987765443333222111100
Q ss_pred -----------cccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 337 -----------EKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 337 -----------~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
......+|+++++||++||.+||++||| ++|+++||||++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t-------~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS-------AKAALAHPFFQDVT 290 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC-------HHHHHTSGGGTTCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC-------HHHHhCCHhhccCC
Confidence 1112357899999999999999999999 99999999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=447.51 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=218.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhh---hHHHHHHHHHHHHhcC--CCceeEEEEEEeeCCe
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GESMVLIEKQILQKIN--SRFVVSLAYAYETKDA 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~---~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~~ 188 (767)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+....... ....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999999999999999999876554322 2234668999999997 8999999999999999
Q ss_pred EEEEEEeccC-CCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC-CCCEEEeecCcccc
Q psy11874 189 LCLVLTIMNG-GDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-YGHVRISDLGLAVE 266 (767)
Q Consensus 189 l~lV~E~~~g-G~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-~g~vkL~DFGla~~ 266 (767)
+|+||||+.| +++..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999986 67877777654 6999999999999999999999999999999999999985 57999999999987
Q ss_pred cCCCCcccccccccccCCcceecCCCC-CCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 267 IPEGESVRGRVGTVGYMAPEVIDNEKY-TYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 267 ~~~~~~~~~~~GT~~Y~APEvl~~~~y-s~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
.... ...+.+||+.|||||++.+..+ +.++|||||||++|||++|+.||.+.+. +......++..+|+
T Consensus 161 ~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------i~~~~~~~~~~~s~ 229 (273)
T d1xwsa_ 161 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQRVSS 229 (273)
T ss_dssp CCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HHHCCCCCSSCCCH
T ss_pred cccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----------HhhcccCCCCCCCH
Confidence 6443 3456789999999999987665 6779999999999999999999976432 22234456778999
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCC
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTN 385 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~ 385 (767)
++++||++||++||++||| ++|+++||||+++-
T Consensus 230 ~~~~li~~~L~~dp~~R~s-------~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 230 ECQHLIRWCLALRPSDRPT-------FEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCC-------HHHHHTSGGGSSCC
T ss_pred HHHHHHHHHccCCHhHCcC-------HHHHhcCHhhCCCC
Confidence 9999999999999999998 99999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-53 Score=449.93 Aligned_cols=263 Identities=23% Similarity=0.341 Sum_probs=219.5
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccC-CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc---CCCceeEEEEEEee----
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKKRKGESMVLIEKQILQKI---NSRFVVSLAYAYET---- 185 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~---- 185 (767)
++|++++.||+|+||+||+|+++.+ ++.||||++....... .....+.+|+.+|+.+ +|||||+++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 6899999999999999999999766 6789999997653322 2233466788877766 89999999999853
Q ss_pred -CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 186 -KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 186 -~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
...+|++||+|+||++....... ...+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 35799999999988776544432 347999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-----------
Q psy11874 265 VEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK----------- 333 (767)
Q Consensus 265 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~----------- 333 (767)
+...........+||+.|||||++.+..|+.++||||+||++|||++|++||.+.+.......+.....
T Consensus 164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 877666666778999999999999999999999999999999999999999988765444333322111
Q ss_pred ------------ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCCh
Q psy11874 334 ------------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNW 386 (767)
Q Consensus 334 ------------~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w 386 (767)
.....++..+|+++++||++||++||++||| |+|+++||||+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s-------a~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS-------AYSALSHPYFQDLER 301 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC-------HHHHHTSGGGTTCCC
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC-------HHHHhcChhhcCchh
Confidence 1112234568999999999999999999999 999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.1e-52 Score=436.40 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=213.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC----eE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----AL 189 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~l 189 (767)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+++|++++|||||++++++.+.+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 57999999999999999999999999999999998776655666678999999999999999999999998754 48
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPE 269 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~ 269 (767)
|+|||||+||+|..++...+ .+++.+++.++.||+.||+|||++|||||||||+|||++.++.++|+|||++.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 99999999999999888765 699999999999999999999999999999999999999999999999999876543
Q ss_pred CC----cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccccCCCCcH
Q psy11874 270 GE----SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSD 345 (767)
Q Consensus 270 ~~----~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~ 345 (767)
.. ...+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.........+.-.......+..+|+
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 32 23456899999999999999999999999999999999999999988765443333332222223344568999
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++++||.+||++||++||+ +++++++
T Consensus 244 ~l~~li~~~L~~dp~~R~~------sa~~l~~ 269 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQ------TAAEMRA 269 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCS------SHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHh------HHHHHHH
Confidence 9999999999999999996 3777763
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-51 Score=437.22 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=215.6
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 192 (767)
+++|++++.||+|+||+||+|+++ +|+.||||++..... .......+.+|+.+|++++|||||++++++.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 368999999999999999999986 889999999976643 334466789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC-
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE- 271 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~- 271 (767)
||++.|+++..+.... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|.......
T Consensus 79 ~e~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9999988776665543 379999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc----------------
Q psy11874 272 SVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE---------------- 334 (767)
Q Consensus 272 ~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~---------------- 334 (767)
......||+.|+|||++.+. .++.++|+|||||++|||++|++||.+.+.......+.+....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 24456799999999998654 5799999999999999999999999877654433332221110
Q ss_pred ---------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 335 ---------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 335 ---------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
........+|++++|||++||++||++||| |+|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s-------~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT-------AKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC-------HHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC-------HHHHhcCcccCc
Confidence 011234567899999999999999999999 999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=442.23 Aligned_cols=260 Identities=21% Similarity=0.262 Sum_probs=216.9
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEccCCc-----EEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEE
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAY 181 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 181 (767)
.+++..++|++.++||+|+||+||+|+++.+++ .||+|++.... .......+.+|+.+|.++ +|||||++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 345677899999999999999999999886654 69999986543 233456788999999998 8999999999
Q ss_pred EEeeCCeEEEEEEeccCCCHHHHHHhcCC--------------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccc
Q psy11874 182 AYETKDALCLVLTIMNGGDLKFHIYNMGG--------------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYR 241 (767)
Q Consensus 182 ~~~~~~~l~lV~E~~~gG~L~~~l~~~~~--------------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHr 241 (767)
++.+.+.+|+|||||+||+|.++|..... ...+++..++.|+.||+.||+|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 99999999999999999999999976532 1348999999999999999999999999999
Q ss_pred cCCcceEEeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCC
Q psy11874 242 DCKPENILLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFR 317 (767)
Q Consensus 242 DLKPeNILld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~ 317 (767)
||||+|||++.+|++||+|||+|+....... ..+..||+.|||||++.+..|+.++|||||||++|||++ |.+||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654432 235678999999999999999999999999999999997 899998
Q ss_pred CchhhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 318 RRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 318 ~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+.+.......+.+. ......|..+|+++++||.+||+.||++||| ++||++|
T Consensus 269 ~~~~~~~~~~~~~~--~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt-------~~ei~~~ 320 (325)
T d1rjba_ 269 GIPVDANFYKLIQN--GFKMDQPFYATEEIYIIMQSCWAFDSRKRPS-------FPNLTSF 320 (325)
T ss_dssp TCCCSHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred CCCHHHHHHHHHhc--CCCCCCCCcCCHHHHHHHHHHcCCChhHCcC-------HHHHHHH
Confidence 76543333222221 1234566789999999999999999999999 9999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-51 Score=434.84 Aligned_cols=254 Identities=18% Similarity=0.246 Sum_probs=217.5
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
+++..++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 4566789999999999999999999999999999999987543 234568999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+|||||++|+|..++.+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+...
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999999999997653 3479999999999999999999999999999999999999999999999999998765
Q ss_pred CCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-ccccccCCCCcH
Q psy11874 269 EGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK-EDAEKYSCRFSD 345 (767)
Q Consensus 269 ~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~~~~~s~ 345 (767)
.... .....||+.|||||++.+..|+.++|||||||++|||++|..||...... .++.+.+. ......+..+|+
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~---~~~~~~i~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDYRMERPEGCPE 243 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH---HHHHHHHhcCCCCCCCccchH
Confidence 4432 23456899999999999999999999999999999999976665433222 12222222 234556778999
Q ss_pred HHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 346 DAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 346 ~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
++++||.+||+.||++||+ ++||++
T Consensus 244 ~l~~li~~cl~~dP~~Rps-------~~ei~~ 268 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPS-------FAEIHQ 268 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcC-------HHHHHH
Confidence 9999999999999999999 888865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-51 Score=444.49 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=214.0
Q ss_pred CeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee------CCe
Q psy11874 115 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------KDA 188 (767)
Q Consensus 115 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~~~ 188 (767)
+|+..++||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|++++|||||+++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 69999999999999999999999999999999966432 23469999999999999999999854 346
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-CEEEeecCccccc
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-HVRISDLGLAVEI 267 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-~vkL~DFGla~~~ 267 (767)
+|+|||||++|.+............+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 899999998775544443333345799999999999999999999999999999999999999775 8999999999988
Q ss_pred CCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcc-----------
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKED----------- 335 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~----------- 335 (767)
.......+.+||+.|+|||++.+ ..|+.++||||+||++|||++|++||...+.......+.+.....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 77776777899999999998865 579999999999999999999999998776544443332211100
Q ss_pred --------------ccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 336 --------------AEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 336 --------------~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.......+|+++++||.+||++||++||| |+|+++||||+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t-------a~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT-------PLEACAHSFFDEL 309 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC-------HHHHHTSGGGGGG
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC-------HHHHhcCHhhccc
Confidence 01123457999999999999999999999 9999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.9e-51 Score=439.70 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=214.6
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEee--CCeE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYET--KDAL 189 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~--~~~l 189 (767)
.++|++++.||+|+||+||+|+++.+|+.||+|++++.. ...+.+|+.+|++++ ||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 368999999999999999999999999999999986432 345788999999995 9999999999975 4579
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC-CEEEeecCcccccC
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG-HVRISDLGLAVEIP 268 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g-~vkL~DFGla~~~~ 268 (767)
|+|||||++|+|.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+...
T Consensus 108 ~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999999996542 2599999999999999999999999999999999999998665 58999999999887
Q ss_pred CCCcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhh-hhhhhhhhh-------------
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVK-RDEVDRRVK------------- 333 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~-~~~i~~~i~------------- 333 (767)
........+||+.|+|||++.+. .|+.++|+||+||++|||++|+.||........ ...+.....
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 77667778899999999998764 589999999999999999999999976543211 111110000
Q ss_pred c--------------------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChh
Q psy11874 334 E--------------------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWK 387 (767)
Q Consensus 334 ~--------------------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~ 387 (767)
. ........+|++++|||++||++||++||| |+|+++||||+++.|+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t-------a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT-------AREAMEHPYFYTVVKD 328 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC-------HHHHHTSGGGTTSCCC
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC-------HHHHhcCcccCCCCCC
Confidence 0 000112347899999999999999999999 9999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=431.35 Aligned_cols=256 Identities=23% Similarity=0.283 Sum_probs=208.7
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
+++..++|++.+.||+|+||+||+|+.+ ..||||++..... .....+.+.+|+.+|++++|||||++++++. .+.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 4567789999999999999999999864 3599999976543 2345667899999999999999999998764 567
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+++|||||+||+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+||||+.++++||+|||+|+...
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 899999999999999997643 369999999999999999999999999999999999999999999999999998764
Q ss_pred CCC---cccccccccccCCcceecC---CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhh-hhhhc-cccccC
Q psy11874 269 EGE---SVRGRVGTVGYMAPEVIDN---EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVD-RRVKE-DAEKYS 340 (767)
Q Consensus 269 ~~~---~~~~~~GT~~Y~APEvl~~---~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~-~~i~~-~~~~~~ 340 (767)
... ...+..||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.+......... +.... .....+
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 332 2345689999999999964 358999999999999999999999998765433222222 21111 223456
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
..+|+++++|+.+||+.||++||+ ++||++|
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt-------~~~il~~ 266 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPL-------FPQILAS 266 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcC-------HHHHHHH
Confidence 678999999999999999999999 8898875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=429.94 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=218.2
Q ss_pred hhhcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe
Q psy11874 105 YNEIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE 184 (767)
Q Consensus 105 ~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 184 (767)
+.+.+++..++|++.+.||+|+||+||+|.++ +++.||||++.+.. ...+.+.+|+.+|++++|||||++++++.
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 34556677789999999999999999999986 67899999997543 23456899999999999999999999775
Q ss_pred eCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 185 TKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
+ +.+|+|||||++|+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+||||++++.+||+|||+|
T Consensus 79 ~-~~~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 79 Q-EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccce
Confidence 4 56899999999999998776542 235899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcC-CCCCCCchhhhhhhhhhhhhhccccccCC
Q psy11874 265 VEIPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEG-QAPFRRRKEMVKRDEVDRRVKEDAEKYSC 341 (767)
Q Consensus 265 ~~~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG-~~PF~~~~~~~~~~~i~~~i~~~~~~~~~ 341 (767)
+....... .....||+.|||||++.+..|+.++|||||||++|||+|| .+||...+.......+. .......+.
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~---~~~~~~~p~ 233 (272)
T d1qpca_ 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---RGYRMVRPD 233 (272)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCCCCCT
T ss_pred EEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcCCCCCcc
Confidence 88765432 3345799999999999989999999999999999999995 55565544332222222 123345567
Q ss_pred CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh--CCCCC
Q psy11874 342 RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ--AEFFK 382 (767)
Q Consensus 342 ~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~--HpfF~ 382 (767)
.+|+++++||.+||+.||++||+ +++|++ |+||.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt-------~~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPT-------FDYLRSVLEDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcC-------HHHHHHHhhhhhh
Confidence 89999999999999999999999 899988 77775
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=434.54 Aligned_cols=260 Identities=24% Similarity=0.288 Sum_probs=212.5
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee-------
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------- 185 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------- 185 (767)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|++++||||+++++++.+
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4789999999999999999999999999999999876643 23445678899999999999999999998865
Q ss_pred -CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcc
Q psy11874 186 -KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLA 264 (767)
Q Consensus 186 -~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla 264 (767)
++.+|+|||||.++++...... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeeccee
Confidence 4568999999998877644433 337999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-----cccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhccccc
Q psy11874 265 VEIPEGE-----SVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAEK 338 (767)
Q Consensus 265 ~~~~~~~-----~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~~ 338 (767)
+...... ...+.+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+.......+.+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 7665322 23446799999999998765 68999999999999999999999998876654444443332222111
Q ss_pred cCC----------------------------CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCC
Q psy11874 339 YSC----------------------------RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKS 383 (767)
Q Consensus 339 ~~~----------------------------~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~ 383 (767)
... ..+++++|||.+||+.||++||| |+|+++||||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s-------a~elL~Hpff~~ 310 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID-------SDDALNHDFFWS 310 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC-------HHHHHHSGGGSS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC-------HHHHHcChhhcc
Confidence 110 13788999999999999999999 999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=439.86 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=212.6
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC------
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD------ 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~------ 187 (767)
++|++++.||+|+||+||+|.++.+|+.||||++.+... .......+.+|+++|++++|||||+++++|...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 689999999999999999999999999999999976532 3445667899999999999999999999998764
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+||||| |++|...+.+. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 56777766543 5999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccccCCcceecC-CCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhh-------------
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDN-EKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVK------------- 333 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~------------- 333 (767)
.. .....+||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.+.......+.....
T Consensus 172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 172 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred CC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 44 3456789999999999876 4578999999999999999999999987755433322221111
Q ss_pred --------------ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhh
Q psy11874 334 --------------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKR 388 (767)
Q Consensus 334 --------------~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~ 388 (767)
..........|++++|||++||..||++||| |+|+++||||+++++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t-------a~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT-------AGEALAHPYFESLHDTE 311 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC-------HHHHHHSGGGTTTC---
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC-------HHHHhcChhhCcCCCcc
Confidence 1111223567999999999999999999999 99999999999987543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-50 Score=431.93 Aligned_cols=254 Identities=21% Similarity=0.333 Sum_probs=204.5
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCCc---EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
.+..++|++.++||+|+||+||+|.++.+|+ .+|+|.+.... .....+.+.+|+.+|++++|||||++++++.+.
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4566789999999999999999999987765 68899886543 233456789999999999999999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+.+|+|||||+||+|..++.... ..+++.++..++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CEEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 99999999999999998887643 3689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhcccccc
Q psy11874 267 IPEGES------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKY 339 (767)
Q Consensus 267 ~~~~~~------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~ 339 (767)
...... .....||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.........+.+ ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~---~~~~~~ 254 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPP 254 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---TCCCCC
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCC
Confidence 654332 122458999999999999999999999999999999998 8999987755433333222 223455
Q ss_pred CCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 340 SCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 340 ~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+..+++++.+|+.+||+.||++||+ ++||++
T Consensus 255 ~~~~~~~l~~li~~cl~~~P~~RPs-------~~ei~~ 285 (299)
T d1jpaa_ 255 PMDCPSALHQLMLDCWQKDRNHRPK-------FGQIVN 285 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCC-------HHHHHH
T ss_pred CccchHHHHHHHHHHcCCCHhHCcC-------HHHHHH
Confidence 6789999999999999999999999 777665
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=422.61 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=204.4
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||+||+|.++ +++.||||++.+... ..+.+.+|+.+|++++|||||++++++.+++.+++
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 4578999999999999999999986 678899999976432 34568999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+|+++.+||+|||+|+......
T Consensus 78 v~E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999999887643 368999999999999999999999999999999999999999999999999998765443
Q ss_pred c--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 272 S--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 272 ~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
. .....||+.|||||++.+..|+.++|||||||++|||+| |.+||...+.......+.. ......|...++++.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~---~~~~~~p~~~~~~l~ 232 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLASTHVY 232 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH---TCCCCCCTTSCHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh---cCCCCCccccCHHHH
Confidence 2 234679999999999999999999999999999999999 5677766544322222222 223445677899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+|+.+||+.||++||+ ++||++|
T Consensus 233 ~li~~cl~~~p~~Rps-------~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPA-------FSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred HHHHHHccCCHhHCcC-------HHHHHHH
Confidence 9999999999999999 8999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=429.26 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=208.2
Q ss_pred eEEeecCcEEEEEEEEcc--CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEEEecc
Q psy11874 120 RVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIMN 197 (767)
Q Consensus 120 ~~LG~G~fG~Vy~a~~~~--tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~E~~~ 197 (767)
+.||+|+||+||+|.++. +++.||+|++.... ......+.+.+|+.+|++++|||||+++++++++ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 579999999999998753 56899999997553 2344456789999999999999999999998754 5789999999
Q ss_pred CCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc----c
Q psy11874 198 GGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES----V 273 (767)
Q Consensus 198 gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~----~ 273 (767)
||+|..++.+.. .+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....... .
T Consensus 91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999999988754 699999999999999999999999999999999999999999999999999987654432 2
Q ss_pred cccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHHHHHH
Q psy11874 274 RGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAKALCK 352 (767)
Q Consensus 274 ~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~ 352 (767)
....||+.|||||++.+..|+.++|||||||++|||++ |++||.+.+.......+. .......+..+|+++++|+.
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~---~~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH---cCCCCCCCcccCHHHHHHHH
Confidence 23469999999999999999999999999999999998 999998765433322222 12345667789999999999
Q ss_pred HhcccCcCccCCCCCCcccHHHH---HhCCCCCCCC
Q psy11874 353 ALLKKSPRSRLGCHCGRYGAREL---KQAEFFKSTN 385 (767)
Q Consensus 353 ~lL~~dP~~Rl~~~~~~~~a~ei---l~HpfF~~i~ 385 (767)
+||+.||++||+ +++| ++|+|+.-+|
T Consensus 245 ~cl~~dp~~RPs-------~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 245 LCWTYDVENRPG-------FAAVELRLRNYYYDVVN 273 (277)
T ss_dssp HHTCSSTTTSCC-------HHHHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcC-------HHHHHHHhhCHHhhcCC
Confidence 999999999999 6666 6777765443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=427.11 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=213.6
Q ss_pred cCCCeEEEeE-EeecCcEEEEEEEEccC--CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCe
Q psy11874 112 TYKTFRMYRV-LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 188 (767)
Q Consensus 112 ~~~~y~~~~~-LG~G~fG~Vy~a~~~~t--g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 188 (767)
..++|.+..+ ||+|+||+||+|.++.+ +..||||++++.. .....+.+.+|+++|++++|||||++++++.+ +.
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 4467888885 99999999999987644 5589999997542 33445678999999999999999999999875 46
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+|||||+||+|..++...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 899999999999999876543 369999999999999999999999999999999999999999999999999998775
Q ss_pred CCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 269 EGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 269 ~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
.... .....||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+.......+. .......|..+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~---~~~~~~~p~~~ 237 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---QGKRMECPPEC 237 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH---TTCCCCCCTTC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCCCCCcC
Confidence 5432 234568999999999999999999999999999999998 999998765433222222 22345667889
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFF 381 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF 381 (767)
|+++.+||.+||+.||++||++. .+.+.++|+|+
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~----~i~~~L~~~~~ 271 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFL----TVEQRMRACYY 271 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHH----HHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHH----HHHHHHHHHHH
Confidence 99999999999999999999932 24445777775
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=420.68 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=219.6
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 193 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV~ 193 (767)
++|++++.||+|+||+||+|+++.+|+.||||+++... ........+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 68999999999999999999999999999999996653 23445678899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES- 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~- 272 (767)
+++.|++|..++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||.|+.......
T Consensus 81 ~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9999999988776654 689999999999999999999999999999999999999999999999999988765433
Q ss_pred ccccccccccCCcceecCCC-CCCCCccccchhhHHHHhcCCCCCCC-chhhhhhhhhhhhhh-----------------
Q psy11874 273 VRGRVGTVGYMAPEVIDNEK-YTYSPDWFSFGCLIFEMIEGQAPFRR-RKEMVKRDEVDRRVK----------------- 333 (767)
Q Consensus 273 ~~~~~GT~~Y~APEvl~~~~-ys~~~DvwSlGviLyElltG~~PF~~-~~~~~~~~~i~~~i~----------------- 333 (767)
.....+++.|+|||++.+.. ++.++|+||+||++|||++|+.||.. .+.......+.....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 34456889999999987665 68999999999999999999998643 333222222211111
Q ss_pred --------ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 334 --------EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 334 --------~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
.........+|+++++||++||+.||.+||| |+|+++||||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s-------a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS-------AEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC-------HHHHTTSGGGSSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC-------HHHHhcChhhcCC
Confidence 1111233467899999999999999999999 9999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-50 Score=417.21 Aligned_cols=250 Identities=20% Similarity=0.275 Sum_probs=217.4
Q ss_pred cCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCCeEEE
Q psy11874 112 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 191 (767)
Q Consensus 112 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 191 (767)
..++|++.+.||+|+||+||+|+++ +++.||+|++++... ..+.+++|+.++++++|||||++++++.+++.+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 3478999999999999999999985 788999999976543 34568999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCC
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGE 271 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~ 271 (767)
||||+++|+|..++.... ..+++..+..++.||+.||+|||+.||+||||||+|||+++++++||+|||+|+......
T Consensus 77 v~Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EEECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred EEEccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999998877653 368999999999999999999999999999999999999999999999999998765443
Q ss_pred c--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHHHH
Q psy11874 272 S--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDDAK 348 (767)
Q Consensus 272 ~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~~~ 348 (767)
. .....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+.......+.. ......|...+++++
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~---~~~~~~p~~~~~~l~ 231 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---GLRLYRPHLASEKVY 231 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT---TCCCCCCTTCCHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh---CCCCCCcccccHHHH
Confidence 3 334679999999999999999999999999999999998 8999987755433332222 223455678899999
Q ss_pred HHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 349 ALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 349 dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+||++||+.||++||+ +++|++|
T Consensus 232 ~li~~cl~~dP~~RPt-------~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPT-------FKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCC-------HHHHHHH
T ss_pred HHHHHHccCCHhHCcC-------HHHHHHH
Confidence 9999999999999999 9999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=433.76 Aligned_cols=272 Identities=24% Similarity=0.345 Sum_probs=209.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee------CC
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------KD 187 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~~ 187 (767)
++|+++++||+|+||+||+|+++.||+.||||++.+... .......+.+|+.+|++++|||||+++++|.. .+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 679999999999999999999999999999999976643 33445678899999999999999999999964 47
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
++|+|||||.|+.+. .+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||+++..
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 899999999876554 332 25899999999999999999999999999999999999999999999999999887
Q ss_pred CCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc----------
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE---------- 337 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~---------- 337 (767)
.........+||+.|+|||++.+..++.++||||+||++|||++|++||.+.+.......+.+.......
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 7766667778999999999999999999999999999999999999999877654433333222111000
Q ss_pred ----------------------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCCChhhH
Q psy11874 338 ----------------------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKSTNWKRL 389 (767)
Q Consensus 338 ----------------------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i~w~~l 389 (767)
......|+++++||++||..||++||| |+|+++||||+..-|..-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t-------a~elL~Hpw~~~~~~~~~ 322 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS-------VDDALQHPYINVWYDPAE 322 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC-------HHHHHTSTTTGGGCCHHH
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC-------HHHHhcCcccCCCCCccc
Confidence 001124788999999999999999999 999999999997544333
Q ss_pred hcCCCCCCCCCC
Q psy11874 390 EAGLCDPPFVPD 401 (767)
Q Consensus 390 ~~~~~~pp~~P~ 401 (767)
.. ..||.+++
T Consensus 323 ~~--~~~~~~~~ 332 (355)
T d2b1pa1 323 VE--APPPQIYD 332 (355)
T ss_dssp HT--CCCC----
T ss_pred cc--CCCCCCCC
Confidence 32 34555544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=431.09 Aligned_cols=257 Identities=21% Similarity=0.315 Sum_probs=210.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC-----e
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD-----A 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~ 188 (767)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .......+++|+.+|++++|||||++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46999999999999999999999999999999997643 3334567889999999999999999999997653 3
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
+|+ ++++.||+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 86 ~~l-~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYL-VTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEE-EEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEE-EEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 455 4566799999998764 59999999999999999999999999999999999999999999999999997654
Q ss_pred CCC----cccccccccccCCcceec-CCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhc---------
Q psy11874 269 EGE----SVRGRVGTVGYMAPEVID-NEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKE--------- 334 (767)
Q Consensus 269 ~~~----~~~~~~GT~~Y~APEvl~-~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~--------- 334 (767)
... .....+||+.|+|||++. +..|+.++|+||+||++|||++|++||.+................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 332 234567999999999984 456899999999999999999999999876543332222111000
Q ss_pred ------------------cccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 335 ------------------DAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 335 ------------------~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
........+|+++++||.+||++||++||+ |+|+++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-------a~e~L~hpf~~~~ 301 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE-------VEQALAHPYLEQY 301 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC-------HHHHHTSGGGTTT
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC-------HHHHhcCHhhccC
Confidence 001223567899999999999999999999 9999999999865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=421.12 Aligned_cols=268 Identities=24% Similarity=0.331 Sum_probs=217.3
Q ss_pred hcCcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 107 EIQPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 107 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+.+.|..++|++.+.||+|+||+||+|.++.+ +.||+|++..... ..+.+.+|+.+|++++|||||++++++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 44557778999999999999999999999755 5799999975432 24568999999999999999999999865
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+.+++|||||++|+|..++.... ...+++.++..++.||+.||+|||++||+||||||+|||||.+|++||+|||+|+.
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred CCeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence 56899999999999988886542 23699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCC-CCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 IPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQ-APFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~-~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
...... .....||+.|+|||++.+..++.++|||||||++|||++|. +|+...........+.+ ......+..+
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~---~~~~~~~~~~ 239 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPEC 239 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCCTTS
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh---cCCCCCCccc
Confidence 654332 33467999999999999999999999999999999999955 55555443333333222 2234567789
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh--CCCCCCCChhhHhcCCCCCCCCCC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ--AEFFKSTNWKRLEAGLCDPPFVPD 401 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~--HpfF~~i~w~~l~~~~~~pp~~P~ 401 (767)
|+++++||.+||+.||++||+ +++|++ |+||.+. +|++.|.
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps-------~~~i~~~L~~~~~~~----------~p~~~p~ 282 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPT-------FEYLQAFLEDYFTST----------EPQYQPG 282 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHHHHHTTTSCS----------CCCCCCS
T ss_pred CHHHHHHHHHHcccCHhHCcC-------HHHHHHHHhhhhcCC----------CCCCCCC
Confidence 999999999999999999999 999988 8898763 4677775
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=417.18 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=205.6
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccC---CcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+|..++|++.+.||+|+||+||+|.+..+ +..||+|++.... .......+.+|+.+|++++|||||++++++. .
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 45667999999999999999999998755 3578999885432 3344567899999999999999999999986 4
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
+.+|+|||||+||+|..++.... ..+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred CeEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence 67999999999999998877643 3689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc--ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCC
Q psy11874 267 IPEGES--VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRF 343 (767)
Q Consensus 267 ~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~ 343 (767)
...... .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+.......+. .......+..+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~---~~~~~~~~~~~ 234 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---NGERLPMPPNC 234 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCCCCCCTTC
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH---cCCCCCCCCCC
Confidence 654332 334568999999999999999999999999999999998 899998776543333322 22334667889
Q ss_pred cHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 344 SDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 344 s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
|+++++||.+||+.||++||+ ++||++|
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps-------~~ei~~~ 262 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPR-------FTELKAQ 262 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcC-------HHHHHHH
Confidence 999999999999999999999 8998875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=413.94 Aligned_cols=254 Identities=19% Similarity=0.253 Sum_probs=205.2
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEccCC----cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
++..+.|++.++||+|+||+||+|.++.++ ..||||++.... .......+++|+.+|++++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 455678999999999999999999988665 479999986543 22334568899999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
.+.+++|||||.+|+|...+.... ..+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhh
Confidence 999999999999999998887653 369999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCC-CCCCchhhhhhhhhhhhhhccccccC
Q psy11874 266 EIPEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQA-PFRRRKEMVKRDEVDRRVKEDAEKYS 340 (767)
Q Consensus 266 ~~~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~-PF~~~~~~~~~~~i~~~i~~~~~~~~ 340 (767)
....... .....||+.|||||++.+..|+.++|||||||++|||++|.. |+...+.......+.. ......+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~---~~~~~~~ 235 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFRLPTP 235 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---TCCCCCC
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc---cCCCCCc
Confidence 7654322 233568999999999999999999999999999999999654 4544433222222221 2234556
Q ss_pred CCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 341 CRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 341 ~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
..+++++.+||.+||+.||++||+ ++||++
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~RPt-------~~eil~ 265 (283)
T d1mqba_ 236 MDCPSAIYQLMMQCWQQERARRPK-------FADIVS 265 (283)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCC-------HHHHHH
T ss_pred hhhHHHHHHHHHHHCcCCHhHCcC-------HHHHHH
Confidence 789999999999999999999999 788765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=420.05 Aligned_cols=254 Identities=22% Similarity=0.264 Sum_probs=209.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCc----EEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 186 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 186 (767)
+..++|+++++||+|+||+||+|.++.+|+ .||+|++.... ..+..+.+.+|+.+|++++|||||++++++.++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345689999999999999999999998887 47777775432 334566789999999999999999999999875
Q ss_pred CeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 187 DALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 187 ~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
..+++||++.+|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++++||+|||+|+.
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred -CeeEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 5788899999999998887753 3699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 267 IPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 267 ~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
...... .....||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+.......+.. ......+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~---~~~~~~p~~ 237 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPI 237 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH---TCCCCCCTT
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCCCCCcc
Confidence 754433 233468999999999999999999999999999999998 8999987654333222221 223456678
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCC
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAE 379 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~Hp 379 (767)
+|+++.+|+.+||+.||++||+ ++||++|.
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs-------~~eil~~l 267 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPK-------FRELIIEF 267 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCC-------HHHHHHHH
T ss_pred cCHHHHHHHHHhCCCChhhCcC-------HHHHHHHH
Confidence 9999999999999999999999 99999883
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=428.30 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=212.7
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeC-----Ce
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----DA 188 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~ 188 (767)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|++++|||||++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 579999999999999999999999999999999976532 333456788999999999999999999999643 33
Q ss_pred EEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccC
Q psy11874 189 LCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIP 268 (767)
Q Consensus 189 l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~ 268 (767)
.+++|+++.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 46667788899999888543 59999999999999999999999999999999999999999999999999997653
Q ss_pred CCCcccccccccccCCcceecCC-CCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhhhcccc----------
Q psy11874 269 EGESVRGRVGTVGYMAPEVIDNE-KYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRVKEDAE---------- 337 (767)
Q Consensus 269 ~~~~~~~~~GT~~Y~APEvl~~~-~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i~~~~~---------- 337 (767)
....+..||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+.+.......
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 234567899999999987665 4689999999999999999999999887665444433322211110
Q ss_pred -----------------ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCCCC
Q psy11874 338 -----------------KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFKST 384 (767)
Q Consensus 338 -----------------~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~~i 384 (767)
......|++++|||++||+.||++||| |+|+++||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t-------a~elL~Hp~f~~~ 307 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT-------AAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC-------HHHHHTSGGGTTT
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC-------HHHHhcCHhhCCC
Confidence 112457899999999999999999999 9999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=415.91 Aligned_cols=257 Identities=24% Similarity=0.297 Sum_probs=203.7
Q ss_pred cccCCCeEEEeEEeecCcEEEEEEEEcc-----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEE
Q psy11874 110 PITYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAY 183 (767)
Q Consensus 110 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~ 183 (767)
++..++|++.+.||+|+||+||+|.++. +++.||+|++.... .......+.+|..++.++ +|+|||.+++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 4566889999999999999999999764 45789999987543 223345677788888776 688999999987
Q ss_pred ee-CCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEE
Q psy11874 184 ET-KDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENIL 249 (767)
Q Consensus 184 ~~-~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNIL 249 (767)
.. ...+++|||||+||+|..++..... ...+++.++..++.||+.||.|||++|||||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 65 4579999999999999999976431 235899999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcC-CCCCCCchhhhhh
Q psy11874 250 LDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEG-QAPFRRRKEMVKR 325 (767)
Q Consensus 250 ld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG-~~PF~~~~~~~~~ 325 (767)
|+++|++||+|||+|+....... ....+||+.|||||++.+..|+.++|||||||++|||++| .+||.+......
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~- 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999986644322 3345799999999999999999999999999999999986 568876543222
Q ss_pred hhhhhhhh-ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 326 DEVDRRVK-EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 326 ~~i~~~i~-~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
+...+. ......+..+|+++++||.+||+.||++||+ ++||++|
T Consensus 246 --~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-------~~eil~~ 290 (299)
T d1ywna1 246 --FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT-------FSELVEH 290 (299)
T ss_dssp --HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred --HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcC-------HHHHHHH
Confidence 222222 2344567789999999999999999999999 9999886
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=416.89 Aligned_cols=256 Identities=19% Similarity=0.278 Sum_probs=213.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcE--EEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKM--YACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~--~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~ 187 (767)
|..++|++.++||+|+||+||+|.++.+|.. ||+|++.... .....+.+.+|+++|+++ +|||||++++++.+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5668999999999999999999999998875 5667664332 333456789999999998 7999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHHhc-------------CCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCC
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNM-------------GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYG 254 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~-------------~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g 254 (767)
.+++||||++||+|.++|... .....+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999754 1234699999999999999999999999999999999999999999
Q ss_pred CEEEeecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCC-CCCCCchhhhhhhhhhhhhh
Q psy11874 255 HVRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQ-APFRRRKEMVKRDEVDRRVK 333 (767)
Q Consensus 255 ~vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~-~PF~~~~~~~~~~~i~~~i~ 333 (767)
.+||+|||+|+............||+.|+|||.+.+..|+.++|||||||++|||++|. +||.+.+.......+. .
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~---~ 241 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---Q 241 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG---G
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH---h
Confidence 99999999998765544445567999999999999999999999999999999999965 6787665433333222 2
Q ss_pred ccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 334 EDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 334 ~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
......+..+|+++++||.+||+.||++||+ ++||++|
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-------~~eil~~ 279 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPS-------FAQILVS 279 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcC-------HHHHHHH
Confidence 2345567789999999999999999999999 9999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=410.34 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=203.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccC-C--cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRAT-G--KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 187 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-g--~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 187 (767)
|..++|++.+.||+|+||+||+|++..+ + ..||+|++.+.........+.+.+|+.+|++++|||||++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 3457899999999999999999987643 3 4789999987766666667789999999999999999999999976 4
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 6799999999999998877653 25999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCc----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCC
Q psy11874 268 PEGES----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCR 342 (767)
Q Consensus 268 ~~~~~----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~ 342 (767)
..... .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+.......+.+. ......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~ 239 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--GERLPRPED 239 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--CCCCCCCTT
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC--CCCCCCccc
Confidence 55432 223468899999999999999999999999999999998 89999887665443333221 123345678
Q ss_pred CcHHHHHHHHHhcccCcCccCCCCCCcccHHHHH
Q psy11874 343 FSDDAKALCKALLKKSPRSRLGCHCGRYGARELK 376 (767)
Q Consensus 343 ~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil 376 (767)
+|+++++||.+||..||++||+ +++|+
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt-------~~ei~ 266 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPT-------FVALR 266 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC-------HHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcC-------HHHHH
Confidence 8999999999999999999999 77775
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-48 Score=411.01 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=214.8
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEcc-----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 185 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 185 (767)
++.++|++.+.||+|+||+||+|+.+. +++.||||++++.. .......+.+|+.+|++++||||+++++++.+
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 456789999999999999999999863 56899999987543 23345678999999999999999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHHhcCC---------------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCC
Q psy11874 186 KDALCLVLTIMNGGDLKFHIYNMGG---------------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCK 244 (767)
Q Consensus 186 ~~~l~lV~E~~~gG~L~~~l~~~~~---------------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLK 244 (767)
.+.+++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+++|||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 9999999999999999999975421 2348999999999999999999999999999999
Q ss_pred cceEEeCCCCCEEEeecCcccccCCCC---cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCC-CCCCCch
Q psy11874 245 PENILLDDYGHVRISDLGLAVEIPEGE---SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQ-APFRRRK 320 (767)
Q Consensus 245 PeNILld~~g~vkL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~-~PF~~~~ 320 (767)
|+|||+|.++++||+|||+|+...... ...+..||+.|+|||++.+..|+.++|||||||++|||++|. +||.+.+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998664432 233567999999999999999999999999999999999985 6887776
Q ss_pred hhhhhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 321 EMVKRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 321 ~~~~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
.......+.. ......+..+++++.+||.+||+.||++||+ +.||.+
T Consensus 248 ~~e~~~~v~~---~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt-------~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRD---GNILACPENCPLELYNLMRLCWSKLPADRPS-------FCSIHR 294 (301)
T ss_dssp HHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHHHHHHHHc---CCCCCCCccchHHHHHHHHHHcCCChhHCcC-------HHHHHH
Confidence 5443333322 2234557789999999999999999999999 888754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=405.23 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=204.9
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEe-eCC
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE-TKD 187 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~ 187 (767)
+.+..++|++.+.||+|+||.||+|+++ |+.||+|+++++. ..+.+.+|+++|++++|||||++++++. +++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4677889999999999999999999985 7899999996542 3456889999999999999999999884 456
Q ss_pred eEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCccccc
Q psy11874 188 ALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEI 267 (767)
Q Consensus 188 ~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~ 267 (767)
.+|+||||+++|+|.+++...+ ...+++..++.++.||+.||.|||+.+|+||||||+|||++.+|++||+|||+++..
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred cEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 7999999999999999997643 224899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhhhhhhhhhhhhccccccCCCCcHH
Q psy11874 268 PEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMVKRDEVDRRVKEDAEKYSCRFSDD 346 (767)
Q Consensus 268 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~~~~~i~~~i~~~~~~~~~~~s~~ 346 (767)
... .....+|+.|+|||++.+..|+.++|||||||++|||+| |++||...+.......+.. ...+..+..++++
T Consensus 154 ~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~ 228 (262)
T d1byga_ 154 SST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPA 228 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT---TCCCCCCTTCCHH
T ss_pred CCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCCCCCccCCHH
Confidence 433 344578999999999999999999999999999999998 7888877654433333322 2345667789999
Q ss_pred HHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 347 AKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 347 ~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
+++||++||..||++||+ +.+|++
T Consensus 229 ~~~li~~cl~~dP~~Rps-------~~~l~~ 252 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPS-------FLQLRE 252 (262)
T ss_dssp HHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHHHHHHHcccCHhHCcC-------HHHHHH
Confidence 999999999999999999 777765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=406.56 Aligned_cols=257 Identities=20% Similarity=0.283 Sum_probs=213.5
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEccCC-------cEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLA 180 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~ 180 (767)
+.+..++|++.+.||+|+||.||+|+...++ ..||+|++.+.. .......+.+|..++.++ +|||||+++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 4567789999999999999999999987654 479999997653 233456688899999888 899999999
Q ss_pred EEEeeCCeEEEEEEeccCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcce
Q psy11874 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGG-------------EPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPEN 247 (767)
Q Consensus 181 ~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~-------------~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeN 247 (767)
+++.+++.+++|||||+||+|.++|..... ...+++..+..++.||+.||+|||+.+||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 999999999999999999999999976531 2358999999999999999999999999999999999
Q ss_pred EEeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhh
Q psy11874 248 ILLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMV 323 (767)
Q Consensus 248 ILld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~ 323 (767)
||++.+|.+||+|||+++....... .....||+.|+|||++.++.|+.++|||||||++|||++ |.+||.+.+...
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 9999999999999999987654332 334679999999999999999999999999999999998 799998766543
Q ss_pred hhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 324 KRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 324 ~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
....+. .......+..+|+++++||.+||+.||++||+ ++||++
T Consensus 246 ~~~~i~---~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps-------~~eil~ 289 (299)
T d1fgka_ 246 LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT-------FKQLVE 289 (299)
T ss_dssp HHHHHH---TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHHHHH---cCCCCCCCccchHHHHHHHHHHccCCHhHCcC-------HHHHHH
Confidence 332222 22345667789999999999999999999999 888876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=408.84 Aligned_cols=266 Identities=20% Similarity=0.250 Sum_probs=222.4
Q ss_pred cCcccCCCeEEEeEEeecCcEEEEEEEEcc-----CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEE
Q psy11874 108 IQPITYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYA 182 (767)
Q Consensus 108 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 182 (767)
.+.+..++|++.+.||+|+||+||+|.++. ++..||||++++.. .......+.+|+.++++++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 356677899999999999999999999863 35789999997543 33445678999999999999999999999
Q ss_pred EeeCCeEEEEEEeccCCCHHHHHHhc-------CCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCC
Q psy11874 183 YETKDALCLVLTIMNGGDLKFHIYNM-------GGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGH 255 (767)
Q Consensus 183 ~~~~~~l~lV~E~~~gG~L~~~l~~~-------~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~ 255 (767)
+..++.+++|||||++|+|..++... .....+++..+..++.||+.||.|||+++|+||||||+|||+|.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999988653 12235789999999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcC-CCCCCCchhhhhhhhhhhh
Q psy11874 256 VRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEG-QAPFRRRKEMVKRDEVDRR 331 (767)
Q Consensus 256 vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG-~~PF~~~~~~~~~~~i~~~ 331 (767)
+||+|||+|+....... .....||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+.......+.
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-- 249 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-- 249 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH--
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--
Confidence 99999999986644322 3345799999999999999999999999999999999998 57887765443333322
Q ss_pred hhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh------CCCCCCCC
Q psy11874 332 VKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ------AEFFKSTN 385 (767)
Q Consensus 332 i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~------HpfF~~i~ 385 (767)
.......+..+|+.+.+|+.+||+.||++||+ +++|++ +|+|++++
T Consensus 250 -~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs-------~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 250 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS-------FLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-------HHHHHHHHGGGSCTTHHHHC
T ss_pred -hCCCCCCcccchHHHHHHHHHHcCCChhHCcC-------HHHHHHHHHHhcCCCCcCCC
Confidence 22334556789999999999999999999999 888887 56655433
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=404.13 Aligned_cols=258 Identities=21% Similarity=0.261 Sum_probs=216.6
Q ss_pred CcccCCCeEEEeEEeecCcEEEEEEEEc-----cCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhc-CCCceeEEEEE
Q psy11874 109 QPITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYA 182 (767)
Q Consensus 109 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 182 (767)
+++..++|++.+.||+|+||.||+|+++ .+++.||+|++.+.. .......+.+|..+++++ +|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4466689999999999999999999874 467899999997653 233455788999999999 79999999999
Q ss_pred EeeCCeEEEEEEeccCCCHHHHHHhcC---------------CCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcce
Q psy11874 183 YETKDALCLVLTIMNGGDLKFHIYNMG---------------GEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPEN 247 (767)
Q Consensus 183 ~~~~~~l~lV~E~~~gG~L~~~l~~~~---------------~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeN 247 (767)
+.+.+.+++|||||+||+|..++.... ....+++..+..++.||+.||+|||+++||||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999998643 12358999999999999999999999999999999999
Q ss_pred EEeCCCCCEEEeecCcccccCCCCc---ccccccccccCCcceecCCCCCCCCccccchhhHHHHhc-CCCCCCCchhhh
Q psy11874 248 ILLDDYGHVRISDLGLAVEIPEGES---VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIE-GQAPFRRRKEMV 323 (767)
Q Consensus 248 ILld~~g~vkL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyEllt-G~~PF~~~~~~~ 323 (767)
||++.++.+||+|||+++....... ....+||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+...
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987754432 234579999999999999999999999999999999998 677776655433
Q ss_pred hhhhhhhhhhccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 324 KRDEVDRRVKEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 324 ~~~~i~~~i~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
....+.. .......+..+|+++.+||.+||+.||++||+ +++|++
T Consensus 256 ~~~~~i~--~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-------~~~il~ 300 (311)
T d1t46a_ 256 KFYKMIK--EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT-------FKQIVQ 300 (311)
T ss_dssp HHHHHHH--HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC-------HHHHHH
T ss_pred HHHHHHh--cCCCCCCcccccHHHHHHHHHHcCCChhHCcC-------HHHHHH
Confidence 2222221 12234456678999999999999999999999 888875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-46 Score=397.24 Aligned_cols=257 Identities=19% Similarity=0.264 Sum_probs=205.0
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCc-eeEEEEEEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF-VVSLAYAYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~~~~~~~l~lV 192 (767)
++|++.+.||+|+||+||+|+++.+|+.||||++..+. ....+.+|.+++++++|++ |+.+.+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 46999999999999999999999999999999986542 1234778999999998766 55566677888999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC---CCCEEEeecCcccccCC
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD---YGHVRISDLGLAVEIPE 269 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~---~g~vkL~DFGla~~~~~ 269 (767)
|||+. |+|...+.... ..+++..+..++.||+.||+|||++|||||||||+|||++. ++.++|+|||+|+....
T Consensus 82 me~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99995 56666665533 36999999999999999999999999999999999999864 45799999999987654
Q ss_pred CCc--------ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhh----hhhcccc
Q psy11874 270 GES--------VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDR----RVKEDAE 337 (767)
Q Consensus 270 ~~~--------~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~----~i~~~~~ 337 (767)
... ....+||+.|||||++.+..|+.++|||||||++|||++|..||...........+.+ .......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 322 2345799999999999999999999999999999999999999977544332222211 1122233
Q ss_pred ccCCCCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHhCCCCC
Q psy11874 338 KYSCRFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQAEFFK 382 (767)
Q Consensus 338 ~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~HpfF~ 382 (767)
..+..+|+++.+|+.+||+.||++||++. .+.++++|+|.+
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~----~i~~~l~~~~~~ 279 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYS----YLRQLFRNLFHR 279 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHH----HHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHH----HHHHHHHHHHHH
Confidence 44568999999999999999999999832 255778887654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=394.84 Aligned_cols=247 Identities=23% Similarity=0.263 Sum_probs=203.8
Q ss_pred EEeEEeecCcEEEEEEEEccCC---cEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEee-CCeEEEEE
Q psy11874 118 MYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-KDALCLVL 193 (767)
Q Consensus 118 ~~~~LG~G~fG~Vy~a~~~~tg---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lV~ 193 (767)
..++||+|+||+||+|.+..++ ..||||++++. ......+.+.+|+++|++++|||||++++++.+ +..+++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3678999999999999987643 36999998643 244456779999999999999999999998765 56899999
Q ss_pred EeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEeecCcccccCCCCc-
Q psy11874 194 TIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISDLGLAVEIPEGES- 272 (767)
Q Consensus 194 E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~DFGla~~~~~~~~- 272 (767)
|||++|+|.+++.... ...++..+..++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp ECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999999887643 3678889999999999999999999999999999999999999999999999987654322
Q ss_pred ----ccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhhhhhhh-hccccccCCCCcHHH
Q psy11874 273 ----VRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDEVDRRV-KEDAEKYSCRFSDDA 347 (767)
Q Consensus 273 ----~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~i~~~i-~~~~~~~~~~~s~~~ 347 (767)
.....||+.|+|||++.+..++.++|||||||++|||++|..||....... ++...+ .......+...++++
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---~~~~~i~~g~~~~~p~~~~~~l 263 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLLQGRRLLQPEYCPDPL 263 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHHTTCCCCCCTTCCHHH
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCCCCcccCcHHH
Confidence 223568999999999999999999999999999999999887776543211 122222 223445567889999
Q ss_pred HHHHHHhcccCcCccCCCCCCcccHHHHHhC
Q psy11874 348 KALCKALLKKSPRSRLGCHCGRYGARELKQA 378 (767)
Q Consensus 348 ~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~H 378 (767)
.+|+.+||+.||++||+ +.||++|
T Consensus 264 ~~li~~cl~~dP~~RPs-------~~ei~~~ 287 (311)
T d1r0pa_ 264 YEVMLKCWHPKAEMRPS-------FSELVSR 287 (311)
T ss_dssp HHHHHHHTCSSGGGSCC-------HHHHHHH
T ss_pred HHHHHHHcCCCHhHCcC-------HHHHHHH
Confidence 99999999999999999 8999887
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.2e-44 Score=379.54 Aligned_cols=244 Identities=16% Similarity=0.238 Sum_probs=204.4
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC-CceeEEEEEEeeCCeEEE
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RFVVSLAYAYETKDALCL 191 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l~l 191 (767)
-++|++.+.||+|+||+||+|+++.+|+.||+|++.... ....+.+|.++++.+.| +|++.+++++.+....|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 368999999999999999999999999999999985542 22346779999999976 899999999999999999
Q ss_pred EEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCC-----CCCEEEeecCcccc
Q psy11874 192 VLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDD-----YGHVRISDLGLAVE 266 (767)
Q Consensus 192 V~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~-----~g~vkL~DFGla~~ 266 (767)
||||+ ||+|..++...+ ..+++..+..++.|++.||+|||++|||||||||+|||++. .+.+||+|||+|+.
T Consensus 79 vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99999 689988887653 36999999999999999999999999999999999999974 67899999999987
Q ss_pred cCCCC--------cccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhhhh---hhh-hhhc
Q psy11874 267 IPEGE--------SVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKRDE---VDR-RVKE 334 (767)
Q Consensus 267 ~~~~~--------~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~~~---i~~-~i~~ 334 (767)
..... ...+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+......... +.. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 64321 13345799999999999999999999999999999999999999976544322221 111 1112
Q ss_pred cccccCCCCcHHHHHHHHHhcccCcCccCC
Q psy11874 335 DAEKYSCRFSDDAKALCKALLKKSPRSRLG 364 (767)
Q Consensus 335 ~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~ 364 (767)
........+|+++.+++..|+..+|++||.
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~ 265 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPD 265 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence 233445678999999999999999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=383.18 Aligned_cols=247 Identities=24% Similarity=0.279 Sum_probs=191.4
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCCceeEEEEEEeeCC----eE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----AL 189 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~l 189 (767)
.+|.+.+.||+|+||.||+|+. +|+.||+|++..... .......|+..+.+++|||||++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4788999999999999999986 589999999864421 1122334555556789999999999997654 68
Q ss_pred EEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH--------CCcccccCCcceEEeCCCCCEEEeec
Q psy11874 190 CLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY--------IGLVYRDCKPENILLDDYGHVRISDL 261 (767)
Q Consensus 190 ~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~--------~~IvHrDLKPeNILld~~g~vkL~DF 261 (767)
|+|||||++|+|..++.+. .+++..+..++.|++.||.|||+ +|||||||||+||||+.+|++||+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 9999999999999999864 58999999999999999999996 59999999999999999999999999
Q ss_pred CcccccCCCCc-----ccccccccccCCcceecCCC------CCCCCccccchhhHHHHhcCCCCCCCchhhh-------
Q psy11874 262 GLAVEIPEGES-----VRGRVGTVGYMAPEVIDNEK------YTYSPDWFSFGCLIFEMIEGQAPFRRRKEMV------- 323 (767)
Q Consensus 262 Gla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~------ys~~~DvwSlGviLyElltG~~PF~~~~~~~------- 323 (767)
|+++....... ....+||+.|||||++.+.. ++.++|||||||+||||+||.+||.......
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 99987654432 23467999999999987643 5678999999999999999998875432111
Q ss_pred ----hhhhhhhhhhccc--cccCC-----CCcHHHHHHHHHhcccCcCccCCCCCCcccHHHHHh
Q psy11874 324 ----KRDEVDRRVKEDA--EKYSC-----RFSDDAKALCKALLKKSPRSRLGCHCGRYGARELKQ 377 (767)
Q Consensus 324 ----~~~~i~~~i~~~~--~~~~~-----~~s~~~~dLi~~lL~~dP~~Rl~~~~~~~~a~eil~ 377 (767)
....+.+...... +..+. .....+.+|+.+||+.||++||+ +.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-------~~ei~~ 290 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT-------ALRIKK 290 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC-------HHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC-------HHHHHH
Confidence 0111111111111 11111 22346899999999999999999 888865
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-43 Score=386.23 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=205.2
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-----------CCceeEEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-----------SRFVVSLAYA 182 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv~l~~~ 182 (767)
++|+++++||+|+||+||+|+++.+|+.||||++++... ..+.+.+|+.+|+.++ |+|||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 469999999999999999999999999999999976532 2345678888888875 4789999888
Q ss_pred Eee--CCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHH-CCcccccCCcceEEeCCCCC----
Q psy11874 183 YET--KDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHY-IGLVYRDCKPENILLDDYGH---- 255 (767)
Q Consensus 183 ~~~--~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~-~~IvHrDLKPeNILld~~g~---- 255 (767)
+.. ....+++|+++.++..............+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 56788888888777666565555556689999999999999999999998 89999999999999987664
Q ss_pred --EEEeecCcccccCCCCcccccccccccCCcceecCCCCCCCCccccchhhHHHHhcCCCCCCCchhhhhh------hh
Q psy11874 256 --VRISDLGLAVEIPEGESVRGRVGTVGYMAPEVIDNEKYTYSPDWFSFGCLIFEMIEGQAPFRRRKEMVKR------DE 327 (767)
Q Consensus 256 --vkL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~~~DvwSlGviLyElltG~~PF~~~~~~~~~------~~ 327 (767)
++|+|||.|..... .....+||+.|+|||++.+..|+.++|+||+||++++|++|+.||......... ..
T Consensus 169 ~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred ceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 99999999986543 335678999999999999999999999999999999999999999754321110 00
Q ss_pred hhhhh--------------------------------------hccccccCCCCcHHHHHHHHHhcccCcCccCCCCCCc
Q psy11874 328 VDRRV--------------------------------------KEDAEKYSCRFSDDAKALCKALLKKSPRSRLGCHCGR 369 (767)
Q Consensus 328 i~~~i--------------------------------------~~~~~~~~~~~s~~~~dLi~~lL~~dP~~Rl~~~~~~ 369 (767)
....+ .......+...+++++|||.+||..||.+|||
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt----- 321 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----- 321 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC-----
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC-----
Confidence 00000 00011112235788999999999999999999
Q ss_pred ccHHHHHhCCCCCCCC
Q psy11874 370 YGARELKQAEFFKSTN 385 (767)
Q Consensus 370 ~~a~eil~HpfF~~i~ 385 (767)
|+|+++||||++..
T Consensus 322 --a~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 322 --AGGLVNHPWLKDTL 335 (362)
T ss_dssp --HHHHHTCGGGTTCT
T ss_pred --HHHHhcCcccCCCC
Confidence 99999999999765
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.7e-24 Score=214.05 Aligned_cols=166 Identities=16% Similarity=0.090 Sum_probs=122.7
Q ss_pred eEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhh---------------hhhhHHHHHHHHHHHHhcCCCceeEEE
Q psy11874 116 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK---------------KRKGESMVLIEKQILQKINSRFVVSLA 180 (767)
Q Consensus 116 y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~---------------~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 180 (767)
+.+.+.||+|+||+||+|.+. +|+.||+|++...... .......+.+|..+|.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 357899999999999999985 7999999987532111 011123456788999999999999887
Q ss_pred EEEeeCCeEEEEEEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHCCcccccCCcceEEeCCCCCEEEee
Q psy11874 181 YAYETKDALCLVLTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYIGLVYRDCKPENILLDDYGHVRISD 260 (767)
Q Consensus 181 ~~~~~~~~l~lV~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~~IvHrDLKPeNILld~~g~vkL~D 260 (767)
+... .++||||++++.+. .+++..+..++.|++.||.|||++||+||||||+|||+++++ ++|+|
T Consensus 81 ~~~~----~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liD 145 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIID 145 (191)
T ss_dssp EEET----TEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECC
T ss_pred EecC----CEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEE
Confidence 6532 27999999987653 244555678999999999999999999999999999999754 89999
Q ss_pred cCcccccCCCCcccccccccccCCc------ceecCCCCCCCCccccchhh
Q psy11874 261 LGLAVEIPEGESVRGRVGTVGYMAP------EVIDNEKYTYSPDWFSFGCL 305 (767)
Q Consensus 261 FGla~~~~~~~~~~~~~GT~~Y~AP------Evl~~~~ys~~~DvwSlGvi 305 (767)
||+|+........ .|... +. -...|+.++|+||+.--
T Consensus 146 FG~a~~~~~~~~~-------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 146 FPQSVEVGEEGWR-------EILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CTTCEETTSTTHH-------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred CCCcccCCCCCcH-------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 9999876433211 11110 11 14678999999997543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=4.1e-20 Score=198.72 Aligned_cols=114 Identities=28% Similarity=0.408 Sum_probs=103.6
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
+++++||++++.||+|+||+||+|+++.||+.||||+|++..+......+++.+|+.||+.++|||||+++++|++.+.+
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 46789999999999999999999999999999999999988766667788999999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|||||||+||+|.+++.+.+.+.+..++..+.++
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qi 114 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHH
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHH
Confidence 9999999999999999888887777776655433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=5.7e-20 Score=193.35 Aligned_cols=116 Identities=21% Similarity=0.283 Sum_probs=103.0
Q ss_pred CCCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCE
Q psy11874 647 QPITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDA 726 (767)
Q Consensus 647 ~~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ 726 (767)
.+...+||++++.||+|+||+||+|+++.||+.||||++++..+.+....+.+.+|++||++++|||||+++++|++.+.
T Consensus 3 ~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 82 (288)
T d1uu3a_ 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82 (288)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE
T ss_pred CCCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE
Confidence 34566899999999999999999999999999999999998766566677889999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
+|||||||+||+|.+++...+.+.+...+..+.+++
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~ 118 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 118 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHH
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHH
Confidence 999999999999999998888877777666555443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=9.5e-20 Score=189.08 Aligned_cols=114 Identities=18% Similarity=0.177 Sum_probs=101.9
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
.++++|++++.||+|+||+||+|+++.+|+.||+|++.+....+....+.+.+|+++|+.++|||||+++++|.+.+.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 46789999999999999999999999999999999999876656666788999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
||||||+||+|.++|.+.+...+......+.+++
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~ 116 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELA 116 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHH
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHH
Confidence 9999999999999998877777776666555443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.7e-19 Score=187.93 Aligned_cols=110 Identities=18% Similarity=0.094 Sum_probs=94.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
+++|++++.||+|+||+||+|+++.||+.||+|++++... ....+.+.+|+.+|++++|||||+++++|.+.+.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 4689999999999999999999999999999999987642 23446789999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
||||+||+|+++|.+.+.+.+......+.+++
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~ 113 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM 113 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHH
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 99999999999998877777777766655544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=6.7e-19 Score=185.26 Aligned_cols=110 Identities=24% Similarity=0.273 Sum_probs=96.0
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccch---hhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~---~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+.|++++.||+|+||+||+|+++.||+.||||++++...... ...+.+.+|+.+|++++|||||+++++|++.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 459999999999999999999999999999999988654322 24578999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
||||||+||+|.++|.+.+...+......+.++
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi 122 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQI 122 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHH
Confidence 999999999999999887777776666655443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=7e-19 Score=187.72 Aligned_cols=110 Identities=17% Similarity=0.167 Sum_probs=97.3
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+.-++|++++.||+|+||+||+|+++.||+.||+|++++.. .....+.+.+|+.||+.++|||||+++++|.+.+.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45678999999999999999999999999999999998753 4455678999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
||||||+||+|.+++.+.+.+.+...+..+.+
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~q 112 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 112 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHH
Confidence 99999999999999988877777666655444
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.75 E-value=8.1e-19 Score=186.08 Aligned_cols=109 Identities=24% Similarity=0.256 Sum_probs=90.5
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
+.|++.+.||+|+||+||+|+++.||+.||||++.+.... ...+.+.+|+.+|+.++|||||+++++|++++.+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4599999999999999999999999999999999986532 33457889999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
|||+||+|.++|.+.+.+.+......+.+++
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~ 117 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVL 117 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHH
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHH
Confidence 9999999999998877777777666555443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.75 E-value=7.5e-19 Score=187.08 Aligned_cols=111 Identities=19% Similarity=0.304 Sum_probs=99.4
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
+++||++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||+++++|++.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 57899999999999999999999999999999999998766566677899999999999999999999999999999999
Q ss_pred EEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 730 VLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
|||||+||+|...+...+...+...+..+.+
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~q 112 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAE 112 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHH
T ss_pred EeeecCCccccccccccccccccHHHHHHHH
Confidence 9999999999999987777666666554433
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=3e-18 Score=182.70 Aligned_cols=107 Identities=21% Similarity=0.277 Sum_probs=92.4
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.++|++++.||+|+||+||+|+++.||+.||+|++++.. .....+.+|+.||+.++|||||+++++|++++.+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999998753 2345688999999999999999999999999999999
Q ss_pred EeccCCccccccccccC-CCChhhhHHHHHHh
Q psy11874 731 LTIIDVMFTCVQPSETN-PCCFPFRRKEVVVV 761 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~-~~~~~~~~~~v~~~ 761 (767)
||||+||+|+++|...+ .+.+......+.++
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi 111 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQV 111 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 99999999999997665 45565555544433
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.8e-18 Score=184.41 Aligned_cols=111 Identities=19% Similarity=0.314 Sum_probs=97.2
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHh-hCCCCceeeeeEEEEeCCEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQ-KINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~-~l~HpnIV~l~~~f~~~~~lyl 729 (767)
+++|++++.||+|+||+||+|+++.||+.||+|++++.........+.+.+|+.+|. .++|||||+++++|++++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999999876555667788888988876 6899999999999999999999
Q ss_pred EEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 730 VLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|||||+||+|.++|...+...+......+..+
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi 112 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 112 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHH
Confidence 99999999999999887777766665554443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=8.3e-19 Score=182.49 Aligned_cols=110 Identities=13% Similarity=0.192 Sum_probs=91.8
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe--CCEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET--KDALC 728 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~--~~~ly 728 (767)
.+||++++.||+|+||+||+|+++.||+.||+|++++... .....+.+.+|+++|++++|||||++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4789999999999999999999999999999999988763 45567789999999999999999999999965 46799
Q ss_pred EEEeccCCcccccccccc----CCCChhhhHHHHHHh
Q psy11874 729 LVLTIIDVMFTCVQPSET----NPCCFPFRRKEVVVV 761 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~----~~~~~~~~~~~v~~~ 761 (767)
||||||+||+|.+++.+. +.+.+...+..+.++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi 118 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHH
Confidence 999999999999998643 345555555544443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.73 E-value=5.2e-18 Score=183.05 Aligned_cols=110 Identities=19% Similarity=0.226 Sum_probs=94.7
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
.+++|++++.||+|+||+||+|+++.||+.||||++.+.. ....+.+.+|+.+|++++|||||+++++|++.+.+||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3679999999999999999999999999999999998753 3456788999999999999999999999999999999
Q ss_pred EEeccCCccccccccc-cCCCChhhhHHHHHHhh
Q psy11874 730 VLTIIDVMFTCVQPSE-TNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~-~~~~~~~~~~~~v~~~a 762 (767)
|||||+||+|+++|.+ .+.+.+......+.+++
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~ 134 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHH
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHH
Confidence 9999999999999854 34556666655544443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.73 E-value=3.7e-18 Score=178.28 Aligned_cols=111 Identities=22% Similarity=0.220 Sum_probs=96.8
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccc------hhhHHHHHHHHHHHhhCC-CCceeeeeEEEEeC
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK------RKGESMVLIEKQILQKIN-SRFVVSLAYAYETK 724 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~------~~~~~~~~~Ei~IL~~l~-HpnIV~l~~~f~~~ 724 (767)
++|++.+.||+|+||+||+|+++.+|+.||||++++..... ....+.+.+|+.+|++++ |||||+++++|+++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999999999999999998865322 223457889999999996 99999999999999
Q ss_pred CEEEEEEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 725 DALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
+.+|||||||+||+|.++|+..+..++..++..+.+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~ 120 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 120 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHH
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHH
Confidence 99999999999999999998888877777776665443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.73 E-value=4e-18 Score=180.82 Aligned_cols=110 Identities=16% Similarity=0.109 Sum_probs=96.9
Q ss_pred CceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEe
Q psy11874 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 732 (767)
Q Consensus 653 ~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmE 732 (767)
.|+.++.||+|+||+||+|+++.||+.||||++++.........+.+.+|++||++++|||||+++++|.+.+.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999998765566677889999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 733 IIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 733 y~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
||+||+|..++...+.+.+......+.+++
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~ 125 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGAL 125 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHH
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHH
Confidence 999999987776666767666666555544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.72 E-value=7.3e-18 Score=181.99 Aligned_cols=108 Identities=19% Similarity=0.269 Sum_probs=93.2
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
.++|++++.||+|+||+||+|+++.||+.||+|++++.. ....+.+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999998753 23456788999999999999999999999999999999
Q ss_pred EeccCCccccccccccC-CCChhhhHHHHHHh
Q psy11874 731 LTIIDVMFTCVQPSETN-PCCFPFRRKEVVVV 761 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~-~~~~~~~~~~v~~~ 761 (767)
||||+||+|++.+.+.+ .+.+......+.++
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi 136 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 136 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHH
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 99999999999876654 45666665554444
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.72 E-value=4e-18 Score=184.95 Aligned_cols=113 Identities=34% Similarity=0.547 Sum_probs=94.9
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHH---HHHHhhCCCCceeeeeEEEEeCC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIE---KQILQKINSRFVVSLAYAYETKD 725 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~E---i~IL~~l~HpnIV~l~~~f~~~~ 725 (767)
+++++|++++.||+|+||+||+|+++.||+.||||++.+..+........+.+| +.+|+.++|||||+++++|++.+
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 468899999999999999999999999999999999988765444444444444 66777789999999999999999
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
.+|||||||+||+|.++|.+.+...+...+..+..+
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi 116 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 116 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHH
Confidence 999999999999999999887776666666554433
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.72 E-value=5.5e-18 Score=182.83 Aligned_cols=114 Identities=25% Similarity=0.381 Sum_probs=102.1
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
..+++|++++.||+|+||+||+|+++.||+.||||++++....+....+.+.+|++||+.++|||||+++++|.+.+.+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 45789999999999999999999999999999999999876666677788999999999999999999999999999999
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
+|||||.||+|...+.+.+.+.+......+.+++
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~ 151 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHH
Confidence 9999999999999998888777777666555443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=5e-18 Score=178.25 Aligned_cols=107 Identities=19% Similarity=0.193 Sum_probs=92.2
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
+.|++++.||+|+||+||+|+++.||+.||+|++++. .....+.+.+|+++|++++|||||+++++|.+.+.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 3589999999999999999999999999999999875 3445678899999999999999999999999999999999
Q ss_pred eccCCcccccccccc-CCCChhhhHHHHHHh
Q psy11874 732 TIIDVMFTCVQPSET-NPCCFPFRRKEVVVV 761 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~-~~~~~~~~~~~v~~~ 761 (767)
|||+||+|.+++.+. +.+.+......+.++
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi 119 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQT 119 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 999999999987654 445666665554443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=6.3e-18 Score=177.92 Aligned_cols=107 Identities=15% Similarity=0.154 Sum_probs=92.3
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVL 731 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVm 731 (767)
.+|++++.||+|+||+||+|+++.||+.||+|++++.. ....+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc---ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 36999999999999999999999999999999998754 234567999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 732 TIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
|||+||+|.+++.+ +.+.+......+.+++
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~ 126 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 126 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHH
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHH
Confidence 99999999988754 4556666666554443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.71 E-value=7.9e-18 Score=175.38 Aligned_cols=111 Identities=15% Similarity=0.073 Sum_probs=97.7
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC----EE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----AL 727 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~----~l 727 (767)
++|++.+.||+|+||+||+|+++.+|+.||+|++++....+....+.+.+|+++|+.++|||||++++++.+.+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 46999999999999999999999999999999999876666667788999999999999999999999998764 48
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
|||||||+||+|.+++...+...+......+.+++
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~ 121 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHH
Confidence 99999999999999998887777776666555543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=2.3e-17 Score=171.48 Aligned_cols=108 Identities=14% Similarity=0.144 Sum_probs=92.3
Q ss_pred ceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe----CCEEEE
Q psy11874 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET----KDALCL 729 (767)
Q Consensus 654 y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~----~~~lyl 729 (767)
|++.+.||+|+||+||+|+++.||+.||+|++.+... .....+.+.+|+++|++++|||||++|++|.+ .+.+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4778899999999999999999999999999987653 44567789999999999999999999999976 356999
Q ss_pred EEeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 730 VLTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
|||||+||+|.+++.+.+...+......+.+++
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~ 122 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHH
Confidence 999999999999998877767666655444443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.69 E-value=2.3e-17 Score=173.03 Aligned_cols=96 Identities=18% Similarity=0.176 Sum_probs=86.9
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++.+.||+|+||+||+|+++.+|+.||+|++++.. ...+.+.+|+++|++++|||||++++++.+.+.+
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 466779999999999999999999999999999999998643 3456789999999999999999999999999999
Q ss_pred EEEEeccCCccccccccccC
Q psy11874 728 CLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~ 747 (767)
|||||||++|+|.++|.+..
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~ 108 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECN 108 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSC
T ss_pred EEEeecccCcchHHHhhhcc
Confidence 99999999999999986543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=1.1e-16 Score=168.39 Aligned_cols=110 Identities=19% Similarity=0.293 Sum_probs=85.6
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
+++|++++.||+|+||+||+|+++.+|+.||+|++++.. ......+.+.+|++||++++|||||+++++|++.+.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 479999999999999999999999999999999997654 3344567899999999999999999999999999999999
Q ss_pred EeccCCccccccccc-cCCCChhhhHHHHHHh
Q psy11874 731 LTIIDVMFTCVQPSE-TNPCCFPFRRKEVVVV 761 (767)
Q Consensus 731 mEy~~gG~L~~~l~~-~~~~~~~~~~~~v~~~ 761 (767)
||||.||.+...... .+...+...+..+.++
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qi 111 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 111 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHH
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHH
Confidence 999987654333222 3344555555544433
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=1.3e-16 Score=170.90 Aligned_cols=104 Identities=16% Similarity=0.155 Sum_probs=85.1
Q ss_pred CCCCCceeee-ecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEe---
Q psy11874 649 ITYKTFRMYR-VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYET--- 723 (767)
Q Consensus 649 ~~~~~y~~~~-~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~--- 723 (767)
..+++|+++. +||+|+||+||+|+++.||+.||||++++. ..+.+|+.++.++ +|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 4468999875 699999999999999999999999999753 2577899997655 89999999999987
Q ss_pred -CCEEEEEEeccCCccccccccccC--CCChhhhHHHHHH
Q psy11874 724 -KDALCLVLTIIDVMFTCVQPSETN--PCCFPFRRKEVVV 760 (767)
Q Consensus 724 -~~~lylVmEy~~gG~L~~~l~~~~--~~~~~~~~~~v~~ 760 (767)
.+.+|||||||+||+|+++|.+++ .+++...+..+.+
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~q 119 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 119 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHH
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHH
Confidence 467999999999999999997654 3444444444433
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.64 E-value=1.4e-16 Score=167.94 Aligned_cols=111 Identities=18% Similarity=0.227 Sum_probs=89.5
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCc---EEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~---~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
.+..++|++.+.||+|+||+||+|+++.+|+ .+|+|.+.... .....+.+.+|+.+|++++|||||++++++.+.
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4556789999999999999999999988775 58889887643 445667899999999999999999999999999
Q ss_pred CEEEEEEeccCCccccccccccC-CCChhhhHHHHHH
Q psy11874 725 DALCLVLTIIDVMFTCVQPSETN-PCCFPFRRKEVVV 760 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~~-~~~~~~~~~~v~~ 760 (767)
+.+|+|||||+||+|.+++.... ...+......+..
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~q 136 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHH
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHH
Confidence 99999999999999999887643 3444444443333
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=4.3e-16 Score=162.58 Aligned_cols=111 Identities=17% Similarity=0.201 Sum_probs=97.2
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
+++|++++.||+|+||+||+|+++.+|+.||+|++++.. ......+.+.+|+.+|+.++|||||+++++|.+.+.+++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 468999999999999999999999999999999998765 3556678899999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
||++.||+|..++...+...+...+..+.+++
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~ 111 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL 111 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHH
T ss_pred eeeccccccccccccccccchhHHHHHHHHHH
Confidence 99999999999887777766666555444443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=1.6e-16 Score=167.06 Aligned_cols=107 Identities=17% Similarity=0.249 Sum_probs=84.6
Q ss_pred eeeeecccCCccceeEEEEccCCcEEEEEEeecccccch--hhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEe
Q psy11874 655 RMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLT 732 (767)
Q Consensus 655 ~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~--~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmE 732 (767)
+.++.||+|+||+||+|+++.+|+.||||+|++...... ...+.+.+|+.+|++++|||||+++++|.+.+++|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 457899999999999999999999999999987653222 224578999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 733 IIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 733 y~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
||.||++...+...+.+.+......+.++
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 109 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMT 109 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHH
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHH
Confidence 99999988777666666666655544433
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.61 E-value=3.6e-16 Score=163.24 Aligned_cols=110 Identities=19% Similarity=0.224 Sum_probs=95.3
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylV 730 (767)
+++|++++.||+|+||+||+|+++ +|+.||||++++.. ......+.+.+|+.||++++|||||+++++|.+.+.+|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSS-GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 468999999999999999999986 78999999998765 3445567899999999999999999999999999999999
Q ss_pred EeccCCccccccccccCCCChhhhHHHHHHhh
Q psy11874 731 LTIIDVMFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
|||+.||.+..+.+..+.+.+......+.+++
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 110 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL 110 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHH
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHH
Confidence 99999998888877777777777776665543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=5.2e-16 Score=160.35 Aligned_cols=106 Identities=14% Similarity=0.123 Sum_probs=86.8
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
..++|++++.||+|+||.||+|+++ +++.||+|++++... ..+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 3568999999999999999999876 567899999986532 23578999999999999999999999999999999
Q ss_pred EEeccCCccccccccccC-CCChhhhHHHHHH
Q psy11874 730 VLTIIDVMFTCVQPSETN-PCCFPFRRKEVVV 760 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~~-~~~~~~~~~~v~~ 760 (767)
|||||++|+|.+++...+ ...+......+..
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~q 109 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHH
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHH
Confidence 999999999999886553 3334433333333
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=4.3e-16 Score=160.67 Aligned_cols=102 Identities=15% Similarity=0.119 Sum_probs=85.6
Q ss_pred CCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEE
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lyl 729 (767)
..++|++++.||+|+||+||+++++ +++.||+|++++... ..+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 3468999999999999999999985 778999999987543 23578999999999999999999999999999999
Q ss_pred EEeccCCcccccccccc-CCCChhhhHH
Q psy11874 730 VLTIIDVMFTCVQPSET-NPCCFPFRRK 756 (767)
Q Consensus 730 VmEy~~gG~L~~~l~~~-~~~~~~~~~~ 756 (767)
|||||++|+|.+++... ....+.....
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~ 104 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLE 104 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHH
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHH
Confidence 99999999999986544 3334444333
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=5.8e-16 Score=163.80 Aligned_cols=96 Identities=18% Similarity=0.264 Sum_probs=81.1
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcE--EEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeCC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKM--YACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETKD 725 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~--~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~~ 725 (767)
+..++|++.+.||+|+||+||+|+++.+|.. +|+|.+++. ......+.+.+|+++|+++ +|||||++++++.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5678999999999999999999999999875 566766543 3445567899999999998 7999999999999999
Q ss_pred EEEEEEeccCCcccccccccc
Q psy11874 726 ALCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~ 746 (767)
.+|+|||||+||+|.++|++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~ 105 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKS 105 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTT
T ss_pred eeEEEEEecCCCcHHHHHhhc
Confidence 999999999999999998654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=1.3e-15 Score=159.41 Aligned_cols=111 Identities=18% Similarity=0.190 Sum_probs=86.7
Q ss_pred CCCCCceeeee-cccCCccceeEEEEccC--CcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC
Q psy11874 649 ITYKTFRMYRV-LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 725 (767)
Q Consensus 649 ~~~~~y~~~~~-LG~GsfG~V~l~~~k~t--g~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~ 725 (767)
+..++|.+... ||+|+||+||+|.++.+ +..||||++++. ......+.+.+|+++|++++|||||++++++++ +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 34467888885 99999999999987654 458999999865 345567789999999999999999999999875 4
Q ss_pred EEEEEEeccCCcccccccccc-CCCChhhhHHHHHHhh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSET-NPCCFPFRRKEVVVVA 762 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~-~~~~~~~~~~~v~~~a 762 (767)
.+|||||||+||+|.+++... +...+......+..+|
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~ 119 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHH
Confidence 589999999999999987554 3455555554444443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=3.5e-16 Score=166.64 Aligned_cols=113 Identities=30% Similarity=0.410 Sum_probs=96.0
Q ss_pred CCCCCCceeeeecccCCccceeEEEE---ccCCcEEEEEEeeccccc-chhhHHHHHHHHHHHhhCCC-CceeeeeEEEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQV---RATGKMYACKKLEKKRIK-KRKGESMVLIEKQILQKINS-RFVVSLAYAYE 722 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~---k~tg~~~AvK~i~k~~~~-~~~~~~~~~~Ei~IL~~l~H-pnIV~l~~~f~ 722 (767)
++++++|++++.||+|+||+||+|++ +.+|+.||+|++++.... +....+.+.+|+.+|++++| |||++++++|.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 46789999999999999999999998 457999999999876543 23445678999999999966 89999999999
Q ss_pred eCCEEEEEEeccCCccccccccccCCCChhhhHHHHHH
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVV 760 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~ 760 (767)
+...+|+|||||.||+|.+++...+...+......+.+
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Q 137 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHH
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHH
Confidence 99999999999999999999988777666666555543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=4.9e-16 Score=161.42 Aligned_cols=111 Identities=23% Similarity=0.223 Sum_probs=92.7
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchh---hHHHHHHHHHHHhhCC--CCceeeeeEEEEeCCE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GESMVLIEKQILQKIN--SRFVVSLAYAYETKDA 726 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~---~~~~~~~Ei~IL~~l~--HpnIV~l~~~f~~~~~ 726 (767)
++|++.+.||+|+||+||+|+++.||+.||+|++++..+.... ....+.+|+.+|++++ |||||+++++|++.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4799999999999999999999999999999999986543322 2234678999999996 9999999999999999
Q ss_pred EEEEEeccCC-ccccccccccCCCChhhhHHHHHHhh
Q psy11874 727 LCLVLTIIDV-MFTCVQPSETNPCCFPFRRKEVVVVA 762 (767)
Q Consensus 727 lylVmEy~~g-G~L~~~l~~~~~~~~~~~~~~v~~~a 762 (767)
+|+||||+.| |++.+++++.+...+...+..+.+++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~ 120 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHH
Confidence 9999999986 67888888777777776666554443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.1e-15 Score=159.08 Aligned_cols=102 Identities=19% Similarity=0.188 Sum_probs=81.0
Q ss_pred eecccCCccceeEEEEc--cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEEEEEeccC
Q psy11874 658 RVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALCLVLTIID 735 (767)
Q Consensus 658 ~~LG~GsfG~V~l~~~k--~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~lylVmEy~~ 735 (767)
+.||+|+||+||+|.++ .+++.||+|+++... .+....+.+.+|+++|++++|||||+++++++++ .+|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 57999999999999865 456789999997654 3445667899999999999999999999999754 5799999999
Q ss_pred CccccccccccCCCChhhhHHHHHHh
Q psy11874 736 VMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 736 gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
||+|.+++.+.+...+......+..+
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi 116 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQV 116 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHH
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHH
Confidence 99999999877766665555444443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.1e-15 Score=162.70 Aligned_cols=96 Identities=18% Similarity=0.223 Sum_probs=81.5
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCc-----EEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYE 722 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~-----~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~ 722 (767)
+..++|++++.||+|+||+||+|+++.+++ .||+|++.+.. .......+.+|+.+|.++ +|||||++++++.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 455789999999999999999999987654 69999987653 344567889999999998 8999999999999
Q ss_pred eCCEEEEEEeccCCcccccccccc
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~ 746 (767)
+.+.+|||||||+||+|.++|+..
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~ 135 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSK 135 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTT
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhc
Confidence 999999999999999999999654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=9.1e-16 Score=158.57 Aligned_cols=92 Identities=20% Similarity=0.282 Sum_probs=78.4
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEE-eCCEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYE-TKDAL 727 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~-~~~~l 727 (767)
+.+++|++++.||+|+||.||+|+++ |+.||+|++++.. ..+.+.+|+.+|++++|||||++++++. +.+.+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 56789999999999999999999884 7789999997642 3467899999999999999999999885 45679
Q ss_pred EEEEeccCCccccccccccC
Q psy11874 728 CLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~ 747 (767)
|||||||++|+|.++|.+.+
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~ 96 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRG 96 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHH
T ss_pred EEEEeccCCCCHHHHHHhcC
Confidence 99999999999999996543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.6e-15 Score=157.86 Aligned_cols=107 Identities=14% Similarity=0.004 Sum_probs=85.6
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++.+.||+|+||+||+|+.+ ..||||+++... ......+.+.+|+.+|++++|||||+++++. +.+.+|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSS-CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-eccEEE
Confidence 45678999999999999999999754 359999998765 3455678899999999999999999999865 566799
Q ss_pred EEEeccCCccccccccccC-CCChhhhHHHHHH
Q psy11874 729 LVLTIIDVMFTCVQPSETN-PCCFPFRRKEVVV 760 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~-~~~~~~~~~~v~~ 760 (767)
||||||+||+|.++|...+ ...+......+.+
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~q 112 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHH
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHH
Confidence 9999999999999996543 3444444443333
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=2.5e-15 Score=155.98 Aligned_cols=93 Identities=16% Similarity=0.234 Sum_probs=79.3
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDALC 728 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~ly 728 (767)
+..++|++++.||+|+||.||+|+++ +++.||||++++.. ...+.+.+|+.+|++++|||||++++++. .+.+|
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~ 83 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeE
Confidence 44578999999999999999999976 57889999998643 23457899999999999999999999774 56689
Q ss_pred EEEeccCCccccccccccC
Q psy11874 729 LVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~ 747 (767)
||||||++|+|.+++....
T Consensus 84 iv~Ey~~~g~L~~~~~~~~ 102 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPS 102 (272)
T ss_dssp EEEECCTTCBHHHHTTSHH
T ss_pred EEEEeCCCCcHHHHHhhcC
Confidence 9999999999999875543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=4.8e-15 Score=159.60 Aligned_cols=104 Identities=17% Similarity=0.218 Sum_probs=82.9
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe------CC
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------KD 725 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~------~~ 725 (767)
++|++++.||+|+||+||+|+++.||+.||||++++.. .+......+.+|+.||++++|||||+++++|.+ .+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 57999999999999999999999999999999998765 345666789999999999999999999999964 47
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVV 759 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~ 759 (767)
.+|+|||||.||.+ +.+. +.+.+...+..+.
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~--~~~~~~~i~~~~~ 126 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ--MELDHERMSYLLY 126 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT--SCCCHHHHHHHHH
T ss_pred eeEEEEeccchHHH-Hhhh--cCCCHHHHHHHHH
Confidence 89999999987655 4442 2344444444333
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=3.6e-15 Score=159.90 Aligned_cols=107 Identities=18% Similarity=0.185 Sum_probs=83.0
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC------
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD------ 725 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~------ 725 (767)
+.|++++.||+|+||+||+|+++.||+.||||++++.. .+....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 57999999999999999999999999999999998764 45566788999999999999999999999998765
Q ss_pred EEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
.+||||||| |++|...+ +.+.+.+...+..+.++
T Consensus 97 ~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi 130 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQM 130 (346)
T ss_dssp CCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHH
T ss_pred eEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHH
Confidence 579999999 56666655 44566666665554443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=7.2e-15 Score=153.26 Aligned_cols=104 Identities=16% Similarity=0.136 Sum_probs=85.8
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCC----cEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg----~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
+..+.|++.++||+|+||.||+|.++.++ ..||||+++... .......+.+|+++|++++|||||++++++.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 45678999999999999999999988765 479999997653 345566789999999999999999999999999
Q ss_pred CEEEEEEeccCCcccccccccc-CCCChhhh
Q psy11874 725 DALCLVLTIIDVMFTCVQPSET-NPCCFPFR 754 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~-~~~~~~~~ 754 (767)
+.+|+|||||.+|+|.+.+... +.......
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 112 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQL 112 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHH
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHH
Confidence 9999999999999999887654 33344333
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=6.3e-15 Score=155.81 Aligned_cols=97 Identities=15% Similarity=0.127 Sum_probs=85.3
Q ss_pred CCCCCceeeeecccCCccceeEEEEc-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYE 722 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k-----~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~ 722 (767)
+..++|++.+.||+|+||.||+|+++ .+++.||+|++++.. .......+.+|+.+++.+ +|||||++++++.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 55679999999999999999999874 466899999998753 445667899999999999 7999999999999
Q ss_pred eCCEEEEEEeccCCccccccccccC
Q psy11874 723 TKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 723 ~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+.+|||||||+||+|.++|++..
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~ 122 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKR 122 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTT
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhcc
Confidence 9999999999999999999987543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=4.2e-15 Score=159.23 Aligned_cols=108 Identities=16% Similarity=0.122 Sum_probs=88.8
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC-----CE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK-----DA 726 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~-----~~ 726 (767)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .+....+.+.+|++||+.++|||||+++++|... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57999999999999999999999999999999998764 3445667889999999999999999999999743 33
Q ss_pred EEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 727 LCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 727 lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
.+++|+|+.||+|.+++.. +.+.+...+..+.++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qi 130 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 130 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHH
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHH
Confidence 4677788889999999854 455666665544443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=6e-15 Score=156.08 Aligned_cols=110 Identities=23% Similarity=0.264 Sum_probs=87.3
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe-------
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET------- 723 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~------- 723 (767)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++.+
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC-----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 579999999999999999999999999999999998765 334556788999999999999999999999865
Q ss_pred -CCEEEEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 724 -KDALCLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 724 -~~~lylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
.+.+|+|||||.+|.+...........+...+..+.++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 126 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHH
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHH
Confidence 34689999999988887666555565666555544433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.53 E-value=5.5e-15 Score=157.13 Aligned_cols=102 Identities=16% Similarity=0.132 Sum_probs=84.5
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEEeC--CEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYETK--DAL 727 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~~~--~~l 727 (767)
.++|++++.||+|+||+||+|+++.+|+.||+|++++.. .+.+.+|+.+|+.+ .|||||+++++|.+. ..+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 468999999999999999999999999999999997642 35788999999999 599999999999854 569
Q ss_pred EEEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 728 CLVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
|+|||||++|+|....+ .+.+...+..+.++
T Consensus 108 ~~v~e~~~~~~L~~~~~---~l~e~~i~~i~~qi 138 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEI 138 (328)
T ss_dssp EEEEECCCSCBGGGTTT---SCCHHHHHHHHHHH
T ss_pred eEEEeecCCCcHHHHhc---CCCHHHHHHHHHHH
Confidence 99999999999987753 34455555444433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=5.7e-15 Score=153.40 Aligned_cols=112 Identities=19% Similarity=0.174 Sum_probs=79.9
Q ss_pred CCCCCceeeeecccCCccceeEEEEccC-C--cEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRAT-G--KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 725 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~t-g--~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~ 725 (767)
+..+||++++.||+|+||.||+|++..+ + ..||+|++++.........+.+.+|+.+|+.++|||||++|+++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 3456899999999999999999987543 3 3689999988766566667889999999999999999999999976 4
Q ss_pred EEEEEEeccCCcccccccccc-CCCChhhhHHHHHHh
Q psy11874 726 ALCLVLTIIDVMFTCVQPSET-NPCCFPFRRKEVVVV 761 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~-~~~~~~~~~~~v~~~ 761 (767)
.+|+|||||++|+|.+++... +.+.+......+..+
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi 120 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHH
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHH
Confidence 689999999999999887554 345555554444433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=8.1e-15 Score=151.96 Aligned_cols=107 Identities=12% Similarity=0.099 Sum_probs=85.2
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCC---cEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD 725 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg---~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~ 725 (767)
+..++|++.+.||+|+||+||+|+++.++ ..+|+|+++.. ......+.+.+|+.+|++++|||||++++++. .+
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 34568999999999999999999987654 56888988654 34556678999999999999999999999995 56
Q ss_pred EEEEEEeccCCccccccccccC-CCChhhhHHHH
Q psy11874 726 ALCLVLTIIDVMFTCVQPSETN-PCCFPFRRKEV 758 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l~~~~-~~~~~~~~~~v 758 (767)
.+|||||||++|+|.+++.... ...+......+
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~ 114 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHH
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHH
Confidence 7999999999999999875443 34444444433
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.1e-14 Score=152.93 Aligned_cols=97 Identities=16% Similarity=0.210 Sum_probs=79.5
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCC-------cEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYA 720 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg-------~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~ 720 (767)
+..++|++++.||+|+||.||+|++..++ ..||+|++++.. .......+.+|..++.++ +|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 55679999999999999999999987664 479999998753 445567889999999888 89999999999
Q ss_pred EEeCCEEEEEEeccCCccccccccccC
Q psy11874 721 YETKDALCLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 721 f~~~~~lylVmEy~~gG~L~~~l~~~~ 747 (767)
+.+++.+|+|||||++|+|.++|..++
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~ 114 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARR 114 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTS
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhc
Confidence 999999999999999999999997554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.3e-14 Score=151.68 Aligned_cols=105 Identities=20% Similarity=0.193 Sum_probs=84.5
Q ss_pred CCCCCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCCEE
Q psy11874 648 PITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKDAL 727 (767)
Q Consensus 648 ~~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~~l 727 (767)
.+..++|++.+.||+|+||+||+|+++.+ +.||||+++.... ..+.+.+|+.+|++++|||||++|+++.+ +.+
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence 35678999999999999999999998766 5699999986542 23578999999999999999999999854 568
Q ss_pred EEEEeccCCcccccccccc--CCCChhhhHHHH
Q psy11874 728 CLVLTIIDVMFTCVQPSET--NPCCFPFRRKEV 758 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~--~~~~~~~~~~~v 758 (767)
|+|||||++|+|..++... +.+.+......+
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~ 119 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 119 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHH
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHH
Confidence 9999999999999887653 233444443333
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=1.4e-14 Score=152.33 Aligned_cols=95 Identities=16% Similarity=0.203 Sum_probs=84.4
Q ss_pred CCCCceeeeecccCCccceeEEEEcc-----CCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 650 TYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 650 ~~~~y~~~~~LG~GsfG~V~l~~~k~-----tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
..++|++++.||+|+||+||+|+.+. +++.||||++++.. .....+.+.+|+.+|++++|||||++++++.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 35689999999999999999999864 56889999998653 445567899999999999999999999999999
Q ss_pred CEEEEEEeccCCcccccccccc
Q psy11874 725 DALCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~ 746 (767)
+.+++|||||++|+|.++|...
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~ 110 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSM 110 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT
T ss_pred CceEEEEEecCCCcHHHHHHhc
Confidence 9999999999999999998654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.6e-14 Score=154.91 Aligned_cols=106 Identities=12% Similarity=0.074 Sum_probs=82.3
Q ss_pred CceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC----EEE
Q psy11874 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----ALC 728 (767)
Q Consensus 653 ~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~----~ly 728 (767)
.|++++.||+|+||+||+|+++.||+.||||+|++.. .....+.+++|+.||+.++|||||++++++.... ..+
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 5999999999999999999999999999999998753 4556678999999999999999999999997653 234
Q ss_pred EEEeccCCccccccccccCCCChhhhHHHHHHh
Q psy11874 729 LVLTIIDVMFTCVQPSETNPCCFPFRRKEVVVV 761 (767)
Q Consensus 729 lVmEy~~gG~L~~~l~~~~~~~~~~~~~~v~~~ 761 (767)
++|+|+.||+|++++... .+.+...+..+.++
T Consensus 87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qi 118 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQI 118 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHH
T ss_pred EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHH
Confidence 445566799999999654 45555555544443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=3.2e-14 Score=150.74 Aligned_cols=109 Identities=19% Similarity=0.203 Sum_probs=82.2
Q ss_pred CCCCCceeeeecccCCccceeEEEEccCCc----EEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK 724 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~tg~----~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~ 724 (767)
+..+||++++.||+|+||+||+|+++.+|+ .||+|.++.. ......+.+.+|+.+|++++|||||++++++.+.
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345689999999999999999999998886 4777777653 2344567899999999999999999999999865
Q ss_pred CEEEEEEeccCCccccccccccC-CCChhhhHHHHHH
Q psy11874 725 DALCLVLTIIDVMFTCVQPSETN-PCCFPFRRKEVVV 760 (767)
Q Consensus 725 ~~lylVmEy~~gG~L~~~l~~~~-~~~~~~~~~~v~~ 760 (767)
..+++|||+.+|+|.+.+...+ ...+......+..
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~q 119 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 119 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHH
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHH
Confidence 5789999999999999886543 3444444433333
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=2e-14 Score=154.34 Aligned_cols=102 Identities=22% Similarity=0.287 Sum_probs=78.8
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeC------C
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETK------D 725 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~------~ 725 (767)
-+|+.+++||+|+||+||+|+++.+|+.||||++.+... ...+|+.||++++|||||+++++|.+. .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 379999999999999999999999999999999987542 234799999999999999999999643 4
Q ss_pred EEEEEEeccCCccccccc---cccCCCChhhhHHHHHH
Q psy11874 726 ALCLVLTIIDVMFTCVQP---SETNPCCFPFRRKEVVV 760 (767)
Q Consensus 726 ~lylVmEy~~gG~L~~~l---~~~~~~~~~~~~~~v~~ 760 (767)
++|||||||++|.+.... .....+.+...+..+.+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~q 130 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHH
Confidence 689999999877443332 23334455444444433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.3e-14 Score=153.15 Aligned_cols=96 Identities=17% Similarity=0.199 Sum_probs=84.2
Q ss_pred CCCCCceeeeecccCCccceeEEEEcc-----CCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET 723 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~-----tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~ 723 (767)
+..++|++++.||+|+||.||+|.++. +++.||||++++.. .......+.+|+.+|++++|||||++++++..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 455799999999999999999999864 35789999998653 44556678999999999999999999999999
Q ss_pred CCEEEEEEeccCCcccccccccc
Q psy11874 724 KDALCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 724 ~~~lylVmEy~~gG~L~~~l~~~ 746 (767)
.+.+|+|||||++|+|.+++...
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~ 117 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSL 117 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHH
T ss_pred CCceeEEEeecCCCCHHHHHHhc
Confidence 99999999999999999988643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=6.2e-14 Score=147.12 Aligned_cols=107 Identities=16% Similarity=0.199 Sum_probs=80.6
Q ss_pred CCceeeeecccCCccceeEEEEccC-CcEEEEEEeecccccchhhHHHHHHHHHHHhhC---CCCceeeeeEEEEe----
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKKRKGESMVLIEKQILQKI---NSRFVVSLAYAYET---- 723 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~t-g~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l---~HpnIV~l~~~f~~---- 723 (767)
++|++++.||+|+||+||+|+++.+ ++.||+|++++.. ........+.+|+.+|+.+ +|||||+++++|.+
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEB-CTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhh-ccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 5899999999999999999999766 6789999998754 2333444677888888776 79999999999964
Q ss_pred -CCEEEEEEeccCCcccccccc-ccCCCChhhhHHHHH
Q psy11874 724 -KDALCLVLTIIDVMFTCVQPS-ETNPCCFPFRRKEVV 759 (767)
Q Consensus 724 -~~~lylVmEy~~gG~L~~~l~-~~~~~~~~~~~~~v~ 759 (767)
...+|++||||+||.+..... ......+...+..+.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 123 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHH
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHH
Confidence 357999999999987754432 223444444444333
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=2.6e-13 Score=143.36 Aligned_cols=91 Identities=20% Similarity=0.136 Sum_probs=76.4
Q ss_pred eeeecccCCccceeEEEEccCC---cEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEe-CCEEEEEE
Q psy11874 656 MYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYET-KDALCLVL 731 (767)
Q Consensus 656 ~~~~LG~GsfG~V~l~~~k~tg---~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~-~~~lylVm 731 (767)
+.++||+|+||+||+|++..++ ..||||++++. .+....+.+.+|+++|++++|||||++++++.+ +..+|+||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3678999999999999987654 36999999764 356677889999999999999999999998765 56899999
Q ss_pred eccCCccccccccccCC
Q psy11874 732 TIIDVMFTCVQPSETNP 748 (767)
Q Consensus 732 Ey~~gG~L~~~l~~~~~ 748 (767)
|||++|+|.+++.....
T Consensus 109 E~~~~g~l~~~~~~~~~ 125 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETH 125 (311)
T ss_dssp ECCTTCBHHHHHHCTTC
T ss_pred EEeecCchhhhhccccc
Confidence 99999999998865543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=2.1e-13 Score=143.41 Aligned_cols=90 Identities=18% Similarity=0.140 Sum_probs=72.3
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCceeeeeEEEEeCC----EE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRFVVSLAYAYETKD----AL 727 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~HpnIV~l~~~f~~~~----~l 727 (767)
.+|.+.+.||+|+||.||+|++ +|+.||+|+++... .......+|+..+..++|||||++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4789999999999999999985 68999999997532 11222334555556789999999999998754 69
Q ss_pred EEEEeccCCccccccccccC
Q psy11874 728 CLVLTIIDVMFTCVQPSETN 747 (767)
Q Consensus 728 ylVmEy~~gG~L~~~l~~~~ 747 (767)
|||||||++|+|.++|++.+
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~~ 96 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRYT 96 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCC
T ss_pred EEEEecccCCCHHHHHhcCC
Confidence 99999999999999997653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=2.9e-13 Score=141.74 Aligned_cols=96 Identities=20% Similarity=0.243 Sum_probs=77.4
Q ss_pred CCCCCceeeeecccCCccceeEEEEcc-----CCcEEEEEEeecccccchhhHHHHHHHHHHHhhC-CCCceeeeeEEEE
Q psy11874 649 ITYKTFRMYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKI-NSRFVVSLAYAYE 722 (767)
Q Consensus 649 ~~~~~y~~~~~LG~GsfG~V~l~~~k~-----tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l-~HpnIV~l~~~f~ 722 (767)
+..++|++++.||+|+||+||+|+++. +++.||+|+++... .....+.+.+|..++.++ +|||||.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 445789999999999999999999765 45789999998653 345566788888888777 7999999999876
Q ss_pred eC-CEEEEEEeccCCcccccccccc
Q psy11874 723 TK-DALCLVLTIIDVMFTCVQPSET 746 (767)
Q Consensus 723 ~~-~~lylVmEy~~gG~L~~~l~~~ 746 (767)
+. +.+|+|||||+||+|.++|...
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~ 112 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSK 112 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHT
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhc
Confidence 54 4699999999999999998654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.36 E-value=6.1e-13 Score=139.11 Aligned_cols=102 Identities=11% Similarity=0.030 Sum_probs=84.0
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCC-CceeeeeEEEEeCCEEEEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-RFVVSLAYAYETKDALCLV 730 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~H-pnIV~l~~~f~~~~~lylV 730 (767)
+.|++++.||+|+||+||+|+++.+|+.||||++++.. ....+.+|+++++.+.| |||+.+++++.+....|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 57999999999999999999999999999999987643 12357789999999965 8999999999999999999
Q ss_pred EeccCCccccccccccC-CCChhhhHHHHH
Q psy11874 731 LTIIDVMFTCVQPSETN-PCCFPFRRKEVV 759 (767)
Q Consensus 731 mEy~~gG~L~~~l~~~~-~~~~~~~~~~v~ 759 (767)
|||| ||+|.+.++..+ .+........+.
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~ 108 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAK 108 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHH
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHH
Confidence 9999 689998886654 344444444333
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.28 E-value=4.9e-12 Score=132.12 Aligned_cols=100 Identities=16% Similarity=0.155 Sum_probs=77.1
Q ss_pred CceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCCCCc-eeeeeEEEEeCCEEEEEE
Q psy11874 653 TFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSRF-VVSLAYAYETKDALCLVL 731 (767)
Q Consensus 653 ~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~Hpn-IV~l~~~f~~~~~lylVm 731 (767)
.|++++.||+|+||+||+|+++.+|+.||||++..... .+.+.+|+++|+.++|+| |+.+++++.+.+..|+||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 59999999999999999999999999999999886431 235788999999997665 566677778899999999
Q ss_pred eccCCccccccccc-cCCCChhhhHHHH
Q psy11874 732 TIIDVMFTCVQPSE-TNPCCFPFRRKEV 758 (767)
Q Consensus 732 Ey~~gG~L~~~l~~-~~~~~~~~~~~~v 758 (767)
|||. |+|.+.+.. .+.+.+......+
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~ 109 (299)
T d1ckia_ 83 ELLG-PSLEDLFNFCSRKFSLKTVLLLA 109 (299)
T ss_dssp ECCC-CBHHHHHHHTTTCCCHHHHHHHH
T ss_pred EEcC-CchhhhhhhccCCCcHHHHHHHH
Confidence 9995 455555433 3444544444433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.95 E-value=6.5e-10 Score=118.45 Aligned_cols=105 Identities=14% Similarity=0.147 Sum_probs=78.2
Q ss_pred CCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC-----------CCceeeeeEE
Q psy11874 652 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-----------SRFVVSLAYA 720 (767)
Q Consensus 652 ~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~-----------HpnIV~l~~~ 720 (767)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+...+|+.+|+.++ |||||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 35999999999999999999999999999999998643 33457788999998875 5789999988
Q ss_pred EEe--CCEEEEEEeccCCcccccccc---ccCCCChhhhHHHHHH
Q psy11874 721 YET--KDALCLVLTIIDVMFTCVQPS---ETNPCCFPFRRKEVVV 760 (767)
Q Consensus 721 f~~--~~~lylVmEy~~gG~L~~~l~---~~~~~~~~~~~~~v~~ 760 (767)
+.. ....+++|+++.+++...... ......+...+..+..
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~q 133 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHH
Confidence 764 467888888887665443322 2233444444444433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=98.54 E-value=6.6e-08 Score=93.38 Aligned_cols=83 Identities=14% Similarity=0.045 Sum_probs=61.9
Q ss_pred ceeeeecccCCccceeEEEEccCCcEEEEEEeeccccc---------------chhhHHHHHHHHHHHhhCCCCceeeee
Q psy11874 654 FRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK---------------KRKGESMVLIEKQILQKINSRFVVSLA 718 (767)
Q Consensus 654 y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~---------------~~~~~~~~~~Ei~IL~~l~HpnIV~l~ 718 (767)
+-+.+.||+|+||.||+|++. +|+.||+|+++..... .........+|..+|.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 357899999999999999874 6899999998643211 011123456799999999999999987
Q ss_pred EEEEeCCEEEEEEeccCCccccc
Q psy11874 719 YAYETKDALCLVLTIIDVMFTCV 741 (767)
Q Consensus 719 ~~f~~~~~lylVmEy~~gG~L~~ 741 (767)
++. .. +++|||++++.+..
T Consensus 81 ~~~--~~--~lvme~~~~~~~~~ 99 (191)
T d1zara2 81 AWE--GN--AVLMELIDAKELYR 99 (191)
T ss_dssp EEE--TT--EEEEECCCCEEGGG
T ss_pred Eec--CC--EEEEEeeccccccc
Confidence 653 22 79999999877644
|
| >d1omwa1 a.91.1.1 (A:29-185) G-protein coupled receptor kinase 2, N-terminal domain {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Regulator of G-protein signaling, RGS superfamily: Regulator of G-protein signaling, RGS family: Regulator of G-protein signaling, RGS domain: G-protein coupled receptor kinase 2, N-terminal domain species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.41 E-value=1.2e-08 Score=96.07 Aligned_cols=57 Identities=28% Similarity=0.425 Sum_probs=48.4
Q ss_pred HHHHHhhhc--ccccCCcchhhhhHHHHHhhhcCCCccccchhhhHHHHhhhhhcccce
Q psy11874 491 LEIIEHCKE--SLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYLQWKWLEHHF 547 (767)
Q Consensus 491 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (767)
..++.++++ ..+++++++|+.+-.+|.++|.+.+|..|+.|++|.|||||||+|.++
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~F~~aq~~V~~lL~~d~fprFl~S~~y~r~LQwK~le~~~ 156 (157)
T d1omwa1 98 KSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNI 156 (157)
T ss_dssp HHHHHHHHHHHTTTCCCTTTTHHHHHHHHHHHTTHHHHHHHTSHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHhccCCCHHHHHHHHHHHHHHHhcCchHHHhcCHHHHHHHhHHhhhccc
Confidence 344444443 346788999999999999999999999999999999999999999654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.10 E-value=6.3e-06 Score=82.40 Aligned_cols=140 Identities=13% Similarity=-0.012 Sum_probs=93.3
Q ss_pred CCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEeeCCeEEEE
Q psy11874 114 KTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCLV 192 (767)
Q Consensus 114 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lV 192 (767)
..|+..+..+.|+.+.||++. .+++.+.+|+...... .....+.+|..+|+.+. +--+.+++++..+.+..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 456666665556667999876 3567788888754422 22334677888888774 33366777888888999999
Q ss_pred EEeccCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHhHHHHHHHC------------------------------------
Q psy11874 193 LTIMNGGDLKFHIYNMGGEPGFDIARARFYAAEVLCGLEHLHYI------------------------------------ 236 (767)
Q Consensus 193 ~E~~~gG~L~~~l~~~~~~~~l~~~~~~~~~~qIl~aL~yLH~~------------------------------------ 236 (767)
|++++|..+...... ... ...++.++...|..||+.
T Consensus 89 ~~~l~G~~~~~~~~~-----~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 89 MSEADGVLCSEEYED-----EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHTTT-----CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEecccccccccccc-----ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999877543221 111 112334444444444421
Q ss_pred -----------------------CcccccCCcceEEeCCCCCEEEeecCcccc
Q psy11874 237 -----------------------GLVYRDCKPENILLDDYGHVRISDLGLAVE 266 (767)
Q Consensus 237 -----------------------~IvHrDLKPeNILld~~g~vkL~DFGla~~ 266 (767)
.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 268999999999999876677999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.57 E-value=8.7e-05 Score=79.20 Aligned_cols=81 Identities=12% Similarity=0.128 Sum_probs=50.4
Q ss_pred EeEEeecCcEEEEEEEEccCCcEEEEEEechh-hhhh---hhhHHHHHHHHHHHHhcC-C--CceeEEEEEEeeCCeEEE
Q psy11874 119 YRVLGKGGFGEVCACQVRATGKMYACKKLEKK-RIKK---RKGESMVLIEKQILQKIN-S--RFVVSLAYAYETKDALCL 191 (767)
Q Consensus 119 ~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~-~~~~---~~~~~~~~~E~~iL~~l~-h--p~Iv~l~~~~~~~~~l~l 191 (767)
.+.||.|....||++....+|+.+++|.-... +... .........|...|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 55789999999999998777889999974321 1111 112344567888887663 2 345566543 4445678
Q ss_pred EEEeccCCCH
Q psy11874 192 VLTIMNGGDL 201 (767)
Q Consensus 192 V~E~~~gG~L 201 (767)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.52 E-value=0.0001 Score=72.79 Aligned_cols=73 Identities=14% Similarity=-0.022 Sum_probs=50.2
Q ss_pred EeecC-cEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC--CceeEEEEEEeeCCeEEEEEEeccC
Q psy11874 122 LGKGG-FGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS--RFVVSLAYAYETKDALCLVLTIMNG 198 (767)
Q Consensus 122 LG~G~-fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~~l~lV~E~~~g 198 (767)
+..|. -+.||++... +|..+.+|.-.... ...+..|...|+.+.. -.+.+++.+..+.+..++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 34444 3689988763 56678888754332 2235667888877643 2366777778888899999999998
Q ss_pred CCH
Q psy11874 199 GDL 201 (767)
Q Consensus 199 G~L 201 (767)
-++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 665
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.17 E-value=0.0065 Score=64.04 Aligned_cols=79 Identities=11% Similarity=0.116 Sum_probs=52.5
Q ss_pred CCCeEEEeEEeecCcEEEEEEEEcc-------CCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcC-CCceeEEEEEEe
Q psy11874 113 YKTFRMYRVLGKGGFGEVCACQVRA-------TGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYE 184 (767)
Q Consensus 113 ~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~ 184 (767)
.+++++ +.|+.|-.-.+|++.... ..+.|.+++.... .......+|..+++.+. +....++++.+.
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~ 115 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFS 115 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhhHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence 345544 578889999999998753 2456777776422 12233557888888875 334457777665
Q ss_pred eCCeEEEEEEeccCCCH
Q psy11874 185 TKDALCLVLTIMNGGDL 201 (767)
Q Consensus 185 ~~~~l~lV~E~~~gG~L 201 (767)
+ .+||||++|..|
T Consensus 116 ~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 G----GRLEEYIPSRPL 128 (395)
T ss_dssp T----EEEECCCCEEEC
T ss_pred C----ceEEEEeccccC
Confidence 3 689999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.38 E-value=0.039 Score=55.48 Aligned_cols=148 Identities=10% Similarity=0.045 Sum_probs=79.3
Q ss_pred ccCCCeEEEeEEeecCcEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCC-----CceeEEE---EE
Q psy11874 111 ITYKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINS-----RFVVSLA---YA 182 (767)
Q Consensus 111 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-----p~Iv~l~---~~ 182 (767)
..++...-.+.|..|--.+.|+++.. +..|++|+..+.. ....+..|..+|..+.. |..+... ..
T Consensus 15 Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~ 87 (316)
T d2ppqa1 15 YDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELL 87 (316)
T ss_dssp BCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSC
T ss_pred CCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCCCcc
Confidence 34556666777778888999998864 3458999986532 12234456666666632 2222110 11
Q ss_pred EeeCCeEEEEEEeccCCCHH--------------HHHHhcCC------CCCCCH------------------HHHHHHHH
Q psy11874 183 YETKDALCLVLTIMNGGDLK--------------FHIYNMGG------EPGFDI------------------ARARFYAA 224 (767)
Q Consensus 183 ~~~~~~l~lV~E~~~gG~L~--------------~~l~~~~~------~~~l~~------------------~~~~~~~~ 224 (767)
...+.....++.++.|.... ..+..... ...... ......+.
T Consensus 88 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 167 (316)
T d2ppqa1 88 GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIR 167 (316)
T ss_dssp EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHH
T ss_pred eeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHH
Confidence 23345677777777764321 00110000 000000 11112223
Q ss_pred HHHhHHHHHH----HCCcccccCCcceEEeCCCCCEEEeecCccc
Q psy11874 225 EVLCGLEHLH----YIGLVYRDCKPENILLDDYGHVRISDLGLAV 265 (767)
Q Consensus 225 qIl~aL~yLH----~~~IvHrDLKPeNILld~~g~vkL~DFGla~ 265 (767)
.+...+.-.+ ..|+||+|+.+.||+++.++..-|.||+.|.
T Consensus 168 ~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 168 PEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 3333333333 2479999999999999988777899999874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.08 E-value=0.055 Score=54.95 Aligned_cols=69 Identities=14% Similarity=0.134 Sum_probs=44.5
Q ss_pred cEEEEEEEEccCCcEEEEEEechhhhhhhhhHHHHHHHHHHHHhcCCC-----ceeEE--EEEEeeCCeEEEEEEeccCC
Q psy11874 127 FGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKINSR-----FVVSL--AYAYETKDALCLVLTIMNGG 199 (767)
Q Consensus 127 fG~Vy~a~~~~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-----~Iv~l--~~~~~~~~~l~lV~E~~~gG 199 (767)
-..||+++. .+|..|++|+....+. ..+.+..|...|..|... ..+.. -..+......+.++++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 368999987 4688999999765432 334566788877776421 11111 12234567889999999874
Q ss_pred C
Q psy11874 200 D 200 (767)
Q Consensus 200 ~ 200 (767)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=92.95 E-value=0.15 Score=49.26 Aligned_cols=88 Identities=10% Similarity=-0.016 Sum_probs=63.9
Q ss_pred CCCceeeeecccCCccceeEEEEccCCcEEEEEEeecccccchhhHHHHHHHHHHHhhCC-CCceeeeeEEEEeCCEEEE
Q psy11874 651 YKTFRMYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMVLIEKQILQKIN-SRFVVSLAYAYETKDALCL 729 (767)
Q Consensus 651 ~~~y~~~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~~~~~~~~~~~~~~Ei~IL~~l~-HpnIV~l~~~f~~~~~lyl 729 (767)
+..|+..+..+.|+-+.||++. ..++.+.+|+..... ......+.+|..+|..+. +--+.+++....+++..|+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~---~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRY---KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGG---TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCc---ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 3467777777777778899875 455667788876542 223346788999887763 4446777788888899999
Q ss_pred EEeccCCccccccc
Q psy11874 730 VLTIIDVMFTCVQP 743 (767)
Q Consensus 730 VmEy~~gG~L~~~l 743 (767)
||++++|..+.+..
T Consensus 88 v~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 88 LMSEADGVLCSEEY 101 (263)
T ss_dssp EEECCSSEEHHHHT
T ss_pred EEEecccccccccc
Confidence 99999998876544
|
| >d1omwa1 a.91.1.1 (A:29-185) G-protein coupled receptor kinase 2, N-terminal domain {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Regulator of G-protein signaling, RGS superfamily: Regulator of G-protein signaling, RGS family: Regulator of G-protein signaling, RGS domain: G-protein coupled receptor kinase 2, N-terminal domain species: Cow (Bos taurus) [TaxId: 9913]
Probab=91.96 E-value=0.0074 Score=55.34 Aligned_cols=57 Identities=32% Similarity=0.617 Sum_probs=40.4
Q ss_pred ccceeeeeccCcchhHHHHHHHhhhcccccccccccccccchhh-cccccccCChHHHh
Q psy11874 48 YVRYSYIIDQQPIGRLLFRQFCAEAKPQYHKYNVFLDSIENYEL-EMDENRRLSTKDIY 105 (767)
Q Consensus 48 ~~~~~~~~~~~p~g~~lf~~f~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~~~~~~~~ 105 (767)
.+.|..|+ .||||+.+|++||....++......||..++.|.. ..++.+...+..++
T Consensus 24 ~~sf~~ll-~~~iG~~lFr~FL~~e~se~~~~l~Fw~a~e~yk~~~~~~~~~~~A~~Iy 81 (157)
T d1omwa1 24 EVTFEKIF-SQKLGYLLFRDFCLKHLEEAKPLVEFYEEIKKYEKLETEEERLVCSREIF 81 (157)
T ss_dssp CCSHHHHH-TSHHHHHHHHHHHHHHCTTTHHHHHHHHHHHHHHTCCSHHHHHHHHHHHH
T ss_pred cCCHHHHH-cCHHHHHHHHHHHHhhchhHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHH
Confidence 45788888 69999999999996656666667789999999974 33333333333443
|
| >d2jm5a1 a.91.1.1 (A:3-134) Regulator of G-protein signaling 18, RGS18 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Regulator of G-protein signaling, RGS superfamily: Regulator of G-protein signaling, RGS family: Regulator of G-protein signaling, RGS domain: Regulator of G-protein signaling 18, RGS18 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.32 E-value=0.032 Score=49.07 Aligned_cols=48 Identities=15% Similarity=0.258 Sum_probs=41.8
Q ss_pred HHHHhhhcccccCCcchhhhhHHHHHhhhcCCCccccchhhhHHHHhh
Q psy11874 492 EIIEHCKESLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYLQ 539 (767)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (767)
.+.+.+.+.+..+.+++|.++.+.|.+.|+...|..|..|+.|.+|||
T Consensus 82 ~~~~~i~~~~~~~~~~~F~~aq~~V~~~l~~~~yp~Fl~S~~y~~ll~ 129 (132)
T d2jm5a1 82 HTKEVITNSITQPTLHSFDAAQSRVYQLMEQDSYTRFLKSDIYLDLME 129 (132)
T ss_dssp HHHHHHHHHTTSCCTTTTHHHHHHHHHHHHHHHHHHHHTSHHHHHHHT
T ss_pred HHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhhhhccCHHHHHHHc
Confidence 344445555667899999999999999999999999999999999997
|
| >d1fqia_ a.91.1.1 (A:) RGS9, RGS domain {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Regulator of G-protein signaling, RGS superfamily: Regulator of G-protein signaling, RGS family: Regulator of G-protein signaling, RGS domain: RGS9, RGS domain species: Cow (Bos taurus) [TaxId: 9913]
Probab=87.19 E-value=0.11 Score=45.83 Aligned_cols=48 Identities=8% Similarity=0.249 Sum_probs=43.0
Q ss_pred HHHHhhhcccccCCcchhhhhHHHHHhhhcCCCccccchhhhHHHHhh
Q psy11874 492 EIIEHCKESLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYLQ 539 (767)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (767)
.+...+++.+.++.+++|+++.+.|...|....|..|..|+.|.++++
T Consensus 86 ~~r~~i~~~~~~~~~~~F~~aq~~V~~~l~~~~~~~Fl~S~~y~~~l~ 133 (138)
T d1fqia_ 86 KTMDITVKGLKHPHRYVLDAAQTHIYMLMKKDSYARYLKSPIYKEMLA 133 (138)
T ss_dssp HHHHHHHHHTTSCCTTTTHHHHHHHHHHHHHHTHHHHHTSHHHHHHHH
T ss_pred HHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhHHHhHhcCHHHHHHHH
Confidence 355566677788999999999999999999999999999999999986
|
| >d1cmza_ a.91.1.1 (A:) Galpha interacting protein, GaIP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Regulator of G-protein signaling, RGS superfamily: Regulator of G-protein signaling, RGS family: Regulator of G-protein signaling, RGS domain: Galpha interacting protein, GaIP species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.20 E-value=0.15 Score=44.21 Aligned_cols=47 Identities=15% Similarity=0.288 Sum_probs=39.9
Q ss_pred HHHHhhhcccccCCcchhhhhHHHHHhhhcCCCccccchhhhHHHHh
Q psy11874 492 EIIEHCKESLDSGNRELFNDCMAAVKTFLAGAPFTEFQDSMFFYRYL 538 (767)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (767)
.+.+.+.+.+..+.+.+|..+.+.|...|....|..|..|+.|.+++
T Consensus 82 ~~r~~i~~~~~~~~~~~F~~aq~~V~~~l~~~~~p~Fl~S~~y~~lL 128 (128)
T d1cmza_ 82 RVREGINKKMQEPSAHTFDDAQLQIYTLMHRDSYPRFLSSPTYRALL 128 (128)
T ss_dssp HHHHHHHHHSSSCCTTSTHHHHHHHHHHHHHHTHHHHTTCHHHHTTC
T ss_pred HHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhCcchhhccCHHHHHhC
Confidence 34444555667788999999999999999999999999999999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=81.33 E-value=0.79 Score=47.32 Aligned_cols=81 Identities=12% Similarity=0.126 Sum_probs=51.5
Q ss_pred eeecccCCccceeEEEEccCCcEEEEEEeecc-cccc---hhhHHHHHHHHHHHhhC-CC--CceeeeeEEEEeCCEEEE
Q psy11874 657 YRVLGKGGFGEVCACQVRATGKMYACKKLEKK-RIKK---RKGESMVLIEKQILQKI-NS--RFVVSLAYAYETKDALCL 729 (767)
Q Consensus 657 ~~~LG~GsfG~V~l~~~k~tg~~~AvK~i~k~-~~~~---~~~~~~~~~Ei~IL~~l-~H--pnIV~l~~~f~~~~~lyl 729 (767)
.+.||.|....||++....+|+.+.+|.-... ++.. .-...+..+|..+|+.+ .+ ..+.+++.+ +.+.-++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 46789999999999988778888999865421 1111 11234567788888766 22 356666643 4445579
Q ss_pred EEeccCCccc
Q psy11874 730 VLTIIDVMFT 739 (767)
Q Consensus 730 VmEy~~gG~L 739 (767)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987655
|